Citrus Sinensis ID: 004442
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 753 | 2.2.26 [Sep-21-2011] | |||||||
| P32361 | 1115 | Serine/threonine-protein | yes | no | 0.328 | 0.221 | 0.322 | 2e-42 | |
| Q55GJ2 | 984 | Probable serine/threonine | yes | no | 0.347 | 0.266 | 0.341 | 4e-39 | |
| Q09499 | 967 | Serine/threonine-protein | yes | no | 0.308 | 0.239 | 0.363 | 8e-38 | |
| O94537 | 1072 | Serine/threonine-protein | yes | no | 0.398 | 0.279 | 0.316 | 1e-37 | |
| Q9Z2E3 | 911 | Serine/threonine-protein | yes | no | 0.284 | 0.234 | 0.320 | 4e-35 | |
| Q76MJ5 | 926 | Serine/threonine-protein | yes | no | 0.324 | 0.263 | 0.329 | 7e-35 | |
| Q55DJ8 | 1444 | Probable serine/threonine | no | no | 0.333 | 0.173 | 0.336 | 7e-34 | |
| Q55DJ9 | 1505 | Probable serine/threonine | no | no | 0.339 | 0.170 | 0.343 | 8e-34 | |
| O75460 | 977 | Serine/threonine-protein | no | no | 0.284 | 0.219 | 0.307 | 2e-33 | |
| Q9EQY0 | 977 | Serine/threonine-protein | no | no | 0.284 | 0.219 | 0.303 | 3e-33 |
| >sp|P32361|IRE1_YEAST Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=IRE1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 174 bits (441), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 106/329 (32%), Positives = 164/329 (49%), Gaps = 82/329 (24%)
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 530
+ LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN++
Sbjct: 670 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 729
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R+Y E+ F+Y++LE C +L DL+ E N +++ L E P+
Sbjct: 730 RYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYN----PI-- 775
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK-- 648
+ R I SG++HLH + +IHRDLKPQN+L+S F A
Sbjct: 776 -------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 816
Query: 649 ---------LSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG------------ 686
+SD G+ K+L S N G+SGW+APE L +
Sbjct: 817 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQCQVETEHS 876
Query: 687 -------------------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--- 724
R TR+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++
Sbjct: 877 SSRHTVVSSDSFYDPFTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 936
Query: 725 ---DRKDLFLVEHIPEAVDLFTRLLDPNP 750
+ K L I EA DL ++++D +P
Sbjct: 937 SLDEMKCLHDRSLIAEATDLISQMIDHDP 965
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices HAC1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 3EC: .EC: 1EC: .EC: 2EC: 6EC: .EC: - |
| >sp|Q55GJ2|IREA_DICDI Probable serine/threonine-protein kinase ireA OS=Dictyostelium discoideum GN=ireA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 163 bits (413), Expect = 4e-39, Method: Compositional matrix adjust.
Identities = 100/293 (34%), Positives = 164/293 (55%), Gaps = 31/293 (10%)
Query: 470 RIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 528
+IGKL ++ NK + GS GT+V EG EGR VAVKR++ A +E+ LI SD+H N
Sbjct: 569 KIGKLEIITNKILGTGSCGTIVYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTN 628
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+VR+Y E D +F+YL++ C SL+ +YV + Q++ + S +
Sbjct: 629 VVRYYAKEEDDEFIYLAISFCQKSLD--MYV-QQTLSLQISPTDSPS------------I 673
Query: 589 MENTKDIELWKANGHPSAQLL------KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ + N + + Q++ ++ ++ GL HLH + ++HRD+KP NVLI D
Sbjct: 674 QSSNNNGNGNNGNNNNNNQIIIDNKTKQMILELFKGLEHLHSLNIVHRDIKPHNVLI--D 731
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 700
+ K+SDMG+ K L D LT + S GWQ P + L G R T+ +D+FSLGC+
Sbjct: 732 PNNRVKISDMGLGKLLDNDDQSLTFTS---DSHGWQ-PAEYLNGTNRNTKKVDIFSLGCV 787
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+++ +TG HP+G + R+ N++K + D+ ++H+P+ L ++ P+ R
Sbjct: 788 VYYLLTGA-HPFGHRYNREKNVLKGKFDIDQIKHLPDIHQLVHSMIQFEPEKR 839
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09499|IRE1_CAEEL Serine/threonine-protein kinase/endoribonuclease ire-1 OS=Caenorhabditis elegans GN=ire-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 8e-38, Method: Compositional matrix adjust.
Identities = 101/278 (36%), Positives = 145/278 (52%), Gaps = 46/278 (16%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540
+ G GTVV G ++GR VAVKR+V A +E L SD HP+++R++ +ESD
Sbjct: 524 LGTGCEGTVVYRGTFDGREVAVKRVVSEFVKFAHREADLLRESDTHPHVIRYFCMESDSQ 583
Query: 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
F YL+LE C SLND + EQ KE N V I L +M+ D
Sbjct: 584 FRYLALELCIASLNDYV--------EQ---KEVQQN----VTIALRDIMKQATD------ 622
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKR 657
GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR
Sbjct: 623 -----------------GLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKR 665
Query: 658 LQGDMSCLTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
+Q + +++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S
Sbjct: 666 VQPGKNSISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKS 725
Query: 716 FERDANIVKDRKDLFLVEHIPE---AVDLFTRLLDPNP 750
R ANIV L + + + A DL + +L+ P
Sbjct: 726 LHRQANIVNGEYTLNKLADLDDWSLADDLISSMLNVEP 763
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices xbp-1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Unfolded protein response (UPR) transcripional activation by ire-1, as well as translational attenuation by pek-1 in a complementary pathway, maintains ER homeostasis. Ire-1 and pek-1 are redundant genes that control a pathway essential for larval development and survival. Caenorhabditis elegans (taxid: 6239) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O94537|PPK4_SCHPO Serine/threonine-protein kinase ppk4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 158 bits (400), Expect = 1e-37, Method: Compositional matrix adjust.
Identities = 117/370 (31%), Positives = 181/370 (48%), Gaps = 70/370 (18%)
Query: 415 RPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKL 474
+ + +N T +NI+ + K TD L + K L +I + + L
Sbjct: 596 QASFEQNQTLDILSENIVEIQDK--STDPLQKSLDSSLKSHLPEATVIQNTDGSVTVNSL 653
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V+ + I GS+GT+V G YE R VAVKR++ +D+A +EI L SD HPNIVR+Y
Sbjct: 654 TVYPEVIGYGSHGTIVYRGVYEDREVAVKRVLMEFYDLASREITLLQQSDNHPNIVRYYC 713
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ F+Y+ +E C C+L+DLI E+ P+ +
Sbjct: 714 KQKSDQFLYIVIELCKCNLSDLI--------------EK-------------PIAYD--- 743
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-------FCA 647
+L+K S L+ + I G+SHLH + L+HRDLKPQN+L+ + S A
Sbjct: 744 -DLFK-----SIDLVSLLYQIAFGVSHLHSLDLVHRDLKPQNILLVVNNSPNLSKTRVRA 797
Query: 648 KLSDMGISKRLQGDMSCLTQNAT--GYGSSGWQAPEQL------------LQGRQTR--- 690
+SD G+SK+L + S L +N T GS GW++PE L ++ R+ R
Sbjct: 798 LISDFGLSKKLDFNQSSL-RNTTFEAAGSYGWRSPEILSGSLSQQSKEIQVKTREGRIRQ 856
Query: 691 ---AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFT 743
A D+F+LGCI ++ +TGG HP+G ++ + NI+K L ++ + E A DL
Sbjct: 857 ASHATDIFALGCIFYYTLTGGMHPFGSHYDCEGNILKGNYCLVHLQSLGECGVLAADLIE 916
Query: 744 RLLDPNPDLR 753
++ P R
Sbjct: 917 DMIAFEPSKR 926
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus GN=Ern2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 150 bits (378), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 83/259 (32%), Positives = 135/259 (52%), Gaps = 45/259 (17%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 503 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 562
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E F Y++LE C SL + +
Sbjct: 563 LRYFCTEHGPQFHYIALELCQASLQEYV-------------------------------- 590
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK- 648
+ D++ W + V + ++SGL+HLH + ++HRDLKP N+L++ S
Sbjct: 591 -ESPDLDRW------GLEPTTVLQQMMSGLAHLHSLHIVHRDLKPANILMAGPDSQGQGR 643
Query: 649 --LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQGRQTRAIDLFSLGCILFFC 704
+SD G+ K+L + ++ G+ GW APE QL T A+D+FS GC+ ++
Sbjct: 644 VVISDFGLCKKLPVGRCSFSLHSGIPGTEGWMAPELLQLPPDSPTSAVDIFSAGCVFYYV 703
Query: 705 ITGGKHPYGESFERDANIV 723
++GG HP+GES R ANI+
Sbjct: 704 LSGGSHPFGESLYRQANIL 722
|
Role in expression of the DDIT3 transcription factor, required for the unfolded-protein response, growth arrest and apoptosis. Has no effect on 28S ribosomal RNA cleavage, unlike the corresponding human protein. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q76MJ5|ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 149 bits (376), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 97/294 (32%), Positives = 147/294 (50%), Gaps = 50/294 (17%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 515 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 574
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E F Y++LE C SL + + N L EV
Sbjct: 575 LRYFCTERGPQFHYIALELCRASLQEYVE----------NPDLDRGGLEPEV-------- 616
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC--- 646
V + ++SGL+HLH + ++HRDLKP N+LI+ S
Sbjct: 617 ---------------------VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGR 655
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFF 703
LSD G+ K+L + ++ G+ GW APE QLL T A+D+FS GC+ ++
Sbjct: 656 VVLSDFGLCKKLPAGRCSFSLHSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYY 715
Query: 704 CITGGKHPYGESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLR 753
++GG HP+G+S R ANI+ L L E + + V DL +L P P R
Sbjct: 716 VLSGGSHPFGDSLYRQANILTGAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPR 769
|
Induces translational repression through 28S ribosomal RNA cleavage in response to ER stress. Pro-apoptotic. Appears to play no role in the unfolded-protein response, unlike closely related proteins. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q55DJ8|IRLC_DICDI Probable serine/threonine-protein kinase irlC OS=Dictyostelium discoideum GN=irlC PE=3 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 7e-34, Method: Compositional matrix adjust.
Identities = 96/285 (33%), Positives = 156/285 (54%), Gaps = 34/285 (11%)
Query: 471 IGKLVVFNKE---IAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLIA--SD 524
IGK KE + +GSNGT+V +G + R VA+K++ K + + KEI+ LI +
Sbjct: 974 IGKFKFNRKEENVLGRGSNGTLVFKGIWNNRIPVAIKQMQKMFNPLISKEIEVLITLTNK 1033
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIVR+ E D+ VYL L C SL +L+ E+ N L +
Sbjct: 1034 NCYNIVRYIDQEEDESCVYLGLTLCDGSLQNLV--------------EKGDNNLTLTQFL 1079
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+ ++K+ +++LL++ +DIV G+ LH+ G++H DL P+N+LI D+
Sbjct: 1080 GYDINSSSKN----------NSRLLELIKDIVYGIQFLHQQGIVHNDLNPRNILIKDDRF 1129
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
+SD+G+SK T +A G G+ E LL+ R+T+++D+FS+GCILF+
Sbjct: 1130 I---ISDLGLSKMEVTSSYSFTMHAPT-GQEGFHPAEVLLEKRKTKSVDIFSMGCILFYL 1185
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN 749
+TGG+HP+G+ F R NI+ D+ L ++H A DL ++++ N
Sbjct: 1186 MTGGQHPFGDKFYRIVNILTDKPILEPLKHNLVACDLISQMISKN 1230
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55DJ9|IRLD_DICDI Probable serine/threonine-protein kinase irlD OS=Dictyostelium discoideum GN=irlD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 146 bits (368), Expect = 8e-34, Method: Compositional matrix adjust.
Identities = 98/285 (34%), Positives = 154/285 (54%), Gaps = 29/285 (10%)
Query: 471 IGKLVVFNKE---IAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLIA--SD 524
IGK K+ I +GSNGT+V +G + R VA+K++ K + + KEI+ LI +
Sbjct: 1047 IGKFKFSRKDEFIIGRGSNGTLVFKGIWNDRIPVAIKQMHKAFNPLISKEIEVLITLTNK 1106
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIVR+ E D FVYL L C SL +L+ K+ + NL++
Sbjct: 1107 NCNNIVRYIDQEEDDMFVYLGLTLCNGSLQNLV------------EKDLEINLISTSNNE 1154
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+ I +LL++ +DIV G+ LH+ G++H DL P+N+LI D+
Sbjct: 1155 NNNNNKLKNFI-------GSELRLLELIKDIVYGIQFLHQQGIVHNDLNPRNILIKDDRF 1207
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
+SD+G+SK T +A G G+ E LL+ R+T+++D+FS+GCILF+
Sbjct: 1208 I---ISDLGLSKMEVTSSYSFTMHAPT-GQEGFHPAEVLLEKRKTKSVDIFSMGCILFYL 1263
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN 749
+TGG+HP+G+ F R ANI+ D+ L ++H A DL ++++ N
Sbjct: 1264 MTGGQHPFGDKFFRMANILTDKPILEPLKHNLVACDLISQMISKN 1308
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O75460|ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 80/260 (30%), Positives = 131/260 (50%), Gaps = 46/260 (17%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ G+ GT+V G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 646
H + + + + SGL+HLH + ++HRDLKP N+LIS +
Sbjct: 659 ------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK 706
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 703
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 766
Query: 704 CITGGKHPYGESFERDANIV 723
I+ G HP+G+S +R ANI+
Sbjct: 767 VISEGSHPFGKSLQRQANIL 786
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus GN=Ern1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (362), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 46/260 (17%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ G+ GT+V +G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYKGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 646
H + + + SGL+HLH + ++HRDLKP N+L+S +
Sbjct: 659 ------------AHLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIK 706
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 703
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYY 766
Query: 704 CITGGKHPYGESFERDANIV 723
I+ G HP+G+S +R ANI+
Sbjct: 767 VISEGNHPFGKSLQRQANIL 786
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 753 | ||||||
| 225457602 | 925 | PREDICTED: uncharacterized protein LOC10 | 0.961 | 0.782 | 0.496 | 0.0 | |
| 297745578 | 827 | unnamed protein product [Vitis vinifera] | 0.885 | 0.806 | 0.490 | 0.0 | |
| 255539280 | 720 | conserved hypothetical protein [Ricinus | 0.864 | 0.904 | 0.520 | 1e-180 | |
| 225438442 | 957 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.754 | 0.465 | 1e-173 | |
| 224074275 | 822 | predicted protein [Populus trichocarpa] | 0.869 | 0.796 | 0.465 | 1e-153 | |
| 356495301 | 895 | PREDICTED: uncharacterized protein LOC10 | 0.895 | 0.753 | 0.463 | 1e-150 | |
| 10177897 | 939 | unnamed protein product [Arabidopsis tha | 0.891 | 0.714 | 0.436 | 1e-148 | |
| 255561453 | 911 | kinase, putative [Ricinus communis] gi|2 | 0.912 | 0.754 | 0.440 | 1e-148 | |
| 224086074 | 496 | predicted protein [Populus trichocarpa] | 0.460 | 0.699 | 0.723 | 1e-146 | |
| 357484205 | 904 | Serine/threonine protein kinase/endoribo | 0.891 | 0.742 | 0.440 | 1e-145 |
| >gi|225457602|ref|XP_002272934.1| PREDICTED: uncharacterized protein LOC100247854 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 699 bits (1803), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/805 (49%), Positives = 520/805 (64%), Gaps = 81/805 (10%)
Query: 1 MRRALVFLLLSTAIIQSVSSSELSATPPNRYVSEIY-----NSLLPPPLPPEPDVALVAA 55
M+R+L+FLL +I ++ S T S+ + NS++P P+ D+ALVAA
Sbjct: 1 MKRSLIFLLWFISISGVLAISTKPETSLLNLDSKGFDILKANSIVPQA--PKNDIALVAA 58
Query: 56 LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSK 110
LDGTI+LV+ KI WSF +G IYSSYQA + + +++F++D +DWELY H+
Sbjct: 59 LDGTIYLVEASSRKILWSFASGSSIYSSYQAFLDGDNDKQLSTDFFIDCGDDWELYRHNI 118
Query: 111 RFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTP 170
FGK +KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S
Sbjct: 119 SFGKREKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIG 177
Query: 171 GFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230
GFQSDE ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +A
Sbjct: 178 GFQSDEENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFA 237
Query: 231 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSL---- 286
D +A F+C G+E+G + + D+ES P H Q ASVYR+R+ SL
Sbjct: 238 DIEAVFQC-------------PGTEIGSEYMSDIES--PLHCQTRASVYRIREPSLLDSF 282
Query: 287 ------PEFLSVIGKVA----------------------------GWISLPGSSQNSLLG 312
P+ L + ++ +SLP S SL
Sbjct: 283 PMHDRLPKTLPAVEVLSLPASEPKSHSLLDSFPMHDRLPKALPAVEVLSLPASEPKSLSQ 342
Query: 313 PVDR-NSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSF 371
PV R P L +P LALP +E TL + GG SE++ + I+
Sbjct: 343 PVGRLPGPHHLGQ--GKPLLALPLSEG----TLSVHGGDASEMD----IMSIVSDNIEKL 392
Query: 372 IVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKKKKSRRPGYNRNTTNSEKMQ 429
+ L I+GF+ Y V+ ++ +K GI PKKKK+R+ N+N ++EK
Sbjct: 393 GIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKKKKARKSVINKNNASNEKRH 452
Query: 430 NIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV 489
I +ESKV + +GLS + N K L L D V R+IGK++V KEIAKGSNGT+
Sbjct: 453 GNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERKIGKMLVSKKEIAKGSNGTI 512
Query: 490 VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549
VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIVRW+GVE DQDFVYLSLERC
Sbjct: 513 VLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIVRWHGVEYDQDFVYLSLERC 572
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
CSL+DLIY+ S S ++QL ++ DSN+LNE +RL +M+ KD ELWK NG+PS QLL
Sbjct: 573 NCSLSDLIYLCSDS-QDQLVNQDWDSNILNEYIVRLHSIMDPNKDFELWKTNGYPSPQLL 631
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
K+ RD+VSGL+HLHE+G+IHRDLKPQN+L I K KS AKLSDMGISKRL GDMS LT +
Sbjct: 632 KLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKLSDMGISKRLLGDMSSLTHH 691
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGKHPYG++ ERD NIV +RKD
Sbjct: 692 GTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGKHPYGDNLERDVNIVNNRKD 751
Query: 729 LFLVEHIPEAVDLFTRLLDPNPDLR 753
LFL+E+IPEAVDLF+ LL+P+PDLR
Sbjct: 752 LFLIENIPEAVDLFSLLLEPDPDLR 776
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745578|emb|CBI40743.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/764 (49%), Positives = 487/764 (63%), Gaps = 97/764 (12%)
Query: 1 MRRALVFLL--LSTAIIQSVSSS-ELSATPPNRYVSEIYNSLLPPPLPPEPDVALVAALD 57
M+R+L+FLL +S + + ++S+ E S + +I + P P+ D+ALVAALD
Sbjct: 1 MKRSLIFLLWFISISGVLAISTKPETSLLNLDSKGFDILKANSIVPQAPKNDIALVAALD 60
Query: 58 GTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSKRF 112
GTI+LV+ KI WSF +G IYSSYQA + + +++F++D +DWELY H+ F
Sbjct: 61 GTIYLVEASSRKILWSFASGSSIYSSYQAFLDGDNDKQLSTDFFIDCGDDWELYRHNISF 120
Query: 113 GKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGF 172
GK +KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GF
Sbjct: 121 GKREKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGF 179
Query: 173 QSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADF 232
QSDE ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD
Sbjct: 180 QSDEENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADI 239
Query: 233 KAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSV 292
+A F+C G+E+G + + D+ES L C T+ S
Sbjct: 240 EAVFQC-------------PGTEIGSEYMSDIESPLHCQTRA----------------SP 270
Query: 293 IGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVS 352
+G+ LPG LG +P LALP +E TL + GG S
Sbjct: 271 VGR------LPGPHH---LGQ-------------GKPLLALPLSEG----TLSVHGGDAS 304
Query: 353 EINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKK 410
E++ + I+ + L I+GF+ Y V+ ++ +K GI PKK
Sbjct: 305 EMD----IMSIVSDNIEKLGIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKK 360
Query: 411 KKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRR 470
KK+R+ N+N ++EK I +ESKV + +GLS + N K L L D V R+
Sbjct: 361 KKARKSVINKNNASNEKRHGNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERK 420
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 530
IGK++V KEIAKGSNGT+VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIV
Sbjct: 421 IGKMLVSKKEIAKGSNGTIVLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIV 480
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
RW+GVE DQDFVYLSLERC CSL+DLIY+ S S ++QL
Sbjct: 481 RWHGVEYDQDFVYLSLERCNCSLSDLIYLCSDS-QDQL---------------------- 517
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 649
D ELWK NG+PS QLLK+ RD+VSGL+HLHE+G+IHRDLKPQN+L I K KS AKL
Sbjct: 518 ---DFELWKTNGYPSPQLLKLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKL 574
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
SDMGISKRL GDMS LT + TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGK
Sbjct: 575 SDMGISKRLLGDMSSLTHHGTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGK 634
Query: 710 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
HPYG++ ERD NIV +RKDLFL+E+IPEAVDLF+ LL+P+PDLR
Sbjct: 635 HPYGDNLERDVNIVNNRKDLFLIENIPEAVDLFSLLLEPDPDLR 678
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539280|ref|XP_002510705.1| conserved hypothetical protein [Ricinus communis] gi|223551406|gb|EEF52892.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 639 bits (1648), Expect = e-180, Method: Compositional matrix adjust.
Identities = 363/697 (52%), Positives = 466/697 (66%), Gaps = 46/697 (6%)
Query: 1 MRRALVFLLLSTA----IIQSVSSSELSA-TPPNR--YVSEIYNSLLPPPLPPEPDVALV 53
MRR L+ LL +I+S+S S +S + P+ +S++Y S LPP P+ DVALV
Sbjct: 1 MRRYLILLLFKLVMLIPLIRSISGSAISQPSIPDESSQISKLYKSFLPPK--PKQDVALV 58
Query: 54 AALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE-----------FYLDVDED 102
AALDGT++ VDT K+RWSF +G PIYSSYQA+ N + +Y+D +D
Sbjct: 59 AALDGTVYFVDTNSRKVRWSFSSGSPIYSSYQANPNDDEDRHNSGSELSNDLYYIDCGDD 118
Query: 103 WELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYV 162
WELY HSKRFGK++KL+ S EEY++ P+IS+DG +TLG +T+ FLVD K+GRVV Y
Sbjct: 119 WELYVHSKRFGKLQKLALSPEEYVKMTPHISEDGEITLGFKRTTAFLVDAKTGRVVRTYG 178
Query: 163 LDFSASTPGFQSDENKHVVPVDGYEELVESG--VGNLKRIRQLVYIMRTDYVLQSTSQDS 220
D S ST G Q DE ++ V EL++S V +L ++ LVYI RTDYVLQ S +S
Sbjct: 179 FDNSTSTFGAQYDERNALLLVKD-AELIKSAAAVADLGTVQHLVYITRTDYVLQHYSPNS 237
Query: 221 GEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR 280
++LWNVA+AD +AEFRCQ + S SG S D + ++E PC QM V R
Sbjct: 238 TDILWNVAFADIEAEFRCQGLRSSLSGV-----SPSASDDVDEIE--FPC--QMRTPVLR 288
Query: 281 LRDNSLPEF--LSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTET 338
+RD+S EF L++ AG LP LGPV R PL LP DR LALP++E
Sbjct: 289 VRDHSFLEFDKLAIAHLGAGARFLPAPDHILPLGPVQR-YPLALPTHEDRVVLALPASEA 347
Query: 339 EIPWTLGMPGGSVSEINKKHAFVEGF-RSYIQSFIVLFIALCPIIGFLFYHSKQVKSK-- 395
P LG+P G ++ IN + E S++ I A+ I+G + Y+ + K
Sbjct: 348 ANPRNLGLPSG-IAGINGTNLSSEIITNSHMWPIIA---AILSIVGSICYNYLTFRKKNE 403
Query: 396 --KQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEK 453
K EE + G+PKKKKS+R G N+ + E+ Q +P E+ VG+ G+SH+ N E+
Sbjct: 404 LNKPVEELKQQAGVPKKKKSKRSG-NKQSPTRERRQRYLPLENNVGDDVGVSHVEEN-ER 461
Query: 454 FLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA 513
LLTF +++D R+DGR+IGKL+V NKEIAKGSNGTVVLEG Y+GRSVAVKRLV+THHDVA
Sbjct: 462 KLLTFANVVDGRIDGRKIGKLIVSNKEIAKGSNGTVVLEGIYDGRSVAVKRLVQTHHDVA 521
Query: 514 LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQ 573
LKEIQNLIASDQHPNIVRWYGVE DQDFVYL+LERCTCSLND IYV S SF+ Q+ +K+
Sbjct: 522 LKEIQNLIASDQHPNIVRWYGVEYDQDFVYLALERCTCSLNDFIYVYSQSFQNQVLSKDV 581
Query: 574 DSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633
DSN L ++ ++E ++IELWK NGHPS +LLK+ RD+V GL+HLHE+G+IHRDLK
Sbjct: 582 DSNCLPVCTVQSRTMLEYNRNIELWKTNGHPSLRLLKLMRDVVYGLAHLHELGIIHRDLK 641
Query: 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
PQNVLI +KSFCAKLSDMGISKRL GDMS LT+N T
Sbjct: 642 PQNVLIINEKSFCAKLSDMGISKRLVGDMSSLTRNTT 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438442|ref|XP_002275036.1| PREDICTED: uncharacterized protein LOC100249111 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 614 bits (1584), Expect = e-173, Method: Compositional matrix adjust.
Identities = 369/793 (46%), Positives = 481/793 (60%), Gaps = 71/793 (8%)
Query: 2 RRALVFLLLSTAIIQSVSSSELSATPPNRYV-SEIYNSLLPPPLPPEPDVALVAALDGTI 60
RR+L+ ++ +SV S TP YV I N L + D ALVAAL+GTI
Sbjct: 48 RRSLL------SLPKSVDSPIFLDTPSTVYVLYSICNVLNHGKFLSKNDTALVAALNGTI 101
Query: 61 HLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSKRFGKM 115
HLV++ K+ WSF +G IYSSYQA + + S F++D EDWELY H + FGK+
Sbjct: 102 HLVESNSMKVLWSFTSGPSIYSSYQAPLDQDNATDWGSGFFVDCGEDWELYMHGRHFGKV 161
Query: 116 KKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSD 175
K L +AEE+I P++S+DGGV LG+ +T+VFL++ K+G+++ +Y S TP S+
Sbjct: 162 K-LPMTAEEFISSTPHVSEDGGVILGSKQTTVFLLNAKTGKLIHSYRSLESPPTP--LSN 218
Query: 176 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 235
+ + VV EE V+SG NL + +YI RTDY LQS +Q S +VLWN+ A+ A
Sbjct: 219 KEESVVHDKDIEEWVDSGSTNLNIVEPRLYITRTDYSLQSFAQGSDKVLWNMTVAEIGAA 278
Query: 236 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPE------F 289
F CQ FS N G ELG + D E LPC Q A VYR R +++ E
Sbjct: 279 FLCQGTENLFSRPPLNLGCELGPEYNCDFEMPLPC--QSKAVVYRYRGHTMLEPFPRHDR 336
Query: 290 LSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS-------------T 336
L + + P + P D P +P+ + LPS
Sbjct: 337 LQEAHQEDRLLLQPNIDKTLDFHPQDMMLPAVVPNHM------LPSEPKDEISLNFQDNN 390
Query: 337 ETEIPWTLGMP---GGSVSEINKKHAFVEGFR-----SYIQSFIVLFIAL--------CP 380
++E L P +S+ N + + +G S + S IV + L P
Sbjct: 391 DSEAVLPLSPPKIKNSGISDQNVQMPYNDGLSMFSGGSILFSLIVFIVILLVSVIYCCTP 450
Query: 381 IIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGE 440
+ G +KQ N +P KK+ R N ++ +K ++++ +E+K
Sbjct: 451 VAGEQGEMNKQPNDSDSN-------SVPSKKRKIRKSAKNNISSGKKDEHVL-SENK--- 499
Query: 441 TDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSV 500
DG +HI + +L L+D +GR +GKL V N IAKGSNGT+VLEG +EGRSV
Sbjct: 500 -DGSAHIASDNSPWL-NLNGLVDGDTNGRIVGKLFVSNIVIAKGSNGTIVLEGIHEGRSV 557
Query: 501 AVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 560
AVKRLV+ HHDVA KEIQNLIASD+HPNIVRWYGVE DQDFVYLSLERCTCSLNDL+ +
Sbjct: 558 AVKRLVRAHHDVAFKEIQNLIASDRHPNIVRWYGVEYDQDFVYLSLERCTCSLNDLLQIH 617
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620
S S + + +Q + + E RI+L V +DI+LWK+NG+PS+ LL + RD+VSGL
Sbjct: 618 SNSSQNPGFSMDQATKAMMEYRIQLDSVKCIVQDIKLWKSNGYPSSVLLSLMRDVVSGLV 677
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
HLH++G+IHRDLKPQNVLI K+KS CAKLSDMGISKRL GDMS L +ATGYGSSGWQAP
Sbjct: 678 HLHDLGIIHRDLKPQNVLIIKEKSLCAKLSDMGISKRLVGDMSSLGHHATGYGSSGWQAP 737
Query: 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD 740
EQLL GRQTRA+DLFSLGCILF CITGG+HP+G+ ERD NIVK++ DLFLVE IPEA+D
Sbjct: 738 EQLLHGRQTRAVDLFSLGCILFSCITGGRHPFGDPLERDVNIVKNKPDLFLVEFIPEALD 797
Query: 741 LFTRLLDPNPDLR 753
LF RLLDP P+LR
Sbjct: 798 LFARLLDPKPELR 810
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074275|ref|XP_002304333.1| predicted protein [Populus trichocarpa] gi|222841765|gb|EEE79312.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-153, Method: Compositional matrix adjust.
Identities = 335/720 (46%), Positives = 448/720 (62%), Gaps = 65/720 (9%)
Query: 52 LVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE---------FYLDVDED 102
LVA L+GTI+ D GKI WSF +G P YSSYQA ++ + F+LD +D
Sbjct: 1 LVALLNGTIYFKDKISGKILWSFSSGGPTYSSYQAPAKHDSDKEKGPGGLTGFFLDYGDD 60
Query: 103 WELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY- 161
W+LY H K G MK L + E++I+ P++S+DG V LG+ KT+VF+V+ K+GR++ +
Sbjct: 61 WQLYAHYKYSGGMK-LPMNIEDFIKITPHMSEDGAVMLGSKKTTVFVVEAKTGRLIRTFK 119
Query: 162 VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSG 221
D +S F+ H ++ ++L++SG N Q++YI+RTDY LQ+ +S
Sbjct: 120 SPDSPSSLQSFEEGSGLHD-DLNNNKDLLKSGSSN---TAQVIYILRTDYALQTFGPNSD 175
Query: 222 EVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRL 281
+V W+ A A F C++V + SE+ +L +++S P Q V +
Sbjct: 176 KVSWSTKVATIGATFLCKDV---------ENPSEV-FNLSFELDSDTPLSCQSRRIVVQR 225
Query: 282 RDNSLPEFLSVIGKVAGWISLPGSSQNSLLGP---VDRNSPLFLPDKVDRPPLALPSTET 338
+D S ++ S G + G LP S+ N +L V+++ L D R LA PS
Sbjct: 226 QDKS--QYSS--GDIHGEDKLPLSAPNLMLTTQPGVEKS----LDDHHARMLLAAPSEHG 277
Query: 339 EIPWTLGMPGGSVS-EINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQ 397
+ L +P S + E++ + + + S QSFI LF+ + ++ F+ Y SK+ +
Sbjct: 278 KE--MLALPSASAAGEVHYRFGMLLMW-STTQSFI-LFVGIL-LLCFVLYLSKESFTL-- 330
Query: 398 NEEHITKTGIPKKKKSRR----PGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEK 453
E +T TG+ ++ PG +N + E I P E K
Sbjct: 331 -EGQLTGTGLKASSSKKKKAKKPG--KNNVSVENGNEIAPGEGV--------------NK 373
Query: 454 FLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA 513
L L+D +GRRIGKL V N EIAKGSNGTVVLEG YEGR VAVKRLV+THHDVA
Sbjct: 374 TLSDLNKLVDGGANGRRIGKLFVSNTEIAKGSNGTVVLEGVYEGRLVAVKRLVQTHHDVA 433
Query: 514 LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQ 573
KEIQNLIASD+HPNIVRWYGVE D+DFVYLSLERCTCSL+DLI + S S + K++
Sbjct: 434 WKEIQNLIASDRHPNIVRWYGVEYDEDFVYLSLERCTCSLDDLIQIYSDSSLNPVYGKDR 493
Query: 574 DSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633
S E ++RL V +D+ LWKA GHPS LL + RD+VSGL HLHE+G+IHRDLK
Sbjct: 494 TSRAAIEHKLRLDSVKGVMQDLNLWKATGHPSPLLLTLMRDMVSGLVHLHELGIIHRDLK 553
Query: 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693
PQNVLI K++S CAKLSDMGISKRL GDMS L +ATG GSSGWQAPEQL R+TRA+D
Sbjct: 554 PQNVLIIKERSLCAKLSDMGISKRLLGDMSSLAYHATGSGSSGWQAPEQLHHRRETRAVD 613
Query: 694 LFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
LFSLGC+LF+CITGG+HP+G+ ERD NIVK++KDLFLVE+IPEA DL +RLL+P+P+LR
Sbjct: 614 LFSLGCVLFYCITGGRHPFGDHLERDVNIVKNQKDLFLVEYIPEAEDLISRLLNPDPELR 673
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495301|ref|XP_003516517.1| PREDICTED: uncharacterized protein LOC100785363 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 347/749 (46%), Positives = 437/749 (58%), Gaps = 75/749 (10%)
Query: 42 PPLPP---EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYS-SYQASFNS---NASE 94
P LP +P ALVAALDGT++LVD+ G++ WSF TG PIY SY+A N N
Sbjct: 37 PSLPAPSLKPATALVAALDGTMYLVDSVSGRVFWSFSTGSPIYHHSYRAPINDPEDNNVT 96
Query: 95 FYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKS 154
++ +DWEL H RFGK +LS S Y+ P +K+G G+ K ++F VD K+
Sbjct: 97 GLIECGDDWELIVHDARFGK-TRLSESIANYVALTPTETKEGASIFGSKKDTMFEVDAKT 155
Query: 155 GRVV-DNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVL 213
G +V +Y LD +AS D+ V ELV+ L L+ I R+DYVL
Sbjct: 156 GALVRTHYDLD-NASNVVLSGDDRLQRVTTTKNNELVDPA--QLDSPEFLLKITRSDYVL 212
Query: 214 QSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQ 273
+S + +G VLW + A+FKA CQ F++ +D D C
Sbjct: 213 KSLGK-AGIVLWTMNVAEFKARLICQHNENPSGRDSFDAEDGYVVDRGLDFAMPYACWDM 271
Query: 274 MTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRP---- 329
VYR R N L A L G Q +++ P S L LP + D
Sbjct: 272 KLNEVYRQRKNFLLH-------PADPGRLSGIYQENIMLPF-HTSELMLPSQPDMDGFIL 323
Query: 330 --------PL----ALPSTETEI------------PWTLGMPGGSVSEINKKHAFVEGFR 365
PL +LPS + ++ PW L M + E++ K +E
Sbjct: 324 GQGGNMMLPLPISNSLPSLQQKLDFCESNDNVAMLPWPL-MEISTQEEVDPKKV-IEWST 381
Query: 366 SYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNS 425
+ +F+ F+FYH V +K QN E +++ PKKKK+R+ N T ++
Sbjct: 382 TLPLILFTIFLGF-----FVFYHYLVVTNKDQNRELNSRSLPPKKKKARKSVKNNITIDN 436
Query: 426 EKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 485
+ + P S E D L+ N + T+T + +VDGRRIGKL V NKEIAKGS
Sbjct: 437 RQDK---PMSS--AEEDKLARKETNTD----TYTQM---QVDGRRIGKLFVSNKEIAKGS 484
Query: 486 NGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545
NGT+V EG YEGR VAVKRLVK HHDVA KEIQNLIASD+HPNIVRWYGVE D DFVYL+
Sbjct: 485 NGTIVFEGTYEGRVVAVKRLVKAHHDVAHKEIQNLIASDRHPNIVRWYGVECDHDFVYLA 544
Query: 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE-LWKANGHP 604
LERCTC+L+DLI++ S E ++Q SN RI + D+ LWKANG P
Sbjct: 545 LERCTCNLDDLIHMYSDISENPTICEDQYSNFFKNARI------DTRNDMRYLWKANGFP 598
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LLK+ RD+VSGL HLHE+G+IHRDLKPQNVLI K+KS CAKLSDMGISKRL DMS
Sbjct: 599 SPLLLKLMRDVVSGLVHLHELGIIHRDLKPQNVLILKEKSLCAKLSDMGISKRLLEDMSS 658
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 724
L TG GSSGWQAPEQL+QGRQTRA+DLFSLGC+LFFC+TGG+HP+GE ERD NIVK
Sbjct: 659 LGHTVTGCGSSGWQAPEQLVQGRQTRAVDLFSLGCVLFFCMTGGRHPFGERLERDFNIVK 718
Query: 725 DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
++KDLFLVE IPEA DL + LL+PNPDLR
Sbjct: 719 NQKDLFLVEFIPEADDLISCLLNPNPDLR 747
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177897|dbj|BAB11229.1| unnamed protein product [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-148, Method: Compositional matrix adjust.
Identities = 315/722 (43%), Positives = 416/722 (57%), Gaps = 51/722 (7%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE----------FY 96
E LV+ +DG+I LVD K+ W+F T PIYSSYQA ++ FY
Sbjct: 105 ESGYVLVSTVDGSISLVDMSSQKLDWTFHTNEPIYSSYQAPHYHYTTDEERSSVLGDDFY 164
Query: 97 LDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGR 156
+D D+DW LY S R GK A E+I +PY S D + LG TSVFL+D K+G+
Sbjct: 165 MDCDKDWRLYNSSVRKGKRVNEIVDASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGK 223
Query: 157 VVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
+V Y +D S ++D+ K +V L SG + +LVYI R D+ +Q
Sbjct: 224 LVKRYRMDELYSNTVVENDKEKAIVLSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCI 283
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTA 276
S+ G+VLW+V+YA +A+ + E + SG + G ++ P +
Sbjct: 284 SK-FGDVLWSVSYAKMEAKLQNHESVQFISGLSSSVG-----------KNQFPLSYTTSV 331
Query: 277 SVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLP-DKVDRPPLALPS 335
+ +LR+ +G + + LP + + + L LP +K L+LP
Sbjct: 332 PMVQLRNVKYETLFPRLGFLDEALYLPFQDRKPNQLAIGDGNQLTLPGNKEAEEVLSLPL 391
Query: 336 TETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQ 391
ET I + GS + GF S IVL C + G FY +Q
Sbjct: 392 PETVISQITDIIDGSTKQ--------AGFASKFSGLIVLIFGFCVTMLSVCGLFFYRLRQ 443
Query: 392 VKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNG 451
S + E ++++ I KK + +K I G SH N
Sbjct: 444 --SIRIKEPYVSEVPIATPKKKKSKKNGTTKAVHKKENGFIS-----GGNKDPSH-EENE 495
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD 511
++ L F L + +G R+GKL V NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHD
Sbjct: 496 KRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHD 555
Query: 512 VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
VA KEI NL+ASD+H NIVRWYGV+ D+ F+Y+SLE C CSLNDLIY S E + +
Sbjct: 556 VAQKEILNLMASDKHSNIVRWYGVDQDEHFIYISLELCACSLNDLIYASSALLESPMASS 615
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
S I++ P+ EN K +ELWK NGHPS LLK+ RDIV+GL HLH+IG++HRD
Sbjct: 616 SIHS-------IQINPIFENGKGVELWKENGHPSPVLLKLMRDIVAGLVHLHDIGIVHRD 668
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
LKPQNVLI K+ S CAKLSDMGISKRL D S LT+N+TG GSSGWQAPEQL RQTRA
Sbjct: 669 LKPQNVLIVKNSSLCAKLSDMGISKRLPADTSALTRNSTGSGSSGWQAPEQLRNERQTRA 728
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
+DLFSLGC+LFFC+TGGKHPYG+++ERD N++ D+KDLFL+E +PEAV L T LL+P+P+
Sbjct: 729 VDLFSLGCVLFFCMTGGKHPYGDNYERDVNVLNDQKDLFLIESLPEAVHLLTGLLNPDPN 788
Query: 752 LR 753
LR
Sbjct: 789 LR 790
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561453|ref|XP_002521737.1| kinase, putative [Ricinus communis] gi|223539128|gb|EEF40724.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1367), Expect = e-148, Method: Compositional matrix adjust.
Identities = 318/722 (44%), Positives = 437/722 (60%), Gaps = 35/722 (4%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN---------ASEFYL 97
E LVA L+GTI+ +T ++ WSF +G PIYSSYQASFN + ++ F++
Sbjct: 61 EDSTELVALLNGTIYFQETNSERVFWSFSSGAPIYSSYQASFNQDNDGENEFGPSTGFFI 120
Query: 98 DVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRV 157
D +DW+LY H K MK LS + E+++ P++S+DG V LG+ T+VF+V+ K+GR+
Sbjct: 121 DYGDDWQLYAHGKHSSGMK-LSMNIEDFMIITPHVSEDGAVILGSKITTVFVVEAKTGRL 179
Query: 158 VDNY-VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
V Y LD +S + +E + + +L+ + + QL+YI RTDY LQ+
Sbjct: 180 VQTYKSLDPPSSLQ--RDEEGNAFLNENRNNDLI---ISDSATSAQLIYITRTDYTLQNF 234
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEV-GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMT 275
+S ++ WN+ A +A F C++V G+S + S ++ + + ++ T
Sbjct: 235 GPNSDKISWNMKVAMIEAAFLCKDVEGRSNFDMPLSCQSR---RMVVRRQGNPQSSSEAT 291
Query: 276 ASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS 335
L +L L +V SL + +L + L L KVD P P+
Sbjct: 292 HGDEMLPVPALDLVLPSQPRVGK--SLQDHHEGRMLSGSASDFVLPLQSKVDELPTFHPT 349
Query: 336 TETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQ---SFIVLFIALCPIIGFLFYHSKQV 392
++E L N + AF + I+ + +F + ++GF FY S V
Sbjct: 350 DDSEGMLALPNDSEGFDAHNARVAFDDWLNILIKRSTTLSFMFFIVIILLGFNFYPSNLV 409
Query: 393 -KSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNG 451
KSK +E + + R+ N + +P E+ G T ++ +
Sbjct: 410 GKSKVASEGLSSDSSSKASSSKRKKSRKSGKKNGKD----VPFENDDGPT-----LSDSS 460
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD 511
+K LL +D V+GRRIGKL V N EIAKGSNGT+VLEG YEGR VAVKRLV+ HH+
Sbjct: 461 DKKLLDLNKHVDRGVNGRRIGKLFVSNAEIAKGSNGTIVLEGIYEGRPVAVKRLVQAHHE 520
Query: 512 VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
VA KEIQNLIASD+HPNIVRWYGVE+D DFVYLSLERCTCSL+DLI + S Q+ ++
Sbjct: 521 VAFKEIQNLIASDRHPNIVRWYGVENDNDFVYLSLERCTCSLDDLIQIYCDSSFNQVFSE 580
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
+Q + + ++RL V +D+ LWK+NGHPS +L + RD+V GL HLHE+G+IHRD
Sbjct: 581 DQATRVATNYKLRLNKVKGILQDLNLWKSNGHPSPLMLLLMRDVVCGLVHLHELGIIHRD 640
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
LKPQNVLI K++S AKLSDMGISKRL GDMS L +ATG GSSGWQAPE LLQGRQTRA
Sbjct: 641 LKPQNVLILKERSLSAKLSDMGISKRLLGDMSSLGYHATGCGSSGWQAPELLLQGRQTRA 700
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
+DLFSLGC+LFFCITGG+HP+G+ ERD NIVK++ DLFLVE+ PEA DL +RLL+ +P+
Sbjct: 701 VDLFSLGCVLFFCITGGRHPFGDRLERDVNIVKNKMDLFLVEYFPEAGDLISRLLNHDPE 760
Query: 752 LR 753
LR
Sbjct: 761 LR 762
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086074|ref|XP_002307805.1| predicted protein [Populus trichocarpa] gi|222857254|gb|EEE94801.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1352), Expect = e-146, Method: Compositional matrix adjust.
Identities = 251/347 (72%), Positives = 297/347 (85%)
Query: 407 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRV 466
+PKKKK+RR G N++ N+ K Q + +SKVGE + L+ + + K LLTFTD +D RV
Sbjct: 1 MPKKKKNRRSGNNKSNPNNLKNQKYLSLQSKVGEINELTRVERDERKLLLTFTDHVDGRV 60
Query: 467 DGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQH 526
DGRRIGKL+V NKEIAKGSNGTVVLEG Y+GR VAVKRLV++HHDVALKEIQNLIASDQH
Sbjct: 61 DGRRIGKLLVSNKEIAKGSNGTVVLEGIYDGRHVAVKRLVQSHHDVALKEIQNLIASDQH 120
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNIVRWYGVE DQDFVYL+LERCTCSLNDLIYV S SF+ Q+ +K+ DSN L E +RL
Sbjct: 121 PNIVRWYGVEYDQDFVYLALERCTCSLNDLIYVNSESFQNQIPSKDMDSNRLPEYMVRLH 180
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ E+ +++ELWKANG+PS QLLK+ RD+VSGL+HLHE+G++HRD+KPQNVLI +KSFC
Sbjct: 181 SMPEHNRNVELWKANGYPSVQLLKLMRDVVSGLAHLHELGIVHRDMKPQNVLIISEKSFC 240
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
AKLSDMGISKRL GDMS LTQ+ TGYGSSGWQAPEQLL GRQTRA+DLFSLGC+LFFCIT
Sbjct: 241 AKLSDMGISKRLLGDMSSLTQHPTGYGSSGWQAPEQLLHGRQTRALDLFSLGCVLFFCIT 300
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
GGKHP+G++ ERD NIV DRKDLFLVE+IPEA+DLFT LLDP+P+ R
Sbjct: 301 GGKHPFGDNIERDVNIVNDRKDLFLVENIPEALDLFTCLLDPDPEKR 347
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484205|ref|XP_003612390.1| Serine/threonine protein kinase/endoribonuclease IRE1 [Medicago truncatula] gi|355513725|gb|AES95348.1| Serine/threonine protein kinase/endoribonuclease IRE1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 322/731 (44%), Positives = 428/731 (58%), Gaps = 60/731 (8%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELY 106
+P ALVA LDGTI+LV++ G++ WSF +G PIY S S N+ S ++ +DWEL
Sbjct: 62 KPVTALVAGLDGTIYLVESASGRVIWSFSSGSPIYHS---SANTPPSSGLIECGDDWELI 118
Query: 107 FHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY-VLDF 165
FH FGK + L S +Y+ P +SKDG V LG+ +++VF VD K+G+++ +Y DF
Sbjct: 119 FHDPHFGKTR-LKESVADYVAVTPIVSKDGAVILGSKRSTVFEVDAKTGKLLRSYGAADF 177
Query: 166 S--ASTPGFQSDENKHVVPVD---GYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDS 220
++T + D++ V D +EL + NL L+ I+RTDY LQS S
Sbjct: 178 RNVSTTAMWSGDKDSEGVTNDLRANNKELADPAKLNLPEF--LLQIVRTDYFLQSVGPGS 235
Query: 221 GEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLP--CHTQMTASV 278
G VLW ++ A+F+A CQ ++ E D+ ++ +P C + V
Sbjct: 236 GIVLWTMSVAEFEAVLFCQHNENPTLTASLDAEGEYAYDVDSGLDFAMPYACPDRKLREV 295
Query: 279 YRLRDNSL--PEFLSVIGKV-----AGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPL 331
YR R N L P+ + + V G + +P L+ P S FLP L
Sbjct: 296 YRQRKNFLFEPDKIQRLSDVDAYQEKGMLPMPDLK---LMLPSQPKSDRFLPGHGGNMML 352
Query: 332 ALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSY-----IQSFIVLFIALCPIIGFLF 386
+P P G+ + + + R I+ + L + L + +
Sbjct: 353 PVPVPNYMQPKITYDSNGNAVMLPQPPMEITAPREVDLSRVIELSMSLLVVLSVVFLLML 412
Query: 387 YHSK---QVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDG 443
Y ++ V SK Q + K+ KKK+ R+ G N NII E+
Sbjct: 413 YQNRLKNNVTSKVQISDSDLKSSPSKKKRVRKSGKN----------NIIVEENI------ 456
Query: 444 LSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVK 503
H E L + V+GRRIGKL V NKEIAKGSNGT+VLEG YEGR+VAVK
Sbjct: 457 RIHKEAENEARLYY------NNVNGRRIGKLCVLNKEIAKGSNGTIVLEGIYEGRTVAVK 510
Query: 504 RLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGS 563
RLV+ HHDVA KEIQNLIASD HPNIVRWYGVE D DFVYL+LERC C+L+DLI S
Sbjct: 511 RLVQAHHDVAHKEIQNLIASDFHPNIVRWYGVEYDHDFVYLALERCACNLDDLITFYSDL 570
Query: 564 FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE-LWKANGHPSAQLLKVTRDIVSGLSHL 622
E + ++Q + + +I D++ LWK+NG+PS LLK+ RD+VSGL HL
Sbjct: 571 SENSVLREDQAFDFFKKAQIE-----AQRDDMQCLWKSNGYPSPLLLKLMRDVVSGLVHL 625
Query: 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 682
HE+G+IHRDLKPQNVL+ K++S CAKLSDMGISKRL DMS L ++TG GSSGWQAPEQ
Sbjct: 626 HELGIIHRDLKPQNVLLIKERSLCAKLSDMGISKRLLEDMSSLGHSSTGCGSSGWQAPEQ 685
Query: 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLF 742
LLQGRQTRA+DLFSLGC+LFFC+T G+HP+GE ERD NIVK++KDLFLVE +PEA DL
Sbjct: 686 LLQGRQTRAVDLFSLGCVLFFCMTAGRHPFGERLERDVNIVKNKKDLFLVEFLPEAEDLI 745
Query: 743 TRLLDPNPDLR 753
+ LL+P+P+LR
Sbjct: 746 SCLLNPDPNLR 756
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 753 | ||||||
| TAIR|locus:2053928 | 841 | IRE1A [Arabidopsis thaliana (t | 0.444 | 0.398 | 0.592 | 9.3e-121 | |
| TAIR|locus:2081551 | 554 | AT3G11870 [Arabidopsis thalian | 0.420 | 0.572 | 0.387 | 1.6e-48 | |
| ASPGD|ASPL0000060900 | 1121 | AN0235 [Emericella nidulans (t | 0.213 | 0.143 | 0.343 | 4.8e-40 | |
| DICTYBASE|DDB_G0267650 | 984 | ireA "IRE family protein kinas | 0.455 | 0.348 | 0.318 | 1.5e-39 | |
| ZFIN|ZDB-GENE-090312-15 | 950 | ern2 "endoplasmic reticulum to | 0.200 | 0.158 | 0.341 | 4.5e-39 | |
| UNIPROTKB|F1NPU5 | 946 | Gga.10887 "Uncharacterized pro | 0.205 | 0.163 | 0.333 | 1.4e-38 | |
| WB|WBGene00002147 | 967 | ire-1 [Caenorhabditis elegans | 0.189 | 0.147 | 0.377 | 2.1e-37 | |
| FB|FBgn0261984 | 1074 | Ire1 "Inositol-requiring enzym | 0.159 | 0.111 | 0.398 | 3.8e-37 | |
| CGD|CAL0001725 | 1224 | IRE1 [Candida albicans (taxid: | 0.369 | 0.227 | 0.270 | 6.9e-36 | |
| UNIPROTKB|Q5A7G9 | 1224 | IRE1 "Likely protein kinase/en | 0.369 | 0.227 | 0.270 | 6.9e-36 |
| TAIR|locus:2053928 IRE1A [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 999 (356.7 bits), Expect = 9.3e-121, Sum P(3) = 9.3e-121
Identities = 208/351 (59%), Positives = 251/351 (71%)
Query: 404 KTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLID 463
K G KKKK+R+ + TN + +P G+ D I G + LL F +
Sbjct: 357 KAGPSKKKKNRK---SAKDTNRQS----VPR----GQ-DQFELIEGG--QMLLGFNNFQS 402
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS 523
DGR+IGKL + +KEIAKGSNGTVV EG YEGR VAVKRLV++HH+VA KEIQNLIAS
Sbjct: 403 GATDGRKIGKLFLSSKEIAKGSNGTVVFEGIYEGRPVAVKRLVRSHHEVAFKEIQNLIAS 462
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVR 582
DQH NI+RWYGVE DQDFVYLSLERCTCSL+DLI L S + L + + +
Sbjct: 463 DQHTNIIRWYGVEYDQDFVYLSLERCTCSLDDLIKSYLEFSMTKVLENNDSTEGVA-AYK 521
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
I+L + K WK GHPS +LK+ RDIV G+ HLHE+G++HRDLKPQNVLISKD
Sbjct: 522 IQLDSLEGVIKGNNFWKVGGHPSPLMLKLMRDIVCGIVHLHELGIVHRDLKPQNVLISKD 581
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
+ AKLSDMGISKR+ DMS L ATG GSSGWQAPEQLLQGRQTRA+D+FSLGC++F
Sbjct: 582 MTLSAKLSDMGISKRMSRDMSSLGHLATGSGSSGWQAPEQLLQGRQTRAVDMFSLGCVIF 641
Query: 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ ITG KHP+G+ ERD NIVK++ DLFLVEH+PEA DL +RLL+P+PDLR
Sbjct: 642 YTITGCKHPFGDDLERDVNIVKNKVDLFLVEHVPEASDLISRLLNPDPDLR 692
|
|
| TAIR|locus:2081551 AT3G11870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 1.6e-48, Sum P(2) = 1.6e-48
Identities = 135/348 (38%), Positives = 191/348 (54%)
Query: 417 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGK-LV 475
G TNSE +P++ + +T L + + E L D ++ G+ + + L+
Sbjct: 69 GEENEKTNSESKVLSVPSDQNINKT--LPVMLPSLE---LRKYD--ENETPGKVVNRRLL 121
Query: 476 VFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRW 532
V E+ G NG V +G Y RS VAVK L H A EI N D H NI+R+
Sbjct: 122 VSTNEMKYGRNGYEVFQGVYGRRSSVAVKCLDLAHTTEAFIQNEIDNHCLCDDHSNIIRF 181
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+G+E DQ F Y+ LE CSL+DLI + + ++D+ + V L VM
Sbjct: 182 HGLEQDQSFAYICLEPWKCSLDDLIKL-------SVRRTKRDTQAVAPVD-DLEKVM--- 230
Query: 593 KDIELWKANGHPS--AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKL 649
K I+ WK G P +LK+ RD+V GL+HLH++ IHR+L PQNVLI KD + AK+
Sbjct: 231 KRIKFWKEKGKPLPLTPMLKLMRDVVCGLAHLHKLKTIHRNLNPQNVLIIVKDMTLTAKI 290
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA---IDLFSLGCILFFCIT 706
SDM +SK L G S AT GSSGWQAPEQL + ++ + D+F+ GC+L + +
Sbjct: 291 SDMSLSKHLGGKKSSYKHLATCSGSSGWQAPEQLNKDKKKKEDFPADMFNFGCLLHYAVM 350
Query: 707 GGKHPYGESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753
G HP+G ERD NI + K +L LV ++ EA++L +LL+ PDLR
Sbjct: 351 G-THPFGSPSERDTNIKTNNKTNLSLVTNL-EAINLIEQLLNYKPDLR 396
|
|
| ASPGD|ASPL0000060900 AN0235 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 209 (78.6 bits), Expect = 4.8e-40, Sum P(4) = 4.8e-40
Identities = 57/166 (34%), Positives = 87/166 (52%)
Query: 396 KQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDG-LSHITGNGEKF 454
K EE + G KKKK+R+ G ++ + I + + G L G
Sbjct: 604 KDVEELSLQDG-EKKKKTRKRGSRGGKSHRRGKKKIESEKEESDHAPGTLQPPAGPDAGL 662
Query: 455 LLTFTDLIDD-RVDGR-RIGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHD 511
LT T + DG +IG+L VF ++ GS+GTVV G+++GR VAVKR++ +D
Sbjct: 663 ALTRTASNEVFEADGVIQIGRLKVFTADVLGHGSHGTVVYRGSFDGRDVAVKRMLVEFYD 722
Query: 512 VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 557
+A E+ L SD H N++R+Y E + F Y++LE C SL D++
Sbjct: 723 IASHEVGLLQESDDHNNVIRYYCREQAKGFFYIALELCPASLQDVV 768
|
|
| DICTYBASE|DDB_G0267650 ireA "IRE family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 448 (162.8 bits), Expect = 1.5e-39, Sum P(3) = 1.5e-39
Identities = 121/380 (31%), Positives = 199/380 (52%)
Query: 393 KSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESK-----VGE---TDGL 444
++ QN +I PKKKK ++ N N E +N I N + + E T+ +
Sbjct: 478 QNSNQNN-NINNKKTPKKKKKKQKNKNNKNNNDEDDENEIENYNDNQNDLIDEFISTNSV 536
Query: 445 SHITGNGEKFLLTFTDLIDD---RV---DGR-RIGKL-VVFNKEIAKGSNGTVVLEGNYE 496
++ L+ ++ I++ ++ +G +IGKL ++ NK + GS GT+V EG E
Sbjct: 537 IQQQQQQQQQLINSSNKINNGSGKIILDNGNVKIGKLEIITNKILGTGSCGTIVYEGKME 596
Query: 497 GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
GR VAVKR++ A +E+ LI SD+H N+VR+Y E D +F+YL++ C SL+
Sbjct: 597 GRKVAVKRMLSQFVKFADREVSILIHSDEHTNVVRYYAKEEDDEFIYLAISFCQKSLDMY 656
Query: 557 IY-VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615
+ LS + Q SN N + ++ N + Q++ ++
Sbjct: 657 VQQTLSLQISPTDSPSIQSSNNNGNGNNG-----NNNNNNQIIIDN--KTKQMIL---EL 706
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 675
GL HLH + ++HRD+KP NVLI D + K+SDMG+ K L D LT + S
Sbjct: 707 FKGLEHLHSLNIVHRDIKPHNVLI--DPNNRVKISDMGLGKLLDNDDQSLTFTSD---SH 761
Query: 676 GWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
GWQ P + L G R T+ +D+FSLGC++++ +TG HP+G + R+ N++K + D+ ++
Sbjct: 762 GWQ-PAEYLNGTNRNTKKVDIFSLGCVVYYLLTGA-HPFGHRYNREKNVLKGKFDIDQIK 819
Query: 734 HIPEAVDLFTRLLDPNPDLR 753
H+P+ L ++ P+ R
Sbjct: 820 HLPDIHQLVHSMIQFEPEKR 839
|
|
| ZFIN|ZDB-GENE-090312-15 ern2 "endoplasmic reticulum to nucleus signaling 2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 252 (93.8 bits), Expect = 4.5e-39, Sum P(4) = 4.5e-39
Identities = 55/161 (34%), Positives = 89/161 (55%)
Query: 603 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMGISKRLQ 659
H + + + GLSHLH + ++HRDLKP+N+L+S + A +SD G+ K+L
Sbjct: 647 HSELNPVSLLEQTMCGLSHLHSLNIVHRDLKPRNILLSLPGALGRVRALISDFGLCKKLP 706
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGGKHPYGESF 716
+ + G+ GW APE L+ +G T A+D+FS GC+ ++ + G+HP+G++
Sbjct: 707 DGRHSFSLRSGIPGTEGWIAPELLINAPKGNPTSAVDIFSAGCVFYYVTSKGQHPFGDTL 766
Query: 717 ERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLR 753
R ANI+ +L +E I E V DL R++ P+ R
Sbjct: 767 RRQANILSGVYNLDHFMEDIHEDVIGRDLIERMISAEPESR 807
|
|
| UNIPROTKB|F1NPU5 Gga.10887 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 244 (91.0 bits), Expect = 1.4e-38, Sum P(4) = 1.4e-38
Identities = 55/165 (33%), Positives = 90/165 (54%)
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMGIS 655
KA H Q + + + SGL++LH + ++HRDLKP N+LIS + A +SD G+
Sbjct: 627 KAFSHHGLQPIALLQQTTSGLAYLHSLSIVHRDLKPHNILISMPNAHGKVKAMISDFGLC 686
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPY 712
K+L ++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+
Sbjct: 687 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPF 746
Query: 713 GESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLR 753
G+S +R ANI+ L FL E + DL ++++ +P R
Sbjct: 747 GKSLQRQANILLGAYSLEFLDAGRHEDIVARDLIEQMINMDPQKR 791
|
|
| WB|WBGene00002147 ire-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 262 (97.3 bits), Expect = 2.1e-37, Sum P(5) = 2.1e-37
Identities = 57/151 (37%), Positives = 88/151 (58%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSC 664
L + + GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR+Q +
Sbjct: 613 LRDIMKQATDGLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKRVQPGKNS 672
Query: 665 LTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 722
+++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S R ANI
Sbjct: 673 ISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKSLHRQANI 732
Query: 723 VKDRKDLFLVEHIPE---AVDLFTRLLDPNP 750
V L + + + A DL + +L+ P
Sbjct: 733 VNGEYTLNKLADLDDWSLADDLISSMLNVEP 763
|
|
| FB|FBgn0261984 Ire1 "Inositol-requiring enzyme-1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 257 (95.5 bits), Expect = 3.8e-37, Sum P(4) = 3.8e-37
Identities = 49/123 (39%), Positives = 77/123 (62%)
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAK--LSDMGISKRLQGDMSCLT 666
+V SGLSHLH + ++HRD+KPQNVLIS D + +SD G+ K+L + +
Sbjct: 646 QVLSQAASGLSHLHSLDIVHRDIKPQNVLISLPDAKGKVRVMISDFGLCKKLNFGKTSFS 705
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
+ + G+ GW APE + R T A+D+FSLGC+ ++ ++GG H +G++ +R ANI+
Sbjct: 706 RRSGVTGTDGWIAPEMMRSQRTTTAVDIFSLGCVYYYVLSGGHHAFGDNLKRQANILSHE 765
Query: 727 KDL 729
+L
Sbjct: 766 YNL 768
|
|
| CGD|CAL0001725 IRE1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 230 (86.0 bits), Expect = 6.9e-36, Sum P(4) = 6.9e-36
Identities = 82/303 (27%), Positives = 134/303 (44%)
Query: 390 KQVKSKKQNEEHITKTGIPKKKKSRRP-GYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 448
+Q ++ I + PKKK+ R G R Q +E + + +
Sbjct: 679 QQTETDTATITEINEETTPKKKRKRGSRGGRRGGARKNNKQKTNGDEDQEDQQQNDESVV 738
Query: 449 GNG---EKFLLTFTDL--IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVK 503
K L+ + L I R + LV+ +K + GS+GTVV +G +E R VAVK
Sbjct: 739 DEEIIPTKSLIPPSSLPAIKSRKKLQIENNLVISDKILGYGSHGTVVFQGTFENRPVAVK 798
Query: 504 RLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLERCTCSLNDLIYVLS 561
R++ +D+A E++ L SD HPN+VR++ +S + F+Y++LE C C+L D+I
Sbjct: 799 RMLLDFYDIANHEVRLLQESDDHPNVVRYFCSQSSESEKFLYIALELCLCTLEDII---- 854
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621
E+ N N++ +L + +++ + P L+ +I
Sbjct: 855 ---EKPQNMPNLCIPKRNDILYQLTSGLHYLHSLKIVHRDIKPQNILVA---NIKKNGKR 908
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
++I I + L+ D C KL + Q TQNA G+SGW+APE
Sbjct: 909 KNQITEIDETCENNVRLLISDFGLCKKLEND------QSSFRATTQNAAS-GTSGWRAPE 961
Query: 682 QLL 684
LL
Sbjct: 962 LLL 964
|
|
| UNIPROTKB|Q5A7G9 IRE1 "Likely protein kinase/endoribonuclease Ire1" [Candida albicans SC5314 (taxid:237561)] | Back alignment and assigned GO terms |
|---|
Score = 230 (86.0 bits), Expect = 6.9e-36, Sum P(4) = 6.9e-36
Identities = 82/303 (27%), Positives = 134/303 (44%)
Query: 390 KQVKSKKQNEEHITKTGIPKKKKSRRP-GYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 448
+Q ++ I + PKKK+ R G R Q +E + + +
Sbjct: 679 QQTETDTATITEINEETTPKKKRKRGSRGGRRGGARKNNKQKTNGDEDQEDQQQNDESVV 738
Query: 449 GNG---EKFLLTFTDL--IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVK 503
K L+ + L I R + LV+ +K + GS+GTVV +G +E R VAVK
Sbjct: 739 DEEIIPTKSLIPPSSLPAIKSRKKLQIENNLVISDKILGYGSHGTVVFQGTFENRPVAVK 798
Query: 504 RLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLERCTCSLNDLIYVLS 561
R++ +D+A E++ L SD HPN+VR++ +S + F+Y++LE C C+L D+I
Sbjct: 799 RMLLDFYDIANHEVRLLQESDDHPNVVRYFCSQSSESEKFLYIALELCLCTLEDII---- 854
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621
E+ N N++ +L + +++ + P L+ +I
Sbjct: 855 ---EKPQNMPNLCIPKRNDILYQLTSGLHYLHSLKIVHRDIKPQNILVA---NIKKNGKR 908
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
++I I + L+ D C KL + Q TQNA G+SGW+APE
Sbjct: 909 KNQITEIDETCENNVRLLISDFGLCKKLEND------QSSFRATTQNAAS-GTSGWRAPE 961
Query: 682 QLL 684
LL
Sbjct: 962 LLL 964
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00002908001 | SubName- Full=Chromosome chr18 scaffold_137, whole genome shotgun sequence; (852 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 753 | |||
| cd09213 | 312 | cd09213, Luminal_IRE1_like, The Luminal domain, a | 5e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-23 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-21 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-19 | |
| cd09769 | 295 | cd09769, Luminal_IRE1, The Luminal domain, a dimer | 7e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 9e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.001 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|188873 cd09213, Luminal_IRE1_like, The Luminal domain, a dimerization domain, of Inositol-requiring protein 1-like proteins | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 76/204 (37%), Positives = 109/204 (53%), Gaps = 19/204 (9%)
Query: 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE----FYLDVDEDWEL 105
+ LVA LDGTI+ VD G+I+WSF G P+YSSYQ+S + NA +D D L
Sbjct: 1 LLLVATLDGTIYAVDASSGEIQWSFDGGGPLYSSYQSSRDGNAESSSTMLIPSLDGDGNL 60
Query: 106 YFHSKRFGKMKKLSSSAEEYIRRMPYISK---DGGVTLGAMKTSVFLVDVKSGRVVDNYV 162
Y H K G +++L + E+ + P +S D V +G+ +TSVF +D K+G+++ Y
Sbjct: 61 YQHDKGHGSLQRLPLTIEDLVEASPLVSDTNEDDVVVVGSKRTSVFALDAKTGKIIKTYR 120
Query: 163 LDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGE 222
D ST G SD N P + EE +L+YI RTDYVLQ+ SG+
Sbjct: 121 ADGLPSTGGSDSDGNSTPGPDELQEE------------EELLYIGRTDYVLQAIDPRSGK 168
Query: 223 VLWNVAYADFKAEFRCQEVGKSFS 246
LWNV Y +++A + + S
Sbjct: 169 ELWNVTYGEYEALTLDADELGTSS 192
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), eukaryotic translation Initiation Factor 2-Alpha Kinase 3 (EIF2AK3), and similar proteins. IRE1 and EIF2AK3 are serine/threonine protein kinases (STKs) and are type I transmembrane proteins that are localized in the endoplasmic reticulum (ER). They are kinase receptors that are activated through the release of BiP, a chaperone bound to their luminal domains under unstressed conditions. This results in dimerization through their luminal domains, allowing trans-autophosphorylation of their kinase domains and activation. They play roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), contains an endoribonuclease domain in its cytoplasmic side and acts as an ER stress sensor. It is the oldest and most conserved component of the UPR in eukaryotes. Its activation results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. EIF2AK3, also called PKR-like Endoplasmic Reticulum Kinase (PERK), phosphorylates the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. It functions as the central regulator of translational control during the UPR pathway. In addition to the eIF-2 alpha subunit, EIF2AK3 also phosphorylates Nrf2, a leucine zipper transcription factor which regulates cellular redox status and promotes cell survival during the UPR. Length = 312 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 81/280 (28%), Positives = 120/280 (42%), Gaps = 82/280 (29%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVK----THHDVALKEIQNLIASDQHPNIVRWYGV 535
+ +G GTV L G+ VA+K + K + + L+EI+ L HPNIV+ YGV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEIL-KKLNHPNIVKLYGV 59
Query: 536 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D++ +YL +E C SL DL+ G E
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSED--------------------------- 92
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L++ I+ GL +LH G+IHRDLKP+N+L+ D + KL+D G+
Sbjct: 93 ------------EILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGL 139
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG 713
SK L D S L T G+ + APE LL G + D++SLG IL+
Sbjct: 140 SKLLTSDKSLLK---TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE---------- 186
Query: 714 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+PE DL ++L +P+ R
Sbjct: 187 ---------------------LPELKDLIRKMLQKDPEKR 205
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 84/287 (29%), Positives = 128/287 (44%), Gaps = 61/287 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+++ +GS G V L G+ VA+K + K L+EI+ L HPNIVR Y
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLY 63
Query: 534 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V D+D +YL +E C L DL+ + L+E R
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---------------KKRGRLSEDEAR-------- 100
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
R I+S L +LH G++HRDLKP+N+L+ D+ KL+D
Sbjct: 101 -----------------FYLRQILSALEYLHSKGIVHRDLKPENILL--DEDGHVKLADF 141
Query: 653 GISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G++++L + T + G+ + APE LL +A+D++SLG IL+ +T GK P
Sbjct: 142 GLARQLDP-----GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPP 195
Query: 712 YGESFERDA--NIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLR 753
+ + + K F PEA DL +LL +P+ R
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKR 242
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 82/295 (27%), Positives = 121/295 (41%), Gaps = 65/295 (22%)
Query: 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNI 529
+++ GS GTV + G+ VAVK L K A +EI+ L HPNI
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRIL-RRLSHPNI 60
Query: 530 VRWYGVESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
VR D+D +YL +E C L D + G E
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSED--------------------- 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ K+ I+ GL +LH G+IHRDLKP+N+L+ ++ K
Sbjct: 99 ------------------EAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV--K 138
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707
++D G++K+L S LT G+ + APE LL G +D++SLG IL + +
Sbjct: 139 IADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGYGPKVDVWSLGVIL-YELLT 194
Query: 708 GKHPYGESFERDANIVKDRKDL---------FLVEHIPEAVDLFTRLLDPNPDLR 753
GK P+ D + R+ L EA DL + L+ +P R
Sbjct: 195 GKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKR 248
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 9e-34
Identities = 84/288 (29%), Positives = 124/288 (43%), Gaps = 58/288 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIA---SDQHPNIVRW 532
+ + +GS G+V L G +AVK V+ D L+ ++ I S QHPNIVR+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS-VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 533 YGVESD--QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
YG E D ++ + + LE + SL+ L+ G E + IR
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--------------IR----- 104
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
K TR I+ GL++LH G++HRD+K N+L+ D KL
Sbjct: 105 --------------------KYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKL 142
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G +KRL + G+ W APE + RA D++SLGC + T GK
Sbjct: 143 ADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GK 200
Query: 710 HPYGESFERDAN---IVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
P+ E A I + + EH+ EA D + L +P R
Sbjct: 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKR 248
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 74/297 (24%), Positives = 117/297 (39%), Gaps = 82/297 (27%)
Query: 479 KEIAKGSNGTVVLEGNYEGRS------VAVKRL---VKTHHDVALKEIQNLIASDQHPNI 529
++I KG G V Y+ R VA+K + K + + EIQ ++ +HPNI
Sbjct: 6 EKIGKGGFGEV-----YKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNI 59
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V++YG +D +++ +E C+ SL DL+ + + E
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES--------------------- 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
Q+ V ++++ GL +LH G+IHRD+K N+L++ D K
Sbjct: 99 ------------------QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VK 138
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L D G+S +L + T G+ W APE + D++SLG G
Sbjct: 139 LIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-G 193
Query: 709 KHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLR 753
K PY E + K LF + E D + L NP+ R
Sbjct: 194 KPPYSEL-----PPM---KALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKR 242
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 7e-25
Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 56/233 (24%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWY 533
K++ G+ G+V L N E G VA+K++ K + + L+E+++L ++HPNIV+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + D +Y E +L L+ K++ +E IR
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLM-------------KDRKGKPFSESVIR--------- 102
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ I+ GL+H+H+ G HRDLKP+N+L+S K++D G
Sbjct: 103 ----------------SIIYQILQGLAHIHKHGFFHRDLKPENLLVS--GPEVVKIADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQT---RAIDLFSLGCILF 702
+++ ++ S T Y S+ W +APE LL R T +D+++LGCI+
Sbjct: 145 LAREIR---SRPPY--TDYVSTRWYRAPEILL--RSTSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 66/296 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQN---LIASDQ 525
+ K++ +G+ G V +G +G+ VAVK L + + ++E ++
Sbjct: 1 LTLGKKLGEGAFG-EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPN+V+ GV ++++ +Y+ +E Y+ G L ++ L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVME----------YMEGGDLLSYL--RKNRPKL-------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ LL I G+ +L IHRDL +N L+ ++
Sbjct: 100 ------------------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-- 139
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K+SD G+S+ L D Y G W APE L +G+ T D++S G
Sbjct: 140 VVKISDFGLSRDLYDDDY--------YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 191
Query: 700 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+L+ T G+ PY S E +K+ L + P + DL + +P+ R
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 75/307 (24%), Positives = 123/307 (40%), Gaps = 77/307 (25%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNI 529
F K I +GS TVVL + + A+K L K E + L + HP I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
++ Y D++ +Y LE G + + L+E R
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPN----------GELLQYIR----KYGSLDEKCTRFY--- 107
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ I+ L +LH G+IHRDLKP+N+L+ KD K+
Sbjct: 108 ---------------AAE-------ILLALEYLHSKGIIHRDLKPENILLDKDMH--IKI 143
Query: 650 SDMGISKRLQGD----------MSCLTQNATGY-------GSSGWQAPEQLLQGRQTRAI 692
+D G +K L + + +Q G++ + +PE L + ++
Sbjct: 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203
Query: 693 DLFSLGCILFFCITGGKHP-YGES----FERDANIVKDRKDLFLVEHIPE-AVDLFTRLL 746
DL++LGCI++ +T GK P G + F++ + + F + P A DL +LL
Sbjct: 204 DLWALGCIIYQMLT-GKPPFRGSNEYLTFQK----ILKLEYSFP-PNFPPDAKDLIEKLL 257
Query: 747 DPNPDLR 753
+P R
Sbjct: 258 VLDPQDR 264
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 71/285 (24%), Positives = 122/285 (42%), Gaps = 54/285 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKR-----LVKTHHDVALKEIQNLIASDQHPNIVRW 532
K+I KGS G V L +G+ +K + + + AL E++ ++ HPNI+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y ++ + + +E Y G +++ ++++ E +I
Sbjct: 65 YESFEEKGKLCIVME----------YADGGDLSQKIKKQKKEGKPFPEEQI--------- 105
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L + L +LH ++HRD+KPQN+ ++ + KL D
Sbjct: 106 ----------------LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDF 147
Query: 653 GISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
GISK L + T T Y S PE L Q + D++SLGC+L+ T KH
Sbjct: 148 GISKVLSSTVDLAKTVVGTPYYLS----PE-LCQNKPYNYKSDIWSLGCVLYELCT-LKH 201
Query: 711 P-YGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
P GE+ A I+K + ++ E +L + LL +P+ R
Sbjct: 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 67/295 (22%), Positives = 115/295 (38%), Gaps = 63/295 (21%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
+ K++ +G+ G V +G+ + VAVK L + + ++E ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNIV+ GV ++++ + + +E Y+ G + L
Sbjct: 61 PNIVKLLGVCTEEEPLMIVME----------YMPGGDLLDYL------------------ 92
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ EL + LL I G+ +L IHRDL +N L+ ++
Sbjct: 93 ---RKNRPKEL------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--V 141
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCI 700
K+SD G+S+ L D Y G W APE L +G+ T D++S G +
Sbjct: 142 VKISDFGLSRDLYDDDY--------YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 701 LFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
L+ T G+ PY S +K L + P + L + +P+ R
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 9e-23
Identities = 79/300 (26%), Positives = 120/300 (40%), Gaps = 64/300 (21%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRW 532
+++ +GS G V L + + VA+K L K L+EIQ L + + PNIV+
Sbjct: 6 RKLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y D+ +YL +E YV GS E+ L + L
Sbjct: 64 YDFFQDEGSLYLVME----------YVDGGSLEDLLKKIGRKGPL--------------- 98
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ L + I+S L +LH G+IHRD+KP+N+L+ +D KL D
Sbjct: 99 -----------SESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-GRVVKLIDF 146
Query: 653 GISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 706
G++K L S + A T G+ G+ APE LL + + D++SLG L+ +T
Sbjct: 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206
Query: 707 GGKHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
G GE + A DL +LL +P R
Sbjct: 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 80/286 (27%), Positives = 122/286 (42%), Gaps = 62/286 (21%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-ALKEIQ---NLIASDQHPNIVRWYG 534
I +G+ G V N E G VA+K++ ALK I +L+ + +HPNIV++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D +Y+ LE Y +GS L
Sbjct: 67 SIETSDSLYIILE----------YAENGS-------------LRQ--------------- 88
Query: 595 IELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ K G L+ V ++ GL++LHE G+IHRD+K N+L +KD KL+D G
Sbjct: 89 --IIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713
++ +L G+ W APE + + A D++SLGC + +T G PY
Sbjct: 145 VATKLNDVSKDDASVV---GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPY- 199
Query: 714 ESFERDA-----NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ + IV+D L E I PE D + +P+LR
Sbjct: 200 --YDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 64/288 (22%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQ---NLIASDQHPNIVRW 532
+ GS G+V N + G AVK + A+K+++ L++ QHPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G E ++D +Y+ LE V GS + L + E IRL
Sbjct: 68 LGTEREEDNLYIFLE----------LVPGGSLAKLL----KKYGSFPEPVIRLY------ 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
TR I+ GL +LH+ +HRD+K N+L+ D + KL+D
Sbjct: 108 -------------------TRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADF 146
Query: 653 GISKRL--QGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGK 709
G++K++ GS W APE + QG A D++SLGC + T GK
Sbjct: 147 GMAKQVVEFSFAKSFK------GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GK 199
Query: 710 HPYGESFERDA--NIVKDRKDLFLV-EHI-PEAVDLFTRLLDPNPDLR 753
P+ + A I + K+L + +H+ EA D + L +P LR
Sbjct: 200 PPWSQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLR 246
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 83/284 (29%), Positives = 126/284 (44%), Gaps = 60/284 (21%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR-W 532
+ KGS G V+L G+ A+K L K + KE++ N+++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y + ++ +YL LE +L L +E R R
Sbjct: 60 YAFQ-TEEKLYLVLEYAPG--GELFSHL------------SKEGRFSEERARF------- 97
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ A +IV L +LH +G+I+RDLKP+N+L+ D KL+D
Sbjct: 98 -----YAA-------------EIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDF 137
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G++K L + S G+ + APE LL +A+D +SLG +L+ +T GK P
Sbjct: 138 GLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPF 193
Query: 712 YGESFER-DANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
Y E + I+KD L E + PEA DL + LL +P R
Sbjct: 194 YAEDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 60/254 (23%), Positives = 98/254 (38%), Gaps = 65/254 (25%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ K++ +G+ G V +G VAVK L + + L+E +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS- 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNIVR GV + + +Y+ E Y+ G + L ++ L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTE----------YMPGGDLLDFL--RKHGEKL-------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
LL++ I G+ +L +HRDL +N L++++
Sbjct: 100 ------------------TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENL-- 139
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
K+SD G+S+ + D Y G W APE L G+ T D++S G
Sbjct: 140 VVKISDFGLSRDIYEDDY--------YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 699 CILFFCITGGKHPY 712
+L+ T G+ PY
Sbjct: 192 VLLWEIFTLGEQPY 205
|
Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 53/246 (21%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQ---NLIASDQHPNIVRW 532
+I G+ G V N + G +AVK R+ +KEI ++ +HPN+V++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHPNLVKY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
YGVE ++ VY+ +E C+ G+ EE L +L+E IR+
Sbjct: 65 YGVEVHREKVYIFMEYCS----------GGTLEELLEHGR----ILDEHVIRVY------ 104
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ QLL+ GL++LH G++HRD+KP N+ + D + KL D
Sbjct: 105 ------------TLQLLE-------GLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDF 143
Query: 653 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQT---RAIDLFSLGCILFFCITGG 708
G + +L+ + + + G+ + APE + G+ RA D++SLGC++ T G
Sbjct: 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-G 202
Query: 709 KHPYGE 714
K P+ E
Sbjct: 203 KRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 61/248 (24%), Positives = 97/248 (39%), Gaps = 50/248 (20%)
Query: 479 KEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVR 531
K++ +G+ G V + + + VAVK L + + K+ HPN+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
GV ++++ +YL LE Y+ G +LL+ +R
Sbjct: 61 LLGVCTEEEPLYLVLE----------YMEGG-------------DLLDYLRKSRPVFPSP 97
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K LL I G+ +L +HRDL +N L+ +D K+SD
Sbjct: 98 EKST-------LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISD 148
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G+S+ + D + + G W APE L G T D++S G +L+ T
Sbjct: 149 FGLSRDVYDDDYYRKK------TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 707 GGKHPYGE 714
G PY
Sbjct: 203 LGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 76/287 (26%), Positives = 122/287 (42%), Gaps = 63/287 (21%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ-------HPNIVRW 532
+ G G V L + + R+ A+K VK H V Q I S++ HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC-VKKRHIVETG-QQEHIFSEKEILEECNHPFIVKL 58
Query: 533 YGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y D+ ++Y+ +E C L ++ +D L +E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------------RDRGLFDE----------- 92
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+A+ +V +LH G+I+RDLKP+N+L+ D + KL D
Sbjct: 93 ------------YTARFY--IACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVD 136
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +K+L+ + T G+ + APE +L ++D +SLG +L+ +TG P
Sbjct: 137 FGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP-P 191
Query: 712 YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+GE E +I+K L +I A DL +LL NP+ R
Sbjct: 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 57/244 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPN 528
+ I KG G V + G+Y G+ VAVK L K Q +A +HPN
Sbjct: 8 LKLGATIGKGEFGDV-MLGDYRGQKVAVKCL-KDD----STAAQAFLAEASVMTTLRHPN 61
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+V+ GV + +Y+ E Y+ G +L++ +R R V
Sbjct: 62 LVQLLGVVLQGNPLYIVTE----------YMAKG-------------SLVDYLRSRGRAV 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ AQ L D+ G+ +L E +HRDL +NVL+S+D AK
Sbjct: 99 IT--------------LAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED--LVAK 142
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+SD G++K + Q +G W APE L + + + D++S G +L+ + G
Sbjct: 143 VSDFGLAKE-----ASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 709 KHPY 712
+ PY
Sbjct: 197 RVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 75/247 (30%), Positives = 105/247 (42%), Gaps = 57/247 (23%)
Query: 481 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV-----------ALKEIQNLIASDQHPN 528
I GS G+V L N G +AVK++ AL L+ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV++ G D D + + LE YV GS LN + E +R
Sbjct: 68 IVQYLGSSLDADHLNIFLE----------YVPGGSVAALLN----NYGAFEETLVR---- 109
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
R I+ GL++LH G+IHRD+K N+L+ D K
Sbjct: 110 ---------------------NFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIK 146
Query: 649 LSDMGISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
+SD GISK+L+ + N + GS W APE + Q TR D++SLGC++ +
Sbjct: 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
Query: 706 TGGKHPY 712
T GKHP+
Sbjct: 207 T-GKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 61/287 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-------SDQHPNIV 530
K I+KG+ G+V L + G A+K L K+ A ++ N+ A + P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVA 60
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ Y +D++YL +E Y+ G L+ +
Sbjct: 61 KLYYSFQSKDYLYLVME----------YLNGGDCAS------------------LIKTL- 91
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
G P + ++V G+ LH+ G+IHRD+KP+N+LI D++ KL+
Sbjct: 92 ----------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLT 139
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+S+ G N G+ + APE +L + D +SLGC++F + G
Sbjct: 140 DFGLSR--NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
Query: 711 PYGESFERD-ANIVKDRKDL--FLVEHI-PEAVDLFTRLLDPNPDLR 753
+ E+ + NI+ R + + E PEAVDL RLL +P R
Sbjct: 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|188875 cd09769, Luminal_IRE1, The Luminal domain, a dimerization domain, of the Serine/Threonine protein kinase, Inositol-requiring protein 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 15/187 (8%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVD-EDWELYF 107
D+ LV+ +DG +H VD K GKI WS P+ + V+ D LY
Sbjct: 2 DLLLVSTVDGGLHAVDRKTGKILWSLKAEDPLVEV-PHHSTLSIDGPTFIVEPRDGSLYV 60
Query: 108 HSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167
+ +KKL + + ++ P S DG + G+ +T+ + VD ++G + +
Sbjct: 61 LNPGNEGLKKLPFTIPQLVQSSPCRSSDGILYTGSKQTTWYTVDPRTGEKIQVLGSGGAD 120
Query: 168 STPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNV 227
S V P D + S +YI RT+Y + + E +WNV
Sbjct: 121 SN-----CPESCVDPDDDEQSECSS--------SSTIYIGRTEYTVTIYDSKTREPIWNV 167
Query: 228 AYADFKA 234
Y+D+
Sbjct: 168 TYSDYTP 174
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), a serine/threonine protein kinase (STK) and a type I transmembrane protein that is localized in the endoplasmic reticulum (ER). IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), is a kinase receptor that also contains an endoribonuclease domain in the cytoplasmic side. It plays roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its luminal domain and forms oligomers, allowing the kinase domain to undergo trans-autophosphorylation. This leads to a conformational change that stimulates its endoribonuclease activity and results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. Mammals contain two IRE1 proteins, IRE1alpha (or ERN1) and IRE1beta (or ERN2). IRE1alpha is expressed in all cells and tissues while IRE1beta is found only in intestinal epithelial cells. Length = 295 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 82/296 (27%), Positives = 125/296 (42%), Gaps = 61/296 (20%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL-KEIQ------NLI 521
R GKL + +G+ G V L + + GR +AVK++ KE+ L+
Sbjct: 5 RRGKL------LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+ QH IV++YG D + + + +E Y+ GS ++QL A L E
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFME----------YMPGGSVKDQLKA----YGALTET 104
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R K TR I+ G+ +LH ++HRD+K N+L +
Sbjct: 105 VTR-------------------------KYTRQILEGVEYLHSNMIVHRDIKGANIL--R 137
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D + KL D G SKRLQ S T + G+ W +PE + R D++S+GC +
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 702 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+T K P+ E FE A I + L H+ P+A + R N R
Sbjct: 198 VEMLT-EKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 74/311 (23%), Positives = 128/311 (41%), Gaps = 83/311 (26%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHD----VALKEIQNLIASDQHPNIVRWYG 534
I +G++G V + E G +VA+K++ ++ AL+EI+ L A QHP +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V L +E L++++ ++++ L
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVL-------------RDEERPL----------------- 96
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
P AQ+ R ++ G++++H G++HRDLKP N+LIS D K++D G+
Sbjct: 97 ---------PEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGL 145
Query: 655 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 712
++ + L + + W +APE L R+ +DL+++GCI + G
Sbjct: 146 ARLFSEEEPRLYSHQVA---TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
Query: 713 GES----------------------FER--DANIV--KDRKDLFLVEHIP----EAVDLF 742
GE+ D N + + K + L E P EA+DL
Sbjct: 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLL 262
Query: 743 TRLLDPNPDLR 753
LL +P R
Sbjct: 263 KGLLVYDPSKR 273
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (213), Expect = 2e-18
Identities = 73/297 (24%), Positives = 114/297 (38%), Gaps = 96/297 (32%)
Query: 506 VKTHHDVALKEIQNLIASD----------------QHPNIVRWYGVESDQDFVYLSLERC 549
KT VALK+I+ + +HPNIV+ V + +YL E C
Sbjct: 21 KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L + G N ++ + QLL
Sbjct: 81 DMDLKKYLDKRPGPLSP------------NLIKSIMY--------------------QLL 108
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN- 668
GL++ H ++HRDLKPQN+LI++D KL+D G+++ + T
Sbjct: 109 -------RGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEV 159
Query: 669 ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP--YGES--------FE 717
T + ++APE LL + + A+D++S+GCI ITG P G+S F+
Sbjct: 160 VTLW----YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG--KPLFPGDSEIDQLFKIFQ 213
Query: 718 ----------RDANIVKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLR 753
+ D K F L + +P E +DL +++L NP R
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 50/147 (34%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK-----RLQGDMSCLTQNA 669
IV L +LH G+IHRDLKP N+LI + KL+D G+SK R ++
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 670 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK 727
G+ + APE +L ++ +D +SLGCIL+ + G P+ + NI+ +
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGKI 218
Query: 728 D-LFLVEHIPEAVDLFTRLLDPNPDLR 753
+ VE EA+DL ++LL P+P+ R
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKR 245
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 60/289 (20%)
Query: 477 FNKEIAKGSNGTV-VLEGNYEGRSVAVKRLVKTHHDVALKEIQN------LIASDQHPNI 529
+ I KG+ G V +++ + A+K + K V ++N ++ HP +
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFL 62
Query: 530 VR-WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V WY + D++ +YL + DL+ L G L+ K + +E +++
Sbjct: 63 VNLWYSFQ-DEENMYLVV--------DLL--LGGDLRYHLSQKVK----FSEEQVKF--- 104
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
W +IV L +LH G+IHRD+KP N+L+ D+
Sbjct: 105 ---------WIC-------------EIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVH 140
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
++D I+ ++ D T + G+ G+ APE L + + A+D +SLG + C+ G
Sbjct: 141 ITDFNIATKVTPD----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-G 195
Query: 709 KHPY-GESFERDANIV---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
K PY G S I + L+ EA+D +LL+ +P R
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 61/251 (24%), Positives = 99/251 (39%), Gaps = 74/251 (29%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 522
K + +GS+G V + T ALK+I L +
Sbjct: 7 KVLGQGSSGVV---------YKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ P +V+ YG + + + LE Y+ GS L ++
Sbjct: 56 C-ESPYVVKCYGAFYKEGEISIVLE----------YMDGGS--------------LADLL 90
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISK 641
++ + E L + R I+ GL +LH +IHRD+KP N+LI+
Sbjct: 91 KKVGKIPEP---------------VLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K++D GISK L+ + L Q T G+ + +PE++ + A D++SLG L
Sbjct: 136 KG--EVKIADFGISKVLE---NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 702 FFCITGGKHPY 712
C GK P+
Sbjct: 191 LECAL-GKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 59/231 (25%), Positives = 101/231 (43%), Gaps = 54/231 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
+I +G+ G V + G VA+K++ AL+EI+ L+ HPNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKL 63
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + +YL E D++L ++ R + E+
Sbjct: 64 LDVFRHKGDLYLVFEFM------------------------DTDLYKLIKDRQRGLPESL 99
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L+ QLL+ GL+ H G++HRDLKP+N+LI+ + KL+D
Sbjct: 100 IKSYLY--------QLLQ-------GLAFCHSHGILHRDLKPENLLINTEGVL--KLADF 142
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
G+++ + T Y + W +APE LL + + +D++S+GCI
Sbjct: 143 GLARSFGSPVRPYTH----YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 59/216 (27%)
Query: 497 GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552
G+ A+K + K + L+EIQ L HPNI+R + ++ +R T
Sbjct: 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL------IEVLF---DRKTGR 74
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
L L++ L D NL ++ R P+ E ++ QLLK
Sbjct: 75 LA-LVFEL------------MDMNLYELIKGRKRPLPEKRVKSYMY--------QLLK-- 111
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT----QN 668
L H+H G+ HRD+KP+N+LI D KL+D G SC
Sbjct: 112 -----SLDHMHRNGIFHRDIKPENILIKDD---ILKLADFG---------SCRGIYSKPP 154
Query: 669 ATGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCILF 702
T Y S+ W +APE LL G +D++++GC+ F
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFF 190
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 70/288 (24%), Positives = 102/288 (35%), Gaps = 62/288 (21%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHP 527
F K++ +G G V L G+ G VAVK L + H +EI+ L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL-RTLDHE 66
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIV++ GV L L + Y+ SGS + L + +D L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLI--------MEYLPSGSLRDYLQ-RHRDQINL--------- 108
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+LL + I G+ +L IHRDL +N+L+ +
Sbjct: 109 ------------------KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LV 148
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+SD G++K L D G W APE L + + A D++S G L+ T
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
Query: 708 G---KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 752
G + P E V LL L
Sbjct: 209 GDPSQSPPAEFLRMIGI-----------AQGQMIVTRLLELLKEGERL 245
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 53/228 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYG 534
+ I G+ G V + G VA+K ++K + IQ I+ + HPNIV ++G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+D +++ +E C SL D+ V G E
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------------------------- 101
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R+ + GL++LHE G IHRD+K N+L+++D KL+D G
Sbjct: 102 -------------QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFG 146
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPE---QLLQGRQTRAIDLFSLG 698
+S +L ++ + + G+ W APE +G D+++LG
Sbjct: 147 VSAQLTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 18/160 (11%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P A+ + I+ GL HLH+ +++RDLKP+NVL+ + ++SD+G++ L+G
Sbjct: 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGG 148
Query: 662 MSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA 720
+ G G+ G+ APE L ++D F+LGC L+ I G+ P+ + E+
Sbjct: 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVE 202
Query: 721 NIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLR 753
++ K L + PEA DL LL +P+ R
Sbjct: 203 K--EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 480 EIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIVR 531
EI +G+ GTV + GR VA+K++ V + L+EI L + S +HPNIVR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
V +R L V FE +QD L +
Sbjct: 66 LLDV-----CHGPRTDREL----KLTLV----FEHV----DQD----------LATYLSK 98
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
G P + + R ++ G+ LH ++HRDLKPQN+L++ D K++D
Sbjct: 99 CP------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV--KIAD 150
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
G+++ +M+ + T + ++APE LLQ +D++S+GCI
Sbjct: 151 FGLARIYSFEMALTSVVVTLW----YRAPEVLLQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 69/248 (27%), Positives = 107/248 (43%), Gaps = 58/248 (23%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASD-------QHP 527
I KG+ G V L N G +AVK + HD K++ + S+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIV++ G E+ ++++ + LE G FEEQL +R
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL--------------VRFF- 113
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
T ++ GL++LH G++HRDLK N+L+ D C
Sbjct: 114 ------------------------TEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GIC- 147
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRA-IDLFSLGCILFFCI 705
K+SD GISK+ D+ QN + GS W APE + + A +D++SLGC++ +
Sbjct: 148 KISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE-M 205
Query: 706 TGGKHPYG 713
G+ P+
Sbjct: 206 FAGRRPWS 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 5e-16
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 49/240 (20%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 530
K I G+ G V GR VA+K++ D+ L+EI+ L+ +H NI+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENII 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ S E ND +Y+++ E L+ + L + I+
Sbjct: 63 GLLDI-----LRPPSPE----DFND-VYIVTELMETDLHKVIKSPQPLTDDHIQYF---- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKL 649
Q+L+ GL +LH +IHRDLKP N+L++ + C K+
Sbjct: 109 --------------LYQILR-------GLKYLHSANVIHRDLKPSNILVNSN---CDLKI 144
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
D G++ R T Y + W +APE LL + T+AID++S+GCI +T
Sbjct: 145 CDFGLA-RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 68/238 (28%), Positives = 105/238 (44%), Gaps = 52/238 (21%)
Query: 484 GSNGTVVLEGNYE-GRSVAVKRLVKTH-HDV--ALKEIQNLIASDQHPNIVRWYGVESDQ 539
GSNG V + + + VAVK++V T V AL+EI+ +I H NIV+ Y V
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGP- 73
Query: 540 DFVYLSLERCTCSLNDL-----IYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTK 593
S T + L +Y++ E L N EQ L+E RL
Sbjct: 74 -----SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLF------- 119
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLL+ GL ++H ++HRDLKP NV I+ + K+ D G
Sbjct: 120 -----------MYQLLR-------GLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDFG 160
Query: 654 ISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
+++ + S L++ + +++P LL T+AID+++ GCI +TG
Sbjct: 161 LARIVDPHYSHKGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 65/239 (27%), Positives = 101/239 (42%), Gaps = 48/239 (20%)
Query: 479 KEIAKGSNGTVVLEGNYEGR-SVAVK--RLVKTHHDVA--LKEIQNLIASDQHPNIVRWY 533
++I KG+ G V +G +G VAVK R L+E + L D HPNIV+
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
GV + +Y+ +E V GS L +R
Sbjct: 59 GVCVQKQPIYIVME----------LVPGGSL-------------LTFLRK---------- 85
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
K N +LL+++ D +G+ +L IHRDL +N L+ ++ K+SD G
Sbjct: 86 -----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL--KISDFG 138
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+S+ +G + + + W APE L GR T D++S G +L+ + G PY
Sbjct: 139 MSREEEGGIYTV-SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 59/251 (23%), Positives = 97/251 (38%), Gaps = 73/251 (29%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK--------EIQNLIASD------ 524
E+ G++G V T +A+K IQ I +
Sbjct: 7 GELGAGNSGVVSK-----------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK 55
Query: 525 -QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
P IV +YG + + + +E GS ++ +L EV+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDG----------GSLDK----------ILKEVQG 95
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKD 642
R+ P L K+ ++ GL++LHE +IHRD+KP N+L++
Sbjct: 96 RI------------------PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
KL D G+S +L ++ T G+S + APE++ + D++SLG L
Sbjct: 138 GQI--KLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 703 FCITGGKHPYG 713
T G+ PY
Sbjct: 191 ELAT-GRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 59/242 (24%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 538
+ +GS G+V + E G+ VA+K + V+ +KEI L D P IV++YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFK 69
Query: 539 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
+++ +E C S++D++ + + + E+
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEE------------------------------ 99
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
++ + + GL +LH IHRD+K N+L++++ AKL+D G+S +
Sbjct: 100 ---------EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQ 148
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPY 712
L M+ + T G+ W APE + + D++SLG IT GK PY
Sbjct: 149 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG------ITAIEMAEGKPPY 199
Query: 713 GE 714
+
Sbjct: 200 SD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 45/148 (30%), Positives = 82/148 (55%), Gaps = 13/148 (8%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
+ I G+ HLH + +++RD+KP+NVL+ D+ C +LSD+G++ L+ + +TQ A
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNC-RLSDLGLAVELKDGKT-ITQRA-- 155
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDR--KD 728
G++G+ APE L + + +D F++GC ++ + G+ P+ + E+ +K R +D
Sbjct: 156 -GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKEKVAKEELKRRTLED 213
Query: 729 LFLVEH---IPEAVDLFTRLLDPNPDLR 753
EH E+ D+ L P+ R
Sbjct: 214 EVKFEHQNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-14
Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 75/227 (33%)
Query: 501 AVKRLVKTHHDVALKEI----QNLIASD---------------QHPNIVRWYGV---ESD 538
A+ R +T VALK+I +N A+D HPNIV+ V E+D
Sbjct: 26 AIDR--RTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81
Query: 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598
+D +YL E L+ +I +N+L +V R + ++
Sbjct: 82 KD-IYLVFEYMETDLHAVI----------------RANILEDVHKRYI----------MY 114
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKR 657
QLLK + I SG +IHRDLKP N+L++ D C KL+D G+++
Sbjct: 115 --------QLLKALKYIHSG-------NVIHRDLKPSNILLNSD---CRVKLADFGLARS 156
Query: 658 LQGDMSCLTQNA-TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
L T Y ++ W +APE LL + T+ +D++S+GCIL
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-14
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQG----DMSCLTQNA 669
++ L+ H G++HRDLKPQN+++S AK+ D GI L G D++ LT+
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 670 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
G+ + APEQL T DL++ G I C+TG + G S
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540
I +G G V L+G Y G+ VAVK + A E ++ H N+VR GV
Sbjct: 14 IGEGEFGAV-LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
+Y+ +E + NL+N +R R ++
Sbjct: 73 -LYIVMELMS-----------------------KGNLVNFLRTRGRALV----------- 97
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK--RL 658
QLL+ + D+ G+ +L L+HRDL +N+L+S+D AK+SD G+++ +
Sbjct: 98 ---SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM 152
Query: 659 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
D S L W APE L + + D++S G +L+ + G+ PY
Sbjct: 153 GVDNSKLPVK--------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-14
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 55/213 (25%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV--RWYGVESDQDFVYLSLERC 549
G VA+K+L +L+EI L+ QHPNIV + V S+ D +Y+ +E
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L L+ + F L +EV+ +L QLL
Sbjct: 89 EHDLKSLMETMKQPF------------LQSEVKCLML--------------------QLL 116
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
SG++HLH+ ++HRDLK N+L++ K+ D G+++ + TQ
Sbjct: 117 -------SGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 670 TGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCI 700
+ W +APE LL + AID++S+GCI
Sbjct: 168 V----TLWYRAPELLLGAKEYSTAIDMWSVGCI 196
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-VLEGNYEGRSVAVK--RLVKT 508
E+ D++ + G K I +G++G V G+ VA+K RL K
Sbjct: 2 EELKAALKDIVSE---GDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQ 57
Query: 509 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
+ ++ + EI ++ +HPNIV +Y D +++ +E Y+ GS + +
Sbjct: 58 NKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME----------YMDGGSLTDII 106
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+NE Q+ V R+++ GL +LH +I
Sbjct: 107 TQNFVR---MNE-------------------------PQIAYVCREVLQGLEYLHSQNVI 138
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRD+K N+L+SKD S KL+D G + +L + S + + G+ W APE + +
Sbjct: 139 HRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDY 193
Query: 689 TRAIDLFSLGCILFFCITGGKHPY 712
+D++SLG I+ + G+ PY
Sbjct: 194 GPKVDIWSLG-IMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 65/255 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
+ I +G+ G V + + G+ VA+K +++ + +E L HPNI +YG
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 536 ------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ D ++L +E C GS ++L+ +R + +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCG----------GGSV----------TDLVKGLRKKGKRLK 111
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
E + + R+ + GL++LHE +IHRD+K QN+L++K+ KL
Sbjct: 112 EE---------------WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN--AEVKL 154
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFC 704
D G+S +L S L + T G+ W APE + Q A D++SLG
Sbjct: 155 VDFGVSAQLD---STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------ 205
Query: 705 ITG-----GKHPYGE 714
IT GK P +
Sbjct: 206 ITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 61/238 (25%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNIV 530
++ +G G V L + G VA+KR+ K H + ++I + + + +V
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI---LTTTKSEWLV 64
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ D +++YL++E YV G F LN +L+E R
Sbjct: 65 KLLYAFQDDEYLYLAME----------YVPGGDFRTLLNNL----GVLSEDHARFYMA-- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
++ + LHE+G IHRDLKP+N LI D S KL+
Sbjct: 109 -----------------------EMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLT 143
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
D G+SK +T + GS + APE +L+G+ +D +SLGC+L+ + G
Sbjct: 144 DFGLSK------GIVTYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 54/162 (33%), Positives = 85/162 (52%), Gaps = 21/162 (12%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P + T I+SGL HLH+ +I+RDLKP+NVL+ D + ++SD+G++ L+
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDG 150
Query: 662 MSCLTQNAT-GY-GSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 718
Q+ T GY G+ G+ APE LLQG + ++D F+LG L+ I + P+ E+
Sbjct: 151 -----QSKTKGYAGTPGFMAPE-LLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEK 203
Query: 719 DANIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLR 753
N K+ K L + + P + LL +P+ R
Sbjct: 204 VEN--KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 43/133 (32%), Positives = 73/133 (54%), Gaps = 4/133 (3%)
Query: 589 MEN-TKDIELWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
MEN + D L K +G + QL+ + R I SG+ +L ++G +HRDL +N+L+ + +
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLV 144
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+SD G+S+ L+ D G W APE + + T A D++S G +++ ++
Sbjct: 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 707 GGKHPYGESFERD 719
G+ PY E +D
Sbjct: 205 YGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 49/144 (34%), Positives = 79/144 (54%), Gaps = 13/144 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+I L HLH+ G+I+RDLKP+N+L+ D KL+D G+ K + T T
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL-- 729
G+ + APE L++ +A+D +SLG +++ +TG E+ ++ + I+K + +L
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLR 753
+L PEA DL +LL NP R
Sbjct: 222 YLT---PEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 82/290 (28%), Positives = 128/290 (44%), Gaps = 66/290 (22%)
Query: 481 IAKGSNGTVVLEGNYEGR------SVAVKRL-VKTHHDVA-LKEIQNLIASDQHPNIVRW 532
+ KG+ G V Y R +A+K + + V L E L + +H NIV++
Sbjct: 16 LGKGTYGIV-----YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G +S+ F + +E+ V GS S LL R + P+ +N
Sbjct: 71 LGSDSENGFFKIFMEQ----------VPGGSL----------SALL---RSKWGPLKDNE 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ I + T+ I+ GL +LH+ ++HRD+K NVL++ K+SD
Sbjct: 108 QTIIFY-------------TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV-KISDF 153
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH 710
G SKRL G C T+ T G+ + APE + +G + D++SLGC + T GK
Sbjct: 154 GTSKRLAGINPC-TETFT--GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKP 209
Query: 711 PYGESFERDANIVKDRKDLFLVEH--IPEAV-----DLFTRLLDPNPDLR 753
P+ E E A + K H IPE++ + R +P+PD R
Sbjct: 210 PFIELGEPQAAMFKVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 67/250 (26%)
Query: 477 FNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHHDVALKE---IQ--NLIASDQHPNIV 530
F KE+ G G V L G + G VA+K + + A+ E I+ ++ HPN+V
Sbjct: 8 FLKELGSGQFGVVHL-GKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ YGV + Q +++ E Y+ +G LLN +R R
Sbjct: 63 QLYGVCTKQRPIFIVTE----------YMANGC-------------LLNYLRER--KGKL 97
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
T LL + D+ + +L G IHRDL +N L+ +D K+S
Sbjct: 98 GT-------------EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED--NVVKVS 142
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+++ + D Y SS W PE R + D++S G +++
Sbjct: 143 DFGLARYVLDDQ---------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 704 CITGGKHPYG 713
+ GK PY
Sbjct: 194 VFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 51/229 (22%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAV------KRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
+ KG+ G L E S+ V RL + AL EI +++ QHPNI+ +Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI-VILSLLQHPNIIAYYN 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D + + + +E G+ +++ Q L E
Sbjct: 67 HFMDDNTLLIEMEYAN----------GGTLYDKIV--RQKGQLFEE-------------- 100
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+L IVS +S++H+ G++HRD+K N+ ++K KL D GI
Sbjct: 101 -----------EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGI 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILF 702
SK L + S T G+ + +PE L QG + D+++LGC+L+
Sbjct: 148 SKILGSEYS---MAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLY 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 53/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V +E+ +G+ G V L Y VAVK L +T + A K+ + L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NIV++YGV ++ D + E Y+ G + L + D+ L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFE----------YMEHGDLNKFLRSHGPDAAFL------- 109
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ EL + QLL++ I SG+ +L +HRDL +N L+ D
Sbjct: 110 --KSPDSPMGELTLS------QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--L 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + T Y G W PE ++ + T D++S
Sbjct: 160 VVKIGDFGMSRDVY---------TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 65/235 (27%), Positives = 107/235 (45%), Gaps = 52/235 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 530
KE+ +G+ G V N E +VA+K++ AL+E++ L H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y D D V+ + N+L Y+ +EE + A L+++ IR
Sbjct: 66 CLY----DMDIVFPG------NFNEL-YL----YEELMEAD------LHQI-IR------ 97
Query: 591 NTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+G P A I+ GL ++H ++HRDLKP N+L++ D K
Sbjct: 98 ----------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD--CELK 145
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ D G+++ + T Y ++ W +APE +L + T+AID++S+GCIL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 26/164 (15%)
Query: 604 PSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM 662
P L K+ IV L +LH + +IHRD+KP NVLI+++ KL D GIS L +
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV--KLCDFGISGYLVDSV 158
Query: 663 SCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSLGCILFFCITGGKHPY---GE 714
+ T +A G + APE++ +G ++ D++SLG I + G+ PY
Sbjct: 159 A-KTIDA---GCKPYMAPERINPELNQKGYDVKS-DVWSLG-ITMIELATGRFPYDSWKT 212
Query: 715 SFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLR 753
F++ +V++ + F PE D + L N R
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKF----SPEFQDFVNKCLKKNYKER 252
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 53/230 (23%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
+ +G+ G V+ N G VA+K+ ++ D AL+E++ L +H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLK 66
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +YL E +L +L+ E L +R
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELL--------------EASPGGLPPDAVRSY------- 105
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+W QLL+ +++ H +IHRD+KP+N+L+S+ KL D G
Sbjct: 106 ---IW--------QLLQ-------AIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
++ L+ T Y ++ W +APE L+ + +D++++GCI+
Sbjct: 146 FARALRARP---ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 63/240 (26%), Positives = 107/240 (44%), Gaps = 56/240 (23%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHDVALKEIQ------NLIASDQHPNIVRW 532
+ KG+ GTV +G+ +AVK++ ++ A KE + +L+ S +H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G L+ T S+ + +V GS LN R P+
Sbjct: 68 LGT---------CLDDNTISIF-MEFVPGGSISSILN--------------RFGPL---- 99
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
P K T+ I+ G+++LH ++HRD+K NV++ + KL D
Sbjct: 100 -----------PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDF 146
Query: 653 GISKRL-----QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
G ++RL G S + ++ +G+ W APE + + R D++S+GC +F TG
Sbjct: 147 GCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/114 (32%), Positives = 64/114 (56%), Gaps = 15/114 (13%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + R I SG+ +L E+ +HRDL +N+L++ + K+SD G+S+RL+
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRRLE------D 158
Query: 667 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
AT Y + G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 159 SEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 490 VLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546
V G + G + VAVK L L+E Q ++ +H +V+ Y V S+++ +Y+
Sbjct: 22 VWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 606
E Y+ GS + L K + L LP
Sbjct: 81 E----------YMSKGSLLDFL--KSGEGKKLR------LP------------------- 103
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I G+++L IHRDL +N+L+ ++ K++D G+++ ++ D
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG--ENLVCKIADFGLARLIEDDEYTAR 161
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ A W APE GR T D++S G +L +T G+ PY
Sbjct: 162 EGAK--FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 32/162 (19%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-----QGDMSCLTQNA 669
+V L +H++G IHRD+KP N+LI D KL+D G+ K++ + + N
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHI--KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 670 TGY---------------------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
G+ + APE L D +SLG IL+ + G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 709 KHPYGESFERDAN-IVKDRKDLFLVEHI---PEAVDLFTRLL 746
Y ++ + N I+ ++ L PEA+DL RLL
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 56/215 (26%)
Query: 497 GRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548
GR VA+K++ + AL+EI+ L+ +HPNI+ V + + L E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLVFE- 82
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
+ E+ ++ + I L P DI+ +
Sbjct: 83 ----------FMETDLEK----------VIKDKSIVLTP-----ADIKSY------MLMT 111
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
L+ GL +LH ++HRDLKP N+LI+ D KL+D G+++ +T
Sbjct: 112 LR-------GLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQ 162
Query: 669 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ W +APE L R +D++S+GCI
Sbjct: 163 VV----TRWYRAPELLFGARHYGVGVDMWSVGCIF 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 55/251 (21%), Positives = 93/251 (37%), Gaps = 82/251 (32%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD---VALKEIQ----------------N 519
+ I KGS GTV R V+ D + KEI N
Sbjct: 6 ETIGKGSFGTV--------------RKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51
Query: 520 LIASDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
++ +HPNIVR+Y ++ +Y+ +E C DL ++ K++ +
Sbjct: 52 ILRELKHPNIVRYYDRIIDRSNQTLYIVME--YCEGGDLAQLIQ-------KCKKERKYI 102
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDL 632
+ ++ ++ L H ++HRDL
Sbjct: 103 --------------------------EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136
Query: 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRA 691
KP N+ + + KL D G++K L D + A Y G+ + +PEQL
Sbjct: 137 KPANIFLDANN--NVKLGDFGLAKILGHD----SSFAKTYVGTPYYMSPEQLNHMSYDEK 190
Query: 692 IDLFSLGCILF 702
D++SLGC+++
Sbjct: 191 SDIWSLGCLIY 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 4e-12
Identities = 58/229 (25%), Positives = 89/229 (38%), Gaps = 72/229 (31%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLER 548
G VA+K+ ++ ++ A++EI+ L+ +HPNIVR + + +Y+ E
Sbjct: 24 GELVALKK-IRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
L L+ F E K QL
Sbjct: 82 MDHDLTGLLDSPEVKFTES-QIK-------------------------------CYMKQL 109
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMS- 663
L+ GL +LH G++HRD+K N+LI+ D KL+D G +KR D +
Sbjct: 110 LE-------GLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTN 160
Query: 664 ---CLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITG 707
L W P +LL G R +D++S+GCIL G
Sbjct: 161 RVITL-----------WYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 55/255 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V +E+ +G+ G V L Y + VAVK L K D A K+ L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQ 65
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IV++YGV + D + + E Y+ G + L A D+ L+ E
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFE----------YMKHGDLNKFLRAHGPDAVLMAEGN--- 112
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E T+ +Q+L + + I +G+ +L +HRDL +N L+ ++
Sbjct: 113 -RPAELTQ------------SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--L 157
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE ++ + T D++SL
Sbjct: 158 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 209 GVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 73/296 (24%), Positives = 126/296 (42%), Gaps = 79/296 (26%)
Query: 477 FNKEIAKGSNGTVVL---EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA------SDQHP 527
F K + GS G V+L +G+ G+ A+K L K V LK++++++ S +HP
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS--GKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+V YG D +YL +E YV G L + P
Sbjct: 62 FLVNLYGSFQDDSNLYLVME----------YVPGGELFSHLR------------KSGRFP 99
Query: 588 VMENTKDIELWKANGHPSAQLLKVTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
V R +V L +LH + +++RDLKP+N+L+ D
Sbjct: 100 ---------------------EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
K++D G +KR++G L G+ + APE +L +A+D ++LG +++
Sbjct: 139 YI--KITDFGFAKRVKGRTYTLC------GTPEYLAPEIILSKGYGKAVDWWALGILIYE 190
Query: 704 CITGGKHP--YGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ G +P + ++ +E+ I++ + F P+A DL LL + R
Sbjct: 191 MLAG--YPPFFDDNPIQIYEK---ILEGKVR-FPSFFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 48/223 (21%)
Query: 497 GRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552
VA+KR+ +T D KE+Q ++ HPN+V++Y D ++L + +
Sbjct: 26 NEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG- 83
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
GS LL +M+++ + G A + V
Sbjct: 84 ---------GS---------------------LLDIMKSS-----YPRGGLDEAIIATVL 108
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GDMSCLTQNAT 670
++++ GL +LH G IHRD+K N+L+ +D S K++D G+S L GD + + T
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRK-T 165
Query: 671 GYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 712
G+ W APE + Q D++S G I + G PY
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG-ITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 64/247 (25%), Positives = 106/247 (42%), Gaps = 50/247 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
K+I +GS G + L + + +K + T V KE L+A +HPNIV ++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +++ +E C G +++N Q L +E
Sbjct: 66 ASFQENGRLFIVMEYCD----------GGDLMKRIN--RQRGVLFSE------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+L I GL H+H+ ++HRD+K QN+ +SK+ AKL D G
Sbjct: 101 ------------DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN-GMVAKLGDFG 147
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF-FCITGGKHPY 712
I+++L M L T G+ + +PE D++SLGC+L+ C KHP+
Sbjct: 148 IARQLNDSME-LAY--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL--KHPF 202
Query: 713 -GESFER 718
G + +
Sbjct: 203 EGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 480 EIAKGSNGTVVLEGNYE--GRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIV 530
EI +G+ G V + + GR VA+KR+ V+T + ++E+ L + + +HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R + V CT S D L+ FE +QD L ++
Sbjct: 68 RLFDV-------------CTVSRTDRETKLTLVFEHV----DQD----------LTTYLD 100
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ G P+ + + ++ GL LH ++HRDLKPQN+L++ KL+
Sbjct: 101 KVPE------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLA 152
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D G+++ M+ + T + ++APE LLQ +DL+S+GCI
Sbjct: 153 DFGLARIYSFQMALTSVVVTLW----YRAPEVLLQSSYATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659
P+ + ++ G++H H+ G++HRDLKPQN+L+ K K K++D+G+ +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL-KIADLGLGRAFS 162
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700
+ T + ++APE LL + +D++S+GCI
Sbjct: 163 IPVKSYTHEIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCI 201
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 75/289 (25%), Positives = 124/289 (42%), Gaps = 64/289 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVR 531
K++ KGS G+V + + + A+K + K D A+ EI+ ++AS HPNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIR-ILASVNHPNIIS 63
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ D + + + +E DL +S ++ L+ E I
Sbjct: 64 YKEAFLDGNKLCIVME--YAPFGDLSKAISKR--------KKKRKLIPEQEI-------- 105
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
W+ QLL+ GL LHE ++HRDLK N+L+ + K+ D
Sbjct: 106 ------WRI----FIQLLR-------GLQALHEQKILHRDLKSANILLVANDLV--KIGD 146
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
+GISK L+ +M+ T G+ + APE + +GR + D++SLGC+L+ T
Sbjct: 147 LGISKVLKKNMA-----KTQIGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMAT-FAP 199
Query: 711 PY-GESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLR 753
P+ S + V+ K IP + + +L P LR
Sbjct: 200 PFEARSMQDLRYKVQRGK----YPPIPPIYSQDLQNFIRSMLQVKPKLR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 73/254 (28%), Positives = 115/254 (45%), Gaps = 49/254 (19%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDVALKEIQ-NLIASDQHPNIV 530
K + +G+ G V L + + GR +A K++ +T +V+ E + L+ + QH IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
++YG D+ L++ + Y+ GS ++QL A L E R
Sbjct: 68 QYYGCLRDRAEKTLTIF--------MEYMPGGSVKDQLKA----YGALTESVTR------ 109
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
K TR I+ G+S+LH ++HRD+K N+L +D + KL
Sbjct: 110 -------------------KYTRQILEGMSYLHSNMIVHRDIKGANIL--RDSAGNVKLG 148
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G SKRLQ T + G+ W +PE + R D++SLGC + +T K
Sbjct: 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKP 207
Query: 711 PYGESFERDANIVK 724
P+ E +E A I K
Sbjct: 208 PWAE-YEAMAAIFK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVES 537
K++ G G V + VAVK L V A E NL+ + QH +VR Y V +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
++ +Y+ E Y+ GS + L + E LL
Sbjct: 72 KEEPIYIITE----------YMAKGSLLDFLKSDEGGKVLL------------------- 102
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+L+ + I G++++ IHRDL+ NVL+S +S K++D G+++
Sbjct: 103 --------PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS--ESLMCKIADFGLARV 152
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++ + + A W APE + G T D++S G +L+ +T GK PY
Sbjct: 153 IEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 40/266 (15%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V K + +G G VV L+G +VAVK L + L+++ NL+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP++++ YG S + L +E Y GS + L E R ++
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVE----------YAKYGSLR----------SFLRESR-KV 100
Query: 586 LPVMENTKDIELWKANGHPSAQ------LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
P + +P + L+ I G+ +L E+ L+HRDL +NVL+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++ + K+SD G+S+ + + S + + + G W A E L T D++S G
Sbjct: 161 AEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 700 ILFFCITGGKHPY-GESFERDANIVK 724
+L+ +T G +PY G + ER N++K
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 73/256 (28%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-------- 524
K + F KE+ G G VV G + G+ +DVA+K I+ S+
Sbjct: 4 KDLTFLKELGTGQFG-VVKYGKWRGQ-----------YDVAIKMIKEGSMSEDEFIEEAK 51
Query: 525 -----QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
H +V+ YGV + Q +Y+ E Y+ +G N L
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTE----------YMSNGCL----------LNYLR 91
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
E R P +QLL++ +D+ G+++L IHRDL +N L+
Sbjct: 92 EHGKRFQP------------------SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFS 696
D C K+SD G+S+ + D + + GS W PE LL + + D+++
Sbjct: 134 --DDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 697 LGCILFFCITGGKHPY 712
G +++ + GK PY
Sbjct: 187 FGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 46/174 (26%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYG 673
I+ GL ++H G+IHRDLKP N+ +++D C K+ D G+++ +M TGY
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDDEM-------TGYV 176
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPY-------------G 713
++ W +APE +L + +D++S+GCI+ +TG G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 714 ESF------ERDANIV--------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
E E N + KD K++F P A+DL ++L +PD R
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKR 289
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 52/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHD---VALKEIQ---NLIASDQH 526
+V +E+ +G+ G V L Y K LV K D A K+ Q L+ + QH
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
+IV++YGV D D + + E Y+ G + L A D+ +L + + R
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFE----------YMKHGDLNKFLRAHGPDAMILVDGQPR-- 114
Query: 587 PVMENTKDIELWKANGHPS-AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+A G +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 115 ------------QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 160
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE ++ + T D++S
Sbjct: 161 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 698 GCILFFCITGGKHPY 712
G IL+ T GK P+
Sbjct: 212 GVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 54/240 (22%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVRW 532
K + G+ G V L + +++ + LK+ Q ++ HP I+R
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ E DQ F+Y+ +E YV G L + SN
Sbjct: 67 FWTEHDQRFLYMLME----------YVPGGELFSYLRNSGRFSNSTG------------- 103
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L +IV L +LH +++RDLKP+N+L+ K+ KL+D
Sbjct: 104 ----------------LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI--KLTDF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G +K+L+ + T G+ + APE + +A+D ++LG IL + + G P+
Sbjct: 146 GFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALG-ILIYEMLVGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 77/264 (29%), Positives = 122/264 (46%), Gaps = 57/264 (21%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRL------VKTHHDV-ALK-EIQNL 520
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-L 57
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ + +H IV++YG D + LS+ + Y+ GS ++QL A L E
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIF--------VEYMPGGSIKDQLKA----YGALTE 105
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
R + TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------RYTRQILQGVSYLHSNMIVHRDIKGANIL-- 138
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
+D + KL D G SKR+Q T + G+ W +PE + R D++S+ C
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 701 LFFCITGGKHPYGESFERDANIVK 724
+ +T K P+ E +E A I K
Sbjct: 199 VVEMLT-EKPPWAE-YEAMAAIFK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 534
I +GS G V N E G+ VA+K+ V++ D +AL+EI+ L +HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML-KQLKHPNLVNLIE 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + ++L E C D +LNE+
Sbjct: 68 VFRRKRKLHLVFEYC------------------------DHTVLNELEKN---------- 93
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
G P + K+ + ++ H+ IHRD+KP+N+LI+K KL D G
Sbjct: 94 -----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQI--KLCDFGF 146
Query: 655 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
++ L G + T Y ++ W +APE L+ Q +D++++GC+ +TG
Sbjct: 147 ARILTGP----GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V E+ +G+ G V L + VAVK L K + A ++ Q L+ Q
Sbjct: 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQ 65
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IVR+YGV ++ + + E Y+ G L + D+ +L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFE----------YMRHGDLNRFLRSHGPDAKILAGGE--- 112
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ L Q+L + I SG+ +L + +HRDL +N L+ +
Sbjct: 113 ---DVAPGQLTL--------GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG--L 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE +L + T D++S
Sbjct: 160 VVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G + + +I GL LH+ +++RDLKP+N+L+ ++SD+G++ +
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI--RISDLGLAVHVPEG 155
Query: 662 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG------- 713
Q G G+ G+ APE + R T + D ++LGC+L+ I G+ P+
Sbjct: 156 -----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIK 209
Query: 714 -ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
E ER +VK+ ++ + + P+A L LL +P R
Sbjct: 210 REEVER---LVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 34/89 (38%), Positives = 52/89 (58%), Gaps = 5/89 (5%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+ R+++ GL +LHE G IHRD+K N+L+S++ KL+D G+S +L MS + T
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMS---KRNT 157
Query: 671 GYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
G+ W APE + Q D++SLG
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 44/181 (24%)
Query: 523 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
S + P IV++YG ++ + +++E C GS + ++ +
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCE----------GGSLD----------SIYKK 94
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
V+ R + E L K+ ++ GLS+LH +IHRD+KP N+L++
Sbjct: 95 VKKRGGRIGEKV---------------LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
+ KL D G+S L + T G+S + APE++ + D++SLG
Sbjct: 140 RKGQ--VKLCDFGVSGEL-----VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 701 L 701
L
Sbjct: 193 L 193
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-ESDQ 539
I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV ++
Sbjct: 14 IGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599
+Y+ E Y+ GS L++ +R R V+
Sbjct: 73 GGLYIVTE----------YMAKGS-------------LVDYLRSRGRSVLGGDC------ 103
Query: 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++K
Sbjct: 104 --------LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS 153
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
TQ+ TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 154 S-----TQD-TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 18/106 (16%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA--KLSDMGISKRLQGDMSCLTQNATGY 672
I++G+ +LH ++HRDLKP N+L+ + K+ D+G+++ + L A
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---APLKPLADLD 173
Query: 673 G---SSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LFFCI 705
+ ++APE LL R T+AID++++GCI +F
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+SD G+S+ L+ D
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDPEG 163
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI---QNLIASDQHPNIVRWYGVE 536
E+ +G+ ++ G+ R VAVK L K D KE +L+++ HPNIV+ GV
Sbjct: 10 EVYEGTATDILGPGSGPIR-VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68
Query: 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 596
+ Y+ +E DL+ L + E+ LL + E
Sbjct: 69 LLNEPQYIIMELMEGG--DLLSYLRDARVERFGPP-------------LLTLKE------ 107
Query: 597 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMG 653
LL + D+ G +L ++ IHRDL +N L+S+ K+ D G
Sbjct: 108 -----------LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+++ + + G W APE LL G+ T D++S G +++ +T G+ PY
Sbjct: 157 LARDIYKS-DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 82/268 (30%), Positives = 123/268 (45%), Gaps = 65/268 (24%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDV-ALK-EIQNL 520
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-L 57
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ + H IV++YG D LS+ + ++ GS ++QL + L E
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIF--------MEHMPGGSIKDQLKS----YGALTE 105
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
R K TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------KYTRQILEGVSYLHSNMIVHRDIKGANIL-- 138
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY----GSSGWQAPEQLLQGRQTRAIDLFS 696
+D KL D G SKRLQ CL+ TG G+ W +PE + R D++S
Sbjct: 139 RDSVGNVKLGDFGASKRLQ--TICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 697 LGCILFFCITGGKHPYGESFERDANIVK 724
+GC + +T K P+ E FE A I K
Sbjct: 195 VGCTVVEMLT-EKPPWAE-FEAMAAIFK 220
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 68/250 (27%), Positives = 100/250 (40%), Gaps = 66/250 (26%)
Query: 479 KEIAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 530
K + G+ GTV + EG VA+K L + A KEI + ++AS HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
R G+ C S LI + G LL+ VR
Sbjct: 73 RLLGI-------------CLSSQVQLITQLMPLGC-------------LLDYVR------ 100
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ +I S LL I G+S+L E L+HRDL +NVL+ + K
Sbjct: 101 -NHKDNIG--------SQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VK 149
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILF 702
++D G++K L D Y + G W A E +L T D++S G ++
Sbjct: 150 ITDFGLAKLLDVD-------EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 703 FCITGGKHPY 712
+T G PY
Sbjct: 203 ELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 475 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQH 526
+ F I +G+ G V+ ++ + + A+K L + H D A E++ L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHH 62
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNI+ G ++ ++Y+++E Y G NLL+ +R +
Sbjct: 63 PNIINLLGACENRGYLYIAIE----------YAPYG-------------NLLDFLRKSRV 99
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ E A+ S QLL+ D+ +G+ +L E IHRDL +NVL+ ++
Sbjct: 100 LETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN--LA 157
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+K++D G+S+ G+ + G W A E L T D++S G +L+ ++
Sbjct: 158 SKIADFGLSR---GE-EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
Query: 707 GGKHPY 712
G PY
Sbjct: 214 LGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 53/243 (21%)
Query: 480 EIAKGSNGTV-VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYG 534
EI +G+ GTV + G +AVKR+ + L ++ ++ S P IV++YG
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ ++ +E SL D Y V E K
Sbjct: 71 ALFREGDCWICMELMDISL-DKFYKY---------------------------VYEVLKS 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ P L K+ V L++L E+ +IHRD+KP N+L+ D++ KL D G
Sbjct: 103 V-------IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFG 153
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGK 709
IS +L D T++A G + APE++ G R+ D++SLG I + + GK
Sbjct: 154 ISGQLV-DSIAKTRDA---GCRPYMAPERIDPSARDGYDVRS-DVWSLG-ITLYEVATGK 207
Query: 710 HPY 712
PY
Sbjct: 208 FPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 83/301 (27%), Positives = 125/301 (41%), Gaps = 79/301 (26%)
Query: 488 TVVLEGNYEGRSVAVKRLVKTHHDVALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLS 545
T+ L N +V + R +T A+K+I QNLI +Q Q FV
Sbjct: 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-----------IQQVFV--- 50
Query: 546 LERCTCSLNDLIYVLS--GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 603
ER + + +V+S SFE + L VME + G
Sbjct: 51 -ERDILTFAENPFVVSMFCSFE---------------TKRHLCMVMEYVE--------GG 86
Query: 604 PSAQLLK--------VTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
A LLK + R + V L +LH G++HRDLKP N+LI+ KL+D
Sbjct: 87 DCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHI--KLTD 144
Query: 652 MGISKRLQGDMSCLTQNATGY--------------GSSGWQAPEQLLQGRQTRAIDLFSL 697
G+SK G MS T G+ G+ + APE +L+ + +D +++
Sbjct: 145 FGLSK--IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAM 202
Query: 698 GCILFFCITGGKHPYGESFER-DANIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDL 752
G IL+ + G +G++ E ++ D D+ E +A DL +RLL NP
Sbjct: 203 GIILYEFLVGCVPFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLE 260
Query: 753 R 753
R
Sbjct: 261 R 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 58/237 (24%)
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNIV+ GV + + +Y+ +E V G F L K+ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVME----------LVPGGDFLSFLRKKKDELKT-------- 92
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
QL+K D +G+++L IHRDL +N L+ ++
Sbjct: 93 --------------------KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
K+SD G+S++ + Y SSG W APE L GR + D++S G
Sbjct: 133 --KISDFGMSRQEDDGI---------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 699 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+L+ + G PY G + ++ V+ + + P+ V + R D P+ R
Sbjct: 182 ILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 12/119 (10%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + R I +G+ +L E+ +HRDL +N+L+ + + K+SD G+S+ L+ D S
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS--- 161
Query: 667 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 719
+ T S G W APE + + T A D++S G +++ ++ G+ PY + +D
Sbjct: 162 -DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 68/237 (28%)
Query: 481 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHD------VALKEIQNLIASDQHPN 528
I +G+ G V Y R VA+K+ V+ ++ +L+EI L+ +HPN
Sbjct: 15 IGEGTYGIV-----YRARDTTSGEIVALKK-VRMDNERDGIPISSLREITLLLNL-RHPN 67
Query: 529 IVRWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
IV V + D ++L +E C L L+ + F E
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-------------------- 107
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+Q+ + ++ GL +LHE +IHRDLK N+L++ DK C
Sbjct: 108 -------------------SQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKG-C 146
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGR-QTRAIDLFSLGCIL 701
K++D G+++ +T + W +APE LL T AID++++GCIL
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 64/237 (27%), Positives = 112/237 (47%), Gaps = 58/237 (24%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 534
+ +GS G V+ + E G+ VA+K+ +++ D +A++EI+ ++ +H N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIE 67
Query: 535 VESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + +YL E + L+DL E+ N L+E R+R
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---------------EKYPNGLDESRVR--------- 103
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
K I+ G+ H +IHRD+KP+N+L+S +S KL D G
Sbjct: 104 ----------------KYLFQILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQG--RQTRAIDLFSLGCILFFCITG 707
++ L + T Y ++ W +APE LL G + RA+D++++GC++ +TG
Sbjct: 146 FARTLAAP----GEVYTDYVATRWYRAPE-LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 46/177 (25%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 673
I+ GL ++H ++HRDLKP N+L++ + C K+ D G++ R+ T T Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLA-RIADPEHDHTGFLTEYV 170
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKH--------------PY 712
++ W +APE +L + T+AID++S+GCIL ++ GK P
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230
Query: 713 GESFERDANIVKDR----------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753
E I+ R LF P+A+DL ++L NP R
Sbjct: 231 QEDLN---CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKR 283
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 18/150 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK + + A +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEE---EERAYSFC 167
Query: 673 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 730
G+ + APE + G +A+D +SLG + F +TG P+ E+ N +
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS-PFTVDGEQ--NSQSEISRRI 224
Query: 731 LVEHIP-------EAVDLFTRLLDPNPDLR 753
L P EA D +LL+ +P R
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 54/230 (23%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
+I +G+ GTV N E VA+KR+ D AL+EI L+ +H NIVR Y
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLY 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + L E C L +G + ++ V+ +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI------------VKSFMF------- 106
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLLK GL+ H ++HRDLKPQN+LI+K+ KL+D G
Sbjct: 107 -------------QLLK-------GLAFCHSHNVLHRDLKPQNLLINKNGEL--KLADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCIL 701
+++ + C + + W P +L G + + +ID++S GCI
Sbjct: 145 LARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 51/235 (21%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVRW 532
++I +G+ G V N G VA+K RL V A++EI +L+ HPNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI-SLLKELNHPNIVKL 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V ++ +YL E F Q K D++ L+ +
Sbjct: 65 LDVIHTENKLYLVFE----------------FLHQDLKKFMDASPLSGI----------- 97
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
P + ++ GL+ H ++HRDLKPQN+LI+ + + KL+D
Sbjct: 98 -----------PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--KLADF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706
G+++ + T + ++APE LL + + A+D++SLGCI +T
Sbjct: 145 GLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 4/89 (4%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H +IHRDLKP N+L+++D ++ D G+++ L + T Y +
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCEL--RIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 675 SGW-QAPEQLLQ-GRQTRAIDLFSLGCIL 701
+ W +APE LL T AID++S+GCI
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 68/250 (27%), Positives = 96/250 (38%), Gaps = 70/250 (28%)
Query: 480 EIAKGSNGTVV-LEGNYEGRSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG 534
EI G+ G V + G +AVK++ +T + K I ++ S P IV+ YG
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 535 V---ESDQDFVYLSLE---RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+SD V++ +E C L I
Sbjct: 82 YFITDSD---VFICMELMSTCLDKLLKRIQ------------------------------ 108
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCA 647
P L K+T IV L +L E G+IHRD+KP N+L+ D S
Sbjct: 109 ------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNV 154
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-----RAIDLFSLGCILF 702
KL D GIS RL + G + + APE++ RA D++SLG L
Sbjct: 155 KLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRA-DVWSLGISLV 209
Query: 703 FCITGGKHPY 712
T G+ PY
Sbjct: 210 ELAT-GQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 33/95 (34%), Positives = 58/95 (61%), Gaps = 11/95 (11%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H G+IHRDLKP N+ +++D K+ D G++++ +M TGY
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL--KILDFGLARQTDSEM-------TGYVV 177
Query: 675 SGW-QAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707
+ W +APE +L T+ +D++S+GCI+ +TG
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 52/214 (24%)
Query: 494 NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548
G VA+K++ D A++EI +L+ HPNIVR V ++ +YL E
Sbjct: 21 KLTGEIVALKKIRLETEDEGVPSTAIREI-SLLKELNHPNIVRLLDVVHSENKLYLVFE- 78
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
F + K DS P+ + +
Sbjct: 79 ---------------FLDLDLKKYMDS----------SPLTGLDPPL------------I 101
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
++ G+++ H ++HRDLKPQN+LI ++ + KL+D G+++ + T
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL--KLADFGLARAFGVPVRTYTHE 159
Query: 669 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI 700
+ W +APE LL RQ + +D++S+GCI
Sbjct: 160 VV----TLWYRAPEILLGSRQYSTPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 10/126 (7%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 674 SSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + DR L +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEI-DRMTLTVN 215
Query: 733 EHIPEA 738
+P++
Sbjct: 216 VELPDS 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 48/242 (19%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK-THHDVALKEIQNLIASDQHPNIV 530
KLV K++ G G V + G Y G VA+K L + + A NL+ QHP +V
Sbjct: 9 KLV---KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R Y V + Q+ +Y+ E Y+ +GS + L E
Sbjct: 65 RLYAVVT-QEPIYIITE----------YMENGSLVDFLKTPE------------------ 95
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ + K L+ + I G++ + IHRDL+ N+L+S ++ C K++
Sbjct: 96 -GIKLTINK--------LIDMAAQIAEGMAFIERKNYIHRDLRAANILVS--ETLCCKIA 144
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++ RL D + + W APE + G T D++S G +L +T G+
Sbjct: 145 DFGLA-RLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 711 PY 712
PY
Sbjct: 203 PY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 501 AVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
A+KR+ + H D A E++ L HPNI+ G + ++YL++E
Sbjct: 38 AIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE-------- 88
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615
Y G NLL+ +R + + I A+ S QLL D+
Sbjct: 89 --YAPHG-------------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 675
G+ +L + IHRDL +N+L+ ++ + AK++D G+S+ + G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSR----GQEVYVKKTMGRLPV 187
Query: 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
W A E L T D++S G +L+ ++ G PY
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 500 VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
VAVK L KT + LKEI+ +++ ++PNI+R GV D + + E
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLLGVCVSDDPLCMITE-------- 97
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS---AQLLKVT 612
Y+ +G + L+ +E +S AN PS A LL +
Sbjct: 98 --YMENGDLNQFLSQREIESTFT--------------------HANNIPSVSIANLLYMA 135
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 671
I SG+ +L + +HRDL +N L+ + K++D G+S+ L GD + A
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAV- 192
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVKDRKDLF 730
W A E +L G+ T A D+++ G L+ T K PY S D ++++ + F
Sbjct: 193 -LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY--SLLSDEQVIENTGEFF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 57/238 (23%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 500 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
VAVK L + + Q L+A HPNIV+ GV + + L E
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE--------- 88
Query: 557 IYVLSGSFEEQL---NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613
Y+ G E L + + Q S + R N + + L + +
Sbjct: 89 -YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG--LNPLPLS--------CTEQLCIAK 137
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 672
+ +G+++L E +HRDL +N L+ ++ K++D G+S+ + D ++N
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSADYYKASEN--DA 193
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFE------RDANIV 723
W PE + R T D+++ G +L+ + G PY G + E RD N++
Sbjct: 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL 251
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 38/112 (33%), Positives = 63/112 (56%), Gaps = 9/112 (8%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 674 SSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 724
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + +
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEID 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 59/233 (25%)
Query: 490 VLEGNYEGRS-VAVKRL---VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545
V EG ++ R VA+K L KE+Q L +H +++ + V
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQAL-KRLRHKHLISLFAV---------- 70
Query: 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS 605
CS+ + +Y+++ +L K L ++LPV
Sbjct: 71 -----CSVGEPVYIIT-----ELMEKGSLLAFLRSPEGQVLPV----------------- 103
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
A L+ + + G+++L E IHRDL +N+L+ +D K++D G+++ ++ D+
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED--LVCKVADFGLARLIKEDV--- 158
Query: 666 TQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Y SS W APE G + D++S G +L+ T G+ PY
Sbjct: 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 39/127 (30%), Positives = 71/127 (55%), Gaps = 17/127 (13%)
Query: 585 LLPVMENTKDIELWKANGHPSAQ--LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
++P M+ +L K GHP ++ + + ++ GL ++H G+IHRDLKP N+ +++D
Sbjct: 98 VMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI 700
K+ D G+++ +M TGY + W +APE +L + +D++S+GCI
Sbjct: 154 CEL--KILDFGLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 701 LFFCITG 707
+ +TG
Sbjct: 205 MAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 32/99 (32%), Positives = 60/99 (60%), Gaps = 8/99 (8%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+ R+++ L ++H++G+IHRD+K N+L++ + KL D G++ L + S + +T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSS---KRST 160
Query: 671 GYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
G+ W APE + +G+ T+A D++SLG ++ TG
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKA-DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 29/152 (19%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+IV GL LHE G+I+RDLK NVL+ + K++D G+ K L G + +T
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHI-KIADFGMCKEGILGGVTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF- 730
G+ + APE L A+D ++LG +L + + G+ P FE D D +LF
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSP----FEGD-----DEDELFQ 206
Query: 731 -LVE---HIP-----EAVDLFTRLLDPNPDLR 753
++E P EA + L NP+ R
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 509 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
H D A E++ L HPNI+ G + ++YL++E Y G
Sbjct: 39 HRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----------YAPHG------ 81
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
NLL+ +R + + I A+ S QLL D+ G+ +L + I
Sbjct: 82 -------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 134
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRDL +N+L+ ++ + AK++D G+S+ G + G W A E L
Sbjct: 135 HRDLAARNILVGEN--YVAKIADFGLSR---GQ-EVYVKKTMGRLPVRWMAIESLNYSVY 188
Query: 689 TRAIDLFSLGCILFFCITGGKHPY 712
T D++S G +L+ ++ G PY
Sbjct: 189 TTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 38/101 (37%), Positives = 62/101 (61%), Gaps = 12/101 (11%)
Query: 605 SAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDM 662
S+ +KV I+ GL +LH G++HRD+KP N+L++ + C K+ D G+++ + D
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDE 157
Query: 663 SC-LTQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700
S +TQ T Y ++APE L+ R T A+D++S+GCI
Sbjct: 158 SKHMTQEVVTQY----YRAPEILMGSRHYTSAVDIWSVGCI 194
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q+ + I+ GL+HLH ++HRD+K N+ + + K+ D+G++K L D +
Sbjct: 99 PEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLL-SDNT 155
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
T G+ + +PE D+++LG +L+ C T GKHP+ ++ + A I+
Sbjct: 156 NFAN--TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPF-DANNQGALIL 211
Query: 724 KDRKDLFL---VEHIPEAVDLFTRLLDPNPDLR 753
K + +F + + L + L + R
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 672
+I+ GL LH ++RDLKP+N+L+ ++SD+G++ ++ +G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHI--RISDLGLAVKIPEGESI-----RGRV 162
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 718
G+ G+ APE L R T + D + LGC+++ I G+ P+ E+
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 45/206 (21%)
Query: 498 RSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 557
+ + V+++ K A E Q ++ HPNI+ +Y + + + +E
Sbjct: 31 KQIPVEQMTKDERLAAQNECQ-VLKLLSHPNIIEYYENFLEDKALMIVME---------- 79
Query: 558 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617
Y G+ E + ++ ++LL+E I L I+
Sbjct: 80 YAPGGTLAEYIQ--KRCNSLLDEDTI-------------------------LHFFVQILL 112
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677
L H+H ++HRDLK QN+L+ K K K+ D GISK L S ++ T G+ +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKIL----SSKSKAYTVVGTPCY 167
Query: 678 QAPEQLLQGRQ-TRAIDLFSLGCILF 702
+PE L +G+ + D+++LGC+L+
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLY 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ L HLH++G+++RD+K +N+L+ + L+D G+SK + T + G
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV--LTDFGLSKEFLSEEKERTYSFC--G 168
Query: 674 SSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
+ + APE + +G +A+D +SLG ++F +TG P+ ER+ R+ L
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS-PFTLEGERNTQSEVSRRILKCD 227
Query: 733 EHIP-----EAVDLFTRLLDPNPDLR 753
P EA DL +LL +P R
Sbjct: 228 PPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 38/250 (15%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVK--THHDVA--LKEIQNLIA 522
+V K + +G G VV Y + +VAVK L T D+A + E++ +
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL 73
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ GV + + +Y+ +E Y G+ E L R
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVE----------YAAKGNLREFL-------------R 110
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P + T DI L+ + G+ +L IHRDL +NVL+++D
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + D+ + + G W APE L T D++S G +++
Sbjct: 171 NVM--KIADFGLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227
Query: 703 FCITGGKHPY 712
T G PY
Sbjct: 228 EIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 69/295 (23%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNI 529
F + + KGS G V L +G+ +K+L + A +E Q L++ +HPNI
Sbjct: 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ-LLSQLKHPNI 61
Query: 530 V----RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
V W G E ++ + C DL + L KEQ LL
Sbjct: 62 VAYRESWEG-EDGLLYIVMGF----CEGGDLYHKL----------KEQKGKLL------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
P Q+++ I L +LHE ++HRDLK QNV ++ ++
Sbjct: 100 ------------------PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT--RTN 139
Query: 646 CAKLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
K+ D+GI++ L Q DM+ +T G+ + +PE D+++LGC ++
Sbjct: 140 IIKVGDLGIARVLENQCDMA-----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 704 CITGGKHPYGESFERDAN-----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
T KH + +D N I++ + ++ PE +L +L P+ R
Sbjct: 195 MAT-LKHAFN---AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 14/148 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK D + A +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFHEDE---VERAYSFC 167
Query: 673 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL- 729
G+ + AP+ + G +A+D +S+G +++ +TG P+ E+++ R+ L
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS-PFTVDGEKNSQAEISRRILK 226
Query: 730 ----FLVEHIPEAVDLFTRLLDPNPDLR 753
+ E A D+ RLL +P R
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 62/237 (26%), Positives = 101/237 (42%), Gaps = 60/237 (25%)
Query: 479 KEIAKGSNGTVV-LEGNYEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
K+I KG V +GR VA+K++ K D LKEI +L+ HPN++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEI-DLLKQLDHPNVI 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVL----SGSFEEQL-NAKEQDSNLLNEVRIRL 585
++ F+ N+L VL +G + + K+Q RL
Sbjct: 66 KYLA-----SFIEN---------NELNIVLELADAGDLSRMIKHFKKQK---------RL 102
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+P E T +WK + S L H+H ++HRD+KP NV I+
Sbjct: 103 IP--ERT----IWK-----------YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
KL D+G+ + S T + G+ + +PE++ + D++SLGC+L+
Sbjct: 146 --KLGDLGLGRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 49/177 (27%), Positives = 78/177 (44%), Gaps = 42/177 (23%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QLLK G++ HE ++HRDLKPQN+LI+K KL+D G+++ ++ +
Sbjct: 108 QLLK-------GIAFCHENRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFS 158
Query: 667 QNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES---------- 715
+ ++AP+ LL R + +ID++S+GCI+ ITG G +
Sbjct: 159 NEVV---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
Query: 716 ------------------FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ + L H P +DL RLL NP+LR
Sbjct: 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 75/293 (25%), Positives = 122/293 (41%), Gaps = 76/293 (25%)
Query: 432 IPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-V 490
+P S + S +G+ + ++L +RV RIG G+ GTV
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSEL--ERV--NRIGS----------GAGGTVYK 92
Query: 491 LEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYGVESDQDFVYLSLE 547
+ GR A+K + H D ++I I HPN+V+ + + + + LE
Sbjct: 93 VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607
++ GS E A EQ
Sbjct: 153 ----------FMDGGSLEGTHIADEQ---------------------------------F 169
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLT 666
L V R I+SG+++LH ++HRD+KP N+LI+ K+ K++D G+S+ L M C
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPC-- 225
Query: 667 QNATGYGSSGWQAPEQ----LLQGR-QTRAIDLFSLG-CILFFCITGGKHPYG 713
N++ G+ + +PE+ L G A D++SLG IL F + G+ P+G
Sbjct: 226 -NSS-VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL--GRFPFG 274
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 50/238 (21%)
Query: 479 KEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPNIV 530
+++ +G G V L EG+ G VAVK L +H LK+ ++ + H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 531 RWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 70 KYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPRNKNKINL----------- 108
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
Q LK I G+ +L +HRDL +NVL+ + K
Sbjct: 109 -----------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VK 149
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+ D G++K ++ D T W APE L+Q + A D++S G L+ +T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 54/243 (22%), Positives = 100/243 (41%), Gaps = 51/243 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-THHDVALKEIQNLIASDQHPNIVRWY 533
+ +EI G G V L E R VA+K + + + E ++ HP +V+ Y
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
GV +++ + L E ++ G + L A+
Sbjct: 66 GVCTERSPICLVFE----------FMEHGCLSDYLRAQR--------------------- 94
Query: 594 DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
G S + LL + D+ G+++L +IHRDL +N L+ +++ K+SD
Sbjct: 95 --------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
G+++ + D Q + G+ W +PE + + D++S G +++ + GK
Sbjct: 145 GMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
Query: 710 HPY 712
PY
Sbjct: 200 TPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 53/239 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHH-DVALKEIQNLIASD-QHPNIVRWY 533
+I +GS G V + + GR VAVK+ L K ++ E+ +I D QHPNIV Y
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPNIVEMY 82
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E ++ G+ ++++ R+
Sbjct: 83 SSYLVGDELWVVME----------FLEGGAL----------TDIVTHTRMN--------- 113
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G
Sbjct: 114 -----------EEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG 160
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++ ++ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 161 FCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG-IMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 69/285 (24%), Positives = 117/285 (41%), Gaps = 76/285 (26%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASD 524
F + + GS G V+L ++ VA+KR K+ H + ++I N I
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYI--- 88
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HP V YG D+ ++YL LE +V+ G F L ++ N
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLE----------FVIGGEFFTFLRRNKRFPN-------- 130
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
D+ + A AQ++ + +L + +++RDLKP+N+L+ KD
Sbjct: 131 ---------DVGCFYA-----AQIVLI-------FEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K++D G +K + T+ T G+ + APE LL +A D ++LG ++
Sbjct: 170 I--KMTDFGFAKVVD------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN 749
+ G Y + L + + I E + F + LD N
Sbjct: 222 LVGCPPFYAN------------EPLLIYQKILEGIIYFPKFLDNN 254
|
Length = 340 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 11/95 (11%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL ++H +IHRDLKP N+ +++D K+ D G+++ +M TGY +
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEM-------TGYVA 179
Query: 675 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
+ W +APE +L + +D++S+GCI+ +TG
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 49/144 (34%), Positives = 77/144 (53%), Gaps = 15/144 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+V GL +LHE +++RDLK N+L+ + K++D G+ K M + +T G+
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFV--KIADFGLCKE---GMGFGDRTSTFCGT 164
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFER--DANIVKD--RKDL 729
+ APE L + TRA+D + LG +L + + G+ P+ G+ E D+ IV D R
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLG-VLIYEMLVGESPFPGDDEEEVFDS-IVNDEVRYPR 222
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLR 753
FL EA+ + RLL NP+ R
Sbjct: 223 FLSR---EAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 38/250 (15%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVK--THHDVA--LKEIQNLIA 522
+ K + +G G VV+ + E +VAVK L T D++ + E++ +
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 76
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ G + +Y+ +E Y G+ E L R
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL-------------R 113
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P ME + DI L+ T + G+ +L IHRDL +NVL++++
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + ++ + G W APE L T D++S G +++
Sbjct: 174 NVM--KIADFGLARDVN-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 703 FCITGGKHPY 712
T G PY
Sbjct: 231 EIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 53/244 (21%)
Query: 479 KEIAKGSNGTVVLEG---NYEGR--SVAVK-----RLVKTHHDVALKEIQNLIASDQHPN 528
K++ GS G VV G G+ VAVK +L D LKE ++ S H N
Sbjct: 1 KKLGDGSFG-VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF-LKEA-AIMHSLDHEN 57
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R YGV + ++ E GS ++L + + L+
Sbjct: 58 LIRLYGVVLTHPLMMVT-ELAPL----------GSLLDRLR--------KDALGHFLIST 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
L + Q I +G+ +L IHRDL +N+L++ D K
Sbjct: 99 --------LC----DYAVQ-------IANGMRYLESKRFIHRDLAARNILLASDDK--VK 137
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+ D G+ + L + W APE L + A D++ G L+ T G
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 709 KHPY 712
+ P+
Sbjct: 198 EEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I G++++ + IHRDL+ N+L+ + K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--LVCKIADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q A W APE L GR T D++S G +L +T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 532
K I G+ G V G +VAVK+L + TH A +E+ L+ H NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISL 85
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + Q SLE D+ V+ + D+NL + + L
Sbjct: 86 LNVFTPQK----SLEE----FQDVYLVM----------ELMDANLCQVIHMEL------- 120
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D + K+ D
Sbjct: 121 -DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDF 167
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
G+++ + T Y ++APE +L +D++S+GCI+
Sbjct: 168 GLARTACTNFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 49/207 (23%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGV 535
+ I G+ G V N +A +++K D A+ + + ++ D +H NIV ++G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+D +++ +E C SL D IY ++G E
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+Q+ V+R+ + GL +LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGV 152
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPE 681
S ++ + + + + G+ W APE
Sbjct: 153 SAQIT---ATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q A W APE L GR T D++S G +L T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 76/281 (27%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKT-HHDVALKEIQN--LIASDQHPNI 529
+ I +G+ G V + GR VAVK +T D+ K +Q ++ HPNI
Sbjct: 1 ERIGRGNFGEV-----FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 55
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-VRIRLLPV 588
VR GV + + +Y+ +E V G F + L E R+++
Sbjct: 56 VRLIGVCTQKQPIYIVME----------LVQGGDFL---------TFLRTEGPRLKV--- 93
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+L+++ + +G+ +L IHRDL +N L+++ K
Sbjct: 94 -----------------KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL--K 134
Query: 649 LSDMGISKRLQGDMSCLTQNATG-YGSSG--------WQAPEQLLQGRQTRAIDLFSLGC 699
+SD G+S+ + G Y S+G W APE L GR + D++S G
Sbjct: 135 ISDFGMSR----------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 700 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV 739
+L+ + G PY S ++ ++ L E P+AV
Sbjct: 185 LLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAV 225
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
NG P ++ ++ + H+ ++HRD+KP+N+LIS + KL D G ++ L
Sbjct: 95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL--KLCDFGFARNLSE 152
Query: 661 DMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
+ N T Y ++ W ++PE LL +A+D++S+GCIL
Sbjct: 153 GSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 63/255 (24%), Positives = 99/255 (38%), Gaps = 67/255 (26%)
Query: 470 RIGKLVVFN------------KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 517
GK ++F+ + I KG+ G V N + S A +++ HD+ +EI
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEI 61
Query: 518 QN----LIASDQHPNIVRWYGVESDQDFV-----YLSLERCTCSLNDLIYVLSGSFEEQL 568
+ L A HPN+V++YG+ +D +L LE C GS + +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN----------GGSVTDLV 111
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+ + E I + + + GL HLH I
Sbjct: 112 KGFLKRGERMEEPIIAY-------------------------ILHEALMGLQHLHVNKTI 146
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP-----EQL 683
HRD+K N+L++ + KL D G+S +L S + T G+ W AP EQ
Sbjct: 147 HRDVKGNNILLTTEGG--VKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 684 LQGRQTRAIDLFSLG 698
L D++SLG
Sbjct: 202 LDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 59/241 (24%)
Query: 479 KEIAKGSNGTV------VLEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHP 527
K I G+ G V +LE R+VA+K+L + TH A +E+ L+ H
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHK 83
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ V + Q SLE D+ V+ + D+NL +++ L
Sbjct: 84 NIIGLLNVFTPQK----SLEE----FQDVYIVM----------ELMDANLCQVIQMEL-- 123
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D +
Sbjct: 124 ------DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-- 165
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+++ T Y ++APE +L +D++S+GCI+ I G
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 708 G 708
G
Sbjct: 222 G 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GS 674
L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y G+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSFCGT 161
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL--FL 731
+ APE + + T++ D +S G ++F +TG G+ + I+K + + FL
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL 221
Query: 732 VEHIPEAVDLFTRLLDPNPDLR 753
PEA L L NP R
Sbjct: 222 S---PEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCL 665
QL+ + I G+S+LH+ G+IH+D+ +N +I D+ K++D +S+ L D CL
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNALSRDLFPMDYHCL 175
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIV 723
N W A E L+ + A D++S G +L+ +T G+ PY E FE A +
Sbjct: 176 GDNE--NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYL 232
Query: 724 KD 725
KD
Sbjct: 233 KD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 30/89 (33%), Positives = 55/89 (61%), Gaps = 11/89 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H G+IHRDLKP NV +++D ++ D G++++ +M TGY +
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL--RILDFGLARQADDEM-------TGYVA 177
Query: 675 SGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ W +APE +L + +D++S+GCI+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G+++
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQ 161
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
M+ T + ++APE LLQ +D++S+GCI
Sbjct: 162 MALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 25/150 (16%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL LH+ G+I+RDLK NVL+ KD K++D G+ K +M+ + +T G
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI--KIADFGMCKE---NMNGEGKASTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--- 730
+ + APE L + ++D +S G +L+ + G +GE D +LF
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----------DEDELFDSI 208
Query: 731 LVE--HIP-----EAVDLFTRLLDPNPDLR 753
L + H P EA D ++L + +P R
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 9e-09
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
L+ + + +G++++ + IHRDL+ N+L+ D C K++D G+++ ++ +
Sbjct: 103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVC-KIADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q A W APE L GR T D++S G +L +T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 19/147 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RDLK +N+++ KD K++D G+ K +S T G
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHI--KITDFGLCKE---GISDGATMKTFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G+ P+ + +D + +L L+E
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF---YNQDHEKL---FELILME 210
Query: 734 HI-------PEAVDLFTRLLDPNPDLR 753
I PEA L LL +P R
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 75/244 (30%)
Query: 497 GRSVAVKR-LVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
GR VA+K+ L+ D AL+EI+ ++ +HPN+V
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVP-------------------- 71
Query: 552 SLNDLIYVLSGSFEEQLNA-------KEQD-SNLLNEVRIRLLPVMENTKDIELWKANGH 603
L D+ + + + + D S LL ++L K L
Sbjct: 72 -LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL--TESQIKCYML------ 122
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI-------SK 656
QLL+ G+++LHE ++HRD+K N+LI D K++D G+
Sbjct: 123 ---QLLE-------GINYLHENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPP 170
Query: 657 RLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGE 714
+G T+ T + W + PE LL R+ T A+D++ +GC+ E
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVF-----------AE 219
Query: 715 SFER 718
F R
Sbjct: 220 MFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 43/142 (30%), Positives = 69/142 (48%), Gaps = 5/142 (3%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T +++ L +LH+ +I+RDLKP+N+L+ D L D G+ K +M + T
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKL---NMKDDDKTNTF 153
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
G+ + APE LL T+A+D ++LG +L+ +TG Y E+ + F
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213
Query: 732 VEHIPEAVDLFTRLLDPNPDLR 753
+A DL LL +P R
Sbjct: 214 DGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 1e-08
Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 10/105 (9%)
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658
K N + + R+I+ GLSHLH+ +IHRD+K QNVL++++ KL D G+S +L
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161
Query: 659 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLG 698
D + +N T G+ W APE + A DL+SLG
Sbjct: 162 --DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 479 KEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEI---QNLIASDQHPNIV 530
KE+ G+ G+VV +G Y +S VAVK L + H KE +++A HP IV
Sbjct: 1 KELGHGNFGSVV-KGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R GV C L+ V+ + L + R +PV
Sbjct: 60 RLIGV---------------CKGEPLMLVMELAPLGPLLKYLKKR--------REIPV-- 94
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
D++ +V G+++L +HRDL +NVL+ AK+S
Sbjct: 95 --SDLKEL---------AHQVAM----GMAYLESKHFVHRDLAARNVLLVNRHQ--AKIS 137
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+S+ L G W APE + G+ + D++S G L+ + G
Sbjct: 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 711 PYGE 714
PYGE
Sbjct: 198 PYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 54/231 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE--GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVR 531
++I +G+ G VV +G + G+ VA+K RL V A++EI +L+ QHPNIV
Sbjct: 6 EKIGEGTYG-VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-SLLKELQHPNIVC 63
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
V + +YL E + L K DS LP
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLK----------------KYLDS----------LP---- 93
Query: 592 TKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ A+L+K I+ G+ H ++HRDLKPQN+LI D KL+
Sbjct: 94 --------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLA 143
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700
D G+++ + T + ++APE LL R + +D++S+G I
Sbjct: 144 DFGLARAFGIPVRVYTHEVV---TLWYRAPEVLLGSPRYSTPVDIWSIGTI 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 79/263 (30%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ----------- 525
F KE+ G G V L G + + VA+K I S++
Sbjct: 8 FMKELGSGQFGVVHL-GKW-----------RAQIKVAIKAINEGAMSEEDFIEEAKVMMK 55
Query: 526 --HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
HP +V+ YGV + Q +Y+ E F E + LLN +R
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTE----------------FME-------NGCLLNYLRQ 92
Query: 584 RLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R G S LL + +D+ G+ +L IHRDL +N L+S
Sbjct: 93 R----------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-- 134
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGC 699
+ K+SD G+++ + D + + G+ W PE + + D++S G
Sbjct: 135 STGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 700 ILFFCITGGKHPYGESFERDANI 722
+++ T GK P FE+ +N
Sbjct: 190 LMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQQLRHPNTI 78
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ G + +L +E C S +D++ V L EV I
Sbjct: 79 EYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--------------LQEVEIA------ 118
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ + GL++LH IHRD+K N+L+++ + KL+
Sbjct: 119 -------------------AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLA 157
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG--CI 700
D G S ++ + G+ W APE +L +G+ +D++SLG CI
Sbjct: 158 DF-------GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ +T G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 14/100 (14%)
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------- 662
I++GL+ LH+ +HRDL P N+ I+ K C K++D G+++R
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGIC-KIADFGLARRYGYPPYSDTLSKDET 183
Query: 663 SCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 700
+ T + W +LL G + A+D++S+GCI
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223
|
Length = 335 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 490 VLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546
V EG + VAVK L D L E Q ++ +HP +++ Y V
Sbjct: 22 VWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAV----------- 69
Query: 547 ERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 601
C+L + IY+++ GS E L R LP
Sbjct: 70 ----CTLEEPIYIVTELMKYGSLLEYLQGGAG--------RALKLP-------------- 103
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
QL+ + + SG+++L IHRDL +NVL+ + + C K++D G+++ ++ D
Sbjct: 104 -----QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNIC-KVADFGLARVIKED 156
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + A W APE L R + D++S G +L +T G+ PY
Sbjct: 157 IYEAREGAK--FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 54/238 (22%), Positives = 104/238 (43%), Gaps = 53/238 (22%)
Query: 480 EIAKGSNGTVVL-EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASD-QHPNIVRWYG 534
+I +GS G V + + GR VAVK + + ++ E+ +I D QH N+V Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEV--VIMRDYQHQNVVEMYK 85
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ +++ +E ++ G+ ++++++ R+
Sbjct: 86 SYLVGEELWVLME----------FLQGGAL----------TDIVSQTRLN---------- 115
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V ++ L +LH G+IHRD+K ++L++ D KLSD G
Sbjct: 116 ----------EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF 163
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++ D+ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 164 CAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG-IMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 63/236 (26%)
Query: 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 532
K I G+ G V + G++VA+K+L + TH A +E+ L+ H NI+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGL 80
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V +S ++F VYL +E +L +I + L+ R+ L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----------------LDHERMSYL 123
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
L+ Q+L G+ HLH G+IHRDLKP N+++ KS C
Sbjct: 124 ----------LY--------QML-------CGIKHLHSAGIIHRDLKPSNIVV---KSDC 155
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K+ D G+++ T Y ++APE +L +D++S+GCI+
Sbjct: 156 TLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 31/89 (34%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL ++H G++HRDLKP N+LI+++ K+ D G+++ M TGY S
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDL--KICDFGLARIQDPQM-------TGYVS 167
Query: 675 SG-WQAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ ++APE +L ++ +D++S GCI
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 5/140 (3%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RD+K +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHI--KITDFGLCKEGISDGATMK---TFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G Y + ER ++ + F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 217
Query: 734 HIPEAVDLFTRLLDPNPDLR 753
PEA L LL +P R
Sbjct: 218 LSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
G P L ++T +V GL L E +IHRD+KP NVL++ + KL D G+S L
Sbjct: 98 GIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA 155
Query: 661 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI------DLFSLGCILFFCITGGKHPY-- 712
++ T G + APE++ G + D++SLG + G++PY
Sbjct: 156 SLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPP 209
Query: 713 ---GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
F + + IV + +A D + L+ P+ R
Sbjct: 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 33/93 (35%), Positives = 53/93 (56%), Gaps = 12/93 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
++V L HLH+ +++RDLKP+N+L+ L D G+SK + LT N T
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIA--LCDFGLSK------ANLTDNKTTNT 155
Query: 673 --GSSGWQAPEQLLQGR-QTRAIDLFSLGCILF 702
G++ + APE LL + T+ +D +SLG ++F
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVF 188
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 24/138 (17%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM--DANGMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGES------------ 715
G+ + +PE L R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 716 ----FERDANIVKDRKDL 729
F D I K KDL
Sbjct: 264 NSLTFPDDIEISKQAKDL 281
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 597 LWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
L K G A QL+ + + SG+ +L E+G +H+ L VL++ D K+S
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD--LVCKISGFR-- 152
Query: 656 KRLQGD-MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
RLQ D + +G W APE + + A D++S G +++ ++ G+ PY +
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 715 SFERDANIVKDRKDLF 730
+D ++K +D F
Sbjct: 212 MSGQD--VIKAVEDGF 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 40/260 (15%)
Query: 500 VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
V VK L KT + E + ++ H N+VR G+ + + Y+ LE
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE--------- 88
Query: 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616
Y G ++ L A E K + Q + + I
Sbjct: 89 -YTDLGDLKQFLRA--------------------TKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 676
G+ HL +HRDL +N L+S K+S + +SK + +NA
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ--REVKVSLLSLSKDVYNSEYYKLRNA--LIPLR 183
Query: 677 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRK-DLFLVEH 734
W APE + + + D++S G +++ T G+ P+ S E N ++ K +L + E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 735 IPEAV-DLFTRLLDPNPDLR 753
P + L TR NP R
Sbjct: 244 CPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+ LL + I S + +L + IHRDL +N L+ ++ K++D G+S+ + GD
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT- 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
T +A W APE L + + D+++ G +L+ T G PY
Sbjct: 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 44/253 (17%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 523
+V K + +G G VV+ E VAVK L D K++ +LI+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEM 76
Query: 524 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL----------- 115
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
R R P ME + L+ + G+ +L IHRDL +NVL+
Sbjct: 116 --RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++D K++D G+++ + + + G W APE L T D++S G
Sbjct: 174 TEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230
Query: 700 ILFFCITGGKHPY 712
+L+ T G PY
Sbjct: 231 LLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGV 535
K++ G G V + + VAVK + V A N++ + QH +V+ + V
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
+ + +Y+ E ++ GS + L + E
Sbjct: 70 VTKEP-IYIITE----------FMAKGSLLDFLKSDE----------------------- 95
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
+ P +L+ + I G++ + + IHRDL+ N+L+S S K++D G++
Sbjct: 96 ----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFGLA 149
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ ++ + + A W APE + G T D++S G +L +T G+ PY
Sbjct: 150 RVIEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +GLIHRD+KP N+L+ DK KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKM--DETGMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK 727
G+ + +PE L G R D +S+G LF + G Y +S + + D K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 728 DLFLVEHIPEAVDL 741
+ + PE V++
Sbjct: 264 NSL---NFPEDVEI 274
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQ+ V R+ + L LH +IHRD+K NVL+ D S KL+D G ++ + S
Sbjct: 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ +T G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 60/195 (30%), Positives = 81/195 (41%), Gaps = 55/195 (28%)
Query: 611 VTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS----------- 655
VTR + V + +H++G IHRD+KP N+LI + KLSD G+S
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI--KLSDFGLSTGFHKQHDSAY 159
Query: 656 --KRLQGD--------------------MSCLTQNAT--------GYGSSG---WQAPEQ 682
K LQG MS Q AT Y + G + APE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHI---PEA 738
LQ + D +SLG I+F C+ G E S E I+ R+ L+ + I EA
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279
Query: 739 VDLFTRLLDPNPDLR 753
DL RL+ N + R
Sbjct: 280 EDLIRRLIT-NAENR 293
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ +T G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 14/158 (8%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G + + +I GL LH +++RDLKP+N+L+ D ++SD+G++ +
Sbjct: 98 GFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEG 155
Query: 662 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP---YGESFE 717
+ G G+ G+ APE + R T + D + LGC+++ I GK P E +
Sbjct: 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVK 209
Query: 718 RDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
R+ VK+ ++ + + A + +LL +P R
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 9/114 (7%)
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAK 648
N K ++L P + + I+ G+ +LH ++HRDLKP N+L+ + + K
Sbjct: 99 NKKPVQL------PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
++DMG ++ + L + ++APE LL R T+AID++++GCI
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 66/238 (27%), Positives = 98/238 (41%), Gaps = 68/238 (28%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRL-------VKTHHDVALK-EIQNLIASDQHPNIVRW 532
+ G+ G V Y+GR V +L V + +K EI L H NI +
Sbjct: 24 VGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 533 YGV------ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
YG D ++L +E C S+ DL+ G NA ++D
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG------NALKED----------- 121
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
W A + R+I+ GL+HLH +IHRD+K QNVL++++
Sbjct: 122 ------------WIA---------YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE- 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLG 698
KL D G+S +L D + +N T G+ W APE + A D++SLG
Sbjct: 160 -VKLVDFGVSAQL--DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQGD 661
P + + + I+ G+ +LH ++HRDLKP N+L+ + + K++DMG ++
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ L + ++APE LL R T+AID++++GCI
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+ ++++ + G+ +L +HRDL +NVL+ AK+SD G+SK L D S
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDS 150
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W APE + + + D++S G ++ + G+ PY
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 5/149 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
+++++ +I G+++L+ +HRDL +N +++ D F K+ D G+++ + +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD--FTVKIGDFGMTRDIY-ETDYYR 176
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKD 725
+ G W APE L G T + D++S G +L+ + + PY G S E+ V D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 726 RKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
L ++ PE V DL NP +R
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ G+ HLH G+IHRDLKP N+++ D + K+ D G+++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRY-- 183
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCIL 701
++APE +L +D++S+GCI+
Sbjct: 184 --YRAPEVILGMGYKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LL I G+S+L E+ L+HRDL +NVL+ K++D G+++ L D
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID--- 162
Query: 665 LTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 718
T Y + G W A E +L R T D++S G ++ +T G PY
Sbjct: 163 ----ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY------ 212
Query: 719 DANIVKDRKDLFLVEHIPEAVDLFTRLLDP 748
D IP+ ++ RL P
Sbjct: 213 ---------DGIPAREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P+ L+K DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC--VADFGLSKKIYNGDY 167
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q W A E L T D++S G ++ T G+ PY
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 63/234 (26%)
Query: 480 EIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTH---HDVALKEIQNLIASDQHPNIVR 531
EI GS G V N + VAVK++ +T+ D+ +KE++ + +HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVK-FLQQLKHPNTIE 85
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ G + +L +E C S +DL+ V +E
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------- 120
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
++ +T + GL++LH +IHRD+K N+L+++ KL+D
Sbjct: 121 --------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLAD 164
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG--CI 700
G S + + G+ W APE +L +G+ +D++SLG CI
Sbjct: 165 F-------GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 66/245 (26%)
Query: 490 VLEGNYEGR---SVAVKRLVKTHHDVALKEIQN-------LIASDQHPNIVRWYGVESDQ 539
V EG Y GR +V ++ VKT + ++ ++ +++ H NIVR GV ++
Sbjct: 22 VYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81
Query: 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599
++ LE +++G + K + L E R R
Sbjct: 82 LPRFILLE-----------LMAGG-----DLK----SFLRENRPRP-------------- 107
Query: 600 ANGHPSA----QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGI 654
PS+ LL RD+ G +L E IHRD+ +N L++ K AK++D G+
Sbjct: 108 --ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 655 SKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
++ + A+ Y G W PE L G T D++S G +L+ +
Sbjct: 166 ARDIYR--------ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 708 GKHPY 712
G PY
Sbjct: 218 GYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 31/90 (34%), Positives = 53/90 (58%), Gaps = 10/90 (11%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 673
++ GL ++H ++HRDLKP N+L++ + C K+ D G+++ +T+ Y
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE----YV 169
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ W +APE LL + T AID++S+GCI
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L +A Q+ + ++I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
+ +L + T G+ W APE + Q D++SLG
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 32/95 (33%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GLS+ H+ ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGEL--KLADFGLARA----KSVPTKTYSNEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
+ W P +L G + ID++ +GCIL+ TG
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 2/95 (2%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677
G+ +L E +HRDL +NVL+ AK+SD G+SK L D + G W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 678 QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
APE + + + D++S G +++ + G+ PY
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 47/138 (34%), Positives = 65/138 (47%), Gaps = 15/138 (10%)
Query: 579 NEVRIRLLPVMENT-----KDIELWKANGHPSAQLLK--VTRDIVSGLSHLHEIGLIHRD 631
NE I L VME K ++ + N H L + + L+++H + HRD
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-T 689
LKPQN+LI + KL D G +K L Q + Y S ++APE +L T
Sbjct: 196 LKPQNLLIDP-NTHTLKLCDFGSAKNLLAG-----QRSVSYICSRFYRAPELMLGATNYT 249
Query: 690 RAIDLFSLGCILFFCITG 707
IDL+SLGCI+ I G
Sbjct: 250 THIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 60/235 (25%), Positives = 106/235 (45%), Gaps = 62/235 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHD-----VALKEIQNLIASDQHP 527
++I +G+ G V Y+ R ++A+K++ D A++EI +L+ QH
Sbjct: 8 EKIGEGTYGVV-----YKARDRVTNETIALKKIRLEQEDEGVPSTAIREI-SLLKEMQHG 61
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIVR V + +YL E Y+ L+ K+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFE----------YL-------DLDLKKH-------------- 90
Query: 588 VMENTKDIELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
M+++ D A +L+K I+ G+++ H ++HRDLKPQN+LI + +
Sbjct: 91 -MDSSPDF----AKNP---RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-A 141
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700
KL+D G+++ + T + ++APE LL R + +D++S+GCI
Sbjct: 142 LKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRHYSTPVDIWSVGCI 193
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQ+ V R ++S + ++H G+IHRD+K +NVL++ + C L D G + +G S
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWS-- 315
Query: 666 TQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 702
YG +G APE L T ++D++S G ++F
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 12/98 (12%)
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMSCL 665
KV + +++GL ++H ++HRD+K N+LI+KD KL+D G S +
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRY 180
Query: 666 TQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
T T + ++ PE LL R ID++ GCI+
Sbjct: 181 TNRVVTLW----YRPPELLLGERDYGPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 6/141 (4%)
Query: 614 DIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 672
+IVS L +LH E +++RDLK +N+++ KD K++D G+ K D + + T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI--KITDFGLCKEGIKDGATMK---TFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE L RA+D + LG +++ + G Y + E+ ++ + F
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
PEA L + LL +P R
Sbjct: 218 TLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 36/115 (31%), Positives = 60/115 (52%), Gaps = 15/115 (13%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
A ++ T ++ GLS+LHE +IHRD+K N+LI +++D G + RL +
Sbjct: 103 AVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGT-- 159
Query: 666 TQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYG 713
G G+ + APE +L+G Q R+ D++S+GC++ T K P+
Sbjct: 160 ---GAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/120 (30%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L K + + R+I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ +L + T G+ W APE + Q D++SLG I + G+ P +
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG-ITAIELAKGEPPNSD 203
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 64/290 (22%), Positives = 109/290 (37%), Gaps = 76/290 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQH------ 526
+ +E+ +GS G V YEG K +VK + VA+K + + +
Sbjct: 8 ITLIRELGQGSFGMV-----YEG---LAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 527 ---------PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
++VR GV S + +E + G + L ++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVME----------LMAKGDLKSYLRSRRPE--- 106
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
L P+ Q +++ +I G+++L +HRDL +N
Sbjct: 107 --AENNPGLGP---------------PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQ 688
++++D K+ D G+++ + T Y G G W APE L G
Sbjct: 150 CMVAED--LTVKIGDFGMTRDI---------YETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 689 TRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPE 737
T D++S G +L+ T + PY G S E V D L L E+ P+
Sbjct: 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPD 248
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L KA P L K++ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 87 DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
G+S +L M+ + G+ + +PE+L T D++SLG
Sbjct: 145 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 61/252 (24%)
Query: 481 IAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDVA------LKEIQNLIASD-QHPNIV 530
I KG G V L Y+ R VA+K++ + + L+E + IA+D HP IV
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAK--IAADLIHPGIV 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVM 589
Y + SD D VY ++ Y+ + + L + +++S L
Sbjct: 66 PVYSICSDGDPVYYTMP----------YIEGYTLKSLLKSVWQKES----------LS-- 103
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
K++ A L + I + + ++H G++HRDLKP N+L+ +
Sbjct: 104 ---KEL----AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVI 154
Query: 650 SDMG--ISKRLQGD-------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694
D G I K+L+ + S +T G+ + APE+LL + + D+
Sbjct: 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 695 FSLGCILFFCIT 706
++LG IL+ +T
Sbjct: 215 YALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 595 IELWKANGH--PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+E K G Q+ + ++ G+ ++H+ ++HRDLK +N+ + + K+ D
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDF 149
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILF 702
G+S+ L G T T G+ + +PE L QG +++ D++SLGCIL+
Sbjct: 150 GVSRLLMGSCDLAT---TFTGTPYYMSPEALKHQGYDSKS-DIWSLGCILY 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ + R+I+ GL +LH IHRD+K NVL+S+ KL+D G++ +L
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---I 156
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ T G+ W APE + Q D++SLG I + G+ P+ E
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPHSE 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 51/230 (22%), Positives = 100/230 (43%), Gaps = 49/230 (21%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 532
K+I +GS G +L + E G+ +K ++ + + KE+ ++++ +HPNIV++
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ +Y+ ++ C G +++NA+
Sbjct: 65 QESFEENGNLYIVMDYCE----------GGDLYKKINAQ--------------------- 93
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ P Q+L I L H+H+ ++HRD+K QN+ ++KD + KL D
Sbjct: 94 ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI--KLGDF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
GI++ L + T G+ + +PE D+++LGC+L+
Sbjct: 146 GIARVLNSTVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLY 192
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIAS-DQHPNIVRWYGV- 535
I KG+ G V N + S+A +++ DV +EI+ N++ S HPN+V++YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 536 -ESDQ---DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
++D+ ++L LE C GS E + L+E I +
Sbjct: 89 YKADKLVGGQLWLVLELCN----------GGSVTELVKGLLICGQRLDEAMISYI----- 133
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L+ A + GL HLH +IHRD+K N+L++ + KL D
Sbjct: 134 -----LYGA---------------LLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVD 171
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
G+S +L S + T G+ W APE
Sbjct: 172 FGVSAQL---TSTRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 24/138 (17%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE--GMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGES------------ 715
G+ + +PE L G R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
Query: 716 ----FERDANIVKDRKDL 729
F D +I K+ K+L
Sbjct: 264 NSLTFPDDNDISKEAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 56/285 (19%)
Query: 475 VVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALK-EIQN---LIASD 524
V F +E+ +G+ G V SVA+K L K + + ++ E + L++
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDL 65
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDL-IYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QHPNIV GV + + + E + DL +++ S + A+ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFE--YLAHGDLHEFLVRNSPHSDVGAESGD--------- 114
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
E K L + L + I +G+ +L +HRDL +N L+ +
Sbjct: 115 ------ETVKSS-LD------CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161
Query: 644 SFCAKLSDMGISK--------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695
+ K+SD G+S+ R+Q S L W PE +L G+ T D++
Sbjct: 162 T--VKISDFGLSRDIYSADYYRVQSK-SLLPVR--------WMPPEAILYGKFTTESDIW 210
Query: 696 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV 739
S G +L+ + G PY G S + +++ R+ L E P V
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+I+ GL LH G+++RDLK N+L+ D K++D G+ K + GD + T
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHI--KIADFGMCKENMLGD----AKTCTFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE LL + ++D +S G +L+ + G +G E ++ +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
EA D+ +L P+ R
Sbjct: 218 WLTREAKDILVKLFVREPERR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 4e-07
Identities = 34/107 (31%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 171
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ +T G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 17/146 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+IV GL LH G+I+RDLK NV++ +D K++D G+ K + GD + +T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI--KIADFGMCKENVFGD----NRASTFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE L + T ++D +S G +L+ + G +G+ + D R D
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVD---T 212
Query: 733 EHIP-----EAVDLFTRLLDPNPDLR 753
H P E+ D+ +L + +P R
Sbjct: 213 PHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 496 EGRS--VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549
+GR VAVK L K + LKE++ +++ + PNI+R GV D+D + + E
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
DL LS L+ KE++ N L + + S LL
Sbjct: 102 ENG--DLNQFLS---SHHLDDKEENGNDAVPPAHCLPAI-------------SYSS--LL 141
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQN 668
V I SG+ +L + +HRDL +N L+ ++ K++D G+S+ L GD +
Sbjct: 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN--LTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 714
A W A E +L G+ T A D+++ G IL C + PYGE
Sbjct: 200 AV--LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC---KEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 56/230 (24%)
Query: 500 VAVKRLVKTHHDVALKEIQNLIAS-------DQHPNIVRWYGVESDQDFVYLSLERCTCS 552
VAVK L + K++ +L++ +H NI+ GV + + +Y+ +E
Sbjct: 45 VAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA--- 98
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
NL + +R R P + D P + L
Sbjct: 99 --------------------AHGNLRDFLRARRPPGEYASPDDP------RPPEETLT-Q 131
Query: 613 RDIVS-------GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
+D+VS G+ L IHRDL +NVL+++D K++D G+++ D+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED--HVMKIADFGLAR----DIHHI 185
Query: 666 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W APE L T D++S G +L+ T G PY
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 27/109 (24%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+++++ +I G+++L+ +HRDL +N ++++D F K+ D G+++ + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIY-ETD 173
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W +PE L G T D++S G +L+ T + PY
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GIEHSKTTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 52/230 (22%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 536
E+ G+ G V N E +A +++ T + L++ +++AS HPNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 596
++ +++ +E C D + +E
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM------------------------------------LE 95
Query: 597 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656
L + P ++ V + + L++LHE +IHRDLK N+L + D KL+D G+S
Sbjct: 96 LERPLTEPQIRV--VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI--KLADFGVSA 151
Query: 657 RLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTR----AIDLFSLGCIL 701
+ + + + + G+ W APE ++ + + R D++SLG L
Sbjct: 152 K---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 7/91 (7%)
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 672
+ ++ GL++ H+ +HRD+K N+L++ KL+D G+++ + S N
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQI--KLADFGLARLYNSEESRPYTNKV-- 178
Query: 673 GSSGWQAPEQLLQG--RQTRAIDLFSLGCIL 701
+ W P +LL G R AID++S GCIL
Sbjct: 179 -ITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 5/140 (3%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RDLK +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHI--KITDFGLCKEGITDAATMK---TFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G Y + E+ ++ F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT 217
Query: 734 HIPEAVDLFTRLLDPNPDLR 753
+A L + LL +P+ R
Sbjct: 218 LSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 44/253 (17%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 523
+ K + +G G VV+ + + +VAVK L D K++ +L++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML---KDDATDKDLSDLVSEMEM 70
Query: 524 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVE----------YASKGNLREYL----------- 109
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
R R P M+ + D L+ + G+ +L IHRDL +NVL+
Sbjct: 110 --RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++D K++D G+++ + ++ + G W APE L T D++S G
Sbjct: 168 TEDNVM--KIADFGLARDVH-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224
Query: 700 ILFFCITGGKHPY 712
+L+ T G PY
Sbjct: 225 LLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 54/217 (24%)
Query: 497 GRSVAVKRLVKTHHDVALKEIQNLIASDQ------HPNIVRWYGVESDQDFVYLSLERCT 550
G A+K L K + +K++Q++ HP IV D++ VY LE
Sbjct: 43 GEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE--- 98
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
+V+ G L +R KA P+
Sbjct: 99 -------FVVGGE-------------LFTHLR----------------KAGRFPNDVAKF 122
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
++V +LH +I+RDLKP+N+L+ K++D G +K++ + T
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV--KVTDFGFAKKVP------DRTFT 174
Query: 671 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
G+ + APE + +A+D +++G +L+ I G
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 6/106 (5%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ V ++ LS+LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI--KLSDFGFCAQVSKEVP--- 173
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG-IMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 39/153 (25%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P L++ DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC--VADFGLSKKIYSGDY 168
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG--ESFERDA 720
Q W A E L T D+++ G ++ +T G+ PY E+ E
Sbjct: 169 --YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
Query: 721 NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
++K + + + + +L + P P R
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 33/109 (30%), Positives = 59/109 (54%), Gaps = 8/109 (7%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P L ++ +V GL++L + ++HRD+KP N+L++ KL D G+S +L ++
Sbjct: 93 PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIA 150
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
T G++ + APE++ + D++SLG I F + G+ PY
Sbjct: 151 -----KTYVGTNAYMAPERISGEQYGIHSDVWSLG-ISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 610 KVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
K+ +V GL++L+ + ++HRD+KP N+L++ KL D G+S L ++
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI--KLCDFGVSGELINSIA----- 159
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
T G+S + +PE++ G+ T D++SLG + GK P+ S D
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGI 218
Query: 729 LFLVEHI--------------PEAVDLFTRLLDPNPDLR 753
L L++ I + D L +P R
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+L + R ++ + +LHE +IHRD+K +N+ I+ C L D G +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFG--------AA 229
Query: 664 CLTQNATGYGSSGW------QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717
C + GW APE L + A+D++S G +LF T + FE
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----HDSLFE 285
Query: 718 RD 719
+D
Sbjct: 286 KD 287
|
Length = 391 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 69/253 (27%), Positives = 101/253 (39%), Gaps = 52/253 (20%)
Query: 470 RIGKLVVFNKE--IAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN--- 519
RI K F K + G+ GTV + EG VA+K L + A KEI +
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
++AS +P++ R G+ C S LI L LL+
Sbjct: 62 VMASVDNPHVCRLLGI-------------CLTSTVQLITQLMPF-----------GCLLD 97
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
VR E+ +I S LL I G+++L E L+HRDL +NVL+
Sbjct: 98 YVR-------EHKDNI--------GSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ K++D G++K L D G W A E +L T D++S G
Sbjct: 143 KTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q L + + I+ GL +LH +IHRD+K +N+ I+ C + D+G ++
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC--IGDLGAAQ------- 205
Query: 664 CLTQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 702
G +G APE L + + D++S G +LF
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 58/265 (21%), Positives = 97/265 (36%), Gaps = 55/265 (20%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPNIVRW 532
+EI G G V+L Y VA + + + + KE + QHPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + L E C L DL LS
Sbjct: 61 LGQCVEAIPYLLVFE--YCELGDLKSYLSQ------------------------------ 88
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E W L ++ +I +G++H+H+ +H DL +N ++ D K+ D
Sbjct: 89 ---EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--LTVKVGDY 143
Query: 653 GIS-KRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 704
GI R + D + W APE L+ QT+ ++++LG L+
Sbjct: 144 GIGPSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
Query: 705 ITGGKHPYGESFERDA--NIVKDRK 727
PY +R+ +++KD++
Sbjct: 202 FENAAQPYSHLSDREVLNHVIKDQQ 226
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 47/167 (28%)
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------------GDM 662
+H++G IHRD+KP N+L+ D KLSD G+ L+ D
Sbjct: 117 IHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 663 SCLTQNATGYGSSGWQ-----------------APEQLLQGRQTRAIDLFSLGCILFFCI 705
++ + W+ APE LQ + D +SLG I++ +
Sbjct: 175 ISKPMSSKRKAET-WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 706 TGGKHP---YGESFERDANIVKDRKDLFLVEHIP---EAVDLFTRLL 746
G +P E I+ ++ L + +P EA DL RL
Sbjct: 234 VG--YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVK-FLQRIKHPNSI 88
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ G + +L +E C S +DL+ V +E
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------ 124
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
++ +T + GL++LH +IHRD+K N+L+++ KL+
Sbjct: 125 ---------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLA 167
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 698
D G S + + G+ W APE +L +G+ +D++SLG
Sbjct: 168 DF-------GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P + K + S L H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
T + G+ + +PE++ + D++SLGC+L+
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 33/111 (29%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSVPTKTYSNEVV 166
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
+ W P +L G + ID++ +GCI F +G G + E + +++
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPN 528
F +++ KG+ G+V L + G VAVK+L H +EI+ L S QH N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDN 66
Query: 529 IVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
IV++ GV + + + L +E Y+ GS + L + R+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVME----------YLPYGSLRDYLQK--------HRERLD-- 106
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
H LL I G+ +L +HRDL +N+L+ +
Sbjct: 107 ----------------HRK--LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE--NR 146
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K+ D G++K L D G W APE L + + + A D++S G +L+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 50/207 (24%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 535
E+ G+ G V + E A ++++ + L+ EI ++++ +HPNIV Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEA 70
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
++ +++ +E C +L+ ++ L E
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTE---------------------------- 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V R ++ L+ LH +IHRDLK N+L++ D KL+D G+
Sbjct: 103 -----------PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGV 149
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPE 681
S + + S L + T G+ W APE
Sbjct: 150 SAKNK---STLQKRDTFIGTPYWMAPE 173
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 29/254 (11%)
Query: 487 GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVY 543
G + L G + VA+K L ++ E Q +L+A HPNIV GV + + V
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 603
+ E Y+ G E L + S++ + +D + + H
Sbjct: 84 MLFE----------YLNQGDLHEFLIMRSPHSDV----------GCSSDEDGTVKSSLDH 123
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
L + I +G+ +L +H+DL +N+LI + K+SD+G+S+ +
Sbjct: 124 --GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISDLGLSREIYSADY 179
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANI 722
Q + W PE ++ G+ + D++S G +L+ + G P YG S + +
Sbjct: 180 YRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 723 VKDRKDLFLVEHIP 736
V+ R+ L E P
Sbjct: 239 VRKRQLLPCSEDCP 252
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 48/209 (22%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 535
E+ G+ G V N E ++A ++++T + L+ EI+ ++A+ HP IV+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGA 77
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
+++ +E C D I + E D L E +I++
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML------------ELDRGL-TEPQIQV---------- 114
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
+ R ++ L +LH + +IHRDLK NVL++ D KL+D G+S
Sbjct: 115 ---------------ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDI--KLADFGVS 157
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLL 684
+ ++ L + + G+ W APE ++
Sbjct: 158 AK---NVKTLQRRDSFIGTPYWMAPEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQLL + I G+++LH IHRDL +NVL+ D+ K+ D G++K +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYY 164
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G W A E L + + + A D++S G L+ +T
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 8/95 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSIPTKTYSNEVV 166
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
+ W P +L G + ID++ +GCI + TG
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 41/153 (26%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCL 665
QLL+ L ++H + HRDLKP+N+L + D C K+ D G+++ D
Sbjct: 111 QLLR-------ALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFND---- 156
Query: 666 TQNA---TGYGSSGW-QAPEQL--LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 719
T A T Y ++ W +APE + T AID++S+GCI +TG
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG------------ 204
Query: 720 ANIVKDRKDLFLVEHIPEAVDLFTRLL-DPNPD 751
K LF +++ +DL T LL P+P+
Sbjct: 205 -------KPLFPGKNVVHQLDLITDLLGTPSPE 230
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 60/253 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHH----DVALKEIQNLIAS 523
+ F K + G+ G VV E G S VAVK L T H + + E++ +
Sbjct: 37 LSFGKTLGAGAFGKVV-EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H NIV G + + + E C Y +LLN +R
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCC-------Y----------------GDLLNFLR- 131
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R +D LL + + G++ L IHRDL +NVL++ K
Sbjct: 132 RKRESFLTLED-------------LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGC 699
K+ D G+++ + D N G++ W APE + T D++S G
Sbjct: 179 --IVKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 700 ILFFCITGGKHPY 712
+L+ + G +PY
Sbjct: 232 LLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 13/144 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + T +T G
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKEGIFN-GKTT--STFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR--KDL 729
+ + APE L + ++D +++G +L + + G P+ E D I+ D
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMG-VLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLR 753
+L + +AVD+ + NP +R
Sbjct: 218 WLSQ---DAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 61/237 (25%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSV-AVKRLV-------KTHHDVALKEIQNLIASD 524
KL +EI GS G V + V A+K++ + D+ +KE++ +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQKL 72
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
+HPN +++ G + +L +E C S +DL+ EV +
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL----------------------EVHKK 110
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
L +E + VT + GL++LH +IHRD+K N+L+S+
Sbjct: 111 PLQEVE-----------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 698
KL D G S + G+ W APE +L +G+ +D++SLG
Sbjct: 154 --VKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 49/207 (23%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGV 535
+ + G+ G V N +A +++K IQ ++ +H NIV ++G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
++ +++ +E C SL D IY ++G E
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V R+ + GL++LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGV 152
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPE 681
+ ++ ++ + + G+ W APE
Sbjct: 153 AAKITATIA---KRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 3/107 (2%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L+ + + +G+ L +HRDL +NVLI + K K+ D G+++ + D + +++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISK 298
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+T + W APE + T D++S G +L+ T G PY E
Sbjct: 299 GST-FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 28/99 (28%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P + K + S + H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
T + G+ + +PE++ + D++SLGC+L+
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 30/105 (28%), Positives = 54/105 (51%), Gaps = 3/105 (2%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL T + G+ L +HRDL +NVL+++ K K+ D G+++ + D + +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSK 296
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+T + W APE + T D++S G +L+ + G PY
Sbjct: 297 GST-FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 46/211 (21%)
Query: 504 RLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLS 561
RL K+ V + KE L+A +HPNIV + +Y+ +E C
Sbjct: 34 RLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVMEYC------------ 80
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621
+L+ + I+L + P +L+ + G+ H
Sbjct: 81 -----------DGGDLMQK--------------IKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
+HE ++HRD+K +N+ ++++ KL D G ++ L + T G+ + PE
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPE 170
Query: 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
D++SLGCIL+ T KHP+
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT-LKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GLS++H+ ++HRDLKPQN+LIS KL+D G+++ S + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGEL--KLADFGLARA----KSVPSHTYSNEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
+ W P +L G + +D++ +GCI I G
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 14/146 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG- 671
++ GL L +++RDLKP+N+L+ D ++SD+G++ ++ +G + G
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEG------ETVRGR 161
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK--HPYGESFERDA--NIVKDRK 727
G+ G+ APE + + T + D + LGC+++ I G E +R+ VK+ +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 728 DLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ + + +A + LL NP R
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 36/249 (14%)
Query: 498 RSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG-VESDQDFVYLSLERCTCS 552
++VA+K L K + L+E + + QHPNIV G V +Q LS+ CS
Sbjct: 36 QAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---LSMIFSYCS 91
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
+DL E L + S++ +T D + K+ P A + +
Sbjct: 92 HSDL--------HEFLVMRSPHSDV------------GSTDDDKTVKSTLEP-ADFVHIV 130
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 671
I +G+ L ++H+DL +NVL+ DK K+SD+G+ + + D L N+
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVF-DK-LNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 730
W +PE ++ G+ + D++S G +L+ + G PY G S + ++++R+ L
Sbjct: 189 --PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 731 LVEHIPEAV 739
+ P V
Sbjct: 247 CPDDCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 6/106 (5%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP--- 171
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLG-IMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 18/128 (14%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L+ LHE G+I+RDLK NVL+ D KL+D G+ K GD + +T
Sbjct: 104 EICIALNFLHERGIIYRDLKLDNVLLDADGHI--KLTDYGMCKEGLGPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
G+ + APE L ++D ++LG +L F + G+ P+ +I+ D D+
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALG-VLMFEMMAGRSPF--------DIITDNPDMNT 207
Query: 732 VEHIPEAV 739
+++ + +
Sbjct: 208 EDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 15/103 (14%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QLL+ GL++ H+ ++HRDLKPQN+LIS+ KL+D G+++ S +
Sbjct: 111 QLLR-------GLAYCHQRRVLHRDLKPQNLLISERGEL--KLADFGLARA----KSVPS 157
Query: 667 QNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
+ + + W P +L G + ++D++ +GCI + TG
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH + +++RDLKP+N+L+ D L+D G+ K ++ +T G
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE---NIEHNGTTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 14/143 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++G +HRD+KP NVL+ DK+ +L+D G RL D + Q+ G
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT--VQSNVAVG 165
Query: 674 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
+ + +PE L +GR D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 729 LF----LVEHIPE-AVDLFTRLL 746
F V + E A DL RL+
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL+++H ++HRDLKPQN+LIS KL+D G+++ S +Q +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGEL--KLADFGLAR----AKSIPSQTYSSEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
+ W P +L G + A+D++ GCI + G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH I +++RDLKP+N+L+ D L+D G+ K ++ T G
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCKE---GIAQSDTTTTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE + + +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++ S + +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GVEPEETTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL I G+ +L E ++HR+L +N+L+ D +++D G++ L D
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD--SIVQIADFGVADLLYPDDKKYFY 168
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ W A E +L GR T D++S G ++ ++ G PY
Sbjct: 169 SEHK-TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LL I G+ +L E L+HRDL +NVL+ K++D G+++ L+GD
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKE 165
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W A E + + T D++S G ++ +T G PY
Sbjct: 166 YNADG-GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 74/259 (28%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHDVALKE--------IQN 519
+ + + I +G G V +G Y E +VAVK K +++E ++
Sbjct: 6 EDITLGRCIGEGQFGDV-YQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQ 63
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HP+IV+ GV ++ V++ +E G L + + L
Sbjct: 64 F----DHPHIVKLIGVITENP-VWIVMELAP----------LGELRSYL---QVNKYSL- 104
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
A L+ + + + L++L +HRD+ +NVL+
Sbjct: 105 ------------------------DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS------GWQAPEQLLQGRQTRAID 693
S C KL D G+S+ L+ + + Y +S W APE + R T A D
Sbjct: 141 SSPD--CVKLGDFGLSRYLEDE--------SYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 694 LFSLGCILFFCITGGKHPY 712
++ G ++ + G P+
Sbjct: 191 VWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 31/153 (20%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I GL LH G+I+RDLK NV++ + K++D G+ K G + T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI--KIADFGMCKENIFGGKTTR-----TF 161
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 730
G+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQPPFDGE----------DEDELF 210
Query: 731 --LVEHIP--------EAVDLFTRLLDPNPDLR 753
++EH EAV + LL +P R
Sbjct: 211 QSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 13/108 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++G +HRD+KP+NVLI D++ KL+D G + RL + ++ G
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPV--G 165
Query: 674 SSGWQAPEQLLQGRQTRA-------IDLFSLGCILFFCITGGKHPYGE 714
+ + APE +L D +SLG I + I G+ P+ E
Sbjct: 166 TPDYIAPE-VLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 10/101 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L+ LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHI--KLTDYGMCKEGIRPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+ + APE L ++D ++LG +L F + G+ P+
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)
Query: 500 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
VAVK L D A ++ +++ PNI R GV + + + +E
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIME--------- 99
Query: 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616
Y+ +G + L +++ L N+K + + LL + I
Sbjct: 100 -YMENGDLNQFLQKHVAETSGLAC----------NSKSL--------SFSTLLYMATQIA 140
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGSS 675
SG+ +L + +HRDL +N L+ K++ K++D G+S+ L D Y
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLV--GKNYTIKIADFGMSRNLYSSDY---------YRVQ 189
Query: 676 G-------WQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 714
G W A E +L G+ T D+++ G IL C + PY
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC---REQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 38/143 (26%), Positives = 69/143 (48%), Gaps = 14/143 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++ +HRD+KP N+L+ D + +L+D G +L D + Q++ G
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT--VQSSVAVG 165
Query: 674 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
+ + +PE L +G+ D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 729 LF----LVEHIPE-AVDLFTRLL 746
F V + E A DL RL+
Sbjct: 226 RFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 72/318 (22%), Positives = 114/318 (35%), Gaps = 91/318 (28%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNI 529
K + KG G V L G+ A+K L K L E + L D HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLD-HPFL 63
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
Y + ++ L ++ C +L +L + Q L+E R
Sbjct: 64 PTLYASFQTETYLCLVMD--YCPGGELFRLL----------QRQPGKCLSEEVARF---- 107
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ A +++ L +LH +G+++RDLKP+N+L+ + L
Sbjct: 108 --------YAA-------------EVLLALEYLHLLGIVYRDLKPENILLHESGHI--ML 144
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQ---------------------------APEQ 682
SD +SK+ A GS APE
Sbjct: 145 SDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDA---NIVKDRKDLFLVEHIP-- 736
+ A+D ++LG IL + + G P+ G + RD NI+K K++ P
Sbjct: 204 ISGDGHGSAVDWWTLG-ILLYEMLYGTTPFKGSN--RDETFSNILK--KEVTFPGSPPVS 258
Query: 737 -EAVDLFTRLLDPNPDLR 753
A DL +LL +P R
Sbjct: 259 SSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G+S +L M+ + G+ + +PE+L + D++S+G L + G++P
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE-MAIGRYPI 202
Query: 712 -----------YGESFERDA 720
+G E D
Sbjct: 203 PPPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 60/264 (22%), Positives = 100/264 (37%), Gaps = 54/264 (20%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVA---VKRLVKT----HHDVALKEIQNLIASDQHPNIVR 531
EI G G V+L + G S A VK L + + L+E+Q HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQ 59
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
G + L LE C L DL L + ++D
Sbjct: 60 CLGQCIESIPYLLVLE--FCPLGDLKNYLRSNRGMVAQMAQKDV---------------- 101
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L ++ ++ SGL LH+ IH DL +N ++ D S K+ D
Sbjct: 102 ----------------LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGD 143
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 704
G++ + +T++ W APE LL QT+ +++SLG ++
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 705 ITGGKHPYGESFERD--ANIVKDR 726
T PY + + +V+++
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQ 226
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P LLK DI G+ +L IHRDL +N ++ +D + C ++D G+SK++ GD
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC--VADFGLSKKIYSGDY 168
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q W A E L T D+++ G ++ T G+ PY
Sbjct: 169 --YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 13/176 (7%)
Query: 584 RLLPVME--NTKDI--ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
RL VME N D+ ++ ++ + ++ L LH G+I+RDLK N+L+
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ C KL+D G+ K +G ++ +T T G+ + APE L + ++D ++LG
Sbjct: 130 DAE-GHC-KLADFGMCK--EGILNGVT-TTTFCGTPDYIAPEILQELEYGPSVDWWALG- 183
Query: 700 ILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+L + + G+ P+ E D +I+ D L+ V EAV + + NP+ R
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESILHD-DVLYPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 22/48 (45%), Positives = 31/48 (64%), Gaps = 2/48 (4%)
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656
+K ++ L +LH G+IHRDLKP N+LIS + KL+D G+SK
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHI--KLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 6/141 (4%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ + H+H +IHRD+K N+L+ + KL D G SK +S T G+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAATVSD-DVGRTFCGT 208
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDAN-IVKDRKDLFLV 732
+ APE + ++ D+FSLG +L+ +T K P+ GE+ E + + R D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
PE ++ T LL +P R
Sbjct: 268 SISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 6e-05
Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 19/166 (11%)
Query: 596 ELWKANGH-PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL--ISKDKSFCAKLSDM 652
+L K G A++ K+ R +V L+ LH+ +IH D+K +NVL +KD+ + L D
Sbjct: 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY---LCDY 154
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+ K + G SC G+ + +PE++ + D +++G +L + + GKHP+
Sbjct: 155 GLCKII-GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVG-VLTYELLTGKHPF 206
Query: 713 GESFERDANI--VKDR--KDLFLVEHIPE-AVDLFTRLLDPNPDLR 753
E + + ++ + R K L ++++ + A D +L N + R
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYR 252
|
Length = 267 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 6e-05
Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMG 653
+ R I+ L LH G++HRD+KPQN++ S SF K+ D+G
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL+ + + G+ L IHRD+ +NVL++ + AK+ D G+++ + D
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMND-----S 266
Query: 668 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
N G++ W APE + T D++S G +L+ + GK PY
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 52/181 (28%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 659
++ + +H++G IHRD+KP N+LI D KL+D G+ SK Q
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 660 -------------------GD-MSCLTQNATG----------YGSSGWQAPEQLLQGRQT 689
GD + L Q AT G+ + APE LL+ T
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 690 RAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHI---PEAVDLFTR 744
+ D +S+G ILF + G+ P+ E ++ L + + PEAVDL T+
Sbjct: 227 QLCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285
Query: 745 L 745
L
Sbjct: 286 L 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V R +++GL LH IG++HRD+KP+N+L++ D K+ D G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/144 (27%), Positives = 69/144 (47%), Gaps = 16/144 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++ +HRD+KP NVL+ D + +L+D G ++ D + Q++ G
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT--VQSSVAVG 165
Query: 674 SSGWQAPEQLLQ------GRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDR 726
+ + +PE +LQ G+ D +SLG ++ + G Y ES E I+
Sbjct: 166 TPDYISPE-ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
Query: 727 KDLFLVEHI----PEAVDLFTRLL 746
+ HI EA DL RL+
Sbjct: 225 ERFQFPSHITDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 41/179 (22%), Positives = 72/179 (40%), Gaps = 44/179 (24%)
Query: 526 HPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HPNIVR+Y + D +Y+ ++ L + L KE+ E
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----------KEKKQRFTEE---- 113
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK 643
+W + +V L +LH E ++HRDL P N+++ +D
Sbjct: 114 -----------RIWN-----------IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
++D G++K+ + S LT G+ + PE + D+++ GCIL+
Sbjct: 152 K--VTITDFGLAKQ-KQPESKLTSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILY 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 41/185 (22%), Positives = 70/185 (37%), Gaps = 33/185 (17%)
Query: 588 VMENTK----DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
V E K D+ L + + S L V + + S L +L + L+H ++ +N+L+++
Sbjct: 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137
Query: 643 K-----SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL--LQGRQTRAIDLF 695
KLSD GI + + + W APE + Q T A D +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVER-------IPWIAPECIRNGQASLTIAADKW 190
Query: 696 SLGCILFFCITGGKHPYG-------ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 748
S G L + G+ P E F +D + + + E +L +
Sbjct: 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-------MPDCAELANLINQCWTY 243
Query: 749 NPDLR 753
+P R
Sbjct: 244 DPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IV L +H ++HRDLK N+ + + KL D G SK+ +S L ++ G+
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLM--PTGIIKLGDFGFSKQYSDSVS-LDVASSFCGT 234
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+ APE + R ++ D++SLG IL+ +T
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 38/113 (33%), Positives = 59/113 (52%), Gaps = 13/113 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L++LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHI--KLTDYGMCKEGLRPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDAN 721
G+ + APE L ++D ++LG +L F + G+ P+ G S D N
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L +A P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
G+S +L M+ + G+ + +PE+L + D++S+G L
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 500 VAVKRLV----KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
VAVK L K + LKEI+ +++ + PNI+R V D + + E
Sbjct: 49 VAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIRLLAVCITSDPLCMITE-------- 99
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615
Y+ +G + L+ E + I + L+ + I
Sbjct: 100 --YMENGDLNQFLSRHEPQEA----------AEKADVVTISY--------STLIFMATQI 139
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGS 674
SG+ +L + +HRDL +N L+ K+ + K++D G+S+ L GD + A
Sbjct: 140 ASGMKYLSSLNFVHRDLATRNCLVGKN--YTIKIADFGMSRNLYSGDYYRIQGRAV--LP 195
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGE 714
W + E +L G+ T A D+++ G L+ +T K PY +
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L ++ +I GL HLH+ IH DL +N L++ D + K+ D G+S + +T
Sbjct: 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTP 159
Query: 668 NATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + W APE LL QT+ +++SLG ++ G PY
Sbjct: 160 DQL-WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q + + R ++ L++LH G+IHRD+K +N+ + D+ A L D G + +L D
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKL--DAH 238
Query: 664 CLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
T G+ G+ +PE L D++S G +LF
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 56/183 (30%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 659
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 660 -----------GDMS---------------------CLTQNATGYGSSGWQAPEQLLQGR 687
GD + CL + G+ + APE LL+
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV--GTPNYIAPEVLLRTG 224
Query: 688 QTRAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFL---VEHIPEAVDLF 742
T+ D +S+G IL+ + G+ P+ E ++ + L + + PEA DL
Sbjct: 225 YTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
Query: 743 TRL 745
+L
Sbjct: 284 IKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 38/140 (27%), Positives = 70/140 (50%), Gaps = 7/140 (5%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSG 676
G+ +L +HRDL +N ++ D+SF K++D G+++ + N TG
Sbjct: 110 GMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 677 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIVKDRKDLFLVEH 734
W A E L + T D++S G +L+ +T G PY + SF+ +++ R+ L E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEY 226
Query: 735 IPEAV-DLFTRLLDPNPDLR 753
P+ + ++ P P++R
Sbjct: 227 CPDPLYEVMLSCWHPKPEMR 246
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 49/191 (25%), Positives = 74/191 (38%), Gaps = 61/191 (31%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ-GD-- 661
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q GD
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 662 ------------------------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
CL + G + + APE LL+ T+
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--YIAPEVLLRTGYTQL 224
Query: 692 IDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIP-------EAVDLF 742
D +S+G IL+ + G+ P+ E ++ L HIP EA DL
Sbjct: 225 CDWWSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTL----HIPSQAKLSREASDLI 279
Query: 743 TRLLDPNPDLR 753
RL + R
Sbjct: 280 LRLC-CGAEDR 289
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 55/242 (22%), Positives = 92/242 (38%), Gaps = 72/242 (29%)
Query: 480 EIAKG-SNGTVVLEGNYE--GRSVAVKRL---VKTHHDVALKEIQNLI---ASDQHPNIV 530
I K + +V ++ VAVK++ + D LK +Q I QHPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED--LKLLQQEIITSRQLQHPNIL 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRL 585
+ F+ + +YV+S GS E+ L K L E+ I
Sbjct: 63 PYV-----TSFIV----------DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF 105
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ +D+++ L ++H G IHR +K ++L+S D
Sbjct: 106 -------------------------ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK- 139
Query: 646 CAKLSDMGIS-------KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFS 696
LS + S KR Q + +++ + W +PE L Q Q D++S
Sbjct: 140 -VVLSGLRYSVSMIKHGKR-QRVVHDFPKSSV--KNLPWLSPEVLQQNLQGYNEKSDIYS 195
Query: 697 LG 698
+G
Sbjct: 196 VG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL + + G+S L IHRDL +N+L++ + K+ D G+++ ++ D
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRND-----S 268
Query: 668 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
N G++ W APE + T D++S G +L+ + G PY
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I GL LH G+I+RDLK NV++ + K++D G+ K D T G
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI--KIADFGMCKEHMVDGVT---TRTFCG 163
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE + +++D ++ G +L+ + G
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 29/119 (24%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL+V R++ S + LHE G + D+ + L+S D + D +
Sbjct: 119 LLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD----------SKVVLVDSDSFQINA 168
Query: 668 NATGY----GSSGWQAPEQLLQGRQTRAI----------DLFSLGCILFFCITGGKHPY 712
N T + G S + PE QT D F L ++F + GG+HPY
Sbjct: 169 NGTLHLCPVGVSEFTPPE-----LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222
|
Length = 637 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 34/132 (25%), Positives = 64/132 (48%), Gaps = 35/132 (26%)
Query: 608 LLKVTRDIVSGLSHLHEIG-------LIHRDLKPQNVLISK---------------DKSF 645
++ +TR ++ L++ H + ++HRDLKPQN+ +S +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 646 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--RAIDLFSLGCI 700
AK+ D G+SK + + SC+ G+ + +PE LL ++ D+++LGCI
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCV-------GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 701 LFFCITGGKHPY 712
++ + GK P+
Sbjct: 233 IYE-LCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 32/126 (25%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------- 659
+ V + +H++G IHRD+KP N+L+ D KLSD G+ L+
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 660 --GDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D S N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 702 FFCITG 707
+ + G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 45/161 (27%), Positives = 65/161 (40%), Gaps = 34/161 (21%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG------ISKR 657
P + + ++V L LH G++ RDL P N+L L D G S+
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL----------LDDRGHIQLTYFSRW 132
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK----HPYG 713
+ + SC + + + APE +T A D +SLG ILF +TG HP G
Sbjct: 133 SEVEDSCDGEAV----ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ L + E + EA L +LL NP R
Sbjct: 189 ---------INTHTTLNIPEWVSEEARSLLQQLLQFNPTER 220
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----------------ISKR 657
+ V + +H++G IHRD+KP N+L+ D KLSD G ++
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 658 LQGDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
L D + N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 702 FFCITG 707
+ + G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+ G+ L IHRDL +N+L+S++ K+ D G+++ + D + + GS
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRK-----GS 235
Query: 675 S----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ W APE + T D++S G +L+ + G PY
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 21/72 (29%), Positives = 41/72 (56%), Gaps = 3/72 (4%)
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
I L ++ENTK+I + + + +D+++ L ++HE G+ H D+KP+N+++ D
Sbjct: 104 ILLEKLVENTKEI-FKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV--D 160
Query: 643 KSFCAKLSDMGI 654
+ + D GI
Sbjct: 161 GNNRGYIIDYGI 172
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 753 | |||
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.98 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.74 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.7 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.59 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.58 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.56 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.56 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.41 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.95 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.82 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.78 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.66 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.53 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.49 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.38 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.35 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.26 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.99 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.93 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 97.87 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 97.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.61 | |
| TIGR03300 | 377 | assembly_YfgL outer membrane assembly lipoprotein | 97.53 | |
| TIGR03300 | 377 | assembly_YfgL outer membrane assembly lipoprotein | 97.49 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.44 | |
| PF13360 | 238 | PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A | 97.36 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 97.32 | |
| cd00216 | 488 | PQQ_DH Dehydrogenases with pyrrolo-quinoline quino | 97.29 | |
| PF13360 | 238 | PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A | 97.28 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.17 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.16 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.08 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.0 | |
| PF01011 | 38 | PQQ: PQQ enzyme repeat family.; InterPro: IPR00237 | 96.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 96.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.52 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.38 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.3 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 96.25 | |
| TIGR03074 | 764 | PQQ_membr_DH membrane-bound PQQ-dependent dehydrog | 96.15 | |
| cd00216 | 488 | PQQ_DH Dehydrogenases with pyrrolo-quinoline quino | 96.15 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.14 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 96.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.05 | |
| COG1520 | 370 | FOG: WD40-like repeat [Function unknown] | 95.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.71 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.46 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.23 | |
| TIGR03075 | 527 | PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methan | 94.68 | |
| TIGR03074 | 764 | PQQ_membr_DH membrane-bound PQQ-dependent dehydrog | 94.63 | |
| TIGR03075 | 527 | PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methan | 94.63 | |
| smart00564 | 33 | PQQ beta-propeller repeat. Beta-propeller repeat o | 94.54 | |
| COG1520 | 370 | FOG: WD40-like repeat [Function unknown] | 94.49 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.27 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.26 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.17 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.13 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=419.82 Aligned_cols=243 Identities=49% Similarity=0.852 Sum_probs=210.8
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChh
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~ 554 (753)
|.-.+.+|.|+-|+|...+..+|+.||||++..+...-+.+|++.+...-+|||||++++...++.+.||..|+|.|+|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 34446799999999877788899999999999888888999999888889999999999999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp 634 (753)
|++... ..+..+.. . ...+.+..|++.||+|||+.+||||||||
T Consensus 591 dlie~~---~~d~~~~~------------------------------~---i~~~~~l~q~~~GlaHLHsl~iVHRDLkP 634 (903)
T KOG1027|consen 591 DLIESS---GLDVEMQS------------------------------D---IDPISVLSQIASGLAHLHSLKIVHRDLKP 634 (903)
T ss_pred HHHhcc---ccchhhcc------------------------------c---ccHHHHHHHHHHHHHHHHhcccccccCCC
Confidence 999543 11111100 0 23367889999999999999999999999
Q ss_pred CcEEEec---CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 635 QNVLISK---DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 635 ~NILL~~---d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
+||||.. ++...++|+|||+++.+..+.+.........||.||+|||++.....+.++||||||||+|+.++|+.+|
T Consensus 635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccC
Confidence 9999987 6778999999999999998877777777788999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHccCcccccCCCH--HHHHHHHHccccCcCCC
Q 004442 712 YGESFERDANIVKDRKDLFLVEHIP--EAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~~~~i~~~~~~~~~~~s~--el~dLI~~cL~~DP~~R 753 (753)
|++..+++.+++........-...+ ++.|||.+|+++||..|
T Consensus 715 FGd~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 715 FGDSLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLR 758 (903)
T ss_pred CCchHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccC
Confidence 9999999999888776655444444 99999999999999998
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=385.26 Aligned_cols=235 Identities=31% Similarity=0.499 Sum_probs=208.8
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..|...+.||+|||++||.+.. ..|+.||+|++.+. ..+...+|++ +.+.++|||||+++++|+|.+..|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIe-IHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIE-IHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHH-HHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6789999999999999999987 77999999999652 2455677776 88999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+|+| .+|+|.+++.. ...+.++++..+..||+.||.|||+.
T Consensus 97 LELC----------~~~sL~el~Kr-----------------------------rk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 97 LELC----------HRGSLMELLKR-----------------------------RKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred EEec----------CCccHHHHHHh-----------------------------cCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 9955 57888877642 35688999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+|||||..|+||+++ +++||+|||||..+..+. ....+.||||.|+|||++....++..+||||+|||||.|+
T Consensus 138 ~IiHRDLKLGNlfL~~~--~~VKIgDFGLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL 212 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFLNEN--MNVKIGDFGLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL 212 (592)
T ss_pred CceecccchhheeecCc--CcEEecccceeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh
Confidence 99999999999999554 679999999999987542 2346789999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| +|||+.. .++....++.....+|...+.++.+||.+||+.||.+|
T Consensus 213 ~G-~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 213 VG-RPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred hC-CCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccC
Confidence 99 7888876 67778889999999999999999999999999999998
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=370.02 Aligned_cols=241 Identities=27% Similarity=0.446 Sum_probs=200.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
+.+.+.|.+.+.||+|+||.|-+|.. .+|+.||||++.+.. .....+++.++|++++|||||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 55677889999999999999998854 569999999996532 11222344458999999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..||||| |+++|.|.+++-... .+.+....-+++|++.|
T Consensus 248 ~ds~YmVlE----------~v~GGeLfd~vv~nk-----------------------------~l~ed~~K~~f~Qll~a 288 (475)
T KOG0615|consen 248 PDSSYMVLE----------YVEGGELFDKVVANK-----------------------------YLREDLGKLLFKQLLTA 288 (475)
T ss_pred CCceEEEEE----------EecCccHHHHHHhcc-----------------------------ccccchhHHHHHHHHHH
Confidence 999999999 999999999886543 23344447789999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC---CchhhH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDL 694 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---t~ksDI 694 (753)
+.|||++||+||||||+|||+..+ ..+.+||+|||+|+.... ...+.+.|||+.|.|||++.++.+ ..++||
T Consensus 289 vkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDi 364 (475)
T KOG0615|consen 289 VKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDI 364 (475)
T ss_pred HHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchhee
Confidence 999999999999999999999776 567899999999998763 345678999999999999977653 458999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHH--HHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 695 FSLGCILFFCITGGKHPYGESFER--DANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 695 wSfGvvL~EllTG~~~Pf~~~~~~--~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+||+||-|++| .+||.+.... ...++..+...+- .+.++++.+||++||.+||++|
T Consensus 365 WSlGcvLfvcLsG-~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R 428 (475)
T KOG0615|consen 365 WSLGCVLFVCLSG-YPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENR 428 (475)
T ss_pred eeccceEEEEecc-CCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccC
Confidence 9999999999998 8899776432 5667777776554 4568899999999999999998
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=361.51 Aligned_cols=237 Identities=29% Similarity=0.363 Sum_probs=202.4
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|++.+.||+|+||+||.+...+ ++.+|+|.+++.. ......|. .++..++||.||+|+-.+.+.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er-~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAER-NILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHH-HHHHhCCCCcEeeeEEecccCCeEEE
Confidence 4678999999999999999986655 8999999997642 12233444 47788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|+| |+.+|.|..+|..+ +.+++..+.-++.+|+.||.|||+
T Consensus 103 Vld----------~~~GGeLf~hL~~e-----------------------------g~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 103 VLD----------YLNGGELFYHLQRE-----------------------------GRFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred EEe----------ccCCccHHHHHHhc-----------------------------CCcchhHHHHHHHHHHHHHHHHHh
Confidence 999 99999999998643 567888889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+||||||||+||||+.+|+ ++|+||||++.... ....+.+.|||+.|||||++.+..|+..+|.||+|+++|||
T Consensus 144 ~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~---~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 144 KGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLK---DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEM 218 (357)
T ss_pred CCeeeccCCHHHeeecCCCc--EEEeccccchhccc---CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHH
Confidence 99999999999999988876 99999999986543 22345668999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHccCcccccC-CCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~~~i~~~~~~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
++|.+|++..+..+....+...+...+.. .+++++++|+++|..||++|
T Consensus 219 L~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~R 268 (357)
T KOG0598|consen 219 LTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQR 268 (357)
T ss_pred hhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHh
Confidence 99955444555677777777777555555 89999999999999999988
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=371.57 Aligned_cols=236 Identities=28% Similarity=0.409 Sum_probs=192.2
Q ss_pred EEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc-eEEEEEcccc
Q 004442 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERCT 550 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-~~~LV~E~c~ 550 (753)
.+.+.||+|+||+||+|.......||||++..... ...++.+..++.+++|||||+|+|+|.+.. ..++|||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE--- 120 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE--- 120 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE---
Confidence 34456999999999986654444499999976431 123444445889999999999999999988 7999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC-ccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIH 629 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~-IiH 629 (753)
|+++|+|.++|+.. ..+.+++..+++||.|||+||.|||+++ |||
T Consensus 121 -------y~~~GsL~~~l~~~---------------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIH 166 (362)
T KOG0192|consen 121 -------YMPGGSLSVLLHKK---------------------------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIH 166 (362)
T ss_pred -------eCCCCcHHHHHhhc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeee
Confidence 99999999999864 1357899999999999999999999999 999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc--CCCCCchhhHHHHHHHHHHHHhC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||||+|||++.+. .++||+|||+++...... .......||+.|||||++. ...|+.|+||||||++||||+||
T Consensus 167 rDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~ 242 (362)
T KOG0192|consen 167 RDLKSDNILVDLKG-KTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG 242 (362)
T ss_pred cccChhhEEEcCCC-CEEEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence 99999999996664 269999999999876432 1122256999999999999 66899999999999999999998
Q ss_pred CCCCCCCChHH--HHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER--DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~--~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||.+.... ....+ ....+.++..+++.+.++|++||+.||++|
T Consensus 243 -~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~R 290 (362)
T KOG0192|consen 243 -EIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRR 290 (362)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcC
Confidence 6788876542 22333 334455677789999999999999999998
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=361.36 Aligned_cols=236 Identities=32% Similarity=0.513 Sum_probs=195.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
..|.+.+.||+|+||+||+|+.. ++..||||.+.+.. .+-...|+. +++.++|||||+|++++.+++.+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~-iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIK-ILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHH-HHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 45777788999999999999654 58999999996653 233456776 889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
||| .+|+|.++|+.+ +.+++..+..++.|+|.||++||+++
T Consensus 89 EyC----------~gGDLs~yi~~~-----------------------------~~l~e~t~r~Fm~QLA~alq~L~~~~ 129 (429)
T KOG0595|consen 89 EYC----------NGGDLSDYIRRR-----------------------------GRLPEATARHFMQQLASALQFLHENN 129 (429)
T ss_pred EeC----------CCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 955 567777777543 46888899999999999999999999
Q ss_pred ccccCCCCCcEEEecC-CC---CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKD-KS---FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 627 IiHrDLKp~NILL~~d-~~---~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
||||||||+||||+.. +. ..+||+|||+|+.+... ....+.||++-|||||++...+|+.|+|+||+|++||
T Consensus 130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILY 205 (429)
T ss_pred eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHH
Confidence 9999999999999775 33 67999999999998743 3446789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++| ++||+.. ..+....++.... ..+...++++.+++...|..+|+.|
T Consensus 206 q~l~g-~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~ 259 (429)
T KOG0595|consen 206 QCLTG-KPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDR 259 (429)
T ss_pred HHHhC-CCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCcccc
Confidence 99998 7788765 4444444444332 3445567788899999999988776
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=360.74 Aligned_cols=231 Identities=28% Similarity=0.412 Sum_probs=195.0
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCc-eEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-~~~LV~E~ 548 (753)
++..+.||+|..|+|||+.. ++++.+|+|.+.-.. ..+..+|++ ++...+||+||.++|.|+.+. .+.|+||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~-il~~~~spyIV~~ygaF~~~~~~isI~mE- 158 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELE-ILRSCQSPYIVGFYGAFYSNGEEISICME- 158 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHH-HHhhCCCCCeeeEeEEEEeCCceEEeehh-
Confidence 34557799999999999854 569999999994332 345677776 667779999999999999988 5999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~I 627 (753)
||.+|||++.+.. ...+++..+-+|+.+|++||.|||+ .+|
T Consensus 159 ---------YMDgGSLd~~~k~-----------------------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~I 200 (364)
T KOG0581|consen 159 ---------YMDGGSLDDILKR-----------------------------VGRIPEPVLGKIARAVLRGLSYLHEERKI 200 (364)
T ss_pred ---------hcCCCCHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhccCe
Confidence 9999999998753 2458889999999999999999996 899
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||||||+|||++..|+ +||||||.++.+... ...+.+||..|||||.+.+..|+.++||||||+.++||.+|
T Consensus 201 IHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G 273 (364)
T KOG0581|consen 201 IHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG 273 (364)
T ss_pred eeccCCHHHeeeccCCC--EEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC
Confidence 99999999999988776 999999999887543 44677899999999999999999999999999999999999
Q ss_pred CCCCCCCC------hHHHH-HHHHccCcccccC-CCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES------FERDA-NIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~------~~~~~-~~i~~~~~~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
+.||... .-... .++....+..|.. +|+|+++||.+||++||.+|
T Consensus 274 -rfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R 326 (364)
T KOG0581|consen 274 -RFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSER 326 (364)
T ss_pred -CCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccC
Confidence 6676542 22333 4444455666775 99999999999999999998
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=346.07 Aligned_cols=240 Identities=22% Similarity=0.351 Sum_probs=199.7
Q ss_pred ceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeeccc-ccCCce-EEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGV-ESDQDF-VYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~-~~~~~~-~~L 544 (753)
..|.+.+.||+|+||+||++ +..+|..||.|.+.=.. .++..+|+. +++.++|||||+++++ +.++.+ ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~-lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEIS-LLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHH-HHHhcCCchHHHHHHHhhhccchhhHH
Confidence 34667788999999999997 67789999999986322 234456665 8899999999999994 555555 899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| +...|+|.+.+...+. ..+.++++.+++++.|+++||.++|.
T Consensus 98 vmE----------~c~~GDLsqmIk~~K~-------------------------qkr~ipE~~Vwk~f~QL~~AL~~cH~ 142 (375)
T KOG0591|consen 98 VME----------LCDAGDLSQMIKHFKK-------------------------QKRLIPEKTVWKYFVQLCRALYHCHS 142 (375)
T ss_pred HHH----------hhcccCHHHHHHHHHh-------------------------ccccCchHHHHHHHHHHHHHHHHHhc
Confidence 999 6678888888765442 24568999999999999999999998
Q ss_pred --CC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 625 --IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 625 --~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
.+ |+||||||.||+|+.+|. +||+||||++.+.... +.....+|||.||+||.+.+..|++||||||+||+
T Consensus 143 ~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCl 217 (375)
T KOG0591|consen 143 KIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCL 217 (375)
T ss_pred cccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHH
Confidence 44 999999999999977765 9999999999987543 34456789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHccCcc-cc-cCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERDANIVKDRKDL-FL-VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~~~~i~~~~~~-~~-~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+..+.|++++..-....++.+...+ .| ..+|.+++++|..|+.+||+.|
T Consensus 218 lyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~R 272 (375)
T KOG0591|consen 218 LYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQR 272 (375)
T ss_pred HHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccC
Confidence 99999996655566666777888887664 45 5689999999999999999987
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=365.94 Aligned_cols=248 Identities=32% Similarity=0.438 Sum_probs=193.6
Q ss_pred ccccccccccccccceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceee
Q 004442 455 LLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 455 ~~~~~~l~~~~~~~~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~ 531 (753)
.+++.++ +.+++.|.-.+.||+|+||.||+|...+|..||||++.... ..++..|+. ++++++|||+|+
T Consensus 64 ~fs~~el-------~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~-~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 64 SFSYDEL-------RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVE-ILSRLRHPNLVK 135 (361)
T ss_pred eeeHHHH-------HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHH-HHhcCCCcCccc
Confidence 4555555 56667888889999999999999999999999999997644 345566665 889999999999
Q ss_pred ecccccCCc-eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHH
Q 004442 532 WYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610 (753)
Q Consensus 532 L~g~~~~~~-~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~ 610 (753)
|+|||.+.+ +.+|||| ||++|+|.++|+.... . .++|.++++
T Consensus 136 LlGyC~e~~~~~~LVYE----------ym~nGsL~d~L~~~~~--------------------------~-~L~W~~R~k 178 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYE----------YMPNGSLEDHLHGKKG--------------------------E-PLDWETRLK 178 (361)
T ss_pred EEEEEecCCceEEEEEE----------ccCCCCHHHHhCCCCC--------------------------C-CCCHHHHHH
Confidence 999999999 5999999 9999999999986532 1 689999999
Q ss_pred HHHHHHHHHHHhhhC---CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccC-CCCccccccccccCC
Q 004442 611 VTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG 686 (753)
Q Consensus 611 Ia~qIa~gL~yLH~~---~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~-~GT~~Y~APE~l~~~ 686 (753)
||.++|+||+|||+. .||||||||+||||+ .++++||+|||+|+..... .....+. .||.+|+|||++..+
T Consensus 179 Ia~g~A~gL~yLH~~~~~~iiHrDiKssNILLD--~~~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 179 IALGAARGLAYLHEGCPPPIIHRDIKSSNILLD--EDFNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred HHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC--CCCCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccC
Confidence 999999999999986 499999999999995 4577999999999766431 1111122 699999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHcc-----Ccccc--cCCC--H---HHHHHHHHcc
Q 004442 687 RQTRAIDLFSLGCILFFCITGGKHPYGESF--------ERDANIVKDR-----KDLFL--VEHI--P---EAVDLFTRLL 746 (753)
Q Consensus 687 ~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--------~~~~~~i~~~-----~~~~~--~~~s--~---el~dLI~~cL 746 (753)
..+.|+|||||||+|+|++||++ +.+... ......+... .++.. ..+. . .+..+..+|+
T Consensus 254 ~lt~KsDVySFGVvllElitgr~-~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~ 332 (361)
T KOG1187|consen 254 KLTEKSDVYSFGVVLLELITGRK-AVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCL 332 (361)
T ss_pred CcCcccccccchHHHHHHHhCCc-ccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHc
Confidence 99999999999999999999964 444321 1101111111 11111 2333 2 2556888999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.+|++|
T Consensus 333 ~~~~~~R 339 (361)
T KOG1187|consen 333 RPDPKER 339 (361)
T ss_pred CcCCCcC
Confidence 9999887
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=363.36 Aligned_cols=238 Identities=26% Similarity=0.392 Sum_probs=199.1
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
+++.+.||+|-||.||.|.......||||.++... ..+.+.+++.+|+.++|+|||+|+|+|..++.+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE------ 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE------ 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE------
Confidence 34557799999999999888777799999998643 33444444458899999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
||++|+|.++|+... ...+...+++.++.|||.||+||+++++|||||.
T Consensus 282 ----~m~~GsLl~yLr~~~---------------------------~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA 330 (468)
T KOG0197|consen 282 ----YMPKGSLLDYLRTRE---------------------------GGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA 330 (468)
T ss_pred ----ecccCcHHHHhhhcC---------------------------CCccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence 999999999997622 3457778999999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
++|||++++ .++||+|||||+...++.. .......-...|.|||.+..+.++.|||||||||+|||++|-++.||.
T Consensus 331 ARNiLV~~~--~~vKIsDFGLAr~~~d~~Y--~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 331 ARNILVDED--LVVKISDFGLARLIGDDEY--TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred hhheeeccC--ceEEEcccccccccCCCce--eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 999999655 5799999999995544322 222233347789999999999999999999999999999999899987
Q ss_pred CCh-HHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESF-ERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~-~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.. .+....+..+. .+-|..+++++.++|+.||..+|++|
T Consensus 407 ~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~R 448 (468)
T KOG0197|consen 407 GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDR 448 (468)
T ss_pred CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccC
Confidence 764 44455555554 45678899999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=335.44 Aligned_cols=234 Identities=26% Similarity=0.373 Sum_probs=204.8
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||.|+||+|.+++.+ +|..+|+|+|.+..-- +-...+..+++.+.||.+++|.+-|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56778899999999999998654 5899999999765311 11223335889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|-|+.+|+. .++++++.+.-+|.+|+.||+|||+.+
T Consensus 124 e----------yv~GGElFS~Lrk-----------------------------~~rF~e~~arFYAAeivlAleylH~~~ 164 (355)
T KOG0616|consen 124 E----------YVPGGELFSYLRK-----------------------------SGRFSEPHARFYAAEIVLALEYLHSLD 164 (355)
T ss_pred e----------ccCCccHHHHHHh-----------------------------cCCCCchhHHHHHHHHHHHHHHHHhcC
Confidence 9 9999999999964 356888889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|++|||||+||||+++|. +||.|||.|+.+... +.+.|||+.|+|||++..+.|..++|.|||||++|||+.
T Consensus 165 iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~r------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGH--IKITDFGFAKRVSGR------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred eeeccCChHHeeeccCCc--EEEEeccceEEecCc------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 999999999999988876 999999999987642 467899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|..|+|+...-....++..++..+|..+++++++||+++|++|-++|
T Consensus 237 G~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 237 GYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 95555555566777889999999999999999999999999998877
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=376.15 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=206.1
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+..+.+.||+|.||+||+|... +.+.||||.|++.... +.|+.+.++++.++|||||+|+|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345677788999999999998654 3578999999875433 3455455699999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+||+| ||..|+|.+||.......+... .+.. ...++...+.+.||.|||.||+||
T Consensus 565 ~MvFE----------Ym~~GDL~eFLra~sP~a~~~~-----------~g~~----~~~~L~~~q~L~iA~QIAaGM~YL 619 (774)
T KOG1026|consen 565 CMVFE----------YMDHGDLHEFLRARSPKADKLA-----------SGQD----TPPPLSTSQFLHIATQIAAGMEYL 619 (774)
T ss_pred EEEEE----------ecccccHHHHHHhhCCcccccc-----------CCCC----CCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 9999999999987765443221 1111 145688999999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
-++.+|||||..+|+|+. .++.+||+||||++..-........ ....-..+|||||.|..++||.+||||||||+||
T Consensus 620 s~~~FVHRDLATRNCLVg--e~l~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLW 696 (774)
T KOG1026|consen 620 SSHHFVHRDLATRNCLVG--ENLVVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLW 696 (774)
T ss_pred HhCcccccchhhhhceec--cceEEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhcCcccchhhhhhhhhhhh
Confidence 999999999999999994 4578999999999977543322111 1112368999999999999999999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGE-SFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~-~~~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+++-++.||.+ ++++..+.+..+. ..-|++++.++.+||..||+.+|++|
T Consensus 697 EIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~R 749 (774)
T KOG1026|consen 697 EIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRR 749 (774)
T ss_pred hhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccC
Confidence 999988888765 4666666666655 45678899999999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=399.61 Aligned_cols=224 Identities=24% Similarity=0.330 Sum_probs=168.4
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
+...+.||+|+||.||+|.. .+|+.||||++..... ....|+ ..++.++|||||+++|+|.+++..++|||
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~-~~l~~l~HpnIv~~~~~~~~~~~~~lv~E------ 763 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEI-ADMGKLQHPNIVKLIGLCRSEKGAYLIHE------ 763 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHH-HHHhhCCCCCcceEEEEEEcCCCCEEEEe------
Confidence 34457799999999999976 5799999999865432 122344 46788999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh---hCCcccc
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH---EIGLIHR 630 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH---~~~IiHr 630 (753)
|+++|+|.++++ .++|.++.+|+.|+|+||+||| +.+|+||
T Consensus 764 ----y~~~g~L~~~l~--------------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 764 ----YIEGKNLSEVLR--------------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred ----CCCCCcHHHHHh--------------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 888999998873 2567788999999999999999 5699999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +++. ||........ ....||..|+|||++.+..++.++|||||||++|||+|| +.
T Consensus 808 dlkp~Nil~~~~~~--~~~~-~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg-~~ 876 (968)
T PLN00113 808 NLSPEKIIIDGKDE--PHLR-LSLPGLLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KS 876 (968)
T ss_pred CCCHHhEEECCCCc--eEEE-eccccccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC-CC
Confidence 99999999976654 5554 6655433211 123578999999999999999999999999999999998 56
Q ss_pred CCCCChH---HHHHHHH---------ccCcc-------cccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFE---RDANIVK---------DRKDL-------FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~---~~~~~i~---------~~~~~-------~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+.... ....... ...++ .......++.+++.+||+.||++|
T Consensus 877 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 938 (968)
T PLN00113 877 PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTAR 938 (968)
T ss_pred CCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhC
Confidence 7643211 1110000 00000 111122357789999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=351.96 Aligned_cols=234 Identities=25% Similarity=0.333 Sum_probs=196.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchH-----HHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~-----~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||+||||+.+ +.+.||+|.+.+....+ ..+|+ ++++.++|||||.++++|....++++|+|
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev-~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEV-RILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHH-HHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4666788999999999999665 58999999997654322 34444 48899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||.+ +|+.+|. ....++++++..|+.+++.||.|||+.+|
T Consensus 82 ~a~g-----------~L~~il~-----------------------------~d~~lpEe~v~~~a~~LVsaL~yLhs~ri 121 (808)
T KOG0597|consen 82 YAVG-----------DLFTILE-----------------------------QDGKLPEEQVRAIAYDLVSALYYLHSNRI 121 (808)
T ss_pred hhhh-----------hHHHHHH-----------------------------hccCCCHHHHHHHHHHHHHHHHHHHhcCc
Confidence 6654 5555543 34678999999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|||+||+||||...+ .+|+||||+|+.+..+. .......||+-|||||++.+..|+..+|+||+||++|||++|
T Consensus 122 lhrd~kPqniLl~~~~--~~KlcdFg~Ar~m~~~t---~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 122 LHRDMKPQNILLEKGG--TLKLCDFGLARAMSTNT---SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred ccccCCcceeeecCCC--ceeechhhhhhhcccCc---eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC
Confidence 9999999999995554 59999999999886543 233445699999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|+|..+.-.....+.......|.+.+.++++|++.+|.+||.+|
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~R 242 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQR 242 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhc
Confidence 6666666666666666666666777899999999999999999988
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=348.42 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=203.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhC-CCCceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~ 540 (753)
++-..+|.+.+.||+|+|.+||+|... .++.+|||++.+.. .....+|-. .|.++ .||.|++|+--|.|+.
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~-~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKE-ALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHH-HHHHhhCCCCeEEEEEEeeccc
Confidence 334467899999999999999999665 59999999996542 122333443 44555 9999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+|+|+| |+++|+|.++|+.. +.+++.-...++.+|+.||+
T Consensus 148 sLYFvLe----------~A~nGdll~~i~K~-----------------------------Gsfde~caR~YAAeIldAle 188 (604)
T KOG0592|consen 148 SLYFVLE----------YAPNGDLLDLIKKY-----------------------------GSFDETCARFYAAEILDALE 188 (604)
T ss_pred ceEEEEE----------ecCCCcHHHHHHHh-----------------------------CcchHHHHHHHHHHHHHHHH
Confidence 9999999 88999999998654 45666777899999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc------c--cc--CccCCCCccccccccccCCCCCc
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------L--TQ--NATGYGSSGWQAPEQLLQGRQTR 690 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~------~--~~--~~~~~GT~~Y~APE~l~~~~~t~ 690 (753)
|||++|||||||||+||||+.|++ +||.|||-|+.+.+.... . .. ....+||..|.+||++..+..+.
T Consensus 189 ylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~ 266 (604)
T KOG0592|consen 189 YLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGP 266 (604)
T ss_pred HHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCc
Confidence 999999999999999999977755 999999999988643211 1 11 24578999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+|||+|||+||.|+.| .+||.+.++- .++.+......+++.++++++|||+++|..||.+|
T Consensus 267 ~sDiWAlGCilyQmlaG-~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~R 329 (604)
T KOG0592|consen 267 SSDLWALGCILYQMLAG-QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDR 329 (604)
T ss_pred ccchHHHHHHHHHHhcC-CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCcccc
Confidence 99999999999999999 7899887664 56777788889999999999999999999999998
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=353.09 Aligned_cols=236 Identities=25% Similarity=0.396 Sum_probs=200.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhC-CCCceeeecccccCCceE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~ 542 (753)
--++|.+.++||+|+||+|+++..+ +++.+|||.+++.. -+....|. +++... +||.+++|+.+|...+++
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~Ek-rI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEK-RIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHH-HHHHHhccCCeEeecccccccCCeE
Confidence 3467899999999999999999765 48899999998753 11222232 233332 799999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |..+|++..+.+ ...+++..+.-+|..|+.||+||
T Consensus 445 ~fvme----------y~~Ggdm~~~~~------------------------------~~~F~e~rarfyaAev~l~L~fL 484 (694)
T KOG0694|consen 445 FFVME----------YVAGGDLMHHIH------------------------------TDVFSEPRARFYAAEVVLGLQFL 484 (694)
T ss_pred EEEEE----------ecCCCcEEEEEe------------------------------cccccHHHHHHHHHHHHHHHHHH
Confidence 99999 888888444322 35688899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+++|||||||.+||||+.+|. +||+||||++..-. ....+.+.|||+.|||||++.+..|+.++|.|||||+||
T Consensus 485 H~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLly 559 (694)
T KOG0694|consen 485 HENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLY 559 (694)
T ss_pred HhcCceeeecchhheEEcccCc--EEecccccccccCC---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHH
Confidence 9999999999999999988887 99999999986532 334667899999999999999999999999999999999
Q ss_pred HHHhCCCCCCC-CChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~-~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+.| ..||. ++.++.+..+.+....+|..++.|+.++|+++|.+||++|
T Consensus 560 eML~G-q~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kR 610 (694)
T KOG0694|consen 560 EMLVG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKR 610 (694)
T ss_pred HHHcC-CCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccc
Confidence 99999 56776 5566778888899999999999999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.37 Aligned_cols=234 Identities=30% Similarity=0.426 Sum_probs=207.0
Q ss_pred ceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.-|++.+.||+|+-|.|-+|. ...|+.+|||.+.+. ......+|+. +|+.+.|||+++|+++|+++.++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIv-iMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIV-IMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhH-HHHHhcCCCeeeeeeeeccCceEEEE
Confidence 457788999999999999884 467999999999654 1234567777 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
.| |+++|-|+++|.. .+++++.+..+++.||+.|+.|+|..
T Consensus 91 lE----------yv~gGELFdylv~-----------------------------kG~l~e~eaa~ff~QIi~gv~yCH~~ 131 (786)
T KOG0588|consen 91 LE----------YVPGGELFDYLVR-----------------------------KGPLPEREAAHFFRQILDGVSYCHAF 131 (786)
T ss_pred EE----------ecCCchhHHHHHh-----------------------------hCCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 99 9999999998854 46788999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~El 704 (753)
+|+||||||+|+||+..++ +||+|||+|..-.++ .-..+.||.+.|.|||++.+..| +.++||||.|||||.|
T Consensus 132 ~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfAL 205 (786)
T KOG0588|consen 132 NICHRDLKPENLLLDVKNN--IKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFAL 205 (786)
T ss_pred cceeccCCchhhhhhcccC--EeeeccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHH
Confidence 9999999999999977765 999999999875433 34567899999999999999998 7999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|| +.||++.+ .....++..+...+|.+.++++++||.+||.+||++|
T Consensus 206 LtG-~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~R 254 (786)
T KOG0588|consen 206 LTG-KLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTR 254 (786)
T ss_pred HhC-CCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCcccc
Confidence 999 78888764 4566888999999999999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.07 Aligned_cols=234 Identities=26% Similarity=0.395 Sum_probs=183.7
Q ss_pred EEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|+....+|+|+||.||+++.++ |+.||||++...+.+ -+++|+. |++.++|+|+|.|+.+|.....++||+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIr-mLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIR-MLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHH-HHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4455679999999999987765 999999999776543 3566665 89999999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+-++.+.+ + ....+++...+.+++.|+++|+.|+|+++||
T Consensus 83 ~dhTvL~eL--------------e-------------------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~I 123 (396)
T KOG0593|consen 83 CDHTVLHEL--------------E-------------------------RYPNGVPSELVKKYLYQLLKAIHFCHKNNCI 123 (396)
T ss_pred cchHHHHHH--------------H-------------------------hccCCCCHHHHHHHHHHHHHHhhhhhhcCee
Confidence 886533222 0 1235677888899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllTG 707 (753)
||||||+||||+..+. +||||||+|+.+....+. .+..+.|..|.|||.+.+ .+|+..+||||+||++.||++|
T Consensus 124 HRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~---YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G 198 (396)
T KOG0593|consen 124 HRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN---YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTG 198 (396)
T ss_pred cccCChhheEEecCCc--EEeccchhhHhhcCCcch---hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcC
Confidence 9999999999988875 999999999988753322 234557999999999988 6799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHc--------------cCc-------cc----------ccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERDANIVKD--------------RKD-------LF----------LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~~~~i~~--------------~~~-------~~----------~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.....+.+.-.+...+.. ..+ +. .+..+.-+.||++.||..||++|
T Consensus 199 ~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 199 EPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred CcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 554445443333322211 110 00 11234568899999999999998
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=341.08 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=200.2
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC--------CchHHHHHHHHHHHhCC-CCceeeecccccCCc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQ-HPNIVRWYGVESDQD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~ 540 (753)
....|.+.+.||+|+||+|++|.. ..|..||||.+.+. ..+...+|+. +++.++ ||||++++.++....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~-~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREIS-ILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHH-HHHHhccCCCEeEEEEEEecCC
Confidence 346788999999999999999954 56899999976543 1223345765 678888 999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+|+||| |..+|+|++++.. ...+.+..+.+++.|++.|++
T Consensus 94 ~~~ivmE----------y~~gGdL~~~i~~-----------------------------~g~l~E~~ar~~F~Qlisav~ 134 (370)
T KOG0583|consen 94 KIYIVME----------YCSGGDLFDYIVN-----------------------------KGRLKEDEARKYFRQLISAVA 134 (370)
T ss_pred eEEEEEE----------ecCCccHHHHHHH-----------------------------cCCCChHHHHHHHHHHHHHHH
Confidence 9999999 6667888888754 245677888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-C-CchhhHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-Q-TRAIDLFSLG 698 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~-t~ksDIwSfG 698 (753)
|||+.||+||||||+|||++.+. .++||+|||++.... .......+.+||+.|+|||++.+.. | +.++||||+|
T Consensus 135 y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~---~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~G 210 (370)
T KOG0583|consen 135 YCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISP---GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLG 210 (370)
T ss_pred HHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccC---CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhH
Confidence 99999999999999999997662 459999999999874 1234557889999999999999988 8 5899999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCC-CHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGES-FERDANIVKDRKDLFLVEH-IPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~-s~el~dLI~~cL~~DP~~R 753 (753)
|+||.|++| ..||++. .......+......++... ++++++||.+||..||.+|
T Consensus 211 ViLy~ml~G-~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R 266 (370)
T KOG0583|consen 211 VILYVLLCG-RLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTR 266 (370)
T ss_pred HHHHHHHhC-CCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccC
Confidence 999999999 6788765 4556667778888888888 9999999999999999988
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.08 Aligned_cols=232 Identities=26% Similarity=0.366 Sum_probs=192.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +|+.||||++.... ....+..+..+++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999765 58999999986432 11223333347899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i 122 (291)
T cd05612 82 ----------YVPGGELFSYLRNS-----------------------------GRFSNSTGLFYASEIVCALEYLHSKEI 122 (291)
T ss_pred ----------CCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77888888877432 346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 ~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g 194 (291)
T cd05612 123 VYRDLKPENILLDKEGH--IKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194 (291)
T ss_pred eecCCCHHHeEECCCCC--EEEEecCcchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999977664 999999999866432 1234689999999999998999999999999999999998
Q ss_pred CCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||... .......+......++..+++++++||++||+.||.+|
T Consensus 195 -~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 240 (291)
T cd05612 195 -YPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR 240 (291)
T ss_pred -CCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHc
Confidence 5566554 44445556666667778889999999999999999988
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=334.94 Aligned_cols=239 Identities=29% Similarity=0.455 Sum_probs=191.3
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCc--eEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--~~~LV~E 547 (753)
.+...+.||+|+||+||++...+ |...|||...... .+...+|+. ++..++|||||+.+|...... .+++.||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~-iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIR-ILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHH-HHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34566889999999999997765 9999999987653 223455665 889999999999999855444 6999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.... . .+++..+.++..||++||+|||++||
T Consensus 97 ----------y~~~GsL~~~~~~~g---------------------------~-~l~E~~v~~ytr~iL~GL~ylHs~g~ 138 (313)
T KOG0198|consen 97 ----------YAPGGSLSDLIKRYG---------------------------G-KLPEPLVRRYTRQILEGLAYLHSKGI 138 (313)
T ss_pred ----------ccCCCcHHHHHHHcC---------------------------C-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 999999999886431 2 58999999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.. +..+||+|||+++................||+.|||||++..+ ...+++|||||||++.||+|
T Consensus 139 vH~DiK~~NiLl~~~-~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 139 VHCDIKPANILLDPS-NGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred eccCcccceEEEeCC-CCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 999999999999773 2359999999999876422222334456799999999999864 34469999999999999999
Q ss_pred CCCCCCCCC---hHHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES---FERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~---~~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.+. .......... ..+..+...++++++||.+|+.+||++|
T Consensus 218 g-~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~R 267 (313)
T KOG0198|consen 218 G-KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKR 267 (313)
T ss_pred C-CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccC
Confidence 9 8898763 2222222222 2456788899999999999999999988
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=343.70 Aligned_cols=241 Identities=26% Similarity=0.405 Sum_probs=199.9
Q ss_pred ccceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 467 DGRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 467 ~~~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
........|...+.||+|+-|.||.|.. ..++.||||++.... .+-.+.|+. +|+..+|+|||+++.-+...+++
T Consensus 267 ~~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~-Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 267 SQGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEIL-VMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred cCCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHH-HHHhccchHHHHHHHHhccccee
Confidence 3344455677778899999999999855 468999999995432 344567776 77999999999999998888999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| ||++|+|.+.+.. ..+++.++..|++++++||+||
T Consensus 346 WVVME----------ym~ggsLTDvVt~------------------------------~~~~E~qIA~Icre~l~aL~fL 385 (550)
T KOG0578|consen 346 WVVME----------YMEGGSLTDVVTK------------------------------TRMTEGQIAAICREILQGLKFL 385 (550)
T ss_pred EEEEe----------ecCCCchhhhhhc------------------------------ccccHHHHHHHHHHHHHHHHHH
Confidence 99999 9999999887642 3478889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|.++|+|||||++|||++.+|. +||+|||++..+.... ....+.+||+.|||||++..+.|++|+||||||++.+
T Consensus 386 H~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~---~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaI 460 (550)
T KOG0578|consen 386 HARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQ---SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAI 460 (550)
T ss_pred HhcceeeeccccceeEeccCCc--EEEeeeeeeecccccc---CccccccCCCCccchhhhhhcccCccccchhhhhHHH
Confidence 9999999999999999999987 9999999999886543 3556778999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHH-HccCc--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDANIV-KDRKD--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~~~i-~~~~~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+-|.+++|.+..-+....+ .++.+ ..+...|++++||+.+||+.||++|
T Consensus 461 EMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~R 514 (550)
T KOG0578|consen 461 EMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQR 514 (550)
T ss_pred HHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcC
Confidence 999995444444444444444 44433 3466789999999999999999998
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=335.68 Aligned_cols=232 Identities=25% Similarity=0.350 Sum_probs=193.3
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|.+.+.||+|+||.||++... +++.||||.+.... .+...+|+. ++..++||||+++++++.+++..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS-ILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 56888999999999999999765 58999999986432 122344544 78899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 97 ~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 97 LE----------FVVGGELFTHLRKA-----------------------------GRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred Ec----------CCCCChHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 77788888877432 3467778889999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 138 ~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred CeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 9999999999999977765 999999999876432 12346899999999999999999999999999999999
Q ss_pred hCCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| ..||.+ ...+....+......++..+++++++||++||++||++|
T Consensus 210 tg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 257 (329)
T PTZ00263 210 AG-YPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKR 257 (329)
T ss_pred cC-CCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 98 556654 444455556666667777889999999999999999998
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.57 Aligned_cols=229 Identities=27% Similarity=0.369 Sum_probs=188.5
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++.. .+|+.||||++++.. .....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e---- 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-VLQNTRHPFLTALKYSFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHH-HHHhCCCCCCCCEEEEEEcCCEEEEEEe----
Confidence 3599999999999865 468999999997532 112334444 7789999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+.+|+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 7778888887743 24577888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||+|| ..|
T Consensus 121 lkp~NIll~~~~~--~kl~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P 194 (323)
T cd05571 121 LKLENLMLDKDGH--IKITDFGLCKEGISD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEECCCCC--EEEeeCCCCcccccC---CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC-CCC
Confidence 9999999977765 999999998754321 1122345699999999999999999999999999999999999 556
Q ss_pred CC-CChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~-~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|. .........+......++..+++++.+||++||++||++|
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 195 FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 64 4445555566666667788899999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=336.52 Aligned_cols=241 Identities=28% Similarity=0.395 Sum_probs=193.5
Q ss_pred eecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.-.++|.+.+.||+|+||.||++...+ |..+|+|+|++.... .-.+-+..+|...+++.||+|+-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 345678999999999999999997665 999999999875421 12333334777799999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |.++|++..+|.. ...|++..+..++.+++.|++-||
T Consensus 218 LiME----------ylPGGD~mTLL~~-----------------------------~~~L~e~~arfYiaE~vlAI~~iH 258 (550)
T KOG0605|consen 218 LIME----------YLPGGDMMTLLMR-----------------------------KDTLTEDWARFYIAETVLAIESIH 258 (550)
T ss_pred EEEE----------ecCCccHHHHHHh-----------------------------cCcCchHHHHHHHHHHHHHHHHHH
Confidence 9999 9999999999853 356788888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCC---------------C------ccc-----c-----------
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD---------------M------SCL-----T----------- 666 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~---------------~------~~~-----~----------- 666 (753)
+.|+|||||||+|+||+..|+ +||+||||+..+... . +.. .
T Consensus 259 ~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (550)
T KOG0605|consen 259 QLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQT 336 (550)
T ss_pred HcCcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHH
Confidence 999999999999999988876 999999999643210 0 000 0
Q ss_pred -------cCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHccC----cccccCC
Q 004442 667 -------QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES-FERDANIVKDRK----DLFLVEH 734 (753)
Q Consensus 667 -------~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~----~~~~~~~ 734 (753)
.....+|||.|||||++.+..|+..+|+||||||+|||+.| .|||... .......+.+.+ .+.....
T Consensus 337 w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvG-yPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~ 415 (550)
T KOG0605|consen 337 WKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVG-YPPFCSETPQETYRKIVNWRETLKFPEEVDL 415 (550)
T ss_pred HHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhhhccCCCcCcc
Confidence 00123699999999999999999999999999999999999 6777655 444444444433 2333456
Q ss_pred CHHHHHHHHHccccCcCCC
Q 004442 735 IPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 735 s~el~dLI~~cL~~DP~~R 753 (753)
++++.|||.+||. ||++|
T Consensus 416 s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 416 SDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cHHHHHHHHHHhc-CHHHh
Confidence 7999999999999 99987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.47 Aligned_cols=247 Identities=30% Similarity=0.401 Sum_probs=196.7
Q ss_pred ccccceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----------------chHHHHHHHHHHHhCCC
Q 004442 465 RVDGRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----------------HDVALKEIQNLIASDQH 526 (753)
Q Consensus 465 ~~~~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----------------~~~~~~Ei~~ll~~l~H 526 (753)
....+..-++|++.+.||+|.||.|-+|... +++.||||++.+.. .+...+|++ ++++++|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa-ilKkl~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA-ILKKLHH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH-HHHhcCC
Confidence 3445667789999999999999999999765 59999999996432 134567777 7899999
Q ss_pred CceeeecccccC--CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCC
Q 004442 527 PNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHP 604 (753)
Q Consensus 527 pNIV~L~g~~~~--~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 604 (753)
+|||+|+.+-.+ .+.+|||+| |+..|.+..- . -....+.
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVle----------y~s~G~v~w~------------------------p-----~d~~els 208 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLE----------YCSKGEVKWC------------------------P-----PDKPELS 208 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEE----------eccCCccccC------------------------C-----CCccccc
Confidence 999999999876 467999999 5555544321 0 0111278
Q ss_pred HHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--ccccCccCCCCcccccccc
Q 004442 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQ 682 (753)
Q Consensus 605 ~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~--~~~~~~~~~GT~~Y~APE~ 682 (753)
+.++++++++++.||+|||.+|||||||||+|+||+.+|. +||+|||.+........ ........+||+.|+|||.
T Consensus 209 ~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~ 286 (576)
T KOG0585|consen 209 EQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL 286 (576)
T ss_pred HHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence 8899999999999999999999999999999999988865 99999999987743211 1112233579999999999
Q ss_pred ccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccC--CCHHHHHHHHHccccCcCCC
Q 004442 683 LLQGR----QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 683 l~~~~----~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~--~s~el~dLI~~cL~~DP~~R 753 (753)
..++. .+.+.||||+||.||+|+.|+.|++++.....+.++.+....+|.. ..++++|||++||.+||++|
T Consensus 287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~R 363 (576)
T KOG0585|consen 287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQR 363 (576)
T ss_pred hcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhe
Confidence 87733 3789999999999999999966666666667778888877777665 57899999999999999998
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=330.76 Aligned_cols=234 Identities=24% Similarity=0.343 Sum_probs=181.2
Q ss_pred EEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCceeeecccccCCc----eEEEEEcccc
Q 004442 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSLERCT 550 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~L~g~~~~~~----~~~LV~E~c~ 550 (753)
++.+.||+|+||.||||.+.+ +.||||++...+.+.+..|... -+-.++|+||++++++-.... +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~--- 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE--- 288 (534)
T ss_pred hhHHHhhcCccceeehhhccC-ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee---
Confidence 455779999999999988755 9999999987766666555542 123679999999999976554 8999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-----
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI----- 625 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~----- 625 (753)
|.++|+|.++|.. ..++|....+|+..+++||+|||+.
T Consensus 289 -------fh~kGsL~dyL~~------------------------------ntisw~~~cria~SmarGLa~LHee~p~~d 331 (534)
T KOG3653|consen 289 -------FHPKGSLCDYLKA------------------------------NTISWNSLCRIAESMARGLAHLHEELPRGD 331 (534)
T ss_pred -------eccCCcHHHHHHh------------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCC
Confidence 9999999999853 5688999999999999999999975
Q ss_pred ----CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC------CchhhHH
Q 004442 626 ----GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLF 695 (753)
Q Consensus 626 ----~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~------t~ksDIw 695 (753)
+|+|||||++|||+.+|.+ +.|+|||||..+........ ....+||.+|||||++.+... -.+.|||
T Consensus 332 ~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY 408 (534)
T KOG3653|consen 332 HHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQGD-THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY 408 (534)
T ss_pred CCCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH
Confidence 5999999999999998865 78999999999876544332 334689999999999977542 2479999
Q ss_pred HHHHHHHHHHhCCC-----------CCCCC------ChHHHHHHHHc--cCcccccCC-----CHHHHHHHHHccccCcC
Q 004442 696 SLGCILFFCITGGK-----------HPYGE------SFERDANIVKD--RKDLFLVEH-----IPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 696 SfGvvL~EllTG~~-----------~Pf~~------~~~~~~~~i~~--~~~~~~~~~-----s~el~dLI~~cL~~DP~ 751 (753)
|+|.|||||++... .||+. +.+++...+.. .++.++..+ ..-+++.|+.||+.||+
T Consensus 409 amgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae 488 (534)
T KOG3653|consen 409 AMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE 488 (534)
T ss_pred HHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence 99999999998532 23331 23344333322 223333322 34688999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
.|
T Consensus 489 AR 490 (534)
T KOG3653|consen 489 AR 490 (534)
T ss_pred hh
Confidence 87
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.34 Aligned_cols=234 Identities=23% Similarity=0.366 Sum_probs=188.6
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----ch-HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HD-VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~-~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|...+.||+|+||.||++.. .+|+.||||.+.... .. ...+|+ .++..++|+||+++.+++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHH-HHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 56778999999999999865 469999999986432 11 233444 47899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ....+++..++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~~g~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHhh---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 77788887766432 12357888899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++. +||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 124 VYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99999999999976654 9999999998764321 12334689999999999999999999999999999999998
Q ss_pred CCCCCCCChH-----HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-----~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||..... .....+.......+..+++++.+||++||++||++|
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R 247 (285)
T cd05631 198 -QSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247 (285)
T ss_pred -CCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHh
Confidence 678865432 122223334445667789999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=311.15 Aligned_cols=235 Identities=26% Similarity=0.381 Sum_probs=201.2
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|.+.+.||+|.||.||.|.. .++-.||+|++.+++ ..+..+|++ +.+.++||||++++||+.+....||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiE-Iqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIE-IQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeE-eecccCCccHHhhhhheeccceeEEE
Confidence 5677889999999999999965 458899999997653 234455554 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| |..+|.+++.|.... ...+++.....++.|+|.||.|+|..
T Consensus 101 lE----------ya~~gel~k~L~~~~---------------------------~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 101 LE----------YAPRGELYKDLQEGR---------------------------MKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred EE----------ecCCchHHHHHHhcc---------------------------cccccccchhHHHHHHHHHHHHhccC
Confidence 99 999999999986433 34567777899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
++|||||||+|+|++.++. +||+|||-+..... ....+.|||..|.+||.+.+..++.++|+|++|++.||++
T Consensus 144 ~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p~-----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 144 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred CcccCCCCHHHhccCCCCC--eeccCCCceeecCC-----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999988776 89999999876532 3446789999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.| .+||+... .+....+......+|...+.++.|+|.+||.++|.+|
T Consensus 217 vg-~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r 264 (281)
T KOG0580|consen 217 VG-LPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIER 264 (281)
T ss_pred hc-CCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCcccc
Confidence 99 67886654 4445566666667788999999999999999999988
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.76 Aligned_cols=242 Identities=26% Similarity=0.421 Sum_probs=190.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHH-HhCCCCceeeecccccCC----ceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLI-ASDQHPNIVRWYGVESDQ----DFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll-~~l~HpNIV~L~g~~~~~----~~~~ 543 (753)
+.+++++.+.+.||+|.||.||+| .+.|+.||||++...++..+++|-+... -.++|+||+.+++.-..+ .+++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG-~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRG-RWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred HhhhheeEEEEEecCccccceeec-cccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 788899999999999999999985 4578999999999998889999877443 357999999999985433 3689
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
||++ |+++|||+|||.. ..++....++++..+|.||+|||
T Consensus 286 LvTd----------YHe~GSL~DyL~r------------------------------~tv~~~~ml~LalS~AsGLaHLH 325 (513)
T KOG2052|consen 286 LVTD----------YHEHGSLYDYLNR------------------------------NTVTTEGMLKLALSIASGLAHLH 325 (513)
T ss_pred Eeee----------cccCCcHHHHHhh------------------------------ccCCHHHHHHHHHHHhhhHHHHH
Confidence 9999 9999999999864 45677888999999999999999
Q ss_pred hC--------CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC-cccccCccCCCCccccccccccCCCC------
Q 004442 624 EI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-SCLTQNATGYGSSGWQAPEQLLQGRQ------ 688 (753)
Q Consensus 624 ~~--------~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~~------ 688 (753)
.+ .|.|||||+.|||+++++. +.|+|+|||....... .-.......+||.+|||||++...-.
T Consensus 326 ~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fes 403 (513)
T KOG2052|consen 326 MEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFES 403 (513)
T ss_pred HHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhh
Confidence 64 4999999999999988876 6799999998876652 33345667889999999999975432
Q ss_pred CchhhHHHHHHHHHHHHhC----C-----CCCCCCC------hHHHHHHH--HccCcccccCCC--HH---HHHHHHHcc
Q 004442 689 TRAIDLFSLGCILFFCITG----G-----KHPYGES------FERDANIV--KDRKDLFLVEHI--PE---AVDLFTRLL 746 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG----~-----~~Pf~~~------~~~~~~~i--~~~~~~~~~~~s--~e---l~dLI~~cL 746 (753)
-..+||||||+|+||++-. + ++||.+. .+++...+ ....+..+..+. +. +.++|+.||
T Consensus 404 yk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW 483 (513)
T KOG2052|consen 404 YKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECW 483 (513)
T ss_pred hhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhh
Confidence 3579999999999997642 2 4576543 33333322 223333444332 33 557999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
..+|..|
T Consensus 484 ~~Np~aR 490 (513)
T KOG2052|consen 484 YANPAAR 490 (513)
T ss_pred cCCchhh
Confidence 9999877
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=332.92 Aligned_cols=233 Identities=27% Similarity=0.362 Sum_probs=192.5
Q ss_pred cceEEEeEEecccCceEEEEEEeeC--CcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~--g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.|.+.+.||+|+||.||+|.... +..||+|++.... .+...+|+ .+++.++||||+++++++.+.+..+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCCcceEEEEEeCCEEE
Confidence 3568888999999999999997543 3689999986421 12333454 4889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++... ..+++..+..++.|++.||.|||
T Consensus 108 lv~E----------y~~~g~L~~~i~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH 148 (340)
T PTZ00426 108 LVLE----------FVIGGEFFTFLRRN-----------------------------KRFPNDVGCFYAAQIVLIFEYLQ 148 (340)
T ss_pred EEEe----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77788888877532 35778888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++||
T Consensus 149 ~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 220 (340)
T PTZ00426 149 SLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYE 220 (340)
T ss_pred HCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHH
Confidence 999999999999999977654 999999999876432 234568999999999999889999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||... .......+......++...++++.++|++||+.||++|
T Consensus 221 ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R 270 (340)
T PTZ00426 221 ILVG-CPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKR 270 (340)
T ss_pred HhcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHc
Confidence 9999 5566554 33445556666666778889999999999999999988
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.32 Aligned_cols=229 Identities=27% Similarity=0.370 Sum_probs=187.4
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++.. .+|+.||+|.+.... . ....+|+ .+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~i~~~~~~~~~~~~~~lv~E---- 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhCCCCCCcceeeEEecCCEEEEEEe----
Confidence 3599999999999865 468999999997531 1 1223344 47889999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 76 ------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 7788888877643 23577888999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| +.|
T Consensus 121 lkp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g-~~P 194 (323)
T cd05595 121 IKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEEcCCCC--EEecccHHhccccCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC-CCC
Confidence 9999999977765 9999999987543211 122345689999999999999999999999999999999998 556
Q ss_pred CCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.. ........+......++..+++++.++|++||++||++|
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 195 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 644 444555555556666778899999999999999999988
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.77 Aligned_cols=240 Identities=23% Similarity=0.294 Sum_probs=185.8
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+...+.+.+.+.||+|+||+||+|.... .||||+|.-.. .-+.|+.++..++.-+|.||+-+.|||..... .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 4444556778899999999999987653 69999996443 22344444448899999999999999998887 99
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|+.+|+ +-+|+.+||..+ ..|+..+.+.||.|||+||.|||.
T Consensus 465 iTqwCe----------GsSLY~hlHv~e----------------------------tkfdm~~~idIAqQiaqGM~YLHA 506 (678)
T KOG0193|consen 465 ITQWCE----------GSSLYTHLHVQE----------------------------TKFDMNTTIDIAQQIAQGMDYLHA 506 (678)
T ss_pred eehhcc----------Cchhhhhccchh----------------------------hhhhHHHHHHHHHHHHHhhhhhhh
Confidence 999555 568888888654 346677889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 701 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL 701 (753)
++|||||||+.||+|.+|+ .+||+||||+...... ..........|...|||||++.. .+|++++||||||+|+
T Consensus 507 K~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~ 583 (678)
T KOG0193|consen 507 KNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVW 583 (678)
T ss_pred hhhhhhhccccceEEccCC--cEEEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHH
Confidence 9999999999999997774 5999999999765432 23334445558889999999963 4589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHH-cc---Cc--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERDANIVK-DR---KD--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~~~~i~-~~---~~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|| ..||.....++...+. .+ ++ ....++++++++|+..||.+++++|
T Consensus 584 YELltg-~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eR 640 (678)
T KOG0193|consen 584 YELLTG-ELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREER 640 (678)
T ss_pred HHHHhC-cCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccC
Confidence 999998 8999844333322111 22 11 1223455699999999999999998
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.20 Aligned_cols=227 Identities=28% Similarity=0.372 Sum_probs=186.7
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||++... +++.||+|++.+.. .....+|+. ++..++||||+++++++.+.+..++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e------ 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLKFSFQSPEKLYLVLA------ 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCcEeceeeEEecCCeEEEEEc------
Confidence 699999999998765 48899999986431 122334444 7788999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+|||||
T Consensus 74 ----~~~~g~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk 120 (312)
T cd05585 74 ----FINGGELFHHLQRE-----------------------------GRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120 (312)
T ss_pred ----CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence 77788888877532 346778889999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+|| .+||.
T Consensus 121 p~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~ 194 (312)
T cd05585 121 PENILLDYQGH--IALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFY 194 (312)
T ss_pred HHHeEECCCCc--EEEEECcccccCccCC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC-CCCcC
Confidence 99999977664 9999999998643221 122345689999999999999999999999999999999999 56765
Q ss_pred C-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 E-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+ ........+......++..+++++.+||.+||+.||++|
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 235 (312)
T cd05585 195 DENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRR 235 (312)
T ss_pred CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHc
Confidence 4 444555555666667778899999999999999999998
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.24 Aligned_cols=236 Identities=27% Similarity=0.447 Sum_probs=187.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCC-CCceeeecccccCCc-eEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQ-HPNIVRWYGVESDQD-FVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~-~~~L 544 (753)
-++|.+.+.||.|+||.||+|... .|..||||++++.. +...++|+.. ++++. |||||+|.+++.|.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvks-L~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKS-LRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHH-HHhcCCCCcchhhHHHhhccCceEee
Confidence 356777889999999999999654 58999999997653 2345788874 56666 999999999999988 9999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|||+++|+|.++| . .+.+.+++..+..|+.||++||+|+|+
T Consensus 88 VfE~Md~NLYqLm-----------K----------------------------~R~r~fse~~irnim~QilqGL~hiHk 128 (538)
T KOG0661|consen 88 VFEFMDCNLYQLM-----------K----------------------------DRNRLFSESDIRNIMYQILQGLAHIHK 128 (538)
T ss_pred eHHhhhhhHHHHH-----------h----------------------------hcCCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 9998888877666 1 235679999999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~E 703 (753)
+|+.|||+||+|||+.. ...+||+||||||.+.... ..+..+.|..|+|||++.. +-|+.+.||||+|||++|
T Consensus 129 ~GfFHRDlKPENiLi~~--~~~iKiaDFGLARev~Skp----PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aE 202 (538)
T KOG0661|consen 129 HGFFHRDLKPENILISG--NDVIKIADFGLAREVRSKP----PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAE 202 (538)
T ss_pred cCcccccCChhheEecc--cceeEecccccccccccCC----CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHH
Confidence 99999999999999954 4569999999999876432 3345567999999999865 558999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHc---------------------cC---------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERDANIVKD---------------------RK---------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~~~~i~~---------------------~~---------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.+.+..+.+.+.-.+..++-. .. .....+.++++.+||.+||.-||++|
T Consensus 203 l~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kR 282 (538)
T KOG0661|consen 203 LYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKR 282 (538)
T ss_pred HHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccC
Confidence 9999665555543333322210 00 01123467899999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=345.80 Aligned_cols=241 Identities=25% Similarity=0.373 Sum_probs=200.7
Q ss_pred cceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCchH----HHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~~----~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
...+++.++||.|-||.|++|+++- ...||||.|+....+. ++.| +.+|...+||||++|-|+....+..+
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~E-AsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSE-ASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhh-hhhcccCCCCcEEEEEEEEecCceeE
Confidence 4567889999999999999998753 4689999998755433 3334 34889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
||+| ||+||+|+.||+.++ ..+.+.++.-+.++||.||.||-
T Consensus 707 IiTE----------yMENGsLDsFLR~~D----------------------------GqftviQLVgMLrGIAsGMkYLs 748 (996)
T KOG0196|consen 707 IITE----------YMENGSLDSFLRQND----------------------------GQFTVIQLVGMLRGIASGMKYLS 748 (996)
T ss_pred EEhh----------hhhCCcHHHHHhhcC----------------------------CceEeehHHHHHHHHHHHhHHHh
Confidence 9999 999999999998764 34667788999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.++|||||.++|||+ |.++++|++||||++.+.++.+....+.......+|.|||.+..+++|.+||||||||||||
T Consensus 749 dm~YVHRDLAARNILV--NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE 826 (996)
T KOG0196|consen 749 DMNYVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 826 (996)
T ss_pred hcCchhhhhhhhheee--ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence 9999999999999999 55689999999999988766533333333344679999999999999999999999999999
Q ss_pred HHhCCCCCC-CCChHHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPY-GESFERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf-~~~~~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++.+.-|| +-++++..+.++.+ ..+.|..++..+.+|+..||++|-..|
T Consensus 827 VmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~R 878 (996)
T KOG0196|consen 827 VMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRR 878 (996)
T ss_pred ecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcC
Confidence 887665555 55666666655554 456677888999999999999998776
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.91 Aligned_cols=230 Identities=25% Similarity=0.394 Sum_probs=186.5
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +++.||||.++... .+....|...+....+||||+++++++...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME---- 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc----
Confidence 35999999999999764 48899999997431 12334455434445689999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+|+|||
T Consensus 77 ------~~~gg~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 77 ------YLNGGDLMFHIQSS-----------------------------GRFDEARARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 77788888776432 3467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nill~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~P 195 (316)
T cd05592 122 LKLDNVLLDKDGH--IKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEEccCcCCeECCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC-CCC
Confidence 9999999977765 9999999998653221 222345689999999999999999999999999999999998 667
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+......++..+++++.+||++||+.||++|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R 238 (316)
T cd05592 196 FHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238 (316)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 7654 34444555556666777889999999999999999988
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.87 Aligned_cols=234 Identities=24% Similarity=0.346 Sum_probs=189.3
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|.+.+.||+|+||.||++... +++.||||.+.+... .....|...+....+|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 677899999999999998665 578999999875321 1233344433334468999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+|
T Consensus 82 ----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 82 ----------YVNGGDLMYQIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred ----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 7778888877643 2346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 123 vHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred EecCCCHHHeEECCCCc--EEEccCCCceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 99999999999977764 9999999997543211 122345689999999999999999999999999999999998
Q ss_pred CCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||... .......+......++...++++.++|.+||++||++|
T Consensus 198 -~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R 243 (323)
T cd05616 198 -QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 243 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhc
Confidence 6677655 34445555666667778899999999999999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=330.29 Aligned_cols=229 Identities=26% Similarity=0.354 Sum_probs=187.7
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++.. .+|+.||||++.+.. .....+|+ .+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~E---- 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTES-RVLKNTRHPFLTSLKYSFQTKDRLCFVME---- 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCEEEEEEe----
Confidence 3599999999999865 468999999997532 12234444 47889999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+.+|+|||
T Consensus 76 ------y~~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 76 ------YVNGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 7778888877643 23577888999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 121 ikp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG-~~P 194 (328)
T cd05593 121 LKLENLMLDKDGH--IKITDFGLCKEGITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (328)
T ss_pred cCHHHeEECCCCc--EEEecCcCCccCCCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC-CCC
Confidence 9999999977654 9999999987643221 122345689999999999999999999999999999999998 567
Q ss_pred CCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.. ........+......++..+++++.+||++||++||++|
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 195 FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred CCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 654 344445555556667788899999999999999999988
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.46 Aligned_cols=230 Identities=27% Similarity=0.364 Sum_probs=188.1
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||+||++... +|+.||||++.+.. ....+.|+..+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e---- 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD---- 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc----
Confidence 35999999999999765 68999999996431 12344555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||+.+|+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d 121 (323)
T cd05575 77 ------YVNGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121 (323)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 7778888877743 23467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~NIll~~~~~--~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~p 195 (323)
T cd05575 122 LKPENILLDSQGH--VVLTDFGLCKEGIEH---SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (323)
T ss_pred CCHHHeEECCCCc--EEEeccCCCcccccC---CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC-CCC
Confidence 9999999977764 999999998754321 1122345689999999999999999999999999999999999 556
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+.......+...++++.++|++||++||++|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKR 238 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhC
Confidence 6543 44455555555566677789999999999999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=326.83 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=190.5
Q ss_pred cceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCC-
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQ- 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~- 539 (753)
.++|.+.+.||+|+||.||+|.. ..+..||||++..... ....+|+. ++..+ +||||++++|+|.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELK-ILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHH-HHHHhccCcceeeEEeEecCCC
Confidence 46788999999999999999853 2357899999975322 23455665 55666 899999999998764
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhh----hhhh---------ccccc-----------------
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE----VRIR---------LLPVM----------------- 589 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~----~~~~---------~~~~~----------------- 589 (753)
+..+++|| |+++|+|.++++..........+ ...+ .....
T Consensus 85 ~~~~lv~e----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (338)
T cd05102 85 GPLMVIVE----------FCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS 154 (338)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence 46899999 77888888888754321100000 0000 00000
Q ss_pred ---ccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc
Q 004442 590 ---ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666 (753)
Q Consensus 590 ---~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~ 666 (753)
.............+++..+++++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++........ .
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~-~ 231 (338)
T cd05102 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDY-V 231 (338)
T ss_pred cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcch-h
Confidence 000000011134688999999999999999999999999999999999997665 4999999999876433221 1
Q ss_pred cCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcc-CcccccCCCHHHHHHHH
Q 004442 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFT 743 (753)
Q Consensus 667 ~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~-~~~~~~~~s~el~dLI~ 743 (753)
......++..|+|||++.+..++.++|||||||++|||++.+.+||.... +.....+... ....+...++++.++|.
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIML 311 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 12233467889999999999999999999999999999983477887643 2222333332 23345667889999999
Q ss_pred HccccCcCCC
Q 004442 744 RLLDPNPDLR 753 (753)
Q Consensus 744 ~cL~~DP~~R 753 (753)
+||+.||++|
T Consensus 312 ~cl~~dp~~R 321 (338)
T cd05102 312 ACWQGDPKER 321 (338)
T ss_pred HHccCChhhC
Confidence 9999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.79 Aligned_cols=230 Identities=26% Similarity=0.388 Sum_probs=186.7
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +++.||||++.+.. ......|+..+....+|+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E---- 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME---- 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc----
Confidence 35999999999999765 58999999986431 12334555544444579999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 77 ------y~~~g~L~~~i~~-----------------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~d 121 (320)
T cd05590 77 ------FVNGGDLMFHIQK-----------------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRD 121 (320)
T ss_pred ------CCCCchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 7778888877643 23577888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| +.|
T Consensus 122 lkp~NIli~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (320)
T cd05590 122 LKLDNVLLDHEGH--CKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195 (320)
T ss_pred CCHHHeEECCCCc--EEEeeCCCCeecCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC-CCC
Confidence 9999999977765 9999999987643221 122345689999999999999999999999999999999998 667
Q ss_pred CCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.... ......+.......+...++++.++|++||++||++|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 238 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMR 238 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 76554 3444555566666777889999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=324.99 Aligned_cols=230 Identities=24% Similarity=0.367 Sum_probs=185.4
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +|+.||||.+++.. ......|+..+....+|+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E---- 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME---- 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC----
Confidence 36999999999999765 58999999997531 22344455444445699999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++.. ...+++.++..++.|++.||+|||+.+|+|||
T Consensus 77 ------~~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrD 121 (316)
T cd05620 77 ------FLNGGDLMFHIQD-----------------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 6677888777643 23467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g-~~P 195 (316)
T cd05620 122 LKLDNVMLDRDGH--IKIADFGMCKENVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEeCccCCCeecccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC-CCC
Confidence 9999999977764 9999999987532211 122345689999999999999999999999999999999998 566
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+.......+...+++++++|++||+.||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (316)
T cd05620 196 FHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 6544 44445555555666777789999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=323.98 Aligned_cols=233 Identities=23% Similarity=0.337 Sum_probs=187.8
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCC-CceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~H-pNIV~L~g~~~~~~~~~LV~ 546 (753)
|.+.+.||+|+||.||+|... .++.||||++.+.. .+....|.. ++..++| ++|+++++++.+.+..|+||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 678899999999999999765 47899999986431 123344444 5566665 56889999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 E----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 81 E----------YVNGGDLMYHIQQ-----------------------------VGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred c----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7778888877643 234677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 122 ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 122 IIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred eEecCCCHHHeEEcCCCC--EEEeecCcceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999977765 9999999987532211 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.... ......+......++...++++.++|++||++||.+|
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (324)
T cd05587 197 G-QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKR 243 (324)
T ss_pred C-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 8 66776553 3444555566666778889999999999999999988
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.15 Aligned_cols=230 Identities=26% Similarity=0.339 Sum_probs=186.2
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||+||++... +++.||+|++.+.. ......|+..+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e---- 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD---- 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe----
Confidence 35999999999999765 57899999986432 12334555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++... ..+.+..+..++.||+.||.|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~L~~lH~~giiHrD 121 (325)
T cd05602 77 ------YINGGELFYHLQRE-----------------------------RCFLEPRARFYAAEIASALGYLHSLNIVYRD 121 (325)
T ss_pred ------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 77788888776432 3456677888999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~Nili~~~~~--~kl~DfG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (325)
T cd05602 122 LKPENILLDSQGH--IVLTDFGLCKENIEH---NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEccCCCCcccccC---CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC-CCC
Confidence 9999999977764 999999999754321 1123345699999999999999999999999999999999999 566
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+...........++++.++|++||++||++|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 238 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHC
Confidence 6544 44444555555555667889999999999999999988
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=330.34 Aligned_cols=236 Identities=25% Similarity=0.379 Sum_probs=185.8
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC--ceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~L 544 (753)
..|+..+.||+|.||.||+|.+ .+|+.||+|++.-.. .....+||. ++++++||||++|.+...+. ..+||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~-ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK-ILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH-HHHhcCCCcccceeeEEEecCCceEEE
Confidence 4566678899999999999965 469999999996543 234678887 88999999999999998776 78999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|+||++-+|.-++ . ...-.|.+.++..++.|++.||+|+|.
T Consensus 196 VFeYMdhDL~GLl-----------~----------------------------~p~vkft~~qIKc~mkQLl~Gl~~cH~ 236 (560)
T KOG0600|consen 196 VFEYMDHDLSGLL-----------S----------------------------SPGVKFTEPQIKCYMKQLLEGLEYCHS 236 (560)
T ss_pred EEecccchhhhhh-----------c----------------------------CCCcccChHHHHHHHHHHHHHHHHHhh
Confidence 9996665544333 1 113468889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~E 703 (753)
+||+|||||.+||||+.+|. +||+|||||+++..... ...+..+.|..|.|||.+.+.. |+.++|+||.||||.|
T Consensus 237 ~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~--~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~E 312 (560)
T KOG0600|consen 237 RGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS--APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAE 312 (560)
T ss_pred cCeeeccccccceEEcCCCC--EEeccccceeeccCCCC--cccccceEEeeccChHHhcCCcccccceeehhhhHHHHH
Confidence 99999999999999977765 99999999998875432 2345667799999999998865 8999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHHc----------c--Ccc-----------------cccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVKD----------R--KDL-----------------FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~~----------~--~~~-----------------~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ++.|.+..+ .+.+++.. . +.+ ....+++.+.+|+..||..||++|
T Consensus 313 l~~g-kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 313 LFLG-KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred HHcC-CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 9999 666655433 33333221 0 000 122356788999999999999998
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.92 Aligned_cols=229 Identities=30% Similarity=0.414 Sum_probs=186.1
Q ss_pred EEecccCceEEEEEEe----eCCcEEEEEEeecCC------c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 479 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH------H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~------~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.||+|+||.||++.. ..++.||||.++... . .....|+ .+++.++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER-NILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHH-HHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5699999999999865 358899999997431 1 1223344 47899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ..+.+..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (323)
T cd05584 81 ----------YLSGGELFMHLERE-----------------------------GIFMEDTACFYLSEISLALEHLHQQGI 121 (323)
T ss_pred ----------CCCCchHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77788888877432 345667788899999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 122 IYRDLKPENILLDAQGH--VKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ecCCCCHHHeEECCCCC--EEEeeCcCCeecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 99999999999977764 9999999987543221 122345689999999999988899999999999999999998
Q ss_pred CCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.... ......+.......+...++++.+||++||++||++|
T Consensus 197 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 242 (323)
T cd05584 197 -APPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242 (323)
T ss_pred -CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHc
Confidence 66776543 3444555556666777889999999999999999998
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=356.07 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=201.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeC--Cc----EEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE--GR----SVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~--g~----~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
...++.+.||+|.||.||.|...+ |. .||||.+.+... ...|..+..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456788999999999999986654 43 499999976532 233444455889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|++| ||++|+|..||+..+... .....+...+++.|+.|||+|+.||+
T Consensus 772 i~le----------yM~gGDL~sflr~~r~~~----------------------~~~~~L~~~dLl~~a~dvA~G~~YLe 819 (1025)
T KOG1095|consen 772 ILLE----------YMEGGDLLSFLRESRPAP----------------------FQPSNLSMRDLLAFALDVAKGMNYLE 819 (1025)
T ss_pred EEeh----------hcccCcHHHHHHhccccc----------------------CCCCCCCHHHHHHHHHHHhhhhHHHH
Confidence 9999 999999999998765421 22567888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
++++|||||..+|+||+.. ..+||+|||||+.+......... ....-...|||||.++.+.+|.|+|||||||+|||
T Consensus 820 ~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlArDiy~~~yyr~~-~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWE 896 (1025)
T KOG1095|consen 820 SKHFVHRDLAARNCLLDER--RVVKIADFGLARDIYDKDYYRKH-GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWE 896 (1025)
T ss_pred hCCCcCcchhhhheeeccc--CcEEEcccchhHhhhhchheecc-CccccceecCCHHHHhhcccccccchhhhHHHHHH
Confidence 9999999999999999665 67999999999965433222111 11223578999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHH-HH-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~-~~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|.+..||.+....+ .. ....+....|..++..+.++|.+||+.+|++|
T Consensus 897 ifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~R 948 (1025)
T KOG1095|consen 897 IFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDR 948 (1025)
T ss_pred HHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhC
Confidence 9999999998764433 33 55667667777888889999999999999998
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=317.71 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=196.5
Q ss_pred ecceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
-.+.|++.+.||.|.-++||+|. .+.+..||||++.-+.. +...+|++ .++.++||||++++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~-~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQ-TMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHH-HhhhcCCCCcceEEEEEEecceeEEe
Confidence 35678999999999999999984 56689999999964322 33455555 77999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|. ||.+||+.+.+...- ..++++..+..|.+++++||.|||++
T Consensus 103 mp----------fMa~GS~ldIik~~~---------------------------~~Gl~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 103 MP----------FMAGGSLLDIIKTYY---------------------------PDGLEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred eh----------hhcCCcHHHHHHHHc---------------------------cccccHHHHHHHHHHHHHHHHHHHhc
Confidence 99 999999999987643 24588999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccC-ccCCCCccccccccccCC--CCCchhhHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILF 702 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGvvL~ 702 (753)
|.||||||+.||||+.||. +||+|||.+..+.......... .+.+||+.|||||++... .|+.|+||||||+...
T Consensus 146 G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 146 GHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred CceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999988876 9999999887665443333322 667899999999996543 4899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHH-ccCccc----------ccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDANIVK-DRKDLF----------LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~~~i~-~~~~~~----------~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.+| ..||..-.+...-..+ +..++. ...++..++++|..||++||++|
T Consensus 224 ELA~G-~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kR 284 (516)
T KOG0582|consen 224 ELAHG-HAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKR 284 (516)
T ss_pred HHhcC-CCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccC
Confidence 99999 7899877544332222 222221 12356689999999999999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.33 Aligned_cols=230 Identities=26% Similarity=0.348 Sum_probs=186.9
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +|+.||+|++.+.. ....++|+..+++.++|+||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e---- 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD---- 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc----
Confidence 35999999999999765 58999999986432 22345565557788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|..++.. ...+++.++..++.||+.||.|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 77 ------YVNGGELFFHLQR-----------------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 7777888776642 23466778889999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kl~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (321)
T cd05603 122 LKPENILLDSQGH--VVLTDFGLCKEGVEP---EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEccCCCCccCCCC---CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC-CCC
Confidence 9999999977765 999999998753221 1122345689999999999998999999999999999999999 566
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+.......+...+.++.++|.+||++||.+|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (321)
T cd05603 196 FYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRR 238 (321)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhc
Confidence 6554 34444555555566677888999999999999999988
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=323.92 Aligned_cols=233 Identities=25% Similarity=0.382 Sum_probs=188.5
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHH--HHHHhCCCCceeeecccccCCceEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~--~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
|.+.+.||+|+||.||++... +|+.||||++++.. .+...+|.. .+++.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456789999999999998654 58999999997432 112233332 234567899999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|..+++. ..+++..++.++.||+.||.|||+.
T Consensus 81 ~E----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 81 ME----------YAAGGDLMMHIHT------------------------------DVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred Ec----------CCCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 7777888766532 3477888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. +||+|||+++...... ......+|++.|+|||.+.+..++.++|||||||++|||+
T Consensus 121 ~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 121 KIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred CeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 9999999999999987765 9999999987543211 1223456899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| ++||.... ......+.......+..+++++.++|++||+.||++|
T Consensus 196 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 243 (324)
T cd05589 196 VG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERR 243 (324)
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 98 66776553 3444555556666778889999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.06 Aligned_cols=230 Identities=24% Similarity=0.376 Sum_probs=185.4
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +++.||||.++... ......|...+....+||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME---- 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe----
Confidence 35999999999999765 47899999997531 22344455534345699999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++.. ...+++.++..++.|++.||.|||+.+|+|||
T Consensus 77 ------y~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 77 ------YLNGGDLMFHIQS-----------------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 7778888887743 23467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 ikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (316)
T cd05619 122 LKLDNILLDTDGH--IKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHEEECCCCC--EEEccCCcceECCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC-CCC
Confidence 9999999977764 9999999987542211 112344689999999999999999999999999999999998 567
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+.......+..++.+++++|.+||+.||++|
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 238 (316)
T cd05619 196 FHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERR 238 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhc
Confidence 7654 33444445555555667788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=328.36 Aligned_cols=229 Identities=27% Similarity=0.367 Sum_probs=186.8
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++.. .+|+.||+|.+.+.. .....+|. .++..++|+||+++++++.+++..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~~~hp~i~~~~~~~~~~~~~~lv~E---- 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLCFVME---- 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCCceEEEEEcCCEEEEEEe----
Confidence 3599999999999865 468999999997531 11223344 37788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCcccc
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHR 630 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~IiHr 630 (753)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred ------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 7778888777642 2357888899999999999999997 799999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+|| ..
T Consensus 121 Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG-~~ 194 (325)
T cd05594 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RL 194 (325)
T ss_pred CCCCCeEEECCCCC--EEEecCCCCeecCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC-CC
Confidence 99999999977765 9999999987643221 122344689999999999999999999999999999999999 55
Q ss_pred CCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||... .+.....+......++..+++++.+||++||+.||++|
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 238 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQR 238 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 66544 44555555666666788899999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=324.29 Aligned_cols=229 Identities=24% Similarity=0.348 Sum_probs=184.8
Q ss_pred EecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 480 EIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
.||+|+||.||++... .++.||||++.+.. ......|...+....+||||+++++++.+.+..|+|||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E----- 76 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME----- 76 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe-----
Confidence 5999999999999765 47899999987531 12234454433334589999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+++|+|..++.. ...+++..+..++.||+.||.|||+.+|+||||
T Consensus 77 -----~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDi 122 (321)
T cd05591 77 -----YVNGGDLMFQIQR-----------------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122 (321)
T ss_pred -----CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 7777888777643 234677888999999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf 712 (753)
||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+|| ++||
T Consensus 123 kp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~Pf 196 (321)
T cd05591 123 KLDNILLDAEGH--CKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-QPPF 196 (321)
T ss_pred CHHHeEECCCCC--EEEeecccceecccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC-CCCC
Confidence 999999977765 9999999987643221 122345689999999999999999999999999999999998 6687
Q ss_pred CCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 713 GESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 713 ~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.... ......+.......+..+++++.++|++||++||++|
T Consensus 197 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R 238 (321)
T cd05591 197 EADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKR 238 (321)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 6654 3444555555566677789999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.51 Aligned_cols=230 Identities=25% Similarity=0.357 Sum_probs=187.2
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||+||++... +|+.||||++.+.. ......|+..+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD---- 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc----
Confidence 35999999999998654 68999999996431 12344555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|..++.. ...+++.++..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 77 ------FVNGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 7778888776642 24577888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (325)
T cd05604 122 LKPENILLDSQGH--VVLTDFGLCKEGIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEeecCCcccCCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC-CCC
Confidence 9999999977765 9999999987543211 122345689999999999999999999999999999999999 556
Q ss_pred CCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+...........+.++.++|++||++||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R 238 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRR 238 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhc
Confidence 6543 44445555555555666788999999999999999998
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.51 Aligned_cols=234 Identities=25% Similarity=0.370 Sum_probs=186.1
Q ss_pred EEEeEEecccCceEEEEEEe----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhC-CCCceeeecccccCCceE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~ 542 (753)
|++.+.||+|+||.||++.. ..++.||+|++.+.. .+...+|+. ++..+ +|+||+++++++.+.+..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERN-VLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHHhccCCCCcccEEEEEecCCEE
Confidence 67889999999999998765 358999999986421 112334444 66666 599999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ...+++.++..++.||+.||+||
T Consensus 81 ~lv~e----------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~l 121 (332)
T cd05614 81 HLILD----------YVSGGEMFTHLYQ-----------------------------RDNFSEDEVRFYSGEIILALEHL 121 (332)
T ss_pred EEEEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888887743 23577888899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 122 H~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 197 (332)
T cd05614 122 HKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197 (332)
T ss_pred HHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence 9999999999999999987765 99999999986543221 1122456899999999998754 78999999999999
Q ss_pred HHHHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|| ..||... .......+.......+..+++++.++|.+||++||++|
T Consensus 198 ~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (332)
T cd05614 198 FELLTG-ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253 (332)
T ss_pred hhhhcC-CCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999998 6787532 12223334445556677889999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.65 Aligned_cols=233 Identities=24% Similarity=0.351 Sum_probs=187.4
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
|.+.+.||+|+||+||++... +|+.||||++.+.. ......|.. ++..+ +|++|+++.+++.+.+..|+||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR-VLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhccCCCchhheeeEEecCCEEEEEE
Confidence 567789999999999998754 58999999987431 122334444 44555 4678889999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++.. ...+++.+++.++.|++.||+|||+.+
T Consensus 81 E----------y~~~g~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ 121 (323)
T cd05615 81 E----------YVNGGDLMYHIQQ-----------------------------VGKFKEPQAVFYAAEISVGLFFLHRRG 121 (323)
T ss_pred c----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7778888877643 235788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 122 ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (323)
T cd05615 122 IIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA 196 (323)
T ss_pred eeccCCCHHHeEECCCCC--EEEeccccccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHh
Confidence 999999999999977765 9999999987543211 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.... ......+.......+...++++.+++.+||++||++|
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R 243 (323)
T cd05615 197 G-QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243 (323)
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhC
Confidence 8 66776653 3444555555566777889999999999999999998
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=325.50 Aligned_cols=241 Identities=26% Similarity=0.345 Sum_probs=194.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.+...+.+.||+|-||.|.++....+..||||.++.... .++.+|+. +|.+++|||||+|+|+|..++.+++++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIk-iLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIK-ILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHH-HHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 455678899999999999998887789999999986542 34566666 7788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||++|+|.+||....... +.-...++|+.|||.||+||.+.++
T Consensus 616 ----------YmEnGDLnqFl~aheapt---------------------------~~t~~~vsi~tqiasgmaYLes~nf 658 (807)
T KOG1094|consen 616 ----------YMENGDLNQFLSAHELPT---------------------------AETAPGVSICTQIASGMAYLESLNF 658 (807)
T ss_pred ----------HHhcCcHHHHHHhccCcc---------------------------cccchhHHHHHHHHHHHHHHHhhch
Confidence 999999999997654321 2234457899999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||||.++|+|+ |+++++||+|||+++.+-.......+ ...+-..+|||+|.+.-+++|.++|||+||+.+||+++-
T Consensus 659 VHrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~yy~vq-gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~ 735 (807)
T KOG1094|consen 659 VHRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDYYRVQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFML 735 (807)
T ss_pred hhccccccceee--cCcccEEecCcccccccccCCceeee-cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHH
Confidence 999999999999 77788999999999976544332222 222347899999999999999999999999999997653
Q ss_pred -CCCCCCCChHHHHHHHHc---------cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 -GKHPYGESFERDANIVKD---------RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 -~~~Pf~~~~~~~~~~i~~---------~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+..||++...++...-.. .....|.-++.++.++|-+||+.|-++|
T Consensus 736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~R 791 (807)
T KOG1094|consen 736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQR 791 (807)
T ss_pred HhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcC
Confidence 467998765544321111 1123566678899999999999999887
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=324.45 Aligned_cols=230 Identities=23% Similarity=0.324 Sum_probs=183.9
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++... +++.||+|.+++.. . .....|+..+....+||||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E---- 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE---- 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe----
Confidence 36999999999999765 58899999997532 1 1233455434445589999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~D 121 (329)
T cd05618 77 ------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRD 121 (329)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 7778888776642 23578888999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++. +||+|||+++...... ......+||..|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nili~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (329)
T cd05618 122 LKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHEEECCCCC--EEEeeCCccccccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC-CCC
Confidence 9999999977765 9999999987543211 122345689999999999999999999999999999999998 677
Q ss_pred CCCC----------hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~----------~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|... .......+......++...++++.++|++||+.||++|
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R 247 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 247 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHc
Confidence 7421 11223344455556778889999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.47 Aligned_cols=237 Identities=29% Similarity=0.419 Sum_probs=188.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||+||++... +|+.||||++... .....+.++..++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5788899999999999999765 6899999999643 222334444558899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ..+++..+..++.||+.||+|||+.||
T Consensus 82 ----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 82 ----------YMPGGDLMNLLIRK-----------------------------DVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred ----------CCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77788888877532 356778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--------------------------ccccCccCCCCccccccc
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--------------------------CLTQNATGYGSSGWQAPE 681 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~--------------------------~~~~~~~~~GT~~Y~APE 681 (753)
+||||||+|||++.++. +||+|||+++....... .........||+.|+|||
T Consensus 123 iH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 123 IHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred eccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999977765 99999999987654320 001223446899999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHc--cC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKD--RK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 682 ~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~--~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+..++.++|||||||++|||++| .+||.... ......+.. .. .+....+++++.+||.+||. ||++|
T Consensus 201 ~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R 275 (350)
T cd05573 201 VLRGTPYGLECDWWSLGVILYEMLYG-FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDR 275 (350)
T ss_pred HHcCCCCCCceeeEecchhhhhhccC-CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Chhhc
Confidence 99999999999999999999999999 56775543 333333333 11 22223368999999999997 99988
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.38 Aligned_cols=236 Identities=25% Similarity=0.352 Sum_probs=176.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----ceE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 542 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-----~~~ 542 (753)
+|.+.+.||+|+||.||++... +|+.||||++.... .....+|+. +++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHH-HHHhCCCCCEeeecceEeccCCCCCceE
Confidence 4778899999999999999754 68999999986421 123455665 77899999999999987543 358
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+|||||++ +|.+++.. ...+++..+..++.||+.||.||
T Consensus 80 ~lv~e~~~~-----------~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~L 119 (338)
T cd07859 80 YVVFELMES-----------DLHQVIKA-----------------------------NDDLTPEHHQFFLYQLLRALKYI 119 (338)
T ss_pred EEEEecCCC-----------CHHHHHHh-----------------------------cccCCHHHHHHHHHHHHHHHHHH
Confidence 999996554 44444421 23477888899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC--CCCCchhhHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCI 700 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIwSfGvv 700 (753)
|+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+ ..++.++|||||||+
T Consensus 120 H~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 120 HTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999977654 999999999865432222222234568999999999876 678999999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHH------------------------H---ccC-cc---cccCCCHHHHHHHHHcccc
Q 004442 701 LFFCITGGKHPYGESFER-DANIV------------------------K---DRK-DL---FLVEHIPEAVDLFTRLLDP 748 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~-~~~~i------------------------~---~~~-~~---~~~~~s~el~dLI~~cL~~ 748 (753)
+|||+|| ++||...... ....+ . ... .. .....++++.++|.+||+.
T Consensus 198 l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 198 FAEVLTG-KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 9999998 6677543211 10000 0 000 00 1124577899999999999
Q ss_pred CcCCC
Q 004442 749 NPDLR 753 (753)
Q Consensus 749 DP~~R 753 (753)
||++|
T Consensus 277 ~P~~R 281 (338)
T cd07859 277 DPKDR 281 (338)
T ss_pred CcccC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.98 Aligned_cols=229 Identities=26% Similarity=0.364 Sum_probs=184.9
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|+||+||++... +++.||||++++.. .....+|+. ++..+ +|+||+++++++.+.+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-il~~~~~h~~i~~~~~~~~~~~~~~lv~e--- 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR-VLALAGKHPFLTQLHSCFQTKDRLFFVME--- 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHH-HHHhccCCCCccceeeEEEcCCEEEEEEc---
Confidence 35999999999998765 48899999997531 122344544 44444 79999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|..++.. ...+++.++..++.|++.||.|||+.+|+||
T Consensus 77 -------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~ 120 (318)
T cd05570 77 -------YVNGGDLMFHIQR-----------------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120 (318)
T ss_pred -------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence 7777888776642 2357888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..
T Consensus 121 dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G-~~ 194 (318)
T cd05570 121 DLKLDNVLLDSEGH--IKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QS 194 (318)
T ss_pred CCCHHHeEECCCCc--EEecccCCCeecCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC-CC
Confidence 99999999977764 9999999987532211 122334689999999999999999999999999999999998 66
Q ss_pred CCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||... .......+......++..+++++.+||++||..||++|
T Consensus 195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 238 (318)
T cd05570 195 PFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238 (318)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHc
Confidence 77654 33444555556666777889999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.40 Aligned_cols=229 Identities=23% Similarity=0.327 Sum_probs=183.3
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|+||.||++... +++.||||.+++... ....+|.. ++..+ +||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~-il~~~~~hp~Iv~~~~~~~~~~~~~lv~e--- 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKH-VFETASNHPFLVGLHSCFQTESRLFFVIE--- 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhccCCCCCCceEEEEEcCCEEEEEEe---
Confidence 35999999999998664 589999999975321 12233444 45555 79999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 77 -------~~~~g~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~ 120 (329)
T cd05588 77 -------FVSGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNFLHERGIIYR 120 (329)
T ss_pred -------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 7778888777642 2457888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||+|| ++
T Consensus 121 dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~ 194 (329)
T cd05588 121 DLKLDNVLLDAEGH--IKLTDYGMCKEGIRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RS 194 (329)
T ss_pred CCCHHHeEECCCCC--EEECcCccccccccC---CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC-CC
Confidence 99999999977754 999999998753221 1122345689999999999999999999999999999999998 67
Q ss_pred CCCCC----------hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~----------~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+.. .......+.......+..+++++.++|++||+.||.+|
T Consensus 195 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 247 (329)
T cd05588 195 PFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKER 247 (329)
T ss_pred CcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 88521 11223444555556777889999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.84 Aligned_cols=234 Identities=25% Similarity=0.336 Sum_probs=185.5
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|...+.||+|.||.||+|.. ..|+.||||+++..+ ...+.+|+. +++.++|+||+.|++++-..+.+.||+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK-~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIK-LLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHH-HHHHccCcchhhhhhhccCCCceEEEEE
Confidence 456678899999999999965 459999999997543 346789998 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|++.+|...+ + .+...+...++..++.++++||+|||.+.|
T Consensus 82 fm~tdLe~vI-----------k----------------------------d~~i~l~pa~iK~y~~m~LkGl~y~H~~~I 122 (318)
T KOG0659|consen 82 FMPTDLEVVI-----------K----------------------------DKNIILSPADIKSYMLMTLKGLAYCHSKWI 122 (318)
T ss_pred eccccHHHHh-----------c----------------------------ccccccCHHHHHHHHHHHHHHHHHHHhhhh
Confidence 7777665554 2 123456777889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
+||||||.|+|++++|. +||+|||+|+.+........ ..+-|..|.|||.+.+.+ |+..+||||.||++.||+-
T Consensus 123 lHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~---~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll 197 (318)
T KOG0659|consen 123 LHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQT---HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL 197 (318)
T ss_pred hcccCCccceEEcCCCc--EEeecccchhccCCCCcccc---cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc
Confidence 99999999999988876 99999999999876543322 225699999999998855 8999999999999999999
Q ss_pred CCCCCCCC-ChHHHHHHHHcc-----------------------Ccc-----cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGE-SFERDANIVKDR-----------------------KDL-----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~-~~~~~~~~i~~~-----------------------~~~-----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .|.|.+ +.-++..++... .+. .+...+.++.||+.+||..||.+|
T Consensus 198 r-~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~R 272 (318)
T KOG0659|consen 198 R-VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKR 272 (318)
T ss_pred c-CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhc
Confidence 7 445543 332333222110 000 122345678999999999999988
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.91 Aligned_cols=231 Identities=29% Similarity=0.422 Sum_probs=186.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.|.+.+.||+|+||.||+|... +++.||||++.+.. .....+|+ .++..++|+||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTER-DILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHH-HHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 5788899999999999999776 48999999997532 12233444 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ..+++.++..++.|++.||.|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~ 121 (333)
T cd05600 81 E----------YVPGGDFRTLLNNL-----------------------------GVLSEDHARFYMAEMFEAVDALHELG 121 (333)
T ss_pred e----------CCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 77788888887432 34677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 193 (333)
T cd05600 122 YIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193 (333)
T ss_pred ccccCCCHHHEEECCCCC--EEEEeCcCCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh
Confidence 999999999999977765 99999999986543 2234568999999999999999999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHccC----cccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDRK----DLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~~----~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||..... .....+.... .+.. ..+++++.+||.+||..+|++|
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr 248 (333)
T cd05600 194 G-FPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRF 248 (333)
T ss_pred C-CCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhc
Confidence 8 668766533 3223222211 1111 2458899999999999888876
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=309.99 Aligned_cols=235 Identities=23% Similarity=0.351 Sum_probs=180.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +++.||||++.... .+...+|+. ++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHH-HHHhCCCccccchhhhEecCCEEEEEEe
Confidence 5788899999999999999775 58899999986532 223455655 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||+ +|.+..+.. ....+++..+..++.|++.||.|||+.+|
T Consensus 81 ~~~----------~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 81 YVE----------KNMLELLEE-----------------------------MPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cCC----------CCHHHHHHh-----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 554 443332211 12357788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 ~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 122 VHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred ecCCCCHHHEEEcCCCc--EEEeeccCccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999977764 99999999987643221 112234689999999999998999999999999999999998
Q ss_pred CCCCCCCChHHH-HHHHHcc--------------C-------c-----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERD-ANIVKDR--------------K-------D-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~-~~~i~~~--------------~-------~-----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||....... ...+... . . ......++++.+||++||++||++|
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R 275 (287)
T cd07848 198 -QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275 (287)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccC
Confidence 67876542211 1111100 0 0 0012357789999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=322.92 Aligned_cols=229 Identities=27% Similarity=0.386 Sum_probs=187.5
Q ss_pred EEecccCceEEEEEEe----eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 479 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
+.||+|+||.||++.. ..|+.||+|++.... .....+|+. +++.++|+||+++++++.+.+..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e-- 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD-ILAEVNHPFIVKLHYAFQTEGKLYLILD-- 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCEEEEEEc--
Confidence 5699999999998754 358999999997532 122344554 7899999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|
T Consensus 79 --------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 79 --------FLRGGDLFTRLSK-----------------------------EVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred --------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 7778888887743 234788889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++| +
T Consensus 122 ~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~ 195 (318)
T cd05582 122 RDLKPENILLDEEGH--IKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-S 195 (318)
T ss_pred CCCCHHHeEECCCCc--EEEeeccCCcccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC-C
Confidence 999999999977765 9999999988654321 122345689999999999988899999999999999999998 6
Q ss_pred CCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||.... ......+.......+...++++.+||++||++||++|
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHc
Confidence 6776543 3344445555566677889999999999999999998
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.62 Aligned_cols=237 Identities=27% Similarity=0.413 Sum_probs=184.9
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||+||++... +|+.||||++.... ....++.+..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5788899999999999998765 58999999997531 11223333447889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------~~~~g~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 82 ----------YLPGGDMMTLLMKK-----------------------------DTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred ----------CCCCcHHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77788888877532 347788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-----------------------------------ccCccCC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------------------------------TQNATGY 672 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-----------------------------------~~~~~~~ 672 (753)
+||||||+|||++.++. +||+|||+++.+....... ......+
T Consensus 123 vH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 123 IHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200 (364)
T ss_pred EeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 99999999999977765 9999999997653211000 0011246
Q ss_pred CCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccC--cccc--cCCCHHHHHHHHHccc
Q 004442 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRK--DLFL--VEHIPEAVDLFTRLLD 747 (753)
Q Consensus 673 GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~--~~~~--~~~s~el~dLI~~cL~ 747 (753)
||+.|+|||++.+..++.++|||||||++|||++| .+||..... .....+.... ..++ ..+++++.+||++||.
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~ 279 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC 279 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence 99999999999999999999999999999999998 667765533 2223332222 1222 2468999999999997
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
+|.+|
T Consensus 280 -~p~~R 284 (364)
T cd05599 280 -EAERR 284 (364)
T ss_pred -CHhhc
Confidence 88887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.97 Aligned_cols=235 Identities=23% Similarity=0.330 Sum_probs=179.2
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.|.+.+.||+|+||.||++... +++.||+|.++... .....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHH-HHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 45788899999999999999665 58999999986432 224456665 7799999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.+ +|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 84 ~~~~-----------~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 124 (288)
T cd07871 84 YLDS-----------DLKQYLDNC----------------------------GNLMSMHNVKIFMFQLLRGLSYCHKRKI 124 (288)
T ss_pred CCCc-----------CHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 5544 454444321 1346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||+|
T Consensus 125 vH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 125 LHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred ccCCCCHHHEEECCCCC--EEECcCcceeeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 99999999986543211 1223457999999999876 458999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHcc-------------------Ccc-----------cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDR-------------------KDL-----------FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~-------------------~~~-----------~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||..... .....+... ... .....++++.+||++||+.||.+|
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R 276 (288)
T cd07871 200 G-RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSR 276 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccC
Confidence 9 567755422 222111100 000 112356789999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.14 Aligned_cols=237 Identities=23% Similarity=0.321 Sum_probs=183.9
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||+||++... +++.||||++.+.. ....++++..++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5778899999999999998654 58999999997532 11223334447888999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+.+|
T Consensus 82 ----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 82 ----------FLPGGDMMTLLMK-----------------------------KDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred ----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7778888887753 2357788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc--------------------------------cccCccCCCCc
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 675 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~--------------------------------~~~~~~~~GT~ 675 (753)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 123 IHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred EecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 99999999999977765 999999999765321100 00112357999
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHcc--Cccccc--CCCHHHHHHHHHccccCc
Q 004442 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDR--KDLFLV--EHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 676 ~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~--~~~~~~--~~s~el~dLI~~cL~~DP 750 (753)
.|+|||++.+..++.++|||||||++|||++| .+||.+.. ......+... ...++. ..+++++++|.+|+. +|
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 99999999999999999999999999999998 66876543 3333333332 122332 467899999999774 55
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
++|
T Consensus 279 ~~r 281 (363)
T cd05628 279 EHR 281 (363)
T ss_pred hhc
Confidence 554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.93 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=189.6
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-----------------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCcee
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-----------------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIV 530 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-----------------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV 530 (753)
.++|.+.+.||+|+||.||++...+ +..||||.+...... .+.+|+. ++..++|+||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHH-HHhhcCCCCee
Confidence 3567888999999999999986432 347999998754322 3445554 77889999999
Q ss_pred eecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHH
Q 004442 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610 (753)
Q Consensus 531 ~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~ 610 (753)
++++++.+.+..++||| |+.+|+|.+++............ ............+++..+++
T Consensus 83 ~~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05096 83 RLLGVCVDEDPLCMITE----------YMENGDLNQFLSSHHLDDKEENG----------NDAVPPAHCLPAISYSSLLH 142 (304)
T ss_pred EEEEEEecCCceEEEEe----------cCCCCcHHHHHHhcccccccccc----------ccccccccccccccHHHHHH
Confidence 99999999999999999 77888888888653221110000 00000011234578889999
Q ss_pred HHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCc
Q 004442 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 690 (753)
Q Consensus 611 Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ 690 (753)
++.||+.||.|||+.+|+||||||+|||++.++ .+||+|||+++....... ........++..|+|||++.+..++.
T Consensus 143 i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~ 219 (304)
T cd05096 143 VALQIASGMKYLSSLNFVHRDLATRNCLVGENL--TIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTT 219 (304)
T ss_pred HHHHHHHHHHHHHHCCccccCcchhheEEcCCc--cEEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCc
Confidence 999999999999999999999999999997765 499999999987643221 11222334678999999999889999
Q ss_pred hhhHHHHHHHHHHHHhC-CCCCCCCChHH-HHHHHH----c----cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 691 AIDLFSLGCILFFCITG-GKHPYGESFER-DANIVK----D----RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG-~~~Pf~~~~~~-~~~~i~----~----~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||||||++|||+++ +..||...... ...... . .....+..+++++.+||.+||+.||++|
T Consensus 220 ~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 99999999999999875 35677654322 221111 1 1112345677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.68 Aligned_cols=229 Identities=24% Similarity=0.325 Sum_probs=183.0
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHh-CCCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIAS-DQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~-l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|+||.||++... +++.||||++++... ....+|.. ++.. .+|+||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e--- 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKH-VFEQASSNPFLVGLHSCFQTTSRLFLVIE--- 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhhcCCCCEeeEEEEEEeCCEEEEEEe---
Confidence 35999999999998764 578999999975321 12334444 4444 479999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 77 -------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr 120 (327)
T cd05617 77 -------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYAAEICIALNFLHERGIIYR 120 (327)
T ss_pred -------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 7778888776632 2457888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..
T Consensus 121 Dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g-~~ 194 (327)
T cd05617 121 DLKLDNVLLDADGH--IKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG-RS 194 (327)
T ss_pred CCCHHHEEEeCCCC--EEEeccccceeccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC-CC
Confidence 99999999987765 9999999987532211 122345689999999999999999999999999999999998 66
Q ss_pred CCCCC--------hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES--------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~--------~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||... .......+.......+...++++.++|++||++||++|
T Consensus 195 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 245 (327)
T cd05617 195 PFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKER 245 (327)
T ss_pred CCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 77421 12233444445556777889999999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=310.15 Aligned_cols=231 Identities=26% Similarity=0.384 Sum_probs=183.2
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||+||++... +|+.||||.+..... +....|+. +++.++|+||+++.+++.+....++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR-ILAKVHSRFIVSLAYAFQTKTDLCLVMT------ 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHH-HHHhCCCCcEeeeeEEEcCCCeEEEEEe------
Confidence 699999999998654 689999999865321 12234444 7889999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.+++..... ....+++..++.++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~~g~L~~~~~~~~~-------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 124 (280)
T cd05608 74 ----IMNGGDLRYHIYNVDE-------------------------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK 124 (280)
T ss_pred ----CCCCCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 7788888877643211 12457889999999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++| +.||.
T Consensus 125 p~Nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~ 198 (280)
T cd05608 125 PENVLLDNDGN--VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA-RGPFR 198 (280)
T ss_pred HHHEEECCCCC--EEEeeCccceecCCCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC-CCCCC
Confidence 99999976654 99999999987643221 12334689999999999999999999999999999999998 67876
Q ss_pred CChH-----HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~-----~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.... .....+.......+..+++++.+++.+||+.||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 199 ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred CCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHh
Confidence 4321 112222223334556788999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.49 Aligned_cols=234 Identities=24% Similarity=0.381 Sum_probs=188.6
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|++.+.||+|+||+||++... +++.||||++..... ....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHH-HHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 667889999999999998754 689999999864321 12344554 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 81 ----------LMNGGDLKFHIYNM---------------------------GNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred ----------ccCCCcHHHHHHhc---------------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77788888776432 12357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||++++++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 vH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 124 VYRDLKPENILLDDYGH--IRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred EecCCCHHHEEECCCCC--EEEeeCCCceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 99999999999976654 9999999998764321 11234689999999999988899999999999999999998
Q ss_pred CCCCCCCChHH-----HHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-----~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||...... ....+.......+..+++.+.+||++||++||++|
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05605 198 -KSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247 (285)
T ss_pred -CCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHh
Confidence 6788654321 11222333444566788999999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=305.79 Aligned_cols=238 Identities=21% Similarity=0.292 Sum_probs=187.5
Q ss_pred ceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+.|++.+.||+|+||.||+|... .+..||+|.++..... .+.+|+. .+..++||||++++|++...+..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL-TLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEecCCCcEE
Confidence 46888999999999999998653 4679999998764322 2344544 7788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ...+++.++++++.|++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 84 VTE----------YMSNGALDSFLRKH----------------------------EGQLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred EEE----------eCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 88888998887532 1347788899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++||||||+||+++.++ .+|++|||.+....... ........++..|+|||.+.+..++.++|||||||++||+
T Consensus 126 ~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 201 (266)
T cd05064 126 MGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEA--IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201 (266)
T ss_pred CCEeeccccHhhEEEcCCC--cEEECCCcccccccccc--hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence 9999999999999997765 58999999876543211 1111223356789999999999999999999999999998
Q ss_pred HhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+..||.+.. ......+... ..+.+..++..+.+++.+||+.||++|
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 252 (266)
T cd05064 202 MSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGER 252 (266)
T ss_pred hcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 863367776543 3333333333 334566778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=306.68 Aligned_cols=237 Identities=27% Similarity=0.435 Sum_probs=186.1
Q ss_pred EEeEEecccCceEEEEEEee-----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 476 VFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~-----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++.+.||.|.||.||+|... .+..|+||.++.... +.+.+|+ ..++.++||||++++|+|.+.+..++||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEI-QILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHH-HHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecc-cccccccccccccccccccccccccccc
Confidence 45688999999999999777 368899999965432 2344454 4778889999999999999888899999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.++|+... ...+++.++++|+.|||+||+|||+.+
T Consensus 81 e----------~~~~g~L~~~L~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~ 123 (259)
T PF07714_consen 81 E----------YCPGGSLDDYLKSKN---------------------------KEPLSEQQRLSIAIQIAEALSYLHSNN 123 (259)
T ss_dssp E------------TTEBHHHHHHHTC---------------------------TTTSBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c----------ccccccccccccccc---------------------------ccccccccccccccccccccccccccc
Confidence 9 888899999887641 245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+|+||+++||+++.++ .+||+|||++........ ........+...|+|||.+....++.++||||||+++||+++
T Consensus 124 iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 124 IIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccc--cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999997765 599999999987732211 122233346789999999999999999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++..||.+..... ...+.. .....+..++.++.++|.+||+.||++|
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~R 249 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKR 249 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS
T ss_pred cccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhC
Confidence 6578887764443 333333 3344566789999999999999999998
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=330.74 Aligned_cols=242 Identities=22% Similarity=0.311 Sum_probs=192.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeC--CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~--g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..|.+.+.||+|+||.||+|.... ++.||+|.+...... ..++.+..+++.++|||||+++++|.+.+..|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E- 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME- 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE-
Confidence 448889999999999999986543 678888876443322 233333448899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.++|+.... ....+++..+..++.||+.||.|||+.+|+
T Consensus 146 ---------~~~gg~L~~~l~~~~~-------------------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 191 (478)
T PTZ00267 146 ---------YGSGGDLNKQIKQRLK-------------------------EHLPFQEYEVGLLFYQIVLALDEVHSRKMM 191 (478)
T ss_pred ---------CCCCCCHHHHHHHHHh-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 8888999888764321 123577888899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+|||++.++. +||+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 192 HrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg- 267 (478)
T PTZ00267 192 HRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL- 267 (478)
T ss_pred ECCcCHHhEEECCCCc--EEEEeCcCceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC-
Confidence 9999999999977754 99999999987654321 1223445699999999999999999999999999999999998
Q ss_pred CCCCCCChH-HHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||..... .....+. ....+.+..+++++.++|.+||.+||++|
T Consensus 268 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 268 HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhC
Confidence 667765433 3333333 33344566788999999999999999998
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.95 Aligned_cols=237 Identities=25% Similarity=0.374 Sum_probs=183.9
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeeccccc--CCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVES--DQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~--~~~~~~ 543 (753)
.+.|+..+.|++|+||.||+|.++ +++.||+|+++-.... ..++||. ++.+.+|||||.+..+.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIn-iLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREIN-ILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHH-HHHhcCCCCeeeeEEEEeccccceee
Confidence 355777788999999999999765 5899999999754432 4688987 678889999999988754 456799
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
||||||+-+|..++ +. -..++...++..++.|+++|++|||
T Consensus 154 ~VMe~~EhDLksl~-----------d~----------------------------m~q~F~~~evK~L~~QlL~glk~lH 194 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLM-----------ET----------------------------MKQPFLPGEVKTLMLQLLRGLKHLH 194 (419)
T ss_pred eeHHHHHhhHHHHH-----------Hh----------------------------ccCCCchHHHHHHHHHHHHHHHHHh
Confidence 99998876665554 11 0135777788999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~ 702 (753)
...|+|||||++|+|++..|. +||+|||||+.+.... ...+..+-|..|.|||.+.+.. |+...|+||+|||+.
T Consensus 195 ~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~---k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~a 269 (419)
T KOG0663|consen 195 DNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL---KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFA 269 (419)
T ss_pred hceeEecccchhheeeccCCc--EEecccchhhhhcCCc---ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHH
Confidence 999999999999999988875 9999999999887542 2334456799999999998865 899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHcc-------------------------------CcccccC-CCHHHHHHHHHccccCc
Q 004442 703 FCITGGKHPYGESFERDANIVKDR-------------------------------KDLFLVE-HIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~~~i~~~-------------------------------~~~~~~~-~s~el~dLI~~cL~~DP 750 (753)
|++++++.+-+.+.-.+.+++... ...|+.. .++...+|++.+|..||
T Consensus 270 E~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP 349 (419)
T KOG0663|consen 270 ELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDP 349 (419)
T ss_pred HHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCc
Confidence 999985444444433333333210 0001111 34788999999999999
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
.+|
T Consensus 350 ~kR 352 (419)
T KOG0663|consen 350 GKR 352 (419)
T ss_pred ccc
Confidence 998
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.95 Aligned_cols=236 Identities=28% Similarity=0.402 Sum_probs=182.2
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.|.+.+.||+|+||.||++.. .+++.||||++.+.. . ....+|+ .+++.++|+||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 577889999999999999865 468999999986432 1 1223344 4788899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++.. ...+++..+..++.|++.||+|||+.+
T Consensus 81 E----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 81 E----------FLPGGDLMTMLIK-----------------------------YDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred e----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 7778888887743 234677788899999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc------------c-----------------------------
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------L----------------------------- 665 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~------------~----------------------------- 665 (753)
|+||||||+|||++.++. +||+|||+++........ .
T Consensus 122 ivHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 122 FIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred eeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999977765 999999999643211000 0
Q ss_pred ---ccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHcc--Cccccc--CCCHH
Q 004442 666 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDR--KDLFLV--EHIPE 737 (753)
Q Consensus 666 ---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~--~~~~~~--~~s~e 737 (753)
......+||+.|+|||++.+..++.++|||||||++|||+|| .+||..... .....+... ...++. .++++
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG-WPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC-CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHH
Confidence 000124699999999999999999999999999999999998 677765433 223333221 122222 46889
Q ss_pred HHHHHHHccccCcCCC
Q 004442 738 AVDLFTRLLDPNPDLR 753 (753)
Q Consensus 738 l~dLI~~cL~~DP~~R 753 (753)
+.+||++||. +|.+|
T Consensus 279 ~~dli~~lL~-~~~~r 293 (377)
T cd05629 279 AEDLIRRLIT-NAENR 293 (377)
T ss_pred HHHHHHHHhc-CHhhc
Confidence 9999999997 77765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.06 Aligned_cols=225 Identities=19% Similarity=0.226 Sum_probs=180.8
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccC----CceEEEEEcc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLER 548 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~LV~E~ 548 (753)
..||+|++|.||+|.. +|+.||||+++.... +.+.+|+. ++.+++||||++++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E- 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIK-NLRRIDSNNILKIYGFIIDIVDDLPRLSLILE- 102 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHH-HHHhcCCCCEEEEeeeEEecccCCCceEEEEE-
Confidence 4599999999999876 789999999975421 22234554 7899999999999999876 457899999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-Cc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~I 627 (753)
|+.+|+|.++++.. ..+++...++++.+++.||.|||+. ++
T Consensus 103 ---------y~~~g~L~~~l~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 144 (283)
T PHA02988 103 ---------YCTRGYLREVLDKE-----------------------------KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144 (283)
T ss_pred ---------eCCCCcHHHHHhhC-----------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCC
Confidence 88889999888532 3467778899999999999999984 89
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC--CCCCchhhHHHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIwSfGvvL~Ell 705 (753)
+||||||+||+++.++ .+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 145 ~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 145 PYKNLTSVSFLVTENY--KLKIICHGLEKILSSPP------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCcCChhhEEECCCC--cEEEcccchHhhhcccc------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 9999999999997765 49999999998654321 23457899999999976 67899999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| +.||.+..... ...+. ......+..+++++.++|.+||+.||++|
T Consensus 217 ~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 266 (283)
T PHA02988 217 TG-KIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKR 266 (283)
T ss_pred HC-CCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccC
Confidence 98 77887664333 33332 22334455788999999999999999998
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=321.67 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=192.7
Q ss_pred cceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCCc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~ 540 (753)
.++|.+.+.||+|+||.||++.. ..+..||||+++.... +...+|+. ++..+ +||||++++|+|.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHH-HHHHhcCCcceeeeeeeeccCC
Confidence 45688899999999999999853 2367899999965321 23456665 66666 8999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccch-----hhh---hhhh----------cc----------------
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-----LNE---VRIR----------LL---------------- 586 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~-----~~~---~~~~----------~~---------------- 586 (753)
..++||| |+++|+|.++++........ ... .+.. +.
T Consensus 113 ~~~lv~E----------~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 182 (375)
T cd05104 113 PTLVITE----------YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTK 182 (375)
T ss_pred cceeeeh----------hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccc
Confidence 9999999 77888888888754321100 000 0000 00
Q ss_pred ----------c--ccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccC
Q 004442 587 ----------P--VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654 (753)
Q Consensus 587 ----------~--~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGl 654 (753)
. ...............+++..+++++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~ 260 (375)
T cd05104 183 ADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGL 260 (375)
T ss_pred cccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCcc
Confidence 0 00000011112334689999999999999999999999999999999999997664 499999999
Q ss_pred ceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcc-Ccccc
Q 004442 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDR-KDLFL 731 (753)
Q Consensus 655 a~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~--~~~~~i~~~-~~~~~ 731 (753)
++........ .......++..|+|||++.+..++.++|||||||++|||++++.+||..... .....+... ....+
T Consensus 261 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 339 (375)
T cd05104 261 ARDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSP 339 (375)
T ss_pred ceeccCcccc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCC
Confidence 9876543211 1112233567899999999999999999999999999999955788866432 222333332 22334
Q ss_pred cCCCHHHHHHHHHccccCcCCC
Q 004442 732 VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 732 ~~~s~el~dLI~~cL~~DP~~R 753 (753)
...+.++.+||.+||+.||++|
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~R 361 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKR 361 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHC
Confidence 4567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.89 Aligned_cols=235 Identities=23% Similarity=0.305 Sum_probs=177.8
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHH-HHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 56888999999999999999765 68999999986432 123445554 7789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||.++ |.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 84 ~~~~~-----------l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i 124 (303)
T cd07869 84 YVHTD-----------LCQYMDKH----------------------------PGGLHPENVKLFLFQLLRGLSYIHQRYI 124 (303)
T ss_pred CCCcC-----------HHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 65544 44443221 2346777889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 125 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 125 LHRDLKPQNLLISDTGE--LKLADFGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ecCCCCHHHEEECCCCC--EEECCCCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999977655 9999999997653221 112334589999999998764 47999999999999999999
Q ss_pred CCCCCCCCChH--HHHHHHHc--cCc------------c---------c---------ccCCCHHHHHHHHHccccCcCC
Q 004442 707 GGKHPYGESFE--RDANIVKD--RKD------------L---------F---------LVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 707 G~~~Pf~~~~~--~~~~~i~~--~~~------------~---------~---------~~~~s~el~dLI~~cL~~DP~~ 752 (753)
| .+||.+... .....+.. ... . . ...+++++.+||++||+.||++
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 200 G-VAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred C-CCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 8 678865322 11111100 000 0 0 0123568899999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 279 R 279 (303)
T cd07869 279 R 279 (303)
T ss_pred c
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.66 Aligned_cols=235 Identities=27% Similarity=0.389 Sum_probs=176.1
Q ss_pred eEEEeEEecccCceEEEEEEee--CCcEEEEEEeecCC-----chHHHHHHHHH--HHhCCCCceeeeccccc-----CC
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVES-----DQ 539 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~--~g~~VAVK~l~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~L~g~~~-----~~ 539 (753)
+|.+.+.||+|+||.||++... +++.||||+++... .....+|+..+ +..++||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5778899999999999999763 47899999986432 12344555422 33457999999999875 34
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++|||++.+ +|.+++... ....+++..++.++.||+.||
T Consensus 82 ~~~~lv~e~~~~-----------~l~~~~~~~---------------------------~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 82 TKLTLVFEHVDQ-----------DLTTYLDKV---------------------------PEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred CcEEEEEccCCC-----------CHHHHHHhC---------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 568999995544 455544321 123477888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||.+.+..++.++|||||||
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999999999999999999977765 999999999876432 1223445899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-Cc--------------------------ccccCCCHHHHHHHHHccccCcC
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KD--------------------------LFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~--------------------------~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
++|||++| ++||.+.... ....+... .. ......++++.+||.+||+.||+
T Consensus 198 il~el~~g-~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 198 IFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHcC-CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 99999998 6787654322 21111110 00 01134567889999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 277 ~R 278 (290)
T cd07862 277 KR 278 (290)
T ss_pred hc
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.86 Aligned_cols=194 Identities=22% Similarity=0.268 Sum_probs=158.6
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
...|.+.+.||+|+||.||++... .++.||+|.... ....+|+. +++.++||||+++++++......++|+|++.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAH-ILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHH-HHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 356999999999999999998664 589999997543 23456665 7899999999999999999999999999554
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+|.+++.. ...+++.+++.|+.||+.||+|||+.+|+||
T Consensus 167 -----------~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHr 206 (391)
T PHA03212 167 -----------TDLYCYLAA-----------------------------KRNIAICDILAIERSVLRAIQYLHENRIIHR 206 (391)
T ss_pred -----------CCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 444444422 2356788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++. +||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.+
T Consensus 207 DiKP~NIll~~~~~--vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p 282 (391)
T PHA03212 207 DIKAENIFINHPGD--VCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282 (391)
T ss_pred CCChHhEEEcCCCC--EEEEeCCccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999977765 9999999997543211 1122345699999999999999999999999999999999999666
Q ss_pred CCC
Q 004442 711 PYG 713 (753)
Q Consensus 711 Pf~ 713 (753)
+|+
T Consensus 283 ~~~ 285 (391)
T PHA03212 283 LFE 285 (391)
T ss_pred cCC
Confidence 664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.59 Aligned_cols=223 Identities=26% Similarity=0.405 Sum_probs=185.1
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhhHHH
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY 558 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy 558 (753)
+-||.|+.|-||+|.+. ++.||||+++... ..+|. -+++++|+||+.|.|+|.....++|||| |
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk----ETdIK-HLRkLkH~NII~FkGVCtqsPcyCIiME----------f 193 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK----ETDIK-HLRKLKHPNIITFKGVCTQSPCYCIIME----------F 193 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhhh----hhhHH-HHHhccCcceeeEeeeecCCceeEEeee----------c
Confidence 45999999999998775 5899999876332 22444 5689999999999999999999999999 6
Q ss_pred HhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEE
Q 004442 559 VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638 (753)
Q Consensus 559 ~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NIL 638 (753)
...|.|++.|+.. +.+....+..+..+||.||.|||.+.|||||||+-|||
T Consensus 194 Ca~GqL~~VLka~-----------------------------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 194 CAQGQLYEVLKAG-----------------------------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL 244 (904)
T ss_pred cccccHHHHHhcc-----------------------------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence 6689999988653 44566777899999999999999999999999999999
Q ss_pred EecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH
Q 004442 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 718 (753)
Q Consensus 639 L~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~ 718 (753)
|+.++. +||+|||-++..... .....++||..|||||++...+.++|+||||||||||||+|| ..||.+....
T Consensus 245 Is~~d~--VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~-EiPYkdVdss 317 (904)
T KOG4721|consen 245 ISYDDV--VKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG-EIPYKDVDSS 317 (904)
T ss_pred eeccce--EEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc-CCCccccchh
Confidence 988865 999999998876543 334467899999999999999999999999999999999998 8899775332
Q ss_pred HHH--H-HHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 719 DAN--I-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 719 ~~~--~-i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... . -.....+.|..+++-+.-||++||+..|..|
T Consensus 318 AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 210 0 0123456788888899999999999999887
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.68 Aligned_cols=241 Identities=25% Similarity=0.362 Sum_probs=192.1
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.+.|++.+.||+|+||.||+|...+++.||+|.+.... ..+.+.++..+++.++|+||+++++++.+.+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE--- 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe---
Confidence 35688899999999999999988888999999986543 22334444458899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++++... ...+++.+++.++.|++.||+|||+.+++||
T Consensus 82 -------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~ 127 (261)
T cd05072 82 -------YMAKGSLLDFLKSDE---------------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127 (261)
T ss_pred -------cCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 888889988876432 2346777889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+|++.+
T Consensus 128 dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~ 203 (261)
T cd05072 128 DLRAANVLVSESL--MCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI 203 (261)
T ss_pred ccchhhEEecCCC--cEEECCCccceecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCC
Confidence 9999999997765 489999999987653221 111223357789999999888899999999999999999994478
Q ss_pred CCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+... ..+....++.++.++|.+||+.||++|
T Consensus 204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (261)
T cd05072 204 PYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEER 248 (261)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 88665333 23333322 233445678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=329.14 Aligned_cols=241 Identities=25% Similarity=0.354 Sum_probs=190.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCC----cE-EEEEEeecCC--ch----HHHHHHHHHHHhCCCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEG----RS-VAVKRLVKTH--HD----VALKEIQNLIASDQHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g----~~-VAVK~l~~~~--~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~ 537 (753)
.....+..+.+.||+|+||.||+|.+..+ .. ||||..+... .. ++++| +++|..++|+|||+|+|++.
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~E-ArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKE-ARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHH-HHHHHhCCCCCEEEEEEEEc
Confidence 33445566778999999999999976542 23 8999987421 12 23333 45788899999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
++..+|+||| ++.+|+|.++|.... ..++..+.++++.+.|+
T Consensus 232 ~~~Pl~ivmE----------l~~gGsL~~~L~k~~----------------------------~~v~~~ek~~~~~~AA~ 273 (474)
T KOG0194|consen 232 LEEPLMLVME----------LCNGGSLDDYLKKNK----------------------------KSLPTLEKLRFCYDAAR 273 (474)
T ss_pred CCCccEEEEE----------ecCCCcHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHh
Confidence 9999999999 777899999997542 24778889999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||++++|||||.++|+|++.++. +||+||||++.... .........-...|+|||.+....|+.++|||||
T Consensus 274 Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 274 GLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred HHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcc---eeeccccccCcceecChhhhccCccccccchhhe
Confidence 999999999999999999999977654 89999999886541 1111112234689999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHH-HHH-H-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFERDA-NIV-K-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~~~-~~i-~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++||+++-+..||.+....+. ..+ . ....+.+...+.++..++.+||..||+.|
T Consensus 349 GV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R 407 (474)
T KOG0194|consen 349 GVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDR 407 (474)
T ss_pred eeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhc
Confidence 99999999954668887754443 333 3 33345566777889999999999999988
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=323.53 Aligned_cols=237 Identities=26% Similarity=0.372 Sum_probs=182.7
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.|.+.+.||+|+||+||++... +++.||||++.+.. ....+..+..+++.++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778899999999999999664 58899999996532 11223333458899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~gg~L~~~l~~~-----------------------------~~~~e~~~~~~~~qi~~al~~lH~~~i 122 (382)
T cd05625 82 ----------YIPGGDMMSLLIRM-----------------------------GIFPEDLARFYIAELTCAVESVHKMGF 122 (382)
T ss_pred ----------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77788888877432 346777888999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--------------------------------------------
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-------------------------------------------- 663 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-------------------------------------------- 663 (753)
+||||||+|||++.++. +||+|||+++.......
T Consensus 123 vHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (382)
T cd05625 123 IHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH 200 (382)
T ss_pred ecCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence 99999999999987765 99999999754321000
Q ss_pred ccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHcc----CcccccCCCHHH
Q 004442 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDR----KDLFLVEHIPEA 738 (753)
Q Consensus 664 ~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~----~~~~~~~~s~el 738 (753)
........+||+.|+|||++.+..++.++|||||||++|||++| .+||...... ....+... ..+.....++++
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 279 (382)
T cd05625 201 QRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEA 279 (382)
T ss_pred ccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhC-CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHH
Confidence 00011234699999999999999999999999999999999998 6677654332 22222221 112234578999
Q ss_pred HHHHHHccccCcCCC
Q 004442 739 VDLFTRLLDPNPDLR 753 (753)
Q Consensus 739 ~dLI~~cL~~DP~~R 753 (753)
.++|.+|+ .||++|
T Consensus 280 ~~li~~l~-~~p~~R 293 (382)
T cd05625 280 SDLIIKLC-RGPEDR 293 (382)
T ss_pred HHHHHHHc-cCHhHc
Confidence 99999986 599887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=298.99 Aligned_cols=238 Identities=22% Similarity=0.366 Sum_probs=189.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.|++.+.||+|+||.||++...++..+|+|.+.... .....+|+. +++.++|+||++++++|.+.+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e--- 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK-VMMKLSHPKLVQLYGVCTQQKPLYIVTE--- 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHH-HHHHCCCCCceeEEEEEccCCCEEEEEE---
Confidence 3467788999999999999988888899999986543 234455554 8899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++++... ..+++..+++++.|++.||+|||+.+|+||
T Consensus 80 -------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05114 80 -------FMENGCLLNYLRQRQ----------------------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124 (256)
T ss_pred -------cCCCCcHHHHHHhCc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 777888888775321 246778889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++++++
T Consensus 125 dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~ 200 (256)
T cd05114 125 DLAARNCLVSSTG--VVKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM 200 (256)
T ss_pred ccCcceEEEcCCC--eEEECCCCCccccCCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCC
Confidence 9999999996654 599999999986543211 111122356789999999888899999999999999999994477
Q ss_pred CCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||..... .....+... ....+...++++.++|.+||+.||++|
T Consensus 201 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 245 (256)
T cd05114 201 PFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGR 245 (256)
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 8876543 333333333 333455567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=312.16 Aligned_cols=233 Identities=24% Similarity=0.341 Sum_probs=185.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|++.+.||+|+||.||++... +|..||+|.+..... ....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 56888899999999999998765 588999999865432 23444554 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-C
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 626 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~ 626 (753)
|+.+|+|.+++... ..+++..+.+++.|++.||.|||+. +
T Consensus 84 ----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 84 ----------HMDGGSLDQVLKEA-----------------------------KRIPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred ----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 77888888887432 3467788899999999999999986 6
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||++....... .....||..|+|||++.+..++.++|||||||++|||+|
T Consensus 125 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred EEcCCCChhhEEEcCCCc--EEEccCcccccccccc-----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999987765 9999999998664321 223468999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHH-----------------------------------------------cc-Ccc-cccCCCHH
Q 004442 707 GGKHPYGESFERDANIVK-----------------------------------------------DR-KDL-FLVEHIPE 737 (753)
Q Consensus 707 G~~~Pf~~~~~~~~~~i~-----------------------------------------------~~-~~~-~~~~~s~e 737 (753)
| +.||............ .. ... ....++++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T cd06649 198 G-RYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276 (331)
T ss_pred C-CCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH
Confidence 8 6677543222111110 00 001 11246789
Q ss_pred HHHHHHHccccCcCCC
Q 004442 738 AVDLFTRLLDPNPDLR 753 (753)
Q Consensus 738 l~dLI~~cL~~DP~~R 753 (753)
+++||++||++||++|
T Consensus 277 l~~li~~~L~~~P~~R 292 (331)
T cd06649 277 FQEFVNKCLIKNPAER 292 (331)
T ss_pred HHHHHHHHccCCcccC
Confidence 9999999999999998
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=328.43 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=193.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCc--
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-- 540 (753)
+...++|.+.+.||+|+||+||++.. .+|+.||||++..... ....+|+. .+..++|+||+++.+.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC-CLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHH-HHhcCCCCcEEEeecceeccccc
Confidence 44557899999999999999999865 4699999999865421 12334444 678889999999988764322
Q ss_pred ------eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHH
Q 004442 541 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (753)
Q Consensus 541 ------~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~q 614 (753)
.+++||| |+++|+|.++++.... ....+++..+..++.|
T Consensus 107 ~~~~~~~i~lV~E----------y~~~gsL~~~l~~~~~-------------------------~~~~l~e~~~~~i~~q 151 (496)
T PTZ00283 107 NPENVLMIALVLD----------YANAGDLRQEIKSRAK-------------------------TNRTFREHEAGLLFIQ 151 (496)
T ss_pred CcccceEEEEEEe----------CCCCCcHHHHHHHhhc-------------------------cCCCCCHHHHHHHHHH
Confidence 3689999 8889999998865321 2345788899999999
Q ss_pred HHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhH
Q 004442 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694 (753)
Q Consensus 615 Ia~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDI 694 (753)
++.||.|||+.+|+||||||+|||++.++. +||+|||+++........ ......+||+.|+|||++.+..++.++||
T Consensus 152 ll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV 228 (496)
T PTZ00283 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADM 228 (496)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHH
Confidence 999999999999999999999999977654 999999999876543211 12234579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 695 FSLGCILFFCITGGKHPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 695 wSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||++|||++| +.||..... ....... ....+.+..+++++.++|.+||+.||++|
T Consensus 229 wSlGvilyeLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 288 (496)
T PTZ00283 229 FSLGVLLYELLTL-KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRR 288 (496)
T ss_pred HHHHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 9999999999998 668765533 3333332 33445677889999999999999999998
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=326.05 Aligned_cols=240 Identities=23% Similarity=0.296 Sum_probs=179.4
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC--------Cc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------QD 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--------~~ 540 (753)
...+.|.+.+.||+|+||.||+|... .++.||||++.... ....+|+. +++.++|+|||++++++.. ..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELL-IMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHH-HHHhcCCCCCcceeeeEeecccccCCCce
Confidence 34567999999999999999999764 58999999986543 22334554 7899999999999887532 22
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+++|||||++++.++ +.... .....+++..+..++.||+.||+
T Consensus 141 ~l~lvmE~~~~~l~~~-----------~~~~~-------------------------~~~~~l~~~~~~~~~~qi~~gL~ 184 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKY-----------MKHYA-------------------------RNNHALPLFLVKLYSYQLCRALA 184 (440)
T ss_pred EEEEEEecCCccHHHH-----------HHHHh-------------------------hcCCCCCHHHHHHHHHHHHHHHH
Confidence 4779999666544333 32111 12345788889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGv 699 (753)
|||+.+|+||||||+|||++.++ ..+||+|||+|+.+.... ......||+.|+|||++.+. .++.++|||||||
T Consensus 185 yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 259 (440)
T PTZ00036 185 YIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGC 259 (440)
T ss_pred HHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99999999999999999997654 358999999998764322 12234689999999998764 5899999999999
Q ss_pred HHHHHHhCCCCCCCCCh-HHHHHHHHcc-----------------------------CcccccCCCHHHHHHHHHccccC
Q 004442 700 ILFFCITGGKHPYGESF-ERDANIVKDR-----------------------------KDLFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~-~~~~~~i~~~-----------------------------~~~~~~~~s~el~dLI~~cL~~D 749 (753)
++|||+|| .+||.+.. ......+... ...++...++++.+||++||.+|
T Consensus 260 il~elltG-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~d 338 (440)
T PTZ00036 260 IIAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYE 338 (440)
T ss_pred HHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCC
Confidence 99999999 66775542 2221111100 01123456789999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 339 P~~R 342 (440)
T PTZ00036 339 PLKR 342 (440)
T ss_pred hhHC
Confidence 9998
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=319.78 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=185.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..+.|.+.+.||+|+||.||++... +++.||+|++.+.. ....+.++..+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467899999999999999998665 58999999996421 12234444458899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++++. ..+++..+..++.|++.||+|||+
T Consensus 121 v~E----------y~~gg~L~~~l~~------------------------------~~l~~~~~~~~~~qi~~aL~~LH~ 160 (370)
T cd05596 121 VME----------YMPGGDLVNLMSN------------------------------YDIPEKWARFYTAEVVLALDAIHS 160 (370)
T ss_pred EEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 7778888887642 235667778899999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC----CCCchhhHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG----RQTRAIDLFSLGCI 700 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~t~ksDIwSfGvv 700 (753)
.+|+||||||+|||++.++. +||+|||++....... .......+||+.|+|||++.+. .++.++|||||||+
T Consensus 161 ~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvi 236 (370)
T cd05596 161 MGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred CCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHH
Confidence 99999999999999977765 9999999998764321 1122345699999999998653 37899999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHccC--ccccc--CCCHHHHHHHHHccccCcCC
Q 004442 701 LFFCITGGKHPYGES-FERDANIVKDRK--DLFLV--EHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-~~~~~~~i~~~~--~~~~~--~~s~el~dLI~~cL~~DP~~ 752 (753)
+|||++| .+||... .......+.... ..++. .+++++.+||++||+.+|++
T Consensus 237 lyelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r 292 (370)
T cd05596 237 LYEMLVG-DTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVR 292 (370)
T ss_pred HHHHHhC-CCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhc
Confidence 9999998 5676554 333333333322 22233 57899999999999998876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=319.73 Aligned_cols=269 Identities=22% Similarity=0.300 Sum_probs=191.5
Q ss_pred ecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCC
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~ 539 (753)
..++|.+.+.||+|+||.||++... ++..||||+++.... ....+|+. +++.+ +|+|||+++|+|.+.
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK-ILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHH-HHHhhccCCceeeEeeEecCC
Confidence 3457889999999999999987532 346899999975432 23345555 66666 899999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhh-hhh-----------------------------------
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-VRI----------------------------------- 583 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~-~~~----------------------------------- 583 (753)
+..++||| |+.+|+|.++++........... ...
T Consensus 115 ~~~~lv~e----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 115 GPVLVITE----------YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred CCeEEeHh----------hccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 99999999 77888888888654321100000 000
Q ss_pred -----hcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 584 -----RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 584 -----~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
...................+++.++++|+.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~ 262 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDI 262 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeec
Confidence 000000000001112234688999999999999999999999999999999999997664 5999999999876
Q ss_pred cCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHcc-CcccccCCC
Q 004442 659 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHI 735 (753)
Q Consensus 659 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~--~~~~~i~~~-~~~~~~~~s 735 (753)
...... .......++..|+|||++.+..++.++|||||||++|||++.++.||..... .....+... ....+...+
T Consensus 263 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (374)
T cd05106 263 MNDSNY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAP 341 (374)
T ss_pred cCCcce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCC
Confidence 433211 1112223567899999999899999999999999999999833778865432 222333332 233445568
Q ss_pred HHHHHHHHHccccCcCCC
Q 004442 736 PEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 736 ~el~dLI~~cL~~DP~~R 753 (753)
+++.++|.+||+.||++|
T Consensus 342 ~~l~~li~~cl~~dp~~R 359 (374)
T cd05106 342 PEIYSIMKMCWNLEPTER 359 (374)
T ss_pred HHHHHHHHHHcCCChhhC
Confidence 999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=320.27 Aligned_cols=238 Identities=26% Similarity=0.366 Sum_probs=180.1
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.|.+.+.||+|+||+||+|... +++.||||++.+.. ....+..+..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4678899999999999999654 58999999996532 11223333347899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~gg~L~~~l~~~-----------------------------~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 82 ----------YIPGGDMMSLLIRM-----------------------------EVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred ----------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77788888877532 346777888999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-------------------------------------------
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------------------------------------- 664 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~------------------------------------------- 664 (753)
+||||||+|||++.++. +||+|||+++........
T Consensus 123 vHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (381)
T cd05626 123 IHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH 200 (381)
T ss_pred eecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence 99999999999977654 999999998643210000
Q ss_pred -cccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHc-c---CcccccCCCHHH
Q 004442 665 -LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKD-R---KDLFLVEHIPEA 738 (753)
Q Consensus 665 -~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~-~---~~~~~~~~s~el 738 (753)
.......+||+.|+|||++.+..++.++|||||||++|||+|| .+||...... ....+.. . ..+....+++++
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 279 (381)
T cd05626 201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG-QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA 279 (381)
T ss_pred cccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhC-CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHH
Confidence 0001234699999999999998999999999999999999999 6677654332 2222222 1 122233578999
Q ss_pred HHHHHHcc--ccCcCCC
Q 004442 739 VDLFTRLL--DPNPDLR 753 (753)
Q Consensus 739 ~dLI~~cL--~~DP~~R 753 (753)
.+||.+|+ ..+|..|
T Consensus 280 ~dli~~ll~~~~~~~~R 296 (381)
T cd05626 280 VDLITKLCCSAEERLGR 296 (381)
T ss_pred HHHHHHHccCcccccCC
Confidence 99999955 4444334
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.97 Aligned_cols=237 Identities=25% Similarity=0.384 Sum_probs=200.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---h---HHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---D---VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.....+|++.+.||+|.||.|-+|.. ..|+.||||.+++..- + ...+|+. +|+.++||||+.++.+|...+.
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIe-IMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIE-IMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHH-HHhhcCCCceeehhhhhcCCce
Confidence 34556788889999999999999865 6799999999865421 1 2345555 8899999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
+.|||| |..+|.|++++... +.+++.+..++++||..|+.|
T Consensus 128 IvivME----------YaS~GeLYDYiSer-----------------------------~~LsErEaRhfFRQIvSAVhY 168 (668)
T KOG0611|consen 128 IVIVME----------YASGGELYDYISER-----------------------------GSLSEREARHFFRQIVSAVHY 168 (668)
T ss_pred EEEEEE----------ecCCccHHHHHHHh-----------------------------ccccHHHHHHHHHHHHHHHHH
Confidence 999999 99999999998643 468888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvv 700 (753)
+|+++++|||||.+||||+.++ ++||+||||+..+... ....++||++-|.+||++.+..| ++.+|-|||||+
T Consensus 169 CHknrVvHRDLKLENILLD~N~--NiKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvL 242 (668)
T KOG0611|consen 169 CHKNRVVHRDLKLENILLDQNN--NIKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVL 242 (668)
T ss_pred HhhccceecccchhheeecCCC--Ceeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHH
Confidence 9999999999999999996654 5999999999887654 34467899999999999999998 799999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.|+.| ..||++. ...+..++..+....| .-+.+++-||+.||.+||++|
T Consensus 243 LYtLVyG-tMPFDG~Dhk~lvrQIs~GaYrEP-~~PSdA~gLIRwmLmVNP~RR 294 (668)
T KOG0611|consen 243 LYTLVYG-TMPFDGRDHKRLVRQISRGAYREP-ETPSDASGLIRWMLMVNPERR 294 (668)
T ss_pred HHHHhhc-ccccCCchHHHHHHHhhcccccCC-CCCchHHHHHHHHHhcCcccc
Confidence 9999998 6677665 5566666666665443 446688999999999999988
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.36 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=193.0
Q ss_pred ecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
.+++|++.+.||+|+||.||+|... .+..||||++..... ..+.+|+. +++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEcCCC
Confidence 4567899999999999999987542 357899999864332 23345554 778899999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++++........ ......+++..++.++.|++.||+
T Consensus 83 ~~~lv~e----------~~~~~~L~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 83 PTLVIME----------LMTRGDLKSYLRSLRPEMEN-------------------NPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred CeEEEEe----------cCCCCCHHHHHHHcCccccc-------------------cccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 88889999888653321100 011234677889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+++||||||+||+++.++ .+||+|||+++........ .......++..|+|||++.+..++.++|||||||+
T Consensus 134 ~lH~~~~vH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANKFVHRDLAARNCMVAEDF--TVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCCcccCCcchheEEEcCCC--CEEECCCCCccccCCccee-ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 99999999999999999997765 4999999999865432211 11122345788999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-HHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~-~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++.+||....... ...+ .......+...++++.++|.+||+.||++|
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05062 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 265 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999996678887654333 2222 233344566778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=316.90 Aligned_cols=236 Identities=25% Similarity=0.340 Sum_probs=187.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +|+.||||+++... ....+.++..+++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5788899999999999998664 68999999997532 22345555568889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ...+++..+..++.|++.||.|||+.+|
T Consensus 82 ----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 82 ----------YQPGGDLLSLLNRY----------------------------EDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred ----------CCCCCCHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77788888887542 1357788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc------CCCCCchhhHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t~ksDIwSfGvvL 701 (753)
+||||||+|||++.++. +||+|||++......... ......||+.|+|||++. ...++.++|||||||++
T Consensus 124 ~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 124 VHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred EcccCchHheEECCCCC--EEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 99999999999977765 999999999876543211 223346899999999986 45678999999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHHccC--c--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF-ERDANIVKDRK--D--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~-~~~~~~i~~~~--~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| ..||.... ......+.... . +....+++++.+||++||. ||++|
T Consensus 200 ~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R 254 (330)
T cd05601 200 YEMIYG-RSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKER 254 (330)
T ss_pred eeeccC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhC
Confidence 999998 66775543 33333333222 1 2223578999999999998 99988
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.94 Aligned_cols=228 Identities=27% Similarity=0.334 Sum_probs=178.5
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhC--CCCceeeecccccCCceEEEEEccccC
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASD--QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l--~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
||+|+||+||++... +++.||||++.+.. ......|...+.... +||||+++++++.+.+..|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e---- 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD---- 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc----
Confidence 799999999998765 58999999986432 112233443333333 79999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrD 121 (330)
T cd05586 77 ------YMSGGELFWHLQK-----------------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121 (330)
T ss_pred ------CCCCChHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 7778888877643 23577888999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
|||+|||++.++. +||+|||+++...... ......+||..|+|||++.+.. ++.++|||||||++|||+|| ..
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG-~~ 195 (330)
T cd05586 122 LKPENILLDATGH--IALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG-WS 195 (330)
T ss_pred CCHHHeEECCCCC--EEEecCCcCcCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC-CC
Confidence 9999999977765 9999999987543221 2223456999999999987654 79999999999999999999 55
Q ss_pred CCCCC-hHHHHHHHHccCccccc-CCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES-FERDANIVKDRKDLFLV-EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~-~~~~~~~i~~~~~~~~~-~~s~el~dLI~~cL~~DP~~R 753 (753)
||... .......+......++. .+++++++||++||+.||++|
T Consensus 196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 66543 44444444444444443 468999999999999999998
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=321.69 Aligned_cols=237 Identities=25% Similarity=0.346 Sum_probs=182.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.|++.+.||+|+||.||++... .++.||||.+.+.. ....+..+..++..++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999998764 58999999986421 11223333448899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (376)
T cd05598 82 ----------YIPGGDMMSLLIR-----------------------------LGIFEEDLARFYIAELTCAIESVHKMGF 122 (376)
T ss_pred ----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 7778888887743 2346777888999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc----------------------------------------cccc
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS----------------------------------------CLTQ 667 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~----------------------------------------~~~~ 667 (753)
+||||||+|||++.++. +||+|||+|..+..... ....
T Consensus 123 vHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (376)
T cd05598 123 IHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL 200 (376)
T ss_pred EeCCCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence 99999999999977765 99999999853310000 0000
Q ss_pred CccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHccC----cccccCCCHHHHHHH
Q 004442 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRK----DLFLVEHIPEAVDLF 742 (753)
Q Consensus 668 ~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~----~~~~~~~s~el~dLI 742 (753)
....+||+.|+|||++.+..++.++|||||||++|||++| ++||...... ....+.... .+.....++++.++|
T Consensus 201 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 279 (376)
T cd05598 201 AHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI 279 (376)
T ss_pred ccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC-CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHH
Confidence 1234699999999999999999999999999999999998 6677655432 222222211 122335789999999
Q ss_pred HHccccCcCCC
Q 004442 743 TRLLDPNPDLR 753 (753)
Q Consensus 743 ~~cL~~DP~~R 753 (753)
.+|+ .+|++|
T Consensus 280 ~~l~-~~p~~R 289 (376)
T cd05598 280 LRLC-CGAEDR 289 (376)
T ss_pred HHHh-cCHhhc
Confidence 9987 599887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=305.57 Aligned_cols=239 Identities=27% Similarity=0.413 Sum_probs=182.8
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccC-----C
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESD-----Q 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-----~ 539 (753)
+...|...+.||+|+||.|..|.. .+|+.||||++... ..++.++|+. +++.++|+||+.+.+.... -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElk-lLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELK-LLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHH-HHHHhcCCCcceEEeeccccccccc
Confidence 344555578899999999999865 45899999998632 3456788887 8899999999999998765 3
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+.+|+|+|+++++|...+ +. ...+....+..++.|+++||
T Consensus 99 ~DvYiV~elMetDL~~ii-----------k~-----------------------------~~~L~d~H~q~f~YQiLrgL 138 (359)
T KOG0660|consen 99 NDVYLVFELMETDLHQII-----------KS-----------------------------QQDLTDDHAQYFLYQILRGL 138 (359)
T ss_pred ceeEEehhHHhhHHHHHH-----------Hc-----------------------------CccccHHHHHHHHHHHHHhc
Confidence 568999996655554444 22 12356667788999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfG 698 (753)
.|+|+.+|+||||||+|+|++.| +.+||+|||+|+..... +.....+..+-|..|.|||++.. ..||.+.||||.|
T Consensus 139 KyiHSAnViHRDLKPsNll~n~~--c~lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvG 215 (359)
T KOG0660|consen 139 KYIHSANVIHRDLKPSNLLLNAD--CDLKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVG 215 (359)
T ss_pred chhhcccccccccchhheeeccC--CCEEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhh
Confidence 99999999999999999999666 56899999999988654 33334455667999999998854 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHH------------------------ccC--c-----ccccCCCHHHHHHHHHccc
Q 004442 699 CILFFCITGGKHPYGESFERDANIVK------------------------DRK--D-----LFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~i~------------------------~~~--~-----~~~~~~s~el~dLI~~cL~ 747 (753)
|++.||++|+..+-+.+.-.+...+. +.. + ...++.++++.+|+++||.
T Consensus 216 CI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~ 295 (359)
T KOG0660|consen 216 CILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLV 295 (359)
T ss_pred HHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhc
Confidence 99999999966555443322222211 100 0 1234567899999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 296 fdP~kR 301 (359)
T KOG0660|consen 296 FDPKKR 301 (359)
T ss_pred cCcccc
Confidence 999998
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.59 Aligned_cols=237 Identities=24% Similarity=0.367 Sum_probs=199.8
Q ss_pred ceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCce-EEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-VYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~-~~LV 545 (753)
+.|...+.+|+|+||.+++. +..+++.+|+|.+.-.. ...+.+|+. ++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~-lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMD-LLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHH-HHHhccCCCeeeeccchhcCCceEEEE
Confidence 45677889999999999876 44568899999985322 234566665 8899999999999999999888 9999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|+ |.++|++.+.+...+ ...++++++++++.|++.|+.|||++
T Consensus 83 m~----------Y~eGg~l~~~i~~~k---------------------------~~~f~E~~i~~~~~Q~~~av~ylH~~ 125 (426)
T KOG0589|consen 83 ME----------YCEGGDLAQLIKEQK---------------------------GVLFPEERILKWFVQILLAVNYLHEN 125 (426)
T ss_pred Ee----------ecCCCCHHHHHHHHh---------------------------hccccHHHHHHHHHHHHHHHHHHHhh
Confidence 99 667888888876532 35688999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
.|+|||||+.||++++++. +||+|||+|+.+.... ....+.+||+.||.||.+.+.+|..|+|||||||++|||+
T Consensus 126 ~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 126 RVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred hhhcccchhhhhhccccCc--eeecchhhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 9999999999999999986 7999999999987653 2345677999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGES-FERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~-~~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+- +++|... .......+.... .+.+..++.+++.+|+.||.++|..|
T Consensus 201 ~l-k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~R 249 (426)
T KOG0589|consen 201 TL-KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHR 249 (426)
T ss_pred hc-ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccC
Confidence 98 6677665 334444444444 77888999999999999999999987
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=303.08 Aligned_cols=253 Identities=24% Similarity=0.348 Sum_probs=192.3
Q ss_pred ceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.+|++.+.||+|+||.||+|.... ...||+|.+...... .+.+|+. ++..++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHH-HHHhcCCcccceEEEEEcCCCce
Confidence 356778899999999999986543 268999998754322 2334444 77889999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+++|| |+++|+|.+++........... ..........+++..++.++.|++.||.||
T Consensus 84 ~~~~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~~l~~al~~l 140 (283)
T cd05048 84 CMLFE----------YLAHGDLHEFLVRNSPHSDVGA-------------ESGDETVKSSLDCSDFLHIAIQIAAGMEYL 140 (283)
T ss_pred EEEEe----------cCCCCcHHHHHHhcCCCccccc-------------ccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7888899888865432111000 000001224688899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++. +||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|
T Consensus 141 H~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 141 SSHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred HhCCeeccccccceEEEcCCCc--EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 9999999999999999977654 99999999986643221 11223335688999999998889999999999999999
Q ss_pred HHHh-CCCCCCCC-ChHHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCIT-GGKHPYGE-SFERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllT-G~~~Pf~~-~~~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++ | ..||.+ ...+....+... ....+..+++++.+|+.+||+.||.+|
T Consensus 218 el~~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~R 270 (283)
T cd05048 218 EIFSYG-LQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270 (283)
T ss_pred HHHcCC-CCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhC
Confidence 9998 6 556654 444444444433 334566788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.99 Aligned_cols=237 Identities=23% Similarity=0.340 Sum_probs=184.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.|++.+.||+|+||+||++... +++.||||++.... ....++.+..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 4778899999999999998665 58999999996421 11223333447788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~gi 122 (360)
T cd05627 82 ----------FLPGGDMMTLLMK-----------------------------KDTLSEEATQFYIAETVLAIDAIHQLGF 122 (360)
T ss_pred ----------CCCCccHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 7778888887743 2356788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc--------------------------------cccCccCCCCc
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 675 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~--------------------------------~~~~~~~~GT~ 675 (753)
+||||||+|||++.++. +||+|||+++........ .......+||+
T Consensus 123 vHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 123 IHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred EccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 99999999999977765 999999998755321100 00112346999
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccC--ccccc--CCCHHHHHHHHHccccCc
Q 004442 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRK--DLFLV--EHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 676 ~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~--~~~~~--~~s~el~dLI~~cL~~DP 750 (753)
.|+|||++.+..++.++|||||||++|||+|| .+||..... .....+.... ..++. ..++++++||.+|+. ||
T Consensus 201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p 278 (360)
T cd05627 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DS 278 (360)
T ss_pred cccCHHHHcCCCCCCcceeccccceeeecccC-CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-Ch
Confidence 99999999999999999999999999999998 667765533 3333333221 22333 368899999999874 99
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
++|
T Consensus 279 ~~R 281 (360)
T cd05627 279 ENR 281 (360)
T ss_pred hhc
Confidence 887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.04 Aligned_cols=230 Identities=27% Similarity=0.383 Sum_probs=177.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|...+.||+|+||.||++... +|+.||||.+...... ...+|+ .+++.++|+||+++++++.+.+..++|||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 152 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREI-EILRDVNHPNVVKCHDMFDHNGEIQVLLE- 152 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHH-HHHHhCCCCCcceeeeEeccCCeEEEEEe-
Confidence 3455678999999999998764 6899999999654322 233444 47899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+.. ...+..+..++.||+.||+|||+.+|+
T Consensus 153 ---------~~~~~~L~~~~---------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~iv 190 (353)
T PLN00034 153 ---------FMDGGSLEGTH---------------------------------IADEQFLADVARQILSGIAYLHRRHIV 190 (353)
T ss_pred ---------cCCCCcccccc---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 66677765321 123456688999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----CCCCchhhHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIwSfGvvL~E 703 (753)
||||||+|||++.++. +||+|||+++....... ......||..|+|||.+.. ...+.++|||||||++||
T Consensus 191 HrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e 265 (353)
T PLN00034 191 HRDIKPSNLLINSAKN--VKIADFGVSRILAQTMD---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265 (353)
T ss_pred ecCCCHHHEEEcCCCC--EEEcccccceecccccc---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence 9999999999977765 99999999987653221 1234468999999998743 224579999999999999
Q ss_pred HHhCCCCCCCCChHH----HHH-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER----DAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~----~~~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| +.||...... ... .........+..+++++.+||.+||+.||++|
T Consensus 266 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 319 (353)
T PLN00034 266 FYLG-RFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKR 319 (353)
T ss_pred HHhC-CCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhC
Confidence 9998 6787643211 111 11223334556778999999999999999998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=302.33 Aligned_cols=228 Identities=23% Similarity=0.414 Sum_probs=179.7
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCC-----ch-HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HD-VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~-~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||++... +|+.||+|.+.... .. ....|++ ++..++||||+++++++.+....++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE-ILEKVNSPFIVNLAYAFESKTHLCLVMS------ 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHH-HHHhcCCCcEEEEEEEEecCCeEEEEEe------
Confidence 699999999998764 58999999986421 11 2234544 7889999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+.+|+|.++++... ...+++..++.++.|++.||+|||+.+|+|||||
T Consensus 74 ----~~~g~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 122 (277)
T cd05607 74 ----LMNGGDLKYHIYNVG---------------------------ERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122 (277)
T ss_pred ----cCCCCCHHHHHHhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC
Confidence 777888887765321 2347788889999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++. ++|+|||++........ .....|+..|+|||++.+..++.++|||||||++|||++| ..||.
T Consensus 123 p~Nili~~~~~--~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~p~~ 195 (277)
T cd05607 123 PENVLLDDQGN--CRLSDLGLAVELKDGKT----ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG-RTPFK 195 (277)
T ss_pred hHhEEEcCCCC--EEEeeceeeeecCCCce----eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC-CCCCC
Confidence 99999977654 89999999987653221 1234589999999999998899999999999999999998 67886
Q ss_pred CChHH-----HHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFER-----DANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~~-----~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..... .......... .....+++++++||++||++||++|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 241 (277)
T cd05607 196 DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241 (277)
T ss_pred CCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhC
Confidence 53221 1111111111 1224678999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=316.24 Aligned_cols=197 Identities=24% Similarity=0.327 Sum_probs=160.0
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.+..|.+.+.||+|+||.||++.... ++.||||.... ....+|+. +++.++|+|||++++++...+..++|||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~-iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEAR-LLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 35579999999999999999997654 78999996432 23445665 889999999999999999999999999944
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
. |+|.+++... ...+++.+++.|+.||+.||.|||+.+|+|
T Consensus 243 ~-----------~~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 243 R-----------SDLYTYLGAR----------------------------LRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred C-----------CCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 3 4555554321 235788999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+|||++.++. +||+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++|+.
T Consensus 284 rDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 284 RDIKTENVLVNGPED--ICLGDFGAACFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred CcCCHHHEEECCCCC--EEEcccCCceeccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999977654 999999999876443211 11223469999999999999999999999999999999999866
Q ss_pred CCCC
Q 004442 710 HPYG 713 (753)
Q Consensus 710 ~Pf~ 713 (753)
++|.
T Consensus 361 ~lf~ 364 (461)
T PHA03211 361 SLFS 364 (461)
T ss_pred Cccc
Confidence 5554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.93 Aligned_cols=243 Identities=28% Similarity=0.389 Sum_probs=181.6
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCC---c--e
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ---D--F 541 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~---~--~ 541 (753)
++...-.|.-.+++|.|+||.||+|... +++.||||+..... +..-+|.+ +|+.++|||||+|.-++... + .
T Consensus 19 ~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~-im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 19 GKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQ-IMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred CcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHH-HHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3445556778899999999999999765 47999999986543 23345666 66799999999999887542 2 3
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
..+||||++.+|. +.++..- .....++...+.-+..||.+||+|
T Consensus 97 lnlVleymP~tL~-----------~~~r~~~-------------------------~~~~~mp~~~iKLYt~Qlfrgl~y 140 (364)
T KOG0658|consen 97 LNLVLEYMPETLY-----------RVIRHYT-------------------------RANQRMPLLEIKLYTYQLFRGLAY 140 (364)
T ss_pred HHHHHHhchHHHH-----------HHHHHHh-------------------------hcCCCCceeeeHHHHHHHHHHHHH
Confidence 5779996665544 4333211 123456666777889999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvv 700 (753)
||+.+|+||||||+|+|++.+. ..+||||||.|+.+..+.. +.....|..|+|||.+.+. .|+.+.||||.|||
T Consensus 141 Lh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~ep----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV 215 (364)
T KOG0658|consen 141 LHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCV 215 (364)
T ss_pred HHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCCC----ceeEEEeccccCHHHHcCccccCceeEEhhhhHH
Confidence 9999999999999999998875 4699999999998865432 2333468899999999875 48999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHc------------c--C---------------cccccCCCHHHHHHHHHccccCcC
Q 004442 701 LFFCITGGKHPYGESFERDANIVKD------------R--K---------------DLFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~~~~i~~------------~--~---------------~~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
+.||+-|+..+-+++...+...+.. . + ..+....++++.+|+.++|..+|+
T Consensus 216 ~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~ 295 (364)
T KOG0658|consen 216 MAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPS 295 (364)
T ss_pred HHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChh
Confidence 9999999665555553333322210 0 0 113445678999999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 296 ~R 297 (364)
T KOG0658|consen 296 KR 297 (364)
T ss_pred hc
Confidence 98
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=317.71 Aligned_cols=238 Identities=24% Similarity=0.356 Sum_probs=186.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+...+.|++.+.||+|+||.||++... +++.||+|.+.+.. ....+.++..+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 444578999999999999999998765 58899999986421 123344555588899999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~E----------y~~gg~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~L 158 (371)
T cd05622 119 YMVME----------YMPGGDLVNLMSN------------------------------YDVPEKWARFYTAEVVLALDAI 158 (371)
T ss_pred EEEEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888877642 2356677889999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC----CCchhhHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 698 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDIwSfG 698 (753)
|+.+|+||||||+|||++.++. +||+|||+++...... .......+||+.|+|||++.+.. ++.++||||||
T Consensus 159 H~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG 234 (371)
T cd05622 159 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (371)
T ss_pred HHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence 9999999999999999977765 9999999998764321 11223457999999999987543 78999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHHccC--c--ccccCCCHHHHHHHHHccccCcCC
Q 004442 699 CILFFCITGGKHPYGESF-ERDANIVKDRK--D--LFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~-~~~~~~i~~~~--~--~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
|++|||++| .+||.... ......+.... . +....++++++++|.+||. +|.+
T Consensus 235 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~ 291 (371)
T cd05622 235 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREV 291 (371)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence 999999998 66776543 33333333322 1 2233578999999999998 5544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=317.90 Aligned_cols=268 Identities=23% Similarity=0.359 Sum_probs=192.1
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCceeeecccccCCc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQD 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~ 540 (753)
.+.|.+.+.||+|+||.||+|... .+..||||++..... +.+.+|+. +++.+. ||||++++|+|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK-IMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCCeeeEEEEEccCC
Confidence 467888999999999999998653 235799999965432 23455665 667775 999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchh------------------hhhhhh-c----------------
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL------------------NEVRIR-L---------------- 585 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~------------------~~~~~~-~---------------- 585 (753)
..||||| |+++|+|.++|+......... ++.+.. .
T Consensus 115 ~~~lv~E----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 115 PIYIITE----------YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred ceEEEEE----------ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 9999999 777888888887543211000 000000 0
Q ss_pred -------------------------cccc----ccchhhhh---hhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 586 -------------------------LPVM----ENTKDIEL---WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 586 -------------------------~~~~----~~~~~~~~---~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
.+.. ........ .....+++.++++++.|++.||+|||+.+|+|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 0000 00000000 112468899999999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+|||++.++ .+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++.+..||.
T Consensus 265 p~Nill~~~~--~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 265 ARNVLLAQGK--IVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred hHhEEEeCCC--EEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 9999997664 5999999999876433221 122233467889999999999999999999999999999984467776
Q ss_pred CChH--HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~--~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.... .....+... ....+..+++++.++|.+||+.||++|
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 384 (400)
T cd05105 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKR 384 (400)
T ss_pred ccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHC
Confidence 5422 222333332 234456778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=298.05 Aligned_cols=240 Identities=26% Similarity=0.373 Sum_probs=195.9
Q ss_pred ecceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeec----CCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVK----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~----~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.+.|.+.++||+|.|..||+. +...|+.+|+|.+.. ...-+.+.++.++...++|||||+|.....+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4456677788999999999985 456789999887732 22334455555688899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| +|.+|+|..-+-.+ .-+++..+...+.||+.+|.|+|.+
T Consensus 89 Fe----------~m~G~dl~~eIV~R-----------------------------~~ySEa~aSH~~rQiLeal~yCH~n 129 (355)
T KOG0033|consen 89 FD----------LVTGGELFEDIVAR-----------------------------EFYSEADASHCIQQILEALAYCHSN 129 (355)
T ss_pred Ee----------cccchHHHHHHHHH-----------------------------HHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 99 88888887655432 1234566788999999999999999
Q ss_pred CccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
+|||||+||.|+||-+ +..--+||+|||+|..+.+. ..--.++|||+|||||+++..+|+..+|||+-||+||-|
T Consensus 130 ~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 130 GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 205 (355)
T ss_pred CceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence 9999999999999954 33346899999999988622 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHccCccccc----CCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDANIVKDRKDLFLV----EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~~~i~~~~~~~~~----~~s~el~dLI~~cL~~DP~~R 753 (753)
+.|..|+|+++..+..+.++.+...++. ..++++++||++||..||.+|
T Consensus 206 L~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kR 258 (355)
T KOG0033|consen 206 LVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKR 258 (355)
T ss_pred HhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhh
Confidence 9996666666888888888887765544 567999999999999999998
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=319.05 Aligned_cols=237 Identities=25% Similarity=0.381 Sum_probs=185.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
....+.|++.+.||+|+||.||++... +++.||+|.+.+. .....+.++..+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344577999999999999999998765 5889999998642 1223455555688999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+++|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~E----------y~~gg~L~~~l~~------------------------------~~~~~~~~~~~~~qil~aL~~L 158 (370)
T cd05621 119 YMVME----------YMPGGDLVNLMSN------------------------------YDVPEKWAKFYTAEVVLALDAI 158 (370)
T ss_pred EEEEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888887642 2356778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC----CCchhhHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 698 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDIwSfG 698 (753)
|+.+|+||||||+|||++.++. +||+|||++....... .......+||+.|+|||++.+.. ++.++||||||
T Consensus 159 H~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05621 159 HSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred HHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh
Confidence 9999999999999999977765 9999999998764321 11223557999999999987543 78999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHHHccC--cccc--cCCCHHHHHHHHHccccCc
Q 004442 699 CILFFCITGGKHPYGES-FERDANIVKDRK--DLFL--VEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~-~~~~~~~i~~~~--~~~~--~~~s~el~dLI~~cL~~DP 750 (753)
|++|||++| .+||... .......+.... ..++ ...++.++++|.+||..+|
T Consensus 235 ~ilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~ 290 (370)
T cd05621 235 VFLFEMLVG-DTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDRE 290 (370)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCch
Confidence 999999998 5666544 333333333222 2223 3468899999999998544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.12 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=191.8
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.+.|++.+.||+|++|.||++...+++.||||.++... .+.+.+|+. +++.++|+||+++++++...+..+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAVCTLEEPIYIVTE-- 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHH-HHHHCCCCCccceeEEEecCCCeeeeee--
Confidence 45688899999999999999988788899999987543 233445554 7889999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|..+|+|.+++.... ...+++.++.+++.|++.||.|||+.+|+|
T Consensus 82 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 126 (261)
T cd05068 82 --------LMKYGSLLEYLQGGA---------------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIH 126 (261)
T ss_pred --------cccCCcHHHHHhccC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 777788888775321 235788899999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||+++........ .......+..|+|||.+.+..++.++||||||+++|||+|+++
T Consensus 127 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~ 202 (261)
T cd05068 127 RDLAARNVLVGENNI--CKVADFGLARVIKEDIYE--AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred ccCCcceEEEcCCCC--EEECCcceEEEccCCccc--ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCC
Confidence 999999999987765 999999999877532111 1111123468999999998889999999999999999999547
Q ss_pred CCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||.+... .....+... ....+...++++.+++.+||+.||++|
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 248 (261)
T cd05068 203 MPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDR 248 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccC
Confidence 88876543 333333332 234456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=296.91 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=189.2
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.|.+.+.||+|+||+||++...++..+|||.+.... .+.+.+|+. ++..++||||++++++|.+.+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMKLSHEKLVQLYGVCTKQRPIYIVTE--- 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHH-HHhcCCCCCeeeEEEEEccCCCcEEEEE---
Confidence 4577889999999999999987777789999987543 233455555 7899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|..+|+|.+++... ...+++.++++++.||+.||+|||+.+++|+
T Consensus 80 -------~~~~~~l~~~i~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05113 80 -------YMSNGCLLNYLREH----------------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124 (256)
T ss_pred -------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 77788888877532 1246788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++.+..
T Consensus 125 dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 125 DLAARNCLVDDQG--CVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ccCcceEEEcCCC--CEEECCCccceecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 9999999997665 499999999987643321 111122356789999999888899999999999999999994477
Q ss_pred CCCCChHH-HHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+.... ...+...++++.+++.+||+.||++|
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 245 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEER 245 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 88765433 333333332 33455678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.35 Aligned_cols=234 Identities=25% Similarity=0.392 Sum_probs=186.9
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|+..+.||+|+||.||++... +++.||||.+..... ....+|+. +++.++|+||+++++.+.+.+..++|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHH-HHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 556788999999999998654 589999999864321 12344554 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++... ....+++.+++.++.|++.||.|||+.+|
T Consensus 81 ----------~~~g~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 81 ----------LMNGGDLKFHIYHM---------------------------GEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHHh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 88888888877532 12357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 124 VYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeccceeecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999977654 9999999997654321 11234689999999999999999999999999999999998
Q ss_pred CCCCCCCChHH-----HHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-----~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||...... ............+..+++++.+||++||+.||++|
T Consensus 198 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (285)
T cd05630 198 -QSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247 (285)
T ss_pred -CCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHc
Confidence 6788654221 11112222334556788999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=296.85 Aligned_cols=239 Identities=24% Similarity=0.346 Sum_probs=190.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
..|.+.+.||+|+||.||++... .++.||+|.+..... ....+|+. ++..++|+||++++++|.+++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE-- 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHH-HHHhCCCCChhheEEEEcCCCCcEEEEE--
Confidence 45778899999999999998765 488999999875432 23455555 7788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 127 (263)
T cd05052 83 --------FMTYGNLLDYLRECN---------------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127 (263)
T ss_pred --------eCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 888889988875421 234778888999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++++.
T Consensus 128 ~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~ 203 (263)
T cd05052 128 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203 (263)
T ss_pred cccCcceEEEcCCCc--EEeCCCcccccccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence 999999999977654 99999999987654321 11112224678999999998999999999999999999999447
Q ss_pred CCCCCC-hHHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~-~~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||... .+.....+... ....+...++++.++|.+||+.||++|
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 249 (263)
T cd05052 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDR 249 (263)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 777654 33333333332 344566788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.53 Aligned_cols=241 Identities=22% Similarity=0.304 Sum_probs=193.2
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.|++.+.||.|.-|+||++.+.+ +..+|+|++.+.... ....-++++|+.++||-++.|++.+..++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 445667889999999999998876 699999999764321 11223345889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |.++|+|+..++.+ ..+.+++..+.-++.+|+-||+|||-.|
T Consensus 157 e----------yCpGGdL~~LrqkQ---------------------------p~~~fse~~aRFYaAEvl~ALEYLHmlG 199 (459)
T KOG0610|consen 157 E----------YCPGGDLHSLRQKQ---------------------------PGKRFSESAARFYAAEVLLALEYLHMLG 199 (459)
T ss_pred e----------cCCCccHHHHHhhC---------------------------CCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence 9 66788998887653 3467888999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC-------------------------------c-c----------
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-------------------------------S-C---------- 664 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~-------------------------------~-~---------- 664 (753)
||+|||||+||||.+||+ +.|+||.|+....... . .
T Consensus 200 ivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~ 277 (459)
T KOG0610|consen 200 IVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESAS 277 (459)
T ss_pred eeeccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccc
Confidence 999999999999999987 8999999876542100 0 0
Q ss_pred -----------cccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHccCccccc
Q 004442 665 -----------LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES-FERDANIVKDRKDLFLV 732 (753)
Q Consensus 665 -----------~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~ 732 (753)
.......+||-.|.|||++.+..++.++|+|+|||+||||+.| ..||.+. +++....+......++.
T Consensus 278 ~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG-~TPFKG~~~~~Tl~NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 278 RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG-TTPFKGSNNKETLRNIVGQPLKFPE 356 (459)
T ss_pred ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC-CCCcCCCCchhhHHHHhcCCCcCCC
Confidence 0112334799999999999999999999999999999999999 5677655 44444444444444443
Q ss_pred --CCCHHHHHHHHHccccCcCCC
Q 004442 733 --EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 733 --~~s~el~dLI~~cL~~DP~~R 753 (753)
+.+-+++|||+++|.+||++|
T Consensus 357 ~~~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 357 EPEVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred CCcchhHHHHHHHHHhccChhhh
Confidence 446899999999999999998
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.31 Aligned_cols=239 Identities=23% Similarity=0.295 Sum_probs=185.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..|...+.||+|+||.||+|... ++. .||||.++.... ...+.++..+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45788899999999999999754 333 489999864432 22333334578999999999999999875 5678
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
++| |+++|+|.++++... ..+++..+++++.||+.||+|||+
T Consensus 86 v~e----------~~~~g~l~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~ 127 (316)
T cd05108 86 ITQ----------LMPFGCLLDYVREHK----------------------------DNIGSQYLLNWCVQIAKGMNYLEE 127 (316)
T ss_pred eee----------cCCCCCHHHHHHhcc----------------------------ccCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 888999999886431 246778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++|||
T Consensus 128 ~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el 204 (316)
T cd05108 128 RRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred cCeeccccchhheEecCCCc--EEEccccccccccCCCcce-eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999977654 9999999998775432211 11222346789999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHH-HHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~-~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+..||++...... ..... ...+.+..++.++.++|.+||..||++|
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 255 (316)
T cd05108 205 MTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 255 (316)
T ss_pred HcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9844778877544332 22222 2234456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.67 Aligned_cols=234 Identities=25% Similarity=0.382 Sum_probs=187.8
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|+..+.||+|+||+||++... +++.||+|.+..... ....+|+. ++..++|+||+++.+++.+++..+++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ-ILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 556788999999999998664 689999999865321 12344554 7888999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ....+++..+..++.|++.||.|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred ----------eccCccHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 77788888776532 12358889999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++ .+||+|||++....... ......|+..|+|||.+.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 124 VYRDLKPENILLDDYG--HIRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred eecCCCHHHEEECCCC--CEEEecCCcceecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 9999999999997665 49999999997654321 12234689999999999988999999999999999999998
Q ss_pred CCCCCCCChHHH-----HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~-----~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+.......+..+++++.+|+.+||++||++|
T Consensus 198 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 198 -QSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHc
Confidence 67886543321 1222233344566788999999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=306.79 Aligned_cols=203 Identities=26% Similarity=0.355 Sum_probs=154.6
Q ss_pred EEecccCceEEEEEEee---CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccccC--CceEEEEEccccCC
Q 004442 479 KEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERCTCS 552 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~~LV~E~c~~~ 552 (753)
+.||+|+||.||+|... +++.||+|.+..... ....+|+. +++.++||||+++++++.+ +...+++||++.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHH-HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 56999999999999754 468999999976543 34556665 7899999999999998754 45689999976655
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|.+++........ ......+++..+..++.||+.||.|||+.+|+||||
T Consensus 86 l~~~~~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDl 134 (317)
T cd07868 86 LWHIIKFHRASKA-------------------------------NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDL 134 (317)
T ss_pred HHHHHHhcccccc-------------------------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence 5444321111000 011235788899999999999999999999999999
Q ss_pred CCCcEEEecC--CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCC
Q 004442 633 KPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 633 Kp~NILL~~d--~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||+|||+..+ ....+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~ 213 (317)
T cd07868 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-E 213 (317)
T ss_pred CHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC-C
Confidence 9999999532 22459999999998765433222233445689999999998774 589999999999999999999 6
Q ss_pred CCCCC
Q 004442 710 HPYGE 714 (753)
Q Consensus 710 ~Pf~~ 714 (753)
+||..
T Consensus 214 ~~f~~ 218 (317)
T cd07868 214 PIFHC 218 (317)
T ss_pred CCccC
Confidence 67753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.19 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=192.0
Q ss_pred ceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+.|.+.+.||+|+||.||+|...+ ++.||||.++..... .+.+|+ .+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA-ELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHH-HHHHhcCCCCchheeeEEecCCCe
Confidence 346677889999999999986643 578999999754322 334454 478999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.++++.......... ........+++.++..++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~L~~~i~~~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~i~~~l~~l 138 (280)
T cd05049 84 IMVFE----------YMEHGDLNKFLRSHGPDAAFLK---------------SPDSPMGELTLSQLLQIAVQIASGMVYL 138 (280)
T ss_pred EEEEe----------cCCCCCHHHHHHhcCCchhhhc---------------ccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999 8888888888865432111000 0001234578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+++||||||+||+++.++ .+||+|||+++........ .......+++.|+|||.+.+..++.++|||||||++|
T Consensus 139 H~~~i~h~dlkp~nili~~~~--~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 139 ASQHFVHRDLATRNCLVGYDL--VVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred hhCCeeccccccceEEEcCCC--eEEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 999999999999999997775 4999999999865432211 1112234578899999999999999999999999999
Q ss_pred HHHh-CCCCCCCC-ChHHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCIT-GGKHPYGE-SFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllT-G~~~Pf~~-~~~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++ | ..||.. ........+.... ...+..++.++.++|.+||++||++|
T Consensus 216 e~~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 268 (280)
T cd05049 216 EIFTYG-KQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQR 268 (280)
T ss_pred HHHhcC-CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 9999 6 667644 3444444444333 33455678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=300.09 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=192.4
Q ss_pred ceEEEeEEecccCceEEEEEEe-----eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-----~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..|++.+.||+|+||+||+|.. ..++.||+|.+...... .+.+|+ .+++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA-SLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCCeeeEEEEEecCCceE
Confidence 3567889999999999999864 34689999999754322 233454 4789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++........... ...........+++.+++.++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~l~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 141 (283)
T cd05090 84 MLFE----------YLNQGDLHEFLIMRSPHSDVGC------------SSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEEE----------cCCCCcHHHHHHhcCCCCcccc------------ccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7778888888764332111000 00000112345788999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++ .+||+|||+++........ .......++..|+|||++.+..++.++|||||||++||
T Consensus 142 ~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e 218 (283)
T cd05090 142 SHFFVHKDLAARNILIGEQL--HVKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWE 218 (283)
T ss_pred hcCeehhccccceEEEcCCC--cEEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHH
Confidence 99999999999999997765 4999999999876433211 11233345778999999988889999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++++.+||.+.. ......+... ....+..+++++.++|.+||++||++|
T Consensus 219 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05090 219 IFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9994477876543 3333333333 234556778999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.11 Aligned_cols=195 Identities=27% Similarity=0.405 Sum_probs=155.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.++|.+.+.||+|+||.||++... .|+.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHH-HHHhCCCCCEeeeeeeeccCCCccc
Confidence 4577899999999999999999664 58999999986432 223455555 77899999999999987644
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...|+|||||.+++. +.++ ..+++..+..++.|++.|
T Consensus 98 ~~~~~lv~e~~~~~l~-----------~~~~-------------------------------~~~~~~~~~~~~~qi~~~ 135 (359)
T cd07876 98 FQDVYLVMELMDANLC-----------QVIH-------------------------------MELDHERMSYLLYQMLCG 135 (359)
T ss_pred cceeEEEEeCCCcCHH-----------HHHh-------------------------------ccCCHHHHHHHHHHHHHH
Confidence 357999996654433 2221 135667778999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|.|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++||||||
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 209 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHH
Confidence 99999999999999999999977765 9999999997653321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGES 715 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~ 715 (753)
|++|||+|| .+||...
T Consensus 210 ~il~el~tg-~~pf~~~ 225 (359)
T cd07876 210 CIMGELVKG-SVIFQGT 225 (359)
T ss_pred HHHHHHHhC-CCCCCCC
Confidence 999999998 6787654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=306.23 Aligned_cols=203 Identities=25% Similarity=0.363 Sum_probs=153.9
Q ss_pred EEecccCceEEEEEEee---CCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCceeeeccccc--CCceEEEEEccccCC
Q 004442 479 KEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSLERCTCS 552 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpNIV~L~g~~~--~~~~~~LV~E~c~~~ 552 (753)
..||+|+||.||+|... ++..||+|.+...... ...+|+. +++.++|+||+++++++. ++...++||||+.++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA-LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHH-HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 56999999999999765 3578999999765433 3445554 789999999999999875 356789999977665
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|.+++ ....... .......+++..+.+++.||+.||.|||+.+|+||||
T Consensus 86 l~~~~-----------~~~~~~~--------------------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dl 134 (317)
T cd07867 86 LWHII-----------KFHRASK--------------------ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDL 134 (317)
T ss_pred HHHHH-----------Hhhhccc--------------------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCC
Confidence 55444 2111000 0011235788899999999999999999999999999
Q ss_pred CCCcEEEecC--CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCC
Q 004442 633 KPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 633 Kp~NILL~~d--~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||+|||+..+ .+..+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||+|| +
T Consensus 135 kp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg-~ 213 (317)
T cd07867 135 KPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-E 213 (317)
T ss_pred CHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC-C
Confidence 9999999432 22359999999998765433222233345689999999998764 579999999999999999998 6
Q ss_pred CCCCC
Q 004442 710 HPYGE 714 (753)
Q Consensus 710 ~Pf~~ 714 (753)
+||..
T Consensus 214 ~~f~~ 218 (317)
T cd07867 214 PIFHC 218 (317)
T ss_pred CCccc
Confidence 67753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.30 Aligned_cols=240 Identities=32% Similarity=0.459 Sum_probs=203.8
Q ss_pred ceecceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
-+|...|.+.+.||+|.|..|-+| +...|..||||++.+... ...|+|+. .|+.++|||||+||.+...+..+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVR-CMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVR-CMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHH-HHHHhcCcCeeeeeehhcccceE
Confidence 456778899999999999999877 457899999999976542 35677776 77999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|||+| .-.+|+|++|+-..+ .++.+....+++.||+.|+.|+
T Consensus 93 yLiLE----------LGD~GDl~DyImKHe----------------------------~Gl~E~La~kYF~QI~~AI~YC 134 (864)
T KOG4717|consen 93 YLILE----------LGDGGDLFDYIMKHE----------------------------EGLNEDLAKKYFAQIVHAISYC 134 (864)
T ss_pred EEEEE----------ecCCchHHHHHHhhh----------------------------ccccHHHHHHHHHHHHHHHHHH
Confidence 99999 556778888775432 4577788899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL 701 (753)
|+..+|||||||+||.+-+.-. .+||.|||++..+.++ .+..+.||+..|-|||++.+..| .+++|||||||+|
T Consensus 135 HqLHVVHRDLKPENVVFFEKlG-lVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 135 HQLHVVHRDLKPENVVFFEKLG-LVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL 209 (864)
T ss_pred hhhhhhcccCCcceeEEeeecC-ceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence 9999999999999998755433 5899999999877643 45577899999999999999999 5899999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.|++| ++||.+.+ .+....+..-+...|...+.|+++||..||.-||++|
T Consensus 210 yMLVCG-q~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkR 261 (864)
T KOG4717|consen 210 YMLVCG-QPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKR 261 (864)
T ss_pred HHHHhC-CCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhh
Confidence 999998 67776654 4455667777888899999999999999999999998
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.21 Aligned_cols=231 Identities=26% Similarity=0.369 Sum_probs=180.7
Q ss_pred EecccCceEEEEEEe---eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 480 EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~---~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.||+|+||.||+|.. .++..+|+|+++.... +.+.+|+ .+++.++|+||++++|++.+ +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~-~~~~lv~e---- 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIVRMIGICEA-ESWMLVME---- 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHH-HHHHhCCCCCcceEEEEEcC-CCcEEEEe----
Confidence 489999999999853 3578999999865432 1233344 47889999999999999854 56789999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|.++|+|.+++... ..+++..+++++.|++.||+|||+.+|+|||
T Consensus 76 ------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 76 ------LAELGPLNKFLQKN-----------------------------KHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred ------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 77788888887432 3467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++ .+||+|||+++................++..|+|||.+....++.++|||||||++|||++.+.+|
T Consensus 121 lkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 198 (257)
T cd05116 121 LAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198 (257)
T ss_pred cchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 999999997664 599999999987654332222222334567999999998888999999999999999999833778
Q ss_pred CCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|..... .....+... ....+...++++.++|.+||+.||++|
T Consensus 199 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~R 242 (257)
T cd05116 199 YKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDER 242 (257)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhC
Confidence 876533 333333333 344566789999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.82 Aligned_cols=239 Identities=25% Similarity=0.381 Sum_probs=189.6
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
..+|.+.+.||+|+||.||+|...++..||+|++..... +.+.+|++ ++..++|+||+++++++. .+..++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~-~~~~~lv~e-- 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVS-EEPIYIVTE-- 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHH-HHHhCCCCCcceEEEEEC-CCCcEEEEE--
Confidence 356889999999999999999877777899999975432 33455555 778899999999999874 456899999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+|+|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 125 (262)
T cd05071 81 --------YMSKGSLLDFLKGEM---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVH 125 (262)
T ss_pred --------cCCCCcHHHHHhhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 888888888875321 234678889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||+++....... .......++..|+|||...+..++.++|||||||++|||+|++.
T Consensus 126 ~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~ 201 (262)
T cd05071 126 RDLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201 (262)
T ss_pred cccCcccEEEcCCCc--EEeccCCceeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999977654 89999999987654321 11122335778999999988899999999999999999999668
Q ss_pred CCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||....... ...+... ..+.....++++.++|.+||++||++|
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 247 (262)
T cd05071 202 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247 (262)
T ss_pred CCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccC
Confidence 8887654332 2222222 233456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=311.17 Aligned_cols=236 Identities=22% Similarity=0.356 Sum_probs=184.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +++.||+|.+.+.. ....++++..++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5788899999999999998765 58899999986421 12334555567888999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.++++.. ...+++..+..++.|++.||+|||+.+|
T Consensus 82 ----------y~~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred ----------CCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 88889999888542 1346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----CCCCchhhHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIwSfGvvL~ 702 (753)
+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 124 iHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCCCC--EEEEeccceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence 99999999999977665 99999999987654321 11223568999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccC--cccc---cCCCHHHHHHHHHccccCcCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRK--DLFL---VEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~--~~~~---~~~s~el~dLI~~cL~~DP~~ 752 (753)
||++| +.||... .......+.... ..++ ...+++++++|.+||..++++
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 200 EMLYG-ETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred hhhhC-CCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhh
Confidence 99998 5677554 333333333221 1222 345789999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=293.56 Aligned_cols=238 Identities=29% Similarity=0.382 Sum_probs=187.1
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+.|.+.+.||+|++|.||++... +++.||+|.+..... ....+|+ .+++.++|+||+++++++.+++..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEI-QLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEccCCeEE
Confidence 35778899999999999998764 589999999864321 1233344 4778999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|+| |+++|+|.+++... ..+++..+.+++.|++.||.|||
T Consensus 81 ~v~e----------~~~~~~l~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lH 121 (263)
T cd06625 81 IFME----------YMPGGSVKDQLKAY-----------------------------GALTETVTRKYTRQILEGVEYLH 121 (263)
T ss_pred EEEE----------ECCCCcHHHHHHHh-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77778888776432 34667788999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||+|+||+++.++. ++|+|||+++................|+..|+|||.+.+..++.++||||||+++||
T Consensus 122 ~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 199 (263)
T cd06625 122 SNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVE 199 (263)
T ss_pred hCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHH
Confidence 999999999999999977665 999999999876432211111123457889999999999889999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++| ++||..... ....... ......+...++++.++|++||++||++|
T Consensus 200 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 251 (263)
T cd06625 200 MLTE-KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKR 251 (263)
T ss_pred HHhC-CCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccC
Confidence 9998 667755422 2222222 22334566788999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=313.58 Aligned_cols=233 Identities=24% Similarity=0.384 Sum_probs=176.9
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCc-----eEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 543 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-----~~~ 543 (753)
|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++|+||+++++++...+ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK-MLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHH-HHHhCCCCCcCCHhheecCCCccccceEE
Confidence 45678899999999999876 468999999986432 123455555 778999999999999998776 789
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|+||+.+ +|.+++. ....+++..+..++.||+.||.|||
T Consensus 81 lv~e~~~~-----------~l~~~~~-----------------------------~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 81 VVTELMQS-----------DLHKIIV-----------------------------SPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred EEeecccc-----------CHHHHHh-----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99995543 3444332 1235778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++ .+||+|||+++....... .......+|..|+|||.+.+.. ++.++|||||||++|
T Consensus 121 ~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred hCCeeCCCCChHHEEECCCC--CEEeccccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 99999999999999997765 499999999987543221 1223345789999999988754 799999999999999
Q ss_pred HHHhCCCCCCCCChHHH-HHHHHc-----------------------cC--c-------ccccCCCHHHHHHHHHccccC
Q 004442 703 FCITGGKHPYGESFERD-ANIVKD-----------------------RK--D-------LFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~-~~~i~~-----------------------~~--~-------~~~~~~s~el~dLI~~cL~~D 749 (753)
||++| ++||....... ...+.. .. . ......++++.+||.+||+.|
T Consensus 197 el~~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 275 (372)
T cd07853 197 ELLGR-RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275 (372)
T ss_pred HHHcC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC
Confidence 99998 67876543221 111100 00 0 122345789999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 276 P~~R 279 (372)
T cd07853 276 PDKR 279 (372)
T ss_pred hhhC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.31 Aligned_cols=235 Identities=23% Similarity=0.360 Sum_probs=189.9
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|.+.+.||+|++|.||++... +++.||+|.+.... .....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSSYIIRYYESFLDKGKLNIVME- 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHH-HHHhcCCCCeehheeeeccCCEEEEEEE-
Confidence 667889999999999998764 58999999986432 223344554 7789999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++++|.++++... ...+++.++++++.+++.||.|||+.+|+
T Consensus 80 ---------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~ 123 (256)
T cd08529 80 ---------YAENGDLHKLLKMQR---------------------------GRPLPEDQVWRFFIQILLGLAHLHSKKIL 123 (256)
T ss_pred ---------eCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 888889988886431 24577888899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||||+||+++.++. ++|+|||+++....... ......|++.|+|||+..+..++.++|||||||++|||++|
T Consensus 124 h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g- 197 (256)
T cd08529 124 HRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG- 197 (256)
T ss_pred cCCCCcceEEEeCCCC--EEEcccccceeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC-
Confidence 9999999999987765 99999999987654321 12234578999999999999999999999999999999998
Q ss_pred CCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||....... ...+.. .....+..+++++.++|.+||+.+|++|
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08529 198 KHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQR 244 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccC
Confidence 66876554322 222222 2334445778999999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.23 Aligned_cols=235 Identities=22% Similarity=0.321 Sum_probs=178.1
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.|.+.+.||+|+||.||++... .++.||+|+++... .....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHH-HHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 45788899999999999998765 58899999986432 123445655 7789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||+++ |.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 85 ~~~~~-----------l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (309)
T cd07872 85 YLDKD-----------LKQYMDDC----------------------------GNIMSMHNVKIFLYQILRGLAYCHRRKV 125 (309)
T ss_pred CCCCC-----------HHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 66544 44433211 1246677889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||+++....... ......+|+.|+|||.+.+ ..++.++|||||||++|||+|
T Consensus 126 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ecCCCCHHHEEECCCCC--EEECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999977655 99999999976543211 1123357899999998865 457999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHcc---------------------C-c--------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDR---------------------K-D--------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~---------------------~-~--------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||..... .....+... . . ......++++.+||.+||+.||.+|
T Consensus 201 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 277 (309)
T cd07872 201 G-RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKR 277 (309)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhC
Confidence 8 667755432 111111100 0 0 0112457899999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.77 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=192.6
Q ss_pred cceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
++.|.+.+.||+|+||.||+|...+ +..||+|.+..... ..+.+|+. +++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-IMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCC
Confidence 4568888999999999999987653 67899998864332 23445544 7789999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.++++...... .....+++.++++++.||+.||+|
T Consensus 84 ~~lv~e----------~~~g~~L~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 84 RFILLE----------LMAGGDLKSFLRENRPRP----------------------ERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred cEEEEe----------cCCCCCHHHHHHHhCCCC----------------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 888889988886543211 012357889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
||+.+++||||||+||+++.++ ...+||+|||+++........ ........+..|+|||++.+..++.++|||||||+
T Consensus 132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccce-ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 9999999999999999997654 245899999999876432111 11112233568999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh-HHHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESF-ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~-~~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++..||.... +.....+. ......+..+++++.++|.+||+.||++|
T Consensus 211 l~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~R 265 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDR 265 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 9999985578887643 33333332 23344567788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.56 Aligned_cols=237 Identities=29% Similarity=0.426 Sum_probs=183.0
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCc-eeeecccccCCc------e
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPN-IVRWYGVESDQD------F 541 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpN-IV~L~g~~~~~~------~ 541 (753)
|...+.||+|+||+||+|... +|+.||+|++.-.. .....+|+. +++.++|+| ||+|++++...+ .
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREis-llk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREIS-LLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHH-HHHHhCCCcceEEEEeeeeecccccccce
Confidence 334466999999999999654 58999999996443 235688987 889999999 999999998877 7
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
++||+|++..+|..|+-... . ...+++...+..++.||++||+|
T Consensus 92 l~lvfe~~d~DL~~ymd~~~-----------~-------------------------~~~g~~~~~ik~~m~Qll~gl~~ 135 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLP-----------K-------------------------KPQGLPPRLIKSFMRQLLRGLAF 135 (323)
T ss_pred EEEEEEeecccHHHHHHhcc-----------c-------------------------cccCCCHHHHHHHHHHHHHHHHH
Confidence 89999999888877762110 0 00346667889999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvv 700 (753)
||+++|+||||||+||||+++|. +||+|||+|+...-.. ......++|..|+|||++.+. .|+...||||+||+
T Consensus 136 ~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~---~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 136 LHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPM---RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred HHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCCc---ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 99999999999999999988776 8999999999664222 123445689999999999987 58999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHc------------------cCcccc------------cCCCHHHHHHHHHccccCc
Q 004442 701 LFFCITGGKHPYGESFERDANIVKD------------------RKDLFL------------VEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~~~~i~~------------------~~~~~~------------~~~s~el~dLI~~cL~~DP 750 (753)
+.||++++.++-+.+...+...+.. .+..++ ....++..|++.+||+.||
T Consensus 211 faEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p 290 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDP 290 (323)
T ss_pred HHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCc
Confidence 9999998655555554343333221 011111 1123478999999999999
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
.+|
T Consensus 291 ~~R 293 (323)
T KOG0594|consen 291 AKR 293 (323)
T ss_pred ccC
Confidence 988
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.60 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=188.8
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.++|++.+.||+|+||.||++...++..||+|.+..... +.+.+|+. +++.++|+||+++++++. .+..+++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~-~~~~~lv~e-- 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQ-IMKKLRHDKLVQLYAVVS-EEPIYIVTE-- 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHH-HHHhcCCCceEEEEeEEC-CCCcEEEEE--
Confidence 346778899999999999999888888999999975332 33445554 788999999999999875 456899999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.++++... ...+++.++++++.+++.||+|||+.+|+|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H 125 (260)
T cd05070 81 --------YMSKGSLLDFLKDGE---------------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIH 125 (260)
T ss_pred --------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 888888888876421 234778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++ .++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++++.
T Consensus 126 ~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~ 201 (260)
T cd05070 126 RDLRSANILVGDGL--VCKIADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201 (260)
T ss_pred CCCccceEEEeCCc--eEEeCCceeeeeccCcccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCC
Confidence 99999999997765 5999999999876532211 1112235678999999988889999999999999999999557
Q ss_pred CCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||.+... .....+... ....+...+.++.++|.+||.+||++|
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05070 202 VPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247 (260)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccC
Confidence 88866433 233333322 334456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=308.67 Aligned_cols=236 Identities=22% Similarity=0.354 Sum_probs=183.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... .++.+|+|.+.+.. ....++++..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5788899999999999998765 47899999986421 22334555557788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.++++.. ...+++..+..++.||+.||.|||+.+|
T Consensus 82 ----------y~~~g~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i 123 (332)
T cd05623 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVIAIDSVHQLHY 123 (332)
T ss_pred ----------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 88889999888542 1346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~ 702 (753)
+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|
T Consensus 124 iHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 124 VHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred EecCCCHHHEEECCCCC--EEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence 99999999999976654 99999999976543211 1223356999999999986 345789999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccC--ccc---ccCCCHHHHHHHHHccccCcCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRK--DLF---LVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~--~~~---~~~~s~el~dLI~~cL~~DP~~ 752 (753)
||++| +.||... .......+.... ..+ ....++++.+||++||..+|++
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 200 EMLYG-ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHR 254 (332)
T ss_pred HHhcC-CCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhh
Confidence 99998 5666543 334444443322 112 2356899999999999765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.34 Aligned_cols=232 Identities=25% Similarity=0.380 Sum_probs=182.9
Q ss_pred EecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChh
Q 004442 480 EIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~ 554 (753)
.||+|+||.||++... +++.||+|.+..... ..+.+|+ ++++.++|+||++++++|.+.+..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e------- 73 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEA-RILKQYSHPNIVRLIGVCTQKQPIYIVME------- 73 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEcCCCCeEEEEe-------
Confidence 5999999999998765 689999998865432 2344454 47889999999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp 634 (753)
|..+|+|.++++.. ...+++.+++.++.|++.||+|||+.+|+||||||
T Consensus 74 ---~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p 122 (252)
T cd05084 74 ---LVQGGDFLTFLRTE----------------------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122 (252)
T ss_pred ---eccCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccch
Confidence 77888888887532 12467888999999999999999999999999999
Q ss_pred CcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004442 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 635 ~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~ 714 (753)
+||+++.++. +||+|||++........ ........++..|+|||.+.+..++.++|||||||++|||++++.+||..
T Consensus 123 ~nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 123 RNCLVTEKNV--LKISDFGMSREEEDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred heEEEcCCCc--EEECccccCcccccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 9999977654 99999999876543211 11111122356799999999999999999999999999999855888865
Q ss_pred ChHHH-HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 715 SFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 715 ~~~~~-~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..... ...+. ......+..++.++.+++++||+.||++|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (252)
T cd05084 200 LSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQR 240 (252)
T ss_pred cCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 54332 22222 23345566778999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=299.72 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=192.6
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+.|.+.+.||+|+||.||++... ++..+|+|.+..... ....+|++ +++.++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccE
Confidence 56788899999999999998642 356799999875432 23445554 788999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.........+. .......+++.++++++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~----------------~~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 84 MVFE----------YMKHGDLNKFLRAHGPDAVLMA----------------EGNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred EEEE----------cCCCCCHHHHHHHcCCcccccc----------------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 8888888888865432111100 0012235899999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+++||||||+||+++.++ .+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++||
T Consensus 138 ~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENL--LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred hCCeeecccCcceEEEccCC--cEEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 99999999999999997765 499999999986643211 111223345788999999998889999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++.+||..... .....+.... ...+..+++++.+|+.+||+.||.+|
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 266 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMR 266 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99944778866533 3333333333 33455678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=294.38 Aligned_cols=237 Identities=24% Similarity=0.371 Sum_probs=188.6
Q ss_pred eEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.|.+.+.||+|+||.||++....+..+|+|.+.... ...+.+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e---- 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK-VMMKLSHPNLVQLYGVCTKQRPIFIVTE---- 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEEEEEEEEcCCCceEEEEe----
Confidence 466778899999999999987777899999986543 234455555 7788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.++++... ..+++..+++++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 125 (256)
T cd05059 80 ------YMANGCLLNYLRERK----------------------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125 (256)
T ss_pred ------cCCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 888888888875321 2467888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++. +||+|||+++....... .......++..|+|||.+.+..++.++||||||+++||+++++.+|
T Consensus 126 l~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 126 LAARNCLVGEDNV--VKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccHhhEEECCCCc--EEECCcccceecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence 9999999977654 99999999986643211 1111112356799999999999999999999999999999965888
Q ss_pred CCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|..... .....+... ....+..+++++.+++.+||..+|++|
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 245 (256)
T cd05059 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDR 245 (256)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 865433 233333332 234456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.55 Aligned_cols=229 Identities=22% Similarity=0.292 Sum_probs=177.9
Q ss_pred EecccCceEEEEEEeeC-------------CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 480 EIAKGSNGTVVLEGNYE-------------GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~-------------g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.||+|+||.||+|.... ...||+|.+..... ...+.|+..++..++||||+++++++.++...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999986421 33689998865432 2344555568899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
+|| |+.+|+|..+++.. ...+++..+++++.||+.||+|||+
T Consensus 82 v~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 123 (262)
T cd05077 82 VEE----------FVEFGPLDLFMHRK----------------------------SDVLTTPWKFKVAKQLASALSYLED 123 (262)
T ss_pred EEe----------cccCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhh
Confidence 999 77788887776432 2347778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCC-----CeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-CCCCCchhhHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLG 698 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~-----~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIwSfG 698 (753)
.+|+||||||+|||++.++. ..++++|||++...... ....++..|+|||.+. +..++.++||||||
T Consensus 124 ~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (262)
T cd05077 124 KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSFG 196 (262)
T ss_pred CCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHHH
Confidence 99999999999999976542 13899999998755321 2234788999999886 46689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++++..|+......................++++.+||.+||+.||++|
T Consensus 197 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 251 (262)
T cd05077 197 TTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQR 251 (262)
T ss_pred HHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhC
Confidence 9999998655788876543333333333333344456889999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.25 Aligned_cols=238 Identities=19% Similarity=0.279 Sum_probs=181.0
Q ss_pred eecceEEEeEEecccCceEEEEEEee---CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
....+|.+.+.||+|+||.||++... .+..||||.+.... ...+|+. +++.++|+||+++++++......+++|
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--~~~~E~~-il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--TPGREID-ILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--cHHHHHH-HHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 34567999999999999999998543 46789999986542 3345665 778999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|++. ++|.+++. ....+++.+++.++.||+.||.|||+.+
T Consensus 166 e~~~-----------~~l~~~l~-----------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~g 205 (392)
T PHA03207 166 PKYK-----------CDLFTYVD-----------------------------RSGPLPLEQAITIQRRLLEALAYLHGRG 205 (392)
T ss_pred hhcC-----------CCHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9544 34555441 1245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 206 ivHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~ 282 (392)
T PHA03207 206 IIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDT-PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV 282 (392)
T ss_pred ccccCCCHHHEEEcCCCC--EEEccCccccccCccccc-ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999977765 999999999876543211 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCChH----HHHHHHHc--------------------------cCc--cc-----ccCCCHHHHHHHHHccccC
Q 004442 707 GGKHPYGESFE----RDANIVKD--------------------------RKD--LF-----LVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 707 G~~~Pf~~~~~----~~~~~i~~--------------------------~~~--~~-----~~~~s~el~dLI~~cL~~D 749 (753)
|+.++++.... ....++.. ... .. ...++.+++++|++||..|
T Consensus 283 g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~d 362 (392)
T PHA03207 283 KNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFD 362 (392)
T ss_pred CCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccC
Confidence 96555443211 11111100 000 00 1234568899999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 363 p~~R 366 (392)
T PHA03207 363 QEFR 366 (392)
T ss_pred hhhC
Confidence 9998
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=322.24 Aligned_cols=233 Identities=31% Similarity=0.429 Sum_probs=191.8
Q ss_pred EecccCceEEEEEEeeC-CcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhhH
Q 004442 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~l 556 (753)
+||+|.||+||-|++.+ ...+|||-+.... ..+.++|+..+-+.++|+|||+.+|.|.+++++-+.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME--------- 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME--------- 652 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee---------
Confidence 49999999999987765 5689999986443 33556666668899999999999999999999999999
Q ss_pred HHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 004442 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636 (753)
Q Consensus 557 iy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~N 636 (753)
.+++|||.+.|+.+ |..-.-.+..+-.+.+||+.||.|||++.|||||||-+|
T Consensus 653 -qVPGGSLSsLLrsk--------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 653 -QVPGGSLSSLLRSK--------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred -cCCCCcHHHHHHhc--------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 99999999999764 433333667778889999999999999999999999999
Q ss_pred EEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004442 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 637 ILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSfGvvL~EllTG~~~Pf~~ 714 (753)
||++.-. ..+||+|||-++.+..-. .-+.+..||..|||||++..++ |+.++|||||||.+.||.|| +|||-+
T Consensus 706 VLvNTyS-GvlKISDFGTsKRLAgin---P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG-rPPF~E 780 (1226)
T KOG4279|consen 706 VLVNTYS-GVLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG-RPPFVE 780 (1226)
T ss_pred EEEeecc-ceEEecccccchhhccCC---ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC-CCCeee
Confidence 9997654 469999999999886532 2345667999999999998765 89999999999999999999 677755
Q ss_pred ChHHHH--HHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 715 SFERDA--NIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 715 ~~~~~~--~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
....+. .++- ...++.|.+++.+++.||.+|+.+||.+|
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R 823 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDR 823 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccC
Confidence 433322 2222 23467788899999999999999999987
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.00 Aligned_cols=239 Identities=27% Similarity=0.384 Sum_probs=189.1
Q ss_pred ceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
++|++.+.||+|+||.||+|.... ...||||.++..... .+.+|+. +++.++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEAS-IMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCcceEeEEEecCCceEE
Confidence 457888999999999999987643 468999998654322 3344554 7789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
+|| |+++|+|.+++... ...+++.++++++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 83 ITE----------YMENGSLDKFLREN----------------------------DGKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred EEE----------cCCCCCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 88888998887542 1257788899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++. ++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||
T Consensus 125 ~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CCcccCCCCcceEEEcCCCC--EEECccchhhcccccccc-eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 99999999999999977654 999999999987522111 111223356789999999988999999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+..||.+. .......+.. ...+.+..+++++.+++.+||+.||++|
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 252 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNER 252 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 98336677554 3333333333 2334566778999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.93 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=187.1
Q ss_pred EEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCce-----
Q 004442 476 VFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF----- 541 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~----- 541 (753)
.+.+.||+|+||.||+|.... +..||||+++.... ..+.+|+. .++.++|+||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAA-CMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHH-HHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456889999999999987653 47899999875321 23445554 7788999999999999876554
Q ss_pred -EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 542 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 542 -~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.++++| |+++|+|..++...... .....+++..++.++.|++.||+
T Consensus 81 ~~~~v~e----------~~~~~~l~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 81 KPMVILP----------FMKHGDLHSFLLYSRLG-----------------------GLPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred ccEEEEe----------ccCCCCHHHHHHHhhcc-----------------------CCcccCCHHHHHHHHHHHHHHHH
Confidence 799999 88899999888654321 11235788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||++++++ .+||+|||+++.+....... ......++..|+|||.+.+..++.++|||||||+
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~i 204 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDM--TVCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204 (273)
T ss_pred HHHhCCeeccccchheEEECCCC--eEEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHH
Confidence 99999999999999999997765 49999999998765432211 1112234678999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~-~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++.+||.+..... ...+. ......+..+++++.++|.+||+.||++|
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 259 (273)
T cd05035 205 MWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDR 259 (273)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhC
Confidence 9999995578886654332 22222 23444567788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.21 Aligned_cols=240 Identities=25% Similarity=0.363 Sum_probs=190.2
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..+.|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+|+ .+++.++|+||+++++++. .+..+++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~-~~~~~~v~e- 80 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEA-NLMKQLQHPRLVRLYAVVT-QEPIYIITE- 80 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHH-HHHHhcCCcCeeeEEEEEc-cCCcEEEEE-
Confidence 3467888999999999999999988899999999975432 3444555 4889999999999999864 567899999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.... ...+++.+++.++.|++.||+|||+.+++
T Consensus 81 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~ 124 (260)
T cd05067 81 ---------YMENGSLVDFLKTPE---------------------------GIKLTINKLIDMAAQIAEGMAFIERKNYI 124 (260)
T ss_pred ---------cCCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence 778888888775321 23577888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||+++.++. ++|+|||++........ .......++..|+|||.+....++.++||||||+++||+++++
T Consensus 125 H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 125 HRDLRAANILVSETLC--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred cccccHHhEEEcCCCC--EEEccCcceeecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence 9999999999977654 99999999987653211 1112233577899999998888999999999999999999944
Q ss_pred CCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||.+... .....+... ....+...+.++.++|.+||+.||++|
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05067 201 RIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEER 247 (260)
T ss_pred CCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 788865543 233333322 334455677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.15 Aligned_cols=229 Identities=22% Similarity=0.254 Sum_probs=178.5
Q ss_pred EecccCceEEEEEEeeC-------------------------CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeee
Q 004442 480 EIAKGSNGTVVLEGNYE-------------------------GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRW 532 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~-------------------------g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L 532 (753)
.||+|+||.||+|.... ...||+|++..... ...+.++..+++.++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 49999999999986421 24689999865432 2334455568899999999999
Q ss_pred cccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHH
Q 004442 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612 (753)
Q Consensus 533 ~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia 612 (753)
+|+|.+....++||| |+.+|+|..++... ...+++..+++++
T Consensus 82 ~~~~~~~~~~~lv~e----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~ 123 (274)
T cd05076 82 HGVCVRGSENIMVEE----------FVEHGPLDVCLRKE----------------------------KGRVPVAWKITVA 123 (274)
T ss_pred EEEEEeCCceEEEEe----------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHH
Confidence 999999999999999 88888888877532 2346788889999
Q ss_pred HHHHHHHHHhhhCCccccCCCCCcEEEecCCC-----CeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-C
Q 004442 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-G 686 (753)
Q Consensus 613 ~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~-----~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~ 686 (753)
.||++||+|||+.+|+||||||+|||++.++. ..+|++|||++...... ....++..|+|||.+.+ .
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCC
Confidence 99999999999999999999999999976432 24799999988654321 12346888999998876 5
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 687 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 687 ~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++.++|||||||++||+++++.+||..................+...++++.++|.+||+.||++|
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 263 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQR 263 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhC
Confidence 5899999999999999996545788876544333333333444555667899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.52 Aligned_cols=234 Identities=26% Similarity=0.381 Sum_probs=191.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|...+.||+|+||.||+|.+. .++.||+|++.-...+ +..+|+. +++..+|+||.+++|.+..+..++++||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~-~Ls~~~~~~it~yygsyl~g~~LwiiMe- 91 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEIS-VLSQCDSPNITEYYGSYLKGTKLWIIME- 91 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHH-HHHhcCcchHHhhhhheeecccHHHHHH-
Confidence 3455588999999999999654 5899999999654332 3334444 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|++.+.|... ..+++..+.-|++++..||.|||.++.+
T Consensus 92 ---------y~~gGsv~~lL~~~-----------------------------~~~~E~~i~~ilre~l~~l~ylH~~~ki 133 (467)
T KOG0201|consen 92 ---------YCGGGSVLDLLKSG-----------------------------NILDEFEIAVILREVLKGLDYLHSEKKI 133 (467)
T ss_pred ---------HhcCcchhhhhccC-----------------------------CCCccceeeeehHHHHHHhhhhhhccee
Confidence 88889988887532 2235566678899999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|||||+.|||+..++. +||+|||.+..+.... ....+.+||+.|||||++++..|+.|+||||||+..+||++|
T Consensus 134 HrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G- 207 (467)
T KOG0201|consen 134 HRDIKAANILLSESGD--VKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG- 207 (467)
T ss_pred cccccccceeEeccCc--EEEEecceeeeeechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC-
Confidence 9999999999988865 9999999998886543 233678899999999999998999999999999999999999
Q ss_pred CCCCCCChH-HHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||+.+..+ +....+ ++..+.....+++.+++||..||++||+.|
T Consensus 208 ePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~R 254 (467)
T KOG0201|consen 208 EPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFR 254 (467)
T ss_pred CCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 889977654 222222 233334445788999999999999999998
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=296.53 Aligned_cols=238 Identities=23% Similarity=0.319 Sum_probs=193.1
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
..|.+.+.||+|+||.||+|...+++.+|+|.+..... ....+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e-- 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQ-ALKRLRHKHLISLFAVCSVGEPVYIITE-- 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHH-HHhcCCCcchhheeeeEecCCCeEEEEe--
Confidence 45777889999999999999888899999999975543 33444554 7789999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.++++... ...+++.++++++.|++.||.|||+.+|+|
T Consensus 83 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h 127 (261)
T cd05148 83 --------LMEKGSLLAFLRSPE---------------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIH 127 (261)
T ss_pred --------ecccCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 888888888876432 234678889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||++......... .....++..|+|||.+.+..++.++||||||+++|+|+++++
T Consensus 128 ~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~ 202 (261)
T cd05148 128 RDLAARNILVGEDLV--CKVADFGLARLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQ 202 (261)
T ss_pred cccCcceEEEcCCce--EEEccccchhhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999977754 999999999876433211 113345778999999988889999999999999999999558
Q ss_pred CCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||...... ....+.. ...+.+...++++.++|.+||++||++|
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05148 203 VPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDR 248 (261)
T ss_pred CCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 888765432 3333332 2345566788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=298.50 Aligned_cols=231 Identities=29% Similarity=0.449 Sum_probs=191.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.|.+.+.||+|+||.||++... +++.||+|.+.... .+...+|+. +++.++|+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKR-ILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 5788899999999999998765 58999999986432 123344544 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++... ..+++..+..++.|++.||.|||+.+
T Consensus 81 e----------~~~~~~L~~~~~~~-----------------------------~~l~~~~~~~~~~qil~~l~~lH~~~ 121 (290)
T cd05580 81 E----------YVPGGELFSHLRKS-----------------------------GRFPEPVARFYAAQVVLALEYLHSLD 121 (290)
T ss_pred e----------cCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 77778888776432 35778888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+|+||+|+||+++.++. +||+|||+++..... .....|++.|+|||.+.+...+.++||||||+++|+|++
T Consensus 122 i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 193 (290)
T cd05580 122 IVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193 (290)
T ss_pred EecCCCCHHHEEECCCCC--EEEeeCCCccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999977764 999999999876433 233458999999999988889999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||.... ......+.......+..+++++.++|++||..||++|
T Consensus 194 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 240 (290)
T cd05580 194 G-YPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240 (290)
T ss_pred C-CCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHc
Confidence 8 66775543 3334444555666777889999999999999999988
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.81 Aligned_cols=235 Identities=24% Similarity=0.366 Sum_probs=182.1
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||+||++... +++.||||.+.+.. ....++++..++..++|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5788899999999999998765 58999999986421 12334455557888999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (331)
T cd05597 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVLAIDSVHQLGY 123 (331)
T ss_pred ----------cCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 78888998887532 2347778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----CCCCchhhHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIwSfGvvL~ 702 (753)
+||||||+|||++.++. +||+|||++........ .......||+.|+|||++.. ..++.++|||||||++|
T Consensus 124 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCCCC--EEEEECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 99999999999977765 99999999976643221 11123458999999999863 45788999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccC--c---ccccCCCHHHHHHHHHccccCcC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRK--D---LFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~--~---~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
||++| +.||... .......+.... . .....++++++++|++||..+++
T Consensus 200 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~ 253 (331)
T cd05597 200 EMLYG-ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPET 253 (331)
T ss_pred HHhhC-CCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCccc
Confidence 99998 5677554 333333333221 1 12234688999999999976443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.54 Aligned_cols=240 Identities=27% Similarity=0.382 Sum_probs=198.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc------hHHHHHHHHHHHhCC-CCceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH------DVALKEIQNLIASDQ-HPNIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~ 540 (753)
..+...|.+.+.||+|.||.||++.... |+.+|+|.+.+... +...+|+. +|..+. |||||.+.+.+.+..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~-il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVA-ILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHH-HHHhccCCCCEEEEEEEEEcCC
Confidence 4456778899999999999999997665 99999999976432 35566766 667777 999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| +..+|.|.+.+... .+++..+..++.|++.++.
T Consensus 110 ~~~lvmE----------L~~GGeLfd~i~~~------------------------------~~sE~da~~~~~~il~av~ 149 (382)
T KOG0032|consen 110 SVYLVME----------LCEGGELFDRIVKK------------------------------HYSERDAAGIIRQILEAVK 149 (382)
T ss_pred eEEEEEE----------ecCCchHHHHHHHc------------------------------cCCHHHHHHHHHHHHHHHH
Confidence 9999999 55578888776431 2677888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCC--CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~--~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|||+.||+||||||+|+|+..... ..+|++|||++..... .......+||+.|+|||++....|+..+||||+|
T Consensus 150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G 225 (382)
T KOG0032|consen 150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG 225 (382)
T ss_pred HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence 999999999999999999976543 4699999999998765 2234567899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|.|++|..|+++.........+......+ ...++..++++|++||.+||.+|
T Consensus 226 vi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R 284 (382)
T KOG0032|consen 226 VILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKR 284 (382)
T ss_pred HHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccC
Confidence 99999999955444555555555666665443 44567899999999999999988
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=300.84 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=189.5
Q ss_pred EEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
|.+.+.||+|+||.||+|.... ++.||||++...... ..+.++..++..++|+||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4556789999999999987543 578999999754322 2344444578899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| |..+++|.+++.......... .. .........+++..+++++.|++.||+|||+.
T Consensus 87 ~e----------~~~~~~l~~~l~~~~~~~~~~------------~~-~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~ 143 (283)
T cd05091 87 FS----------YCSHSDLHEFLVMRSPHSDVG------------ST-DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH 143 (283)
T ss_pred EE----------cCCCCcHHHHHHhcCCCcccc------------cc-ccccccccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 99 666777777775332111000 00 00001234588889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. +||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||+
T Consensus 144 gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 144 HVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred CccccccchhheEecCCCc--eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 9999999999999977654 99999999887643221 11122334678999999998888999999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+||.+... .....+.... ...+..++.++.+++.+||+.||++|
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05091 221 SYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRR 270 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccC
Confidence 955778866533 3333333333 34566788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=294.90 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=193.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|.+.+.||+|+||.||++.... +..||+|.+...... ...+|+ .+++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA-SVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEcCCCC
Confidence 3568888999999999999986643 478999998654321 233444 47788999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+++|+|.+++......... ......+++..++.++.|++.||.|
T Consensus 84 ~~~v~e----------~~~~~~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 84 TLVVME----------LMAKGDLKSYLRSRRPEAEN-------------------NPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred cEEEEe----------cCCCCCHHHHHHhcccchhh-------------------ccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 77788888888653321100 0123457888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+||+++.++. +||+|||+++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 135 lH~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 135 LAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred HHhCCccccccChheEEEcCCCC--EEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 99999999999999999977765 99999999986643321 1122334568899999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|++.+||..... .....+.. .....+..++.++.++|.+||+.||++|
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMR 265 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999944778865433 33333332 2344567788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=293.40 Aligned_cols=231 Identities=23% Similarity=0.338 Sum_probs=179.7
Q ss_pred ecccCceEEEEEEee---CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||+|... .+..||||++...... .+.+|+. +++.++|+||++++++|. .+..++|||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~-~~~~~lv~e------ 74 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAE-IMHQLDNPYIVRMIGVCE-AEALMLVME------ 74 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHH-HHHhcCCCCeEEEEEEEc-CCCeEEEEE------
Confidence 899999999998653 3567999998654322 2334444 788899999999999885 457899999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.+++... ...+++..+++++.|++.||+|||+.+++|||||
T Consensus 75 ----~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 122 (257)
T cd05115 75 ----MASGGPLNKFLSGK----------------------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLA 122 (257)
T ss_pred ----eCCCCCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccc
Confidence 88888888887532 2357888999999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++ .+||+|||+++................++..|+|||.+....++.++|||||||++||+++.+.+||.
T Consensus 123 p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 123 ARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred hheEEEcCCC--cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 9999997665 49999999998664432221212222346789999999888899999999999999999973377887
Q ss_pred CChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.... ....+.. .....+...++++.++|.+||..||++|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~R 242 (257)
T cd05115 201 KMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDR 242 (257)
T ss_pred cCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 65433 3333333 3344566778999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.82 Aligned_cols=195 Identities=26% Similarity=0.392 Sum_probs=161.3
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|++.+.||+|+||.||++... ++..+|+|.+..... ....+|+. +++.++|+||++++++|.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 56788899999999999998765 588999998865422 23445554 7789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-C
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 626 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~ 626 (753)
|+.+|+|.+++... ..+++..+..++.+++.||.|||+. +
T Consensus 84 ----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 84 ----------HMDGGSLDQVLKKA-----------------------------GRIPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred ----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 77788888887432 3467778899999999999999975 7
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||++....... .....|+..|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred EEecCCChhhEEEcCCCC--EEEeeCCcchhhhhhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999977765 9999999987653321 123458999999999998889999999999999999999
Q ss_pred CCCCCCCCC
Q 004442 707 GGKHPYGES 715 (753)
Q Consensus 707 G~~~Pf~~~ 715 (753)
| +.||...
T Consensus 198 g-~~p~~~~ 205 (333)
T cd06650 198 G-RYPIPPP 205 (333)
T ss_pred C-CCCCCCc
Confidence 8 5677543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=291.57 Aligned_cols=238 Identities=24% Similarity=0.371 Sum_probs=187.6
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
++|.+.+.||+|++|.||++....+..+|+|++..... +...+|+. +++.++|+||+++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~-~~~~~~v~e--- 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQ-IMKKLRHDKLVPLYAVVS-EEPIYIVTE--- 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHH-HHHhCCCCCeeeEEEEEc-CCCcEEEEE---
Confidence 45788899999999999999887777899999865432 33445554 788999999999999875 456899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.++++... ...+++..+..++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05069 81 -------FMGKGSLLDFLKEGD---------------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126 (260)
T ss_pred -------cCCCCCHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 778888888875421 1346788889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .++|+|||+++....... .......++..|+|||...+..++.++|||||||++|||+|++.+
T Consensus 127 dl~~~Nill~~~~--~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 127 DLRAANILVGDNL--VCKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCcceEEEcCCC--eEEECCCccceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999997665 499999999987643221 111222357789999999888899999999999999999995578
Q ss_pred CCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.+.... ....+... ....+...+.++.++|++||++||++|
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (260)
T cd05069 203 PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDER 247 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccC
Confidence 88765433 33333322 233456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=333.35 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=189.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|.+.+.||+|+||.||+|... .|+.||||++.... .+.+.+|+ .+++.++||||+++++++.+.+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi-~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA-KIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHH-HHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 46888999999999999999765 58999999986432 12334454 478999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++........ .. .......++..+++++.||++||+|||+.
T Consensus 81 ME----------Y~eGGSL~~lL~s~~~~~~-l~-----------------e~~~~~lsv~~iL~I~~QIa~AL~yLHs~ 132 (932)
T PRK13184 81 MP----------YIEGYTLKSLLKSVWQKES-LS-----------------KELAEKTSVGAFLSIFHKICATIEYVHSK 132 (932)
T ss_pred EE----------cCCCCCHHHHHHHhhhccc-cc-----------------hhhhcccCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 8888899888864321110 00 01123467788899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc---------------ccccCccCCCCccccccccccCCCCCc
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---------------CLTQNATGYGSSGWQAPEQLLQGRQTR 690 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~---------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ 690 (753)
+|+||||||+||+++.++. +||+|||+++....... ........+||+.|+|||++.+..++.
T Consensus 133 GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 133 GVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred CccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 9999999999999987765 89999999987622110 111122346999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccC----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||||||++|||+|| ..||............... .......++.+.+++.+||+.||++|
T Consensus 211 kSDIWSLGVILyELLTG-~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR 276 (932)
T PRK13184 211 STDIYALGVILYQMLTL-SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276 (932)
T ss_pred HhHHHHHHHHHHHHHHC-CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999 6687654322111111111 11124678899999999999999998
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.31 Aligned_cols=195 Identities=27% Similarity=0.405 Sum_probs=155.6
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.++|.+.+.||+|+||.||++... .++.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHH-HHHhcCCCCccccceeecccccccc
Confidence 4567899999999999999998754 58999999986432 223445554 77899999999999987543
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...|+||||++++|.+++ . ..+++..+..++.|++.|
T Consensus 101 ~~~~~lv~e~~~~~l~~~~-----------~-------------------------------~~~~~~~~~~~~~qi~~a 138 (364)
T cd07875 101 FQDVYIVMELMDANLCQVI-----------Q-------------------------------MELDHERMSYLLYQMLCG 138 (364)
T ss_pred cCeEEEEEeCCCCCHHHHH-----------H-------------------------------hcCCHHHHHHHHHHHHHH
Confidence 357999996655443322 1 135567778999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++||||||
T Consensus 139 L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 212 (364)
T cd07875 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 212 (364)
T ss_pred HHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHH
Confidence 99999999999999999999977754 9999999998654321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGES 715 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~ 715 (753)
|++|||++| +.||...
T Consensus 213 ~il~ell~g-~~pf~~~ 228 (364)
T cd07875 213 CIMGEMIKG-GVLFPGT 228 (364)
T ss_pred HHHHHHHhC-CCCCCCC
Confidence 999999999 6677543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=296.81 Aligned_cols=250 Identities=20% Similarity=0.293 Sum_probs=190.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
..++|.+.+.||+|+||.||+|... .+..||+|.+...... ...+| ...++.++|+||+++++++.+.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE-ASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHH-HHHHHhCCCCCeeeEEEEEcCCC
Confidence 3467889999999999999998543 2568999988644321 22334 34778999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++......... ........+..+.+++.|++.||.
T Consensus 83 ~~~lv~e----------~~~~g~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~ 133 (288)
T cd05061 83 PTLVVME----------LMAHGDLKSYLRSLRPEAEN-------------------NPGRPPPTLQEMIQMAAEIADGMA 133 (288)
T ss_pred CcEEEEe----------CCCCCCHHHHHHHhcccccc-------------------CCCCCCCCHHHHHHHHHHHHHHHH
Confidence 9999999 88889999988654321100 011234567788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++ .++|+|||+++....... ........++..|+|||.+.+..++.++|||||||+
T Consensus 134 ~lH~~~i~H~dikp~nili~~~~--~~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~ 210 (288)
T cd05061 134 YLNAKKFVHRDLAARNCMVAHDF--TVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210 (288)
T ss_pred HHHhCCCcCCCCChheEEEcCCC--cEEECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence 99999999999999999997665 499999999986543221 111222345778999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~-~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++.+||....... ...+. ......+...++++.++|.+||+.||++|
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (288)
T cd05061 211 LWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMR 265 (288)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 9999996678887654333 23222 23344556678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=289.83 Aligned_cols=241 Identities=26% Similarity=0.375 Sum_probs=192.8
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..++|.+.+.||+|+||.||++...+++.||||.+..... ....+|+. +++.++|+||+++++++.+....+++||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVTE- 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHH-HHhhCCCCCEeeeeeeeecCCceEEEEe-
Confidence 3467889999999999999999888889999999975432 33444544 7889999999999999999899999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++.... ...+++.++..++.+++.||.|||+.+++
T Consensus 82 ---------~~~~~~L~~~i~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~ 125 (261)
T cd05034 82 ---------YMSKGSLLDFLKSGE---------------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYI 125 (261)
T ss_pred ---------ccCCCCHHHHHhccc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 888888888875421 23577888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||||+||+++.++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++||++|++
T Consensus 126 h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g 201 (261)
T cd05034 126 HRDLAARNILVGENLV--CKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred cCCcchheEEEcCCCC--EEECccccceeccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCC
Confidence 9999999999977754 89999999987653211 1111222467899999999888999999999999999999944
Q ss_pred CCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||...... ....+... ....+...++++.+++.+||+.||++|
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (261)
T cd05034 202 RVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEER 248 (261)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 7888665433 23333322 334456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=315.80 Aligned_cols=197 Identities=18% Similarity=0.253 Sum_probs=152.4
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhC------CCCceeeecccccCC-c
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASD------QHPNIVRWYGVESDQ-D 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l------~HpNIV~L~g~~~~~-~ 540 (753)
..++|.+.+.||+|+||+||++... .++.||||+++... ......|++ ++..+ +|.+|+++++++... +
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQ-FMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHH-HHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 3578999999999999999999764 58899999996432 122233443 33443 355689999988754 5
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++|||++.+ +|.+++.. ...+++..+..|+.||+.||+
T Consensus 206 ~~~iv~~~~g~-----------~l~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~ 245 (467)
T PTZ00284 206 HMCIVMPKYGP-----------CLLDWIMK-----------------------------HGPFSHRHLAQIIFQTGVALD 245 (467)
T ss_pred eEEEEEeccCC-----------CHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 78999996544 44444421 235778888999999999999
Q ss_pred Hhhh-CCccccCCCCCcEEEecCCC--------------CeEEEEeccCceeccCCCcccccCccCCCCccccccccccC
Q 004442 621 HLHE-IGLIHRDLKPQNVLISKDKS--------------FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ 685 (753)
Q Consensus 621 yLH~-~~IiHrDLKp~NILL~~d~~--------------~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 685 (753)
|||+ .+||||||||+|||++.++. +.+||+|||++..... .....+||+.|+|||++.+
T Consensus 246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc
Confidence 9997 59999999999999976653 2589999998764321 1234578999999999999
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 686 GRQTRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 686 ~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
..++.++|||||||++|||+|| ++||...
T Consensus 320 ~~~~~~~DiwSlGvil~elltG-~~pf~~~ 348 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTG-KLLYDTH 348 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCC
Confidence 9999999999999999999998 6788654
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=292.40 Aligned_cols=237 Identities=27% Similarity=0.352 Sum_probs=186.5
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
|++.+.||+|+||.||+|...+|+.+|||.+..... ...+.++.+.++.++|+||++++++|.+.+..+++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 556788999999999999888899999998864321 122333334788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ..+++..+..++.|++.||+|||+.+
T Consensus 82 e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (265)
T cd06631 82 E----------FVPGGSISSILNRF-----------------------------GPLPEPVFCKYTKQILDGVAYLHNNC 122 (265)
T ss_pred e----------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 77788888887431 34677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc---ccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~---~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
|+|+||+|+||+++.++. ++|+|||++........ .........|+..|+|||.+.+..++.++|||||||++||
T Consensus 123 i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 123 VVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred cccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 999999999999976654 99999999886532111 1111223458999999999998889999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHHc---cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER-DANIVKD---RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~~i~~---~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||...... ....+.. .....+..+++++.++|++||..||++|
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 253 (265)
T cd06631 201 MATG-KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER 253 (265)
T ss_pred HHhC-CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccC
Confidence 9998 6677654322 2222221 2234566788999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=291.80 Aligned_cols=240 Identities=21% Similarity=0.355 Sum_probs=186.2
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---c---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---H---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.+|.+.+.||+|+||.||++... +++.||||.+.... . ....+|+. +++.++||||+++++++.+.+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEID-LLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCcceeeeeeeEEECCeEEEE
Confidence 46788999999999999999764 68999999875421 1 12344554 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| |+++|+|.+++..... ....+++..+++++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 81 LE----------LADAGDLSQMIKYFKK-------------------------QKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred EE----------ecCCCcHHHHHHHhhh-------------------------ccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 99 7778888887753221 123477888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+++|+||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||+
T Consensus 126 ~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 126 RVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CeeCCCCCHHHEEEcCCCC--EEECccccceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 9999999999999977765 89999999987653221 112345789999999999888999999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHHHHccC-ccc-ccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF--ERDANIVKDRK-DLF-LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~--~~~~~~i~~~~-~~~-~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+.+++.... ......+.... .+. ...++.++.++|.+||..||++|
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 252 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252 (267)
T ss_pred cCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccC
Confidence 99554333322 12222222222 122 23567889999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=297.57 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=191.4
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+++.+.+.||+|+||.||++... ++..+|+|.+..... ..+.+|+. +++.++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHH-HHhcCCCCCCceEEEEEecCCceE
Confidence 45677889999999999998532 467899998875432 23444544 788999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
++|| |+++|+|.++++........... ........+++..++.++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~~--------------~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 84 MVFE----------YMRHGDLNRFLRSHGPDAKILAG--------------GEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred EEEe----------cCCCCCHHHHHHhcCcchhhhcc--------------cccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77888888888654321111000 00012245788999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++ .+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 140 ~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGL--VVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HCCeecccccHhhEEEcCCC--CEEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 99999999999999997665 499999999986643221 111222335788999999999999999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++++.+||..... .....+.. .....+..+++++.++|.+||..||.+|
T Consensus 217 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 268 (280)
T cd05092 217 IFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQR 268 (280)
T ss_pred HHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99954788865433 33333333 3334556788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=299.63 Aligned_cols=238 Identities=26% Similarity=0.336 Sum_probs=206.2
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHH--HHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALK--EIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~--Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
-+.|.+.++||+|.||+|.+++.+ .|+.+|+|+++++-- ++.-+ -+.+.+...+||.+..|.-.+..++.+++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 466788899999999999987554 599999999986531 11111 122477888999999998888999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|.|+-+|... +.+++....-+...|+.||.|||++
T Consensus 247 Me----------yanGGeLf~HLsre-----------------------------r~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 247 ME----------YANGGELFFHLSRE-----------------------------RVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred EE----------EccCceEeeehhhh-----------------------------hcccchhhhhhhHHHHHHhhhhhhC
Confidence 99 99999999888643 3466667778899999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+||+||||.+|.||+.||+ +||.||||++. +........+.|||+.|.|||++....|++++|.|.+|||+|||+
T Consensus 288 ~ivYRDlKLENLlLDkDGH--IKitDFGLCKE---~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 288 NIVYRDLKLENLLLDKDGH--IKITDFGLCKE---EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred CeeeeechhhhheeccCCc--eEeeecccchh---cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 9999999999999999887 99999999975 344556678899999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+-|+|....++.+..+......+|...++|++.|+.-+|.+||++|
T Consensus 363 CGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kR 410 (516)
T KOG0690|consen 363 CGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKR 410 (516)
T ss_pred hccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhh
Confidence 997777788889999999999999999999999999999999999998
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=293.85 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=185.6
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+|.+.+.||+|+||+||+|... +|. .||+|.+...... ...+|+ .++..++|+||++++++|... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA-YVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHH-HHHHhcCCCCCceEEEEEcCC-CcE
Confidence 56788899999999999998643 444 4899998654322 233444 467889999999999999754 578
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+++| |+++|+|.++++.. ...+++..++.++.|++.||+|||
T Consensus 85 l~~~----------~~~~g~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH 126 (279)
T cd05109 85 LVTQ----------LMPYGCLLDYVREN----------------------------KDRIGSQDLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEE----------cCCCCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 8999 88899999887642 134778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++||
T Consensus 127 ~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05109 127 EVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203 (279)
T ss_pred HCCeeccccccceEEEcCCCc--EEECCCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHH
Confidence 999999999999999977654 8999999998775322111 1112234678999999998899999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++.+.+||+..... ....+... ....+..+++++.++|.+||+.||++|
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 255 (279)
T cd05109 204 LMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECR 255 (279)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 999447888765433 33333332 334456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.24 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=182.5
Q ss_pred EeEEecccCceEEEEEEeeCC---cEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC------ceE
Q 004442 477 FNKEIAKGSNGTVVLEGNYEG---RSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 542 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g---~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~------~~~ 542 (753)
+.+.||+|+||.||+|..... ..||||.++... .+.+.+|.. .++.++|+||++++++|... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAV-CMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 557899999999999976543 269999886432 122334444 77889999999999987532 246
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+++|| |+.+|+|.+++...... .....+++..++.++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~l~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 82 VVILP----------FMKHGDLHSFLLYSRLG-----------------------DCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred EEEEE----------eCCCCcHHHHHHHhccc-----------------------CCcccCCHHHHHHHHHHHHHHHHHH
Confidence 89999 88888988877433211 1123478889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++. +||+|||+++.+...... .......+++.|+|||...+..++.++|||||||++|
T Consensus 129 H~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 9999999999999999976654 999999999876543211 1112234577899999999999999999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++++..||..... .....+.... ...+..++.++.++|.+||++||++|
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDR 258 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 999955788865433 3333333332 24456778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=294.86 Aligned_cols=239 Identities=21% Similarity=0.275 Sum_probs=182.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCCchHHHHHHH---HHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~~~~~~~Ei~---~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+.|.+.+.||+|+||+||+|... +++ .+|+|.+........+.++. ..++.++|+||++++|++.+ ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35667788999999999998764 344 47888875443333333322 25678999999999999864 45788
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
++| |+++|+|.++++.. ...+++..+++++.||+.||+|||+
T Consensus 86 i~e----------~~~~gsL~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 127 (279)
T cd05111 86 VTQ----------LSPLGSLLDHVRQH----------------------------RDSLDPQRLLNWCVQIAKGMYYLEE 127 (279)
T ss_pred EEE----------eCCCCcHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 88899999988643 2347788999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++||||||+||+++.++ .+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++||+
T Consensus 128 ~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el 204 (279)
T cd05111 128 HRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204 (279)
T ss_pred CCEeccccCcceEEEcCCC--cEEEcCCccceeccCCCcc-cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 9999999999999997664 5999999999876433211 112234467899999999988999999999999999999
Q ss_pred HhCCCCCCCCChHH-HHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFER-DANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~-~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+..||.+.... ....+..... ..+..++.++.+++.+||..||++|
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 255 (279)
T cd05111 205 MSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVR 255 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 98337788665433 3344443332 2334456789999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=298.60 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=191.5
Q ss_pred cceEEEeEEecccCceEEEEEEee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
.+.|.+.+.||+|+||.||++... .+..+|+|.+...... ...+|+. ++..+ +|+||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEec
Confidence 467889999999999999998642 2357999999754322 3444554 56666 89999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+.+|+|.++++......... ...........+++.++++++.|++.|
T Consensus 96 ~~~~~lv~e----------~~~~~~L~~~i~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~a 152 (307)
T cd05098 96 DGPLYVIVE----------YASKGNLREYLRARRPPGMEY-------------CYNPTQVPEEQLSFKDLVSCAYQVARG 152 (307)
T ss_pred CCceEEEEe----------cCCCCcHHHHHHhcCCccccc-------------ccccccCccccCCHHHHHHHHHHHHHH
Confidence 999999999 778889998887543211000 000000123458889999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+++||||||+||+++.++ .+||+|||+++....... ........++..|+|||.+.+..++.++||||||
T Consensus 153 L~~lH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 229 (307)
T cd05098 153 MEYLASKKCIHRDLAARNVLVTEDN--VMKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229 (307)
T ss_pred HHHHHHCCcccccccHHheEEcCCC--cEEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHH
Confidence 9999999999999999999997765 499999999876643211 1111222345789999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHH-HHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFERD-ANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~-~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++++.+||....... ...+.... ...+...++++.++|.+||..+|++|
T Consensus 230 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 230 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred HHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 999999996578887654433 33333332 34556678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.77 Aligned_cols=234 Identities=27% Similarity=0.379 Sum_probs=185.0
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCceeeeccccc-CCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVES-DQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~L~g~~~-~~~~~~LV~E~c~ 550 (753)
+.|.+.+.||+|+||.||++.. .|..||+|.++...... +.+|+. +++.++|+||+++++++. +.+..+++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~lv~e--- 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCchHHHHHHHHH-HHHhCCCCCeeeEEEEEEcCCCceEEEEE---
Confidence 3567889999999999999865 47889999987654443 444544 789999999999999764 4567899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++++... ...+++..+++++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 126 (256)
T cd05082 81 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126 (256)
T ss_pred -------CCCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 778888888875421 1246788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +||+|||+++...... ....++..|+|||++.+..++.++|||||||++|||++.+++
T Consensus 127 dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~ 198 (256)
T cd05082 127 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred ccchheEEEcCCCc--EEecCCccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999977764 9999999988654321 122346789999999888899999999999999999984477
Q ss_pred CCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+... ....+..+++++.++|.+||++||++|
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05082 199 PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATR 243 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 88654332 22223222 333456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=306.00 Aligned_cols=195 Identities=26% Similarity=0.387 Sum_probs=155.2
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.++|.+.+.||+|+||.||++... .++.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHH-HHHHhCCCchhceeeeeeccccccc
Confidence 4567899999999999999998654 58999999996532 123445554 77889999999999987543
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...++|||+|.++ |.+.+. ..+++..+..++.|++.|
T Consensus 94 ~~~~~lv~e~~~~~-----------l~~~~~-------------------------------~~l~~~~~~~~~~qi~~a 131 (355)
T cd07874 94 FQDVYLVMELMDAN-----------LCQVIQ-------------------------------MELDHERMSYLLYQMLCG 131 (355)
T ss_pred cceeEEEhhhhccc-----------HHHHHh-------------------------------hcCCHHHHHHHHHHHHHH
Confidence 3579999955433 333321 235667788999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++||||||
T Consensus 132 L~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG 205 (355)
T cd07874 132 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_pred HHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHH
Confidence 99999999999999999999977765 9999999998654321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGES 715 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~ 715 (753)
|++|||++| +.||.+.
T Consensus 206 ~il~el~~g-~~pf~~~ 221 (355)
T cd07874 206 CIMGEMVRH-KILFPGR 221 (355)
T ss_pred HHHHHHHhC-CCCCCCC
Confidence 999999998 6677543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=295.58 Aligned_cols=235 Identities=26% Similarity=0.332 Sum_probs=180.1
Q ss_pred EEEeEEecccCceEEEEEE-----eeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC--ceEE
Q 004442 475 VVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 543 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~-----~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~ 543 (753)
|++.+.||+|+||+||++. ..++..||+|.+..... ..+.+|+. +++.++|+||++++++|.+. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN-ILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4788999999999998753 23578999999875432 23345554 78999999999999987653 4689
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
++|| |+.+|+|.+++.. ..+++.+++.++.|++.||.|||
T Consensus 85 lv~e----------~~~~~~l~~~~~~------------------------------~~l~~~~~~~i~~~l~~~l~~lH 124 (283)
T cd05080 85 LIME----------YVPLGSLRDYLPK------------------------------HKLNLAQLLLFAQQICEGMAYLH 124 (283)
T ss_pred EEec----------CCCCCCHHHHHHH------------------------------cCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7778888887642 24778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++ .+||+|||+++................++..|+|||.+.+..++.++||||||+++||
T Consensus 125 ~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~e 202 (283)
T cd05080 125 SQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202 (283)
T ss_pred HCCeeccccChheEEEcCCC--cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHH
Confidence 99999999999999997765 4999999999876543221111222345677999999988889999999999999999
Q ss_pred HHhCCCCCCCCChHHHHH----------------HHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERDAN----------------IVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~~~----------------~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| ..|+......... ... ....+.+..++.++.+++.+||+.||++|
T Consensus 203 l~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 268 (283)
T cd05080 203 LLTH-CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFR 268 (283)
T ss_pred HHhC-CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhC
Confidence 9998 5676543211110 011 11122345677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=289.08 Aligned_cols=235 Identities=24% Similarity=0.352 Sum_probs=187.8
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
|.+.+.||+|+||.||++... +++.+|+|.+.... .+...+|.. +++.++|+||+++++++.+++..+++||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVME-- 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEECCEEEEEEe--
Confidence 677899999999999998664 58999999985432 123344444 7789999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++.... ...+++..+++++.|++.||.|||+.+|+|
T Consensus 79 --------~~~~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 123 (255)
T cd08219 79 --------YCDGGDLMQKIKLQR---------------------------GKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123 (255)
T ss_pred --------eCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 777888888765321 234677888999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
+||||+||+++.++. ++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++| .
T Consensus 124 ~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~ 197 (255)
T cd08219 124 RDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL-K 197 (255)
T ss_pred CCCCcceEEECCCCc--EEEcccCcceeeccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc-c
Confidence 999999999977654 89999999987643221 11234578999999999988899999999999999999998 5
Q ss_pred CCCCCChH-HHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~-~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||..... .....+. ......+..++.++.++|.+||+.||++|
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 243 (255)
T cd08219 198 HPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243 (255)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccC
Confidence 67765433 2333332 23334566788899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=296.67 Aligned_cols=229 Identities=24% Similarity=0.318 Sum_probs=181.9
Q ss_pred EecccCceEEEEEEeeC--------CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 480 EIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.||+|+||.||++.... ...||+|.+..... .+.+.++..+++.++|+||+++++++...+..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e-- 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE-- 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe--
Confidence 59999999999986532 34588998865432 2344455558899999999999999999899999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.++++... ..+++..+++++.||+.||+|||+.+|+|
T Consensus 80 --------~~~~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~iiH 123 (258)
T cd05078 80 --------YVKFGSLDTYLKKNK----------------------------NLINISWKLEVAKQLAWALHFLEDKGLTH 123 (258)
T ss_pred --------cCCCCcHHHHHhcCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 778888988876432 24677788999999999999999999999
Q ss_pred cCCCCCcEEEecCCCC------eEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHH
Q 004442 630 RDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 702 (753)
Q Consensus 630 rDLKp~NILL~~d~~~------~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~ 702 (753)
|||||+||+++.++.. .++++|||++...... ....++..|+|||++.+. .++.++|||||||++|
T Consensus 124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 196 (258)
T cd05078 124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW 196 (258)
T ss_pred CCCccceEEEecccccccCCCceEEecccccccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence 9999999999877642 3799999998755321 223578899999999874 4799999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|+.+|+..................+...++++.++|.+||+.||++|
T Consensus 197 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 247 (258)
T cd05078 197 EIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFR 247 (258)
T ss_pred HHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhC
Confidence 999997778766544433333334445566677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=292.71 Aligned_cols=239 Identities=26% Similarity=0.382 Sum_probs=182.6
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhC-CCCceeeecccccCC------c
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGVESDQ------D 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~------~ 540 (753)
....|.+.+.||+|+||.||+|... .++.||+|++.... .....+|+. ++..+ +|+||+++++++.+. .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN-MLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHH-HHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3456777788999999999998765 58899999986543 234556665 45555 799999999998652 4
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++|| |+.+|+|.+++.... ...+++..+..++.|++.||+
T Consensus 83 ~~~iv~e----------~~~~~~L~~~l~~~~---------------------------~~~l~~~~~~~~~~qi~~~l~ 125 (272)
T cd06637 83 QLWLVME----------FCGAGSVTDLIKNTK---------------------------GNTLKEEWIAYICREILRGLS 125 (272)
T ss_pred EEEEEEE----------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 6899999 777888888775321 235778888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIw 695 (753)
|||+.+|+||||||+||+++.++. +||+|||+++...... .......|+..|+|||++. +..++.++|||
T Consensus 126 ~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 200 (272)
T cd06637 126 HLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200 (272)
T ss_pred HHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHH
Confidence 999999999999999999977654 9999999998764321 1223456899999999986 34578899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| ..||..... ......... .......+++++++||.+||..||++|
T Consensus 201 slGv~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 260 (272)
T cd06637 201 SLGITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 260 (272)
T ss_pred HHHHHHHHHHhC-CCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhC
Confidence 999999999999 556654322 222222211 122334567899999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=295.04 Aligned_cols=235 Identities=26% Similarity=0.371 Sum_probs=175.3
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHH--HHHhCCCCceeeecccccC-----Cc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVESD-----QD 540 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~L~g~~~~-----~~ 540 (753)
+|.+.+.||+|+||+||++... +|+.||+|.++... .....+|+.. .+..++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3678899999999999999765 58999999986432 1234455542 2344589999999998764 34
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++||+|.+ +|.+++... ....+++..+..++.|++.||.
T Consensus 81 ~~~lv~e~~~~-----------~l~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 81 KVTLVFEHVDQ-----------DLRTYLDKV---------------------------PPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred eEEEEEccccc-----------CHHHHHHhc---------------------------CCCCCCHHHHHHHHHHHHHHHH
Confidence 58999995543 454444321 1234788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++. +||+|||+++...... ......||..|+|||++.+..++.++|||||||+
T Consensus 123 ~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 123 FLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred HHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 999999999999999999987765 9999999998764321 1223457999999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHHHcc----------------C-----------cccccCCCHHHHHHHHHccccCcCC
Q 004442 701 LFFCITGGKHPYGESFER-DANIVKDR----------------K-----------DLFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~-~~~~i~~~----------------~-----------~~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
+|||++| .+||...... ....+... . ......+++++.++|.+||++||++
T Consensus 197 l~~l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (288)
T cd07863 197 FAEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHK 275 (288)
T ss_pred HHHHHhC-CcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCccc
Confidence 9999998 6677554322 11111110 0 0011345678999999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 276 R 276 (288)
T cd07863 276 R 276 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=292.21 Aligned_cols=233 Identities=32% Similarity=0.503 Sum_probs=181.3
Q ss_pred EEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCchHHH-----HHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~~~~-----~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|++.+.||+|+||+||++.... ++.||+|.+......... +|.. .+..++|+||+++++++.+.+..++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~v~~- 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIK-ILRRLRHPNIVQILDVFQDDNYLYIVME- 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHH-HHHHHTBTTBCHEEEEEEESSEEEEEEE-
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhh-cccccccccccccccccccccccccccc-
Confidence 6788999999999999997765 679999999876543322 2444 6777899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.. ...+++..++.++.|+++||+|||+.+|+
T Consensus 79 ---------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~ 120 (260)
T PF00069_consen 79 ---------YCPGGSLQDYLQK-----------------------------NKPLSEEEILKIAYQILEALAYLHSKGIV 120 (260)
T ss_dssp ---------EETTEBHHHHHHH-----------------------------HSSBBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------ccccccccccccc-----------------------------ccccccccccccccccccccccccccccc
Confidence 5556677766641 24567888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-CCCCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|+||||+||+++.++ .++|+|||.+..... .........++..|+|||++. +..++.++||||+|+++|+|++|
T Consensus 121 H~dikp~NIl~~~~~--~~~l~Dfg~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 121 HRDIKPENILLDENG--EVKLIDFGSSVKLSE---NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ESSBSGGGEEESTTS--EEEESSGTTTEESTS---TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHS
T ss_pred ccccccccccccccc--ccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999997665 489999999986522 112334456899999999998 78899999999999999999998
Q ss_pred CCCCCCCCh-HHHHHHH---HccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-ERDANIV---KDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-~~~~~~i---~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||.... ....... ........ ....+++.++|++||+.||++|
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 248 (260)
T PF00069_consen 196 -KLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQR 248 (260)
T ss_dssp -SSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGS
T ss_pred -ccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHC
Confidence 56777651 1111111 11111111 1123799999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=284.96 Aligned_cols=236 Identities=24% Similarity=0.394 Sum_probs=186.1
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC-CceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~~LV~E~ 548 (753)
|++.+.||+|++|.||++... +++.||+|++..... ...+.++..+++.++|+||+++++.+.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e- 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG- 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec-
Confidence 778899999999999998765 478999999864321 1223333347889999999999988764 456899999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++.... ...+++.++.+++.+++.||+|||+.+|+
T Consensus 81 ---------~~~~~~l~~~l~~~~---------------------------~~~l~~~~~~~~~~~l~~~l~~lH~~~i~ 124 (257)
T cd08223 81 ---------FCEGGDLYHKLKEQK---------------------------GKLLPENQVVEWFVQIAMALQYLHEKHIL 124 (257)
T ss_pred ---------ccCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 777888888875421 23578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||+++.++. ++|+|||++....... .......+++.|+|||++.+..++.++||||||+++||+++|
T Consensus 125 H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g- 198 (257)
T cd08223 125 HRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL- 198 (257)
T ss_pred ccCCCchhEEEecCCc--EEEecccceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC-
Confidence 9999999999977654 9999999998764321 122344589999999999999999999999999999999998
Q ss_pred CCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||.... ......+... ....+..+++++.++|.+||+.||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd08223 199 KHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKR 245 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccC
Confidence 56776543 2322223232 334556788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=289.61 Aligned_cols=239 Identities=24% Similarity=0.353 Sum_probs=185.8
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-C---cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-G---RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g---~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..|...+.||+|+||.||++.... + ..+|||.+..... +...+|+ .+++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEA-SIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 456778999999999999997753 3 3799999865432 2334454 47789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++++.. ...+++.+++.++.|++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~al~~lH~ 125 (268)
T cd05063 84 ITE----------YMENGALDKYLRDH----------------------------DGEFSSYQLVGMLRGIAAGMKYLSD 125 (268)
T ss_pred EEE----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 88888888887532 2346788889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++||||||+||+++.++ .+||+|||++..................+..|+|||.+....++.++|||||||++||+
T Consensus 126 ~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 126 MNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CCeeccccchhhEEEcCCC--cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 9999999999999997665 49999999998765432211111112235679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCC-hHHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 IT-GGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lT-G~~~Pf~~~-~~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++ | ..||... .......+... ..+.+...+.++.+++.+||..||++|
T Consensus 204 l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 254 (268)
T cd05063 204 MSFG-ERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARR 254 (268)
T ss_pred HhCC-CCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 98 6 6677543 33333333332 334445678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=290.40 Aligned_cols=229 Identities=23% Similarity=0.303 Sum_probs=178.3
Q ss_pred EEecccCceEEEEEEeeCCc-----------EEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 479 KEIAKGSNGTVVLEGNYEGR-----------SVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~-----------~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.||+|+||.||+|...+.. .|++|.+..... ...+.++..+++.++|+||++++|+|.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 35899999999999776533 588888765443 3444444458899999999999999988 7889999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.... ..+++..+++++.||+.||+|||+.+
T Consensus 80 e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 80 E----------YVKFGPLDVFLHREK----------------------------NNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred E----------cCCCCcHHHHHHhhc----------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9 888899988876431 25678888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCC-----eEEEEeccCceeccCCCcccccCccCCCCccccccccccCC--CCCchhhHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSF-----CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 699 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~-----~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGv 699 (753)
|+||||||+||+++.++.- .+||+|||++..... .....++..|+|||++.+. .++.++|||||||
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 9999999999999876521 599999999986543 1223467789999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++|+..||..................+.....++.++|.+||..||++|
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDPTKR 248 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHHHHHHHHhccChhhC
Confidence 999999976888866532222222222222223334799999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=293.66 Aligned_cols=239 Identities=26% Similarity=0.368 Sum_probs=181.8
Q ss_pred ceEEEeEEecccCceEEEEEEe-----eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccC--CceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-----~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~ 542 (753)
+.|++.+.||+|+||.||++.. .++..||||++...... .+.+|+. +++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIE-ILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEEEEccCCCCce
Confidence 4577889999999999999853 35889999998754422 3344554 7788999999999998754 4568
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.+++... ...+++..++.++.|++.||+||
T Consensus 83 ~lv~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~aL~~L 124 (284)
T cd05081 83 RLVME----------YLPYGSLRDYLQKH----------------------------RERLDHRKLLLYASQICKGMEYL 124 (284)
T ss_pred EEEEE----------ecCCCCHHHHHHhc----------------------------CcCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 88899999887532 12467888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++ .+||+|||+++................++..|+|||.+.+..++.++|||||||++|
T Consensus 125 H~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 125 GSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HHCCceeccCCHhhEEECCCC--eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 999999999999999997765 489999999987754322211112223455699999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHH-----------------HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFER-----------------DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~-----------------~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|.. ++...... ....+.. ...+.+..+++++.+||.+||..||++|
T Consensus 203 el~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05081 203 ELFTYSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQR 270 (284)
T ss_pred HHhhcCC-cCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999844 33221111 0111111 1223445678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.17 Aligned_cols=254 Identities=25% Similarity=0.366 Sum_probs=191.3
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+.|.+.+.||+|+||.||++... ++..+|+|++..... +.+.+|+. .++.++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCceE
Confidence 45778899999999999998643 356799999865442 23444544 788999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.++++..........+ .........+++..+++++.||+.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 84 MVFE----------YMKHGDLNKFLRAHGPDAMILVD-------------GQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEEe----------cCCCCcHHHHHHhcCcccccccc-------------cccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 88888888888654321100000 000011235789999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+++|+||||||+||+++.++ .++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++||
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~--~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANL--LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCCeeecccCcceEEEccCC--cEEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 99999999999999997665 599999999986543221 112223446789999999999999999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++..||..... .....+..... ..+...+.++.+++.+||++||++|
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 269 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQR 269 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhC
Confidence 99944778755433 33333333332 2345567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=289.66 Aligned_cols=237 Identities=23% Similarity=0.353 Sum_probs=191.7
Q ss_pred cceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC------c-----hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH------H-----DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~------~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
...|.-.+.||.|...+|-+. ....|+..|+|++.... . +.-.+|+..+-....||||+.+.+++..+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 344555677999999988775 44568999999985321 1 12345555555667899999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
.++++|+| .|+.|.|+++|... -.++++...+|++|+..|+
T Consensus 96 sF~FlVFd----------l~prGELFDyLts~-----------------------------VtlSEK~tR~iMrqlfegV 136 (411)
T KOG0599|consen 96 AFVFLVFD----------LMPRGELFDYLTSK-----------------------------VTLSEKETRRIMRQLFEGV 136 (411)
T ss_pred chhhhhhh----------hcccchHHHHhhhh-----------------------------eeecHHHHHHHHHHHHHHH
Confidence 99999999 88999999999654 3467788899999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC------CCCCchhh
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAID 693 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ksD 693 (753)
+|||..+|+||||||+|||+++ +..+||+|||++..+..+ ......|||++|.|||.+.- ..|+..+|
T Consensus 137 eylHa~~IVHRDLKpENILldd--n~~i~isDFGFa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD 210 (411)
T KOG0599|consen 137 EYLHARNIVHRDLKPENILLDD--NMNIKISDFGFACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVD 210 (411)
T ss_pred HHHHHhhhhhcccChhheeecc--ccceEEeccceeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhh
Confidence 9999999999999999999954 466999999999988754 34567799999999998853 34788999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+.||++|.|+.|..|+|....--+...+..++..|- ..++.+.+|||.+||++||++|
T Consensus 211 ~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~R 274 (411)
T KOG0599|consen 211 EWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKR 274 (411)
T ss_pred HHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhc
Confidence 99999999999999665665544455566667766543 3567889999999999999998
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.06 Aligned_cols=268 Identities=21% Similarity=0.335 Sum_probs=190.7
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccC-C
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD-Q 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~-~ 539 (753)
.++|++.+.||+|+||.||+|... .++.||+|++..... +...+|+. ++..+ +|+||++++++|.. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~-~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK-ILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHH-HHHhhccCcchhheeeeEecCC
Confidence 457888999999999999998532 357899999875332 23455666 55566 89999999998865 4
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhh--h-----------hhh-------------------ccc
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE--V-----------RIR-------------------LLP 587 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~--~-----------~~~-------------------~~~ 587 (753)
..++++|| |+++|+|.++++........... . ..+ ...
T Consensus 85 ~~~~~v~e----------y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (337)
T cd05054 85 GPLMVIVE----------YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154 (337)
T ss_pred CCEEEEEe----------cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchh
Confidence 56899999 77888888887643221000000 0 000 000
Q ss_pred ccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccccc
Q 004442 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667 (753)
Q Consensus 588 ~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~ 667 (753)
..+............+++..+.+++.||+.||+|||+.+|+||||||+||+++.++ .+||+|||+++.+....... .
T Consensus 155 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~-~ 231 (337)
T cd05054 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYV-R 231 (337)
T ss_pred hcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchh-h
Confidence 00011111223345799999999999999999999999999999999999997765 49999999998764332211 1
Q ss_pred CccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHcc-CcccccCCCHHHHHHHHH
Q 004442 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 668 ~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~-~~~~~~~~s~el~dLI~~ 744 (753)
.....++..|+|||++.+..++.++|||||||++|||++.+.+||.... +.....+... ....+...++++.+++.+
T Consensus 232 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 232 KGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred ccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHH
Confidence 2233467889999999999999999999999999999983377886532 2222222222 233455678899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.+|++|
T Consensus 312 cl~~~p~~R 320 (337)
T cd05054 312 CWHNNPEDR 320 (337)
T ss_pred HccCChhhC
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.35 Aligned_cols=237 Identities=21% Similarity=0.322 Sum_probs=182.2
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.+.|++.+.||+|+||.||+|.. .+++.||+|++..... ...++.+..++..++|+||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e- 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME- 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe-
Confidence 35678889999999999999976 4689999999865432 2223333347889999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.++++.. ..+++.++..++.|++.||.|||+.+|+
T Consensus 87 ---------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 87 ---------YCGGGSLQDIYHVT-----------------------------GPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred ---------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 77788888877432 3467788899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~Ell 705 (753)
||||||+||+++.++. +||+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||+
T Consensus 129 H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 129 HRDIKGANILLTDNGD--VKLADFGVAAKITATIA---KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ccCCCHHHEEECCCCC--EEECcCccceeeccccc---ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999976654 99999999987643211 122345789999999884 344788999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHccC--c---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-RDANIVKDRK--D---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-~~~~~i~~~~--~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||..... .....+.... . .....++.++.+||++||..||++|
T Consensus 204 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06646 204 EL-QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256 (267)
T ss_pred hC-CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhC
Confidence 98 456643322 1111111111 1 1123467899999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=295.40 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=190.8
Q ss_pred EEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
|++.+.||+|+||.||+|... ....+|+|.+..... ....+|+. +++.++||||++++++|.+++..++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN-LLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCCEeeEEEEEecCCCcEE
Confidence 566788999999999998653 235799998865432 23445655 7789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
++| |+.+|+|.+++............. ................+++..++.++.|++.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 145 (290)
T cd05045 81 IVE----------YAKYGSLRSFLRESRKVGPSYLGS-----DGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145 (290)
T ss_pred EEE----------ecCCCCHHHHHHhcCCcccccccc-----ccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999 777888888876533211100000 00000000001123468899999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++ .+||+|||+++......... ......++..|+|||.+.+..++.++||||||+++|||
T Consensus 146 ~~ivH~dikp~nill~~~~--~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 222 (290)
T cd05045 146 MKLVHRDLAARNVLVAEGR--KMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred CCeehhhhhhheEEEcCCC--cEEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHH
Confidence 9999999999999997665 59999999998664332211 11223457789999999888899999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++..||..... +....... .....+..+++++.++|.+||+.||++|
T Consensus 223 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~R 273 (290)
T cd05045 223 VTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKR 273 (290)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 9944788876543 33333332 2334466788999999999999999998
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=286.52 Aligned_cols=242 Identities=25% Similarity=0.338 Sum_probs=190.6
Q ss_pred EEecccCceEEEEEEeeC----CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||++.... +..||||.+...... ..+.++..++..++|+||+++++++.+....+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e---- 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLE---- 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEE----
Confidence 359999999999997764 889999999765432 233333347788899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++....... .......+++.++++++.|++.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~l~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 77 ------YMEGGDLLDYLRKSRPVF--------------------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130 (262)
T ss_pred ------eccCCcHHHHHhhccccc--------------------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence 777888888876542110 001135688999999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++. +||+|||.+........ ........++..|+|||.+....++.++|||||||++|||++++..|
T Consensus 131 i~p~nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 207 (262)
T cd00192 131 LAARNCLVGEDLV--VKISDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207 (262)
T ss_pred cCcceEEECCCCc--EEEcccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCC
Confidence 9999999977754 99999999988764322 12223345788999999998888999999999999999999966888
Q ss_pred CCCChHH-HHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~-~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|...... ....+. ......+...++++.++|.+||..||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 251 (262)
T cd00192 208 YPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDR 251 (262)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccC
Confidence 8766433 333333 23334566778999999999999999998
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=290.76 Aligned_cols=239 Identities=25% Similarity=0.374 Sum_probs=186.3
Q ss_pred ceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.+|++.+.||+|+||.||+|... .+..+|+|.++.... ..+.+|+ .+++.++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHH-HHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999998764 234799999865432 2334444 47788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ...+++.++++++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~ 124 (267)
T cd05066 83 VTE----------YMENGSLDAFLRKH----------------------------DGQFTVIQLVGMLRGIASGMKYLSD 124 (267)
T ss_pred EEE----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 77888888887532 1246778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++||||||+||+++.++ .++|+|||+++................++..|+|||.+.+..++.++|||||||++||+
T Consensus 125 ~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 125 MGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CCEeehhhchhcEEECCCC--eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 9999999999999997665 59999999998765432222222222345789999999988999999999999999998
Q ss_pred Hh-CCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 IT-GGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lT-G~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++ | ..||.+.. ......+... ..+.+...++++.+++.+||+++|++|
T Consensus 203 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (267)
T cd05066 203 MSYG-ERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNER 253 (267)
T ss_pred hcCC-CCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhC
Confidence 87 6 66775543 3333333332 233445678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=291.56 Aligned_cols=237 Identities=27% Similarity=0.379 Sum_probs=184.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|.+.+.||+|+||.||++... +|+.||+|++.... ....+.|+..+++..+|+||+++++++.+++..+++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e- 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME- 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh-
Confidence 5778899999999999998765 59999999987542 23455666666788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-Cc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~I 627 (753)
|++ |+|.+++..... ....+++..+++++.||+.||+|||++ ++
T Consensus 81 ---------~~~-~~l~~~l~~~~~-------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i 125 (283)
T cd06617 81 ---------VMD-TSLDKFYKKVYD-------------------------KGLTIPEDILGKIAVSIVKALEYLHSKLSV 125 (283)
T ss_pred ---------hhc-ccHHHHHHHhcc-------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 554 566666543211 124578899999999999999999997 99
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC----CCCCchhhHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~t~ksDIwSfGvvL~E 703 (753)
+||||||+||+++.++. +||+|||++....... ......|+..|+|||.+.+ ..++.++|+|||||++||
T Consensus 126 ~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 126 IHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred ecCCCCHHHEEECCCCC--EEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 99999999999977754 9999999998664321 1122457899999998865 446899999999999999
Q ss_pred HHhCCCCCCCCC---hHHHHHHHHccCcccc-cCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES---FERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~---~~~~~~~i~~~~~~~~-~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||... .+.............+ ..+++++.++|.+||..||++|
T Consensus 200 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 252 (283)
T cd06617 200 LATG-RFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKER 252 (283)
T ss_pred HHhC-CCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 9998 6677542 2222232222222222 3578999999999999999998
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=288.09 Aligned_cols=232 Identities=27% Similarity=0.392 Sum_probs=181.1
Q ss_pred EEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|+||.||+|.... +..+|+|.+..... +...+|+. +++.+.|+||+++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~~~v~e--- 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS-VMAQLDHPCIVRLIGVCK-GEPLMLVME--- 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEc-CCceEEEEE---
Confidence 359999999999985432 37899999875443 23344554 778899999999999876 456799999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.+++... ..+++..+++++.|++.||+|||+.+++||
T Consensus 76 -------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 119 (257)
T cd05060 76 -------LAPLGPLLKYLKKR-----------------------------REIPVSDLKELAHQVAMGMAYLESKHFVHR 119 (257)
T ss_pred -------eCCCCcHHHHHHhC-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 77788888887532 246788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +||+|||+++................++..|+|||.+.+..++.++|||||||++||+++++.+
T Consensus 120 di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~ 197 (257)
T cd05060 120 DLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197 (257)
T ss_pred CcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence 99999999977764 9999999998775433222222222345689999999988999999999999999999984478
Q ss_pred CCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||....... ...+... ....+..+++++.++|.+||..||++|
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 242 (257)
T cd05060 198 PYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDR 242 (257)
T ss_pred CcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 987654433 2333332 234556678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=289.01 Aligned_cols=234 Identities=21% Similarity=0.318 Sum_probs=178.2
Q ss_pred EEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeeccccc-CCceEEEEEccc
Q 004442 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES-DQDFVYLSLERC 549 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~-~~~~~~LV~E~c 549 (753)
+.||+|+||.||+|...+ +..||+|++..... +...+|+. +++.++|+||++++++|. .++..++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~lv~e-- 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVLSLLGICLPSEGSPLVVLP-- 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHH-HHccCCCCCcceEEEEeecCCCCcEEEEe--
Confidence 358999999999987542 46899999854322 23334444 778899999999999876 4556899999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.++++... ..+.+..++.++.|++.||.|||+.+|+|
T Consensus 78 --------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 78 --------YMKHGDLRNFIRSET----------------------------HNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred --------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 888899988875421 22455677899999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|||||+|||++.++ .+||+|||+++....... .........++..|+|||.+.+..++.++|||||||++|||++|+
T Consensus 122 ~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 122 RDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccCcceEEEcCCC--cEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 99999999997765 499999999986543211 111112234577899999998888999999999999999999987
Q ss_pred CCCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+... ....+...++++.+++.+||..||++|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 246 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMR 246 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhC
Confidence 88887654332 2222222 233445567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=286.41 Aligned_cols=231 Identities=26% Similarity=0.392 Sum_probs=183.1
Q ss_pred EecccCceEEEEEEeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhh
Q 004442 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
.||+|+||.||++...++..+|+|++...... .+.+|+. +++.++|+||++++++|.+.+..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-------- 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVME-------- 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEE--------
Confidence 58999999999998888999999998754322 3344544 7788999999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~ 635 (753)
|.++|+|.+++... ...+++..+++++.+++.||.|||+.+++||||||+
T Consensus 73 --~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ 122 (250)
T cd05085 73 --LVPGGDFLSFLRKK----------------------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122 (250)
T ss_pred --CCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChh
Confidence 77788888877432 124677888999999999999999999999999999
Q ss_pred cEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 636 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 636 NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
||+++.++ .+||+|||++........ .......++..|+|||++.+..++.++||||||+++||+++.+..||...
T Consensus 123 nili~~~~--~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 123 NCLVGENN--VLKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred eEEEcCCC--eEEECCCccceecccccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 99997765 499999999976543221 11122234678999999998889999999999999999999447788665
Q ss_pred hHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 716 FERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 716 ~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.... ...+... ....+...+.++.+++.+||+.||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 238 (250)
T cd05085 199 TNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENR 238 (250)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 3332 2233322 233456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=291.11 Aligned_cols=235 Identities=23% Similarity=0.327 Sum_probs=175.9
Q ss_pred EecccCceEEEEEEeeC---CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 480 EIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~---g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
.||+|+||.||+|.... ...+|+|.+...... .+.+|+. .++.++|+||++++++|.+.+..++|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~h~nii~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ-PYRELNHPNVLQCLGQCIESIPYLLVLE----- 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHH-HHHhCCCCCcceEEEEECCCCceEEEEE-----
Confidence 58999999999986554 457888887644322 2334444 6788999999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+++|+|.+++...... .....++..+++++.||+.||+|||+.+|+||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 126 (269)
T cd05042 76 -----FCPLGDLKNYLRSNRGM------------------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL 126 (269)
T ss_pred -----eCCCCcHHHHHHhcccc------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence 88889999988654321 1123456778999999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-------CCCCchhhHHHHHHHHHHHH
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDIwSfGvvL~Ell 705 (753)
||+|||++.++. +||+|||+++......... ......++..|+|||++.. ..++.++|||||||++|||+
T Consensus 127 kp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 127 ALRNCQLTADLS--VKIGDYGLALEQYPEDYYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred cHhheEecCCCc--EEEeccccccccccchhee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 999999977654 9999999987543321111 1122345778999998743 35688999999999999999
Q ss_pred hCCCCCCCCChHHH-H-HHHHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-A-NIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~-~~i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+||....... . ..+.... +.....+++++.+++..|| .||++|
T Consensus 204 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~R 257 (269)
T cd05042 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETR 257 (269)
T ss_pred hCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccc
Confidence 96688887654332 2 2222221 1233467788999999999 599998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.87 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=189.8
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..+.|.+.+.||+|+||.||++....+..+|+|.+..... +.+.+|+. +++.++|+||+++++++.+ ...+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~-~~~~~v~e- 80 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEAN-VMKTLQHDKLVKLHAVVTK-EPIYIITE- 80 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHH-HHHhcCCCCcceEEEEEcC-CCeEEEEE-
Confidence 3567889999999999999999877788899998875432 23445554 7889999999999999887 77899999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.... ...+++..++.++.|++.||.|||+.+++
T Consensus 81 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 124 (260)
T cd05073 81 ---------FMAKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124 (260)
T ss_pred ---------eCCCCcHHHHHHhCC---------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 778888888875421 23467778899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||+++.++ .+||+|||++........ .......++..|+|||.+....++.++|||||||++|+++|++
T Consensus 125 H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g 200 (260)
T cd05073 125 HRDLRAANILVSASL--VCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200 (260)
T ss_pred ccccCcceEEEcCCC--cEEECCCcceeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcC
Confidence 999999999997665 599999999986643211 1112223567899999999888999999999999999999955
Q ss_pred CCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||..... .....+... ....+...+.++.+++.+||++||++|
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 247 (260)
T cd05073 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 247 (260)
T ss_pred CCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccC
Confidence 888876533 333333332 223455678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=287.57 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=187.7
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.|.+.+.||+|+||.||++...+ ++.+|+|.+........+.++..+++.++|+||+++++++.+.+..++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e---- 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME---- 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe----
Confidence 457778889999999999997765 899999998755423334333447788899999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+++|.+++... ...+++..+..++.|++.||.|||+.+|+|||
T Consensus 79 ------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~d 124 (256)
T cd06612 79 ------YCGAGSVSDIMKIT----------------------------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124 (256)
T ss_pred ------cCCCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 77788888877432 24578889999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|+|+||+++.++. +||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++| ++|
T Consensus 125 l~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g-~~p 198 (256)
T cd06612 125 IKAGNILLNEEGQ--AKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPP 198 (256)
T ss_pred CCcceEEECCCCc--EEEcccccchhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC-CCC
Confidence 9999999987765 99999999987654321 12234478899999999988999999999999999999998 667
Q ss_pred CCCChHHHHHHHH-ccC---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERDANIVK-DRK---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~~~~i~-~~~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|............ ... ...+..+++++.++|.+||+.||++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 244 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER 244 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhC
Confidence 7654332221111 111 11234567899999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=296.85 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=192.6
Q ss_pred cceEEEeEEecccCceEEEEEEe--------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~--------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
..+|.+.+.||+|+||.||++.. .++..||+|.+..... ....+|+. +++.+ +|+||+++++++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHH-HHHhhccCCCchheeEEEec
Confidence 46678889999999999998853 1355899999865322 23445555 66777 89999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..+++|| |+.+|+|.+++........... ..........+++.++++++.||+.|
T Consensus 93 ~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 93 DGPLYVIVE----------YASKGNLREYLRARRPPGMEYS-------------YDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred CCceEEEEe----------cCCCCcHHHHHHhcCCcccccc-------------cccccCCcccccHHHHHHHHHHHHHH
Confidence 999999999 8888899988876432111000 00000123468889999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+||+++.++ .+||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 150 l~~LH~~givH~dlkp~Nili~~~~--~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 150 MEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred HHHHHHCCeeecccccceEEEcCCC--cEEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 9999999999999999999997665 4999999999877543211 112233457789999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF-ERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~-~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++|||++++..||.... ......+.... ...+..++.++.+||.+||..+|++|
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 999999995577776543 33333333332 23456678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=292.11 Aligned_cols=235 Identities=25% Similarity=0.338 Sum_probs=178.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||.||++... +|+.||+|++.... .....+|+. +++.++|+||+++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHH-HHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 3677889999999999998765 58999999986432 123455665 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||.+ +|.+++... ...+++..++.++.||++||.|||+.+|
T Consensus 80 ~~~~-----------~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~i 120 (284)
T cd07839 80 YCDQ-----------DLKKYFDSC----------------------------NGDIDPEIVKSFMFQLLKGLAFCHSHNV 120 (284)
T ss_pred cCCC-----------CHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 6554 444443221 2347788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||+++....... ......++..|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 121 ~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 121 LHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred ecCCCCHHHEEEcCCCc--EEECccchhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 99999999986543211 112335789999999987654 6999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHcc--------------------C---------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDR--------------------K---------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~--------------------~---------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+.++|..... .....+... . .......+++++++|.+||+.||.+|
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 196 AGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred cCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 97666654322 111111000 0 01123467899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.41 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=190.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC-Cce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~ 541 (753)
+++|.+.+.||+|+||.||+|...+ +..||+|++..... ....+|.. +++.++|+||+++++++.+ +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC-LLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCCC
Confidence 4578889999999999999998766 78999999875432 22344544 7788999999999999876 567
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++++| |..+|+|.+++........ .....+++.+++.++.|++.||+|
T Consensus 84 ~~~~~~----------~~~~~~L~~~l~~~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~ 132 (280)
T cd05043 84 PFVLYP----------YMNWGNLKLFLQQCRLGEA---------------------NNPQALSTQQLVHMAIQIACGMSY 132 (280)
T ss_pred CEEEEE----------cCCCCcHHHHHHhcccccc---------------------ccccCCCHHHHHHHHHHHHHHHHH
Confidence 899999 7778888888765422100 012468889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+++||||||+||+++.++ .+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++
T Consensus 133 LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 133 LHKRGVIHKDIAARNCVIDEEL--QVKITDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHCCEeecccCHhhEEEcCCC--cEEECCCCCcccccCCceEE-eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 9999999999999999997665 49999999998764322111 11223357789999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+++.+++||....... ...+... .......+++++.+++.+||..||++|
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 263 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEER 263 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhC
Confidence 999993377887654333 2223322 223345568899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.52 Aligned_cols=237 Identities=32% Similarity=0.459 Sum_probs=185.6
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch-----------HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD-----------VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~-----------~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
|.+.+.||+|++|.||+|... +++.+|+|.+...... ..+..+..+++.++|+||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456678999999999999664 5899999988643210 1233333478899999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+++|| |+++++|.+++... ..+++..+..++.|++.||+||
T Consensus 82 ~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~l 122 (267)
T cd06628 82 NIFLE----------YVPGGSVAALLNNY-----------------------------GAFEETLVRNFVRQILKGLNYL 122 (267)
T ss_pred EEEEE----------ecCCCCHHHHHHhc-----------------------------cCccHHHHHHHHHHHHHHHHHH
Confidence 99999 77788888877432 3467778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc---ccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|+.+++||||+|+||+++.++ .++|+|||+++......... .......|+..|+|||.+.+..++.++|||||||
T Consensus 123 H~~~ivH~di~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~ 200 (267)
T cd06628 123 HNRGIIHRDIKGANILVDNKG--GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGC 200 (267)
T ss_pred HhcCcccccCCHHHEEEcCCC--CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHH
Confidence 999999999999999997665 49999999998775322111 1112335789999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-H-HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFER-D-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~-~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|+|++| ..||...... . ...........+..++.++.++|++||+.||++|
T Consensus 201 il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (267)
T cd06628 201 LVVEMLTG-KHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKR 255 (267)
T ss_pred HHHHHhhC-CCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhC
Confidence 99999998 6788654322 2 2222223344566788999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.42 Aligned_cols=238 Identities=25% Similarity=0.391 Sum_probs=188.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
....++|++.+.||+|+||.||++.. .+++.||+|.+..... +...+|+. +++.++|+||+++++++.+.+..++
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHH-HHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 34456788999999999999999975 4689999999865432 23344544 7788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++.. ..+++.+++.++.|++.||+|||+
T Consensus 95 v~e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~i~~ql~~aL~~LH~ 134 (296)
T cd06654 95 VME----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHS 134 (296)
T ss_pred eec----------ccCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 8888898887642 235667889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++ .+||+|||++........ ......|++.|+|||.+.+..++.++|||||||++|||
T Consensus 135 ~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l 209 (296)
T cd06654 135 NQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209 (296)
T ss_pred CCcccCCCCHHHEEEcCCC--CEEECccccchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHH
Confidence 9999999999999997765 499999999886543221 12234588999999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHH-H-HHHHccCc--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERD-A-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~-~-~~i~~~~~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| ++||....... . ........ ..+..+++.+.++|.+||.+||++|
T Consensus 210 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (296)
T cd06654 210 IEG-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261 (296)
T ss_pred HhC-CCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccC
Confidence 998 56775543321 1 11112211 2345677899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.85 Aligned_cols=232 Identities=31% Similarity=0.423 Sum_probs=185.5
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
|...+.||+|+||.||+|... +++.||+|.+.... .+...+|+ .+++.++|+||+++++++.+.+..+++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEI-ALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHH-HHHHhcCCCCchheeeeEecCCeEEEE
Confidence 455678999999999999776 78999999986432 12334444 478899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| |+++++|.+++... ..+++..++.++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 81 LE----------LVPGGSLAKLLKKY-----------------------------GSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred EE----------ecCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 77788888877431 2467788899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~El 704 (753)
+|+|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|++
T Consensus 122 ~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 122 NTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred CcccCCCCHHHEEECCCCC--EEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999977654 9999999988764332 123345889999999987776 89999999999999999
Q ss_pred HhCCCCCCCCChHHHH-HHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDA-NIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~-~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||........ .... ......+..+++++.++|++||+.||++|
T Consensus 196 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 246 (258)
T cd06632 196 ATG-KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLR 246 (258)
T ss_pred HhC-CCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccC
Confidence 998 678866543222 1111 12334556678999999999999999998
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.92 Aligned_cols=193 Identities=22% Similarity=0.299 Sum_probs=157.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
..|.+.+.||+|+||.||+|... .++.||+|..... ....|.. +++.++|+||+++++++.+.+..++|+|++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 140 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAM-LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS- 140 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHH-HHHhCCCCCCcChhheEEeCCeeEEEEEccC-
Confidence 45889999999999999999765 4789999975433 2344554 7899999999999999999999999999554
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+|.+++... ...+++..+++|+.||+.||.|||+.+|+|||
T Consensus 141 ----------~~l~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 182 (357)
T PHA03209 141 ----------SDLYTYLTKR----------------------------SRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182 (357)
T ss_pred ----------CcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 4555554321 24578889999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++|||||||++|||++++.++
T Consensus 183 lkp~Nill~~~~~--~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQ--VCIGDLGAAQFPVVAP----AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCC--EEEecCccccccccCc----ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999977765 8999999997543221 122345899999999999999999999999999999999987777
Q ss_pred CCC
Q 004442 712 YGE 714 (753)
Q Consensus 712 f~~ 714 (753)
|+.
T Consensus 257 f~~ 259 (357)
T PHA03209 257 FED 259 (357)
T ss_pred ccC
Confidence 654
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=296.28 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=188.7
Q ss_pred eecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
...++|.+.+.||+|+||.||++... .+..||||+++.... +...+|+. +++++ +|+||++++++|..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK-IMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHH-HHHhccCCCCcceEEEEEec
Confidence 34467889999999999999998642 356899999875432 22344555 77788 89999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..+++|| |+.+|+|.++++... ...+++.++++++.+++.|
T Consensus 111 ~~~~~lv~e----------~~~~~~L~~~i~~~~---------------------------~~~l~~~~~~~i~~~i~~~ 153 (302)
T cd05055 111 GGPILVITE----------YCCYGDLLNFLRRKR---------------------------ESFLTLEDLLSFSYQVAKG 153 (302)
T ss_pred CCceEEEEE----------cCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHH
Confidence 999999999 888899988886422 1237888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+|+||||+||+++.++ .++|+|||+++........ .......++..|+|||.+.+..++.++||||||
T Consensus 154 l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 230 (302)
T cd05055 154 MAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 230 (302)
T ss_pred HHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHH
Confidence 9999999999999999999996654 5999999999866433211 111223457889999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHH--HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~--~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++++.+||...... ....+... ....+...++++.++|.+||++||++|
T Consensus 231 vil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 288 (302)
T cd05055 231 ILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288 (302)
T ss_pred HHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 99999998337787654322 22233322 223344567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=293.71 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=192.3
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccccCCc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~ 540 (753)
.++|.+.+.||+|+||.||++... ....+|+|.+...... ...+|+. ++..+ +|+||++++++|.+++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEcCCC
Confidence 356788899999999999998654 2468999998754322 3445555 56666 8999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++|| |.++|+|.++++.......... ..........+++..+++++.|++.||+
T Consensus 90 ~~~li~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~~al~ 146 (293)
T cd05053 90 PLYVVVE----------YAAHGNLRDFLRARRPPGEYAS-------------PDDPRPPEETLTQKDLVSFAYQVARGME 146 (293)
T ss_pred CeEEEEE----------eCCCCcHHHHHHhcCCCccccc-------------cccccccccccCHHHHHHHHHHHHHHHH
Confidence 9999999 7788888888875432111000 0000012456889999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++ .+||+|||+++.+..... ........++..|+|||.+.+..++.++|||||||+
T Consensus 147 ~LH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 223 (293)
T cd05053 147 FLASKKCIHRDLAARNVLVTEDH--VMKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223 (293)
T ss_pred HHHHCCccccccceeeEEEcCCC--eEEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhH
Confidence 99999999999999999997765 499999999987654221 111122235678999999988899999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||+++.+..||..... .....+... ....+...+.++.+|+.+||..||++|
T Consensus 224 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 224 LWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 99999844678766533 333333333 234556678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.56 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=187.8
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||+||++.... ++.||+|.+...... ..+.++..++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 57888999999999999997764 899999999754321 223333347899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|..+|+|.+++.... ...+++..+..++.|++.||+|||+.++
T Consensus 82 ----------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i 124 (316)
T cd05574 82 ----------YCPGGELFRLLQRQP---------------------------GKCLSEEVARFYAAEVLLALEYLHLLGI 124 (316)
T ss_pred ----------ecCCCCHHHHHHhCC---------------------------CCccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 777888888775321 2357788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc--------------------------ccCccCCCCccccccc
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--------------------------TQNATGYGSSGWQAPE 681 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~--------------------------~~~~~~~GT~~Y~APE 681 (753)
+|+||||+||+++.++. ++|+|||++.......... .......||..|+|||
T Consensus 125 ~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE 202 (316)
T cd05574 125 VYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202 (316)
T ss_pred eccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHH
Confidence 99999999999987765 8999999987653221100 0112346889999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCcccccC--CCHHHHHHHHHccccCcCCC
Q 004442 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 682 ~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~--~s~el~dLI~~cL~~DP~~R 753 (753)
.+.+..++.++||||||+++|+|++| ..||.... ......+.......+.. .+++++++|++||..||++|
T Consensus 203 ~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 203 VISGDGHGSAVDWWTLGILLYEMLYG-TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred HHcCCCCCchHHHHHHHHHHHHHhhC-CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHC
Confidence 99998899999999999999999998 66775543 33333333333333333 58899999999999999998
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=283.87 Aligned_cols=238 Identities=23% Similarity=0.387 Sum_probs=188.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
..|++.+.||+|+||.||++...++..+|+|.+.... ...+.+|+. ++..++|+||+++++++.+....+++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e--- 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQ-VMMKLSHPKLVQLYGVCTERSPICLVFE--- 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHH-HHHhCCCCCeeeEEEEEccCCceEEEEE---
Confidence 3577889999999999999988778899999987543 234455554 7889999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++... ...+++..++.++.+++.||+|||+.+++||
T Consensus 80 -------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~ 124 (256)
T cd05112 80 -------FMEHGCLSDYLRAQ----------------------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124 (256)
T ss_pred -------cCCCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 77788888877532 1246778889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .+||+|||++........ .......++.+|+|||.+.+..++.++||||||+++|||++.+.+
T Consensus 125 dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 200 (256)
T cd05112 125 DLAARNCLVGENQ--VVKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200 (256)
T ss_pred ccccceEEEcCCC--eEEECCCcceeecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 9999999997665 499999999986543211 111122346789999999988999999999999999999994478
Q ss_pred CCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||..... .....+... ....+...++++.+|+.+||+.+|++|
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 245 (256)
T cd05112 201 PYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDR 245 (256)
T ss_pred CCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 8875533 333333322 223345568899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=286.44 Aligned_cols=239 Identities=23% Similarity=0.386 Sum_probs=188.3
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|.+.+.||+|+||.||+|... +|+.||+|.++... .....+|+. +++.++|+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~-~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID-LLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46888999999999999999776 79999999886321 223345554 78899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++..... ....+++.++++++.+++.||.|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 81 LE----------LADAGDLSRMIKHFKK-------------------------QKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred Ee----------cCCCCCHHHHHHHhcc-------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 7888888887754211 124578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 126 ~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 126 RIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CEecCCcChhhEEECCCCc--EEEeccceeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 9999999999999977765 89999999886643221 112335788999999999888999999999999999999
Q ss_pred hCCCCCCCCChH---HHHHHHHc-cCccccc-CCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE---RDANIVKD-RKDLFLV-EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~---~~~~~i~~-~~~~~~~-~~s~el~dLI~~cL~~DP~~R 753 (753)
+| ..||..... ........ ...+.+. .++.++.++|.+||..+|++|
T Consensus 201 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~R 252 (267)
T cd08224 201 AL-QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKR 252 (267)
T ss_pred HC-CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccC
Confidence 98 556644322 12222222 2223333 677899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=285.03 Aligned_cols=234 Identities=29% Similarity=0.422 Sum_probs=188.2
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.|.+.+.||+|+||.||++... |+.||||.+..... +...+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e--- 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEAS-VMTTLRHPNLVQLLGVVLQGNPLYIVTE--- 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHH-HHHhcCCcceeeeEEEEcCCCCeEEEEE---
Confidence 45677899999999999998754 78999999976543 34455555 7889999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 126 (256)
T cd05039 81 -------YMAKGSLVDYLRSRG---------------------------RAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126 (256)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence 777888888775421 1357888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +||+|||.++....... ...++..|+|||.+....++.++||||||+++||+++.+..
T Consensus 127 di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 127 DLAARNVLVSEDLV--AKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred hcccceEEEeCCCC--EEEcccccccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999999976654 89999999987643211 22346789999999888899999999999999999983377
Q ss_pred CCCCChHHHH-HHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~~~-~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||........ ..+... ....+..+++++.++|.+||+.+|++|
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 243 (256)
T cd05039 199 PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKR 243 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhC
Confidence 8876643332 222222 333455678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=328.60 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=188.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC--Cc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD--QD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~ 540 (753)
......|.+.+.||+|+||+||++... .+..||+|.+.... ...+..|+. ++..++|||||++++++.+ ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~-IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN-VMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHH-HHHHcCCCCcCeEEEEEEecCCC
Confidence 445568999999999999999998665 47899999886432 223445555 7899999999999998754 46
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+||||| |+.+|+|.++|..... ....+++..++.|+.||+.||+
T Consensus 88 ~lyIVME----------Y~~gGSL~~lL~k~~~-------------------------~~g~L~E~~Il~Ia~QIL~ALa 132 (1021)
T PTZ00266 88 KLYILME----------FCDAGDLSRNIQKCYK-------------------------MFGKIEEHAIVDITRQLLHALA 132 (1021)
T ss_pred EEEEEEe----------CCCCCcHHHHHHHHhh-------------------------ccCCCCHHHHHHHHHHHHHHHH
Confidence 7899999 7778888888764321 1245889999999999999999
Q ss_pred HhhhC-------CccccCCCCCcEEEecC---------------CCCeEEEEeccCceeccCCCcccccCccCCCCcccc
Q 004442 621 HLHEI-------GLIHRDLKPQNVLISKD---------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 678 (753)
Q Consensus 621 yLH~~-------~IiHrDLKp~NILL~~d---------------~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~ 678 (753)
|||+. +||||||||+||||+.+ +...+||+|||++..+.... ......||+.|+
T Consensus 133 YLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~Ym 208 (1021)
T PTZ00266 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYW 208 (1021)
T ss_pred HHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc----cccccCCCcccc
Confidence 99984 49999999999999642 23458999999998764321 123446899999
Q ss_pred ccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 679 APEQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 679 APE~l~~--~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++.+ ..++.++|||||||+||||+|| .+||.... ......+..........+++++.+||.+||.+||++|
T Consensus 209 APEvL~ge~~~~s~KSDVWSLG~ILYELLTG-k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 209 SPELLLHETKSYDDKSDMWALGCIIYELCSG-KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred CHHHHhccCCCCCchhHHHHHHHHHHHHHHC-CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHC
Confidence 9999864 4589999999999999999998 66775432 2223333333333335578999999999999999998
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.34 Aligned_cols=235 Identities=26% Similarity=0.344 Sum_probs=178.0
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|++.+.||+|++|.||+|... +++.||||++.... .....+|+. ++..++|+||+++++++.+++..++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS-LLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHH-HHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 677889999999999999765 58999999986432 123445554 77889999999999999999999999994
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|. |+|.+++.... ....+++.++..++.|++.||+|||+.+|+
T Consensus 81 ~~-----------~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 123 (285)
T cd07861 81 LS-----------MDLKKYLDSLP--------------------------KGQYMDAELVKSYLYQILQGILFCHSRRVL 123 (285)
T ss_pred CC-----------CCHHHHHhcCC--------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 44 45555543211 124578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG 707 (753)
||||||+||+++.++. +||+|||++....... .......+++.|+|||.+.+. .++.++|||||||++|||+||
T Consensus 124 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 124 HRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred ecCCCHHHEEEcCCCc--EEECcccceeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 9999999999987765 9999999997654321 111223568899999988764 468999999999999999998
Q ss_pred CCCCCCCChHHHH--HHHHcc----------------------------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERDA--NIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~~--~~i~~~----------------------------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.+..+... ...... .......+++++.++|++||+.||++|
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 273 (285)
T cd07861 199 -KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKR 273 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhC
Confidence 667765432111 100000 001123468899999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=306.54 Aligned_cols=271 Identities=21% Similarity=0.297 Sum_probs=192.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCC-CCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQ-HPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~-HpNIV~L~g~~~ 537 (753)
+...+++.+.+.||+|+||.||++... .++.||||+++..... ...+|+. ++..+. |+||++++|+|.
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK-IMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHH-HHHhcCCCCCeEEEEEEEc
Confidence 344456788899999999999998642 3568999999754322 3445555 667776 999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhh-hhhc-------------------------------
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV-RIRL------------------------------- 585 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~-~~~~------------------------------- 585 (753)
+.+..++||| |+.+|+|.++|+............ ....
T Consensus 112 ~~~~~~iv~E----------~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (401)
T cd05107 112 KGGPIYIITE----------YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDM 181 (401)
T ss_pred cCCCcEEEEe----------ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCcccccc
Confidence 9999999999 777888888887543211000000 0000
Q ss_pred ------------------------------------cccccc-chhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 586 ------------------------------------LPVMEN-TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 586 ------------------------------------~~~~~~-~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
....+. ...........+++.++++++.|++.||+|||+.+|+
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 261 (401)
T cd05107 182 SKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261 (401)
T ss_pred CCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC
Confidence 000000 0000111234588899999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+|||++.++ .+||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|||++++
T Consensus 262 Hrdlkp~NiLl~~~~--~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g 338 (401)
T cd05107 262 HRDLAARNVLICEGK--LVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLG 338 (401)
T ss_pred cccCCcceEEEeCCC--EEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcC
Confidence 999999999997654 5999999999875432211 1112334688999999999888999999999999999999944
Q ss_pred CCCCCCChH-H-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-R-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||..... . ....+... ....+...+.++.++|++||..||++|
T Consensus 339 ~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~R 386 (401)
T cd05107 339 GTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIR 386 (401)
T ss_pred CCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 678865422 2 22333333 233455678999999999999999988
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.79 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=186.0
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-C--cEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-G--RSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~L 544 (753)
+.|.+.+.||+|+||.||++...+ + ..+|+|.++.... +.+.+|+. ++.++ +||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE-VLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHH-HHHhhcCCCchhheEEEEccCCcceE
Confidence 357888999999999999987654 3 3578888864321 23445555 55566 79999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
++| |+++|+|.++++.......... ..........+++..+++++.|++.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~ 137 (297)
T cd05089 81 AIE----------YAPYGNLLDFLRKSRVLETDPA-------------FAKEHGTASTLTSQQLLQFASDVATGMQYLSE 137 (297)
T ss_pred EEE----------ecCCCcHHHHHHhccccccccc-------------cccccCccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 8888999998865432110000 00000112458899999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++ .+||+|||++...... ........+..|+|||.+....++.++|||||||++|||
T Consensus 138 ~~ivH~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 138 KQFIHRDLAARNVLVGENL--ASKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred CCcccCcCCcceEEECCCC--eEEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999997664 5999999998643211 111112235679999999888899999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+.+||..... ......... ....+..+++++.+||.+||+.||.+|
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 262 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYER 262 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9833678866533 333333332 233455688999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=321.39 Aligned_cols=238 Identities=26% Similarity=0.395 Sum_probs=182.9
Q ss_pred cceEEEeEEecccCceEEEEEEeeCC-cEEEEEEeecCCc---hHHHHHHHHHHHhCC-CCceeeeccccc----C---C
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHH---DVALKEIQNLIASDQ-HPNIVRWYGVES----D---Q 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g-~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~-HpNIV~L~g~~~----~---~ 539 (753)
..++++.+.|.+|||+.||+|.+..+ ..+|+|++...+. ....+|+. +|+.+. |+|||.+++... . .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~-~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREID-IMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHH-HHHHhcCCCceeeEeccccccccCCCce
Confidence 35678899999999999999988876 9999999865432 23345655 667766 999999999321 1 2
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
-+++|.||||. +|+|-++++.+. ...|.+.++++|+.++|+|+
T Consensus 115 ~EvllLmEyC~----------gg~Lvd~mn~Rl---------------------------q~~lte~eVLkIf~dv~~AV 157 (738)
T KOG1989|consen 115 WEVLLLMEYCK----------GGSLVDFMNTRL---------------------------QTRLTEDEVLKIFYDVCEAV 157 (738)
T ss_pred eEEEeehhhcc----------CCcHHHHHHHHH---------------------------hccCChHHHHHHHHHHHHHH
Confidence 36899999555 566666665432 23488999999999999999
Q ss_pred HHhhhCC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc------ccccCccCCCCcccccccccc---CCCC
Q 004442 620 SHLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------CLTQNATGYGSSGWQAPEQLL---QGRQ 688 (753)
Q Consensus 620 ~yLH~~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~------~~~~~~~~~GT~~Y~APE~l~---~~~~ 688 (753)
++||..+ |||||||-+||||..+++ .||||||.|........ .........-|+.|+|||.+. +...
T Consensus 158 a~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI 235 (738)
T KOG1989|consen 158 AAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI 235 (738)
T ss_pred HHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC
Confidence 9999885 999999999999988886 89999999875432221 001111223599999999874 5668
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccc--cCCCHHHHHHHHHccccCcCCC
Q 004442 689 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|+|||+|||+||-|+.. .+||++.-.- .|.+++..+| ..|+..+.+||+.||+.||++|
T Consensus 236 ~eKsDIWALGclLYkLCy~-t~PFe~sg~l---aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~R 298 (738)
T KOG1989|consen 236 GEKSDIWALGCLLYKLCYF-TTPFEESGKL---AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDER 298 (738)
T ss_pred cchhHHHHHHHHHHHHHHh-CCCcCcCcce---eEEeccccCCCCccHHHHHHHHHHHHhccCcccC
Confidence 9999999999999999997 8899886322 1234555444 4789999999999999999998
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=292.05 Aligned_cols=236 Identities=26% Similarity=0.408 Sum_probs=188.1
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
..++|++.+.||.|+||.||++.. .+|+.||+|.+..... +...+|+ .+++.++|+||+++++++.+.+..++|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI-LVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHH-HHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 346789999999999999999865 5689999999864321 2333444 4778999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.. ..+++.+++.++.+++.||+|||+.+
T Consensus 96 e----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~~ 135 (296)
T cd06655 96 E----------YLAGGSLTDVVTE------------------------------TCMDEAQIAAVCRECLQALEFLHANQ 135 (296)
T ss_pred E----------ecCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7778888877632 24678899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
++||||||+||+++.++. +||+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 136 i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~llt 210 (296)
T cd06655 136 VIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVE 210 (296)
T ss_pred cccCCCCHHHEEECCCCC--EEEccCccchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999977665 99999999886644321 1123357899999999998889999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHH-ccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVK-DRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~-~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| +.||..... .....+. ... ...+..+++++.++|++||..||++|
T Consensus 211 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 260 (296)
T cd06655 211 G-EPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKR 260 (296)
T ss_pred C-CCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhC
Confidence 8 667765432 2222222 221 12345678899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.87 Aligned_cols=234 Identities=24% Similarity=0.304 Sum_probs=183.1
Q ss_pred EEecccCceEEEEEEeeC--C--cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~--g--~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|++|.||++...+ + ..||||.+..... +.+.+|+. .++.++|+||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~-~~~~~v~e--- 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAA-IMHSLDHENLIRLYGVVLT-HPLMMVTE--- 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHH-HHhhcCCCCccceeEEEcC-CeEEEEEE---
Confidence 358999999999997643 3 3699999976543 23344544 7889999999999999988 88999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+++||
T Consensus 76 -------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 121 (257)
T cd05040 76 -------LAPLGSLLDRLRKDA---------------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHR 121 (257)
T ss_pred -------ecCCCcHHHHHHhcc---------------------------cccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 777888888875431 1357888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++ .+||+|||+++................++..|+|||.+.+..++.++|||||||++|||++.+..
T Consensus 122 di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 122 DLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred ccCcccEEEecCC--EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999997775 59999999998775432222222334578899999999988999999999999999999993377
Q ss_pred CCCCChHH-HHHHHHc--cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~--~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+.. .....+...+.++.+++.+||+.+|++|
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 245 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADR 245 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccC
Confidence 88654333 2222221 2223345667899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.71 Aligned_cols=249 Identities=23% Similarity=0.306 Sum_probs=188.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-----------------CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceee
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-----------------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-----------------g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 531 (753)
.+|.+.+.||+|+||.||++.... +..||+|++...... ...+|+. +++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK-ILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHH-HHHhcCCCCEeE
Confidence 457788999999999999976542 356899998755322 2334544 778899999999
Q ss_pred ecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 532 L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
++++|.+++..++++| |..+|+|.+++.......... ......+++..++.+
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 135 (296)
T cd05051 84 LLGVCTVDPPLCMIME----------YMENGDLNQFLQKHVAETSGL------------------ACNSKSLSFSTLLYM 135 (296)
T ss_pred EEEEEecCCCcEEEEe----------cCCCCCHHHHHHhcccccccc------------------cccCCCCCHHHHHHH
Confidence 9999999999999999 777888888886543211100 122346889999999
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k 691 (753)
+.|++.||+|||+.+|+||||||+||+++.++ .++|+|||+++........ .......++..|+|||.+.+..++.+
T Consensus 136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNY--TIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred HHHHHHHHHHHHHcCccccccchhceeecCCC--ceEEccccceeecccCcce-eecCcCCCCceecCHHHhhcCCCCcc
Confidence 99999999999999999999999999997775 4999999999865433211 12223346789999999988889999
Q ss_pred hhHHHHHHHHHHHHhC-CCCCCCCChHHH-HHHHHcc--------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITG-GKHPYGESFERD-ANIVKDR--------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG-~~~Pf~~~~~~~-~~~i~~~--------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||+++ +..||....... ....... ....+..+++++.++|.+||+.||++|
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 284 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDR 284 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcC
Confidence 9999999999999983 367886643222 2221111 112344567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.11 Aligned_cols=254 Identities=25% Similarity=0.351 Sum_probs=190.2
Q ss_pred ceEEEeEEecccCceEEEEEEee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccccCC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~ 539 (753)
.+|.+.+.||+|+||.||++... ....+|+|.++..... ...+|+. +++.+ +|+||++++++|.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME-LMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHH-HHHhccCCCCeeeEEEEEccC
Confidence 56788899999999999998542 3567999998754322 3345554 55666 699999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..+++|| |+.+|+|.+++.......... ...........+++.++++++.|++.||
T Consensus 91 ~~~~lv~e----------~~~~g~L~~~i~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 91 GPLYVIVE----------YAAKGNLREFLRARRPPGPDY-------------TFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCCcccc-------------cccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999999 888899999886543210000 0000001234588899999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.|||+.+|+||||||+||+++.++. +||+|||+++........ .......++..|+|||.+.+..++.++|||||||
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 9999999999999999999977754 999999999876432111 1111223456899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++++..||..... .....+.... ...+..++.++.++|.+||+.||++|
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 280 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQR 280 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 999999955778866543 3333333332 23456678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=290.29 Aligned_cols=235 Identities=23% Similarity=0.355 Sum_probs=181.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+.|.+.+.||+|+||.||++... +++.||+|.++..... ...+|+ .+++.++|+||+++++++.+.+..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~-~~~~~l~h~~ii~~~~~~~~~~~~~lv~e- 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IMMKDCKHSNIVAYFGSYLRRDKLWICME- 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCEEEEEEe-
Confidence 45667788999999999998664 5899999998754322 233444 47889999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|.++|+|.+++.. ...+++.+++.++.|++.||.|||+.+|+
T Consensus 87 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 128 (267)
T cd06645 87 ---------FCGGGSLQDIYHV-----------------------------TGPLSESQIAYVSRETLQGLYYLHSKGKM 128 (267)
T ss_pred ---------ccCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 7777888877642 23577888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||+||+++.++. +||+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||+
T Consensus 129 H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 129 HRDIKGANILLTDNGH--VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred cCCCCHHHEEECCCCC--EEECcceeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 9999999999976654 9999999987664321 1223346899999999874 455889999999999999999
Q ss_pred hCCCCCCCC-ChHHHHHHHHccC--cc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGE-SFERDANIVKDRK--DL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~-~~~~~~~~i~~~~--~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+ +||.. ............. .. ....++..+.++|.+||..||++|
T Consensus 204 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 256 (267)
T cd06645 204 ELQ-PPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR 256 (267)
T ss_pred cCC-CCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhC
Confidence 994 55543 3222222111111 11 112467889999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=292.36 Aligned_cols=237 Identities=25% Similarity=0.330 Sum_probs=183.8
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.|.+.+.||+|+||.||++... .++.||+|.+..... ....+|+ .+++.++|+||+++++++.+++..++||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-DILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4678899999999999998664 478999999865421 1223444 4788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ..+++..+..++.+++.||.|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (305)
T cd05609 81 E----------YVEGGDCATLLKNI-----------------------------GALPVDMARMYFAETVLALEYLHNYG 121 (305)
T ss_pred e----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 88889998887432 34677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc------------ccccCccCCCCccccccccccCCCCCchhhH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDI 694 (753)
|+||||||+||+++.++. +||+|||+++....... .........++..|+|||.+.+..++.++||
T Consensus 122 i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 122 IVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred ccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999977654 99999999874211100 0001112357889999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHccCccc---ccCCCHHHHHHHHHccccCcCCC
Q 004442 695 FSLGCILFFCITGGKHPYGE-SFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 695 wSfGvvL~EllTG~~~Pf~~-~~~~~~~~i~~~~~~~---~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||++|||++| ..||.+ ................ ...+++++.++|++||++||++|
T Consensus 200 ~slG~vl~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 261 (305)
T cd05609 200 WAMGIILYEFLVG-CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261 (305)
T ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhc
Confidence 9999999999999 456644 3333333333332222 22568899999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.27 Aligned_cols=232 Identities=24% Similarity=0.338 Sum_probs=182.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|.+.+.||+|+||.||++... ++..+|+|.+..... ....+|+. ++..++|+||++++++|.+++..++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK-VLHECNSPYIVGFYGAFYSDGEISICME- 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCEEEEEee-
Confidence 4778899999999999998654 588999998865422 23445555 7788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~I 627 (753)
|+++|+|.++++.. ..+++..+..++.|++.||.|||+ .++
T Consensus 80 ---------y~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 80 ---------HMDGGSLDQVLKKA-----------------------------GRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred ---------ccCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 88888998887532 346778889999999999999997 589
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++. +||+|||++...... ......|+..|+|||.+.+..++.++|||||||++|||++|
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 122 MHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred EECCCChHHEEEecCCc--EEEccCCCccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999977754 899999998765332 12344689999999999888899999999999999999998
Q ss_pred CCCCCCCChHHHHHHHHcc--------------------------------------Ccccc-cCCCHHHHHHHHHcccc
Q 004442 708 GKHPYGESFERDANIVKDR--------------------------------------KDLFL-VEHIPEAVDLFTRLLDP 748 (753)
Q Consensus 708 ~~~Pf~~~~~~~~~~i~~~--------------------------------------~~~~~-~~~s~el~dLI~~cL~~ 748 (753)
..||.............. .+..+ ..+++++.++|.+||..
T Consensus 195 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 195 -RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred -CCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 556643322211111110 00111 12577899999999999
Q ss_pred CcCCC
Q 004442 749 NPDLR 753 (753)
Q Consensus 749 DP~~R 753 (753)
||++|
T Consensus 274 ~P~~R 278 (308)
T cd06615 274 NPKER 278 (308)
T ss_pred ChhhC
Confidence 99998
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=301.48 Aligned_cols=232 Identities=22% Similarity=0.361 Sum_probs=175.7
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.++|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR-LLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHH-HHHhcCCCchhhhhhhhcccccccc
Confidence 456788889999999999999975 458899999986532 123445555 78899999999999987543
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...|+++|++.+ +|.+++. ...+++..+..++.||+.|
T Consensus 92 ~~~~~~~~~~~~~-----------~l~~~~~------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 92 FNEVYLVTNLMGA-----------DLNNIVK------------------------------CQKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred cCcEEEEeecCCC-----------CHHHHHh------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 457999995544 4444331 2347788889999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 697 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSf 697 (753)
|+|||+.+|+||||||+||+++.++. +||+|||+++..... .....||..|+|||++.+ ..++.++|||||
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhH
Confidence 99999999999999999999977765 999999999876432 123468999999999877 468999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-HHHHHHHc-----------------------cCc--------ccccCCCHHHHHHHHHc
Q 004442 698 GCILFFCITGGKHPYGESFE-RDANIVKD-----------------------RKD--------LFLVEHIPEAVDLFTRL 745 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~-~~~~~i~~-----------------------~~~--------~~~~~~s~el~dLI~~c 745 (753)
||++|||++| .+||..... .....+.. ... ......++.+.+||.+|
T Consensus 203 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 203 GCIMAELLKG-KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 9999999998 667754321 11111100 000 01123566789999999
Q ss_pred cccCcCCC
Q 004442 746 LDPNPDLR 753 (753)
Q Consensus 746 L~~DP~~R 753 (753)
|+.||++|
T Consensus 282 L~~dp~~R 289 (343)
T cd07878 282 LVLDSDKR 289 (343)
T ss_pred cCCChhhC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.62 Aligned_cols=228 Identities=23% Similarity=0.363 Sum_probs=179.2
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|++.+.||+|+||.||++.. .+++.||+|.+..... ..+.+|+. +++.++|+||+++++++...+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE-ILYKCDSPYIIGFYGAFFVENRISICTE- 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEECCEEEEEEe-
Confidence 466778999999999999965 4689999999865422 22334444 7788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|..+. .+++..+..++.|++.||.|||+.+|+
T Consensus 80 ---------~~~~~~l~~~~---------------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~ 117 (279)
T cd06619 80 ---------FMDGGSLDVYR---------------------------------KIPEHVLGRIAVAVVKGLTYLWSLKIL 117 (279)
T ss_pred ---------cCCCCChHHhh---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 77777775431 245667789999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||||+||+++.++. ++|+|||++...... ......||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 118 H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g- 189 (279)
T cd06619 118 HRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG- 189 (279)
T ss_pred eCCCCHHHEEECCCCC--EEEeeCCcceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC-
Confidence 9999999999987765 999999999866432 12334689999999999988999999999999999999998
Q ss_pred CCCCCCChH--------HHHHHHHccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE--------RDANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~--------~~~~~i~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||..... .....+...... ....+++++.++|.+||+.||++|
T Consensus 190 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 244 (279)
T cd06619 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKER 244 (279)
T ss_pred CCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhC
Confidence 667754211 111111111111 233577899999999999999998
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.98 Aligned_cols=260 Identities=22% Similarity=0.287 Sum_probs=190.5
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
++|.+.+.||+|+||.||++... ++..||+|++..... ..+.+|+. +++.++|+||++++++|.+++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCcc
Confidence 45778889999999999998653 468999999875432 22334444 78899999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+++|| |+.+|+|.+++............. ..............+++.++++++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~L~~~l~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l 146 (288)
T cd05050 84 CLLFE----------YMAYGDLNEFLRHRSPRAQCSLSH-------STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL 146 (288)
T ss_pred EEEEe----------cCCCCCHHHHHHHcCccccccccc-------cccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 99999 777888888876432211000000 0000000112234588999999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+++||||||+||+++.++. ++|+|||+++........ ........+..|+|||.+.+..++.++|||||||++|
T Consensus 147 H~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 223 (288)
T cd05050 147 SERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223 (288)
T ss_pred HhCCeecccccHhheEecCCCc--eEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHH
Confidence 9999999999999999977754 999999998865432211 1112223467899999999899999999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGE-SFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~-~~~~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++.+..||.+ ..++....+.... ...+...+.++.+||.+||+.||++|
T Consensus 224 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 276 (288)
T cd05050 224 EIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999843556644 3444333333333 23355678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.14 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=185.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCc--EEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~--~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~L 544 (753)
+.|.+.+.||+|+||.||+|... ++. .+|+|+++.... ....+|+. ++..+ +|+||+++++++.+++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~-~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHH-HHHHhcCCCCcceEEEEECCCCCceE
Confidence 45778899999999999999764 344 568887764322 23344555 55666 89999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++++.......... ..........+++.+++.++.|++.||+|||+
T Consensus 86 v~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 142 (303)
T cd05088 86 AIE----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 142 (303)
T ss_pred EEE----------eCCCCcHHHHHHhccccccccc-------------ccccccccCcCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 8888899988875432110000 00000122458899999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++ .+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||
T Consensus 143 ~gi~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 216 (303)
T cd05088 143 KQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred CCccccccchheEEecCCC--cEEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHH
Confidence 9999999999999997765 4999999998643211 111122346789999999888899999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++.+||..... .....+... ....+...++++.++|.+||+.||++|
T Consensus 217 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 267 (303)
T cd05088 217 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 267 (303)
T ss_pred HhcCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9833677765433 333333222 223445578899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.73 Aligned_cols=240 Identities=26% Similarity=0.352 Sum_probs=183.5
Q ss_pred ceEEEeEEecccCceEEEEEEe-----eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC--ce
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DF 541 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-----~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~ 541 (753)
+.|++.+.||+|+||.||++.. .++..||+|.++.... ..+.+|+. +++.++|+||+++++++.+. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEecCCCCc
Confidence 3467788999999999999853 4588999999864432 23344555 78999999999999998775 56
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+++|+|.+++... ...+++..++.++.|++.||+|
T Consensus 83 ~~lv~e----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~i~~aL~~ 124 (284)
T cd05079 83 IKLIME----------FLPSGSLKEYLPRN----------------------------KNKINLKQQLKYAVQICKGMDY 124 (284)
T ss_pred eEEEEE----------ccCCCCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 88888998887432 1246788899999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+||+++.++. +||+|||+++................++..|+|||.+.+..++.++|||||||++
T Consensus 125 lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il 202 (284)
T cd05079 125 LGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202 (284)
T ss_pred HHHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhh
Confidence 99999999999999999977765 8999999998765432222222334567789999999888899999999999999
Q ss_pred HHHHhCCCCCCCCC---------------hHHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGES---------------FERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~---------------~~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|++.+.+... .......... .....+..+++++.+||.+||+.||++|
T Consensus 203 ~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 270 (284)
T cd05079 203 YELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKR 270 (284)
T ss_pred hhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccC
Confidence 99999744322110 0111111111 2223455678999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=286.48 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=184.9
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-C---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-G---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..|.+.+.||+|+||.||+|.... + ..||||.+...... .+..|+. +++.++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCcCcceEEEEECCCCceEE
Confidence 347788999999999999987653 3 36999998754322 3334444 7788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++... ...+++.+++.++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~l~~al~~lH~ 124 (269)
T cd05065 83 ITE----------FMENGALDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYLSE 124 (269)
T ss_pred EEe----------cCCCCcHHHHHhhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 77788888887532 1346788899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccC--CCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~--~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
.+++||||||+||+++.++ .+||+|||++................ ..+..|+|||.+.+..++.++|||||||++|
T Consensus 125 ~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ 202 (269)
T cd05065 125 MNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMW 202 (269)
T ss_pred CCEeecccChheEEEcCCC--cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHH
Confidence 9999999999999996654 59999999988665432211111111 1245799999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESF-ERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~-~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+++.+.+||.... ......+.. ...+.+..++.++.+++.+||..+|.+|
T Consensus 203 e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (269)
T cd05065 203 EVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNAR 255 (269)
T ss_pred HHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 99873366775543 333333322 2334456778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=309.14 Aligned_cols=200 Identities=31% Similarity=0.357 Sum_probs=164.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCC-C-----CceeeecccccCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-H-----PNIVRWYGVESDQ 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-H-----pNIV~L~g~~~~~ 539 (753)
+.+..+|.+.+.||+|+||.|.++.+. +++.||||+++... ..+...|+. +|..++ | -|+|++++|+...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~-iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIR-ILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHH-HHHHHhccCCCCCeeEEEeeeccccc
Confidence 445558999999999999999999664 59999999997653 234444554 556655 3 4899999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+++|||+|+...+| +++|... +-.+++...+..|+.||+.||
T Consensus 261 ~HlciVfELL~~NL-----------YellK~n---------------------------~f~Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 261 NHLCIVFELLSTNL-----------YELLKNN---------------------------KFRGLSLPLVRKFAQQILTAL 302 (586)
T ss_pred cceeeeehhhhhhH-----------HHHHHhc---------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 99999999666554 4444432 245789999999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.+||+.+|||+||||+||||..-+...+||+|||.+........ +.+-+..|+|||++.+.+|+.+.|||||||
T Consensus 303 ~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 303 LFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred HHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce------eeeeccccccchhhccCCCCCccceeehhh
Confidence 99999999999999999999888888999999999998765432 334577899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 004442 700 ILFFCITGGKHPYGE 714 (753)
Q Consensus 700 vL~EllTG~~~Pf~~ 714 (753)
|+.||++| .|-|.+
T Consensus 377 IlAEL~tG-~PLfpG 390 (586)
T KOG0667|consen 377 ILAELFTG-EPLFPG 390 (586)
T ss_pred hHHhHhcC-ccccCC
Confidence 99999999 555543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=284.77 Aligned_cols=234 Identities=25% Similarity=0.365 Sum_probs=183.5
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
+.|++.+.||+|+||.||++. ..++.||+|.++.......+..+..+++.++|+||+++++++.+. ..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e----- 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME----- 78 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE-----
Confidence 457888999999999999875 478899999987654333333334478899999999999998765 4799999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+.+|+|.+++.... ...+++..+++++.|++.||.|||+.+++||||
T Consensus 79 -----~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl 126 (254)
T cd05083 79 -----LMSKGNLVNFLRTRG---------------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126 (254)
T ss_pred -----CCCCCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 777888888875421 234678888999999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf 712 (753)
||+||+++.++ .+||+|||+++...... .....+..|+|||.+.+..++.++|||||||++|||++++.+||
T Consensus 127 ~p~nili~~~~--~~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~ 198 (254)
T cd05083 127 AARNILVSEDG--VAKVSDFGLARVGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198 (254)
T ss_pred CcceEEEcCCC--cEEECCCccceeccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999997765 49999999997653221 11224678999999988899999999999999999998447788
Q ss_pred CCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 713 GESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 713 ~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..... .....+... ....+..+++++.++|.+||+.+|++|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 241 (254)
T cd05083 199 PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKR 241 (254)
T ss_pred ccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhC
Confidence 65533 333333332 223345678899999999999999988
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=287.61 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=183.6
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCceeeeccccc-----CCc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVES-----DQD 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~L~g~~~-----~~~ 540 (753)
.+.++|++.+.||+|+||.||++... +++.+|+|.+..... .....|+. ++..+ +|+||++++++|. +.+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~ 93 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN-ILKALSDHPNVVKFYGMYYKKDVKNGD 93 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHH-HHHHHhcCCCeeeeeeeeeecccCCCC
Confidence 34577889999999999999998664 588999999865332 23344554 55666 7999999999874 346
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++++.... ....+++..+..++.|++.||.
T Consensus 94 ~~~lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 94 QLWLVLE----------LCNGGSVTDLVKGFLK-------------------------RGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred eEEEEEe----------ecCCCCHHHHHHHhhc-------------------------cCccccHHHHHHHHHHHHHHHH
Confidence 7899999 8888888887754211 1245778889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----CCCCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIw 695 (753)
|||+.+|+||||||+||+++.++. +||+|||+++....... ......|+..|+|||++.. ..++.++|||
T Consensus 139 ~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 213 (286)
T cd06638 139 HLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213 (286)
T ss_pred HHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhh
Confidence 999999999999999999987765 99999999987643211 1223458999999998753 4478999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHccC---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| +.||..... .......... ...+..++.++.++|.+||+.||++|
T Consensus 214 slGvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd06638 214 SLGITAIELGDG-DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274 (286)
T ss_pred hHHHHHHHHhcC-CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccC
Confidence 999999999998 566655432 2222111111 11233467889999999999999998
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=285.96 Aligned_cols=233 Identities=27% Similarity=0.443 Sum_probs=189.8
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+|++.+.||+|+||.||++... +++.||+|.+.+.. .+...+|++ .++.++||||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERR-ILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHH-HHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 3678899999999999999775 58999999996432 123344444 788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+++|.+++... ..+++..+..++.|++.||.|||+.+
T Consensus 80 e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~ 120 (258)
T cd05578 80 D----------LLLGGDLRYHLSQK-----------------------------VKFSEEQVKFWICEIVLALEYLHSKG 120 (258)
T ss_pred e----------CCCCCCHHHHHHhc-----------------------------CCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 77788888877432 35677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
++|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 121 i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 194 (258)
T cd05578 121 IIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194 (258)
T ss_pred eeccCCCHHHeEEcCCCC--EEEeecccccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHh
Confidence 999999999999977765 8999999988764332 1233457889999999988889999999999999999999
Q ss_pred CCCCCCCCCh---HHH-HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF---ERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~---~~~-~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||.... ... ...........+...++++.++|.+||+.||++|
T Consensus 195 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (258)
T cd05578 195 G-KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKR 244 (258)
T ss_pred C-CCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHc
Confidence 8 66776543 222 2222224556677788999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.25 Aligned_cols=238 Identities=22% Similarity=0.373 Sum_probs=185.4
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.|.+.+.||+|+||.||++.. .+++.+|||.+.... .....+|+. +++.++|+||+++++++.+.+..+++|
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEID-LLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHH-HHHHccCCchhhhhheeEeCCeEEEEE
Confidence 466778899999999999875 579999999886422 123334444 778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |.++|+|.+++..... ....+++..+++++.+++.||.|||+.+
T Consensus 82 e----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 126 (267)
T cd08229 82 E----------LADAGDLSRMIKHFKK-------------------------QKRLIPEKTVWKYFVQLCSALEHMHSRR 126 (267)
T ss_pred E----------ecCCCCHHHHHHHhhc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7778888887753211 1245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
++|+||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++||||||+++|||++
T Consensus 127 i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 201 (267)
T cd08229 127 VMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred eecCCCCHHHEEEcCCCC--EEECcchhhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh
Confidence 999999999999977654 99999999887643221 1123458899999999998889999999999999999999
Q ss_pred CCCCCCCCChHH---HHHHHHccC-ccc-ccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFER---DANIVKDRK-DLF-LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~---~~~~i~~~~-~~~-~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||...... ....+.... ... ...+++++.++|.+||+.||++|
T Consensus 202 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T cd08229 202 L-QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252 (267)
T ss_pred C-CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccC
Confidence 8 5576543221 112222111 222 23467899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=287.66 Aligned_cols=240 Identities=25% Similarity=0.365 Sum_probs=185.0
Q ss_pred EecccCceEEEEEEeeC-------CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 480 EIAKGSNGTVVLEGNYE-------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~-------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.||+|+||.||++...+ ++.+|||.+.... ...+.+|+. +++.++|+||++++++|.+.+..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH-LMSNFNHPNIVKLLGVCLLNEPQYIIME- 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHH-HHHhcCCCCeeeEeeeecCCCCeEEEEe-
Confidence 58999999999986543 3689999886532 223344444 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.++++...... .....+++.+++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 128 (269)
T cd05044 80 ---------LMEGGDLLSYLRDARVER----------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFI 128 (269)
T ss_pred ---------ccCCCcHHHHHHHhhhcc----------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 888999999987543210 1234478889999999999999999999999
Q ss_pred ccCCCCCcEEEecCC---CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 629 HrDLKp~NILL~~d~---~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||+||+++.++ ...++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||+
T Consensus 129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred cCCCChheEEEecCCCCCCcceEECCcccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 999999999997765 23699999999986643211 11122334578899999999999999999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.+..||....... ...+. ......+...++++.++|.+||.++|++|
T Consensus 208 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (269)
T cd05044 208 TLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSER 257 (269)
T ss_pred HcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccC
Confidence 83367886543322 22222 22334556678899999999999999998
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=291.25 Aligned_cols=235 Identities=21% Similarity=0.302 Sum_probs=177.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.|.+.+.||+|+||.||++... +++.||+|.+.... .....+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHH-HHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 46888899999999999998664 58999999986432 123445554 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||.+ +|.+++... ...+++..+..++.|++.||+|||+.+|
T Consensus 85 ~~~~-----------~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (301)
T cd07873 85 YLDK-----------DLKQYLDDC----------------------------GNSINMHNVKLFLFQLLRGLNYCHRRKV 125 (301)
T ss_pred cccc-----------CHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5543 455544321 2346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||++........ ......+++.|+|||.+.+. .++.++|||||||++|||+|
T Consensus 126 ~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred eCCCCCHHHEEECCCCc--EEECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 99999999999977765 99999999976532211 11223468999999988764 47899999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHcc-------------------C---c--------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDR-------------------K---D--------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~-------------------~---~--------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||..... .....+... . . ......++++.+||.+||+.||.+|
T Consensus 201 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 277 (301)
T cd07873 201 G-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKR 277 (301)
T ss_pred C-CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccC
Confidence 8 667755432 211111000 0 0 0112457789999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=292.11 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=187.5
Q ss_pred ceEEEeEEecccCceEEEEEEee-----------------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceee
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-----------------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~ 531 (753)
++|++.+.||+|+||.||++... ++..||+|++..... ..+.+|+. +++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCcce
Confidence 46888999999999999987432 245799999875432 23445554 778999999999
Q ss_pred ecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 532 L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
+++++.+.+..+++|| |+.+|+|.+++......... .......+++.+++++
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~------------------~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 84 LLAVCITSDPLCMITE----------YMENGDLNQFLSRHEPQEAA------------------EKADVVTISYSTLIFM 135 (296)
T ss_pred EEEEEecCCccEEEEE----------eCCCCcHHHHHHhcCccccc------------------ccccccccCHHHHHHH
Confidence 9999999999999999 77888888888654321110 0123445888999999
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k 691 (753)
+.|++.||+|||+.+|+||||||+||+++.++ .++|+|||+++.+...... .......++..|+|||......++.+
T Consensus 136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNY--TIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHCCeecccCChheEEEcCCC--CEEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccch
Confidence 99999999999999999999999999997665 4999999999866432211 11122234678999999888889999
Q ss_pred hhHHHHHHHHHHHHhC-CCCCCCCChH-HHHHHHH--------ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITG-GKHPYGESFE-RDANIVK--------DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG-~~~Pf~~~~~-~~~~~i~--------~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||+++ +..||..... +...... ....+.+..+++.+.+||.+||+.||++|
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 284 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKER 284 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 9999999999999984 3677765432 2111110 11123345567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=281.53 Aligned_cols=236 Identities=25% Similarity=0.368 Sum_probs=189.1
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||.||.+.. .+++.+|+|.+.... ...+.+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV-ILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHH-HHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 367889999999999988754 458999999876432 223455654 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.++
T Consensus 80 ----------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08221 80 ----------YANGGTLYDKIVRQK---------------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGI 122 (256)
T ss_pred ----------ecCCCcHHHHHHhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 777888888875321 2356788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||+|+||+++.++. +||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|||++|
T Consensus 123 ~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 123 LHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred cccCCChHhEEEeCCCC--EEECcCcceEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence 99999999999987765 99999999987654332 22344589999999999888899999999999999999999
Q ss_pred CCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||..... .....+... ....+..++.++.++|.+||..||++|
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (256)
T cd08221 198 -KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKR 244 (256)
T ss_pred -CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccC
Confidence 557765433 333333333 233345678899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=289.37 Aligned_cols=238 Identities=24% Similarity=0.339 Sum_probs=184.7
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
..+.|++.+.||+|+||.||++... +++.||+|.+...... ...+|+. +++.++|+||+++++++..++..++||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 3456788899999999999999765 4899999998755422 2334444 778999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|..++... ...+++..++.++.|++.||+|||+.+
T Consensus 89 e----------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~ 130 (292)
T cd06644 89 E----------FCPGGAVDAIMLEL----------------------------DRGLTEPQIQVICRQMLEALQYLHSMK 130 (292)
T ss_pred e----------cCCCCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 9 77778887765432 234778899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL 701 (753)
|+||||||+||+++.++. +||+|||++....... .......++..|+|||.+. ...++.++|||||||++
T Consensus 131 i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 131 IIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred eeecCCCcceEEEcCCCC--EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 999999999999977665 9999999987643321 1122345788999999884 34568899999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF-ERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~-~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| .+||.... ............ ..+..++.++.++|++||+.||++|
T Consensus 206 ~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 260 (292)
T cd06644 206 IEMAQI-EPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR 260 (292)
T ss_pred HHHhcC-CCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccC
Confidence 999999 56775532 222222222221 2345677899999999999999998
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=281.87 Aligned_cols=236 Identities=25% Similarity=0.423 Sum_probs=188.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||.||++... +|+.||+|++.... .....+|+. +++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHH-HHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 3678899999999999998654 68999999986421 123444544 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++.... ...+++.++++++.|++.||.|||+.++
T Consensus 80 ----------~~~~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (256)
T cd08218 80 ----------YCEGGDLYKKINAQR---------------------------GVLFPEDQILDWFVQICLALKHVHDRKI 122 (256)
T ss_pred ----------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 777888888775321 2346778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||+|+||+++.++. ++|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 123 ~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08218 123 LHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197 (256)
T ss_pred ecCCCCHHHEEEcCCCC--EEEeeccceeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC
Confidence 99999999999976654 99999999987644321 11234578899999999988899999999999999999999
Q ss_pred CCCCCCCC-hHHHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES-FERDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~-~~~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||... .......+ .......+..++.++.++|.+||+++|++|
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08218 198 -KHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDR 244 (256)
T ss_pred -CCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhC
Confidence 5566543 33333222 333344566788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=282.75 Aligned_cols=236 Identities=25% Similarity=0.389 Sum_probs=184.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+.|.+.+.||+|+||.||++... +++.+|+|.+..... +...+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~l~~e- 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS-MLKECRHPNIVAYFGSYLRRDKLWIVME- 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHH-HHHhCCCCChhceEEEEEeCCEEEEEEe-
Confidence 56888899999999999999764 578999999875432 23344444 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|..+++|.+++... ...+++.++..++.|++.||+|||+.+|+
T Consensus 81 ---------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 123 (262)
T cd06613 81 ---------YCGGGSLQDIYQVT----------------------------RGPLSELQIAYVCRETLKGLAYLHETGKI 123 (262)
T ss_pred ---------CCCCCcHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 77777777766432 13577888899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC---CCCchhhHHHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDIwSfGvvL~Ell 705 (753)
|+||+|+||+++.++. +||+|||++....... .......++..|+|||.+.+. .++.++|||||||++|||+
T Consensus 124 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 124 HRDIKGANILLTEDGD--VKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ecCCChhhEEECCCCC--EEECccccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999987765 8999999988654321 112234578899999999777 7899999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHcc--Cc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF-ERDANIVKDR--KD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~-~~~~~~i~~~--~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||.... .......... .. .....++.++.++|++||..||.+|
T Consensus 199 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 251 (262)
T cd06613 199 EL-QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR 251 (262)
T ss_pred hC-CCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhC
Confidence 98 66765543 2222222221 11 1233456789999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=289.40 Aligned_cols=234 Identities=25% Similarity=0.321 Sum_probs=182.2
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
|++.+.||+|+||.||++... ++..+|+|.+..... ....+|+. +++.++|+||+++++++.+++..++|+|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~~v~e--- 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIE--- 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHH-HHHHCCCCCeeeEEEEEeeCCEEEEEEE---
Confidence 455677999999999998765 478899999865432 23344554 7788999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|..+|+|..+++.. ...+++..+..++.|++.||.|||+.+|+||
T Consensus 83 -------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~ 127 (282)
T cd06643 83 -------FCAGGAVDAVMLEL----------------------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127 (282)
T ss_pred -------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 77778887766432 2357888899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHHHH
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~Ell 705 (753)
||||+||+++.++. +||+|||++....... .......++..|+|||++. +..++.++|||||||++|||+
T Consensus 128 dlkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 128 DLKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred CCCcccEEEccCCC--EEEccccccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 99999999977765 9999999987654321 1122345899999999884 445788999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHccC---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-RDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-~~~~~i~~~~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||..... .......... ...+..++.++.++|.+||++||++|
T Consensus 203 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (282)
T cd06643 203 QI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDAR 253 (282)
T ss_pred cC-CCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 98 567765432 2222222221 12345678899999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=290.83 Aligned_cols=241 Identities=17% Similarity=0.203 Sum_probs=170.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCchH-----------HHHHHH--HHHHhCCCCceee
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDV-----------ALKEIQ--NLIASDQHPNIVR 531 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~~-----------~~~Ei~--~ll~~l~HpNIV~ 531 (753)
+...++|.+.+.||+|+||+||+|...+ +..+|+|......... ...++. ..+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3445789999999999999999997654 3456666533221110 001111 1234678999999
Q ss_pred ecccccCCc----eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHH
Q 004442 532 WYGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (753)
Q Consensus 532 L~g~~~~~~----~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 607 (753)
+++++.... ..++++|++..++.++ +.. ....++..
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~-----------------------------~~~~~~~~ 127 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVENTKEI-----------FKR-----------------------------IKCKNKKL 127 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhccCHHHH-----------HHh-----------------------------hccCCHHH
Confidence 999766543 4577888544333222 211 12245667
Q ss_pred HHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc----cccCccCCCCccccccccc
Q 004442 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQL 683 (753)
Q Consensus 608 ~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l 683 (753)
+..|+.|++.||+|||+.+|+||||||+|||++.++ .++|+|||+|+........ ........||+.|+|||+.
T Consensus 128 ~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~ 205 (294)
T PHA02882 128 IKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH 205 (294)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence 889999999999999999999999999999997665 4899999999876432111 1112234699999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHH--------HHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDA--------NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 684 ~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~--~~~--------~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+..++.++|||||||++|||++| .+||..... ... ..+... .......++++.++++.||..+|++|
T Consensus 206 ~~~~~~~~~DiwSlG~~l~el~~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~r 283 (294)
T PHA02882 206 NGACVTRRGDLESLGYCMLKWAGI-KLPWKGFGHNGNLIHAAKCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEK 283 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhC-CCCCCccccchHHHHHhHHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998 789865521 111 111111 12344567899999999999999998
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=280.51 Aligned_cols=237 Identities=22% Similarity=0.332 Sum_probs=189.1
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|.+.+.||+|+||.||++... +++.+|||.+.... ....+..+..+++.++|+||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME- 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe-
Confidence 3678899999999999998654 68999999986532 12233333447899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++.... ...+++..+++++.+++.||.|||+++|+
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 123 (256)
T cd08220 80 ---------YAPGGTLAEYIQKRC---------------------------NSLLDEDTILHFFVQILLALHHVHTKLIL 123 (256)
T ss_pred ---------cCCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 888889988886432 23477888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||+|+||+++.++ ..+||+|||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 124 h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~- 197 (256)
T cd08220 124 HRDLKTQNILLDKHK-MVVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL- 197 (256)
T ss_pred cCCCCHHHEEEcCCC-CEEEEccCCCceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC-
Confidence 999999999997654 358999999998765331 12234578999999999988899999999999999999998
Q ss_pred CCCCCCChH-HHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||..... .....+ .......+..+++++.++|.+||..||++|
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 244 (256)
T cd08220 198 KRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244 (256)
T ss_pred CCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhC
Confidence 567765432 222222 223344566788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=291.71 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=186.3
Q ss_pred ceEEEeEEecccCceEEEEEEeeC---------------CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeec
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE---------------GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWY 533 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~---------------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~ 533 (753)
++|.+.+.||+|+||.||++.... ...||||.+..... ..+.+|+. +++.++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCcCeEE
Confidence 467888999999999999875432 23589999875432 23444555 78999999999999
Q ss_pred ccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 534 g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
+++...+..++||| |+.+|+|.+++......... ........+++.++++++.
T Consensus 84 ~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~~~i~~ 136 (295)
T cd05097 84 GVCVSDDPLCMITE----------YMENGDLNQFLSQREIESTF-----------------THANNIPSVSIANLLYMAV 136 (295)
T ss_pred EEEcCCCccEEEEe----------cCCCCcHHHHHHhccccccc-----------------cccccCCcccHHHHHHHHH
Confidence 99999999999999 88888998888643211000 0001223478889999999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhh
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksD 693 (753)
|++.||+|||+.+++||||||+||+++.++ .+||+|||++........ ........++..|+|||.+.+..++.++|
T Consensus 137 ~i~~al~~lH~~~i~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 137 QIASGMKYLASLNFVHRDLATRNCLVGNHY--TIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHhcCeeccccChhhEEEcCCC--cEEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhh
Confidence 999999999999999999999999997665 499999999986543211 11122234577899999999889999999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCChHHH-HHHHH----c----cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITG-GKHPYGESFERD-ANIVK----D----RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG-~~~Pf~~~~~~~-~~~i~----~----~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||+++ +..||....... ..... . .....+...++.+.+||.+||+.||++|
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 283 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDR 283 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 99999999999984 356776543222 11111 0 1122344567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=285.32 Aligned_cols=236 Identities=29% Similarity=0.362 Sum_probs=180.3
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCceeeecccccC--CceE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~ 542 (753)
.|...+.||+|+||.||++... .+..||+|++.... . ....+|+ .+++.++|+||+++++++.+ .+..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEI-QLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHH-HHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4667789999999999999764 58999999986431 1 1233444 47889999999999998765 4678
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++++| |.++++|.+++... ..+++..++.++.|++.||+||
T Consensus 82 ~l~~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~L 122 (266)
T cd06651 82 TIFME----------YMPGGSVKDQLKAY-----------------------------GALTESVTRKYTRQILEGMSYL 122 (266)
T ss_pred EEEEe----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77788888877432 2366778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++ .+||+|||+++................++..|+|||.+.+..++.++|||||||++|
T Consensus 123 H~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~ 200 (266)
T cd06651 123 HSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVV 200 (266)
T ss_pred HhCCeeeCCCCHHHEEECCCC--CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHH
Confidence 999999999999999997665 499999999986643211111222345789999999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHH--HHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~--~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||........ ...... ....+...++.+.++| +||..||++|
T Consensus 201 el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~R 252 (266)
T cd06651 201 EMLTE-KPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHR 252 (266)
T ss_pred HHHHC-CCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhC
Confidence 99998 678865532221 111111 2334556678899999 5777899998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=298.76 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=187.7
Q ss_pred cceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCC-
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQ- 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~- 539 (753)
.++|.+.+.||+|+||.||+|.. ..++.||||+++.... ....+|+. ++..+ +|+||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK-ILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHH-HHHhccCCccHhhhcceeecCC
Confidence 35688899999999999999853 4578999999975332 23456666 55665 789999999988654
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchh-----------------hhhhh-hc----------------
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL-----------------NEVRI-RL---------------- 585 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~-----------------~~~~~-~~---------------- 585 (753)
...+++|| |+.+|+|.++++......... .+... +.
T Consensus 85 ~~~~lv~e----------y~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 85 GPLMVIVE----------FCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred CceEEEEe----------ccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 56899999 666777777776432111000 00000 00
Q ss_pred ----ccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCC
Q 004442 586 ----LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661 (753)
Q Consensus 586 ----~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~ 661 (753)
.................+++.++.+++.|++.||+|||+.+|+||||||+||+++.++ .+||+|||++......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~ 232 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKD 232 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccC
Confidence 0000000011112234688999999999999999999999999999999999997665 4999999999876432
Q ss_pred CcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHc-cCcccccCCCHHH
Q 004442 662 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKD-RKDLFLVEHIPEA 738 (753)
Q Consensus 662 ~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~-~~~~~~~~~s~el 738 (753)
... .......++..|+|||.+.+..++.++||||||+++|||++++..||.... ......+.. .....+...++++
T Consensus 233 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (343)
T cd05103 233 PDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 311 (343)
T ss_pred cch-hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHH
Confidence 211 111223356789999999988999999999999999999984477886532 122222222 2233455567899
Q ss_pred HHHHHHccccCcCCC
Q 004442 739 VDLFTRLLDPNPDLR 753 (753)
Q Consensus 739 ~dLI~~cL~~DP~~R 753 (753)
.+++.+||+.||++|
T Consensus 312 ~~~~~~cl~~~p~~R 326 (343)
T cd05103 312 YQTMLDCWHGEPSQR 326 (343)
T ss_pred HHHHHHHccCChhhC
Confidence 999999999999998
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=295.78 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=191.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeC--------CcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
..+|++.+.||+|+||.||++.... +..||+|.+..... ....+|+. ++..+ +|+||++++++|.+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHH-HHHhhcCCCCeeeeeEEEcc
Confidence 3568899999999999999986421 34799998875332 23455555 66666 89999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..+++|| |+++|+|.+++.......... ...........+++.++++++.|++.|
T Consensus 90 ~~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~a 146 (334)
T cd05100 90 DGPLYVLVE----------YASKGNLREYLRARRPPGMDY-------------SFDTCKLPEEQLTFKDLVSCAYQVARG 146 (334)
T ss_pred CCceEEEEe----------cCCCCcHHHHHHhcCCccccc-------------ccccccCccccCCHHHHHHHHHHHHHH
Confidence 999999999 778888888886532110000 000000123458889999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+||+++.++. +||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 147 l~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 223 (334)
T cd05100 147 MEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223 (334)
T ss_pred HHHHHHCCeeccccccceEEEcCCCc--EEECCcccceeccccccc-ccccCCCcCceEcCHHHhccCCcCchhhhHHHH
Confidence 99999999999999999999977654 999999999876432111 111223346789999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++++.+||.... +.....+... ....+..++.++.++|.+||+.+|++|
T Consensus 224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 999999995577886653 3333333332 334556778899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=288.72 Aligned_cols=227 Identities=25% Similarity=0.362 Sum_probs=176.0
Q ss_pred EecccCceEEEEEEee-CCcEEEEEEeecCC-----chHH-HHHH--HHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 480 EIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVA-LKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~-~~Ei--~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.||+|+||.||++... +++.+|||.+.+.. .... .+|. ..++...+|+||+.+.+++.+++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e--- 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD--- 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe---
Confidence 3899999999998765 58999999886432 1122 2222 123445689999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 78 -------~~~~~~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 121 (279)
T cd05633 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121 (279)
T ss_pred -------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCC
Confidence 8888888887643 2357888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||||+||+++.++ .++|+|||++....... .....|+..|+|||.+.. ..++.++|||||||++|||++| .
T Consensus 122 dikp~Nil~~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~ 193 (279)
T cd05633 122 DLKPANILLDEHG--HVRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG-H 193 (279)
T ss_pred CCCHHHEEECCCC--CEEEccCCcceeccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC-C
Confidence 9999999997665 49999999987553221 123458999999998864 5589999999999999999998 5
Q ss_pred CCCCCChH----HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~----~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||..... .............+..+++++.++|++||++||++|
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 241 (279)
T cd05633 194 SPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241 (279)
T ss_pred CCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHh
Confidence 67754321 111122222334566788999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=299.82 Aligned_cols=236 Identities=26% Similarity=0.383 Sum_probs=195.2
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|..-++||+|+||.||-... ..|+.+|.|++.+.. ....+.|-+ ++.++..+.||.|--.+...+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~-iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQ-ILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHH-HHHHhccCcEEEEeeeecCCCceEEE
Confidence 4467778999999999996544 459999999885432 223455554 78999999999998778889999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+. .|.+|+|.-+|.. ....++++..++-+|.+|+.||++||+.
T Consensus 264 Lt----------lMNGGDLkfHiyn---------------------------~g~~gF~e~ra~FYAAEi~cGLehlH~~ 306 (591)
T KOG0986|consen 264 LT----------LMNGGDLKFHIYN---------------------------HGNPGFDEQRARFYAAEIICGLEHLHRR 306 (591)
T ss_pred EE----------eecCCceeEEeec---------------------------cCCCCCchHHHHHHHHHHHhhHHHHHhc
Confidence 99 8899998876643 2346899999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+||+|||||+||||+++|+ ++|+|+|||..+..+. ....++||.+|||||++.+..|+...|.|||||+||||+
T Consensus 307 ~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 307 RIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred ceeeccCChhheeeccCCC--eEeeccceEEecCCCC----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence 9999999999999977776 9999999999886542 234458999999999999999999999999999999999
Q ss_pred hCCCCCCCCChH-----HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-----~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.| +.||....+ +.-..+......++..++++++++.+.+|.+||++|
T Consensus 381 ~G-~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~R 432 (591)
T KOG0986|consen 381 AG-HSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKR 432 (591)
T ss_pred cc-cCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHh
Confidence 99 678865433 233344445556678899999999999999999988
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=296.55 Aligned_cols=199 Identities=21% Similarity=0.279 Sum_probs=156.3
Q ss_pred EeEEeccc--CceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 477 FNKEIAKG--SNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 477 i~~~IG~G--~fG~Vyka~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
+.++||+| +|++||++.. .+|+.||||++.... ....++++..+++.++||||++++++|.+++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e-- 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS-- 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe--
Confidence 34679999 7889999865 568999999997542 12344444558888999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++.... ...+++..+++++.|++.||+|||+.+|+|
T Consensus 80 --------~~~~~~l~~~~~~~~---------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 124 (327)
T cd08227 80 --------FMAYGSAKDLICTHF---------------------------MDGMSELAIAYILQGVLKALDYIHHMGYVH 124 (327)
T ss_pred --------ccCCCcHHHHHHhhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 888888888875321 234788889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccC--CCCCchhhHHHHHHHHHH
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIwSfGvvL~E 703 (753)
|||||+|||++.++. ++++|||.+.......... .......++..|+|||++.+ ..++.++|||||||++||
T Consensus 125 ~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~e 202 (327)
T cd08227 125 RSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 202 (327)
T ss_pred CCCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHH
Confidence 999999999987765 8999998755432111100 01122346788999999976 458999999999999999
Q ss_pred HHhCCCCCCCCC
Q 004442 704 CITGGKHPYGES 715 (753)
Q Consensus 704 llTG~~~Pf~~~ 715 (753)
|++| ..||...
T Consensus 203 l~~g-~~pf~~~ 213 (327)
T cd08227 203 LANG-HVPFKDM 213 (327)
T ss_pred HHHC-CCCCCCc
Confidence 9998 6788654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=281.11 Aligned_cols=232 Identities=28% Similarity=0.374 Sum_probs=183.6
Q ss_pred EecccCceEEEEEEeeCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhh
Q 004442 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
.||+|+||.||++...+++.||+|.+...... .+.+|+ .+++.++|+||+++++++.+....++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e-------- 72 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEA-EILKQYDHPNIVKLIGVCVQKQPIYIVME-------- 72 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCCeEEEEE--------
Confidence 58999999999998877999999998754322 333444 47899999999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~ 635 (753)
|+.+++|.+++... ...+++..++.++.+++.||+|||+++++||||||+
T Consensus 73 --~~~~~~l~~~l~~~----------------------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ 122 (251)
T cd05041 73 --LVPGGSLLTFLRKK----------------------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122 (251)
T ss_pred --cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcc
Confidence 77888888887532 124567788999999999999999999999999999
Q ss_pred cEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 636 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 636 NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
||+++.++. +||+|||++......... .......++..|+|||.+.+..++.++|||||||++|||+|++..||...
T Consensus 123 nili~~~~~--~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 123 NCLVGENNV--LKISDFGMSREEEGGIYT-VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred eEEEcCCCc--EEEeeccccccccCCcce-eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 999977654 999999999865432111 11112234677999999988889999999999999999999657888665
Q ss_pred hHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 716 FER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 716 ~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... ....+... ....+...+.++.++|.+||..+|++|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 239 (251)
T cd05041 200 SNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENR 239 (251)
T ss_pred CHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhC
Confidence 433 33333332 233455678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=290.79 Aligned_cols=239 Identities=24% Similarity=0.362 Sum_probs=188.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
....++|.+.+.||+|+||.||++.. .+++.||+|.+..... ...+.++..+++.++|+||+++++++...+..++|
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 33447788999999999999999975 4699999999864332 22333333478899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ..+++.++.+++.|++.||.|||+.
T Consensus 95 ~e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~l~~~L~~LH~~ 134 (297)
T cd06656 95 ME----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALDFLHSN 134 (297)
T ss_pred ec----------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 8888888887642 2356778899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. ++|+|||++........ ......+++.|+|||.+.+..++.++|||||||++|+++
T Consensus 135 ~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~ 209 (297)
T cd06656 135 QVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209 (297)
T ss_pred CcccCCCCHHHEEECCCCC--EEECcCccceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999977764 99999999987644321 122345789999999999888999999999999999999
Q ss_pred hCCCCCCCCChHHH-HH-HHHccCc--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-AN-IVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~-~i~~~~~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||....... .. ....... ..+...++.+++||.+||..||++|
T Consensus 210 tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 260 (297)
T cd06656 210 EG-EPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR 260 (297)
T ss_pred hC-CCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 98 66775543211 11 1111111 2345677889999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=282.74 Aligned_cols=237 Identities=28% Similarity=0.362 Sum_probs=181.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----c----hHHHHHHHHHHHhCCCCceeeecccccCC--ce
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DF 541 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~ 541 (753)
..|.+.+.||+|+||.||++... +|..||||.+.... . ....+|+. +++.++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-LLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHH-HHHhcCCCCeeeEEeEeccCCCce
Confidence 35778899999999999998764 48999999885321 1 12233544 78899999999999988763 56
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.+++|| |+++|+|.+++... ..+++..+++++.|++.||+|
T Consensus 81 ~~~v~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~ 121 (265)
T cd06652 81 LSIFME----------HMPGGSIKDQLKSY-----------------------------GALTENVTRKYTRQILEGVSY 121 (265)
T ss_pred EEEEEE----------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHH
Confidence 889999 77788888876432 235677789999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+|+||||+||+++.++. ++|+|||+++................|+..|+|||.+.+..++.++|||||||++
T Consensus 122 lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 199 (265)
T cd06652 122 LHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTV 199 (265)
T ss_pred HHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHH
Confidence 99999999999999999977664 8999999998664321111122334589999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHH-c-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVK-D-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~-~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| ++||..... ....... . .....+...+..+.++|.+||. +|++|
T Consensus 200 ~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~R 252 (265)
T cd06652 200 VEMLTE-KPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLR 252 (265)
T ss_pred HHHhhC-CCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhC
Confidence 999998 667765422 2221111 1 1233455667889999999995 89887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=284.37 Aligned_cols=237 Identities=21% Similarity=0.366 Sum_probs=185.1
Q ss_pred EEEeEEecccCceEEEEEEeeC--CcEEEEEEeecCC---------c----hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH---------H----DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~--g~~VAVK~l~~~~---------~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
|++.+.||+|+||.||++.... ++.+|||.+.... . ....+|+..+.+.++|+||+++++++.+.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5667889999999999997765 7899999885321 1 12445555444568999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..+++|| |+++++|.+++..... ....+++..+++++.|++.||
T Consensus 82 ~~~~lv~e----------~~~~~~l~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~l~~~l 126 (269)
T cd08528 82 DRLYIVMD----------LIEGAPLGEHFNSLKE-------------------------KKQRFTEERIWNIFVQMVLAL 126 (269)
T ss_pred CeEEEEEe----------cCCCCcHHHHHHHHHh-------------------------ccCCCCHHHHHHHHHHHHHHH
Confidence 99999999 7788888887753221 124578888999999999999
Q ss_pred HHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 620 SHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
.|||+ .+++|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.+..++.++||||||
T Consensus 127 ~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 200 (269)
T cd08528 127 RYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFG 200 (269)
T ss_pred HHhccCCceeecCCCHHHEEECCCCc--EEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHH
Confidence 99996 68999999999999977754 8999999998765432 22334588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHHccC-cccc-cCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIVKDRK-DLFL-VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i~~~~-~~~~-~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++|||++| .+||..... .....+.... .+.. ..+++++.++|++||+.||++|
T Consensus 201 ~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 257 (269)
T cd08528 201 CILYQMCTL-QPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257 (269)
T ss_pred HHHHHHHhC-CCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccC
Confidence 999999999 667765432 2222222222 2222 2568899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=285.00 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=189.4
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+.|.+.+.||+|+||.||++... ..+.||+|.+...... ...+|+. +++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD-MFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHH-HHHhcCCcceeeeEEEECCCCcc
Confidence 45677888999999999998753 3578999998654332 3444544 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |.++|+|.++++........ .+...+++..++.++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~L~~~i~~~~~~~~~--------------------~~~~~l~~~~~~~~~~~l~~~l~~L 133 (275)
T cd05046 84 YMILE----------YTDLGDLKQFLRATKSKDEK--------------------LKPPPLSTKQKVALCTQIALGMDHL 133 (275)
T ss_pred eEEEE----------ecCCCcHHHHHHhccccccc--------------------ccccCCCHHHHHHHHHHHHHHHHHh
Confidence 99999 77788888887644311000 1123578899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++. ++|+|||+++...... ........++..|+|||.+.+..++.++||||||+++|
T Consensus 134 H~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~ 209 (275)
T cd05046 134 SNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMW 209 (275)
T ss_pred hhcCcccCcCccceEEEeCCCc--EEEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHH
Confidence 9999999999999999987765 8999999987543221 11222334678899999998888999999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFER-DANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~-~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+++++.+||...... ......... ...+..+++++.++|.+||+.||++|
T Consensus 210 ~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R 263 (275)
T cd05046 210 EVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDR 263 (275)
T ss_pred HHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 9999667888654332 233333222 23355678899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=286.10 Aligned_cols=229 Identities=22% Similarity=0.344 Sum_probs=179.4
Q ss_pred EEEeEE--ecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 475 VVFNKE--IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 475 ~~i~~~--IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
|.+.+. ||+|+||.||++.. .++..+|+|.+..........+...+ ..+|+||+++++++.+.+..++|||
T Consensus 16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~--~~~h~~iv~~~~~~~~~~~~~iv~e---- 89 (267)
T PHA03390 16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL--MKDNPNFIKLYYSVTTLKGHVLIMD---- 89 (267)
T ss_pred hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHH--hhcCCCEEEEEEEEecCCeeEEEEE----
Confidence 344444 59999999999865 45889999998764322211111111 2379999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++... ..+++.++..++.|+++||.|||+.+++|||
T Consensus 90 ------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 134 (267)
T PHA03390 90 ------YIKDGDLFDLLKKE-----------------------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHND 134 (267)
T ss_pred ------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 88888998887532 2578889999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++. .++|+|||+++..... ....++..|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 135 l~p~nil~~~~~~-~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p 205 (267)
T PHA03390 135 IKLENVLYDRAKD-RIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG-KHP 205 (267)
T ss_pred CCHHHEEEeCCCC-eEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC-CCC
Confidence 9999999987761 4999999998865432 123478999999999998999999999999999999998 678
Q ss_pred CCCChHHH-----HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~-----~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|....... ...........+...++.+.+||.+||+.||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (267)
T PHA03390 206 FKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYR 252 (267)
T ss_pred CCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhC
Confidence 76543221 1111233334555788999999999999999998
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=281.66 Aligned_cols=237 Identities=29% Similarity=0.485 Sum_probs=185.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +++.||+|.+..... .....|+ .+++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEM-KVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHH-HHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 4677899999999999998764 689999999875432 1233444 47899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+++|.++++.. ..+++..+..++.++++||+|||+.+|
T Consensus 80 ----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i 120 (264)
T cd06626 80 ----------YCSGGTLEELLEHG-----------------------------RILDEHVIRVYTLQLLEGLAYLHSHGI 120 (264)
T ss_pred ----------cCCCCcHHHHHhhc-----------------------------CCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence 77788888876532 235677889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccccc-CccCCCCccccccccccCCC---CCchhhHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ-NATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFF 703 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~---~t~ksDIwSfGvvL~E 703 (753)
+|+||+|+||+++.++. +||+|||++............ .....++..|+|||++.+.. ++.++||||||+++||
T Consensus 121 ~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~ 198 (264)
T cd06626 121 VHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLE 198 (264)
T ss_pred ccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHH
Confidence 99999999999977654 999999999876543222111 12345788999999998766 8999999999999999
Q ss_pred HHhCCCCCCCCChH--HHHHHHHc-cCcccccCC--CHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE--RDANIVKD-RKDLFLVEH--IPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~--~~~~~i~~-~~~~~~~~~--s~el~dLI~~cL~~DP~~R 753 (753)
+++| ..||..... .....+.. .....+... ++++.++|++||+.||++|
T Consensus 199 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 252 (264)
T cd06626 199 MATG-KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR 252 (264)
T ss_pred HHhC-CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccC
Confidence 9998 668865422 22222222 222333333 7899999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-32 Score=282.87 Aligned_cols=234 Identities=29% Similarity=0.412 Sum_probs=180.4
Q ss_pred eEEecccCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 478 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
...||+|+||.||++... ++..||+|.+...... ...+|+ .+++.++|+||+++++++.+++..++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e------ 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI-ALHSYLKHRNIVQYLGSDSENGFFKIFME------ 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHH-HHHHhcCCCCeeeeeeeeccCCEEEEEEe------
Confidence 357999999999999754 5788999998655322 333444 47899999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.++++.... ....++..+..++.||+.||+|||+.+|+|||||
T Consensus 86 ----~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~ 135 (268)
T cd06624 86 ----QVPGGSLSALLRSKWG--------------------------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135 (268)
T ss_pred ----cCCCCCHHHHHHHhcc--------------------------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 8888889888764311 1112667788999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|+||+++.+. ..++|+|||++........ ......|+..|+|||.+.... ++.++||||||+++|+|++| .+|
T Consensus 136 p~nil~~~~~-~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g-~~p 210 (268)
T cd06624 136 GDNVLVNTYS-GVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG-KPP 210 (268)
T ss_pred HHHEEEcCCC-CeEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC-CCC
Confidence 9999997643 3599999999976643211 112234789999999986644 78999999999999999998 667
Q ss_pred CCCChHHHH---HH-HHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERDA---NI-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~~---~~-i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|........ .. ........+...++++.++|++||+.+|++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 256 (268)
T cd06624 211 FIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKR 256 (268)
T ss_pred CccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhC
Confidence 754322111 11 1122334566788999999999999999998
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=285.29 Aligned_cols=234 Identities=23% Similarity=0.344 Sum_probs=174.6
Q ss_pred EecccCceEEEEEEeeCC---cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 480 EIAKGSNGTVVLEGNYEG---RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g---~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
.||+|+||.||++...++ ..+++|.+..... +.+.+|. .+++.++||||++++++|.+....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQG-DPYRILQHPNILQCLGQCVEAIPYLLVFE----- 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHH-HHHhccCCcchhheEEEecCCCccEEEEe-----
Confidence 599999999999876554 3566776654322 2334444 46788999999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+++|+|.++++.... .....++..+++++.||+.||+|||+.+|+||||
T Consensus 76 -----~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 76 -----YCELGDLKSYLSQEQW-------------------------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred -----cCCCCcHHHHHHhhhc-------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 8888999998865421 1234566677899999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-------CCCCchhhHHHHHHHHHHHH
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~t~ksDIwSfGvvL~Ell 705 (753)
||+|||++.++ .+||+|||++....... .........++..|+|||++.. ..++.++|||||||++|||+
T Consensus 126 kp~nil~~~~~--~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 126 ALRNCFLTSDL--TVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ccceEEEcCCc--cEEecccccccccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 99999997665 49999999986432211 1112234467899999998753 24578999999999999999
Q ss_pred hCCCCCCCCChHH-HHHH-HHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER-DANI-VKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~-~~~~-i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+||...... .... ..... +.....+++.+.+++.+|| .+|++|
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 256 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKR 256 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccC
Confidence 8778888765332 2222 22211 2234457889999999999 689998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=284.84 Aligned_cols=234 Identities=23% Similarity=0.310 Sum_probs=175.0
Q ss_pred EecccCceEEEEEEeeC---CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 480 EIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~---g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
.||+|+||.||+|...+ +..+|+|+++.... ..+.+|+ .+++.++|+||++++|++.+....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEA-QPYRSLQHSNLLQCLGQCTEVTPYLLVME----- 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCCcEEEEE-----
Confidence 58999999999986543 46899999865432 1333444 47899999999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+++|+|.++++..... .....++..+++++.|++.||+|||+.+++||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 126 (269)
T cd05087 76 -----FCPLGDLKGYLRSCRKA------------------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL 126 (269)
T ss_pred -----CCCCCcHHHHHHHhhhc------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 88889999988654321 1123556777899999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-------CCCchhhHHHHHHHHHHHH
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-------RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-------~~t~ksDIwSfGvvL~Ell 705 (753)
||+||+++.++ .+||+|||+++....... ........++..|+|||++.+. .++.++|||||||++|||+
T Consensus 127 kp~nil~~~~~--~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 127 ALRNCLLTADL--TVKIGDYGLSHNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred CcceEEEcCCC--cEEECCccccccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 99999997664 599999999875433211 1112234578899999998642 3578999999999999999
Q ss_pred h-CCCCCCCCChHHHH--HHHHccCc-----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 T-GGKHPYGESFERDA--NIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 T-G~~~Pf~~~~~~~~--~~i~~~~~-----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+ | .+||........ ..+..... ......++++.++|++|| .||++|
T Consensus 204 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~R 257 (269)
T cd05087 204 ELG-SQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQR 257 (269)
T ss_pred hCC-CCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccC
Confidence 7 6 778865433322 11222111 122245678999999999 689998
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-32 Score=284.26 Aligned_cols=234 Identities=26% Similarity=0.383 Sum_probs=180.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|++.+.||+|+||.||++... +|+.||+|++.... . +...+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR-MLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHH-HHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5788899999999999999765 58999999986432 1 22344544 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|++++.|..++.. ...+++..++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~i 121 (286)
T cd07847 81 ----------YCDHTVLNELEKN-----------------------------PRGVPEHLIKKIIWQTLQAVNFCHKHNC 121 (286)
T ss_pred ----------ccCccHHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6666666554321 2347888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 122 IHRDVKPENILITKQGQ--IKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred eecCCChhhEEEcCCCc--EEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999977764 99999999987654321 1123347889999999876 457899999999999999999
Q ss_pred CCCCCCCCChHHH--HHHHHcc----------------------Cc--------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD--ANIVKDR----------------------KD--------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~--~~~i~~~----------------------~~--------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.+..... ....... .. ......++++.+||.+||+.||++|
T Consensus 197 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 274 (286)
T cd07847 197 G-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTER 274 (286)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCcccc
Confidence 8 67876543211 1111000 00 0112457789999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=286.04 Aligned_cols=237 Identities=24% Similarity=0.292 Sum_probs=185.7
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-Cc----EEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GR----SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~----~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..|.+.+.||+|+||.||+|...+ |. .+|+|.+..... ....+|+. +++.++|+||++++++|.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY-VMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEec-CceE
Confidence 567788999999999999987543 33 699998865542 23334444 7788999999999999987 7889
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.++++.. ...+++..+++++.|++.||+|||
T Consensus 85 ~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 85 LITQ----------LMPLGCLLDYVRNH----------------------------KDNIGSQYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEe----------cCCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 88889998887532 224778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++ .+||+|||+++.......... .....++..|+|||.+....++.++|||||||++||
T Consensus 127 ~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05057 127 EKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203 (279)
T ss_pred hCCEEecccCcceEEEcCCC--eEEECCCcccccccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHH
Confidence 99999999999999997665 499999999987653322111 112224678999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CIT-GGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llT-G~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++ | ..||...... ....+... ....+...+.++.+++.+||..||.+|
T Consensus 204 l~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~R 255 (279)
T cd05057 204 LMTFG-AKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESR 255 (279)
T ss_pred HhcCC-CCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999 6 7788765433 33333332 334455677899999999999999988
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.24 Aligned_cols=235 Identities=28% Similarity=0.424 Sum_probs=184.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|++.+.||+|+||.||++... +|+.||+|.+..... ....+|+. ++..++|+||+++++++...+..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD-ILHKAVSPYIVDFYGAFFIEGAVYMCME- 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHhcCCCcHHhhhhheecCCeEEEEEe-
Confidence 4667788999999999998765 689999999865322 23445554 7788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~I 627 (753)
|+++|+|..+++... ....+++..+.+++.+++.||.|||+ .+|
T Consensus 80 ---------~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 124 (286)
T cd06622 80 ---------YMDAGSLDKLYAGGV--------------------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124 (286)
T ss_pred ---------ecCCCCHHHHHHhcc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence 777888877765321 02357888999999999999999997 599
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC------CCchhhHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR------QTRAIDLFSLGCIL 701 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~t~ksDIwSfGvvL 701 (753)
+||||||+||+++.++. +||+|||++...... ......++..|+|||.+.+.. ++.++|||||||++
T Consensus 125 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 197 (286)
T cd06622 125 IHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197 (286)
T ss_pred eeCCCCHHHEEECCCCC--EEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHH
Confidence 99999999999977654 999999999765432 122345788999999985543 48899999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHH----HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDAN----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~----~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| ..||..... .... .........+..+++++.++|++||++||++|
T Consensus 198 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (286)
T cd06622 198 LEMALG-RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253 (286)
T ss_pred HHHHhC-CCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccC
Confidence 999998 668754322 2111 12223344566788999999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.24 Aligned_cols=238 Identities=22% Similarity=0.293 Sum_probs=197.0
Q ss_pred EEEeEEecccCceEEEEEEeeC--C--cEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~--g--~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.+.++||+|+||.|++|.... | ..||||.++... ..++++|.. .|.+++|+|+++|||+..+ ....||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas-~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREAS-HMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHH-HHHhccCcceeEEeeeecc-chhhHHh
Confidence 4556789999999999986653 4 468999997543 346677766 6788999999999999877 7889999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| ..+.|||.+.|+... ...|....+..++.|||.||.||..++
T Consensus 190 E----------LaplGSLldrLrka~---------------------------~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 190 E----------LAPLGSLLDRLRKAK---------------------------KAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred h----------hcccchHHHHHhhcc---------------------------ccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 9 677899999998722 245667788999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
+|||||..+|+||-... .+|||||||.+.+..+...........-.+.|+|||.+....++.++|||+|||.||||+|
T Consensus 233 lvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPR--TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred hhhhhhhhhhheecccc--eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 99999999999996654 4999999999998876555554455556789999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHH-HHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERDA-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~~-~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.-||-+....+. +.++.+ ..+.++.+++++.++++.||..+|.+|
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDR 359 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADR 359 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCcccc
Confidence 99999988755443 344433 345667788999999999999999988
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=286.05 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=184.9
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCceeeecccccCC-----c
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESDQ-----D 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~-----~ 540 (753)
.+.++|.+.+.||+|+||.||++... +++.+|+|.+..... ....+|+. ++..+ +|+||+++++++... +
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN-ILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHH-HHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 34677999999999999999998764 589999999865432 23344555 45555 899999999998653 3
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++++.... ....+++..++.++.|++.||.
T Consensus 98 ~~~lv~e----------y~~~~sL~~~~~~~~~-------------------------~~~~~~~~~~~~~~~qi~~al~ 142 (291)
T cd06639 98 QLWLVLE----------LCNGGSVTELVKGLLI-------------------------CGQRLDEAMISYILYGALLGLQ 142 (291)
T ss_pred eeEEEEE----------ECCCCcHHHHHHHhhh-------------------------cCCCCCHHHHHHHHHHHHHHHH
Confidence 5899999 8888888888754221 2345788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-----CCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----QTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----~t~ksDIw 695 (753)
|||+.+|+||||||+||+++.++. +||+|||+++....... ......|+..|+|||.+.... ++.++|||
T Consensus 143 ~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 143 HLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999999999999999977765 89999999887643211 112335789999999886443 68999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| ++||..... .....+..... ..+..++.++.++|.+||+.||++|
T Consensus 218 slGvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 278 (291)
T cd06639 218 SLGITAIELGDG-DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEAR 278 (291)
T ss_pred HHHHHHHHHhhC-CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhC
Confidence 999999999998 667765432 22222222211 2244567889999999999999998
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=301.76 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred EEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.....||-|-||.||.|..+. .-.||||.|+... -+++++|.+ +|+.++|||+|+|+|+|..+..+|||+|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAA-vMKeikHpNLVqLLGVCT~EpPFYIiTE---- 343 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTHEPPFYIITE---- 343 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHH-HHHhhcCccHHHHhhhhccCCCeEEEEe----
Confidence 4556789999999999987765 7899999998653 345666665 7899999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
||.+|+|.++|+...+ ..++--.++.+|.||+.||+||..+++||||
T Consensus 344 ------fM~yGNLLdYLRecnr---------------------------~ev~avvLlyMAtQIsSaMeYLEkknFIHRD 390 (1157)
T KOG4278|consen 344 ------FMCYGNLLDYLRECNR---------------------------SEVPAVVLLYMATQISSAMEYLEKKNFIHRD 390 (1157)
T ss_pred ------cccCccHHHHHHHhch---------------------------hhcchhHHHHHHHHHHHHHHHHHHhhhhhhh
Confidence 9999999999987543 3345567799999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|..+|+|+.++ ..+||+||||++++.++.. +......-.+.|.|||.+....++.|+|||+|||+|||+.|.+..|
T Consensus 391 LAARNCLVgEn--hiVKvADFGLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 391 LAARNCLVGEN--HIVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred hhhhhcccccc--ceEEeeccchhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCC
Confidence 99999999665 4699999999999987633 2222223467899999999999999999999999999999999999
Q ss_pred CCCChHH-HHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFER-DANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~-~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|-+.... ...++..+-. .-++.+++...+||..||+-.|..|
T Consensus 467 YPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDR 510 (1157)
T KOG4278|consen 467 YPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDR 510 (1157)
T ss_pred CCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccC
Confidence 9886443 3444444433 3567889999999999999999987
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=283.26 Aligned_cols=237 Identities=25% Similarity=0.386 Sum_probs=185.5
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
|+..+.||+|+||.||++.. .+++.||+|.+.... .+...+|+. +++.++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR-LMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHH-HHHHcCCCceehhhceeccCCeEEE
Confidence 55668899999999999865 568999999986432 123344544 7788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|+| |+++|+|.+++... ..+++..+++++.|++.||.|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 81 FVE----------WMAGGSVSHLLSKY-----------------------------GAFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred EEe----------ccCCCcHHHHHHHh-----------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 77788888877432 346778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+++|+||+|+||+++.++ ..+||+|||++.......... .......|+..|+|||.+.+..++.++||||||+++|+
T Consensus 122 ~~i~H~~i~~~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 200 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTG-QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200 (268)
T ss_pred CCeecCCCCHHHEEEcCCC-CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHH
Confidence 9999999999999997654 358999999998775432111 11223457899999999988889999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHH-----HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIV-----KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i-----~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||..... .....+ .......+...++++.++|.+||..||++|
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 255 (268)
T cd06630 201 MATA-KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDR 255 (268)
T ss_pred HHhC-CCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccC
Confidence 9998 667754321 111111 112234556678999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=281.05 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=187.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|++.+.||+|+||+||++... ++..+|+|++..... ....+|+ ..++.++|+||+++++.+.+.+..++++|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~iv~e- 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEV-QAMSQCNHPNVVKYYTSFVVGDELWLVMP- 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHH-HHHHhcCCCCEEEEEEEEeeCCEEEEEEe-
Confidence 5788899999999999999754 588999999864331 2333444 47788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++++|.++++... ....+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~ 124 (267)
T cd06610 80 ---------YLSGGSLLDIMKSSY--------------------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124 (267)
T ss_pred ---------ccCCCcHHHHHHHhc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 777888888775431 124578888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
||||+|+||++++++. ++|+|||++.......... .......|+..|+|||.+... .++.++|+|||||++|||++
T Consensus 125 h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred cCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999977654 9999999998775433221 122334589999999998777 68999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHccCcc-c-----ccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDRKDL-F-----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~~~~-~-----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| +.||..... ............ . ...+++++.++|.+||..||++|
T Consensus 203 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (267)
T cd06610 203 G-AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKR 255 (267)
T ss_pred C-CCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhC
Confidence 8 667765432 222222222111 1 12567899999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-32 Score=289.95 Aligned_cols=204 Identities=25% Similarity=0.382 Sum_probs=158.2
Q ss_pred EEEeEEecccCceEEEEEEee---CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCC--ceEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 543 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~ 543 (753)
|.+.+.||+|+||.||+|... +++.||+|.+.... .....+|+. +++.++||||+++++++.+. +..+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA-LLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHH-HHHhcCCCCccceEEEEeCCCCceEE
Confidence 677888999999999999765 47999999997622 234455655 78899999999999999988 8899
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||+|++++.++ +..... .....+++..++.++.|++.||.|||
T Consensus 81 lv~e~~~~~l~~~-----------~~~~~~------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 81 LLFDYAEHDLWQI-----------IKFHRQ------------------------AKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred EEEeCCCcCHHHH-----------HHhhcc------------------------CCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999665544333 321111 01135778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCC--CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvv 700 (753)
+.+|+||||||+||+++.++ +..+||+|||+++................++..|+|||.+.+. .++.++|||||||+
T Consensus 126 ~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 205 (316)
T cd07842 126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCI 205 (316)
T ss_pred hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 99999999999999997711 2459999999998765432222222344678999999988764 47999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 004442 701 LFFCITGGKHPYGES 715 (753)
Q Consensus 701 L~EllTG~~~Pf~~~ 715 (753)
+|||++| .+||...
T Consensus 206 l~~l~~~-~~~~~~~ 219 (316)
T cd07842 206 FAELLTL-EPIFKGR 219 (316)
T ss_pred HHHHHhc-CCCCcCC
Confidence 9999998 6777543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.05 Aligned_cols=235 Identities=25% Similarity=0.405 Sum_probs=193.0
Q ss_pred eEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 474 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.|.+.+.||+|+||.||+| +...|+.||||++.-. ..++.++|+. ++...+.+++|+++|.+..+..+++|||||+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEIS-IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG- 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEIS-IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG- 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHH-HHHHcCCchhhhhhhhhccCCceEeehhhcC-
Confidence 3455678999999999998 5567999999998643 4456677776 6688899999999999999999999999665
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
.|+..+.++. +..++.+.++..+.+..+.||+|||...-||||
T Consensus 112 ---------AGSiSDI~R~----------------------------R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRD 154 (502)
T KOG0574|consen 112 ---------AGSISDIMRA----------------------------RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRD 154 (502)
T ss_pred ---------CCcHHHHHHH----------------------------hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhh
Confidence 4666665543 345678888999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
||..||||+.+|. +||+|||.|..+... .....+..||+-|||||++..-.|..++||||||+...||..| ++|
T Consensus 155 IKAGNILLNT~G~--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG-~PP 228 (502)
T KOG0574|consen 155 IKAGNILLNTDGI--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG-RPP 228 (502)
T ss_pred cccccEEEcccch--hhhhhccccchhhhh---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC-CCC
Confidence 9999999988876 999999999877543 3345677899999999999999999999999999999999998 789
Q ss_pred CCCChHHHHHHHHc-cCcc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERDANIVKD-RKDL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~~~~i~~-~~~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.+...--...+.. ..++ -|+.++.++.|||++||.+.|++|
T Consensus 229 YsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R 274 (502)
T KOG0574|consen 229 YSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEER 274 (502)
T ss_pred cccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHH
Confidence 98764422222222 2222 255688999999999999999987
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=279.69 Aligned_cols=236 Identities=27% Similarity=0.390 Sum_probs=187.4
Q ss_pred EEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCCc---h-HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 476 VFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH---D-VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~~---~-~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++.+.||.|+||.||++...+ +..||+|.+..... . ...+|+. ++..++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREAR-IMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356789999999999987754 48899999975542 2 3344444 778889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |.++|+|.+++..... ..+++.++..++.|++.||+|||+.+
T Consensus 81 e----------~~~~~~l~~~~~~~~~---------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 81 E----------YMEGGDLLDYLRKNRP---------------------------KELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred e----------ccCCCCHHHHHHhhhh---------------------------ccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 9 7778888888764321 12788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
++||||||+||+++.++ .++|+|||+++.......... ....+++.|+|||.+.+..++.++||||||+++|||++
T Consensus 124 ~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~ 199 (258)
T smart00219 124 FIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199 (258)
T ss_pred eeecccccceEEEccCC--eEEEcccCCceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHh
Confidence 99999999999997775 499999999987754322111 12236789999999988889999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+||..... .....+.. .....+...+.++.+++.+||+.||++|
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 248 (258)
T smart00219 200 LGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDR 248 (258)
T ss_pred CCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhC
Confidence 65888875433 33333332 3334556678999999999999999998
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=277.62 Aligned_cols=245 Identities=25% Similarity=0.336 Sum_probs=188.7
Q ss_pred eecceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCC-----c
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-----~ 540 (753)
...++|.+.+.+|+|||..||++ +..++..+|+|++.... .+...+|+. .-++++|||++++++++..+ .
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid-~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREID-NHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHH-HHHhhCCcchHHHHHHHHHhhccCce
Confidence 34578999999999999999997 46679999999986443 344566665 77999999999999997643 3
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
+.||+++ |...|+|.+.+..... +...+++.++++|+.+|++||+
T Consensus 97 ~~yll~P----------yy~~Gsl~d~i~~~k~-------------------------kg~~~sE~~iL~if~gic~gL~ 141 (302)
T KOG2345|consen 97 EAYLLLP----------YYKRGSLLDEIERLKI-------------------------KGNFVSEAQILWIFLGICRGLE 141 (302)
T ss_pred eEEEEee----------hhccccHHHHHHHHhh-------------------------cCCccCHHHHHHHHHHHHHHHH
Confidence 4899999 9999999998876543 3456889999999999999999
Q ss_pred HhhhCC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc------cCccCCCCccccccccccCC---CCC
Q 004442 621 HLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT------QNATGYGSSGWQAPEQLLQG---RQT 689 (753)
Q Consensus 621 yLH~~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~------~~~~~~GT~~Y~APE~l~~~---~~t 689 (753)
+||+.. ++||||||.|||+..++ .++|.|||.+....-...... .-.....|..|.|||.+.-+ ..+
T Consensus 142 ~lH~~~~~yAH~DiKP~NILls~~~--~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ 219 (302)
T KOG2345|consen 142 ALHEKEPPYAHRDIKPANILLSDSG--LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTIT 219 (302)
T ss_pred HHhccCCcccccCCCcceeEecCCC--ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccc
Confidence 999986 99999999999997765 499999999876532111111 00112358999999988543 458
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHccCcccc--cCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGESFER---DANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~~~~---~~~~i~~~~~~~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++|||||||+||+|+.| .-||+...++ ....+.+....+| ..+++.+.++|+.||++||.+|
T Consensus 220 ertDIWSLGCtLYa~mf~-~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qR 287 (302)
T KOG2345|consen 220 ERTDIWSLGCTLYAMMFG-ESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQR 287 (302)
T ss_pred cccchhhhhHHHHHHHHc-CCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccC
Confidence 999999999999999998 7788653221 0111122222222 3488999999999999999998
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=287.25 Aligned_cols=236 Identities=24% Similarity=0.328 Sum_probs=186.1
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
++|.+.+.||+|+||.||++... +++.||+|.+...... .+.+|+ .+++.++|+||+++++++.+++..++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEAYFYENKLWILIE- 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEecCCeEEEEee-
Confidence 45677788999999999999764 5899999998654322 334454 47899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++... ...+++..+.+++.|++.||.|||+.+|+
T Consensus 83 ---------~~~~~~L~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 125 (280)
T cd06611 83 ---------FCDGGALDSIMLEL----------------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVI 125 (280)
T ss_pred ---------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 88888888877532 23578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~E 703 (753)
|+||||+||+++.++. ++|+|||++........ ......++..|+|||.+. ...++.++|||||||++||
T Consensus 126 h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~ 200 (280)
T cd06611 126 HRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQ---KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIE 200 (280)
T ss_pred cCCCChhhEEECCCCC--EEEccCccchhhccccc---ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHH
Confidence 9999999999977654 99999999876543211 122345899999999875 3446789999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ++||.... .+....+..... ..+..++.++.++|.+||+.||++|
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 201 LAQM-EPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred HHhC-CCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhC
Confidence 9998 66776543 233333333322 2345678899999999999999998
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-32 Score=279.44 Aligned_cols=237 Identities=27% Similarity=0.422 Sum_probs=188.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +|..||+|.+... ..+...+|++ +++.++|+||+++++++.+.+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHH-HHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 3678899999999999998765 5899999998643 2233445554 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++++|.+++.... ...+++..+++++.|++.||.|||+.++
T Consensus 80 ----------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (257)
T cd08225 80 ----------YCDGGDLMKRINRQR---------------------------GVLFSEDQILSWFVQISLGLKHIHDRKI 122 (257)
T ss_pred ----------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 777888888775321 2346788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||||+||+++.++. .+||+|||.+........ ......|++.|+|||.+.+..++.++||||||+++||+++|
T Consensus 123 ~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 123 LHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred ccccCCHHHEEEcCCCC-eEEecccccchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999977653 579999999987653321 11233588999999999888899999999999999999998
Q ss_pred CCCCCCCCh-HHHHH-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-ERDAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-~~~~~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||.... .+... .............+.+++++|.+||..+|++|
T Consensus 199 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 245 (257)
T cd08225 199 -KHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDR 245 (257)
T ss_pred -CCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhC
Confidence 56776543 22222 22223333455678899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=289.33 Aligned_cols=238 Identities=25% Similarity=0.299 Sum_probs=182.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..|+..+.||+|+||.||++... +|. .||+|.+...... ...+|. .+++.++|+||++++|+|... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-LIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcccEEEEEcCC-Cce
Confidence 45667788999999999998654 343 5789988654332 233444 477889999999999998764 467
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+++| |+++|+|.+++... ...+++..++.++.|++.||+|||
T Consensus 85 ~v~e----------~~~~g~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH 126 (303)
T cd05110 85 LVTQ----------LMPHGCLLDYVHEH----------------------------KDNIGSQLLLNWCVQIAKGMMYLE 126 (303)
T ss_pred eeeh----------hcCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHh
Confidence 8999 88889998887532 124677888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++. +||+|||+++........ .......++..|+|||.+.+..++.++|||||||++||
T Consensus 127 ~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~e 203 (303)
T cd05110 127 ERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKE-YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE 203 (303)
T ss_pred hcCeeccccccceeeecCCCc--eEEccccccccccCcccc-cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHH
Confidence 999999999999999977654 899999999876533211 11222345778999999998999999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+..||.+.... ....+... ..+.+..++.++.++|.+||..||++|
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~R 255 (303)
T cd05110 204 LMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSR 255 (303)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 998436788665333 33333322 233445577899999999999999998
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=284.96 Aligned_cols=234 Identities=24% Similarity=0.376 Sum_probs=179.3
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.|++.+.||+|+||.||++... +++.||+|++..... +...+|+ .+++.++|+||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI-RMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHH-HHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5778899999999999998775 489999999854321 2334455 47889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+++|.++.+. ...+++.+++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (286)
T cd07846 81 ----------FVDHTVLDDLEKY-----------------------------PNGLDESRVRKYLFQILRGIEFCHSHNI 121 (286)
T ss_pred ----------cCCccHHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6666666654421 2347788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+|+||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+. .++.++|||||||++|||++
T Consensus 122 ~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 122 IHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred cccCCCHHHEEECCCCc--EEEEeeeeeeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 99999999999977754 99999999987644321 12234578999999998764 47899999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHc--------------------cC--c---------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKD--------------------RK--D---------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~--------------------~~--~---------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||..... .....+.. .. . .....++.++.+||.+||+.||++|
T Consensus 197 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 197 G-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred C-CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 9 567754321 11100000 00 0 0123567889999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-32 Score=293.58 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=177.2
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCC-----c
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-----~ 540 (753)
++++|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++|+||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-ILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHH-HHHhCCCCCcCchhheeecccccccc
Confidence 457899999999999999999865 468999999986432 123444554 78899999999999986544 3
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++++|++.+ +|.+.+. ...+++..+..++.|++.||+
T Consensus 82 ~~~lv~e~~~~-----------~l~~~~~------------------------------~~~l~~~~~~~i~~ql~~aL~ 120 (336)
T cd07849 82 DVYIVQELMET-----------DLYKLIK------------------------------TQHLSNDHIQYFLYQILRGLK 120 (336)
T ss_pred eEEEEehhccc-----------CHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 57999995543 4443331 235778888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGv 699 (753)
|||+.+|+||||||+||+++.++. +||+|||+++................||..|+|||.+.+ ..++.++|||||||
T Consensus 121 ~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 121 YIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred HHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 999999999999999999977655 999999999876543222222233568999999998755 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHH---------------c-----------cCc-----ccccCCCHHHHHHHHHccc
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVK---------------D-----------RKD-----LFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~---------------~-----------~~~-----~~~~~~s~el~dLI~~cL~ 747 (753)
++|||++| ++||..... .....+. . ... ......++++.++|.+||+
T Consensus 199 il~el~~G-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (336)
T cd07849 199 ILAEMLSN-RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT 277 (336)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC
Confidence 99999998 667754321 1110000 0 000 0113457889999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 278 ~dP~~R 283 (336)
T cd07849 278 FNPHKR 283 (336)
T ss_pred CChhhC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=284.29 Aligned_cols=233 Identities=26% Similarity=0.382 Sum_probs=186.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|.+.+.||.|++|.||++... +++.||+|.+..... ....+|+. +++.++|+||+++++++.++...++|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ-FLSQCRSPYITKYYGSFLKGSKLWIIME- 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHH-HHHHcCCCCeeeeeEEEEECCeEEEEEE-
Confidence 4667788999999999999765 589999999865431 23344544 7889999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.++++. ..+++..+..++.|++.||.|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~ 120 (274)
T cd06609 80 ---------YCGGGSCLDLLKP------------------------------GKLDETYIAFILREVLLGLEYLHEEGKI 120 (274)
T ss_pred ---------eeCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 7778888887642 2567888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||+|+||+++.++. ++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||+||
T Consensus 121 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg- 194 (274)
T cd06609 121 HRDIKAANILLSEEGD--VKLADFGVSGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG- 194 (274)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999977665 9999999998876432 122334578899999999988899999999999999999998
Q ss_pred CCCCCCChHHH-HHHHHc-cCcccccC-CCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKD-RKDLFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~-~~~~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+.. ........ +++++.++|.+||..||++|
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~R 242 (274)
T cd06609 195 EPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKER 242 (274)
T ss_pred CCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhC
Confidence 67886543222 222222 22233333 78899999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=285.74 Aligned_cols=228 Identities=28% Similarity=0.438 Sum_probs=181.5
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||+||++... +|+.||+|.+.... ......|+ .++..++|+||+++++++...+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEK-KILEKVSSRFIVSLAYAFETKDDLCLVMT------ 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHH-HHHHhCCCCCEeeeeeEEecCCeEEEEEe------
Confidence 689999999998654 68999999986432 11223444 47899999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+++||||+
T Consensus 74 ----~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~ 122 (277)
T cd05577 74 ----LMNGGDLKYHIYNVG---------------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122 (277)
T ss_pred ----cCCCCcHHHHHHHcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 888888888875432 1357888999999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++. +||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++| +.||.
T Consensus 123 p~Nil~~~~~~--~~l~dfg~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 195 (277)
T cd05577 123 PENVLLDDHGN--VRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG-RSPFR 195 (277)
T ss_pred HHHEEECCCCC--EEEccCcchhhhccC----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC-CCCCC
Confidence 99999977764 999999998765432 112233578899999999888899999999999999999998 67876
Q ss_pred CChH-----HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFE-----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~-----~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.... .............+..+++++.++|++||+.||++|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 240 (277)
T cd05577 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240 (277)
T ss_pred CCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence 5432 111222223334556678999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=282.09 Aligned_cols=237 Identities=23% Similarity=0.333 Sum_probs=184.1
Q ss_pred ceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
++|.+.+.||+|+||.||+|...+ ...||||....... +.+.+|+ .+++.++|+||++++++|.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA-YIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHH-HHHHhCCCCchhceeEEEcC-CCcEE
Confidence 457788999999999999987654 25799998865432 2333444 47899999999999999876 45789
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ...+++..++.++.+++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 84 VME----------LAPLGELRSYLQVN----------------------------KYSLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred EEE----------cCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 77788888887532 1246788899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++||||||+||+++.++. +||+|||+++......... .....++..|+|||.+....++.++|||||||++||+
T Consensus 126 ~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 201 (270)
T cd05056 126 KRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201 (270)
T ss_pred CCeeccccChheEEEecCCC--eEEccCceeeeccccccee--cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999977654 9999999998765432111 1122345689999999888899999999999999999
Q ss_pred HhCCCCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+.+||...... ....+.. .....+...++++.++|.+||..+|++|
T Consensus 202 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 252 (270)
T cd05056 202 LMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKR 252 (270)
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 97337788665332 2333333 3344566778999999999999999998
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-32 Score=281.06 Aligned_cols=226 Identities=30% Similarity=0.429 Sum_probs=183.3
Q ss_pred ecccCceEEEEEEeeC-CcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||++.... ++.||+|.+.+.. . +...+|+ .+++.++|+||+++++++.+++..++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLYRTFKDKKYIYMLME------ 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHH-HHHHhCCCCCEeeeeeeEEcCCccEEEEe------
Confidence 6999999999997754 8999999986432 1 2234444 47889999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 74 ----YCLGGELWTILRDR-----------------------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred ----cCCCCcHHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 88899999988542 236777889999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++. ++|+|||+++...... ......++..|+|||.+.+..++.++|+||||+++|||++| .+||.
T Consensus 121 ~~nilv~~~~~--~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 193 (262)
T cd05572 121 PENLLLDSNGY--VKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG-RPPFG 193 (262)
T ss_pred HHHEEEcCCCC--EEEeeCCcccccCccc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC-CCCcC
Confidence 99999977765 9999999998775432 12234578999999999888899999999999999999998 67776
Q ss_pred CCh---HHHHHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESF---ERDANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~---~~~~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... ......+. .....++...++++.++|++||..||++|
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 238 (262)
T cd05572 194 EDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238 (262)
T ss_pred CCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 554 22223333 33444556668899999999999999998
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-32 Score=280.70 Aligned_cols=226 Identities=30% Similarity=0.478 Sum_probs=179.8
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.||+|+||.||+|... +|+.||||.+.+... .....|...+....+|+||+++++++.+.+..++|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e---- 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME---- 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe----
Confidence 46999999999999764 589999999865321 1223444445566799999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++... ..+++..+.+++.|++.||.|||+.+++|||
T Consensus 78 ------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 78 ------YLNGGDCASLIKTL-----------------------------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred ------ccCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 88888888887432 3467788899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|+|+||+++.++. +||+|||+++.... .....++..|+|||.+.+..++.++||||||+++|||++| .+|
T Consensus 123 l~p~nil~~~~~~--~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g-~~p 192 (260)
T cd05611 123 IKPENLLIDQTGH--LKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPP 192 (260)
T ss_pred CCHHHeEECCCCc--EEEeecccceeccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC-CCC
Confidence 9999999977654 99999999876432 1234578999999999888899999999999999999998 678
Q ss_pred CCCChHHH-HHHHHccCc----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERD-ANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~-~~~i~~~~~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|....... ...+..... .....+++++.++|++||+.||++|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 86543332 222222221 2233578999999999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=282.96 Aligned_cols=235 Identities=28% Similarity=0.447 Sum_probs=182.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||+|... +|+.||||++.... .....+|+. +++.++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK-ALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHH-HHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 3678899999999999999764 68999999997543 123445554 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+ +++|.+++... ...+++.++++++.||+.||+|||+.+|
T Consensus 80 ----------~~-~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i 120 (286)
T cd07832 80 ----------YM-PSDLSEVLRDE----------------------------ERPLPEAQVKSYMRMLLKGVAYMHANGI 120 (286)
T ss_pred ----------cc-CCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77 77887776532 1357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
+|+||||+||+++.++. ++|+|||++........ .......|+..|+|||.+.+.. ++.++|||||||++|||+|
T Consensus 121 ~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 121 MHRDLKPANLLISADGV--LKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred ecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence 99999999999977654 99999999987654321 1123345899999999986554 6899999999999999999
Q ss_pred CCCCCCCCChHH-HHHHHHcc-C-----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFER-DANIVKDR-K-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~-~~~~i~~~-~-----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||...... ....+... . .....+.++++.++|++||+.||++|
T Consensus 197 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 273 (286)
T cd07832 197 G-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKR 273 (286)
T ss_pred C-CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhC
Confidence 9 6777554321 11111100 0 00113456889999999999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=310.48 Aligned_cols=235 Identities=24% Similarity=0.298 Sum_probs=191.0
Q ss_pred EeEEecccCceEEEEEEee-C----CcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 477 FNKEIAKGSNGTVVLEGNY-E----GRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~-~----g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..++||+|+||+||+|... . .-+||+|++..... ...+.|++..|++++|+|++||+|+|.... ..||++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq- 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ- 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH-
Confidence 3478999999999998653 2 45899999865432 344555555789999999999999998766 888999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
||+.|.|.++++..+ ..+..+.++.|..|||+||.|||+++++
T Consensus 778 ---------~mP~G~LlDyvr~hr----------------------------~~igsq~lLnw~~QIAkgM~YLe~qrlV 820 (1177)
T KOG1025|consen 778 ---------LMPLGCLLDYVREHR----------------------------DNIGSQDLLNWCYQIAKGMKYLEEQRLV 820 (1177)
T ss_pred ---------hcccchHHHHHHHhh----------------------------ccccHHHHHHHHHHHHHHHHHHHhcchh
Confidence 999999999998653 3466778899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||..+|||+++-.. +||.|||+++....+...... ....-.+.|||-|.+....|+.++|||||||.+||++|-+
T Consensus 821 HrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~-~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFG 897 (1177)
T KOG1025|consen 821 HRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSA-PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFG 897 (1177)
T ss_pred hhhhhhhheeecCCCe--EEEEecchhhccCcccccccc-cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcC
Confidence 9999999999987754 999999999988765433222 2222367899999999999999999999999999999988
Q ss_pred CCCCCCChH-HHHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.-||++... +....++.+.. .-|+.++-++..++.+||..|++.|
T Consensus 898 a~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~r 944 (1177)
T KOG1025|consen 898 AKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSR 944 (1177)
T ss_pred CCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccC
Confidence 888887644 44455554443 4566778899999999999999987
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=284.33 Aligned_cols=239 Identities=25% Similarity=0.377 Sum_probs=180.7
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCceeeecccccC------Cc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESD------QD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~------~~ 540 (753)
....|++.+.||+|+||.||++... +++.+|+|.+..... .....|+. ++..+ +|+||+++++++.. .+
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEIN-MLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHH-HHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 3456778889999999999998764 589999999865432 23344554 44554 79999999999853 46
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++|| |+.+|+|.+++.... ...+++..++.++.|++.||.
T Consensus 93 ~~~iv~e----------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~al~ 135 (282)
T cd06636 93 QLWLVME----------FCGAGSVTDLVKNTK---------------------------GNALKEDWIAYICREILRGLA 135 (282)
T ss_pred EEEEEEE----------eCCCCcHHHHHHHcc---------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 7899999 777788887765321 234667788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIw 695 (753)
|||+.+|+|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||.+. ...++.++|||
T Consensus 136 ~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 136 HLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 999999999999999999987765 9999999987654321 1223445899999999875 34578899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHcc-Cc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDR-KD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| .+||..... .....+... .. .....+++++.+||.+||+.||++|
T Consensus 211 slG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (282)
T cd06636 211 SLGITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSR 270 (282)
T ss_pred HHHHHHHHHHhC-CCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhC
Confidence 999999999998 667754432 222212221 11 1233578899999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=284.90 Aligned_cols=244 Identities=24% Similarity=0.325 Sum_probs=179.9
Q ss_pred EecccCceEEEEEEeeC-Cc--EEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEccccC
Q 004442 480 EIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~-g~--~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.||+|+||.||++...+ +. .+|+|.++.... +...+|+. ++..+ +||||++++++|.+.+..+++||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~lv~e---- 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYLAIE---- 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHH-HHHhhccCCCeeeEEEEEecCCCceEEEE----
Confidence 58999999999997754 33 578898874321 23445555 55666 89999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.++++.......... ..........+++.++++++.|++.||+|||+.+++|||
T Consensus 77 ------~~~~~~L~~~i~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~d 137 (270)
T cd05047 77 ------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 137 (270)
T ss_pred ------eCCCCcHHHHHHhccccccccc-------------cccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 8888899988875432110000 000001223578899999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++ .+||+|||++...... ........+..|+|||++....++.++|||||||++|||++++..|
T Consensus 138 ikp~nili~~~~--~~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 138 LAARNILVGENY--VAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccceEEEcCCC--eEEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999997665 5999999998643211 1111222467899999998888999999999999999999833678
Q ss_pred CCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|..... .....+... ....+...+.++.+++.+||+.||.+|
T Consensus 212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (270)
T cd05047 212 YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 255 (270)
T ss_pred ccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 765433 333333332 223455677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=284.57 Aligned_cols=227 Identities=26% Similarity=0.387 Sum_probs=177.4
Q ss_pred EecccCceEEEEEEee-CCcEEEEEEeecCCc-----hH-HHHHH--HHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 480 EIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DV-ALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~-~~~Ei--~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.||+|+||.||++... +++.||+|.+.+... .. ...|. ..++....|+||+++++++.+.+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD--- 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe---
Confidence 3899999999998764 589999999865321 11 22222 123455689999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++.. ...+++..+..++.|++.||.|||+.+|+||
T Consensus 78 -------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 121 (278)
T cd05606 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121 (278)
T ss_pred -------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 7778888776632 2357888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||||+||+++.++. +||+|||++...... ......|+..|+|||.+.++ .++.++|||||||++|||++| .
T Consensus 122 di~p~nili~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g-~ 193 (278)
T cd05606 122 DLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-H 193 (278)
T ss_pred CCCHHHEEECCCCC--EEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC-C
Confidence 99999999977654 999999998765432 11234689999999998754 589999999999999999998 6
Q ss_pred CCCCCCh---HH-HHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESF---ER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~---~~-~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||.... .. ............+..+++++.++|.+||..||.+|
T Consensus 194 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R 241 (278)
T cd05606 194 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 241 (278)
T ss_pred CCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhc
Confidence 6776542 11 12222233344566678999999999999999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=332.02 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=195.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+.+.-++.....||.|.||.||-+... +|...|||-++-... -....|+..++..++|||+|+.+|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 455566777788999999999998665 599999998753221 123456666889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|.|| |..+|+|.+.+.-. +..++.....+-.|++.|++|||
T Consensus 1311 IFME----------yC~~GsLa~ll~~g-----------------------------ri~dE~vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1311 IFME----------YCEGGSLASLLEHG-----------------------------RIEDEMVTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred HHHH----------HhccCcHHHHHHhc-----------------------------chhhhhHHHHHHHHHHHHHHHHH
Confidence 9999 66778888876432 23444455678899999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccCCC---CCchhhHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGC 699 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~---~t~ksDIwSfGv 699 (753)
+.|||||||||.||+|+.+| .+|++|||.|+.+..+.+. ........||+-|||||++.+.. ...+.||||+||
T Consensus 1352 ~~gIVHRDIK~aNI~Ld~~g--~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1352 EHGIVHRDIKPANILLDFNG--LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred hcCceecCCCccceeeecCC--cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 99999999999999997766 5999999999988765321 12223457999999999997644 678999999999
Q ss_pred HHHHHHhCCCCCCCC---ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGE---SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~---~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+.||+|| +-||.. .+.-+.+.-...++.+|...+++.++||..||..||++|
T Consensus 1430 VVlEM~tG-krPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~R 1485 (1509)
T KOG4645|consen 1430 VVLEMATG-KRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMR 1485 (1509)
T ss_pred eEEEeecC-CCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhh
Confidence 99999999 557754 344455666677888999999999999999999999998
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=282.18 Aligned_cols=234 Identities=26% Similarity=0.430 Sum_probs=178.1
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|+..+.||+|++|.||+|... +|+.||||++.... .....+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVFE- 79 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHH-HHHhcCCCCCcchhhhcccCCcEEEEee-
Confidence 677889999999999999764 68999999986432 123445555 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+. ++|.++++... ...+++..+..++.|++.||+|||+.+++
T Consensus 80 ---------~~~-~~l~~~~~~~~---------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 80 ---------FLH-QDLKKFMDASP---------------------------LSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred ---------ccc-cCHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 553 45666554321 24578888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllTG 707 (753)
||||+|+||+++.++. +||+|||++........ ......++..|+|||.+.+.. ++.++|||||||++|||+||
T Consensus 123 H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 123 HRDLKPQNLLINTEGA--IKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred cCCCCHHHEEECCCCC--EEEeeccchhhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999977764 99999999876543211 112334688999999887655 58999999999999999999
Q ss_pred CCCCCCCChHH-HH-HHHHccC----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-DA-NIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-~~-~~i~~~~----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||....+. .. ....... .......+++++++|.+||+.||++|
T Consensus 198 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07860 198 -RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccC
Confidence 5676543221 11 1111000 00123467889999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=286.79 Aligned_cols=233 Identities=24% Similarity=0.356 Sum_probs=182.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
..|++.+.||+|+||+||++... +|+.||+|.+..... ....+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHH-HHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35667788999999999998765 589999998864332 23445554 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IG 626 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~ 626 (753)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+ .+
T Consensus 84 ----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 124 (284)
T cd06620 84 ----------FMDCGSLDRIYKK-----------------------------GGPIPVEILGKIAVAVVEGLTYLYNVHR 124 (284)
T ss_pred ----------cCCCCCHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 8888888877643 2346788889999999999999997 58
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||+++.++ .++|+|||++...... ......|+..|+|||++.+..++.++|||||||++||++|
T Consensus 125 i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 125 IMHRDIKPSNILVNSRG--QIKLCDFGVSGELINS-----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred eeccCCCHHHEEECCCC--cEEEccCCcccchhhh-----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 99999999999997665 4999999998755322 1123468999999999988889999999999999999999
Q ss_pred CCCCCCCCChHH------------HHHHHH-ccCccccc-CCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFER------------DANIVK-DRKDLFLV-EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~------------~~~~i~-~~~~~~~~-~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||...... ....+. ......+. .++.++.+||.+||++||++|
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (284)
T cd06620 198 G-KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257 (284)
T ss_pred C-CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccC
Confidence 8 6788654321 111111 11222222 367899999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=281.71 Aligned_cols=238 Identities=30% Similarity=0.433 Sum_probs=191.9
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCC-CCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+|.+.+.||+|+||.||++... +|+.||+|.+.... ....+.++..++..++ |+||+++++++.+.+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5788899999999999999765 69999999986421 1222333334677888 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.. ...+++..++.++.|++.||.|||+.+
T Consensus 82 e----------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 82 E----------YAPNGELLQYIRK-----------------------------YGSLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred c----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7777888877743 235788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-----------------cccCccCCCCccccccccccCCCCC
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----------------LTQNATGYGSSGWQAPEQLLQGRQT 689 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-----------------~~~~~~~~GT~~Y~APE~l~~~~~t 689 (753)
++|+||+|+||+++.++. ++|+|||++......... ........++..|+|||......++
T Consensus 123 ~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~ 200 (280)
T cd05581 123 IIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAG 200 (280)
T ss_pred eeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCC
Confidence 999999999999987765 899999999876543211 1222334578999999999888899
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++||||||++++++++| ..||..... .............+..+++++.++|.+||+.||++|
T Consensus 201 ~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 264 (280)
T cd05581 201 KSSDLWALGCIIYQMLTG-KPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDR 264 (280)
T ss_pred hhhhHHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhC
Confidence 999999999999999998 678866532 333444455566777889999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=281.93 Aligned_cols=236 Identities=22% Similarity=0.306 Sum_probs=175.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
...|.+.+.||+|+||.||++... +|+.||+|++..... ....+|+. +++.++|+||+++++++.+.+..++|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHH-HHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 467889999999999999998654 689999999864321 23445654 778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|++. ++|.+++... ...+++..+..++.|++.||.|||+.+
T Consensus 83 e~~~-----------~~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 83 EYMH-----------TDLAQYMIQH----------------------------PGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred eccc-----------CCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9544 3444433211 123566778899999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~Ell 705 (753)
|+|+||||+||+++.++. +||+|||+++....... ......++..|+|||.+.+. .++.++|||||||++|||+
T Consensus 124 i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 198 (291)
T cd07870 124 ILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198 (291)
T ss_pred cccCCCChHHEEEcCCCc--EEEeccccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999977765 99999999976533211 11233478999999998764 4789999999999999999
Q ss_pred hCCCCCCCCChHHHH--HHH-Hc-------------c----Cccc-----c---------cCCCHHHHHHHHHccccCcC
Q 004442 706 TGGKHPYGESFERDA--NIV-KD-------------R----KDLF-----L---------VEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~--~~i-~~-------------~----~~~~-----~---------~~~s~el~dLI~~cL~~DP~ 751 (753)
+| .+||........ ... .. . .... + ...++++.++|.+||..||+
T Consensus 199 ~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~ 277 (291)
T cd07870 199 QG-QPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK 277 (291)
T ss_pred hC-CCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence 98 668865432111 100 00 0 0000 0 01246889999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 278 ~R 279 (291)
T cd07870 278 DR 279 (291)
T ss_pred cC
Confidence 98
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=286.95 Aligned_cols=232 Identities=25% Similarity=0.347 Sum_probs=182.2
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
|...+.||+|+||.||+|... +++.||+|.+...... ...+|+ .+++.++|+||+++++++.+++..++|||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYITRYYGSYLKGTKLWIIME-- 82 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHH-HHHHcCCCCccHhhhcccccCCceEEEEE--
Confidence 334567999999999999654 5889999998644321 233444 47789999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.+++.. ..+++..+..++.|++.||.|||+.+++|
T Consensus 83 --------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH 124 (277)
T cd06642 83 --------YLGGGSALDLLKP------------------------------GPLEETYIATILREILKGLDYLHSERKIH 124 (277)
T ss_pred --------ccCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 7778888877632 24667788999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
+||+|+||+++.++. ++|+|||++....... .......|+..|+|||.+.+..++.++|||||||++|||+|| .
T Consensus 125 ~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~ 198 (277)
T cd06642 125 RDIKAANVLLSEQGD--VKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-E 198 (277)
T ss_pred cCCChheEEEeCCCC--EEEccccccccccCcc---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC-C
Confidence 999999999987765 9999999998764321 111234578899999999988899999999999999999998 6
Q ss_pred CCCCCChHHH-HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~~-~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|+....... ...+. ..........+.++.++|.+||+.+|++|
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06642 199 PPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFR 244 (277)
T ss_pred CCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccC
Confidence 6776543222 22222 22223344567889999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=284.81 Aligned_cols=234 Identities=25% Similarity=0.382 Sum_probs=184.2
Q ss_pred EEEeEEecccCceEEEEEEe----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhC-CCCceeeecccccCCceE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~ 542 (753)
|++.+.||+|+||.||++.. .+|+.||+|++.... .+...+|+. ++..+ +|+||+++++++..+...
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHH-HHHhcccCCChhceeeEeecCCeE
Confidence 66788999999999999865 368999999986432 122334554 66666 699999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.+++... ..+++..+..++.|++.||.||
T Consensus 81 ~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~al~~l 121 (290)
T cd05613 81 HLILD----------YINGGELFTHLSQR-----------------------------ERFKEQEVQIYSGEIVLALEHL 121 (290)
T ss_pred EEEEe----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 88888888887532 3466778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC--CCCchhhHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 700 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGvv 700 (753)
|+.+++||||+|+|||++.++. +||+|||++........ .......|+..|+|||.+.+. .++.++||||||++
T Consensus 122 H~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 122 HKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197 (290)
T ss_pred HhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence 9999999999999999977754 99999999987643211 122234589999999998753 46889999999999
Q ss_pred HHHHHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+|++| ..||... .......+.....+.+..+++.+.+++++||+.||++|
T Consensus 198 l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R 254 (290)
T cd05613 198 MYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254 (290)
T ss_pred HHHHhcC-CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHh
Confidence 9999998 6677532 22223333334455667788999999999999999988
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=276.97 Aligned_cols=234 Identities=29% Similarity=0.423 Sum_probs=187.8
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|.+.+.||+|++|.||++.... ++.||||++..... ....+|+. .+..++|+||+++++++...+..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK-TLRSCESPYVVKCYGAFYKEGEISIVLE- 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEccCCeEEEEEE-
Confidence 46778999999999999997764 99999999876542 23344444 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~I 627 (753)
|+++++|.+++... ..+++..+++++.|+++||+|||+ .++
T Consensus 80 ---------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 80 ---------YMDGGSLADLLKKV-----------------------------GKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred ---------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 77788888877432 356778889999999999999999 999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||+|+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++||||||+++|+|+||
T Consensus 122 ~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 122 IHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999977654 999999999876543221 1233578999999999988899999999999999999998
Q ss_pred CCCCCCCCh----HHHHH-HHHccCcccccC-CCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF----ERDAN-IVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~----~~~~~-~i~~~~~~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.... ..... .........+.. ++..+.++|++||..+|++|
T Consensus 197 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 247 (264)
T cd06623 197 -KFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKR 247 (264)
T ss_pred -CCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhC
Confidence 66776553 11122 222233334445 78899999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=282.43 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=183.1
Q ss_pred EEEeEEecccCceEEEEEEee----CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCc-----
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD----- 540 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~----- 540 (753)
|.+.+.||+|+||.||+|... .++.||||++.... .+...+|+. +++.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAA-CMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCCCCcc
Confidence 345678999999999998653 37899999986532 123445554 789999999999999876532
Q ss_pred -eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 541 -FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 541 -~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
..++++| |+.+|+|.+++...... .+...+++..+++++.|++.||
T Consensus 80 ~~~~~~~~----------~~~~~~l~~~~~~~~~~-----------------------~~~~~l~~~~~~~~~~~i~~~l 126 (273)
T cd05074 80 PIPMVILP----------FMKHGDLHTFLLMSRIG-----------------------EEPFTLPLQTLVRFMIDIASGM 126 (273)
T ss_pred cceEEEEe----------cCCCCcHHHHHHHhccc-----------------------CCCCCCCHHHHHHHHHHHHHHH
Confidence 2478888 88888888877543211 0112477888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
+|||+.+|+||||||+||+++.++ .+||+|||+++........ .......++..|++||.+....++.++|||||||
T Consensus 127 ~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~ 203 (273)
T cd05074 127 EYLSSKNFIHRDLAARNCMLNENM--TVCVADFGLSKKIYSGDYY-RQGCASKLPVKWLALESLADNVYTTHSDVWAFGV 203 (273)
T ss_pred HHHHhCCEeecccchhhEEEcCCC--CEEECcccccccccCCcce-ecCCCccCchhhcCHhHHhcCccchhhhhHHHHH
Confidence 999999999999999999997665 4899999999876432211 1112233567899999998888999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++++.+||....... ...+.. .....+...++++.+++.+||+.+|++|
T Consensus 204 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 259 (273)
T cd05074 204 TMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCR 259 (273)
T ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 99999995578887654332 222222 2233445677899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=275.26 Aligned_cols=237 Identities=25% Similarity=0.394 Sum_probs=187.9
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC--CceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~~LV~ 546 (753)
|.+.+.||+|+||.||++.. .+++.||+|.+..... +....|+ .+++.++|+||+++++++.. ....+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHH-HHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 66778999999999999865 4689999999864321 1223344 47899999999999998754 45689999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh---
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--- 623 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH--- 623 (753)
| |+.+|+|.+++..... ....+++..++.++.+++.||.|||
T Consensus 81 e----------~~~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 125 (265)
T cd08217 81 E----------YCEGGDLAQLIQKCKK-------------------------ERKYIEEEFIWRILTQLLLALYECHNRS 125 (265)
T ss_pred h----------hccCCCHHHHHHHHhh-------------------------cccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence 9 8888999988864321 1346788899999999999999999
Q ss_pred --hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 624 --EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 624 --~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
+.+|+|+||+|+||+++.++. +||+|||++........ ......++..|+|||.+.+..++.++||||||+++
T Consensus 126 ~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 126 DPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 889999999999999977654 99999999987754321 12234589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++| ..||..... .....+... ....+..++.++.+++.+||+.||++|
T Consensus 201 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~R 253 (265)
T cd08217 201 YELCAL-SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253 (265)
T ss_pred HHHHHC-CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccC
Confidence 999998 678866533 222333332 234566788999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=284.20 Aligned_cols=239 Identities=28% Similarity=0.379 Sum_probs=183.1
Q ss_pred ceEEEeEEecccCceEEEEEEee-----CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC--Cce
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDF 541 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-----~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~ 541 (753)
+.|++.+.||+|+||.||++... .++.||||.+..... ..+.+|+. +++.++|+||+++++++.+ ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~-~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE-ILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHH-HHHhCCCCChheEEeeeecCCCCc
Confidence 34667788999999999998643 478999999976543 23444544 7788999999999999877 567
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.+++|| |.++|+|.+++.... ..+++..++.++.|++.||+|
T Consensus 83 ~~lv~e----------~~~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~l~~aL~~ 124 (284)
T cd05038 83 LRLIME----------YLPSGSLRDYLQRHR----------------------------DQINLKRLLLFSSQICKGMDY 124 (284)
T ss_pred eEEEEe----------cCCCCCHHHHHHhCc----------------------------cccCHHHHHHHHHHHHHHHHH
Confidence 899999 777888888875421 247788899999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+||+++.++ .++|+|||++.................++..|+|||.+.+..++.++||||||+++
T Consensus 125 lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 125 LGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred HHhCCeecCCCCHHhEEEcCCC--CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 9999999999999999997775 49999999998776332222222223356679999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChHH----------------HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFER----------------DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~----------------~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+||+ .|+...... ....+.. .....+..++.++.+++.+||+.||++|
T Consensus 203 ~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05038 203 YELFTYG-DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDR 270 (284)
T ss_pred heeeccC-CCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhC
Confidence 9999985 455432111 1111121 1223345567899999999999999998
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=279.65 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=184.0
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhC-CCCceeeecccccCCc------
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESDQD------ 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~------ 540 (753)
..++|.+.+.||+|++|.||++... +++.+|+|.+..... +.+.+|+. +++.+ +|+||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-ILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhcCCCChheEEEEEEecCCCCcce
Confidence 3577899999999999999999775 578999999875432 33444554 56666 7999999999986544
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+++|.++++.... ....+++..+..++.|++.||.
T Consensus 83 ~~~lv~e----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~ql~~al~ 127 (275)
T cd06608 83 QLWLVME----------LCGGGSVTDLVKGLRK-------------------------KGKRLKEEWIAYILRETLRGLA 127 (275)
T ss_pred EEEEEEE----------cCCCCcHHHHHHHHhh-------------------------cCCCCCHHHHHHHHHHHHHHHH
Confidence 5899999 7778888887754321 1245778889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----CCCCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIw 695 (753)
|||+.+++|+||+|+||+++.++. +||+|||++....... .......|+..|+|||.+.. ..++.++|||
T Consensus 128 ~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 202 (275)
T cd06608 128 YLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVW 202 (275)
T ss_pred HHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHH
Confidence 999999999999999999977654 9999999998764322 12233458999999998753 3467899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|+|++| .+||..... .....+..... ..+..+++++++||++||..||++|
T Consensus 203 slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 263 (275)
T cd06608 203 SLGITAIELADG-KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR 263 (275)
T ss_pred HhHHHHHHHHhC-CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhC
Confidence 999999999998 667765422 22222222211 1223467899999999999999998
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=285.17 Aligned_cols=235 Identities=23% Similarity=0.343 Sum_probs=180.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
....+.|...+.||+|+||.||++... +|+.||+|.+..... ....+|+. +++.++|+||++++++|.+.+.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~ 89 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQQLRHPNTIEYKGCYLREHT 89 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHHhCCCCCEEEEEEEEEeCCe
Confidence 334456888899999999999999765 589999999864321 23345554 7888999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++|||||. |++.+++... ...+++..+..++.|++.||.|
T Consensus 90 ~~lv~e~~~-----------g~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~L~~ 130 (307)
T cd06607 90 AWLVMEYCL-----------GSASDILEVH----------------------------KKPLQEVEIAAICHGALQGLAY 130 (307)
T ss_pred EEEEHHhhC-----------CCHHHHHHHc----------------------------ccCCCHHHHHHHHHHHHHHHHH
Confidence 999999544 3444433211 2346788889999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 698 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfG 698 (753)
||+.+|+||||+|+||+++.++. +||+|||++...... ....++..|+|||++. ...++.++||||||
T Consensus 131 LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G 201 (307)
T cd06607 131 LHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201 (307)
T ss_pred HHHCCceecCCCcccEEECCCCC--EEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHH
Confidence 99999999999999999977754 999999998765432 2345788999999874 45688999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHHcc-Ccc-cccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIVKDR-KDL-FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~-~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++|||+|| .+||..... .....+... ... ....+++++.++|.+||+.||++|
T Consensus 202 ~il~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (307)
T cd06607 202 ITCIELAER-KPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDR 258 (307)
T ss_pred HHHHHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhC
Confidence 999999998 566655432 222222222 111 233567899999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=284.54 Aligned_cols=233 Identities=25% Similarity=0.376 Sum_probs=179.4
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch--------HHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD--------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~--------~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
|.+.+.||+|+||.||+|... +|+.||||++...... ....|+. +++.++|+||+++++++.+.+..++|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHH-HHhhcCCCCChhhhheeecCCEEEEE
Confidence 667788999999999999764 5899999999654321 2234544 77899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+ .|+|.+++.... ..+++..+++++.||++||+|||+.
T Consensus 81 ~e----------~~-~~~L~~~i~~~~----------------------------~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 81 FE----------FM-ETDLEKVIKDKS----------------------------IVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred Ec----------cc-CCCHHHHHhccC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 77 778877764321 2478888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~El 704 (753)
+|+|+||+|+||+++.++. ++|+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 122 ~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 122 WILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred CeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999987765 99999999987654321 1122346888999998865 4578999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHccC----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~~~----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||..... .....+.... .......+.++.++|.+||++||++|
T Consensus 197 ~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 273 (298)
T cd07841 197 LLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKR 273 (298)
T ss_pred HcC-CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccC
Confidence 999 667754322 1111111000 00113346789999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=304.52 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=189.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEee------cCCchHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLV------KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~------~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
..-++..++..+||+|+|-+||+|-+. .|..||.-.++ .....+.+.++..+++.++|+|||+++.+|.+...
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n 115 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN 115 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence 344455678889999999999999654 58888865443 22223556666679999999999999999988655
Q ss_pred --EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 542 --VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 542 --~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+-+|+| .+..|+|..|+... +..+.+.+.+|++||++||
T Consensus 116 ~~in~iTE----------L~TSGtLr~Y~kk~-----------------------------~~vn~kaik~W~RQILkGL 156 (632)
T KOG0584|consen 116 KTINFITE----------LFTSGTLREYRKKH-----------------------------RRVNIKAIKSWCRQILKGL 156 (632)
T ss_pred ceeeeeee----------cccCCcHHHHHHHh-----------------------------ccCCHHHHHHHHHHHHHHh
Confidence 788999 88899999988643 4466678899999999999
Q ss_pred HHhhhC--CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 620 SHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 620 ~yLH~~--~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
.|||++ +|||||||-+||+|+.+. ..+||+|+|||..+... .....+|||.|||||... ..|.+.+|||||
T Consensus 157 ~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaF 229 (632)
T KOG0584|consen 157 VYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAF 229 (632)
T ss_pred hhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchhhhhhhh
Confidence 999988 799999999999996543 36999999999987643 234467999999999876 889999999999
Q ss_pred HHHHHHHHhCCCCCCCCC--hHHHHHHHHccCccc--ccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGES--FERDANIVKDRKDLF--LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~--~~~~~~~i~~~~~~~--~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++++||+|+ ..||.+. .....+++..+..+. -.--.|++++||.+||.. .++|
T Consensus 230 GMCmLEMvT~-eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R 287 (632)
T KOG0584|consen 230 GMCMLEMVTS-EYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSER 287 (632)
T ss_pred hHHHHHHHhc-cCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhc
Confidence 9999999998 7899875 345566777766542 222368999999999998 5554
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-33 Score=304.95 Aligned_cols=230 Identities=24% Similarity=0.346 Sum_probs=184.0
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|.-.+.||.|+||-||.|.+ .+.+.||||++.-.. ..+.++|+. .+..++|||++.+.|+|..+...+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVr-FL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVR-FLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHH-HHHhccCCCcccccceeeccchHHHHHH
Confidence 44457799999999999965 468899999995322 335567766 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||-++-.|++-+. ..++.+.++..|+.+.+.||+|||+.+.
T Consensus 107 YClGSAsDlleVh---------------------------------------kKplqEvEIAAi~~gaL~gLaYLHS~~~ 147 (948)
T KOG0577|consen 107 YCLGSASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHNR 147 (948)
T ss_pred HHhccHHHHHHHH---------------------------------------hccchHHHHHHHHHHHHHHHHHHHHhhH
Confidence 9987766665221 2356667788999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~El 704 (753)
||||||..||||+..|. +||+|||.|..+.+. ..++|||.|||||++. .++|+-|+||||||+...||
T Consensus 148 IHRDiKAGNILLse~g~--VKLaDFGSAsi~~PA-------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 148 IHRDIKAGNILLSEPGL--VKLADFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred HhhhccccceEecCCCe--eeeccccchhhcCch-------hcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence 99999999999987765 999999999876543 4678999999999985 57899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHccCcc-c-ccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDANIVKDRKDL-F-LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~~~i~~~~~~-~-~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.-.++|-|...--.....+.....+ . ..+|+..+++|+..||++-|.+|
T Consensus 219 AERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeR 269 (948)
T KOG0577|consen 219 AERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQER 269 (948)
T ss_pred hhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccC
Confidence 9974444444433333333333333 2 34688999999999999999987
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=277.57 Aligned_cols=230 Identities=30% Similarity=0.466 Sum_probs=182.2
Q ss_pred ecccCceEEEEEEeeC-CcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||++.... |+.+|+|.+..... ....+|+ +++..++|+||+++++.+.+.+..|++||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e------ 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTER-DILSQAQSPYVVKLYYSFQGKKNLYLVME------ 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHH-HHHHhCCCcchhHHHHheecCcEEEEEEe------
Confidence 6899999999997764 99999999865432 1233344 47788999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+.+|+|.+++... ..+++..+++++.|++.||+|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 74 ----YLPGGDLASLLENV-----------------------------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred ----cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 77788888877532 257788899999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcc-----cccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~-----~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||+++.++. ++|+|||++......... ........++..|+|||.......+.++||||||+++||+++|
T Consensus 121 ~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 197 (265)
T cd05579 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG- 197 (265)
T ss_pred HHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC-
Confidence 99999987765 999999998765432110 1122334578899999999888899999999999999999998
Q ss_pred CCCCCCCh-HHHHHHHHccCcccccCC--CHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESF-ERDANIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~-~~~~~~i~~~~~~~~~~~--s~el~dLI~~cL~~DP~~R 753 (753)
..||.... ......+.......+... ++++.++|++||+.||++|
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 245 (265)
T cd05579 198 IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKR 245 (265)
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhc
Confidence 66776543 333444444344444444 8899999999999999988
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=281.69 Aligned_cols=233 Identities=25% Similarity=0.364 Sum_probs=184.3
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|+..+.||+|+||.||+|... ++..||+|.+...... ...+|+. +++.++|+||+++++++.+....++|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYVTKYYGSYLKGTKLWIIME- 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCEEEEEEe-
Confidence 3556678999999999999764 5899999998754322 2333444 7788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.. ..+++.++..++.|++.||+|||+.+++
T Consensus 83 ---------~~~~~~L~~~i~~------------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~iv 123 (277)
T cd06640 83 ---------YLGGGSALDLLRA------------------------------GPFDEFQIATMLKEILKGLDYLHSEKKI 123 (277)
T ss_pred ---------cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 8888888887642 2356677889999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|+||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|||+||
T Consensus 124 H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg- 197 (277)
T cd06640 124 HRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG- 197 (277)
T ss_pred CcCCChhhEEEcCCCC--EEEcccccceeccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC-
Confidence 9999999999977765 99999999987643221 12233578899999999888899999999999999999998
Q ss_pred CCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+.. ..+..+..++.++.++|.+||+.||++|
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (277)
T cd06640 198 EPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR 244 (277)
T ss_pred CCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccC
Confidence 66776543322 222222 2233444567889999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=277.62 Aligned_cols=237 Identities=27% Similarity=0.351 Sum_probs=181.8
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----c---hHHHHHHHHHHHhCCCCceeeecccccCC--ce
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----H---DVALKEIQNLIASDQHPNIVRWYGVESDQ--DF 541 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~ 541 (753)
..|.+.+.||+|+||.||++... +++.||+|.+.... . ....+|+ .+++.++|+||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei-~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEI-QLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHH-HHHHHcCCCCcceEEEEEEcCCCCE
Confidence 35788899999999999999764 58999999875321 1 1223344 478899999999999998653 56
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++++| |.++|+|.+++.. ...+++..+++++.|++.||.|
T Consensus 81 ~~~v~e----------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~al~~ 121 (264)
T cd06653 81 LSIFVE----------YMPGGSIKDQLKA-----------------------------YGALTENVTRRYTRQILQGVSY 121 (264)
T ss_pred EEEEEE----------eCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 889999 7777788777642 1346777889999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+++|+||||+||+++.++. ++|+|||+++................++..|+|||.+.+..++.++|||||||++
T Consensus 122 LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 199 (264)
T cd06653 122 LHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTV 199 (264)
T ss_pred HHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHH
Confidence 99999999999999999977654 8999999998764321111111234588999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCChHHH-HHHHHc--cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERD-ANIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~-~~~i~~--~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+++| .+||.+..... ...... .....+..+++++.++|++||+. |.+|
T Consensus 200 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~~-~~~r 252 (264)
T cd06653 200 VEMLTE-KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVE-EKRR 252 (264)
T ss_pred HHHHhC-CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhcC-cccC
Confidence 999998 67886653222 222221 22446777889999999999994 5665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=302.58 Aligned_cols=237 Identities=27% Similarity=0.382 Sum_probs=201.7
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.-...|.+.+.||+|.|+.|.++... .+..||||.+.+... ...++|++ +|+.+.|||||+|+.+...+..+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~-imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVD-IMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHH-HHHhcCCcceeeeeeeeeecceeE
Confidence 33466889999999999999998654 599999999987643 23567776 779999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |..+|.++++|....+ +.+.....++.|+.++++|||
T Consensus 132 lV~e----------ya~~ge~~~yl~~~gr-----------------------------~~e~~ar~~F~q~vsaveYcH 172 (596)
T KOG0586|consen 132 LVME----------YASGGELFDYLVKHGR-----------------------------MKEKEARAKFRQIVSAVEYCH 172 (596)
T ss_pred EEEE----------eccCchhHHHHHhccc-----------------------------chhhhhhhhhHHHHHHHHHHh
Confidence 9999 8889999999876543 233456788999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~ 702 (753)
+++|+|||||++||||+.+ .++||+|||++.++... ....+.||++.|.|||+..+..| ++++|+||+|++||
T Consensus 173 ~k~ivHrdLk~eNilL~~~--mnikIaDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly 246 (596)
T KOG0586|consen 173 SKNIVHRDLKAENILLDEN--MNIKIADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLY 246 (596)
T ss_pred hcceeccccchhhcccccc--cceeeeccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhhe
Confidence 9999999999999999555 55999999999988633 34567889999999999999887 79999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|+.| ..||++. .......+..++...+..++-+++++|+++|.++|.+|
T Consensus 247 ~LV~G-sLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr 297 (596)
T KOG0586|consen 247 ALVEG-SLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKR 297 (596)
T ss_pred eeeec-ccccCCcccccccchheeeeecccceeechhHHHHHHhhccCcccc
Confidence 99998 7888765 44555566677777888889999999999999999988
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-31 Score=278.63 Aligned_cols=236 Identities=30% Similarity=0.456 Sum_probs=181.6
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----c---------hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----H---------DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~---------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
.|...+.||+|+||.||+|... +|+.||||.++... . +...+|+ .+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEI-ETLKDLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHH-HHHHhcCCCCcceEEEEeccC
Confidence 3667788999999999999654 68999999885321 0 1123344 478899999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.++++.. ..+++..+..++.|++.||
T Consensus 81 ~~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l 121 (272)
T cd06629 81 EYLSIFLE----------YVPGGSIGSCLRTY-----------------------------GRFEEQLVRFFTEQVLEGL 121 (272)
T ss_pred CceEEEEe----------cCCCCcHHHHHhhc-----------------------------cCCCHHHHHHHHHHHHHHH
Confidence 99999999 88888888887532 3467778899999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSL 697 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSf 697 (753)
.|||+.+++||||+|+||+++.++ .++|+|||+++........ .......|+..|+|||.+.... ++.++|+|||
T Consensus 122 ~~lH~~~i~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~sl 198 (272)
T cd06629 122 AYLHSKGILHRDLKADNLLVDADG--ICKISDFGISKKSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198 (272)
T ss_pred HHHhhCCeeecCCChhhEEEcCCC--eEEEeeccccccccccccc-cccccccCCccccCHHHhccccCCCCccchhHHH
Confidence 999999999999999999997665 5999999999865432111 1123345789999999987655 7899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH--HHHHHHcc-Cccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFER--DANIVKDR-KDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~--~~~~i~~~-~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+++||+++| ..||...... ........ ...+ ...++.++.++|.+||++||++|
T Consensus 199 G~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 260 (272)
T cd06629 199 GCVVLEMFAG-RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR 260 (272)
T ss_pred HHHHHHHHhC-CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhC
Confidence 9999999998 6677554322 11111111 1122 23457899999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=289.05 Aligned_cols=236 Identities=23% Similarity=0.335 Sum_probs=197.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---c---hHHHHHHHHHHHhC-CCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---H---DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~---~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~ 543 (753)
..+|.+..+||+|+||.|.+|... ..+.+|||+|++.- . +--..|. ++++.. +-|.+++|..++..-+.+|
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EK-rvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK-RVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhh-hheecCCCCchHHHHHHHhhhhhhee
Confidence 456889999999999999998665 47899999997642 1 1112232 245544 5678999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.-+++.. ..+.++.+.-+|..||-||-+||
T Consensus 427 FVME----------yvnGGDLMyhiQQ~-----------------------------GkFKEp~AvFYAaEiaigLFFLh 467 (683)
T KOG0696|consen 427 FVME----------YVNGGDLMYHIQQV-----------------------------GKFKEPVAVFYAAEIAIGLFFLH 467 (683)
T ss_pred eEEE----------EecCchhhhHHHHh-----------------------------cccCCchhhhhhHHHHHHhhhhh
Confidence 9999 78888888777543 34566677899999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
++|||+||||.+||+|+.+|+ +||+|||+++.. .-....+.+.|||+.|+|||++...+|+..+|.|||||+|||
T Consensus 468 ~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEn---i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyE 542 (683)
T KOG0696|consen 468 SKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEN---IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 542 (683)
T ss_pred cCCeeeeeccccceEeccCCc--eEeeeccccccc---ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHH
Confidence 999999999999999988876 999999999853 223455678999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+.| ++||++.. ++.+..+...+..+|..+|.|+.++.+..|.+.|.+|
T Consensus 543 mlaG-QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kR 592 (683)
T KOG0696|consen 543 MLAG-QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKR 592 (683)
T ss_pred HHcC-CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccc
Confidence 9999 67887664 4566778888899999999999999999999999998
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=286.93 Aligned_cols=230 Identities=25% Similarity=0.430 Sum_probs=180.9
Q ss_pred EeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 477 FNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
....||+|+||.||++... +++.||+|.+.... .+...+|+. ++..++||||+++++++..++..++++|
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~iv~e----- 98 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHQNVVEMYKSYLVGEELWVLME----- 98 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHH-HHHhCCCCchhhhhhheeeCCeEEEEEe-----
Confidence 3456999999999998764 68999999985432 233445554 6788999999999999999999999999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCC
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDL 632 (753)
|+++|+|.+++.. ..+++..++.++.|++.||+|||+.+|+||||
T Consensus 99 -----~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl 143 (297)
T cd06659 99 -----FLQGGALTDIVSQ------------------------------TRLNEEQIATVCESVLQALCYLHSQGVIHRDI 143 (297)
T ss_pred -----cCCCCCHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 7777888776532 34677888999999999999999999999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf 712 (753)
||+||+++.++. +||+|||++....... .......|+..|+|||.+.+..++.++|||||||++|||++| +.||
T Consensus 144 ~p~Nill~~~~~--~kL~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~~p~ 217 (297)
T cd06659 144 KSDSILLTLDGR--VKLSDFGFCAQISKDV---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG-EPPY 217 (297)
T ss_pred CHHHeEEccCCc--EEEeechhHhhccccc---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCC
Confidence 999999977754 9999999987654322 112334689999999999988899999999999999999999 5566
Q ss_pred CCC-hHHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 713 GES-FERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 713 ~~~-~~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... .......+..... .....+++++.++|.+||+.||++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~R 262 (297)
T cd06659 218 FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262 (297)
T ss_pred CCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccC
Confidence 433 2233333322221 2234567899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-31 Score=279.65 Aligned_cols=236 Identities=25% Similarity=0.383 Sum_probs=182.7
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC--CceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~~LV~ 546 (753)
.|...+.||.|++|.||++... +++.+|+|.+..... ....+|++ +++.++|+||++++++|.+ .+..++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE-INKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5778899999999999999775 589999999875432 34556665 7789999999999999865 34689999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++..... ....+++..+.+++.|++.||.|||+.+
T Consensus 81 e----------~~~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 81 E----------YCEGGSLDSIYKKVKK-------------------------RGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred E----------ecCCCCHHHHHHHHHh-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7778888887654321 1245778889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
++|+||+|+||+++.++ .++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|||++
T Consensus 126 i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 126 IIHRDIKPSNILLTRKG--QVKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred cccCCCCHHHEEEecCC--eEEEeeccccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999997765 49999999987654321 123347889999999998899999999999999999999
Q ss_pred CCCCCCCCCh------HHHHHHHHccCcc-cc------cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF------ERDANIVKDRKDL-FL------VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~------~~~~~~i~~~~~~-~~------~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||.... ......+...... .. ..++++++++|.+||..||++|
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (287)
T cd06621 199 N-RFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR 257 (287)
T ss_pred C-CCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccC
Confidence 8 66776441 1122222221111 11 2345789999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=280.84 Aligned_cols=235 Identities=22% Similarity=0.364 Sum_probs=179.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +++.||||+++... .+...+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-VLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHH-HHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5788899999999999999765 58899999986432 223445554 7889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+| .++.+..++. ....+++.++..++.+|+.||.|||+.++
T Consensus 81 ~~----------~~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 81 YV----------ERTLLELLEA-----------------------------SPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cC----------CCCHHHHHHh-----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44 4444433321 12346788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||+|+||+++.++ .+||+|||++........ .......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 122 ~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 122 IHRDIKPENILVSESG--VLKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred ecCCCCHHHeEECCCC--CEEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 9999999999997665 499999999987654321 122334578899999999888 78999999999999999999
Q ss_pred CCCCCCCCChHHHH-HHHHc--------------------c------------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERDA-NIVKD--------------------R------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~~-~~i~~--------------------~------------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||........ ..... . ....+..+++++.+||++||+.||++|
T Consensus 198 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 198 G-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 8 567754422111 10000 0 001223347889999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-31 Score=282.50 Aligned_cols=239 Identities=25% Similarity=0.341 Sum_probs=175.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCc-----
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD----- 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~----- 540 (753)
.++|++.+.||+|+||.||++... +++.||||.+.... .....+|+. +++.++||||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHH-HHHhCCCCCccceEEEEecccccccC
Confidence 356889999999999999999764 58999999986432 113345655 788999999999999986643
Q ss_pred ---eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 541 ---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 541 ---~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
..++|||+|.++| .+++... ...+++.++++++.|++.
T Consensus 90 ~~~~~~lv~e~~~~~l-----------~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~ 130 (310)
T cd07865 90 YKGSFYLVFEFCEHDL-----------AGLLSNK----------------------------NVKFTLSEIKKVMKMLLN 130 (310)
T ss_pred CCceEEEEEcCCCcCH-----------HHHHHhc----------------------------ccCCCHHHHHHHHHHHHH
Confidence 4599999665443 3333211 124788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCCC-CCchhhHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR-QTRAIDLF 695 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIw 695 (753)
||+|||+.+++|+||||+||+++.++ .+||+|||++.......... .......++..|+|||.+.+.. ++.++|||
T Consensus 131 al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 208 (310)
T cd07865 131 GLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMW 208 (310)
T ss_pred HHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhH
Confidence 99999999999999999999997765 49999999998764322111 1122345788999999887654 68999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHH-HHHHHccC-------------------ccc-------------ccCCCHHHHHHH
Q 004442 696 SLGCILFFCITGGKHPYGESFERD-ANIVKDRK-------------------DLF-------------LVEHIPEAVDLF 742 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~~-~~~i~~~~-------------------~~~-------------~~~~s~el~dLI 742 (753)
|||+++|||+|| .+||....... ...+.... ... ....++.+.++|
T Consensus 209 slG~~l~el~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli 287 (310)
T cd07865 209 GAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLI 287 (310)
T ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHH
Confidence 999999999998 56775543221 11111100 000 011246788999
Q ss_pred HHccccCcCCC
Q 004442 743 TRLLDPNPDLR 753 (753)
Q Consensus 743 ~~cL~~DP~~R 753 (753)
.+||..||++|
T Consensus 288 ~~~l~~~P~~R 298 (310)
T cd07865 288 DKLLVLDPAKR 298 (310)
T ss_pred HHHhcCChhhc
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=280.71 Aligned_cols=233 Identities=27% Similarity=0.405 Sum_probs=183.1
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|++.+.||+|+||.||++... +++.||+|++..... ....+|+. +++.++|+||+++++++..++..++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD-ILHKCNSPYIVGFYGAFYNNGDISICME- 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHH-HHHHCCCCchhhhheeeecCCEEEEEEE-
Confidence 3556678999999999999775 589999999875432 23455554 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~I 627 (753)
|+.+++|.+++.... ..+++..+.+++.|++.||+|||+ .++
T Consensus 80 ---------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~~i 122 (265)
T cd06605 80 ---------YMDGGSLDKILKEVQ----------------------------GRIPERILGKIAVAVLKGLTYLHEKHKI 122 (265)
T ss_pred ---------ecCCCcHHHHHHHcc----------------------------CCCCHHHHHHHHHHHHHHHHHHcCCCCe
Confidence 666777777764321 356778889999999999999999 999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||||+||+++.++. ++|+|||.+........ ....++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 123 ~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 123 IHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987654 99999999876543211 115578999999999999999999999999999999998
Q ss_pred CCCCCCCCh------HHHHHHHH-ccCcccccC-CCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF------ERDANIVK-DRKDLFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~------~~~~~~i~-~~~~~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
..||.... ........ ......+.. +++++.++|.+||..||++|
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (265)
T cd06605 196 -RFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER 248 (265)
T ss_pred -CCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhC
Confidence 55665431 11112222 222233333 78899999999999999998
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.62 Aligned_cols=233 Identities=23% Similarity=0.386 Sum_probs=181.2
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.|.....||+|+||.||++... ++..||||++..... +...+|+. .+..++|+||+++++++.+.+..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~lv~e-- 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-IMRDYHHENVVDMYNSYLVGDELWVVME-- 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHH-HHHhCCCCcHHHHHHheecCCeEEEEEe--
Confidence 3344466999999999998664 589999999864332 23445555 7788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++.. ..+++.+++.++.||+.||+|||+.+|+|
T Consensus 100 --------~~~~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH 141 (292)
T cd06658 100 --------FLEGGALTDIVTH------------------------------TRMNEEQIATVCLSVLRALSYLHNQGVIH 141 (292)
T ss_pred --------CCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 7777888776532 23567788999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++|||||||++|||++| .
T Consensus 142 ~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g-~ 215 (292)
T cd06658 142 RDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG-E 215 (292)
T ss_pred cCCCHHHEEEcCCCC--EEEccCcchhhcccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-C
Confidence 999999999977754 99999999876543221 12234589999999999888899999999999999999998 5
Q ss_pred CCCCCCh-HHHHHHHHccCcc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESF-ERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~-~~~~~~i~~~~~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||.... ......+...... .....++++.++|.+||..||++|
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 263 (292)
T cd06658 216 PPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263 (292)
T ss_pred CCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHC
Confidence 5665432 2222222222111 223467899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=298.89 Aligned_cols=237 Identities=24% Similarity=0.379 Sum_probs=189.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+...+.||+|-||.||+|...+ .-.||||..+... .+.++.|- .+|+.++|||||+|+|+|.+ ...+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa-~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEA-SIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHH-HHHHhCCCcchhheeeeeec-ccee
Confidence 345566789999999999986543 3468889887532 23344444 58899999999999999976 4789
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| ..+.|-|..+|... ...++...+..++.||+.+|+|||
T Consensus 467 ivmE----------L~~~GELr~yLq~n----------------------------k~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 467 IVME----------LAPLGELREYLQQN----------------------------KDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred EEEe----------cccchhHHHHHHhc----------------------------cccchHHHHHHHHHHHHHHHHHHH
Confidence 9999 56678888888643 245677788999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.++|||||..+|||+.+.. ++||+||||++.+........ ....-...|||||.+.-++++.++|||-|||++||
T Consensus 509 SkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~yYka--S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWE 584 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAYYKA--SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWE 584 (974)
T ss_pred hhchhhhhhhhhheeecCcc--eeeecccchhhhccccchhhc--cccccceeecCccccchhcccchhhHHHHHHHHHH
Confidence 99999999999999997664 699999999998876533222 12234678999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHH-H-HHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~-~-~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.-+.-||.+....+ . .+......+.|+++++.+..|+.+||..||.+|
T Consensus 585 Il~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kR 636 (974)
T KOG4257|consen 585 ILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKR 636 (974)
T ss_pred HHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccC
Confidence 9887777887653332 2 333445567899999999999999999999998
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=278.84 Aligned_cols=234 Identities=24% Similarity=0.406 Sum_probs=178.0
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|++.+.||+|++|.||++... +|+.||||++.... .....+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~iv~~~~~~~~~~~~~iv~e- 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-LLKELNHPNIVRLLDVVHSENKLYLVFE- 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHH-HHHhcCCCCccCHhheeccCCeEEEEEe-
Confidence 345678999999999998764 69999999986432 133455665 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+ .++|.+++.... ...+++..+++++.|++.||+|||+.+++
T Consensus 79 ---------~~-~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~ 121 (283)
T cd07835 79 ---------FL-DLDLKKYMDSSP---------------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121 (283)
T ss_pred ---------cc-CcCHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 55 356666654321 13578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG 707 (753)
||||+|+||+++.++ .++|+|||+++....... ......++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 122 H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 196 (283)
T cd07835 122 HRDLKPQNLLIDREG--ALKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR 196 (283)
T ss_pred CCCCCHHHEEEcCCC--cEEEeecccccccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC
Confidence 999999999997765 499999999976543211 11223468899999988665 468999999999999999998
Q ss_pred CCCCCCCChHH--HHHHHHc----------------------------cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER--DANIVKD----------------------------RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~--~~~~i~~----------------------------~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||...... ....... ........+++++.++|.+||+.||++|
T Consensus 197 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 271 (283)
T cd07835 197 -RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271 (283)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhC
Confidence 5677543221 1111110 0001134567889999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=278.33 Aligned_cols=233 Identities=24% Similarity=0.345 Sum_probs=184.1
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
|...+.||+|+||.||++.. .++..||||.+...... ..+.++...++.++|+||+++++++.+++..++|||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e--- 82 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME--- 82 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE---
Confidence 55678899999999999865 46899999998643321 223333347788999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++.. ..+++..+..++.+++.||.|||+.+++|+
T Consensus 83 -------~~~~~~l~~~i~~------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 125 (277)
T cd06641 83 -------YLGGGSALDLLEP------------------------------GPLDETQIATILREILKGLDYLHSEKKIHR 125 (277)
T ss_pred -------eCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHccCCeecC
Confidence 7777788776632 246778889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++| ..
T Consensus 126 dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~ 199 (277)
T cd06641 126 DIKAANVLLSEHGE--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EP 199 (277)
T ss_pred CCCHHhEEECCCCC--EEEeecccceecccchh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC-CC
Confidence 99999999977654 99999999887643211 11234578899999999888899999999999999999998 67
Q ss_pred CCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+.. ........++.++.++|.+||..||++|
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (277)
T cd06641 200 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 244 (277)
T ss_pred CCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence 88654332 2222222 2333455678899999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.84 Aligned_cols=236 Identities=27% Similarity=0.356 Sum_probs=175.4
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|...+.||+|+||.||++... +++.||+|.+.... .....+|+. ++.++ +|+||+++++++.+++..+++||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD-VVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHH-HHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 334567999999999998654 58999999986532 123455655 45555 599999999999999999999997
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-Cc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 627 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~I 627 (753)
|..++.++. ..+.. .....+++..+.+++.+++.||+|||+. +|
T Consensus 85 ~~~~l~~l~--------~~~~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i 129 (288)
T cd06616 85 MDISLDKFY--------KYVYE---------------------------VLKSVIPEEILGKIAVATVKALNYLKEELKI 129 (288)
T ss_pred ccCCHHHHH--------HHHHH---------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 765443332 11111 1124578889999999999999999975 99
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC---CCCchhhHHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDIwSfGvvL~El 704 (753)
+||||||+||+++.++. +||+|||+++...... ......|+..|+|||.+.+. .++.++|||||||++|||
T Consensus 130 ~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 203 (288)
T cd06616 130 IHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203 (288)
T ss_pred eccCCCHHHEEEccCCc--EEEeecchhHHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHH
Confidence 99999999999977654 9999999997654321 11223578999999999776 689999999999999999
Q ss_pred HhCCCCCCCCChHH--HHHHHHccCc-c----cccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFER--DANIVKDRKD-L----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~--~~~~i~~~~~-~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| ++||...... .......... . ....+++++.+||++||++||++|
T Consensus 204 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (288)
T cd06616 204 ATG-KFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR 258 (288)
T ss_pred HhC-CCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhC
Confidence 998 7788654321 1111111111 1 123478899999999999999998
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=290.13 Aligned_cols=195 Identities=27% Similarity=0.419 Sum_probs=155.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.++|...+.||+|+||.||++... +|+.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHH-HHHhcCCCCCcceeeeeccCCCccc
Confidence 4577899999999999999999764 68999999986432 123445655 78899999999999987643
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...|+|||+|.++|.+++ . ..+++.++..++.|++.|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~-----------~-------------------------------~~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 93 FQDVYLVMELMDANLCQVI-----------Q-------------------------------MDLDHERMSYLLYQMLCG 130 (353)
T ss_pred cCcEEEEEeccCCCHHHHH-----------h-------------------------------hcCCHHHHHHHHHHHHHH
Confidence 357999996654443332 1 115667788999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+||+++.++. +||+|||+++...... ......++..|+|||.+.+..++.++||||||
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 99999999999999999999977765 9999999998764321 12334578999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGES 715 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~ 715 (753)
|++|+|++| +.||...
T Consensus 205 ~~l~~l~~g-~~pf~~~ 220 (353)
T cd07850 205 CIMGEMIRG-TVLFPGT 220 (353)
T ss_pred HHHHHHHHC-CCCCCCC
Confidence 999999998 5677543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=284.01 Aligned_cols=231 Identities=23% Similarity=0.348 Sum_probs=177.2
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|...+.||+|+||.||++... ++..||+|++.... . ....+|+. +++.++|+|++++++++.+++..++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK-FLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHH-HHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 44667788999999999998764 58999999986432 1 13344554 77899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||||.++ |.+.+.. ....+++.++..++.+++.||.|||+.
T Consensus 104 ~e~~~g~-----------l~~~~~~----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~ 144 (317)
T cd06635 104 MEYCLGS-----------ASDLLEV----------------------------HKKPLQEVEIAAITHGALQGLAYLHSH 144 (317)
T ss_pred EeCCCCC-----------HHHHHHH----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9965544 4333321 123477888899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~ 702 (753)
+|+||||+|+||+++.++. +||+|||++...... ....|+..|+|||.+. .+.++.++|||||||++|
T Consensus 145 ~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~ 215 (317)
T cd06635 145 NMIHRDIKAGNILLTEPGQ--VKLADFGSASIASPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 215 (317)
T ss_pred CcccCCCCcccEEECCCCC--EEEecCCCccccCCc-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHH
Confidence 9999999999999977654 999999998754321 2345789999999874 456899999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHH-HccCcc-cccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGE-SFERDANIV-KDRKDL-FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~-~~~~~~~~i-~~~~~~-~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|+ +||.. ........+ ...... ....+++.+.++|.+||+.||.+|
T Consensus 216 el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 268 (317)
T cd06635 216 ELAERK-PPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDR 268 (317)
T ss_pred HHHhCC-CCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccC
Confidence 999995 45544 333322222 222222 234567899999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=309.98 Aligned_cols=245 Identities=18% Similarity=0.232 Sum_probs=173.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC--CcEEEEE------------------EeecCC--chHHHHHHHHHHHhCCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVK------------------RLVKTH--HDVALKEIQNLIASDQH 526 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~--g~~VAVK------------------~l~~~~--~~~~~~Ei~~ll~~l~H 526 (753)
..+...|.+.+.||+|+||+||++.... +...++| ++.... .....+|+. +++.++|
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~-il~~l~H 222 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL-ALGRLNH 222 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHH-HHHhCCC
Confidence 3455789999999999999999875432 2222222 111111 112344554 7899999
Q ss_pred CceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHH
Q 004442 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 606 (753)
Q Consensus 527 pNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 606 (753)
+|||++++++.+.+..|+++|++..++.++++ ..... |. ......
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~-----------~~~~~-----------------------~~-~~~~~~ 267 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYDFDLYSFMY-----------DEAFD-----------------------WK-DRPLLK 267 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccccCHHHHHh-----------hcccc-----------------------cc-ccccHH
Confidence 99999999999999999999977655544432 11100 11 112345
Q ss_pred HHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC
Q 004442 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG 686 (753)
Q Consensus 607 ~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 686 (753)
++.+|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+..... .......||..|+|||++.+.
T Consensus 268 ~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 343 (501)
T PHA03210 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGD 343 (501)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCC
Confidence 66889999999999999999999999999999977765 99999999987654321 122335689999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHccC---------------------c-----c-----cc
Q 004442 687 RQTRAIDLFSLGCILFFCITGGKHPYGESF----ERDANIVKDRK---------------------D-----L-----FL 731 (753)
Q Consensus 687 ~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~----~~~~~~i~~~~---------------------~-----~-----~~ 731 (753)
.++.++|||||||++|||++|+.+|+.... ......+.... . . ..
T Consensus 344 ~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 423 (501)
T PHA03210 344 GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423 (501)
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh
Confidence 999999999999999999999777775432 11111111000 0 0 00
Q ss_pred cCCCHHHHHHHHHccccCcCCC
Q 004442 732 VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 732 ~~~s~el~dLI~~cL~~DP~~R 753 (753)
...+.++.++|.+||+.||++|
T Consensus 424 ~~~~~~~~~li~kmL~~DP~~R 445 (501)
T PHA03210 424 LGLPADFEYPLVKMLTFDWHLR 445 (501)
T ss_pred cCCChHHHHHHHHHhccCcccC
Confidence 1245677889999999999998
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=282.49 Aligned_cols=236 Identities=26% Similarity=0.333 Sum_probs=177.5
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCC--ceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~ 543 (753)
.+.|.+.+.||+|+||.||++... +|+.||+|+++.... ....+|+. ++..++|+||+++++++.+. +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT-LLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHH-HHHhCCCCCCcceEEEEecCCCCeEE
Confidence 356888999999999999999765 589999999864321 12345655 77899999999999998754 5689
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||+|.++|.++ +... ...+++.+++.++.|++.||+|||
T Consensus 85 lv~e~~~~~l~~~-----------l~~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH 125 (309)
T cd07845 85 LVMEYCEQDLASL-----------LDNM----------------------------PTPFSESQVKCLMLQLLRGLQYLH 125 (309)
T ss_pred EEEecCCCCHHHH-----------HHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999665544433 3211 134778888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~ 702 (753)
+.+++||||||+||+++.++. +||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|
T Consensus 126 ~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~ 200 (309)
T cd07845 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILA 200 (309)
T ss_pred hCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHH
Confidence 999999999999999977765 99999999987654321 1122335788999999876 45799999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHHHccC-------------------cc-----------cccCCCHHHHHHHHHccccCcC
Q 004442 703 FCITGGKHPYGESFER-DANIVKDRK-------------------DL-----------FLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~-~~~~i~~~~-------------------~~-----------~~~~~s~el~dLI~~cL~~DP~ 751 (753)
||++| .+||...... ....+.... .. .....++++.++|++||+.||+
T Consensus 201 el~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~ 279 (309)
T cd07845 201 ELLAH-KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK 279 (309)
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh
Confidence 99998 6677654322 222111100 00 0123578899999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 280 ~R 281 (309)
T cd07845 280 KR 281 (309)
T ss_pred hC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=281.90 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=176.9
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.|.+.+.||+|+||.||++.... ++.||||+++.... ....+|+..+.....|+||++++++|.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 557788999999999999997765 89999999975432 2344555545455569999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CC
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IG 626 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~ 626 (753)
++.+. +.+++.. ....+++..+.+++.+++.||+|||+ .+
T Consensus 95 ~~~~~-----------l~~l~~~----------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 95 LMSTC-----------LDKLLKR----------------------------IQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred ccCcC-----------HHHHHHH----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 55433 3333211 12357788889999999999999997 59
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC----CCchhhHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLGCILF 702 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDIwSfGvvL~ 702 (753)
|+||||+|+||+++.++ .+||+|||++........ .....++..|+|||.+.+.. ++.++||||||+++|
T Consensus 136 i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 136 VIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred EecCCCcHHHEEEcCCC--CEEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 99999999999997665 499999999876643211 12234788999999987554 789999999999999
Q ss_pred HHHhCCCCCCCCChH--HHHHHHHccC-cccc--cCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFE--RDANIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~--~~~~~i~~~~-~~~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| +.||..... .....+.... ...+ ..+++++.+||.+||+.||++|
T Consensus 210 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 264 (296)
T cd06618 210 ELATG-QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264 (296)
T ss_pred HHHhC-CCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99998 677765322 2222222222 2222 2467899999999999999998
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=313.77 Aligned_cols=254 Identities=26% Similarity=0.362 Sum_probs=197.8
Q ss_pred cceEEEeEEecccCceEEEEEEee--------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~--------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
.+...+.+.||+|.||.|++|... ....||||.++.... +....|+..|....+|+||+.|+|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344456678999999999998543 146899999975433 34566777666677899999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhh-cccchhhhhhhhcccccccchhhhhhhc--CCCCHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE-QDSNLLNEVRIRLLPVMENTKDIELWKA--NGHPSAQLLKVTRDIV 616 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~l~Ia~qIa 616 (753)
+..++|+| |..+|+|.++|+..+ ....... + .... ..++..+++.++.|||
T Consensus 375 ~~~~~v~E----------y~~~G~L~~~Lr~~r~~~~~~~~----------~------~~~~~~~~L~~~dLlsfa~QIa 428 (609)
T KOG0200|consen 375 GPLYVIVE----------YAEHGDLLEFLRKKRVTESIDGS----------G------VFPNERDALTTKDLLSFAYQIA 428 (609)
T ss_pred CceEEEEE----------eccCCcHHHHHHhcccccccccc----------C------CCccccCCcCHHHHHHHHHHHH
Confidence 99999999 888999999998776 1000000 0 0011 3488999999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
.||+||++.+++||||..+|||++.+. .+||+|||+|+................-...|||||.+....|+.|+||||
T Consensus 429 ~GMe~L~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWS 506 (609)
T KOG0200|consen 429 NGMEYLASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWS 506 (609)
T ss_pred HHHHHHhhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhH
Confidence 999999999999999999999997774 599999999997654322221111100245699999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC--hHHHHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGES--FERDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~--~~~~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|||++|.+..||.+. .+.....+..+.. ..|..+++++.++|+.||+.+|++|
T Consensus 507 fGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~R 566 (609)
T KOG0200|consen 507 FGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDR 566 (609)
T ss_pred HHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccC
Confidence 9999999999999999873 3344555666555 5666779999999999999999998
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-33 Score=302.69 Aligned_cols=235 Identities=23% Similarity=0.280 Sum_probs=185.1
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.|.+...||.|+||.||+|...+ +...|-|.+.... -++++-||. +++..+||+||+|++.|+.++.++|..|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIe-ILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIE-ILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhh-hhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34566779999999999997776 4455667665433 234555665 789999999999999999999999999977
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
+++ -.+..+-. -.+.+.+.++.-++++++.||.|||+++|||
T Consensus 112 ~GG----------AVDaimlE----------------------------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIH 153 (1187)
T KOG0579|consen 112 GGG----------AVDAIMLE----------------------------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIH 153 (1187)
T ss_pred CCc----------hHhHHHHH----------------------------hccccchHHHHHHHHHHHHHHHHHhhcchhh
Confidence 654 33332221 2367888999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHHH
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~El 704 (753)
||||..|||++-||. ++|+|||.+..... .......+.||+.|||||+.. ..+|+.++||||||+.|.||
T Consensus 154 RDLKAGNiL~TldGd--irLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM 228 (1187)
T KOG0579|consen 154 RDLKAGNILLTLDGD--IRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM 228 (1187)
T ss_pred hhccccceEEEecCc--Eeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence 999999999999988 99999998865433 233456778999999999874 56799999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHHccCcc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~~~~~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..+ .||..+.. -+...++....++ .|..|+..+.||+++||.+||..|
T Consensus 229 Aqi-EPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~R 280 (1187)
T KOG0579|consen 229 AQI-EPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNR 280 (1187)
T ss_pred hcc-CCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccC
Confidence 998 67776543 2333333333333 466788999999999999999987
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=279.19 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=177.6
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|++|.||++... +|+.||+|++..... ....+|+. +++.++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHH-HHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 35788899999999999999765 689999999864321 23445554 778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+. ++|.+++.... ...+++..+..++.||+.||+|||+.+
T Consensus 81 e----------~~~-~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ 122 (294)
T PLN00009 81 E----------YLD-LDLKKHMDSSP---------------------------DFAKNPRLIKTYLYQILRGIAYCHSHR 122 (294)
T ss_pred e----------ccc-ccHHHHHHhCC---------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 553 45555543211 123466778899999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~Ell 705 (753)
++||||+|+||+++.++ ..+||+|||++........ ......+++.|+|||.+.+. .++.++|||||||++|+|+
T Consensus 123 i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 123 VLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred eeCCCCCcceEEEECCC-CEEEEcccccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999997544 3589999999976543211 11233468899999988764 4789999999999999999
Q ss_pred hCCCCCCCCChHH-HHHHH-Hc-c-------------------Cc--------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER-DANIV-KD-R-------------------KD--------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~-~~~~i-~~-~-------------------~~--------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||....+. ....+ .. . .. ......++++.++|.+||+.||++|
T Consensus 199 tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (294)
T PLN00009 199 NQ-KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275 (294)
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhC
Confidence 98 6777654321 11111 10 0 00 0123567889999999999999998
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=280.05 Aligned_cols=239 Identities=26% Similarity=0.388 Sum_probs=175.1
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhC-CCCceeeecccccCCce-----
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDF----- 541 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~----- 541 (753)
.|++.+.||+|+||.||++... +++.||||++.... .....+|+. +++.+ +|+||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREIS-LLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHH-HHHHccCCCCccceeeeEeecCCCCCce
Confidence 5778899999999999999765 58999999886432 234556666 55666 56999999999877655
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.|+|||||++ +|.+++..... .....+++..++.++.||+.||.|
T Consensus 81 ~~lv~e~~~~-----------~l~~~~~~~~~------------------------~~~~~~~~~~~~~~~~qi~~~L~~ 125 (295)
T cd07837 81 LYLVFEYLDS-----------DLKKFMDSNGR------------------------GPGRPLPAKTIKSFMYQLLKGVAH 125 (295)
T ss_pred EEEEeeccCc-----------CHHHHHHHhcc------------------------cCCCCCCHHHHHHHHHHHHHHHHH
Confidence 8999995443 45555443211 112457888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvv 700 (753)
||+.+|+||||||+||+++.++ ..+||+|||+++....... ......+++.|+|||.+.+ ..++.++||||||++
T Consensus 126 LH~~~i~H~dl~~~nil~~~~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 201 (295)
T cd07837 126 CHKHGVMHRDLKPQNLLVDKQK-GLLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201 (295)
T ss_pred HHHCCeeecCCChHHEEEecCC-CeEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence 9999999999999999997622 3599999999986543211 1122346889999998865 457999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HH-HHHHHcc-----------------------C----cccccCCCHHHHHHHHHccccCcC
Q 004442 701 LFFCITGGKHPYGESFE-RD-ANIVKDR-----------------------K----DLFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~-~~~i~~~-----------------------~----~~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
+|||++| .+||..... .. ....... . .......++++.+||.+||+.||+
T Consensus 202 l~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 202 FAEMSRK-QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHcC-CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 9999998 567654322 11 1111100 0 001134678899999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 281 ~R 282 (295)
T cd07837 281 KR 282 (295)
T ss_pred hc
Confidence 98
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=269.39 Aligned_cols=233 Identities=28% Similarity=0.451 Sum_probs=185.0
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
|...+.||+|++|.||++... +++.+|+|++..... ....+|+ ++++.++|+||+++++++...+..++++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~l~~e--- 77 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEI-QILKKCKHPNIVKYYGSYLKKDELWIVME--- 77 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCCeEEEEEe---
Confidence 567788999999999999775 689999999976542 2344454 47889999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+++|.+++... ...+++..+..++.+++.||.|||+.+++||
T Consensus 78 -------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 78 -------FCSGGSLKDLLKST----------------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred -------cCCCCcHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 77777777776432 1357888899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+..++.++||||||+++|+|++| ..
T Consensus 123 dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g-~~ 195 (253)
T cd05122 123 DIKAANILLTSDG--EVKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG-KP 195 (253)
T ss_pred CCCHHHEEEccCC--eEEEeecccccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC-CC
Confidence 9999999997765 499999999987654321 2344578999999999888899999999999999999998 56
Q ss_pred CCCCC-hHHHHHHHH-ccCcccc--cCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGES-FERDANIVK-DRKDLFL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~-~~~~~~~i~-~~~~~~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
||... ......... ......+ ..++.++.++|.+||+.||++|
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 242 (253)
T cd05122 196 PYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKR 242 (253)
T ss_pred CCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhC
Confidence 77654 222222222 2222222 2337899999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=280.75 Aligned_cols=239 Identities=27% Similarity=0.430 Sum_probs=190.3
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
...+.|...+.||+|++|.||++... +++.||+|++.... .....+|+. +++.++|+||+++++++...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHH-HHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45566788889999999999998776 68999999997654 234455555 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+++|.+++.... ..+++..++.++.+++.||+|||+.|
T Consensus 95 e----------~~~~~~L~~~l~~~~----------------------------~~l~~~~~~~i~~~i~~~L~~lH~~g 136 (286)
T cd06614 95 E----------YMDGGSLTDIITQNF----------------------------VRMNEPQIAYVCREVLQGLEYLHSQN 136 (286)
T ss_pred e----------ccCCCcHHHHHHHhc----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 777888888875421 25778889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+|+||+|+||+++.++. ++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 137 i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~ 211 (286)
T cd06614 137 VIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211 (286)
T ss_pred eeeCCCChhhEEEcCCCC--EEECccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh
Confidence 999999999999987765 89999999876543211 1123347889999999988889999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHH-HccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIV-KDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i-~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||....... ...+ ...... ....++.++.++|++||+.||.+|
T Consensus 212 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (286)
T cd06614 212 G-EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261 (286)
T ss_pred C-CCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhC
Confidence 8 67876553322 2222 222222 222377899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=280.05 Aligned_cols=233 Identities=26% Similarity=0.440 Sum_probs=182.5
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.|...+.||+|++|.||++.. .+++.+|+|++.... .+...+|+. +++.++|+||+++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~-~l~~~~h~~vv~~~~~~~~~~~~~~v~e-- 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV-IMRDYQHPNIVEMYSSYLVGDELWVVME-- 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHHcCCCChheEEEEEEcCCeEEEEEe--
Confidence 344457899999999999875 468999999986432 223445554 7788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+++|.+++.. ..+++..+..++.|++.||+|||+.+|+|
T Consensus 97 --------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 138 (285)
T cd06648 97 --------FLEGGALTDIVTH------------------------------TRMNEEQIATVCLAVLKALSFLHAQGVIH 138 (285)
T ss_pred --------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 7778888877642 24677788999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||+|+||+++.++ .++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|||++| .
T Consensus 139 ~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g-~ 212 (285)
T cd06648 139 RDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG-E 212 (285)
T ss_pred CCCChhhEEEcCCC--cEEEcccccchhhccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC-C
Confidence 99999999997765 499999998876543211 12234589999999999888899999999999999999998 5
Q ss_pred CCCCCC-hHHHHHHHHccCccc---ccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGES-FERDANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~-~~~~~~~i~~~~~~~---~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||... .......+....... +...++++.++|.+||+.||++|
T Consensus 213 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 260 (285)
T cd06648 213 PPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260 (285)
T ss_pred CCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhC
Confidence 566443 323333333332222 23367899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=278.74 Aligned_cols=232 Identities=25% Similarity=0.406 Sum_probs=180.7
Q ss_pred EEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCC---CCceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ---HPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~---HpNIV~L~g~~~~~~~~~LV~ 546 (753)
|++.+.||+|+||.||+|.. .+++.||||.+..... ....+|+. +++.++ |+||+++++++.+....++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA-LLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHH-HHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 55667899999999999875 5689999999864322 23444554 556665 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+++|.+++.. ..+++..++.++.|++.||.|||+.+
T Consensus 82 e----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 82 E----------YAEGGSVRTLMKA------------------------------GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred e----------cCCCCcHHHHHHc------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 7778888777532 24677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~Ell 705 (753)
|+|+||+|+||+++.++. ++|+|||++........ ......|+..|+|||.+.++ .++.++|||||||++|+|+
T Consensus 122 i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll 196 (277)
T cd06917 122 VIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSS---KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196 (277)
T ss_pred cccCCcCHHHEEEcCCCC--EEEccCCceeecCCCcc---ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence 999999999999977654 99999999987754321 12234588999999988754 4689999999999999999
Q ss_pred hCCCCCCCCChHHHH-HHHHccC-ccccc-CCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDA-NIVKDRK-DLFLV-EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~-~~i~~~~-~~~~~-~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||........ ..+.... ..... .++.++.++|.+||+.||++|
T Consensus 197 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (277)
T cd06917 197 TG-NPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKER 246 (277)
T ss_pred hC-CCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccC
Confidence 98 678866533222 1111111 12222 367899999999999999998
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=277.73 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=178.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+|++.+.||+|++|.||+|... +|+.||||.+.... .....+|+. +++.++|+||+++++++.+.+..++|||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-LMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHH-HHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 3678899999999999999875 58999999986532 234445554 77889999999999999999999999995
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
+.+ +|.+++.... ....+++.++++++.|++.||+|||+.+|+
T Consensus 80 ~~~-----------~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 122 (284)
T cd07836 80 MDK-----------DLKKYMDTHG--------------------------VRGALDPNTVKSFTYQLLKGIAFCHENRVL 122 (284)
T ss_pred CCc-----------cHHHHHHhcC--------------------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 443 5555543221 123578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG 707 (753)
||||||+||+++.++. ++|+|||++........ ......++..|++||.+.+. .++.++|||||||++|||++|
T Consensus 123 h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 123 HRDLKPQNLLINKRGE--LKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred eCCCCHHHEEECCCCc--EEEeecchhhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999977654 99999999976543211 11233468899999988664 468999999999999999998
Q ss_pred CCCCCCCChHH-HHHHHHcc---------------C---c-----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-DANIVKDR---------------K---D-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-~~~~i~~~---------------~---~-----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.+.... ....+... . . ......+++++++|.+||++||++|
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 272 (284)
T cd07836 198 -RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272 (284)
T ss_pred -CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccC
Confidence 6677654221 11111100 0 0 0112456789999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=278.54 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=176.3
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.|.+.+.||+|++|.||++... +++.||||.+.... .....+|+. +++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS-LLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHH-HHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 56788899999999999999765 68999999986432 123445555 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
| +. |+|.+++... ...+++..+..++.|++.||.|||+.+|
T Consensus 84 ~----------~~-~~L~~~~~~~----------------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i 124 (291)
T cd07844 84 Y----------LD-TDLKQYMDDC----------------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRV 124 (291)
T ss_pred c----------CC-CCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4 44 3555554321 1356778889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||+++....... ......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 125 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 125 LHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ecccCCHHHEEEcCCCC--EEECccccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 99999999875432111 1122346889999999876 457999999999999999999
Q ss_pred CCCCCCCCCh--HHHHHHHHcc-------------------C--------c---ccccCCC--HHHHHHHHHccccCcCC
Q 004442 707 GGKHPYGESF--ERDANIVKDR-------------------K--------D---LFLVEHI--PEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 707 G~~~Pf~~~~--~~~~~~i~~~-------------------~--------~---~~~~~~s--~el~dLI~~cL~~DP~~ 752 (753)
| .+||.... ......+... . . ......+ +++.++|.+||+.||++
T Consensus 200 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 200 G-RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred C-CCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 8 67775543 1111111000 0 0 0001223 78899999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 279 R 279 (291)
T cd07844 279 R 279 (291)
T ss_pred c
Confidence 8
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.19 Aligned_cols=236 Identities=33% Similarity=0.465 Sum_probs=188.2
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC--ceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~LV~E 547 (753)
|...+.||+|++|.||++... +++.|++|++..... ...+..+..+++.++|+||+++++++.+. +..++++|
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 567788999999999999776 689999999876542 22333333478999999999999999988 89999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+++|.+++... ..+++..++.++.+++.||+|||+.++
T Consensus 82 ----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~ 122 (260)
T cd06606 82 ----------YVSGGSLSSLLKKF-----------------------------GKLPEPVIRKYTRQILEGLAYLHSNGI 122 (260)
T ss_pred ----------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77778888776432 257788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||+|+||+++.++. ++|+|||.+......... .......++..|+|||.+.....+.++||||||+++|+|++|
T Consensus 123 ~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g 199 (260)
T cd06606 123 VHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATG 199 (260)
T ss_pred cccCCCHHHEEEcCCCC--EEEcccccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987654 899999999887654221 112334578999999999888899999999999999999998
Q ss_pred CCCCCCCChHH--HHHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER--DANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~--~~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||...... ...... ......+...++++.++|.+||..||++|
T Consensus 200 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R 248 (260)
T cd06606 200 -KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKR 248 (260)
T ss_pred -CCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhC
Confidence 6677665321 112222 13334556678999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=277.17 Aligned_cols=232 Identities=26% Similarity=0.398 Sum_probs=173.6
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCC--ceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~LV~E 547 (753)
|.+.+.||+|+||.||++... +++.||+|+++... ....++|+..+....+|+||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999998754 68999999986532 123456666443344699999999999887 88999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+. |+|.+++... ...+++.+++.++.|++.||+|||+.+|
T Consensus 81 ----------~~~-~~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 81 ----------LMD-MNLYELIKGR----------------------------KRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred ----------cCC-ccHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 543 4555554321 1357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||+|+||+++. + .+||+|||+++....... .....++..|+|||.+.. ..++.++|||||||++|||++
T Consensus 122 ~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 122 FHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred eecccCHHHEEEcC-C--CeEEEecccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 99999999999976 4 599999999987643221 122357889999997654 457899999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHc------------------cCc-----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKD------------------RKD-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~------------------~~~-----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||....... ...+.. ... ......+.++.++|.+||++||++|
T Consensus 195 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 270 (282)
T cd07831 195 L-FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDER 270 (282)
T ss_pred C-CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccc
Confidence 8 77886543211 111100 000 0122457899999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=277.43 Aligned_cols=235 Identities=25% Similarity=0.364 Sum_probs=193.6
Q ss_pred EEecccCceEEEEE-EeeCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChh
Q 004442 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (753)
Q Consensus 479 ~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~ 554 (753)
+.||+|+|+.|--+ ...+|+.+|||++.+.. ..+.++|+...-..-.|+||++|+.++.++..+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE------- 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE------- 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe-------
Confidence 56999999999765 45679999999997653 34678999877677789999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp 634 (753)
-|.+|+|-.+++.+ ..+.+.++.++..+||.||.+||.+||.||||||
T Consensus 157 ---Km~GGplLshI~~~-----------------------------~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP 204 (463)
T KOG0607|consen 157 ---KMRGGPLLSHIQKR-----------------------------KHFNEREASRVVKDIASALDFLHTKGIAHRDLKP 204 (463)
T ss_pred ---cccCchHHHHHHHh-----------------------------hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc
Confidence 99999999998654 4577888899999999999999999999999999
Q ss_pred CcEEEecCCC-CeEEEEeccCceeccCCCc----ccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHHH
Q 004442 635 QNVLISKDKS-FCAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 635 ~NILL~~d~~-~~~KLsDFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~El 704 (753)
+|||-..-.. .-+|||||.|+..+..+.. ......+.+|+..|||||++. ...|+.++|.||||||+|-|
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 9999864433 3589999998876543221 112334567999999999873 24479999999999999999
Q ss_pred HhCCCCCCCCC----------------hHHHHHHHHccCcccccC----CCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES----------------FERDANIVKDRKDLFLVE----HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~----------------~~~~~~~i~~~~~~~~~~----~s~el~dLI~~cL~~DP~~R 753 (753)
+.| .+||.+. .+..+..+..++..||.+ .|.++.|+|..+|..|+..|
T Consensus 285 LsG-YpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 285 LSG-YPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred HhC-CCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhh
Confidence 998 8888542 345667788888888865 57899999999999999876
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=269.88 Aligned_cols=234 Identities=29% Similarity=0.470 Sum_probs=187.7
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
|.+.+.||+|++|.||++... +++.||+|.+..... ...+.++.+++..++|+|++++++++.+.+..+++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e-- 79 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE-- 79 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe--
Confidence 667889999999999998665 588999999975532 1223333347788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+|+|
T Consensus 80 --------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H 122 (254)
T cd06627 80 --------YAENGSLRQIIKK-----------------------------FGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122 (254)
T ss_pred --------cCCCCcHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 7777888877642 135778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||+|+||+++.++ .++|+|||++......... .....++..|+|||...+..++.++||||||+++|+|++| .
T Consensus 123 ~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g-~ 196 (254)
T cd06627 123 RDIKAANILTTKDG--VVKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG-N 196 (254)
T ss_pred CCCCHHHEEECCCC--CEEEeccccceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC-C
Confidence 99999999997765 4999999999877543221 2234578999999999888899999999999999999998 5
Q ss_pred CCCCCChHH--HHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFER--DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~--~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||...... ............+...++++.++|.+||+.+|++|
T Consensus 197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 242 (254)
T cd06627 197 PPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLR 242 (254)
T ss_pred CCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhC
Confidence 677544321 22222344445666778999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=280.48 Aligned_cols=235 Identities=27% Similarity=0.392 Sum_probs=177.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCC--ceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~L 544 (753)
+.|++.+.||+|+||.||+|... +++.+|+|.++.... ....+|+. ++..++|+||+++++++.+. +..|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN-ILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHH-HHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 45677788999999999999775 589999999964321 12345655 77889999999999998877 88999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+. ++|.+++... ...+++..+++++.|++.||+|||+
T Consensus 84 v~e----------~~~-~~L~~~~~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~ 124 (293)
T cd07843 84 VME----------YVE-HDLKSLMETM----------------------------KQPFLQSEVKCLMLQLLSGVAHLHD 124 (293)
T ss_pred Eeh----------hcC-cCHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 443 3555555321 1247888899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~E 703 (753)
.+|+|+||||+||+++.++ .+||+|||++....... .......++..|+|||.+.+.. ++.++||||||+++||
T Consensus 125 ~~i~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~ 199 (293)
T cd07843 125 NWILHRDLKTSNLLLNNRG--ILKICDFGLAREYGSPL---KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199 (293)
T ss_pred CCeeeccCCHHHEEECCCC--cEEEeecCceeeccCCc---cccccccccccccCchhhcCCccccchhhHHHHHHHHHH
Confidence 9999999999999997765 49999999998765432 1112334688999999987654 6899999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHHc-------------------------------cCcccccC-CCHHHHHHHHHccccCc
Q 004442 704 CITGGKHPYGESFER-DANIVKD-------------------------------RKDLFLVE-HIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~~i~~-------------------------------~~~~~~~~-~s~el~dLI~~cL~~DP 750 (753)
|++| .+||...... ....+.. ....++.. +++.+.++|++||+.||
T Consensus 200 l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 278 (293)
T cd07843 200 LLTK-KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278 (293)
T ss_pred HHhC-CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCc
Confidence 9998 6677543221 1111100 00112222 57889999999999999
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
++|
T Consensus 279 ~~R 281 (293)
T cd07843 279 AKR 281 (293)
T ss_pred ccc
Confidence 998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=281.66 Aligned_cols=235 Identities=26% Similarity=0.412 Sum_probs=185.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.++|.+.+.||+|+||.||++... +++.||+|.+.... .+...+|+. +++.++||||+++++++...+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHH-HHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 357888899999999999998654 68899999985432 223445554 7788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ..+++.++..++.+++.||.|||+.++
T Consensus 97 ----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~gi 136 (293)
T cd06647 97 ----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQV 136 (293)
T ss_pred ----------cCCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 7888888887642 235677889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++. +||+|||++........ ......|++.|+|||.+....++.++|||||||++|++++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g 211 (293)
T cd06647 137 IHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (293)
T ss_pred eeccCCHHHEEEcCCCC--EEEccCcceeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999977754 99999999876543221 11233578899999999888899999999999999999998
Q ss_pred CCCCCCCChHHHH-H-HHHccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERDA-N-IVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~~-~-~i~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||........ . ........ .+...+.++.++|++||+.||++|
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 260 (293)
T cd06647 212 -EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 260 (293)
T ss_pred -CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 678865432211 1 11112222 223456789999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.20 Aligned_cols=236 Identities=26% Similarity=0.395 Sum_probs=189.8
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+|+ .+++.++|+||+++++++.+....++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEI-RILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHH-HHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 367788999999999999854 468899999986532 11233444 47789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++++|.+++..... ....+++..++.++.+++.||+|||+.++
T Consensus 80 ----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~al~~lh~~~i 124 (256)
T cd08530 80 ----------YAPFGDLSKAISKRKK-------------------------KRKLIPEQEIWRIFIQLLRGLQALHEQKI 124 (256)
T ss_pred ----------hcCCCCHHHHHHHHHh-------------------------hcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 8888999988765321 12457888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||+|+||+++.++. +||+|||++....... .....++..|+|||.+.+..++.++|+||||+++|||++|
T Consensus 125 ~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 197 (256)
T cd08530 125 LHRDLKSANILLVANDL--VKIGDLGISKVLKKNM-----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF 197 (256)
T ss_pred ccCCCCcceEEEecCCc--EEEeeccchhhhccCC-----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987654 9999999998775431 1234578999999999999899999999999999999998
Q ss_pred CCCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.||...... ....+.. .....+..++.+++++|.+||+.+|++|
T Consensus 198 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08530 198 -APPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLR 244 (256)
T ss_pred -CCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccC
Confidence 6788665432 2222222 2234455678899999999999999998
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.34 Aligned_cols=238 Identities=28% Similarity=0.429 Sum_probs=175.9
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCC--------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQ-------- 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-------- 539 (753)
+.+|.+.+.||+|+||.||++... +|+.||+|++..... +...+|+. +++.++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHH-HHHhcCCCcchhhHhhhccccccccccc
Confidence 467899999999999999999764 589999999865432 23445554 77899999999999876543
Q ss_pred ------ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 540 ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 540 ------~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
...++||||+++ +|.+++. ...+++..+..++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-----------~L~~~~~------------------------------~~~l~~~~~~~~~~ 121 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-----------DLANVLE------------------------------QGPLSEEHARLFMY 121 (342)
T ss_pred ccccccceEEEEeecccc-----------cHHHHHH------------------------------cCCCCHHHHHHHHH
Confidence 357999995443 4444432 13467788899999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchh
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAI 692 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ks 692 (753)
||+.||.|||+.+|+||||||+||+++.++ ..+||+|||+++................++..|+|||.+.. ..++.++
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence 999999999999999999999999997554 35899999999876433222222223357889999998754 4578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc------------------------cCc------ccccCCCHHHHHH
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFE-RDANIVKD------------------------RKD------LFLVEHIPEAVDL 741 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~------------------------~~~------~~~~~~s~el~dL 741 (753)
|||||||++|||++| ..||..... ........ ... ......+.++.+|
T Consensus 201 DiwSlGvil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 201 DMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999999 566654322 11111100 000 1123567899999
Q ss_pred HHHccccCcCCC
Q 004442 742 FTRLLDPNPDLR 753 (753)
Q Consensus 742 I~~cL~~DP~~R 753 (753)
|.+||+.||++|
T Consensus 280 i~~~L~~dP~~R 291 (342)
T cd07854 280 LEQILTFNPMDR 291 (342)
T ss_pred HHHHhCCCchhc
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=286.90 Aligned_cols=238 Identities=23% Similarity=0.399 Sum_probs=179.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC----Cce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD----QDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~ 541 (753)
+..|.+.+.||+|+||.||++... +|+.||+|++.... .....+|+. +++.++|+||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-ILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHH-HHHhcCCCCccCHHHhccccCCCCce
Confidence 467888899999999999998765 59999999986532 223455654 7899999999999998753 456
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+. |+|.+++.. ...+++..+.+++.||+.||+|
T Consensus 83 ~~lv~e----------~~~-~~l~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~ 122 (334)
T cd07855 83 VYVVMD----------LME-SDLHHIIHS-----------------------------DQPLTEEHIRYFLYQLLRGLKY 122 (334)
T ss_pred EEEEEe----------hhh-hhHHHHhcc-----------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 553 466665532 2347888899999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccC-CCCCchhhHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 699 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGv 699 (753)
||+.+|+||||||+||+++.++. +||+|||++......... ........|+..|+|||.+.+ ..++.++|||||||
T Consensus 123 LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~ 200 (334)
T cd07855 123 IHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGC 200 (334)
T ss_pred HHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHH
Confidence 99999999999999999977765 999999999876432211 111123468899999998866 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHH------------------------HHc--cCcc-----cccCCCHHHHHHHHHccc
Q 004442 700 ILFFCITGGKHPYGESFER-DANI------------------------VKD--RKDL-----FLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~------------------------i~~--~~~~-----~~~~~s~el~dLI~~cL~ 747 (753)
++|||++| ++||...... .... ... .... .....++++.++|++||+
T Consensus 201 ~l~el~~g-~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 279 (334)
T cd07855 201 IFAEMLGR-RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQ 279 (334)
T ss_pred HHHHHHcC-CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHcc
Confidence 99999998 6677543211 1000 000 0000 123467899999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 280 ~~P~~R 285 (334)
T cd07855 280 FDPEER 285 (334)
T ss_pred CChhhC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=287.48 Aligned_cols=240 Identities=26% Similarity=0.381 Sum_probs=177.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhC-CCCceeeecccccCC--
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASD-QHPNIVRWYGVESDQ-- 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~-- 539 (753)
..+.++|.+.+.||+|+||.||+|... +|+.+|||++... ......+|+. +++.+ +|+||++++++|...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM-FLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHH-HHHHhcCCCCccceeeeeccCCC
Confidence 345567888899999999999999765 5889999988542 1233455665 77888 999999999998653
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++|||+|.+ +|.+++.. ..+++..++.++.||+.||
T Consensus 82 ~~~~lv~e~~~~-----------~L~~~~~~------------------------------~~~~~~~~~~i~~qi~~~L 120 (337)
T cd07852 82 KDIYLVFEYMET-----------DLHAVIRA------------------------------NILEDVHKRYIMYQLLKAL 120 (337)
T ss_pred ceEEEEeccccc-----------CHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHH
Confidence 468999995544 44444321 1456677789999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc--cccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~--~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
+|||+.+|+||||||+||+++.++. +||+|||+++........ ........|+..|+|||.+.+ ..++.++||||
T Consensus 121 ~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s 198 (337)
T cd07852 121 KYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS 198 (337)
T ss_pred HHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHH
Confidence 9999999999999999999977754 999999999876543221 112223458999999998765 45789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH-HHHHHHcc---------------------------C----cccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFER-DANIVKDR---------------------------K----DLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~---------------------------~----~~~~~~~s~el~dLI~~ 744 (753)
||+++|||+|| ++||...... ....+... . .....+++.++.++|.+
T Consensus 199 lG~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 277 (337)
T cd07852 199 VGCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277 (337)
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHH
Confidence 99999999999 5677543211 11110000 0 01123467899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 278 ~l~~~P~~R 286 (337)
T cd07852 278 LLVFNPNKR 286 (337)
T ss_pred hccCCcccc
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=283.63 Aligned_cols=236 Identities=27% Similarity=0.394 Sum_probs=180.5
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCc-----eE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-----FV 542 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-----~~ 542 (753)
+|.+.+.||+|++|.||++.... ++.||||++.... .+...+|+. .++.++|+||+++++++.+.+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHH-HHHhcCCcchhhhhhhhcccCcccccce
Confidence 36788999999999999997754 8999999986532 223445554 778899999999999998875 78
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|++|| |+. ++|.+++.. ...+++..++.++.+++.||+||
T Consensus 80 ~lv~e----------~~~-~~l~~~l~~-----------------------------~~~l~~~~~~~i~~~l~~~l~~L 119 (330)
T cd07834 80 YIVTE----------LME-TDLHKVIKS-----------------------------PQPLTDDHIQYFLYQILRGLKYL 119 (330)
T ss_pred EEEec----------chh-hhHHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 544 345555432 23578888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+||+++.++ .++|+|||++.................++..|+|||.+.+. .++.++||||||+++
T Consensus 120 H~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il 197 (330)
T cd07834 120 HSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF 197 (330)
T ss_pred HhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence 999999999999999997775 49999999999875542211222334578899999999888 789999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHccC-------------------------------cccccCCCHHHHHHHHHccccC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKDRK-------------------------------DLFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~~~-------------------------------~~~~~~~s~el~dLI~~cL~~D 749 (753)
|+|++| .+||..... .....+.... .......++++.++|.+||++|
T Consensus 198 ~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 276 (330)
T cd07834 198 AELLTR-KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFD 276 (330)
T ss_pred HHHHcC-CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCC
Confidence 999998 667755432 1111111100 0012335788999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 277 P~~R 280 (330)
T cd07834 277 PKKR 280 (330)
T ss_pred hhhC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.01 Aligned_cols=238 Identities=27% Similarity=0.421 Sum_probs=190.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+|.+.+.||+|+||.||++... +++.||+|++..... ....+|+ +.++.++|+|++++++.+.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEV-KILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHH-HHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 3677889999999999998765 589999999975422 2333444 47889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|.++++|.+++.... .....+++.++..++.+++.||.|||+.++
T Consensus 80 ----------~~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 124 (258)
T cd08215 80 ----------YADGGDLSQKIKKQK-------------------------KEGKPFPEEQILDWFVQLCLALKYLHSRKI 124 (258)
T ss_pred ----------ecCCCcHHHHHHHhh-------------------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 777888888776432 123567889999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+|+||+|+||+++.++. ++|+|||++....... .......|++.|+|||...+..++.++||||||+++|+|++|
T Consensus 125 ~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 199 (258)
T cd08215 125 LHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199 (258)
T ss_pred ecccCChHHeEEcCCCc--EEECCccceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC
Confidence 99999999999977654 8999999998765432 112234588999999999888899999999999999999998
Q ss_pred CCCCCCCCh-HHHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-ERDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-~~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||.... ....... .......+..++.++.++|++||+.||++|
T Consensus 200 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (258)
T cd08215 200 -KHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEER 246 (258)
T ss_pred -CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 67876543 3333222 223344555778999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=273.81 Aligned_cols=234 Identities=28% Similarity=0.431 Sum_probs=176.8
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC--ceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~LV~ 546 (753)
|.+.+.||+|+||.||++... +++.+|+|++.... .....+|+. +++.++|+||+++++++.+. +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHH-HHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 456788999999999999766 48999999997652 123445555 77889999999999999887 8999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+. ++|.+++... ...+++.+++.++.|++.||+|||+.+
T Consensus 80 e----------~~~-~~l~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~ 120 (287)
T cd07840 80 E----------YMD-HDLTGLLDSP----------------------------EVKFTESQIKCYMKQLLEGLQYLHSNG 120 (287)
T ss_pred c----------ccc-ccHHHHHhcc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 554 3555554321 135778889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~Ell 705 (753)
++|+||+|+||++++++. +||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||+
T Consensus 121 ~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 121 ILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred ceeccCcHHHeEEcCCCC--EEEccccceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 999999999999977654 99999999987754321 11223356889999998765 45799999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHccC-----------------------c-------ccccC-CCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKDRK-----------------------D-------LFLVE-HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~~~-----------------------~-------~~~~~-~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||....... ...+.... . ..... +++++.++|++||+.||++|
T Consensus 197 t~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 275 (287)
T cd07840 197 LG-KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKR 275 (287)
T ss_pred hC-CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhC
Confidence 98 67776543221 11111100 0 00112 37889999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=284.03 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=176.3
Q ss_pred ceEE-EeEEecccCceEEEEEEee-CCcEEEEEEeecCCch-----------------HHHHHHHHHHHhCCCCceeeec
Q 004442 473 KLVV-FNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD-----------------VALKEIQNLIASDQHPNIVRWY 533 (753)
Q Consensus 473 ~~~~-i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~-----------------~~~~Ei~~ll~~l~HpNIV~L~ 533 (753)
++|. +.+.||+|+||+||++... .++.||||.++..... ...+|+. +++.++|+||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-IMNEIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHH-HHHhCCCcceeeee
Confidence 3443 4577999999999999765 5899999998643211 2345555 78899999999999
Q ss_pred ccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 534 g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
+++...+..++||| |+. |+|.+++.. ...+++..+..++.
T Consensus 87 ~~~~~~~~~~lv~e----------~~~-~~l~~~l~~-----------------------------~~~~~~~~~~~~~~ 126 (335)
T PTZ00024 87 DVYVEGDFINLVMD----------IMA-SDLKKVVDR-----------------------------KIRLTESQVKCILL 126 (335)
T ss_pred EEEecCCcEEEEEe----------ccc-cCHHHHHHh-----------------------------cCCCCHHHHHHHHH
Confidence 99999999999999 443 455555432 13467788899999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-----------ccccCccCCCCcccccccc
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQ 682 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-----------~~~~~~~~~GT~~Y~APE~ 682 (753)
|++.||+|||+.+|+|+||+|+||+++.++. +||+|||++........ .........++..|+|||.
T Consensus 127 ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 204 (335)
T PTZ00024 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPEL 204 (335)
T ss_pred HHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccccccccccccccccccccccccCCCCChh
Confidence 9999999999999999999999999977764 99999999987651110 0111122346889999999
Q ss_pred ccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHH-HccCc---------------------------cccc
Q 004442 683 LLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIV-KDRKD---------------------------LFLV 732 (753)
Q Consensus 683 l~~~~-~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~-~~~i-~~~~~---------------------------~~~~ 732 (753)
+.+.. ++.++|||||||++|||++| .+||....... ...+ ..... ....
T Consensus 205 ~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (335)
T PTZ00024 205 LMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFP 283 (335)
T ss_pred cccCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCc
Confidence 87654 69999999999999999998 67776543221 1111 10000 0112
Q ss_pred CCCHHHHHHHHHccccCcCCC
Q 004442 733 EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 733 ~~s~el~dLI~~cL~~DP~~R 753 (753)
..++++.++|.+||+.||++|
T Consensus 284 ~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 284 NASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred CCChHHHHHHHHHcCCCchhc
Confidence 346789999999999999998
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=276.85 Aligned_cols=234 Identities=26% Similarity=0.382 Sum_probs=183.0
Q ss_pred EEEeEEecccCceEEEEEEe----eCCcEEEEEEeecCC-------chHHHHHHHHHHHhC-CCCceeeecccccCCceE
Q 004442 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~ 542 (753)
|.+.+.||+|+||.||++.. .+++.||||.+++.. .+...+|+. ++..+ +|+||+++++.+...+..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQ-VLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHH-HHHhccCCcchhhhheeeecCCEE
Confidence 66788999999999999764 357899999986432 122344554 56666 699999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ...+++..+..++.|+++||.||
T Consensus 81 ~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~~l~~l 121 (288)
T cd05583 81 HLILD----------YVNGGELFTHLYQ-----------------------------REHFTESEVRVYIAEIVLALDHL 121 (288)
T ss_pred EEEEe----------cCCCCcHHHHHhh-----------------------------cCCcCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888887642 13467778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCI 700 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSfGvv 700 (753)
|+.+++||||+|+||+++.++. ++|+|||+++........ ......|+..|+|||.+.+.. .+.++||||||++
T Consensus 122 H~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 122 HQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEE--RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197 (288)
T ss_pred HHCCeeccCCCHHHeEECCCCC--EEEEECcccccccccccc--ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence 9999999999999999977654 999999998875433211 112345789999999987765 7889999999999
Q ss_pred HHHHHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||... .......+.......+..+++++.++|.+||+.||++|
T Consensus 198 l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 254 (288)
T cd05583 198 TFELLTG-ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254 (288)
T ss_pred HHHHHhC-CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhc
Confidence 9999998 6677432 12222333344455666788999999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.65 Aligned_cols=237 Identities=22% Similarity=0.325 Sum_probs=183.2
Q ss_pred eEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecC--------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......+|.. +++.++||||+++++++.+.+..++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ-LLSKLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHH-HHHhCCCCcHHHHHHHHhcCCceEE
Confidence 36778999999999999986643 455666665421 1112334544 7789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++++|.++++... .....+++.+++.++.|++.||.|||+
T Consensus 80 v~e----------~~~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 80 ITE----------YCEGRDLDCKLEELK-------------------------HTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred EEE----------eCCCCCHHHHHHHHh-------------------------hcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999 777888888776432 123568889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+++|+||+|+||+++.+ .+||+|||+++....... ......|+..|+|||...+..++.++|+||||+++|+|
T Consensus 125 ~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 125 RRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred cCccccCCChhheEeecC---CEeecccCceeecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 999999999999999643 389999999987643321 12234578899999999888899999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| ..||.... ........ ......+..+++++.++|.+||+.||++|
T Consensus 199 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 248 (260)
T cd08222 199 CCL-AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLR 248 (260)
T ss_pred HhC-CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhC
Confidence 998 56775442 22222222 22334456778899999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=284.18 Aligned_cols=236 Identities=23% Similarity=0.364 Sum_probs=177.2
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+.+.|.+.+.||+|+||+||++... +++.||||.+.... .....+|+. +++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK-LLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHH-HHHhcCCCCccchHHheeccccccc
Confidence 3457889999999999999998654 58999999986431 223445554 77889999999999988654
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...+++|||+.+ +|.+++.. ...+++..+..++.|++.||
T Consensus 82 ~~~~lv~e~~~~-----------~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~aL 121 (337)
T cd07858 82 NDVYIVYELMDT-----------DLHQIIRS-----------------------------SQTLSDDHCQYFLYQLLRGL 121 (337)
T ss_pred CcEEEEEeCCCC-----------CHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 348999995544 44444321 23577888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfG 698 (753)
.|||+.+++||||||+||+++.++. +||+|||+++...... .......++..|+|||.+.. ..++.++||||||
T Consensus 122 ~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (337)
T cd07858 122 KYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG 196 (337)
T ss_pred HHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHH
Confidence 9999999999999999999977754 9999999998764321 11223457889999998865 4689999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHH------------------------Hc---cC----cccccCCCHHHHHHHHHcc
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIV------------------------KD---RK----DLFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i------------------------~~---~~----~~~~~~~s~el~dLI~~cL 746 (753)
|++|+|++| .+||..... .....+ .. .. .......++++.++|++||
T Consensus 197 ~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 275 (337)
T cd07858 197 CIFAELLGR-KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML 275 (337)
T ss_pred HHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh
Confidence 999999998 667754321 000000 00 00 0112356889999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 276 ~~~P~~R 282 (337)
T cd07858 276 VFDPSKR 282 (337)
T ss_pred cCChhhc
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=276.67 Aligned_cols=239 Identities=24% Similarity=0.332 Sum_probs=177.6
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCc---
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD--- 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--- 540 (753)
...+.|.+.+.||+|+||.||+|... +|+.||||+++.... ....+|+. +++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-ILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHH-HHHhCCCCCeeeeeheecCcchhh
Confidence 34467888899999999999999775 589999999964321 23344554 778999999999999987655
Q ss_pred -------eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 541 -------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 541 -------~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
..++|+|+|+++ +.+.+.. ....+++.+++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~-----------l~~~l~~----------------------------~~~~~~~~~~~~i~~ 123 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHD-----------LMGLLES----------------------------GLVHFSEDHIKSFMK 123 (302)
T ss_pred hccccCCcEEEEEcccCcc-----------HHHHHhc----------------------------CCCCCCHHHHHHHHH
Confidence 789999955443 3333321 123578889999999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchh
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAI 692 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ks 692 (753)
|++.||+|||+.+|+||||||+||+++.++ .+||+|||++........ .......++..|+|||.+.+. .++.++
T Consensus 124 qi~~aL~~LH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~ 199 (302)
T cd07864 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKG--QIKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAI 199 (302)
T ss_pred HHHHHHHHHHhCCeecCCCCHHHEEECCCC--cEEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchh
Confidence 999999999999999999999999997665 499999999987654321 111222457889999988654 478999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHc---cC---------------------------cccccCCCHHHHHH
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFER-DANIVKD---RK---------------------------DLFLVEHIPEAVDL 741 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~---~~---------------------------~~~~~~~s~el~dL 741 (753)
|||||||++|||++| ++||...... ....+.. .. .......++++.++
T Consensus 200 Di~slG~~~~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 278 (302)
T cd07864 200 DVWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDL 278 (302)
T ss_pred HHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHH
Confidence 999999999999998 6777654221 1111111 00 00122357899999
Q ss_pred HHHccccCcCCC
Q 004442 742 FTRLLDPNPDLR 753 (753)
Q Consensus 742 I~~cL~~DP~~R 753 (753)
|.+||+.||++|
T Consensus 279 i~~~l~~~P~~R 290 (302)
T cd07864 279 LDHMLTLDPSKR 290 (302)
T ss_pred HHHHccCChhhC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=278.17 Aligned_cols=229 Identities=25% Similarity=0.362 Sum_probs=174.6
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
|...+.||+|+||+||+|... +|+.||+|++..... ....+|+ .+++.++|+||+++++++.+.+..|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV-KFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHH-HHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 555677999999999999764 589999999864321 1234444 47889999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.+++ .+++.. ....+++.+++.++.|++.||.|||+.+|
T Consensus 102 ~~~~~l-----------~~~l~~----------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 102 YCLGSA-----------SDLLEV----------------------------HKKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred cCCCCH-----------HHHHHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 665443 333321 12347788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~El 704 (753)
+|+||+|+||+++.++. +||+|||++..... .....|+..|+|||.+. ...++.++|||||||++|||
T Consensus 143 ~H~dl~p~nili~~~~~--~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 143 IHRDIKAGNILLTEPGQ--VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred ecCCCChhhEEECCCCC--EEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999977654 99999999864322 12345889999999984 45688999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHcc-Cc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKDR-KD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~~-~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||... ........... .. .....++..+++||.+||+.+|++|
T Consensus 214 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 264 (313)
T cd06633 214 AER-KPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQER 264 (313)
T ss_pred HhC-CCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhC
Confidence 999 4565443 22222222222 21 1233567789999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=300.43 Aligned_cols=199 Identities=33% Similarity=0.558 Sum_probs=168.9
Q ss_pred EEEeEEecccCceEEEEEE-eeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCceeeecccccCC------ceEE
Q 004442 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFVY 543 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~------~~~~ 543 (753)
+...+.||+|+||.||+++ ...|+.||||.+.+. ..+.+.+|++ ++++++|+|||++++.-.+. +...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eie-ilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIE-ILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHH-HHHHcCchhhhhhcccCCccccCcccccce
Confidence 4455779999999999998 567999999998753 3456778887 78999999999999986553 3579
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |..+|||...|...+ +..++++.+++.+..+++.||.|||
T Consensus 94 lvmE----------yC~gGsL~~~L~~PE--------------------------N~~GLpE~e~l~lL~d~~~al~~Lr 137 (732)
T KOG4250|consen 94 LVME----------YCSGGSLRKVLNSPE--------------------------NAYGLPESEFLDLLSDLVSALRHLR 137 (732)
T ss_pred EEEe----------ecCCCcHHHHhcCcc--------------------------cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 666899999886542 4678999999999999999999999
Q ss_pred hCCccccCCCCCcEEEe--cCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-CCCCCchhhHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCI 700 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~--~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~t~ksDIwSfGvv 700 (753)
++||+||||||.||++- .||...-||+|||.|+.+.++ ......+||..|.+||... .+.|+..+|.|||||+
T Consensus 138 En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gvt 213 (732)
T KOG4250|consen 138 ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN----SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVT 213 (732)
T ss_pred HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC----CeeeeecCchhhcChHHHhhccCcCceeehhhhhhH
Confidence 99999999999999884 445667899999999988754 3566788999999999998 4889999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 004442 701 LFFCITGGKHPYGES 715 (753)
Q Consensus 701 L~EllTG~~~Pf~~~ 715 (753)
+||++|| ..||...
T Consensus 214 lY~caTG-~lPF~p~ 227 (732)
T KOG4250|consen 214 LYECATG-ELPFIPF 227 (732)
T ss_pred HHHHhcc-CCCCCcC
Confidence 9999999 6777543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=276.39 Aligned_cols=239 Identities=23% Similarity=0.354 Sum_probs=176.1
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~------ 539 (753)
.++|.+.+.||+|+||.||++... +++.+|||++.... .....+|+. +++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHH-HHHhcCCCCccchhhheecccccccc
Confidence 578999999999999999999764 58999999985432 123456665 78899999999999987543
Q ss_pred --ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 540 --~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
...++|+||+..+ |...++. ....+++..+..++.|+++
T Consensus 86 ~~~~~~lv~~~~~~~-----------l~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~ 126 (311)
T cd07866 86 KRGSVYMVTPYMDHD-----------LSGLLEN----------------------------PSVKLTESQIKCYMLQLLE 126 (311)
T ss_pred cCceEEEEEecCCcC-----------HHHHHhc----------------------------cccCCCHHHHHHHHHHHHH
Confidence 3469999955433 3333321 1235788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc--------cCccCCCCccccccccccCC-CC
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--------QNATGYGSSGWQAPEQLLQG-RQ 688 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~--------~~~~~~GT~~Y~APE~l~~~-~~ 688 (753)
||+|||+.+|+||||||+||++++++. +||+|||+++.......... ......+++.|+|||.+.+. .+
T Consensus 127 al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 127 GINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 999999999999999999999977754 99999999986643321111 11223568889999988654 47
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHcc-C-------------c----------------ccccCCCHH
Q 004442 689 TRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDR-K-------------D----------------LFLVEHIPE 737 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~-~~~i~~~-~-------------~----------------~~~~~~s~e 737 (753)
+.++|||||||++|||++| ++||.+..... ...+... . . .......++
T Consensus 205 ~~~~Dv~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283 (311)
T ss_pred CchhHhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChh
Confidence 9999999999999999998 67776543221 1111100 0 0 001234568
Q ss_pred HHHHHHHccccCcCCC
Q 004442 738 AVDLFTRLLDPNPDLR 753 (753)
Q Consensus 738 l~dLI~~cL~~DP~~R 753 (753)
+.++|.+||+.||++|
T Consensus 284 ~~~~i~~~l~~~p~~R 299 (311)
T cd07866 284 GLDLLSKLLSLDPYKR 299 (311)
T ss_pred HHHHHHHHcccCcccC
Confidence 8999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=282.52 Aligned_cols=231 Identities=23% Similarity=0.404 Sum_probs=173.4
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+..+|.+.+.||+|+||.||+|... +|+.||||++.... .....+|+. +++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT-LLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHH-HHHhcCCCCccchhheecccccCCC
Confidence 3467888999999999999999764 68999999986532 123455655 77889999999999998654
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...++|+|++.. +|.+++ ...+++..+..++.|++.|
T Consensus 92 ~~~~~lv~e~~~~-----------~l~~~~-------------------------------~~~~~~~~~~~~~~qi~~a 129 (342)
T cd07879 92 FQDFYLVMPYMQT-----------DLQKIM-------------------------------GHPLSEDKVQYLVYQMLCG 129 (342)
T ss_pred CceEEEEeccccc-----------CHHHHH-------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 346999994432 333221 2346778889999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 697 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSf 697 (753)
|+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||.+.+ ..++.++|||||
T Consensus 130 L~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 201 (342)
T cd07879 130 LKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSV 201 (342)
T ss_pred HHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHH
Confidence 99999999999999999999977654 999999998765322 123357889999999876 458999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh-HHHHHHHHc-----------------------cCccc--------ccCCCHHHHHHHHHc
Q 004442 698 GCILFFCITGGKHPYGESF-ERDANIVKD-----------------------RKDLF--------LVEHIPEAVDLFTRL 745 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~-~~~~~~i~~-----------------------~~~~~--------~~~~s~el~dLI~~c 745 (753)
||++|||++| +.||.... ......+.. ..... ....++++.+||++|
T Consensus 202 Gvil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 280 (342)
T cd07879 202 GCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM 280 (342)
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHH
Confidence 9999999998 56775542 111111110 00000 124567899999999
Q ss_pred cccCcCCC
Q 004442 746 LDPNPDLR 753 (753)
Q Consensus 746 L~~DP~~R 753 (753)
|+.||++|
T Consensus 281 l~~dP~~R 288 (342)
T cd07879 281 LELDVDKR 288 (342)
T ss_pred cCCChhhC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=293.63 Aligned_cols=235 Identities=28% Similarity=0.348 Sum_probs=186.7
Q ss_pred ceecceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
..+...|.+...+|.|+|+.|-++. ...++..|||++.+.. .+..+|+..++...+|+||+++.+.|.+..+.|+|||
T Consensus 318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred CCcchhhccccccCCCCccceeeeeccccccchhheeccccc-cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3466788888899999999997764 4568999999997762 3334555556777899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
.+.+|-+.+.+... +.+. ..+..|+.+|+.++.|||++|+
T Consensus 397 ----------~l~g~ell~ri~~~-----------------------------~~~~-~e~~~w~~~lv~Av~~LH~~gv 436 (612)
T KOG0603|consen 397 ----------LLDGGELLRRIRSK-----------------------------PEFC-SEASQWAAELVSAVDYLHEQGV 436 (612)
T ss_pred ----------hccccHHHHHHHhc-----------------------------chhH-HHHHHHHHHHHHHHHHHHhcCe
Confidence 66666666555322 1122 5667899999999999999999
Q ss_pred cccCCCCCcEEE-ecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL-~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||+ +.+++ ++|+|||.++..... ..+.+-|..|.|||++....|++++||||||++||+|++
T Consensus 437 vhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~ 508 (612)
T KOG0603|consen 437 VHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT 508 (612)
T ss_pred eecCCChhheeecCCCCc--EEEEEechhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh
Confidence 999999999999 46665 999999999987653 234456899999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| +.||..........-......+-...|+++++||++||++||.+|
T Consensus 509 G-~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~R 554 (612)
T KOG0603|consen 509 G-RTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALR 554 (612)
T ss_pred C-CCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhC
Confidence 9 667765533311111223333447889999999999999999998
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=267.05 Aligned_cols=227 Identities=32% Similarity=0.457 Sum_probs=184.3
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 481 IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
||+|+||.||++... +++.+|+|.+..... .....|+ .+++.++|+||+++++.+.+++..+++||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e------ 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLHYAFQTEEKLYLVLE------ 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHH-HHHHHcCCCcHHHHHHHeecCCeeEEEEe------
Confidence 689999999998765 489999999865431 1334444 47899999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|..+++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~ 120 (250)
T cd05123 74 ----YAPGGELFSHLSKE-----------------------------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120 (250)
T ss_pred ----cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 66677777776422 246788889999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
|+||+++.++. ++|+|||++....... .......++..|+|||.+.+...+.++|+||||+++||+++| ..||.
T Consensus 121 p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g-~~p~~ 194 (250)
T cd05123 121 PENILLDADGH--IKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFY 194 (250)
T ss_pred cceEEEcCCCc--EEEeecCcceecccCC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC-CCCCC
Confidence 99999977754 8999999998765432 112334578899999999888899999999999999999998 66775
Q ss_pred CCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... ......+.......+...++++.++|++||..||++|
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R 235 (250)
T cd05123 195 AEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKR 235 (250)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhC
Confidence 543 3334444445556677778999999999999999988
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=289.57 Aligned_cols=240 Identities=27% Similarity=0.433 Sum_probs=181.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHh-CCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIAS-DQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~-l~HpNIV~L~g~~~~~~~~ 542 (753)
..-++.|++.+.||+||...||++...+.+.+|+|++.... ...+..|+. +|.+ -.|.+||+|++|...++.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~-lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIA-LLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHH-HHHHhcCCceEEEEeeeeccCceE
Confidence 34456788999999999999999998888999999875432 234566777 5555 4699999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|||||+-+++|..++ +.+. ..++.-.+..+..||+.++.+.
T Consensus 436 YmvmE~Gd~DL~kiL-----------~k~~----------------------------~~~~~~~lk~ywkqML~aV~~I 476 (677)
T KOG0596|consen 436 YMVMECGDIDLNKIL-----------KKKK----------------------------SIDPDWFLKFYWKQMLLAVKTI 476 (677)
T ss_pred EEEeecccccHHHHH-----------Hhcc----------------------------CCCchHHHHHHHHHHHHHHHHH
Confidence 999996555665554 3221 1122125678889999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-----------CCch
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----------QTRA 691 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-----------~t~k 691 (753)
|++||||.||||.|+|+-.. .+||+|||+|..+..+... ......+||+.||+||.+.... .+++
T Consensus 477 H~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTs-I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~ 552 (677)
T KOG0596|consen 477 HQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTS-IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK 552 (677)
T ss_pred HHhceeecCCCcccEEEEee---eEEeeeechhcccCccccc-eeeccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence 99999999999999999543 4899999999998765433 3345568999999999986543 3579
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHcc--CcccccCCC-HHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERDANI--VKDR--KDLFLVEHI-PEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~--i~~~--~~~~~~~~s-~el~dLI~~cL~~DP~~R 753 (753)
+||||+||+||+|+.| ++||+.-....... +... ...++.--. .++.+++++||.-||++|
T Consensus 553 SDvWSLGCILYqMvYg-ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR 618 (677)
T KOG0596|consen 553 SDVWSLGCILYQMVYG-KTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKR 618 (677)
T ss_pred cchhhhhhHHHHHHhc-CCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccC
Confidence 9999999999999998 78998764332221 1111 112332222 249999999999999998
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=279.95 Aligned_cols=231 Identities=24% Similarity=0.339 Sum_probs=175.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|...+.||+|+||.||++... ++..+|+|.+.... . ....+|+. +++.++|+|++++++++.+.+..++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34556678999999999999765 58899999986421 1 12344544 78889999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||||.++ +.+++... ...+++.++..++.|++.||.|||+.
T Consensus 94 ~e~~~~~-----------l~~~~~~~----------------------------~~~l~~~~~~~~~~~l~~~l~~LH~~ 134 (308)
T cd06634 94 MEYCLGS-----------ASDLLEVH----------------------------KKPLQEVEIAAVTHGALQGLAYLHSH 134 (308)
T ss_pred EEccCCC-----------HHHHHHHc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9955544 44333211 13467778899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~ 702 (753)
+++||||+|+||+++.++. ++|+|||++...... ....++..|+|||.+. ...++.++|||||||++|
T Consensus 135 ~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 205 (308)
T cd06634 135 NMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205 (308)
T ss_pred CcccCCCCHHhEEECCCCc--EEECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHH
Confidence 9999999999999977654 999999998765432 2335789999999874 356789999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHHH-ccCcc-cccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESF-ERDANIVK-DRKDL-FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~-~~~~~~i~-~~~~~-~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| ..||.... ........ ..... ....++.++.++|++||+++|++|
T Consensus 206 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R 258 (308)
T cd06634 206 ELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258 (308)
T ss_pred HHHcC-CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccC
Confidence 99998 55654432 22222222 22222 234577899999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=272.08 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=193.2
Q ss_pred ecceEEEe-EEecccCceEEEEEE-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC----CceEEE
Q 004442 471 IGKLVVFN-KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYL 544 (753)
Q Consensus 471 i~~~~~i~-~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~L 544 (753)
++++|.+. ++||-|-.|.|.... ...|+.+|+|+|... ..+.+|+.--...-.|+|||++++++.. .+.+++
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 44555544 569999999998753 456999999999765 4566777644556689999999999753 567899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| +|++|.|++.+..++ ...+.+.++-.|+.||+.|+.|||+
T Consensus 137 VmE----------~meGGeLfsriq~~g---------------------------~~afTErea~eI~~qI~~Av~~lH~ 179 (400)
T KOG0604|consen 137 VME----------CMEGGELFSRIQDRG---------------------------DQAFTEREASEIMKQIGLAVRYLHS 179 (400)
T ss_pred eee----------cccchHHHHHHHHcc---------------------------cccchHHHHHHHHHHHHHHHHHHHh
Confidence 999 999999999987654 3458888999999999999999999
Q ss_pred CCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+|.||||||+|+|.+.. .+..+||+|||+|+..... ....+.|-|+.|.|||++-..+|+..+|+||+||++|-
T Consensus 180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYI 255 (400)
T KOG0604|consen 180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255 (400)
T ss_pred cchhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHH
Confidence 999999999999999654 3467999999999976532 23455678999999999999999999999999999999
Q ss_pred HHhCCCCCC-CCC----hHHHHHHHHccCcccccC----CCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPY-GES----FERDANIVKDRKDLFLVE----HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf-~~~----~~~~~~~i~~~~~~~~~~----~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+|| ... ..-+...+..+...||.. .|++++|+|+++|..+|++|
T Consensus 256 lLCG-yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteR 313 (400)
T KOG0604|consen 256 LLCG-YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTER 313 (400)
T ss_pred hhcC-CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhh
Confidence 9999 5555 332 234556677777776653 46889999999999999998
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=279.96 Aligned_cols=233 Identities=24% Similarity=0.372 Sum_probs=176.3
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCc---
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD--- 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--- 540 (753)
.++++|.+.+.||+|+||.||++.. .+|..||||++..... ....+|+. +++.++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCccceeeeecCCcccc
Confidence 3567799999999999999999865 4689999999864321 23445554 789999999999999887543
Q ss_pred ---eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 541 ---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 541 ---~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
..++|||++++ +|.+++. ...+++..++.++.|++.
T Consensus 91 ~~~~~~lv~e~~~~-----------~l~~~~~------------------------------~~~l~~~~~~~i~~qi~~ 129 (343)
T cd07880 91 RFHDFYLVMPFMGT-----------DLGKLMK------------------------------HEKLSEDRIQFLVYQMLK 129 (343)
T ss_pred ccceEEEEEecCCC-----------CHHHHHh------------------------------cCCCCHHHHHHHHHHHHH
Confidence 46899995543 4443332 134677888999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
||+|||+.+|+||||||+||+++.++. +||+|||++...... .....+++.|+|||.+.+ ..++.++||||
T Consensus 130 al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 201 (343)
T cd07880 130 GLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWS 201 (343)
T ss_pred HHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHH
Confidence 999999999999999999999977654 999999999865432 123347889999999876 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH-HH-HHHHcc------------------------------CcccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFER-DA-NIVKDR------------------------------KDLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~-~~-~~i~~~------------------------------~~~~~~~~s~el~dLI~~ 744 (753)
|||++|++++| .+||...... .. ...... ........++++.++|.+
T Consensus 202 lG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 280 (343)
T cd07880 202 VGCIMAEMLTG-KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK 280 (343)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHH
Confidence 99999999998 6677654221 11 110000 001123567889999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 281 ~l~~dP~~R 289 (343)
T cd07880 281 MLVLDAESR 289 (343)
T ss_pred HcCCChhhC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=271.21 Aligned_cols=234 Identities=29% Similarity=0.418 Sum_probs=175.0
Q ss_pred EEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc-----hHHHHHHHH--HHHhCCCCceeeecccccCCce-----
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH-----DVALKEIQN--LIASDQHPNIVRWYGVESDQDF----- 541 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~-----~~~~~Ei~~--ll~~l~HpNIV~L~g~~~~~~~----- 541 (753)
|++.+.||+|+||.||++.... ++.||+|++..... ....+|+.. .+..++|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4567889999999999998764 89999999964321 223445442 2344579999999999988776
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.+++|| |+. ++|.+++.... ...+++.++++++.|++.||.|
T Consensus 81 ~~l~~e----------~~~-~~l~~~l~~~~---------------------------~~~l~~~~~~~~~~~i~~al~~ 122 (287)
T cd07838 81 LTLVFE----------HVD-QDLATYLSKCP---------------------------KPGLPPETIKDLMRQLLRGVDF 122 (287)
T ss_pred eEEEeh----------hcc-cCHHHHHHHcc---------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 443 35555553221 1247888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+++|+||+|+||+++.++ .+||+|||++....... ......++..|+|||.+.+..++.++|||||||++
T Consensus 123 LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 123 LHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred HHHCCeeeccCChhhEEEccCC--CEEEeccCcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 9999999999999999997775 49999999998764321 11223478899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHH-HHHHHHc-cC--------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFER-DANIVKD-RK--------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~-~~~~i~~-~~--------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| .+||...... ....+.. .. .......++++.++|.+||+.||++|
T Consensus 197 ~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (287)
T cd07838 197 AELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKR 275 (287)
T ss_pred HHHHhC-CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccC
Confidence 999998 6777654322 2211111 00 00012345678899999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=270.69 Aligned_cols=233 Identities=27% Similarity=0.475 Sum_probs=176.0
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCceeeecccccCCceEEEEEcc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
|.+.+.||+|++|.||+|... +++.||||++..... ....+|+. .++.++ |+||+++++++.+++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~lv~e- 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVK-SLRKLNEHPNIVKLKEVFRENDELYFVFE- 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHH-HHHhccCCCCchhHHHHhhcCCcEEEEEe-
Confidence 456788999999999999876 488999999865422 23345555 566777 9999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+ +|+|.+++.... ...+++.+++.++.|++.+|.|||+.+++
T Consensus 79 ---------~~-~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~ 121 (283)
T cd07830 79 ---------YM-EGNLYQLMKDRK---------------------------GKPFSESVIRSIIYQILQGLAHIHKHGFF 121 (283)
T ss_pred ---------cC-CCCHHHHHHhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 55 566666654321 23578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllTG 707 (753)
|+||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|||++|
T Consensus 122 H~dl~~~ni~i~~~~--~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 122 HRDLKPENLLVSGPE--VVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred cCCCChhhEEEcCCC--CEEEeecccceeccCCCC----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 999999999997665 499999999987643221 123457889999998754 4579999999999999999998
Q ss_pred CCCCCCCChH-HHHHHHHc-------------------cC-----------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKD-------------------RK-----------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~-------------------~~-----------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||..... .....+.. .. .......++++.++|++||..||++|
T Consensus 196 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 271 (283)
T cd07830 196 -RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKR 271 (283)
T ss_pred -CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccC
Confidence 567754322 11111100 00 00111235789999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=280.24 Aligned_cols=198 Identities=24% Similarity=0.292 Sum_probs=153.0
Q ss_pred EEeccc--CceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKG--SNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G--~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
..||+| +||+||++... .|+.||||.+..... .+.++++..+++.++|+||+++++++..++..++|+|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e---- 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP---- 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe----
Confidence 346666 99999998764 699999999864331 1334444457788999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+.+|+|.+++.... ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrD 126 (328)
T cd08226 80 ------FMAYGSANSLLKTYF---------------------------PEGMSEALIGNILFGALRGLNYLHQNGYIHRN 126 (328)
T ss_pred ------cccCCCHHHHHHhhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 888888888775431 23477888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCC--CCCchhhHHHHHHHHHHHH
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGvvL~Ell 705 (753)
|||+||+++.++. ++++|||.+.......... .......++..|+|||++.+. .++.++|||||||++|||+
T Consensus 127 lkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 127 IKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred CCHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 9999999987764 8999998654332211100 011112356779999998764 4789999999999999999
Q ss_pred hCCCCCCCCCh
Q 004442 706 TGGKHPYGESF 716 (753)
Q Consensus 706 TG~~~Pf~~~~ 716 (753)
+| ++||....
T Consensus 205 ~g-~~p~~~~~ 214 (328)
T cd08226 205 TG-RVPFQDML 214 (328)
T ss_pred hC-CCCCCCcC
Confidence 98 67886653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=270.68 Aligned_cols=232 Identities=25% Similarity=0.424 Sum_probs=176.8
Q ss_pred EEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.+.+.||+|++|.||++... +++.+|+|++..... ....+|+. +++.++|+||+++++++.+++..++++||+
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHH-HHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45578999999999998764 689999999865432 23445554 778899999999999999999999999955
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
++ +|.+++... ...+++.+++.++.+++.||.|||+.+|+|
T Consensus 81 ~~-----------~l~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 121 (283)
T cd05118 81 DT-----------DLYKLIKDR----------------------------QRGLPESLIKSYLYQLLQGLAFCHSHGILH 121 (283)
T ss_pred CC-----------CHHHHHHhh----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 43 444444321 135778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~ 708 (753)
+||||+||+++.++. ++|+|||.+....... .......++..|+|||.+.+. .++.++||||||+++|+|+||
T Consensus 122 ~dl~p~nili~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg- 195 (283)
T cd05118 122 RDLKPENLLINTEGV--LKLADFGLARSFGSPV---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR- 195 (283)
T ss_pred cCcCHHHEEECCCCc--EEEeeeeeeEecCCCc---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC-
Confidence 999999999976654 9999999998775432 111223478899999998877 689999999999999999998
Q ss_pred CCCCCCChH-HHHHHHHc-cC-----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVKD-RK-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~~-~~-----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||..... .....+.. .. .......+++++++|.+||++||.+|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 271 (283)
T cd05118 196 RPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKR 271 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccC
Confidence 667754332 11111100 00 00122457889999999999999998
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=280.60 Aligned_cols=233 Identities=22% Similarity=0.373 Sum_probs=175.0
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ---- 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~---- 539 (753)
.+.++|.+.+.||+|+||.||++.. .+++.||||++.... .+...+|+. ++..++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHH-HHHHcCCCcccceeeeeeeccccc
Confidence 4557899999999999999999865 468999999986532 123445554 78899999999999987542
Q ss_pred --ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 540 --~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
...+++++++ +++|.+++. ...+++..+..++.|+++
T Consensus 93 ~~~~~~lv~~~~-----------~~~L~~~~~------------------------------~~~l~~~~~~~i~~qi~~ 131 (345)
T cd07877 93 EFNDVYLVTHLM-----------GADLNNIVK------------------------------CQKLTDDHVQFLIYQILR 131 (345)
T ss_pred ccccEEEEehhc-----------ccCHHHHHh------------------------------cCCCCHHHHHHHHHHHHH
Confidence 3468888843 455555442 124677888999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
||+|||+.+|+||||||+||+++.++. +||+|||+++..... .....++..|+|||.+.+ ..++.++||||
T Consensus 132 aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 132 GLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 999999999999999999999987765 999999998865322 123457899999998866 45789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH-HHHHHHHcc-----------------------Cc--------ccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFE-RDANIVKDR-----------------------KD--------LFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-----------------------~~--------~~~~~~s~el~dLI~~ 744 (753)
|||++|||++| .+||..... .....+... .. ......++++.++|.+
T Consensus 204 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 204 VGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 99999999998 567754321 111111000 00 0112457889999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 283 ~L~~dp~~R 291 (345)
T cd07877 283 MLVLDSDKR 291 (345)
T ss_pred HcCCChhhc
Confidence 999999998
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=279.64 Aligned_cols=233 Identities=24% Similarity=0.390 Sum_probs=178.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCce--
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-- 541 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~-- 541 (753)
.++++|.+.+.||+|++|.||++... +++.||||++.... .....+|+. +++.++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-LLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHH-HHHhccCCCHHHHHHHhhcccccc
Confidence 45678999999999999999999765 58899999986431 233455665 7788999999999998876654
Q ss_pred ----EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 542 ----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 542 ----~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
.++|+|++.+ +|.+++. ...+++..+++++.|++.
T Consensus 91 ~~~~~~lv~e~~~~-----------~L~~~~~------------------------------~~~l~~~~~~~~~~ql~~ 129 (343)
T cd07851 91 DFQDVYLVTHLMGA-----------DLNNIVK------------------------------CQKLSDDHIQFLVYQILR 129 (343)
T ss_pred ccccEEEEEecCCC-----------CHHHHHh------------------------------cCCCCHHHHHHHHHHHHH
Confidence 8999995543 4444432 134778889999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
||+|||+.+|+||||||+||+++.++. +||+|||++...... .....++..|+|||.+.+ ..++.++||||
T Consensus 130 aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (343)
T cd07851 130 GLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201 (343)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHH
Confidence 999999999999999999999977755 999999999866432 223457889999998865 35789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH-HHHHHHccCc-------------------------------ccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFER-DANIVKDRKD-------------------------------LFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~-------------------------------~~~~~~s~el~dLI~~ 744 (753)
|||++||+++| ++||...... ....+..... .....+++++.++|.+
T Consensus 202 lGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~ 280 (343)
T cd07851 202 VGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH
Confidence 99999999998 5677544221 1111111000 0112458899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||++||++|
T Consensus 281 ~l~~~P~~R 289 (343)
T cd07851 281 MLVLDPDKR 289 (343)
T ss_pred hCCCChhhC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=278.18 Aligned_cols=233 Identities=20% Similarity=0.252 Sum_probs=171.5
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
+.+|.|+++.||++.. +++.||||++.... .....+|+. .++.++|+||+++++++.+.+..+++||
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~e------ 79 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEII-TSRQLQHPNILPYVTSFIVDSELYVVSP------ 79 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHH-HHHhcCCcchhhhhheeecCCeEEEEEe------
Confidence 4455566666665443 79999999986541 123344544 7788999999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLK 633 (753)
|+.+|+|.++++... ...+++..+..++.|++.||+|||+.+|+|||||
T Consensus 80 ----~~~~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk 128 (314)
T cd08216 80 ----LMAYGSCEDLLKTHF---------------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVK 128 (314)
T ss_pred ----ccCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 777888888876431 2346778889999999999999999999999999
Q ss_pred CCcEEEecCCCCeEEEEeccCceeccCCCcc----cccCccCCCCccccccccccCC--CCCchhhHHHHHHHHHHHHhC
Q 004442 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 634 p~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGvvL~EllTG 707 (753)
|+||+++.++. +||+|||.+......... ........++..|+|||.+... .++.++|||||||++|||++|
T Consensus 129 ~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g 206 (314)
T cd08216 129 ASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206 (314)
T ss_pred cceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhC
Confidence 99999987765 999999998766432111 1111233467889999998763 478999999999999999998
Q ss_pred CCCCCCCChHHHH--HHHHcc---------------------------------CcccccCCCHHHHHHHHHccccCcCC
Q 004442 708 GKHPYGESFERDA--NIVKDR---------------------------------KDLFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 708 ~~~Pf~~~~~~~~--~~i~~~---------------------------------~~~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
..||........ ...... .......+++++.+||.+||..||++
T Consensus 207 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 285 (314)
T cd08216 207 -HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285 (314)
T ss_pred -CCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCc
Confidence 678865432211 111100 00111223467889999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 286 R 286 (314)
T cd08216 286 R 286 (314)
T ss_pred C
Confidence 8
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=310.64 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=201.6
Q ss_pred ccceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 467 DGRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 467 ~~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
.-+.-.++|.+.++||+|+||.|...+.. .++.+|+|++.+ ......|+|+..+|...+.+=|++|.-.|.|++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33556678999999999999999987665 489999999975 335578999998999989999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
++||||| ||++|+|-.++... ..+|+.-+.-++..|+-||.
T Consensus 149 ~LYlVMd----------Y~pGGDlltLlSk~-----------------------------~~~pE~~ArFY~aEiVlAld 189 (1317)
T KOG0612|consen 149 YLYLVMD----------YMPGGDLLTLLSKF-----------------------------DRLPEDWARFYTAEIVLALD 189 (1317)
T ss_pred ceEEEEe----------cccCchHHHHHhhc-----------------------------CCChHHHHHHHHHHHHHHHH
Confidence 9999999 99999999988643 24677777889999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc----C-CCCCchhhHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL----Q-GRQTRAIDLF 695 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~----~-~~~t~ksDIw 695 (753)
-||+.|+|||||||+||||+..|+ +||+|||-+-.+..+. .-.....+|||.|++||++. + +.|++.+|.|
T Consensus 190 slH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwW 265 (1317)
T KOG0612|consen 190 SLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWW 265 (1317)
T ss_pred HHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchh
Confidence 999999999999999999988776 9999999998887543 23445668999999999985 3 5689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHccC--cccc--cCCCHHHHHHHHHccc
Q 004442 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK--DLFL--VEHIPEAVDLFTRLLD 747 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~--~~~~--~~~s~el~dLI~~cL~ 747 (753)
|+||++|||+.|..|+|.++......++.+.+ ..|| ...|+++++||.+++.
T Consensus 266 SlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~ 321 (1317)
T KOG0612|consen 266 SLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC 321 (1317)
T ss_pred hhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc
Confidence 99999999999988888888777777776663 3355 5579999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=266.36 Aligned_cols=216 Identities=24% Similarity=0.238 Sum_probs=170.9
Q ss_pred cCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhhHHHHhcC
Q 004442 484 GSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSG 562 (753)
Q Consensus 484 G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~G 562 (753)
|.+|.||++.+. +++.||+|++.... ...+|.. .+....||||+++++++.+.+..+++|| |+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e----------~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERL-TIIPHCVPNMVCLHKYIVSEDSVFLVLQ----------HAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHH-HHHhcCCCceeehhhheecCCeEEEEEe----------cCCCC
Confidence 899999998664 58999999997653 2223333 3445579999999999999999999999 88888
Q ss_pred ChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC
Q 004442 563 SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642 (753)
Q Consensus 563 sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d 642 (753)
+|.+++... ..+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 71 ~L~~~l~~~-----------------------------~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~ 121 (237)
T cd05576 71 KLWSHISKF-----------------------------LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121 (237)
T ss_pred CHHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence 998887432 247788899999999999999999999999999999999777
Q ss_pred CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 004442 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 722 (753)
Q Consensus 643 ~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~ 722 (753)
+. ++++|||++....... ....++..|+|||.+.+..++.++||||+|+++|||++| ..|+........
T Consensus 122 ~~--~~l~df~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~~~~~~~~~~~-- 190 (237)
T cd05576 122 GH--IQLTYFSRWSEVEDSC------DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGIN-- 190 (237)
T ss_pred CC--EEEecccchhcccccc------ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHC-cchhhcCchhcc--
Confidence 65 9999999887654321 123357789999999888899999999999999999998 556543321110
Q ss_pred HHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 723 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 723 i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.......+..++++++++|.+||++||++|
T Consensus 191 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 220 (237)
T cd05576 191 -THTTLNIPEWVSEEARSLLQQLLQFNPTER 220 (237)
T ss_pred -cccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence 111123456678999999999999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=275.42 Aligned_cols=236 Identities=26% Similarity=0.380 Sum_probs=172.3
Q ss_pred eEEEeEEecccCceEEEEEEee-C--CcEEEEEEeecCC-----chHHHHHHHHHHHhC-CCCceeeecccccC----Cc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-E--GRSVAVKRLVKTH-----HDVALKEIQNLIASD-QHPNIVRWYGVESD----QD 540 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~--g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~----~~ 540 (753)
+|.+.+.||+|+||.||++... . +..||||++.... .....+|+. ++..+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELK-LLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHH-HHHHhcCCCChheeeeeeeeccccCC
Confidence 3677899999999999998764 3 7899999986432 224455665 55555 69999999997543 24
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++++|++.+ +|.+++. ....+++..+..++.||+.||+
T Consensus 80 ~~~~~~e~~~~-----------~L~~~l~-----------------------------~~~~~~~~~~~~~~~qi~~aL~ 119 (332)
T cd07857 80 ELYLYEELMEA-----------DLHQIIR-----------------------------SGQPLTDAHFQSFIYQILCGLK 119 (332)
T ss_pred cEEEEEecccC-----------CHHHHHh-----------------------------cCCCCCHHHHHHHHHHHHHHHH
Confidence 57889995443 4544442 1245778889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccC-CCCCchhhHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfG 698 (753)
|||+.+|+||||||+||+++.++. +||+|||+++........ ........||..|+|||.+.+ ..++.++||||||
T Consensus 120 ~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slG 197 (332)
T cd07857 120 YIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG 197 (332)
T ss_pred HHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHH
Confidence 999999999999999999977754 999999999876532211 111233468999999998766 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHH------------------------c----cCc---ccccCCCHHHHHHHHHcc
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIVK------------------------D----RKD---LFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i~------------------------~----~~~---~~~~~~s~el~dLI~~cL 746 (753)
|++|+|++| .+||..... .....+. . ... ......+.++.++|.+||
T Consensus 198 v~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 276 (332)
T cd07857 198 CILAELLGR-KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLL 276 (332)
T ss_pred HHHHHHHhC-CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHc
Confidence 999999998 677765321 1110000 0 000 011235678999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 277 ~~~P~~R 283 (332)
T cd07857 277 AFDPTKR 283 (332)
T ss_pred cCCcccC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=286.93 Aligned_cols=233 Identities=26% Similarity=0.427 Sum_probs=184.1
Q ss_pred EeEEecccCceEEEEE-EeeCCcEEEEEEeecC----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 477 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
-.+.||+|-||+||-| +.++|+.||||++.+. ..+..++.+..++..++||.||.|--.|...+..++|||-+.+
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 3478999999999976 5678999999998653 2334444444488999999999999999999999999994443
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
+.... .|..+ ...+++..-.-++.||+.||.|||.++|+|+|
T Consensus 648 DMLEM----------ILSsE----------------------------kgRL~er~TkFlvtQIL~ALr~LH~knIvHCD 689 (888)
T KOG4236|consen 648 DMLEM----------ILSSE----------------------------KGRLPERITKFLVTQILVALRYLHFKNIVHCD 689 (888)
T ss_pred hHHHH----------HHHhh----------------------------cccchHHHHHHHHHHHHHHHHHhhhcceeecc
Confidence 33222 23221 24566666678899999999999999999999
Q ss_pred CCCCcEEEecCCCC-eEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 632 LKPQNVLISKDKSF-CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 632 LKp~NILL~~d~~~-~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
|||+||||.....| .+||||||.|+...+. ......+||+.|.|||++..+.|.+.-|+||.||++|--++| ..
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG-TF 764 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG-TF 764 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchh----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc-cc
Confidence 99999999776554 7999999999998753 344667899999999999999999999999999999999998 78
Q ss_pred CCCCChHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.+. +....++.+...++ ..+.++++.|||+.+|++.=.+|
T Consensus 765 PFNEd-EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kR 810 (888)
T KOG4236|consen 765 PFNED-EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKR 810 (888)
T ss_pred cCCCc-cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHh
Confidence 98765 33344444444333 45678999999999998765554
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=274.55 Aligned_cols=233 Identities=24% Similarity=0.379 Sum_probs=176.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC-CceE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFV 542 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~ 542 (753)
.++++|.+.+.||+|+||.||++... +++.||||++.+.. .....+|+. ++..++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK-LLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHH-HHHhcCCCCeeeEeeeEecCCCcE
Confidence 35678999999999999999999655 69999999885422 234445555 7889999999999998865 5678
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++++| |+ +++|.++++ ...+++..+..++.|++.||+||
T Consensus 86 ~lv~e----------~~-~~~L~~~~~------------------------------~~~~~~~~~~~~~~ql~~aL~~L 124 (328)
T cd07856 86 YFVTE----------LL-GTDLHRLLT------------------------------SRPLEKQFIQYFLYQILRGLKYV 124 (328)
T ss_pred EEEee----------hh-ccCHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 54 345555442 12456677789999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||+|+||+++.++ .+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++
T Consensus 125 H~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il 196 (328)
T cd07856 125 HSAGVVHRDLKPSNILINENC--DLKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF 196 (328)
T ss_pred HhCCcccCCCCHHHEeECCCC--CEEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHH
Confidence 999999999999999997665 4999999998764322 123356889999998766 5689999999999999
Q ss_pred HHHHhCCCCCCCCChHHH-HHH------------------------HHccC--cc-----cccCCCHHHHHHHHHccccC
Q 004442 702 FFCITGGKHPYGESFERD-ANI------------------------VKDRK--DL-----FLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~-~~~------------------------i~~~~--~~-----~~~~~s~el~dLI~~cL~~D 749 (753)
|||+|| .+||....... ... ..... .. .....++++.++|++||+.|
T Consensus 197 ~el~tg-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 275 (328)
T cd07856 197 AEMLEG-KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFD 275 (328)
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCC
Confidence 999998 66775432110 000 00000 00 11345789999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 276 P~~R 279 (328)
T cd07856 276 PQKR 279 (328)
T ss_pred hhhC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=272.72 Aligned_cols=228 Identities=25% Similarity=0.447 Sum_probs=179.3
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChh
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~ 554 (753)
..||+|+||.||++.. .+++.||||++.... .....+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e------- 97 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVME------- 97 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHH-HHHhcCCcchhheeeEEEeCCEEEEEEe-------
Confidence 5699999999999866 468999999985322 123445555 7789999999999999999999999999
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp 634 (753)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|
T Consensus 98 ---~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p 144 (292)
T cd06657 98 ---FLEGGALTDIVTH------------------------------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144 (292)
T ss_pred ---cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 7777777776521 2356778899999999999999999999999999
Q ss_pred CcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004442 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 635 ~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~ 714 (753)
+||+++.++. ++|+|||++....... .......|+..|+|||.+.+..++.++||||||+++|||++| .+||..
T Consensus 145 ~Nilv~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg-~~p~~~ 218 (292)
T cd06657 145 DSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFN 218 (292)
T ss_pred HHEEECCCCC--EEEcccccceeccccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999987765 8999999987654321 112234578999999999888899999999999999999998 667755
Q ss_pred ChH-HHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 715 SFE-RDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 715 ~~~-~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
... .....+....+ ......++++.++|.+||+.||.+|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 261 (292)
T cd06657 219 EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR 261 (292)
T ss_pred CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccC
Confidence 432 22222222221 1234568899999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=267.75 Aligned_cols=232 Identities=29% Similarity=0.458 Sum_probs=176.3
Q ss_pred EEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.+.+.||+|++|.||++.... ++.||+|.+.... .+....|+. +++.++|+||+++++++.+.+..++|||++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS-LLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHH-HHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456779999999999987764 9999999987542 123445554 778899999999999999999999999954
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
.+ +|.+++... ...+++..+++++.+++.||+|||+.+|+|
T Consensus 81 ~~-----------~l~~~i~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 121 (282)
T cd07829 81 DM-----------DLKKYLDKR----------------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121 (282)
T ss_pred Cc-----------CHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 43 555555321 135778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~ 708 (753)
|||+|+||+++.++. +||+|||+++....... ......++..|+|||.+.+. .++.++|||||||++||+++|
T Consensus 122 ~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~- 195 (282)
T cd07829 122 RDLKPQNILINRDGV--LKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG- 195 (282)
T ss_pred CCCChheEEEcCCCC--EEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC-
Confidence 999999999977654 99999999987643321 11223457889999998776 789999999999999999998
Q ss_pred CCCCCCChHH-HHHHHHc---------------c---Cc-----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFER-DANIVKD---------------R---KD-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~-~~~~i~~---------------~---~~-----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||...... ....+.. . .. ......++++.++|++||..||++|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 270 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccC
Confidence 6777654321 1111100 0 00 1112346789999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=269.44 Aligned_cols=203 Identities=26% Similarity=0.340 Sum_probs=163.2
Q ss_pred eEEEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC-CceE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFV 542 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~ 542 (753)
.|+....||+|.||.||+|...+ .+.+|+|+++.+. ...+.+|++ +++.++|+||+.|..++.. +..+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREia-L~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIA-LLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHH-HHHHhcCCcchhHHHHHhccCceE
Confidence 46677889999999999995443 3479999997652 457889998 8899999999999999887 7789
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
+|++||.+-+|...| +-.+. .+.+.++...+..|+.||+.|+.||
T Consensus 104 ~l~fdYAEhDL~~II-----------~fHr~------------------------~~~~~lp~~mvKsilwQil~Gv~YL 148 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHII-----------KFHRA------------------------SKAKQLPRSMVKSILWQILDGVHYL 148 (438)
T ss_pred EEEehhhhhhHHHHH-----------HHhcc------------------------chhccCCHHHHHHHHHHHHhhhHHH
Confidence 999996665555544 33222 1234677788899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCC--CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGC 699 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGv 699 (753)
|++=|+||||||.|||+..|+ ..++||+|||+++.+.............+-|..|.|||.+.+.. ||.+.|||+.||
T Consensus 149 H~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC 228 (438)
T KOG0666|consen 149 HSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC 228 (438)
T ss_pred hhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence 999999999999999998772 23599999999999876544443445556799999999998865 899999999999
Q ss_pred HHHHHHhCCCCCC
Q 004442 700 ILFFCITGGKHPY 712 (753)
Q Consensus 700 vL~EllTG~~~Pf 712 (753)
++.||+|..+.++
T Consensus 229 IfaElLtl~PlF~ 241 (438)
T KOG0666|consen 229 IFAELLTLEPLFK 241 (438)
T ss_pred HHHHHHccCcccc
Confidence 9999999854443
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=260.80 Aligned_cols=232 Identities=26% Similarity=0.340 Sum_probs=176.1
Q ss_pred EEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHH----HHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~----~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
++...||.|+.|.|++... ..|..+|||.+.+....+.. ..+..++..-+.|.||+.+||+..+...++.||.+.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4456699999999999855 45999999999876544433 333345555568999999999999988999999433
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-Cccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIH 629 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~IiH 629 (753)
..+ +.+|.. ...++++.-+-++...+..||.||.++ +|+|
T Consensus 175 ~C~-----------ekLlkr----------------------------ik~piPE~ilGk~tva~v~AL~YLKeKH~viH 215 (391)
T KOG0983|consen 175 TCA-----------EKLLKR----------------------------IKGPIPERILGKMTVAIVKALYYLKEKHGVIH 215 (391)
T ss_pred HHH-----------HHHHHH----------------------------hcCCchHHhhhhhHHHHHHHHHHHHHhcceee
Confidence 211 122211 124577777889999999999999975 8999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHHHHHHHh
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL~EllT 706 (753)
||+||+|||++..|+ +|+||||++-++.+... .....|.+.|||||.+.. ..|+.++||||||+.++||.|
T Consensus 216 RDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT 289 (391)
T KOG0983|consen 216 RDVKPSNILLDERGN--IKLCDFGISGRLVDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT 289 (391)
T ss_pred cccCccceEEccCCC--EEeecccccceeecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc
Confidence 999999999976665 99999999988765322 223358999999999864 458999999999999999999
Q ss_pred CCCCCCCCC--hHHHHHHHHccCccc-c--cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES--FERDANIVKDRKDLF-L--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~--~~~~~~~i~~~~~~~-~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||... ..+...++.+..++. + ..+++++++|+..||.+|+.+|
T Consensus 290 g-~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~R 340 (391)
T KOG0983|consen 290 G-QYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKR 340 (391)
T ss_pred c-cCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccC
Confidence 9 6688763 233333444444332 2 2379999999999999999988
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=266.60 Aligned_cols=233 Identities=27% Similarity=0.375 Sum_probs=183.0
Q ss_pred EEecccCceEEEEE-EeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 479 ~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
..||.|+||+|+|- +...|+.+|||+++... ..+.+.|....++.-+.||||+++|.+..++..++.||++..++
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 45999999999984 66779999999997543 34566777778888999999999999999999999999888776
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-CccccCC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDL 632 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~IiHrDL 632 (753)
..+ | .+.+. .....+++.-+-+|..-+++||.||-+. .|||||+
T Consensus 150 Dkl-Y-------k~vy~---------------------------vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv 194 (361)
T KOG1006|consen 150 DKL-Y-------KRVYS---------------------------VQKSRIPENILGHITVATVDALDYLKEELKIIHRDV 194 (361)
T ss_pred HHH-H-------HHHHH---------------------------HHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence 544 2 12211 3345688888889999999999999965 8999999
Q ss_pred CCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCC
Q 004442 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 633 Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||+||||+..|. +||||||++-.+.... ..+...|...|||||.+... .|+.+|||||||+.|+|+.|| ..
T Consensus 195 KPSNILldr~G~--vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG-~f 267 (361)
T KOG1006|consen 195 KPSNILLDRHGD--VKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG-NF 267 (361)
T ss_pred ChhheEEecCCC--EeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC-CC
Confidence 999999976665 9999999998775432 12234588899999998643 489999999999999999999 78
Q ss_pred CCCCChH--HHHHHHHccCccc---c---cCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFE--RDANIVKDRKDLF---L---VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~--~~~~~i~~~~~~~---~---~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.+-.. ++..++..+.++. . .+++..++.+|..||.+|-..|
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~R 318 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDR 318 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccC
Confidence 9876432 2333344443332 2 3478999999999999998876
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=303.25 Aligned_cols=273 Identities=29% Similarity=0.430 Sum_probs=178.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.|+..+.||+||||.||+++++ ||+.+|||++.-.. ....++|+. ++++++|||||+++..|.+.....-++|-
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk-~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVK-LLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHH-HHhhcCCcceeeeehhhhccCCccccccc
Confidence 3455578999999999999765 89999999996442 234566776 88999999999999887654322222211
Q ss_pred ccC---------------------------ChhhH----------HHHh-----c-------------C-----------
Q 004442 549 CTC---------------------------SLNDL----------IYVL-----S-------------G----------- 562 (753)
Q Consensus 549 c~~---------------------------~L~~l----------iy~~-----~-------------G----------- 562 (753)
... .+... .|.+ + |
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 100 00000 0000 0 0
Q ss_pred --------ChHHHhhhhhcccchhhhhh--h---hcccccccchhhhhhhcCCCC--HHHHHHHHHHHHHHHHHhhhCCc
Q 004442 563 --------SFEEQLNAKEQDSNLLNEVR--I---RLLPVMENTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 563 --------sL~~~L~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~l~--~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
...+.+...+...+.+...+ . .-+.+++.....+..+.+.+. ....++++++|+.||+|+|+.||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 00011110100011000000 0 012234444444444555553 67889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccC---------------CCcccccCccCCCCccccccccccCCC---CC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG---------------DMSCLTQNATGYGSSGWQAPEQLLQGR---QT 689 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~---------------~~~~~~~~~~~~GT~~Y~APE~l~~~~---~t 689 (753)
|||||||.||+|+++++ +||+|||+|..... ........+..+||.-|+|||++.+.. |+
T Consensus 719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999987765 99999999987220 011112335568999999999997654 99
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccC--cccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK--DLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~--~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|+||||||||++||+. ||+..-++...+..-+. .+.+ .+..++-..+|+.|++.||.+|
T Consensus 797 ~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred chhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccC
Confidence 99999999999999984 68877666554433333 2322 2334567789999999999998
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=269.37 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=192.1
Q ss_pred cceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCC-c
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ-D 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-~ 540 (753)
..+++....+-+|.||.||+|-+ .+.+.|-||.++....+ .++.|- .++..+.|||+....|++.+. +
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es-~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQES-MLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHH-HHHhcCcCCCccceeEEEeeccC
Confidence 35577778899999999999833 34567778877654322 223333 366778899999999998864 4
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++|. ++.-|+|..||...+.... ...+.+...++..++.|++.|++
T Consensus 362 ~P~V~y~----------~~~~gNLK~FL~~Cr~~~~---------------------~~aqtvtt~qlV~masQla~am~ 410 (563)
T KOG1024|consen 362 TPFVLYP----------ATGVGNLKSFLQICRGDDP---------------------SYAQTVTTIQLVLMASQLAMAME 410 (563)
T ss_pred cceEEEe----------ccCcchHHHHHHHhccCCC---------------------ccccchhHHHHHHHHHHHHHHHH
Confidence 5688888 8888999999985542111 12345667788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|||+.++||.||..+|++| |+.+.+||+|=.+++.+-+... .... .......||+||.+....|+.++|||||||
T Consensus 411 hlh~~~ViHkDiAaRNCvI--dd~LqVkltDsaLSRDLFP~DYhcLGD--nEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 411 HLHNHGVIHKDIAARNCVI--DDQLQVKLTDSALSRDLFPGDYHCLGD--NENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHhcCcccchhhhhccee--hhheeEEeccchhccccCcccccccCC--CCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 9999999999999999999 6668899999999987644321 1111 112467899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHccCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~~~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||||+|.++.||.+..+ ++...++.+.. .-|-++++|+..+|-.||..+|++|
T Consensus 487 llWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeR 542 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEER 542 (563)
T ss_pred HHHHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccC
Confidence 999999999999988644 44455555544 5677889999999999999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=294.15 Aligned_cols=143 Identities=31% Similarity=0.459 Sum_probs=119.8
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.|.+.+.||+|+||+||++... .++.||||+++.... ...+..+..+++.++|+||+++++++.+.+..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888999999999999999776 589999999975421 122333334778999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.++++.. ..+++..+++|+.||+.||.|||+.+
T Consensus 84 E----------y~~g~~L~~li~~~-----------------------------~~l~~~~~~~i~~qil~aL~yLH~~g 124 (669)
T cd05610 84 E----------YLIGGDVKSLLHIY-----------------------------GYFDEEMAVKYISEVALALDYLHRHG 124 (669)
T ss_pred e----------CCCCCCHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 77788888877532 24667788999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCce
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~ 656 (753)
|+||||||+||||+.++. +||+|||+++
T Consensus 125 IiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 125 IIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred EEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 999999999999977654 9999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=240.75 Aligned_cols=232 Identities=27% Similarity=0.413 Sum_probs=180.1
Q ss_pred EeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 477 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
..+.||+|.||+||+|+.++ ++.||+|+++-.. ...+++|+. +++.++|+|||+|+++...++.+-+|+|+|.
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreic-llkelkhknivrl~dvlhsdkkltlvfe~cd 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHH-HHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence 34679999999999998765 8899999986432 346889998 8899999999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
.+|..|+---||. ++...+..++.|+++||.++|++++.||
T Consensus 85 qdlkkyfdslng~---------------------------------------~d~~~~rsfmlqllrgl~fchshnvlhr 125 (292)
T KOG0662|consen 85 QDLKKYFDSLNGD---------------------------------------LDPEIVRSFMLQLLRGLGFCHSHNVLHR 125 (292)
T ss_pred HHHHHHHHhcCCc---------------------------------------CCHHHHHHHHHHHHhhhhhhhhhhhhhc
Confidence 8888776444443 4445668899999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||||+|.||+.+|+ +|++|||+++.+.-..... ...+-|..|.+|.++.+.+ |+...|+||-||++.|+...+.
T Consensus 126 dlkpqnllin~nge--lkladfglarafgipvrcy---saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagr 200 (292)
T KOG0662|consen 126 DLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200 (292)
T ss_pred cCCcceEEeccCCc--EEecccchhhhcCCceEee---eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCC
Confidence 99999999988876 9999999999775432221 2234599999999998866 7999999999999999988767
Q ss_pred CCCCCC-hHHHHHHHHccC--------------------cccc---------cCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGES-FERDANIVKDRK--------------------DLFL---------VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~-~~~~~~~i~~~~--------------------~~~~---------~~~s~el~dLI~~cL~~DP~~R 753 (753)
+-|.+. ...+...+.... +.++ ++....-+|+++++|.-+|.+|
T Consensus 201 plfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 201 PLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred CCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccc
Confidence 666554 333332222100 0011 1112247899999999999876
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=277.42 Aligned_cols=232 Identities=26% Similarity=0.374 Sum_probs=191.2
Q ss_pred EEEeEEecccCceEEEEEEeeCCc-EEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~-~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++....||-|+||.|=+....+.. .+|+|.+++.+ .+..+.|-. +|...+.+.||+|+-.+.++++.||.||
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~-Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERN-IMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHH-HHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 344566999999999876655433 48999887643 223344544 5666779999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
-..+|.|...|+.+ ..++.....-++..++.|++|||.++|
T Consensus 501 ----------aClGGElWTiLrdR-----------------------------g~Fdd~tarF~~acv~EAfeYLH~k~i 541 (732)
T KOG0614|consen 501 ----------ACLGGELWTILRDR-----------------------------GSFDDYTARFYVACVLEAFEYLHRKGI 541 (732)
T ss_pred ----------hhcCchhhhhhhhc-----------------------------CCcccchhhhhHHHHHHHHHHHHhcCc
Confidence 56678888877654 345666678899999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|+|||||+|.+|+.+|- +||.|||+|+.+..+ ..+.+.|||+.|.|||++..+.++.++|.||||+++|||+||
T Consensus 542 IYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 542 IYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSG----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred eeccCChhheeeccCCc--eEEeehhhHHHhccC----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 99999999999987775 899999999988743 456789999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHH-HHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFERD-ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~~-~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|||.+..+-. .+.+..+. ..+|......+.+||+++...+|.+|
T Consensus 616 -~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 616 -SPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred -CCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhh
Confidence 78998875543 44444443 45788889999999999999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=285.44 Aligned_cols=258 Identities=17% Similarity=0.181 Sum_probs=163.1
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeeccc------ccCC
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ESDQ 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~------~~~~ 539 (753)
..++|.+.+.||+|+||.||+|...+ +..||||++......+...+. .+....|.++..++.. +.+.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 45678999999999999999997754 689999998654322221111 1222233333333222 2456
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.++++.......... +.... ....-.........+..++.|++.||
T Consensus 208 ~~~~LV~e----------y~~~gsL~~~l~~~~~~~~v~~--------~l~~~-~~~l~~~~~r~~~~i~~i~~qll~aL 268 (566)
T PLN03225 208 DEYWLVWR----------YEGESTLADLMQSKEFPYNVEP--------YLLGK-VQDLPKGLERENKIIQTIMRQILFAL 268 (566)
T ss_pred CceEEEEE----------ecCCCcHHHHHHhcCCchhHHH--------Hhccc-hhhccccchhhHHHHHHHHHHHHHHH
Confidence 78999999 7777888887764321100000 00000 00000111123345678999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-------------
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG------------- 686 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------------- 686 (753)
+|||+.+|+||||||+|||++.+. ..+||+|||+|+.+..... ......++|+.|+|||.+...
T Consensus 269 ~yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 269 DGLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred HHHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccc
Confidence 999999999999999999997542 3599999999987643322 122345689999999966432
Q ss_pred ---------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCc-------ccccCC--------------CH
Q 004442 687 ---------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD-------LFLVEH--------------IP 736 (753)
Q Consensus 687 ---------~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~-------~~~~~~--------------s~ 736 (753)
.++.++|||||||+||||+++ ..+++.........+..... ...... ..
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 424 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFP-NLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGG 424 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhC-cCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccch
Confidence 234567999999999999997 45554432222222111100 001111 22
Q ss_pred HHHHHHHHccccCcCCC
Q 004442 737 EAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 737 el~dLI~~cL~~DP~~R 753 (753)
+..+||++||++||++|
T Consensus 425 ~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 425 AGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHccCCcccC
Confidence 45589999999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-28 Score=274.86 Aligned_cols=261 Identities=20% Similarity=0.290 Sum_probs=174.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-----------------eCCcEEEEEEeecCCc---hHH--------------H
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-----------------YEGRSVAVKRLVKTHH---DVA--------------L 514 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-----------------~~g~~VAVK~l~~~~~---~~~--------------~ 514 (753)
+...++|.+.+.||+|+||+||+|.. ..++.||||++..... +++ .
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34467899999999999999999853 2457899999864321 111 2
Q ss_pred HHHHHHHHhCCCCce-----eeecccccC--------CceEEEEEccccCChhhHHHHhcCChHHHhhhhhccc-chhhh
Q 004442 515 KEIQNLIASDQHPNI-----VRWYGVESD--------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDS-NLLNE 580 (753)
Q Consensus 515 ~Ei~~ll~~l~HpNI-----V~L~g~~~~--------~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~-~~~~~ 580 (753)
.|+. ++.+++|.|+ +++++||.. ++..+|||| |+++|+|.++|+...... ..+.+
T Consensus 221 vE~~-~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E----------y~~~gsL~~~L~~~~~~~~~~L~e 289 (507)
T PLN03224 221 VEAY-MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK----------FESDATLGDALDGKLGPFPGCLEE 289 (507)
T ss_pred HHHH-HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE----------cCCCCcHHHHHhhccCCCcchHHH
Confidence 2333 4566666654 778888763 356899999 888888888887543211 11111
Q ss_pred hhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccC
Q 004442 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (753)
Q Consensus 581 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~ 660 (753)
.. ..............+++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.+..
T Consensus 290 ~l------~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~ 361 (507)
T PLN03224 290 FM------MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCT 361 (507)
T ss_pred HH------hcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCcccccc
Confidence 00 0011111112234578889999999999999999999999999999999997765 499999999976543
Q ss_pred CCcccccCccCCCCccccccccccCCCC----------------------CchhhHHHHHHHHHHHHhCCCCCCCCCh--
Q 004442 661 DMSCLTQNATGYGSSGWQAPEQLLQGRQ----------------------TRAIDLFSLGCILFFCITGGKHPYGESF-- 716 (753)
Q Consensus 661 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~----------------------t~ksDIwSfGvvL~EllTG~~~Pf~~~~-- 716 (753)
... .......+|+.|+|||.+..... ..+.||||+||++++|+++...|+....
T Consensus 362 ~~~--~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f 439 (507)
T PLN03224 362 GIN--FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF 439 (507)
T ss_pred CCc--cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh
Confidence 211 11122345889999998864321 1347999999999999998655775321
Q ss_pred HHHH-------H---HHHccCc--ccccCCCHHHHHHHHHccccCc
Q 004442 717 ERDA-------N---IVKDRKD--LFLVEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 717 ~~~~-------~---~i~~~~~--~~~~~~s~el~dLI~~cL~~DP 750 (753)
.... . ....... ......++++.||+.+||.++|
T Consensus 440 ~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~ 485 (507)
T PLN03224 440 NTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRD 485 (507)
T ss_pred hhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCC
Confidence 0000 0 1111111 1234567899999999999877
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=254.93 Aligned_cols=236 Identities=22% Similarity=0.298 Sum_probs=194.0
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHH-HHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEI-QNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei-~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.|.+..+||+|+|.+|..+.+. ..+.+|+|+++++. .-.+.+.+ ...-..-+||.+|.|..++..+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 56788899999999999988664 58899999987642 11222222 2233456899999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
.| |+++|+|.-+.. +.+.+|++.+.-+...|.-||.|||++
T Consensus 330 ie----------yv~ggdlmfhmq-----------------------------rqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 330 IE----------YVNGGDLMFHMQ-----------------------------RQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred EE----------EecCcceeeehh-----------------------------hhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 99 888888875543 346788899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
|||+||||.+|+||+..|+ +||.|+|+++..-. ....+.+.|||+.|+|||++.+..|++.+|.|+|||+++||+
T Consensus 371 giiyrdlkldnvlldaegh--ikltdygmcke~l~---~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLG---PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred CeeeeeccccceEEccCCc--eeecccchhhcCCC---CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 9999999999999988776 99999999986543 233457889999999999999999999999999999999999
Q ss_pred hCCCCCCCC--------Ch-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGE--------SF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~--------~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.| +.||+- .. .-.++++.......|+.++-.+..+++.-|++||++|
T Consensus 446 ag-rspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~er 501 (593)
T KOG0695|consen 446 AG-RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKER 501 (593)
T ss_pred cC-CCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHh
Confidence 99 567741 12 2234566667777888999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=243.06 Aligned_cols=222 Identities=36% Similarity=0.534 Sum_probs=177.6
Q ss_pred CceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhhHHHH
Q 004442 485 SNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 559 (753)
Q Consensus 485 ~fG~Vyka~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~ 559 (753)
+||.||++.... |+.+|+|++..... +...+|+. .++.++|+||+++++++......++++| |+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e----------~~ 69 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREIS-ILKKLKHPNIVRLYDVFEDEDKLYLVME----------YC 69 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHH-HHHhCCCCcHHHHHhheeeCCEEEEEEe----------CC
Confidence 589999997764 89999999975442 33444444 7788899999999999999999999999 77
Q ss_pred hcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEE
Q 004442 560 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639 (753)
Q Consensus 560 ~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL 639 (753)
.+|+|.+++... ..+++..+++++.++++++.|||+.+++|+||+|+||++
T Consensus 70 ~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 70 DGGDLFDLLKKR-----------------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL 120 (244)
T ss_pred CCCCHHHHHHhc-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE
Confidence 777888876432 126778889999999999999999999999999999999
Q ss_pred ecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-C-hH
Q 004442 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-S-FE 717 (753)
Q Consensus 640 ~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~-~-~~ 717 (753)
+.++ .++|+|||.+....... ......++..|++||...+..++.++||||||+++|++++| ..||.. . ..
T Consensus 121 ~~~~--~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~ 193 (244)
T smart00220 121 DEDG--HVKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTG-KPPFPGDDQLL 193 (244)
T ss_pred CCCC--cEEEccccceeeecccc----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Confidence 7775 49999999998775432 22344578899999999888899999999999999999998 567765 2 33
Q ss_pred HHHHHHHccCcccccC---CCHHHHHHHHHccccCcCCC
Q 004442 718 RDANIVKDRKDLFLVE---HIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 718 ~~~~~i~~~~~~~~~~---~s~el~dLI~~cL~~DP~~R 753 (753)
................ ++.++.+++.+||..||++|
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 194 ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 3334444333333222 77899999999999999998
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=253.49 Aligned_cols=237 Identities=24% Similarity=0.378 Sum_probs=176.6
Q ss_pred EEEeEEecccCceEEEEEEee-CCcEEEEEEeec-----CCchHHHHHHHHHHHhCCCCceeeecccccC--------Cc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESD--------QD 540 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~-----~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--------~~ 540 (753)
|.....||+|.||.||+|+.. .|+.||+|+..- .....+++|+. ++..++|+|++.++..|.. ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreik-iL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHH-HHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 444467999999999998655 478899997632 22346788887 7899999999999999864 23
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+|||+++|+.+|.-++ . -....++...+.+++.++..||.
T Consensus 98 t~ylVf~~cehDLaGlL-------s--------------------------------n~~vr~sls~Ikk~Mk~Lm~GL~ 138 (376)
T KOG0669|consen 98 TFYLVFDFCEHDLAGLL-------S--------------------------------NRKVRFSLSEIKKVMKGLMNGLY 138 (376)
T ss_pred eeeeeHHHhhhhHHHHh-------c--------------------------------CccccccHHHHHHHHHHHHHHHH
Confidence 48999999987765444 1 11234677788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCC-CcccccCccCCCCccccccccccCC-CCCchhhHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD-MSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLG 698 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~-~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfG 698 (753)
|+|...|+|||+|+.|+||+.|+. +||+|||+++.+... .........++-|..|.+||.+.+. .|+++.|||..|
T Consensus 139 ~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 139 YIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 999999999999999999988875 899999999766432 1122223445669999999999875 589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHcc----------------------Ccccc-------------cCCCHHHHHHHH
Q 004442 699 CILFFCITGGKHPYGESFERDANIVKDR----------------------KDLFL-------------VEHIPEAVDLFT 743 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~i~~~----------------------~~~~~-------------~~~s~el~dLI~ 743 (753)
|++.||.|+.+...++....+...+... ..+.+ ..-.+++.+|+.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 9999999984433344333333332210 00011 111358999999
Q ss_pred HccccCcCCC
Q 004442 744 RLLDPNPDLR 753 (753)
Q Consensus 744 ~cL~~DP~~R 753 (753)
++|..||++|
T Consensus 297 ~ll~~DP~kR 306 (376)
T KOG0669|consen 297 KLLKLDPTKR 306 (376)
T ss_pred HHhccCcccC
Confidence 9999999998
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=276.61 Aligned_cols=239 Identities=25% Similarity=0.365 Sum_probs=187.3
Q ss_pred cceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCCch-HHHHHHH-HHHHhCCCCceeeeccccc-----CCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD-VALKEIQ-NLIASDQHPNIVRWYGVES-----DQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~~~-~~~~Ei~-~ll~~l~HpNIV~L~g~~~-----~~~~~~ 543 (753)
.+-|++.+.||+|.+|.||++ +..+|+.+|||++...... +.+.++. .++..-+|||++.++|++. .+++++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 345788999999999999998 4567999999998765433 2333333 3445668999999999975 367899
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||||| .+||..+++.... ...+.|.-+..|++.+++||.|||
T Consensus 98 LVMEfC----------~gGSVTDLVKn~~---------------------------g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 98 LVMEFC----------GGGSVTDLVKNTK---------------------------GNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred EEeecc----------CCccHHHHHhhhc---------------------------ccchhhHHHHHHHHHHHHHHHHHh
Confidence 999955 4677777665432 456778888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-----CCCchhhHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSLG 698 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ksDIwSfG 698 (753)
...++|||||=.||||+.++. +||+|||.+..+... .....+.+||+.|||||++... .|+..+|+||||
T Consensus 141 ~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT---~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST---VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred hcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc---cccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 999999999999999998876 999999999887653 3345677899999999999543 367899999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHHccCcc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++..||.-| .||+-+... +...++....++ .+..+++++.+||..||.+|-++|
T Consensus 216 ITaIEladG-~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~R 273 (953)
T KOG0587|consen 216 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQR 273 (953)
T ss_pred ceeehhcCC-CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccC
Confidence 999999998 677766543 333333332222 356788999999999999998877
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=267.19 Aligned_cols=233 Identities=24% Similarity=0.375 Sum_probs=182.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
...|..++.||-|+||.|-+++..+ ...+|.|.|.+.. .-.-.+.+..+|+..+.+=||+|+-.|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4568888999999999999987655 6789999997643 112234444588999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|++..+|-. ...|++..+.-++.+++.|+++.|..
T Consensus 708 Md----------YIPGGDmMSLLIr-----------------------------mgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 708 MD----------YIPGGDMMSLLIR-----------------------------MGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred Ee----------ccCCccHHHHHHH-----------------------------hccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 99 9999999998843 34577777888999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceecc---C-----CCc--------------cc-----------------c
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ---G-----DMS--------------CL-----------------T 666 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~---~-----~~~--------------~~-----------------~ 666 (753)
|+|||||||+||||+.||+ +||.||||+.-+. . +.+ .. .
T Consensus 749 GFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~ 826 (1034)
T KOG0608|consen 749 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRI 826 (1034)
T ss_pred cceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhh
Confidence 9999999999999999887 9999999986431 0 000 00 0
Q ss_pred cCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHH-HHHHHcc---CcccccCCCHHHHHH
Q 004442 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES-FERD-ANIVKDR---KDLFLVEHIPEAVDL 741 (753)
Q Consensus 667 ~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~-~~~~-~~~i~~~---~~~~~~~~s~el~dL 741 (753)
.....+||+.|+|||++....|+..+|.||.|||||||+.| ++||... .... ..++.+. ..+...+.++|+.+|
T Consensus 827 ~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g-~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~l 905 (1034)
T KOG0608|consen 827 LAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDL 905 (1034)
T ss_pred hhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC-CCCccCCCCCcceeeeeehhhccccccccccCHHHHHH
Confidence 01223699999999999999999999999999999999999 5666543 2222 2222222 234556789999999
Q ss_pred HHHcc
Q 004442 742 FTRLL 746 (753)
Q Consensus 742 I~~cL 746 (753)
|.++.
T Consensus 906 i~kLc 910 (1034)
T KOG0608|consen 906 IQKLC 910 (1034)
T ss_pred HHHHh
Confidence 98754
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=261.96 Aligned_cols=244 Identities=26% Similarity=0.378 Sum_probs=180.1
Q ss_pred ceecceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecC-C---------chHHHHHHHHHHHhCCCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT-H---------HDVALKEIQNLIASDQHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~-~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~ 537 (753)
..+.++|-+..+||+|+|..||+|- +...+.||||+-.-. . .+.+.+|.. +-+.++||.||++++|+.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyr-IHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYR-IHKELDHPRIVKLYDYFS 537 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHh-hhhccCcceeeeeeeeee
Confidence 4555667777889999999999994 456889999975321 1 112334443 678899999999999986
Q ss_pred -CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 538 -DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 538 -~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
+.+.++-|+|||+++ +|+-+|. ..+.++++++..|+.||+
T Consensus 538 lDtdsFCTVLEYceGN----------DLDFYLK-----------------------------QhklmSEKEARSIiMQiV 578 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGN----------DLDFYLK-----------------------------QHKLMSEKEARSIIMQIV 578 (775)
T ss_pred eccccceeeeeecCCC----------chhHHHH-----------------------------hhhhhhHHHHHHHHHHHH
Confidence 567889999977763 3333332 234467788899999999
Q ss_pred HHHHHhhhC--CccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCcc----cccCccCCCCccccccccccCC---
Q 004442 617 SGLSHLHEI--GLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--- 686 (753)
Q Consensus 617 ~gL~yLH~~--~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~--- 686 (753)
.||.||.+. +|||-||||.||||-.... ..+||.||||++.+.++... ...+....||..|++||.+.-+
T Consensus 579 nAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkeP 658 (775)
T KOG1151|consen 579 NALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEP 658 (775)
T ss_pred HHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCC
Confidence 999999986 7999999999999965433 26999999999999765332 2234456799999999987533
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHccCccccc--CCCHHHHHHHHHccccCcCCC
Q 004442 687 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA-----NIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 687 -~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~-----~~i~~~~~~~~~--~~s~el~dLI~~cL~~DP~~R 753 (753)
..+.|+||||.||++|.|+.|+ -||+....... .+++.....||. -.+.++.+||++||..--+.|
T Consensus 659 PKIsnKVDVWSvGVIFyQClYGr-KPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR 732 (775)
T KOG1151|consen 659 PKISNKVDVWSVGVIFYQCLYGR-KPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDR 732 (775)
T ss_pred CccccceeeEeeehhhhhhhccC-CCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhh
Confidence 3688999999999999999995 58887643322 122233334443 467899999999998755444
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=235.11 Aligned_cols=197 Identities=28% Similarity=0.391 Sum_probs=157.5
Q ss_pred EEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 476 VFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.-...||+|++|.|=+- +..+|+..|||++...- ..+.++|+...++...+|.+|.++|........++.||.+.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 34466999999998653 55689999999996542 33456677666777889999999999999999999999777
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-Cccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIH 629 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~IiH 629 (753)
.+|..+. .. -..+...+++..+-+||..+.+||.|||++ .+||
T Consensus 129 tSldkfy-----------~~-------------------------v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIH 172 (282)
T KOG0984|consen 129 TSLDKFY-----------RK-------------------------VLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIH 172 (282)
T ss_pred hhHHHHH-----------HH-------------------------HHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhh
Confidence 6654432 10 113456788889999999999999999987 8999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC----CCCCchhhHHHHHHHHHHHH
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~----~~~t~ksDIwSfGvvL~Ell 705 (753)
||+||+||||+.+|. +|+||||++-.+.+.... ....|...|||||.+.. ..|+.++||||||+.+.||.
T Consensus 173 RDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA 246 (282)
T KOG0984|consen 173 RDVKPSNILINYDGQ--VKICDFGISGYLVDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA 246 (282)
T ss_pred ccCCcceEEEccCCc--EEEcccccceeehhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence 999999999988887 999999999887643221 11347889999998853 46899999999999999999
Q ss_pred hCCCCCCCCC
Q 004442 706 TGGKHPYGES 715 (753)
Q Consensus 706 TG~~~Pf~~~ 715 (753)
++ ++||+.-
T Consensus 247 ~l-r~PY~~w 255 (282)
T KOG0984|consen 247 IL-RFPYESW 255 (282)
T ss_pred hc-ccccccc
Confidence 99 6788654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=250.62 Aligned_cols=203 Identities=22% Similarity=0.255 Sum_probs=159.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC--CchHHHHHHHHHHHhCCCC-----ceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT--HHDVALKEIQNLIASDQHP-----NIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~--~~~~~~~Ei~~ll~~l~Hp-----NIV~L~g~~~~~~ 540 (753)
+.+..+|++...+|+|.||.|...-+ ..+..||||+++.- ..+.+.-|+..+.+...+. -+|++.+|+.-.+
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 45578899999999999999987643 33799999999753 2455666776433332321 3789999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++|+|.++- |++++|... .-.+++...+..|+.|++++++
T Consensus 165 hiCivfellG~-----------S~~dFlk~N---------------------------~y~~fpi~~ir~m~~QL~~sv~ 206 (415)
T KOG0671|consen 165 HICIVFELLGL-----------STFDFLKEN---------------------------NYIPFPIDHIRHMGYQLLESVA 206 (415)
T ss_pred ceEEEEeccCh-----------hHHHHhccC---------------------------CccccchHHHHHHHHHHHHHHH
Confidence 99999995443 555555432 1346888999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCC------------------CCeEEEEeccCceeccCCCcccccCccCCCCcccccccc
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDK------------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 682 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~------------------~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~ 682 (753)
|||+.+++|-||||+|||+.+.. +..+||+|||.|..-.+.. ...+.|..|.|||+
T Consensus 207 fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEV 280 (415)
T KOG0671|consen 207 FLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEV 280 (415)
T ss_pred HHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchh
Confidence 99999999999999999995322 2468999999998765432 34557999999999
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 683 l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
+.+-.++..+||||+||||.|+.||...++...
T Consensus 281 iLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 281 ILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred eeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 999999999999999999999999976666544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=243.21 Aligned_cols=189 Identities=24% Similarity=0.404 Sum_probs=145.7
Q ss_pred EEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCC-----ceEEEEEc
Q 004442 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFVYLSLE 547 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-----~~~~LV~E 547 (753)
+.||-|+||.||-..+. +|+.||.|++..- .....|+|+. |+.-.+|.|++.+++.-.-. .++|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~k-mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIK-MLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHH-HHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 56999999999976554 6999999998643 2457889987 88999999999998875433 23566666
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+++.+|..+| .....++...+.-+..||++||.|||+.+|
T Consensus 138 LmQSDLHKII----------------------------------------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~I 177 (449)
T KOG0664|consen 138 LMQSDLHKII----------------------------------------VSPQALTPDHVKVFVYQILRGLKYLHTANI 177 (449)
T ss_pred HHHhhhhhee----------------------------------------ccCCCCCcchhhhhHHHHHhhhHHHhhcch
Confidence 4433322222 223445666677889999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
.||||||.|.|+ +.++.+||||||+|+....+. ....+..+-|..|.|||++++.. |+.+.||||.||++.|++.
T Consensus 178 LHRDIKPGNLLV--NSNCvLKICDFGLARvee~d~--~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 178 LHRDIKPGNLLV--NSNCILKICDFGLARTWDQRD--RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred hhccCCCccEEe--ccCceEEecccccccccchhh--hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 999999999999 555889999999999765432 22334445689999999999865 8999999999999999987
Q ss_pred CCCCCCC
Q 004442 707 GGKHPYG 713 (753)
Q Consensus 707 G~~~Pf~ 713 (753)
. +.-|.
T Consensus 254 R-rILFQ 259 (449)
T KOG0664|consen 254 R-KILFQ 259 (449)
T ss_pred h-hhhhh
Confidence 5 55443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=249.72 Aligned_cols=193 Identities=24% Similarity=0.371 Sum_probs=157.5
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCC---CCceeeecccccC
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQ---HPNIVRWYGVESD 538 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~---HpNIV~L~g~~~~ 538 (753)
.|...+.+|+|+||.|+++..+ +...|+||.+.++.- ...-.|++ +|+.++ |+||+++++++.+
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIq-Ila~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQ-ILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHH-HHHHhhhcCccchhhhhheeec
Confidence 3788899999999999998554 578899999876531 12345777 667777 9999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
++++||+||-=+ ++=+|++++.. ...+++.+..-|++||+.|
T Consensus 641 dd~yyl~te~hg---------~gIDLFd~IE~-----------------------------kp~m~E~eAk~IFkQV~ag 682 (772)
T KOG1152|consen 641 DDYYYLETEVHG---------EGIDLFDFIEF-----------------------------KPRMDEPEAKLIFKQVVAG 682 (772)
T ss_pred CCeeEEEecCCC---------CCcchhhhhhc-----------------------------cCccchHHHHHHHHHHHhc
Confidence 999999999322 23355555532 3457888889999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSL 697 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSf 697 (753)
+++||+++|||||||-+|+.++.+ ..+||+|||.|.....+ .....+||.+|.|||++.+..| +..-|||++
T Consensus 683 i~hlh~~~ivhrdikdenvivd~~--g~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 683 IKHLHDQGIVHRDIKDENVIVDSN--GFVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred cccccccCceecccccccEEEecC--CeEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 999999999999999999999555 56999999999876543 3456789999999999999988 788999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 004442 698 GCILFFCITGGKHPYG 713 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~ 713 (753)
|++||.++.. ..||-
T Consensus 756 gillytivyk-enpyy 770 (772)
T KOG1152|consen 756 GILLYTIVYK-ENPYY 770 (772)
T ss_pred hheeeEEEec-cCCCc
Confidence 9999998885 56663
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-24 Score=213.47 Aligned_cols=198 Identities=38% Similarity=0.641 Sum_probs=165.9
Q ss_pred ecccCceEEEEEEeeC-CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhh
Q 004442 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 481 IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
||+|++|.||++...+ ++.++||++..... +...+|+. .+..++|++|+++++++......++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~~~e-------- 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE-ILKKLNHPNIVKLYGVFEDENHLYLVME-------- 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeEEEEEe--------
Confidence 6899999999987765 89999999987654 34555655 7788999999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~ 635 (753)
|..+++|.+++.... ..+++..+..++.+++++|.|||+.+++|+||+|.
T Consensus 72 --~~~~~~l~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ 121 (215)
T cd00180 72 --YCEGGSLKDLLKENE----------------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121 (215)
T ss_pred --cCCCCcHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHh
Confidence 666677777664321 24677888999999999999999999999999999
Q ss_pred cEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 636 NVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 636 NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
||+++. ++ .++|+|||.+........ ......+...|++||..... .++.+.|+|++|++++++
T Consensus 122 ni~~~~~~~--~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 122 NILLDSDNG--KVKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred hEEEeCCCC--cEEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999987 54 489999999987654321 12233468899999999887 789999999999999999
Q ss_pred CChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 714 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 714 ~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+++.+||+.||++|
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccC
Confidence 789999999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=217.86 Aligned_cols=208 Identities=32% Similarity=0.508 Sum_probs=163.9
Q ss_pred EEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.+.+.||+|++|.||++...+ ++.+|+|.+.... .+...+|+. .+..++|+|++++++++...+..++++|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIR-ILKKLKHPNIVKLYGVFEDPEPLYLVME--- 77 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHH-HHHhCCCCChhhheeeeecCCceEEEEe---
Confidence 456889999999999997765 8999999997653 233444554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+++|.+++.... ..+++..+..++.+++.++.|||+.+++|+
T Consensus 78 -------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 122 (225)
T smart00221 78 -------YCEGGDLFDYLRKKG----------------------------GKLSEEEARFYLRQILEALEYLHSLGIVHR 122 (225)
T ss_pred -------ccCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 777778887765321 016777889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccc-cCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l-~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
||+++||+++.++ .++|+|||.+........ .......++..|++||.. ....++.++|||+||++++||++| +
T Consensus 123 di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g-~ 197 (225)
T smart00221 123 DLKPENILLGMDG--LVKLADFGLARFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG-P 197 (225)
T ss_pred CCCHHHEEEcCCC--CEEEeeCceeeEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC-C
Confidence 9999999997664 599999999988754321 112334578899999998 666788899999999999999998 6
Q ss_pred CCCCC--Ch-HHHHHHHHccC
Q 004442 710 HPYGE--SF-ERDANIVKDRK 727 (753)
Q Consensus 710 ~Pf~~--~~-~~~~~~i~~~~ 727 (753)
.||.. .. +...+.+..+.
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 198 EPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred CCccccchhHHHHHHHHhcCC
Confidence 78855 22 24445555444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=232.12 Aligned_cols=193 Identities=30% Similarity=0.444 Sum_probs=150.7
Q ss_pred ecceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
+..+|.-.+.+|.|.- .|.-+- .-.+++||+|++... +...+.+|.. ++..+.|+||++++.++.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~-l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELK-LMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhh-hhhhhcccceeeeeeccCccccHHH
Confidence 3456666778999998 444443 335899999998543 3456788887 78999999999999998654
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...|+|||++..+|.+.+.+ .++-..+..|..|++.|
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~------------------------------------------elDH~tis~i~yq~~~~ 130 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILM------------------------------------------ELDHETISYILYQMLCG 130 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHH------------------------------------------hcchHHHHHHHHHHHHH
Confidence 34799999666555444421 13335668999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
+.|||+.+|+||||||+||+++.+ +.+||.|||+|+.-... -.....+.|..|.|||++.+..+.+.+||||.|
T Consensus 131 ik~lhs~~IihRdLkPsnivv~~~--~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvG 204 (369)
T KOG0665|consen 131 IKHLHSAGIIHRDLKPSNIVVNSD--CTLKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (369)
T ss_pred HHHHHhcceeecccCcccceecch--hheeeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhh
Confidence 999999999999999999999766 56999999999865432 233455679999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC
Q 004442 699 CILFFCITGGKHPYG 713 (753)
Q Consensus 699 vvL~EllTG~~~Pf~ 713 (753)
|++.||++|+-.+-+
T Consensus 205 ci~gEli~~~Vlf~g 219 (369)
T KOG0665|consen 205 CIMGELILGTVLFPG 219 (369)
T ss_pred hHHHHHhhceEEecC
Confidence 999999999543333
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=243.00 Aligned_cols=211 Identities=23% Similarity=0.316 Sum_probs=166.4
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCC------CCceeeecccccC
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQ------HPNIVRWYGVESD 538 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~------HpNIV~L~g~~~~ 538 (753)
++.+-.+|.+....|+|-|++|..|.+. .|+.||||++...+ ...-++|++ +|++++ .-|+++|+-.|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~Ele-iLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELE-ILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHH-HHHHhhccCchhhhHHHHHHHHhhh
Confidence 3455577888889999999999998664 48899999997653 345577776 556654 3579999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+++|||+|.+.- +|.+.|.... +.-+|....+..++.|+.-|
T Consensus 506 knHLClVFE~Lsl-----------NLRevLKKyG--------------------------~nvGL~ikaVRsYaqQLflA 548 (752)
T KOG0670|consen 506 KNHLCLVFEPLSL-----------NLREVLKKYG--------------------------RNVGLHIKAVRSYAQQLFLA 548 (752)
T ss_pred cceeEEEehhhhc-----------hHHHHHHHhC--------------------------cccceeehHHHHHHHHHHHH
Confidence 9999999994433 4555554433 23467778889999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|.+|-..+|+|.||||.|||+++..+ .+||||||.|.....+.. +...-+.-|.|||++.+-.|+...|+||.|
T Consensus 549 LklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvg 622 (752)
T KOG0670|consen 549 LKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVG 622 (752)
T ss_pred HHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeec
Confidence 99999999999999999999987764 799999999987754311 112235569999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHH
Q 004442 699 CILFFCITGGKHPYGESFERDANI 722 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~ 722 (753)
|+||||.||+-.+.+..+..+...
T Consensus 623 ctLYElYtGkIlFpG~TNN~MLrl 646 (752)
T KOG0670|consen 623 CTLYELYTGKILFPGRTNNQMLRL 646 (752)
T ss_pred eeeEEeeccceecCCCCcHHHHHH
Confidence 999999999666666666555443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=226.57 Aligned_cols=236 Identities=22% Similarity=0.379 Sum_probs=179.3
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeeccc-ccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~-~~~~~~~~LV~ 546 (753)
+.+.|.+.+.+|+|.||.+-++.. .....+|+|.+.... ..++.+|+.--.-...|.||+.-+++ +...+.+.+++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 346688889999999999998854 457899999987654 34667777655556679999988776 56678889999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |.+.|+|..-+. ..++.+....+++.|+++|+.|||+++
T Consensus 102 E----------~aP~gdL~snv~------------------------------~~GigE~~~K~v~~ql~SAi~fMHskn 141 (378)
T KOG1345|consen 102 E----------FAPRGDLRSNVE------------------------------AAGIGEANTKKVFAQLLSAIEFMHSKN 141 (378)
T ss_pred c----------cCccchhhhhcC------------------------------cccccHHHHHHHHHHHHHHHHHhhccc
Confidence 9 888898887543 245666677899999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC---C--CCchhhHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---R--QTRAIDLFSLGCIL 701 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~--~t~ksDIwSfGvvL 701 (753)
+||||||.+||||-..+...+||||||+.+........ ..-+..|.+||..... . ..+.+|||.||+++
T Consensus 142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~ 215 (378)
T KOG1345|consen 142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIF 215 (378)
T ss_pred hhhcccccceEEEecCCccEEEeeecccccccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeee
Confidence 99999999999996555568999999999876432211 1136679999977532 2 36889999999999
Q ss_pred HHHHhCCCCCCCCChH---HHHHHHH--cc-C---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE---RDANIVK--DR-K---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~---~~~~~i~--~~-~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.|+|| .+||....- +..+... .+ . +.....+++.+..+.++-|..+|+.|
T Consensus 216 f~cltG-~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 216 FYCLTG-KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eeeecC-CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 999999 889975421 1111111 11 1 22334568899999999999999887
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=217.70 Aligned_cols=234 Identities=21% Similarity=0.294 Sum_probs=178.3
Q ss_pred ceEEEeEEecccCceEEEEEE-eeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCC--ceEEEEEccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLERC 549 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~-~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~LV~E~c 549 (753)
+.|++.+.+|+|.|+.||.|. ..+++.++||.+++.......+|+..+.....||||+.|++...+. ....|++|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE-- 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE-- 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh--
Confidence 567788899999999999885 4568999999999887788888998554444599999999998875 44689999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+-++...- ..++-.++...+.+++.||.|+|+.||+|
T Consensus 116 --------~v~n~Dfk~ly--------------------------------~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 116 --------YVNNTDFKQLY--------------------------------PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred --------hhccccHHHHh--------------------------------hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 77666554432 23444567889999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||+||.|++|+.... .++|+|+|||.+..+..+. ..++.+..|--||.+..- .|+..-|+|||||++..|+..+
T Consensus 156 RDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccCCcceeeechhhc-eeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 999999999976543 6899999999999876543 233456678899988654 4799999999999999999987
Q ss_pred CCCCCCChH-HHHHHHH----------------------------ccCcc----c-----ccCCCHHHHHHHHHccccCc
Q 004442 709 KHPYGESFE-RDANIVK----------------------------DRKDL----F-----LVEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~----------------------------~~~~~----~-----~~~~s~el~dLI~~cL~~DP 750 (753)
.|+|.+... .+...+. ..... | ..-.++|+.||+.++|..|.
T Consensus 231 epFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 231 EPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred CcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 777755422 2211110 00000 0 01135899999999999998
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
.+|
T Consensus 311 qeR 313 (338)
T KOG0668|consen 311 QER 313 (338)
T ss_pred ccc
Confidence 877
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=246.89 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=188.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+...++|.....+|.|.||.|||+++.. ++..|||.++-.-.. ...+|+. +++.-+|+|||.++|-+-..+..++
T Consensus 11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~-~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIG-MLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccccccccee-eeecCCCcChHHHHhhhhhhcCcEE
Confidence 3445678889999999999999997764 899999998754322 2334554 6788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
+||||++ |+|.+.- .-..++.+.++...++...+||+|||+
T Consensus 90 cMEycgg----------gslQdiy-----------------------------~~TgplselqiayvcRetl~gl~ylhs 130 (829)
T KOG0576|consen 90 CMEYCGG----------GSLQDIY-----------------------------HVTGPLSELQIAYVCRETLQGLKYLHS 130 (829)
T ss_pred EEEecCC----------Cccccee-----------------------------eecccchhHHHHHHHhhhhccchhhhc
Confidence 9997764 4444432 223456667788999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccc---cCCCCCchhhHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l---~~~~~t~ksDIwSfGvvL 701 (753)
.+-+|||||-.|||++..|+ +|++|||.+..+... ..+...+.||+.|||||+. ..+.|..++|||+.|+..
T Consensus 131 ~gk~hRdiKGanilltd~gD--vklaDfgvsaqitat---i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitA 205 (829)
T KOG0576|consen 131 QGKIHRDIKGANILLTDEGD--VKLADFGVSAQITAT---IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITA 205 (829)
T ss_pred CCcccccccccceeecccCc--eeecccCchhhhhhh---hhhhhcccCCccccchhHHHHHhcccccccccccccccch
Confidence 99999999999999988877 999999998776542 3345667899999999976 456799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHccCcc-----cccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERDANIVKDRKDL-----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~~~~i~~~~~~-----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|+--.+.+-|+-...+....+...... -...+++-+-+|++.+|.++|++|
T Consensus 206 iel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkR 262 (829)
T KOG0576|consen 206 IELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKR 262 (829)
T ss_pred hhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccC
Confidence 9998875555666555554444332221 234578889999999999999998
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-23 Score=221.85 Aligned_cols=135 Identities=27% Similarity=0.354 Sum_probs=107.7
Q ss_pred ceec-ceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC--chHHHHHHHHHHHhC--------CCCceeeecccc
Q 004442 469 RRIG-KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH--HDVALKEIQNLIASD--------QHPNIVRWYGVE 536 (753)
Q Consensus 469 ~~i~-~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l--------~HpNIV~L~g~~ 536 (753)
+.+. .+|.+.+.||=|.|.+||++.+.. .+.||+|+.+..+ .+.++.||. +++.+ ....||+|++.|
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIk-lL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIK-LLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHH-HHHHHHhcCCCCCCCceeeeeeccc
Confidence 4444 778899999999999999997654 6899999998754 456778887 44433 234799999998
Q ss_pred cC----CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHH
Q 004442 537 SD----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612 (753)
Q Consensus 537 ~~----~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia 612 (753)
.. ..+++||+|+.+.+|..+| .. ..-++++...+.+|+
T Consensus 152 khsGpNG~HVCMVfEvLGdnLLklI-----------~~---------------------------s~YrGlpl~~VK~I~ 193 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLGDNLLKLI-----------KY---------------------------SNYRGLPLSCVKEIC 193 (590)
T ss_pred eecCCCCcEEEEEehhhhhHHHHHH-----------HH---------------------------hCCCCCcHHHHHHHH
Confidence 75 4578999997777766665 11 234789999999999
Q ss_pred HHHHHHHHHhhhC-CccccCCCCCcEEEecC
Q 004442 613 RDIVSGLSHLHEI-GLIHRDLKPQNVLISKD 642 (753)
Q Consensus 613 ~qIa~gL~yLH~~-~IiHrDLKp~NILL~~d 642 (753)
+||+.||.|||.+ ||||-||||+||||..+
T Consensus 194 ~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 194 RQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred HHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 9999999999976 99999999999999644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=260.56 Aligned_cols=192 Identities=19% Similarity=0.229 Sum_probs=133.7
Q ss_pred HhCCC-Cceeeecccc-------cCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccch
Q 004442 522 ASDQH-PNIVRWYGVE-------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593 (753)
Q Consensus 522 ~~l~H-pNIV~L~g~~-------~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 593 (753)
+.++| +||++++++| .+.+.+++++| |+ .++|.++|+..
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e----------~~-~~~L~~~l~~~---------------------- 73 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALE----------CE-DVSLRQWLDNP---------------------- 73 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhc----------cC-CccHHHHHhcc----------------------
Confidence 34455 5888888887 33345677788 43 44667766421
Q ss_pred hhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecC-----------------CCCeEEEEeccCce
Q 004442 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD-----------------KSFCAKLSDMGISK 656 (753)
Q Consensus 594 ~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d-----------------~~~~~KLsDFGla~ 656 (753)
...+++.+++.++.||++||.|||+++|+||||||+||||+.. ....+|++|||+++
T Consensus 74 ------~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~ 147 (793)
T PLN00181 74 ------DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSR 147 (793)
T ss_pred ------cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccc
Confidence 2347888999999999999999999999999999999999642 23357788888876
Q ss_pred eccCCCc-------------ccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004442 657 RLQGDMS-------------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723 (753)
Q Consensus 657 ~~~~~~~-------------~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i 723 (753)
....... ........+||+.|||||++.+..++.++|||||||+||||++| .+|+...........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~-~~~~~~~~~~~~~~~ 226 (793)
T PLN00181 148 REEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP-VSSREEKSRTMSSLR 226 (793)
T ss_pred ccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC-CCchhhHHHHHHHHH
Confidence 5321000 00011124589999999999999999999999999999999997 566654322222221
Q ss_pred HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 724 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 724 ~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
....++......++..+++.+||++||.+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~L~~~P~~R 256 (793)
T PLN00181 227 HRVLPPQILLNWPKEASFCLWLLHPEPSCR 256 (793)
T ss_pred HhhcChhhhhcCHHHHHHHHHhCCCChhhC
Confidence 111122222235677899999999999998
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-23 Score=219.75 Aligned_cols=202 Identities=28% Similarity=0.429 Sum_probs=156.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCC-chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+.+.|...+.||+|+|++||++.+. ..+.||+|.+.... ......|++.+-....|.||+++.++...++...
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 455566788899999999999998554 47899999996554 4556677774445567999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|+| |++.-...+++. .++..++..+++.+..||.|+|
T Consensus 112 ivlp----------~~~H~~f~~l~~--------------------------------~l~~~~i~~Yl~~ll~Al~~~h 149 (418)
T KOG1167|consen 112 IVLP----------YFEHDRFRDLYR--------------------------------SLSLAEIRWYLRNLLKALAHLH 149 (418)
T ss_pred EEec----------ccCccCHHHHHh--------------------------------cCCHHHHHHHHHHHHHHhhhhh
Confidence 9999 766666666543 3556788899999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC-----------------------------------------
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM----------------------------------------- 662 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~----------------------------------------- 662 (753)
.+|||||||||+|+|.+.... .-.|.|||||.......
T Consensus 150 ~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~ 228 (418)
T KOG1167|consen 150 KNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCND 228 (418)
T ss_pred ccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCC
Confidence 999999999999999976543 35699999997321000
Q ss_pred cccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 004442 663 SCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG 713 (753)
Q Consensus 663 ~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllTG~~~Pf~ 713 (753)
..........||+||.|||++.. ...+.++||||.||+++.+++++.|+|.
T Consensus 229 ~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 229 GRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred CccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccccccc
Confidence 00011123459999999999865 4579999999999999999998655553
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=194.56 Aligned_cols=134 Identities=22% Similarity=0.221 Sum_probs=103.9
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccc
Q 004442 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (753)
Q Consensus 601 ~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP 680 (753)
..+++.+++.|+.||+.||.|||+.+ ||+|||++.++. +|+ ||+++..... ...||+.||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~--------~~~g~~~y~aP 73 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE--------QSRVDPYFMAP 73 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc--------cCCCcccccCh
Confidence 45899999999999999999999988 999999976654 777 9999876432 12589999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHccCcc-------cccCCCH--HHHHHHHHccccC
Q 004442 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKDL-------FLVEHIP--EAVDLFTRLLDPN 749 (753)
Q Consensus 681 E~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~--~~~~~i~~~~~~-------~~~~~s~--el~dLI~~cL~~D 749 (753)
|++.+..++.++|||||||++|||+|| .+||..... .....+...... .+...++ ++.++|.+||+.|
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 152 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDY-ELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRL 152 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhC-CCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcc
Confidence 999999999999999999999999999 567754322 222222211111 1222333 6899999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 153 p~~R 156 (176)
T smart00750 153 PQRR 156 (176)
T ss_pred cccc
Confidence 9998
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-20 Score=191.99 Aligned_cols=238 Identities=33% Similarity=0.501 Sum_probs=178.3
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCC-ceeeecccccCCceEEEEEc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHP-NIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~Hp-NIV~L~g~~~~~~~~~LV~E 547 (753)
|.+.+.||.|+||.||++... ..+|+|.+..... ..+.+|.. +++.+.|+ ||+++.+++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQ-ILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHH-HHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566788999999999998776 8899999865432 23444544 77888888 79999999977777899999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+..++++.+++..... . ..+.......++.+++.++.|+|+.++
T Consensus 79 ----------~~~~~~l~~~~~~~~~------------------------~--~~~~~~~~~~~~~~~~~~l~~~H~~~~ 122 (384)
T COG0515 79 ----------YVDGGSLEDLLKKIGR------------------------K--GPLSESEALFILAQILSALEYLHSKGI 122 (384)
T ss_pred ----------cCCCCcHHHHHHhccc------------------------c--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6667777754432210 0 256777889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc---cCccCCCCccccccccccC---CCCCchhhHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT---QNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 701 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~---~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL 701 (753)
+|||+||+||+++..+. .++++|||.++.......... ......||..|+|||.+.+ ..+....|+||+|+++
T Consensus 123 ~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 123 IHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999976652 489999999986654332221 2355679999999999988 5789999999999999
Q ss_pred HHHHhCCCCCCCCChH-----HHHHHHHccCcc-cccCCC--------HHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-----RDANIVKDRKDL-FLVEHI--------PEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-----~~~~~i~~~~~~-~~~~~s--------~el~dLI~~cL~~DP~~R 753 (753)
+++++| ..||..... .....+...... ...... ..+.+++.+|+..+|..|
T Consensus 202 ~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 266 (384)
T COG0515 202 YELLTG-LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266 (384)
T ss_pred HHHHhC-CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhc
Confidence 999998 556665532 333333322222 111111 478899999999999876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.8e-21 Score=208.54 Aligned_cols=166 Identities=19% Similarity=0.142 Sum_probs=121.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee--CCcEEEEEEeecCC-------chH-HHHHHHHHHHhCCCCceee-eccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH-------HDV-ALKEIQNLIASDQHPNIVR-WYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~--~g~~VAVK~l~~~~-------~~~-~~~Ei~~ll~~l~HpNIV~-L~g~~~ 537 (753)
+.+...|.+.+.||+|+||+||+|... +++.||||++.... ... +.+|+ ++++.++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~-~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREI-RALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHH-HHHHhccCCCCCcEEEEc--
Confidence 445677899999999999999999664 57888999875321 122 34454 4889999999984 5443
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+..||||| |+++++|... ... . ...++.++++
T Consensus 91 --~~~~LVmE----------~~~G~~L~~~-~~~-----------------------------~------~~~~~~~i~~ 122 (365)
T PRK09188 91 --GKDGLVRG----------WTEGVPLHLA-RPH-----------------------------G------DPAWFRSAHR 122 (365)
T ss_pred --CCcEEEEE----------ccCCCCHHHh-Ccc-----------------------------c------hHHHHHHHHH
Confidence 45799999 6666666521 000 0 1356789999
Q ss_pred HHHHhhhCCccccCC-CCCcEEEecCCCCeEEEEeccCceeccCCCcccc-----cCccCCCCccccccccccCCC
Q 004442 618 GLSHLHEIGLIHRDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-----QNATGYGSSGWQAPEQLLQGR 687 (753)
Q Consensus 618 gL~yLH~~~IiHrDL-Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~-----~~~~~~GT~~Y~APE~l~~~~ 687 (753)
||.|||+.||+|||| ||+|||++.++. +||+|||+|+.+........ .....++++.|+|||.+...+
T Consensus 123 aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 123 ALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred HHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999999999999 999999976654 99999999998754321111 113456889999999886543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-19 Score=195.08 Aligned_cols=202 Identities=24% Similarity=0.293 Sum_probs=156.2
Q ss_pred eEEEeEEecccCceEEEEEEeeCC--cEEEEEEeecCCc---hHHHHHHHHHHHhCC----CCceeeecccc-cCCceEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYEG--RSVAVKRLVKTHH---DVALKEIQNLIASDQ----HPNIVRWYGVE-SDQDFVY 543 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~g--~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~----HpNIV~L~g~~-~~~~~~~ 543 (753)
.|.+.+.||+|+||.||++..... ..+|+|.-..... .....|.. ++..+. -+++.++++.. ..+++.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~-vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQ-VLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHH-HHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 789999999999999999977664 4888888765321 13444554 334433 25888888888 5788999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||+.++.+|.++.-. ...+.++..+.++|+.|++.+|++||
T Consensus 98 iVM~l~G~sL~dl~~~--------------------------------------~~~~~fs~~T~l~ia~q~l~~l~~lH 139 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKR--------------------------------------NPPGRFSRKTVLRIAIQNLNALEDLH 139 (322)
T ss_pred EEEeccCccHHHHHHh--------------------------------------CCCCCcCHhHHHHHHHHHHHHHHHHH
Confidence 9999888888776511 11245777889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCC-C--CeEEEEeccCce--eccCCCcc----ccc-CccCCCCccccccccccCCCCCchhh
Q 004442 624 EIGLIHRDLKPQNVLISKDK-S--FCAKLSDMGISK--RLQGDMSC----LTQ-NATGYGSSGWQAPEQLLQGRQTRAID 693 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~-~--~~~KLsDFGla~--~~~~~~~~----~~~-~~~~~GT~~Y~APE~l~~~~~t~ksD 693 (753)
+.|++||||||.|+++.... . ..+.|.|||+++ ........ ... .....||..|+++++..+...+++.|
T Consensus 140 ~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DD 219 (322)
T KOG1164|consen 140 SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDD 219 (322)
T ss_pred hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchh
Confidence 99999999999999997653 1 468999999999 43222111 111 22345999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~ 715 (753)
+||++.++.|++.| ..||...
T Consensus 220 les~~Y~l~el~~g-~LPW~~~ 240 (322)
T KOG1164|consen 220 LESLFYMLLELLKG-SLPWEAL 240 (322)
T ss_pred hhhHHHHHHHHhcC-CCCCccc
Confidence 99999999999998 5899654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=181.23 Aligned_cols=207 Identities=22% Similarity=0.284 Sum_probs=163.0
Q ss_pred ceecceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC-chHHHHHHHHHHHhCCC-CceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~H-pNIV~L~g~~~~~~~~~LV 545 (753)
...+..|.+.+.||.|+||.+|.| ...+|..||||.-+... +.+...|-. +-..++| ..|..+..|..+.++..||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEsk-vY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESK-VYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHH-HHHHhccCCCCchhhhhccccccceee
Confidence 445677999999999999999998 45679999999875543 233344433 4455554 5688888899999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||+.+.+|.+++-+ -.+.++.++++-+|-|++.-++|+|.+
T Consensus 90 MdLLGPsLEdLfnf---------------------------------------C~R~ftmkTvLMLaDQml~RiEyvH~r 130 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNF---------------------------------------CSRRFTMKTVLMLADQMLSRIEYVHLR 130 (341)
T ss_pred eeccCccHHHHHHH---------------------------------------HhhhhhHHhHHHHHHHHHHHHHHHHhh
Confidence 99887777776622 234577788899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCC-eEEEEeccCceeccCCCc----ccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSF-CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~-~~KLsDFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
++|||||||+|.|..-+..+ .+.++|||||+.+.+... .........||.+|.+-....+...++..|+=|+|.+
T Consensus 131 ~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYv 210 (341)
T KOG1163|consen 131 NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYV 210 (341)
T ss_pred ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcce
Confidence 99999999999999655443 588999999998754321 1222334469999999888888888999999999999
Q ss_pred HHHHHhCCCCCCCCCh
Q 004442 701 LFFCITGGKHPYGESF 716 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~ 716 (753)
|.++--| ..||.+..
T Consensus 211 LmYfnrG-~LPWQglk 225 (341)
T KOG1163|consen 211 LMYFNRG-SLPWQGLK 225 (341)
T ss_pred eeeeecC-CCcccccc
Confidence 9998887 88998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=185.60 Aligned_cols=205 Identities=21% Similarity=0.314 Sum_probs=165.1
Q ss_pred eecceEEEeEEecccCceEEEEE-EeeCCcEEEEEEeecCC-chHHHHHHHHHHHh-CCCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-HDVALKEIQNLIAS-DQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~-l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++-.|.+.+.||+|+||..+.| .+.++++||||.-.... ..+...|.. .-+. ...++|...+-+..+..+..||+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr-~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYR-TYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHH-HHHHHcCCCCCCceeeeccccchhhhhh
Confidence 45667899999999999999998 45789999999764333 233333443 3333 35688988888878888899999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|+.+-+|.|++ .|-.+.++.+.+..||.|+..-++|+|++.
T Consensus 104 dLLGPSLEDLF---------------------------------------D~CgR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 104 DLLGPSLEDLF---------------------------------------DLCGRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred hhhCcCHHHHH---------------------------------------HHhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 98877777765 177889999999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCC---CeEEEEeccCceeccCCCc----ccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~---~~~KLsDFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
+|+|||||+|+||..-++ -.+.|+|||+|+.+.+... .........||.+||+-....++..++.-|+=|+|-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 999999999999964332 3689999999998865322 122334456999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC
Q 004442 700 ILFFCITGGKHPYGES 715 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~ 715 (753)
|+.+.+-| ..||.+.
T Consensus 225 vFmYFLRG-sLPWQGL 239 (449)
T KOG1165|consen 225 VFMYFLRG-SLPWQGL 239 (449)
T ss_pred hhhhhccC-CCccccc
Confidence 99999998 8899764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-19 Score=188.66 Aligned_cols=189 Identities=21% Similarity=0.308 Sum_probs=137.8
Q ss_pred CCCCceeeecccccC---------------------------CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccc
Q 004442 524 DQHPNIVRWYGVESD---------------------------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 576 (753)
Q Consensus 524 l~HpNIV~L~g~~~~---------------------------~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~ 576 (753)
-+|||||++.+++.+ ...+|+||.++.++|..|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl------------------- 333 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYL------------------- 333 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHH-------------------
Confidence 469999999987532 3457899998887776666
Q ss_pred hhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEe--cCCCCeEEEEeccC
Q 004442 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGI 654 (753)
Q Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~--~d~~~~~KLsDFGl 654 (753)
|. +..+.....-|+.|+++|+.|||++||.|||+|++|||+. +|+...+.|+|||+
T Consensus 334 ---------------------~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 334 ---------------------WT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred ---------------------hc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 22 2233344567889999999999999999999999999994 44555788999998
Q ss_pred ceeccCC---CcccccCccCCCCccccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHH
Q 004442 655 SKRLQGD---MSCLTQNATGYGSSGWQAPEQLLQGR------QTRAIDLFSLGCILFFCITGGKHPYGES--FERDANIV 723 (753)
Q Consensus 655 a~~~~~~---~~~~~~~~~~~GT~~Y~APE~l~~~~------~t~ksDIwSfGvvL~EllTG~~~Pf~~~--~~~~~~~i 723 (753)
+-.-... ....+.....-|...-||||+....+ ...|+|.|+.|.+.||+++...|+|... .-......
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq 471 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ 471 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh
Confidence 7543221 01111222233667789999875432 2469999999999999998766555422 11222344
Q ss_pred HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 724 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 724 ~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
....+..+...++.+++++..+|+.||.+|
T Consensus 472 e~qLPalp~~vpp~~rqlV~~lL~r~pskR 501 (598)
T KOG4158|consen 472 ESQLPALPSRVPPVARQLVFDLLKRDPSKR 501 (598)
T ss_pred hhhCCCCcccCChHHHHHHHHHhcCCcccc
Confidence 566778889999999999999999999998
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.7e-20 Score=185.17 Aligned_cols=225 Identities=20% Similarity=0.273 Sum_probs=170.4
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCCh
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L 553 (753)
.-.|.+...|..|+|+ +.|..+++|++.-.+ ..+.|+|+.-.++...||||+..+|.|.......++..
T Consensus 195 ~tkl~e~hsgelwrgr-wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq------ 267 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGR-WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ------ 267 (448)
T ss_pred hhhhccCCCccccccc-ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee------
Confidence 3457788889999754 467778888885332 23445555556788899999999999999999999999
Q ss_pred hhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-C-ccccC
Q 004442 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G-LIHRD 631 (753)
Q Consensus 554 ~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~-~-IiHrD 631 (753)
||+.|+|++.||+... --.+..+..+++.+||+|++|||+. . |.---
T Consensus 268 ----~mp~gslynvlhe~t~---------------------------vvvd~sqav~faldiargmaflhslep~ipr~~ 316 (448)
T KOG0195|consen 268 ----YMPFGSLYNVLHEQTS---------------------------VVVDHSQAVRFALDIARGMAFLHSLEPMIPRFY 316 (448)
T ss_pred ----eccchHHHHHHhcCcc---------------------------EEEecchHHHHHHHHHhhHHHHhhcchhhhhhh
Confidence 9999999999987532 1234567899999999999999987 3 44456
Q ss_pred CCCCcEEEecCCCCeEEEE--eccCceeccCCCcccccCccCCCCccccccccccCCCC---CchhhHHHHHHHHHHHHh
Q 004442 632 LKPQNVLISKDKSFCAKLS--DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLs--DFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~---t~ksDIwSfGvvL~EllT 706 (753)
|.+..+++++| ++++|+ |--++... ....-.+.||+||.+..++- -+++|+|||+++|||+.|
T Consensus 317 lns~hvmided--ltarismad~kfsfqe----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t 384 (448)
T KOG0195|consen 317 LNSKHVMIDED--LTARISMADTKFSFQE----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT 384 (448)
T ss_pred cccceEEecch--hhhheecccceeeeec----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence 88999999666 445553 43222211 11223789999999987664 468999999999999999
Q ss_pred CCCCCCCCChHHHHH---HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERDAN---IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~~~---~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
. ..||.+-..-... .........|+..++....||+-|++.||.+|
T Consensus 385 r-evpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkr 433 (448)
T KOG0195|consen 385 R-EVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKR 433 (448)
T ss_pred c-ccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcC
Confidence 5 8899876544332 23344566888999999999999999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.1e-20 Score=206.82 Aligned_cols=219 Identities=27% Similarity=0.386 Sum_probs=177.0
Q ss_pred ecccCceEEEEE----EeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCceeeecccccCCceEEEEEccccC
Q 004442 481 IAKGSNGTVVLE----GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 481 IG~G~fG~Vyka----~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+|+|+||.|++. +...|..+|.|.+++... ....+.+..++...+ |+.+|++.-.+..+...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld---- 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD---- 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh----
Confidence 799999999974 334578899998865421 112222233556666 9999999988888999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|..+|.|...+... ..+.+.........+|-+++++|+.+|+|||
T Consensus 78 ------~~rgg~lft~l~~~-----------------------------~~f~~~~~~~~~aelaLald~lh~l~iiyrd 122 (612)
T KOG0603|consen 78 ------FLRGGDLFTRLSKE-----------------------------VMFDELDVAFYLAELALALDHLHKLGIAYRD 122 (612)
T ss_pred ------hcccchhhhccccC-----------------------------CchHHHHHHHHHHHHHHHHhhcchhHHHHhc
Confidence 99999998877543 2344555677888999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
+|++||+++.+|+ +++.|||+++...... ..|||..|||||++. .+...+|.||||++++||+|| ..|
T Consensus 123 ~k~enilld~~Gh--i~~tdfglske~v~~~-------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg-~~p 190 (612)
T KOG0603|consen 123 YKLENVLLLLEGH--IKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG-TLP 190 (612)
T ss_pred ccccceeecccCc--cccCCchhhhHhHhhh-------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC-CCC
Confidence 9999999988776 8999999998764321 228999999999987 677889999999999999998 778
Q ss_pred CCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.. .....+...+..+|.+.+.++++++..++..+|.+|
T Consensus 191 f~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 191 FGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred Cch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 876 455566666888999999999999999999999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.6e-19 Score=206.42 Aligned_cols=234 Identities=22% Similarity=0.319 Sum_probs=166.5
Q ss_pred EeEEecccCceEEEEEEee-CCcEEEEEEee----cCCchHH----HHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 477 FNKEIAKGSNGTVVLEGNY-EGRSVAVKRLV----KTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~----~~~~~~~----~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
..+.+|.|++|.|+..... ..+..+.|.+. ....+.. +.++..+-..+.|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4577999999977765433 34445555433 2222211 1122224456899999999998888777777799
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
||+ + +|+.++-.. ..+...++..++.|+..|+.|||+.||
T Consensus 402 ~~~----------~-Dlf~~~~~~-----------------------------~~~~~~e~~c~fKqL~~Gv~y~h~~Gi 441 (601)
T KOG0590|consen 402 YCP----------Y-DLFSLVMSN-----------------------------GKLTPLEADCFFKQLLRGVKYLHSMGL 441 (601)
T ss_pred ccc----------H-HHHHHHhcc-----------------------------cccchhhhhHHHHHHHHHHHHHHhcCc
Confidence 655 4 455444221 234455678899999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~Ell 705 (753)
.|||||++|++++.++. +||+|||.+....-..+. .......+|+..|+|||++.+..| .+..||||.|+++..|+
T Consensus 442 ahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~ 519 (601)
T KOG0590|consen 442 AHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMI 519 (601)
T ss_pred eeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEe
Confidence 99999999999988874 999999999877654432 233455679999999999999998 56899999999999999
Q ss_pred hCCCCCCCCChHHHHH----------HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDAN----------IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~----------~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| +.||.-....+.. .+..+........+.+.+.+|.+||+.||++|
T Consensus 520 ~~-~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R 576 (601)
T KOG0590|consen 520 LG-RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKR 576 (601)
T ss_pred cC-CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhe
Confidence 98 7788543222111 11112222334456678899999999999998
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.6e-18 Score=168.71 Aligned_cols=138 Identities=18% Similarity=0.135 Sum_probs=99.4
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCCch----------------------------HH-HHHHHHHHHhCCCCc
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----------------------------VA-LKEIQNLIASDQHPN 528 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~----------------------------~~-~~Ei~~ll~~l~HpN 528 (753)
...||+|++|.||+|...+|+.||||++...... .. .+|. ..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF-RNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH-HHHHHHHhCC
Confidence 3579999999999998878999999998754210 01 1233 3667788888
Q ss_pred eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHH
Q 004442 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608 (753)
Q Consensus 529 IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 608 (753)
|.....+... ..+||||||+ ++++.... .....++..+.
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~----------g~~~~~~~-----------------------------l~~~~~~~~~~ 119 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIG----------DDGSPAPR-----------------------------LKDVPLEEEEA 119 (190)
T ss_pred CCCceEEEec--CCEEEEEEec----------CCCchhhh-----------------------------hhhccCCHHHH
Confidence 7544333332 2489999554 43322211 01123556678
Q ss_pred HHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceeccC
Q 004442 609 LKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (753)
Q Consensus 609 l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~ 660 (753)
.+++.+++.+|.+||+ .||+||||||.||+++ ++ .++|+|||+++....
T Consensus 120 ~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~~~liDFG~a~~~~~ 169 (190)
T cd05145 120 EELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--KPYIIDVSQAVELDH 169 (190)
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--CEEEEEcccceecCC
Confidence 9999999999999999 9999999999999997 44 499999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-18 Score=171.46 Aligned_cols=135 Identities=17% Similarity=0.106 Sum_probs=95.9
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCc---h---------H-----------------HHHHHHHHHHhCCCCce
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---D---------V-----------------ALKEIQNLIASDQHPNI 529 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~---~---------~-----------------~~~Ei~~ll~~l~HpNI 529 (753)
..||+|+||.||+|...+|+.||||+++.... . . ..+|.. .+..+.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR-NLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH-HHHHHHHCCC
Confidence 56999999999999888899999999965321 0 0 012443 5666666665
Q ss_pred eeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHH
Q 004442 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (753)
Q Consensus 530 V~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 609 (753)
.....+.. ...+||||||+ ++++..... ....+++.++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~----------g~~l~~~~~-----------------------------~~~~~~~~~~~ 120 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIG----------DDGWAAPRL-----------------------------KDAPLSESKAR 120 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeC----------CCCCcchhh-----------------------------hcCCCCHHHHH
Confidence 33222211 22389999554 443332211 12356778889
Q ss_pred HHHHHHHHHHHHh-hhCCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 610 KVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 610 ~Ia~qIa~gL~yL-H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
+++.|++.+|.|| |+.||+||||||+||+++. + .++|+|||+|...
T Consensus 121 ~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~LiDFG~a~~~ 167 (190)
T cd05147 121 ELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLYIIDVSQSVEH 167 (190)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEEEEEccccccC
Confidence 9999999999999 6899999999999999973 3 4899999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.4e-18 Score=175.75 Aligned_cols=171 Identities=12% Similarity=0.088 Sum_probs=124.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHH---------HHHHHHHHHhCCCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVA---------LKEIQNLIASDQHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~---------~~Ei~~ll~~l~HpNIV~L~g~~~ 537 (753)
+.+..+|...+.+|.|+||.||++.. ++..+|||.+.+.. .+.+ +..+...+.+++|++|.....++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 44567899999999999999999655 67789999996543 1221 233334678889999999988855
Q ss_pred CC--------ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHH
Q 004442 538 DQ--------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (753)
Q Consensus 538 ~~--------~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 609 (753)
.. ...+|+|| |+++.+|.++.. ++ .
T Consensus 106 ~~~~~~~~~~~~~~lvmE----------yi~G~tL~~~~~---------------------------------~~----~ 138 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIE----------YIEGVELNDMPE---------------------------------IS----E 138 (232)
T ss_pred ecccccccccCCeEEEEE----------EECCccHHHhhh---------------------------------cc----H
Confidence 33 35899999 555555554421 01 1
Q ss_pred HHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCC
Q 004442 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 689 (753)
Q Consensus 610 ~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t 689 (753)
....+++.+|..||+.|++|||++|+||+++.++ ++|+|||..+........ ...+....+.
T Consensus 139 ~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~---------------d~~vler~y~ 200 (232)
T PRK10359 139 DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK---------------DRIDLERHYG 200 (232)
T ss_pred HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH---------------HHHHHHhHhc
Confidence 2355899999999999999999999999998776 899999988755322110 1134556677
Q ss_pred chhhHHHHHHHHHHHH
Q 004442 690 RAIDLFSLGCILFFCI 705 (753)
Q Consensus 690 ~ksDIwSfGvvL~Ell 705 (753)
.++|+|+||+.+.-+.
T Consensus 201 ~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 201 IKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccccceeEeehHHH
Confidence 8999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.72 E-value=6e-17 Score=171.32 Aligned_cols=236 Identities=26% Similarity=0.284 Sum_probs=143.3
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCC----------------Ccee
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH-----DVALKEIQNLIASDQH----------------PNIV 530 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~H----------------pNIV 530 (753)
..+...+.||.|+++.||.+.+.. |+.+|||.+..... -+.++|..-.+..+.+ --++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345677899999999999987755 89999999853321 1223333211122111 1122
Q ss_pred eeccc---cc---CCc-----eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhh
Q 004442 531 RWYGV---ES---DQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599 (753)
Q Consensus 531 ~L~g~---~~---~~~-----~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (753)
++-+- .. +.. ..+++|+...++|.+++ ..|......
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~--------~~l~~~~~~------------------------- 138 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLV--------EALFSRAQT------------------------- 138 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHH--------HHHHHHTTT-------------------------
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHH--------HHHhhcccc-------------------------
Confidence 22221 00 011 23778887777765554 222222111
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccc
Q 004442 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 679 (753)
Q Consensus 600 ~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~A 679 (753)
...+....++.+..|+.+.+++||..|++|+||+|+|++++++|. ++|+||+........... ...+..|.+
T Consensus 139 ~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~------~~~~~~~~P 210 (288)
T PF14531_consen 139 HSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC------SEFPVAFTP 210 (288)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEEG------GGS-TTTS-
T ss_pred cchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceeec------cCCCcccCC
Confidence 001122344778899999999999999999999999999988876 899999987765432111 224678999
Q ss_pred cccccCC--------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcC
Q 004442 680 PEQLLQG--------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 680 PE~l~~~--------~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
||..... .++.+.|.|+||++||.|.++ ..||+.......... ......++++.+++||..+|+.||.
T Consensus 211 Pe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~-~lPf~~~~~~~~~~~---~f~~C~~~Pe~v~~LI~~lL~~~~~ 286 (288)
T PF14531_consen 211 PELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG-RLPFGLSSPEADPEW---DFSRCRDMPEPVQFLIRGLLQRNPE 286 (288)
T ss_dssp HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS-S-STCCCGGGSTSGG---GGTTSS---HHHHHHHHHHT-SSGG
T ss_pred hhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc-cCCCCCCCccccccc---cchhcCCcCHHHHHHHHHHccCCcc
Confidence 9977442 468999999999999999998 789986533321110 1122336788999999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 287 ~R 288 (288)
T PF14531_consen 287 DR 288 (288)
T ss_dssp GS
T ss_pred cC
Confidence 98
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=193.61 Aligned_cols=199 Identities=23% Similarity=0.238 Sum_probs=157.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCC---CCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~---HpNIV~L~g~~~~~~~~~LV 545 (753)
..-+..|.+.+.||+|+||+||+|...+|+.||+|.=+....-++.--.+ ++.+++ -+-|..+...+.-.+.-+||
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q-~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQ-VMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHH-HHHhhchhhhcchHHHHHHHccCCcceee
Confidence 34456788999999999999999988889999999987765433222111 233333 24456666666778889999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
+| |.+.|+|.++++. ...++|..++.++.|+++.+++||..
T Consensus 773 ~e----------y~~~Gtlld~~N~-----------------------------~~~m~e~lv~~~~~qml~ive~lH~~ 813 (974)
T KOG1166|consen 773 SE----------YSPYGTLLDLINT-----------------------------NKVMDEYLVMFFSCQMLRIVEHLHAM 813 (974)
T ss_pred ee----------ccccccHHHhhcc-----------------------------CCCCCchhhhHHHHHHHHHHHHHHhc
Confidence 99 8899999998862 24577788899999999999999999
Q ss_pred CccccCCCCCcEEEec-----CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISK-----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~-----d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
+|||+||||+|.||.. .+...++|+|||.+-.+.--. ........++|-.+-.+|...++.++.+.|.|.|+.+
T Consensus 814 ~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp-~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~ 892 (974)
T KOG1166|consen 814 GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP-DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAAT 892 (974)
T ss_pred ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC-CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHH
Confidence 9999999999999953 234569999999987664211 1133445568999999999999999999999999999
Q ss_pred HHHHHhCC
Q 004442 701 LFFCITGG 708 (753)
Q Consensus 701 L~EllTG~ 708 (753)
++-|+.|+
T Consensus 893 ~h~mLFG~ 900 (974)
T KOG1166|consen 893 VHVMLFGK 900 (974)
T ss_pred HHHHHHHH
Confidence 99999994
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.1e-18 Score=196.35 Aligned_cols=232 Identities=22% Similarity=0.268 Sum_probs=159.4
Q ss_pred eEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.+...+.||.+.|-+|.++...+|. |+||++.+... .+.++|+. ....+|||.+++.-+-..++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 4567788999999999999888887 99999966542 23344443 56789999999888766677777777
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
+ |+. -+|+|.|..+. =+..-+...|+.|++.||.-+|+.|
T Consensus 101 q----------yvk-hnLyDRlSTRP-----------------------------FL~~iEKkWiaFQLL~al~qcH~~g 140 (1431)
T KOG1240|consen 101 Q----------YVK-HNLYDRLSTRP-----------------------------FLVLIEKKWIAFQLLKALSQCHKLG 140 (1431)
T ss_pred H----------HHh-hhhhhhhccch-----------------------------HHHHHHHHHHHHHHHHHHHHHHHcC
Confidence 7 332 35666554321 1223455789999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceec--cCC-Ccc-cccCccCCCCccccccccccCC----------C-CCch
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRL--QGD-MSC-LTQNATGYGSSGWQAPEQLLQG----------R-QTRA 691 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~--~~~-~~~-~~~~~~~~GT~~Y~APE~l~~~----------~-~t~k 691 (753)
|+|+|||.+||||+.-. + +.|+||.--+.. .++ ... .-...+......|+|||.+... . .+++
T Consensus 141 VcHGDIKsENILiTSWN-W-~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~pa 218 (1431)
T KOG1240|consen 141 VCHGDIKSENILITSWN-W-LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPA 218 (1431)
T ss_pred ccccccccceEEEeeec-h-hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChh
Confidence 99999999999998764 3 689999754432 111 100 0011112234579999987541 1 5789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcc----cccCC-CHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL----FLVEH-IPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~----~~~~~-s~el~dLI~~cL~~DP~~R 753 (753)
-||||+||++.||++-+.|+|.-+.--.. +.+... ..+.+ ...+++||..|++.||++|
T Consensus 219 MDIFS~GCViaELf~Eg~PlF~LSQL~aY---r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~R 282 (1431)
T KOG1240|consen 219 MDIFSAGCVIAELFLEGRPLFTLSQLLAY---RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKR 282 (1431)
T ss_pred hhhhhhhHHHHHHHhcCCCcccHHHHHhH---hccCccCHHHHHHhCcCccHHHHHHHHHccCchhc
Confidence 99999999999999988889854311111 011000 01111 3478999999999999998
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=160.47 Aligned_cols=184 Identities=18% Similarity=0.158 Sum_probs=130.6
Q ss_pred EeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--h-----HHHHHHHHHHHhCC-CCceeeecccccCCceEEEEEcc
Q 004442 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--D-----VALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~-----~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
....|++|+||+||.+.. .+..++.+.+..... . .+.+|+. +++.++ |++|++++++ +..+++||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~-iL~~L~~~~~vP~ll~~----~~~~lvme- 78 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREAL-ALRQLDGLPRTPRLLHW----DGRHLDRS- 78 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHH-HHHhcCCCCCCCEEEEE----cCEEEEEe-
Confidence 346799999999998766 788888888765432 1 2345655 667774 5889999886 34699999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+++|.+.+.. ....++.+++++|.++|+.||+
T Consensus 79 ---------yI~G~~L~~~~~~------------------------------------~~~~~~~qi~~~L~~lH~~GIv 113 (218)
T PRK12274 79 ---------YLAGAAMYQRPPR------------------------------------GDLAYFRAARRLLQQLHRCGVA 113 (218)
T ss_pred ---------eecCccHHhhhhh------------------------------------hhHHHHHHHHHHHHHHHHCcCc
Confidence 6666666543210 0134678999999999999999
Q ss_pred ccCC-CCCcEEEecCCCCeEEEEeccCceeccCCCcc---cc-------cCccCCCCccccccccccC--CCCCchhhHH
Q 004442 629 HRDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC---LT-------QNATGYGSSGWQAPEQLLQ--GRQTRAIDLF 695 (753)
Q Consensus 629 HrDL-Kp~NILL~~d~~~~~KLsDFGla~~~~~~~~~---~~-------~~~~~~GT~~Y~APE~l~~--~~~t~ksDIw 695 (753)
|||| ||.|||++.++. ++|+|||+|........- .. .......++.|++|+...- ...-...+.+
T Consensus 114 HrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 114 HNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred cCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 9999 799999987765 999999999865432210 00 0011225778888875432 2223678999
Q ss_pred HHHHHHHHHHhCCCCCCCC
Q 004442 696 SLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~ 714 (753)
+-|+-+|.++|++-+.|++
T Consensus 192 ~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HhcchHHHHHhccCCcccc
Confidence 9999999999996665654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6e-16 Score=158.00 Aligned_cols=135 Identities=16% Similarity=0.189 Sum_probs=96.4
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecC---CchHHHHHHHHHHHhC-----CCCceeeecccccCCc---eEE-EEE
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT---HHDVALKEIQNLIASD-----QHPNIVRWYGVESDQD---FVY-LSL 546 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~---~~~~~~~Ei~~ll~~l-----~HpNIV~L~g~~~~~~---~~~-LV~ 546 (753)
+.||+|+||.||. +..++.. +||++... ..+...+|+. +++.+ .||||++++|++.++. ..+ +|+
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~-~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELK-YYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHH-HHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 6799999999995 4444444 79988653 2345566766 55666 6899999999988763 434 789
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH-HHhhhC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL-SHLHEI 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL-~yLH~~ 625 (753)
|+++ ..+|+|.+++... .+++. ..++.+++.++ +|||++
T Consensus 85 e~~G--------~~~~tL~~~l~~~------------------------------~~~e~--~~~~~~~L~~l~~yLh~~ 124 (210)
T PRK10345 85 DFDG--------KPSITLTEFAEQC------------------------------RYEED--VAQLRQLLKKLKRYLLDN 124 (210)
T ss_pred cCCC--------CcchhHHHHHHcc------------------------------cccHh--HHHHHHHHHHHHHHHHHC
Confidence 9422 3467888877421 12223 35677888887 999999
Q ss_pred CccccCCCCCcEEEecC--CCCeEEEEeccCce
Q 004442 626 GLIHRDLKPQNVLISKD--KSFCAKLSDMGISK 656 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d--~~~~~KLsDFGla~ 656 (753)
+|+||||||+|||++.. +...++|+||+.+.
T Consensus 125 ~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 125 RIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99999999999999753 34469999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.9e-16 Score=183.61 Aligned_cols=136 Identities=32% Similarity=0.440 Sum_probs=112.4
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCC------------CcccccCccCCCCccccccccc
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD------------MSCLTQNATGYGSSGWQAPEQL 683 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~------------~~~~~~~~~~~GT~~Y~APE~l 683 (753)
+.+++|||+.+|+|||+||+|.+|+.-|. +|+.|||+.+..... ....-.....+||+.|+|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 88999999999999999999999998876 999999998754211 0111123456899999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccc---cCCCHHHHHHHHHccccCcCCC
Q 004442 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL---VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 684 ~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~---~~~s~el~dLI~~cL~~DP~~R 753 (753)
....|+..+|+|++|+++||.+.|..++|++..++.+.++.......+ ...++|++++|.++|+++|-.|
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 999999999999999999999999777778878888777665544443 4467899999999999999876
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-16 Score=175.24 Aligned_cols=190 Identities=26% Similarity=0.336 Sum_probs=142.0
Q ss_pred HhCCCCceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcC
Q 004442 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 601 (753)
Q Consensus 522 ~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (753)
+.+.|.|+.+++|.|.++...+.|.+ |...|+|.+.+... ..
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~----------~c~rGsl~D~i~~~----------------------------~~ 43 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWE----------YCSRGSLLDILSNE----------------------------DI 43 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEe----------eecCccHHhHHhcc----------------------------cc
Confidence 46789999999999999999999999 55677888777542 23
Q ss_pred CCCHHHHHHHHHHHHHHHHHhhhCCc-cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccc
Q 004442 602 GHPSAQLLKVTRDIVSGLSHLHEIGL-IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (753)
Q Consensus 602 ~l~~~~~l~Ia~qIa~gL~yLH~~~I-iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP 680 (753)
.+++.....++++|+.||+|||...| .|+.++++|+++ |..+.+||+|||+............ .....-..-|.||
T Consensus 44 ~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv--d~~w~lklt~~Gl~~~~~~~~~~~~-~~~~~~~~lw~aP 120 (484)
T KOG1023|consen 44 KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV--DSRWVLKLTDFGLNSLLEETAEPEA-HHPIRKALLWTAP 120 (484)
T ss_pred CccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee--eeeEEEEechhhhcccccccccccc-cchhHHHHhccCH
Confidence 56777789999999999999998876 999999999999 6679999999999887743111111 1111124569999
Q ss_pred ccccCCC-------CCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHc-cCcccc------cCCCHHHHHH
Q 004442 681 EQLLQGR-------QTRAIDLFSLGCILFFCITGGKHPYGESF-----ERDANIVKD-RKDLFL------VEHIPEAVDL 741 (753)
Q Consensus 681 E~l~~~~-------~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-----~~~~~~i~~-~~~~~~------~~~s~el~dL 741 (753)
|.+.... .+.+.||||||++++|+++. ..||+... .+....+.. ....+- .+..+++..+
T Consensus 121 ellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r-~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l 199 (484)
T KOG1023|consen 121 ELLRGALSQSLESALTQKGDIYSFGIIMYEILFR-SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLL 199 (484)
T ss_pred HHhcccccccccccccccCCeehHHHHHHHHHhc-cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHH
Confidence 9987632 46789999999999999995 77886521 123333333 222111 1345579999
Q ss_pred HHHccccCcCCC
Q 004442 742 FTRLLDPNPDLR 753 (753)
Q Consensus 742 I~~cL~~DP~~R 753 (753)
+++||..+|.+|
T Consensus 200 ~~~cw~e~P~~r 211 (484)
T KOG1023|consen 200 VARCWEEIPEKR 211 (484)
T ss_pred HHHhcccChhhC
Confidence 999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.6e-15 Score=155.36 Aligned_cols=141 Identities=20% Similarity=0.158 Sum_probs=98.2
Q ss_pred cceEEEeEEecccCceEEEEEE--eeCCcEEEEEEeecCCc---------------------------hHHHHHHHHHHH
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEG--NYEGRSVAVKRLVKTHH---------------------------DVALKEIQNLIA 522 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~--~~~g~~VAVK~l~~~~~---------------------------~~~~~Ei~~ll~ 522 (753)
+..|.+.+.||+|+||.||+|. ..+|+.||||++..... ....+|.. .+.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~L~ 105 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR-NLQ 105 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH-HHH
Confidence 3456778899999999999997 56899999999864321 01123444 455
Q ss_pred hCCCCc--eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhc
Q 004442 523 SDQHPN--IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600 (753)
Q Consensus 523 ~l~HpN--IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 600 (753)
.+.|.+ +.+.+++ ...++|||++ .+++|..+... .
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~----------~g~~L~~~~~~-----------------------------~ 142 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFI----------GGDGLPAPRLK-----------------------------D 142 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEe----------cCCcccccccc-----------------------------c
Confidence 555432 3344443 2358999944 44444432210 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCC-ccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 601 NGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 601 ~~l~~~~~l~Ia~qIa~gL~yLH~~~-IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
..+...+...++.|++.+|++||+.+ |+||||||+||+++ ++ .++|+|||++....
T Consensus 143 ~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~LiDFg~a~~~~ 199 (237)
T smart00090 143 VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVIIDVSQSVELD 199 (237)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEEEEChhhhccC
Confidence 12334456889999999999999999 99999999999997 43 48999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.7e-16 Score=169.43 Aligned_cols=229 Identities=23% Similarity=0.387 Sum_probs=149.6
Q ss_pred EEecccCceEEEEEEeeC----CcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeec--cc----cc-----CCc
Q 004442 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWY--GV----ES-----DQD 540 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~--g~----~~-----~~~ 540 (753)
+..+..+++.+..+...+ ...++.|+.+... ....++++..+.....|++.+..- .+ .. ...
T Consensus 250 k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~ 329 (516)
T KOG1033|consen 250 KSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKV 329 (516)
T ss_pred ccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccccc
Confidence 445556666655433222 2344444443222 223455555444444455444322 11 11 123
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
.+|+.|+ ....++|.+||...+. ....++...+.++.|++.|+.
T Consensus 330 ~lyI~Mn----------~c~~~tledWl~rr~~--------------------------~e~~s~s~~~~~~~q~~~~~~ 373 (516)
T KOG1033|consen 330 YLYIQMN----------LCEKETLEDWLRRRRT--------------------------GEERSLSLMLDIFKQIAPAVE 373 (516)
T ss_pred chhhhhh----------hhhhhhHHHHhhCCCc--------------------------ccccchhHHHHHHHhhccchh
Confidence 5788999 5567788888865433 234556677999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC---cccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~---~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
| ++.+|||+||.||+...|+. +||+|||+........ ..........||..||+||.+.+..|+.|+|||||
T Consensus 374 y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL 448 (516)
T KOG1033|consen 374 Y---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL 448 (516)
T ss_pred h---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence 9 99999999999999977764 8999999998775433 11223345579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHH--HHHccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFERDAN--IVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~~~~--~i~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|+|+++ +|....++... -+..+..+ +..+ -|+-..|+.+|+...|++|
T Consensus 449 Glil~EL~~----~f~T~~er~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~R 503 (516)
T KOG1033|consen 449 GLILAELLI----QFSTQFERIATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEER 503 (516)
T ss_pred HHHHHHHHH----HhccHHHHHHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccC
Confidence 999999998 22222222221 12222222 2223 2566789999999999988
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.4e-15 Score=148.50 Aligned_cols=132 Identities=20% Similarity=0.311 Sum_probs=103.3
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.||+|++|.||++.. .|..|+||+...... ....+|.. ++..++|+||.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREAR-IMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHH-HHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4699999999999876 778899998653221 12334444 6778889998877777777788899999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++++|.+++.... . .+..++.+++.+|.+||+.++
T Consensus 80 ----------~~~G~~L~~~~~~~~--------------------------------~-~~~~i~~~i~~~l~~lH~~~i 116 (211)
T PRK14879 80 ----------YIEGEPLKDLINSNG--------------------------------M-EELELSREIGRLVGKLHSAGI 116 (211)
T ss_pred ----------EeCCcCHHHHHHhcc--------------------------------H-HHHHHHHHHHHHHHHHHhCCc
Confidence 667777777653210 1 558899999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
+|||++|.||+++ ++ .++|+|||++...
T Consensus 117 ~H~Dl~p~Nil~~-~~--~~~liDf~~a~~~ 144 (211)
T PRK14879 117 IHGDLTTSNMILS-GG--KIYLIDFGLAEFS 144 (211)
T ss_pred ccCCCCcccEEEE-CC--CEEEEECCcccCC
Confidence 9999999999997 43 4899999998753
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-14 Score=169.40 Aligned_cols=132 Identities=18% Similarity=0.264 Sum_probs=101.5
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEe-ecCC----------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRL-VKTH----------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l-~~~~----------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
|...+.||+|+||+||++..... .+++|+. .+.. .+...+|. .++..++|+||+....++.+.+..+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEA-RLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHH-HHHHhhcccCCCeeEEEEEeCCCCE
Confidence 34568899999999999866444 4444443 2211 01223344 4788999999998888888878889
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++++|.+++. ....++.+++++|.|||
T Consensus 413 lv~E----------~~~g~~L~~~l~-------------------------------------~~~~~~~~i~~~L~~lH 445 (535)
T PRK09605 413 IVME----------YIGGKDLKDVLE-------------------------------------GNPELVRKVGEIVAKLH 445 (535)
T ss_pred EEEE----------ecCCCcHHHHHH-------------------------------------HHHHHHHHHHHHHHHHH
Confidence 9999 778888887764 12678999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
+.+|+||||||+|||++ ++ .++|+|||+++..
T Consensus 446 ~~giiHrDlkp~NILl~-~~--~~~liDFGla~~~ 477 (535)
T PRK09605 446 KAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKYS 477 (535)
T ss_pred hCCCccCCCChHHEEEE-CC--cEEEEeCcccccC
Confidence 99999999999999993 43 4899999999764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.3e-14 Score=146.77 Aligned_cols=133 Identities=18% Similarity=0.158 Sum_probs=96.7
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-------------------------hHHHHHHHHHHHhCCCCc-
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------------------------DVALKEIQNLIASDQHPN- 528 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-------------------------~~~~~Ei~~ll~~l~HpN- 528 (753)
|.+.+.||+|+||.||++...+|+.||||++..... ....+|.. ++..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA-ALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH-HHHHHHHcCC
Confidence 556688999999999999888899999998754220 01233443 556666664
Q ss_pred -eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHH
Q 004442 529 -IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (753)
Q Consensus 529 -IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 607 (753)
+...++. ...++||| |+.+++|.+.... ..
T Consensus 96 ~v~~~~~~----~~~~lv~e----------~~~g~~L~~~~~~-----------------------------------~~ 126 (198)
T cd05144 96 PVPKPIDW----NRHAVVME----------YIDGVELYRVRVL-----------------------------------ED 126 (198)
T ss_pred CCCceeec----CCceEEEE----------EeCCcchhhcccc-----------------------------------cc
Confidence 3444432 34589999 6666666543210 12
Q ss_pred HHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 608 ~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
..+++.+++.++.++|+.+|+||||||.||+++.++ .++|+|||++....
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDfg~~~~~~ 176 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--cEEEEECCccccCC
Confidence 367889999999999999999999999999997665 49999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=146.02 Aligned_cols=128 Identities=23% Similarity=0.376 Sum_probs=97.0
Q ss_pred EecccCceEEEEEEeeCCcEEEEEEeecCC--c---------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--H---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~---------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.||+|+||.||++. .+|..|++|+..... . ....+|+. ++..++|+++.....++.+.+..+++||
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e- 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEAR-LLSRARKAGVNTPVVYDVDPDNKTIVME- 77 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHH-HHHHHHHCCCCCCEEEEEECCCCEEEEE-
Confidence 38999999999987 578899999865321 0 12223444 6677888876655555556667799999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++++|.+++.... ..++.+++.+|.+||+.+++
T Consensus 78 ---------~~~g~~l~~~~~~~~------------------------------------~~~~~~i~~~l~~lH~~gi~ 112 (199)
T TIGR03724 78 ---------YIEGKPLKDVIEEGN------------------------------------DELLREIGRLVGKLHKAGIV 112 (199)
T ss_pred ---------EECCccHHHHHhhcH------------------------------------HHHHHHHHHHHHHHHHCCee
Confidence 667777777653210 17899999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
|+|++|.||+++ ++ .+++.|||+++..
T Consensus 113 H~Dl~~~Nil~~-~~--~~~liDfg~a~~~ 139 (199)
T TIGR03724 113 HGDLTTSNIIVR-DD--KLYLIDFGLGKYS 139 (199)
T ss_pred cCCCCcceEEEE-CC--cEEEEECCCCcCC
Confidence 999999999997 44 4899999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.2e-14 Score=139.70 Aligned_cols=133 Identities=19% Similarity=0.220 Sum_probs=87.3
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCCch--HHH-------------------------HHHHHHHHhCCCC--c
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VAL-------------------------KEIQNLIASDQHP--N 528 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~--~~~-------------------------~Ei~~ll~~l~Hp--N 528 (753)
.+.||+|+||+||+|...+|+.||||++...... ... .|.. .+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFR-NLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHH-HHHHHHHcCCC
Confidence 3569999999999998888999999998653211 100 1111 12222222 1
Q ss_pred eeeecccccCCceEEEEEccccCChhhHHHHhcCChHH-HhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHH
Q 004442 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEE-QLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (753)
Q Consensus 529 IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 607 (753)
+.+.+++ ...++||| |+++|.+.. .+... ... .+
T Consensus 81 ~~~~~~~----~~~~lv~e----------~~~g~~~~~~~l~~~------------------------------~~~-~~ 115 (187)
T cd05119 81 VPKPIDL----NRHVLVME----------FIGGDGIPAPRLKDV------------------------------RLL-ED 115 (187)
T ss_pred CCceEec----CCCEEEEE----------EeCCCCccChhhhhh------------------------------hhc-cc
Confidence 2333332 23589999 444433211 11000 000 34
Q ss_pred HHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 608 LLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 608 ~l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
..+++.+++.++.++|. .+|+||||||+||+++ ++ .++|+|||.+....
T Consensus 116 ~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--~~~liDfg~a~~~~ 165 (187)
T cd05119 116 PEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--KVYIIDVPQAVEID 165 (187)
T ss_pred HHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--cEEEEECccccccc
Confidence 57899999999999999 9999999999999998 44 48999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.7e-14 Score=168.45 Aligned_cols=239 Identities=27% Similarity=0.372 Sum_probs=174.1
Q ss_pred EEEeEEecccCceEEEEEEee--CCcEEEEEEeecCC-chHHH----HHHHHHHHhCC-CCceeeecccccCCceEEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH-HDVAL----KEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~--~g~~VAVK~l~~~~-~~~~~----~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~ 546 (753)
|.+.+.||+|+|+.|-..... ....+|+|.+.... ..... .|.. +..... |+|++++++...+.+..++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~-~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETD-IQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccc-ccccccccccccccCCccCCCccccccc
Confidence 445566999999999765443 35677777775442 11111 1222 334444 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh-hC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EI 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH-~~ 625 (753)
| |..+|++.+.+... .....+....-.+..|+..++.|+| ..
T Consensus 101 ~----------~s~g~~~f~~i~~~---------------------------~~~~~~~~~~~~~~~ql~s~l~~~H~~~ 143 (601)
T KOG0590|consen 101 S----------YSDGGSLFSKISHP---------------------------DSTGTSSSSASRYLPQLNSGLSYLHPEN 143 (601)
T ss_pred C----------cccccccccccccC---------------------------CccCCCCcchhhhhhhhccCccccCccc
Confidence 9 77777777765211 0113344555788999999999999 99
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCC-CccccccccccCCC-CCchhhHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSGWQAPEQLLQGR-QTRAIDLFSLGCILFF 703 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~G-T~~Y~APE~l~~~~-~t~ksDIwSfGvvL~E 703 (753)
++.||||||+|.+++..+. .++++|||+|..+.............+| ++.|+|||...+.. .....|+||.|+++.-
T Consensus 144 ~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 144 GVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred ccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 9999999999999977762 5899999999887662233344455678 99999999998855 4789999999999999
Q ss_pred HHhCCCCCCCCChHHHHH---HHHcc---CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERDAN---IVKDR---KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~~~---~i~~~---~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++| ..||+........ ..... ........+....+++.+++..+|.+|
T Consensus 223 ~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r 277 (601)
T KOG0590|consen 223 MLTG-ELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNR 277 (601)
T ss_pred cccC-CCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhc
Confidence 9998 6788665333221 11111 234455677889999999999998877
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=135.84 Aligned_cols=132 Identities=16% Similarity=0.203 Sum_probs=92.3
Q ss_pred EEec-ccCceEEEEEEeeCCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCce--eeecccccCC
Q 004442 479 KEIA-KGSNGTVVLEGNYEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNI--VRWYGVESDQ 539 (753)
Q Consensus 479 ~~IG-~G~fG~Vyka~~~~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNI--V~L~g~~~~~ 539 (753)
..|| .|+.|+||+... ++..+|||++.... .....+|+. ++..++|++| ++.++++...
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~-ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFR-LLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHH-HHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888887655 47889999885321 123445554 7788888875 6777765432
Q ss_pred -ce---EEEEEccccCChhhHHHHhc-CChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHH
Q 004442 540 -DF---VYLSLERCTCSLNDLIYVLS-GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (753)
Q Consensus 540 -~~---~~LV~E~c~~~L~~liy~~~-GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~q 614 (753)
.. .++|+| ++++ ++|.+++... .++. ..+.+
T Consensus 115 ~~~~~~~~lV~e----------~l~G~~~L~~~l~~~------------------------------~l~~----~~~~~ 150 (239)
T PRK01723 115 HGLFYRADILIE----------RIEGARDLVALLQEA------------------------------PLSE----EQWQA 150 (239)
T ss_pred cCcceeeeEEEE----------ecCCCCCHHHHHhcC------------------------------CCCH----HHHHH
Confidence 22 259999 5554 4666554321 1121 23568
Q ss_pred HHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 615 Ia~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
++.+|.+||+.||+||||||.|||++.++. ++|+|||.+...
T Consensus 151 i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~~ 192 (239)
T PRK01723 151 IGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGELR 192 (239)
T ss_pred HHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCcccC
Confidence 999999999999999999999999977664 999999988753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.6e-12 Score=121.25 Aligned_cols=131 Identities=18% Similarity=0.256 Sum_probs=100.1
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC--CceeeecccccCCceEEEEEccccCChh
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSLERCTCSLN 554 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H--pNIV~L~g~~~~~~~~~LV~E~c~~~L~ 554 (753)
.+.||+|.++.||++...+ ..++||....... ....+|.. ++..++| .++.+++++...++..+++||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~-~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e------- 73 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVA-ILQLLARKGLPVPKVLASGESDGWSYLLME------- 73 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCccEEEEE-------
Confidence 4679999999999987654 7899999866543 23444554 5666665 588999998888889999999
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC---CccccC
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRD 631 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~---~IiHrD 631 (753)
|+.++.+..+ +......++.+++++|++||.. +++|+|
T Consensus 74 ---~~~g~~~~~~------------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~D 114 (155)
T cd05120 74 ---WIEGETLDEV------------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114 (155)
T ss_pred ---ecCCeecccC------------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecC
Confidence 5544444321 2233467899999999999985 699999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceec
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
++|+||++++++ .+++.|||.++..
T Consensus 115 l~~~Nil~~~~~--~~~l~Df~~~~~~ 139 (155)
T cd05120 115 LHPGNILVDDGK--ILGIIDWEYAGYG 139 (155)
T ss_pred CCcceEEEECCc--EEEEEecccccCC
Confidence 999999997754 4899999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-12 Score=143.62 Aligned_cols=237 Identities=27% Similarity=0.320 Sum_probs=168.9
Q ss_pred eEEEeEEecc--cCceEEEEEEe---eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 474 LVVFNKEIAK--GSNGTVVLEGN---YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 474 ~~~i~~~IG~--G~fG~Vyka~~---~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.+.+.+|. |.+|.||.+.. .++..+|+|+=+.. ......+|...-.+.-.|+|.++....+.+.+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3456677999 99999998755 56899999984321 12234455553344456999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH----HH
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS----GL 619 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~----gL 619 (753)
+-+|+|..++..+... ...-++...++.+..+..+ ||
T Consensus 195 iqtE~~~~sl~~~~~~---------------------------------------~~~~~p~~~l~~~~~~~~~~~~~al 235 (524)
T KOG0601|consen 195 IQTELCGESLQSYCHT---------------------------------------PCNFLPDNLLWNSLRDWLSRDVTAL 235 (524)
T ss_pred eeeccccchhHHhhhc---------------------------------------ccccCCchhhhhHHhhhhhcccccc
Confidence 9999998665555411 1223555666777777777 99
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC-cccccC-ccCCCCccccccccccCCCCCchhhHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-SCLTQN-ATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~-~~~~~~-~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
.++|..+|+|-|+||.||++..|. ...++.|||+...+.... ...... ....|...|++||.. .+.++.+.|||++
T Consensus 236 ~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl 313 (524)
T KOG0601|consen 236 SHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSL 313 (524)
T ss_pred cccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcch
Confidence 999999999999999999998873 358999999999886543 111111 112477889999975 5678999999999
Q ss_pred HHHHHHHHhCCCCCCCC--C-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGE--S-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~--~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.++.+-.++..+|-.+ . +....+.. ....+....+.++...+..|++.||-.|
T Consensus 314 ~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~ 370 (524)
T KOG0601|consen 314 GEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLR 370 (524)
T ss_pred hhhhHhhHhhcccccCCCCCCcccccccc--CchhhhcCcchhhhhHHHHhcCcchhhh
Confidence 99999999987666544 1 11111111 2222344456677788999999888654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.1e-11 Score=136.69 Aligned_cols=139 Identities=24% Similarity=0.231 Sum_probs=92.3
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCchHHH-----------------------------H--------------
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----------------------------K-------------- 515 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~-----------------------------~-------------- 515 (753)
+.||.|++|.||+|.+.+|+.||||+.++...+... .
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998654211111 1
Q ss_pred HHHH---HHHhCCCCceeeeccccc-CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhccccccc
Q 004442 516 EIQN---LIASDQHPNIVRWYGVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591 (753)
Q Consensus 516 Ei~~---ll~~l~HpNIV~L~g~~~-~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~ 591 (753)
|... +....+|.+-+..-.++. .....+|||| |+++++|.+.+.....
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE----------~i~G~~L~~~~~~~~~------------------ 254 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTME----------WIDGIPLSDIAALDEA------------------ 254 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEE----------eECCcccccHHHHHhc------------------
Confidence 1110 111223333333333332 2445799999 6666776665432110
Q ss_pred chhhhhhhcCCCCHHHHHHHHHHHHH-HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccC
Q 004442 592 TKDIELWKANGHPSAQLLKVTRDIVS-GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (753)
Q Consensus 592 ~~~~~~~~~~~l~~~~~l~Ia~qIa~-gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~ 660 (753)
.. ...+++..++. .+..+|..|++|+|++|.||+++.++. ++++|||++..+..
T Consensus 255 ----------~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l~~ 309 (437)
T TIGR01982 255 ----------GL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRLSE 309 (437)
T ss_pred ----------CC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeECCH
Confidence 01 12456666666 478899999999999999999977765 89999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-10 Score=119.44 Aligned_cols=152 Identities=20% Similarity=0.266 Sum_probs=110.9
Q ss_pred HHHhCCCCceeeecccccCCce-----EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchh
Q 004442 520 LIASDQHPNIVRWYGVESDQDF-----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594 (753)
Q Consensus 520 ll~~l~HpNIV~L~g~~~~~~~-----~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 594 (753)
-+-.+.|.|||+++.||.+.++ ..++.| ||..|++..+|+..+..
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFite----------ymssgs~~~fLkrt~~~-------------------- 169 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITE----------YMSSGSLKQFLKRTKKN-------------------- 169 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEe----------cccchhHHHHHHHHHHh--------------------
Confidence 3455679999999999976543 688999 99999999999876542
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC--CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--ccccCcc
Q 004442 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNAT 670 (753)
Q Consensus 595 ~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~--~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~--~~~~~~~ 670 (753)
...+......+++.||..||.|||+. .|+|+++..+-|+++.++- +|++- +--...+.... .......
T Consensus 170 -----~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~-~ap~s~h~s~~~~~~~Ek~~ 241 (458)
T KOG1266|consen 170 -----QKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGS-VAPDSTHPSVNSTREAEKSV 241 (458)
T ss_pred -----hhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecc-cCccccchhhhhhhHhhhhc
Confidence 23345556689999999999999987 6999999999999986653 45432 11111111000 0011112
Q ss_pred CCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 671 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 671 ~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
..+-++|.|||.-.....+-.+|||+||...+||.-+.-
T Consensus 242 ~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 242 NTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 236789999998777778889999999999999988743
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4e-09 Score=120.20 Aligned_cols=164 Identities=20% Similarity=0.334 Sum_probs=116.0
Q ss_pred EeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhh
Q 004442 493 GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNA 570 (753)
Q Consensus 493 ~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~ 570 (753)
...++.+|.|...+.... ....++-..-++.++||||++++..+..++.+|||+|+|. .|...+..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~------------Pl~~~lk~ 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR------------PLETVLKE 100 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc------------cHHHHHHH
Confidence 345688999998876554 2233344446789999999999999999999999999764 22222221
Q ss_pred hhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEE
Q 004442 571 KEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKL 649 (753)
Q Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KL 649 (753)
. ....+.-.+.||+.||.|||+ .+++|++|.-..|+++.+|+ .||
T Consensus 101 l--------------------------------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkL 146 (690)
T KOG1243|consen 101 L--------------------------------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKL 146 (690)
T ss_pred h--------------------------------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEE
Confidence 1 122345678999999999985 58999999999999999887 889
Q ss_pred EeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 650 sDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
++|.++....+... ......--..|..|+.+.... -..|.|-|||+++|++.|
T Consensus 147 ggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 147 GGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEeccccCCc---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99988865543211 011111123456666543322 457999999999999998
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=106.14 Aligned_cols=125 Identities=17% Similarity=0.086 Sum_probs=85.4
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCcee-eecccccCCceEEEEEccccCChhh
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIV-RWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV-~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
+.|+.|.++.||+... .+..+++|...... .....+|.. .+..+.+.+++ +++++.. ...++|||
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~P~~~~~~~--~~~~lv~e-------- 71 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAE-NSKLAAEAGIGPKLYYFDP--ETGVLITE-------- 71 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHH-HHHHHHHhCCCCceEEEeC--CCCeEEEE--------
Confidence 5689999999998765 47889999976543 122344544 44554444443 4554432 33579999
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc-----ccc
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHR 630 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I-----iHr 630 (753)
|+++.++.+.. . ....++.+++++|+.||..++ +|+
T Consensus 72 --~i~G~~l~~~~----~---------------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg 112 (170)
T cd05151 72 --FIEGSELLTED----F---------------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHN 112 (170)
T ss_pred --ecCCCcccccc----c---------------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence 66665554320 0 003456789999999999875 999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
|++|.||+++ ++ .++++|||.+..
T Consensus 113 D~~~~Nil~~-~~--~~~liDf~~a~~ 136 (170)
T cd05151 113 DLLPGNFLLD-DG--RLWLIDWEYAGM 136 (170)
T ss_pred CCCcCcEEEE-CC--eEEEEecccccC
Confidence 9999999997 33 389999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.8e-10 Score=127.33 Aligned_cols=233 Identities=22% Similarity=0.170 Sum_probs=161.8
Q ss_pred cceEEEeEEecccCceEEEEEEe--eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~--~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..+|.....||.|.|+.|+.... .++..+|+|.+.+... ...+.|+........|.++++....|...+..|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 34566778899999999998643 4588999998865421 2234555534455679999999999998888899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
-.| |..+|++...+.. ...+++..++++..|++.++-++|+
T Consensus 344 p~e----------~~~~~s~~l~~~~-----------------------------~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 344 PLE----------FCEGGSSSLRSVT-----------------------------SQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred chh----------hhcCcchhhhhHH-----------------------------HHhcCcchhhhhHHHHHhccccccc
Confidence 999 5556665554411 1124445668999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccc--ccccccCCCCCchhhHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ--APEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~--APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
..++|+|+||+||++..++ +..+++|||++..+.-.. ....++-+++ +++......+..+.|++|||.-+.
T Consensus 385 ~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~ 457 (524)
T KOG0601|consen 385 KLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVD 457 (524)
T ss_pred hhhhcccccccceeeccch-hhhhccccccccccceec------ccccccccccccchhhcccccccccccccccccccc
Confidence 9999999999999998876 567899999987532110 1111233344 555556677899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.+++...+....... .+..+..+.......++..+.+.++..|+..|
T Consensus 458 e~~~~~~ls~~~~~~~---~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~ 505 (524)
T KOG0601|consen 458 EAITGSPLSESGVQSL---TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRR 505 (524)
T ss_pred ccccCcccCcccccce---eeecccccCCCchHHhhhhhhhhhcCCccccc
Confidence 9999855555433211 12233333334444677777777777777643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.95 E-value=7.4e-10 Score=127.47 Aligned_cols=39 Identities=28% Similarity=0.426 Sum_probs=31.9
Q ss_pred hhhCCccccCCCCCcEEEecCC--CCeEEEEeccCceeccC
Q 004442 622 LHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQG 660 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~ 660 (753)
++..|++|+|+||.||+++.++ ...+++.|||++..+..
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3458999999999999998776 12488999999987754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-09 Score=128.39 Aligned_cols=241 Identities=24% Similarity=0.254 Sum_probs=161.1
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHH---HHHHhCCCCceeeecccccCCceEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~---~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
-.+.+.+.+.+-+|+++.++.+.-. .|...+.|...... .....+++. .+.-..+||-+++..--+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455666778899999999865332 24444444432211 000111110 11122345556655444445677899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
+++ |..+|+|...||.... .+..-.......+..+++|||.
T Consensus 882 ~~~----------~~~~~~~~Skl~~~~~-----------------------------~saepaRs~i~~~vqs~e~L~s 922 (1205)
T KOG0606|consen 882 VGH----------YLNGGDLPSKLHNSGC-----------------------------LSAEPARSPILERVQSLESLHS 922 (1205)
T ss_pred hhH----------HhccCCchhhhhcCCC-----------------------------cccccccchhHHHHhhhhcccc
Confidence 999 8889999998876431 1112224456678889999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccC------C---------------C-------cccccCccCCCCcc
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG------D---------------M-------SCLTQNATGYGSSG 676 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~------~---------------~-------~~~~~~~~~~GT~~ 676 (753)
..+.|||++|.|+++..++. .+++|||......- . . ..........||+.
T Consensus 923 ~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~ 1000 (1205)
T KOG0606|consen 923 SLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPD 1000 (1205)
T ss_pred chhhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCc
Confidence 99999999999999988876 77999984332210 0 0 00011233468999
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCC
Q 004442 677 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 677 Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
|.+||...+......+|+|++|++++|.++| .+||.... ++.+..+.+... .-+...++++++++.+.+..+|.+
T Consensus 1001 ~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g-~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1001 YLAPEILLGRRHGSAADWWSSGVCLFEVLTG-IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred ccCCcccccccCCCcchhhhhhhhhhhhhcC-CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 9999999999999999999999999999999 67776653 444443333332 234567889999999999999998
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 1080 r 1080 (1205)
T KOG0606|consen 1080 R 1080 (1205)
T ss_pred c
Confidence 7
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.4e-08 Score=100.80 Aligned_cols=52 Identities=21% Similarity=0.281 Sum_probs=43.8
Q ss_pred HHHHHHHHHHHHHHHHHh-hhCCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 605 SAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 605 ~~~~l~Ia~qIa~gL~yL-H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
..+..++..+++.+|.+| |+.+|+|+||++.||++..+ . +.|+|||.+....
T Consensus 123 ~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~~-~--v~iIDF~qav~~~ 175 (197)
T cd05146 123 DEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHDG-K--VWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEECC-c--EEEEECCCceeCC
Confidence 345567889999999999 88999999999999999643 3 8899999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=104.48 Aligned_cols=213 Identities=19% Similarity=0.186 Sum_probs=138.6
Q ss_pred eEEEEE-EeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeeccccc----CCceEEEEEccccC--ChhhHH
Q 004442 487 GTVVLE-GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVES----DQDFVYLSLERCTC--SLNDLI 557 (753)
Q Consensus 487 G~Vyka-~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~----~~~~~~LV~E~c~~--~L~~li 557 (753)
.+.|++ ...+|..|++||++.... -.....+.++.+++.|.|||+|..++. .+..+++||+|.++ +|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 466877 456899999999943211 112233445679999999999999876 34568999998776 455553
Q ss_pred HHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcE
Q 004442 558 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637 (753)
Q Consensus 558 y~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NI 637 (753)
|... .... .............++..+|.++.|++.||.++|+.|+..+-|.+++|
T Consensus 370 F~~~-----------~~t~--------------~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 370 FANP-----------PFTK--------------RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred ccCC-----------cccc--------------ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 3221 1100 00111123456788999999999999999999999999999999999
Q ss_pred EEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Q 004442 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717 (753)
Q Consensus 638 LL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~ 717 (753)
++ +|...++|+-.|....+..+.. |-+. --.+-|.=.||.+++.|.||..--+.....
T Consensus 425 lv--~G~~RIriS~C~i~Dvl~~d~~-----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~ 482 (655)
T KOG3741|consen 425 LV--TGKMRIRISGCGIMDVLQEDPT-----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST 482 (655)
T ss_pred Ee--eCcceEEEecccceeeecCCCC-----------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch
Confidence 99 4445688888887766544320 1111 124568889999999999995433322211
Q ss_pred HHHHHHHccCcccccCCCHHHHHHHHHccccCcC
Q 004442 718 RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 718 ~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
... .....-..++.+++++|.-+...++.
T Consensus 483 ~~s-----~~~~I~~~yS~D~rn~v~yl~s~~~~ 511 (655)
T KOG3741|consen 483 QSS-----HLTRITTTYSTDLRNVVEYLESLNFR 511 (655)
T ss_pred HHH-----HHHHhhhhhhHHHHHHHHHHHhcCcc
Confidence 111 11222345666777766665555554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=96.55 Aligned_cols=72 Identities=13% Similarity=0.178 Sum_probs=50.6
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCC----chHHHHHHHHHHHhCCC--CceeeecccccCCc---eEEEEEccc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH--PNIVRWYGVESDQD---FVYLSLERC 549 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~H--pNIV~L~g~~~~~~---~~~LV~E~c 549 (753)
+.|+.|..+.||+....+|+.+++|...... .....+|.. ++..+.+ .++.+++.++.+.+ ..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~-~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYR-VLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHH-HHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999877777899999976532 233444544 5566655 34566777766543 568999977
Q ss_pred cC
Q 004442 550 TC 551 (753)
Q Consensus 550 ~~ 551 (753)
++
T Consensus 83 ~G 84 (223)
T cd05154 83 DG 84 (223)
T ss_pred CC
Confidence 65
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.5e-07 Score=93.82 Aligned_cols=55 Identities=13% Similarity=0.190 Sum_probs=46.9
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEec-----CCCCeEEEEeccCcee
Q 004442 603 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-----DKSFCAKLSDMGISKR 657 (753)
Q Consensus 603 l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~-----d~~~~~KLsDFGla~~ 657 (753)
.+......++.+++..+.-||+.||+|+|++++|||++. ++...+.++||+.+..
T Consensus 135 ~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 135 PDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 344566789999999999999999999999999999975 2456799999998854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.7e-07 Score=88.79 Aligned_cols=127 Identities=20% Similarity=0.335 Sum_probs=84.5
Q ss_pred EecccCceEEEEEEeeCCcEEEEEE-eecCCc----h------HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 480 EIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----D------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g~~VAVK~-l~~~~~----~------~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.+++|+-..+|.+.. -|.++++|. +.+... + ...+|. .++...+--.|.--.-|..+.+...|+||
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Ea-ril~~a~~~GV~~P~v~dvD~~~~~I~me- 79 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREA-RILAKAREAGVPVPIVYDVDPDNGLIVME- 79 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHH-HHHHHHHHcCCCCCeEEEEcCCCCEEEEE-
Confidence 478899999998744 344566663 333211 1 122232 35555443333333334567888899999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++-.|.+.|... ...++..+-.-+.-||..||+
T Consensus 80 ---------~I~G~~lkd~l~~~------------------------------------~~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 80 ---------YIEGELLKDALEEA------------------------------------RPDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred ---------EeCChhHHHHHHhc------------------------------------chHHHHHHHHHHHHHHhcCee
Confidence 55555555555322 145677777888899999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
|+||.++||.+..++ +.++||||+..
T Consensus 115 HGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 115 HGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred cCCCccceEEEeCCc---EEEEECCcccc
Confidence 999999999997654 78999999974
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-06 Score=94.96 Aligned_cols=199 Identities=19% Similarity=0.243 Sum_probs=125.8
Q ss_pred EeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeeccc------cc-CCceEEEEEccc
Q 004442 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ES-DQDFVYLSLERC 549 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~------~~-~~~~~~LV~E~c 549 (753)
....||+|+-+.+|--... ...+-|++...-....-+...++.+.-.||-+-.-+.| .- .+...-+.|..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 3466999999999942221 22345666544322222333334456667655442222 11 222366777754
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
.+. .....+++... +. ......+|..+++.++.+|.+.+-||+.|.+-
T Consensus 93 ~g~---------~pI~~~y~p~t---------RR--------------qs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~v 140 (637)
T COG4248 93 SGK---------EPIHMIYSPAT---------RR--------------QSYPHCAWDFLLRVARNLASAFATLHEHGHVV 140 (637)
T ss_pred CCc---------cchhhhcCchh---------hc--------------ccCCccccHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 431 11111211110 00 12345788999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHHH
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~El 704 (753)
+|+.++|+|+.+++. +.|.|-..-.... ..+.....+|...|.+||.-. +-.-+...|-|.|||+|+++
T Consensus 141 GDVn~~~~lVsd~~~--V~LVdsDsfqi~~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~l 214 (637)
T COG4248 141 GDVNQNSFLVSDDSK--VVLVDSDSFQINA----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHL 214 (637)
T ss_pred cccCccceeeecCce--EEEEcccceeecc----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHH
Confidence 999999999987765 6676633211111 222334557899999999654 23346789999999999999
Q ss_pred HhCCCCCCCCC
Q 004442 705 ITGGKHPYGES 715 (753)
Q Consensus 705 lTG~~~Pf~~~ 715 (753)
+.|+++||.+.
T Consensus 215 L~ggrHPysGI 225 (637)
T COG4248 215 LFGGRHPYSGI 225 (637)
T ss_pred HhcCCCCCCcc
Confidence 99999999763
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-07 Score=109.02 Aligned_cols=140 Identities=20% Similarity=0.292 Sum_probs=100.3
Q ss_pred HHHHHHHHHHhhhC-CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc----c--ccCccCCCCcccccccccc
Q 004442 612 TRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----L--TQNATGYGSSGWQAPEQLL 684 (753)
Q Consensus 612 a~qIa~gL~yLH~~-~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~--~~~~~~~GT~~Y~APE~l~ 684 (753)
+.+++.||.|+|.. ++||++|.|++|.++..+. .||+.|+.+....+.... . .......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 45666999999976 8999999999999977766 899999988765542110 0 0111112456799999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-----HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV-----KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 685 ~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i-----~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+...+.++|+||+||++|.+..|++.-+........... .........+.++|+++-|.+++..|+..|
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 988899999999999999988665655544322222111 112222345678999999999999998776
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.9e-06 Score=83.62 Aligned_cols=142 Identities=20% Similarity=0.241 Sum_probs=87.8
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEE-eecCCc----------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~-l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
...|-+|+-+.|+++. ..|+...||. +.+... ....+|. +++.+.+--.|.--.-++.+...-.|+|
T Consensus 12 l~likQGAEArv~~~~-~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ea-r~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGS-FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEA-RLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred ceeeeccceeeEeeec-cCCceeEEeecccccccchHHHHHHHHHHHHHHH-HHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4668899999998754 4577767763 433211 1122233 3445443323332233445566667889
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|+.++. -++.+++...... .........++..|-+.+.-||..+
T Consensus 90 E~~~g~---------~~vk~~i~~~~~~---------------------------~~~d~~~~~~~~~iG~~igklH~nd 133 (229)
T KOG3087|consen 90 EFIDGA---------STVKDFILSTMED---------------------------ESEDEGLAELARRIGELIGKLHDND 133 (229)
T ss_pred Eeccch---------hHHHHHHHHHccC---------------------------cccchhHHHHHHHHHHHHHHhhhCC
Confidence 955540 1344444322110 0111122678888999999999999
Q ss_pred ccccCCCCCcEEEecCCC-CeEEEEeccCcee
Q 004442 627 LIHRDLKPQNVLISKDKS-FCAKLSDMGISKR 657 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~ 657 (753)
|||+||..+||+|.++++ ..+.++|||++..
T Consensus 134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eecccccccceEEecCCCcCceEEEeecchhc
Confidence 999999999999988765 3468999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.7e-06 Score=85.60 Aligned_cols=48 Identities=23% Similarity=0.442 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHHH-hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 609 LKVTRDIVSGLSH-LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 609 l~Ia~qIa~gL~y-LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
..++.+++..+.. +|..||+|+||.+.||+++.+ .+.|+|||.+....
T Consensus 109 ~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 109 KELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEecCcceecC
Confidence 5677788886555 578999999999999999776 38999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.6e-05 Score=76.09 Aligned_cols=138 Identities=12% Similarity=0.110 Sum_probs=92.0
Q ss_pred ecccCceEEEEEEeeCCcEEEEEEee---------cCCchHHHHHHHHHHHhCCCCc--eeeeccccc-C----CceEEE
Q 004442 481 IAKGSNGTVVLEGNYEGRSVAVKRLV---------KTHHDVALKEIQNLIASDQHPN--IVRWYGVES-D----QDFVYL 544 (753)
Q Consensus 481 IG~G~fG~Vyka~~~~g~~VAVK~l~---------~~~~~~~~~Ei~~ll~~l~HpN--IV~L~g~~~-~----~~~~~L 544 (753)
-|+||.+.|+.- ..+|+.+-+|+-. +-....+.+|+. .+..+...+ +.+.+ ++. . .-.-+|
T Consensus 26 ~~rgG~SgV~r~-~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~-~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCV-ERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVA-VIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEE-EeCCcEEEEEeccCcccccccCCCCchHHHHHHH-HHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 466888888863 3456678888764 222346677777 444443222 44444 332 1 224689
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
|+|-+++ --+|.+++.. +.....+..+...+..+++..+.-||+
T Consensus 103 VTe~L~g---------~~~L~~~l~~---------------------------~~~~~~~~~~k~~il~~va~~ia~LH~ 146 (216)
T PRK09902 103 VTEDMAG---------FISIADWYAQ---------------------------HAVSPYSDEVRQAMLKAVALAFKKMHS 146 (216)
T ss_pred EEEeCCC---------CccHHHHHhc---------------------------CCcCCcchHHHHHHHHHHHHHHHHHHH
Confidence 9996653 1234444322 112344556678999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.|+.|+|+.+.||+++.++.+.++++||.-++.
T Consensus 147 ~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 147 VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999999999999999877767899999986654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.8e-05 Score=79.42 Aligned_cols=55 Identities=25% Similarity=0.437 Sum_probs=47.2
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceec
Q 004442 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRL 658 (753)
Q Consensus 604 ~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~ 658 (753)
+......++.+++..++-||+.||+|+|+++.|||++.++ ...+.++||+.++..
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 3345578999999999999999999999999999998875 456899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.7e-05 Score=79.00 Aligned_cols=131 Identities=17% Similarity=0.162 Sum_probs=85.4
Q ss_pred EEeEEecccCceEEEEEEeeCCcEEEEEEeecC-----------------C--------chHHHHHHHHHHHhCCCC--c
Q 004442 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-----------------H--------HDVALKEIQNLIASDQHP--N 528 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~-----------------~--------~~~~~~Ei~~ll~~l~Hp--N 528 (753)
.+...||.|.-+.||.|....|.++|||.=+-. . ...+.+|++ .|.++.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~-~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFE-ALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHH-HHHHhhhcCCC
Confidence 466789999999999999999999999954211 0 012455655 34444433 4
Q ss_pred eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHH
Q 004442 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608 (753)
Q Consensus 529 IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 608 (753)
+.+-++ .+...+||| |+.+--|...- ++....
T Consensus 173 VP~P~~----~nRHaVvMe----------~ieG~eL~~~r----------------------------------~~~en~ 204 (304)
T COG0478 173 VPKPIA----WNRHAVVME----------YIEGVELYRLR----------------------------------LDVENP 204 (304)
T ss_pred CCCccc----cccceeeee----------hcccceeeccc----------------------------------CcccCH
Confidence 444444 367899999 44443332210 011122
Q ss_pred HHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 609 l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
-.|+..|++-+.-+-..||||+|++.=||++++||+ +.++||-.+..
T Consensus 205 ~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v~ 251 (304)
T COG0478 205 DEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAVP 251 (304)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCccccc
Confidence 344445555555555789999999999999999876 88999976653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.87 E-value=2.3e-05 Score=93.14 Aligned_cols=49 Identities=16% Similarity=0.036 Sum_probs=38.0
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|+|+|.|| .+..+ .|+.|||++|+|+|.||..+..+.+|.
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~ 493 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCC
Confidence 45667777888888887 57777 788899999999999988776655544
|
|
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00027 Score=79.30 Aligned_cols=112 Identities=18% Similarity=0.188 Sum_probs=79.1
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCC--cccc----cc--cCCCCCCceeeeccCCCceeeeeccccCcee-ee
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRP--IYSS----YQ--ASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 118 (753)
.|...+++.+|.|+.+|..+|+.+|++..+.. .++. +. .+.-.+..+|.- ..+..||-=+...|++. +.
T Consensus 69 ~~~vy~~~~~g~l~ald~~tG~~~W~~~~~~~~~~~~~~~~~~~~~~~~v~~~~v~v~--~~~g~l~ald~~tG~~~W~~ 146 (394)
T PRK11138 69 YNKVYAADRAGLVKALDADTGKEIWSVDLSEKDGWFSKNKSALLSGGVTVAGGKVYIG--SEKGQVYALNAEDGEVAWQT 146 (394)
T ss_pred CCEEEEECCCCeEEEEECCCCcEeeEEcCCCcccccccccccccccccEEECCEEEEE--cCCCEEEEEECCCCCCcccc
Confidence 45667788899999999999999999987652 1111 11 112223335543 35677888888888876 44
Q ss_pred ccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCC
Q 004442 119 SSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLD 164 (753)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (753)
.. +..+.-+|.+. +|.|+++.....++++|++||+++-.+..+
T Consensus 147 ~~--~~~~~ssP~v~-~~~v~v~~~~g~l~ald~~tG~~~W~~~~~ 189 (394)
T PRK11138 147 KV--AGEALSRPVVS-DGLVLVHTSNGMLQALNESDGAVKWTVNLD 189 (394)
T ss_pred cC--CCceecCCEEE-CCEEEEECCCCEEEEEEccCCCEeeeecCC
Confidence 32 23355678887 566999999899999999999999886554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=1.3e-05 Score=91.60 Aligned_cols=177 Identities=21% Similarity=0.262 Sum_probs=127.0
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCc-eeeecccccCCceEEEEEccccCChhhHH
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSLNDLI 557 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN-IV~L~g~~~~~~~~~LV~E~c~~~L~~li 557 (753)
...++|+++++||++....+...++.+.... ...-++ +++.+.+||| .++.++-+..++...+++++|.+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l--~~rl~~-eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~------ 318 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTL--SRRLAI-ELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST------ 318 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccch--hhHHHH-HHHHHccCCCCcccccccCCcccccchhhhhhcC------
Confidence 4588999999999776666666677665442 222233 4889999999 77777777778889999995543
Q ss_pred HHhcC-ChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCc
Q 004442 558 YVLSG-SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636 (753)
Q Consensus 558 y~~~G-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~N 636 (753)
| +...... -....+...+...+.+.-+++++|||+..=+||| |
T Consensus 319 ----~rs~~~~~~----------------------------~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~ 362 (829)
T KOG0576|consen 319 ----GRSSALEMT----------------------------VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----N 362 (829)
T ss_pred ----CccccccCC----------------------------hhhHhhhhhhhhhhhhhhcccccccccccccCcc----c
Confidence 3 1100000 0001122334467778888999999988778999 8
Q ss_pred EEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 637 ILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|+..+.. .|..||+....+.... ...+..+|+.|+|||+.....+....|+|++|+--.++.-|
T Consensus 363 ~l~s~~~---~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 363 ILGSEEE---VKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred ccccccc---cccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 8886643 6899999887776543 34566789999999999999999999999999876677665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00021 Score=82.41 Aligned_cols=139 Identities=22% Similarity=0.197 Sum_probs=83.9
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCch-----------------------------HHHHHHHH----------
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----------------------------VALKEIQN---------- 519 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~-----------------------------~~~~Ei~~---------- 519 (753)
+.|+.++-|.||+|.+.+|+.||||+.++.-.+ ....|+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 569999999999999999999999988643111 01111110
Q ss_pred -------HHHhCC-CCceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhccccccc
Q 004442 520 -------LIASDQ-HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591 (753)
Q Consensus 520 -------ll~~l~-HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~ 591 (753)
.-...+ .+++.--.=|+.-.....|+|||++| =.+.+....+.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~G----------i~i~d~~~l~~------------------- 261 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDG----------IKISDIAALKS------------------- 261 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCC----------EecccHHHHHh-------------------
Confidence 111122 23332222233346678999995554 34443321111
Q ss_pred chhhhhhhcCCCCHHHHHHHHHHHHHH-HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccC
Q 004442 592 TKDIELWKANGHPSAQLLKVTRDIVSG-LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (753)
Q Consensus 592 ~~~~~~~~~~~l~~~~~l~Ia~qIa~g-L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~ 660 (753)
.+++ ...|+..++++ +..+-..|+.|.|..|.||++..++. +.+-|||+.....+
T Consensus 262 ---------~g~d---~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~~ 317 (517)
T COG0661 262 ---------AGID---RKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLDP 317 (517)
T ss_pred ---------cCCC---HHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCc--EEEEcCcceecCCH
Confidence 1122 12333333333 33344579999999999999988866 77999999887654
|
|
| >TIGR03300 assembly_YfgL outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00074 Score=75.09 Aligned_cols=112 Identities=22% Similarity=0.272 Sum_probs=65.6
Q ss_pred CCceeeeeccccCcee-eeccCHHHH---HHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCccc
Q 004442 101 EDWELYFHSKRFGKMK-KLSSSAEEY---IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDE 176 (753)
Q Consensus 101 ~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (753)
.+..||.-+...|++. ++....+.+ ...+|.+.+ |.+.+|+....++.+|++||+++-........ +...
T Consensus 153 ~~g~l~a~d~~tG~~~W~~~~~~~~~~~~~~~sp~~~~-~~v~~~~~~g~v~ald~~tG~~~W~~~~~~~~-----g~~~ 226 (377)
T TIGR03300 153 NDGRLTALDAATGERLWTYSRVTPALTLRGSASPVIAD-GGVLVGFAGGKLVALDLQTGQPLWEQRVALPK-----GRTE 226 (377)
T ss_pred CCCeEEEEEcCCCceeeEEccCCCceeecCCCCCEEEC-CEEEEECCCCEEEEEEccCCCEeeeeccccCC-----CCCc
Confidence 4566666666667665 333222221 124676654 67999999899999999999998764321110 1000
Q ss_pred CcceeccCCcchhhccccccccccccceEEEEeeeeeeecCCCCceEEEEee
Q 004442 177 NKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVA 228 (753)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (753)
..++..+..- |.+. ...|++...+-.+..+.+++|+.+|+..
T Consensus 227 ~~~~~~~~~~-----p~~~-----~~~vy~~~~~g~l~a~d~~tG~~~W~~~ 268 (377)
T TIGR03300 227 LERLVDVDGD-----PVVD-----GGQVYAVSYQGRVAALDLRSGRVLWKRD 268 (377)
T ss_pred hhhhhccCCc-----cEEE-----CCEEEEEEcCCEEEEEECCCCcEEEeec
Confidence 0111111111 2111 2356776667778889999999999875
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ. |
| >TIGR03300 assembly_YfgL outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0015 Score=72.67 Aligned_cols=152 Identities=18% Similarity=0.183 Sum_probs=99.2
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYI 126 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 126 (753)
.|...+++.||+||.+|..+|+++|++..+.++.+ ++.-++.-+|.- ..+..||.=+...|++. +.. ...-+
T Consensus 65 ~~~v~v~~~~g~v~a~d~~tG~~~W~~~~~~~~~~---~p~v~~~~v~v~--~~~g~l~ald~~tG~~~W~~~--~~~~~ 137 (377)
T TIGR03300 65 GGKVYAADADGTVVALDAETGKRLWRVDLDERLSG---GVGADGGLVFVG--TEKGEVIALDAEDGKELWRAK--LSSEV 137 (377)
T ss_pred CCEEEEECCCCeEEEEEccCCcEeeeecCCCCccc---ceEEcCCEEEEE--cCCCEEEEEECCCCcEeeeec--cCcee
Confidence 45678888999999999999999999999987643 233334334432 34678888888888887 333 22334
Q ss_pred HhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccccceEE
Q 004442 127 RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYI 206 (753)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (753)
.-+|.+ .++.|+++.....++++|++||+++-....+...-. .... ..|.+.+ -.+++
T Consensus 138 ~~~p~v-~~~~v~v~~~~g~l~a~d~~tG~~~W~~~~~~~~~~-------------~~~~---~sp~~~~-----~~v~~ 195 (377)
T TIGR03300 138 LSPPLV-ANGLVVVRTNDGRLTALDAATGERLWTYSRVTPALT-------------LRGS---ASPVIAD-----GGVLV 195 (377)
T ss_pred ecCCEE-ECCEEEEECCCCeEEEEEcCCCceeeEEccCCCcee-------------ecCC---CCCEEEC-----CEEEE
Confidence 456776 466799999889999999999999987644321100 0000 0011111 12334
Q ss_pred EEeeeeeeecCCCCceEEEEee
Q 004442 207 MRTDYVLQSTSQDSGEVLWNVA 228 (753)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~ 228 (753)
--.+-.+-.+.+++|+.+|...
T Consensus 196 ~~~~g~v~ald~~tG~~~W~~~ 217 (377)
T TIGR03300 196 GFAGGKLVALDLQTGQPLWEQR 217 (377)
T ss_pred ECCCCEEEEEEccCCCEeeeec
Confidence 3344566777888999999754
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00058 Score=78.66 Aligned_cols=140 Identities=21% Similarity=0.177 Sum_probs=85.1
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCch----------------------------------------HHHHHHH
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----------------------------------------VALKEIQ 518 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~----------------------------------------~~~~Ei~ 518 (753)
+.||.-+.|.||+|.+.+|+.||||+-++.-.+ ++.+|-+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 669999999999999999999999987543111 0111111
Q ss_pred ---HHHHhCCCCce---eeeccc-ccCCceEEEEEccccC-ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccc
Q 004442 519 ---NLIASDQHPNI---VRWYGV-ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590 (753)
Q Consensus 519 ---~ll~~l~HpNI---V~L~g~-~~~~~~~~LV~E~c~~-~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~ 590 (753)
+....++|-++ |..-.+ +.-.....|+||||+| .++|+.++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~------------------------------ 296 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID------------------------------ 296 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH------------------------------
Confidence 12334456551 222222 2335678999996665 344443321
Q ss_pred cchhhhhhhcCCCCHHHHHHHHHHHHHHH-HHhhhCCccccCCCCCcEEEecC--CCCeEEEEeccCceeccC
Q 004442 591 NTKDIELWKANGHPSAQLLKVTRDIVSGL-SHLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQG 660 (753)
Q Consensus 591 ~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL-~yLH~~~IiHrDLKp~NILL~~d--~~~~~KLsDFGla~~~~~ 660 (753)
..+++... |+..+.++. +-+-..|++|+|-.|-||+++++ +...+.+-|||+......
T Consensus 297 ---------~~gi~~~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 297 ---------KRGISPHD---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---------HcCCCHHH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22333333 333333321 11223589999999999999864 457799999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00079 Score=69.84 Aligned_cols=70 Identities=11% Similarity=0.024 Sum_probs=47.0
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCch-HHHHHHHHHHHhCCCCc--eeeecccccCCceEEEEEccccCC
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPN--IVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~-~~~~Ei~~ll~~l~HpN--IV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
..||+|..+.||+. .|..+++|........ ...+|.. .+..+..-. +.+.++++.+.+...+|||++.+.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~-~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFD-ASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHH-HHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 45899999999973 3556788887654333 3344444 555554333 356677777777788999988873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13360 PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A 3Q54_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0013 Score=67.64 Aligned_cols=164 Identities=19% Similarity=0.283 Sum_probs=100.6
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeee-ccCHHH-
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKL-SSSAEE- 124 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~- 124 (753)
..+..++++.+|+||.+|..+|+.+|++..+.++... +...+..+|... .+..||.=+...|++..- ....++
T Consensus 35 ~~~~v~~~~~~~~l~~~d~~tG~~~W~~~~~~~~~~~---~~~~~~~v~v~~--~~~~l~~~d~~tG~~~W~~~~~~~~~ 109 (238)
T PF13360_consen 35 DGGRVYVASGDGNLYALDAKTGKVLWRFDLPGPISGA---PVVDGGRVYVGT--SDGSLYALDAKTGKVLWSIYLTSSPP 109 (238)
T ss_dssp ETTEEEEEETTSEEEEEETTTSEEEEEEECSSCGGSG---EEEETTEEEEEE--TTSEEEEEETTTSCEEEEEEE-SSCT
T ss_pred eCCEEEEEcCCCEEEEEECCCCCEEEEeeccccccce---eeeccccccccc--ceeeeEecccCCcceeeeeccccccc
Confidence 4566777889999999999999999999998887554 344444455555 334888888888988732 222211
Q ss_pred --HH-HhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccc
Q 004442 125 --YI-RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIR 201 (753)
Q Consensus 125 --~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (753)
+. ...|.+. ++.++++.....++.+|++||+++-.+...... +..++-.+... . ..+-..+
T Consensus 110 ~~~~~~~~~~~~-~~~~~~~~~~g~l~~~d~~tG~~~w~~~~~~~~--------~~~~~~~~~~~-----~--~~~~~~~ 173 (238)
T PF13360_consen 110 AGVRSSSSPAVD-GDRLYVGTSSGKLVALDPKTGKLLWKYPVGEPR--------GSSPISSFSDI-----N--GSPVISD 173 (238)
T ss_dssp CSTB--SEEEEE-TTEEEEEETCSEEEEEETTTTEEEEEEESSTT---------SS--EEEETTE-----E--EEEECCT
T ss_pred cccccccCceEe-cCEEEEEeccCcEEEEecCCCcEEEEeecCCCC--------CCcceeeeccc-----c--cceEEEC
Confidence 22 2333344 556999999999999999999999886442211 00111000000 0 0000112
Q ss_pred cceEEEEeeeeeeecCCCCceEEEEeeecc
Q 004442 202 QLVYIMRTDYVLQSTSQDSGEVLWNVAYAD 231 (753)
Q Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (753)
-.|++.-.+..+-.+...+|+.+|.....+
T Consensus 174 ~~v~~~~~~g~~~~~d~~tg~~~w~~~~~~ 203 (238)
T PF13360_consen 174 GRVYVSSGDGRVVAVDLATGEKLWSKPISG 203 (238)
T ss_dssp TEEEEECCTSSEEEEETTTTEEEEEECSS-
T ss_pred CEEEEEcCCCeEEEEECCCCCEEEEecCCC
Confidence 255665555544555778888888655444
|
... |
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.002 Score=72.31 Aligned_cols=36 Identities=22% Similarity=0.279 Sum_probs=29.3
Q ss_pred HhCceeecCCeeeeeceeeeEEEEecccccEEecccC
Q 004442 127 RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
..+|.+. +|.|++++....++++|++||+++-...+
T Consensus 249 ~~sP~v~-~~~vy~~~~~g~l~ald~~tG~~~W~~~~ 284 (394)
T PRK11138 249 DTTPVVV-GGVVYALAYNGNLVALDLRSGQIVWKREY 284 (394)
T ss_pred CCCcEEE-CCEEEEEEcCCeEEEEECCCCCEEEeecC
Confidence 3578876 56799999889999999999999877433
|
|
| >cd00216 PQQ_DH Dehydrogenases with pyrrolo-quinoline quinone (PQQ) as cofactor, like ethanol, methanol, and membrane bound glucose dehydrogenases | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0021 Score=74.36 Aligned_cols=162 Identities=15% Similarity=0.198 Sum_probs=98.4
Q ss_pred CeeEEEecCceEEEEeccCCeeeEEecCCCCccccc---ccCCCCCCceeeec--------cCCCceeeeeccccCcee-
Q 004442 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY---QASFNSNASEFYLD--------VDEDWELYFHSKRFGKMK- 116 (753)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~- 116 (753)
+...|++.||.|+.+|..+|+.+|+|..+.+..-.| -+|.-.+ -++|+- |..+..+|--+...|++.
T Consensus 111 ~~V~v~~~~g~v~AlD~~TG~~~W~~~~~~~~~~~~~i~ssP~v~~-~~v~vg~~~~~~~~~~~~g~v~alD~~TG~~~W 189 (488)
T cd00216 111 RKVFFGTFDGRLVALDAETGKQVWKFGNNDQVPPGYTMTGAPTIVK-KLVIIGSSGAEFFACGVRGALRAYDVETGKLLW 189 (488)
T ss_pred CeEEEecCCCeEEEEECCCCCEeeeecCCCCcCcceEecCCCEEEC-CEEEEeccccccccCCCCcEEEEEECCCCceee
Confidence 888999999999999999999999999887631111 1111111 233332 234567777777788776
Q ss_pred eeccCHHH-H------------------HHhCceee-cCCeeeeecee------------------eeEEEEecccccEE
Q 004442 117 KLSSSAEE-Y------------------IRRMPYIS-KDGGVTLGAMK------------------TSVFLVDVKSGRVV 158 (753)
Q Consensus 117 ~~~~~~~~-~------------------~~~~~~~~-~~~~~~~~~~~------------------~~~~~~~~~~~~~~ 158 (753)
+.....++ . +--+|.+. .+|.|++|+-. .+++++|++||+++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~g~~vw~~pa~d~~~g~V~vg~~~g~~~~~~~~~~~~~~~~~~~l~Ald~~tG~~~ 269 (488)
T cd00216 190 RFYTTEPDPNAFPTWGPDRQMWGPGGGTSWASPTYDPKTNLVYVGTGNGSPWNWGGRRTPGDNLYTDSIVALDADTGKVK 269 (488)
T ss_pred EeeccCCCcCCCCCCCCCcceecCCCCCccCCeeEeCCCCEEEEECCCCCCCccCCccCCCCCCceeeEEEEcCCCCCEE
Confidence 44432111 0 11245555 46889999743 38999999999999
Q ss_pred ecccC---C-----CCCCCCCCCcccCcceeccCCcchhhccccccccccccceEEEEeeeeeeecCCCCceEEEEeeec
Q 004442 159 DNYVL---D-----FSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (753)
Q Consensus 159 ~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (753)
-.+.. | ..+++ .+..++. .+ ...+..|++-=.|=.+--+.+++|+++|.....
T Consensus 270 W~~~~~~~~~~~~~~~s~p---------~~~~~~~---------~~-g~~~~~V~~g~~~G~l~ald~~tG~~~W~~~~~ 330 (488)
T cd00216 270 WFYQTTPHDLWDYDGPNQP---------SLADIKP---------KD-GKPVPAIVHAPKNGFFYVLDRTTGKLISARPEV 330 (488)
T ss_pred EEeeCCCCCCcccccCCCC---------eEEeccc---------cC-CCeeEEEEEECCCceEEEEECCCCcEeeEeEee
Confidence 88532 1 11111 0000010 01 122345555444555777889999999987654
|
The alignment model contains an 8-bladed beta-propeller. |
| >PF13360 PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A 3Q54_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0014 Score=67.47 Aligned_cols=150 Identities=23% Similarity=0.399 Sum_probs=99.8
Q ss_pred CceEEEEeccCCeeeEEecCCCCccccccc-CCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHHHhCceeec
Q 004442 57 DGTIHLVDTKLGKIRWSFGTGRPIYSSYQA-SFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYIRRMPYISK 134 (753)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 134 (753)
||+|+.+|..+|+.+|+..-+.+. ..+.+ +...+..+|.. ..+..||.-+...|++. +... ++-+...| ..+
T Consensus 2 ~g~l~~~d~~tG~~~W~~~~~~~~-~~~~~~~~~~~~~v~~~--~~~~~l~~~d~~tG~~~W~~~~--~~~~~~~~-~~~ 75 (238)
T PF13360_consen 2 DGTLSALDPRTGKELWSYDLGPGI-GGPVATAVPDGGRVYVA--SGDGNLYALDAKTGKVLWRFDL--PGPISGAP-VVD 75 (238)
T ss_dssp TSEEEEEETTTTEEEEEEECSSSC-SSEEETEEEETTEEEEE--ETTSEEEEEETTTSEEEEEEEC--SSCGGSGE-EEE
T ss_pred CCEEEEEECCCCCEEEEEECCCCC-CCccceEEEeCCEEEEE--cCCCEEEEEECCCCCEEEEeec--ccccccee-eec
Confidence 799999999999999999876554 33331 22122234433 47888999998899887 4443 45555557 555
Q ss_pred CCeeeeeceeeeEEEEecccccEEec-ccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccccceEEEEeeeee
Q 004442 135 DGGVTLGAMKTSVFLVDVKSGRVVDN-YVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVL 213 (753)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 213 (753)
+|.|.++....+++.+|++||+++.. +....... . + . .-..+.+. ...+.+..++..+
T Consensus 76 ~~~v~v~~~~~~l~~~d~~tG~~~W~~~~~~~~~~---------~-~---~---~~~~~~~~-----~~~~~~~~~~g~l 134 (238)
T PF13360_consen 76 GGRVYVGTSDGSLYALDAKTGKVLWSIYLTSSPPA---------G-V---R---SSSSPAVD-----GDRLYVGTSSGKL 134 (238)
T ss_dssp TTEEEEEETTSEEEEEETTTSCEEEEEEE-SSCTC---------S-T---B-----SEEEEE-----TTEEEEEETCSEE
T ss_pred ccccccccceeeeEecccCCcceeeeecccccccc---------c-c---c---cccCceEe-----cCEEEEEeccCcE
Confidence 55588888767999999999999998 43310000 0 0 0 00001111 3456777778999
Q ss_pred eecCCCCceEEEEeeecccc
Q 004442 214 QSTSQDSGEVLWNVAYADFK 233 (753)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~ 233 (753)
--+.+.+|+++|.....+-.
T Consensus 135 ~~~d~~tG~~~w~~~~~~~~ 154 (238)
T PF13360_consen 135 VALDPKTGKLLWKYPVGEPR 154 (238)
T ss_dssp EEEETTTTEEEEEEESSTT-
T ss_pred EEEecCCCcEEEEeecCCCC
Confidence 99999999999999885534
|
... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00073 Score=70.15 Aligned_cols=50 Identities=24% Similarity=0.398 Sum_probs=41.6
Q ss_pred HHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 607 QLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 607 ~~l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
+...+..++++.+.-|-. .++||+||+.=|||+. ++. +.|+|||.|....
T Consensus 167 e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~~~ 217 (268)
T COG1718 167 EAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVTID 217 (268)
T ss_pred hHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccccC
Confidence 456778888888888887 7999999999999997 443 8999999887654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0016 Score=66.18 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=44.4
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCC--ceeeeccccc---CCceEEEEEccccCC
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHP--NIVRWYGVES---DQDFVYLSLERCTCS 552 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~Hp--NIV~L~g~~~---~~~~~~LV~E~c~~~ 552 (753)
+.|+.|..+.||+....+ ..+++|.............+..++..+... .+.++++++. .....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999877766 699999976552222222222233333322 3456665432 234579999988873
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0025 Score=66.40 Aligned_cols=69 Identities=12% Similarity=-0.000 Sum_probs=42.5
Q ss_pred ecccCc-eEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEccccC
Q 004442 481 IAKGSN-GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 481 IG~G~f-G~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
|-.|.. ..||+.... +..+.||+..........+|.. ++..+ .+--+.++++++...+.-++|||++++
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~~~~~~~E~~-~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGPTYELEREAE-RLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCcccchHHHHH-HHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 444544 788887554 4788888876543333445554 22332 233355777777666678999997776
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0046 Score=63.52 Aligned_cols=43 Identities=28% Similarity=0.516 Sum_probs=37.1
Q ss_pred HHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCce
Q 004442 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (753)
Q Consensus 611 Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~ 656 (753)
++..++.++.-||+.|+.|+|..|.|++++.++ +++.||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 456677889999999999999999999998665 8899998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0048 Score=62.16 Aligned_cols=97 Identities=22% Similarity=0.169 Sum_probs=71.1
Q ss_pred HHHhCCC-CceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhh
Q 004442 520 LIASDQH-PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598 (753)
Q Consensus 520 ll~~l~H-pNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (753)
++..+++ +++.+++|+|.. ++|.| |...+++...-. .+ .
T Consensus 12 ll~~l~~~~~~pk~lG~CG~----~~v~E----------~~~~~~~~~~~~-------~l-------------------~ 51 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSCGR----FYVVE----------YVGAGSLYGIYR-------PL-------------------S 51 (188)
T ss_pred HHHHcCCCCCCCCeeeECCC----EEEEE----------eecCcccccccc-------cc-------------------c
Confidence 6666766 699999999954 67888 544444332100 00 0
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHhhh---CCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 599 KANGHPSAQLLKVTRDIVSGLSHLHE---IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 599 ~~~~l~~~~~l~Ia~qIa~gL~yLH~---~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
.....+|..+.+||.++++.+.+|++ ..+.-.|++++|+-+++++. +|+.|...+...
T Consensus 52 ~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~~~ 112 (188)
T PF12260_consen 52 QFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVFVE 112 (188)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcchh
Confidence 11245788999999999999999998 35888999999999987765 999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0057 Score=62.20 Aligned_cols=133 Identities=18% Similarity=0.230 Sum_probs=87.7
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCC-------------------chHHHHHHHHH--HH---hCCCCceeeecc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-------------------HDVALKEIQNL--IA---SDQHPNIVRWYG 534 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-------------------~~~~~~Ei~~l--l~---~l~HpNIV~L~g 534 (753)
..||+|+.-.||. .++....+||++.... ..+..+|+... ++ ...+.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999994 4556778899887655 34445555432 12 345889999999
Q ss_pred cccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHH
Q 004442 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (753)
Q Consensus 535 ~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~q 614 (753)
+...+.-.-+|+|.....-. ...-+|.+++.. ..++. .+...
T Consensus 85 ~veT~~G~Glv~e~I~d~dG----~~s~TL~~~l~~------------------------------~~~~~----~~~~~ 126 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADG----NISPTLEDYLKE------------------------------GGLTE----ELRQA 126 (199)
T ss_pred EEecCCceEEEEEEEECCCC----CcCccHHHHHHc------------------------------CCccH----HHHHH
Confidence 99988889999997653100 012334444421 22222 33334
Q ss_pred HHHHHHHhhhCCccccCCCCCcEEEecCCCC--eEEEEe
Q 004442 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSF--CAKLSD 651 (753)
Q Consensus 615 Ia~gL~yLH~~~IiHrDLKp~NILL~~d~~~--~~KLsD 651 (753)
+-+-..||-+..|+.+|++|.||++....+. .+.|+|
T Consensus 127 L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 127 LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 4455667788899999999999999765432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01011 PQQ: PQQ enzyme repeat family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0014 Score=48.12 Aligned_cols=36 Identities=39% Similarity=0.617 Sum_probs=31.6
Q ss_pred CeeEEEecCceEEEEeccCCeeeEEecCCCCccccc
Q 004442 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY 84 (753)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (753)
++..+++.||.||.+|..+|+.+|+|.++.+..+..
T Consensus 1 ~~v~~~~~~g~l~AlD~~TG~~~W~~~~~~~~~~~p 36 (38)
T PF01011_consen 1 GRVYVGTPDGYLYALDAKTGKVLWKFQTGPPVDSSP 36 (38)
T ss_dssp TEEEEETTTSEEEEEETTTTSEEEEEESSSGGGSCB
T ss_pred CEEEEeCCCCEEEEEECCCCCEEEeeeCCCCCccCc
Confidence 345678999999999999999999999999986654
|
; InterPro: IPR002372 Pyrrolo-quinoline quinone (PQQ) is a redox coenzyme, which serves as a cofactor for a number of enzymes (quinoproteins) and particularly for some bacterial dehydrogenases [, ]. A number of bacterial quinoproteins belong to this family. Enzymes in this group have repeats of a beta propeller.; PDB: 1H4I_C 1H4J_E 1W6S_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A 1G72_A .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0078 Score=74.12 Aligned_cols=74 Identities=12% Similarity=0.196 Sum_probs=49.5
Q ss_pred eEEecccCceEEEEEEeeCC---cEEEEEEeecCC----chHHHHHHHHHHHhCC-CCce--eeecccccCC---ceEEE
Q 004442 478 NKEIAKGSNGTVVLEGNYEG---RSVAVKRLVKTH----HDVALKEIQNLIASDQ-HPNI--VRWYGVESDQ---DFVYL 544 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g---~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~-HpNI--V~L~g~~~~~---~~~~L 544 (753)
.+.++.|.++.+|+....++ ..+++|+..... .....+|.. +++.+. |.++ .+.+++|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~-~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQ-VLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHH-HHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 46689999999998655443 467788764321 123445555 556554 6665 7888888765 45789
Q ss_pred EEccccCC
Q 004442 545 SLERCTCS 552 (753)
Q Consensus 545 V~E~c~~~ 552 (753)
|||++++.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99988773
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.023 Score=57.75 Aligned_cols=40 Identities=33% Similarity=0.582 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCc
Q 004442 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655 (753)
Q Consensus 609 l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla 655 (753)
.+-+.+|.+-|..||..||+-+|+++.|.. +| ||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 445678888899999999999999999987 43 69999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.019 Score=62.10 Aligned_cols=73 Identities=16% Similarity=0.015 Sum_probs=46.9
Q ss_pred EeEEecccCceEEEEEEeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCC-C--CceeeecccccC---CceEEEEEccc
Q 004442 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQ-H--PNIVRWYGVESD---QDFVYLSLERC 549 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~-H--pNIV~L~g~~~~---~~~~~LV~E~c 549 (753)
-.+.||+|..+.||.....++ .+.||..+.. ....+..|.. .++.+. + -.+.+.+++|.. .+..+||||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~~~~~~~~Ea~-~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFSTPGVAQQEAW-KLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccccchHHHHHHH-HHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 346799999999998766555 4667775442 2234445554 444432 2 246677776654 46689999977
Q ss_pred cC
Q 004442 550 TC 551 (753)
Q Consensus 550 ~~ 551 (753)
++
T Consensus 96 ~G 97 (297)
T PRK10593 96 RG 97 (297)
T ss_pred CC
Confidence 65
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0026 Score=75.79 Aligned_cols=44 Identities=14% Similarity=0.010 Sum_probs=38.5
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCC
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSS 306 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s 306 (753)
.|+.+.+.+|+|+|.|| .+.++ .|+.|||++|+|+|.||..+..
T Consensus 467 ~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 45778888999999998 47888 7999999999999999988764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.023 Score=58.65 Aligned_cols=68 Identities=16% Similarity=0.085 Sum_probs=39.8
Q ss_pred EEecccCceEEEEEEeeC--CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCc-eeeecccccCCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~--g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpN-IV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.|..|-...+|+....+ ++.|++|........ ...+|.. ++..+...+ ..++++.+. + .++|||+++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~-~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELR-IHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHH-HHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence 567888888999876654 678899977543211 2234544 344443222 344444332 1 479998876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.025 Score=56.14 Aligned_cols=127 Identities=20% Similarity=0.258 Sum_probs=79.8
Q ss_pred EeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCcee-eecccccCCceEEEEEccccCChhh
Q 004442 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV-RWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV-~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
..+.|++|.+|.||++... |..+|+|+=+.......+.-+.+++..+.-.++. +++.|.. -++.||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me-------- 92 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME-------- 92 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh--------
Confidence 4467999999999986654 5588888776555444444444466666655554 4555532 234499
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCC-
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP- 634 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp- 634 (753)
|+.+-.|.++-... + .+-...++..---|-..||-|..|.-
T Consensus 93 --~i~G~~L~~~~~~~--------------------------------~----rk~l~~vlE~a~~LD~~GI~H~El~~~ 134 (201)
T COG2112 93 --YIDGRPLGKLEIGG--------------------------------D----RKHLLRVLEKAYKLDRLGIEHGELSRP 134 (201)
T ss_pred --hhcCcchhhhhhcc--------------------------------c----HHHHHHHHHHHHHHHHhccchhhhcCC
Confidence 77666666543211 0 22334555554556667999999974
Q ss_pred -CcEEEecCCCCeEEEEeccCcee
Q 004442 635 -QNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 635 -~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.||++ .++. +.|+||.-|+.
T Consensus 135 ~k~vlv-~~~~--~~iIDFd~At~ 155 (201)
T COG2112 135 WKNVLV-NDRD--VYIIDFDSATF 155 (201)
T ss_pred ceeEEe-cCCc--EEEEEccchhh
Confidence 45555 3433 88999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.061 Score=60.49 Aligned_cols=70 Identities=23% Similarity=0.247 Sum_probs=46.2
Q ss_pred EEecccCceEEEEEEeeCC-cEEEEEEeec------C----CchHHHHHHHHHHHh---CCCCceeeecccccCCceEEE
Q 004442 479 KEIAKGSNGTVVLEGNYEG-RSVAVKRLVK------T----HHDVALKEIQNLIAS---DQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g-~~VAVK~l~~------~----~~~~~~~Ei~~ll~~---l~HpNIV~L~g~~~~~~~~~L 544 (753)
+.||.|.+..||+....+| +.|+||.-.+ . ..+....|.. .+.. ....++.+++.+ +.+..++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae-~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAE-ALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHH-HHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 5699999999999988777 5899998431 1 1122333433 2332 223457777777 4466789
Q ss_pred EEccccC
Q 004442 545 SLERCTC 551 (753)
Q Consensus 545 V~E~c~~ 551 (753)
|||+++.
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9998875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.019 Score=59.56 Aligned_cols=30 Identities=27% Similarity=0.433 Sum_probs=24.2
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.++|+|+.+.||+++.++ ..-|.||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGR--LSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEECCC--EEEEEeCcccCc
Confidence 599999999999996543 356999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.004 Score=73.45 Aligned_cols=176 Identities=17% Similarity=0.097 Sum_probs=128.9
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCC----------ceeeeccCCCceeeeeccccCceeeec
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNA----------SEFYLDVDEDWELYFHSKRFGKMKKLS 119 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (753)
+...+..++..|+||..+|+..|-|++..||+++++++--+.+ .-+|.++.+.|..|+.+.+.+++..+.
T Consensus 109 i~ysg~k~d~~~lvD~~tg~~~~tf~~~~~~~~~v~~grt~ytv~m~d~~~~~~~wn~t~~dy~a~~~~~~~~~~~~~~~ 188 (903)
T KOG1027|consen 109 ILYSGSKQDIWYLVDPKTGEIDYTFNTAEPIKQLVYLGRTNYTVTMYDKNVRGKTWNTTFGDYSAQYPSGVRGEKMSHFH 188 (903)
T ss_pred eEEecccccceEEecCCccceeEEEecCCcchhheecccceeEEecccCcccCceeeccccchhccCCCccCCceeEEEe
Confidence 5667788999999999999999999999999999998743322 278999999999999999999999666
Q ss_pred cCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccC-----cceeccCCcchhhcccc
Q 004442 120 SSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDEN-----KHVVPVDGYEELVESGV 194 (753)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 194 (753)
..--+|+--.++-+.+- +-+|-+.+.+++++-+.+.-++.|.|++.+..--..-... .++...++. ...
T Consensus 189 ~~~~g~i~t~D~~~g~~-~~~q~~~spvv~~~~~~~~gl~~~~~~~v~~~t~~~~~~~~~~v~~~~~~~~~~-----s~~ 262 (903)
T KOG1027|consen 189 SLGNGYIVTVDSESGEK-LWLQDLLSPVVALYTLFNDGLHSYPFVTVARETYQINALESGTVLLNIAPTKDE-----SPL 262 (903)
T ss_pred ecCCccEEeccCcccce-eeccccCCceEEEEeeccCceeeecceehhHHHHHHHHhhccccccccCCCcCc-----ccc
Confidence 55577776677777777 8899999999999999999999998888765411110000 112222222 111
Q ss_pred ccccccccceEEEEeeeeeeecCCCCceEEEEeeeccc
Q 004442 195 GNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADF 232 (753)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (753)
+..-..+....|++-|+.+.=|..-++ |-||+++..=
T Consensus 263 ~s~~~~~~~~~l~~~~~~~~l~~~~~~-v~~~v~~~~~ 299 (903)
T KOG1027|consen 263 ESSLDFQLLPTLYVGDSSTGLYASFSL-VHQNVPLVPR 299 (903)
T ss_pred ccccccccceeeEecCceeeEEeehhh-cccCceeccC
Confidence 222245667888888888887765544 4777766543
|
|
| >TIGR03074 PQQ_membr_DH membrane-bound PQQ-dependent dehydrogenase, glucose/quinate/shikimate family | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.023 Score=68.86 Aligned_cols=112 Identities=18% Similarity=0.230 Sum_probs=78.9
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCccccccc-----------------------CCCCCCceeeeccCCCce
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQA-----------------------SFNSNASEFYLDVDEDWE 104 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~ 104 (753)
-|+.-+++.+|.||.+|..+|+.+|+|..+.+..+.++. ++..+..||+-+ .|..
T Consensus 194 gg~lYv~t~~~~V~ALDa~TGk~lW~~d~~~~~~~~~~~~~cRGvay~~~p~~~~~~~~~~~p~~~~~rV~~~T--~Dg~ 271 (764)
T TIGR03074 194 GDTLYLCTPHNKVIALDAATGKEKWKFDPKLKTEAGRQHQTCRGVSYYDAPAAAAGPAAPAAPADCARRIILPT--SDAR 271 (764)
T ss_pred CCEEEEECCCCeEEEEECCCCcEEEEEcCCCCcccccccccccceEEecCCcccccccccccccccCCEEEEec--CCCe
Confidence 578888999999999999999999999999887443321 112222355433 3777
Q ss_pred eeeeccccCcee-eec------cCH-------HH-HHHhCceeecCCeeeeece----------eeeEEEEecccccEEe
Q 004442 105 LYFHSKRFGKMK-KLS------SSA-------EE-YIRRMPYISKDGGVTLGAM----------KTSVFLVDVKSGRVVD 159 (753)
Q Consensus 105 ~~~~~~~~~~~~-~~~------~~~-------~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~ 159 (753)
||--+...|++. .+. |.. .. .+--.|.|.++- |++|+- .-.+.+.|++||+++-
T Consensus 272 LiALDA~TGk~~W~fg~~G~vdl~~~~g~~~~g~~~~ts~P~V~~g~-VIvG~~v~d~~~~~~~~G~I~A~Da~TGkl~W 350 (764)
T TIGR03074 272 LIALDADTGKLCEDFGNNGTVDLTAGMGTTPPGYYYPTSPPLVAGTT-VVIGGRVADNYSTDEPSGVIRAFDVNTGALVW 350 (764)
T ss_pred EEEEECCCCCEEEEecCCCceeeecccCcCCCcccccccCCEEECCE-EEEEecccccccccCCCcEEEEEECCCCcEee
Confidence 888888888877 322 211 11 245668888665 888853 4568999999999998
Q ss_pred ccc
Q 004442 160 NYV 162 (753)
Q Consensus 160 ~~~ 162 (753)
..+
T Consensus 351 ~~~ 353 (764)
T TIGR03074 351 AWD 353 (764)
T ss_pred EEe
Confidence 743
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Members of this family have several predicted transmembrane helices in the N-terminal region, and include the quinoprotein glucose dehydrogenase (EC 1.1.5.2) of Escherichia coli and the quinate/shikimate dehydrogenase of Acinetobacter sp. ADP1 (EC 1.1.99.25). Sequences closely related except for the absense of the N-terminal hydrophobic region, scoring in the gray zone between the trusted and noise cutoffs, include PQQ-dependent glycerol (EC 1.1.99.22) and and other polyol (sugar alcohol) dehydrogenases. |
| >cd00216 PQQ_DH Dehydrogenases with pyrrolo-quinoline quinone (PQQ) as cofactor, like ethanol, methanol, and membrane bound glucose dehydrogenases | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.023 Score=65.73 Aligned_cols=128 Identities=14% Similarity=0.069 Sum_probs=81.5
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecCC-CCcccccccCCCCCCceeeec-----------------cCCCceeeeeccc
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGTG-RPIYSSYQASFNSNASEFYLD-----------------VDEDWELYFHSKR 111 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 111 (753)
+.++++.+|.+|.+|-.+|+++|++..+ .++.. ++ ...|+. -+.+..||-=+..
T Consensus 303 ~V~~g~~~G~l~ald~~tG~~~W~~~~~~~~~~~-------~~-~~vyv~~~~~~~~~~~~~~~~~~~~~~G~l~AlD~~ 374 (488)
T cd00216 303 AIVHAPKNGFFYVLDRTTGKLISARPEVEQPMAY-------DP-GLVYLGAFHIPLGLPPQKKKRCKKPGKGGLAALDPK 374 (488)
T ss_pred EEEEECCCceEEEEECCCCcEeeEeEeecccccc-------CC-ceEEEccccccccCcccccCCCCCCCceEEEEEeCC
Confidence 5778889999999999999999999865 22211 11 112331 1234567777777
Q ss_pred cCcee-eeccC-------HHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCC--CcccCccee
Q 004442 112 FGKMK-KLSSS-------AEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGF--QSDENKHVV 181 (753)
Q Consensus 112 ~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 181 (753)
.|++. +.... ...-..-.|+...+|.|+.|+....++++|++||+++-.+........-+. -.++..-|.
T Consensus 375 tG~~~W~~~~~~~~~~~~~g~~~~~~~~~~~g~~v~~g~~dG~l~ald~~tG~~lW~~~~~~~~~a~P~~~~~~g~~yv~ 454 (488)
T cd00216 375 TGKVVWEKREGTIRDSWNIGFPHWGGSLATAGNLVFAGAADGYFRAFDATTGKELWKFRTPSGIQATPMTYEVNGKQYVG 454 (488)
T ss_pred CCcEeeEeeCCccccccccCCcccCcceEecCCeEEEECCCCeEEEEECCCCceeeEEECCCCceEcCEEEEeCCEEEEE
Confidence 88776 33322 001112246666778899999999999999999999999766444333222 233444444
Q ss_pred ccCC
Q 004442 182 PVDG 185 (753)
Q Consensus 182 ~~~~ 185 (753)
....
T Consensus 455 ~~~g 458 (488)
T cd00216 455 VMVG 458 (488)
T ss_pred EEec
Confidence 4444
|
The alignment model contains an 8-bladed beta-propeller. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.0099 Score=72.84 Aligned_cols=184 Identities=19% Similarity=0.213 Sum_probs=109.9
Q ss_pred HHHhCCCCceeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhh
Q 004442 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599 (753)
Q Consensus 520 ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (753)
.+..+.|+|++++++|..+....-++++-... +...-++...+ ..
T Consensus 235 ~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~------~~s~~~~~~~~-----------------------------q~ 279 (1351)
T KOG1035|consen 235 SLSKIAHDNLGGYFVYGLERLFRGIVLDVLQE------ICSKVELRSLL-----------------------------QS 279 (1351)
T ss_pred HHHhhccccccceeEEeehhhcchHHHHHHHh------hcCccchHHHH-----------------------------hh
Confidence 67788999999999987655433333221110 22222222222 22
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC---cEEEecCCCCeEEEE--eccCceeccCCCcccccCccCCCC
Q 004442 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ---NVLISKDKSFCAKLS--DMGISKRLQGDMSCLTQNATGYGS 674 (753)
Q Consensus 600 ~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~---NILL~~d~~~~~KLs--DFGla~~~~~~~~~~~~~~~~~GT 674 (753)
...++....+.+..+...||.|+|+....|.-+..+ +--. ++.....++ ||+..+........ ....-+
T Consensus 280 v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~--~~e~~~~~sl~~~~ss~~l~d~~~~----~~~~~~ 353 (1351)
T KOG1035|consen 280 VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTV--DGEGVVAISLSDFDSSKPLPDNEKS----FSDLLA 353 (1351)
T ss_pred ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccccccc--CccceeecchhhhcccccCCCcccc----hhhcCc
Confidence 345677888899999999999999986666655554 3333 333345555 88877766543211 112235
Q ss_pred ccccccccccCCCCCc--hhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCC
Q 004442 675 SGWQAPEQLLQGRQTR--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 675 ~~Y~APE~l~~~~~t~--ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
..|.|+|......+.. ..|+|.+|.....+..|...+-.... .. .. .......+..++..+|+.-|+++
T Consensus 354 ~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~---~~---~~---l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 354 EIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV---PV---SL---LDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred cccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc---hh---hh---hccccchhhhhhhhhhcchhhhh
Confidence 6788999887777654 47999999999999988433221110 00 00 01111115667777777777766
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 425 R 425 (1351)
T KOG1035|consen 425 R 425 (1351)
T ss_pred c
Confidence 5
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.0063 Score=76.25 Aligned_cols=41 Identities=15% Similarity=0.115 Sum_probs=20.7
Q ss_pred cccccCCccccccc-cccCC-CcccceeecCccccccCCCCCC
Q 004442 266 SHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSS 306 (753)
Q Consensus 266 ~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s 306 (753)
.+.+.+|+++|.+| .+.++ .|+.|||++|+++|.+|..+..
T Consensus 527 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 569 (968)
T PLN00113 527 SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGN 569 (968)
T ss_pred EEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhc
Confidence 33444555555554 34444 4555555555555555554433
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.068 Score=57.84 Aligned_cols=31 Identities=35% Similarity=0.491 Sum_probs=25.9
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.++||+|+.+.||+++.++ ...|.||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeecccccC
Confidence 4799999999999997765 367999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG1520 FOG: WD40-like repeat [Function unknown] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.15 Score=56.81 Aligned_cols=159 Identities=21% Similarity=0.304 Sum_probs=106.8
Q ss_pred CeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccC--HHHH
Q 004442 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSS--AEEY 125 (753)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~ 125 (753)
...+|++.||++|..|..+|+..|+++.+. . -.+-+++.-....-|... ++..+|-=.+..|+.+ ....+ +..-
T Consensus 112 G~i~~g~~~g~~y~ld~~~G~~~W~~~~~~-~-~~~~~~~v~~~~~v~~~s-~~g~~~al~~~tG~~~W~~~~~~~~~~~ 188 (370)
T COG1520 112 GKIYVGSWDGKLYALDASTGTLVWSRNVGG-S-PYYASPPVVGDGTVYVGT-DDGHLYALNADTGTLKWTYETPAPLSLS 188 (370)
T ss_pred CeEEEecccceEEEEECCCCcEEEEEecCC-C-eEEecCcEEcCcEEEEec-CCCeEEEEEccCCcEEEEEecCCccccc
Confidence 457899999999999999999999999998 2 223333333334445444 7788888888888887 44433 3555
Q ss_pred HHhCceeecCCeeeeece--eeeEEEEecccccEEecccC----CCCCCCCCCCcccCcceeccCCcchhhccccccccc
Q 004442 126 IRRMPYISKDGGVTLGAM--KTSVFLVDVKSGRVVDNYVL----DFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKR 199 (753)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (753)
+.-.|. ..+|.|++|.. ....+++|+.+|..+-+... +.+... .+.. +.+-...++
T Consensus 189 ~~~~~~-~~~~~vy~~~~~~~~~~~a~~~~~G~~~w~~~~~~~~~~~~~~-------~~~~--~~~~~v~v~-------- 250 (370)
T COG1520 189 IYGSPA-IASGTVYVGSDGYDGILYALNAEDGTLKWSQKVSQTIGRTAIS-------TTPA--VDGGPVYVD-------- 250 (370)
T ss_pred cccCce-eecceEEEecCCCcceEEEEEccCCcEeeeeeeecccCccccc-------cccc--ccCceEEEC--------
Confidence 566666 56666999998 77899999999999998322 111110 0111 112101111
Q ss_pred cccceEEEEeeeeeeecCCCCceEEEEeeec
Q 004442 200 IRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (753)
Q Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (753)
.-+++...+..+--+-.++|+.+|+....
T Consensus 251 --~~~~~~~~~g~~~~l~~~~G~~~W~~~~~ 279 (370)
T COG1520 251 --GGVYAGSYGGKLLCLDADTGELIWSFPAG 279 (370)
T ss_pred --CcEEEEecCCeEEEEEcCCCceEEEEecc
Confidence 12267777777778888999999999884
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.088 Score=56.38 Aligned_cols=167 Identities=14% Similarity=0.033 Sum_probs=80.1
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCc--eeeecccc------cCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN--IVRWYGVE------SDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN--IV~L~g~~------~~~~~~~LV~E~c~ 550 (753)
+.|..|....+|+... ++..+++|+...........|.. ++..+.+.+ +.+.+... ...+..++++++++
T Consensus 20 ~~i~~G~~n~~y~v~~-~~~~~vLr~~~~~~~~~~~~e~~-~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~ 97 (296)
T cd05153 20 EGISAGIENTNYFVTT-DSGRYVLTLFEKVSAEELPFFLA-LLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLA 97 (296)
T ss_pred ecccCccccceEEEEe-CCCcEEEEEcCCCChHhccHHHH-HHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCC
Confidence 5577788789998654 34578889876532223333333 444443322 44444421 12345689999888
Q ss_pred CC-hh---hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh--
Q 004442 551 CS-LN---DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-- 624 (753)
Q Consensus 551 ~~-L~---~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-- 624 (753)
+. +. .-.+..-|..--.+|........... ..+. ..............+.. ... ..+...+.++.+
T Consensus 98 G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~l~~-~~~---~~~~~~~~~l~~~~ 169 (296)
T cd05153 98 GEHLTRPTAAHCRQIGEALARLHLAAQSFPGERN-NLRG---LAWIRELGKDLLPLLSA-EDR---ALLADELARQDAFD 169 (296)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCC-CcCC---cHHHHHHHHHhccccCH-HHH---HHHHHHHHHHHhhh
Confidence 63 21 11223334444444433221110000 0000 00000000000001111 111 122333333332
Q ss_pred -----CCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 625 -----IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 625 -----~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.++||+|+.|.||+++.++ .+.|.||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDE--LSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCc--eEEEeehhhhcC
Confidence 3699999999999997654 357999997754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.15 Score=55.23 Aligned_cols=31 Identities=32% Similarity=0.432 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.++||+|+.+.||+++.+. ..-|.||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEecccccC
Confidence 3799999999999997543 247999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.17 Score=54.41 Aligned_cols=30 Identities=27% Similarity=0.347 Sum_probs=25.2
Q ss_pred CccccCCCCCcEEEecC----CCCeEEEEeccCcee
Q 004442 626 GLIHRDLKPQNVLISKD----KSFCAKLSDMGISKR 657 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d----~~~~~KLsDFGla~~ 657 (753)
.++|+|+.+.||+++.+ +. ++++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~--i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKK--LVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCc--EEEEeeCCCCC
Confidence 68999999999999764 44 78999997753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR03075 PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methanol/ethanol family | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.24 Score=57.98 Aligned_cols=113 Identities=15% Similarity=0.165 Sum_probs=67.3
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCc--ccccccCCCCCCceeee----ccCCCceeeeeccccCcee-eec
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPI--YSSYQASFNSNASEFYL----DVDEDWELYFHSKRFGKMK-KLS 119 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~-~~~ 119 (753)
..+..+|++.||.|+.+|..+|+.+|++..+.+- |+.-.+|.-.+..+|.= ++..+..||--+...|++. ++.
T Consensus 119 ~~~~v~v~t~dg~l~ALDa~TGk~~W~~~~~~~~~~~~~tssP~v~~g~Vivg~~~~~~~~~G~v~AlD~~TG~~lW~~~ 198 (527)
T TIGR03075 119 YDGKVFFGTLDARLVALDAKTGKVVWSKKNGDYKAGYTITAAPLVVKGKVITGISGGEFGVRGYVTAYDAKTGKLVWRRY 198 (527)
T ss_pred ECCEEEEEcCCCEEEEEECCCCCEEeecccccccccccccCCcEEECCEEEEeecccccCCCcEEEEEECCCCceeEecc
Confidence 3467889999999999999999999999875432 11111121112122221 1223456666666666666 444
Q ss_pred cCHHH------------------------HHHh-------Cceee-cCCeeeeece----------------eeeEEEEe
Q 004442 120 SSAEE------------------------YIRR-------MPYIS-KDGGVTLGAM----------------KTSVFLVD 151 (753)
Q Consensus 120 ~~~~~------------------------~~~~-------~~~~~-~~~~~~~~~~----------------~~~~~~~~ 151 (753)
++++ .-++ ++.+- +.|.|++|.- ..|++++|
T Consensus 199 -~~p~~~~~~~~~~~~~~~~~~~~tw~~~~~~~gg~~~W~~~s~D~~~~lvy~~tGnp~p~~~~~r~gdnl~~~s~vAld 277 (527)
T TIGR03075 199 -TVPGDMGYLDKADKPVGGEPGAKTWPGDAWKTGGGATWGTGSYDPETNLIYFGTGNPSPWNSHLRPGDNLYTSSIVARD 277 (527)
T ss_pred -CcCCCcccccccccccccccccCCCCCCccccCCCCccCceeEcCCCCeEEEeCCCCCCCCCCCCCCCCccceeEEEEc
Confidence 2221 1111 11222 2567888872 35999999
Q ss_pred cccccEEec
Q 004442 152 VKSGRVVDN 160 (753)
Q Consensus 152 ~~~~~~~~~ 160 (753)
++||++.=.
T Consensus 278 ~~TG~~~W~ 286 (527)
T TIGR03075 278 PDTGKIKWH 286 (527)
T ss_pred cccCCEEEe
Confidence 999999855
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Genes in this family often are found adjacent to the PQQ biosynthesis genes themselves. An unusual, strained disulfide bond between adjacent Cys residues contributes to PQQ-binding, as does a Trp residue that is part of a PQQ enzyme repeat (see pfam01011). Characterized members include the dehydrogenase subunit of a membrane-anchored, three subunit alcohol (ethanol) dehydrogenase of Gluconobacter suboxydans, a homodimeric ethanol dehydrogenase in Pseudomonas aeruginosa, and the large subunit of an alpha2/beta2 heterotetrameric methanol dehydrogenase in Methylobacterium extorquens. |
| >TIGR03074 PQQ_membr_DH membrane-bound PQQ-dependent dehydrogenase, glucose/quinate/shikimate family | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.26 Score=59.88 Aligned_cols=151 Identities=15% Similarity=0.260 Sum_probs=88.9
Q ss_pred CCCeeEEEe----------cCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee
Q 004442 47 EPDVALVAA----------LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK 116 (753)
Q Consensus 47 ~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (753)
..|+.+|+. .+|.|+..|..+|+.+|.|.+|.|....-. .+...|--..+.-|..+-=++..|.|-
T Consensus 315 ~~g~VIvG~~v~d~~~~~~~~G~I~A~Da~TGkl~W~~~~g~p~~~~~~----~~g~~~~~gg~n~W~~~s~D~~~glvy 390 (764)
T TIGR03074 315 AGTTVVIGGRVADNYSTDEPSGVIRAFDVNTGALVWAWDPGNPDPTAPP----APGETYTRNTPNSWSVASYDEKLGLVY 390 (764)
T ss_pred ECCEEEEEecccccccccCCCcEEEEEECCCCcEeeEEecCCCCcccCC----CCCCEeccCCCCccCceEEcCCCCeEE
Confidence 467788873 489999999999999999999988753211 122244445666676666666666553
Q ss_pred eecc--CHHHHH--HhCceeecCCeeeeeceeeeEEEEecccccEEecc--------cCCCCCCCCCCCcccCcceeccC
Q 004442 117 KLSS--SAEEYI--RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY--------VLDFSASTPGFQSDENKHVVPVD 184 (753)
Q Consensus 117 ~~~~--~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~ 184 (753)
++. ..+++. .|+|. |. --..+++++|++||++.=.| |+|..+.+
T Consensus 391 -~ptGn~~pd~~g~~r~~~---~n-----~y~~slvALD~~TGk~~W~~Q~~~hD~WD~D~~~~p--------------- 446 (764)
T TIGR03074 391 -LPMGNQTPDQWGGDRTPA---DE-----KYSSSLVALDATTGKERWVFQTVHHDLWDMDVPAQP--------------- 446 (764)
T ss_pred -EeCCCccccccCCccccC---cc-----cccceEEEEeCCCCceEEEecccCCccccccccCCc---------------
Confidence 321 112221 22232 11 22678999999999998653 33444433
Q ss_pred CcchhhccccccccccccceEEEEeeeeeeecCCCCceEEEEeee
Q 004442 185 GYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAY 229 (753)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (753)
-|+|-...+ +...+.|...=.+=.+--+-.++|+.+|.+..
T Consensus 447 ---~L~d~~~~~-G~~~~~v~~~~K~G~~~vlDr~tG~~l~~~~e 487 (764)
T TIGR03074 447 ---SLVDLPDAD-GTTVPALVAPTKQGQIYVLDRRTGEPIVPVEE 487 (764)
T ss_pred ---eEEeeecCC-CcEeeEEEEECCCCEEEEEECCCCCEEeecee
Confidence 122211011 22344444444444455667789999997643
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Members of this family have several predicted transmembrane helices in the N-terminal region, and include the quinoprotein glucose dehydrogenase (EC 1.1.5.2) of Escherichia coli and the quinate/shikimate dehydrogenase of Acinetobacter sp. ADP1 (EC 1.1.99.25). Sequences closely related except for the absense of the N-terminal hydrophobic region, scoring in the gray zone between the trusted and noise cutoffs, include PQQ-dependent glycerol (EC 1.1.99.22) and and other polyol (sugar alcohol) dehydrogenases. |
| >TIGR03075 PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methanol/ethanol family | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.12 Score=60.50 Aligned_cols=112 Identities=21% Similarity=0.199 Sum_probs=75.4
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCccccc-cc-------CCCCCCceeeeccCCCceeeeeccccCcee-ee
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY-QA-------SFNSNASEFYLDVDEDWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 118 (753)
.++..|++.+|.|+.+|..+|+.+|++..+.|....- .+ ++-.+..+|+- .-|..||--+...|++. +.
T Consensus 69 ~g~vyv~s~~g~v~AlDa~TGk~lW~~~~~~~~~~~~~~~~~~~~rg~av~~~~v~v~--t~dg~l~ALDa~TGk~~W~~ 146 (527)
T TIGR03075 69 DGVMYVTTSYSRVYALDAKTGKELWKYDPKLPDDVIPVMCCDVVNRGVALYDGKVFFG--TLDARLVALDAKTGKVVWSK 146 (527)
T ss_pred CCEEEEECCCCcEEEEECCCCceeeEecCCCCcccccccccccccccceEECCEEEEE--cCCCEEEEEECCCCCEEeec
Confidence 4677788999999999999999999999877632110 00 00111224442 34567777778888887 33
Q ss_pred ccC---HHHHHHhCceeecCCeeeeece------eeeEEEEecccccEEeccc
Q 004442 119 SSS---AEEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 119 ~~~---~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 162 (753)
... ....+.-+|.+.++ .|.+|+. .-.++++|++||+++=...
T Consensus 147 ~~~~~~~~~~~tssP~v~~g-~Vivg~~~~~~~~~G~v~AlD~~TG~~lW~~~ 198 (527)
T TIGR03075 147 KNGDYKAGYTITAAPLVVKG-KVITGISGGEFGVRGYVTAYDAKTGKLVWRRY 198 (527)
T ss_pred ccccccccccccCCcEEECC-EEEEeecccccCCCcEEEEEECCCCceeEecc
Confidence 321 11235567888755 5999864 4579999999999998743
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Genes in this family often are found adjacent to the PQQ biosynthesis genes themselves. An unusual, strained disulfide bond between adjacent Cys residues contributes to PQQ-binding, as does a Trp residue that is part of a PQQ enzyme repeat (see pfam01011). Characterized members include the dehydrogenase subunit of a membrane-anchored, three subunit alcohol (ethanol) dehydrogenase of Gluconobacter suboxydans, a homodimeric ethanol dehydrogenase in Pseudomonas aeruginosa, and the large subunit of an alpha2/beta2 heterotetrameric methanol dehydrogenase in Methylobacterium extorquens. |
| >smart00564 PQQ beta-propeller repeat | Back alignment and domain information |
|---|
Probab=94.54 E-value=0.048 Score=38.16 Aligned_cols=28 Identities=32% Similarity=0.652 Sum_probs=25.0
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEec
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFG 75 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 75 (753)
.+...+++.||.|+.+|..+|+.+|++.
T Consensus 6 ~~~v~~~~~~g~l~a~d~~~G~~~W~~~ 33 (33)
T smart00564 6 DGTVYVGSTDGTLYALDAKTGEILWTYK 33 (33)
T ss_pred CCEEEEEcCCCEEEEEEcccCcEEEEcC
Confidence 4478899999999999999999999974
|
Beta-propeller repeat occurring in enzymes with pyrrolo-quinoline quinone (PQQ) as cofactor, in Ire1p-like Ser/Thr kinases, and in prokaryotic dehydrogenases. |
| >COG1520 FOG: WD40-like repeat [Function unknown] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.28 Score=54.63 Aligned_cols=158 Identities=18% Similarity=0.254 Sum_probs=97.1
Q ss_pred CCCCCeeEEE-ecCceEEEEeccCCeeeEEecCCC--CcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eecc
Q 004442 45 PPEPDVALVA-ALDGTIHLVDTKLGKIRWSFGTGR--PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSS 120 (753)
Q Consensus 45 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 120 (753)
|..-|=.+++ +.||+|+.+|..+|+++|+..... .. -+..+..+ |--+|.=+. +..+|.=+.+.|++. ..+.
T Consensus 64 ~~~~dg~v~~~~~~G~i~A~d~~~g~~~W~~~~~~~~~~-~~~~~~~~-~G~i~~g~~--~g~~y~ld~~~G~~~W~~~~ 139 (370)
T COG1520 64 PADGDGTVYVGTRDGNIFALNPDTGLVKWSYPLLGAVAQ-LSGPILGS-DGKIYVGSW--DGKLYALDASTGTLVWSRNV 139 (370)
T ss_pred cEeeCCeEEEecCCCcEEEEeCCCCcEEecccCcCccee-ccCceEEe-CCeEEEecc--cceEEEEECCCCcEEEEEec
Confidence 4555555544 599999999999999999877664 11 11111111 111333332 226666666677776 3332
Q ss_pred CHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhcccccccccc
Q 004442 121 SAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRI 200 (753)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (753)
.-. +....|.+-.||.|+.++-.-.++.||+.||...-.+..+.. .. .+ + .+. |+ ..
T Consensus 140 ~~~-~~~~~~~v~~~~~v~~~s~~g~~~al~~~tG~~~W~~~~~~~-~~---~~-----~---~~~-----~~-----~~ 196 (370)
T COG1520 140 GGS-PYYASPPVVGDGTVYVGTDDGHLYALNADTGTLKWTYETPAP-LS---LS-----I---YGS-----PA-----IA 196 (370)
T ss_pred CCC-eEEecCcEEcCcEEEEecCCCeEEEEEccCCcEEEEEecCCc-cc---cc-----c---ccC-----ce-----ee
Confidence 221 666788889999899998888999999999999888655332 11 00 0 111 11 11
Q ss_pred ccceEEEEe--eeeeeecCCCCceEEEEeee
Q 004442 201 RQLVYIMRT--DYVLQSTSQDSGEVLWNVAY 229 (753)
Q Consensus 201 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 229 (753)
.-.|++.-. +..+--+-++.|...|+..+
T Consensus 197 ~~~vy~~~~~~~~~~~a~~~~~G~~~w~~~~ 227 (370)
T COG1520 197 SGTVYVGSDGYDGILYALNAEDGTLKWSQKV 227 (370)
T ss_pred cceEEEecCCCcceEEEEEccCCcEeeeeee
Confidence 123444433 44677788999999999643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.043 Score=59.23 Aligned_cols=130 Identities=15% Similarity=0.170 Sum_probs=82.0
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeecC-----------------C--------chHHHHHHHHHHHhCC-CCc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-----------------H--------HDVALKEIQNLIASDQ-HPN 528 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~-----------------~--------~~~~~~Ei~~ll~~l~-HpN 528 (753)
+.+.+.||-|.-..||.+...+|++.++|.-+-. . .-.+.+|++-| +.+. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm-kaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM-KALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH-HHHHHcCC
Confidence 4567889999999999999999999999943100 0 01234555533 3332 211
Q ss_pred -eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHH
Q 004442 529 -IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (753)
Q Consensus 529 -IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 607 (753)
+.+- .+.+..++|||++. +=.|.+.-+- ..
T Consensus 173 pVPkp----iD~~RH~Vvmelv~----------g~Pl~~v~~v-----------------------------------~d 203 (465)
T KOG2268|consen 173 PVPKP----IDHNRHCVVMELVD----------GYPLRQVRHV-----------------------------------ED 203 (465)
T ss_pred CCCCc----ccccceeeHHHhhc----------ccceeeeeec-----------------------------------CC
Confidence 1122 24567889999443 2222221110 01
Q ss_pred HHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCce
Q 004442 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (753)
Q Consensus 608 ~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~ 656 (753)
.-.+...+..-+.-|...|+||+|..-=||+++.|+. ++++||-...
T Consensus 204 ~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 204 PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--EEEeechHhh
Confidence 1344455555667788899999999999999987765 8899996543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.48 Score=52.51 Aligned_cols=70 Identities=24% Similarity=0.295 Sum_probs=42.5
Q ss_pred EecccCceEEEEEEeeCC-cEEEEEEeec------CC----chHHHHHHHHHHHhCC-CC-ceeeecccccCCceEEEEE
Q 004442 480 EIAKGSNGTVVLEGNYEG-RSVAVKRLVK------TH----HDVALKEIQNLIASDQ-HP-NIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 480 ~IG~G~fG~Vyka~~~~g-~~VAVK~l~~------~~----~~~~~~Ei~~ll~~l~-Hp-NIV~L~g~~~~~~~~~LV~ 546 (753)
.||.|....||++...+| +.|+||.-.. .. .++...|...+...-. -| .+.+++.| +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 489999999999887654 6899997521 11 1233344432322211 13 45555554 667778999
Q ss_pred ccccC
Q 004442 547 ERCTC 551 (753)
Q Consensus 547 E~c~~ 551 (753)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 97754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.092 Score=55.15 Aligned_cols=30 Identities=20% Similarity=0.280 Sum_probs=25.6
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
.++|+|+.+.||+++.++ +.|.||..+...
T Consensus 147 ~l~H~Dl~~~Nil~~~~~---~~lIDwE~a~~g 176 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG---LKLIDWEYASDG 176 (256)
T ss_pred eeecCCCCcCcEEEeCCC---CEEEeccccCcC
Confidence 589999999999998765 579999988654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.13 E-value=0.76 Score=49.38 Aligned_cols=30 Identities=20% Similarity=0.355 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
.+++|+|+.+.||+++. +. +.|.||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-Cc--EEEEECccccc
Confidence 37899999999999976 33 68999996643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 753 | ||||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-46 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 8e-46 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-46 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-45 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 9e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-07 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-04 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 3e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 2hz6_A | 369 | The Crystal Structure Of Human Ire1-Alpha Luminal D | 9e-04 |
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2HZ6|A Chain A, The Crystal Structure Of Human Ire1-Alpha Luminal Domain Length = 369 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 277 bits (709), Expect = 1e-85
Identities = 84/306 (27%), Positives = 141/306 (46%), Gaps = 50/306 (16%)
Query: 459 TDLIDDRVDGRRIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 517
D D+ +GK+ + G+ GT+V G ++ R VAVKR++ A +E+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV 68
Query: 518 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
Q L SD+HPN++R++ E D+ F Y+++E C +L + +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV-------------------- 108
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
K H + + + + SGL+HLH + ++HRDLKP N+
Sbjct: 109 -------------------EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 638 LIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRA 691
LIS A +SD G+ K+L ++ + G+ GW APE L + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIPEAVDLFTRLLD 747
+D+FS GC+ ++ I+ G HP+G+S +R ANI+ L + A +L +++
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 748 PNPDLR 753
+P R
Sbjct: 270 MDPQKR 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 5e-83
Identities = 105/310 (33%), Positives = 163/310 (52%), Gaps = 58/310 (18%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 528
+ + LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPN 70
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R+Y E+ F+Y++LE C +L DL+ E N +++ L E
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYNPI---- 118
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-- 646
+ R I SG++HLH + +IHRDLKPQN+L+S F
Sbjct: 119 ---------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157
Query: 647 ---------AKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQG-------RQT 689
+SD G+ K+L S N G+SGW+APE L + R T
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK------DRKDLFLVEHIPEAVDLFT 743
R+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++ + K L I EA DL +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 744 RLLDPNPDLR 753
+++D +P R
Sbjct: 278 QMIDHDPLKR 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 4e-40
Identities = 69/283 (24%), Positives = 99/283 (34%), Gaps = 57/283 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ GS G V +GR AVKR + L E+ + QHP VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ +YL E C SL S E
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE-------------------------- 156
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
AQ+ RD + L+HLH GL+H D+KP N+ + KL D
Sbjct: 157 -------------AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDF 201
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G+ L + Q G + APE LLQG A D+FSLG + + P
Sbjct: 202 GLLVELGTAGAGEVQE----GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH 256
Query: 712 YGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
GE +++ + + + E + +L+P+P LR
Sbjct: 257 GGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 58/282 (20%), Positives = 108/282 (38%), Gaps = 46/282 (16%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-E 536
+ I G G V + +G++ +KR VK +++ A +E+ +A H NIV + G +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREV-KALAKLDHVNIVHYNGCWD 74
Query: 537 SDQDFVYLSLERCTCSLNDLIYVL-----SGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
S + + S +++ G+ E+ + +++ L++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDK----------- 121
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L++ I G+ ++H LI+RDLKP N+ + K K+ D
Sbjct: 122 --------------VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD 165
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+ L+ D T + +PEQ+ + +DL++LG IL +
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLR----YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
FE R + + L +LL P+ R
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDR 259
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 56/302 (18%), Positives = 104/302 (34%), Gaps = 74/302 (24%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
++I G G+V +G A+KR K AL+E+ QH ++VR+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ ++ D + + E Y GS + ++ + + E ++
Sbjct: 77 FSAWAEDDHMLIQNE----------YCNGGSLADAISENYRIMSYFKEAELK-------- 118
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---------- 642
+ + GL ++H + L+H D+KP N+ IS+
Sbjct: 119 -----------------DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161
Query: 643 -------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAID 693
K+ D+G R+ G S + A E +LQ D
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRISSPQVEE-------GDSRFLANE-VLQENYTHLPKAD 213
Query: 694 LFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
+F+L + C G + G+ + I + R E +L ++ P+P+
Sbjct: 214 IFALALTV-VCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE 269
Query: 752 LR 753
R
Sbjct: 270 RR 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 73/293 (24%), Positives = 113/293 (38%), Gaps = 20/293 (6%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
I +GS G V + N A+K + K + E++ + HPNI
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
R Y V D+ ++ L +E C L D + V + + + +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ + + R I S L +LH G+ HRD+KP+N L S +KSF K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 649 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 705
L D G+SK + T G+ + APE L + D +S G +L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 706 TGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
G P G + + V ++K F + P A DL + LL+ N D R
Sbjct: 271 M-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 57/296 (19%), Positives = 107/296 (36%), Gaps = 66/296 (22%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 532
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y E ++Y+ +E LN + S + E +
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 112 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDF 151
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 701
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 152 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 702 FFCITGGKHPYG---ESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ GK P+ + I+ ++ + + D+ L +P R
Sbjct: 211 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 6e-32
Identities = 60/312 (19%), Positives = 111/312 (35%), Gaps = 43/312 (13%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 534
+ + +G G V + + + A+KR+ + ++A +++ +A +HP IVR++
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP------- 587
+ E L D S ++A ++ +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 588 -------VME--NTKDIELWKANG-----HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633
M+ ++++ W L + I + LH GL+HRDLK
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191
Query: 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLL 684
P N+ + D K+ D G+ + D T + +PEQ+
Sbjct: 192 PSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDL 741
+ +D+FSLG ILF + + + ER I R F + P+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 742 FTRLLDPNPDLR 753
+L P+P R
Sbjct: 306 VQDMLSPSPTER 317
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 54/284 (19%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 536
+ KG+ G V + +A+K + + + L +H NIV++ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 537 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
S+ F+ + +E+ SL+ L+ G ++ NE I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKD------------NEQTIGFY--------- 127
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
T+ I+ GL +LH+ ++HRD+K NVLI+ S K+SD G S
Sbjct: 128 ----------------TKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTS 170
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYG 713
KRL G C T G+ + APE + +G + +A D++SLGC + T GK P+
Sbjct: 171 KRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFY 226
Query: 714 ESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
E E A + + + E + EA + +P+PD R
Sbjct: 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-32
Identities = 73/303 (24%), Positives = 119/303 (39%), Gaps = 79/303 (26%)
Query: 464 DRVDGR-RIGKLVVFNKEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHDVALK----E 516
D V G+ + IA G G + L + N GR V +K LV + A E
Sbjct: 76 DIVAGQYEVKGC------IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAE 129
Query: 517 IQNLIASDQHPNIVRWY--GVESDQD---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
Q L A HP+IV+ + +D+ Y+ +E YV S
Sbjct: 130 RQFL-AEVVHPSIVQIFNFVEHTDRHGDPVGYIVME----------YVGGQS-------- 170
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
L + + LPV A+ + +I+ LS+LH IGL++ D
Sbjct: 171 ------LKRSKGQKLPV-----------------AEAIAYLLEILPALSYLHSIGLVYND 207
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
LKP+N+++++++ KL D+G R + YG+ G+QAPE ++ T A
Sbjct: 208 LKPENIMLTEEQ---LKLIDLGAVSR-------INSFGYLYGTPGFQAPEI-VRTGPTVA 256
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNP 750
D++++G L + V + V ++ L R +DP+P
Sbjct: 257 TDIYTVGRTLAALTL-DLPTR------NGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 751 DLR 753
R
Sbjct: 310 RQR 312
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 59/282 (20%), Positives = 98/282 (34%), Gaps = 51/282 (18%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 537
+ +GS G V + + G AVK+ V+ ++E+ A P IV YG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLE-VFRVEEL-VACAGLSSPRIVPLYGAVR 120
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
+ +V + +E + GS + + + L E R
Sbjct: 121 EGPWVNIFME----------LLEGGSLGQLI----KQMGCLPEDRAL------------- 153
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+ GL +LH ++H D+K NVL+S D S L D G +
Sbjct: 154 ------------YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA-ALCDFGHALC 200
Query: 658 LQGDMSCLTQNATGY--GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
LQ D + Y G+ APE ++ +D++S C++ + G HP+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259
Query: 716 FERDA--NIVKDRKDLF-LVEHI-PEAVDLFTRLLDPNPDLR 753
F I + + + P L P R
Sbjct: 260 FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 66/296 (22%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 532
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y E ++Y+ +E LN + S + E +
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 130
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 131 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM---LKLIDF 170
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 701
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 171 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 702 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ GK P+ + + + I+ ++ + + D+ L +P R
Sbjct: 230 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 56/287 (19%), Positives = 110/287 (38%), Gaps = 54/287 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVR 531
K+I +G V +G VA+K++ +KEI +L+ HPN+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIK 96
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+Y + + + + LE +G + ++ L+ E +
Sbjct: 97 YYASFIEDNELNIVLE----------LADAGDLSRMIKHFKKQKRLIPERTV-------- 138
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K + S L H+H ++HRD+KP NV I+ KL D
Sbjct: 139 -----------------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGD 179
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
+G+ + + + G+ + +PE++ + D++SLGC+L+ + P
Sbjct: 180 LGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSP 235
Query: 712 Y-GESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ G+ + I + +H E L ++P+P+ R
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 64/388 (16%), Positives = 129/388 (33%), Gaps = 98/388 (25%)
Query: 387 YHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 446
+H + +T K ++ + T + +K + V
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-------- 53
Query: 447 ITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV 506
G + + ++IG G + V N + + A+K +
Sbjct: 54 ---KGRIYSI-----------LKQIGS----------GGSSKVFQVLNEKKQIYAIKYVN 89
Query: 507 KTHHD-VALKEIQNLIA-----SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 560
D L +N IA I+R Y E ++Y+ +E LN +
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KK 148
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620
S + E + ++++ +
Sbjct: 149 KKSIDP------------WERK---------------------------SYWKNMLEAVH 169
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
+H+ G++H DLKP N LI KL D GI+ ++Q D + + ++ + G+ + P
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPP 225
Query: 681 EQLL-----------QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR 726
E + + + + D++SLGCIL++ GK P+ + + + I+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPN 284
Query: 727 KDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ + + D+ L +P R
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQR 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 59/290 (20%), Positives = 114/290 (39%), Gaps = 66/290 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
++I +GS G +L + +GR +K + + + +E+ ++A+ +HPNIV++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV-AVLANMKHPNIVQY 88
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ +Y+ ++ C L I Q L E
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-------------NAQKGVLFQE----------- 124
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
Q+L I L H+H+ ++HRD+K QN+ ++KD + +L D
Sbjct: 125 --------------DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGD 168
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
GI++ L + G+ + +PE + + + D+++LGC+L+ T KH
Sbjct: 169 FGIARVLNSTVELAR---ACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCT-LKH 223
Query: 711 PY-GESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLR 753
+ S + I+ + + L ++L NP R
Sbjct: 224 AFEAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLVSQLFKRNPRDR 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 46/302 (15%), Positives = 98/302 (32%), Gaps = 28/302 (9%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 522
+ G R + +V + + + + E G S V T + +
Sbjct: 70 ESELGER-PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 122
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++R + ++ + DL+ ++ E+D +L+
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 583 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ E+ ++ L++T ++ L+ LH GL+H L+P ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAI 692
++ + L+ R S ++ G+ A L G+ T A
Sbjct: 243 VLDQRGG--VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPD 751
D ++LG +++ P DA + ++IP+ V L L +
Sbjct: 299 DTWTLGLAIYWIWC-ADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
Query: 752 LR 753
R
Sbjct: 354 DR 355
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 66/310 (21%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLI 521
+D + +F +++ +G V L EG ++G A+KR++ A +E
Sbjct: 26 IDNKH----YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH- 80
Query: 522 ASDQHPNIVRWYGVESDQDF----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
HPNI+R + +L L + G+ ++ + N
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLP----------FFKRGTLWNEIERLKDKGNF 130
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
L E +I L + I GL +H G HRDLKP N+
Sbjct: 131 LTEDQI-------------------------LWLLLGICRGLEAIHAKGYAHRDLKPTNI 165
Query: 638 LISKDKSFCAKLSDMGISK------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
L+ + L D+G L A + ++APE L +
Sbjct: 166 LLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCV 222
Query: 692 I----DLFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLFLVEHI-PEAVDLFT 743
I D++SLGC+L+ + G+ PY F++ A V+++ + L
Sbjct: 223 IDERTDVWSLGCVLYAMMF-GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281
Query: 744 RLLDPNPDLR 753
++ +P R
Sbjct: 282 SMMTVDPHQR 291
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/314 (20%), Positives = 115/314 (36%), Gaps = 89/314 (28%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGV 535
+ +G+ G VV + R A+K++ T + L E+ L+AS H +VR+Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAA 70
Query: 536 ESDQD-------------FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
++ +++ +E C +L DLI+ + + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-------------- 116
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
+ ++ R I+ LS++H G+IHRDLKP N+ I +
Sbjct: 117 -------------------------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-----------GSSGWQAPEQLLQ-GRQT 689
++ K+ D G++K + + L ++ G++ + A E L G
Sbjct: 152 SRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----------PEAV 739
ID++SLG I F I F V K L V
Sbjct: 210 EKIDMYSLGIIFFEMIYP--------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
Query: 740 DLFTRLLDPNPDLR 753
+ L+D +P+ R
Sbjct: 262 KIIRLLIDHDPNKR 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/306 (18%), Positives = 110/306 (35%), Gaps = 76/306 (24%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+ + +G G V + + + A+KR+ + ++ ++E++ +A +HP IVR++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYF 69
Query: 534 GVESDQD------------FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+++ ++Y+ ++ C +L D + + + E
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------------NGRCTIEERE 116
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
L + I + LH GL+HRDLKP N+ +
Sbjct: 117 RS------------------------VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLLQGRQTRA 691
D K+ D G+ + D T + +PEQ+ +
Sbjct: 153 MDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 692 IDLFSLGCILF-FCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLD 747
+D+FSLG ILF +P+ ER + R F + P + +L
Sbjct: 211 VDIFSLGLILFELL-----YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265
Query: 748 PNPDLR 753
P+P R
Sbjct: 266 PSPMER 271
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 45/309 (14%), Positives = 83/309 (26%), Gaps = 46/309 (14%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIA 522
+ + + + + G V L + E A+K + L E A
Sbjct: 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ D + V S QL+ + D + N +
Sbjct: 118 RLLGESPEEARDRRRLLLPS------------DAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 583 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ ++ L +T ++ ++L GL+H P N+
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL 225
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDL 694
I D L D+ ++ AP + L T A++
Sbjct: 226 FIMPDGR--LMLGDVSALWKVGTRGPAS-------SVPVTYAPREFLNASTATFTHALNA 276
Query: 695 FSLGCILFFCITGGKHPYGESFERDANIVK---------DRKDLFLVEHIPEAV-DLFTR 744
+ LG ++ P+G K D +P+ V L R
Sbjct: 277 WQLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 745 LLDPNPDLR 753
L+ + R
Sbjct: 336 FLNFDRRRR 344
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 56/287 (19%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWY 533
+ + + +G+ G V + + + VA+K++ ++ + E++ L + HPNIV+ Y
Sbjct: 10 IEVEEVVGRGAFGVV-CKAKWRAKDVAIKQIESESERKAFIVELRQL-SRVNHPNIVKLY 67
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + V L +E Y GS L+ E
Sbjct: 68 GACLNP--VCLVME----------YAEGGSLYNVLHGAEPLPYY---------------- 99
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLS 650
+A + G+++LH + LIHRDLKP N+L+ + K+
Sbjct: 100 ----------TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKIC 148
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G + +Q M+ GS+ W APE + D+FS G IL+ IT +
Sbjct: 149 DFGTACDIQTHMTNNK------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRK 201
Query: 711 PYGE---SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
P+ E R V + L++++P+ + L TR +P R
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 67/297 (22%), Positives = 120/297 (40%), Gaps = 60/297 (20%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ ++ K++ G+ G V+L A+K + + + L+E+ L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
D HPNI++ Y D+ YL +E L D I + F E A
Sbjct: 94 D-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAV----------- 140
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
+ + ++SG+++LH+ ++HRDLKP+N+L+ SK
Sbjct: 141 ----------------------------IIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+K K+ D G+S + + G++ + APE +L+ + D++S+G IL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKER----LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 702 FFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
F + G P G++ + V+ K F A DL ++L + R
Sbjct: 228 FILLA-GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 63/289 (21%), Positives = 106/289 (36%), Gaps = 54/289 (18%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 529
+ ++I GS GTV + G VAVK L++ +E+ + +HPNI
Sbjct: 39 LNIKEKIGAGSFGTV-HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIM-KRLRHPNI 96
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + G + + + E Y+ GS L+ L
Sbjct: 97 VLFMGAVTQPPNLSIVTE----------YLSRGSLYRLLHKSGAREQL------------ 134
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLISKDKSFCA 647
+ L + D+ G+++LH ++HR+LK N+L+ DK +
Sbjct: 135 --------------DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTV 178
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+S+ A G+ W APE L D++S G IL+ T
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT- 234
Query: 708 GKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+ P+G + A + K L + ++ V + P R
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 61/299 (20%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLI 521
+ + KGS G V+L + G+ AVK + K + L+E+Q L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
D HPNI++ Y D+ + YL E T L D I + F E A+
Sbjct: 82 QLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAAR--------- 130
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI- 639
+ R ++SG++++H+ ++HRDLKP+N+L+
Sbjct: 131 ------------------------------IIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
SK K ++ D G+S + + G++ + APE +L G D++S G
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDK----IGTAYYIAPE-VLHGTYDEKCDVWSTGV 215
Query: 700 ILFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
IL+ ++ G P G + V+ K F + A DL ++L P +R
Sbjct: 216 ILYILLS-GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 62/296 (20%), Positives = 104/296 (35%), Gaps = 69/296 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I GS G +G+ + K L + E+ NL+ +HPNIVR+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRY 70
Query: 533 YG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y ++ +Y+ +E C G + ++ L+E +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCE----------GGDLASVITKGTKERQYLDEEFV------- 113
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHRDLKPQNVLISKDKSF 645
L+V + L H +HRDLKP NV + ++
Sbjct: 114 ------------------LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN- 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704
KL D G+++ L D S T G+ + +PE + D++SLGC+L+
Sbjct: 155 -VKLGDFGLARILNHDTSFAK---TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209
Query: 705 ITGGKHP-YGESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLR 753
P S + I + + IP E ++ TR+L+ R
Sbjct: 210 CA-LMPPFTAFSQKELAGKIREGK-----FRRIPYRYSDELNEIITRMLNLKDYHR 259
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-26
Identities = 46/308 (14%), Positives = 99/308 (32%), Gaps = 39/308 (12%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 522
+ G R LV + + + + E G S V T + +
Sbjct: 65 ESELGERPRTLV-RGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 117
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++R + ++ + DL+ ++ E+D +L+
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 583 IRLLPVMENTKDIELWKANGHPSAQL-----LKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ E+ ++ L L++T ++ L+ LH GL+H L+P ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----------QG 686
++ + L+ R + S G++ PE +
Sbjct: 238 VLDQRGG--VFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRT 288
Query: 687 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRL 745
T + D ++LG ++++ P +DA + ++IP+ V L
Sbjct: 289 LMTFSFDAWALGLVIYWIWC-ADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGF 343
Query: 746 LDPNPDLR 753
L + R
Sbjct: 344 LRYPKEDR 351
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 70/303 (23%), Positives = 118/303 (38%), Gaps = 69/303 (22%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK-EIQ 518
VD R + V + + KG + + A K L+K H + EI
Sbjct: 9 VDPRSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67
Query: 519 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 577
S H ++V ++G D DFV++ LE C SL +L + E
Sbjct: 68 IH-RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEP---------- 115
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
E R R IV G +LH +IHRDLK N+
Sbjct: 116 --EAR---------------------------YYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 696
+ ++ K+ D G++ +++ D G+ + APE +L + + +D++S
Sbjct: 147 FL--NEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VLSKKGHSFEVDVWS 200
Query: 697 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 750
+GCI++ + GK P FE + + + + + +HI P A L ++L +P
Sbjct: 201 IGCIMYTLLV-GKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 751 DLR 753
R
Sbjct: 255 TAR 257
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 60/250 (24%)
Query: 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIV 530
+ + + +G+ V + + G A+K DV ++E + L + H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIV 70
Query: 531 RWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + +E + L +E + GS L + L E
Sbjct: 71 KLFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL---- 115
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFC 646
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 ---------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSL 697
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+
Sbjct: 155 YKLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSI 209
Query: 698 GCILFFCITG 707
G + TG
Sbjct: 210 GVTFYHAATG 219
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 70/298 (23%), Positives = 122/298 (40%), Gaps = 60/298 (20%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA 522
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 78 LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR---------- 125
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-S 640
+ + + SG++++H+ ++HRDLKP+N+L+ S
Sbjct: 126 -----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
K+K K+ D G+S Q + + + G++ + APE +L+G D++S G I
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 701 LFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
L+ ++ G P YG++ V+ K F + +A DL ++L +P LR
Sbjct: 212 LYILLS-GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 66/290 (22%), Positives = 108/290 (37%), Gaps = 59/290 (20%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
++I GS AVK + K+ D +EI+ L+ QHPNI+ V
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-TEEIEILLRYGQHPNIITLKDV 84
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D +VY+ E L D I + F E+
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKI-LRQKFFSER--------------------------- 116
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDM 652
+A+ V I + +LH G++HRDLKP N+L ++ D
Sbjct: 117 ----EAS--------AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G +K+L+ + L T ++ + APE L + A D++SLG +L+ +TG +
Sbjct: 165 GFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTP 219
Query: 712 -YGESFERDANI---VKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+ I + K + A DL +++L +P R
Sbjct: 220 FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 71/302 (23%)
Query: 473 KLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR 531
L + +K + +GS ++ AVK + K KEI L + HPNIV+
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 532 WYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ V DQ +L +E L + I F E +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASY------------------- 110
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 649
+ R +VS +SH+H++G++HRDLKP+N+L ++ + K+
Sbjct: 111 --------------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
D G ++ D L T + + APE L Q + DL+SLG IL+ ++G
Sbjct: 151 IDFGFARLKPPDNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-- 205
Query: 710 HP--YGESFERDANIVKDRKDLFLVEHI----------------PEAVDLFTRLLDPNPD 751
+ ++ + I EA DL LL +P+
Sbjct: 206 QVPFQSHD---RSLTCTSAVEIM--KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260
Query: 752 LR 753
R
Sbjct: 261 KR 262
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 68/294 (23%), Positives = 126/294 (42%), Gaps = 54/294 (18%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQH 526
I L +F +++ G+ G V L E G +K + K V +++I+ I S H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNI++ + V D +Y+ +E C +L E RI
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEG--GEL-------LE----------------RI--- 111
Query: 587 PVMENTKDIELWKANGHPS-AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKS 644
+ S + ++ + +++ L++ H ++H+DLKP+N+L
Sbjct: 112 --------VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPH 163
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G+++ + D T A G++ + APE + + T D++S G +++F
Sbjct: 164 SPIKIIDFGLAELFKSD-EHSTNAA---GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFL 218
Query: 705 ITGGKHP--YGESFERDANIVKDRKDLFLVE--HI-PEAVDLFTRLLDPNPDLR 753
+TG G S E ++ + VE + P+AVDL ++L +P+ R
Sbjct: 219 LTG--CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 64/271 (23%), Positives = 107/271 (39%), Gaps = 67/271 (24%)
Query: 497 GRSVAVK-----RLVKTHHDVALK-EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
A K L+K H + EI S H ++V ++G D DFV++ LE C
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIH-RSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 551 C-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
SL +L + E E R
Sbjct: 125 RRSLLELH-KRRKALTEP------------EAR--------------------------- 144
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
R IV G +LH +IHRDLK N+ + ++ K+ D G++ +++ D
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGERKK--- 199
Query: 670 TGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK- 727
G+ + APE +L + + +D++S+GCI++ + GK P FE + + +
Sbjct: 200 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV-GKPP----FE-TSCLKETYLR 252
Query: 728 ----DLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + +HI P A L ++L +P R
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 60/249 (24%)
Query: 477 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 531
+ + +G+ V + + G A+K DV ++E + L + H NIV+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVK 71
Query: 532 WYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ +E + L +E + GS L + L E
Sbjct: 72 LFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL----- 115
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCA 647
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 --------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSLG 698
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+G
Sbjct: 156 KLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSIG 210
Query: 699 CILFFCITG 707
+ TG
Sbjct: 211 VTFYHAATG 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 37/298 (12%), Positives = 85/298 (28%), Gaps = 64/298 (21%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPN 528
+ + +G+ V + +K + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+++Y Q+ L E + +L + I K ++ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI----------NLYKNTPEKVMPQGLVI--- 175
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS------- 640
++ + +H+ +IH D+KP N ++
Sbjct: 176 ----------------------SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 641 --KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSGWQAPEQLLQGRQTRAIDLF 695
D S L D+G S DM + +SG+Q E L ID F
Sbjct: 214 DEDDLSAGLALIDLGQSI----DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ ++ + G + ++ + + L ++ + F +L+
Sbjct: 270 GVAATVYCMLF-GTYMKVKNEGGECKPEGLFRRLPHLDMWN---EFFHVMLNIPDCHH 323
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-26
Identities = 68/308 (22%), Positives = 125/308 (40%), Gaps = 71/308 (23%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT----------------HHDV 512
+IG+ +++ G+ G V+L + A+K + K+ H+
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 513 ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAK 571
EI L + D HPNI++ + V D+ + YL E L + I + F+E A
Sbjct: 93 IYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAAN 150
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
+ + I+SG+ +LH+ ++HRD
Sbjct: 151 ---------------------------------------IMKQILSGICYLHKHNIVHRD 171
Query: 632 LKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 690
+KP+N+L+ +K+ K+ D G+S D L G++ + APE +L+ +
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL---GTAYYIAPE-VLKKKYNE 226
Query: 691 AIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRL 745
D++S G I++ + G P G++ + V+ K F +I EA +L +
Sbjct: 227 KCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 746 LDPNPDLR 753
L + + R
Sbjct: 286 LTYDYNKR 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 58/298 (19%), Positives = 114/298 (38%), Gaps = 61/298 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNI 529
++ + + KG G ++ + G + +K L++ + LKE++ ++ +HPN+
Sbjct: 12 LIHGEVLGKGCFGQA-IKVTHRETGEVMVMKELIRFDEETQRTFLKEVK-VMRCLEHPNV 69
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+++ GV + E Y+ G+ + K DS
Sbjct: 70 LKFIGVLYKDKRLNFITE----------YIKGGTLRGII--KSMDSQY------------ 105
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
P +Q + +DI SG+++LH + +IHRDL N L+ ++ +
Sbjct: 106 --------------PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVV 149
Query: 650 SDMGISKRLQGDMSCLTQNA-----------TGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
+D G+++ + + + T G+ W APE + +D+FS G
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 699 CILFFCITGGK-HPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+L I P D V+ D + + P + + R D +P+ R
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 62/298 (20%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 79 D-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR----------- 125
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
+ + + SG++++H+ ++HRDLKP+N+L+ SK
Sbjct: 126 ----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+K K+ D G+S Q + + + G++ + APE +L+G D++S G IL
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
Query: 702 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+ ++G P YG++ V+ K F + I +A DL ++L +P LR
Sbjct: 213 YILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 65/323 (20%), Positives = 120/323 (37%), Gaps = 93/323 (28%)
Query: 459 TDLIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHD 511
+ +I ++ R +I + G TV Y VA+K +
Sbjct: 2 SHMIGKIINERYKIVDK------LGGGGMSTV-----YLAEDTILNIKVAIKAI---FIP 47
Query: 512 VAL---------KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLS 561
+E+ N + H NIV V+ + D YL +E +L++ I
Sbjct: 48 PREKEETLKRFEREVHN-SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---- 102
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSGLS 620
+++G + T I+ G+
Sbjct: 103 -------------------------------------ESHGPLSVDTAINFTNQILDGIK 125
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
H H++ ++HRD+KPQN+LI +K+ K+ D GI+K L + LTQ G+ + +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSP 181
Query: 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDLFL 731
EQ D++S+G +L+ + G+ P+ GE+ + V +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVPNVTTD----V 236
Query: 732 VEHIPEAVD-LFTRLLDPNPDLR 753
+ IP+++ + R + + R
Sbjct: 237 RKDIPQSLSNVILRATEKDKANR 259
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 1e-25
Identities = 71/291 (24%), Positives = 112/291 (38%), Gaps = 58/291 (19%)
Query: 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIV 530
+ + G G V+ + + G VA+K L + + EIQ + HPN+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVV 75
Query: 531 RWYGVESDQ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
V D L++E Y G + LN E L E IR
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAME----------YCEGGDLRKYLNQFEN-CCGLKEGPIR 124
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 643
+ DI S L +LHE +IHRDLKP+N+++ +
Sbjct: 125 -------------------------TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 702
K+ D+G +K L C G+ + APE LL+ ++ T +D +S G + F
Sbjct: 160 RLIHKIIDLGYAKELDQGELC----TEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAF 214
Query: 703 FCITGG--KHPYGESFERDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNP 750
CITG P + + + K + + + + + AV + L PN
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 51/295 (17%), Positives = 103/295 (34%), Gaps = 67/295 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 529
+ F ++ + +G + +G ++G + VK L +E L HPN+
Sbjct: 12 LNFLTKLNENHSGEL-WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL-RIFSHPNV 69
Query: 530 VRWYGVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ G + +L ++ GS L
Sbjct: 70 LPVLGACQSPPAPHPTLITH----------WMPYGS---------------------LYN 98
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSF 645
V+ + + +Q +K D+ G++ LH E + L ++V+I D+
Sbjct: 99 VLHEGTNFVV------DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDM 150
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----TRAIDLFSLGCIL 701
A++S D+ Q+ + W APE LQ + R+ D++S +L
Sbjct: 151 TARISM--------ADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLL 201
Query: 702 FFCITGGKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+ +T + P+ + + E + + + I V L ++ +P R
Sbjct: 202 WELVT-REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/306 (18%), Positives = 113/306 (36%), Gaps = 79/306 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR--SVAVKRLVKTHHDVA----------LKEIQNLIA 522
+ + K+I KG G V +G VA+K L+ + +E+ + +
Sbjct: 21 IEYEKQIGKGGFGLV-HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM-S 78
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNE 580
+ HPNIV+ YG+ ++ +V G + L +
Sbjct: 79 NLNHPNIVKLYGL-------------MHNPPR-MVMEFVPCGDL----------YHRLLD 114
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVL 638
+ + L++ DI G+ ++ ++HRDL+ N+
Sbjct: 115 KAHPI------------------KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 639 IS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAI 692
+ ++ CAK++D G+S++ +S L G+ W APE + + T
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLL------GNFQWMAPE-TIGAEEESYTEKA 209
Query: 693 DLFSLGCILFFCITGGKHPYGE----SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLD 747
D +S IL+ +T G+ P+ E + I ++ + E P + ++
Sbjct: 210 DTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 748 PNPDLR 753
+P R
Sbjct: 269 GDPKKR 274
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 62/290 (21%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIVR 531
F + + G+ V L + G+ A+K + EI L H NIV
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-ENEIAVLKKIK-HENIVT 70
Query: 532 WYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ YL ++ + L D I + G + E+ +
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASL------------------- 110
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 649
V + ++S + +LHE G++HRDLKP+N+L ++ +++ +
Sbjct: 111 --------------------VIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMI 150
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G+SK Q + ++ G+ G+ APE L Q ++A+D +S+G I + + G
Sbjct: 151 TDFGLSKMEQNGI--MSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG-- 203
Query: 710 HP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+P Y E+ + +K+ F I A D LL+ +P+ R
Sbjct: 204 YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNER 253
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 63/296 (21%), Positives = 115/296 (38%), Gaps = 62/296 (20%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQ 525
I + I +GS G V + A K V+ +EI+ + + D
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLD- 64
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HPNI+R Y D +YL +E CT L + + V F E A+
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAAR------------- 110
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDK 643
+ +D++S +++ H++ + HRDLKP+N L ++
Sbjct: 111 --------------------------IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
KL D G++ R + + G+ + +P+ +L+G D +S G +++
Sbjct: 145 DSPLKLIDFGLAARFKPG-KMMRTKV---GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 199
Query: 704 CITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+ G +P + +++ F + ++ P+A L RLL +P R
Sbjct: 200 LLCG--YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQR 253
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 64/298 (21%), Positives = 105/298 (35%), Gaps = 67/298 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-------LKEIQNLIASDQHP 527
+ + I G G V + G VAVK + +E + L A +HP
Sbjct: 9 LTLEEIIGIGGFGKV-YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK-LFAMLKHP 66
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ GV + + L +E + G L+ K
Sbjct: 67 NIIALRGVCLKEPNLCLVME----------FARGGPLNRVLSGKRI-------------- 102
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG---LIHRDLKPQNVLISKDKS 644
P L+ I G+++LH+ +IHRDLK N+LI +
Sbjct: 103 ----------------PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 645 F------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
K++D G+++ T + G+ W APE + ++ D++S G
Sbjct: 147 NGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 699 CILFFCITGGKHPYGE-SFERDANIVKDRKD-LFLVEHIPEAV-DLFTRLLDPNPDLR 753
+L+ +T G+ P+ A V K L + PE L +P+P R
Sbjct: 202 VLLWELLT-GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 72/303 (23%)
Query: 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK---EIQ 518
G +I V + KGS V + G VA+K + K ++ +I
Sbjct: 7 GEKIEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 519 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 577
+ +HP+I+ Y D ++VYL LE C +N + F E
Sbjct: 66 CQL---KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---------- 112
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
E R I++G+ +LH G++HRDL N+
Sbjct: 113 --EAR---------------------------HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 696
L+ ++ K++D G++ +L+ T G+ + +PE + D++S
Sbjct: 144 LL--TRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPE-IATRSAHGLESDVWS 197
Query: 697 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 750
LGC+ + + G+ P F+ + D + + EA DL +LL NP
Sbjct: 198 LGCMFYTLLI-GRPP----FD-TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNP 251
Query: 751 DLR 753
R
Sbjct: 252 ADR 254
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 64/298 (21%)
Query: 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQ 525
G+ + F+ EI +GS TV + E VA +L K+ +E + L Q
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-Q 83
Query: 526 HPNIVR----WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNIVR W + + L E + SG+ + L + ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYL----KRFKVMKIK 129
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 639
+R R I+ GL LH +IHRDLK N+ I
Sbjct: 130 VLR-------------------------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ + K+ D+G++ + + G+ + APE + + + ++D+++ G
Sbjct: 165 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPE-MYEEKYDESVDVYAFGM 217
Query: 700 ILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLR 753
+ T ++PY E V + + PE ++ + N D R
Sbjct: 218 CMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 61/312 (19%), Positives = 109/312 (34%), Gaps = 81/312 (25%)
Query: 475 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIV 530
+ + +A+G V + GR A+KRL+ + ++E+ + HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 531 RWYGV--------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++ ++ Q L E C L + + K + L+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK------------KMESRGPLSC-- 135
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLIS 640
+LK+ + H+H +IHRDLK +N+L+S
Sbjct: 136 -----------------------DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172
Query: 641 KDKSFCAKLSDMGISKRLQG---------DMSCLTQNATGYGSSGWQAPEQL-LQGRQ-- 688
+ KL D G + + + + + T + ++ PE + L
Sbjct: 173 NQGTI--KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 689 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-------EAVDL 741
D+++LGCIL+ +HP FE D ++ + IP L
Sbjct: 231 GEKQDIWALGCILYLLCF-RQHP----FE-DGAKLRIVNGKY---SIPPHDTQYTVFHSL 281
Query: 742 FTRLLDPNPDLR 753
+L NP+ R
Sbjct: 282 IRAMLQVNPEER 293
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/314 (20%), Positives = 112/314 (35%), Gaps = 83/314 (26%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVA---- 513
+ +G + G + + + +G G V YE R VA+K + ++
Sbjct: 26 ESREGTQFGPYRL-RRLVGRGGMGDV-----YEAEDTVRERIVALKLM---SETLSSDPV 76
Query: 514 -----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
+E + Q P++V + +Y+ + + +
Sbjct: 77 FRTRMQREART-AGRLQEPHVVPIHDFGEIDGQLYVDMR----------LI------NGV 119
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+ +L + L + + + R I S L H G
Sbjct: 120 DLAA----MLRR-QGPL------------------APPRAVAIVRQIGSALDAAHAAGAT 156
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRD+KP+N+L+S D A L D GI+ LTQ G+ + APE+ +
Sbjct: 157 HRDVKPENILVSADDF--AYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 689 TRAIDLFSLGCILFFCITGGKHPY-GES-------FERDANIVKDRKDLFLVEHIPEAVD 740
T D+++L C+L+ C+T G PY G+ + + IP A D
Sbjct: 213 TYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST-----VRPGIPVAFD 266
Query: 741 -LFTRLLDPNPDLR 753
+ R + NP+ R
Sbjct: 267 AVIARGMAKNPEDR 280
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 60/302 (19%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQN 519
+ R + +E+ KG+ V G+ A +L H +E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLL 578
HPNIVR + S++ YL + T L + I V + E +
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASH------- 114
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+ I+ + H H++G++HR+LKP+N+L
Sbjct: 115 --------------------------------CIQQILEAVLHCHQMGVVHRNLKPENLL 142
Query: 639 -ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697
SK K KL+D G++ ++G+ G+ G+ +PE L + + +DL++
Sbjct: 143 LASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 698 GCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPD 751
G IL+ + G +P + E R +K F + PEA DL ++L NP
Sbjct: 200 GVILYILLVG--YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 752 LR 753
R
Sbjct: 258 KR 259
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 69/325 (21%), Positives = 117/325 (36%), Gaps = 96/325 (29%)
Query: 461 LIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHDVA 513
+ R +G++ + G V + R VAVK L D+A
Sbjct: 5 TTPSHLSDRYELGEI------LGFGGMSEV-----HLARDLRDHRDVAVKVL---RADLA 50
Query: 514 L---------KEIQNLIASDQHPNIVRWYGVESDQD----FVYLSLERCT-CSLNDLIYV 559
+E QN A+ HP IV Y + Y+ +E +L D++
Sbjct: 51 RDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-- 107
Query: 560 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSG 618
G + ++V D
Sbjct: 108 ---------------------------------------HTEGPMTPKRAIEVIADACQA 128
Query: 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 678
L+ H+ G+IHRD+KP N++IS + K+ D GI++ + + +TQ A G++ +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 679 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDL 729
+PEQ D++SLGC+L+ +T G+ P+ G+S D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 730 FLVEHIPEAVD-LFTRLLDPNPDLR 753
E + +D + + L NP+ R
Sbjct: 242 -RHEGLSADLDAVVLKALAKNPENR 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 63/326 (19%), Positives = 109/326 (33%), Gaps = 83/326 (25%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 526
R + + + + + KG G V G+++G +VAVK E+ N + +H
Sbjct: 4 RTVARDITLLECVGKGRYGEV-WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML-RH 61
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NI+ + SD + S + LI Y GS + L D
Sbjct: 62 ENILGFIA--SDMTSRHSSTQLW------LITHYHEMGSLYDYLQLTTLD---------- 103
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQN 636
L++ I SGL+HLH + HRDLK +N
Sbjct: 104 -------------TV-------SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQT 689
+L+ K+ ++D+G++ + L G+ + APE Q+
Sbjct: 144 ILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 690 RAIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK------- 727
+ +D+++ G + + K P+ + SFE +V +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261
Query: 728 DLFLVEHIPEAVDLFTRLLDPNPDLR 753
F + L NP R
Sbjct: 262 RWFSDPTLTSLAKLMKECWYQNPSAR 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 68/306 (22%), Positives = 117/306 (38%), Gaps = 63/306 (20%)
Query: 463 DDRVDGRR---IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EI 517
D +DG + E+ +G+ V + + A+K L KT ++ EI
Sbjct: 40 DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 518 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSN 576
L+ HPNI++ + + L LE T L D I V G + E+ A
Sbjct: 100 GVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAAD----- 152
Query: 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
+ I+ +++LHE G++HRDLKP+N
Sbjct: 153 ----------------------------------AVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 637 VL-ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695
+L + K++D G+SK ++ + G+ G+ APE L +D++
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVC---GTPGYCAPEILRGCAYGPEVDMW 234
Query: 696 SLGCILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLD 747
S+G I + + G Y E ++ I+ F+ + A DL +L+
Sbjct: 235 SVGIITYILLCG--FEPFYDERGDQFMFRRILNCEYY-FISPWWDEVSLNAKDLVRKLIV 291
Query: 748 PNPDLR 753
+P R
Sbjct: 292 LDPKKR 297
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 79/352 (22%), Positives = 135/352 (38%), Gaps = 80/352 (22%)
Query: 434 NESKVG--------ETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 485
N VG ++ + F+ + D V + + + +K + G+
Sbjct: 88 NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 486 NGTVVL-EGNYEGRSVAVKRLVK-----------THHDVALKEIQNLIASDQHPNIVRWY 533
G V L + VA++ + K EI+ L + HP I++
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+D Y+ LE L D + V + +E K
Sbjct: 207 NFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK--------------------- 242
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLSD 651
++ + +LHE G+IHRDLKP+NVL+ S+++ K++D
Sbjct: 243 -----------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGG 708
G SK + G+ S + T G+ + APE L+ RA+D +SLG ILF C++G
Sbjct: 286 FGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG- 340
Query: 709 KHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+P + + + K F+ E + +A+DL +LL +P R
Sbjct: 341 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 61/292 (20%), Positives = 103/292 (35%), Gaps = 56/292 (19%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIA---SDQHPN 528
+ I KG V G+ AVK + ++ ++++ + +HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV S +Y+ E + DL E + + + +E
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGA--DL-------CFE-IVKRADAGFVYSEAVAS---- 133
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 647
R I+ L + H+ +IHRD+KP VL SK+ S
Sbjct: 134 ---------------------HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
KL G++ +L G+ + APE + + + +D++ G ILF ++G
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV---GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 708 GKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
YG I+K + HI A DL R+L +P R
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAER 278
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 49/250 (19%), Positives = 87/250 (34%), Gaps = 57/250 (22%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 526
R I + +V + I KG G V G + G VAVK EI +H
Sbjct: 38 RTIARTIVLQESIGKGRFGEV-WRGKWRGEEVAVKIFSSREERSWFREAEIYQT-VMLRH 95
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + ++ + + L + Y GS + LN
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRYTVT------------ 137
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 638
+ ++K+ SGL+HLH + HRDLK +N+L
Sbjct: 138 -----------VE-------GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQTRA 691
+ K+ ++D+G++ R + G+ + APE + +
Sbjct: 180 VKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 692 IDLFSLGCIL 701
D++++G +
Sbjct: 238 ADIYAMGLVF 247
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-23
Identities = 55/319 (17%), Positives = 113/319 (35%), Gaps = 85/319 (26%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYG 534
+ A+G G V VAVK E+ +L +H NI+++ G
Sbjct: 28 LLEVKARGRFGCVWK-AQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIG 85
Query: 535 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+++ + ++ LI + GS + L +N+++
Sbjct: 86 --AEKRGTSVDVDLW------LITAFHEKGSLSDFLK-----ANVVS------------- 119
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE----------IGLIHRDLKPQNVLISKD 642
W +L + + GL++LHE + HRD+K +NVL+
Sbjct: 120 -----WN-------ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--K 165
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSL 697
+ A ++D G++ + + S + G+ + APE L Q ID++++
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 698 GCILFFCITG----------GKHPYGESFERDANI-------VKDRKDLFLVEHIP--EA 738
G +L+ + P+ E + ++ V +K L ++
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 739 VDLFTRLL----DPNPDLR 753
+ + + D + + R
Sbjct: 285 MAMLCETIEECWDHDAEAR 303
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 70/325 (21%), Positives = 111/325 (34%), Gaps = 81/325 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKE--IQNLIASDQH 526
R I K + K+I KG G V G + G VAVK T +E I + +H
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEV-WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM-RH 90
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + + + L T Y +GS + L + D
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITD------YHENGSLYDYLKSTTLD------------ 132
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 638
K +LK+ VSGL HLH + HRDLK +N+L
Sbjct: 133 -----------AK-------SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-------TR 690
+ K+ ++D+G++ + D + + G+ + PE +L
Sbjct: 175 VKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYI 231
Query: 691 AIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK-------D 728
D++S G C+ + + PY + S+E IV +K
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 729 LFLVEHIPEAVDLFTRLLDPNPDLR 753
E + + L T NP R
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASR 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 56/247 (22%), Positives = 92/247 (37%), Gaps = 56/247 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 529
+ + I GS GTV +G + G VAVK L T E+ L +H NI
Sbjct: 26 ITVGQRIGSGSFGTV-YKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNI 82
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + G S + + + C SL ++ FE +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMK--------------------- 120
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+L+ + R G+ +LH +IHRDLK N+ + + K
Sbjct: 121 ------------------KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVK 160
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCI 705
+ D G++ + S Q GS W APE + + D+++ G +L+ +
Sbjct: 161 IGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 706 TGGKHPY 712
T G+ PY
Sbjct: 220 T-GQLPY 225
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 65/289 (22%), Positives = 110/289 (38%), Gaps = 61/289 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 532
+E+ KG+ V G A K +L +E + QHPNIVR
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRL 70
Query: 533 YGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ ++ F YL + T L + I V + E +
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH-------------------- 109
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 650
+ I+ +++ H G++HR+LKP+N+L SK K KL+
Sbjct: 110 -------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++ + D A G+ G+ +PE L + ++ +D+++ G IL+ + G +
Sbjct: 151 DFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--Y 204
Query: 711 P--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
P + E R +K + + PEA L +L NP R
Sbjct: 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 253
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 65/298 (21%), Positives = 111/298 (37%), Gaps = 61/298 (20%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ +E+ KG+ V G A K +L +E +
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RK 84
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
QHPNIVR + ++ F YL + T L + I V + E +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH----------- 132
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISK 641
+ I+ +++ H G++HR+LKP+N+L SK
Sbjct: 133 ----------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K KL+D G++ + D A G+ G+ +PE L + ++ +D+++ G IL
Sbjct: 165 AKGAAVKLADFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
Query: 702 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+ + G +P + E R +K + + PEA L +L NP R
Sbjct: 221 YILLVG--YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 276
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 69/292 (23%), Positives = 109/292 (37%), Gaps = 74/292 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
+ + KG G V L + +A+K L K H EIQ+ + +HPNI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNI 71
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R YG D VYL LE Y G + + Q + +E R
Sbjct: 72 LRLYGYFHDATRVYLILE----------YAPLG----TVYRELQKLSKFDEQRTA----- 112
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
++ + LS+ H +IHRD+KP+N+L+ + K+
Sbjct: 113 --------------------TYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKI 150
Query: 650 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+D G S C G+ + PE + +DL+SLG + + +
Sbjct: 151 ADFGWSVHAPSSRRTDLC--------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 707 GGKHPYGESFERDANIVKDRK----DLFLVEHI-PEAVDLFTRLLDPNPDLR 753
GK P FE + ++ + + + A DL +RLL NP R
Sbjct: 203 -GKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 249
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 71/396 (17%), Positives = 127/396 (32%), Gaps = 77/396 (19%)
Query: 386 FYHSKQVKSKKQNEEHITK---TGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETD 442
+HS V +K E + +P + +R + R+ + + E+K
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 443 GLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVA 501
+ + D + D + + I +G + V G A
Sbjct: 65 QPKGTENLYFQSM-GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 502 VKRLVKT-----------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
VK + T + +E L HP+I+ F++L +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 551 CS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L D + + E+ +
Sbjct: 184 KGELFDYL-TEKVALSEK-ETR-------------------------------------- 203
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
+ R ++ +S LH ++HRDLKP+N+L+ + +LSD G S L+ L
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI--RLSDFGFSCHLEPG-EKLR--- 257
Query: 670 TGYGSSGWQAPEQLLQGRQTR------AIDLFSLGCILFFCITGGKHP--YGESFERDAN 721
G+ G+ APE L +DL++ G ILF + G P +
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWHRRQILMLR 315
Query: 722 IVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
++ + + F DL +RLL +P+ R
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR 351
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 56/303 (18%), Positives = 100/303 (33%), Gaps = 74/303 (24%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------------HDVALKEIQNLIAS 523
+ + +G + V + AVK + T + LKE+ L
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
HPNI++ F +L + L D + + E+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEK-ETR----------- 127
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
K+ R ++ + LH++ ++HRDLKP+N+L+ D
Sbjct: 128 ---------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 696
+ KL+D G S +L L G+ + APE + + +D++S
Sbjct: 161 MNI--KLTDFGFSCQLDPG-EKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 697 LGCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 750
G I++ + G P + ++ F DL +R L P
Sbjct: 215 TGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 751 DLR 753
R
Sbjct: 273 QKR 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 71/335 (21%), Positives = 122/335 (36%), Gaps = 96/335 (28%)
Query: 462 IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK 515
D ++ + + EI KGS G V L N A+K +L++
Sbjct: 3 SGSSGDCVQLNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 516 EIQNLIASDQ-----------------------HPNIVRWYGV--ESDQDFVYLSLERCT 550
+ + HPN+V+ V + ++D +Y+ E
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE--- 118
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
V G PVM ++ Q
Sbjct: 119 -------LVNQG------------------------PVM----EVP--TLKPLSEDQARF 141
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+D++ G+ +LH +IHRD+KP N+L+ +D K++D G+S +G + L +
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALL---SN 196
Query: 671 GYGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGESFERDANIV--- 723
G+ + APE L + +A+D++++G L +C G+ P F D I+
Sbjct: 197 TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL-YCFVFGQCP----FM-DERIMCLH 249
Query: 724 -KDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR 753
K + + DL TR+LD NP+ R
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 67/313 (21%), Positives = 112/313 (35%), Gaps = 87/313 (27%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALK---EIQNL 520
+ IGK ++ + +GS G V + E AVK + ++ + EIQ L
Sbjct: 2 KLIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 521 IASDQHPNIVRWYGV---ESDQDFVYLSLERCTCSLNDLI-YVLSGSFEEQLNAKEQDSN 576
H N+++ V E Q +Y+ +E C C + +++ V F
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKRFPV---------- 108
Query: 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
+ ++ GL +LH G++H+D+KP N
Sbjct: 109 --CQAH---------------------------GYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 637 VLISKDKSFCAKLSDMGIS----KRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT 689
+L+ K+S +G++ D S GS +Q PE + G T
Sbjct: 140 LLL--TTGGTLKISALGVAEALHPFAADDTCRTSQ--------GSPAFQPPE-IANGLDT 188
Query: 690 ---RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK-----DRKDLFLVEHI-PEAVD 740
+D++S G L+ T G +P FE NI K + + P D
Sbjct: 189 FSGFKVDIWSAGVTLYNITT-GLYP----FE-GDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 741 LFTRLLDPNPDLR 753
L +L+ P R
Sbjct: 243 LLKGMLEYEPAKR 255
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 46/300 (15%), Positives = 97/300 (32%), Gaps = 68/300 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 529
+ + I KG G V G + G VA++ + + +E+ +H N+
Sbjct: 35 LEIGELIGKGRFGQV-YHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAY-RQTRHENV 91
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V + G + + C +L ++ +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--------------------- 130
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ ++ ++IV G+ +LH G++H+DLK +NV K
Sbjct: 131 ------------------KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK---VV 169
Query: 649 LSDMGIS--KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----------TRAIDLFS 696
++D G+ + + G APE +++ ++ D+F+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 697 LGCILFFCITGGKHPY-GESFERDANIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
LG I + + P+ + E + + +L + E D+ + R
Sbjct: 229 LGTIWYELHA-REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 63/294 (21%), Positives = 109/294 (37%), Gaps = 78/294 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
+ + KG G V L + +A+K L K+ H EIQ+ + +HPNI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL---RHPNI 76
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R Y D+ +YL LE + G +L + Q +E R
Sbjct: 77 LRMYNYFHDRKRIYLMLE----------FAPRG----ELYKELQKHGRFDEQRSA----- 117
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
++ L + HE +IHRD+KP+N+L+ K+
Sbjct: 118 --------------------TFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKI 155
Query: 650 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705
+D G S C G+ + PE +++G+ +DL+ G + + +
Sbjct: 156 ADFGWSVHAPSLRRRTMC--------GTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 706 TGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNPDLR 753
G P F+ + + + DL + + DL ++LL +P R
Sbjct: 207 V-GMPP----FD-SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 64/291 (21%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 529
F K + +GS TVVL R A+K L K H + ++ ++++ HP
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V+ Y D + +Y L Y +G + + + +E R
Sbjct: 93 VKLYFTFQDDEKLYFGLS----------YAKNGELLKYI----RKIGSFDETCTRFY--- 135
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ IVS L +LH G+IHRDLKP+N+L+ ++ ++
Sbjct: 136 ---------------TAE-------IVSALEYLHGKGIIHRDLKPENILL--NEDMHIQI 171
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G +K L + N + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 172 TDFGTAKVLSPESKQARAN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-- 228
Query: 710 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
P + F+ I+K + E P+A DL +LL + R
Sbjct: 229 LPPFRAGNEYLIFQ---KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKR 274
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 75/303 (24%), Positives = 123/303 (40%), Gaps = 76/303 (25%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK------------THHDVALKEIQNLIAS 523
+K + G+ G V L + VA+K + K +V EI+ L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-ETEIEILKKL 72
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ HP I++ +D Y+ LE L D + V + +E K
Sbjct: 73 N-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK----------- 117
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
++ + +LHE G+IHRDLKP+NVL+ S+
Sbjct: 118 ---------------------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLG 698
++ K++D G SK + G+ S + T G+ + APE L+ RA+D +SLG
Sbjct: 151 EEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 699 CILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 750
ILF C++G +P + I + + F+ E + +A+DL +LL +P
Sbjct: 207 VILFICLSG--YPPFSEHRTQVSLKDQITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 751 DLR 753
R
Sbjct: 264 KAR 266
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 62/312 (19%), Positives = 106/312 (33%), Gaps = 78/312 (25%)
Query: 478 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---THHDVALKEIQNLIASDQHPNIVRWY 533
+ +G++ V + AVK + K +E++ L H N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 534 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
++D YL E+ S+ I F E +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEASV--------------------- 115
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLSD 651
V +D+ S L LH G+ HRDLKP+N+L ++ K+ D
Sbjct: 116 ------------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 652 MGISKRLQGDMSCLTQNA----TGYGSSGWQAPEQLLQGRQTR-----AIDLFSLGCILF 702
+ ++ + C + T GS+ + APE + + DL+SLG IL+
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 703 FCITG-----GKHPYGESFERDANIVKDRKDLFLVEHI----------------PEAVDL 741
++G G+ ++R + LF E I A DL
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF--ESIQEGKYEFPDKDWAHISCAAKDL 275
Query: 742 FTRLLDPNPDLR 753
++LL + R
Sbjct: 276 ISKLLVRDAKQR 287
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 67/296 (22%), Positives = 97/296 (32%), Gaps = 78/296 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNLI---ASDQ 525
+ KG GTV VA+K + + E+ L A
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 526 HPNIVRWYGVESDQDFVYLSLER-CTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
HP ++R Q+ L LER L D I G E R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGE------------GPSR- 142
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+V+ + H H G++HRD+K +N+LI +
Sbjct: 143 --------------------------CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 644 SFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLG 698
CAKL D G L + G+ + PE + Q ++SLG
Sbjct: 177 -GCAKLIDFGSGALLHDEPYTDFD--------GTRVYSPPE-WISRHQYHALPATVWSLG 226
Query: 699 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+L+ + G P FERD I+ +L H+ P+ L R L P P R
Sbjct: 227 ILLYDMVC-GDIP----FERDQEIL--EAELHFPAHVSPDCCALIRRCLAPKPSSR 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 52/295 (17%), Positives = 106/295 (35%), Gaps = 56/295 (18%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQ 525
+ + + + +++ +G G V ++ K + D KEI ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIAR 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NI+ + + + + E ++ E++N + LNE I
Sbjct: 60 HRNILHLHESFESMEELVMIFE----------FISGLDIFERINTSAFE---LNEREIV- 105
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ L LH + H D++P+N++ +S
Sbjct: 106 ------------------------SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ + G +++L+ + + + APE + A D++SLG +++ +
Sbjct: 142 TIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 706 TGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+ G +P E+ + NI+ F E I EA+D RLL R
Sbjct: 198 S-GINPFLAET-NQQIIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSR 249
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 62/294 (21%), Positives = 114/294 (38%), Gaps = 66/294 (22%)
Query: 478 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV- 535
+ + G NG V+ G+ A+K L + A +E+ + + P+IV V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVY 91
Query: 536 ---ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ + + +E L I +E+ E
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRI-------------QERGDQAFTE----------- 127
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 650
++ +A++++ DI + + LH + HRD+KP+N+L SK+K KL+
Sbjct: 128 -RE----------AAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 651 DMGISKRL-QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
D G +K Q + T + + APE L + ++ D++SLG I++ + G
Sbjct: 174 DFGFAKETTQNALQ------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-- 225
Query: 710 HP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
P Y + + + +K R + F + +A L LL +P R
Sbjct: 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 57/294 (19%), Positives = 95/294 (32%), Gaps = 76/294 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNL-IASDQHP 527
+ G G+V VA+K + K + E+ L S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS--LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
++R D L LER L D I G+ +E R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQE------------ELAR--- 152
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ + H H G++HRD+K +N+LI ++
Sbjct: 153 ------------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-G 187
Query: 646 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCI 700
KL D G L+ + G+ + PE ++ + R+ ++SLG +
Sbjct: 188 ELKLIDFGSGALLKDTVYTDFD--------GTRVYSPPE-WIRYHRYHGRSAAVWSLGIL 238
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
L+ + G P FE D I++ +F + + E L L P R
Sbjct: 239 LYDMVC-GDIP----FEHDEEIIRG--QVFFRQRVSSECQHLIRWCLALRPSDR 285
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 50/328 (15%), Positives = 102/328 (31%), Gaps = 103/328 (31%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----------------------E 516
+ + +G ++L + + A+K+ K+ + +
Sbjct: 37 RTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 517 IQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGS-FE---EQLNAKE 572
I I ++ + G+ ++ D VY+ E Y+ + S + +
Sbjct: 96 IITDI---KNEYCLTCEGIITNYDEVYIIYE----------YMENDSILKFDEYFFVLDK 142
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRD 631
+ + I+ + + +++ S++H E + HRD
Sbjct: 143 NYTCFIPIQVIK-------------------------CIIKSVLNSFSYIHNEKNICHRD 177
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ 688
+KP N+L+ DK+ KLSD G S+ + S G+ + PE
Sbjct: 178 VKPSNILM--DKNGRVKLSDFGESEYMVDKKIKGSR--------GTYEFMPPE-FFSNES 226
Query: 689 T---RAIDLFSLGCILFFCITG-------------------GKHPYGESFERDANIVKDR 726
+ +D++SLG L+ Y + ++
Sbjct: 227 SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNK 286
Query: 727 KDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
K + E +D L NP R
Sbjct: 287 KSTCSNNFLSNEDIDFLKLFLRKNPAER 314
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 65/307 (21%), Positives = 108/307 (35%), Gaps = 75/307 (24%)
Query: 465 RVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-------HDVALK- 515
+G K + G+ G V + E + V VK + K D L
Sbjct: 17 ACEGEYSQKYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 516 ---EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS---LNDLIYVLSGSFEEQLN 569
EI L + +H NI++ + +Q F L +E+ S L I +E
Sbjct: 76 VTLEIAIL-SRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFI-DRHPRLDE--- 129
Query: 570 AKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629
+ R +VS + +L +IH
Sbjct: 130 ---------PLAS---------------------------YIFRQLVSAVGYLRLKDIIH 153
Query: 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 689
RD+K +N++I + F KL D G + L+ T G+ + APE +L G
Sbjct: 154 RDIKDENIVI--AEDFTIKLIDFGSAAYLERG-KLFY---TFCGTIEYCAPE-VLMGNPY 206
Query: 690 R--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLL 746
R ++++SLG L+ + ++P F V + + E + L + LL
Sbjct: 207 RGPELEMWSLGVTLYTLVF-EENP----FCELEETV--EAAIHPPYLVSKELMSLVSGLL 259
Query: 747 DPNPDLR 753
P P+ R
Sbjct: 260 QPVPERR 266
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 63/295 (21%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 122
Query: 535 V----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + + + + +E L I +++ E
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 160
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 648
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 161 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L+D G +K S T + + APE L + ++ D++SLG I++ + G
Sbjct: 205 LTDFGFAKETTSHNSLTTP----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG- 259
Query: 709 KHP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
+P Y + +K R + F + E L LL P R
Sbjct: 260 -YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 313
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} Length = 339 | Back alignment and structure |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 38/201 (18%), Positives = 77/201 (38%), Gaps = 30/201 (14%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSF--GTGRPIYSSYQASFNSNASEFYLDVDEDWELY 106
D+ + A ++G +H VD + G I WS +P+ + S ++ D +Y
Sbjct: 11 DILIAADVEGGLHAVDRRNGHIIWSIEPENFQPLIEIQEPSRLETYETLIIEPFGDGNIY 70
Query: 107 FHSKRFGKMKKLSSSAEEYIRRMPYISK-------------DGGVTLGAMKTSVFLVDVK 153
+ + G ++KL S + + P K D V G+M+T ++ +++
Sbjct: 71 YFNAHQG-LQKLPLSIRQLVSTSPLHLKTNIVVNDSGKIVEDEKVYTGSMRTIMYTINML 129
Query: 154 SGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVL 213
+G ++ + G QS + + E ++ I +T + L
Sbjct: 130 NGEIISAFGPGSKNGYFGSQSVDCSPEEKIKLQEC------------ENMIVIGKTIFEL 177
Query: 214 QSTSQDSGEVLWNVAYADFKA 234
S D +NV Y+ ++
Sbjct: 178 GIHSYDGAS--YNVTYSTWQQ 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 57/292 (19%), Positives = 104/292 (35%), Gaps = 65/292 (22%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQ--NLIASDQHPNI 529
+E+ G+ G V GR K + V EI N + HP +
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQL---HHPKL 110
Query: 530 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + D+ + L LE + L D I + ++E +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIA--------------AEDYKMSEAEVINY-- 154
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
R GL H+HE ++H D+KP+N++ K+ K
Sbjct: 155 -----------------------MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVK 191
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+ D G++ +L D ++ + APE + + D++++G + + ++ G
Sbjct: 192 IIDFGLATKLNPD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-G 246
Query: 709 KHP-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
P GE + + N+ + + F + + PEA D LL P R
Sbjct: 247 LSPFAGED-DLETLQNVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKR 296
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 60/245 (24%), Positives = 95/245 (38%), Gaps = 57/245 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
E+ G+ G V + G +AVK++ ++ + K I ++ S P IV+ +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G V++++E L + G E+
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER-------------------------- 124
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K+T IV L +L E G+IHRD+KP N+L+ + KL D
Sbjct: 125 -------------ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDF 169
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITG 707
GIS RL D + G + + APE++ T+ D++SLG L T
Sbjct: 170 GISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT- 224
Query: 708 GKHPY 712
G+ PY
Sbjct: 225 GQFPY 229
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 5e-20
Identities = 65/375 (17%), Positives = 124/375 (33%), Gaps = 68/375 (18%)
Query: 389 SKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 448
+K +SK ++K+ R + + N +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY- 144
Query: 449 GNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK 507
+ + D + D D ++E+ G+ G V G + A K ++
Sbjct: 145 ---PQPVEIKHDHVLDHYD---------IHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 508 TH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGS 563
H + KEIQ ++ +HP +V + D + + + E + L + +
Sbjct: 193 PHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 564 FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623
E + ++ R + GL H+H
Sbjct: 252 MSE--------------------------DEA-------------VEYMRQVCKGLCHMH 272
Query: 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 683
E +H DLKP+N++ + +S KL D G++ L G++ + APE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVA 328
Query: 684 LQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEA 738
D++S+G + + ++ G P GE+ + VK I +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 739 VDLFTRLLDPNPDLR 753
D +LL +P+ R
Sbjct: 388 KDFIRKLLLADPNTR 402
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 73/294 (24%), Positives = 119/294 (40%), Gaps = 77/294 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNIVRW 532
K I KG+ V L + GR VA+K + KT + +E++ + HPNIV+
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKL 79
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ V + +YL +E + + D + V G +E E R
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKE------------KEAR--------- 117
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
R IVS + + H+ ++HRDLK +N+L+ D K++D
Sbjct: 118 ------------------SKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIAD 157
Query: 652 MGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 705
G S C G+ + APE L QG++ +D++SLG IL+ +
Sbjct: 158 FGFSNEFTVGGKLDAFC--------GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 706 TGGKHPYGESFERDANIVKDRKDLFLVE-HIP-----EAVDLFTRLLDPNPDLR 753
+ G P F+ N+ + R+ + + IP + +L R L NP R
Sbjct: 209 S-GSLP----FD-GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKR 256
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 66/296 (22%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNI 529
+ +KE+ +G V G+ A K R + L EI L + P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 530 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + V + + L LE + L + + +++E +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCL-------------PELAEMVSENDVI---- 134
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 647
++ + I+ G+ +LH+ ++H DLKPQN+L S
Sbjct: 135 ---------------------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+S+++ L + G+ + APE L T A D++++G I + +T
Sbjct: 174 KIVDFGMSRKIGHA-CELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 708 GKHP--YGES----FERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
GE + NI + D + E + A D LL NP+ R
Sbjct: 230 --TSPFVGEDNQETYL---NISQVNVD-YSEETFSSVSQLATDFIQSLLVKNPEKR 279
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 50/251 (19%), Positives = 87/251 (34%), Gaps = 66/251 (26%)
Query: 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNIVRWYG 534
+ I +G G V +G+ + R VAVK + + E + +H NI R+
Sbjct: 16 KLLELIGRGRYGAV-YKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 535 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ + +E L+ Y +GS + L+ D
Sbjct: 75 GDE-RVTADGRMEYL------LVMEYYPNGSLXKYLSLHTSDWV---------------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---------IGLIHRDLKPQNVLISKDK 643
++ + GL++LH + HRDL +NVL+
Sbjct: 112 --------------SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KN 155
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY-----GSSGWQAPEQLLQGR--------QTR 690
+SD G+S RL G+ G+ + APE +L+G +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALK 214
Query: 691 AIDLFSLGCIL 701
+D+++LG I
Sbjct: 215 QVDMYALGLIY 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 59/293 (20%), Positives = 106/293 (36%), Gaps = 64/293 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHPNI 529
+E+ G V G+ A K RL + V+ +EI+ + +HPNI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 530 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + + ++ V L LE + L D + S E E
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTED------------EAT------ 111
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 646
+ + I+ G+ +LH + H DLKP+N+++ +
Sbjct: 112 ---------------------QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
KL D GI+ +++ + +G+ + APE + D++S+G I + ++
Sbjct: 151 IKLIDFGIAHKIEAG-NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
Query: 707 GGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
G GE+ + + F E + A D RLL +P R
Sbjct: 207 G--ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ ++ G G V EG ++ S VAVK L + +V LKE + +HPN+V
Sbjct: 222 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM-KEIKHPNLV 279
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 280 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 315
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ LL + I S + +L + IHR+L +N L+ ++ K++
Sbjct: 316 -------------SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN--HLVKVA 360
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 361 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 704 CITGGKHPY 712
T G PY
Sbjct: 412 IATYGMSPY 420
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 61/245 (24%), Positives = 104/245 (42%), Gaps = 54/245 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
EI +G+ G+V + G+ +AVKR+ T + K++ ++ S P IV++Y
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + ++ +E + S + K
Sbjct: 88 GALFREGDCWICMELMSTSFDKFY-----------------------------------K 112
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 652
+ + P L K+T V L+HL E +IHRD+KP N+L+ + + KL D
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDF 170
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 707
GIS +L ++ T++A G + APE++ R+ D++SLG L+ T
Sbjct: 171 GISGQLVDSIAK-TRDA---GCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELAT- 224
Query: 708 GKHPY 712
G+ PY
Sbjct: 225 GRFPY 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 58/296 (19%), Positives = 104/296 (35%), Gaps = 66/296 (22%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K + + V+ +EI+ ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
N++ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSF 645
+ I+ G+++LH + H DLKP+N+++ K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
KL D G++ ++ +G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 705 ITGGKHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
++G G++ + ANI D F E H A D +LL R
Sbjct: 212 LSG--ASPFLGDTKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKR 264
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 53/224 (23%), Positives = 100/224 (44%), Gaps = 50/224 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGV 535
+++ +GS G+V + E G+ VA+K V D+ KEI + D P++V++YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIK-QVPVESDLQEIIKEISIMQQCD-SPHVVKYYGS 92
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+++ +E C S++D+I + + + E
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED--------------------------- 125
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++ + + + GL +LH + IHRD+K N+L++ + AKL+D G+
Sbjct: 126 ------------EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGV 171
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
+ +L M+ + T G+ W APE + + D++SLG
Sbjct: 172 AGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 55/245 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWY 533
E+ +G+ G V + G+ +AVKR+ T + L ++ + + P V +Y
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + V++ +E SL+ +V + + E+
Sbjct: 73 GALFREGDVWICMELMDTSLDKF---------------------YKQVIDKGQTIPED-- 109
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K+ IV L HLH ++ +IHRD+KP NVLI+ K+ D
Sbjct: 110 -------------ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDF 154
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 707
GIS L D++ +A G + APE++ ++ D++SLG +
Sbjct: 155 GISGYLVDDVAKDI-DA---GCKPYMAPERINPELNQKGYSVKS-DIWSLGITMIELAI- 208
Query: 708 GKHPY 712
+ PY
Sbjct: 209 LRFPY 213
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 56/294 (19%), Positives = 100/294 (34%), Gaps = 62/294 (21%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K + + V +EI+ ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 645
+ I+ G+++LH + H DLKP+N++ + K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
KL D G++ ++ G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 705 ITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
++ G P G++ + + F E A D +LL R
Sbjct: 212 LS-GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 70/313 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNIVRWYG 534
K + G NG V + + + VA+K++V T L+EI+ +I H NIV+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFE 75
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ LN +Y++ E L + L E RL
Sbjct: 76 ILGPSGSQLTDDVGSLTELNS-VYIVQEYMETDLANVLE-QGPLLEEHARLF-------- 125
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCA-KLSDM 652
++ QLL+ GL ++H ++HRDLKP N+ I ++D K+ D
Sbjct: 126 --MY--------QLLR-------GLKYIHSANVLHRDLKPANLFINTED---LVLKIGDF 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG--- 707
G++ R+ + + + W ++P LL T+AID+++ GCI +TG
Sbjct: 166 GLA-RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224
Query: 708 --GKH--------------PYGESFERDANIVKD---------RKDL--FLVEHIPEAVD 740
G H + E + +++ K L L EAVD
Sbjct: 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD 284
Query: 741 LFTRLLDPNPDLR 753
++L +P R
Sbjct: 285 FLEQILTFSPMDR 297
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 56/297 (18%), Positives = 109/297 (36%), Gaps = 68/297 (22%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K R + V+ ++I+ ++ QHP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
N++ + V ++ V L LE L D + S E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTE-------------------- 113
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKS 644
++ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------EEA-------------TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G++ ++ + G+ + APE + D++S+G I +
Sbjct: 155 PRIKIIDFGLAHKIDFG-NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 705 ITGGKHP--YGESFERD--ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
++G G++ +++ AN+ + F E+ A D RLL +P R
Sbjct: 211 LSG--ASPFLGDT-KQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKR 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 68/304 (22%), Positives = 123/304 (40%), Gaps = 78/304 (25%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
R IG ++ + + +GS G V L +Y+ + VA+K + + D+ ++ EI L
Sbjct: 6 RHIGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL- 63
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V + + + +E L D I V E +E
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTE------------DEG 110
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R + + I+ + + H ++HRDLKP+N+L+
Sbjct: 111 R---------------------------RFFQQIICAIEYCHRHKIVHRDLKPENLLL-- 141
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D + K++D G+S + SC GS + APE ++ G+ +D++
Sbjct: 142 DDNLNVKIADFGLSNIMTDGNFLKTSC--------GSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE-HIP-----EAVDLFTRLLDPN 749
S G +L+ + G+ P F+ D I K + +P A L R++ +
Sbjct: 193 SCGIVLYVMLV-GRLP----FD-DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 750 PDLR 753
P R
Sbjct: 247 PMQR 250
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 64/321 (19%), Positives = 118/321 (36%), Gaps = 66/321 (20%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
K + GS G V + E G+ A+K+ V +E+ ++ H NI++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK-VLQDPRYKNRELD-IMKVLDHVNIIKLVDYFY 70
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT--K 593
+ + + + + + + LN + + + +T K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI----MEYVPDTLHK 126
Query: 594 DIELWKANGHP---------SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
++ + +G QL + + +H +G+ HRD+KPQN+L+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLV--NSK 177
Query: 645 FCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
KL D G +K+L + + Y S + +APE +L + T +IDL+S+GC+
Sbjct: 178 DNTLKLCDFGSAKKLIPS-----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 702 FFCITG-----GKH--------------PYGESFERDANIVKDRK----------DLFLV 732
I G G+ P E R + + +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
A+DL ++L PDLR
Sbjct: 293 GTPSLAIDLLEQILRYEPDLR 313
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-18
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 70/293 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 533
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 653 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 708
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 709 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLR 753
+ P +++ ++ ++ D + I + L ++L NP R
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ F K + G+ G VV L + +VAVK L + H + E++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIV G + + E Y G +LLN +R +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITE----------YCCYG-------------DLLNFLRRK 121
Query: 585 LLPVMENTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ + + + + LL + + G++ L IHRDL +N+L++
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
+ K+ D G+++ ++ D + Y G W APE + T D++
Sbjct: 182 R--ITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 696 SLGCILFFCITGGKHPY 712
S G L+ + G PY
Sbjct: 232 SYGIFLWELFSLGSSPY 248
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 3e-18
Identities = 54/279 (19%), Positives = 99/279 (35%), Gaps = 54/279 (19%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 534
E+ G+ G V + G +A K + +I ++ P IV +YG
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 535 VESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ + +E SL D + +G EQ
Sbjct: 99 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQ-------------------------- 131
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 652
L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 132 -------------ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDF 176
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+S +L M+ + G+ + +PE+L + D++S+G L G++P
Sbjct: 177 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 230
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
++ ++ + P R L+
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 63/251 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRL--VKTHHDVA--LKEIQNLIASDQHPN 528
+V ++I +G+ G V G + VAVK A L+E + ++ HPN
Sbjct: 116 LVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPN 173
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IVR GV + + +Y+ +E V G F L + + + L
Sbjct: 174 IVRLIGVCTQKQPIYIVME----------LVQGGDFLTFL--RTEGARL----------- 210
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
LL++ D +G+ +L IHRDL +N L+++ K
Sbjct: 211 ---------------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLK 253
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCIL 701
+SD G+S+ + S G W APE L GR + D++S G +L
Sbjct: 254 ISDFGMSREEADGVY--------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 702 FFCITGGKHPY 712
+ + G PY
Sbjct: 306 WETFSLGASPY 316
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 20/149 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+V L +L +IHRD+KP N+L+ D+ ++D I+ L + TQ T G+
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRE----TQITTMAGT 177
Query: 675 SGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
+ APE + + A+D +SLG + + G+ PY R + K+ F
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY---HIRSSTSSKEIVHTFE 233
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR 753
+ E V L +LL+PNPD R
Sbjct: 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 74/304 (24%), Positives = 124/304 (40%), Gaps = 77/304 (25%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
+IG V+ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 8 VKIGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL- 65
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V S ++ +E YV G + + + + E+
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVME----------YVSGGELFDYICKHGR----VEEM 111
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R ++ + I+S + + H ++HRDLKP+NVL+
Sbjct: 112 EAR-------------------------RLFQQILSAVDYCHRHMVVHRDLKPENVLL-- 144
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 195
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 749
S G IL+ + G P F+ D ++ K ++ E++ L +L +
Sbjct: 196 SCGVILYALLC-GTLP----FD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249
Query: 750 PDLR 753
P R
Sbjct: 250 PLKR 253
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 70/293 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 533
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 653 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 708
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 709 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLR 753
+ P +++ ++ ++ D + I + L ++L NP R
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 70/386 (18%), Positives = 135/386 (34%), Gaps = 77/386 (19%)
Query: 387 YHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESK---VGETDG 443
+HS V +N + + + ++ + +P +SK D
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 444 LSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAV 502
+ + + ++ + K + + G G V E G +A
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYT---VSKT----EILGGGRFGQVHKCEETATGLKLAA 119
Query: 503 K----RLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LN 554
K R +K +V EI L H N+++ Y ++ + L +E L
Sbjct: 120 KIIKTRGMKDKEEV-KNEISVMNQL----DHANLIQLYDAFESKNDIVLVMEYVDGGELF 174
Query: 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614
D I S + E D + +
Sbjct: 175 DRIIDESYNLTE--------------------------LDT-------------ILFMKQ 195
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I G+ H+H++ ++H DLKP+N+L + K+ D G+++R + + +G+
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGT 251
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERD--ANIVKDRKDLFL 731
+ APE + + D++S+G I + ++ G P G++ + + NI+ R D
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDN-DAETLNNILACRWD-LE 308
Query: 732 VE---HI-PEAVDLFTRLLDPNPDLR 753
E I EA + ++LL R
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWR 334
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ F +EI G G +V G + + VA+K + + ++E + ++ HP +V+
Sbjct: 10 LTFVQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQ 67
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YGV +Q + L E ++ G + L + Q
Sbjct: 68 LYGVCLEQAPICLVTE----------FMEHGCLSDYL--RTQRGLF-------------- 101
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ LL + D+ G+++L E +IHRDL +N L+ ++ K+SD
Sbjct: 102 ------------AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN--QVIKVSD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ + D S+G W +PE R + D++S G +++
Sbjct: 148 FGMTRFVLDD--------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 200 SEGKIPY 206
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 8e-18
Identities = 59/232 (25%), Positives = 96/232 (41%), Gaps = 53/232 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----WY 533
K I GS G V + G VA+K+ V +E+Q ++ H NIVR +Y
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQ-IMRKLDHCNIVRLRYFFY 117
Query: 534 GVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+D VYL+L + ++ + S + L + ++L
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKLY----- 161
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL + L+++H G+ HRD+KPQN+L+ D + KL D
Sbjct: 162 -------------MYQLFR-------SLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCD 200
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
G +K+L + Y S + +APE + T +ID++S GC+L
Sbjct: 201 FGSAKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 8e-18
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 186 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 243
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 244 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 277
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 278 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 323
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 704
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 324 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 705 ITGGKHPY 712
T G+ PY
Sbjct: 375 TTKGRVPY 382
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 67/346 (19%)
Query: 391 QVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGN 450
+++ + K+ RR + T ++E ++ N V T LS
Sbjct: 4 SHHHHHHSQDPPAVHKLTKRIPLRR----QVTVSAESSSSMNSNTPLVRITTRLSSTADT 59
Query: 451 GEKFLLTFTDLIDDR---VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-------- 499
++ +L +D ++ K + +G G VV G
Sbjct: 60 PMLAGVSEYELPEDPKWEFPRDKL----TLGKPLGEGCFGQVV-MAEAVGIDKDKPKEAV 114
Query: 500 -VAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554
VAVK L + + E++ + +H NI+ G + +Y+ +E
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE------- 167
Query: 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614
Y G NL +R R P ME + DI L+ T
Sbjct: 168 ---YASKG-------------NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
+ G+ +L IHRDL +NVL++++ K++D G+++ D+ N Y
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLAR----DI-----NNIDYYK 260
Query: 673 -GSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++G W APE L T D++S G +++ T G PY
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 43/255 (16%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ F K + G+ G V+ + VAVK L + + E++ +
Sbjct: 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIV G + +YL E Y G L +K + +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFE----------YCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+ E L LL + G+ L +HRDL +NVL++ K
Sbjct: 157 QKRLEEEEDLNVL------TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK- 209
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+++ + D + Y G W APE L +G T D++S
Sbjct: 210 -VVKICDFGLARDIMSDSN--------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 698 GCILFFCITGGKHPY 712
G +L+ + G +PY
Sbjct: 261 GILLWEIFSLGVNPY 275
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 57/230 (24%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 534
I +G+ G V N G + A+K+ ++ + ++EI +++ +H NIV+ Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREI-SILKELKHSNIVKLYD 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + L E L L+ V G E + LL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES------------VTAKSFLL-------- 107
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
QLL G+++ H+ ++HRDLKPQN+LI+++ K++D G+
Sbjct: 108 ------------QLLN-------GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGL 146
Query: 655 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
++ + T T W +AP+ L+ ++ + ID++S+GCI
Sbjct: 147 ARAFGIPVRKYTHEIVT-----LWYRAPDVLMGSKKYSTTIDIWSVGCIF 191
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 69/313 (22%), Positives = 114/313 (36%), Gaps = 79/313 (25%)
Query: 463 DDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA--LKEIQN 519
D + K+I G+ G L + VAVK + + +EI N
Sbjct: 11 LDMPIMHDSDRYDF-VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN 69
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLL 578
S +HPNIVR+ V + + +E + L + I +G F E
Sbjct: 70 H-RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSE------------ 115
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+E R + ++SG+S+ H + + HRDLK +N L
Sbjct: 116 DEAR---------------------------FFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 639 ISKDKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAI 692
+ + K+ D G SK + G+ + APE +L ++ +
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTV--------GTPAYIAPE-VLLRQEYDGKIA 199
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKD-RKDLFLVE----HIP-------EAVD 740
D++S G L+ + G +P FE D +D RK + + IP E
Sbjct: 200 DVWSCGVTLYVMLV-GAYP----FE-DPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253
Query: 741 LFTRLLDPNPDLR 753
L +R+ +P R
Sbjct: 254 LISRIFVADPATR 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 269 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 326
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 327 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 360
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 361 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 406
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 704
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 407 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 705 ITGGKHPY 712
T G+ PY
Sbjct: 458 TTKGRVPY 465
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 50/252 (19%)
Query: 475 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQHP 527
+ F I +G+ G V+ ++ + A+KR+ + E++ L HP
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ G + ++YL++E Y G NLL+ +R +
Sbjct: 87 NIINLLGACEHRGYLYLAIE----------YAPHG-------------NLLDFLRKSRVL 123
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ ++ A
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA 181
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G L++ Y W A E L T D++S G +
Sbjct: 182 KIADFG-----------LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 701 LFFCITGGKHPY 712
L+ ++ G PY
Sbjct: 231 LWEIVSLGGTPY 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 52/225 (23%), Positives = 89/225 (39%), Gaps = 52/225 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYG 534
+I +GS G V L GR VAVK + + + N + QH N+V Y
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +++ +E +L D++ LNE +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----------------SQVRLNEEQIAT-------- 145
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V ++ L++LH G+IHRD+K ++L++ D KLSD G
Sbjct: 146 -----------------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFG 186
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
++ D+ + + G+ W APE + + +D++SLG
Sbjct: 187 FCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLG 228
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 521
+ K + +G+ G VV G VAVK L + + E++ +
Sbjct: 37 LTLGKPLGEGAFGQVV-MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 132
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R R P ME + DI L+ T + G+ +L IHRDL +NVL+++
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 693
+ K++D G+++ D+ N Y ++G W APE L T D
Sbjct: 193 NNV--MKIADFGLAR----DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 694 LFSLGCILFFCITGGKHPY 712
++S G +++ T G PY
Sbjct: 242 VWSFGVLMWEIFTLGGSPY 260
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 52/225 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLI---ASDQHPNIVRWYG 534
++I +G++GTV + G+ VA+++ + + I N I +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E SL D++ ++E +I
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----------------TETCMDEGQIAA-------- 120
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 121 -----------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
++ + S + +T G+ W APE + + +D++SLG
Sbjct: 162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 68/329 (20%), Positives = 118/329 (35%), Gaps = 102/329 (31%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--------------ALKEIQNLIASD 524
+ I+ GS G V + EG VA+KR+ T D L+EI+ L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHF 86
Query: 525 QHPNIVRWYGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HPNI+ + + +YL E L +I+ +++
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--------------DQRIVIS 132
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
I+ ++ +L GL LHE G++HRDL P N+L+
Sbjct: 133 PQHIQYF----------MY--------HILL-------GLHVLHEAGVVHRDLHPGNILL 167
Query: 640 SKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFS 696
+ + + D +++ D N T Y + W +APE ++Q + T+ +D++S
Sbjct: 168 ADN---NDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 697 LGCILFFCITG-----GKH-------------------------PYGESFERDANIVKDR 726
GC++ G P + R++
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 727 KDLFLV--EHIPEAVDLFTRLLDPNPDLR 753
+ V P A+DL ++L+ NP R
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRR 308
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 56/235 (23%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKR--LVKTHHDVAL--KEIQNLIASDQHPN 528
+ I G+ V VA+KR L K + KEIQ + HPN
Sbjct: 21 EVIGSGATAVV-----QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPN 74
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
IV +Y +D ++L ++ + S+ D+I + + E S +L+E I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII-------KHIVAKGEHKSGVLDESTIAT-- 125
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ R+++ GL +LH+ G IHRD+K N+L+ +D S
Sbjct: 126 -----------------------ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--V 160
Query: 648 KLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLG 698
+++D G+S L GD++ T G+ W APE + Q R +A D++S G
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA-DIWSFG 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 71/257 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR---------SVAVKRLVKTHHDVA----LKEIQNLI 521
+ +K + G G V GR SVA+K L + + L E ++
Sbjct: 47 ISIDKVVGAGEFGEV-----CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS-IM 100
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNI+R GV + V + E Y+ +GS + L ++ D+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTE----------YMENGSLDSFL--RKHDAQF---- 144
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
QL+ + R I SG+ +L ++G +HRDL +N+LI+
Sbjct: 145 ----------------------TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLF 695
+ K+SD G+ + L+ D Y + G W +PE + + T A D++
Sbjct: 183 N--LVCKVSDFGLGRVLEDDPE------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ ++ G+ PY
Sbjct: 235 SYGIVLWEVMSYGERPY 251
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 56/222 (25%), Positives = 87/222 (39%), Gaps = 57/222 (25%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
VA+KR V+ D AL+EI L+ +H NIVR + V + L E C
Sbjct: 27 HEIVALKR-VRLDDDDEGVPSSALREI-CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
L +G + V+ L QLLK
Sbjct: 85 QDLKKYFDSCNGDLDP------------EIVKSFLF--------------------QLLK 112
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 669
GL H ++HRDLKPQN+LI+++ KL++ G+++ + C +
Sbjct: 113 -------GLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVV 163
Query: 670 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK 709
T W + P+ L + + +ID++S GCI G+
Sbjct: 164 T-----LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ ++ G G V EG ++ S VAVK L + +V LKE ++ +HPN+V
Sbjct: 15 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLV 72
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 73 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ LL + I S + +L + IHRDL +N L+ ++ K++
Sbjct: 109 -------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVA 153
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 154 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 704 CITGGKHPY 712
T G PY
Sbjct: 205 IATYGMSPY 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 53/257 (20%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 525 QHPNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H N+V G + + + +E + G NL +R
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVE----------FCKFG-------------NLSTYLRS 125
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ + E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+ D G+++ D+ W APE + T D++
Sbjct: 186 --VVKICDFGLAR----DI-----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ + G PY
Sbjct: 235 SFGVLLWEIFSLGASPY 251
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 52/231 (22%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV--- 535
K I GS G V E VA+K+ V +E+Q ++ +HPN+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK-VLQDKRFKNRELQ-IMRIVKHPNVVDLKAFFYS 103
Query: 536 ---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ D+ F+ L LE ++ + + + + I+L
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYA-----------KLKQTMPMLLIKLY------ 146
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
QLL+ L+++H IG+ HRD+KPQN+L+ KL D
Sbjct: 147 ------------MYQLLR-------SLAYIHSIGICHRDIKPQNLLLDPPSGVL-KLIDF 186
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
G +K L + Y S + +APE + T ID++S GC++
Sbjct: 187 GSAKILIAG-----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL H+H +++RDLKP N+L+ D+ ++SD+G++ + G+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK-----KPHASVGT 353
Query: 675 SGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 730
G+ APE L +G + D FSLGC+LF + G P+ + +D + + +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLR 753
L + PE L LL + + R
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 58/296 (19%), Positives = 102/296 (34%), Gaps = 86/296 (29%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 78
Query: 535 V----ESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + + + + +E L I +++ E
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 116
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 648
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 117 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF--CIT 706
L+D G A E + ++ D++SLG I++ C
Sbjct: 161 LTDFGF------------------------AKE-TTGEKYDKSCDMWSLGVIMYILLC-- 193
Query: 707 GGKHP-YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLR 753
G P Y + +K R + F + E L LL P R
Sbjct: 194 -GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 57/229 (24%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHHDVALKEIQNLI---ASDQHPNIVRW 532
+EI GS G V + VA+K+ + ++I + +HPN +++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + +L +E C S +DL+ V +E
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------- 154
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 155 --------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDF 198
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLG 698
G + S + + G+ W APE +L + + +D++SLG
Sbjct: 199 GSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 56/230 (24%), Positives = 103/230 (44%), Gaps = 57/230 (24%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 534
+ +G+ G V + +GR VA+KR ++ + A++EI +L+ HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREI-SLLKELHHPNIVSLID 86
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + L E L ++ ++ ++++I L
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD------------SQIKIYLY-------- 126
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
QLL+ G++H H+ ++HRDLKPQN+LI+ D KL+D G+
Sbjct: 127 ------------QLLR-------GVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGL 165
Query: 655 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
++ + T T W +AP+ L+ ++ + ++D++S+GCI
Sbjct: 166 ARAFGIPVRSYTHEVVT-----LWYRAPDVLMGSKKYSTSVDIWSIGCIF 210
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ KE+ G G VV G ++G+ VAVK + + D +E Q + HP +V+
Sbjct: 10 ITLLKELGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVK 67
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+YGV S + +Y+ E Y+ +G L + +
Sbjct: 68 FYGVCSKEYPIYIVTE----------YISNGCLLNYLRSHGKGLEP-------------- 103
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+QLL++ D+ G++ L IHRDL +N L+ +D C K+SD
Sbjct: 104 --------------SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD--LCVKVSD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ + D S G W APE + + D+++ G +++
Sbjct: 148 FGMTRYVLDD--------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 200 SLGKMPY 206
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ F KE+ G G VV G + G VA+K + + D ++E + ++ + H +V+
Sbjct: 26 LTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQ 83
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YGV + Q +++ E Y+ +G L +E
Sbjct: 84 LYGVCTKQRPIFIITE----------YMANGCLLNYL--REMRHRF-------------- 117
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ QLL++ +D+ + +L +HRDL +N L++ K+SD
Sbjct: 118 ------------QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ--GVVKVSD 163
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+S+ + D S G W PE L+ + + D+++ G +++
Sbjct: 164 FGLSRYVLDD--------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 216 SLGKMPY 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 77/321 (23%), Positives = 130/321 (40%), Gaps = 98/321 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ + G+ G V + G VA+K+L + A +E++ L+ +H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 89
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V E+ DF YL + L L+ L E RI+ L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----------------HEKLGEDRIQFL 133
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ Q+LK GL ++H G+IHRDLKP N+ +++D C
Sbjct: 134 ----------VY--------QMLK-------GLRYIHAAGIIHRDLKPGNLAVNED---C 165
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
K+ D G++++ +M TGY + W +APE +L + T+ +D++S+GCI+
Sbjct: 166 ELKILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 704 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 732
ITG G P E +R + ++KD L
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
P AV+L ++L + + R
Sbjct: 279 NASPLAVNLLEKMLVLDAEQR 299
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 6e-17
Identities = 43/145 (29%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IVSGL HLH+ +I+RDLKP+NVL+ D ++SD+G++ + T+ G+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVE---LKAGQTKTKGYAGT 352
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KDL 729
G+ APE LL ++D F+LG L+ I + + +K R + +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA--RGPFRARGEKVENKELKQRVLEQAV 410
Query: 730 FLVEHI-PEAVDLFTRLLDPNPDLR 753
+ P + D LL +P+ R
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 6e-17
Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 77/304 (25%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
+IG ++ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 13 VKIGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL- 70
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V S +++ +E YV G + + + L+E
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVME----------YVSGGELFDYICKNGR----LDEK 116
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R ++ + I+SG+ + H ++HRDLKP+NVL+
Sbjct: 117 ESR-------------------------RLFQQILSGVDYCHRHMVVHRDLKPENVLL-- 149
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 200
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 749
S G IL+ + G P F+ D ++ K + +++ P + L +L +
Sbjct: 201 SSGVILYALLC-GTLP----FD-DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 750 PDLR 753
P R
Sbjct: 255 PMKR 258
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 52/231 (22%), Positives = 100/231 (43%), Gaps = 54/231 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
+I +GS G V N + G+ VA+K+ +++ D +AL+EI ++ +HPN+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNL 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + ++L E C ++ + ++ + E ++ +
Sbjct: 68 LEVFRRKRRLHLVFEYCDHTVLHEL--------------DRYQRGVPEHLVKSI------ 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
W Q L+ ++ H+ IHRD+KP+N+LI+K KL D
Sbjct: 108 ----TW--------QTLQ-------AVNFCHKHNCIHRDVKPENILITKHSVI--KLCDF 146
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
G ++ L G ++ W ++PE L+ Q +D++++GC+
Sbjct: 147 GFARLLTGPSDYYDD----EVATRWYRSPELLVGDTQYGPPVDVWAIGCVF 193
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 65/240 (27%), Positives = 95/240 (39%), Gaps = 68/240 (28%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ + G+ G V Y+GR A+K + T + +EI L H NI
Sbjct: 30 ELVGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 531 RWYG------VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+YG D ++L +E C S+ DLI K N L E I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------------KNTKGNTLKEEWI 131
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ R+I+ GLSHLH+ +IHRD+K QNVL++++
Sbjct: 132 AY-------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLG 698
KL D G+S +L + + T G+ W APE + A DL+SLG
Sbjct: 167 E--VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 72/258 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR----------SVAVKRLVKTHHDVA----LKEIQNL 520
V K I G G V Y+G VA+K L + + L E +
Sbjct: 46 VTRQKVIGAGEFGEV-----YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-I 99
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ H NI+R GV S + + E Y+ +G+ ++ L +E+D
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITE----------YMENGALDKFL--REKDGEF--- 144
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
QL+ + R I +G+ +L + +HRDL +N+L++
Sbjct: 145 -----------------------SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDL 694
+ K+SD G+S+ L+ D Y +SG W APE + + T A D+
Sbjct: 182 SN--LVCKVSDFGLSRVLEDDPE------ATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 695 FSLGCILFFCITGGKHPY 712
+S G +++ +T G+ PY
Sbjct: 234 WSFGIVMWEVMTYGERPY 251
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 63/253 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ K I G +G V G VA+K L + + L E ++
Sbjct: 51 IHIEKIIGSGDSG-EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS-IMGQFD 108
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNI+R GV + + E Y+ +GS + L + D
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTE----------YMENGSLDTFL--RTHDGQF-------- 148
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
QL+ + R + +G+ +L ++G +HRDL +NVL+ +
Sbjct: 149 ------------------TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--L 188
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K+SD G+S+ L+ D Y ++G W APE + + A D++S G
Sbjct: 189 VCKVSDFGLSRVLEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 700 ILFFCITGGKHPY 712
+++ + G+ PY
Sbjct: 243 VMWEVLAYGERPY 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 61/230 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVALKEIQNLI---ASDQHPNI 529
++I KGS G V ++G VA+K + + +++IQ I + P +
Sbjct: 28 EKIGKGSFGEV-----FKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++YG +++ +E S DL+ + L+E +I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----------------EPGPLDETQIAT--- 123
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ R+I+ GL +LH IHRD+K NVL+S+ K
Sbjct: 124 ----------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VK 159
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
L+D G++ +L + T G+ W APE + Q D++SLG
Sbjct: 160 LADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 206
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 52/247 (21%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ K++ G G V Y VAVK + V L E + + QH +V+
Sbjct: 190 LKLEKKLGAGQFG-EVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVK 247
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ V + ++ +Y+ E ++ GS + L K + +
Sbjct: 248 LHAVVT-KEPIYIITE----------FMAKGSLLDFL--KSDEGSKQ------------- 281
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
P +L+ + I G++ + + IHRDL+ N+L+S K++D
Sbjct: 282 ------------PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS--LVCKIAD 327
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 328 FGLARVIEDN--------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 706 TGGKHPY 712
T G+ PY
Sbjct: 380 TYGRIPY 386
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 96/322 (29%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
I +G+ G V + VA+K++ H L+EI+ ++ +H NI+
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGIN 91
Query: 534 GV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + + VY+ + L L+ + L+ I
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLK----------------TQHLSNDHICYF-- 133
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA- 647
L+ Q+L+ GL ++H ++HRDLKP N+L++ C
Sbjct: 134 --------LY--------QILR-------GLKYIHSANVLHRDLKPSNLLLNTT---CDL 167
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705
K+ D G++ R+ T T Y ++ W +APE +L + T++ID++S+GCIL +
Sbjct: 168 KICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 706 TG-----GKH--------------PYGESFERDANI----------VKDRKDLFLVEHI- 735
+ GKH P E N+ K++ +
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW---NRLF 283
Query: 736 ----PEAVDLFTRLLDPNPDLR 753
+A+DL ++L NP R
Sbjct: 284 PNADSKALDLLDKMLTFNPHKR 305
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 67/258 (25%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRS----VAVKRL-----VKTHHDVALKEIQNLIAS 523
L + +KE+ G+ G V +G Y+ + VAVK L D L E ++
Sbjct: 17 LLTLEDKELGSGNFG-TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQ 74
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+P IVR G+ + + L +E G L ++
Sbjct: 75 LDNPYIVRMIGI-CEAESWMLVME----------MAELGP-------------LNKYLQ- 109
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
AK+SD G+SK L+ D + Y + W APE + + + D++S
Sbjct: 155 --YAKISDFGLSKALRADENY-------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 697 LGCILFFCITGGKHPYGE 714
G +++ + G+ PY
Sbjct: 206 FGVLMWEAFSYGQKPYRG 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 53/214 (24%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
G VA+K VK + A++EI +L+ +H NIVR Y V ++ + L E
Sbjct: 30 GVYVALKE-VKLDSEEGTPSTAIREI-SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
L + + L LN V+ QLL+
Sbjct: 88 DLKKYM--------DSRTVGNTPRGLELNLVKYFQW--------------------QLLQ 119
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 669
GL+ HE ++HRDLKPQN+LI+K KL D G+++ ++ +
Sbjct: 120 -------GLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 670 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
T W +AP+ L+ R + +ID++S GCIL
Sbjct: 171 T-----LWYRAPDVLMGSRTYSTSIDIWSCGCIL 199
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 59/259 (22%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 521
+V K + +G+ G VV G VAVK L + + E++ +
Sbjct: 71 LVLGKPLGEGAFGQVV-LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 166
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
+ R P +E + + S L+ + G+ +L IHRDL +NVL+++
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 693
D K++D G+++ D+ + Y ++G W APE L T D
Sbjct: 227 DN--VMKIADFGLAR----DI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 694 LFSLGCILFFCITGGKHPY 712
++S G +L+ T G PY
Sbjct: 276 VWSFGVLLWEIFTLGGSPY 294
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 65/276 (23%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 526
+ + ++ KG+ G+V L G+ G VAVK+L + D +EIQ ++ +
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ-ILKALHS 83
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
IV++ GV + + L +E Y+ SG + L + + L
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVME----------YLPSGCLRDFL--QRHRARL------- 124
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+++LL + I G+ +L +HRDL +N+L+ +
Sbjct: 125 -------------------DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-- 163
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K++D G++K L D Y W APE L +R D++S
Sbjct: 164 AHVKIADFGLAKLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
G +L+ T S E + +R L
Sbjct: 217 GVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 61/246 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 533
+ + I KG G V+ G+Y G VAVK + A L E ++ +H N+V+
Sbjct: 23 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLL 80
Query: 534 GVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 81 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 114
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 115 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 161
Query: 653 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G++K W APE L + + + D++S G +L+ +
Sbjct: 162 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
Query: 707 GGKHPY 712
G+ PY
Sbjct: 210 FGRVPY 215
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-16
Identities = 67/363 (18%), Positives = 125/363 (34%), Gaps = 61/363 (16%)
Query: 358 HAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPG 417
VE + I CP + + H + P+++
Sbjct: 233 WQLVEYLKLKADGLIYCLKEACPNSS---ASNASGAAAPTLPAHPSTLTHPQRRIDTLNS 289
Query: 418 YNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVF 477
+ T ++ + +T + E+ L D L++
Sbjct: 290 -DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD--------NLLIA 340
Query: 478 NKEIAKGSNGTVVLEGNYEGRS----VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIV 530
+ E+ G+ G+V +G Y R VA+K L + +E+ ++ +P IV
Sbjct: 341 DIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R GV + + L +E G + L + +
Sbjct: 400 RLIGVCQAEA-LMLVME----------MAGGGPLHKFL--VGKREEI------------- 433
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
P + + ++ + G+ +L E +HR+L +NVL+ AK+S
Sbjct: 434 -------------PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKIS 478
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+SK L D S T + G W APE + + + D++S G ++ ++ G+
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 711 PYG 713
PY
Sbjct: 539 PYK 541
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 68/321 (21%), Positives = 128/321 (39%), Gaps = 98/321 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V + + G VAVK+L + + +E++ L+ +H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 93
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V S ++F VYL LN+++ L + ++ L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFL 137
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ Q+L+ GL ++H +IHRDLKP N+ +++D C
Sbjct: 138 ----------IY--------QILR-------GLKYIHSADIIHRDLKPSNLAVNED---C 169
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
K+ D G+++ +M TGY ++ W +APE +L + +D++S+GCI+
Sbjct: 170 ELKILDFGLARHTADEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 704 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 732
+TG G P E ++ ++ + + +
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
P AVDL ++L + D R
Sbjct: 283 GANPLAVDLLEKMLVLDSDKR 303
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 61/246 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 533
+ + I KG G V+ G+Y G VAVK + A L E + +H N+V+
Sbjct: 195 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM-TQLRHSNLVQLL 252
Query: 534 GVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 253 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 286
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 287 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 333
Query: 653 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G++K W APE L + + + D++S G +L+ +
Sbjct: 334 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 707 GGKHPY 712
G+ PY
Sbjct: 382 FGRVPY 387
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 59/257 (22%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-------RSVAVKRLVKTHHDVA----LKEIQNLIAS 523
+ F K + G+ G VV E G VAVK L T H + E++ +
Sbjct: 48 LQFGKTLGAGAFGKVV-EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
QH NIV G + V + E C L + + S E +S
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA----- 161
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ LL + + G++ L IHRD+ +NVL++
Sbjct: 162 ---------------------STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
AK+ D G+++ + D + Y G W APE + T D++
Sbjct: 201 H--VAKIGDFGLARDIMNDSN--------YIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ + G +PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 44/236 (18%), Positives = 76/236 (32%), Gaps = 56/236 (23%)
Query: 479 KEIAKGSNGT-VVLEGNYE--GRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNIV 530
I KG V Y+ G V V+R+ E+ + HPNIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIV 89
Query: 531 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + +++ S DLI + +NE+ I
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLI-------------CTHFMDGMNELAIAY---- 132
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ + ++ L ++H +G +HR +K ++LIS D L
Sbjct: 133 ---------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169
Query: 650 SDMGISKRLQGDMSCL-TQNATGYGSSG---WQAPEQLLQGRQ--TRAIDLFSLGC 699
S + + + + S W +PE L Q Q D++S+G
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGI 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 48/212 (22%), Positives = 91/212 (42%), Gaps = 53/212 (25%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
GR VA+K+ +++ D +A++EI L+ +H N+V V + YL E
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611
++ D + E N L+ ++ L+ Q++
Sbjct: 109 TILDDL--------------ELFPNGLDYQVVQKY----------LF--------QIIN- 135
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
G+ H +IHRD+KP+N+L+S+ KL D G ++ L
Sbjct: 136 ------GIGFCHSHNIIHRDIKPENILVSQSGVV--KLCDFGFARTLAAPGEVYDD---- 183
Query: 672 YGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
++ W +APE L+ + +A+D++++GC++
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 56/258 (21%), Positives = 100/258 (38%), Gaps = 56/258 (21%)
Query: 462 IDDRVDGRRIGKLVVFNKEIAKGSNGT--VVLEG----NYEGRSVAVKRLVKTHHDV-AL 514
++ R +F E K GT V + + + A+K++ T + A
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC 66
Query: 515 KEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 572
+EI L+ +HPN++ V V+L + E
Sbjct: 67 REIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYA----------------------E 103
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRD 631
D L +++ + + K ++K + I+ G+ +LH ++HRD
Sbjct: 104 HD----------LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 632 LKPQNVLISKDKSF--CAKLSDMGISKRLQGDMSCLTQNATG-----YGSSGWQAPEQLL 684
LKP N+L+ + K++DMG ++ + L Y +APE LL
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY-----RAPELLL 208
Query: 685 QGRQ-TRAIDLFSLGCIL 701
R T+AID++++GCI
Sbjct: 209 GARHYTKAIDIWAIGCIF 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+V K + +G G VV L+G +VAVK L + L E N++
Sbjct: 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQV 83
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRI 583
HP++++ YG S + L +E Y GS L +++ L
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVE----------YAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R +++ + L L+ I G+ +L E+ L+HRDL +N+L+++ +
Sbjct: 134 RNSSSLDHPDERAL------TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+SD G+S+ D+ S G W A E L T D++
Sbjct: 188 --KMKISDFGLSR----DV-----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ +T G +PY
Sbjct: 237 SFGVLLWEIVTLGGNPY 253
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 73/291 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR 531
K + GS G V+L + G A+K L K V LK+I+ ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D +Y+ +E YV G L + +E R
Sbjct: 106 LEFSFKDNSNLYMVME----------YVAGGEMFSHL----RRIGRFSEPHARFY----- 146
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+AQ IV +LH + LI+RDLKP+N+LI D+ +++D
Sbjct: 147 -------------AAQ-------IVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTD 184
Query: 652 MGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
G +KR++G C G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-- 234
Query: 710 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+P + + +E IV + + H + DL LL + R
Sbjct: 235 YPPFFADQPIQIYE---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 53/257 (20%), Positives = 101/257 (39%), Gaps = 61/257 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
+ ++E+ +GS G V EG +G VA+K + + L E ++
Sbjct: 27 ITMSRELGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKE 84
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
++VR GV S + +E + G +L + +R
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIME----------LMTRG-------------DLKSYLRS 121
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ N ++++++ +I G+++L+ +HRDL +N ++++D
Sbjct: 122 LRPAMANNPVLAPP------SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 174
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
F K+ D G+++ + T Y G G W +PE L G T D++
Sbjct: 175 -FTVKIGDFGMTRDIY---------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ T + PY
Sbjct: 225 SFGVVLWEIATLAEQPY 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 64/299 (21%), Positives = 103/299 (34%), Gaps = 92/299 (30%)
Query: 497 GRSVAVKRLVKTHHDV---------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547
+ VA+K+ +K H AL+EI L+ HPNI+ + + L +
Sbjct: 35 NQIVAIKK-IKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607
L +I S + ++ +L
Sbjct: 93 FMETDLEVIIKDNSLVLTP------------SHIKAYML--------------------M 120
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L+ GL +LH+ ++HRDLKP N+L+ ++ KL+D G++K T
Sbjct: 121 TLQ-------GLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTH 171
Query: 668 N-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES------- 715
T W +APE L R +D++++GCIL + P+ G+S
Sbjct: 172 QVVT-----RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR--VPFLPGDSDLDQLTR 224
Query: 716 -FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
FE D K + L + +DL L NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 60/257 (23%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASD 524
+ +++ +G G V L + G VAVK L K +EI ++ +
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID-ILRTL 90
Query: 525 QHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
H +I+++ G ++ + L +E YV GS + L
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVME----------YVPLGSLRDYL-------------- 126
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ AQLL + I G+++LH IHRDL +NVL+ D
Sbjct: 127 ----------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQTRAIDLFSLGCI 700
K+ D G++K + G S W APE L + + A D++S G
Sbjct: 171 --RLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 701 LFFCITGGKHPYGESFE 717
L+ +T +
Sbjct: 227 LYELLTHCDSSQSPPTK 243
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 74/252 (29%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K++ KG+ G V + G VAVK++ + +EI L H NIV
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 533 YGV---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V ++D+D VYL + L+ +I +N+L V + +
Sbjct: 75 LNVLRADNDRD-VYLVFDYMETDLHAVIR----------------ANILEPVHKQYV--- 114
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-K 648
++ QL+K + +LH GL+HRD+KP N+L++ + C K
Sbjct: 115 -------VY--------QLIK-------VIKYLHSGGLLHRDMKPSNILLNAE---CHVK 149
Query: 649 LSDMGISKRLQGDMSCLTQNA-----------------TGYGSSGW-QAPEQLLQGRQ-T 689
++D G+S+ T Y ++ W +APE LL + T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 690 RAIDLFSLGCIL 701
+ ID++SLGCIL
Sbjct: 210 KGIDMWSLGCIL 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-16
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 16/146 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-G 673
I GL LH +++RDLKP+N+L+ D ++SD+G++ + Q G G
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEG-----QTIKGRVG 347
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KD 728
+ G+ APE + R T + D ++LGC+L+ I G + V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG--QSPFQQRKKKIKREEVERLVKEVP 405
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
E P+A L ++LL +P R
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 34/310 (10%), Positives = 71/310 (22%), Gaps = 109/310 (35%)
Query: 466 VDGR-RIGKLVVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALKEIQ 518
+GR R+ L R VA+ V + +Q
Sbjct: 29 ANGRYRLLIF------HGGVPPLQFWQALDTAL-----DRQVALT-FVDPQGVLPDDVLQ 76
Query: 519 NLI------ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 572
+ + P + R V + + E ++ GS +E +
Sbjct: 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE----------WIRGGSLQEVADT-- 124
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632
P ++ + + + H G+
Sbjct: 125 -----------SPSP------------------VGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 692
P V +S D L+
Sbjct: 156 HPSRVRVSIDGD--VVLAYPATM-----------------------PDA-------NPQD 183
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--------LVEHIPEAVD-LFT 743
D+ +G L+ + + P E+ + + +D + IP + +
Sbjct: 184 DIRGIGASLYALLV-NRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 744 RLLDPNPDLR 753
R + + +R
Sbjct: 242 RSVQGDGGIR 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 526
+ F +++ KG+ G+V + + G VAVK+L + + +EI+ ++ S QH
Sbjct: 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 70
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 111
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 112 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 150
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G++K L D + W APE L + + + A D++S
Sbjct: 151 NRVKIGDFGLTKVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 204 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 9e-16
Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 70/327 (21%)
Query: 400 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 459
I +K+ R + + + Q + + V ETD + I + T+T
Sbjct: 323 GATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED----TYT 378
Query: 460 DLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVAL 514
+ +R + + + I +G G V +G Y VA+K D
Sbjct: 379 MPSTRDYEIQR--ERIELGRCIGEGQFGDVH-QGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 515 KEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
++ + HP+IV+ GV ++ V++ +E G L +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--Q 482
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
+ +L A L+ + + L++L +HRD
Sbjct: 483 VRKFSL--------------------------DLASLILYAYQLSTALAYLESKRFVHRD 516
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQ 685
+ +NVL+S + C KL D G+S+ ++ T Y +S W APE +
Sbjct: 517 IAARNVLVSSN--DCVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINF 566
Query: 686 GRQTRAIDLFSLGCILFFCITGGKHPY 712
R T A D++ G ++ + G P+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 54/223 (24%), Positives = 87/223 (39%), Gaps = 65/223 (29%)
Query: 497 GRSVAVKRLVKTHHD---------VALKEIQNL--IASDQHPNIVRWYGVESDQDF---- 541
G VA+K V+ + ++E+ L + + +HPN+VR V +
Sbjct: 34 GHFVALKS-VRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92
Query: 542 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
V L E +QD L ++ L
Sbjct: 93 KVTLVFEHV----------------------DQD----------LRTYLDKAPPPGL--- 117
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G++ R+
Sbjct: 118 ---PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLA-RIYS 171
Query: 661 DMSCLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
LT T W +APE LLQ +D++S+GCI
Sbjct: 172 YQMALTPVVVT-----LWYRAPEVLLQSTYATPVDMWSVGCIF 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 55/230 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVAL--KEIQNLIASDQHPNIVRWYG 534
E+ G+ G V N E G A K + K+ ++ EI+ L D HP IV+ G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLG 83
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+++ +E C +++ ++ L E
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------------------------- 117
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R ++ L+ LH +IHRDLK NVL++ + +L+D G
Sbjct: 118 -------------QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFG 162
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLG 698
+S + + + + G+ W APE ++ D++SLG
Sbjct: 163 VSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG 209
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 45/256 (17%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ + ++I +G+ G V L VAVK L + +E L+A
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEF 107
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
+PNIV+ GV + + L E Y+ G E L + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
++ A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 158 STRARVSSPGPPPL-----SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-- 210
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLFS 696
K++D G+S+ + + Y + W PE + R T D+++
Sbjct: 211 MVVKIADFGLSRNIY---------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261
Query: 697 LGCILFFCITGGKHPY 712
G +L+ + G PY
Sbjct: 262 YGVVLWEIFSYGLQPY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 63/256 (24%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
L++ + E+ G+ G+V V + VA+K L + ++E Q ++
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLD 68
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P IVR GV + + L +E G + L + +
Sbjct: 69 NPYIVRLIGV-CQAEALMLVME----------MAGGGPLHKFL--VGKREEI-------- 107
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
P + + ++ + G+ +L E +HRDL +NVL+
Sbjct: 108 ------------------PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-- 147
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
AK+SD G+SK L D S Y + W APE + + + D++S G
Sbjct: 148 YAKISDFGLSKALGADDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 699 CILFFCITGGKHPYGE 714
++ ++ G+ PY +
Sbjct: 201 VTMWEALSYGQKPYKK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 55/220 (25%), Positives = 90/220 (40%), Gaps = 62/220 (28%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNL--IASDQHPNIVRWYGV-----ESDQDFVY 543
GR VA+KR V+ ++E+ L + + +HPN+VR + V + +
Sbjct: 37 GRFVALKR-VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 603
L E +QD L ++ + +
Sbjct: 96 LVFEHV----------------------DQD----------LTTYLDKVPEPGV------ 117
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P+ + + ++ GL LH ++HRDLKPQN+L++ KL+D G++ R+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA-RIYSFQM 174
Query: 664 CLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
LT T W +APE LLQ +DL+S+GCI
Sbjct: 175 ALTSVVVT-----LWYRAPEVLLQSSYATPVDLWSVGCIF 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 46/213 (21%), Positives = 82/213 (38%), Gaps = 56/213 (26%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
VA+K ++ H+ A++E+ +L+ +H NIV + + + + L E
Sbjct: 27 DNLVALKE-IRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611
L + + V++ L QLL+
Sbjct: 85 DLKQYLDDCGNIINM------------HNVKLFLF--------------------QLLR- 111
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-AT 670
GL++ H ++HRDLKPQN+LI++ KL+D G+++ T
Sbjct: 112 ------GLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 671 GYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
W + P+ LL + ID++ +GCI
Sbjct: 164 -----LWYRPPDILLGSTDYSTQIDMWGVGCIF 191
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 71/322 (22%), Positives = 123/322 (38%), Gaps = 101/322 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V + G VA+K+L + A +E+ L+ QH N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGL 88
Query: 533 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
V + D YL + L ++ E +I+
Sbjct: 89 LDVFTPASSLRNFYD-FYLVMPFMQTDLQKIMG----------------LKFSEE-KIQY 130
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L ++ Q+LK GL ++H G++HRDLKP N+ +++D
Sbjct: 131 L----------VY--------QMLK-------GLKYIHSAGVVHRDLKPGNLAVNED--- 162
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILF 702
C K+ D G+++ +M TGY + W +APE +L + +D++S+GCI+
Sbjct: 163 CELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 703 FCITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FL 731
+TG GK P E ++ + RKD
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 732 VEHIPEAVDLFTRLLDPNPDLR 753
P+A DL ++L+ + D R
Sbjct: 276 PRASPQAADLLEKMLELDVDKR 297
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQH 526
+ F +++ KG+ G+V + + G VAVK+L + H +EI+ ++ S QH
Sbjct: 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 101
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 142
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 143 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 181
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G++K L D Y W APE L + + + A D++S
Sbjct: 182 NRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 53/256 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
V F +E+ + G V +G+ G + VA+K L E L A
Sbjct: 11 VRFMEELGEDRFGKVY-KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM-LRAR 68
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QHPN+V GV + + + ++ F + +L + +
Sbjct: 69 LQHPNVVCLLGV---------------VTKDQPLSMI---FSYCSH-----GDLHEFLVM 105
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R + D + + + + I +G+ +L ++H+DL +NVL+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK- 164
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
K+SD+G+ + + A Y G W APE ++ G+ + D++S
Sbjct: 165 -LNVKISDLGLFREV--------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 697 LGCILFFCITGGKHPY 712
G +L+ + G PY
Sbjct: 216 YGVVLWEVFSYGLQPY 231
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 55/283 (19%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASD 524
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 525 QHPNIVRWYGVESDQDF-VYLSLERCTC-SLNDLI---------YVLSGSFEEQLNAKEQ 573
H N+V G + + + +E C +L+ + Y G+ Q
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 574 DSNLLNEVRIRLLPVMENTKDIELWKANGH-----------------PSAQLLKVTRDIV 616
+ + R+ + +++ + L+ + +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 676
G+ L IHRDL +N+L+S+ K+ D G+++ + D Y G
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD--------YVRKG 253
Query: 677 -------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
W APE + T D++S G +L+ + G PY
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ + + G G V G Y G VAVK L + L E L+ QH +VR
Sbjct: 15 LKLVERLGAGQFG-EVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVR 72
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V + Q+ +Y+ E Y+ +GS + L K L
Sbjct: 73 LYAVVT-QEPIYIITE----------YMENGSLVDFL--KTPSGIKLT------------ 107
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+LL + I G++ + E IHRDL+ N+L+S K++D
Sbjct: 108 -------------INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT--LSCKIAD 152
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 153 FGLARLIEDN--------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 706 TGGKHPY 712
T G+ PY
Sbjct: 205 THGRIPY 211
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 59/253 (23%), Positives = 98/253 (38%), Gaps = 48/253 (18%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRL-VKTHHDVA--LKEIQNLIASD 524
+V +E+ +G+ G V S VAVK L T +E + L+ +
Sbjct: 17 IVLKRELGEGAFGKVF-LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNL 74
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
QH +IV++YGV D D + + E Y+ G +L +R
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFE----------YMKHG-------------DLNKFLRAH 111
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
M +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-- 169
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGC 699
K+ D G+S+ + + + G W PE ++ + T D++S G
Sbjct: 170 LLVKIGDFGMSRDVY------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 700 ILFFCITGGKHPY 712
IL+ T GK P+
Sbjct: 224 ILWEIFTYGKQPW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
+V E+ +G+ G V VAVK L K + A +E + L+
Sbjct: 43 IVLKWELGEGAFGKVF-LAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAE-LLTM 99
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QH +IVR++GV ++ + + E Y+ G LN
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFE----------YMRHGD--------------LNRFLR 135
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
P + E QLL V + +G+ +L + +HRDL +N L+ +
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+ D G+S+ + +T Y G W PE +L + T D++
Sbjct: 195 -LVVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ T GK P+
Sbjct: 245 SFGVVLWEIFTYGKQPW 261
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 18/149 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IV L HLH++G+I+RD+K +N+L+ D + L+D G+SK D + G+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAY--DFCGT 223
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP--YGESFERDA-----NIVKD 725
+ AP+ + G +A+D +SLG +++ +TG + + I+K
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKS 281
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + + A DL RLL +P R
Sbjct: 282 --EPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 70/259 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA---LKEIQNLIA 522
++FN+ + +G+ + +G V +K L K H + + + +++
Sbjct: 10 LIFNESLGQGTFTKIF-KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS-MMS 67
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
H ++V YGV D L E +V GS + L K+ + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQE----------FVKFGSLDTYL--KKNKNCI----- 110
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
L+V + + + + L E LIH ++ +N+L+ ++
Sbjct: 111 ---------------------NILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 643 KSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQ-TRAID 693
+ KLSD GIS + W PE + + A D
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATD 200
Query: 694 LFSLGCILFFCITGGKHPY 712
+S G L+ +GG P
Sbjct: 201 KWSFGTTLWEICSGGDKPL 219
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 37/187 (19%), Positives = 68/187 (36%), Gaps = 34/187 (18%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFH 108
+ V+ LDG++H V + G I+W+ + + F D D LY
Sbjct: 10 TLLFVSTLDGSLHAVSKRTGSIKWTLKEDPVLQVPTHVEEPA----FLPD-PNDGSLYTL 64
Query: 109 SKRFGK-MKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167
+ + + KL + E ++ P S DG + +G + +++D+ +G
Sbjct: 65 GSKNNEGLTKLPFTIPELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQT------- 117
Query: 168 STPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNV 227
S + P L+Y+ RT+Y + + E+ WN
Sbjct: 118 ----LSSAFADSLSPSTS-----------------LLYLGRTEYTITMYDTKTRELRWNA 156
Query: 228 AYADFKA 234
Y D+ A
Sbjct: 157 TYFDYAA 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 72/246 (29%)
Query: 481 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDV------ALKEIQNLIASDQHPN 528
+ +G+ G V Y+ VA+KR ++ H+ A++E+ +L+ QH N
Sbjct: 42 LGEGTYGEV-----YKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIREV-SLLKELQHRN 94
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLP 587
I+ V ++L E L + D N ++ I+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYM----------------DKNPDVSMRVIKSF- 137
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF-- 645
QL+ G++ H +HRDLKPQN+L+S +
Sbjct: 138 -----------------LYQLIN-------GVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 646 -CAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
K+ D G+++ + T T W + PE LL R + ++D++S+ CI
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEIIT-----LWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 702 FFCITG 707
+
Sbjct: 229 AEMLMK 234
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-15
Identities = 64/330 (19%), Positives = 126/330 (38%), Gaps = 104/330 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+ +G+ G V + G VA+K++ + L+EI+ ++ +H NI+ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIF 75
Query: 534 GV------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ E+ + VY+ E L+ +I + +L++ I+
Sbjct: 76 NIQRPDSFENFNE-VYIIQELMQTDLHRVI----------------STQMLSDDHIQYF- 117
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
++ Q L+ + LH +IHRDLKP N+LI+ + C
Sbjct: 118 ---------IY--------QTLR-------AVKVLHGSNVIHRDLKPSNLLINSN---CD 150
Query: 648 -KLSDMGISKRLQGDMSCLTQNA------TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLG 698
K+ D G+++ + + ++ + ++ W +APE +L + +RA+D++S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 699 CILFFCITG-----GKH--------------PYGESF------ERDANIV-----KDRKD 728
CIL G+ P+ ++ R +
Sbjct: 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270
Query: 729 LFLVEHI-----PEAVDLFTRLLDPNPDLR 753
L E + P+ +DL R+L +P R
Sbjct: 271 L---EKMFPRVNPKGIDLLQRMLVFDPAKR 297
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 54/253 (21%), Positives = 93/253 (36%), Gaps = 66/253 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ + I +G G V +G Y VA+K D L+E +
Sbjct: 17 IELGRCIGEGQFGDVH-QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-TMRQFD 74
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP+IV+ GV ++ V++ +E G L + + +L
Sbjct: 75 HPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--QVRKYSL-------- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
A L+ + + L++L +HRD+ +NVL+S +
Sbjct: 114 ------------------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--D 153
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
C KL D G+S+ ++ T Y +S W APE + R T A D++ G
Sbjct: 154 CVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 700 ILFFCITGGKHPY 712
++ + G P+
Sbjct: 206 CMWEILMHGVKPF 218
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 53/227 (23%), Positives = 85/227 (37%), Gaps = 71/227 (31%)
Query: 497 GRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGV--------ESDQDFV 542
G+ VA+K+ V ++ AL+EI+ L H N+V + + +
Sbjct: 42 GQKVALKK-VLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSI 99
Query: 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQD-SNLLNEVRIRLLPVMENTKDIELWKAN 601
YL + C E D + LL+ V ++ K +
Sbjct: 100 YLVFDFC----------------------EHDLAGLLSNVLVKFTL--SEIKRVMQ---- 131
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
LL GL ++H ++HRD+K NVLI++D KL+D G+++
Sbjct: 132 -----MLLN-------GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLA 177
Query: 662 MSCLTQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ T Y + PE LL R IDL+ GCI+
Sbjct: 178 KNSQPNRYTNRVVTLWY-----RPPELLLGERDYGPPIDLWGAGCIM 219
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 58/243 (23%), Positives = 105/243 (43%), Gaps = 58/243 (23%)
Query: 477 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
F+ + I G G V VL +G VA+KR ++E + ++ +HP+
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPH 96
Query: 529 IVRWYG--VESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+V G E ++ +Y + Y+ +G+ + L + + ++
Sbjct: 97 LVSLIGFCDERNEMILIY---K----------YMENGNLKRHLYGSDLPTMSMS------ 137
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
W+ Q L++ GL +LH +IHRD+K N+L+ D++F
Sbjct: 138 ------------WE-------QRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENF 176
Query: 646 CAKLSDMGISK-RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K++D GISK + D + L+ G+ G+ PE ++GR T D++S G +LF
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 705 ITG 707
+
Sbjct: 235 LCA 237
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 69/322 (21%), Positives = 116/322 (36%), Gaps = 91/322 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGV 535
+ +G+ GTV L G SVA+K+ V +E+Q + +A HPNIV+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 536 -----ESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
E D+ +YL++ E +L+ ++ + I++
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCC--------RNYYRRQVA---PPPILIKVF-- 134
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--IGLIHRDLKPQNVLISKDKSFC 646
QL++ + LH + + HRD+KP NVL+ +++
Sbjct: 135 ----------------LFQLIR-------SIGCLHLPSVNVCHRDIKPHNVLV--NEADG 169
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
KL D G +K+L + Y S + +APE + + T A+D++S+GCI
Sbjct: 170 TLKLCDFGSAKKLSPS-----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 704 CITG-----GKH--------------PYGESFERDANIVKDRKDLFLVEH---------- 734
+ G G + P E + D
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284
Query: 735 ---IPEAVDLFTRLLDPNPDLR 753
EA DL + LL P+ R
Sbjct: 285 LKDAKEAYDLLSALLQYLPEER 306
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 70/257 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL-------VKTHHDVALKEIQNLIA 522
+ +++ GS G V G ++ S VAVK L + D ++E+ +
Sbjct: 20 LRLLEKLGDGSFGVV-RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF-IREVN-AMH 76
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
S H N++R YGV + + E GS ++L ++ +
Sbjct: 77 SLDHRNLIRLYGVVLTPP-MKMVTE----------LAPLGSLLDRL--RKHQGHF----- 118
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
L + + G+ +L IHRDL +N+L++
Sbjct: 119 ---------------------LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
K+ D G+ + L + Y W APE L + A D +
Sbjct: 158 D--LVKIGDFGLMRALPQNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 696 SLGCILFFCITGGKHPY 712
G L+ T G+ P+
Sbjct: 209 MFGVTLWEMFTYGQEPW 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 70/273 (25%)
Query: 477 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
F+ + + +G G V L +G VAVKRL + + Q +I+ H N
Sbjct: 32 FSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 529 IVRWYG--VESDQDFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIR 584
++R G + + R L+Y + +GS L + + L+
Sbjct: 89 LLRLRGFCMTPTE--------RL------LVYPYMANGSVASCLRERPESQPPLD----- 129
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---IGLIHRDLKPQNVLISK 641
W ++ GL++LH+ +IHRD+K N+L+
Sbjct: 130 -------------WPKR-------QRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 642 DKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
D+ F A + D G++K + + + T G+ G APE L G+ + D+F G +
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR---GTIGHIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
L IT G+ + D + + D+ L++
Sbjct: 225 LLELIT-GQRAF------DLARLANDDDVMLLD 250
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 43/230 (18%), Positives = 78/230 (33%), Gaps = 57/230 (24%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
+++ +G V N V VK L +EI+ L PNI+ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 536 -ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + L L+ ++R +
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT----------------DYDIRFYMY-------- 137
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 653
++LK L + H +G++HRD+KP NV+I D +L D G
Sbjct: 138 ------------EILK-------ALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWG 176
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
++ +S + + PE L+ + ++D++SLGC+L
Sbjct: 177 LA-EFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 76/255 (29%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I +GS G V L + ++VA+K++ + D+ L+EI ++ + I+R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRL 90
Query: 533 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
Y + + F +Y+ LE L L L E I+ +
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKT---------------PIFLTEEHIKTI- 134
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L+ LL G + +HE G+IHRDLKP N L+++D C+
Sbjct: 135 ---------LY--------NLLL-------GENFIHESGIIHRDLKPANCLLNQD---CS 167
Query: 648 -KLSDMGISKRLQGDMSCLTQNA------------------TGYGSSGW-QAPEQLLQGR 687
K+ D G+++ + + N T + + W +APE +L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 688 Q-TRAIDLFSLGCIL 701
T++ID++S GCI
Sbjct: 228 NYTKSIDIWSTGCIF 242
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 51/253 (20%), Positives = 94/253 (37%), Gaps = 66/253 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
VV N+ + +G G V EG Y VAVK K + E ++ +
Sbjct: 14 VVLNRILGEGFFGEV-YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLD 71
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP+IV+ G+ ++ ++ +E G L + +L
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIME----------LYPYGELGHYLERNKNSLKVL------- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + I +++L I +HRD+ +N+L++
Sbjct: 114 ---------------------TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP--E 150
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
C KL D G+S+ ++ + Y +S W +PE + R T A D++
Sbjct: 151 CVKLGDFGLSRYIEDE--------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 700 ILFFCITGGKHPY 712
++ ++ GK P+
Sbjct: 203 CMWEILSFGKQPF 215
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 57/255 (22%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQ 525
+ + + G+ G V + + VAVK L + + + +I+
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NIVR GV ++ LE + G +L + +R
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLE----------LMAGG-------------DLKSFLR-ET 168
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKS 644
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 169 RPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
AK+ D G+++ + A Y G W PE ++G T D +S
Sbjct: 221 RVAKIGDFGMARDI--------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 698 GCILFFCITGGKHPY 712
G +L+ + G PY
Sbjct: 273 GVLLWEIFSLGYMPY 287
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 65/237 (27%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGL 89
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V +S ++F VY+ +E +L +I + + L+ R+ L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------------QME---LDHERMSYL 132
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
L+ Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 133 ----------LY--------QMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 164
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
K+ D G+++ T Y + + +APE +L +D++S+GCI+
Sbjct: 165 TLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 73/293 (24%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 529
+ + GS G V L + GR A+K L K V LK+++ +++ HP I
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R +G D +++ ++ Y+ G L + S +
Sbjct: 69 IRMWGTFQDAQQIFMIMD----------YIEGGELFSLL----RKSQRFPNPVAKFY--- 111
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ + L +LH +I+RDLKP+N+L+ DK+ K+
Sbjct: 112 ---------------AAE-------VCLALEYLHSKDIIYRDLKPENILL--DKNGHIKI 147
Query: 650 SDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+D G +K + C G+ + APE + ++ID +S G +++ + G
Sbjct: 148 TDFGFAKYVPDVTYTLC--------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 708 GKHP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ Y + +E I+ L + DL +RL+ + R
Sbjct: 200 --YTPFYDSNTMKTYE---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 66/266 (24%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ +++ +G G V L EG+ G VAVK L KEI+ ++ +
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLY 81
Query: 526 HPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H NIV++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPKNKNKINL------ 125
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
Q LK I G+ +L +HRDL +NVL+ +
Sbjct: 126 ----------------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE- 162
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
K+ D G++K ++ D Y W APE L+Q + A D++S
Sbjct: 163 -HQVKIGDFGLTKAIETDKE-------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 697 LGCILFFCITGGKHPYGESFERDANI 722
G L +T I
Sbjct: 215 FGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 56/257 (21%), Positives = 91/257 (35%), Gaps = 61/257 (23%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ + + G+ G V + + VAVK L + + L E +I+
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKF 90
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIVR GV ++ +E + G +L + +R
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILME----------LMAGG-------------DLKSFLR-E 126
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDK 643
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 127 TRPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
AK+ D G+++ + Y G W PE ++G T D +
Sbjct: 179 GRVAKIGDFGMARDIYR---------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ + G PY
Sbjct: 230 SFGVLLWEIFSLGYMPY 246
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 19/146 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IVS L +LH +++RD+K +N+++ KD K++D G+ K +S T G+
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKD-GHI-KITDFGLCKE---GISDGATMKTFCGT 168
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE L RA+D + LG +++ + G Y + FE I+ + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHERLFE---LILME--E 221
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + PEA L LL +P R
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 16/149 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 173
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 731
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR 753
+ I +A + L+ +P R
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
+V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + A G
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 672 YGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGKHP--YGES-FERDANIVK 724
Y +PE L G R D +S+G L+ + G Y +S + I+
Sbjct: 235 Y-----ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSLVGTYSKIMN 287
Query: 725 DRKDLFLVEHI---PEAVDLFTRLL-DPN 749
+ L + EA +L L D
Sbjct: 288 HKNSLTFPDDNDISKEAKNLICAFLTDRE 316
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 24/151 (15%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
+V + +H++ +HRD+KP N+L+ D + +L+D G +L D + + A G
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 672 YGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIV 723
Y +PE L +GR D +SLG ++ + G Y ES I+
Sbjct: 242 Y-----ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIM 294
Query: 724 KDRKDLFLVEHI----PEAVDLFTRLLDPNP 750
++ + A DL RL+
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSRE 325
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 44/149 (29%), Positives = 70/149 (46%), Gaps = 25/149 (16%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
+ L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSF 186
Query: 673 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 725
G+ + APE + + T++ D +S G ++F +TG G+ I+K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMT---MILKA 241
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
L + + + PEA L L NP R
Sbjct: 242 --KLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 25/149 (16%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
I L HLH+ G+I+RDLKP+N+++ + KL+D G+ K + +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCKE------SIHDGTVTHTF 181
Query: 673 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 725
G+ + APE L++ RA+D +SLG +++ +TG P GE+ + I+K
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID---KILKC 236
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
L L ++ EA DL +LL N R
Sbjct: 237 --KLNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 42/156 (26%), Positives = 64/156 (41%), Gaps = 27/156 (17%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
IV + +H +G +HRD+KP N+L+ D+ +L+D G +L+ D + + A G
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 672 YGSSGWQAPEQLL-------QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-AN 721
Y +PE L G D ++LG + G Y +S
Sbjct: 229 Y-----LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG--QTPFYADSTAETYGK 281
Query: 722 IVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR 753
IV ++ L L EA D RLL P+ R
Sbjct: 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR 316
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 16/149 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 216
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 731
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR 753
+ I +A + L+ +P R
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 53/253 (20%), Positives = 90/253 (35%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+ K + G GTV +G + V +K + + + + I S
Sbjct: 15 LRKLKVLGSGVFGTVH-KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IVR G+ + L + Y+ GS LL+ VR
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQ----------YLPLGS-------------LLDHVR--- 106
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ + LL I G+ +L E G++HR+L +NVL+
Sbjct: 107 ----QHRGAL--------GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP--S 152
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
+++D G++ L D S W A E + G+ T D++S G
Sbjct: 153 QVQVADFGVADLLPPD-------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 206 TVWELMTFGAEPY 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 19/146 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL LH G+++RDLK N+L+ KD K++D G+ K +M + T G+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKD-GHI-KIADFGMCKE---NMLGDAKTNTFCGT 181
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE LL + ++D +S G +L+ + G +G+ F +I D +
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG--QSPFHGQDEEELFH---SIRMD--N 234
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
F + EA DL +L P+ R
Sbjct: 235 PFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 42/149 (28%), Positives = 68/149 (45%), Gaps = 25/149 (16%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
I S L +LH + +++RDLKP+N+L+ D L+D G+ K + N+T
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE------NIEHNSTTSTF 199
Query: 673 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 725
G+ + APE L + R +D + LG +L+ + G P Y + ++ NI+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYD---NILNK 254
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
L L +I A L LL + R
Sbjct: 255 --PLQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 62/238 (26%), Positives = 97/238 (40%), Gaps = 67/238 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 126
Query: 533 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
V E QD VYL +E +L +I L+ R+
Sbjct: 127 LNVFTPQKTLEEFQD-VYLVMELMDANLCQVI-----------------QMELDHERMSY 168
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L Q+L G+ HLH G+IHRDLKP N+++ D
Sbjct: 169 L------------------LYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD--- 200
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
C K+ D G++ R G + T Y + + +APE +L +D++S+GCI+
Sbjct: 201 CTLKILDFGLA-RTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 20/147 (13%)
Query: 615 IVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
IVS L +LH E +++RDLK +N+++ DK K++D G+ K + T G
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKE---GIKDGATMKTFCG 311
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRK 727
+ + APE L RA+D + LG +++ + G Y + FE I+ +
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHEKLFE---LILME-- 364
Query: 728 DLFLVEHI-PEAVDLFTRLLDPNPDLR 753
++ + PEA L + LL +P R
Sbjct: 365 EIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 19/146 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + AT G+
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKE---GICNGVTTATFCGT 187
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE L + A+D +++G +L+ + G H E+ FE I+ D +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG--HAPFEAENEDDLFE---AILND--E 240
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + +A + + NP +R
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 4e-13
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 81/260 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I GS G V + R VA+K++++ D+ L+EI ++ H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKV 117
Query: 533 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ + + F +Y+ LE L L E+ I+ L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---------------PVYLTELHIKTL- 161
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L+ LL G+ ++H G++HRDLKP N L+++D C+
Sbjct: 162 ---------LY--------NLLV-------GVKYVHSAGILHRDLKPANCLVNQD---CS 194
Query: 648 -KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ------------------------APEQ 682
K+ D G+++ + + +Q APE
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 683 LLQGRQ-TRAIDLFSLGCIL 701
+L T AID++S+GCI
Sbjct: 255 ILLQENYTEAIDVWSIGCIF 274
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 184
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 237
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + + EAV + L+ +P R
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 84/281 (29%)
Query: 490 VLEGNYEGRSVAVKRLVKTHHDVA--------LKEIQNLIASDQHPNIVRWYG--VESDQ 539
V +G +VAVK+L D+ +EI ++A QH N+V G + D
Sbjct: 47 VYKGYVNNTTVAVKKL-AAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDGDD 104
Query: 540 DFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
C L+Y + +GS ++L+ + L +R
Sbjct: 105 --------LC------LVYVYMPNGSLLDRLSCLDGTPPLSWHMR--------------- 135
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
K+ + +G++ LHE IHRD+K N+L+ D++F AK+SD G+++
Sbjct: 136 -----------CKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLAR- 181
Query: 658 LQGDMSCLTQNAT------GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
+ T + Y APE L+G T D++S G +L ITG
Sbjct: 182 -ASEKFAQTVMTSRIVGTTAY-----MAPE-ALRGEITPKSDIYSFGVVLLEIITGLP-- 232
Query: 712 YGESFERDANIVKDRKDLFLVEH---IPEAVDLFTRLLDPN 749
+ + R+ L++ I + +D
Sbjct: 233 ---------AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQN---LIASDQH 526
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 91 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 527 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + + L Y+ G + + + N
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 189
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ L +HRDL +N ++ + F
Sbjct: 190 ------------------TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--F 229
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ + N TG W A E L + T D++S G +
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 286 LWELMTRGAPPY 297
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 9e-13
Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 505
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 558
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + + EAV + L+ +P R
Sbjct: 559 VAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQ---NLIASDQH 526
++ I KG G V G Y ++ A+K L + ++ L+ H
Sbjct: 23 THSDRVIGKGHFGVVY-HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 527 PNIVRWYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + ++ L Y+ G + + + N
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLP----------YMCHGDLLQFI--RSPQRNP-------- 121
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ +L E +HRDL +N ++ + F
Sbjct: 122 ------------------TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES--F 161
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ + Q W A E L R T D++S G +
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRH----ARLPVKWTALESLQTYRFTTKSDVWSFGVL 217
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 218 LWELLTRGAPPY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 70/262 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL---VKTHHDVA--LKEIQNLIASD 524
+ + KG G+V E + VAVK L + D+ L+E +
Sbjct: 25 FTLGRMLGKGEFGSVR-EAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEF 82
Query: 525 QHPNIVRWYGVESDQD------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL 578
HP++ + GV + L ++ G +L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILP----------FMKHG-------------DLH 119
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+ + EN ++ P L++ DI G+ +L IHRDL +N +
Sbjct: 120 AFLLASRIG--ENPFNL--------PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTR 690
+++D ++D G+S+++ + Y G + W A E L T
Sbjct: 170 LAED--MTVCVADFGLSRKIY---------SGDYYRQGCASKLPVKWLALESLADNLYTV 218
Query: 691 AIDLFSLGCILFFCITGGKHPY 712
D+++ G ++ +T G+ PY
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPY 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-----SVAVKRLVKTHHDVALKEIQN---LIASDQH 526
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 27 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 527 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + + L Y+ G + + + N
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 125
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ +L +HRDL +N ++ + F
Sbjct: 126 ------------------TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK--F 165
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ DM + + W A E L + T D++S G +
Sbjct: 166 TVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 222 LWELMTRGAPPY 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 67/260 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA-----LKEIQNLIASD 524
++ K + +G G+V+ EGN + VAVK + + L E +
Sbjct: 36 LILGKILGEGEFGSVM-EGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA-CMKDF 93
Query: 525 QHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HPN++R GV + + L ++ G +L
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILP----------FMKYG-------------DLHT 130
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
+ L T + P LLK DI G+ +L +HRDL +N ++
Sbjct: 131 YLLYSRLE----TGPKHI------PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAI 692
D ++D G+SK++ + Y W A E L T
Sbjct: 181 RDD--MTVCVADFGLSKKI--------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 693 DLFSLGCILFFCITGGKHPY 712
D+++ G ++ T G PY
Sbjct: 231 DVWAFGVTMWEIATRGMTPY 250
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 61/235 (25%), Positives = 98/235 (41%), Gaps = 56/235 (23%)
Query: 483 KGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEI---QNLIASDQHP--NIVRWYG 534
KGS G VV +++ + VA+K R K H A +EI ++L D+ N++
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ ++ + ++ E + +L +LI K+ + +R
Sbjct: 167 NFTFRNHICMTFELLSMNLYELI-------------KKNKFQGFSLPLVR---------- 203
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
K I+ L LH+ +IH DLKP+N+L+ + K+ D G
Sbjct: 204 ---------------KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG- 247
Query: 655 SKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
S SC Q Y S + +APE +L R ID++SLGCIL +TG
Sbjct: 248 S-------SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 478 NKEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNL------IASDQHPN 528
+ I KGS G VV + VA+K + K + A E++ L ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY-Y 117
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV ++ + L E + +L DL+ + + ++ R
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL-------------RNTNFRGVSLNLTR---- 160
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSFC 646
K + + + L L E+ +IH DLKP+N+L+ K
Sbjct: 161 ---------------------KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199
Query: 647 AKLSDMGISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G SC L Q Y S + ++PE LL AID++SLGCIL
Sbjct: 200 IKIVDFG--------SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 705 ITG 707
TG
Sbjct: 252 HTG 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 28/126 (22%), Positives = 51/126 (40%), Gaps = 14/126 (11%)
Query: 596 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E K N +P + + + L LHE L H DLKP+N+L +
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 653 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 701
++ + + ++ T ++ ++ PE +L+ + D++S+GCIL
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 702 FFCITG 707
F G
Sbjct: 230 FEYYRG 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 60/430 (13%), Positives = 127/430 (29%), Gaps = 149/430 (34%)
Query: 425 SEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKG 484
+ ++I+ E E D HI + + R L+ +E+ +
Sbjct: 39 QDMPKSILSKE----EID---HIIMSKDA---------VSGTL-RLFWTLLSKQEEMVQK 81
Query: 485 SNGTVVLEGNYE-----------GRSVAVKRLVKTH------------HDV----ALKEI 517
V L NY+ S+ + ++ ++V ++
Sbjct: 82 FVEEV-LRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 518 QNLIASDQ-HPNIV-----------------RWYGVESDQDF-VY-LSLERCTCS----- 552
+ + + N++ Y V+ DF ++ L+L+ C
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 553 -LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL------------LPVMENTKDIELWK 599
L L+Y + ++ + + ++ ++ L L V+ N ++ + W
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 600 A-NGHPSAQLLKVTRD--IVSGLSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMG- 653
A N ++L TR + LS H L ++ ++ D+ K D
Sbjct: 261 AFNLS--CKILLTTRFKQVTDFLSAATT---THISLDHHSMTLTPDEVKSLLLKYLDCRP 315
Query: 654 -----------------ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696
I++ ++ D N W+ + + T I+ S
Sbjct: 316 QDLPREVLTTNPRRLSIIAESIR-DGLATWDN--------WK---HVNCDKLTTIIES-S 362
Query: 697 LGCI-------LF--FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFT---- 743
L + +F + F A+I L + I V +
Sbjct: 363 LNVLEPAEYRKMFDRLSV----------FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 744 --RLLDPNPD 751
L++ P
Sbjct: 413 KYSLVEKQPK 422
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 77/595 (12%), Positives = 171/595 (28%), Gaps = 154/595 (25%)
Query: 231 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVE-SHLPCHTQMTASVYRL-------R 282
F F C++V ++ ++ E H+ + RL +
Sbjct: 28 AFVDNFDCKDV------------QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 283 DNSLPEFL-SVIGKVAGWI-----------SLPGSSQNSLLGPVDRNSPLFLPDKVDRPP 330
+ + +F+ V+ ++ S+ + ++ +F V R
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135
Query: 331 L------ALPSTETEIPWTL--GMPG-G-SV--SEINKKHAFVEGFRSYIQSFIVLFIAL 378
AL L G+ G G + ++ + F + ++ L
Sbjct: 136 PYLKLRQALLELRPA-KNVLIDGVLGSGKTWVALDVCLSYKVQCKM-----DFKIFWLNL 189
Query: 379 ----CP--IIGFL--FYHSKQVKSKKQNEEHITKTGIP----KKKKSR---RPGYNR--- 420
P ++ L + + + +H + + + + R Y
Sbjct: 190 KNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 421 ---NTTNSEKMQ--NIIPNESKVGETDGLSHITGNGEKFLLTFTDL-IDDRVDGRRIGKL 474
N N++ N+ K+ LLT + D + +
Sbjct: 249 VLLNVQNAKAWNAFNL---SCKI----------------LLTTRFKQVTDFLSAATTTHI 289
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVA-VKRLVKTHHDVALKEIQNLIASDQHPNIVRWY 533
+ + + + L Y + R V T + L ++IA + W
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL----SIIAESIRDGLATW- 344
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
++ +++ ++ L +I S L E + + + + P +
Sbjct: 345 -----DNWKHVNCDK----LTTII----ESSLNVLEPAEY-RKMFDRLSV--FP--PSAH 386
Query: 594 DIE------LWKANGHPS------AQLLK---VTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
I +W + S +L K V + + I+ +LK +
Sbjct: 387 -IPTILLSLIW-FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVK--- 438
Query: 639 ISKDKSFCAKLSDM-GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697
+ + + + D I K D + Y L + LF +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQY--FYSHIGHHLKNIEHPERMTLFRM 495
Query: 698 GCILF--FCITGGK--HPYGESFERDANIVKDRKDL-FLVEHIPEAVDLFTRLLD 747
+F F K H ++ +I+ + L F +I + + RL++
Sbjct: 496 ---VFLDFRFLEQKIRHD-STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 29/126 (23%), Positives = 53/126 (42%), Gaps = 14/126 (11%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ K NG + K+ I ++ LH L H DLKP+N+L + A +
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 653 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 701
+R + + ++ + S+ ++APE +L ++ D++S+GCIL
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 702 FFCITG 707
G
Sbjct: 225 IEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 25/132 (18%), Positives = 53/132 (40%), Gaps = 20/132 (15%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E+ N + + +I+ L++L ++ L H DLKP+N+L+ + ++
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 653 GISKRLQGDMSCLTQNATG---YGSSGWQ--------------APEQLLQGRQTRAIDLF 695
++ + + +G + ++ APE +L + D++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 696 SLGCILFFCITG 707
S GC+L TG
Sbjct: 244 SFGCVLAELYTG 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 32/138 (23%), Positives = 61/138 (44%), Gaps = 21/138 (15%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISK----DKSFCA 647
L K H P + ++++ ++ GL ++H G+IH D+KP+NVL+ +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-APEQLLQGRQTRAIDLFSLGCILFFCIT 706
K++D+G + ++ T + +PE LL D++S C++F IT
Sbjct: 178 KIADLGNA-------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 707 G-----GKHPYGESFERD 719
G + + + D
Sbjct: 231 GDFLFEPDEGHSYTKDDD 248
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 48/195 (24%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 527
+G K+I G+ G + L N Y VA+K +K+ E +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 528 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
I V ++G + + LE SL DL + +F
Sbjct: 66 GIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTF--------------------- 102
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ K + L + ++S + ++H LI+RD+KP+N LI + +
Sbjct: 103 -----SLKTV-------------LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK 144
Query: 646 CAK---LSDMGISKR 657
+ + D ++K
Sbjct: 145 TQQVIHIIDFALAKE 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 55/203 (27%)
Query: 463 DDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKR-LVKTHHDVALKEIQN 519
++ V ++G+ I +GS G + N + VA+K ++ E +
Sbjct: 5 NNVVGVHYKVGR------RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 58
Query: 520 LIASDQHPNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
I V ++G E L ++ SL DL+ + F
Sbjct: 59 YKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKF------------- 103
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ K + + +++ + +HE L++RD+KP N
Sbjct: 104 -------------SVKTV-------------AMAAKQMLARVQSIHEKSLVYRDIKPDNF 137
Query: 638 LISKDKSFCAK---LSDMGISKR 657
LI + S A + D G+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 5e-07
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 24/240 (10%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVK-------RLVKTHHDVALKEIQNLIASDQHPNIVR 531
++I +G G V + VA+K LV H +EI I + +++
Sbjct: 26 EKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 532 WYGVESDQDFVYL-SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ F+ L S+ S L+ + + + + ++ ++ E
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 591 N-TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAK 648
D+E + A + + + L+ + HRDL NVL+ K+ K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL--KKTSLKK 202
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG-----------WQAPEQLLQGRQTRAIDLFSL 697
L K L + Y S E L G D++ L
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 45/194 (23%), Positives = 69/194 (35%), Gaps = 46/194 (23%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKR-LVKTHHDVALKEIQNLIASDQH 526
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 527 PNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
I +RW G E D+ + +E SL DL S F
Sbjct: 65 VGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKF-------------------- 102
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-DK 643
+ K + L + ++S + ++H IHRD+KP N L+ K
Sbjct: 103 ------SLKTV-------------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143
Query: 644 SFCAKLSDMGISKR 657
+ D G++K+
Sbjct: 144 GNLVYIIDFGLAKK 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 596 ELWKANGHPSAQL-LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++ NG L++ ++ L ++HE +H D+K N+L+ L+D G+
Sbjct: 140 KISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 655 SKR 657
S R
Sbjct: 200 SYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 11/49 (22%), Positives = 23/49 (46%)
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
L+V ++ L LHE +H ++ +N+ + + L+ G + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 46/193 (23%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKR-LVKTHHDVALKEIQNLIASDQHP 527
R+G ++I GS G + L N VA+K VKT H L E +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 528 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
I VRW+GVE D+ L ++ SL DL S
Sbjct: 64 GIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKL--------------------- 100
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ K + L + +++ + +H +HRD+KP N L+ +
Sbjct: 101 -----SLKTV-------------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 646 -CAKLSDMGISKR 657
+ D G++K+
Sbjct: 143 NQVYIIDFGLAKK 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 13/43 (30%), Positives = 23/43 (53%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
I+ L ++HE +H D+K N+L++ L D G++ R
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 28/155 (18%), Positives = 52/155 (33%), Gaps = 42/155 (27%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLIS------------- 640
I G P + K+ + ++ GL +LH + +IH D+KP+N+L+S
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 641 --------------KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-------- 678
+ A + ++ + L G++ W
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254
Query: 679 ------APEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ E L+ D++S C+ F TG
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 753 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 2be1_A | 339 | Serine/threonine-protein kinase/endoribonuclease; | 99.39 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.85 | |
| 2hz6_A | 369 | Endoplasmic reticulum to nucleus signalling 1 isof | 98.68 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.56 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.9 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.51 | |
| 3q7m_A | 376 | Lipoprotein YFGL, BAMB; beta-propeller, BAM comple | 97.48 | |
| 3q7m_A | 376 | Lipoprotein YFGL, BAMB; beta-propeller, BAM comple | 97.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.2 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 97.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.97 | |
| 1w6s_A | 599 | Methanol dehydrogenase subunit 1; anisotropic, ele | 96.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.84 | |
| 2hz6_A | 369 | Endoplasmic reticulum to nucleus signalling 1 isof | 96.8 | |
| 2ad6_A | 571 | Methanol dehydrogenase subunit 1; PQQ configuratio | 96.8 | |
| 1kb0_A | 677 | Quinohemoprotein alcohol dehydrogenase; beta-prope | 96.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.63 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 96.52 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 96.33 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 96.25 | |
| 2ad6_A | 571 | Methanol dehydrogenase subunit 1; PQQ configuratio | 96.23 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.1 | |
| 1yiq_A | 689 | Quinohemoprotein alcohol dehydrogenase; electron t | 96.09 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.91 | |
| 1kb0_A | 677 | Quinohemoprotein alcohol dehydrogenase; beta-prope | 95.91 | |
| 1flg_A | 582 | Protein (quinoprotein ethanol dehydrogenase); supe | 95.8 | |
| 2be1_A | 339 | Serine/threonine-protein kinase/endoribonuclease; | 95.79 | |
| 1kv9_A | 668 | Type II quinohemoprotein alcohol dehydrogenase; el | 95.72 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.7 | |
| 1yiq_A | 689 | Quinohemoprotein alcohol dehydrogenase; electron t | 95.63 | |
| 1kv9_A | 668 | Type II quinohemoprotein alcohol dehydrogenase; el | 95.46 | |
| 1flg_A | 582 | Protein (quinoprotein ethanol dehydrogenase); supe | 95.23 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.14 | |
| 1w6s_A | 599 | Methanol dehydrogenase subunit 1; anisotropic, ele | 95.14 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 94.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 94.95 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 94.67 | |
| 3hxj_A | 330 | Pyrrolo-quinoline quinone; all beta protein. incom | 94.63 | |
| 3hxj_A | 330 | Pyrrolo-quinoline quinone; all beta protein. incom | 94.34 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.26 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.04 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 93.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 93.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 93.52 | |
| 3vgz_A | 353 | Uncharacterized protein YNCE; beta-propeller, prot | 93.31 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 93.21 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 93.11 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 92.87 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 92.73 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 92.59 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 92.52 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 92.41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 92.24 | |
| 3dsm_A | 328 | Uncharacterized protein bacuni_02894; seven_blated | 92.13 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 91.94 | |
| 1jmx_B | 349 | Amine dehydrogenase; oxidoreductase; HET: TRQ HEC; | 91.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 91.4 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 91.37 | |
| 1pby_B | 337 | Quinohemoprotein amine dehydrogenase 40 kDa subuni | 90.93 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 90.91 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 90.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 90.33 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 90.14 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 90.07 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 90.03 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.62 | |
| 3dsm_A | 328 | Uncharacterized protein bacuni_02894; seven_blated | 89.59 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.14 | |
| 3vgz_A | 353 | Uncharacterized protein YNCE; beta-propeller, prot | 88.9 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 88.67 | |
| 4gqb_B | 344 | Methylosome protein 50; TIM barrel, beta-propeller | 88.66 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 88.51 | |
| 3ow8_A | 321 | WD repeat-containing protein 61; structural genomi | 87.97 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 87.95 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 87.62 | |
| 1l0q_A | 391 | Surface layer protein; SLP, S-layer, 7-bladed beta | 87.01 | |
| 3gre_A | 437 | Serine/threonine-protein kinase VPS15; seven-blade | 86.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 86.7 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 86.48 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 86.48 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 86.02 | |
| 1l0q_A | 391 | Surface layer protein; SLP, S-layer, 7-bladed beta | 85.64 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 85.56 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 85.55 | |
| 1gxr_A | 337 | ESG1, transducin-like enhancer protein 1; transcri | 85.46 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 85.45 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 85.39 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 85.36 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 85.15 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 85.1 | |
| 4gqb_B | 344 | Methylosome protein 50; TIM barrel, beta-propeller | 85.0 | |
| 4g56_B | 357 | MGC81050 protein; protein arginine methyltransfera | 84.88 | |
| 1sq9_A | 397 | Antiviral protein SKI8; WD repeat, beta-transducin | 84.41 | |
| 4aow_A | 340 | Guanine nucleotide-binding protein subunit beta-2; | 84.34 | |
| 3sjl_D | 386 | Methylamine dehydrogenase heavy chain; MAUG, C-hem | 84.14 | |
| 3ow8_A | 321 | WD repeat-containing protein 61; structural genomi | 83.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 83.91 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 83.77 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 83.54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 83.25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 83.12 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 83.11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 82.63 | |
| 3u4y_A | 331 | Uncharacterized protein; structural genomics, PSI- | 82.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.6 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 82.56 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 82.52 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 82.13 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 82.12 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 81.93 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 81.87 | |
| 3vl1_A | 420 | 26S proteasome regulatory subunit RPN14; beta-prop | 81.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 81.77 | |
| 2pm9_A | 416 | Protein WEB1, protein transport protein SEC31; bet | 81.68 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 81.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 81.62 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 81.54 | |
| 1r5m_A | 425 | SIR4-interacting protein SIF2; transcription corep | 81.41 | |
| 3odt_A | 313 | Protein DOA1; ubiquitin, nuclear protein; HET: MSE | 81.39 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 81.35 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 80.99 | |
| 1jmx_B | 349 | Amine dehydrogenase; oxidoreductase; HET: TRQ HEC; | 80.88 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 80.76 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 80.76 | |
| 3c75_H | 426 | MADH, methylamine dehydrogenase heavy chain; coppe | 80.61 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 80.39 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 80.19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 80.09 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=420.46 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=193.2
Q ss_pred ceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+++.+.+.||+|+||+||+|... +++.||||+++.... +.+.+|+. +++.++|||||+++|+|.+.+..|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~-il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEE
Confidence 56788899999999999999753 478999999976542 23445554 889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++|+........... ........++|.++++|+.|||+||+|||
T Consensus 120 lV~E----------y~~~G~L~~~l~~~~~~~~~~~~--------------~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 120 MVFE----------YMRHGDLNRFLRSHGPDAKLLAG--------------GEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp EEEE----------CCTTCBHHHHHHTSSCC-------------------------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------cCCCCcHHHHHHhcCcccccccc--------------cccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 9999 88899999999865432211110 01123457999999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+||||||||+||||+.+ ..+||+|||+|+....... .......+||+.|||||++.+..++.++|||||||+|||
T Consensus 176 ~~~iiHRDLKp~NILl~~~--~~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQG--LVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTTCCCSCCCGGGEEEETT--TEEEECCCC-----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCeecccccHhhEEECCC--CcEEEcccccceeccCCCc-ceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 9999999999999999766 4699999999997654321 222334579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|.+++||.+. .......+.. .....+..+++++.+||.+||++||++|
T Consensus 253 llt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~R 304 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304 (329)
T ss_dssp HHTTSCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHC
Confidence 999436787664 3344444444 3456778899999999999999999998
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=415.61 Aligned_cols=237 Identities=27% Similarity=0.409 Sum_probs=202.9
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-----C-chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----H-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-----~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|++.+.||+|+||+||+|.. .+|+.||||++.+. . .+...+|+. +++.++|||||++++++.+++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5699999999999999999965 46999999999642 2 234455655 88999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.++|.. ...+++.++..++.||+.||+|||++
T Consensus 111 mE----------y~~gG~L~~~i~~-----------------------------~~~l~e~~~~~~~~qi~~al~ylH~~ 151 (311)
T 4aw0_A 111 LS----------YAKNGELLKYIRK-----------------------------IGSFDETCTRFYTAEIVSALEYLHGK 151 (311)
T ss_dssp EC----------CCTTEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------cCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 7778888888753 24688899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||||+.++. +||+|||+|+.+.... ......+.+||+.|||||++.+..|+.++||||+||++|||+
T Consensus 152 ~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~-~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 152 GIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPES-KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp TEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTT-TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred CCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCC-CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999987765 9999999999875432 223345678999999999999999999999999999999999
Q ss_pred hCCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||.+ +.......+......++..+++++++||++||++||++|
T Consensus 229 ~G-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 229 AG-LPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHC
Confidence 99 667755 455556667777778889999999999999999999998
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=417.67 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=199.0
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.++|.+.+.||+|+||+||+|... +++.||||+++.... +.+.+|+. +++.++|||||+++|+|.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~-il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHH-HHHhCCCCCCccEEEEEeeCCEE
Confidence 356889999999999999999753 478999999976542 23445554 88999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
||||| |+++|+|.++|+.......... .......++|.++++|+.|||+||+||
T Consensus 91 ~lV~E----------y~~~G~L~~~l~~~~~~~~~~~----------------~~~~~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T 4asz_A 91 IMVFE----------YMKHGDLNKFLRAHGPDAVLMA----------------EGNPPTELTQSQMLHIAQQIAAGMVYL 144 (299)
T ss_dssp EEEEE----------CCTTCBHHHHHHHTSHHHHHC--------------------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------cCCCCcHHHHHHhcCccccccc----------------ccCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 8889999999976532110000 001235699999999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+++|+||||||+||||+.++ .+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||++|
T Consensus 145 H~~~iiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~-~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~ 221 (299)
T 4asz_A 145 ASQHFVHRDLATRNCLVGENL--LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 221 (299)
T ss_dssp HHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGGC-EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCCcccCccCHhhEEECCCC--cEEECCcccceecCCCCc-eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHH
Confidence 999999999999999997664 599999999987654321 12223345899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|++++||.+. ..+....+..+ ....+..+++++.+||.+||++||++|
T Consensus 222 Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~R 274 (299)
T 4asz_A 222 EIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMR 274 (299)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHC
Confidence 9999447788665 33444444444 456778899999999999999999998
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=417.11 Aligned_cols=255 Identities=21% Similarity=0.296 Sum_probs=200.0
Q ss_pred ceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+++.+.||+|+||+||+|.. .+++.||||+++... ..+.+.++..+++.++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4567889999999999999975 357899999996532 2233444444889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++|+.......... ..........++|.++++|+.|||+||+|||
T Consensus 106 lV~E----------y~~~G~L~~~L~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 106 MIFS----------YCSHGDLHEFLVMRSPHSDVGS-------------TDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp EEEE----------CCSSCBHHHHHHTTCSSCCCC------------------CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------cCCCCcHHHHHHhhCccccccc-------------cccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 8889999999976543221100 0000122456999999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+++||||||||+||||+.+ +.+||+|||+|+...... ........+||+.|||||++.++.|+.++|||||||+|||
T Consensus 163 ~~~iiHRDLK~~NILl~~~--~~~Ki~DFGlar~~~~~~-~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~E 239 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDK--LNVKISDLGLFREVYAAD-YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239 (308)
T ss_dssp HTTCCCSCCSGGGEEECGG--GCEEECCSCCBCGGGGGG-CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCccccceEECCC--CCEEECCcccceeccCCC-ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHH
Confidence 9999999999999999766 459999999998765432 1222345579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++.+||.+... .....+..+ ..+.+..+++++.+||.+||+.||++|
T Consensus 240 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 240 VFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp HHTTTCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 99944778876543 344444443 345677889999999999999999998
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=403.30 Aligned_cols=233 Identities=24% Similarity=0.349 Sum_probs=183.0
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+. +++.++|||||++++++.+++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREIS-YLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999976 469999999996532 123455665 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||||++ +|.+++. +...+++.++..++.||+.||+|||++
T Consensus 92 mEy~~g-----------~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~~ 131 (275)
T 3hyh_A 92 IEYAGN-----------ELFDYIV-----------------------------QRDKMSEQEARRFFQQIISAVEYCHRH 131 (275)
T ss_dssp EECCCE-----------EHHHHHH-----------------------------HSCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EeCCCC-----------CHHHHHH-----------------------------HcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 996654 4444442 234688899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~El 704 (753)
+|+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++.+..+ +.++|||||||++|||
T Consensus 132 ~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~l 205 (275)
T 3hyh_A 132 KIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 205 (275)
T ss_dssp TCCCCCCCTTTEEECTTCC--EEECCSSCC-------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHH
T ss_pred CcccccCChHHeEECCCCC--EEEeecCCCeecCCC----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHH
Confidence 9999999999999977765 999999999876532 22345689999999999998886 6899999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|| ++||.+. .......+......++..+++++++||++||++||++|
T Consensus 206 ltg-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 254 (275)
T 3hyh_A 206 LCR-RLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNR 254 (275)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHC
Confidence 999 6677654 44555667777778888999999999999999999998
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=414.71 Aligned_cols=235 Identities=25% Similarity=0.419 Sum_probs=196.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC---CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT---HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~---~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.+.|++.+.||+|+||+||+|... +|+.||||++... ..+...+|+. +++.++|||||++++++.+++.+|||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356888999999999999999765 6999999999643 2334566766 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ..+++.++..|+.||+.||+|||+++|
T Consensus 152 ----------y~~gg~L~~~l~~------------------------------~~l~e~~~~~~~~qi~~aL~ylH~~~I 191 (346)
T 4fih_A 152 ----------FLEGGALTDIVTH------------------------------TRMNEEQIAAVCLAVLQALSVLHAQGV 191 (346)
T ss_dssp ----------CCTTEEHHHHHHH------------------------------SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------CCCCCcHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6677888877642 357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||||||+||||+.++. +||+|||+|+.+.... ....+.+||+.|||||++.+..|+.++|||||||++|||+||
T Consensus 192 iHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 266 (346)
T 4fih_A 192 IHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266 (346)
T ss_dssp ECCCCSGGGEEECTTCC--EEECCCTTCEECCSSS---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ccccCCHHHEEECCCCC--EEEecCcCceecCCCC---CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999987765 9999999999875432 233567899999999999999999999999999999999999
Q ss_pred CCCCCCCC-hHHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES-FERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~-~~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.+. .......+..... ..+..+++++++||.+||.+||++|
T Consensus 267 -~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 315 (346)
T 4fih_A 267 -EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 315 (346)
T ss_dssp -SCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred -CCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 6677554 3444444444332 2345689999999999999999998
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=419.81 Aligned_cols=237 Identities=24% Similarity=0.390 Sum_probs=191.6
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|+||+||+|.. .+|+.||||++..... +.+.+|+. +++.++|||||++++++.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA-VLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999976 4699999999975431 23445555 889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.++|...+ ...+++.+++.|+.||+.||+|||+++
T Consensus 103 E----------y~~gg~L~~~i~~~~---------------------------~~~~~e~~~~~~~~qi~~aL~ylH~~~ 145 (350)
T 4b9d_A 103 D----------YCEGGDLFKRINAQK---------------------------GVLFQEDQILDWFVQICLALKHVHDRK 145 (350)
T ss_dssp E----------CCTTCBHHHHHHHTT---------------------------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------CCCCCcHHHHHHHcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 777889988886432 245688889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
||||||||+||||+.++. +||+|||+|+..... .......+||+.|||||++.+..|+.++|||||||++|||+|
T Consensus 146 IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 146 ILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNST---VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220 (350)
T ss_dssp CEETTCCGGGEEECTTCC--EEECSTTEESCCCHH---HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeeccCCHHHEEECCCCC--EEEcccccceeecCC---cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999988765 999999999876432 122344579999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.+.. ......+... .++.+..+++++++||.+||++||++|
T Consensus 221 G-~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 221 L-KHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp S-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred C-CCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHC
Confidence 9 66776553 3444444433 345677889999999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=412.42 Aligned_cols=235 Identities=26% Similarity=0.358 Sum_probs=195.5
Q ss_pred ceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
++|++.+.||+|+||+||+|... .++.||||++.+.. .....+|+. +++.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD-ILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------C-CCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999998653 47899999996432 224455554 778999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++|.. ...+++.++..++.||+.||+|||
T Consensus 103 ivmE----------y~~gg~L~~~l~~-----------------------------~~~l~e~~~~~~~~qi~~aL~ylH 143 (304)
T 3ubd_A 103 LILD----------FLRGGDLFTRLSK-----------------------------EVMFTEEDVKFYLAELALALDHLH 143 (304)
T ss_dssp EEEC----------CCTTCEEHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7778888888753 246888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+++|+||||||+|||++.++. +||+|||+|+..... .....+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 144 ~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 218 (304)
T 3ubd_A 144 SLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDH---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFE 218 (304)
T ss_dssp HTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC--------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHH
T ss_pred HCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCC---CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHH
Confidence 999999999999999987765 999999999875432 123345789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| ++||.+. .......+......++..+++++++||++||++||++|
T Consensus 219 mltG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 219 MLTG-TLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhC-CCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHC
Confidence 9999 6677654 44555666677778888999999999999999999998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=411.63 Aligned_cols=238 Identities=23% Similarity=0.292 Sum_probs=194.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
.+.|.+.+.||+|+||+||+|... +|+.||||+++.... ..+|+. +++.++|||||++++++.+++.+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~-il~~l~HpnIV~l~~~~~~~~~~~ivmE--- 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELV-ACAGLSSPRIVPLYGAVREGPWVNIFME--- 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CTHHHH-TTTTCCCTTBCCEEEEEEETTEEEEEEC---
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--HHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEEe---
Confidence 356888999999999999999764 599999999976532 234555 7899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++|+. ...+++.++..++.||+.||+|||+++||||
T Consensus 131 -------y~~gg~L~~~l~~-----------------------------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR 174 (336)
T 4g3f_A 131 -------LLEGGSLGQLIKQ-----------------------------MGCLPEDRALYYLGQALEGLEYLHTRRILHG 174 (336)
T ss_dssp -------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred -------ccCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 7778999988853 2458899999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCccc--ccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||+||||+.++. .+||+|||+|+.+....... ......+||+.|||||++.+..|+.++|||||||++|||+||
T Consensus 175 DlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG- 252 (336)
T 4g3f_A 175 DVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG- 252 (336)
T ss_dssp CCCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-
T ss_pred ccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-
Confidence 99999999987762 49999999999876432211 123446799999999999999999999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGES-FERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~-~~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||.+. .......+..... ..+..+++++.+||.+||++||++|
T Consensus 253 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 253 CHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp SCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHC
Confidence 6777654 3333344444332 3466789999999999999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=399.01 Aligned_cols=233 Identities=26% Similarity=0.365 Sum_probs=187.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC----Cce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~ 541 (753)
++.+++.+.||+|+||+||+|... +++.||||++..... +.+.+|+ .+++.++|||||+++++|.+ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA-EMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344578889999999999999764 589999999965321 2334455 48899999999999999864 456
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
+||||| |+++|+|.++|+. ...+++..+..|+.||+.||+|
T Consensus 104 ~~lvmE----------y~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 104 IVLVTE----------LMTSGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp EEEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 7778999988853 2457889999999999999999
Q ss_pred hhhCC--ccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 622 LHEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 622 LH~~~--IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
||+++ ||||||||+||||+. ++ .+||+|||+|+..... ...+.+||+.|||||++.+ .|+.++||||||
T Consensus 145 lH~~~~~IiHRDlKp~NILl~~~~g--~vKl~DFGla~~~~~~-----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlG 216 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 216 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEESSTTS--CEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEECCCC--CEEEEeCcCCEeCCCC-----ccCCcccCccccCHHHcCC-CCCcHHHHHHHH
Confidence 99998 999999999999964 44 4999999999864332 2345689999999998865 699999999999
Q ss_pred HHHHHHHhCCCCCCCCC-h-HHHHHHHHccCc--ccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGES-F-ERDANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~-~-~~~~~~i~~~~~--~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|| ++||.+. . ......+..... .++...++++++||.+||++||++|
T Consensus 217 vilyelltg-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (290)
T 3fpq_A 217 MCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp HHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHC-CCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHC
Confidence 999999999 6788543 2 233344444332 3456678999999999999999998
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=404.00 Aligned_cols=236 Identities=22% Similarity=0.307 Sum_probs=182.9
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.+.+.+.+.||+|+||+||+|... ..||||+++.... +.+.+|+ .+++.++|||||+++|+|.+ +.++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~-~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEV-AVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 345678899999999999999754 3699999864321 2334454 48899999999999999865 5689999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.++|+.. ...+++.++++|+.|||+||+|||+++
T Consensus 111 E----------y~~gGsL~~~l~~~----------------------------~~~l~~~~~~~i~~qia~gL~yLH~~~ 152 (307)
T 3omv_A 111 Q----------WCEGSSLYKHLHVQ----------------------------ETKFQMFQLIDIARQTAQGMDYLHAKN 152 (307)
T ss_dssp E----------CCSSCBHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------cCCCCCHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 77889999988643 245889999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL~E 703 (753)
||||||||+||||+.+ ..+||+|||+|+...... ........+||+.|||||++.+ ..|+.++|||||||+|||
T Consensus 153 IiHRDlKp~NILl~~~--~~~Ki~DFGla~~~~~~~-~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~E 229 (307)
T 3omv_A 153 IIHRDMKSNNIFLHEG--LTVKIGDFGLATVKSRWS-GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYE 229 (307)
T ss_dssp CBCSCCCSSSEEEETT--EEEEECCCSSCBC-------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHH
T ss_pred ccCCccCHHHEEECCC--CcEEEeeccCceecccCC-cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHH
Confidence 9999999999999766 459999999998765322 1223345679999999999964 458999999999999999
Q ss_pred HHhCCCCCCCCCh-H-HHHHHHHccC-c----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-E-RDANIVKDRK-D----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~-~~~~~i~~~~-~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| ++||.+.. . .....+.... . ..+..+++++.+||.+||++||++|
T Consensus 230 lltg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~R 285 (307)
T 3omv_A 230 LMTG-ELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEER 285 (307)
T ss_dssp HHHS-SCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTS
T ss_pred HHHC-CCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHC
Confidence 9998 67886543 2 2233333322 1 2345678999999999999999998
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=416.89 Aligned_cols=235 Identities=25% Similarity=0.419 Sum_probs=196.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.+.|++.+.||+|+||+||+|... +|+.||||++.... .+...+|+. +++.++|||||++++++.+++.+|||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 456999999999999999999764 59999999996432 344566776 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+++|+|.+++.. ..+++.++..|+.||+.||+|||+++|
T Consensus 229 ----------y~~gG~L~~~i~~------------------------------~~l~e~~~~~~~~qil~aL~ylH~~~I 268 (423)
T 4fie_A 229 ----------FLEGGALTDIVTH------------------------------TRMNEEQIAAVCLAVLQALSVLHAQGV 268 (423)
T ss_dssp ----------CCTTEEHHHHHHH------------------------------SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------CCCCCcHHHHHhc------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6677888877632 357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||||||+||||+.++. +||+|||+|+.+.... ....+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 269 iHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~---~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 343 (423)
T 4fie_A 269 IHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343 (423)
T ss_dssp ECCCCSTTTEEECTTCC--EEECCCTTCEECCSSC---CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ecccCCHHHEEEcCCCC--EEEecCccceECCCCC---ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999988765 9999999999875432 233466899999999999999999999999999999999999
Q ss_pred CCCCCCCC-hHHHHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGES-FERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~-~~~~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.+. .......+..... ..+..+++++++||.+||.+||++|
T Consensus 344 -~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 392 (423)
T 4fie_A 344 -EPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQR 392 (423)
T ss_dssp -SCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTS
T ss_pred -CCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 6677554 3444444444332 2345689999999999999999998
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=402.08 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=198.9
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCc----hHHHHHHHHHHHhCC-CCceeeecccccCC
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQ 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~ 539 (753)
..++|++.+.||+|+||+||+|.... ++.||||++..... +.+.+|+. +++.++ |||||+++|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~-il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK-ILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECCT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHH-HHHHcCCCCcEEEEEEEEEec
Confidence 34679999999999999999997543 46899999976542 23455665 556665 59999999999764
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
+.++|||| |+++|+|.++|+.......... ..........+++.+++.|+.|||+|
T Consensus 141 ~~~~~iV~E----------y~~~G~L~~~L~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qia~g 197 (353)
T 4ase_A 141 GGPLMVIVE----------FCKFGNLSTYLRSKRNEFVPYK-------------VAPEDLYKDFLTLEHLICYSFQVAKG 197 (353)
T ss_dssp TSCCEEEEE----------CCTTEEHHHHHHHTGGGBCCC--------------------CTTCBCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEE----------cCCCCCHHHHHHhccccccccc-------------ccchhhccccCCHHHHHHHHHHHHHH
Confidence 57899999 7889999999986543211100 00011223568999999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+++||||||||+|||++.++ .+||+|||+|+.+..+... ......+||+.|||||++.+..|+.++||||||
T Consensus 198 l~yLH~~~iiHRDLK~~NILl~~~~--~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~G 274 (353)
T 4ase_A 198 MEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 274 (353)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHhHhhCCeecCccCccceeeCCCC--CEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhcCCCCCcccEeehH
Confidence 9999999999999999999997765 5999999999977544322 223445689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCh--HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~--~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+||||+|.+.+||.+.. +.....+..+ ....+..+++++.++|.+||+.||++|
T Consensus 275 v~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~R 332 (353)
T 4ase_A 275 VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 332 (353)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHC
Confidence 999999994477887642 3334444443 455677889999999999999999998
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=394.15 Aligned_cols=238 Identities=21% Similarity=0.325 Sum_probs=180.7
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHH-HHHHhCCCCceeeecccccCCc----eEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNIVRWYGVESDQD----FVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~-~ll~~l~HpNIV~L~g~~~~~~----~~~LV~ 546 (753)
.++|.+.+.||+|+||+||+|.. +|+.||||++.........+|.+ ..+..++|||||+++|+|.+++ .+||||
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46788999999999999999975 78999999998766555555543 2345789999999999998653 689999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~- 625 (753)
| |+++|+|.++|+. .+++|..+++|+.|+|+||+|||++
T Consensus 81 E----------y~~~gsL~~~l~~------------------------------~~l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 81 D----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp E----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred c----------CCCCCcHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 9 8889999998853 3477888999999999999999987
Q ss_pred -------CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCC------CCCch
Q 004442 626 -------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG------RQTRA 691 (753)
Q Consensus 626 -------~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~------~~t~k 691 (753)
+|+||||||+||||+.++ .+||+|||+|+......... ......+||+.|||||++.+. .++.+
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~--~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCC--CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChh
Confidence 899999999999997665 59999999999876543222 223345799999999999765 36789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCC----------CC------hHHHHHHHHcc-C-cccccC-----CCHHHHHHHHHcccc
Q 004442 692 IDLFSLGCILFFCITGGKHPYG----------ES------FERDANIVKDR-K-DLFLVE-----HIPEAVDLFTRLLDP 748 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~----------~~------~~~~~~~i~~~-~-~~~~~~-----~s~el~dLI~~cL~~ 748 (753)
+|||||||+||||+||+ +|++ +. .+.....+... . +..+.. .++++.+||.+||+.
T Consensus 199 ~DVwS~Gvvl~El~tg~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRC-SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHTB-CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCS
T ss_pred HhhhhHHHHHHHHHHCC-CCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHccc
Confidence 99999999999999984 3432 11 11222222221 1 122222 224688999999999
Q ss_pred CcCCC
Q 004442 749 NPDLR 753 (753)
Q Consensus 749 DP~~R 753 (753)
||++|
T Consensus 278 dP~~R 282 (303)
T 3hmm_A 278 NGAAR 282 (303)
T ss_dssp SGGGS
T ss_pred CHhHC
Confidence 99998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=387.80 Aligned_cols=238 Identities=23% Similarity=0.430 Sum_probs=176.2
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc-------
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD------- 540 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~------- 540 (753)
.+|++.+.||+|+||+||+|.. .+|+.||||+++.... +...+|+. +++.++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~-il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3588999999999999999975 4699999999975442 23455655 789999999999999986543
Q ss_pred -----eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 541 -----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 541 -----~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
.+||||| |+.+|+|.+++..... ....++..++.|+.||
T Consensus 84 ~~~~~~l~ivmE----------~~~gg~L~~~l~~~~~--------------------------~~~~~~~~~~~i~~qi 127 (299)
T 4g31_A 84 SSPKVYLYIQMQ----------LCRKENLKDWMNGRCT--------------------------IEERERSVCLHIFLQI 127 (299)
T ss_dssp ---CEEEEEEEE----------CCCSCCHHHHHHTCCS--------------------------GGGSCHHHHHHHHHHH
T ss_pred cCCCcEEEEEEe----------cCCCCcHHHHHHhcCC--------------------------CChhHHHHHHHHHHHH
Confidence 4799999 6678888888864321 1123456678999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc---------ccCccCCCCccccccccccCC
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---------TQNATGYGSSGWQAPEQLLQG 686 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~---------~~~~~~~GT~~Y~APE~l~~~ 686 (753)
+.||+|||+++|+||||||+||||+.++. +||+|||+|+.+....... ......+||+.|||||++.+.
T Consensus 128 ~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC--------------------------CCCTTSCHHHHTTC
T ss_pred HHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence 99999999999999999999999987765 9999999999875432211 122345799999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 687 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 687 ~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~--~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.|+.++|||||||++|||++ ||....+... ..+... .++.+...++++.+||++||++||++|
T Consensus 206 ~y~~~~DiwSlGvilyell~----Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~R 271 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY----PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS----CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCHHHHHHHHHHHHHHcc----CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999996 6655433322 222222 223334557788999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=392.59 Aligned_cols=239 Identities=22% Similarity=0.345 Sum_probs=185.7
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeeccccc------C
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVES------D 538 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~------~ 538 (753)
++++|++.+.||+|+||+||+|.. .+|+.||||++++... +...+|+. +++.++|||||++++++. +
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELK-ILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHH-HHHhcCCCCcceEeeeeeccccccc
Confidence 457899999999999999999976 4699999999965431 23456766 789999999999999865 3
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+.+|||||||++ +|.+++. +...+++.++..++.||+.|
T Consensus 131 ~~~~~ivmE~~~g-----------~L~~~i~-----------------------------~~~~l~~~~~~~~~~qil~a 170 (398)
T 4b99_A 131 FKSVYVVLDLMES-----------DLHQIIH-----------------------------SSQPLTLEHVRYFLYQLLRG 170 (398)
T ss_dssp CCCEEEEEECCSE-----------EHHHHHT-----------------------------SSSCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEeCCCC-----------CHHHHHH-----------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 4679999996554 4444442 23568899999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCC-cccccCccCCCCccccccccccCCC-CCchhhHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-SCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFS 696 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~-~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwS 696 (753)
|+|||+++||||||||+|||++.++. +||+|||+|+.+.... .......+.+||+.|||||++.+.. ++.++||||
T Consensus 171 l~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS 248 (398)
T 4b99_A 171 LKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS 248 (398)
T ss_dssp HHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH
T ss_pred HHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheeh
Confidence 99999999999999999999977765 9999999998764322 1223345678999999999988765 699999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCc-------------------------------ccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESF-ERDANIVKDRKD-------------------------------LFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~-------------------------------~~~~~~s~el~dLI~~ 744 (753)
+||++|||++| ++||.+.. ......+..... ......++++.+||++
T Consensus 249 lG~il~ell~G-~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 327 (398)
T 4b99_A 249 VGCIFGEMLAR-RQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR 327 (398)
T ss_dssp HHHHHHHHHHT-SCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHH
T ss_pred hHHHHHHHHHC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHH
Confidence 99999999999 66776543 333333221100 0123468899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||.+||++|
T Consensus 328 mL~~dP~~R 336 (398)
T 4b99_A 328 MLRFEPSAR 336 (398)
T ss_dssp HSCSSTTTS
T ss_pred HCcCChhHC
Confidence 999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=406.44 Aligned_cols=235 Identities=24% Similarity=0.356 Sum_probs=196.5
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHH-HHH--HHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVA-LKE--IQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~-~~E--i~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
-++|.+.+.||+|+||+||+|... +|+.||||++.+. ..... .+| +..+++.++|||||++++++.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999765 5999999999643 22222 222 22355678999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
||||| |+++|+|.++|.. ...+++..+..++.||+.||+||
T Consensus 268 ylVmE----------y~~GGdL~~~l~~-----------------------------~~~l~E~~a~~y~~qIl~aL~yL 308 (689)
T 3v5w_A 268 SFILD----------LMNGGDLHYHLSQ-----------------------------HGVFSEADMRFYAAEIILGLEHM 308 (689)
T ss_dssp EEEEC----------CCCSCBHHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7788999988853 24688899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL 701 (753)
|++|||||||||+||||+.++. +||+|||+|+.+... ...+.+||+.|||||++.. ..|+.++|||||||+|
T Consensus 309 H~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~~-----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvil 381 (689)
T 3v5w_A 309 HNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 381 (689)
T ss_dssp HTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHH
T ss_pred HHCCccccCCchHHeEEeCCCC--EEecccceeeecCCC-----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999988775 999999999987543 2346789999999999975 5799999999999999
Q ss_pred HHHHhCCCCCCCCCh----HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~----~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| .+||.+.. ......+......++..+++++++||.+||.+||++|
T Consensus 382 YEmLtG-~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~R 436 (689)
T 3v5w_A 382 FKLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436 (689)
T ss_dssp HHHHHS-SCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGC
T ss_pred HHHHhC-CCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHC
Confidence 999999 67885432 2334455566677888999999999999999999998
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=380.62 Aligned_cols=202 Identities=25% Similarity=0.379 Sum_probs=161.5
Q ss_pred eecceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCc-hHHHHHHHHHHHhC-CCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH-DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.+.|++.+.||+|+||+||+|... .++.||||++.+... ....+|+. ++..+ +|||||++++++.+++.+|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~-~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQ-CLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHH-HHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHH-HHHHhcCCCCCceEEEEEEECCEEE
Confidence 45677999999999999999999653 478999999976544 34566776 44554 7999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++++ .+++.++..++.||+.||+|||
T Consensus 97 lvmE----------~~~g~~L~~~~~--------------------------------~l~~~~~~~~~~qll~al~ylH 134 (361)
T 4f9c_A 97 IAMP----------YLEHESFLDILN--------------------------------SLSFQEVREYMLNLFKALKRIH 134 (361)
T ss_dssp EEEE----------CCCCCCHHHHHT--------------------------------TCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------CCCcccHHHHHc--------------------------------CCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 666777777652 3677888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-------------------------cccCccCCCCcccc
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-------------------------LTQNATGYGSSGWQ 678 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-------------------------~~~~~~~~GT~~Y~ 678 (753)
++||+||||||+|||++.+. ..+||+|||+|+........ .....+.+||+.||
T Consensus 135 ~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 213 (361)
T 4f9c_A 135 QFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFR 213 (361)
T ss_dssp HTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGC
T ss_pred HCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCcccc
Confidence 99999999999999997663 25999999999876532211 11223457999999
Q ss_pred ccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 679 APEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 679 APE~l~~~~-~t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
|||++.+.. |+.++||||+||++|||+||+.|+|.+.
T Consensus 214 APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 214 APEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 999998764 8999999999999999999954444443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=396.03 Aligned_cols=239 Identities=23% Similarity=0.368 Sum_probs=198.6
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.++|.+.+.||+|+||+||++... +|+.||||++..... +...+|+. +++.++|||||++++++.+++.+||||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHH-HHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 3467999999999999999999764 699999999976542 23455655 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.++|... ...+++.++..++.||+.||+|||+++
T Consensus 234 E----------~~~gg~L~~~i~~~----------------------------~~~l~e~~~~~~~~qi~~al~ylH~~~ 275 (573)
T 3uto_A 234 E----------FMSGGELFEKVADE----------------------------HNKMSEDEAVEYMRQVCKGLCHMHENN 275 (573)
T ss_dssp E----------CCCCCBHHHHHTCT----------------------------TSCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------ecCCCcHHHHHHHh----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 77788888877432 235778899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.+....+||+|||+|+.+.... .....+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 276 iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~----~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~ 351 (573)
T 3uto_A 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351 (573)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS----EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred eeeccCChhhccccCCCCCCEEEeeccceeEccCCC----ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999987654569999999999876432 2244579999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.+.. ......+...... .+..+++++++||++||.+||++|
T Consensus 352 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R 402 (573)
T 3uto_A 352 G-LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 402 (573)
T ss_dssp S-CCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred C-CCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHC
Confidence 9 66776554 4444555544332 335689999999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.76 Aligned_cols=235 Identities=26% Similarity=0.355 Sum_probs=197.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|.+.+.||+|+||+||++... +|+.||||++++. ......+|. .+++.++||||+++++++.+.+..|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHH-HHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 57889999999999999999765 5999999999643 122344454 477899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ...+++..+..++.||+.||+|||++
T Consensus 84 ~E----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 124 (337)
T 1o6l_A 84 ME----------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EE----------CCTTCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 7778888887743 24578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 125 ~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 199 (337)
T 1o6l_A 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CeecCcCCHHHEEECCCCC--EEEeeccchhhcccCC---CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHh
Confidence 9999999999999977765 9999999998643321 2234567999999999999999999999999999999999
Q ss_pred hCCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||.. ........+......++..+++++.+||++||++||++|
T Consensus 200 ~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 200 CG-RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred cC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHh
Confidence 99 556654 445555666667777888899999999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=350.78 Aligned_cols=237 Identities=27% Similarity=0.380 Sum_probs=199.3
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
...++|.+.+.||+|+||.||+|.. .+|+.||||++..... +...+|+. +++.++||||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVR-IMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCEEE
Confidence 3446799999999999999999976 5799999999965421 23445555 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.+++... ..+++..+..++.|++.||+|||
T Consensus 91 lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~al~~lH 131 (328)
T 3fe3_A 91 LIME----------YASGGEVFDYLVAH-----------------------------GRMKEKEARSKFRQIVSAVQYCH 131 (328)
T ss_dssp EEEC----------CCTTCBHHHHHHHH-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77788888877432 45788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCC-chhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t-~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..+. .++|||||||++|
T Consensus 132 ~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 205 (328)
T 3fe3_A 132 QKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILY 205 (328)
T ss_dssp HTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSC----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHH
T ss_pred HCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCC----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHH
Confidence 999999999999999977654 9999999998765331 23456799999999999988874 8999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| .+||.+. .......+.......+...++++.+||++||+.||++|
T Consensus 206 ell~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 256 (328)
T 3fe3_A 206 TLVSG-SLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKR 256 (328)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHC
Confidence 99998 6677655 44555666677777788899999999999999999998
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=357.43 Aligned_cols=236 Identities=24% Similarity=0.371 Sum_probs=193.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHhC-CCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~ 543 (753)
.++|.+.+.||+|+||+||++... +|+.||||++++. ......+|.. ++..+ +||||+++++++.+.+..|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~-il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR-ILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHH-HHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHH-HHHhccCCCceeeEEEEEEeCCEEE
Confidence 357899999999999999999765 5899999999753 1223445554 55555 7999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++..+..++.||+.||+|||
T Consensus 101 lv~E----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH 141 (353)
T 3txo_A 101 FVME----------FVNGGDLMFHIQK-----------------------------SRRFDEARARFYAAEIISALMFLH 141 (353)
T ss_dssp EEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7777888887753 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++||
T Consensus 142 ~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 142 DKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICN---GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp HTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHH
T ss_pred HCCCcccCCCHHHEEECCCCC--EEEccccceeecccC---CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHH
Confidence 999999999999999977765 999999999864322 123345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||... .......+......++..+++++.+||++||.+||++|
T Consensus 217 ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R 266 (353)
T 3txo_A 217 MLCG-HAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMR 266 (353)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHc
Confidence 9998 5666554 45556667777778888899999999999999999998
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=351.90 Aligned_cols=237 Identities=24% Similarity=0.368 Sum_probs=197.4
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|.+.+.||+|+||+||++... +|+.||||++++. .......|...+....+||||+++++++.+.+..|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 467889999999999999999765 5899999999753 223345565544444599999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ..+++.++..++.||+.||+|||+
T Consensus 96 v~E----------~~~gg~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH~ 136 (345)
T 1xjd_A 96 VME----------YLNGGDLMYHIQSC-----------------------------HKFDLSRATFYAAEIILGLQFLHS 136 (345)
T ss_dssp EEE----------CCTTCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 77788888887532 357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 137 ~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 211 (345)
T 1xjd_A 137 KGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 211 (345)
T ss_dssp TTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCC---CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHH
Confidence 99999999999999977765 9999999998643221 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||... .......+......++..+++++.+||++||..||++|
T Consensus 212 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R 260 (345)
T 1xjd_A 212 LIG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260 (345)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hcC-CCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHc
Confidence 999 5666554 44555666667777788899999999999999999998
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.25 Aligned_cols=233 Identities=23% Similarity=0.370 Sum_probs=196.7
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|.+.+.||+|+||+||++... +|+.||||++.+. .....+.++..+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56889999999999999998765 6999999999653 12233344445789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 86 e----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ 126 (318)
T 1fot_A 86 D----------YIEGGELFSLLRK-----------------------------SQRFPNPVAKFYAAEVCLALEYLHSKD 126 (318)
T ss_dssp C----------CCCSCBHHHHHHH-----------------------------TSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred e----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 7777888887753 235778889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 127 ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 127 IIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp EECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred ccccCCChheEEEcCCCC--EEEeecCcceecCCc------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999977765 999999999876432 234579999999999999999999999999999999999
Q ss_pred CCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.. ........+......++..+++++.++|++||..||++|
T Consensus 199 g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R 245 (318)
T 1fot_A 199 G-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 245 (318)
T ss_dssp S-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTC
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHc
Confidence 9 556654 444555566666677788899999999999999999998
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=357.87 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=196.9
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|.+.+.||+|+||+||++... +++.||||++++.. .....+|...+....+||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357899999999999999999765 58899999997532 12345566544445699999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++.. ...+++..+..++.||+.||+|||+
T Consensus 131 V~E----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~ 171 (396)
T 4dc2_A 131 VIE----------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHE 171 (396)
T ss_dssp EEE----------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 7778888887753 2457889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||||+.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 172 ~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyel 246 (396)
T 4dc2_A 172 RGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246 (396)
T ss_dssp TTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT---TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCEEeccCCHHHEEECCCCC--EEEeecceeeecccC---CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 99999999999999977765 999999999864322 1233456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC----------hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~----------~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||... .......+......++..+++++.+||++||++||++|
T Consensus 247 l~G-~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 304 (396)
T 4dc2_A 247 MAG-RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304 (396)
T ss_dssp HHS-SCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTS
T ss_pred HhC-CCCCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHc
Confidence 998 6787421 22344556667777888999999999999999999998
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.16 Aligned_cols=235 Identities=23% Similarity=0.319 Sum_probs=193.7
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--c----hHHHHHHHHHHHhC-CCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--H----DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~L 544 (753)
++|.+.+.||+|+||.||++... +++.||||++.+.. . ....+|.. ++..+ +||||+++++++.+.+..|+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-VFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHH-HHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHH-HHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 56889999999999999999765 58999999997542 1 12334444 55554 89999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++.. ...+++..++.++.||+.||+|||+
T Consensus 88 v~e----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~ 128 (345)
T 3a8x_A 88 VIE----------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHE 128 (345)
T ss_dssp EEC----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 7777888887743 2357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 129 ~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 129 RGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp TTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCceecCCCHHHEEECCCCC--EEEEeccccccccCCC---CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 99999999999999977765 9999999998643221 223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCC----------ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGE----------SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~----------~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||.. ........+......++..+++++.+||++||++||++|
T Consensus 204 l~g-~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 261 (345)
T 3a8x_A 204 MAG-RSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261 (345)
T ss_dssp HHS-SCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HhC-CCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHC
Confidence 998 668753 222334455566667788899999999999999999998
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.89 Aligned_cols=236 Identities=23% Similarity=0.324 Sum_probs=196.7
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecC------CchHHHHHHHHHHHhC-CCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT------HHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~ 543 (753)
.++|.+.+.||+|+||+||++.... |+.||||++.+. ..+....|.. ++..+ +||||+++++++.+.+..|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~-~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHH-HHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999997764 889999999753 1223444544 55555 8999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.+++... ..+++..++.++.||+.||+|||
T Consensus 98 lv~E----------~~~gg~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH 138 (353)
T 2i0e_A 98 FVME----------YVNGGDLMYHIQQV-----------------------------GRFKEPHAVFYAAEIAIGLFFLQ 138 (353)
T ss_dssp EEEE----------CCCSCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77778888877532 35788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++||
T Consensus 139 ~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 139 SKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWD---GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp HTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCT---TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred HCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccC---CcccccccCCccccChhhhcCCCcCCcccccchHHHHHH
Confidence 999999999999999977765 999999999864322 122345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||... .......+......++..+++++.+||++||.+||++|
T Consensus 214 ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 263 (353)
T 2i0e_A 214 MLAG-QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263 (353)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSC
T ss_pred HHcC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHc
Confidence 9999 5676554 44555666677777888999999999999999999998
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=356.13 Aligned_cols=237 Identities=25% Similarity=0.324 Sum_probs=193.6
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|.+.+.||+|+||.||++... +++.||||++.+.. .....+|...+++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467899999999999999999765 48899999997543 12334444434577899999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++... ..+++..+..++.||+.||+|||+
T Consensus 117 v~E----------~~~gg~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH~ 157 (373)
T 2r5t_A 117 VLD----------YINGGELFYHLQRE-----------------------------RCFLEPRARFYAAEIASALGYLHS 157 (373)
T ss_dssp EEE----------CCCSCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 77788888877532 356778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
++|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 232 (373)
T 2r5t_A 158 LNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHN---STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 232 (373)
T ss_dssp TTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCC---CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred CCceecCCCHHHEEECCCCC--EEEeeCccccccccCC---CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999977765 9999999998643321 233456799999999999999999999999999999999
Q ss_pred HhCCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||.. ........+......++..+++++++||++||++||++|
T Consensus 233 l~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R 281 (373)
T 2r5t_A 233 LYG-LPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281 (373)
T ss_dssp HHS-SCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGS
T ss_pred HcC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhC
Confidence 999 556654 445555666666667788899999999999999999998
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.46 Aligned_cols=240 Identities=21% Similarity=0.318 Sum_probs=196.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---------hHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
..+.+.|.+.+.||+|+||.||++... +|+.||||.+.+... +...+|+. ++..++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS-ILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHTTCCCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHH-HHHhCCCcCCCcEEEEEEe
Confidence 456678999999999999999999765 599999999975431 23445554 7899999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+.+|+|.+++.. ...+++..+..++.||+.|
T Consensus 87 ~~~~~lv~e----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~a 127 (361)
T 2yab_A 87 RTDVVLILE----------LVSGGELFDFLAQ-----------------------------KESLSEEEATSFIKQILDG 127 (361)
T ss_dssp SSEEEEEEE----------CCCSCBHHHHHTT-----------------------------CSCCBHHHHHHHHHHHHHH
T ss_pred CCEEEEEEE----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHH
Confidence 999999999 6667888887742 2357888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCC--CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~--~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
|.|||+.+|+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|||++.+..++.++||||
T Consensus 128 L~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 203 (361)
T 2yab_A 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203 (361)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred HHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC----ccccCCCCccEECchHHcCCCCCccccHHH
Confidence 99999999999999999999976652 259999999998875432 234457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC-hHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGES-FERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|+|++| .+||.+. .......+......+ +..+++++.+||.+||.+||++|
T Consensus 204 lGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 264 (361)
T 2yab_A 204 IGVITYILLSG-ASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKR 264 (361)
T ss_dssp HHHHHHHHHHS-CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHC
Confidence 99999999999 5666554 444444454444333 35678999999999999999998
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.78 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=197.9
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC--------CchHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~--------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
.+.+.|++.+.||+|+||+||++... +|+.||||++... ..+...+|+. +++.++||||+++++++.+++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS-ICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCC
Confidence 44577999999999999999999664 6899999998532 1233445554 789999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..|+||| |+.+|+|.+++..... ....+++..+..++.||+.||+
T Consensus 100 ~~~lv~e----------~~~g~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~qi~~al~ 144 (351)
T 3c0i_A 100 MLYMVFE----------FMDGADLCFEIVKRAD-------------------------AGFVYSEAVASHYMRQILEALR 144 (351)
T ss_dssp EEEEEEE----------CCSSCBHHHHHHHHHH-------------------------TTCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEe----------CCCCCCHHHHHHHhcc-------------------------cCCCCCHHHHHHHHHHHHHHHH
Confidence 9999999 6667788777654321 1235788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|||+++|+||||||+|||++.++. ..+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||
T Consensus 145 ~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG---LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGV 221 (351)
T ss_dssp HHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS---CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred HHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC---eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHH
Confidence 999999999999999999976542 459999999998875432 1223457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++| .+||..........+........ ..+++++.+||.+||++||++|
T Consensus 222 il~~ll~g-~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 278 (351)
T 3c0i_A 222 ILFILLSG-CLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAER 278 (351)
T ss_dssp HHHHHHHS-SCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHC-CCCCCCcHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHC
Confidence 99999998 67887776655555544443332 4678999999999999999998
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.94 Aligned_cols=236 Identities=28% Similarity=0.379 Sum_probs=190.0
Q ss_pred cceEEEeEEecccCceEEEEEEe----eCCcEEEEEEeecCC------c-hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH------H-DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~~------~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
.++|.+.+.||+|+||.||++.. .+|+.||||++++.. . ....+|+ .+++.++||||+++++++.+.+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER-NILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HH-HHHHHCCCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHH-HHHHhCCCCCccceeEEEEcCC
Confidence 46799999999999999999876 468999999997542 1 1233444 4789999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..|+||| |+.+|+|.+++... ..+++..+..++.||+.||.
T Consensus 95 ~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~al~ 135 (327)
T 3a62_A 95 KLYLILE----------YLSGGELFMQLERE-----------------------------GIFMEDTACFYLAEISMALG 135 (327)
T ss_dssp CEEEEEE----------CCTTEEHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEe----------CCCCCcHHHHHHhC-----------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 9999999 66677887777432 34677888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 136 ~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 136 HLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDG---TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp HHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred HHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCC---ccccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 999999999999999999977765 9999999998653321 22334579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| .+||... .......+......++..+++++.+||++||..||++|
T Consensus 211 l~el~~g-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R 263 (327)
T 3a62_A 211 MYDMLTG-APPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263 (327)
T ss_dssp HHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGS
T ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhc
Confidence 9999998 6677654 44445555666667778899999999999999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.88 Aligned_cols=233 Identities=26% Similarity=0.337 Sum_probs=197.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|.+.+.||+|+||.||++... +|+.||||++.+.. .+...+|.. +++.++||||+++++++.+.+..|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 467999999999999999999765 59999999996432 223444554 7789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ..+++..+..++.||+.||+|||+
T Consensus 119 v~e----------~~~gg~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH~ 159 (350)
T 1rdq_E 119 VME----------YVAGGEMFSHLRRI-----------------------------GRFSEPHARFYAAQIVLTFEYLHS 159 (350)
T ss_dssp EEE----------CCTTCBHHHHHHHH-----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEc----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 77778888877532 357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 160 ~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 160 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp TTEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred CCcccccCccceEEECCCCC--EEEcccccceeccCC------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 99999999999999977765 999999999876432 2345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||... .......+......++..+++++.+||++||+.||++|
T Consensus 232 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R 280 (350)
T 1rdq_E 232 AAG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTC
T ss_pred hhC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhc
Confidence 999 5566554 44555666667777888999999999999999999998
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.92 Aligned_cols=238 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
...++|.+.+.||+|+||+||++.. .+|+.||||++.... ....+.++..+++.++||||+++++++.+.+..++||
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 3456788889999999999999975 569999999986432 2333333444789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.. ..+++.++..++.|++.||+|||+.+
T Consensus 97 e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (297)
T 3fxz_A 97 E----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQ 136 (297)
T ss_dssp E----------CCTTCBHHHHHHH------------------------------SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------CCCCCCHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 6677888887642 24678889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++. +||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 137 i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 211 (297)
T 3fxz_A 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (297)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTC---CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH
T ss_pred ceeCCCCHHHEEECCCCC--EEEeeCCCceecCCccc---ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999987765 99999999987754322 2334569999999999999999999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHH-Hcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIV-KDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i-~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||..... .....+ ... ....+..+++++.+||.+||+.||++|
T Consensus 212 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (297)
T 3fxz_A 212 G-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261 (297)
T ss_dssp S-SCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHC
Confidence 8 667765533 222222 222 233466789999999999999999998
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=342.73 Aligned_cols=240 Identities=19% Similarity=0.279 Sum_probs=195.2
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.+.++|.+.+.||+|+||.||++... +++.||+|.+...... ...+|+. +++.++||||+++++++.+.+..++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHH-HHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 35678999999999999999999765 5899999998754422 2344554 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ...+++.+++.++.||+.||.|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~g 122 (321)
T 1tki_A 81 E----------FISGLDIFERINTS----------------------------AFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp C----------CCCCCBHHHHHTSS----------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------eCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 66677888776432 235788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.+++..+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 123 ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 198 (321)
T 1tki_A 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198 (321)
T ss_dssp EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC----ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987444569999999998875432 1233458999999999998889999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES-FERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~-~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||... .......+......++ ..+++++.+||.+||..||++|
T Consensus 199 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 249 (321)
T 1tki_A 199 G-INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249 (321)
T ss_dssp S-SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred C-CCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHC
Confidence 9 5677554 4444444444443333 4678999999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=345.73 Aligned_cols=240 Identities=24% Similarity=0.365 Sum_probs=194.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.+.|.+.+.||+|+||.||++... +|+.||||++..... +...+|+. +++.++||||+++++++.+.+..
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR-ICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEE
Confidence 345678999999999999999998764 589999999975431 22334544 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+.+|+|.+++.. ...+++..+..++.||+.||.||
T Consensus 104 ~lv~e----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~l 144 (362)
T 2bdw_A 104 YLVFD----------LVTGGELFEDIVA-----------------------------REFYSEADASHCIQQILESIAYC 144 (362)
T ss_dssp EEEEC----------CCCSCBHHHHHTT-----------------------------CSCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6667788777642 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+|||++.++ ...+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++
T Consensus 145 H~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 220 (362)
T 2bdw_A 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220 (362)
T ss_dssp HHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC----SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred HHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc----ccccCCCCccccCHHHHccCCCCchhhHHHHHHHH
Confidence 999999999999999997653 2469999999998765321 22345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-ChHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGE-SFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~-~~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| .+||.+ ........+......++ ..+++++.+||.+||++||++|
T Consensus 221 ~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (362)
T 2bdw_A 221 YILLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 276 (362)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhC
Confidence 999999 556654 44444455554443332 4578999999999999999998
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.56 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=194.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
+....+|.+.+.||+|+||.||+|... .+..||||+++..... .+.+|+ .+++.++||||+++++++.+.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA-SIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEEeCC
Confidence 344578999999999999999999774 3557999999764322 334454 4789999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.++++.. ...+++.+++.++.|++.||+
T Consensus 124 ~~~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~L~ 165 (325)
T 3kul_A 124 LAMIVTE----------YMENGSLDTFLRTH----------------------------DGQFTIMQLVGMLRGVGAGMR 165 (325)
T ss_dssp CCEEEEE----------CCTTCBHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHH
T ss_pred ccEEEee----------CCCCCcHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 77778888887532 235788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+|||++.++ .+||+|||+++................+|+.|+|||++.+..++.++|||||||+
T Consensus 166 ~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 243 (325)
T 3kul_A 166 YLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243 (325)
T ss_dssp HHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHH
T ss_pred HHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHH
Confidence 99999999999999999997665 4999999999987654333333334456889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++..||..... .....+.. .....+..+++++.+||.+||..||++|
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 298 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhC
Confidence 99999933677766543 33333333 3455677889999999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=336.19 Aligned_cols=239 Identities=25% Similarity=0.417 Sum_probs=185.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+.++|.+.+.||+|+||+||++...+|+.||||++..... ....+|+. +++.++||||+++++++.+++..+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREIS-LLKELHHPNIVSLIDVIHSERCLT 95 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHH-HHHHCCCTTBCCEEEEECCSSCEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHH-HHHHcCCCCEeeeeeEEccCCEEE
Confidence 556688999999999999999999988899999999964321 23445554 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||+|.++|.+++ .. ....+++..+..++.|++.||+|||
T Consensus 96 lv~e~~~~~l~~~~-----------~~----------------------------~~~~~~~~~~~~~~~qi~~~l~~LH 136 (311)
T 3niz_A 96 LVFEFMEKDLKKVL-----------DE----------------------------NKTGLQDSQIKIYLYQLLRGVAHCH 136 (311)
T ss_dssp EEEECCSEEHHHHH-----------HT----------------------------CTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEcCCCCCHHHHH-----------Hh----------------------------ccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99997665444333 21 1234788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 137 ~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPV---RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp HTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCC---C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred HCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCc---ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 999999999999999987765 9999999998765322 12234468999999999876 55899999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHc---cCc---------------------------ccccCCCHHHHHHHHHccccCcC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKD---RKD---------------------------LFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~---~~~---------------------------~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
||++| .+||..... .....+.. ... .....+++++.+||++||+.||+
T Consensus 212 ~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 290 (311)
T 3niz_A 212 EMITG-KPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPN 290 (311)
T ss_dssp HHHHS-SCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTT
T ss_pred HHHhC-CCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChh
Confidence 99998 667765432 22211111 000 01234678999999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 291 ~R 292 (311)
T 3niz_A 291 KR 292 (311)
T ss_dssp TS
T ss_pred HC
Confidence 98
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.09 Aligned_cols=239 Identities=23% Similarity=0.360 Sum_probs=196.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.++|++.+.||+|+||.||++...+++.||||++.... .+...+|+ .+++.++||||+++++++.+++..++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEA-EVMMKLSHPKLVQLYGVCLEQAPICLVFE-- 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEEEEEE--
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCceEEEEE--
Confidence 46789999999999999999998889999999997643 23344555 48899999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++... ...+++..+++++.|++.||+|||+.+|+|
T Consensus 86 --------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 129 (269)
T 4hcu_A 86 --------FMEHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIH 129 (269)
T ss_dssp --------CCTTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --------eCCCCcHHHHHHhc----------------------------CcccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 77778888887532 235788899999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++++.
T Consensus 130 ~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 130 RDLAARNCLVGENQV--IKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp SCCCGGGEEECGGGC--EEECCTTGGGGBCCHH--HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCcchheEEEcCCCC--EEeccccccccccccc--cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 999999999977654 9999999998764321 122233457889999999999999999999999999999999447
Q ss_pred CCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||...... ....+... ....+...++++.++|.+||+.||++|
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 251 (269)
T 4hcu_A 206 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 251 (269)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccC
Confidence 888766443 33333333 445566778999999999999999998
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=348.24 Aligned_cols=236 Identities=25% Similarity=0.377 Sum_probs=195.8
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..++|.+.+.||+|+||.||++... +++.||||++.+.. .....+|+. +++.++|||||++++++.+.+..|
T Consensus 13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~ 91 (384)
T 4fr4_A 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ-IMQGLEHPFLVNLWYSFQDEEDMF 91 (384)
T ss_dssp CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3467899999999999999998765 48999999986431 234445555 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 92 lv~e----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH 132 (384)
T 4fr4_A 92 MVVD----------LLLGGDLRYHLQQ-----------------------------NVHFKEETVKLFICELVMALDYLQ 132 (384)
T ss_dssp EEEC----------CCTTEEHHHHHHT-----------------------------TCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7777888877743 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCI 700 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvv 700 (753)
+.||+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.. ..++.++|||||||+
T Consensus 133 ~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 133 NQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRE----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp HTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTT----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred HCCceeccCcHHHeEECCCCC--EEEeccceeeeccCC----CceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 999999999999999977765 999999999876533 22345679999999999864 458999999999999
Q ss_pred HHHHHhCCCCCCCCC----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| .+||... .......+......++..+++++.+||++||+.||++|
T Consensus 207 l~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 262 (384)
T 4fr4_A 207 AYELLRG-RRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262 (384)
T ss_dssp HHHHHHS-SCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHhC-CCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHh
Confidence 9999998 6677532 33344455566677788899999999999999999998
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.39 Aligned_cols=241 Identities=24% Similarity=0.393 Sum_probs=189.0
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--c----hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
++.+.++|++.+.||+|+||.||++... .++.||||++.... . +.+.+|+ .+++.++||||+++++++.+.+
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREV-HNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHH-HHHTTCCBTTBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHH-HHHhcCCCCCCceEEEeeeeCC
Confidence 4667788999999999999999999754 68999999985432 1 1233444 4778899999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.+++.. ...+++..++.++.|++.||+
T Consensus 85 ~~~lv~e----------~~~g~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~ 125 (294)
T 4eqm_A 85 CYYLVME----------YIEGPTLSEYIES-----------------------------HGPLSVDTAINFTNQILDGIK 125 (294)
T ss_dssp EEEEEEE----------CCCSCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEe----------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 9999999 6677888887743 235788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++. +||+|||+++...... ........||+.|+|||++.+..++.++|||||||+
T Consensus 126 ~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 201 (294)
T 4eqm_A 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETS--LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIV 201 (294)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC---------------CCSSCCHHHHHTCCCCTTHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccccc--ccccCccccCccccCHhHhcCCCCCchHhHHHHHHH
Confidence 999999999999999999977765 9999999998764322 122334568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHH--HHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERDA--NIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~~--~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| .+||........ ..+...... ....+++++.++|.+||++||++|
T Consensus 202 l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 259 (294)
T 4eqm_A 202 LYEMLVG-EPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259 (294)
T ss_dssp HHHHHHS-SCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHhC-CCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHc
Confidence 9999998 678876543332 222222221 235678999999999999999998
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=345.75 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=198.0
Q ss_pred ecceEEEeEEecccCceEEEEEEee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeeccccc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVES 537 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~ 537 (753)
..++|.+.+.||+|+||.||+|... ++..||||+++..... ...+|+. +++.+ +||||++++++|.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHH-HHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEc
Confidence 3467899999999999999999753 3568999999765432 3445555 67777 8999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+.+..|+||| |+.+|+|.+++........... ..........+++.++++++.||+.
T Consensus 158 ~~~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~qi~~ 214 (370)
T 2psq_A 158 QDGPLYVIVE----------YASKGNLREYLRARRPPGMEYS-------------YDINRVPEEQMTFKDLVSCTYQLAR 214 (370)
T ss_dssp SSSSCEEEEE----------CCTTCBHHHHHHHTCCC------------------------CCCCCCHHHHHHHHHHHHH
T ss_pred cCCCEEEEEE----------cCCCCCHHHHHHhhCCcccccc-------------ccccccccccCCHHHHHHHHHHHHH
Confidence 9999999999 7778888888875432110000 0000122346889999999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++|||||
T Consensus 215 aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 215 GMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp HHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCT-TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccc-eecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 999999999999999999999977765 99999999987654321 122334457889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|++.+||.+.. ......+... ....+..+++++.++|.+||+.||++|
T Consensus 292 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 292 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999994477886653 3334444443 345667789999999999999999998
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=357.36 Aligned_cols=237 Identities=26% Similarity=0.342 Sum_probs=193.1
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..++|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|. .+++.++||||++++++|.+.+..+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHH-HHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 346799999999999999999865 458999999996431 12233344 3678889999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.+++.. ...+++..+..++.||+.||+|||
T Consensus 225 lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH 265 (446)
T 4ejn_A 225 FVME----------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLH 265 (446)
T ss_dssp EEEC----------CCSSCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------eCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHh
Confidence 9999 7778888887743 245788899999999999999999
Q ss_pred h-CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 E-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+ .+|+||||||+|||++.++. +||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 266 ~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 266 SEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKD---GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp HHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC--------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred hcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCC---CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 8 89999999999999977764 999999999864332 12234567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~-~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||.. ........+......++..+++++.+||.+||++||++|
T Consensus 341 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 391 (446)
T 4ejn_A 341 EMMCG-RLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391 (446)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHhhC-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHh
Confidence 99998 556654 455556666677777888899999999999999999998
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=337.52 Aligned_cols=240 Identities=22% Similarity=0.322 Sum_probs=194.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
..+.+.|.+.+.||+|+||.||++... +|+.||||.+.... .+...+|+. +++.++||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEe
Confidence 455678999999999999999999765 58999999996532 123445554 7899999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+++|+|.+++.. ...+++.+++.++.||+.|
T Consensus 86 ~~~~~lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~a 126 (326)
T 2y0a_A 86 KTDVILILE----------LVAGGELFDFLAE-----------------------------KESLTEEEATEFLKQILNG 126 (326)
T ss_dssp SSEEEEEEE----------CCCSCBHHHHHTT-----------------------------SSCCBHHHHHHHHHHHHHH
T ss_pred CCEEEEEEE----------cCCCCCHHHHHHh-----------------------------cCCcCHHHHHHHHHHHHHH
Confidence 999999999 6667788877642 2357888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCC--CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
|.|||+.+|+||||||+|||++.++ ...+||+|||+++...... ......||+.|+|||++.+..++.++||||
T Consensus 127 l~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 202 (326)
T 2y0a_A 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 202 (326)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS----CCCCCCSCTTTCCHHHHTTCCCCTHHHHHH
T ss_pred HHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC----ccccccCCcCcCCceeecCCCCCcHHHHHH
Confidence 9999999999999999999997765 1259999999998875332 223456999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC-hHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGES-FERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||++| .+||... .......+......+ ....++++.+||++||..||++|
T Consensus 203 lG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 263 (326)
T 2y0a_A 203 IGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263 (326)
T ss_dssp HHHHHHHHHHS-CCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHC-cCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhC
Confidence 99999999999 5677554 333333333333222 35678999999999999999998
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.25 Aligned_cols=235 Identities=27% Similarity=0.364 Sum_probs=185.4
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.++|.+.+.||+|+||+||+|... +|+.||||++.... ....+.|+..+....+|+||++++++|.+.+..+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 34567999999999999999999776 69999999986532 1234555555666679999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||+|.+ +|.+++... ...+++..+++|+.||+.||+|||
T Consensus 134 lv~e~~~~-----------~L~~~~~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH 174 (311)
T 3p1a_A 134 LQTELCGP-----------SLQQHCEAW----------------------------GASLPEAQVWGYLRDTLLALAHLH 174 (311)
T ss_dssp EEEECCCC-----------BHHHHHHHH----------------------------CSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeccCC-----------CHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99996654 444444321 245888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++||
T Consensus 175 ~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~e 247 (311)
T 3p1a_A 175 SQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILE 247 (311)
T ss_dssp HTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHH
T ss_pred HCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCC----CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHH
Confidence 999999999999999977654 9999999998765322 2234468999999999876 79999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFERDANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|+.+|+.... ...+... ....+..+++++.+||.+||+.||++|
T Consensus 248 l~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 296 (311)
T 3p1a_A 248 VACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296 (311)
T ss_dssp HHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhC
Confidence 9999777765432 1122222 223456788999999999999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=337.75 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=186.5
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
....+|.+.+.||+|+||+||++.. +|+.||||++..... ..+.+|+. +++.++||||+++++++.+.+..++
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVA-IMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCceEE
Confidence 3456789999999999999999865 689999999965431 13344554 7899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++..... ...+++..++.++.|++.||+|||+
T Consensus 112 v~e----------~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~i~~qi~~aL~~LH~ 155 (309)
T 3p86_A 112 VTE----------YLSRGSLYRLLHKSGA--------------------------REQLDERRRLSMAYDVAKGMNYLHN 155 (309)
T ss_dssp EEE----------CCTTCBHHHHHHSTTH--------------------------HHHSCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEe----------cCCCCcHHHHHhhcCC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHc
Confidence 999 7778888888764321 1237788899999999999999999
Q ss_pred CC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 625 IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 625 ~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
.+ |+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 156 RNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTF---LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp SSSCCCCTTCCGGGEEECTTCC--EEECCCC--------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred CCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccccc---cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 99 999999999999977654 9999999998654321 1223456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHH-HHH--HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDA-NIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~-~~i--~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| ..||........ ..+ .......+..+++++.+||++||+.||++|
T Consensus 231 elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 231 ELATL-QQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHHC-CCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 99999 678876644332 222 233445677889999999999999999998
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=353.23 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=194.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.+.|.+.+.||+|+||.||++.. .+|+.||+|++..... +...+|+ .+++.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREA-RICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHH-HHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCcCCCeEEEEEEECCEE
Confidence 45667899999999999999999865 4699999999976432 2233444 478999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+.+|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 86 ~lv~E----------~~~gg~L~~~i~~-----------------------------~~~~~e~~~~~i~~qil~aL~~l 126 (444)
T 3soa_A 86 YLIFD----------LVTGGELFEDIVA-----------------------------REYYSEADASHCIQQILEAVLHC 126 (444)
T ss_dssp EEEEC----------CCBCCBHHHHHHH-----------------------------CSCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------eCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6667788777643 24578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+|||++.+ ....+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++
T Consensus 127 H~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvil 203 (444)
T 3soa_A 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203 (444)
T ss_dssp HHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred HHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC---ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHH
Confidence 99999999999999999753 23469999999998765432 122345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCC-ChHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGE-SFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~-~~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++| .+||.+ ........+......++ ..+++++.+||.+||++||++|
T Consensus 204 yell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 259 (444)
T 3soa_A 204 YILLVG-YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKR 259 (444)
T ss_dssp HHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHHhC-CCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHC
Confidence 999999 556644 44455555555544333 3678999999999999999998
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=330.82 Aligned_cols=236 Identities=25% Similarity=0.325 Sum_probs=185.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|+||+||+|... +|+.||||++..... ....+|+. +++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHH-HHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 46889999999999999999765 589999999964331 23445554 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|+|.+++.+++ . .....+++..+..++.|++.||+|||+.+
T Consensus 81 e~~~~~l~~~~-----------~----------------------------~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ 121 (292)
T 3o0g_A 81 EFCDQDLKKYF-----------D----------------------------SCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECCSEEHHHHH-----------H----------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecCCCCHHHHH-----------H----------------------------hCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 97765544433 1 11245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 122 ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 196 (292)
T 3o0g_A 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPV---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECCSCC---SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred eecCCCCHHHEEEcCCCC--EEEeecccceecCCcc---ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHH
Confidence 999999999999977765 9999999998765322 2223456899999999998766 799999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHcc-----------------------------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKDR-----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~~-----------------------------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+.+||....... ...+... ........++++++||++||+.||++|
T Consensus 197 ~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (292)
T 3o0g_A 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhC
Confidence 99777776654332 2222110 001123467899999999999999998
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=342.20 Aligned_cols=243 Identities=23% Similarity=0.373 Sum_probs=182.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc--h---HHHHHHHHHHHhCCCCceeeecccccCCc--
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--D---VALKEIQNLIASDQHPNIVRWYGVESDQD-- 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-- 540 (753)
..+.++|.+.+.||+|+||.||++.. .+++.||||++..... . ..+.++..+++.++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 45667899999999999999999975 5689999999975421 1 12333334678889999999999987644
Q ss_pred --eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 541 --~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
..|+||| |+++|+|.++++.. ..+++.++++++.|++.|
T Consensus 88 ~~~~~lv~e----------~~~g~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~ 128 (311)
T 3ork_A 88 GPLPYIVME----------YVDGVTLRDIVHTE-----------------------------GPMTPKRAIEVIADACQA 128 (311)
T ss_dssp EEEEEEEEE----------CCCEEEHHHHHHHH-----------------------------CSCCHHHHHHHHHHHHHH
T ss_pred CcccEEEEe----------cCCCCCHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHH
Confidence 3499999 66677888777432 357888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+..++.++||||||
T Consensus 129 l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 206 (311)
T 3ork_A 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206 (311)
T ss_dssp HHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHH
T ss_pred HHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHH
Confidence 99999999999999999999987765 9999999998775543333334455689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHH-HHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFERDA-NIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~-~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|| .+||........ ......... ....+++++.++|.+||++||++|
T Consensus 207 ~~l~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 265 (311)
T 3ork_A 207 CVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265 (311)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhC-CCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhC
Confidence 999999998 678866544332 222222221 234588999999999999999998
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.50 Aligned_cols=235 Identities=22% Similarity=0.356 Sum_probs=189.9
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-----C-chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----H-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-----~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..++|.+.+.||+|+||.||+|.. .+|+.||||++... . .....+|+. +++.++||||+++++++.+.+..+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS-YLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEEE
Confidence 346799999999999999999976 56899999998642 1 234445554 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||||. |+|.+++.. ...+++.++.+++.|++.||.|||
T Consensus 86 lv~E~~~-----------g~l~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH 125 (336)
T 3h4j_B 86 MVIEYAG-----------GELFDYIVE-----------------------------KKRMTEDEGRRFFQQIICAIEYCH 125 (336)
T ss_dssp EEECCCC-----------EEHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCC-----------CcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999554 445554432 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++. +||+|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 126 ~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 199 (336)
T 3h4j_B 126 RHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDG----NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLY 199 (336)
T ss_dssp HHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTS----BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHH
T ss_pred HCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCC----cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHH
Confidence 999999999999999976654 999999999876533 22345579999999999988876 78999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||.+... .....+.......+..+++++.+||++||+.||++|
T Consensus 200 ~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 250 (336)
T 3h4j_B 200 VMLVG-RLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQR 250 (336)
T ss_dssp HHHHS-SCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHHhC-CCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHC
Confidence 99998 678765432 222223334455677789999999999999999998
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=351.04 Aligned_cols=239 Identities=23% Similarity=0.339 Sum_probs=191.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+...++|.+.+.||+|+||+||++... +++.||||++.+. .....+.++..+++.++|||||+++++|.+.+..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 445678999999999999999999765 5899999999642 1222344444588999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+++|+|.++++. ..+++..+..++.||+.||+||
T Consensus 145 ~lV~E----------~~~gg~L~~~l~~------------------------------~~~~e~~~~~~~~qi~~aL~~L 184 (410)
T 3v8s_A 145 YMVME----------YMPGGDLVNLMSN------------------------------YDVPEKWARFYTAEVVLALDAI 184 (410)
T ss_dssp EEEEC----------CCTTEEHHHHHHH------------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------CCCCCcHHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888887642 2467888899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC----CCchhhHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 698 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~t~ksDIwSfG 698 (753)
|+.+|+||||||+|||++.++. +||+|||+++...... .......+||+.|+|||++.+.. ++.++||||||
T Consensus 185 H~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlG 260 (410)
T 3v8s_A 185 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 260 (410)
T ss_dssp HHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS--EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHH
T ss_pred HHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCC--cccccCCcCCccccCHHHhhccCCCcCCCCcceEecch
Confidence 9999999999999999977765 9999999998775432 22334567999999999998765 78999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHHHcc----CcccccCCCHHHHHHHHHccccCcCC
Q 004442 699 CILFFCITGGKHPYGES-FERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~-~~~~~~~i~~~----~~~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
|++|||+|| .+||... .......+... ..+....+++++++||++||..+|++
T Consensus 261 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~r 318 (410)
T 3v8s_A 261 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVR 318 (410)
T ss_dssp HHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGC
T ss_pred HHHHHHHhC-CCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhh
Confidence 999999999 5566554 44444444332 22333468999999999999987766
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=342.50 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=180.8
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
..+.+.|.+.+.||+|+||.||++... +++.||||++........++.+..+++.++||||++++++|.+.+..++|||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 445678999999999999999999776 4889999999865444444434447899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++.. ...+++.+++.++.|++.||.|||+.+|
T Consensus 129 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i 169 (349)
T 2w4o_A 129 ----------LVTGGELFDRIVE-----------------------------KGYYSERDAADAVKQILEAVAYLHENGI 169 (349)
T ss_dssp ----------CCCSCBHHHHHTT-----------------------------CSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ----------eCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6677888877643 2347888999999999999999999999
Q ss_pred cccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++. +.+..+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 170 vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 245 (349)
T 2w4o_A 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245 (349)
T ss_dssp CCCCCCGGGEEESSSSTTCCEEECCCC--------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred EecCCCcccEEEecCCCCCCEEEccCccccccCcc----cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999975 22346999999999876432 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCh-HH-HHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF-ER-DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~-~~-~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||.... .. ....+...... ....+++++.+||++||..||++|
T Consensus 246 g-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 297 (349)
T 2w4o_A 246 G-FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297 (349)
T ss_dssp S-SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred C-CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhC
Confidence 9 55664432 22 33334333322 234678999999999999999998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=351.60 Aligned_cols=241 Identities=23% Similarity=0.346 Sum_probs=191.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+...++|.+.+.||+|+||+||++... +|+.||||++.+.. ....++++..++..++|+||+++++++.+.+..
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL 136 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 344578999999999999999999775 69999999996532 112234444577889999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
||||| |+++|+|.+++... ...+++..+..++.||+.||+||
T Consensus 137 ~lVmE----------~~~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~L 178 (412)
T 2vd5_A 137 YLVME----------YYVGGDLLTLLSKF----------------------------GERIPAEMARFYLAEIVMAIDSV 178 (412)
T ss_dssp EEEEC----------CCCSCBHHHHHHHH----------------------------SSCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEc----------CCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77788998888532 13578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-------CCCCCchhhHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-------QGRQTRAIDLF 695 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-------~~~~t~ksDIw 695 (753)
|+.+|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++. ...++.++|||
T Consensus 179 H~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~Diw 254 (412)
T 2vd5_A 179 HRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGT--VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWW 254 (412)
T ss_dssp HHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC--EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHH
T ss_pred HHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCc--cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhh
Confidence 9999999999999999977765 99999999988754321 2233457999999999997 35689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCC-hHHHHHHHHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGES-FERDANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| .+||... .......+.... +.....+++++++||++||. ||++|
T Consensus 255 SlGvilyelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~R 316 (412)
T 2vd5_A 255 ALGVFAYEMFYG-QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETR 316 (412)
T ss_dssp HHHHHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGC
T ss_pred HHhHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-Chhhc
Confidence 999999999999 5666554 334443333211 22235789999999999999 99987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.33 Aligned_cols=240 Identities=24% Similarity=0.363 Sum_probs=195.8
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..++|++.+.||+|+||.||++...++..||||++.... .+...+|+. ++..++||||+++++++.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVKFYGVCSKEYPIYIVTE- 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSEEEEEE-
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCceEEEEE-
Confidence 346789999999999999999988888899999997643 234455555 7789999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++... ...+++.+++.++.|++.||+|||+.+|+
T Consensus 84 ---------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 126 (268)
T 3sxs_A 84 ---------YISNGCLLNYLRSH----------------------------GKGLEPSQLLEMCYDVCEGMAFLESHQFI 126 (268)
T ss_dssp ---------CCTTCBHHHHHHHH----------------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------ccCCCcHHHHHHHc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 66778888877543 13478889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||+++.++. +||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+|++
T Consensus 127 H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 127 HRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp ESSCSGGGEEECTTCC--EEECCTTCEEECCTTCE--EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred cCCcCcceEEECCCCC--EEEccCccceecchhhh--hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence 9999999999977754 99999999987754322 2223344678899999999889999999999999999999944
Q ss_pred CCCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+... ....+...++++.++|.+||+.||++|
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 249 (268)
T 3sxs_A 203 KMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKR 249 (268)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGS
T ss_pred CCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhC
Confidence 78887654433 3333333 334556678999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=353.13 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=192.8
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+...++|.+.+.||+|+||+||++.... ++.||||++.+.. ....++++..++..++||||++++++|.+.+..
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL 149 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence 4456789999999999999999997765 8899999996421 122244444578889999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
||||| |+++|+|.++|... ...+++..+..++.||+.||+||
T Consensus 150 ~lV~E----------y~~gg~L~~~l~~~----------------------------~~~l~e~~~~~~~~qi~~aL~~L 191 (437)
T 4aw2_A 150 YLVMD----------YYVGGDLLTLLSKF----------------------------EDRLPEEMARFYLAEMVIAIDSV 191 (437)
T ss_dssp EEEEC----------CCTTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cCCCCcHHHHHHHc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77889999888542 24578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSL 697 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSf 697 (753)
|+.+|+||||||+||||+.++. +||+|||+++....... ......+||+.|+|||++. ...++.++|||||
T Consensus 192 H~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSl 267 (437)
T 4aw2_A 192 HQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSL 267 (437)
T ss_dssp HHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHH
T ss_pred HhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHH
Confidence 9999999999999999977765 99999999987654322 2234467999999999997 5668999999999
Q ss_pred HHHHHHHHhCCCCCCCCC-hHHHHHHHHcc--Ccccc---cCCCHHHHHHHHHccccCcCC
Q 004442 698 GCILFFCITGGKHPYGES-FERDANIVKDR--KDLFL---VEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~-~~~~~~~i~~~--~~~~~---~~~s~el~dLI~~cL~~DP~~ 752 (753)
||++|||++| .+||... .......+... ...++ ..+++++.+||++||..+|++
T Consensus 268 Gvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r 327 (437)
T 4aw2_A 268 GVCMYEMLYG-ETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHR 327 (437)
T ss_dssp HHHHHHHHHS-SCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGC
T ss_pred HHHHHHHHhC-CCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccc
Confidence 9999999999 5666554 34444443322 12233 458999999999999988776
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.98 Aligned_cols=235 Identities=29% Similarity=0.443 Sum_probs=183.6
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----------------------------chHHHHHHHHHH
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----------------------------HDVALKEIQNLI 521 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----------------------------~~~~~~Ei~~ll 521 (753)
.++|.+.+.||+|+||.||+|... +++.||||++.... .+...+|+. ++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l 90 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA-IL 90 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH-HH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH-HH
Confidence 357899999999999999999764 58999999996542 123445555 78
Q ss_pred HhCCCCceeeecccccC--CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhh
Q 004442 522 ASDQHPNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599 (753)
Q Consensus 522 ~~l~HpNIV~L~g~~~~--~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 599 (753)
+.++||||+++++++.+ .+..++||| |+.+|+|.+++ .
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e----------~~~~~~l~~~~------------------------------~ 130 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFE----------LVNQGPVMEVP------------------------------T 130 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEE----------CCTTCBSCCSS------------------------------C
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEe----------cCCCCcHHHHh------------------------------h
Confidence 99999999999999886 678999999 55566665432 1
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccc
Q 004442 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 679 (753)
Q Consensus 600 ~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~A 679 (753)
...+++.+++.++.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ......||+.|+|
T Consensus 131 ~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~a 205 (298)
T 2zv2_A 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDA---LLSNTVGTPAFMA 205 (298)
T ss_dssp SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSC---EECCCCSCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--EEEecCCCccccccccc---cccCCcCCccccC
Confidence 245788999999999999999999999999999999999977765 99999999987754321 1234568999999
Q ss_pred cccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 680 PEQLLQGR---QTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 680 PE~l~~~~---~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++.+.. ++.++|||||||++|||++| .+||..... .....+...... ....+++++.+||.+||++||++|
T Consensus 206 PE~~~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 284 (298)
T 2zv2_A 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFG-QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESR 284 (298)
T ss_dssp GGGCCTTCCCEESHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTS
T ss_pred hhhhccCCCCCCCchhhhHhHHHHHHHHHHC-CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhC
Confidence 99997765 37899999999999999998 667765533 333333333322 334688999999999999999998
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=332.88 Aligned_cols=242 Identities=26% Similarity=0.342 Sum_probs=186.7
Q ss_pred eecceEEEeEEecccCceEEEEEEe-----eCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCC--
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQ-- 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-----~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-- 539 (753)
...++|++.+.||+|+||+||++.. .+++.||||++...... .+.+|+ .+++.++||||++++++|.+.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECHHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCC
Confidence 3457899999999999999999863 36899999999765432 234444 478999999999999998653
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++||| |+++|+|.+++.... ..+++.++++++.|++.||
T Consensus 86 ~~~~lv~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l 127 (295)
T 3ugc_A 86 RNLKLIME----------YLPYGSLRDYLQKHK----------------------------ERIDHIKLLQYTSQICKGM 127 (295)
T ss_dssp TSCEEEEE----------CCTTCBHHHHHHHCG----------------------------GGCCHHHHHHHHHHHHHHH
T ss_pred CceEEEEE----------eCCCCCHHHHHHhcc----------------------------cccCHHHHHHHHHHHHHHH
Confidence 55899999 777888888875432 2377888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
+|||+.+|+||||||+|||++.++. +||+|||+++................++..|+|||++.+..++.++||||||+
T Consensus 128 ~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (295)
T 3ugc_A 128 EYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 205 (295)
T ss_dssp HHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHH
Confidence 9999999999999999999987754 99999999988765433333334445788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHH-----------------HH-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFERD-----------------AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~~-----------------~~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|| ..|+....... .. .......+.+..+++++.++|++||+.||++|
T Consensus 206 ~l~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 276 (295)
T 3ugc_A 206 VLYELFTY-IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276 (295)
T ss_dssp HHHHHHHT-TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHhc-ccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhC
Confidence 99999998 55665432221 11 11223445667889999999999999999998
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.60 Aligned_cols=243 Identities=22% Similarity=0.382 Sum_probs=184.3
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD----- 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~----- 540 (753)
+.++|.+.+.||+|+||.||+|... +|+.||||++..... +...+|+ .+++.++||||++++++|.+.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREV-KALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHH-HHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHH-HHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3467899999999999999999775 799999999974332 2334454 4789999999999999875433
Q ss_pred ----------------------------------------------------eEEEEEccccCChhhHHHHhcCChHHHh
Q 004442 541 ----------------------------------------------------FVYLSLERCTCSLNDLIYVLSGSFEEQL 568 (753)
Q Consensus 541 ----------------------------------------------------~~~LV~E~c~~~L~~liy~~~GsL~~~L 568 (753)
..++||| |+.+|+|.+++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e----------~~~~~~L~~~~ 152 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQ----------LCRKENLKDWM 152 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEE----------CCCSSCHHHHH
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEE----------ecCCCCHHHHH
Confidence 3899999 66678888887
Q ss_pred hhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEE
Q 004442 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648 (753)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~K 648 (753)
..... .....+..+++++.||+.||+|||+.+|+||||||+|||++.++. +|
T Consensus 153 ~~~~~--------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~k 204 (332)
T 3qd2_B 153 NRRCS--------------------------LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VK 204 (332)
T ss_dssp HTCCS--------------------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EE
T ss_pred hcccC--------------------------ccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EE
Confidence 64321 122455678999999999999999999999999999999977764 99
Q ss_pred EEeccCceeccCCCcc---------cccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 004442 649 LSDMGISKRLQGDMSC---------LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 719 (753)
Q Consensus 649 LsDFGla~~~~~~~~~---------~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~ 719 (753)
|+|||+++........ ........||+.|+|||++.+..++.++|||||||++|||++| ..|+.......
T Consensus 205 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~-~~~~~~~~~~~ 283 (332)
T 3qd2_B 205 VGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-FSTQMERVRII 283 (332)
T ss_dssp ECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSC-CCCHHHHHHHH
T ss_pred EeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHc-CCChhHHHHHH
Confidence 9999999987654211 1122345699999999999999999999999999999999998 44443222222
Q ss_pred HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 720 ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 720 ~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
........+......++++.+||.+||+.||++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence 2222222233345567889999999999999998
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.56 Aligned_cols=241 Identities=22% Similarity=0.334 Sum_probs=193.5
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
...++|.+.+.||+|+||.||++...++..||||++.... .+...+|+ .++..++|+||+++++++.+.+..++|||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHH-HHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456789999999999999999988888899999997653 23444555 48899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ...+++.++++++.|++.||+|||+.+|
T Consensus 100 ----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i 141 (283)
T 3gen_A 100 ----------YMANGCLLNYLREM----------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQF 141 (283)
T ss_dssp ----------CCTTCBHHHHHHCG----------------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ----------ccCCCcHHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 77778888887532 2357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+||+++.++. +||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||+|+
T Consensus 142 ~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~ 217 (283)
T 3gen_A 142 LHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217 (283)
T ss_dssp CCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHH--HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred cCCCCccceEEEcCCCC--EEEccccccccccccc--cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999977654 9999999998764321 1222334468899999999999999999999999999999993
Q ss_pred CCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.+||...... ....+... ....+...++++.++|.+||+.||++|
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (283)
T 3gen_A 218 GKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 265 (283)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred CCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHC
Confidence 37788765433 33333333 344556678999999999999999998
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.20 Aligned_cols=235 Identities=24% Similarity=0.406 Sum_probs=181.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|.+.+.||+|+||+||++...+|+.||||++.... .....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHH-HHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 4688999999999999999988779999999996432 234455655 7789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.++|.++ +.. ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ~~~~~l~~~-----------~~~----------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (288)
T 1ob3_A 81 HLDQDLKKL-----------LDV----------------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (288)
T ss_dssp CCSEEHHHH-----------HHT----------------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ecCCCHHHH-----------HHh----------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 766544443 321 12357788889999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 122 ~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 196 (288)
T 1ob3_A 122 LHRDLKPQNLLINREGE--LKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (288)
T ss_dssp CCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCC--EEEeECccccccCccc---cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 9999999998764321 122334689999999999764 58999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHcc--C---------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKDR--K---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~~--~---------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||....... ...+... . ......+++++.+||++||+.||++|
T Consensus 197 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 272 (288)
T 1ob3_A 197 G-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272 (288)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred C-CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccC
Confidence 9 66776653322 2221110 0 01124578899999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=333.80 Aligned_cols=234 Identities=25% Similarity=0.417 Sum_probs=190.6
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..|...+.||+|+||.||+|... +|+.||||++.... .+...+|+. +++.++|+||++++++|...+..++|||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e- 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHFNVVEMYKSYLVGEELWVLME- 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEEC-
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEECCEEEEEEe-
Confidence 45778889999999999999776 69999999996533 233445554 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+|+
T Consensus 123 ---------~~~~~~L~~~l~~------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~iv 163 (321)
T 2c30_A 123 ---------FLQGGALTDIVSQ------------------------------VRLNEEQIATVCEAVLQALAYLHAQGVI 163 (321)
T ss_dssp ---------CCCSCBHHHHHTT------------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------cCCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 7777888877632 3478889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+|||++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 164 H~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g- 237 (321)
T 2c30_A 164 HRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG- 237 (321)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSSSC---CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-
T ss_pred cCCCCHHHEEECCCCc--EEEeeeeeeeecccCcc---ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999977765 99999999987754321 22345699999999999999999999999999999999998
Q ss_pred CCCCCCC-hHHHHHHHHccCcc---cccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGES-FERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~-~~~~~~~i~~~~~~---~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||... .......+.....+ ....+++++.++|.+||+.||++|
T Consensus 238 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 286 (321)
T 2c30_A 238 EPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286 (321)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhC
Confidence 5566554 33333333333322 234578999999999999999998
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=342.01 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=193.9
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.+.+.|.+.+.||+|+||.||++... +|+.||||++.+... ...+|+..+....+||||+++++++.+.+..|+|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E- 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE- 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC-
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe-
Confidence 45678999999999999999999765 589999999976542 334566655556689999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+.+|+
T Consensus 97 ---------~~~gg~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~giv 138 (342)
T 2qr7_A 97 ---------LMKGGELLDKILR-----------------------------QKFFSEREASAVLFTITKTVEYLHAQGVV 138 (342)
T ss_dssp ---------CCCSCBHHHHHHT-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence 6667788777642 23578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCC-C-CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 629 HRDLKPQNVLISKDK-S-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 629 HrDLKp~NILL~~d~-~-~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
||||||+|||+..+. + ..+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 139 HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 215 (342)
T 2qr7_A 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT 215 (342)
T ss_dssp CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT---CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC---CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence 999999999985432 1 359999999998765432 12345578999999999988889999999999999999999
Q ss_pred CCCCCCCC----ChHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGE----SFERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~----~~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.. ........+......++ ..+++++.+||++||..||++|
T Consensus 216 g-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 269 (342)
T 2qr7_A 216 G-YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269 (342)
T ss_dssp S-SCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTS
T ss_pred C-CCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHC
Confidence 8 667764 23344444444444333 4678999999999999999998
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=337.22 Aligned_cols=237 Identities=28% Similarity=0.386 Sum_probs=173.1
Q ss_pred ceEEEe---EEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCC-CCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFN---KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~---~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|.+. +.||+|+||+||++... +|+.||||++.+.......+|+. ++..+. ||||+++++++.+++..|+|||
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~-~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEIT-ALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHH-HHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHH-HHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 344543 67999999999998765 58999999998766566667776 556665 9999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++.. ...+++.++..++.||+.||+|||+.+|
T Consensus 87 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i 127 (325)
T 3kn6_A 87 ----------LLNGGELFERIKK-----------------------------KKHFSETEASYIMRKLVSAVSHMHDVGV 127 (325)
T ss_dssp ----------CCCSCBHHHHHHH-----------------------------CSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------ccCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 6667888887743 2457888999999999999999999999
Q ss_pred cccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++ ...+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 128 vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 204 (325)
T 3kn6_A 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204 (325)
T ss_dssp ECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred eecCCCHHHEEEecCCCcccEEEeccccceecCCCC---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHh
Confidence 9999999999997654 3469999999998765432 22234568999999999999999999999999999999999
Q ss_pred CCCCCCCCCh--------HHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESF--------ERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~--------~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.... ......+......++ ..+++++.+||.+||+.||++|
T Consensus 205 g-~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (325)
T 3kn6_A 205 G-QVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKR 262 (325)
T ss_dssp S-SCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTC
T ss_pred C-CCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHC
Confidence 8 67886532 223333444333322 3578999999999999999998
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=334.02 Aligned_cols=240 Identities=23% Similarity=0.386 Sum_probs=188.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.++|.+.+.||+|+||+||++... +++.||+|++..... +.+.+|+ .+++.++||||+++++++.+++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEV-KVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHH-HHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 367889999999999999999764 589999999865432 2334454 47899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ...+++.++++++.|++.||+|||+.+|
T Consensus 88 ----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i 129 (310)
T 3s95_A 88 ----------YIKGGTLRGIIKSM----------------------------DSQYPWSQRVSFAKDIASGMAYLHSMNI 129 (310)
T ss_dssp ----------CCTTCBHHHHHHHC----------------------------CTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------ecCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 77788888887542 2357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-----------ccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------TQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-----------~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+..++.++||||
T Consensus 130 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 207 (310)
T 3s95_A 130 IHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS 207 (310)
T ss_dssp ECSCCSTTSEEECTTSC--EEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred cCCCCCcCeEEECCCCC--EEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHH
Confidence 99999999999977655 9999999998775432211 1112457999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHH----HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESFERD----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~~----~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||++| ..|+....... ...........+..+++++.++|.+||+.||++|
T Consensus 208 lG~~l~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 267 (310)
T 3s95_A 208 FGIVLCEIIGR-VNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267 (310)
T ss_dssp HHHHHHHHHHT-CCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhcC-CCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998 55654321110 0011111123456788999999999999999998
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.35 Aligned_cols=243 Identities=17% Similarity=0.171 Sum_probs=189.1
Q ss_pred eecceEEEeEEecccCceEEEEE------EeeCCcEEEEEEeecCCchHHHHHHHHHHHhCC---CCceeeecccccCCc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLE------GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYGVESDQD 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka------~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~---HpNIV~L~g~~~~~~ 540 (753)
...+.|.+.+.||+|+||+||+| ....++.||||++.........+|.. ++..++ |+||+++++++.+.+
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~-~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHH-HHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHH-HHHHhhhhhhhhhhhhheeeecCC
Confidence 34577999999999999999999 45568999999998776666666655 556666 999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++++.... .....+++..++.|+.||+.||+
T Consensus 141 ~~~lv~e----------~~~~g~L~~~l~~~~~------------------------~~~~~l~~~~~~~i~~qi~~~L~ 186 (365)
T 3e7e_A 141 GSVLVGE----------LYSYGTLLNAINLYKN------------------------TPEKVMPQGLVISFAMRMLYMIE 186 (365)
T ss_dssp CEEEEEC----------CCCSCBHHHHHHHHHT------------------------STTCSCCHHHHHHHHHHHHHHHH
T ss_pred CcEEEEe----------ccCCCcHHHHHHHhhc------------------------ccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 7778899988875432 12356899999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecC---------CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch
Q 004442 621 HLHEIGLIHRDLKPQNVLISKD---------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d---------~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k 691 (753)
|||+.+|+||||||+|||++.+ ....+||+|||+|+.+.... ........+||+.|+|||++.+..++.+
T Consensus 187 ~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 265 (365)
T 3e7e_A 187 QVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP-KGTIFTAKCETSGFQCVEMLSNKPWNYQ 265 (365)
T ss_dssp HHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSC-TTEEECCSSCTTSCCCHHHHTTCCBSTH
T ss_pred HHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccC-CCceeeeecCCCCCCChHHhcCCCCCcc
Confidence 9999999999999999999770 12459999999998764221 1223345679999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCccc-ccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF-LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~-~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||+|| ++||......... ....+ ....++.+.+++.+||+.+|.+|
T Consensus 266 ~DiwslG~il~elltg-~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~~p~~r 323 (365)
T 3e7e_A 266 IDYFGVAATVYCMLFG-TYMKVKNEGGECK----PEGLFRRLPHLDMWNEFFHVMLNIPDCHH 323 (365)
T ss_dssp HHHHHHHHHHHHHHHS-SCCCEEEETTEEE----ECSCCTTCSSHHHHHHHHHHHHCCCCTTC
T ss_pred ccHHHHHHHHHHHHhC-CCccccCCCCcee----echhccccCcHHHHHHHHHHHcCCCCCCc
Confidence 9999999999999999 5566432211100 00111 11235678899999999999887
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=357.62 Aligned_cols=241 Identities=25% Similarity=0.365 Sum_probs=200.5
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|.. +++.++||||+++++++.+.+..|
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK-ILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHH-HHHhcCCCCEeeEEEEEeeCCEEE
Confidence 3477999999999999999999775 59999999996432 223444554 788999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.+++..... ....+++..++.++.||+.||+|||
T Consensus 262 lVmE----------~~~gg~L~~~l~~~~~-------------------------~~~~l~e~~~~~~~~qi~~aL~~LH 306 (543)
T 3c4z_A 262 LVMT----------IMNGGDIRYHIYNVDE-------------------------DNPGFQEPRAIFYTAQIVSGLEHLH 306 (543)
T ss_dssp EEEC----------CCTTCBHHHHHHTSST-------------------------TSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------eccCCCHHHHHHHhhc-------------------------ccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999 7778888888754321 1345888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 307 ~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilye 381 (543)
T 3c4z_A 307 QRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQ---TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYE 381 (543)
T ss_dssp HTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC---CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred HcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCCC---cccccccCCccccChhhhcCCCCChHHhcCcchHHHHH
Confidence 999999999999999977765 9999999998875432 12234579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| .+||... .......+......++..+++++.+||++||++||++|
T Consensus 382 lltG-~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 435 (543)
T 3c4z_A 382 MIAA-RGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKR 435 (543)
T ss_dssp HHHS-SCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHhC-CCCCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHC
Confidence 9998 6677653 23444555566667788899999999999999999998
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=338.25 Aligned_cols=239 Identities=25% Similarity=0.387 Sum_probs=189.2
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.++|.+.+.||+|+||+||++... +++.||||++..... +...+|+. +++.++|+||+++++++.+.+..++|
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-INKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3467999999999999999999765 689999999864432 23344554 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ...+++.++++++.||+.||+|||+.
T Consensus 84 ~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~ 124 (323)
T 3tki_A 84 LE----------YCSGGELFDRIEP-----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGI 124 (323)
T ss_dssp EE----------CCTTEEGGGGSBT-----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cCCCCcHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 5666777766532 23578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~El 704 (753)
+|+||||||+|||++.++. +||+|||+++....... .......+||+.|+|||++.+..+ +.++|||||||++|||
T Consensus 125 givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 201 (323)
T 3tki_A 125 GITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201 (323)
T ss_dssp TEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHH
T ss_pred CccccccchHHEEEeCCCC--EEEEEeeccceeccCCc-ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHH
Confidence 9999999999999977765 99999999987643221 122234579999999999988775 7899999999999999
Q ss_pred HhCCCCCCCCChHH--HHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFER--DANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~--~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||...... ......... ......+++++.+||.+||+.||++|
T Consensus 202 l~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 202 LAG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHS-SCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HhC-CCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhC
Confidence 998 6788654332 222222222 22335688999999999999999998
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.22 Aligned_cols=237 Identities=26% Similarity=0.361 Sum_probs=183.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.++|.+.+.||+|+||+||++... +++.||||++.... .+...+|+. +++.++||||+++++++.+.+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~lv~e- 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIIME- 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEEEEE-
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHH-HHHhCCCCCCCcEEEEEeeCCEEEEEEE-
Confidence 467899999999999999999765 68999999997543 344555655 7799999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+|+
T Consensus 97 ---------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 97 ---------YASGGELYERICN-----------------------------AGRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp ---------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ---------eCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 6677888877743 24578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch-hhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k-sDIwSfGvvL~EllTG 707 (753)
||||||+|||++.++...+||+|||+++..... ......+||+.|+|||++.+..++.+ +|||||||++|||++|
T Consensus 139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 214 (361)
T 3uc3_A 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214 (361)
T ss_dssp SCCCCGGGEEECSSSSCCEEECCCCCC-------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEEcCCCCceEEEeecCcccccccc----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhC
Confidence 999999999997776556999999999754322 12234569999999999988887655 9999999999999998
Q ss_pred CCCCCCCCh-----HHHHHHHHccCcccc--cCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-----ERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-----~~~~~~i~~~~~~~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
++||.... ......+.......+ ..+++++++||.+||+.||++|
T Consensus 215 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 266 (361)
T 3uc3_A 215 -AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATR 266 (361)
T ss_dssp -SCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTS
T ss_pred -CCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHC
Confidence 67876532 222233333333333 3578999999999999999998
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.14 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=196.5
Q ss_pred ecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
..++|.+.+.||+|+||+||+|.. ..++.||||++..... ..+.+|+. +++.++||||+++++++.+.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHH-HHHhCCCCCCCeEEEEEecCC
Confidence 356789999999999999999873 2477999999965432 23445554 788999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++....... .....+++.++++++.||+.||+
T Consensus 148 ~~~lv~e----------~~~~g~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~i~~qi~~aL~ 195 (367)
T 3l9p_A 148 PRFILLE----------LMAGGDLKSFLRETRPRP----------------------SQPSSLAMLDLLHVARDIACGCQ 195 (367)
T ss_dssp SCEEEEE----------CCTTEEHHHHHHHHSCCS----------------------SSCCCCCHHHHHHHHHHHHHHHH
T ss_pred CCEEEEE----------eCCCCCHHHHHHhhcccc----------------------CccccccHHHHHHHHHHHHHHHH
Confidence 9999999 677788888886543211 11245888999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|||+.+|+||||||+|||++.++ ...+||+|||+++...... .........||+.|+|||++.+..++.++|||||||
T Consensus 196 ~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 274 (367)
T 3l9p_A 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGV 274 (367)
T ss_dssp HHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHS-SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccccccc-ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHH
Confidence 99999999999999999997543 3469999999998653221 111223345799999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|++.+||...... ....+... ....+..+++++.+||.+||+.||++|
T Consensus 275 il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 330 (367)
T 3l9p_A 275 LLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330 (367)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHC
Confidence 9999999447788765443 33334433 345567789999999999999999998
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.78 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=195.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
....+.|.+.+.||+|+||.||+|...++..||||+++... .+.+.+|+ .+++.++|||||++++++. .+..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEA-NVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHH-HHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHH-HHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 34456789999999999999999988888999999997643 23444555 4889999999999999986 56789999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.++|+... ...+++..+++++.|||.||+|||+++
T Consensus 262 e----------~~~~g~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 262 E----------FMAKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp C----------CCTTCBHHHHHHSHH---------------------------HHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------ecCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 778889999886432 124677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.++ .+||+|||+++...... ........+|..|+|||++....++.++|||||||++|||+|
T Consensus 305 ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 380 (454)
T 1qcf_A 305 YIHRDLRAANILVSASL--VCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380 (454)
T ss_dssp CCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHH--HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCc--eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHh
Confidence 99999999999997765 49999999998764321 112223346889999999999999999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+||.+... .....+.. ...+.+..+++++.+||.+||+.||++|
T Consensus 381 ~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 429 (454)
T 1qcf_A 381 YGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEER 429 (454)
T ss_dssp TSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHC
Confidence 44788876533 33333333 3445667889999999999999999998
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=366.95 Aligned_cols=236 Identities=23% Similarity=0.327 Sum_probs=198.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHh-CCCCceeeecccccCCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIAS-DQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~-l~HpNIV~L~g~~~~~~~~~ 543 (753)
..+|.+.+.||+|+||.||++... +++.||||++++. ..+....|.. ++.. .+|+||+++++++.+.+.+|
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHH-HHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHH-HHHhccCCCeEEEEEEEEEeCCEEE
Confidence 356899999999999999999765 5889999999742 2233455555 4454 48999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+.+|+|.++++.. ..+++..++.++.||+.||+|||
T Consensus 419 lV~E----------~~~gg~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH 459 (674)
T 3pfq_A 419 FVME----------YVNGGDLMYHIQQV-----------------------------GRFKEPHAVFYAAEIAIGLFFLQ 459 (674)
T ss_dssp EEEE----------CCCSCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------CcCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77888998887532 35788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||||+.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+|||
T Consensus 460 ~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilye 534 (674)
T 3pfq_A 460 SKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534 (674)
T ss_dssp HTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTT---CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHH
T ss_pred hCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCC---cccccccCCCcccCHhhhcCCCCCccceEechHHHHHH
Confidence 999999999999999977765 9999999998653321 23345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||.+. .......+......++..+++++.+||++||++||++|
T Consensus 535 lltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 584 (674)
T 3pfq_A 535 MLAG-QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584 (674)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTC
T ss_pred HHcC-CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHC
Confidence 9999 5666554 55566777777788889999999999999999999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=346.08 Aligned_cols=241 Identities=25% Similarity=0.357 Sum_probs=194.2
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..++|.+.+.||+|+||.||+|... +++.||||.++..... .+.+|+ .+++.++||||++++|+|.+++..++|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEA-RILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHH-HHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3467889999999999999999876 6899999999754322 233454 478999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.++++... ..+++..+++++.||+.||+|||+.
T Consensus 191 ~e----------~~~~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~LH~~ 232 (377)
T 3cbl_A 191 ME----------LVQGGDFLTFLRTEG----------------------------ARLRVKTLLQMVGDAAAGMEYLESK 232 (377)
T ss_dssp EE----------CCTTCBHHHHHHHHG----------------------------GGCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 777888888886432 2467888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+
T Consensus 233 ~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~ 309 (377)
T 3cbl_A 233 CCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309 (377)
T ss_dssp TEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEE-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred CcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCce-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999977754 99999999987543211 11111223577899999999899999999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++..||....... ...+.. ...+.+..+++++.+||.+||+.||++|
T Consensus 310 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 359 (377)
T 3cbl_A 310 SLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQR 359 (377)
T ss_dssp TTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 94478887764433 333333 3345667788999999999999999998
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=322.05 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=192.6
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.+.++|.+.+.||+|+||.||++... +|+.||||++..... ...+..+..+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45678999999999999999998764 589999999965431 1223333347889999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 83 v~e----------~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~ 123 (284)
T 3kk8_A 83 VFD----------LVTGGELFEDIVA-----------------------------REFYSEADASHCIQQILESIAYCHS 123 (284)
T ss_dssp EEC----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 6667777776643 2457888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+|+||||||+||+++.++. ..+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+
T Consensus 124 ~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (284)
T 3kk8_A 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 199 (284)
T ss_dssp TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC----BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc----cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHH
Confidence 99999999999999976543 458999999998765432 2234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||... .......+.......+ ..+++++.+||.+||+.||++|
T Consensus 200 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (284)
T 3kk8_A 200 LLVG-YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 253 (284)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHC-CCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhC
Confidence 9999 5566544 4444444444433322 4678999999999999999998
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=345.48 Aligned_cols=242 Identities=26% Similarity=0.365 Sum_probs=180.7
Q ss_pred ecceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
...+|.+.+.||+|+||.||+|... .+..||||+++..... .+.+|+ .+++.++||||++++++|.+.+..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA-SIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECSSSSC
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEeeCCce
Confidence 3456788899999999999998765 5788999999754322 234444 478999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.++++.. ...+++.++++++.||+.||+||
T Consensus 122 ~lv~e----------~~~~~sL~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~L 163 (373)
T 2qol_A 122 MIVTE----------YMENGSLDSFLRKH----------------------------DAQFTVIQLVGMLRGIASGMKYL 163 (373)
T ss_dssp EEEEE----------CCTTCBHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------CCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77788888887532 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++ .+||+|||+++................+|+.|+|||++.+..++.++|||||||++|
T Consensus 164 H~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ 241 (373)
T 2qol_A 164 SDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLW 241 (373)
T ss_dssp HHTTCCCSCCCGGGEEECTTC--CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHH
Confidence 999999999999999997665 499999999987754332222222334578899999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++.+..||.... ......+... ..+.+..+++++.++|.+||+.||++|
T Consensus 242 ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 294 (373)
T 2qol_A 242 EVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNR 294 (373)
T ss_dssp HHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhC
Confidence 99983366775543 3333333333 334556788999999999999999998
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.93 Aligned_cols=242 Identities=21% Similarity=0.329 Sum_probs=195.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..+.+.|.+.+.||+|+||.||+|... +|+.||+|.+..... ...+.++..+++.++||||+++++++.+.+..++|
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 345578999999999999999999765 589999999976532 22333334478999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++... ...+++.+++.++.||+.||+|||+.
T Consensus 127 ~E----------~~~gg~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~ 168 (387)
T 1kob_A 127 LE----------FLSGGELFDRIAAE----------------------------DYKMSEAEVINYMRQACEGLKHMHEH 168 (387)
T ss_dssp EE----------CCCCCBHHHHTTCT----------------------------TCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cCCCCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 77778888877432 23578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++...+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus 169 givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI----VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC----EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred CeeecccchHHeEEecCCCCceEEEecccceecCCCcc----eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 99999999999999765556699999999998754321 12346899999999999999999999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||..... .....+...... ....+++++.+||++||..||++|
T Consensus 245 tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 296 (387)
T 1kob_A 245 SG-LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 296 (387)
T ss_dssp HS-CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHC
Confidence 98 667765533 333333333322 234678999999999999999998
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=345.13 Aligned_cols=237 Identities=23% Similarity=0.327 Sum_probs=182.6
Q ss_pred ceEEEe-EEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC----CceEEEEE
Q 004442 473 KLVVFN-KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~-~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~LV~ 546 (753)
+.|.+. +.||+|+||+||++... +|+.||||++... ....+|+..+....+|+||+++++++.. .+..||||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 345554 78999999999999765 5899999999753 4566777766678899999999998764 67789999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.... ...+++.++..|+.||+.||.|||+.+
T Consensus 139 E----------~~~gg~L~~~l~~~~---------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ 181 (400)
T 1nxk_A 139 E----------CLDGGELFSRIQDRG---------------------------DQAFTEREASEIMKSIGEAIQYLHSIN 181 (400)
T ss_dssp E----------CCCSEEHHHHHHCC------------------------------CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------eCCCCcHHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 667788888775421 235788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+|||++.++ +..+||+|||+++..... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 182 ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred ccccCcCcceEEEecCCCCccEEEEecccccccCCC----CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence 99999999999997632 356999999999876432 1224557899999999999999999999999999999999
Q ss_pred hCCCCCCCCChH-----HHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-----RDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-----~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||..... .....+......++ ..+++++.+||++||+.||++|
T Consensus 258 ~g-~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 313 (400)
T 1nxk_A 258 CG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 313 (400)
T ss_dssp HS-SCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred hC-CCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHC
Confidence 99 567754321 12333333333322 4678999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.54 Aligned_cols=238 Identities=26% Similarity=0.353 Sum_probs=192.1
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCc-eEEEEEcc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLER 548 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-~~~LV~E~ 548 (753)
...+.|.+.+.||+|+||.||++.. .|+.||||+++.......+.++..+++.++||||++++++|.+.+ ..++|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e- 267 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE- 267 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE-
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE-
Confidence 3456789999999999999999865 478999999986654444444445889999999999999987655 7999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+.+|+|.++++... ...+++..+++++.||+.||+|||+++|+
T Consensus 268 ---------~~~~g~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 311 (450)
T 1k9a_A 268 ---------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311 (450)
T ss_dssp ---------CCTTCBHHHHHHHHC---------------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 777889998886432 12367888999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+|||++.++. +||+|||+++..... .....++..|+|||++.+..++.++|||||||++|||+|++
T Consensus 312 HrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 312 HRDLAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp CSCCCGGGEEECTTSC--EEECCCTTCEECC------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCCHhhEEECCCCC--EEEeeCCCccccccc------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999977654 999999999865322 12235788999999999999999999999999999999933
Q ss_pred CCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..||..... .....+.. .....+..+++++.+||.+||+.||++|
T Consensus 384 ~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~R 430 (450)
T 1k9a_A 384 RVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATR 430 (450)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 778876532 33333333 3445677889999999999999999998
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=329.87 Aligned_cols=238 Identities=24% Similarity=0.318 Sum_probs=194.7
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-C-------cEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-G-------RSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-g-------~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
..++|.+.+.||+|+||+||++.... + ..||+|++..... ...+.++..+++.++||||+++++++.+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 35678999999999999999986653 3 5799999965432 233334445889999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++.... ..+++..+++++.||+.||.
T Consensus 86 ~~~lv~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~L~ 127 (289)
T 4fvq_A 86 ENILVQE----------FVKFGSLDTYLKKNK----------------------------NCINILWKLEVAKQLAAAMH 127 (289)
T ss_dssp CCEEEEE----------CCTTCBHHHHHHHTG----------------------------GGCCHHHHHHHHHHHHHHHH
T ss_pred CCEEEEE----------CCCCCCHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 9999999 667788888875421 23678888999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCC------eEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhh
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAID 693 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~------~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksD 693 (753)
|||+.+|+||||||+|||++.++.. .+||+|||++...... ....||+.|+|||++.+ ..++.++|
T Consensus 128 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~D 200 (289)
T 4fvq_A 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-------DILQERIPWVPPECIENPKNLNLATD 200 (289)
T ss_dssp HHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCGGGCCHHHH
T ss_pred HHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc-------cccCCcCcccCHHHhCCCCCCCchhH
Confidence 9999999999999999999877642 2899999998755321 12236889999999987 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||++|+.+||..................+...++++.+||.+||+.||++|
T Consensus 201 iwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 260 (289)
T 4fvq_A 201 KWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHR 260 (289)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 999999999999987888887766555555555666677788999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=321.08 Aligned_cols=236 Identities=26% Similarity=0.388 Sum_probs=190.8
Q ss_pred eecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.+.++|.+.+.||+|+||.||++.... +..||+|++.... .+...+|+ .+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEI-EIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 456789999999999999999997654 7899999996532 23344454 478999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++.. ...+++.++++++.|++.||+|||+.
T Consensus 85 ~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (277)
T 3f3z_A 85 ME----------LCTGGELFERVVH-----------------------------KRVFRESDAARIMKDVLSAVAYCHKL 125 (277)
T ss_dssp EE----------CCCSCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------ccCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 6667777776643 24578889999999999999999999
Q ss_pred CccccCCCCCcEEE---ecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 626 ~IiHrDLKp~NILL---~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+|+||||||+||++ +.++ .+||+|||++....... ......||+.|+|||++.+. ++.++||||||+++|
T Consensus 126 ~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~ 198 (277)
T 3f3z_A 126 NVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGK----MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMY 198 (277)
T ss_dssp TEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHH
T ss_pred CccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCcc----chhccCCCCCccChHHhccc-CCchhhehhHHHHHH
Confidence 99999999999999 4444 59999999998765432 22345689999999988654 899999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHHHccCccccc----CCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESF-ERDANIVKDRKDLFLV----EHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~-~~~~~~i~~~~~~~~~----~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||.... ......+.......+. .+++++.+||.+||+.||++|
T Consensus 199 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (277)
T 3f3z_A 199 VLLCG-YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQR 253 (277)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhC
Confidence 99998 66776653 3344444444444433 678999999999999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=334.71 Aligned_cols=238 Identities=23% Similarity=0.382 Sum_probs=181.6
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCC--CceeeecccccCCceE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQH--PNIVRWYGVESDQDFV 542 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~H--pNIV~L~g~~~~~~~~ 542 (753)
..++.|.+.+.||+|+||.||++...+++.||||++..... +...+|+. ++..++| +||+++++++.+.+..
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHH-HHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34678999999999999999999888899999999975432 23344554 6677766 9999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++|||++. |+|.+++.. ...+++.++..++.||+.||.||
T Consensus 85 ~lv~e~~~-----------~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~al~~l 124 (343)
T 3dbq_A 85 YMVMECGN-----------IDLNSWLKK-----------------------------KKSIDPWERKSYWKNMLEAVHTI 124 (343)
T ss_dssp EEEECCCS-----------EEHHHHHHH-----------------------------SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCC-----------CCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999443 455555432 24577888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----------CCCCch
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRA 691 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~k 691 (753)
|+.+|+||||||+|||++ ++ .+||+|||+++........ ......+||+.|+|||++.+ ..++.+
T Consensus 125 H~~~iiHrDikp~NIll~-~~--~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 200 (343)
T 3dbq_A 125 HQHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 200 (343)
T ss_dssp HHTTCCCCCCCGGGEEEE-TT--EEEECCCSSSCCC-------------CCCCSSCCHHHHHHCC-----------CCHH
T ss_pred HhCCeecCCCCcceEEEE-CC--cEEEeecccccccCccccc-ccCCCCcCCcCcCCHHHHhhccccccccccccCCCch
Confidence 999999999999999996 33 4999999999876543211 12234569999999999865 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERD--ANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~--~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||++| .+||....... ...+. .....++...++++.+||.+||+.||++|
T Consensus 201 ~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~R 265 (343)
T 3dbq_A 201 SDVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 265 (343)
T ss_dssp HHHHHHHHHHHHHHHS-SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred hhHHHHHHHHHHHHhC-CCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999998 67886643322 22222 22334556677899999999999999998
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=329.04 Aligned_cols=240 Identities=20% Similarity=0.306 Sum_probs=194.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
..+.+.|.+.+.||+|+||.||++... +|+.||||.+.... .+...+|+. +++.++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS-ILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHH-HHHhCCCCCcceEEEEEec
Confidence 456678999999999999999999765 58999999996532 123445554 7899999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+++|+|.+++.. ...+++..++.++.|++.|
T Consensus 87 ~~~~~lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~a 127 (321)
T 2a2a_A 87 RTDVVLILE----------LVSGGELFDFLAQ-----------------------------KESLSEEEATSFIKQILDG 127 (321)
T ss_dssp SSEEEEEEC----------CCCSCBHHHHHHT-----------------------------CSCEEHHHHHHHHHHHHHH
T ss_pred CCEEEEEEE----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHH
Confidence 999999999 6667788877743 2346778889999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCC--CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~--~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
|+|||+.+|+||||||+||+++.++. ..+||+|||+++...... ......||+.|+|||++.+..++.++||||
T Consensus 128 L~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 203 (321)
T 2a2a_A 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 203 (321)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC----CCCCCCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred HHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc----cccccCCCCCccCcccccCCCCCCccccHH
Confidence 99999999999999999999977652 159999999998775432 223456899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESF-ERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||++| ..||.... ......+....... +..+++++.+||.+||..||++|
T Consensus 204 lG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 264 (321)
T 2a2a_A 204 IGVITYILLSG-ASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKR 264 (321)
T ss_dssp HHHHHHHHHHS-CCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTS
T ss_pred HHHHHHHHHHC-CCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhC
Confidence 99999999999 56775543 33334444333322 35678999999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.14 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=181.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--------chHHHHHHHH--HHHhCCCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--------HDVALKEIQN--LIASDQHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--------~~~~~~Ei~~--ll~~l~HpNIV~L~g~~~ 537 (753)
..+.++|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+.. .+..++||||++++++|.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 44567899999999999999999976 568999999986322 2344555542 234456999999999987
Q ss_pred CCc-----eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHH
Q 004442 538 DQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612 (753)
Q Consensus 538 ~~~-----~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia 612 (753)
+.. ..++|||+|.+ +|.+++... ....+++.+++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-----------~L~~~~~~~---------------------------~~~~~~~~~~~~i~ 126 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQ-----------DLRTYLDKA---------------------------PPPGLPAETIKDLM 126 (308)
T ss_dssp ECCSSSEEEEEEEEECCCC-----------BHHHHHHTC---------------------------CTTCSCHHHHHHHH
T ss_pred ccCCCCceeEEEEehhhhc-----------CHHHHHhhc---------------------------cCCCCCHHHHHHHH
Confidence 654 58999996554 455544321 12348889999999
Q ss_pred HHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchh
Q 004442 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 692 (753)
Q Consensus 613 ~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ks 692 (753)
.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++
T Consensus 127 ~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~ 200 (308)
T 3g33_A 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQ----MALTPVVVTLWYRAPEVLLQSTYATPV 200 (308)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTC----CCSGGGGCCCSSCCHHHHHTSCCCSTH
T ss_pred HHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCC----cccCCccccccccCchHHcCCCCCchH
Confidence 99999999999999999999999999977765 999999999866432 222345689999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHccC---------------------------cccccCCCHHHHHHHHH
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFER-DANIVKDRK---------------------------DLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~---------------------------~~~~~~~s~el~dLI~~ 744 (753)
|||||||++|||++| .+||...... ....+.... ......+++++.+||.+
T Consensus 201 DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 279 (308)
T 3g33_A 201 DMWSVGCIFAEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE 279 (308)
T ss_dssp HHHHHHHHHHHTTTS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHH
Confidence 999999999999998 6677655332 222222110 00123577899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 280 ~L~~dP~~R 288 (308)
T 3g33_A 280 MLTFNPHKR 288 (308)
T ss_dssp HTCSSTTTS
T ss_pred HhcCCCccC
Confidence 999999998
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=358.10 Aligned_cols=239 Identities=26% Similarity=0.390 Sum_probs=199.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----Cc-hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
...++|.+.+.||+|+||.||++... +|+.||||++.+. .. ....+|+. +++.++|||||++++++.+.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHH-HHHHcCCCCEeeEEEEEeeCCEE
Confidence 34577999999999999999998765 6999999999642 12 23345554 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+++|+|.+++.... ...+++..++.++.||+.||+||
T Consensus 260 ~lVmE----------y~~gg~L~~~l~~~~---------------------------~~~l~e~~~~~i~~qIl~aL~yL 302 (576)
T 2acx_A 260 CLVLT----------LMNGGDLKFHIYHMG---------------------------QAGFPEARAVFYAAEICCGLEDL 302 (576)
T ss_dssp EEEEC----------CCCSCBHHHHHHSSS---------------------------SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------cCCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 777888888775321 23488899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|
T Consensus 303 H~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~----~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvily 376 (576)
T 2acx_A 303 HRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLY 376 (576)
T ss_dssp HHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTC----CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHH
T ss_pred HHCCEeccCCchheEEEeCCCC--eEEEecccceecccCc----cccccCCCccccCHHHHcCCCCCccchHHHHHHHHH
Confidence 9999999999999999977765 9999999998875432 123457999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||... .......+......++..+++++.+||++||.+||++|
T Consensus 377 eLltG-~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R 431 (576)
T 2acx_A 377 EMIAG-QSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431 (576)
T ss_dssp HHHHS-SCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhC-CCCCcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHc
Confidence 99998 6677654 23344555556666778899999999999999999998
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.83 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=190.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.++|.+.+.||+|+||+||++... +++.||||++.... .....+|+..+....+||||+++++++.+.+..+
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 34577999999999999999999775 69999999997532 2345566664433349999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.+++..... ....+++..+++++.||+.||+|||
T Consensus 88 lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~qi~~al~~lH 132 (289)
T 1x8b_A 88 IQNE----------YCNGGSLADAISENYR-------------------------IMSYFKEAELKDLLLQVGRGLRYIH 132 (289)
T ss_dssp EEEE----------CCTTCBHHHHHHHHHH-------------------------HTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ecCCCcHHHHHHhhcc-------------------------cccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6677888888765321 1246888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCC-----------------CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC
Q 004442 624 EIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG 686 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~-----------------~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 686 (753)
+.+|+||||||+||+++.++ ...+||+|||++...... ....||+.|+|||++.+.
T Consensus 133 ~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN 205 (289)
T ss_dssp HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC
T ss_pred hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC
Confidence 99999999999999997543 346899999999876532 223589999999999876
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 687 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 687 -~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++.++|||||||++|||++|.. |+... ..............+..+++++.+||.+||+.||++|
T Consensus 206 ~~~~~~~Di~slG~il~~l~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 206 YTHLPKADIFALALTVVCAAGAEP-LPRNG-DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp CTTHHHHHHHHHHHHHHHHTTCCC-CCSSS-HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCchhhHHHHHHHHHHHhcCCC-CCcch-hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccC
Confidence 56789999999999999999844 44333 2222333344455677889999999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.31 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=194.8
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.++|.+.+.||+|+||.||++...+++.||||++.... .+...+|+. +++.++||||+++++++.+++..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYGVCLEQAPICLVTE-- 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSCEEEEC--
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCCeEEEEe--
Confidence 35788999999999999999988889999999997653 234445554 7899999999999999999999999999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.+++... ...+++..+++++.|++.||+|||+.+|+|
T Consensus 84 --------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 127 (267)
T 3t9t_A 84 --------FMEHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIH 127 (267)
T ss_dssp --------CCTTCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --------CCCCCcHHHHHhhC----------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 67778888877532 134778889999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. +||+|||+++..... .........++..|+|||++.+..++.++||||||+++|||++++.
T Consensus 128 ~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~ 203 (267)
T 3t9t_A 128 RDLAARNCLVGENQV--IKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203 (267)
T ss_dssp SSCCGGGEEECGGGC--EEECCTTGGGGBCCH--HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCchheEEECCCCC--EEEcccccccccccc--cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCC
Confidence 999999999977654 999999999876432 1122233457889999999998999999999999999999999547
Q ss_pred CCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||..... .....+... ....+..+++++.++|.+||+.||++|
T Consensus 204 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 249 (267)
T 3t9t_A 204 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDR 249 (267)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhC
Confidence 88876543 333333333 344566778999999999999999998
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=340.07 Aligned_cols=234 Identities=20% Similarity=0.324 Sum_probs=183.9
Q ss_pred EEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
...+.||+|+||.||++.. .+|+.||||++..... +...+|+ .+++.++||||++++++|.+.+..++|||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~hpnIv~~~~~~~~~~~~~lv~E---- 166 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI-SVMNQLDHANLIQLYDAFESKNDIVLVME---- 166 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEECSSEEEEEEE----
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHH-HHHHhCCCCCCCeEEEEEEECCEEEEEEe----
Confidence 3467899999999999876 4699999999976542 2334454 47899999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+|+|||
T Consensus 167 ------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 212 (373)
T 2x4f_A 167 ------YVDGGELFDRIIDE----------------------------SYNLTELDTILFMKQICEGIRHMHQMYILHLD 212 (373)
T ss_dssp ------CCTTCEEHHHHHHT----------------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ------CCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 66778887777532 12467888899999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+|||+..++...+||+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~p 287 (373)
T 2x4f_A 213 LKPENILCVNRDAKQIKIIDFGLARRYKPRE----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-LSP 287 (373)
T ss_dssp CCGGGEEEEETTTTEEEECCCSSCEECCTTC----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS-SCT
T ss_pred CCHHHEEEecCCCCcEEEEeCCCceecCCcc----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC-CCC
Confidence 9999999976555679999999999875432 22344689999999999999999999999999999999998 567
Q ss_pred CCCCh-HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESF-ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~-~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.... ......+...... ....+++++.+||.+||+.||++|
T Consensus 288 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 334 (373)
T 2x4f_A 288 FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334 (373)
T ss_dssp TCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred CCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhC
Confidence 75543 3333333333322 235678999999999999999998
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.87 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=180.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCC----cEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEG----RSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g----~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
....++|.+.+.||+|+||.||++..... ..||||++.... .+.+.+|+. +++.++||||+++++++.+.
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHH-HHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHH-HHHHCCCCceehhhceeecc
Confidence 34456789999999999999999976543 289999996532 123344554 77889999999999999877
Q ss_pred ceE------EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 540 DFV------YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 540 ~~~------~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
+.. ++||| |+.+|+|.+++...... .....+++.++++++.
T Consensus 98 ~~~~~~~~~~~v~e----------~~~~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~i~~ 144 (323)
T 3qup_A 98 RAKGRLPIPMVILP----------FMKHGDLHAFLLASRIG-----------------------ENPFNLPLQTLVRFMV 144 (323)
T ss_dssp -------CEEEEEE----------CCTTCBHHHHHHHHHC--------------------------CCCCCHHHHHHHHH
T ss_pred ccccCCCccEEEEE----------eccCCcHHHHHHhhhcc-----------------------ccccccCHHHHHHHHH
Confidence 665 99999 77788888888654321 1123588999999999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhh
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksD 693 (753)
|++.||+|||+.+|+||||||+|||++.++ .+||+|||+++........ .......+++.|+|||.+.+..++.++|
T Consensus 145 qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (323)
T 3qup_A 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVADFGLSRKIYSGDYY-RQGCASKLPVKWLALESLADNLYTVHSD 221 (323)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC------------------CCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEeeccccccccccccc-cccccccCcccccCchhhcCCCCCCccc
Confidence 999999999999999999999999997775 4999999999876543211 1222334688999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||++++.+||..... .....+. ......+..+++++.+||.+||+.||++|
T Consensus 222 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 283 (323)
T 3qup_A 222 VWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283 (323)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhC
Confidence 999999999999944788876533 3333333 33455677889999999999999999998
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.58 Aligned_cols=236 Identities=26% Similarity=0.380 Sum_probs=192.6
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+.++..+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467899999999999999999665 47899999986432 12334444458899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++.. ...+++..++.++.|++.||+|||+
T Consensus 87 v~e----------~~~~~~l~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~LH~ 127 (279)
T 3fdn_A 87 ILE----------YAPLGTVYRELQK-----------------------------LSKFDEQRTATYITELANALSYCHS 127 (279)
T ss_dssp EEC----------CCTTEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred EEe----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 6677788777643 2357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++. +||+|||++...... ......||+.|+|||.+.+..++.++||||||+++|||
T Consensus 128 ~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 128 KRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp TTCEECCCCGGGEEECTTSC--EEECSCCEESCC-------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred CCEecccCChHhEEEcCCCC--EEEEeccccccCCcc-----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 99999999999999977765 999999998654332 12344689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| .+||.... ......+......++..+++++.+||.+||+.||++|
T Consensus 201 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 249 (279)
T 3fdn_A 201 LVG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 249 (279)
T ss_dssp HHS-SCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGS
T ss_pred HHC-CCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhC
Confidence 998 66776653 4445555666667778889999999999999999998
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=340.20 Aligned_cols=243 Identities=20% Similarity=0.236 Sum_probs=187.6
Q ss_pred ecceEEEeEEeccc--CceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKG--SNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G--~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+++|++.+.||+| +||+||++... +|+.||||++..... ...+.++..+++.++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45679999999999 99999999776 699999999975431 123333445889999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.... ...+++..+..++.||+.||+|||
T Consensus 103 lv~e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH 145 (389)
T 3gni_B 103 VVTS----------FMAYGSAKDLICTHF---------------------------MDGMNELAIAYILQGVLKALDYIH 145 (389)
T ss_dssp EEEE----------CCTTCBHHHHHHHTC---------------------------TTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ccCCCCHHHHHhhhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 777888888875421 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc----ccccCccCCCCccccccccccC--CCCCchhhHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSL 697 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~--~~~t~ksDIwSf 697 (753)
+.+|+||||||+|||++.++. +||+|||++........ ........+||+.|+|||++.+ ..++.++|||||
T Consensus 146 ~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 223 (389)
T 3gni_B 146 HMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 223 (389)
T ss_dssp HTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHH
Confidence 999999999999999977764 99999999876532211 1112233468999999999987 578999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH-HHHHHHcc----------------------------------------------Cccc
Q 004442 698 GCILFFCITGGKHPYGESFER-DANIVKDR----------------------------------------------KDLF 730 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~-~~~~i~~~----------------------------------------------~~~~ 730 (753)
||++|||++| .+||.+.... ........ ....
T Consensus 224 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (389)
T 3gni_B 224 GITACELANG-HVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302 (389)
T ss_dssp HHHHHHHHHS-SCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence 9999999998 6677553221 11110000 1123
Q ss_pred ccCCCHHHHHHHHHccccCcCCC
Q 004442 731 LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 731 ~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+..+++++.+||++||+.||++|
T Consensus 303 ~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 303 HRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp ---CCHHHHHHHHHHTCSCTTTS
T ss_pred ccccCHHHHHHHHHHhhcCcccC
Confidence 45678899999999999999998
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.47 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=187.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCc--e
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD--F 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--~ 541 (753)
....++|.+.+.||+|+||+||++.... |+.||||++.... .+...+|+. +++.++||||+++++++.+.+ .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE-VLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECTTTCC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHH-HHHhcCCCCcceEEEEeecCCCce
Confidence 3456789999999999999999997754 8999999997532 233445554 789999999999999987654 7
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++.... ....+++.+++.++.||+.||+|
T Consensus 84 ~~lv~e----------~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~i~~qi~~~L~~ 127 (319)
T 4euu_A 84 KVLIME----------FCPCGSLYTVLEEPS--------------------------NAYGLPESEFLIVLRDVVGGMNH 127 (319)
T ss_dssp EEEEEE----------CCTTCBHHHHHHSGG--------------------------GTTCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------CCCCCCHHHHHHHhc--------------------------cccCCCHHHHHHHHHHHHHHHHH
Confidence 899999 777788888876432 12348889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEe--cCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc--------CCCCCch
Q 004442 622 LHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--------QGRQTRA 691 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~--~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~--------~~~~t~k 691 (753)
||+.+|+||||||+|||+. .++...+||+|||+++...... ......||+.|+|||++. +..++.+
T Consensus 128 LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 203 (319)
T 4euu_A 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203 (319)
T ss_dssp HHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT
T ss_pred HHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC----ceeecccCCCccCHHHhhhccccccccCCCCcH
Confidence 9999999999999999982 2333569999999998875432 223456899999999986 5778999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHccCc-------------------------ccccCCCHHHHHH
Q 004442 692 IDLFSLGCILFFCITGGKHPYGES-----FERDANIVKDRKD-------------------------LFLVEHIPEAVDL 741 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~-----~~~~~~~i~~~~~-------------------------~~~~~~s~el~dL 741 (753)
+|||||||++|||+|| .+||... .......+....+ .....+++.+.+|
T Consensus 204 ~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 282 (319)
T 4euu_A 204 VDLWSIGVTFYHAATG-SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (319)
T ss_dssp HHHHHHHHHHHHHHHS-SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhC-CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHH
Confidence 9999999999999998 6677532 1222222222221 1112234578899
Q ss_pred HHHccccCcCCC
Q 004442 742 FTRLLDPNPDLR 753 (753)
Q Consensus 742 I~~cL~~DP~~R 753 (753)
|++||+.||++|
T Consensus 283 l~~~L~~dP~~R 294 (319)
T 4euu_A 283 LANILEADQEKC 294 (319)
T ss_dssp HHHHSCCCTTTS
T ss_pred HHHhccCChhhh
Confidence 999999999998
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.88 Aligned_cols=240 Identities=28% Similarity=0.360 Sum_probs=172.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCC-CCceeeecccccCC--
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQ-HPNIVRWYGVESDQ-- 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~~-- 539 (753)
+.+.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....++|+. ++..+. |+||+++++++...
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~-~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIM-ILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHH-HHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHH-HHHhccCCCCCCeeeeEEecCCC
Confidence 34567899999999999999999965 468999999986432 234456666 556665 99999999998654
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...|+|||||.++| .+++. ...+++..+..++.||+.||
T Consensus 84 ~~~~lv~e~~~~~L-----------~~~~~------------------------------~~~~~~~~~~~i~~qi~~~L 122 (388)
T 3oz6_A 84 RDVYLVFDYMETDL-----------HAVIR------------------------------ANILEPVHKQYVVYQLIKVI 122 (388)
T ss_dssp SCEEEEEECCSEEH-----------HHHHH------------------------------HTCCCHHHHHHHHHHHHHHH
T ss_pred CEEEEEecccCcCH-----------HHHHH------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 47899999665444 44332 13467778899999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc------------------ccccCccCCCCccccccc
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------------CLTQNATGYGSSGWQAPE 681 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~------------------~~~~~~~~~GT~~Y~APE 681 (753)
+|||+.+|+||||||+|||++.++ .+||+|||+++....... ........+||+.|+|||
T Consensus 123 ~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (388)
T 3oz6_A 123 KYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPE 200 (388)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHH
T ss_pred HHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHH
Confidence 999999999999999999997765 499999999987643110 111223457999999999
Q ss_pred cccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHccC-c------------------------------
Q 004442 682 QLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDRK-D------------------------------ 728 (753)
Q Consensus 682 ~l~~-~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~-~------------------------------ 728 (753)
++.+ ..++.++|||||||++|||++| ++||.+.. ......+.... .
T Consensus 201 ~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (388)
T 3oz6_A 201 ILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279 (388)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC----
T ss_pred HhcCCCCCCChhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCC
Confidence 9987 6789999999999999999998 66775543 22222221100 0
Q ss_pred ----------------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 729 ----------------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 729 ----------------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
......++++.+||++||..||++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp -CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred CHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 0112668899999999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=324.81 Aligned_cols=244 Identities=17% Similarity=0.220 Sum_probs=192.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhC-CCCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV 545 (753)
..+.++|.+.+.||+|+||.||++.. .+|+.||||++..... ....+|+. .+..+ +|+||+++++++.+....++|
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~-~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR-TYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHH-HHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHH-HHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 45678899999999999999999975 5699999999975443 34555665 55555 899999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+ +|+|.+++... ...+++.++++++.||+.||+|||+.
T Consensus 85 ~e----------~~-~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~ 125 (298)
T 1csn_A 85 ID----------LL-GPSLEDLLDLC----------------------------GRKFSVKTVAMAAKQMLARVQSIHEK 125 (298)
T ss_dssp EE----------CC-CCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EE----------ec-CCCHHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 55 56666666432 23578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCC---CeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~---~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
+|+||||||+||+++.++. ..+||+|||+++......... .......||+.|+|||++.+..++.++||||||
T Consensus 126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 9999999999999976542 349999999999876532211 123455699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC----hHHHHHHHHcc-----CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGES----FERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~----~~~~~~~i~~~-----~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++| .+||... .......+... .......+++++.++|.+||+.||++|
T Consensus 206 ~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 268 (298)
T 1csn_A 206 HVFMYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 268 (298)
T ss_dssp HHHHHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HHHHHHHcC-CCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccC
Confidence 999999998 6787653 22222222111 112334688999999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.24 Aligned_cols=239 Identities=24% Similarity=0.349 Sum_probs=195.3
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
...++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.++..+++.++|+||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34578999999999999999999776 48899999986532 1222333334789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++.+++.++.|++.||+|||
T Consensus 92 lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~lH 132 (294)
T 2rku_A 92 VVLE----------LCRRRSLLELHKR-----------------------------RKALTEPEARYYLRQIVLGCQYLH 132 (294)
T ss_dssp EEEE----------CCTTCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6666777776532 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++. +||+|||++........ ......||+.|+|||++.+..++.++||||||+++||
T Consensus 133 ~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 207 (294)
T 2rku_A 133 RNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207 (294)
T ss_dssp HTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHH
T ss_pred HCCccccCCChHhEEEcCCCC--EEEEeccCceecccCcc---ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999977654 99999999987653221 2234568999999999999889999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||.... ......+.......+..+++++.++|++||+.||++|
T Consensus 208 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 208 LLVG-KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhC-CCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhC
Confidence 9998 66776653 3344445555666777889999999999999999998
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.88 Aligned_cols=271 Identities=21% Similarity=0.282 Sum_probs=193.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~ 537 (753)
....++|.+.+.||+|+||.||++.. .+++.||||++..... +.+.+|+. ++..+ +||||++++++|.
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK-ILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHH-HHHhhcCCcceeeeeeeee
Confidence 34567899999999999999999963 3468999999976442 23455665 55555 8999999999988
Q ss_pred CCc-eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhh------------------hhc-------------
Q 004442 538 DQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR------------------IRL------------- 585 (753)
Q Consensus 538 ~~~-~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~------------------~~~------------- 585 (753)
+.+ ..++||| |+.+|+|.++++............. .++
T Consensus 97 ~~~~~~~iv~e----------~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (359)
T 3vhe_A 97 KPGGPLMVIVE----------FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG 166 (359)
T ss_dssp STTSCCEEEEE----------CCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred cCCCceEEEEE----------ecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence 754 4899999 6667777777765432110000000 000
Q ss_pred ------ccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 586 ------LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 586 ------~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
.................+++..+++++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIY 244 (359)
T ss_dssp -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTT
T ss_pred cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeec
Confidence 0000000001111233489999999999999999999999999999999999997665 49999999998764
Q ss_pred CCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH-HccCcccccCCCH
Q 004442 660 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIV-KDRKDLFLVEHIP 736 (753)
Q Consensus 660 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i-~~~~~~~~~~~s~ 736 (753)
..... .......||+.|+|||++.+..++.++|||||||++|||+|++.+||.... ......+ .......+..+++
T Consensus 245 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (359)
T 3vhe_A 245 KDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP 323 (359)
T ss_dssp SCTTC-EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCH
T ss_pred ccccc-hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCH
Confidence 43221 223344578999999999999999999999999999999993377886642 2222233 3334556677899
Q ss_pred HHHHHHHHccccCcCCC
Q 004442 737 EAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 737 el~dLI~~cL~~DP~~R 753 (753)
++.++|.+||+.||++|
T Consensus 324 ~l~~li~~~l~~dP~~R 340 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQR 340 (359)
T ss_dssp HHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHccCChhhC
Confidence 99999999999999998
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=329.53 Aligned_cols=240 Identities=26% Similarity=0.369 Sum_probs=173.5
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.+|++.+.||+|+||.||+|... +|+.||||++.... .....+|+. +++.++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS-LMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHH-HHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHH-HHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46888899999999999999765 58999999996432 234555665 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.+ +|.+++...... .....+++..+..++.||+.||+|||+.+|
T Consensus 84 ~~~~-----------~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i 129 (317)
T 2pmi_A 84 FMDN-----------DLKKYMDSRTVG-----------------------NTPRGLELNLVKYFQWQLLQGLAFCHENKI 129 (317)
T ss_dssp CCCC-----------BHHHHHHHHHSS-----------------------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ecCC-----------CHHHHHHhcccc-----------------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6654 444444332210 112457888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||+|
T Consensus 130 vH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 204 (317)
T 2pmi_A 130 LHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPV---NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204 (317)
T ss_dssp ECCCCCGGGEEECTTCC--EEECCCSSCEETTSCC---CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred eeCCCChHHeEEcCCCC--EEECcCccceecCCCc---ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 9999999998765322 122344689999999999764 58999999999999999999
Q ss_pred CCCCCCCCChHH-HHHHHHcc----------------------------------CcccccCCCHHHHHHHHHccccCcC
Q 004442 707 GGKHPYGESFER-DANIVKDR----------------------------------KDLFLVEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 707 G~~~Pf~~~~~~-~~~~i~~~----------------------------------~~~~~~~~s~el~dLI~~cL~~DP~ 751 (753)
| .+||...... ....+... .......+++++.+||.+||+.||+
T Consensus 205 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 283 (317)
T 2pmi_A 205 G-KPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283 (317)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGG
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcc
Confidence 9 6677665332 22222110 0011235678999999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 284 ~R 285 (317)
T 2pmi_A 284 MR 285 (317)
T ss_dssp GS
T ss_pred cC
Confidence 98
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=330.24 Aligned_cols=237 Identities=25% Similarity=0.364 Sum_probs=195.1
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..++|.+.+.||+|+||.||++...+ ++.||+|++.... . +...+|+ .+++.++|+||+++++++.+.+..+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEI-SIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEecCCeEE
Confidence 35679999999999999999997654 8899999986542 1 2233444 4789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++.+++.++.||+.||+|||
T Consensus 118 lv~e----------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~LH 158 (335)
T 2owb_A 118 VVLE----------LCRRRSLLELHKR-----------------------------RKALTEPEARYYLRQIVLGCQYLH 158 (335)
T ss_dssp EEEC----------CCTTCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------cCCCCCHHHHHhc-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6666777776532 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++. +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 159 ~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 233 (335)
T 2owb_A 159 RNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGE---RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233 (335)
T ss_dssp HTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTC---CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHH
T ss_pred HCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcc---cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999977754 99999999987653221 2234568999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||.... ......+.......+..+++++.+||++||+.||++|
T Consensus 234 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 234 LLVG-KPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp HHHS-SCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHC-cCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHC
Confidence 9998 66776653 3444445555666777889999999999999999998
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.99 Aligned_cols=243 Identities=19% Similarity=0.242 Sum_probs=188.4
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++++|.+.+.||+|+||.||++.. .+|+.||||.+..... ....+|+. +++.+ +|+||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYR-FYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHH-HHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHH-HHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 4567899999999999999999975 5699999999975443 34556665 66777 9999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+ +|+|.+++... ...+++..++.|+.|++.||+|||+.+
T Consensus 85 e----------~~-~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 85 E----------LL-GPSLEDLFDLC----------------------------DRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp E----------CC-CCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------eC-CCCHHHHHHHc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 55 56666665421 245788999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCC---CeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~---~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|+||||||+|||++.++. ..+||+|||+++......... .......||+.|+|||++.+..++.++|||||||
T Consensus 126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 205 (330)
T 2izr_A 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGH 205 (330)
T ss_dssp EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHH
Confidence 999999999999976543 239999999999765432211 1224567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh----HHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESF----ERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~----~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++| .+||.... ......+.......+ ....+++.++|.+||+.||++|
T Consensus 206 il~ell~g-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~R 266 (330)
T 2izr_A 206 MFMYFLRG-SLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEK 266 (330)
T ss_dssp HHHHHHHS-SCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCC
T ss_pred HHHHHhcC-CCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCC
Confidence 99999998 67886532 122222222222211 1223499999999999999998
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=350.00 Aligned_cols=238 Identities=25% Similarity=0.374 Sum_probs=198.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
....+.|.+.+.||+|+||.||+|... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ-NLKLFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCE
Confidence 444567999999999999999999765 69999999996432 123445554 7799999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+++|+|.+++.. ...+++..+..++.||+.||+|
T Consensus 91 ~~lv~E----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~aL~~ 131 (476)
T 2y94_A 91 IFMVME----------YVSGGELFDYICK-----------------------------NGRLDEKESRRLFQQILSGVDY 131 (476)
T ss_dssp EEEEEE----------CCSSEEHHHHTTS-----------------------------SSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 6667888877642 2357888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvv 700 (753)
||+.+|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..+ +.++|||||||+
T Consensus 132 LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi 205 (476)
T 2y94_A 132 CHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDG----EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVI 205 (476)
T ss_dssp HHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTT----CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHH
T ss_pred HHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccc----ccccccCCCcCeEChhhccCCCCCCCcceehhhHHH
Confidence 99999999999999999977765 999999999876542 12345579999999999988776 789999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| .+||.+. .......+.......+..+++++.+||++||+.||++|
T Consensus 206 l~elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~R 258 (476)
T 2y94_A 206 LYALLCG-TLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKR 258 (476)
T ss_dssp HHHHHHS-SCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhC-CCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhC
Confidence 9999998 6677654 44555666666667778889999999999999999998
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.15 Aligned_cols=267 Identities=21% Similarity=0.269 Sum_probs=195.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
....++|.+.+.||+|+||.||++... +++.||||+++..... ..+..+..+++.++||||++++++|.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344577899999999999999999775 3489999999765432 2233334478999999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.+++............. ... .............+++.++++++.||+.||
T Consensus 123 ~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l 187 (343)
T 1luf_A 123 KPMCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSH----SDL-STRARVSSPGPPPLSCAEQLCIARQVAAGM 187 (343)
T ss_dssp SSCEEEEE----------CCTTCBHHHHHHHTCC---------------------------CCCCHHHHHHHHHHHHHHH
T ss_pred CceEEEEe----------cCCCCcHHHHHHHhCccccccccc----ccc-cccccccccCCCCCCHHHHHHHHHHHHHHH
Confidence 99999999 666778888776532211000000 000 000000001135789999999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.|||+.+|+||||||+|||++.++ .+||+|||+++...... .........+|+.|+|||++.+..++.++|||||||
T Consensus 188 ~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~ 264 (343)
T 1luf_A 188 AYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264 (343)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGG--CEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHHhCCeecCCCCcceEEECCCC--eEEEeecCCCcccccCc-cccccCCCcccceecChhhhccCCcCcccccHHHHH
Confidence 999999999999999999997765 49999999998764321 111223445789999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|++..||.+... .....+... ....+..+++++.++|++||+.||++|
T Consensus 265 il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 265 VLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 999999933667765533 333333333 334667889999999999999999998
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.44 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=181.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
....++|.+.+.||+|+||.||+|.... +..||||++...... ...+|+ .+++.++||||+++++++. ++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVIT-EN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEC-SS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCccceEEEEEc-cC
Confidence 3445789999999999999999987643 567999998754322 233444 4788999999999999985 45
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++... ...+++..++.++.|++.||.
T Consensus 89 ~~~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~ 130 (281)
T 1mp8_A 89 PVWIIME----------LCTLGELRSFLQVR----------------------------KYSLDLASLILYAYQLSTALA 130 (281)
T ss_dssp SCEEEEE----------CCTTEEHHHHHHHT----------------------------TTTSCHHHHHHHHHHHHHHHH
T ss_pred ccEEEEe----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 7899999 66677888877532 235788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+
T Consensus 131 ~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (281)
T 1mp8_A 131 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 206 (281)
T ss_dssp HHHHTTCCCSCCSGGGEEEEETTE--EEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred HHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccc--cccccCCCcccccChhhcccCCCCCccCchHHHHH
Confidence 999999999999999999987764 99999999987654321 12223346889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++.+||..... .....+.. .....+..+++++.++|.+||+.||++|
T Consensus 207 l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 261 (281)
T 1mp8_A 207 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 261 (281)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999844778876533 33333333 3445677889999999999999999998
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=333.08 Aligned_cols=234 Identities=24% Similarity=0.346 Sum_probs=184.9
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
...+.|...+.||+|+||+||+|.. .+|+.||||++..... +...+|+. +++.++||||++++++|.+++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~ 129 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTA 129 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCeE
Confidence 3446689999999999999999975 5699999999965321 12344554 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++|||||.+++ .+++.. ....+++..+..++.|+++||+||
T Consensus 130 ~lv~e~~~g~l-----------~~~l~~----------------------------~~~~l~~~~~~~i~~qi~~aL~~L 170 (348)
T 1u5q_A 130 WLVMEYCLGSA-----------SDLLEV----------------------------HKKPLQEVEIAAVTHGALQGLAYL 170 (348)
T ss_dssp EEEEECCSEEH-----------HHHHHH----------------------------HTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCCCH-----------HHHHHH----------------------------hcCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665444 443321 124578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGC 699 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGv 699 (753)
|+.+|+||||||+|||++.++ .+||+|||+++..... ....||+.|+|||++. ...++.++|||||||
T Consensus 171 H~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~ 241 (348)
T 1u5q_A 171 HSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241 (348)
T ss_dssp HHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHH
T ss_pred HhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCCC-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHH
Confidence 999999999999999998775 5999999999865431 2346899999999985 567899999999999
Q ss_pred HHHHHHhCCCCCCCCC-hHHHHHHHHc-cCc-ccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGES-FERDANIVKD-RKD-LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~-~~~~~~~i~~-~~~-~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++| .+||... .......+.. ... .....+++++.+||.+||+.||++|
T Consensus 242 il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 297 (348)
T 1u5q_A 242 TCIELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297 (348)
T ss_dssp HHHHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 99999999 5566544 3333322322 222 2345678999999999999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=347.70 Aligned_cols=241 Identities=24% Similarity=0.363 Sum_probs=190.8
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
...+.|.+.+.||+|+||.||+|...++..||||+++... .+.+.+|+. +++.++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456789999999999999999988888899999997543 234445554 8899999999999999876 67899999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.++|.... ...+++.++++++.||+.||+|||+++|
T Consensus 259 ----------~~~~gsL~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i 301 (452)
T 1fmk_A 259 ----------YMSKGSLLDFLKGET---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNY 301 (452)
T ss_dssp ----------CCTTCBHHHHHSHHH---------------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ----------hhcCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 778889999886432 2357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++ .+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+|+
T Consensus 302 vHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 302 VHRDLRAANILVGENL--VCKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp CCSCCSGGGEEECGGG--CEEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCChhhEEECCCC--CEEECCCccceecCCCce--ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 9999999999997665 499999999987653211 122233468899999999999999999999999999999994
Q ss_pred CCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+.+||.+... .....+... ..+.+..+++++.+||.+||+.||++|
T Consensus 378 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 425 (452)
T 1fmk_A 378 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 425 (452)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 4788876543 333333333 345567889999999999999999998
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.72 Aligned_cols=242 Identities=23% Similarity=0.428 Sum_probs=188.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.+.+.|.+.+.||+|+||.||++... +++.||||++.... . +...+|+. +++.++||||+++++++.+.+..++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIE-VLKSLDHPNIIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHH-HHHhCCCchHHhHHHheecCCeEEE
Confidence 45578999999999999999998764 58999999996543 1 33445554 7899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++.... .....+++..+++++.|++.||+|||+
T Consensus 98 v~e----------~~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 98 VME----------TCEGGELLERIVSAQ-------------------------ARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp EEC----------CCSCCBHHHHHHHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eCCCCcHHHHHHhhh-------------------------hcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 667788888775432 123568889999999999999999999
Q ss_pred CCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+|+||||||+||+++.+ ....+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++||
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ 217 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE----HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYF 217 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHH
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc----cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHH
Confidence 999999999999999542 23459999999998765321 223456899999999875 568999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHHccCccc---ccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER-DANIVKDRKDLF---LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~~i~~~~~~~---~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||...... ............ ...+++++.+||.+||+.||++|
T Consensus 218 ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 270 (285)
T 3is5_A 218 LLTG-CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERR 270 (285)
T ss_dssp HHHS-SCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTS
T ss_pred HHhC-CCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhC
Confidence 9998 6677665433 333333332222 23468999999999999999998
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.13 Aligned_cols=266 Identities=26% Similarity=0.336 Sum_probs=197.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
+...++|.+.+.||+|+||.||++.. .+++.||||++...... ...+|+ .+++.++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHH-HHHhhCCCCceeeEEEEEec
Confidence 34467899999999999999999975 34589999999764432 233444 47789999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+.+|+|.+++............ .................+++.++++++.||+.|
T Consensus 98 ~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 162 (314)
T 2ivs_A 98 DGPLLLIVE----------YAKYGSLRGFLRESRKVGPGYLG-----SGGSRNSSSLDHPDERALTMGDLISFAWQISQG 162 (314)
T ss_dssp SSSCEEEEE----------CCTTCBHHHHHHHTTTSTTEEC---------------------CEECHHHHHHHHHHHHHH
T ss_pred CCceEEEEe----------ecCCCCHHHHHHHHhhccCCccc-----ccccccccccccccccCcCHHHHHHHHHHHHHH
Confidence 999999999 66678888887654321100000 000000001111223458899999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+||+++.++ .+||+|||+++........ .......+|+.|+|||++.+..++.++||||||
T Consensus 163 l~~lH~~~ivH~dikp~NIli~~~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 239 (314)
T 2ivs_A 163 MQYLAEMKLVHRDLAARNILVAEGR--KMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG 239 (314)
T ss_dssp HHHHHHTTEECCCCSGGGEEEETTT--EEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHH
T ss_pred HHHHHHCCCcccccchheEEEcCCC--CEEEccccccccccccccc-eeccCCCCcccccChhhhcCCCcCchhhHHHHH
Confidence 9999999999999999999998775 4999999999877543221 223344578999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|++.+||.... ......+... ....+..+++++.++|.+||+.||++|
T Consensus 240 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 296 (314)
T 2ivs_A 240 VLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKR 296 (314)
T ss_dssp HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999993377886653 3344444433 345667789999999999999999998
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=325.73 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=195.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~ 537 (753)
+...++|.+.+.||+|+||.||++.. .+++.||||++..... +...+|+. +++.+ +||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHH-HHhhcccCCCeeeEEEEEe
Confidence 34457899999999999999999974 3478999999976542 23345554 66777 9999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+.+..++||| |+++|+|.+++........+.. ............+++.++++++.|++.
T Consensus 98 ~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~qi~~ 156 (313)
T 1t46_A 98 IGGPTLVITE----------YCCYGDLLNFLRRKRDSFICSK-----------TSPAIMEDDELALDLEDLLSFSYQVAK 156 (313)
T ss_dssp SSSSCEEEEE----------CCTTEEHHHHHHHTTTTC-------------------------CCCCHHHHHHHHHHHHH
T ss_pred cCCCcEEEEe----------cCCCCCHHHHHHhccccccccc-----------ccccccccccccCCHHHHHHHHHHHHH
Confidence 9999999999 6667778777765432111000 000000112346899999999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+||+++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 157 ~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 233 (313)
T 1t46_A 157 GMAFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233 (313)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHHCCeecCCCccceEEEcCCC--CEEEccccccccccccccc-eeccCCCCcceeeChHHhcCCCCChHHHHHHH
Confidence 99999999999999999999997775 4999999999877543221 12233457889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH--HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFE--RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~--~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|++.+||..... .....+.. .....+..+++++.++|.+||+.||++|
T Consensus 234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 292 (313)
T 1t46_A 234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292 (313)
T ss_dssp HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhC
Confidence 99999999944778866432 22222222 3334466788999999999999999998
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=345.75 Aligned_cols=195 Identities=25% Similarity=0.393 Sum_probs=144.0
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC-----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----- 538 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----- 538 (753)
.+.++|.+.+.||+|+||+||+|... +|+.||||++..... +...+|+. +++.++|+|||++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHH-HHHhCCCCCCCceEEEEecCCccc
Confidence 44578999999999999999999654 689999999965321 23445665 7899999999999999844
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..|+|||+|+++|. +++. ....+++..+..++.||+.|
T Consensus 129 ~~~~~lv~e~~~~~L~-----------~~~~-----------------------------~~~~l~~~~~~~~~~qi~~a 168 (458)
T 3rp9_A 129 FDELYVVLEIADSDFK-----------KLFR-----------------------------TPVYLTELHIKTLLYNLLVG 168 (458)
T ss_dssp CCCEEEEECCCSEEHH-----------HHHH-----------------------------SSCCCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEeccccchh-----------hhcc-----------------------------cCCCCCHHHHHHHHHHHHHH
Confidence 3579999996655444 4332 12457888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc------------------------cccCccCCCC
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------------------LTQNATGYGS 674 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~------------------------~~~~~~~~GT 674 (753)
|+|||+.+|+||||||+||||+.++ .+||+|||+++........ .......+||
T Consensus 169 L~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 246 (458)
T 3rp9_A 169 VKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT 246 (458)
T ss_dssp HHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSCTTCCCCCC---------------------------CC
T ss_pred HHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCccccccccccCccccccccccccccccccccccCCccc
Confidence 9999999999999999999997765 4999999999876532111 0123345789
Q ss_pred ccccccccc-cCCCCCchhhHHHHHHHHHHHHhC
Q 004442 675 SGWQAPEQL-LQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 675 ~~Y~APE~l-~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 247 ~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 247 RWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999999986 456699999999999999999994
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.61 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=196.7
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
....|.+.+.||+|+||.||+|.... +..||||+++... .+.+.+|+. +++.++||||++++++|.+.+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHH-HHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34668899999999999999997765 8999999997543 234445554 8899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.++|+... ...+++..++.|+.||+.||+|||+++|
T Consensus 297 ----------~~~~g~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~i 339 (495)
T 1opk_A 297 ----------FMTYGNLLDYLRECN---------------------------RQEVSAVVLLYMATQISSAMEYLEKKNF 339 (495)
T ss_dssp ----------CCTTCBHHHHHHHSC---------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------ccCCCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 777889988886421 2357788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++ .+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||+|+
T Consensus 340 vHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 340 IHRNLAARNCLVGENH--LVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp ECSCCSGGGEEECGGG--CEEECCTTCEECCTTCC--EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCChhhEEECCCC--cEEEeecccceeccCCc--eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 9999999999997665 49999999999775432 1222334467899999999999999999999999999999995
Q ss_pred CCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+..||..... .....+... ....+..+++++.+||.+||+.||++|
T Consensus 416 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 463 (495)
T 1opk_A 416 GMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 463 (495)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHC
Confidence 4788876543 333333333 344567789999999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.68 Aligned_cols=237 Identities=25% Similarity=0.366 Sum_probs=190.9
Q ss_pred cceEEEeEEecccCceEEEEEEe----eCCcEEEEEEeecC-------CchHHHHHHHHHHHhC-CCCceeeecccccCC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKT-------HHDVALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~----~~g~~VAVK~l~~~-------~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~ 539 (753)
.++|.+.+.||+|+||.||++.. .+|+.||||+++.. ..+...+|+. ++..+ +|+||+++++++.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHH-HHHHHHTCTTBCCEEEEEEET
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHH-HHHHccCCCceeEEEEEEeeC
Confidence 36799999999999999999976 36899999998642 1233445665 55666 799999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.+++... ..+++..+..++.||+.||
T Consensus 132 ~~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~aL 172 (355)
T 1vzo_A 132 TKLHLILD----------YINGGELFTHLSQR-----------------------------ERFTEHEVQIYVGEIVLAL 172 (355)
T ss_dssp TEEEEEEC----------CCCSCBHHHHHHHH-----------------------------SCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEee----------cCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHH
Confidence 99999999 77778888887532 3577888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC--CCCchhhHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSL 697 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDIwSf 697 (753)
.|||+.+|+||||||+|||++.++. +||+|||+++...... .......+||+.|+|||++.+. .++.++|||||
T Consensus 173 ~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 173 EHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADE--TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGG--GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCC--CCcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 9999999999999999999977654 9999999998764321 1222345699999999999863 47899999999
Q ss_pred HHHHHHHHhCCCCCCCCC-----hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGES-----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~-----~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|| ..||... .......+.......+..+++++.+||.+||.+||++|
T Consensus 249 G~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 308 (355)
T 1vzo_A 249 GVLMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 308 (355)
T ss_dssp HHHHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHC-CCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHh
Confidence 9999999998 6677532 22333444455667788899999999999999999998
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=326.18 Aligned_cols=241 Identities=24% Similarity=0.367 Sum_probs=184.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHh--CCCCceeeecccccC----CceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--DQHPNIVRWYGVESD----QDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~--l~HpNIV~L~g~~~~----~~~~ 542 (753)
+.+.++|.+.+.||+|+||+||+|.. +|+.||||++.........+|.+ ++.. ++||||+++++++.+ ....
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~-~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETE-LYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHH-HHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccchhhHHHHH-HHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 45667899999999999999999876 79999999998766555556655 3344 799999999998654 4568
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.++++. ..+++..+++++.|++.||+||
T Consensus 82 ~lv~e----------~~~~g~L~~~l~~------------------------------~~~~~~~~~~i~~~i~~~l~~l 121 (301)
T 3q4u_A 82 WLITH----------YHEMGSLYDYLQL------------------------------TTLDTVSCLRIVLSIASGLAHL 121 (301)
T ss_dssp EEEEC----------CCTTCBHHHHHTT------------------------------CCBCHHHHHHHHHHHHHHHHHH
T ss_pred EEehh----------hccCCCHHHHHhh------------------------------cccCHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888888732 3477888999999999999999
Q ss_pred h--------hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCC------C
Q 004442 623 H--------EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG------R 687 (753)
Q Consensus 623 H--------~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~------~ 687 (753)
| +.+|+||||||+|||++.++ .+||+|||+++......... .......||+.|+|||++.+. .
T Consensus 122 H~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 199 (301)
T 3q4u_A 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199 (301)
T ss_dssp HSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHH
T ss_pred HHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCccc
Confidence 9 89999999999999997765 49999999998765433221 122344799999999999877 4
Q ss_pred CCchhhHHHHHHHHHHHHhCC---------CCCCCCC------hHHHHHHHHc--cCcccc-----cCCCHHHHHHHHHc
Q 004442 688 QTRAIDLFSLGCILFFCITGG---------KHPYGES------FERDANIVKD--RKDLFL-----VEHIPEAVDLFTRL 745 (753)
Q Consensus 688 ~t~ksDIwSfGvvL~EllTG~---------~~Pf~~~------~~~~~~~i~~--~~~~~~-----~~~s~el~dLI~~c 745 (753)
++.++|||||||++|||+||. .+||... .......... .....+ ...++++.+||.+|
T Consensus 200 ~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 279 (301)
T 3q4u_A 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKEC 279 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHH
Confidence 557999999999999999981 3455332 1112221111 111122 12446899999999
Q ss_pred cccCcCCC
Q 004442 746 LDPNPDLR 753 (753)
Q Consensus 746 L~~DP~~R 753 (753)
|+.||++|
T Consensus 280 l~~dP~~R 287 (301)
T 3q4u_A 280 WYQNPSAR 287 (301)
T ss_dssp CCSSGGGS
T ss_pred hhcChhhC
Confidence 99999998
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=328.41 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=184.7
Q ss_pred ecceEEEe-EEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFN-KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~-~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.+.|.+. +.||+|+||+||++... +++.||||++.... .....+|+..+.+..+||||+++++++.+++..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 34567774 77999999999999754 69999999996543 345667776444447899999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++... ..+++..+..++.||+.||+|||+.
T Consensus 90 ~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~ 130 (316)
T 2ac3_A 90 FE----------KMRGGSILSHIHKR-----------------------------RHFNELEASVVVQDVASALDFLHNK 130 (316)
T ss_dssp EE----------CCTTCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cCCCCcHHHHHhcc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 66678888877532 3577888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCc----ccccCccCCCCccccccccccC-----CCCCchhhHH
Q 004442 626 GLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLF 695 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~----~~~~~~~~~GT~~Y~APE~l~~-----~~~t~ksDIw 695 (753)
+|+||||||+|||++.++. ..+||+|||+++....... ........+||+.|+|||++.+ ..++.++|||
T Consensus 131 ~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 210 (316)
T 2ac3_A 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW 210 (316)
T ss_dssp TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHH
T ss_pred CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccH
Confidence 9999999999999977653 3489999999986643211 1112233469999999999875 5578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCh----------------HHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESF----------------ERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~----------------~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| .+||.... ......+......++ ..+++++.+||++||+.||++|
T Consensus 211 slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (316)
T 2ac3_A 211 SLGVILYILLSG-YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQR 287 (316)
T ss_dssp HHHHHHHHHHHS-SCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hHHHHHHHHHHC-CCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhC
Confidence 999999999998 66775532 122333444443333 3578999999999999999998
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=320.50 Aligned_cols=242 Identities=25% Similarity=0.348 Sum_probs=194.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
....++|.+.+.||+|+||.||++...++..||||.+.... .+...+|+ .+++.++|+||+++++++.+ +..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEA-NLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHH-HHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 44457899999999999999999988888899999997543 23344455 47899999999999999864 4589999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.... ...+++.++++++.|++.||+|||+.+
T Consensus 87 e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 87 E----------YMENGSLVDFLKTPS---------------------------GIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp E----------CCTTCBHHHHTTSHH---------------------------HHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------cCCCCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 777888888875321 125788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||+++.++ .+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++
T Consensus 130 i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 205 (279)
T 1qpc_A 130 YIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (279)
T ss_dssp EECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred eeccCCCHhhEEEcCCC--CEEECCCcccccccCccc--ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHh
Confidence 99999999999997665 499999999988754321 22233456889999999998889999999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++.+||..... .....+... ....+..+++++.++|.+||+.||++|
T Consensus 206 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 254 (279)
T 1qpc_A 206 HGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254 (279)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhC
Confidence 44778876543 333333332 344566788999999999999999998
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.43 Aligned_cols=273 Identities=27% Similarity=0.340 Sum_probs=192.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-------Cc-hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-------HH-DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-------~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
..+.++|.+.+.||+|+||.||++.. .+++.||||++... .. +...+|+ .+++.++||||+++++++.+.
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEV-RLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHH-HHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHH-HHHHhCCCCCcceeehhhccC
Confidence 44567899999999999999999976 45889999998643 11 2334454 478999999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhh---hhhhccccc--------ccchhhhhhhcCCCCHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE---VRIRLLPVM--------ENTKDIELWKANGHPSAQL 608 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~ 608 (753)
+..++||| |+++|+|.+++............ ......+.. .............+++..+
T Consensus 101 ~~~~lv~e----------~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (345)
T 3hko_A 101 QYICLVME----------LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLI 170 (345)
T ss_dssp SEEEEEEE----------CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHH
T ss_pred CeEEEEEe----------CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHH
Confidence 99999999 77788888888532211000000 000000000 0000000000112356778
Q ss_pred HHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccC--
Q 004442 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQ-- 685 (753)
Q Consensus 609 l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~-- 685 (753)
+.|+.||+.||+|||+.+|+||||||+||+++.++...+||+|||+++....... .........||+.|+|||++.+
T Consensus 171 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 250 (345)
T 3hko_A 171 SNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred HHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence 8999999999999999999999999999999887766799999999987643211 1112334569999999999975
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 686 GRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 686 ~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
..++.++|||||||++|||++| .+||..... .....+...... ....+++++.+||++||+.||++|
T Consensus 251 ~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMG-AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred CCCCcHHHHHHHHHHHHHHHHC-CCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 6789999999999999999999 667766533 333333333322 223478999999999999999998
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.38 Aligned_cols=235 Identities=23% Similarity=0.340 Sum_probs=194.1
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.++|.+.+.||+|+||.||++... +++.||||++... .....+.++..+++.++|+||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367899999999999999999765 5789999998642 1223344444488999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++... ..+++..++.++.|++.||.|||+.
T Consensus 93 ~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~ 133 (284)
T 2vgo_A 93 LE----------FAPRGELYKELQKH-----------------------------GRFDEQRSATFMEELADALHYCHER 133 (284)
T ss_dssp EC----------CCTTEEHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EE----------eCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 66677777776432 3477888999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. +||+|||++...... ......|++.|+|||++.+..++.++||||||+++|||+
T Consensus 134 ~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (284)
T 2vgo_A 134 KVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206 (284)
T ss_dssp TEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS-----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred CceecCCCHHHEEEcCCCC--EEEecccccccCccc-----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHH
Confidence 9999999999999977765 999999999766432 123456899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~-~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||.... ......+......++..+++++.++|.+||+.||++|
T Consensus 207 ~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 254 (284)
T 2vgo_A 207 VG-MPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQR 254 (284)
T ss_dssp HS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HC-CCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhC
Confidence 98 66776553 3344455555666778889999999999999999998
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.41 Aligned_cols=258 Identities=23% Similarity=0.321 Sum_probs=199.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee--------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeeccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGV 535 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~--------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~ 535 (753)
+...++|.+.+.||+|+||.||+|... .+..||||++...... ...+|+. +++.+ +||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHH-HHHHhcCCchhhhheee
Confidence 444578999999999999999999753 2468999999765432 3445555 55666 99999999999
Q ss_pred ccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 536 ~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
|.+.+..++||| |+.+|+|.+++........... ..........+++.++++|+.||
T Consensus 144 ~~~~~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi 200 (382)
T 3tt0_A 144 CTQDGPLYVIVE----------YASKGNLREYLQARRPPGLEYS-------------YNPSHNPEEQLSSKDLVSCAYQV 200 (382)
T ss_dssp ECSSSSCEEEEE----------CCTTCBHHHHHHHTCCSSSSSC-------------CCCCSSCCCCCCHHHHHHHHHHH
T ss_pred eccCCceEEEEE----------ecCCCcHHHHHHHhcccccccc-------------cccccccccccCHHHHHHHHHHH
Confidence 999999999999 7778888888875432110000 00000123468999999999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHH
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIw 695 (753)
+.||+|||+.+|+||||||+|||++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++|||
T Consensus 201 ~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diw 277 (382)
T 3tt0_A 201 ARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 277 (382)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCT-TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHH
T ss_pred HHHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCcccccccccc-cccccCCCCCcceeCHHHhcCCCCCchhHHH
Confidence 99999999999999999999999977764 99999999987654321 1223344578999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||+|++..||..... .....+... ....+..+++++.+||.+||+.||++|
T Consensus 278 slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 278 SFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999944778876543 333444333 445667789999999999999999998
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.15 Aligned_cols=237 Identities=24% Similarity=0.392 Sum_probs=180.8
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC--CCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ--HPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~--HpNIV~L~g~~~~~~~~~ 543 (753)
.++.|.+.+.||+|+||.||++...+++.||||++..... +...+|+. ++..++ |+||+++++++...+..|
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHH-HHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3467999999999999999999888899999999965431 23445555 566665 599999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||++. |+|.+++.. ...+++.++..++.||+.||.|||
T Consensus 133 lv~E~~~-----------~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 133 MVMECGN-----------IDLNSWLKK-----------------------------KKSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp EEEECCS-----------EEHHHHHHH-----------------------------CSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCC-----------CCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999433 445555432 235677788999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----------CCCCchh
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAI 692 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~ks 692 (753)
+.+|+||||||+|||++ ++ .+||+|||+++........ ......+||+.|+|||++.+ ..++.++
T Consensus 173 ~~~ivHrDlkp~NIll~-~~--~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLIV-DG--MLKLIDFGIANQMQPDTTS-VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TTTCCCCCCCGGGEEES-SS--CEEECCCSSSCCC----------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HCCeeecCCCHHHEEEE-CC--eEEEEecCccccccCCCcc-ccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 99999999999999994 33 4999999999876543211 12234579999999999875 4689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFER--DANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~~--~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||||++|||++| .+||...... ....+... ...++...++++.+||.+||+.||++|
T Consensus 249 DiwSlGvil~ell~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 312 (390)
T 2zmd_A 249 DVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 312 (390)
T ss_dssp HHHHHHHHHHHHHHS-SCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred hHHHHHHHHHHHHHC-CCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhC
Confidence 999999999999998 6788654322 22222222 233455667899999999999999998
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.04 Aligned_cols=240 Identities=27% Similarity=0.361 Sum_probs=190.6
Q ss_pred cceEEEeEEecccCceEEEEEE-----eeCCcEEEEEEeecCC---c-hHHHHHHHHHHHhCCCCceeeecccccCC--c
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTH---H-DVALKEIQNLIASDQHPNIVRWYGVESDQ--D 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~-----~~~g~~VAVK~l~~~~---~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~ 540 (753)
.+.|++.+.||+|+||.||++. ..+++.||||++.... . ....+|+ .+++.++|+||+++++++.+. +
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEI-EILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHH-HHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHH-HHHHhCCCCCeeeeeeEEecCCCc
Confidence 4568899999999999999987 3468999999997542 1 3344455 478999999999999999876 6
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++... ...+++.+++.++.|++.||+
T Consensus 99 ~~~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~ 140 (302)
T 4e5w_A 99 GIKLIME----------FLPSGSLKEYLPKN----------------------------KNKINLKQQLKYAVQICKGMD 140 (302)
T ss_dssp CEEEEEE----------CCTTCBHHHHHHHH----------------------------TTTCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEE----------eCCCCcHHHHHHhc----------------------------cccCCHHHHHHHHHHHHHHHH
Confidence 7899999 67778888887532 234788899999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++ .+||+|||+++................||..|+|||++.+..++.++||||||++
T Consensus 141 ~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 218 (302)
T 4e5w_A 141 YLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVT 218 (302)
T ss_dssp HHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred HhhcCCcccCCCchheEEEcCCC--CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHH
Confidence 99999999999999999998776 4999999999987655443344455668999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh----------------HHHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESF----------------ERDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~----------------~~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| ..|+.... ......+ .......+..+++++.+||.+||+.||++|
T Consensus 219 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 287 (302)
T 4e5w_A 219 LHELLTY-CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNR 287 (302)
T ss_dssp HHHHHTT-TCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred HHHHHHc-cCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCC
Confidence 9999998 44543221 1111112 223345667889999999999999999998
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.75 Aligned_cols=237 Identities=22% Similarity=0.333 Sum_probs=189.4
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|.+.+.||+|+||.||++... +|+.||||.+.... .+...+|+. +++.++||||+++++++.+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN-ILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHH-HHHhCCCCCeeehhheecCCCe
Confidence 467899999999999999999776 58999999986532 223444554 7899999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+++|+|.+++.. ...+++.+++.++.|++.||.|
T Consensus 83 ~~lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~ 123 (283)
T 3bhy_A 83 VVLILE----------LVSGGELFDFLAE-----------------------------KESLTEDEATQFLKQILDGVHY 123 (283)
T ss_dssp EEEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------ecCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 6667788777643 2357888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCC--CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
||+.+|+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||++.+..++.++||||||+
T Consensus 124 lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 199 (283)
T 3bhy_A 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199 (283)
T ss_dssp HHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC----cccccCCCcCccCcceecCCCCCcchhhhhHHH
Confidence 9999999999999999997765 2259999999998765422 123346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++| ..||..... .....+...... .....++++.+||++||..||++|
T Consensus 200 il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 200 ITYILLSG-ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp HHHHHHHS-SCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHHHHHHC-CCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHC
Confidence 99999998 567765533 333333333322 235678899999999999999998
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=330.57 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=185.4
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.++|.+.+.||+|+||+||+|... +++ .||+|.+.... ...+.+|+ .+++.++||||++++++|.+.+ .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHH-HHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCC-e
Confidence 466899999999999999999754 344 46888875432 22344454 4789999999999999998765 7
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++|+| |+.+|+|.++++.. ...+++..+++++.||+.||+||
T Consensus 92 ~~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~L 133 (327)
T 3poz_A 92 QLITQ----------LMPFGCLLDYVREH----------------------------KDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp EEEEE----------CCTTCBHHHHHHHS----------------------------TTSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 78999 77889999888643 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++. +||+|||+++........ .......+|..|+|||++.+..++.++|||||||++|
T Consensus 134 H~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3poz_A 134 EDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC--------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCccc-ccccCCCccccccChHHhccCCCCchhhhhhhHHHHH
Confidence 9999999999999999987764 999999999877543221 2223345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|++.+||....... ...+.. .....+..+++++.++|.+||+.||++|
T Consensus 211 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 263 (327)
T 3poz_A 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 263 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGS
T ss_pred HHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 99993377887654433 333333 3345667788999999999999999998
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=324.80 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=185.5
Q ss_pred cceecceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
.....++|.+.+.||+|+||.||+|.... +..||||++..... +.+.+|+ .+++.++||||+++++++.+
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEA-ACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHH-HHHhcCCCCCeeeeeEEEee
Confidence 34556789999999999999999986653 45899999875421 2234444 47899999999999999887
Q ss_pred Cce-----EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 539 QDF-----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 539 ~~~-----~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
.+. .++||| |+.+|+|.+++...... .....+++..+++++.
T Consensus 108 ~~~~~~~~~~~v~e----------~~~~~~L~~~l~~~~~~-----------------------~~~~~~~~~~~~~i~~ 154 (313)
T 3brb_A 108 MSSQGIPKPMVILP----------FMKYGDLHTYLLYSRLE-----------------------TGPKHIPLQTLLKFMV 154 (313)
T ss_dssp -------CEEEEEE----------CCTTCBHHHHHHHTTBT-----------------------TSCCCCCHHHHHHHHH
T ss_pred ccccCCcccEEEEe----------cccCCCHHHHHHHhhhh-----------------------cCCccCCHHHHHHHHH
Confidence 553 599999 77788888887543221 1235688999999999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhh
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksD 693 (753)
||+.||.|||+.+|+||||||+||+++.++. +||+|||+++....... ........+++.|+|||.+.+..++.++|
T Consensus 155 qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 231 (313)
T 3brb_A 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIYSGDY-YRQGRIAKMPVKWIAIESLADRVYTSKSD 231 (313)
T ss_dssp HHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC-----------------CCGGGSCHHHHHSSCCCHHHH
T ss_pred HHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceecccccc-cCcccccCCCccccCchhhcCCCccchhh
Confidence 9999999999999999999999999977654 99999999987654321 11223345788999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHH-HHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||+++|||++++.+||...... ....+ .......+..+++++.++|.+||..||++|
T Consensus 232 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 293 (313)
T 3brb_A 232 VWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDR 293 (313)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGS
T ss_pred hHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhC
Confidence 9999999999999557888765433 33333 333455677889999999999999999998
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=322.83 Aligned_cols=236 Identities=25% Similarity=0.395 Sum_probs=169.1
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|.+.+.||+|+||.||++.. .+|+.||||.+.... . +...+|+ .+++.++||||+++++++.+.+..++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV-KIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHH-HHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 5689999999999999999976 469999999996432 1 2334444 478899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++... ...+++.+++.++.|++.||+|||+.
T Consensus 90 ~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~ 131 (278)
T 3cok_A 90 LE----------MCHNGEMNRYLKNR----------------------------VKPFSENEARHFMHQIITGMLYLHSH 131 (278)
T ss_dssp EE----------CCTTEEHHHHHHTC----------------------------SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------cCCCCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 66677777776432 24578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. +||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||+
T Consensus 132 ~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 206 (278)
T 3cok_A 132 GILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206 (278)
T ss_dssp TEECSSCCGGGEEECTTCC--EEECCCTTCEECC-------------------------------CTHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCC---cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999977754 99999999987653221 122346899999999999988999999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~-~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||..... .....+.......+..+++++.++|.+||+.||++|
T Consensus 207 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 254 (278)
T 3cok_A 207 IG-RPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADR 254 (278)
T ss_dssp HS-SCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hC-CCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhC
Confidence 98 667765432 222222223334566788999999999999999998
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.80 Aligned_cols=252 Identities=19% Similarity=0.269 Sum_probs=197.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
+...++|.+.+.||+|+||.||+|... .++.||||.+...... ...+|+. +++.++|+||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHH-HGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHH-HHHhcCCCCEeeeEEEEcc
Confidence 455678999999999999999998654 3789999999765432 2334444 7789999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+.+|+|.+++........ .......+++..+++++.||+.|
T Consensus 100 ~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~qi~~~ 150 (322)
T 1p4o_A 100 GQPTLVIME----------LMTRGDLKSYLRSLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIADG 150 (322)
T ss_dssp SSSCEEEEE----------CCTTCBHHHHHHHHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHHH
T ss_pred CCccEEEEE----------eCCCCcHHHHHHHhchhhc-------------------cCCCCCCcCHHHHHHHHHHHHHH
Confidence 999999999 6677888888765432100 00112456888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|.|||+.+|+||||||+||+++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++||||||
T Consensus 151 l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 227 (322)
T 1p4o_A 151 MAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227 (322)
T ss_dssp HHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHCCCccCCCccceEEEcCCCe--EEECcCccccccccccc-cccccCCCCCCCccChhhhccCCCCchhhHHHHH
Confidence 99999999999999999999977754 99999999986643221 1222334578899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+||+.+||...... ....+.. .....+..+++++.++|.+||+.||++|
T Consensus 228 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 284 (322)
T 1p4o_A 228 VVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 284 (322)
T ss_dssp HHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 99999999557888765433 3333333 3345667889999999999999999998
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.55 Aligned_cols=240 Identities=20% Similarity=0.302 Sum_probs=190.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE-E
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV-Y 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~-~ 543 (753)
..|...+.||+|+||+||+|...+ +..||||.+...... .+.+|+ .+++.++||||+++++++.+.+.. +
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG-LLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 356778999999999999997543 237999999754432 233444 478999999999999999876655 9
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++... ...+++..++.++.|++.||+|||
T Consensus 100 ~v~e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~LH 141 (298)
T 3pls_A 100 VLLP----------YMCHGDLLQFIRSP----------------------------QRNPTVKDLISFGLQVARGMEYLA 141 (298)
T ss_dssp EEEC----------CCTTCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------cccCCCHHHHHhcc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77788888887532 245678889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+||+++.++. +||+|||+++....... .........+|+.|+|||.+.+..++.++|||||||++|
T Consensus 142 ~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 219 (298)
T 3pls_A 142 EQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219 (298)
T ss_dssp HTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred hCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHH
Confidence 999999999999999977654 99999999986643211 112223446789999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHH-HHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~-~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+||+.+||........ ..+.. .....+..+++++.++|.+||+.||++|
T Consensus 220 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 272 (298)
T 3pls_A 220 ELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVR 272 (298)
T ss_dssp HHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhC
Confidence 999987888876644333 33333 3345667788999999999999999998
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=325.26 Aligned_cols=234 Identities=27% Similarity=0.390 Sum_probs=182.6
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~ 552 (753)
++|.+.+.||+|+||+||++.. .++.||||++........+..+..+++.++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e----- 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME----- 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE-----
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE-----
Confidence 5688999999999999999865 5789999999766544444444457899999999999999874 4789999
Q ss_pred hhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh---CCccc
Q 004442 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---IGLIH 629 (753)
Q Consensus 553 L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~---~~IiH 629 (753)
|+++|+|.++++.... ...+++..+++++.|+++||+|||+ .+|+|
T Consensus 80 -----~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH 128 (307)
T 2eva_A 80 -----YAEGGSLYNVLHGAEP--------------------------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128 (307)
T ss_dssp -----CCTTCBHHHHHHCSSS--------------------------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCC
T ss_pred -----cCCCCCHHHHHhccCC--------------------------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeec
Confidence 7778888888764321 1246778889999999999999999 89999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||+++.++. .+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||+|| +
T Consensus 129 ~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g-~ 200 (307)
T 2eva_A 129 RDLKPPNLLLVAGGT-VLKICDFGTACDIQTH------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITR-R 200 (307)
T ss_dssp CCCSGGGEEEETTTT-EEEECCCCC------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHT-C
T ss_pred CCCChhHEEEeCCCC-EEEEcccccccccccc------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHC-C
Confidence 999999999987763 5799999999765432 1233589999999999999999999999999999999998 6
Q ss_pred CCCCCChH---HHH-HHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFE---RDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~---~~~-~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||..... ... ..........+..+++++.++|.+||+.||++|
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 248 (307)
T 2eva_A 201 KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248 (307)
T ss_dssp CTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhC
Confidence 68865322 122 222333445667889999999999999999998
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.46 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=186.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-----CcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-----g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
+.....|.+.+.||+|+||.||+|.... +..||||++...... ...+|+ .+++.++||||+++++++.+.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA-GIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCCCCCcEEEEEecC
Confidence 3445678899999999999999987653 346999999764322 233444 478999999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.+++... ...+++.++++++.||+.||
T Consensus 119 ~~~~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL 160 (333)
T 1mqb_A 119 KPMMIITE----------YMENGALDKFLREK----------------------------DGEFSVLQLVGMLRGIAAGM 160 (333)
T ss_dssp SSEEEEEE----------CCTTEEHHHHHHHT----------------------------TTCSCHHHHHHHHHHHHHHH
T ss_pred CCcEEEEe----------CCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHH
Confidence 99999999 66677888777532 23578889999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
+|||+.+|+||||||+||+++.++ .+||+|||+++................+|+.|+|||++.+..++.++|||||||
T Consensus 161 ~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 161 KYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp HHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred HHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 999999999999999999997765 499999999987754332222223334688999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++++..||.... ......+... ..+.+..+++++.++|.+||+.||++|
T Consensus 239 il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 294 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 294 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhC
Confidence 99999993367776543 3333333333 445566789999999999999999998
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=321.58 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=196.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+...++|++.+.||+|+||.||++.... +..||||.+..... +...+|+ .+++.++|+||+++++++.+.+..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA-AVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3456779999999999999999997765 88999999976542 2344555 488999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++... ....+++..++.++.|++.||+|||+.
T Consensus 88 ~e----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 88 TE----------FMTYGNLLDYLREC---------------------------NRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp EE----------CCTTEEHHHHHHHC---------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EE----------cCCCCcHHHHHHhc---------------------------ccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 99 66677888777532 124578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++. +||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|+
T Consensus 131 ~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll 206 (288)
T 3kfa_A 131 NFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 206 (288)
T ss_dssp TCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSS--EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CccCCCCCcceEEEcCCCC--EEEccCccceeccCCcc--ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999977654 99999999987654322 1222334688999999999999999999999999999999
Q ss_pred hCCCCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+++.+||...... ....+.. .....+..+++++.+||.+||+.||++|
T Consensus 207 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 256 (288)
T 3kfa_A 207 TYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 256 (288)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhC
Confidence 9447888765433 3333333 3445667789999999999999999998
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=330.97 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=178.0
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
...++|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+. +++.++||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS-LLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHH-HGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHH-HHHHcCCCCcceEEEEEecCCEEE
Confidence 3446799999999999999999965 4689999999965432 22345554 778999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||||+++| .+++.. ...+++..+..|+.||+.||+|||
T Consensus 110 lv~e~~~~~L-----------~~~~~~-----------------------------~~~~~~~~~~~i~~ql~~~l~~LH 149 (329)
T 3gbz_A 110 LIFEYAENDL-----------KKYMDK-----------------------------NPDVSMRVIKSFLYQLINGVNFCH 149 (329)
T ss_dssp EEEECCSEEH-----------HHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCH-----------HHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999666544 444321 235788889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCC---CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGC 699 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~---~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGv 699 (753)
+.+|+||||||+|||++.++ ...+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||
T Consensus 150 ~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI---RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226 (329)
T ss_dssp HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--------------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc---cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence 99999999999999996432 2459999999998765322 1223446899999999998754 899999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-Cc-----------------------------ccccCCCHHHHHHHHHcccc
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KD-----------------------------LFLVEHIPEAVDLFTRLLDP 748 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~-----------------------------~~~~~~s~el~dLI~~cL~~ 748 (753)
++|||++| .+||...... ....+... .. .....+++++.+||++||+.
T Consensus 227 il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 305 (329)
T 3gbz_A 227 IWAEMLMK-TPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM 305 (329)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCS
T ss_pred HHHHHHHC-CCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccC
Confidence 99999998 6677655332 22222110 00 01112678999999999999
Q ss_pred CcCCC
Q 004442 749 NPDLR 753 (753)
Q Consensus 749 DP~~R 753 (753)
||++|
T Consensus 306 dP~~R 310 (329)
T 3gbz_A 306 DPVKR 310 (329)
T ss_dssp SGGGS
T ss_pred ChhhC
Confidence 99998
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=332.27 Aligned_cols=204 Identities=25% Similarity=0.319 Sum_probs=165.1
Q ss_pred ccceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCC-----CCceeeecccccC
Q 004442 467 DGRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-----HPNIVRWYGVESD 538 (753)
Q Consensus 467 ~~~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-----HpNIV~L~g~~~~ 538 (753)
.+..+.++|.+.+.||+|+||+||++.. .+++.||||++.... ......|.. ++..++ |+||+++++++..
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~h~~iv~~~~~~~~ 107 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD-ILKKIQNDDINNNNIVKYHGKFMY 107 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHH-HHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHH-HHHHhcccCCCCCCeecccceeeE
Confidence 3467788999999999999999999976 468999999997532 223334444 667665 9999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++|||+| +|+|.+++.... ...+++..+..++.||+.|
T Consensus 108 ~~~~~lv~e~~-----------~~~L~~~~~~~~---------------------------~~~~~~~~~~~i~~qi~~a 149 (360)
T 3llt_A 108 YDHMCLIFEPL-----------GPSLYEIITRNN---------------------------YNGFHIEDIKLYCIEILKA 149 (360)
T ss_dssp TTEEEEEECCC-----------CCBHHHHHHHTT---------------------------TCCCCHHHHHHHHHHHHHH
T ss_pred CCeeEEEEcCC-----------CCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHH
Confidence 99999999954 455655554321 2357888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecC-----------------------CCCeEEEEeccCceeccCCCcccccCccCCCCc
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKD-----------------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 675 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d-----------------------~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~ 675 (753)
|+|||+.+|+||||||+|||++.+ ....+||+|||+++..... .....||+
T Consensus 150 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------~~~~~gt~ 223 (360)
T 3llt_A 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------HGSIINTR 223 (360)
T ss_dssp HHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------CCSCCSCG
T ss_pred HHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC------CcCccCcc
Confidence 999999999999999999999641 1345999999999875432 23456899
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 004442 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 716 (753)
Q Consensus 676 ~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~ 716 (753)
.|+|||++.+..++.++|||||||++|||+|| .+||....
T Consensus 224 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~ 263 (360)
T 3llt_A 224 QYRAPEVILNLGWDVSSDMWSFGCVLAELYTG-SLLFRTHE 263 (360)
T ss_dssp GGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS-SCSCCCSS
T ss_pred cccCcHHHcCCCCCCccchHHHHHHHHHHHHC-CCCCCCCc
Confidence 99999999999999999999999999999999 66776543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=346.83 Aligned_cols=196 Identities=27% Similarity=0.388 Sum_probs=155.0
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ---- 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~---- 539 (753)
.+.++|.+.+.||+|+||+||+|... +|+.||||++.... .....+|+. +++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHH-HHHhCCCCCCCcEEEEEccCCccc
Confidence 44578999999999999999999654 58999999997532 223455555 78999999999999998654
Q ss_pred --ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 540 --~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
...|+|||||.+++.+.+ ...+++..+..++.||+.
T Consensus 138 ~~~~~~lv~E~~~~~l~~~~------------------------------------------~~~l~~~~~~~~~~qil~ 175 (464)
T 3ttj_A 138 EFQDVYLVMELMDANLCQVI------------------------------------------QMELDHERMSYLLYQMLC 175 (464)
T ss_dssp TCCEEEEEEECCSEEHHHHH------------------------------------------TSCCCHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCHHHHH------------------------------------------hhcCCHHHHHHHHHHHHH
Confidence 467999996665433222 123677888999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+|||++.++. +||+|||+++..... ......+||+.|+|||++.+..++.++|||||
T Consensus 176 aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 249 (464)
T 3ttj_A 176 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249 (464)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----C----CCC----CCCTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCC----cccCCCcccccccCHHHHcCCCCCHHHHHHHH
Confidence 999999999999999999999977754 999999999876532 12344579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 004442 698 GCILFFCITGGKHPYGES 715 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~ 715 (753)
||++|||++| ++||.+.
T Consensus 250 G~il~ell~g-~~pF~g~ 266 (464)
T 3ttj_A 250 GCIMGEMVRH-KILFPGR 266 (464)
T ss_dssp HHHHHHHHHS-SCSSCCS
T ss_pred HHHHHHHHhC-CCCCCCC
Confidence 9999999999 6677654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.74 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=190.3
Q ss_pred ceEEEeE-EecccCceEEEEEEee---CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNK-EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~-~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
++|.+.+ .||+|+||.||+|... .+..||||+++..... ...+|+ .+++.++||||+++++++ +.+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA-QIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHH-HHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4455555 8999999999998643 5789999999764322 234444 477889999999999999 5567899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++... ...+++..+++++.|++.||.|||+
T Consensus 87 v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~ 128 (287)
T 1u59_A 87 VME----------MAGGGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEE 128 (287)
T ss_dssp EEE----------CCTTEEHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eCCCCCHHHHHHhC----------------------------CccCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 66677888776432 2357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++ .+||+|||+++................+|+.|+|||++.+..++.++||||||+++|||
T Consensus 129 ~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 129 KNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp TTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999998775 49999999999876543333333445578999999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 IT-GGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lT-G~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| | ..||..... .....+... ....+..+++++.++|.+||+.||++|
T Consensus 207 lt~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 257 (287)
T 1u59_A 207 LSYG-QKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 257 (287)
T ss_dssp HTTS-CCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred HcCC-CCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhC
Confidence 99 6 778866533 333333333 345677889999999999999999998
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.32 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=187.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
+...++|.+.+.||+|+||.||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ-NLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHH-HHhcCCCCCEeEEEEEEecCCe
Confidence 445578999999999999999999775 69999999986432 123344544 7799999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++... ..+++..+++++.|++.||.|
T Consensus 86 ~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~ 126 (276)
T 2h6d_A 86 FFMVME----------YVSGGELFDYICKH-----------------------------GRVEEMEARRLFQQILSAVDY 126 (276)
T ss_dssp EEEEEE----------CCCSCBHHHHHHHH-----------------------------CSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------ccCCCcHHHHHhcc-----------------------------CCCCHHHHHHHHHHHHHHHHH
Confidence 999999 66677777776432 346788899999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvv 700 (753)
||+.+|+||||||+||+++.++. +||+|||++....... ......||+.|+|||.+.+..+ +.++||||||++
T Consensus 127 lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~ 200 (276)
T 2h6d_A 127 CHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGE----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200 (276)
T ss_dssp HHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC-----------------CCTGGGTTSCCCHHHHHHHHHHHH
T ss_pred HHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCc----ceecccCCccccCHHHHcCCCCCCccchHHHHHHH
Confidence 99999999999999999977654 9999999998765321 1234468999999999988776 689999999999
Q ss_pred HHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||... .......+.......+..+++++.++|.+||+.||++|
T Consensus 201 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 253 (276)
T 2h6d_A 201 LYALLCG-TLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKR 253 (276)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhC-CCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhC
Confidence 9999998 6677654 34444555566666777889999999999999999998
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=344.97 Aligned_cols=239 Identities=27% Similarity=0.447 Sum_probs=193.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCceee
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNIV~ 531 (753)
..+.+.|.+.+.||+|+||+||++... +++.||||++.... .+...+|+. +++.++||||++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS-LLKSLDHPNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHH-HHHTCCCTTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHH-HHHhCCCCCCCe
Confidence 456788999999999999999999765 58899999996532 123445554 789999999999
Q ss_pred ecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 532 L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
++++|.+.+..++||| |+.+|+|.+++.. ...+++..+..+
T Consensus 111 ~~~~~~~~~~~~lv~e----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~i 151 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTE----------FYEGGELFEQIIN-----------------------------RHKFDECDAANI 151 (504)
T ss_dssp EEEEEECSSEEEEEEE----------CCTTCBHHHHHHH-----------------------------HSCCCHHHHHHH
T ss_pred EEEEEEcCCEEEEEEe----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHH
Confidence 9999999999999999 6667788777643 245788899999
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCc
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 690 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ 690 (753)
+.||+.||+|||+.+|+||||||+|||++.++. ..+||+|||+++...... .....+||+.|+|||++. ..++.
T Consensus 152 ~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~ 226 (504)
T 3q5i_A 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY----KLRDRLGTAYYIAPEVLK-KKYNE 226 (504)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS----CBCCCCSCTTTCCHHHHT-TCBCT
T ss_pred HHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC----ccccccCCcCCCCHHHhc-cCCCc
Confidence 999999999999999999999999999987653 369999999998775432 223456999999999986 56999
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||||||++|+|++| .+||.... ......+......++ ..+++++.+||++||..||++|
T Consensus 227 ~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 293 (504)
T 3q5i_A 227 KCDVWSCGVIMYILLCG-YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293 (504)
T ss_dssp HHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred hHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999998 66776654 444455555443332 5679999999999999999998
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=320.72 Aligned_cols=241 Identities=20% Similarity=0.328 Sum_probs=188.7
Q ss_pred cceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeeccccc-CCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES-DQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~-~~~~~ 542 (753)
...|.+.+.||+|+||+||+|...+ ...||||.+..... +...+|+. +++.++||||++++++|. +++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHH-HHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHH-HHHhCCCCCEeeeeeEEEcCCCce
Confidence 3568899999999999999987543 34689999875432 23344444 789999999999999865 45678
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++... ...+++..+++++.|++.||+||
T Consensus 103 ~~v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~ql~~~l~~l 144 (298)
T 3f66_A 103 LVVLP----------YMKHGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKYL 144 (298)
T ss_dssp EEEEE----------CCTTCBHHHHHHCT----------------------------TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------CCCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77778888887532 23567888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+||+++.++ .+||+|||+++........ ........||+.|+|||.+.+..++.++||||||+++
T Consensus 145 H~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 222 (298)
T 3f66_A 145 ASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 222 (298)
T ss_dssp HHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhCCccCCCCchheEEECCCC--CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHH
Confidence 999999999999999997665 4999999999876542211 1122334578899999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHH-HH-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~-~~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|+.+||....... .. .........+..+++++.++|.+||+.||++|
T Consensus 223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 276 (298)
T 3f66_A 223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 276 (298)
T ss_dssp HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 999998788887654332 22 23333444566788999999999999999998
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.38 Aligned_cols=242 Identities=20% Similarity=0.267 Sum_probs=186.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccc-cCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVE-SDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~-~~~~~~~LV 545 (753)
..++++|.+.+.||+|+||.||++.. .+|+.||||++..... ....+|+. +++.++|+|++..++++ .+.+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHH-HHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHH-HHHHhhcCCCCCccccccCCCCceEEE
Confidence 35678899999999999999999976 5799999999876543 34445554 77888888876666655 567788999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+ +|+|.+++... ...+++.++++++.|++.||+|||+.
T Consensus 84 ~e----------~~-~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (296)
T 3uzp_A 84 ME----------LL-GPSLEDLFNFC----------------------------SRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp EE----------CC-CCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------ec-CCCHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 55 56666665421 23578889999999999999999999
Q ss_pred CccccCCCCCcEEEe---cCCCCeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 626 GLIHRDLKPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 626 ~IiHrDLKp~NILL~---~d~~~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
+|+||||||+|||++ .++ .+||+|||+++......... .......||+.|+|||++.+..++.++||||||
T Consensus 125 ~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 202 (296)
T 3uzp_A 125 NFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 202 (296)
T ss_dssp TEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHH
Confidence 999999999999994 444 59999999999876542211 122445799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCh----HHHHHHHHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF----ERDANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~----~~~~~~i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++| +.||.... ......+.... ......+++++.++|++||+.||++|
T Consensus 203 ~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 265 (296)
T 3uzp_A 203 YVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HHHHHHHHS-SCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred HHHHHHHhC-CCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcC
Confidence 999999998 67776521 11222222211 12336788999999999999999998
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=342.43 Aligned_cols=252 Identities=38% Similarity=0.720 Sum_probs=183.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..+.+.|...+.||+|+||+||++...+|+.||||++.....+...+|+..+....+|||||++++++.+++..++|||+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 34456677889999999999998888889999999998766566677877554456999999999999999999999996
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|.++ |.+++........ ......+..+++++.||+.||+|||+.+|+
T Consensus 91 ~~gs-----------L~~~l~~~~~~~~----------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 137 (434)
T 2rio_A 91 CNLN-----------LQDLVESKNVSDE----------------------NLKLQKEYNPISLLRQIASGVAHLHSLKII 137 (434)
T ss_dssp CSEE-----------HHHHHHTC----------------------------------CCHHHHHHHHHHHHHHHHHTTEE
T ss_pred CCCC-----------HHHHHhccCCCch----------------------hhhhccchhHHHHHHHHHHHHHHHHHCCcc
Confidence 6544 4444432211000 000112234578999999999999999999
Q ss_pred ccCCCCCcEEEecC-----------CCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccC-------CCCC
Q 004442 629 HRDLKPQNVLISKD-----------KSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQ-------GRQT 689 (753)
Q Consensus 629 HrDLKp~NILL~~d-----------~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~-------~~~t 689 (753)
||||||+|||++.+ +...+||+|||+++......... .......||+.|+|||++.+ ..++
T Consensus 138 HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 217 (434)
T 2rio_A 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217 (434)
T ss_dssp CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC
T ss_pred ccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc
Confidence 99999999999764 34579999999999876532211 12234569999999999976 6689
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCccc------ccCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF------LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~------~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++|||||||++|||+|++.+||++........+....... ...+++++.+||.+||+.||++|
T Consensus 218 ~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp THHHHHHHHHHHHHHHTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred hhhhhHhHHHHHHHHHhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhC
Confidence 99999999999999999558899776554444433322111 12335789999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=344.11 Aligned_cols=241 Identities=32% Similarity=0.632 Sum_probs=181.6
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEccccC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
..|...+.||+|+||+||.....+|+.||||++.........+|+. +++.+ +|||||++++++.+.+..|+|||+|.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~-~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g 102 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQ-LLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA 102 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHH-HHHHSCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHH-HHHhccCCCCcCeEEEEEecCCEEEEEEECCCC
Confidence 4688999999999999887778889999999998766555667776 55666 899999999999999999999997765
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
+|.++ +.... ..+.+..++.++.||+.||+|||+.+|+|||
T Consensus 103 ~L~~~-----------l~~~~----------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 143 (432)
T 3p23_A 103 TLQEY-----------VEQKD----------------------------FAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143 (432)
T ss_dssp EHHHH-----------HHSSS----------------------------CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CHHHH-----------HHhcC----------------------------CCccchhHHHHHHHHHHHHHHHHHCcCEeCC
Confidence 55444 33221 1122234578999999999999999999999
Q ss_pred CCCCcEEEe---cCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHHHHHHH
Q 004442 632 LKPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 632 LKp~NILL~---~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvvL~Ell 705 (753)
|||+|||++ .++.+.+||+|||+++...............+||+.|+|||++. ...++.++|||||||++|||+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 999999995 35556799999999988764432223344567999999999997 456788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++.+||+................. ....++.+.+||.+||+.||++|
T Consensus 224 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 224 SEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp TTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred cCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhC
Confidence 9558899877655554443322211 12234568899999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.72 Aligned_cols=243 Identities=14% Similarity=0.164 Sum_probs=183.3
Q ss_pred eecceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCchHHHHHHH--------------HHHHhCCCCce
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVALKEIQ--------------NLIASDQHPNI 529 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~~~~~~Ei~--------------~ll~~l~HpNI 529 (753)
...+.|.+.+.||+|+||.||+|.... ++.||||++..... ...+|+. ..+..++|+||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG-PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH-HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch-hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 345689999999999999999997654 47899999876542 2222221 13466789999
Q ss_pred eeecccccCC----ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCH
Q 004442 530 VRWYGVESDQ----DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS 605 (753)
Q Consensus 530 V~L~g~~~~~----~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 605 (753)
+++++++.+. ...+|||| |+ +|+|.+++... ...+++
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e----------~~-g~~L~~~~~~~----------------------------~~~l~~ 151 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMD----------RF-GSDLQKIYEAN----------------------------AKRFSR 151 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEE----------CE-EEEHHHHHHHT----------------------------TSCCCH
T ss_pred CeEEeeeeeccCCcceEEEEEe----------CC-CCCHHHHHHhc----------------------------cCCCCH
Confidence 9999998764 55899999 55 66677666432 245888
Q ss_pred HHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc----cccCccCCCCccccccc
Q 004442 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPE 681 (753)
Q Consensus 606 ~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE 681 (753)
.++++|+.||+.||+|||+.+|+||||||+|||++.+....+||+|||+++.+...... ........||+.|+|||
T Consensus 152 ~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 231 (364)
T 3op5_A 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSID 231 (364)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHH
Confidence 99999999999999999999999999999999998334456999999999876532211 11123445999999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHc----cCc------ccccCCCHHHHHHHHHccccC
Q 004442 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKD----RKD------LFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 682 ~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~----~~~------~~~~~~s~el~dLI~~cL~~D 749 (753)
++.+..++.++|||||||++|||+|| .+||.+.. ......... ... .....+++++.++|..||..|
T Consensus 232 ~~~~~~~~~~~Di~slG~~l~el~~g-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 310 (364)
T 3op5_A 232 AHNGVAPSRRGDLEILGYCMIQWLTG-HLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLD 310 (364)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHS-CCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCC
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHhC-CCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCC
Confidence 99999999999999999999999998 67887431 111111110 000 112567899999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 311 p~~R 314 (364)
T 3op5_A 311 YTEK 314 (364)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 9998
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.60 Aligned_cols=196 Identities=26% Similarity=0.426 Sum_probs=154.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCC---
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--- 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--- 539 (753)
..+.++|.+.+.||+|+||.||+|... +|+.||||++..... ....+|+. +++.++|+||+++++++...
T Consensus 22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~ 100 (432)
T 3n9x_A 22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRLYDLIIPDDLL 100 (432)
T ss_dssp CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCTT
T ss_pred ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHH-HHHHcCCCCcceEEEEEecCCCC
Confidence 445678999999999999999999764 588999999975321 23455655 78999999999999998776
Q ss_pred --ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 540 --~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+..|+|||+|+++| .+++. ....+++..+..++.||++
T Consensus 101 ~~~~~~lv~e~~~~~L-----------~~~~~-----------------------------~~~~l~~~~~~~i~~qil~ 140 (432)
T 3n9x_A 101 KFDELYIVLEIADSDL-----------KKLFK-----------------------------TPIFLTEEHIKTILYNLLL 140 (432)
T ss_dssp TCCCEEEEEECCSEEH-----------HHHHH-----------------------------SSCCCCHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCcCH-----------HHHHh-----------------------------ccCCCCHHHHHHHHHHHHH
Confidence 57999999665544 44432 1245788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-------------------ccCccCCCCcccc
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-------------------TQNATGYGSSGWQ 678 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-------------------~~~~~~~GT~~Y~ 678 (753)
||.|||+.+|+||||||+|||++.++ .+||+|||+++......... ......+||+.|+
T Consensus 141 aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 218 (432)
T 3n9x_A 141 GENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYR 218 (432)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC-------------------------------CCCCCTTC
T ss_pred HHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCcccc
Confidence 99999999999999999999997765 49999999999875432110 1234567999999
Q ss_pred ccccc-cCCCCCchhhHHHHHHHHHHHHhC
Q 004442 679 APEQL-LQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 679 APE~l-~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
|||++ ....++.++|||||||++|||++|
T Consensus 219 APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 219 APELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp CHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred CHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 99986 556699999999999999999974
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=332.99 Aligned_cols=242 Identities=16% Similarity=0.155 Sum_probs=181.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecCCch--------------HHHHHHHHHHHhCCCCceee
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD--------------VALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~~~~--------------~~~~Ei~~ll~~l~HpNIV~ 531 (753)
...++|.+.+.||+|+||.||+|... .+..||||++...... ...+|+ ..+..++|+||++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~-~~~~~l~h~ni~~ 112 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW-IERKQLDYLGIPL 112 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHH-HHHHTCSCCCCCC
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHH-HhhccccccCcce
Confidence 34578999999999999999999775 5789999998754321 122333 3567889999999
Q ss_pred ecccccC----CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHH
Q 004442 532 WYGVESD----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (753)
Q Consensus 532 L~g~~~~----~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 607 (753)
+++++.+ .+..++||| |+ +|+|.+++... ..+++.+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e----------~~-~~~L~~~l~~~-----------------------------~~~~~~~ 152 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVME----------RL-GIDLQKISGQN-----------------------------GTFKKST 152 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEE----------CE-EEEHHHHCBGG-----------------------------GBCCHHH
T ss_pred eecccccccCCCcEEEEEEe----------cc-CCCHHHHHHhc-----------------------------CCCCHHH
Confidence 9999887 788999999 66 67777766432 2578889
Q ss_pred HHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc----cccCccCCCCccccccccc
Q 004442 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQL 683 (753)
Q Consensus 608 ~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l 683 (753)
+++|+.||+.||+|||+.+|+||||||+|||++.++...+||+|||+++.+...... ........||+.|+|||++
T Consensus 153 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 232 (345)
T 2v62_A 153 VLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH 232 (345)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence 999999999999999999999999999999998876446999999999877432111 1112345699999999999
Q ss_pred cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHccCcccc---------cCCCHHHHHHHHHccccCcC
Q 004442 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGES---FERDANIVKDRKDLFL---------VEHIPEAVDLFTRLLDPNPD 751 (753)
Q Consensus 684 ~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~---~~~~~~~i~~~~~~~~---------~~~s~el~dLI~~cL~~DP~ 751 (753)
.+..++.++|||||||++|||+|| ..||... ...............+ ..+++++.++|.+||..||+
T Consensus 233 ~~~~~~~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 311 (345)
T 2v62_A 233 KGVALSRRSDVEILGYCMLRWLCG-KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYD 311 (345)
T ss_dssp HTCCCCHHHHHHHHHHHHHHHHHS-SCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTT
T ss_pred cCCCCCchhhHHHHHHHHHHHHhC-CCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcc
Confidence 999999999999999999999998 6788542 1111111111111111 17889999999999999999
Q ss_pred CC
Q 004442 752 LR 753 (753)
Q Consensus 752 ~R 753 (753)
+|
T Consensus 312 ~R 313 (345)
T 2v62_A 312 EK 313 (345)
T ss_dssp CC
T ss_pred cC
Confidence 98
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=330.67 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=179.6
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchH--HHHHHHHHHHhCCCCceeeecccccCCc----eEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQD----FVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~--~~~Ei~~ll~~l~HpNIV~L~g~~~~~~----~~~LV 545 (753)
.++|++.+.||+|+||+||+|... ++.||||++....... ..+|+. +++.++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVY-SLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHH-TSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHH-HHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467899999999999999998654 8999999997654332 223333 567889999999999988643 47999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.++++. ..+++..+++++.|++.||+|||+.
T Consensus 101 ~e----------~~~~g~L~~~l~~------------------------------~~~~~~~~~~i~~qi~~al~~LH~~ 140 (322)
T 3soc_A 101 TA----------FHEKGSLSDFLKA------------------------------NVVSWNELCHIAETMARGLAYLHED 140 (322)
T ss_dssp EE----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHTCC
T ss_pred Ee----------cCCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhh
Confidence 99 7778888888742 2477888999999999999999999
Q ss_pred ----------CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-----CCCc
Q 004442 626 ----------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTR 690 (753)
Q Consensus 626 ----------~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~t~ 690 (753)
+|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+. .++.
T Consensus 141 ~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 217 (322)
T 3soc_A 141 IPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217 (322)
T ss_dssp EEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHH
T ss_pred ccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCc
Confidence 999999999999997765 4999999999887654321 223345699999999999873 4567
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCh-----------------HHHHHHHHc-cCccccc------CCCHHHHHHHHHcc
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESF-----------------ERDANIVKD-RKDLFLV------EHIPEAVDLFTRLL 746 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~-----------------~~~~~~i~~-~~~~~~~------~~s~el~dLI~~cL 746 (753)
++|||||||++|||+|| .+||.... ......+.. ...+... ..++++.+||.+||
T Consensus 218 ~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 296 (322)
T 3soc_A 218 RIDMYAMGLVLWELASR-CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296 (322)
T ss_dssp HHHHHHHHHHHHHHHTT-BTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHT
T ss_pred cchhHHHHHHHHHHHhC-CCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHc
Confidence 89999999999999998 55665321 111111111 1111111 12346999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 297 ~~dP~~R 303 (322)
T 3soc_A 297 DHDAEAR 303 (322)
T ss_dssp CSSGGGS
T ss_pred cCChhhC
Confidence 9999998
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=335.35 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=188.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
....++|.+.+.||+|+||.||+|...+|+.||||++..... +...+|+ .+++.++||||++++++|.+.+..++|
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv 113 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI-ETLSFCRHPHLVSLIGFCDERNEMILI 113 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHH-HGGGSCCCTTBCCEEEECCCTTCCEEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 445677888899999999999999988899999999865432 2334444 477899999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++..... ....+++.++++++.|++.||+|||+.
T Consensus 114 ~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~ 158 (321)
T 2qkw_B 114 YK----------YMENGNLKRHLYGSDL-------------------------PTMSMSWEQRLEICIGAARGLHYLHTR 158 (321)
T ss_dssp EE----------CCTTCBTGGGSSSSCC-------------------------CSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cCCCCcHHHHHhccCC-------------------------CccccCHHHHHHHHHHHHHHHHHhcCC
Confidence 99 6677888777643221 123588899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (321)
T 2qkw_B 159 AIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQ-THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235 (321)
T ss_dssp TEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSC-CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEECCCC--CEEEeecccccccccccc-cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHH
Confidence 999999999999997665 499999999987543221 11223345899999999999999999999999999999999
Q ss_pred hCCCCCCCCChHH-HH-------HHHHccC----------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER-DA-------NIVKDRK----------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~-~~-------~~i~~~~----------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| +.||...... .. ....... .......++++.++|.+||+.||++|
T Consensus 236 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 300 (321)
T 2qkw_B 236 CA-RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDR 300 (321)
T ss_dssp HC-CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred hC-CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccC
Confidence 99 5566443211 10 0111110 01122345678899999999999998
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.90 Aligned_cols=240 Identities=26% Similarity=0.325 Sum_probs=177.2
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..++|++.+.||+|+||+||++.. .+|+.||||++..... ...+.|+..+++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457799999999999999999876 4689999999975432 23445555567889999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||+|+++ |.+++.... .....+++..+++++.|++.||+|||+.
T Consensus 85 ~e~~~~~-----------l~~~l~~~~-------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (290)
T 3fme_A 85 MELMDTS-----------LDKFYKQVI-------------------------DKGQTIPEDILGKIAVSIVKALEHLHSK 128 (290)
T ss_dssp EECCSEE-----------HHHHHHHHH-------------------------HTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred Eehhccc-----------hHHHHHHHH-------------------------hcCCCCCHHHHHHHHHHHHHHHHHHhhc
Confidence 9966544 444433211 1235688999999999999999999998
Q ss_pred -CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccc----cCCCCCchhhHHHHHHH
Q 004442 626 -GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL----LQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 -~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDIwSfGvv 700 (753)
+|+||||||+||+++.++. +||+|||+++...... ......||+.|+|||++ .+..++.++|||||||+
T Consensus 129 ~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 129 LSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDV----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp SCCCCCCCSGGGCEECTTCC--EEBCCC-------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred CCeecCCCCHHHEEECCCCC--EEEeecCCcccccccc----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 9999999999999977654 9999999998765432 12234589999999996 55678999999999999
Q ss_pred HHHHHhCCCCCCCCC--hHH-HHHHHHccCccc-ccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES--FER-DANIVKDRKDLF-LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~--~~~-~~~~i~~~~~~~-~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| ..||... ... ............ ...+++++.++|.+||+.||++|
T Consensus 203 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (290)
T 3fme_A 203 MIELAIL-RFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 258 (290)
T ss_dssp HHHHHHT-SCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHC-CCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhC
Confidence 9999999 6788642 222 222233333322 34678999999999999999998
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.59 Aligned_cols=239 Identities=26% Similarity=0.398 Sum_probs=190.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
..+.++|.+.+.||+|+||.||++... +|+.||||.+.... .....+|+. +++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA-VLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHH-HHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHH-HHHhCCCCCeeehhhhcccCCEEEE
Confidence 455678999999999999999998765 69999999997543 223344554 7889999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++.. ...+++..+..++.|++.||.|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~ 124 (304)
T 2jam_A 84 VMQ----------LVSGGELFDRILE-----------------------------RGVYTEKDASLVIQQVLSAVKYLHE 124 (304)
T ss_dssp EEC----------CCCSCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------cCCCccHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 6667777777643 2357788899999999999999999
Q ss_pred CCccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+|+||||||+||++.. +....+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++||
T Consensus 125 ~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (304)
T 2jam_A 125 NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199 (304)
T ss_dssp TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHH
T ss_pred CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHH
Confidence 99999999999999932 22345999999999764322 1223358999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHHccCc----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF-ERDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~-~~~~~~i~~~~~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| .+||.... ......+..... .....+++++.+||.+||..||++|
T Consensus 200 l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 253 (304)
T 2jam_A 200 LLCG-YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNER 253 (304)
T ss_dssp HHHS-SCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTS
T ss_pred HHHC-CCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHC
Confidence 9998 56776543 333344444332 2335678999999999999999998
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=351.73 Aligned_cols=241 Identities=24% Similarity=0.364 Sum_probs=195.5
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
...+.|.+.+.||+|+||.||++...++..||||+++... .+.+.+|+. +++.++|+||++++++|.+ +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHH-HHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788999999999999999988888899999997643 234455554 8899999999999999876 67899999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.++|+... ...+++.++++|+.||+.||+|||+++|
T Consensus 342 ----------~~~~gsL~~~l~~~~---------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~i 384 (535)
T 2h8h_A 342 ----------YMSKGSLLDFLKGET---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNY 384 (535)
T ss_dssp ----------CCTTEEHHHHHSHHH---------------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ----------hhcCCcHHHHHhhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 777888988886431 2357888999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++ .+||+|||+++..... .........++..|+|||++.+..++.++|||||||+||||+|+
T Consensus 385 vHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 385 VHRDLRAANILVGENL--VCKVADFGLARLIEDN--EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp CCSCCSGGGEEECGGG--CEEECCTTSTTTCCCH--HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred eCCCCCHhhEEEcCCC--cEEEcccccceecCCC--ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999997665 5999999999876432 11122233468899999999999999999999999999999994
Q ss_pred CCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+..||.+... .....+... ....+..+++++.+||.+||+.||++|
T Consensus 461 g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 508 (535)
T 2h8h_A 461 GRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 508 (535)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHC
Confidence 4788876543 333344333 344567889999999999999999998
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.14 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=181.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccc-cCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVE-SDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~-~~~~~~~LV 545 (753)
..++++|.+.+.||+|+||.||++.. .+++.||||++..... ....+|.. ++..++|+|++..++++ .+.+..++|
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHH-HHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHH-HHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 34567899999999999999999975 5689999998765433 34445554 67888888777666665 567788999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+ +|+|.+++... ...+++..++.++.||+.||.|||+.
T Consensus 84 ~e----------~~-~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 84 ME----------LL-GPSLEDLFNFC----------------------------SRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp EE----------CC-CCBHHHHHHHT----------------------------TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------cc-CCCHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 54 56666655421 24578899999999999999999999
Q ss_pred CccccCCCCCcEEE---ecCCCCeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 626 GLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 626 ~IiHrDLKp~NILL---~~d~~~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
+|+||||||+|||+ +.++ .+||+|||+++......... .......||+.|+|||.+.+..++.++||||||
T Consensus 125 ~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 202 (296)
T 4hgt_A 125 NFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 202 (296)
T ss_dssp TEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred CeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHH
Confidence 99999999999999 5554 49999999999876532211 122345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH----HHHHHHHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE----RDANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~----~~~~~i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||++| .+||..... .....+.... ......+++++.++|.+||+.||++|
T Consensus 203 ~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 265 (296)
T 4hgt_A 203 YVLMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 265 (296)
T ss_dssp HHHHHHHHS-SCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred HHHHHHhcC-CCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCC
Confidence 999999998 668765311 1112211111 12236678999999999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.58 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=193.8
Q ss_pred eecceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCCc----hHHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
...+.|.+.+.||+|+||.||++.... ++.||||.+..... +...+|+. +++.+ +||||++++++|.+
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK-IMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEec
Confidence 345678999999999999999987542 35899999976532 23345554 66777 89999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+++|+|.+++......... .....+....+++..+++++.||+.|
T Consensus 122 ~~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~qi~~~ 176 (333)
T 2i1m_A 122 GGPVLVITE----------YCCYGDLLNFLRRKSRVLET---------------DPAFAIANSTASTRDLLHFSSQVAQG 176 (333)
T ss_dssp SSSCEEEEE----------CCTTEEHHHHHHHHHHHHSC---------------C-------CCCCHHHHHHHHHHHHHH
T ss_pred CCceEEEEe----------cCCCCcHHHHHHHhcccccc---------------cccccccccccCHHHHHHHHHHHHHH
Confidence 999999999 66777888887654321100 00011224568899999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 177 l~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 253 (333)
T 2i1m_A 177 MAFLASKNCIHRDVAARNVLLTNGH--VAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 253 (333)
T ss_dssp HHHHHHTTEECSCCSGGGCEEEGGG--EEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHhcCCcccCCcccceEEECCCC--eEEECccccccccccccce-eecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence 9999999999999999999997765 5999999999876443221 122334468899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH--HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE--RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~--~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|++.+||..... ........ .....+...++++.++|.+||+.||++|
T Consensus 254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 311 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHR 311 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhC
Confidence 9999999954788876432 22223332 2334556678999999999999999998
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=332.62 Aligned_cols=232 Identities=24% Similarity=0.288 Sum_probs=189.5
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----------chHHHHHHHHHHHhCCCCceeeeccccc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----------HDVALKEIQNLIASDQHPNIVRWYGVES 537 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~ 537 (753)
.+.++|.+.+.||+|+||.||++.. .+++.||||++.... .....+|+. +++.++||||+++++++.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIA-ILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHH-HHTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHH-HHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999975 568999999997542 123344555 778999999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcC-ChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSG-SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~G-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
+.+..++||| |+..| +|.+++.. ...+++..++.|+.||+
T Consensus 100 ~~~~~~lv~e----------~~~~g~~l~~~~~~-----------------------------~~~l~~~~~~~i~~qi~ 140 (335)
T 3dls_A 100 NQGFFQLVME----------KHGSGLDLFAFIDR-----------------------------HPRLDEPLASYIFRQLV 140 (335)
T ss_dssp CSSEEEEEEE----------CCTTSCBHHHHHHT-----------------------------CCCCCHHHHHHHHHHHH
T ss_pred eCCEEEEEEE----------eCCCCccHHHHHHh-----------------------------cCCCCHHHHHHHHHHHH
Confidence 9999999999 44444 67666632 23578889999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLF 695 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIw 695 (753)
.||+|||+.+|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..+ +.++|||
T Consensus 141 ~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 214 (335)
T 3dls_A 141 SAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGK----LFYTFCGTIEYCAPEVLMGNPYRGPELEMW 214 (335)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTC----CBCEECSCGGGCCHHHHTTCCBCSHHHHHH
T ss_pred HHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCC----ceeccCCCccccChhhhcCCCCCCCcccch
Confidence 9999999999999999999999977654 9999999998775432 1233568999999999988887 8999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 696 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||++|||++| ..||....+. .......+..+++++.+||.+||+.||++|
T Consensus 215 slG~il~el~~g-~~pf~~~~~~-----~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 266 (335)
T 3dls_A 215 SLGVTLYTLVFE-ENPFCELEET-----VEAAIHPPYLVSKELMSLVSGLLQPVPERR 266 (335)
T ss_dssp HHHHHHHHHHHS-SCSCSSGGGG-----TTTCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHhC-CCchhhHHHH-----HhhccCCCcccCHHHHHHHHHHccCChhhC
Confidence 999999999998 6788654321 123334456689999999999999999998
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.63 Aligned_cols=240 Identities=24% Similarity=0.347 Sum_probs=192.5
Q ss_pred cceEEEeEEecccCceEEEEEE-----eeCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeeccccc--CCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVES--DQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~-----~~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~--~~~~ 541 (753)
.++|++.+.||+|+||.||++. ..+++.||||++...... ...+|+ .+++.++|+||+++++++. +.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI-QILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHH-HHHHhcCCCceeEEEEEEecCCCce
Confidence 4678999999999999999987 346899999999765432 234454 4889999999999999876 4667
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+++|+|.+++.... ..+++.++++++.|++.||+|
T Consensus 101 ~~lv~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~al~~ 142 (327)
T 3lxl_A 101 LRLVME----------YLPSGCLRDFLQRHR----------------------------ARLDASRLLLYSSQICKGMEY 142 (327)
T ss_dssp EEEEEE----------CCTTCBHHHHHHHHG----------------------------GGCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------ecCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHH
Confidence 899999 677788888875421 247888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+|||++.++. +||+|||+++................||..|+|||++.+..++.++|||||||++
T Consensus 143 lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 143 LGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 99999999999999999987765 9999999999876544333344455689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHH----------------HHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFER----------------DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~----------------~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| ..||...... ....+ .......+..+++++.+||.+||+.||++|
T Consensus 221 ~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 288 (327)
T 3lxl_A 221 YELFTY-CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDR 288 (327)
T ss_dssp HHHHTT-TCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhC-CCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 999999 4565433221 11111 223345567789999999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=327.66 Aligned_cols=239 Identities=24% Similarity=0.344 Sum_probs=182.5
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC-------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD------- 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------- 538 (753)
..+|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++|+||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHH-HHHhccCCCcccHhheeecccccccc
Confidence 36789999999999999999976 568999999985432 234556665 7799999999999999876
Q ss_pred -CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 539 -QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 539 -~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
.+..++|||+|.++|.+.+ .. ....+++.+++.++.|++.
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l-----------~~----------------------------~~~~~~~~~~~~i~~qi~~ 135 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLL-----------SN----------------------------VLVKFTLSEIKRVMQMLLN 135 (351)
T ss_dssp --CEEEEEEECCSEEHHHHH-----------HC----------------------------TTSCCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEeccCCCHHHHH-----------hh----------------------------ccCCCCHHHHHHHHHHHHH
Confidence 4568999997765544333 21 1235788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccCC-CCCchhhHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLF 695 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIw 695 (753)
||+|||+.+|+||||||+|||++.++. +||+|||+++....... .........||+.|+|||++.+. .++.++|||
T Consensus 136 ~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 213 (351)
T 3mi9_A 136 GLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 213 (351)
T ss_dssp HHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHH
T ss_pred HHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHH
Confidence 999999999999999999999977764 99999999987753221 12223445689999999998764 579999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHH-HHHHHHccCccccc--------------------------------CCCHHHHHHH
Q 004442 696 SLGCILFFCITGGKHPYGESFER-DANIVKDRKDLFLV--------------------------------EHIPEAVDLF 742 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~~~~~--------------------------------~~s~el~dLI 742 (753)
||||++|||+|| .+||...... ....+.......+. ..++++.+||
T Consensus 214 slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (351)
T 3mi9_A 214 GAGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292 (351)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHH
Confidence 999999999998 6677665433 22222211111000 0267899999
Q ss_pred HHccccCcCCC
Q 004442 743 TRLLDPNPDLR 753 (753)
Q Consensus 743 ~~cL~~DP~~R 753 (753)
.+||..||++|
T Consensus 293 ~~~L~~dP~~R 303 (351)
T 3mi9_A 293 DKLLVLDPAQR 303 (351)
T ss_dssp HHHSCSSGGGS
T ss_pred HHHhcCChhhC
Confidence 99999999998
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=320.95 Aligned_cols=235 Identities=25% Similarity=0.389 Sum_probs=179.6
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch-----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~-----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|.+.+.||+|+||+||++... +|+.||||++...... ...+|+ .+++.++||||+++++++.+.+..++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHhCCCCCccchhheeecCCeEEEEE
Confidence 57899999999999999999775 4899999998654422 233444 4789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++.. ...+++..+..++.|++.||+|||+.+
T Consensus 82 e----------~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~~l~~lH~~~ 122 (311)
T 4agu_A 82 E----------YCDHTVLHELDRY-----------------------------QRGVPEHLVKSITWQTLQAVNFCHKHN 122 (311)
T ss_dssp E----------CCSEEHHHHHHHT-----------------------------SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------eCCCchHHHHHhh-----------------------------hcCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5555666655432 245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+||+++.++. +||+|||+++....... ......||+.|+|||++.+ ..++.++|||||||++|||+
T Consensus 123 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 123 CIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSD---YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECC---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CcCCCCChhhEEEcCCCC--EEEeeCCCchhccCccc---ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 999999999999977754 99999999987653321 2234468999999999976 56899999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHcc---------------------Cc----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKDR---------------------KD----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~~---------------------~~----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| .+||....... ...+... .. .....+++++.+||.+||+.||++|
T Consensus 198 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 198 SG-VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 98 67776653322 2211110 00 0113578899999999999999998
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=342.71 Aligned_cols=238 Identities=25% Similarity=0.384 Sum_probs=191.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.+.++|.+.+.||+|+||+||++... +++.||||++... ......+|+. +++.++||||+++++++.+.+..+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-LLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHH-HHHhCCCCCcCeEEEEEEcCCEEE
Confidence 45578999999999999999999765 6899999998532 2334455655 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++..+..++.||+.||.|||
T Consensus 98 lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~al~~lH 138 (486)
T 3mwu_A 98 IVGE----------LYTGGELFDEIIK-----------------------------RKRFSEHDAARIIKQVFSGITYMH 138 (486)
T ss_dssp EEEC----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6667778776643 245788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.+ ....+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|
T Consensus 139 ~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ 213 (486)
T 3mwu_A 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN----TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILY 213 (486)
T ss_dssp HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHH
T ss_pred HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC----CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHH
Confidence 9999999999999999643 2346999999999876543 22334569999999999875 5999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGES-FERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~-~~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++| .+||.+. .......+...... ....+++++.+||++||++||++|
T Consensus 214 ~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 268 (486)
T 3mwu_A 214 ILLSG-TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268 (486)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhC
Confidence 99999 5666554 34444444444332 235678999999999999999998
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.37 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=187.2
Q ss_pred cceEEEeE-EecccCceEEEEEEee---CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 472 GKLVVFNK-EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~-~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
.++|.+.+ .||+|+||.||++... .++.||||++..... ...+..+..+++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999998543 478999999975431 12233333478999999999999999 567789
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.. ...+++..++.++.|++.||+|||
T Consensus 94 lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~LH 134 (291)
T 1xbb_A 94 LVME----------MAELGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLE 134 (291)
T ss_dssp EEEE----------CCTTEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------eCCCCCHHHHHHh-----------------------------CcCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6667778777743 234778889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++ .+||+|||+++................+|+.|+|||.+.+..++.++||||||+++||
T Consensus 135 ~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 212 (291)
T 1xbb_A 135 ESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 212 (291)
T ss_dssp HTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred hCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHH
Confidence 99999999999999998776 4999999999887654333333334457899999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CIT-GGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llT-G~~~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+| | ..||....... ...+... ....+..+++++.++|.+||+.||++|
T Consensus 213 l~~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 264 (291)
T 1xbb_A 213 AFSYG-QKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 264 (291)
T ss_dssp HHTTT-CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred HHhcC-CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 999 6 67887654333 3333333 345567789999999999999999998
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.84 Aligned_cols=242 Identities=26% Similarity=0.420 Sum_probs=178.7
Q ss_pred cceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccc-------
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVE------- 536 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~------- 536 (753)
+..+.++|.+.+.||+|+||.||++.... |+.||||++..... +...+|+. +++.++||||+++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECTTSCBC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHH-HHHhcCCCCeeEEEEecccccccc
Confidence 45677889999999999999999997764 89999999875542 23345554 78999999999999876
Q ss_pred -------cCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHH
Q 004442 537 -------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (753)
Q Consensus 537 -------~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 609 (753)
.+.+..++|||+|.+ +|.+++. ...+++..++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~-----------~L~~~~~------------------------------~~~~~~~~~~ 123 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMET-----------DLANVLE------------------------------QGPLLEEHAR 123 (320)
T ss_dssp CC----CCSCSEEEEEEECCSE-----------EHHHHHT------------------------------TCCCCHHHHH
T ss_pred ccccccccccCceeEEeeccCC-----------CHHHHhh------------------------------cCCccHHHHH
Confidence 345788999995554 4444442 1346778889
Q ss_pred HHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCC
Q 004442 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQ 688 (753)
Q Consensus 610 ~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~ 688 (753)
.++.|++.||+|||+.+|+||||||+||+++.++ ..+||+|||+++................+|..|+|||.+.+ ..+
T Consensus 124 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (320)
T 2i6l_A 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY 202 (320)
T ss_dssp HHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCC
T ss_pred HHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccC
Confidence 9999999999999999999999999999997443 46999999999876543222233344457999999998876 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHccC------------------------------cccccCCCHH
Q 004442 689 TRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRK------------------------------DLFLVEHIPE 737 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~------------------------------~~~~~~~s~e 737 (753)
+.++|||||||++|||+|| ++||...... ....+.... ......++++
T Consensus 203 ~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (320)
T 2i6l_A 203 TKAIDMWAAGCIFAEMLTG-KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISRE 281 (320)
T ss_dssp CHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHH
T ss_pred CchhhhHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHH
Confidence 9999999999999999998 6677665332 222211110 0122457899
Q ss_pred HHHHHHHccccCcCCC
Q 004442 738 AVDLFTRLLDPNPDLR 753 (753)
Q Consensus 738 l~dLI~~cL~~DP~~R 753 (753)
+.+||++||+.||++|
T Consensus 282 ~~~li~~~L~~dP~~R 297 (320)
T 2i6l_A 282 AVDFLEQILTFSPMDR 297 (320)
T ss_dssp HHHHHHTTSCSSGGGS
T ss_pred HHHHHHHHcCCCcccc
Confidence 9999999999999998
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=336.38 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=189.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
....++|.+.+.||+|+||.||++...+|+.||||++..... ....+|+. +++.++||||++++++|.+.+..++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE-MISMAVHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHH-GGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHH-HHHhccCCCccceEEEEecCCceEE
Confidence 344566778889999999999999888899999999965432 23445554 7789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.++++.... ....+++..++.|+.|++.||+|||+
T Consensus 105 v~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~ 149 (326)
T 3uim_A 105 VYP----------YMANGSVASCLRERPE-------------------------SQPPLDWPKRQRIALGSARGLAYLHD 149 (326)
T ss_dssp EEE----------CCTTCBHHHHHHCCST-------------------------TCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eccCCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 7778888888865321 23458899999999999999999999
Q ss_pred C---CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 625 I---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 625 ~---~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
. +|+||||||+|||++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++
T Consensus 150 ~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 225 (326)
T 3uim_A 150 HCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225 (326)
T ss_dssp SSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSS--CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHH
T ss_pred CCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCcccc--cccccccCCcCccCHHHhccCCCCccccchhHHHHH
Confidence 9 9999999999999977654 99999999987754322 222344589999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCCh------HHHHHHHHcc--------------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF------ERDANIVKDR--------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~------~~~~~~i~~~--------------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|| .+||+... .......... ........++++.++|.+||+.||++|
T Consensus 226 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 296 (326)
T 3uim_A 226 LELITG-QRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296 (326)
T ss_dssp HHHHHC-CCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGS
T ss_pred HHHHhC-CCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccC
Confidence 999998 67874211 0111111110 001122234679999999999999998
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.53 Aligned_cols=237 Identities=23% Similarity=0.318 Sum_probs=180.2
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|.+.+.||+|+||.||++... +++.||||++..... +...+|+ .+++.++||||+++++++.+++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREA-RTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHH-HHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 467999999999999999999765 689999999965421 2233444 47789999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++... ..+++.+++.++.|++.||+|||+
T Consensus 112 v~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~~l~~lH~ 152 (309)
T 2h34_A 112 DMR----------LINGVDLAAMLRRQ-----------------------------GPLAPPRAVAIVRQIGSALDAAHA 152 (309)
T ss_dssp EEE----------CCCCEEHHHHHHHH-----------------------------CSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------ecCCCCHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 66667777776432 357888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++. +||+|||++....... ........||+.|+|||++.+..++.++||||||+++|||
T Consensus 153 ~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (309)
T 2h34_A 153 AGATHRDVKPENILVSADDF--AYLVDFGIASATTDEK--LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYEC 228 (309)
T ss_dssp TTCCCSCCCGGGEEECTTSC--EEECSCCC------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHH
T ss_pred CcCCcCCCChHHEEEcCCCC--EEEecCccCccccccc--cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHH
Confidence 99999999999999977765 9999999998765432 1222344689999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHccCc----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~~~~i~~~~~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++| ..||................ ..+..+++++.++|.+||+.||++|
T Consensus 229 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 280 (309)
T 2h34_A 229 LTG-SPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280 (309)
T ss_dssp HHS-SCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGS
T ss_pred HHC-CCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHH
Confidence 998 67887765543333222221 2345678999999999999999998
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.80 Aligned_cols=239 Identities=26% Similarity=0.335 Sum_probs=181.9
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC------CceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD------QDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------~~~~~ 543 (753)
....|.+.+.||+|+||.||+|... +|+.||||++.... ....+|+. +++.++|+|||+++++|.. ...++
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~-il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHH-HHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHH-HHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3457899999999999999999775 59999999986543 22234555 7899999999999998743 23468
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+|||||++++.+++ .... .....+++..+..++.||++||+|||
T Consensus 130 lv~e~~~~~l~~~~-----------~~~~-------------------------~~~~~l~~~~~~~~~~qi~~aL~~LH 173 (420)
T 1j1b_A 130 LVLDYVPETVYRVA-----------RHYS-------------------------RAKQTLPVIYVKLYMYQLFRSLAYIH 173 (420)
T ss_dssp EEEECCCEEHHHHH-----------HHHH-------------------------HTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eehhcccccHHHHH-----------HHHh-------------------------hccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99997765443332 2111 12356888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++ ..+||+|||+++...... .....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 174 ~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 248 (420)
T 1j1b_A 174 SFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248 (420)
T ss_dssp TTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCTTC----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEeCCC-CeEEeccchhhhhcccCC----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHH
Confidence 99999999999999998654 358999999999765332 22345689999999999765 6899999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHcc-----------------Cc------------ccccCCCHHHHHHHHHccccCcCC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKDR-----------------KD------------LFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~~-----------------~~------------~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
||++| ++||.+... .....+... .. .+....++++.+||++||.+||++
T Consensus 249 ell~G-~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 249 ELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHHS-SCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99998 667765432 222111110 00 023456789999999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 328 R 328 (420)
T 1j1b_A 328 R 328 (420)
T ss_dssp S
T ss_pred C
Confidence 8
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.79 Aligned_cols=236 Identities=23% Similarity=0.369 Sum_probs=190.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC---------
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------- 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--------- 538 (753)
..+..+|.+.+.||+|+||.||++... +|+.||||++.... +...+|+. ++..++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVK-ALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHH-HHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHH-HHHhCCCCCEEEEeeeEeccccCccccc
Confidence 456678999999999999999999775 69999999997654 34455665 7789999999999998754
Q ss_pred -------CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 539 -------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 539 -------~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
....++||| |+.+|+|.+++.... ...+++..++++
T Consensus 85 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i 127 (284)
T 2a19_B 85 KNSSRSKTKCLFIQME----------FCDKGTLEQWIEKRR---------------------------GEKLDKVLALEL 127 (284)
T ss_dssp ----CCEEEEEEEEEC----------CCCSCBHHHHHHHGG---------------------------GSCCCHHHHHHH
T ss_pred ccccccCcceEEEEEe----------ccCCCCHHHHHhhcc---------------------------CCCCCHHHHHHH
Confidence 455899999 667788888875431 245788899999
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k 691 (753)
+.|++.||.|||+.+|+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.+
T Consensus 128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGDFGLVTSLKNDG----KRTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEESSCCS----CCCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred HHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECcchhheeccccc----cccccCCcccccChhhhccCCCcch
Confidence 99999999999999999999999999998775 49999999998775432 1233458999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||||||+++|||++|.. |+.... ....... ....+..+++++.++|.+||+.||++|
T Consensus 202 ~Di~slG~il~~l~~~~~-~~~~~~-~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R 259 (284)
T 2a19_B 202 VDLYALGLILAELLHVCD-TAFETS-KFFTDLR--DGIISDIFDKKEKTLLQKLLSKKPEDR 259 (284)
T ss_dssp HHHHHHHHHHHHHHSCCS-SHHHHH-HHHHHHH--TTCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hhhHHHHHHHHHHHhcCC-cchhHH-HHHHHhh--cccccccCCHHHHHHHHHHccCChhhC
Confidence 999999999999999954 443221 1112222 223456788999999999999999998
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=319.34 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=187.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+...+.|.+.+.||+|+||.||++... +|+.||||.+..... ....+|+. ++..++||||+++++++.+.+..++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS-IMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHH-HHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345577999999999999999999765 489999999976543 34455554 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|.+++... ...+++..++.++.|++.||.|||+.+
T Consensus 104 e----------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (314)
T 3com_A 104 E----------YCGAGSVSDIIRLR----------------------------NKTLTEDEIATILQSTLKGLEYLHFMR 145 (314)
T ss_dssp E----------CCTTEEHHHHHHHH----------------------------TCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------cCCCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 55666777766421 245788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||+++.++. +||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 146 i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 220 (314)
T 3com_A 146 KIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220 (314)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBS---CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred CcCCCcCHHHEEECCCCC--EEEeecccchhhhhhcc---ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999977765 99999999987654321 2234468999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHccC---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~~~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||....... ...+.... ...+..+++++.+||.+||+.||++|
T Consensus 221 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 270 (314)
T 3com_A 221 G-KPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270 (314)
T ss_dssp S-SCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTS
T ss_pred C-CCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhC
Confidence 8 66776653322 22222222 12345678999999999999999998
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.14 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=193.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCC----chHHHHHHHHHHHhC-CCCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~ 537 (753)
+...++|.+.+.||+|+||.||++... .+..||||++.... .+...+|+. ++..+ +||||+++++++.
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK-MMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHH-HHHHHCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEe
Confidence 445678999999999999999999752 46789999996432 234556665 66777 9999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+.+..++||| |+++|+|.+++.......... .... ..............+++..++.++.||+.
T Consensus 120 ~~~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 183 (344)
T 1rjb_A 120 LSGPIYLIFE----------YCCYGDLLNYLRSKREKFSED---EIEY---ENQKRLEEEEDLNVLTFEDLLCFAYQVAK 183 (344)
T ss_dssp SSSSCEEEEE----------CCTTCBHHHHHHTTTTCC---------------------------CCHHHHHHHHHHHHH
T ss_pred eCCccEEEEe----------cCCCCcHHHHHhhcccccccc---ccch---hhhcccccccccccCCHHHHHHHHHHHHH
Confidence 9999999999 666778887776543211000 0000 00000001112345899999999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 184 aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 184 GMEFLEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp HHHHHHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHhCCcccCCCChhhEEEcCCC--cEEeCCCccCcccccCccc-eeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 99999999999999999999997775 5999999999876543221 12223346889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH--HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~--~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|++.+||..... .....+... ....+..+++++.+||.+||+.||++|
T Consensus 261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 319 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 319 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhC
Confidence 99999999933778866432 222333332 344566788999999999999999998
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=314.66 Aligned_cols=235 Identities=24% Similarity=0.336 Sum_probs=179.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.++|.+.+.||+|+||.||++.. .|+.||||++..... ...++++..+++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788999999999999999876 489999999864321 13344444588999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++. ...+++..+++++.|++.||+|||+.
T Consensus 85 ~e----------~~~~~~L~~~~~------------------------------~~~~~~~~~~~i~~~l~~~l~~lH~~ 124 (271)
T 3dtc_A 85 ME----------FARGGPLNRVLS------------------------------GKRIPPDILVNWAVQIARGMNYLHDE 124 (271)
T ss_dssp EE----------CCTTEEHHHHHT------------------------------SSCCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred EE----------cCCCCCHHHHhh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 666777777653 23578889999999999999999999
Q ss_pred C---ccccCCCCCcEEEecC------CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 626 G---LIHRDLKPQNVLISKD------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 626 ~---IiHrDLKp~NILL~~d------~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
+ |+||||||+||+++.+ ....+||+|||+++...... .....||+.|+|||.+.+..++.++||||
T Consensus 125 ~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 199 (271)
T 3dtc_A 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-----KMSAAGAYAWMAPEVIRASMFSKGSDVWS 199 (271)
T ss_dssp SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC------------------CCGGGSCHHHHHHCCCSHHHHHHH
T ss_pred CCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-----ccCCCCccceeCHHHhccCCCCchhhHHH
Confidence 8 9999999999999752 13459999999998764322 12345899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHH-HHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESFERD-ANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~~-~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+++|||++| .+||....... ....... ....+..+++++.++|.+||+.||++|
T Consensus 200 lG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 258 (271)
T 3dtc_A 200 YGVLLWELLTG-EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258 (271)
T ss_dssp HHHHHHHHHHC-CCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccC
Confidence 99999999998 66776654332 2222222 234567788999999999999999998
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.50 Aligned_cols=235 Identities=23% Similarity=0.306 Sum_probs=177.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|.+.+.||+|+||+||++... +++.||||++...... ...+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHH-HHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHH-HHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 46889999999999999999765 6899999999644322 2234555 7789999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.++|. +++... ...+++..+..++.|++.||+|||+.+|
T Consensus 81 ~~~~~l~-----------~~~~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 121 (324)
T 3mtl_A 81 YLDKDLK-----------QYLDDC----------------------------GNIINMHNVKLFLFQLLRGLAYCHRQKV 121 (324)
T ss_dssp CCSEEHH-----------HHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ccccCHH-----------HHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6665444 433221 2357788899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 122 vH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 196 (324)
T 3mtl_A 122 LHRDLKPQNLLINERGE--LKLADFGLARAKSIPT---KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196 (324)
T ss_dssp EESSCCGGGEEECTTCC--EEECSSSEEECC---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred cCCCcCHHHEEECCCCC--EEEccCcccccccCCc---cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999977765 9999999998654321 12234468999999999877 568999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHcc-C-----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKDR-K-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~~-~-----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.+..... ...+... . ......+++++.+||++||+.||++|
T Consensus 197 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 273 (324)
T 3mtl_A 197 G-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR 273 (324)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccC
Confidence 8 67776654332 2222110 0 01123467899999999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.30 Aligned_cols=240 Identities=20% Similarity=0.304 Sum_probs=179.2
Q ss_pred ceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC-CceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~~ 543 (753)
..|.+.+.||+|+||+||+|...+ +..||||.+..... +.+.+|.. +++.++||||++++++|.+ ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI-IMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHT-TSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEEcCCCCeE
Confidence 457888999999999999987643 24689999865432 23344444 7788999999999998765 56789
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++... ...+++.+++.++.||+.||+|||
T Consensus 168 lv~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH 209 (373)
T 3c1x_A 168 VVLP----------YMKHGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKFLA 209 (373)
T ss_dssp EEEE----------CCTTCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------CCCCCCHHHHHhhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 77788888887532 234677888999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++ .+||+|||+++........ ........+|+.|+|||++.+..++.++|||||||++|
T Consensus 210 ~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 210 SKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp HTTCCCSCCCGGGEEECTTC--CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HCCEecCccchheEEECCCC--CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999997665 4999999999876432211 11122345788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~-~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+||+.+||...... ....+. ......+..+++++.++|.+||+.||++|
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~R 340 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 340 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999778888765332 222233 33344566788999999999999999998
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=342.50 Aligned_cols=239 Identities=25% Similarity=0.403 Sum_probs=189.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.+.|.+.+.||+|+||+||++... ++..||||++.+.. .....+|+. +++.++||||++++++|.+.+..
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVA-VLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHH-HHHhCCCCCCCeEEEEEEeCCEE
Confidence 345678999999999999999999765 68999999996532 234445554 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 112 ~lv~e----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~l 152 (494)
T 3lij_A 112 YLVME----------CYKGGELFDEIIH-----------------------------RMKFNEVDAAVIIKQVLSGVTYL 152 (494)
T ss_dssp EEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6667777776643 24578888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+|||++.++ ...+||+|||+++...... .....+||+.|+|||++. ..++.++|||||||++
T Consensus 153 H~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il 227 (494)
T 3lij_A 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK----KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVIL 227 (494)
T ss_dssp HHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB----CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHH
T ss_pred HHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc----cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHH
Confidence 999999999999999997543 3469999999998775432 234456999999999886 5699999999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF-ERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~-~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++| .+||.... ......+......+ ...+++++.+||++||+.||++|
T Consensus 228 ~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 283 (494)
T 3lij_A 228 FILLAG-YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283 (494)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhC
Confidence 999998 66776654 34444444443332 24678999999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=339.37 Aligned_cols=213 Identities=24% Similarity=0.362 Sum_probs=150.2
Q ss_pred ceecceEEE-eEEecccCceEEEEEEee---CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeeecccc--cCCce
Q 004442 469 RRIGKLVVF-NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVE--SDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i-~~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~--~~~~~ 541 (753)
+.+.+.|.+ .+.||+|+||+||+|... +++.||||++..... ....+|+. +++.++||||+++++++ .....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHH-HHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHH-HHHhcCCCCeeeEeeEEecCCCCe
Confidence 445566776 457999999999999765 578999999976543 34556665 88999999999999998 45778
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++|||||.++|.+++ ........ ......+++..++.|+.||+.||+|
T Consensus 95 ~~lv~e~~~~~l~~~~-----------~~~~~~~~--------------------~~~~~~l~~~~~~~i~~qi~~al~~ 143 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHII-----------KFHRASKA--------------------NKKPVQLPRGMVKSLLYQILDGIHY 143 (405)
T ss_dssp EEEEEECCSEEHHHHH-----------HHHHHHC---------------------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCHHHHH-----------HHhccccc--------------------cccccCCCHHHHHHHHHHHHHHHHH
Confidence 9999997776555444 22111000 0112358899999999999999999
Q ss_pred hhhCCccccCCCCCcEEEec--CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISK--DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLG 698 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~--d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfG 698 (753)
||+.+|+||||||+|||+.. +....+||+|||+++...............+||+.|+|||++.+. .++.++||||||
T Consensus 144 LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG 223 (405)
T 3rgf_A 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223 (405)
T ss_dssp HHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHH
T ss_pred HHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHH
Confidence 99999999999999999943 222459999999998775433332334456799999999999874 489999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGE 714 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~ 714 (753)
|++|||+|| .+||..
T Consensus 224 ~il~ell~g-~~pf~~ 238 (405)
T 3rgf_A 224 CIFAELLTS-EPIFHC 238 (405)
T ss_dssp HHHHHHHHS-SCTTCC
T ss_pred HHHHHHHhC-CCCCCC
Confidence 999999998 677754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-36 Score=326.99 Aligned_cols=239 Identities=23% Similarity=0.348 Sum_probs=184.1
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCC-----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~----- 539 (753)
.++.+|.+.+.||+|+||.||++... +++.||||++...... ...+|+. ++..++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHH-HHHhcCCCCCccceeEEecCCcccc
Confidence 34578999999999999999999754 6889999999754322 3345554 78899999999999998654
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++|||+|.++ |.+++. ...+++.++..++.||+.||
T Consensus 103 ~~~~iv~e~~~~~-----------L~~~l~------------------------------~~~~~~~~~~~i~~qi~~aL 141 (364)
T 3qyz_A 103 KDVYIVQDLMETD-----------LYKLLK------------------------------TQHLSNDHICYFLYQILRGL 141 (364)
T ss_dssp CCEEEEEECCSEE-----------HHHHHH------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEcccCcC-----------HHHHHH------------------------------hCCCCHHHHHHHHHHHHHHH
Confidence 4689999966544 444332 23578888999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfG 698 (753)
+|||+.+|+||||||+|||++.++. +||+|||+++...............+||+.|+|||++.+ ..++.++||||||
T Consensus 142 ~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 219 (364)
T 3qyz_A 142 KYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 219 (364)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH
T ss_pred HHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHH
Confidence 9999999999999999999977755 999999999877543322223345579999999998765 4489999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHHcc--C-----------------------------cccccCCCHHHHHHHHHcc
Q 004442 699 CILFFCITGGKHPYGESFE-RDANIVKDR--K-----------------------------DLFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~-~~~~~i~~~--~-----------------------------~~~~~~~s~el~dLI~~cL 746 (753)
|++|||++| .+||.+... .....+... . ......+++++.+||.+||
T Consensus 220 ~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 298 (364)
T 3qyz_A 220 CILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 298 (364)
T ss_dssp HHHHHHHHS-SCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHc
Confidence 999999998 677765432 222221100 0 0112456889999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 299 ~~dP~~R 305 (364)
T 3qyz_A 299 TFNPHKR 305 (364)
T ss_dssp CSSTTTS
T ss_pred CCChhhC
Confidence 9999998
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=344.33 Aligned_cols=239 Identities=26% Similarity=0.427 Sum_probs=192.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
..+.++|.+.+.||+|+||.||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQ-LLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHH-HHHhCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999765 69999999986432 233455555 7899999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++.. ...+++..+..++.||+.||.|
T Consensus 101 ~~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~ 141 (484)
T 3nyv_A 101 FYLVGE----------VYTGGELFDEIIS-----------------------------RKRFSEVDAARIIRQVLSGITY 141 (484)
T ss_dssp EEEEEC----------CCCSCBHHHHHHT-----------------------------CSCCBHHHHHHHHHHHHHHHHH
T ss_pred EEEEEe----------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 6667788777642 2457888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecC-CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d-~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
||+.+|+||||||+|||++.+ ....+||+|||+++...... .....+||+.|+|||++.+ .++.++|||||||+
T Consensus 142 lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~i 216 (484)
T 3nyv_A 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK----KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVI 216 (484)
T ss_dssp HHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC----SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHH
T ss_pred HHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc----ccccCCCCccccCceeecC-CCCCcceeHHHHHH
Confidence 999999999999999999532 22459999999998765432 1233468999999999876 69999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+|++| .+||..... .....+...... ....+++++.+||++||++||++|
T Consensus 217 l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 273 (484)
T 3nyv_A 217 LYILLSG-CPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMR 273 (484)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHC
Confidence 9999998 667766543 344444444332 235678999999999999999998
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=317.27 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=188.7
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeeccccc--CCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES--DQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~--~~~~~~L 544 (753)
.++|++.+.||+|+||.||++... +|+.||+|++..... ...+.++..+++.++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999765 689999999975431 122333334788999999999999874 4678999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++..... ....+++..+++++.|++.||+|||+
T Consensus 85 v~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (279)
T 2w5a_A 85 VME----------YCEGGDLASVITKGTK-------------------------ERQYLDEEFVLRVMTQLTLALKECHR 129 (279)
T ss_dssp EEE----------CCTTEEHHHHHHHHHH-------------------------TTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------CCCCCCHHHHHHhhcc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 999 6667778777764321 12458889999999999999999999
Q ss_pred CC-----ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 625 IG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 625 ~~-----IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.+ |+||||||+||+++.++. +||+|||+++....... ......||+.|+|||++.+..++.++||||||+
T Consensus 130 ~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 204 (279)
T 2w5a_A 130 RSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTS---FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 204 (279)
T ss_dssp HC------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CH---HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHH
T ss_pred ccCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccc---cccccCCCccccChHHhccCCCCchhhHHHHHH
Confidence 98 999999999999976654 99999999987653221 112335899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|| .+||...... ....+... ....+..+++++.++|.+||+.||++|
T Consensus 205 il~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 259 (279)
T 2w5a_A 205 LLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 259 (279)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHC-CCCCcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccC
Confidence 99999998 6787765433 33333333 335667889999999999999999998
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.89 Aligned_cols=239 Identities=21% Similarity=0.273 Sum_probs=186.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcE----EEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRS----VAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~----VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.++|.+.+.||+|+||+||+|... +++. ||+|.+.... .....+|+. +++.++||||++++++|. .+..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML-AIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHH-HHHTCCCTTBCCEEEEEC-BSSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEc-CCcc
Confidence 356889999999999999999754 3443 8888875432 123344554 778999999999999986 5668
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.... ..+++..++.++.||+.||+||
T Consensus 90 ~~v~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~l 131 (325)
T 3kex_A 90 QLVTQ----------YLPLGSLLDHVRQHR----------------------------GALGPQLLLNWGVQIAKGMYYL 131 (325)
T ss_dssp EEEEE----------CCTTCBSHHHHHSSG----------------------------GGSCTTHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------eCCCCCHHHHHHHcc----------------------------ccCCHHHHHHHHHHHHHHHHHH
Confidence 99999 777888888875421 2466778899999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++. +||+|||+++........ .......||..|+|||++.+..++.++|||||||++|
T Consensus 132 H~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 208 (325)
T 3kex_A 132 EEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQ-LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVW 208 (325)
T ss_dssp HHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTTC-CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCCCCCCccchheEEECCCCe--EEECCCCcccccCccccc-ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHH
Confidence 9999999999999999977665 999999999887543221 1223445788999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|++..||..... .....+... ....+..+++++.++|.+||..||++|
T Consensus 209 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 261 (325)
T 3kex_A 209 ELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIR 261 (325)
T ss_dssp HHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTS
T ss_pred HHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhC
Confidence 999933778876543 333334433 445566778899999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=337.61 Aligned_cols=203 Identities=26% Similarity=0.296 Sum_probs=164.5
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhC------CCCceeeecccccC
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASD------QHPNIVRWYGVESD 538 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l------~HpNIV~L~g~~~~ 538 (753)
...+..+|.+.+.||+|+||+||+|... +++.||||++..... ....+|+. ++..+ .|+||+++++++..
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR-ILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHH-HHHHHhhccccCCcCEEEEEeeccc
Confidence 3566778999999999999999999665 489999999976432 23344444 33433 68899999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++|||+|.++ |.+++... ....+++..+.+|+.||+.|
T Consensus 171 ~~~~~lv~e~~~~~-----------L~~~l~~~---------------------------~~~~~~~~~~~~i~~qi~~a 212 (429)
T 3kvw_A 171 RNHICMTFELLSMN-----------LYELIKKN---------------------------KFQGFSLPLVRKFAHSILQC 212 (429)
T ss_dssp TTEEEEEECCCCCB-----------HHHHHHHT---------------------------TTCCCCHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeccCCC-----------HHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHH
Confidence 99999999966544 44444322 12357888999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|+|||+.+|+||||||+|||++.++...+||+|||+++..... ....+||+.|+|||++.+..++.++||||||
T Consensus 213 L~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 286 (429)
T 3kvw_A 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR------VYTYIQSRFYRAPEVILGARYGMPIDMWSLG 286 (429)
T ss_dssp HHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHH
T ss_pred HHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc------ccccCCCCCccChHHHhCCCCCchHHHHhHH
Confidence 9999999999999999999998877656999999999765432 2345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCh
Q 004442 699 CILFFCITGGKHPYGESF 716 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~ 716 (753)
|++|||+|| .+||....
T Consensus 287 ~il~elltG-~~pf~~~~ 303 (429)
T 3kvw_A 287 CILAELLTG-YPLLPGED 303 (429)
T ss_dssp HHHHHHHHS-SCSSCCSS
T ss_pred HHHHHHHhC-CCCCCCCC
Confidence 999999999 66776553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=323.33 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=194.7
Q ss_pred eecceEEEeEEecccCceEEEEEEe--------eCCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVE 536 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~--------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~ 536 (753)
...++|.+.+.||+|+||.||+|.. .++..||||++...... ...+|+. +++.+ +||||++++++|
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHH-HHHHhhcCCCEeeEEEEE
Confidence 3457899999999999999999975 35789999999765432 3345555 56666 999999999999
Q ss_pred cCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 537 ~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
.+.+..++||| |+.+|+|.+++........... ..........+++.++++++.||+
T Consensus 111 ~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~qi~ 167 (334)
T 2pvf_A 111 TQDGPLYVIVE----------YASKGNLREYLRARRPPGMEYS-------------YDINRVPEEQMTFKDLVSCTYQLA 167 (334)
T ss_dssp CSSSCCEEEEE----------CCTTCBHHHHHHTTSCTTCCSC-------------C--------CCCHHHHHHHHHHHH
T ss_pred ccCCceEEEEE----------CCCCCcHHHHHHHhcccccccc-------------ccccccccccCCHHHHHHHHHHHH
Confidence 99999999999 6777888888865432110000 000012234588999999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
.||+|||+.+|+||||||+||+++.++. +||+|||+++....... ........+|+.|+|||++.+..++.++||||
T Consensus 168 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 244 (334)
T 2pvf_A 168 RGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244 (334)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSS-EECCSCCCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHhCCeeCCCCccceEEEcCCCC--EEEcccccccccccccc-ccccCCCCcccceeChHHhcCCCcChHHHHHH
Confidence 9999999999999999999999977764 99999999987754321 12223445788999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||+|++..||..... .....+.. .....+..+++++.++|.+||+.||++|
T Consensus 245 lG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 245 FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 999999999944778866533 33333333 3345667789999999999999999998
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=315.11 Aligned_cols=238 Identities=23% Similarity=0.315 Sum_probs=185.6
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..++|.+.+.||+|+||+||+|...+ +..||||.+..... +...+|+. +++.++||||+++++++.++ ..
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLDHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHH-HHHHHCCTTBCCEEEEECSS-SC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHH-HHHhCCCCCcceEEEEEcCC-CC
Confidence 34678999999999999999987653 34699999976532 23344444 77888999999999998654 56
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++... ...+++..++.++.|++.||.||
T Consensus 88 ~~v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~l 129 (281)
T 3cc6_A 88 WIIME----------LYPYGELGHYLERN----------------------------KNSLKVLTLVLYSLQICKAMAYL 129 (281)
T ss_dssp EEEEE----------CCTTCBHHHHHHHH----------------------------TTTCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cCCCCCHHHHHHhc----------------------------cccCCHHHHHHHHHHHHHHHHHH
Confidence 89999 66778888877532 23477888999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++ .+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|
T Consensus 130 H~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 205 (281)
T 3cc6_A 130 ESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY--YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205 (281)
T ss_dssp HHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc--cccccCCCCcceeCchhhccCCCCchhccHHHHHHHH
Confidence 999999999999999998776 499999999987654321 1123345788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCC-hHHHHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCIT-GGKHPYGES-FERDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllT-G~~~Pf~~~-~~~~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+| | ++||... .......+ .......+..+++++.++|.+||+.||++|
T Consensus 206 ~llt~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (281)
T 3cc6_A 206 EILSFG-KQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258 (281)
T ss_dssp HHHTTT-CCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCC-CCCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhC
Confidence 9999 6 6677543 33333333 333445667789999999999999999998
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=353.93 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=184.9
Q ss_pred eEEEeE-EecccCceEEEEEEee---CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 474 LVVFNK-EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 474 ~~~i~~-~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.+.+.+ .||+|+||.||+|... ++..||||+++... .+.+.+|+. +++.++|||||+++++|.+ +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~-il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHH-HHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999998664 46789999997532 234455555 7899999999999999976 569999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++... ...+++.+++.|+.||+.||+|||+.
T Consensus 414 ~E----------~~~~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~ 455 (613)
T 2ozo_A 414 ME----------MAGGGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEEK 455 (613)
T ss_dssp EE----------CCTTCBHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------eCCCCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 77788998887532 23578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++ .+||+|||+++................+|+.|+|||++.+..++.++|||||||++|||+
T Consensus 456 ~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 456 NFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp TCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999998775 599999999987654332222223334678999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|.+..||.... ......+... ....+..+++++.+||.+||+.||++|
T Consensus 534 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 583 (613)
T 2ozo_A 534 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 583 (613)
T ss_dssp TTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTS
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 93377887653 3333444443 345667789999999999999999998
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.22 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=190.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----------hHHHHHHHHHHHhC-CCCceeeeccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----------DVALKEIQNLIASD-QHPNIVRWYGV 535 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l-~HpNIV~L~g~ 535 (753)
..+.++|.+.+.||+|+||.||+|... +|+.||||++..... +...+|+. ++..+ +||||++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH-ILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHH-HHHHHTTCTTBCCEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHH-HHHHhcCCCCEeEEEEE
Confidence 344577999999999999999999875 699999999865431 12334544 55666 89999999999
Q ss_pred ccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 536 ~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
+...+..++||| |+.+|+|.+++.. ...+++..+..++.||
T Consensus 169 ~~~~~~~~lv~e----------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi 209 (365)
T 2y7j_A 169 YESSSFMFLVFD----------LMRKGELFDYLTE-----------------------------KVALSEKETRSIMRSL 209 (365)
T ss_dssp EEBSSEEEEEEC----------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHH
T ss_pred EeeCCEEEEEEE----------eCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHH
Confidence 999999999999 7777888887743 2357888999999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC------CCCC
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQT 689 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t 689 (753)
+.||.|||+.||+||||||+|||++.++. +||+|||++..+.... .....+||+.|+|||++.+ ..++
T Consensus 210 ~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 283 (365)
T 2y7j_A 210 LEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGE----KLRELCGTPGYLAPEILKCSMDETHPGYG 283 (365)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHTTCTTSCCBC
T ss_pred HHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCc----ccccCCCCCCccChhhccccccccCcCCC
Confidence 99999999999999999999999977765 9999999998775432 2234579999999999863 3578
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGES-FERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++|||||||++|||+|| .+||... .......+......+ ....++++.+||++||+.||++|
T Consensus 284 ~~~Di~slG~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 351 (365)
T 2y7j_A 284 KEVDLWACGVILFTLLAG-SPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEAR 351 (365)
T ss_dssp TTHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTS
T ss_pred chhhHHhHHHHHHHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999 5676554 333333343333222 24678899999999999999998
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=324.06 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=187.8
Q ss_pred eEEEeEEecccCceEEEEEEe-----eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccC--CceE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-----~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~ 542 (753)
.|++.+.||+|+||+||++.. .+++.||||++...... .+.+|+ .+++.++||||+++++++.+ ....
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEI-DILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHH-HHHHhCCCcchhhEEEEEecCCCceE
Confidence 458999999999999988743 36899999999765422 234454 47899999999999999986 4678
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ..+++.++++++.|++.||+||
T Consensus 111 ~lv~e----------~~~~~~L~~~l~~------------------------------~~~~~~~~~~i~~~l~~~l~~L 150 (318)
T 3lxp_A 111 QLVME----------YVPLGSLRDYLPR------------------------------HSIGLAQLLLFAQQICEGMAYL 150 (318)
T ss_dssp EEEEC----------CCTTCBHHHHGGG------------------------------SCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------cccCCcHHHHHhh------------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6677888887632 3478889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||+++.++. +||+|||+++................+|..|+|||++.+..++.++|||||||++|
T Consensus 151 H~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 228 (318)
T 3lxp_A 151 HAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228 (318)
T ss_dssp HHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred HhCCccCCCCchheEEEcCCCC--EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHH
Confidence 9999999999999999977754 99999999998765443333344556889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHH----------------HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD----------------ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~----------------~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| ..||....... ...+. ......+..+++++.+||++||+.||++|
T Consensus 229 ~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 295 (318)
T 3lxp_A 229 ELLTH-CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFR 295 (318)
T ss_dssp HHHTT-TCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhC-CCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccC
Confidence 99998 56775532211 11111 22345667789999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.11 Aligned_cols=236 Identities=27% Similarity=0.378 Sum_probs=182.4
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccCC-ceEEEEEcccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ-DFVYLSLERCT 550 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-~~~~LV~E~c~ 550 (753)
.++|++.+.||+|+||+||++.. .|+.||||.+......+.+.++..+++.++|+||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e--- 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC---
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe---
Confidence 46789999999999999999865 58999999997665444444444478999999999999997654 57899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++.... ...+++..+++++.|++.||+|||+.+|+||
T Consensus 96 -------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 141 (278)
T 1byg_A 96 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141 (278)
T ss_dssp -------CCTTEEHHHHHHHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -------cCCCCCHHHHHHhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 666777877775432 1236778889999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+||+++.++. +||+|||++....... ....+++.|+|||.+.+..++.++||||||+++|||+|++.+
T Consensus 142 dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 213 (278)
T 1byg_A 142 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213 (278)
T ss_dssp CCSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCcceEEEeCCCc--EEEeeccccccccccc------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCC
Confidence 99999999977764 9999999998654321 233478899999999999999999999999999999993377
Q ss_pred CCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||....... ...+.. .....+..+++++.++|++||+.||++|
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 258 (278)
T 1byg_A 214 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 258 (278)
T ss_dssp SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhC
Confidence 887654333 333332 2345567789999999999999999998
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.87 Aligned_cols=232 Identities=19% Similarity=0.258 Sum_probs=185.1
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCC--ceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--~~~~L 544 (753)
.++|.+.+.||+|+||.||++.. .++.||||++..... +.+.+|+ .+++.++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEEC-PRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHG-GGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHH-HHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 35688899999999999999876 489999999975431 1233444 477889999999999999887 78899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++++... ...+++.++++++.|++.||+|||+
T Consensus 87 v~e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 129 (271)
T 3kmu_A 87 ITH----------WMPYGSLYNVLHEGT---------------------------NFVVDQSQAVKFALDMARGMAFLHT 129 (271)
T ss_dssp EEE----------CCTTCBHHHHHHSCS---------------------------SCCCCHHHHHHHHHHHHHHHHHHTT
T ss_pred eec----------ccCCCcHHHHHhhcc---------------------------cCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 999 777788888875421 2357889999999999999999999
Q ss_pred CC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCc---hhhHHHHHH
Q 004442 625 IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLGC 699 (753)
Q Consensus 625 ~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~---ksDIwSfGv 699 (753)
.+ |+||||||+||+++.++. ++|+|||++..... ....||+.|+|||++.+..++. ++|||||||
T Consensus 130 ~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~~~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 130 LEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSFQS--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp SSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTTSC--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred CCCceecCCCccceEEEcCCcc--eeEEeccceeeecc--------cCccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence 99 999999999999977755 88998888754322 2345899999999998766544 899999999
Q ss_pred HHHHHHhCCCCCCCCChHHHH-HH-HH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFERDA-NI-VK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~~~-~~-i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|| ..||........ .. .. ......+..+++++.++|.+||+.||++|
T Consensus 200 il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (271)
T 3kmu_A 200 LLWELVTR-EVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255 (271)
T ss_dssp HHHHHHHC-SCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHhC-CCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 99999998 667766543322 22 22 23445667889999999999999999998
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=316.12 Aligned_cols=235 Identities=25% Similarity=0.366 Sum_probs=191.3
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.+.|.+.+.||+|+||.||+|.. .+++.||||++.... .+...+|+ .+++.++|+||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 35688999999999999999965 468999999996543 13334444 4788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++. ...+++..++.++.|++.||.|||+.+
T Consensus 100 e----------~~~~~~L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 139 (303)
T 3a7i_A 100 E----------YLGGGSALDLLE------------------------------PGPLDETQIATILREILKGLDYLHSEK 139 (303)
T ss_dssp E----------CCTTEEHHHHHT------------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------eCCCCcHHHHHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 666677777653 135778889999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||+++.++. +||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 140 i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 214 (303)
T 3a7i_A 140 KIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214 (303)
T ss_dssp EECCCCSGGGEEECTTSC--EEECCCTTCEECBTTB---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CccCCCChheEEECCCCC--EEEeecccceecCccc---cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHcc
Confidence 999999999999977764 9999999998765432 12234568999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||....... ...+ .......+..+++++.+||.+||+.||++|
T Consensus 215 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 262 (303)
T 3a7i_A 215 G-EPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFR 262 (303)
T ss_dssp S-SCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGS
T ss_pred C-CCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhC
Confidence 8 66776653332 2222 233344566789999999999999999998
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=337.84 Aligned_cols=240 Identities=28% Similarity=0.415 Sum_probs=183.4
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----------chHHHHHHHHHHHhCCCCceeeeccc
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----------HDVALKEIQNLIASDQHPNIVRWYGV 535 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----------~~~~~~Ei~~ll~~l~HpNIV~L~g~ 535 (753)
...+.++|.+.+.||+|+||+||+|... +++.||||++.... .....+|+. +++.++||||++++++
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE-ILKKLNHPCIIKIKNF 208 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHH-HHHHCCCTTBCCCCEE
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHH-HHHhCCCCCEeeEEEE
Confidence 3456678999999999999999999664 58999999996532 012345554 7899999999999999
Q ss_pred ccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 536 ~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
+.. +..++||| |+++|+|.+++.. ...+++.++..++.|+
T Consensus 209 ~~~-~~~~lv~e----------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi 248 (419)
T 3i6u_A 209 FDA-EDYYIVLE----------LMEGGELFDKVVG-----------------------------NKRLKEATCKLYFYQM 248 (419)
T ss_dssp EES-SEEEEEEE----------CCTTCBGGGGTSS-----------------------------SCCCCHHHHHHHHHHH
T ss_pred Eec-CceEEEEE----------cCCCCcHHHHHhc-----------------------------cCCCCHHHHHHHHHHH
Confidence 754 45799999 6777888776532 2457888999999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCch
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRA 691 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~k 691 (753)
+.||+|||+.+|+||||||+|||++.++ ...+||+|||+++..... ......+||+.|+|||++.+ ..++.+
T Consensus 249 ~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 324 (419)
T 3i6u_A 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324 (419)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC---------------CTTCCTTTTC----CTTHHH
T ss_pred HHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC----ccccccCCCCCccCceeeecCCCCCCCch
Confidence 9999999999999999999999997543 356999999999876432 22334579999999999863 567899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||+|| .+||.... ......+......+ ...+++++.+||++||+.||++|
T Consensus 325 ~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 391 (419)
T 3i6u_A 325 VDCWSLGVILFICLSG-YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391 (419)
T ss_dssp HHHHHHHHHHHHHHHS-SCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hhhHhHHHHHHHHHHC-CCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHC
Confidence 9999999999999998 67876532 22333444443332 24678999999999999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=328.81 Aligned_cols=197 Identities=26% Similarity=0.396 Sum_probs=151.8
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCc---
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD--- 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--- 540 (753)
.+.++|.+.+.||+|+||.||++... +++.||||++..... ....+|+. +++.++||||+++++++...+
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHH-HHHhcCCCCccceEEeeccccccc
Confidence 34578999999999999999999654 589999999975321 23345554 788999999999999987654
Q ss_pred ---eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 541 ---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 541 ---~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
..++|||+|.++|.+++ . ..+++..+..++.||+.
T Consensus 101 ~~~~~~lv~e~~~~~l~~~~-----------~-------------------------------~~~~~~~~~~i~~qi~~ 138 (371)
T 2xrw_A 101 EFQDVYIVMELMDANLCQVI-----------Q-------------------------------MELDHERMSYLLYQMLC 138 (371)
T ss_dssp TCCEEEEEEECCSEEHHHHH-----------H-------------------------------SCCCHHHHHHHHHHHHH
T ss_pred cccceEEEEEcCCCCHHHHH-----------h-------------------------------hccCHHHHHHHHHHHHH
Confidence 78999997765543332 1 23677788999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++|||||
T Consensus 139 al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 212 (371)
T 2xrw_A 139 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212 (371)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC--------------------CTTCCHHHHTTCCCCTTHHHHHH
T ss_pred HHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeeccccccccc----ccCCceecCCccCHHHhcCCCCCchHhHHHH
Confidence 999999999999999999999977764 9999999998764321 2234568999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh
Q 004442 698 GCILFFCITGGKHPYGESF 716 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~ 716 (753)
||++|||++| .+||.+..
T Consensus 213 G~il~el~~g-~~pf~~~~ 230 (371)
T 2xrw_A 213 GCIMGEMIKG-GVLFPGTD 230 (371)
T ss_dssp HHHHHHHHHS-SCSSCCSS
T ss_pred HHHHHHHHhC-CCCCCCCC
Confidence 9999999998 66776553
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.68 Aligned_cols=233 Identities=24% Similarity=0.382 Sum_probs=175.8
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCC----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ---- 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~---- 539 (753)
.+.++|.+.+.||+|+||.||+|.. .+|+.||||++..... ....+|+. +++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHH-HHHhCCCcCCCCceeeEecCCccc
Confidence 3457899999999999999999976 4699999999964321 23345554 78999999999999998765
Q ss_pred --ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 540 --~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
...|+|||+|+ ++|.+++. ...+++..+..++.||++
T Consensus 101 ~~~~~~lv~e~~~-----------~~L~~~~~------------------------------~~~l~~~~~~~~~~qi~~ 139 (367)
T 1cm8_A 101 DFTDFYLVMPFMG-----------TDLGKLMK------------------------------HEKLGEDRIQFLVYQMLK 139 (367)
T ss_dssp TCCCCEEEEECCS-----------EEHHHHHH------------------------------HCCCCHHHHHHHHHHHHH
T ss_pred cCceEEEEEecCC-----------CCHHHHHh------------------------------cCCCCHHHHHHHHHHHHH
Confidence 34699999554 44444432 134677888999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
||+|||+.+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+ ..++.++||||
T Consensus 140 ~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 211 (367)
T 1cm8_A 140 GLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWS 211 (367)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccccccc------cCcCcCCCCcCCHHHHhCCCCCChhhhHHH
Confidence 999999999999999999999977754 999999999876432 234568999999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH-HHHHHHHcc-------------------------------CcccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFE-RDANIVKDR-------------------------------KDLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-------------------------------~~~~~~~~s~el~dLI~~ 744 (753)
|||++|||++| ++||.+... .....+... ........++++.+||++
T Consensus 212 lG~il~ell~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 290 (367)
T 1cm8_A 212 VGCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290 (367)
T ss_dssp HHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 99999999998 667765432 222211110 001234568899999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||..||++|
T Consensus 291 mL~~dP~~R 299 (367)
T 1cm8_A 291 MLVLDAEQR 299 (367)
T ss_dssp HSCSSTTTS
T ss_pred HccCChhHC
Confidence 999999998
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=324.92 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=191.9
Q ss_pred eecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
...++|.+.+.||+|+||.||++.. .+++.||||++..... ..+.+|+. +++.++||||+++++++.+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHH-HHhhCCCCCCCeEEEEEcCC
Confidence 3456789999999999999999863 3578999999965432 23344544 77889999999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+++|+|.+++....... .....+++.++++++.|++.||
T Consensus 106 ~~~~lv~e----------~~~~~~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~i~~qi~~al 153 (327)
T 2yfx_A 106 LPRFILME----------LMAGGDLKSFLRETRPRP----------------------SQPSSLAMLDLLHVARDIACGC 153 (327)
T ss_dssp SSCEEEEE----------CCTTEEHHHHHHHTSCCS----------------------SSTTSCCHHHHHHHHHHHHHHH
T ss_pred CCcEEEEe----------cCCCCcHHHHHHhhcccc----------------------cccccccHHHHHHHHHHHHHHH
Confidence 99999999 666788888876543211 1124578889999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
.|||+.+|+||||||+|||++.++ ...+||+|||+++....... ........||+.|+|||++.+..++.++||||||
T Consensus 154 ~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc-cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999999997543 34699999999986543221 1122334578999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|++.+||...... ....+.. .....+..+++++.++|.+||+.||++|
T Consensus 233 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 289 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhC
Confidence 99999999447888765433 3333333 3344567789999999999999999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=323.09 Aligned_cols=239 Identities=23% Similarity=0.298 Sum_probs=182.4
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcE----EEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRS----VAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~----VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.++|.+.+.||+|+||+||+|... +++. ||+|.+.... .....+|+ .+++.++||||++++++|.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA-YVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHH-HHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHH-HHHHhCCCCCeeEEEEEEecCC-c
Confidence 467899999999999999999754 3443 5777775322 23344455 4789999999999999998765 7
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++++| |+.+|+|.+++... ...+++..+++++.||+.||.||
T Consensus 92 ~~v~~----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~L 133 (327)
T 3lzb_A 92 QLITQ----------LMPFGCLLDYVREH----------------------------KDNIGSQYLLNWCVQIAKGMNYL 133 (327)
T ss_dssp EEEEC----------CCSSCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHH
T ss_pred eEEEE----------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 88899 77788888887543 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+|||++.++. +||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|
T Consensus 134 H~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3lzb_A 134 EDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp HHTTCCCSCCCGGGEEEEETTE--EEECCTTC-----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCcccc-ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHH
Confidence 9999999999999999987764 999999999876543221 1222344688999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++++.+||....... ...+.. .....+..+++++.++|.+||..||++|
T Consensus 211 ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 263 (327)
T 3lzb_A 211 ELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSR 263 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHC
Confidence 99993378887764433 333333 3345667788999999999999999998
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=331.01 Aligned_cols=240 Identities=23% Similarity=0.346 Sum_probs=181.5
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeeccccc-----------
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES----------- 537 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~----------- 537 (753)
...++|.+.+.||+|+||+||+|.. .+|+.||||++..... ...+|+. +++.++|+||+++++++.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-~~~~E~~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-YKNRELD-IMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-SCCHHHH-HHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-hHHHHHH-HHHHcCCCCccchhheeeecCcccccccc
Confidence 3456799999999999999999965 5699999999865432 2234555 779999999999999983
Q ss_pred ---------------------------CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccc
Q 004442 538 ---------------------------DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590 (753)
Q Consensus 538 ---------------------------~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~ 590 (753)
+....++|||||+++ |.+.+....
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-----------L~~~l~~~~------------------ 132 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-----------LHKVLKSFI------------------ 132 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEE-----------HHHHHHHHH------------------
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCcc-----------HHHHHHHHH------------------
Confidence 344589999966544 444443221
Q ss_pred cchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCcc
Q 004442 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670 (753)
Q Consensus 591 ~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~ 670 (753)
.....+++..+..++.||++||+|||+.+|+||||||+|||++.++ ..+||+|||+++...... ....
T Consensus 133 -------~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~----~~~~ 200 (383)
T 3eb0_A 133 -------RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD-NTLKLCDFGSAKKLIPSE----PSVA 200 (383)
T ss_dssp -------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTT-TEEEECCCTTCEECCTTS----CCCC
T ss_pred -------hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCC-CcEEEEECCCCcccCCCC----CCcC
Confidence 1235688999999999999999999999999999999999997422 359999999999765432 2234
Q ss_pred CCCCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHc-c---------------------
Q 004442 671 GYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKD-R--------------------- 726 (753)
Q Consensus 671 ~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~-~--------------------- 726 (753)
..||+.|+|||++.+.. ++.++|||||||++|||++| .+||.+.... ....+.. .
T Consensus 201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 279 (383)
T 3eb0_A 201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279 (383)
T ss_dssp CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCC
T ss_pred cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCC
Confidence 56899999999988754 89999999999999999998 6677654322 2222111 0
Q ss_pred -------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 727 -------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 727 -------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
...++...++++.+||.+||+.||++|
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred ccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 011345578899999999999999998
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=329.08 Aligned_cols=240 Identities=15% Similarity=0.204 Sum_probs=185.5
Q ss_pred cceEEEeEEecccCceEEEEEEeeC---------CcEEEEEEeecCCchHHHHHHHHHHHhCCCCceee-----------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE---------GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----------- 531 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~---------g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~----------- 531 (753)
+++|.+.+.||+|+||.||++.... ++.||||.+... +...+|+. ++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQN-FFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHH-HHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHH-HHHHhcccchhhhhhhhccCCcc
Confidence 5789999999999999999997763 889999999765 34556665 778889999988
Q ss_pred ----ecccccC-CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHH
Q 004442 532 ----WYGVESD-QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 606 (753)
Q Consensus 532 ----L~g~~~~-~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 606 (753)
+++++.. .+..++||| |+ +|+|.+++... ....+++.
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e----------~~-~~~L~~~l~~~---------------------------~~~~l~~~ 159 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLP----------SL-GRSLQSALDVS---------------------------PKHVLSER 159 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEE----------CC-CEEHHHHHHHS---------------------------GGGCCCHH
T ss_pred CccchhhccccCCcEEEEEec----------CC-CcCHHHHHHhC---------------------------CcCCCCHH
Confidence 4556554 678999999 55 66777766532 12468889
Q ss_pred HHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc----cccCccCCCCcccccccc
Q 004442 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQ 682 (753)
Q Consensus 607 ~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~ 682 (753)
++++|+.||+.||+|||+.+|+||||||+|||++.++...+||+|||+++........ ........||+.|+|||+
T Consensus 160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 239 (352)
T 2jii_A 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL 239 (352)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence 9999999999999999999999999999999998776346999999999876532211 111233479999999999
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHH---HccCcccc------cCCCHHHHHHHHHccccCc
Q 004442 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF---ERDANIV---KDRKDLFL------VEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 683 l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~---~~~~~~i---~~~~~~~~------~~~s~el~dLI~~cL~~DP 750 (753)
+.+..++.++|||||||++|||+|| ..||.... ....... ......+. ..+++++.+||.+||+.||
T Consensus 240 ~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 318 (352)
T 2jii_A 240 HKGCGPSRRSDLQSLGYCMLKWLYG-FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTY 318 (352)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHS-CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCT
T ss_pred HccCCCCchhhHHHHHHHHHHHHhC-CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCCh
Confidence 9999999999999999999999998 67886542 1121111 11222222 2568999999999999999
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
++|
T Consensus 319 ~~R 321 (352)
T 2jii_A 319 EEK 321 (352)
T ss_dssp TCC
T ss_pred hhC
Confidence 998
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.52 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=185.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC----C
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD----Q 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~ 539 (753)
...++.|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.++..+++.++||||+++++++.+ .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 445667899999999999999999764 588999999865321 1233334457899999999999998754 4
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++||| |+++|+|.+++... ..+++..++.++.|++.||
T Consensus 102 ~~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l 142 (290)
T 1t4h_A 102 KCIVLVTE----------LMTSGTLKTYLKRF-----------------------------KVMKIKVLRSWCRQILKGL 142 (290)
T ss_dssp EEEEEEEE----------CCCSCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEE----------ecCCCCHHHHHHHc-----------------------------cCCCHHHHHHHHHHHHHHH
Confidence 66899999 66778888877432 3577888999999999999
Q ss_pred HHhhhCC--ccccCCCCCcEEEe-cCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 620 SHLHEIG--LIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 620 ~yLH~~~--IiHrDLKp~NILL~-~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
.|||+.+ |+||||||+||+++ .++ .+||+|||++...... ......||+.|+|||++. ..++.++||||
T Consensus 143 ~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~s 214 (290)
T 1t4h_A 143 QFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYE-EKYDESVDVYA 214 (290)
T ss_dssp HHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGG-TCCCTHHHHHH
T ss_pred HHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccccccc-----ccccccCCcCcCCHHHHh-ccCCCcchHHH
Confidence 9999999 99999999999996 444 5999999999755432 123346899999999886 45999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChH--HHHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESFE--RDANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~--~~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|+|++| ..||..... .....+... ....+...++++.+||.+||+.||++|
T Consensus 215 lG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 274 (290)
T 1t4h_A 215 FGMCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 274 (290)
T ss_dssp HHHHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHhC-CCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999998 667765322 222223222 223455677899999999999999998
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=325.01 Aligned_cols=242 Identities=28% Similarity=0.407 Sum_probs=182.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHH-HhCCCCceeeecccccCC----ceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLI-ASDQHPNIVRWYGVESDQ----DFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll-~~l~HpNIV~L~g~~~~~----~~~~ 543 (753)
..+.++|.+.+.||+|+||.||++.. .|+.||||++.........+|.+.+. ..++|+||+++++++.+. ...+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 111 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY 111 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence 45567899999999999999999876 48999999997766555555554222 235999999999998876 7899
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.++++. ..+++..+++++.|++.||+|||
T Consensus 112 lv~e----------~~~~g~L~~~l~~------------------------------~~~~~~~~~~i~~~i~~~l~~lH 151 (337)
T 3mdy_A 112 LITD----------YHENGSLYDYLKS------------------------------TTLDAKSMLKLAYSSVSGLCHLH 151 (337)
T ss_dssp EEEC----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------ccCCCcHHHHhhc------------------------------cCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7777888887742 24678889999999999999999
Q ss_pred hC--------CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCCCCCch---
Q 004442 624 EI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRA--- 691 (753)
Q Consensus 624 ~~--------~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~k--- 691 (753)
+. +|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+...+.+
T Consensus 152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 229 (337)
T 3mdy_A 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229 (337)
T ss_dssp SCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH
T ss_pred HhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC
Confidence 98 9999999999999977754 9999999998765432221 12234579999999999988776554
Q ss_pred ---hhHHHHHHHHHHHHhCC---------CCCCCCC------hHHHHHHHHc--cCccccc-----CCCHHHHHHHHHcc
Q 004442 692 ---IDLFSLGCILFFCITGG---------KHPYGES------FERDANIVKD--RKDLFLV-----EHIPEAVDLFTRLL 746 (753)
Q Consensus 692 ---sDIwSfGvvL~EllTG~---------~~Pf~~~------~~~~~~~i~~--~~~~~~~-----~~s~el~dLI~~cL 746 (753)
+|||||||++|||+||. ..||... .......+.. .....+. .+++++.+||.+||
T Consensus 230 ~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 309 (337)
T 3mdy_A 230 YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHS
T ss_pred ccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhh
Confidence 99999999999999983 3455432 1111111111 1122222 44567999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 310 ~~dP~~R 316 (337)
T 3mdy_A 310 AHNPASR 316 (337)
T ss_dssp CSSGGGS
T ss_pred hhChhhC
Confidence 9999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.44 Aligned_cols=240 Identities=22% Similarity=0.349 Sum_probs=182.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCC----
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ---- 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~---- 539 (753)
..+.++|.+.+.||+|+||.||++... +|+.||||++...... ...+|+. +++.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHH-HHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHH-HHHhCcCCCcCCeeeeecccccCc
Confidence 345678999999999999999999765 5899999999654322 2345554 78899999999999987654
Q ss_pred -ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 540 -~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
...++|||+|.++ |.+++. ...+++..+..++.|++.|
T Consensus 86 ~~~~~lv~e~~~~~-----------L~~~~~------------------------------~~~~~~~~~~~~~~qi~~~ 124 (353)
T 2b9h_A 86 FNEVYIIQELMQTD-----------LHRVIS------------------------------TQMLSDDHIQYFIYQTLRA 124 (353)
T ss_dssp CCCEEEEECCCSEE-----------HHHHHH------------------------------HCCCCHHHHHHHHHHHHHH
T ss_pred cceEEEEEeccCcc-----------HHHHHh------------------------------hcCCCHHHHHHHHHHHHHH
Confidence 6789999966544 444332 1357788899999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc-------cCccCCCCccccccccccC-CCCCc
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-------QNATGYGSSGWQAPEQLLQ-GRQTR 690 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~-~~~t~ 690 (753)
|+|||+.+|+||||||+|||++.++. +||+|||+++.......... .....+||+.|+|||++.+ ..++.
T Consensus 125 L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (353)
T 2b9h_A 125 VKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202 (353)
T ss_dssp HHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCH
T ss_pred HHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccc
Confidence 99999999999999999999977755 99999999987753221111 1233468999999998765 67899
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHc------------------------cC--------cccccCCCHH
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKD------------------------RK--------DLFLVEHIPE 737 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~~~~-~~~i~~------------------------~~--------~~~~~~~s~e 737 (753)
++|||||||++|||++| .+||.+..... ...+.. .. ......++++
T Consensus 203 ~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T 2b9h_A 203 AMDVWSCGCILAELFLR-RPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281 (353)
T ss_dssp HHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred hhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHH
Confidence 99999999999999998 66776653322 111110 00 0112467889
Q ss_pred HHHHHHHccccCcCCC
Q 004442 738 AVDLFTRLLDPNPDLR 753 (753)
Q Consensus 738 l~dLI~~cL~~DP~~R 753 (753)
+.+||.+||+.||++|
T Consensus 282 ~~~li~~~L~~dP~~R 297 (353)
T 2b9h_A 282 GIDLLQRMLVFDPAKR 297 (353)
T ss_dssp HHHHHHHHSCSSGGGS
T ss_pred HHHHHHHhcCcCcccC
Confidence 9999999999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=313.80 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=188.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
.++|.+.+.||+|+||.||++... +++.||||++.... ....+.++..+++.++|+||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999765 68999999986432 12333344447899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++.. ...+++..++.++.|++.||+|||+.+|
T Consensus 86 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (276)
T 2yex_A 86 ----------YCSGGELFDRIEP-----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (276)
T ss_dssp ----------CCTTEEGGGGSBT-----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------ecCCCcHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5556666665532 2347788999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~EllT 706 (753)
+||||||+||+++.++. +||+|||++........ ........||+.|+|||++.+..+ +.++||||||+++|||++
T Consensus 127 ~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 127 THRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp ECSCCSGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCChHHEEEccCCC--EEEeeCCCccccCCCcc-hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 99999999999977765 99999999987643221 112234568999999999987775 789999999999999999
Q ss_pred CCCCCCCCChHH--HHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFER--DANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~--~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ..||...... ......... ......+++++.+||++||+.||++|
T Consensus 204 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (276)
T 2yex_A 204 G-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (276)
T ss_dssp S-SCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred C-CCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhC
Confidence 8 6788654322 222222222 22235678999999999999999998
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=323.53 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=186.7
Q ss_pred ceecceEEEe-EEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 469 RRIGKLVVFN-KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~-~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
+.+.+.|.+. +.||+|+||.||++... +|+.||||++.... .....+|+..+.....||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 4455667776 88999999999999765 58999999986432 23455666644344467999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++... ....+++.+++.++.|++.||+|
T Consensus 104 ~~lv~e----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~i~~ql~~~L~~ 146 (327)
T 3lm5_A 104 IILILE----------YAAGGEIFSLCLPE---------------------------LAEMVSENDVIRLIKQILEGVYY 146 (327)
T ss_dssp EEEEEE----------CCTTEEGGGGGSSC---------------------------C-CCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------ecCCCcHHHHHHHh---------------------------cccCCCHHHHHHHHHHHHHHHHH
Confidence 999999 66677777665321 12457889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
||+.+|+||||||+|||++... ...+||+|||+++...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 147 LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 222 (327)
T 3lm5_A 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC----ELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222 (327)
T ss_dssp HHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc----ccccccCCcCccCCeeecCCCCCchhhHHHHHHH
Confidence 9999999999999999997611 2359999999998775332 1234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHHccCc----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE-RDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~-~~~~~i~~~~~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||..... .....+..... .....+++++.+||.+||+.||++|
T Consensus 223 l~~ll~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 279 (327)
T 3lm5_A 223 AYMLLTH-TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKR 279 (327)
T ss_dssp HHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHhC-CCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhC
Confidence 9999999 567765533 33333333222 2334678999999999999999998
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.60 Aligned_cols=235 Identities=24% Similarity=0.407 Sum_probs=185.6
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----------hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
..++|.+.+.||+|+||+||++.. .+++.||||++..... +...+|+. +++.++|+||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF-IMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHH-HHTTCCCTTBCCEEEEETTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHH-HHHhCCCCCchhhheeecCC
Confidence 346789999999999999999976 4689999999854321 23344554 78899999999999999776
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
. ++||| |+.+|+|.+++... ...+++..++.++.|++.||
T Consensus 96 ~--~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~l~~~l 135 (287)
T 4f0f_A 96 P--RMVME----------FVPCGDLYHRLLDK----------------------------AHPIKWSVKLRLMLDIALGI 135 (287)
T ss_dssp T--EEEEE----------CCTTCBHHHHHHCT----------------------------TSCCCHHHHHHHHHHHHHHH
T ss_pred C--eEEEE----------ecCCCCHHHHHhcc----------------------------cCCccHHHHHHHHHHHHHHH
Confidence 6 69999 66678887776432 24578889999999999999
Q ss_pred HHhhhCC--ccccCCCCCcEEEecCCC---CeEEEEeccCceeccCCCcccccCccCCCCcccccccccc--CCCCCchh
Q 004442 620 SHLHEIG--LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAI 692 (753)
Q Consensus 620 ~yLH~~~--IiHrDLKp~NILL~~d~~---~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~t~ks 692 (753)
+|||+.+ |+||||||+||+++.++. ..+||+|||+++..... .....||+.|+|||++. ...++.++
T Consensus 136 ~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~ 209 (287)
T 4f0f_A 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKA 209 (287)
T ss_dssp HHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHH
T ss_pred HHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchh
Confidence 9999999 999999999999976542 34899999999854332 23356899999999984 45578999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH--ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFERD---ANIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~~~---~~~i~--~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||||++|||++| .+||....... ..... ......+..+++++.++|.+||+.||++|
T Consensus 210 Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 274 (287)
T 4f0f_A 210 DTYSFAMILYTILTG-EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274 (287)
T ss_dssp HHHHHHHHHHHHHHS-SCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHcC-CCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhC
Confidence 999999999999998 67886543221 12211 23345667789999999999999999998
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=332.54 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=184.6
Q ss_pred cccceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC------C
Q 004442 466 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD------Q 539 (753)
Q Consensus 466 ~~~~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------~ 539 (753)
..+.....+|.+.+.||+|+||+||+|....+..||+|++..... ...+|+. +++.++|+||+++++++.. .
T Consensus 33 ~~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-FKNRELQ-IMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp SSCCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-SCCHHHH-HHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred CCCCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-hHHHHHH-HHHhCCCCCcceEEEEEEecCCCCCc
Confidence 344566778999999999999999999888877899999865431 1224554 7899999999999999843 3
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++|||||.+++.+.+ .... .....+++..+..++.||++||
T Consensus 111 ~~~~lv~e~~~~~l~~~~-----------~~~~-------------------------~~~~~~~~~~~~~~~~qi~~aL 154 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRAS-----------RHYA-------------------------KLKQTMPMLLIKLYMYQLLRSL 154 (394)
T ss_dssp EEEEEEEECCSEEHHHHH-----------HHHH-------------------------HTTSCCCHHHHHHHHHHHHHHH
T ss_pred eEEEEEeeccCccHHHHH-----------HHHH-------------------------hhcCCCCHHHHHHHHHHHHHHH
Confidence 348899997765443222 1110 1235688889999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEe-cCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 697 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~-~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSf 697 (753)
+|||+.+|+||||||+|||++ .++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||
T Consensus 155 ~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 155 AYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGE----PNVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp HHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCTTC----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccCCC----CCcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 999999999999999999997 444 59999999998775432 22345689999999998765 48999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-HHHHHHHcc-----------------------------CcccccCCCHHHHHHHHHccc
Q 004442 698 GCILFFCITGGKHPYGESFE-RDANIVKDR-----------------------------KDLFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-----------------------------~~~~~~~~s~el~dLI~~cL~ 747 (753)
||++|||++| .+||.+... .....+... ...+....++++.+||.+||+
T Consensus 229 G~il~ell~g-~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (394)
T 4e7w_A 229 GCVMAELMQG-QPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLE 307 (394)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhC
Confidence 9999999999 667765432 222211110 001233478899999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 308 ~dP~~R 313 (394)
T 4e7w_A 308 YTPSAR 313 (394)
T ss_dssp SSGGGS
T ss_pred CChhhC
Confidence 999998
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.29 Aligned_cols=237 Identities=14% Similarity=0.123 Sum_probs=175.7
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHH--HHHHhCCCCceeeecccc-----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWYGVE----- 536 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~--~ll~~l~HpNIV~L~g~~----- 536 (753)
..+.|.+.+.||+|+||+||+|.. .+|+.||||++.... .+...+|+. .+++.++|||||++++.+
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 457899999999999999999986 469999999996431 123445553 345667899999999443
Q ss_pred --cCCc-----------------eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhh
Q 004442 537 --SDQD-----------------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597 (753)
Q Consensus 537 --~~~~-----------------~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (753)
.+.+ ..||||| |+ +|+|.+++.......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E----------~~-~g~L~~~l~~~~~~~---------------------- 197 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYP----------RM-QSNLQTFGEVLLSHS---------------------- 197 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEE----------CC-SEEHHHHHHHHHHTT----------------------
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEe----------cc-CCCHHHHHHhccccc----------------------
Confidence 3332 2799999 44 356666665432110
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccc
Q 004442 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677 (753)
Q Consensus 598 ~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y 677 (753)
.....+++..+++|+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.... .....+| +.|
T Consensus 198 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~------~~~~~~g-~~y 268 (377)
T 3byv_A 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGA------RVVSSVS-RGF 268 (377)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTC------EEECCCC-TTC
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheecCC------cccCCCC-cCc
Confidence 01123455778899999999999999999999999999999987764 99999999986432 2234467 999
Q ss_pred cccccccCC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHcc
Q 004442 678 QAPEQLLQG-----------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 678 ~APE~l~~~-----------~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL 746 (753)
+|||++.+. .++.++|||||||++|||+|| .+||........ ..........+++++.+||.+||
T Consensus 269 ~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg-~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L 344 (377)
T 3byv_A 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA-DLPITKDAALGG---SEWIFRSCKNIPQPVRALLEGFL 344 (377)
T ss_dssp CCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS-SCCC------CC---SGGGGSSCCCCCHHHHHHHHHHT
T ss_pred cChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC-CCCCcccccccc---hhhhhhhccCCCHHHHHHHHHHc
Confidence 999999887 899999999999999999998 678865432211 01111223577899999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 345 ~~dp~~R 351 (377)
T 3byv_A 345 RYPKEDR 351 (377)
T ss_dssp CSSGGGC
T ss_pred CCCchhC
Confidence 9999998
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.15 Aligned_cols=237 Identities=22% Similarity=0.341 Sum_probs=188.3
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------------chHHHHHHHHHHHhC-CCCceeeeccc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------------HDVALKEIQNLIASD-QHPNIVRWYGV 535 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------------~~~~~~Ei~~ll~~l-~HpNIV~L~g~ 535 (753)
.+.++|.+.+.||+|+||.||++... +|+.||||++.... .+...+|+. ++..+ +||||++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD-ILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHH-HHHHHTTCTTBCCEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHH-HHHHhcCCCCEeeeeee
Confidence 44567899999999999999999765 58999999996542 122344555 55666 59999999999
Q ss_pred ccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 536 ~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
+.+.+..++||| |+.+|+|.+++... ..+++..++.++.||
T Consensus 93 ~~~~~~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi 133 (298)
T 1phk_A 93 YETNTFFFLVFD----------LMKKGELFDYLTEK-----------------------------VTLSEKETRKIMRAL 133 (298)
T ss_dssp EECSSEEEEEEE----------CCTTCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHH
T ss_pred eccCCeEEEEEe----------ccCCCcHHHHHhcc-----------------------------CCCCHHHHHHHHHHH
Confidence 999999999999 66677888877432 357888999999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc------CCCCC
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQT 689 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~------~~~~t 689 (753)
+.||.|||+.+|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++. ...++
T Consensus 134 ~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 207 (298)
T 1phk_A 134 LEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYG 207 (298)
T ss_dssp HHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBC
T ss_pred HHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCc----ccccccCCccccCHHHhccccccccccCC
Confidence 99999999999999999999999977765 9999999998765432 223456899999999985 45689
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 690 RAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 690 ~ksDIwSfGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.++||||||+++|||++| ..||.... ......+...... ....+++++.+||.+||+.||++|
T Consensus 208 ~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 275 (298)
T 1phk_A 208 KEVDMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 275 (298)
T ss_dssp THHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGS
T ss_pred cccccHhHHHHHHHHHHC-CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccC
Confidence 999999999999999998 56665543 3333333333322 224678999999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=325.68 Aligned_cols=238 Identities=22% Similarity=0.277 Sum_probs=178.9
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
...++|.+.+.||+|+||.||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHH-HHhhCCCCCCCeEEEEEeeCC
Confidence 34567889999999999999999775 48999999986422 123455665 778999999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++|||+|+++| .+++... ...+++..+..++.|++.||+
T Consensus 86 ~~~lv~e~~~~~l-----------~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~l~ 126 (346)
T 1ua2_A 86 NISLVFDFMETDL-----------EVIIKDN----------------------------SLVLTPSHIKAYMLMTLQGLE 126 (346)
T ss_dssp CCEEEEECCSEEH-----------HHHHTTC----------------------------CSSCCSSHHHHHHHHHHHHHH
T ss_pred ceEEEEEcCCCCH-----------HHHHHhc----------------------------CcCCCHHHHHHHHHHHHHHHH
Confidence 9999999666444 3333211 234667788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGC 699 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGv 699 (753)
|||+.+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||
T Consensus 127 ~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 201 (346)
T 1ua2_A 127 YLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201 (346)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHH
T ss_pred HHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCc---ccCCcccccccccCchHhhCCCCCCchhhhHhHHH
Confidence 999999999999999999977765 9999999998764322 222345689999999999764 4899999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-Ccc---------------------------cccCCCHHHHHHHHHccccCc
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KDL---------------------------FLVEHIPEAVDLFTRLLDPNP 750 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~~---------------------------~~~~~s~el~dLI~~cL~~DP 750 (753)
++|||++| .+||...... ....+... ..+ .....++++.+||++||..||
T Consensus 202 il~ell~g-~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 280 (346)
T 1ua2_A 202 ILAELLLR-VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 280 (346)
T ss_dssp HHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSST
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccCh
Confidence 99999998 6677665332 22222110 000 114557899999999999999
Q ss_pred CCC
Q 004442 751 DLR 753 (753)
Q Consensus 751 ~~R 753 (753)
++|
T Consensus 281 ~~R 283 (346)
T 1ua2_A 281 CAR 283 (346)
T ss_dssp TTS
T ss_pred hhC
Confidence 998
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.28 Aligned_cols=236 Identities=22% Similarity=0.296 Sum_probs=185.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCC-CCceeeecccccC--CceEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQ-HPNIVRWYGVESD--QDFVYL 544 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~-HpNIV~L~g~~~~--~~~~~L 544 (753)
....++|++.+.||+|+||+||++.. .+++.||||++.....+...+|+. ++..++ |+||+++++++.+ ....++
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~-~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-ILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHH-HHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHH-HHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 34457899999999999999999965 568999999998776666777776 556665 9999999999987 677899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++. .+++.++..++.||+.||+|||+
T Consensus 111 v~e----------~~~~~~l~~~~~--------------------------------~~~~~~~~~~~~qi~~~l~~lH~ 148 (330)
T 3nsz_A 111 VFE----------HVNNTDFKQLYQ--------------------------------TLTDYDIRFYMYEILKALDYCHS 148 (330)
T ss_dssp EEE----------CCCCCCHHHHGG--------------------------------GCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------ccCchhHHHHHH--------------------------------hCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 666777776652 25667889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~E 703 (753)
.+|+||||||+|||++.++ ..+||+|||+++...... ......||..|+|||++.+ ..++.++|||||||++||
T Consensus 149 ~~ivH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 149 MGIMHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp TTEECCCCSGGGEEEETTT-TEEEECCCTTCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CCeeeCCCCHHHEEEcCCC-CEEEEEeCCCceEcCCCC----ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 9999999999999998665 269999999998765432 2234568999999999987 668999999999999999
Q ss_pred HHhCCCCCC-CCChH-HHHHH-------------HHccC------------------------cccccCCCHHHHHHHHH
Q 004442 704 CITGGKHPY-GESFE-RDANI-------------VKDRK------------------------DLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 704 llTG~~~Pf-~~~~~-~~~~~-------------i~~~~------------------------~~~~~~~s~el~dLI~~ 744 (753)
|++|+ .|| ..... ..... +.... ......+++++.+||.+
T Consensus 224 ll~g~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 302 (330)
T 3nsz_A 224 MIFRK-EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 302 (330)
T ss_dssp HHHTC-SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHT
T ss_pred HHhCC-CCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHH
Confidence 99994 555 33221 11111 01000 01122368999999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 303 ~L~~dP~~R 311 (330)
T 3nsz_A 303 LLRYDHQSR 311 (330)
T ss_dssp TSCSSGGGS
T ss_pred HhcCCcccC
Confidence 999999998
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=325.92 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=188.4
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
+....++|.+.+.||+|+||.||++... +++.||+|++...... ...+|+ .+++.++|+||+++++++.+++..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL-QVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHH-HHHHHCCCCCEEEEeEEEEECCEE
Confidence 3555678999999999999999999765 6899999999765322 233444 477889999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++... ..+++..+.+++.+++.||+||
T Consensus 107 ~lv~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~l 147 (360)
T 3eqc_A 107 SICME----------HMDGGSLDQVLKKA-----------------------------GRIPEQILGKVSIAVIKGLTYL 147 (360)
T ss_dssp EEEEC----------CCTTCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------CCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 66778888877432 3577888999999999999999
Q ss_pred hhC-CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~-~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+. +|+||||||+|||++.++. +||+|||+++..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 148 h~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 220 (360)
T 3eqc_A 148 REKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 220 (360)
T ss_dssp HHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHH
T ss_pred HHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccccc-----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHH
Confidence 996 9999999999999977765 999999999765321 22344689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHH-------------------------------------------Hcc-Ccc-cccCCCH
Q 004442 702 FFCITGGKHPYGESFERDANIV-------------------------------------------KDR-KDL-FLVEHIP 736 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~~~~i-------------------------------------------~~~-~~~-~~~~~s~ 736 (753)
|||+|| ..||........... ... ... ....+++
T Consensus 221 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (360)
T 3eqc_A 221 VEMAVG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299 (360)
T ss_dssp HHHHHT-SCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred HHHHhC-CCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccH
Confidence 999999 667765433221111 111 111 1234688
Q ss_pred HHHHHHHHccccCcCCC
Q 004442 737 EAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 737 el~dLI~~cL~~DP~~R 753 (753)
++.+||++||+.||++|
T Consensus 300 ~~~~li~~~L~~dP~~R 316 (360)
T 3eqc_A 300 EFQDFVNKCLIKNPAER 316 (360)
T ss_dssp HHHHHHHHHHCSSTTTS
T ss_pred HHHHHHHHHhhcChhhC
Confidence 99999999999999998
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=324.87 Aligned_cols=239 Identities=22% Similarity=0.303 Sum_probs=177.4
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCceeeeccc-----ccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGV-----ESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~L~g~-----~~~~~~~~LV 545 (753)
.++|++.+.||+|+||.||+|.. +++.||||++..........|... .+..++|+||++++++ +.+....++|
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 46789999999999999999854 789999999986654444444331 2345899999999974 3345578999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ...++..+++++.||+.||+|||+.
T Consensus 91 ~e----------~~~~g~L~~~l~~------------------------------~~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 91 ME----------YYPNGSLXKYLSL------------------------------HTSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp EC----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred Ee----------cCCCCcHHHHHhh------------------------------cccchhHHHHHHHHHHHHHHHHHhh
Confidence 99 7777888888743 2346778899999999999999999
Q ss_pred ---------CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-----ccccCccCCCCccccccccccC------
Q 004442 626 ---------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----CLTQNATGYGSSGWQAPEQLLQ------ 685 (753)
Q Consensus 626 ---------~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-----~~~~~~~~~GT~~Y~APE~l~~------ 685 (753)
+|+||||||+|||++.++ .+||+|||+++.+..... .........||+.|+|||++.+
T Consensus 131 ~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 208 (336)
T 3g2f_A 131 LPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRD 208 (336)
T ss_dssp BCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGG
T ss_pred hccccccccceeecccccceEEEcCCC--cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccc
Confidence 999999999999997765 499999999987754321 1122234569999999999987
Q ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-----------------HHHHH-HH--ccCcccccC------CCHHH
Q 004442 686 -GRQTRAIDLFSLGCILFFCITGGKHPYGESFE-----------------RDANI-VK--DRKDLFLVE------HIPEA 738 (753)
Q Consensus 686 -~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-----------------~~~~~-i~--~~~~~~~~~------~s~el 738 (753)
..++.++|||||||++|||+||+.+||..... ..... .. .....++.. .++++
T Consensus 209 ~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 288 (336)
T 3g2f_A 209 XESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHH
Confidence 35678999999999999999997766643210 01111 11 111222222 23479
Q ss_pred HHHHHHccccCcCCC
Q 004442 739 VDLFTRLLDPNPDLR 753 (753)
Q Consensus 739 ~dLI~~cL~~DP~~R 753 (753)
.+||.+||+.||++|
T Consensus 289 ~~li~~cl~~dP~~R 303 (336)
T 3g2f_A 289 KETIEDCWDQDAEAR 303 (336)
T ss_dssp HHHHHHHSCSSGGGS
T ss_pred HHHHHHHhcCChhhC
Confidence 999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=325.33 Aligned_cols=238 Identities=25% Similarity=0.383 Sum_probs=177.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--------------hHHHHHHHHHHHhCCCCceeeecc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--------------DVALKEIQNLIASDQHPNIVRWYG 534 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--------------~~~~~Ei~~ll~~l~HpNIV~L~g 534 (753)
..+.+.|.+.+.||+|+||.||++...+|+.||||++..... +...+|+. +++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHH-HHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHH-HHHhCCCcCccceee
Confidence 456678999999999999999999888899999999854221 33445554 789999999999999
Q ss_pred ccc-----CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHH
Q 004442 535 VES-----DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (753)
Q Consensus 535 ~~~-----~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l 609 (753)
++. .....++|||+|.++|. +++.. ....+++..+.
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~-----------~~~~~----------------------------~~~~~~~~~~~ 137 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLA-----------QVIHD----------------------------QRIVISPQHIQ 137 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHH-----------HHHHC----------------------------TTSCCCHHHHH
T ss_pred eEEeccCCCcceEEEEEccCCCCHH-----------HHHHh----------------------------cccCCCHHHHH
Confidence 983 34578999996665444 43321 12357888999
Q ss_pred HHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCC
Q 004442 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQ 688 (753)
Q Consensus 610 ~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~ 688 (753)
.++.||+.||.|||+.+|+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+ ..+
T Consensus 138 ~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~ 211 (362)
T 3pg1_A 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADA----NKTHYVTHRWYRAPELVMQFKGF 211 (362)
T ss_dssp HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC-------------------CGGGCCHHHHTTCTTC
T ss_pred HHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCccccccccc----ccceecccceecCcHHhcCCCCC
Confidence 99999999999999999999999999999977765 9999999998654321 2234468999999999887 678
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHc------------------------cC--------cccccCCC
Q 004442 689 TRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKD------------------------RK--------DLFLVEHI 735 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~------------------------~~--------~~~~~~~s 735 (753)
+.++|||||||++|||++| .+||..... .....+.. .. .......+
T Consensus 212 ~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (362)
T 3pg1_A 212 TKLVDMWSAGCVMAEMFNR-KALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290 (362)
T ss_dssp CTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSC
T ss_pred CcHhHHHhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCC
Confidence 9999999999999999998 667765432 22221111 00 01234567
Q ss_pred HHHHHHHHHccccCcCCC
Q 004442 736 PEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 736 ~el~dLI~~cL~~DP~~R 753 (753)
+++.+||.+||+.||++|
T Consensus 291 ~~~~~li~~~L~~dP~~R 308 (362)
T 3pg1_A 291 PVALDLIAKMLEFNPQRR 308 (362)
T ss_dssp HHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHhcCChhhC
Confidence 899999999999999998
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=320.47 Aligned_cols=257 Identities=21% Similarity=0.281 Sum_probs=192.8
Q ss_pred eecceEEEeEEecccCceEEEEEEe------eCCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccccC
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESD 538 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~------~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~~ 538 (753)
...++|.+.+.||+|+||.||++.. .+++.||||++...... ...+|+. ++..+ +||||++++++|.+
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK-ILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHH-HHHhcccCCCeeeEEEEEec
Confidence 3457899999999999999999964 34689999999765432 3445555 55555 79999999999877
Q ss_pred Cc-eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 539 QD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 539 ~~-~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
.+ ..++||| |+++|+|.+++........... ..........+++..++.++.|++.
T Consensus 103 ~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~ 159 (316)
T 2xir_A 103 PGGPLMVIVE----------FCKFGNLSTYLRSKRNEFVPYK-------------VAPEDLYKDFLTLEHLICYSFQVAK 159 (316)
T ss_dssp TTSCCEEEEE----------CCTTEEHHHHHHTCTTSEECC--------------------CTTCEEHHHHHHHHHHHHH
T ss_pred CCCceEEEEE----------cCCCCcHHHHHHhccccccccc-------------ccchhhhccccCHHHHHHHHHHHHH
Confidence 54 5899999 6667788888765432111000 0000011234788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||.|||+.+|+||||||+||+++.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||
T Consensus 160 al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 236 (316)
T 2xir_A 160 GMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236 (316)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccc-eeccCCCcceeecCchhhccccccchhHHHHH
Confidence 999999999999999999999976654 999999999876543221 12223457889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh--HHHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESF--ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~--~~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|++.+||.... ......+. ......+..+++++.++|.+||+.||++|
T Consensus 237 G~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 295 (316)
T 2xir_A 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 295 (316)
T ss_dssp HHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999994477886643 22223333 33345567789999999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=316.50 Aligned_cols=239 Identities=24% Similarity=0.343 Sum_probs=186.4
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------c-hHHHHHHHHHHHhCCCCceeeecccc--cCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------H-DVALKEIQNLIASDQHPNIVRWYGVE--SDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~-~~~~~Ei~~ll~~l~HpNIV~L~g~~--~~~~~ 541 (753)
.++|.+.+.||+|+||.||++... +++.||||++.... . ....+|+ .+++.++|+||+++++++ .+.+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI-QLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHH-HHHTTCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHH-HHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 456788899999999999999764 58999999996431 2 2334444 478999999999999998 44568
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++|||+|.++|. +++.. .....+++..+++++.||+.||.|
T Consensus 83 ~~lv~e~~~~~l~-----------~~~~~---------------------------~~~~~~~~~~~~~~~~qi~~al~~ 124 (305)
T 2wtk_C 83 MYMVMEYCVCGMQ-----------EMLDS---------------------------VPEKRFPVCQAHGYFCQLIDGLEY 124 (305)
T ss_dssp EEEEEECCSEEHH-----------HHHHH---------------------------STTCSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEehhccCCHH-----------HHHHh---------------------------CcccccCHHHHHHHHHHHHHHHHH
Confidence 8999996665443 33321 113457888999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC--CchhhHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGC 699 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~--t~ksDIwSfGv 699 (753)
||+.+|+||||||+||+++.++. +||+|||++......... .......||+.|+|||++.+... +.++||||||+
T Consensus 125 LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 201 (305)
T 2wtk_C 125 LHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV 201 (305)
T ss_dssp HHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHH
T ss_pred HHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHH
Confidence 99999999999999999977765 999999999876532211 22234568999999999976543 78999999999
Q ss_pred HHHHHHhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||++| ..||... .......+.......+..+++++.+||++||+.||++|
T Consensus 202 il~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 255 (305)
T 2wtk_C 202 TLYNITTG-LYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKR 255 (305)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHhC-CCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhC
Confidence 99999998 5677654 34444555666667778899999999999999999998
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=317.90 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=178.1
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
..++|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+ .+++.++|+||+++++++.+.+..+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHH-HHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 345799999999999999999876 569999999997522 12234444 4789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++..... ....+++..+++++.|++.||.|||
T Consensus 109 lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~qi~~~l~~LH 153 (310)
T 2wqm_A 109 IVLE----------LADAGDLSRMIKHFKK-------------------------QKRLIPERTVWKYFVQLCSALEHMH 153 (310)
T ss_dssp EEEE----------CCCSCBHHHHHHHHHH-------------------------TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------cCCCCCHHHHHHHhcc-------------------------cccCCCHHHHHHHHHHHHHHHHHHh
Confidence 9999 6667788877754321 2345788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
+.+|+||||||+||+++.++. +||+|||+++...... .......||+.|+|||++.+..++.++||||||+++||
T Consensus 154 ~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 154 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HTTCCCCCCCGGGEEECTTSC--EEECCC---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred hCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCCC---ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999977664 9999999998764322 11223458999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh---HHHHHHHHccCc-c-cccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESF---ERDANIVKDRKD-L-FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~---~~~~~~i~~~~~-~-~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++| ..||.... ......+..... . ....+++++.++|.+||+.||++|
T Consensus 229 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 282 (310)
T 2wqm_A 229 MAAL-QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282 (310)
T ss_dssp HHHS-SCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhC-CCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhC
Confidence 9999 55664432 122223333222 2 235678999999999999999998
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=335.09 Aligned_cols=243 Identities=23% Similarity=0.417 Sum_probs=187.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCc--e
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD--F 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~--~ 541 (753)
....++|.+.+.||+|+||+||+|.... |+.||||++.... .+...+|+. +++.++||||+++++++.+.+ .
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE-VLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHH-HHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHH-HHHhcCCCCCCeEEEeeccCCCCe
Confidence 3456789999999999999999997754 8999999997532 233445554 789999999999999987654 7
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++.... ....+++..++.++.||+.||+|
T Consensus 84 ~~lv~e----------~~~~g~L~~~l~~~~--------------------------~~~~l~~~~~~~i~~qi~~aL~~ 127 (396)
T 4eut_A 84 KVLIME----------FCPCGSLYTVLEEPS--------------------------NAYGLPESEFLIVLRDVVGGMNH 127 (396)
T ss_dssp EEEEEC----------CCTTEEHHHHTTSGG--------------------------GTTCCCHHHHHHHHHHHHHHHHH
T ss_pred eEEEEe----------cCCCCCHHHHHHhhh--------------------------cccCCCHHHHHHHHHHHHHHHHH
Confidence 899999 777788888876432 12348889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEe--cCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC--------CCCCch
Q 004442 622 LHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--------GRQTRA 691 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~--~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~t~k 691 (753)
||+.+|+||||||+|||+. .++...+||+|||+++..... .......||+.|+|||++.+ ..++.+
T Consensus 128 LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~ 203 (396)
T 4eut_A 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD----EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203 (396)
T ss_dssp HHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG----GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHH
T ss_pred HHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC----CccccccCCccccCHHHhhccccccccccCCCcH
Confidence 9999999999999999982 233456999999999876543 22234568999999999865 567889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHccCcc-------------------------cccCCCHHHHHH
Q 004442 692 IDLFSLGCILFFCITGGKHPYGES-----FERDANIVKDRKDL-------------------------FLVEHIPEAVDL 741 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~-----~~~~~~~i~~~~~~-------------------------~~~~~s~el~dL 741 (753)
+|||||||++|||+|| ..||... .......+....+. .....++.+.++
T Consensus 204 ~DiwSlG~il~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~l 282 (396)
T 4eut_A 204 VDLWSIGVTFYHAATG-SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPV 282 (396)
T ss_dssp HHHHHHHHHHHHHHHS-SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHC-CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHH
Confidence 9999999999999998 6677421 22223333222211 112234578899
Q ss_pred HHHccccCcCCC
Q 004442 742 FTRLLDPNPDLR 753 (753)
Q Consensus 742 I~~cL~~DP~~R 753 (753)
|.+||+.||++|
T Consensus 283 l~~~L~~dP~~R 294 (396)
T 4eut_A 283 LANILEADQEKC 294 (396)
T ss_dssp HHHHSCCCTTTS
T ss_pred HHHhhccChhhh
Confidence 999999999998
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=351.74 Aligned_cols=233 Identities=24% Similarity=0.343 Sum_probs=182.4
Q ss_pred eEEecccCceEEEEEEee---CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 478 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.+.||+|+||.||+|... .++.||||+++.... +.+.+|+. +++.++|||||+++++|.+ +..++|||
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~-~~~~lv~E-- 449 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVME-- 449 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEEEEE--
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEec-CCEEEEEE--
Confidence 357999999999998543 468999999975321 23445554 8899999999999999965 45889999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+.+|+|.+++.. ...+++.+++.|+.||+.||+|||+.+|+|
T Consensus 450 --------~~~~g~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiH 492 (635)
T 4fl3_A 450 --------MAELGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVH 492 (635)
T ss_dssp --------CCTTEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --------ccCCCCHHHHHhh-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeC
Confidence 7778888888743 235788899999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+|||++.++ .+||+|||+++................+|+.|+|||++.+..++.++|||||||++|||+|++.
T Consensus 493 rDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~ 570 (635)
T 4fl3_A 493 RDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 570 (635)
T ss_dssp SCCSGGGEEEEETT--EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999998775 5999999999877544332233334457889999999999999999999999999999999337
Q ss_pred CCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.||.+.... ....+... ....+..+++++.+||.+||+.||++|
T Consensus 571 ~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 616 (635)
T 4fl3_A 571 KPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 616 (635)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHC
Confidence 788765443 33444433 345677889999999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=321.35 Aligned_cols=236 Identities=25% Similarity=0.354 Sum_probs=179.0
Q ss_pred cceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCch----H-HHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD----V-ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~----~-~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
.++|++.+.||+|+||.||++.... |+.||||++...... . ..+|+ .+++.++||||++++++|.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHH-HHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 3678999999999999999997754 899999998654322 2 23444 478999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||+| .+|+|.+++. ....+++..+.+++.|++.||+|||+.
T Consensus 103 ~e~~----------~~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~ 143 (331)
T 4aaa_A 103 FEFV----------DHTILDDLEL-----------------------------FPNGLDYQVVQKYLFQIINGIGFCHSH 143 (331)
T ss_dssp EECC----------SEEHHHHHHH-----------------------------STTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecC----------CcchHHHHHh-----------------------------hccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9954 4555555432 124578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~El 704 (753)
+|+||||||+||+++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 144 ~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 218 (331)
T 4aaa_A 144 NIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPG---EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218 (331)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCTTC---------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred CEEccCcChheEEEcCCCc--EEEEeCCCceeecCCc---cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHH
Confidence 9999999999999977764 9999999998765322 122344689999999999876 689999999999999999
Q ss_pred HhCCCCCCCCChHHH-HHHHHcc-C------------------------------cccccCCCHHHHHHHHHccccCcCC
Q 004442 705 ITGGKHPYGESFERD-ANIVKDR-K------------------------------DLFLVEHIPEAVDLFTRLLDPNPDL 752 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~-~~~i~~~-~------------------------------~~~~~~~s~el~dLI~~cL~~DP~~ 752 (753)
++| .+||....... ...+... . ......+++++.+||.+||+.||++
T Consensus 219 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 297 (331)
T 4aaa_A 219 FMG-EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297 (331)
T ss_dssp HHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhC-CCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCccc
Confidence 999 66776553322 1111100 0 0011356889999999999999999
Q ss_pred C
Q 004442 753 R 753 (753)
Q Consensus 753 R 753 (753)
|
T Consensus 298 R 298 (331)
T 4aaa_A 298 R 298 (331)
T ss_dssp S
T ss_pred C
Confidence 8
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.14 Aligned_cols=244 Identities=20% Similarity=0.260 Sum_probs=193.2
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--------------------hHHHHHHHHHHHhCCCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--------------------DVALKEIQNLIASDQHPN 528 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--------------------~~~~~Ei~~ll~~l~HpN 528 (753)
....++|.+.+.||+|+||.||++.. +|+.||||++..... +...+|+. +++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ-IITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHH-HHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHH-HHHhCCCCC
Confidence 44557899999999999999999988 999999999964311 34455554 789999999
Q ss_pred eeeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHH
Q 004442 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608 (753)
Q Consensus 529 IV~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 608 (753)
|+++++++.+.+..++||| |+++|+|.+++.....-. ......+++..+
T Consensus 105 i~~~~~~~~~~~~~~lv~e----------~~~~~~L~~~~~~~~~l~---------------------~~~~~~~~~~~~ 153 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYE----------YMENDSILKFDEYFFVLD---------------------KNYTCFIPIQVI 153 (348)
T ss_dssp BCCCSEEEESSSEEEEEEE----------CCTTCBSSEESSSEESSC---------------------SSSCCCCCHHHH
T ss_pred cceEEEEEeeCCeEEEEEe----------ccCCCcHHHHHHHhhhhh---------------------hccccCCCHHHH
Confidence 9999999999999999999 666677766532110000 011356889999
Q ss_pred HHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-
Q 004442 609 LKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG- 686 (753)
Q Consensus 609 l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~- 686 (753)
+.++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++...... ......||..|+|||++.+.
T Consensus 154 ~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~ 226 (348)
T 2pml_X 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNES 226 (348)
T ss_dssp HHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSCC
T ss_pred HHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEEeccccccccccc-----cccCCCCCcCccCchhhcCCC
Confidence 9999999999999999 99999999999999977764 999999999876543 22345689999999999887
Q ss_pred CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHccCcccc-------------------cCCCHHHHHHHHH
Q 004442 687 RQTR-AIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDRKDLFL-------------------VEHIPEAVDLFTR 744 (753)
Q Consensus 687 ~~t~-ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~~~~~~-------------------~~~s~el~dLI~~ 744 (753)
.++. ++|||||||++|||++| .+||.... ......+.......+ ..+++++.+||.+
T Consensus 227 ~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 305 (348)
T 2pml_X 227 SYNGAKVDIWSLGICLYVMFYN-VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL 305 (348)
T ss_dssp CEEHHHHHHHHHHHHHHHHHHS-SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH
T ss_pred CCCcchhhHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH
Confidence 5665 99999999999999998 66776543 344444544444444 5678999999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 306 ~L~~dP~~R 314 (348)
T 2pml_X 306 FLRKNPAER 314 (348)
T ss_dssp HCCSSGGGS
T ss_pred HccCChhhC
Confidence 999999998
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=320.97 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=190.0
Q ss_pred ecceEEEeEEecccCceEEEEEE-----eeCCcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCc--
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQD-- 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~-----~~~g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~-- 540 (753)
..+.|++.+.||+|+||.||++. ..+|+.||||++...... ...+|+ .+++.++|+||+++++++.+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI-EILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHH-HHHHTCCCTTBCCEEEEECC----
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEEecCCC
Confidence 45678999999999999999987 346899999999764432 334444 4789999999999999987654
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.+++... ...+++.++++++.|++.||+
T Consensus 118 ~~~lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~aL~ 159 (326)
T 2w1i_A 118 NLKLIME----------YLPYGSLRDYLQKH----------------------------KERIDHIKLLQYTSQICKGME 159 (326)
T ss_dssp CCEEEEC----------CCTTCBHHHHHHHS----------------------------TTSSCHHHHHHHHHHHHHHHH
T ss_pred ceEEEEE----------CCCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHH
Confidence 6899999 67778888877532 134778889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+||+++.++. +||+|||+++................++..|+|||.+.+..++.++|||||||+
T Consensus 160 ~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 237 (326)
T 2w1i_A 160 YLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237 (326)
T ss_dssp HHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred HHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHH
Confidence 999999999999999999987764 999999999987654333233344557889999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-----------------HHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERD-----------------ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~-----------------~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| ..|+....... ...+. ....+.+..+++++.++|++||+.||++|
T Consensus 238 l~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 307 (326)
T 2w1i_A 238 LYELFTY-IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307 (326)
T ss_dssp HHHHHHT-TCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHhc-CCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhC
Confidence 9999998 55665332111 11112 22344567789999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=314.38 Aligned_cols=233 Identities=30% Similarity=0.393 Sum_probs=182.6
Q ss_pred EEecccCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccCChhh
Q 004442 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~~L~~ 555 (753)
..||+|+||.||+|.. .+++.||||.+..... ...+.++..+++.++||||+++++++.+.+..++|||
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e-------- 99 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME-------- 99 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE--------
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE--------
Confidence 4799999999999975 4588999999975432 2334444458899999999999999999999999999
Q ss_pred HHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCC
Q 004442 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (753)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~ 635 (753)
|+++|+|.+++.... ....+++..+..++.|++.||+|||+.+|+||||||+
T Consensus 100 --~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 151 (295)
T 2clq_A 100 --QVPGGSLSALLRSKW--------------------------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGD 151 (295)
T ss_dssp --CCSEEEHHHHHHHTT--------------------------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred --eCCCCCHHHHHHhhc--------------------------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChh
Confidence 666778887775431 1234567788999999999999999999999999999
Q ss_pred cEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCC
Q 004442 636 NVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPY 712 (753)
Q Consensus 636 NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSfGvvL~EllTG~~~Pf 712 (753)
||+++. ++ .+||+|||+++...... .......||+.|+|||++.+.. ++.++||||||+++|||++| ..||
T Consensus 152 Nil~~~~~~--~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf 225 (295)
T 2clq_A 152 NVLINTYSG--VLKISDFGTSKRLAGIN---PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG-KPPF 225 (295)
T ss_dssp GEEEETTTC--CEEECCTTTCEESCC--------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT-SCTT
T ss_pred hEEEECCCC--CEEEeecccccccCCCC---CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC-CCCc
Confidence 999976 44 49999999998765421 1223456899999999997654 89999999999999999998 6677
Q ss_pred CCChHHH--H-H-HHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 713 GESFERD--A-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 713 ~~~~~~~--~-~-~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
....... . . .........+..+++++.++|.+||+.||++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 270 (295)
T 2clq_A 226 YELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270 (295)
T ss_dssp GGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTS
T ss_pred cCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhC
Confidence 5432211 1 1 12233445667889999999999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.92 Aligned_cols=239 Identities=27% Similarity=0.395 Sum_probs=184.7
Q ss_pred eecceEEEeEEecccCceEEEEEEe--eCCcEEEEEEeecCC-----chHHHHHHHH--HHHhCCCCceeeeccccc---
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQN--LIASDQHPNIVRWYGVES--- 537 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~--~~g~~VAVK~l~~~~-----~~~~~~Ei~~--ll~~l~HpNIV~L~g~~~--- 537 (753)
...++|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+.. .+..++||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4457899999999999999999987 468999999986422 2244555542 234559999999999987
Q ss_pred --CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 538 --DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 538 --~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
.....++|||+|. |+|.+++... ....+++..++.++.||
T Consensus 88 ~~~~~~~~lv~e~~~-----------~~L~~~l~~~---------------------------~~~~~~~~~~~~~~~qi 129 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-----------QDLTTYLDKV---------------------------PEPGVPTETIKDMMFQL 129 (326)
T ss_dssp CSSEEEEEEEEECCS-----------CBHHHHHHHS---------------------------CTTCSCHHHHHHHHHHH
T ss_pred cCCCceEEEEEecCC-----------CCHHHHHHhc---------------------------ccCCCCHHHHHHHHHHH
Confidence 5678899999554 4555555322 12347888999999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHH
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIw 695 (753)
+.||.|||+.||+||||||+||+++.++. +||+|||+++..... .......||..|+|||++.+..++.++|||
T Consensus 130 ~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 203 (326)
T 1blx_A 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLW 203 (326)
T ss_dssp HHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHH
T ss_pred HHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCC----CCccccccccceeCHHHHhcCCCCcchhHH
Confidence 99999999999999999999999977765 999999999865422 122345689999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHH-HHHHHcc---------------------------CcccccCCCHHHHHHHHHccc
Q 004442 696 SLGCILFFCITGGKHPYGESFERD-ANIVKDR---------------------------KDLFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~~-~~~i~~~---------------------------~~~~~~~~s~el~dLI~~cL~ 747 (753)
||||++|||++| .+||....... ...+... .......+++++.+||.+||+
T Consensus 204 slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 282 (326)
T 1blx_A 204 SVGCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 282 (326)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSC
T ss_pred HHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcC
Confidence 999999999998 66776654322 2222110 001234578899999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 283 ~dP~~R 288 (326)
T 1blx_A 283 FNPAKR 288 (326)
T ss_dssp SSTTTS
T ss_pred CCcccC
Confidence 999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.49 Aligned_cols=241 Identities=26% Similarity=0.384 Sum_probs=182.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhC-CCCceeeecccccC------
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGVESD------ 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~------ 538 (753)
....++|.+.+.||+|+||.||+|... +|+.||||++.... .....+|+. ++..+ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEIN-MLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHH-HHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHH-HHHhccCCCCeeeeeeEEeeccCccc
Confidence 445678999999999999999999764 68999999986532 345556666 45555 89999999999876
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++||| |+.+|+|.+++.... ...+++..++.++.||+.|
T Consensus 99 ~~~~~lv~e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~ 141 (326)
T 2x7f_A 99 DDQLWLVME----------FCGAGSVTDLIKNTK---------------------------GNTLKEEWIAYICREILRG 141 (326)
T ss_dssp CCEEEEEEE----------CCTTEEHHHHHHHSG---------------------------GGCCCHHHHHHHHHHHHHH
T ss_pred cceEEEEEE----------cCCCCcHHHHHHhcc---------------------------cCCCCHHHHHHHHHHHHHH
Confidence 568999999 666777777775421 2457888899999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhh
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAID 693 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksD 693 (753)
|.|||+.+|+||||||+||+++.++. +||+|||++....... .......||+.|+|||++. +..++.++|
T Consensus 142 l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D 216 (326)
T 2x7f_A 142 LSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSD 216 (326)
T ss_dssp HHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHH
T ss_pred HHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCc---cccccccCCccccChhhhccccccCcCCCccch
Confidence 99999999999999999999977765 9999999998764321 1223446899999999987 566899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFE-RDANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||++| .+||..... .....+.... ......+++++.+||.+||..||++|
T Consensus 217 i~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 278 (326)
T 2x7f_A 217 LWSLGITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 278 (326)
T ss_dssp HHHHHHHHHHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHHHHHHHhC-CCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhC
Confidence 99999999999998 667765433 2222222222 22345678999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-36 Score=319.02 Aligned_cols=243 Identities=24% Similarity=0.353 Sum_probs=184.8
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeeccccc----CCceEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVES----DQDFVY 543 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~----~~~~~~ 543 (753)
.++|.+.+.||+|+||.||++.. .+|+.||||++..... +...+|+ .+++.++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA-DMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46799999999999999999976 5699999999865432 2333444 4789999999999999987 355789
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++..... ....+++.++++++.|++.||+|||
T Consensus 107 lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~i~~qi~~~L~~LH 151 (317)
T 2buj_A 107 LLLP----------FFKRGTLWNEIERLKD-------------------------KGNFLTEDQILWLLLGICRGLEAIH 151 (317)
T ss_dssp EEEE----------CCTTCBHHHHHHHHHT-------------------------TTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------eCCCCcHHHHHHHHHh-------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 7777888888764321 2356889999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc------ccCccCCCCccccccccccCCC---CCchhhH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL------TQNATGYGSSGWQAPEQLLQGR---QTRAIDL 694 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~------~~~~~~~GT~~Y~APE~l~~~~---~t~ksDI 694 (753)
+.+|+||||||+||+++.++. +||+|||++.......... .......||+.|+|||++.+.. ++.++||
T Consensus 152 ~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 152 AKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp HTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred hCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 999999999999999977765 9999999988653211100 0011234799999999987654 6899999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChH---HHHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 695 FSLGCILFFCITGGKHPYGESFE---RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 695 wSfGvvL~EllTG~~~Pf~~~~~---~~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||++|||++| ..||..... ....... ....+....+++++.++|.+||+.||++|
T Consensus 230 ~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 291 (317)
T 2buj_A 230 WSLGCVLYAMMFG-EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291 (317)
T ss_dssp HHHHHHHHHHHHS-SCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHhC-CCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhC
Confidence 9999999999998 678753211 1111122 22233445788999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=314.54 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=180.6
Q ss_pred cceEEEeEEecccCceEEEEEEee--CCc--EEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY--EGR--SVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~--~g~--~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|++.+.||+|+||+||++... +++ .||||+++... .+...+|+. +++.++||||+++++++.+.+
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHH-HHHHCCCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHH-HHHhCCCCCcccEEEEEccCC-
Confidence 467899999999999999998753 233 69999986432 123344444 778899999999999988765
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++.... ..+++..+++++.|++.||.|
T Consensus 95 ~~~v~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~ 136 (291)
T 1u46_A 95 MKMVTE----------LAPLGSLLDRLRKHQ----------------------------GHFLLGTLSRYAVQVAEGMGY 136 (291)
T ss_dssp CEEEEE----------CCTTCBHHHHHHHHG----------------------------GGSCHHHHHHHHHHHHHHHHH
T ss_pred ceeeEe----------cccCCCHHHHHHhcc----------------------------CCcCHHHHHHHHHHHHHHHHH
Confidence 889999 677788888775431 246788899999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+||+++.++. +||+|||+++................+|..|+|||++.+..++.++||||||+++
T Consensus 137 lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 137 LESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp HHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HHhCCcccCCCchheEEEcCCCC--EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 99999999999999999987764 9999999998876543333333445678899999999988899999999999999
Q ss_pred HHHHhCCCCCCCCChHH-HHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFER-DANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~-~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++++.+||...... ....+... ....+..+++++.++|.+||+.||++|
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 269 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 269 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccC
Confidence 99999337788665433 33333322 234556788999999999999999998
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=319.43 Aligned_cols=248 Identities=25% Similarity=0.324 Sum_probs=177.1
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..++|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQ-AMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHH-HHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3467889999999999999999754 68999999986432 123344444 66788999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++........ .....+++..++.++.||+.||.|||+.
T Consensus 92 ~e----------~~~~~~L~~~l~~~~~~~~---------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 92 MK----------LLSGGSVLDIIKHIVAKGE---------------------HKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp EE----------CCTTCBHHHHHHHHHHTTT---------------------TTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eh----------hccCCchHHHHHHHhhccc---------------------cccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 6667788777754321100 1234588999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--ccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~ 702 (753)
+|+||||||+||+++.++. +||+|||++........ .........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 141 ~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 218 (303)
T 2vwi_A 141 GQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAI 218 (303)
T ss_dssp TCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHH
T ss_pred CCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHH
Confidence 9999999999999977765 99999999986643211 1112234568999999999876 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHH-HHHHHccCc----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD-ANIVKDRKD----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~-~~~i~~~~~----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| ..||....... ......... .....+++++.++|.+||+.||++|
T Consensus 219 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 279 (303)
T 2vwi_A 219 ELATG-AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279 (303)
T ss_dssp HHHHS-SCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhC-CCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhC
Confidence 99998 66776643322 222222111 1234678899999999999999998
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.35 Aligned_cols=233 Identities=23% Similarity=0.395 Sum_probs=178.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.++|.+.+.||+|+||.||+|... +|+.||||++..... ....+|+ .+++.++||||+++++++...+..
T Consensus 38 ~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~ 116 (371)
T 4exu_A 38 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL-LLLKHMQHENVIGLLDVFTPASSL 116 (371)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHH-HHHHHCCCTTBCCCSEEECSCSSS
T ss_pred ecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHH-HHHHhcCCCCchhhhhheeccCCc
Confidence 346678999999999999999999754 589999999975432 2334444 478999999999999999877654
Q ss_pred ------EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 543 ------YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 543 ------~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
++|||+|.++| .+++ ...+++..+..++.||+
T Consensus 117 ~~~~~~~lv~e~~~~~l-----------~~~~-------------------------------~~~~~~~~~~~i~~qi~ 154 (371)
T 4exu_A 117 RNFYDFYLVMPFMQTDL-----------QKIM-------------------------------GMEFSEEKIQYLVYQML 154 (371)
T ss_dssp TTCCCCEEEEECCCEEH-----------HHHT-------------------------------TSCCCHHHHHHHHHHHH
T ss_pred ccceeEEEEEccccccH-----------HHHh-------------------------------hcCCCHHHHHHHHHHHH
Confidence 99999665443 3322 13477888999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLF 695 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIw 695 (753)
.||+|||+.+|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||
T Consensus 155 ~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (371)
T 4exu_A 155 KGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIW 226 (371)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC--------------CTTCCCTTSCHHHHSCCSCCCTTHHHH
T ss_pred HHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccccC------cCCcccCccccCHHHhcCCCCCCcHHhHH
Confidence 9999999999999999999999977755 999999999865432 234568999999999987 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHH-HHHHHHc-cC------------------------------cccccCCCHHHHHHHH
Q 004442 696 SLGCILFFCITGGKHPYGESFER-DANIVKD-RK------------------------------DLFLVEHIPEAVDLFT 743 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~-~~------------------------------~~~~~~~s~el~dLI~ 743 (753)
||||++|||++| .+||.+.... ....+.. .. ...+..+++++.+||+
T Consensus 227 slG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 305 (371)
T 4exu_A 227 SVGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 305 (371)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHH
Confidence 999999999998 6677665322 2111110 00 0112456899999999
Q ss_pred HccccCcCCC
Q 004442 744 RLLDPNPDLR 753 (753)
Q Consensus 744 ~cL~~DP~~R 753 (753)
+||+.||++|
T Consensus 306 ~~L~~dP~~R 315 (371)
T 4exu_A 306 KMLELDVDKR 315 (371)
T ss_dssp HHSCSCTTTS
T ss_pred HHCCCChhhc
Confidence 9999999998
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=314.11 Aligned_cols=239 Identities=25% Similarity=0.336 Sum_probs=185.4
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
...+.|.+.+.||+|+||.||++... +++.||+|++.... .+...+|+. +++.++||||+++++++.+.+..++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE-ILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHH-HHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHH-HHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 34577999999999999999999775 48999999986432 234455555 77889999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++... ...+++..++.++.|++.||.|||+.
T Consensus 95 ~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (302)
T 2j7t_A 95 IE----------FCPGGAVDAIMLEL----------------------------DRGLTEPQIQVVCRQMLEALNFLHSK 136 (302)
T ss_dssp EE----------CCTTEEHHHHHHHH----------------------------TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------eCCCCcHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 99 66667777766432 24578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccc-----cCCCCCchhhHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l-----~~~~~t~ksDIwSfGvv 700 (753)
+|+||||||+||+++.++. +||+|||++...... ........||+.|+|||++ .+..++.++||||||++
T Consensus 137 ~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 211 (302)
T 2j7t_A 137 RIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKT---LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGIT 211 (302)
T ss_dssp TCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHH---HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHH
T ss_pred CcccCCCCHHHEEECCCCC--EEEEECCCCcccccc---ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHH
Confidence 9999999999999977765 999999997643211 1112334689999999998 36778999999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHHHccCc---ccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFER-DANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~-~~~~i~~~~~---~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| .+||...... ....+..... ..+..+++++.++|.+||+.||++|
T Consensus 212 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 267 (302)
T 2j7t_A 212 LIEMAQI-EPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267 (302)
T ss_dssp HHHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHhcC-CCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhC
Confidence 9999998 6677665332 2222222221 2356788999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=311.55 Aligned_cols=239 Identities=24% Similarity=0.383 Sum_probs=190.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.++|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.++||||+++++++.+.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE-LLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhccCCCccEEEEEEeCCCeE
Confidence 455678999999999999999999775 68999999986432 234445554 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ...+++.++++++.||+.||.||
T Consensus 97 ~lv~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~~l~~L 137 (287)
T 2wei_A 97 YIVGE----------LYTGGELFDEIIK-----------------------------RKRFSEHDAARIIKQVFSGITYM 137 (287)
T ss_dssp EEEEC----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ccCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6666777776642 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
|+.+|+||||||+||+++.++ ...+||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++
T Consensus 138 H~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l 212 (287)
T 2wei_A 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT----KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212 (287)
T ss_dssp HHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS----SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHH
T ss_pred HHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC----ccccccCcccccChHHhcC-CCCCchhhHhHHHHH
Confidence 999999999999999997643 3469999999998764332 1123347899999998865 489999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|++| .+||..... .....+...... ....+++++.++|.+||+.||++|
T Consensus 213 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 268 (287)
T 2wei_A 213 YILLSG-TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLR 268 (287)
T ss_dssp HHHHHS-SCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhC
Confidence 999998 567665433 333444443322 225678999999999999999998
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.30 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=175.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+...++|.+.+.||+|+||+||++... ..||||+++.... +.+.+|+ .+++.++|+||+++++++. .+..+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~-~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYST-APQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHH-HHHHhCCCCcEEEEEeecc-CCccE
Confidence 445677899999999999999998654 4699999965432 2233444 4789999999999999764 55689
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.++++.. ...+++..+++++.|++.||+|||
T Consensus 96 lv~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~~L~~lH 137 (289)
T 3og7_A 96 IVTQ----------WCEGSSLYHHLHAS----------------------------ETKFEMKKLIDIARQTARGMDYLH 137 (289)
T ss_dssp EEEE----------CCCEEEHHHHHTTC-------------------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ecCCCcHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 66677888777432 235788899999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchhhHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCI 700 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ksDIwSfGvv 700 (753)
+.+|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++. +..++.++||||||++
T Consensus 138 ~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 214 (289)
T 3og7_A 138 AKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIV 214 (289)
T ss_dssp HTTCCCSCCCGGGEEEETTT--EEEECCCC-------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHH
T ss_pred hCCcccccCccceEEECCCC--CEEEccceeccccccccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHH
Confidence 99999999999999998776 499999999986543211 12223456899999999986 6678999999999999
Q ss_pred HHHHHhCCCCCCCCChH--HHHHHHHccCc-----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE--RDANIVKDRKD-----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~--~~~~~i~~~~~-----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||..... .....+..... .....+++++.+||.+||+.||++|
T Consensus 215 l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 273 (289)
T 3og7_A 215 LYELMTG-QLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273 (289)
T ss_dssp HHHHHHS-SCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHC-CCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhC
Confidence 9999998 678865422 22233332221 1234678999999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=323.91 Aligned_cols=239 Identities=22% Similarity=0.332 Sum_probs=169.4
Q ss_pred eecceEEEe-EEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC----CceEE
Q 004442 470 RIGKLVVFN-KEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVY 543 (753)
Q Consensus 470 ~i~~~~~i~-~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~ 543 (753)
.+.++|.+. +.||+|+||+||++... +|+.||||++... ....+|+...+..++|+||+++++++.. ....+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 345677775 56999999999999765 6999999999764 4556677767888999999999999865 55689
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+.+|+|.+++.... ...+++.++++++.|++.||.|||
T Consensus 103 lv~e----------~~~gg~L~~~l~~~~---------------------------~~~l~~~~~~~i~~ql~~~l~~LH 145 (336)
T 3fhr_A 103 IIME----------CMEGGELFSRIQERG---------------------------DQAFTEREAAEIMRDIGTAIQFLH 145 (336)
T ss_dssp EEEE----------CCTTEEHHHHHHTC----------------------------CCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------ccCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 667788888775421 235788999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||++.++ ...+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 146 ~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 220 (336)
T 3fhr_A 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220 (336)
T ss_dssp HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------------CHHHHHHHHHHHHHHHH
T ss_pred hCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc-----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHH
Confidence 99999999999999997643 356999999999876432 123446899999999998888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHH-----HHHHccC----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERDA-----NIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~~-----~~i~~~~----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++| .+||........ ..+.... ......+++++.+||.+||+.||++|
T Consensus 221 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 279 (336)
T 3fhr_A 221 ILLCG-FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTER 279 (336)
T ss_dssp HHHHS-SCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHC-CCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHC
Confidence 99998 667755432221 1111111 12235678999999999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=319.57 Aligned_cols=239 Identities=29% Similarity=0.420 Sum_probs=186.0
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCceeeecccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVE 536 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~L~g~~ 536 (753)
..+.++|.+.+.||+|+||.||++... +++.||||.+..... ....+|+. +++.++||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE-ILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHH-HHHHCCCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHH-HHHhCCCCCCceEeeEE
Confidence 445678999999999999999999764 589999999864321 12344554 78899999999999998
Q ss_pred cCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 537 ~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
..++ .++||| |+.+|+|.+++.. ...+++..+..++.||+
T Consensus 85 ~~~~-~~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~ 124 (322)
T 2ycf_A 85 DAED-YYIVLE----------LMEGGELFDKVVG-----------------------------NKRLKEATCKLYFYQML 124 (322)
T ss_dssp ESSS-EEEEEE----------CCTTEETHHHHST-----------------------------TCCCCHHHHHHHHHHHH
T ss_pred cCCc-eEEEEe----------cCCCCcHHHHHhc-----------------------------cCCCCHHHHHHHHHHHH
Confidence 7655 899999 6667777776632 23578888999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc---CCCCCchh
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAI 692 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~---~~~~t~ks 692 (753)
.||.|||+.+|+||||||+|||++.++ ...+||+|||+++...... ......||+.|+|||++. ...++.++
T Consensus 125 ~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 200 (322)
T 2ycf_A 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAV 200 (322)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHH
T ss_pred HHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc----ccccccCCcCccCchhhccCCCCCCCchh
Confidence 999999999999999999999997654 3469999999998765321 112345899999999974 56689999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 693 DLFSLGCILFFCITGGKHPYGESFE--RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 693 DIwSfGvvL~EllTG~~~Pf~~~~~--~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||||||++|||++| .+||..... .....+...... ....+++++.+||++||..||++|
T Consensus 201 Di~slG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 266 (322)
T 2ycf_A 201 DCWSLGVILFICLSG-YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266 (322)
T ss_dssp HHHHHHHHHHHHHHS-SCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hHHHHHHHHHHHHhC-CCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhC
Confidence 999999999999998 668765422 222333333322 235678999999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.08 Aligned_cols=203 Identities=22% Similarity=0.261 Sum_probs=162.2
Q ss_pred cceecceEEEeEEecccCceEEEEEEe--eCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCC------Cceeeeccccc
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQH------PNIVRWYGVES 537 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~--~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~H------pNIV~L~g~~~ 537 (753)
+..+.++|.+.+.||+|+||+||++.. .+++.||||++..... +...+|+. ++..++| ++|+++++++.
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ-VLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHH-HHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHH-HHHHhhhcCCCCceeeEeeecccc
Confidence 456678899999999999999999975 4689999999975432 23344544 5555544 45999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+.+..++|||+| +|+|.+++.... ...+++..+.+++.||+.
T Consensus 88 ~~~~~~lv~e~~-----------~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~ 129 (339)
T 1z57_A 88 HHGHICIVFELL-----------GLSTYDFIKENG---------------------------FLPFRLDHIRKMAYQICK 129 (339)
T ss_dssp ETTEEEEEEECC-----------CCBHHHHHHHTT---------------------------TCCCCHHHHHHHHHHHHH
T ss_pred cCCcEEEEEcCC-----------CCCHHHHHHhcC---------------------------CCCCcHHHHHHHHHHHHH
Confidence 999999999955 455555553221 235778899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCC-----------------CCeEEEEeccCceeccCCCcccccCccCCCCcccccc
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~-----------------~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP 680 (753)
||+|||+.+|+||||||+|||++.++ +..+||+|||+++..... .....||+.|+||
T Consensus 130 ~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aP 203 (339)
T 1z57_A 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAP 203 (339)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCH
T ss_pred HHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc------cccccCCccccCh
Confidence 99999999999999999999997643 345999999999875432 2345689999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 004442 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 716 (753)
Q Consensus 681 E~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~ 716 (753)
|++.+..++.++|||||||++|||++| .+||....
T Consensus 204 E~~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~ 238 (339)
T 1z57_A 204 EVILALGWSQPCDVWSIGCILIEYYLG-FTVFPTHD 238 (339)
T ss_dssp HHHTTSCCCTHHHHHHHHHHHHHHHHS-SCSCCCSC
T ss_pred HHhhCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCC
Confidence 999999999999999999999999999 66776543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.07 Aligned_cols=234 Identities=23% Similarity=0.382 Sum_probs=167.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCC---
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--- 539 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~--- 539 (753)
..+.++|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+|+. +++.++||||+++++++...
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 25 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp EEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSG
T ss_pred cCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEecCCcc
Confidence 34567899999999999999999975 468999999996532 123445555 78899999999999998654
Q ss_pred ---ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 540 ---DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 540 ---~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
...|+|+|++.++|.+++ . ...+++..+..++.||+
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~-----------~------------------------------~~~l~~~~~~~i~~qi~ 142 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIV-----------K------------------------------CQKLTDDHVQFLIYQIL 142 (367)
T ss_dssp GGCCCCEEEEECCCEECC----------------------------------------------CCCCHHHHHHHHHHHH
T ss_pred ccCCeEEEEecccCCCHHHHH-----------h------------------------------cCCCCHHHHHHHHHHHH
Confidence 567999996655444333 1 13577888999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLF 695 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIw 695 (753)
+||+|||+.+|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+ ..++.++|||
T Consensus 143 ~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 214 (367)
T 2fst_X 143 RGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTADE------MTGYVATRWYRAPEIMLNWMHYNQTVDIW 214 (367)
T ss_dssp HHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC---------------------CCCTTCCHHHHTTCCSCCTTHHHH
T ss_pred HHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccccc------CCCcCcCcCccChHHHcCCcCCCchhhHH
Confidence 9999999999999999999999977654 999999999875432 234568999999999987 6789999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH-HHHHHHHcc-----------------------Cc--------ccccCCCHHHHHHHH
Q 004442 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDR-----------------------KD--------LFLVEHIPEAVDLFT 743 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~-----------------------~~--------~~~~~~s~el~dLI~ 743 (753)
||||++|||++| ++||.+... .....+... .. ......++++.+||+
T Consensus 215 slG~il~ell~g-~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 293 (367)
T 2fst_X 215 SVGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293 (367)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHH
T ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 999999999998 667765432 222221110 00 012346789999999
Q ss_pred HccccCcCCC
Q 004442 744 RLLDPNPDLR 753 (753)
Q Consensus 744 ~cL~~DP~~R 753 (753)
+||..||++|
T Consensus 294 ~mL~~dP~~R 303 (367)
T 2fst_X 294 KMLVLDSDKR 303 (367)
T ss_dssp HHSCSSGGGS
T ss_pred HhCCCCcccC
Confidence 9999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=318.29 Aligned_cols=240 Identities=26% Similarity=0.345 Sum_probs=166.9
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++|.+.+.||+|+||.||++... +|+.||||++..... ....+|+..+++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 466888899999999999999774 689999999976532 244556666778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~- 625 (753)
|+|.++|.+++ ..... .....+++..+.+++.|++.||.|||+.
T Consensus 101 e~~~~~l~~~~-----------~~~~~------------------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 145 (327)
T 3aln_A 101 ELMSTSFDKFY-----------KYVYS------------------------VLDDVIPEEILGKITLATVKALNHLKENL 145 (327)
T ss_dssp CCCSEEHHHHH-----------HHHHH------------------------TTCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCChHHHH-----------HHHHh------------------------hhcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence 97765554443 21110 1235678889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccc----cCCCCCchhhHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL----LQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l----~~~~~t~ksDIwSfGvvL 701 (753)
+|+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++ .+..++.++|||||||++
T Consensus 146 ~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il 219 (327)
T 3aln_A 146 KIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITL 219 (327)
T ss_dssp SCCCSCCCGGGEEEETTT--EEEECCCSSSCC----------------------------------CCSHHHHHHHHHHH
T ss_pred CEeECCCCHHHEEEcCCC--CEEEccCCCceeccccc----ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHH
Confidence 999999999999997775 49999999998765332 12233589999999998 456689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHH--HHHccCc-c----cccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFERDAN--IVKDRKD-L----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~~~~~--~i~~~~~-~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| ..||......... .+..... . ....+++++.+||.+||+.||++|
T Consensus 220 ~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 277 (327)
T 3aln_A 220 YELATG-RFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277 (327)
T ss_dssp HHHHHS-CCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHC-CCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhC
Confidence 999998 6788654322111 1111111 1 123578999999999999999998
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.69 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=166.1
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhC-CCCceeeecccc--------cC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASD-QHPNIVRWYGVE--------SD 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l-~HpNIV~L~g~~--------~~ 538 (753)
..+|.+.+.||+|+||.||++... +|+.||||++..... ....+|+. ++..+ +||||+++++++ ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~-~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC-FMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHH-HHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHH-HHHHhccCCChhhccccccccccccccC
Confidence 457999999999999999999764 689999999865542 23455555 55555 599999999988 44
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
....++|||+|.+ +|.+++.... ....+++.++++++.||+.|
T Consensus 106 ~~~~~lv~e~~~g-----------~L~~~l~~~~--------------------------~~~~~~~~~~~~i~~qi~~~ 148 (337)
T 3ll6_A 106 QAEFLLLTELCKG-----------QLVEFLKKME--------------------------SRGPLSCDTVLKIFYQTCRA 148 (337)
T ss_dssp SEEEEEEEECCSE-----------EHHHHHHHHH--------------------------TTCSCCHHHHHHHHHHHHHH
T ss_pred CceEEEEEEecCC-----------CHHHHHHHhh--------------------------ccCCCCHHHHHHHHHHHHHH
Confidence 5668999996654 4444443221 13458889999999999999
Q ss_pred HHHhhhCC--ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc---------ccCccCCCCccccccccc---c
Q 004442 619 LSHLHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---------TQNATGYGSSGWQAPEQL---L 684 (753)
Q Consensus 619 L~yLH~~~--IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~---------~~~~~~~GT~~Y~APE~l---~ 684 (753)
|+|||+.+ |+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++ .
T Consensus 149 l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 226 (337)
T 3ll6_A 149 VQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS 226 (337)
T ss_dssp HHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC-------------------------------CCT
T ss_pred HHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc
Confidence 99999999 999999999999977764 9999999998765432111 111244589999999998 5
Q ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 685 ~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+..++.++|||||||++|||+|| .+||........ .............++++.+||.+||+.||++|
T Consensus 227 ~~~~~~~~Dv~slG~il~el~~g-~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 293 (337)
T 3ll6_A 227 NFPIGEKQDIWALGCILYLLCFR-QHPFEDGAKLRI-VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEER 293 (337)
T ss_dssp TSCSSHHHHHHHHHHHHHHHHHS-SCCC-------------CCCCTTCCSSGGGHHHHHHHSCSSGGGS
T ss_pred cCCCChHHhHHHHHHHHHHHHhC-CCCCcchhHHHh-hcCcccCCcccccchHHHHHHHHHccCChhhC
Confidence 66789999999999999999998 678765432221 11122233445667889999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.78 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=187.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcE--EEEEEeecCC----chHHHHHHHHHHHhC-CCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRS--VAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~--VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~L 544 (753)
++|.+.+.||+|+||.||++... +|.. ||||++.... .+...+|+. ++..+ +||||+++++++.+.+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHH-HHHhccCCCchhhhceeeeeCCceEE
Confidence 56788899999999999999765 4654 4999986532 233445555 67788 99999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++........... ..........+++.++++++.||+.||+|||+
T Consensus 104 v~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 160 (327)
T 1fvr_A 104 AIE----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160 (327)
T ss_dssp EEC----------CCTTCBHHHHHHTTCHHHHCHH-------------HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------cCCCCCHHHHHHhccccccccc-------------ccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 6667778777764321000000 00000123468999999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++ .+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|||
T Consensus 161 ~~ivH~dlkp~NIl~~~~~--~~kL~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 234 (327)
T 1fvr_A 161 KQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234 (327)
T ss_dssp TTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEE----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCccCCCCccceEEEcCCC--eEEEcccCcCcccccc----ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHH
Confidence 9999999999999997765 4999999999743321 122334578899999999988899999999999999999
Q ss_pred Hh-CCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 IT-GGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lT-G~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| | .+||...... ....+... ....+..+++++.+||.+||..||++|
T Consensus 235 lt~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 285 (327)
T 1fvr_A 235 VSLG-GTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 285 (327)
T ss_dssp HTTS-CCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HcCC-CCCCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 98 6 6788665433 33333332 334566788999999999999999998
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.68 Aligned_cols=233 Identities=15% Similarity=0.081 Sum_probs=162.8
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHH---HHHHhCCCCceeeecccc------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQ---NLIASDQHPNIVRWYGVE------ 536 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~---~ll~~l~HpNIV~L~g~~------ 536 (753)
...|.+.+.||+|+||.||++... +|+.||||++..... ...++++. .++.. +||||++++..+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 355889999999999999999764 689999999986542 22333432 34555 799988855322
Q ss_pred -cCC-----------------ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhh
Q 004442 537 -SDQ-----------------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598 (753)
Q Consensus 537 -~~~-----------------~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 598 (753)
... ...++||| |+. |+|.+++.....
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e----------~~~-~~L~~~l~~~~~------------------------- 183 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMP----------AAS-VDLELLFSTLDF------------------------- 183 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEEC----------CCS-EEHHHHHHHHHH-------------------------
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEec----------CCC-CCHHHHHHHhcc-------------------------
Confidence 111 44899999 444 566666554321
Q ss_pred hcCCCCHHHH------HHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCC
Q 004442 599 KANGHPSAQL------LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 672 (753)
Q Consensus 599 ~~~~l~~~~~------l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~ 672 (753)
.+.+..+ +.++.||+.||+|||+++|+||||||+|||++.++. +||+|||+++...... ....
T Consensus 184 ---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~~~------~~~~ 252 (371)
T 3q60_A 184 ---VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKVGTRG------PASS 252 (371)
T ss_dssp ---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEETTCEE------EGGG
T ss_pred ---ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeecCCCc------cCcc
Confidence 1222333 678899999999999999999999999999977765 9999999998764321 1334
Q ss_pred CCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------ccC--cccccCCCHHHHH
Q 004442 673 GSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--------DRK--DLFLVEHIPEAVD 740 (753)
Q Consensus 673 GT~~Y~APE~l~~--~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~--------~~~--~~~~~~~s~el~d 740 (753)
+|+.|+|||++.+ ..++.++|||||||++|||+|| .+||............ ... .+....+++++.+
T Consensus 253 ~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (371)
T 3q60_A 253 VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT 331 (371)
T ss_dssp SCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS-SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHH
T ss_pred CCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC-CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHH
Confidence 6799999999987 6799999999999999999998 6788665322111000 011 1223467899999
Q ss_pred HHHHccccCcCCC
Q 004442 741 LFTRLLDPNPDLR 753 (753)
Q Consensus 741 LI~~cL~~DP~~R 753 (753)
||.+||+.||++|
T Consensus 332 li~~~L~~dP~~R 344 (371)
T 3q60_A 332 LIGRFLNFDRRRR 344 (371)
T ss_dssp HHHHHTCSSTTTC
T ss_pred HHHHHcCCChhhC
Confidence 9999999999998
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=310.95 Aligned_cols=236 Identities=25% Similarity=0.315 Sum_probs=170.3
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++|.+.+.||+|+||.||++... +|+.||||++..... ...+.|+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356888999999999999999775 689999999976542 234556666788899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~- 625 (753)
|+|++.+..+. . .....+++..+++++.|++.||.|||+.
T Consensus 104 e~~~~~~~~l~------------~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 104 ELMGTCAEKLK------------K---------------------------RMQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp CCCSEEHHHHH------------H---------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred eccCCcHHHHH------------H---------------------------HhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 96643222221 1 1124578889999999999999999995
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvv 700 (753)
+|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++. ...++.++|||||||+
T Consensus 145 ~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~i 218 (318)
T 2dyl_A 145 GVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218 (318)
T ss_dssp CCCCCCCCGGGEEECTTSC--EEECCCTTC------------------CCTTCCHHHHC--------CCTHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc----cccccCCCccccChhhcccccccccCCccccchhhHHHH
Confidence 9999999999999977754 9999999997664321 122345899999999984 4568999999999999
Q ss_pred HHHHHhCCCCCCCCC--hHHHHHHHHccCcc-cc--cCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGES--FERDANIVKDRKDL-FL--VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~--~~~~~~~i~~~~~~-~~--~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||... .......+...... .+ ..+++++.+||.+||+.||++|
T Consensus 219 l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 275 (318)
T 2dyl_A 219 LVELATG-QFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275 (318)
T ss_dssp HHHHHHS-SCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTS
T ss_pred HHHHHhC-CCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHC
Confidence 9999998 6788653 22333333333222 22 3578999999999999999998
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.55 Aligned_cols=234 Identities=24% Similarity=0.326 Sum_probs=180.6
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccccC
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.+.||+|+||.||+|.. +++.||||++.... ....+..+..+++.++||||+++++++.+.+..++|||
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 110 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV---- 110 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE----
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE----
Confidence 37799999999999876 68999999986421 12333333447899999999999999999999999999
Q ss_pred ChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccC
Q 004442 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (753)
Q Consensus 552 ~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrD 631 (753)
|+++|+|.+++.... ....+++..+++++.|++.||+|||+.+|+|||
T Consensus 111 ------~~~~~~L~~~l~~~~--------------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~d 158 (307)
T 2nru_A 111 ------YMPNGSLLDRLSCLD--------------------------GTPPLSWHMRCKIAQGAANGINFLHENHHIHRD 158 (307)
T ss_dssp ------CCTTCBHHHHHHTGG--------------------------GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ------ecCCCcHHHHHHhcc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCC
Confidence 777888888875432 134588899999999999999999999999999
Q ss_pred CCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 004442 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (753)
Q Consensus 632 LKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~P 711 (753)
|||+||+++.++ .+||+|||+++........ .......||+.|+|||++.+ .++.++||||||+++|||++| .+|
T Consensus 159 lkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g-~~p 233 (307)
T 2nru_A 159 IKSANILLDEAF--TAKISDFGLARASEKFAQT-VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG-LPA 233 (307)
T ss_dssp CCGGGEEECTTC--CEEECCCTTCEECCSCSSC-EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC-CCS
T ss_pred CCHHHEEEcCCC--cEEEeeccccccccccccc-ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC-CCC
Confidence 999999997665 4999999999876543221 12234568999999998864 589999999999999999998 678
Q ss_pred CCCChHH-----HHHHHHccC-----------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 712 YGESFER-----DANIVKDRK-----------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 712 f~~~~~~-----~~~~i~~~~-----------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|...... ......... ...+...++++.++|.+||+.||++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 291 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKR 291 (307)
T ss_dssp BCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTS
T ss_pred cccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccC
Confidence 7654221 111111111 11223345678999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-35 Score=312.44 Aligned_cols=239 Identities=23% Similarity=0.375 Sum_probs=179.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCC--CCceeeecccccCCce
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ--HPNIVRWYGVESDQDF 541 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~--HpNIV~L~g~~~~~~~ 541 (753)
...+++|.+.+.||+|+||.||++...+++.||||++..... +...+|+. ++..++ |+||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIA-YLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHH-HHHhccccCCceEEEEEEeecCCE
Confidence 344577999999999999999999888899999999965432 23344554 566666 5999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++|||++.+ +|.+++.. ...+++.+++.++.|++.||.|
T Consensus 103 ~~lv~e~~~~-----------~L~~~l~~-----------------------------~~~~~~~~~~~i~~qi~~aL~~ 142 (313)
T 3cek_A 103 IYMVMECGNI-----------DLNSWLKK-----------------------------KKSIDPWERKSYWKNMLEAVHT 142 (313)
T ss_dssp EEEEECCCSE-----------EHHHHHHH-----------------------------CSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCC-----------cHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHH
Confidence 9999995444 44444432 2356778889999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-----------CCCCc
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTR 690 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-----------~~~t~ 690 (753)
||+.+|+||||||+|||++. ..+||+|||+++........ .......||+.|+|||++.+ ..++.
T Consensus 143 LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~ 218 (313)
T 3cek_A 143 IHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218 (313)
T ss_dssp HHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC---------------CCGGGCCHHHHTTCC----------CCCH
T ss_pred HHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCc
Confidence 99999999999999999953 35999999999876543211 12234468999999999875 46889
Q ss_pred hhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHc--cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 691 AIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 691 ksDIwSfGvvL~EllTG~~~Pf~~~~~~~--~~~i~~--~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||||||++|||++| ..||....... ...... ....++...++++.++|.+||+.||++|
T Consensus 219 ~~Di~slG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 284 (313)
T 3cek_A 219 KSDVWSLGCILYYMTYG-KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQR 284 (313)
T ss_dssp HHHHHHHHHHHHHHHHS-SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTS
T ss_pred hHHHHHHHHHHHHHHhC-CCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccC
Confidence 99999999999999999 66886643222 222222 2234556678899999999999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=321.23 Aligned_cols=241 Identities=23% Similarity=0.374 Sum_probs=186.4
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHh--CCCCceeeecccccCCc----eE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--DQHPNIVRWYGVESDQD----FV 542 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~--l~HpNIV~L~g~~~~~~----~~ 542 (753)
+.+.++|.+.+.||+|+||.||++.. +|+.||||++.........+|.. ++.. ++||||+++++++.+.+ ..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~-~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAE-IYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGHHHHHHHHH-HHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhHHHHHHHHH-HHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 45567899999999999999999876 68999999998766566666666 4444 79999999999998775 89
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|+|.+++.. ..+++.++++++.|++.||+||
T Consensus 116 ~lv~e----------~~~~g~L~~~l~~------------------------------~~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 116 WLVSD----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp EEEEC----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------ecCCCcHHHHHhc------------------------------cCccHHHHHHHHHHHHHHHHHH
Confidence 99999 7777888887742 2467888999999999999999
Q ss_pred h--------hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCCC------
Q 004442 623 H--------EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------ 687 (753)
Q Consensus 623 H--------~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~------ 687 (753)
| +.+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++.+..
T Consensus 156 H~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 233 (342)
T 1b6c_B 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233 (342)
T ss_dssp HCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHH
T ss_pred HHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccc
Confidence 9 889999999999999977764 9999999998775443221 1234456999999999997763
Q ss_pred CCchhhHHHHHHHHHHHHhCC---------CCCCCCC------hHHHHHHHHcc--Cccccc-----CCCHHHHHHHHHc
Q 004442 688 QTRAIDLFSLGCILFFCITGG---------KHPYGES------FERDANIVKDR--KDLFLV-----EHIPEAVDLFTRL 745 (753)
Q Consensus 688 ~t~ksDIwSfGvvL~EllTG~---------~~Pf~~~------~~~~~~~i~~~--~~~~~~-----~~s~el~dLI~~c 745 (753)
++.++|||||||++|||+||+ ..||... .......+... ....+. ..++.+.+||.+|
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 313 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC 313 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHH
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHH
Confidence 347899999999999999983 3566443 12222222221 112222 2235788999999
Q ss_pred cccCcCCC
Q 004442 746 LDPNPDLR 753 (753)
Q Consensus 746 L~~DP~~R 753 (753)
|+.||++|
T Consensus 314 l~~dp~~R 321 (342)
T 1b6c_B 314 WYANGAAR 321 (342)
T ss_dssp CCSSGGGS
T ss_pred hccChhhC
Confidence 99999998
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.75 Aligned_cols=200 Identities=22% Similarity=0.308 Sum_probs=160.6
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCC--------CCceeeeccccc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ--------HPNIVRWYGVES 537 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~--------HpNIV~L~g~~~ 537 (753)
..+.++|.+.+.||+|+||+||++.. .+++.||||++.... .+...+|+. +++.++ |+||+++++++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR-LLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHH-HHHHHhhcCCCCCCcceeeeeeccee
Confidence 45667899999999999999999965 458999999997543 234445555 455553 888999999987
Q ss_pred ----CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 538 ----DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 538 ----~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
+....++|||+|.+++.+++ ... ....+++..++.|+.
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~-----------~~~---------------------------~~~~~~~~~~~~i~~ 153 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWI-----------IKS---------------------------NYQGLPLPCVKKIIQ 153 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHH-----------HHT---------------------------TTSCCCHHHHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHH-----------Hhc---------------------------ccCCCCHHHHHHHHH
Confidence 66789999996655444433 211 124578889999999
Q ss_pred HHHHHHHHhhhC-CccccCCCCCcEEEecCCC-----------------------------------------------C
Q 004442 614 DIVSGLSHLHEI-GLIHRDLKPQNVLISKDKS-----------------------------------------------F 645 (753)
Q Consensus 614 qIa~gL~yLH~~-~IiHrDLKp~NILL~~d~~-----------------------------------------------~ 645 (753)
||+.||+|||++ +|+||||||+|||++.++. .
T Consensus 154 qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (397)
T 1wak_A 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKL 233 (397)
T ss_dssp HHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGC
T ss_pred HHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccccccc
Confidence 999999999998 9999999999999976641 3
Q ss_pred eEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 004442 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 646 ~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~ 714 (753)
.+||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|||+|| .+||..
T Consensus 234 ~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~ 295 (397)
T 1wak_A 234 KVKIADLGNACWVHKH------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG-DYLFEP 295 (397)
T ss_dssp CEEECCGGGCEETTBC------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS-SCSCCC
T ss_pred ceEecccccccccccc------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhC-CCCCCC
Confidence 6999999999876432 2344689999999999999999999999999999999998 667754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=317.00 Aligned_cols=232 Identities=23% Similarity=0.395 Sum_probs=177.7
Q ss_pred eecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCce--
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF-- 541 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~-- 541 (753)
.+.++|.+.+.||+|+||.||+|... +|+.||||++..... ....+|+. +++.++||||+++++++.+.+.
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCcccHhheEecccccc
Confidence 45678999999999999999999764 599999999965432 22344544 7889999999999999887654
Q ss_pred ----EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 542 ----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 542 ----~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
.++|||+|.++|.+++ ...+++..+..++.||+.
T Consensus 100 ~~~~~~lv~e~~~~~l~~~~------------------------------------------~~~~~~~~~~~i~~qi~~ 137 (353)
T 3coi_A 100 NFYDFYLVMPFMQTDLQKIM------------------------------------------GLKFSEEKIQYLVYQMLK 137 (353)
T ss_dssp GCCCCEEEEECCSEEGGGTT------------------------------------------TSCCCHHHHHHHHHHHHH
T ss_pred cceeEEEEeccccCCHHHHh------------------------------------------cCCCCHHHHHHHHHHHHH
Confidence 4999996665443222 124778889999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwS 696 (753)
||+|||+.+|+||||||+||+++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++||||
T Consensus 138 al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s 209 (353)
T 3coi_A 138 GLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS 209 (353)
T ss_dssp HHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--------------CCSBCCSCHHHHSCCSCCCTTHHHHH
T ss_pred HHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCCC------ccccccCcCcCCHHHHhCcCCCCchhhHHH
Confidence 999999999999999999999977754 999999999865432 223468999999999887 67899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH-HHHHHHcc-------------------------------CcccccCCCHHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFER-DANIVKDR-------------------------------KDLFLVEHIPEAVDLFTR 744 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~-------------------------------~~~~~~~~s~el~dLI~~ 744 (753)
|||++|||++| .+||.+.... ....+... .......+++++.+||.+
T Consensus 210 lG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 3coi_A 210 VGCIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288 (353)
T ss_dssp HHHHHHHHHHS-SCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH
Confidence 99999999998 6677654322 11111100 011234568999999999
Q ss_pred ccccCcCCC
Q 004442 745 LLDPNPDLR 753 (753)
Q Consensus 745 cL~~DP~~R 753 (753)
||+.||++|
T Consensus 289 ~L~~dp~~R 297 (353)
T 3coi_A 289 MLELDVDKR 297 (353)
T ss_dssp HSCSCTTTS
T ss_pred HcCCCcccC
Confidence 999999998
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=317.95 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=170.0
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCc-------
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQD------- 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~------- 540 (753)
..++|.+.+.||+|+||.||++... +|+.||||++.... .....+++. .++.++||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-DLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHH-HHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHH-HHHhcCCCCcccHHHhhhccccccccce
Confidence 3467899999999999999999764 58999999986532 233444443 567889999999999985433
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++|||||.++|.+.+ .... .....+++..+..++.|++.||.
T Consensus 100 ~~~lv~e~~~~~l~~~~-----------~~~~-------------------------~~~~~~~~~~~~~~~~qi~~al~ 143 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCC-----------RNYY-------------------------RRQVAPPPILIKVFLFQLIRSIG 143 (360)
T ss_dssp EEEEEEECCSCBHHHHH-----------HHHH-------------------------TTTCCCCHHHHHHHHHHHHHHHH
T ss_pred eEEEEeecccccHHHHH-----------HHHh-------------------------hcccCCCHHHHHHHHHHHHHHHH
Confidence 38999997776544332 1110 12346788889999999999999
Q ss_pred Hhh--hCCccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHH
Q 004442 621 HLH--EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFS 696 (753)
Q Consensus 621 yLH--~~~IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwS 696 (753)
||| +.+|+||||||+|||++. ++ .+||+|||+++...... ......||+.|+|||++.+.. ++.++||||
T Consensus 144 ~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 217 (360)
T 3e3p_A 144 CLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKLSPSE----PNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217 (360)
T ss_dssp HHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCCCTTS----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceecCCCC----CcccccCCcceeCHHHHcCCCCCCcHHHHHH
Confidence 999 999999999999999976 44 59999999998765432 223456899999999987655 899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH-HHHHHHcc--------------------------------CcccccCCCHHHHHHHH
Q 004442 697 LGCILFFCITGGKHPYGESFER-DANIVKDR--------------------------------KDLFLVEHIPEAVDLFT 743 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~--------------------------------~~~~~~~~s~el~dLI~ 743 (753)
|||++|||+|| .+||...... ....+... ........++++.+||.
T Consensus 218 lG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 296 (360)
T 3e3p_A 218 VGCIFAEMMLG-EPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296 (360)
T ss_dssp HHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHHHHHHHHhC-CCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHH
Confidence 99999999998 6677665332 22222110 00112225678999999
Q ss_pred HccccCcCCC
Q 004442 744 RLLDPNPDLR 753 (753)
Q Consensus 744 ~cL~~DP~~R 753 (753)
+||+.||++|
T Consensus 297 ~~L~~dP~~R 306 (360)
T 3e3p_A 297 ALLQYLPEER 306 (360)
T ss_dssp HHTCSSGGGS
T ss_pred HHhccCcccc
Confidence 9999999998
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=320.69 Aligned_cols=203 Identities=28% Similarity=0.317 Sum_probs=162.1
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCC-CC-----ceeeecccccC
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQ-HP-----NIVRWYGVESD 538 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~-Hp-----NIV~L~g~~~~ 538 (753)
+..+.++|.+.+.||+|+||+||+|... +++.||||++..... ....+|+. ++..++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR-LLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHH-HHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHH-HHHHHHhcccccceeEEEeeeeecc
Confidence 4566788999999999999999999765 588999999975432 22333443 444443 44 49999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+..++|||+|.+ +|.+++... ....+++..+..++.|++.|
T Consensus 128 ~~~~~lv~e~~~~-----------~L~~~l~~~---------------------------~~~~~~~~~~~~i~~qi~~a 169 (382)
T 2vx3_A 128 RNHLCLVFEMLSY-----------NLYDLLRNT---------------------------NFRGVSLNLTRKFAQQMCTA 169 (382)
T ss_dssp TTEEEEEEECCCC-----------BHHHHHHHT---------------------------TTSCCCHHHHHHHHHHHHHH
T ss_pred CCceEEEEecCCC-----------CHHHHHhhc---------------------------CcCCCCHHHHHHHHHHHHHH
Confidence 9999999996654 455544322 12457888999999999999
Q ss_pred HHHhh--hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 619 LSHLH--EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 619 L~yLH--~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
|.||| +.+|+||||||+|||++.++...+||+|||+++..... .....||+.|+|||++.+..++.++||||
T Consensus 170 l~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DiwS 243 (382)
T 2vx3_A 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQYIQSRFYRSPEVLLGMPYDLAIDMWS 243 (382)
T ss_dssp HHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC------CCSSCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred HHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc------cccccCCccccChHHHcCCCCCcHHHHHH
Confidence 99999 46999999999999997655567999999999876432 23456899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh
Q 004442 697 LGCILFFCITGGKHPYGESF 716 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~ 716 (753)
|||++|||+|| .+||....
T Consensus 244 lG~il~elltg-~~pf~~~~ 262 (382)
T 2vx3_A 244 LGCILVEMHTG-EPLFSGAN 262 (382)
T ss_dssp HHHHHHHHHHS-SCSSCCSS
T ss_pred HHHHHHHHHhC-CCCCCCCC
Confidence 99999999998 67776653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.31 Aligned_cols=232 Identities=23% Similarity=0.344 Sum_probs=179.5
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---------hHHHHHHHHHHHhC----CCCceeeecc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---------DVALKEIQNLIASD----QHPNIVRWYG 534 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---------~~~~~Ei~~ll~~l----~HpNIV~L~g 534 (753)
..+.++|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+. ++..+ +|+||+++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA-LLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHH-HHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHH-HHHhhcccCCCCCeeeEEE
Confidence 45567899999999999999999966 4689999999965421 12234554 44555 8999999999
Q ss_pred cccCCceEEEEEccccCChhhHHH-HhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 535 VESDQDFVYLSLERCTCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 535 ~~~~~~~~~LV~E~c~~~L~~liy-~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
++.+.+..++||| | +.+|+|.+++... ..+++..+++++.
T Consensus 106 ~~~~~~~~~~v~e----------~~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~ 146 (312)
T 2iwi_A 106 WFETQEGFMLVLE----------RPLPAQDLFDYITEK-----------------------------GPLGEGPSRCFFG 146 (312)
T ss_dssp EC-----CEEEEE----------CCSSEEEHHHHHHHH-----------------------------CSCCHHHHHHHHH
T ss_pred EEecCCeEEEEEE----------ecCCCCCHHHHHHhc-----------------------------CCCCHHHHHHHHH
Confidence 9999999999999 5 5677787777432 3478889999999
Q ss_pred HHHHHHHHhhhCCccccCCCCCcEEEe-cCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-Cch
Q 004442 614 DIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRA 691 (753)
Q Consensus 614 qIa~gL~yLH~~~IiHrDLKp~NILL~-~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~k 691 (753)
||+.||+|||+.+|+||||||+||+++ .++ .+||+|||+++...... .....||..|+|||++.+..+ +.+
T Consensus 147 qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~ 219 (312)
T 2iwi_A 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRHQYHALP 219 (312)
T ss_dssp HHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHSCBCHHH
T ss_pred HHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccCc-----ccccCCcccccCceeeecCCCCCcc
Confidence 999999999999999999999999997 454 59999999998775431 234458999999999987776 469
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||||||++|||++| +.||..... +......++..+++++.++|.+||+.||++|
T Consensus 220 ~Di~slG~il~~l~~g-~~pf~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 275 (312)
T 2iwi_A 220 ATVWSLGILLYDMVCG-DIPFERDQE-----ILEAELHFPAHVSPDCCALIRRCLAPKPSSR 275 (312)
T ss_dssp HHHHHHHHHHHHHHHS-SCSCCSHHH-----HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred chHHHHHHHHHHHHHC-CCCCCChHH-----HhhhccCCcccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999998 678865422 2334455677889999999999999999998
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=332.44 Aligned_cols=242 Identities=20% Similarity=0.265 Sum_probs=187.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC-CceeeecccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H-pNIV~L~g~~~~~~~~~LV 545 (753)
..++++|.+.+.||+|+||.||++.. .+++.||||++..... ....+|+. ++..++| ++|..+..++.+.+..+||
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK-IYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHH-HHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHH-HHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 34667899999999999999999975 5699999999865433 34555665 6677766 5666777777788899999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||+| +|+|.+++... ...+++.+++.|+.||+.||+|||+.
T Consensus 82 me~~-----------g~sL~~ll~~~----------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~ 122 (483)
T 3sv0_A 82 MDLL-----------GPSLEDLFNFC----------------------------SRKLSLKTVLMLADQMINRVEFVHSK 122 (483)
T ss_dssp EECC-----------CCBHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EECC-----------CCCHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9954 55555555321 24588899999999999999999999
Q ss_pred CccccCCCCCcEEEe---cCCCCeEEEEeccCceeccCCCccc----ccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 626 GLIHRDLKPQNVLIS---KDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 626 ~IiHrDLKp~NILL~---~d~~~~~KLsDFGla~~~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
+|+||||||+||||+ .++ .+||+|||+++......... .......||+.|+|||++.+..++.++||||||
T Consensus 123 gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlG 200 (483)
T 3sv0_A 123 SFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200 (483)
T ss_dssp TEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHH
Confidence 999999999999994 444 59999999999876533211 122356799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH----HHHHHHH-----ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFE----RDANIVK-----DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~----~~~~~i~-----~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+||||++| ..||..... .....+. .........+++++.+||.+||+.||++|
T Consensus 201 vil~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~R 263 (483)
T 3sv0_A 201 YVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (483)
T ss_dssp HHHHHHHHS-SCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCC
T ss_pred HHHHHHHhC-CCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhC
Confidence 999999998 678865321 1111111 11122346788999999999999999998
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=316.36 Aligned_cols=234 Identities=21% Similarity=0.260 Sum_probs=187.0
Q ss_pred cceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCC--CCceeeeccc
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQ--HPNIVRWYGV 535 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~--HpNIV~L~g~ 535 (753)
...+.++|.+.+.||+|+||.||++.. .+++.||||++.... .....+|+. +++.++ |+||++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-LLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHH-HHHHHCSSSCSBCCEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHH-HHHhhccCCCCceEEEEE
Confidence 355677899999999999999999965 468999999996532 123345655 556664 6999999999
Q ss_pred ccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHH
Q 004442 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (753)
Q Consensus 536 ~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qI 615 (753)
+.+.+..++|||++.. .|+|.+++.. ...+++..++.++.||
T Consensus 117 ~~~~~~~~lv~e~~~~---------~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi 158 (320)
T 3a99_A 117 FERPDSFVLILERPEP---------VQDLFDFITE-----------------------------RGALQEELARSFFWQV 158 (320)
T ss_dssp EECSSEEEEEEECCSS---------EEEHHHHHHH-----------------------------HCSCCHHHHHHHHHHH
T ss_pred EecCCcEEEEEEcCCC---------CccHHHHHhc-----------------------------cCCCCHHHHHHHHHHH
Confidence 9999999999995431 2566666542 2357788899999999
Q ss_pred HHHHHHhhhCCccccCCCCCcEEEe-cCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-Cchhh
Q 004442 616 VSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAID 693 (753)
Q Consensus 616 a~gL~yLH~~~IiHrDLKp~NILL~-~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksD 693 (753)
+.||+|||+.+|+||||||+|||++ .++ .+||+|||+++...... .....||+.|+|||++.+..+ +.++|
T Consensus 159 ~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~D 231 (320)
T 3a99_A 159 LEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDTV-----YTDFDGTRVYSPPEWIRYHRYHGRSAA 231 (320)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCSSC-----BCCCCSCGGGSCHHHHHHSCBCHHHHH
T ss_pred HHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccccccc-----ccCCCCCccCCChHHhccCCCCCccch
Confidence 9999999999999999999999997 443 59999999998775421 233468999999999987775 78999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||+|| ..||..... +.......+..+++++.+||++||+.||++|
T Consensus 232 i~slG~il~el~~g-~~pf~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 285 (320)
T 3a99_A 232 VWSLGILLYDMVCG-DIPFEHDEE-----IIRGQVFFRQRVSSECQHLIRWCLALRPSDR 285 (320)
T ss_dssp HHHHHHHHHHHHHS-SCSCCSHHH-----HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhHHHHHHHHHHC-CCCCCChhh-----hhcccccccccCCHHHHHHHHHHccCChhhC
Confidence 99999999999998 678865422 2334455667889999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=341.78 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=189.7
Q ss_pred ceecceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
....++|.+.+.||+|+||.||+|.... +..||||++..... +.+.+|+ .+++.++||||++++|++.+ +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~-~ 463 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVITE-N 463 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHH-HHHHhCCCCCCCeEEEEEec-C
Confidence 3345779999999999999999997642 56899999875432 2333444 47899999999999999854 5
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+.+|+|.+++... ...+++..++.++.|++.||+
T Consensus 464 ~~~lv~E----------~~~~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~aL~ 505 (656)
T 2j0j_A 464 PVWIIME----------LCTLGELRSFLQVR----------------------------KFSLDLASLILYAYQLSTALA 505 (656)
T ss_dssp SCEEEEE----------CCTTCBHHHHHHHT----------------------------TTTCCHHHHHHHHHHHHHHHH
T ss_pred ceEEEEE----------cCCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 6899999 77788888887532 234788889999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+
T Consensus 506 ~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 581 (656)
T 2j0j_A 506 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 581 (656)
T ss_dssp HHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcc--eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHH
Confidence 999999999999999999987764 99999999987654321 12223457889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHH-HHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~-~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++++.+||.+.... ....+ .......+..+++++.++|.+||+.||++|
T Consensus 582 l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 636 (656)
T 2j0j_A 582 MWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636 (656)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHC
Confidence 999998447788765433 33333 334455777889999999999999999998
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.51 Aligned_cols=203 Identities=22% Similarity=0.286 Sum_probs=159.9
Q ss_pred cceecceEEEeEEecccCceEEEEEEee-CC-cEEEEEEeecCCc--hHHHHHHHHHHHhCCCCc------eeeeccccc
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY-EG-RSVAVKRLVKTHH--DVALKEIQNLIASDQHPN------IVRWYGVES 537 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g-~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpN------IV~L~g~~~ 537 (753)
+..+.++|.+.+.||+|+||+||++... ++ +.||||++..... +...+|+. +++.++|+| ++.+.+++.
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~-~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN-VLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHH-HHHHHhhcCCCCceeEEEeeeeee
Confidence 3556788999999999999999999764 34 7999999975432 23334444 566666555 999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
..+..++|||+|.+++. +++... ....+++.++++++.||+.
T Consensus 93 ~~~~~~lv~e~~~~~l~-----------~~l~~~---------------------------~~~~~~~~~~~~i~~qi~~ 134 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTF-----------EFLKEN---------------------------NFQPYPLPHVRHMAYQLCH 134 (355)
T ss_dssp ETTEEEEEEECCCCBHH-----------HHHHHT---------------------------TTCCCCHHHHHHHHHHHHH
T ss_pred eCCeEEEEEeccCCChH-----------HHHHhc---------------------------cCCCCCHHHHHHHHHHHHH
Confidence 99999999996654443 333221 1235788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecC-----------------CCCeEEEEeccCceeccCCCcccccCccCCCCcccccc
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKD-----------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d-----------------~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP 680 (753)
||+|||+.+|+||||||+|||+..+ ....+||+|||+++..... .....||+.|+||
T Consensus 135 ~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aP 208 (355)
T 2eu9_A 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH------HTTIVATRHYRPP 208 (355)
T ss_dssp HHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC------CCSSCSCGGGCCH
T ss_pred HHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc------ccCCcCCCcccCC
Confidence 9999999999999999999999432 2345999999999875432 2345689999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Q 004442 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 716 (753)
Q Consensus 681 E~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~ 716 (753)
|++.+..++.++|||||||++|||++| .+||....
T Consensus 209 E~~~~~~~~~~~Di~slG~il~el~~g-~~pf~~~~ 243 (355)
T 2eu9_A 209 EVILELGWAQPCDVWSIGCILFEYYRG-FTLFQTHE 243 (355)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSS
T ss_pred eeeecCCCCCccchHHHHHHHHHHHhC-CCCCCCCC
Confidence 999999999999999999999999998 66776653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=307.44 Aligned_cols=238 Identities=24% Similarity=0.423 Sum_probs=176.8
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccC---------
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD--------- 538 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--------- 538 (753)
+.++|.+.+.||+|+||.||++... +|+.||||++..... +...+|+ .+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHH-HHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHH-HHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4567899999999999999999764 699999999965322 2334444 47889999999999998754
Q ss_pred ----CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHH
Q 004442 539 ----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (753)
Q Consensus 539 ----~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~q 614 (753)
.+..++||| |+++|+|.+++.... ..+++..+++++.|
T Consensus 83 ~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~q 124 (303)
T 1zy4_A 83 AVKKKSTLFIQME----------YCENGTLYDLIHSEN----------------------------LNQQRDEYWRLFRQ 124 (303)
T ss_dssp ---CEEEEEEEEE----------CCCSCBHHHHHHHSC----------------------------GGGCHHHHHHHHHH
T ss_pred ccccCCceEEEEe----------cCCCCCHHHhhhccc----------------------------cccchHHHHHHHHH
Confidence 467899999 666788888775421 23456778999999
Q ss_pred HHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-----------ccccCccCCCCccccccccc
Q 004442 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQL 683 (753)
Q Consensus 615 Ia~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-----------~~~~~~~~~GT~~Y~APE~l 683 (753)
++.||+|||+.+|+||||||+||+++.++. +||+|||+++....... .........||+.|+|||++
T Consensus 125 i~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 202 (303)
T 1zy4_A 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202 (303)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC-------------------------CTTSCHHHH
T ss_pred HHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccc
Confidence 999999999999999999999999977764 99999999987643211 01122344689999999999
Q ss_pred cCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 684 LQG-RQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 684 ~~~-~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~--~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+. .++.++|||||||++|||++ ||.... ......+...... .....++++.++|.+||+.||++|
T Consensus 203 ~~~~~~~~~~Di~slG~il~~l~~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (303)
T 1zy4_A 203 DGTGHYNEKIDMYSLGIIFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275 (303)
T ss_dssp TSCSCCCTHHHHHHHHHHHHHHHS----CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGS
T ss_pred cCCCCCcchhhHHHHHHHHHHHHh----ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccC
Confidence 865 68999999999999999998 343321 2222333333222 334556789999999999999998
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.94 Aligned_cols=198 Identities=21% Similarity=0.349 Sum_probs=156.3
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC--chHHHHHHHHHHHhCC-----------CCceeeeccccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-----------HPNIVRWYGVES 537 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~-----------HpNIV~L~g~~~ 537 (753)
.++|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+. ++..++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHH-HHHHhhcccccchhccccchHHHHHHHhh
Confidence 45799999999999999999976 568999999997543 223344544 444443 899999999987
Q ss_pred CCc----eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHH
Q 004442 538 DQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (753)
Q Consensus 538 ~~~----~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~ 613 (753)
..+ ..++|||+| +|+|.+++... ....+++..+++++.
T Consensus 97 ~~~~~~~~~~lv~e~~-----------~~~L~~~~~~~---------------------------~~~~~~~~~~~~i~~ 138 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-----------GENLLALIKKY---------------------------EHRGIPLIYVKQISK 138 (373)
T ss_dssp EEETTEEEEEEEECCC-----------CEEHHHHHHHT---------------------------TTSCCCHHHHHHHHH
T ss_pred ccCCCCceEEEEEecC-----------CCCHHHHHHHh---------------------------hccCCcHHHHHHHHH
Confidence 654 789999955 44555554322 124578889999999
Q ss_pred HHHHHHHHhhhC-CccccCCCCCcEEEecC----CCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC
Q 004442 614 DIVSGLSHLHEI-GLIHRDLKPQNVLISKD----KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688 (753)
Q Consensus 614 qIa~gL~yLH~~-~IiHrDLKp~NILL~~d----~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~ 688 (753)
||+.||+|||++ +|+||||||+|||++.+ ....+||+|||+++..... .....||+.|+|||++.+..+
T Consensus 139 qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCCCC
Confidence 999999999998 99999999999999643 2346999999999876432 233468999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCC
Q 004442 689 TRAIDLFSLGCILFFCITGGKHPYGES 715 (753)
Q Consensus 689 t~ksDIwSfGvvL~EllTG~~~Pf~~~ 715 (753)
+.++|||||||++|||+|| .+||...
T Consensus 213 ~~~~Di~slG~il~el~~g-~~pf~~~ 238 (373)
T 1q8y_A 213 GCGADIWSTACLIFELITG-DFLFEPD 238 (373)
T ss_dssp CTHHHHHHHHHHHHHHHHS-SCCC---
T ss_pred CchHhHHHHHHHHHHHHhC-CCCCCCC
Confidence 9999999999999999998 6788643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=310.83 Aligned_cols=239 Identities=17% Similarity=0.144 Sum_probs=181.6
Q ss_pred eecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
...++|.+.+.||+|+||.||++.... .||||++.... .+.+.+|+. +++.++|+||+++++++.+.+..++
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVM-AYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGG-GGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHH-HHhcCCCCCEeEEEEEEecCCceEE
Confidence 334678889999999999999987643 49999986432 123344554 7788999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+.+|+|.+++... ...+++.++++++.||+.||+|||+
T Consensus 107 v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~ 148 (319)
T 2y4i_B 107 ITS----------LCKGRTLYSVVRDA----------------------------KIVLDVNKTRQIAQEIVKGMGYLHA 148 (319)
T ss_dssp ECB----------CCCSEEHHHHTTSS----------------------------CCCCCSHHHHHHHHHHHHHHHHHHH
T ss_pred Eee----------cccCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 66677888777432 2347788899999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc--ccccCccCCCCccccccccccC---------CCCCchhh
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQ---------GRQTRAID 693 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~--~~~~~~~~~GT~~Y~APE~l~~---------~~~t~ksD 693 (753)
.+|+||||||+||+++ ++ .+||+|||+++....... .........||+.|+|||++.+ ..++.++|
T Consensus 149 ~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~D 225 (319)
T 2y4i_B 149 KGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSD 225 (319)
T ss_dssp TTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHH
T ss_pred CCccccCCChhhEEEe-CC--CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhh
Confidence 9999999999999996 33 489999999876532111 1122233458999999999874 45789999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHccCcc--cccCCCHHHHHHHHHccccCcCCC
Q 004442 694 LFSLGCILFFCITGGKHPYGESFE-RDANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf~~~~~-~~~~~i~~~~~~--~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||||||++|||++| ..||..... .....+.....+ ....+++++.++|.+||+.||++|
T Consensus 226 i~slG~il~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 287 (319)
T 2y4i_B 226 VFALGTIWYELHAR-EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287 (319)
T ss_dssp HHHHHHHHHHHHHS-SCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTS
T ss_pred HHHHHHHHHHHHhC-CCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhC
Confidence 99999999999998 667766543 333333333332 233578899999999999999998
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=337.91 Aligned_cols=227 Identities=29% Similarity=0.432 Sum_probs=177.8
Q ss_pred cceecceEEEeEEecccCceEEEEEEee--CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 468 ~~~i~~~~~i~~~IG~G~fG~Vyka~~~--~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
+..+.++|.+.+.||+|+||+||++... +|+.||||++...... .+.+|+ .+++.++||||++++++|.+.+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER-QFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHH-GGGGGCCCTTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHH-HHHHhcCCCCcCeEeeeEeecCC
Confidence 3556788999999999999999999775 5899999998654322 223444 47789999999999999887655
Q ss_pred -----EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 542 -----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 542 -----~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
.||||| |+++|+|.+++. ..+++.+++.|+.||+
T Consensus 154 ~~~~~~~lv~E----------~~~g~~L~~~~~-------------------------------~~l~~~~~~~~~~qi~ 192 (681)
T 2pzi_A 154 HGDPVGYIVME----------YVGGQSLKRSKG-------------------------------QKLPVAEAIAYLLEIL 192 (681)
T ss_dssp TSCEEEEEEEE----------CCCCEECC-----------------------------------CCCCHHHHHHHHHHHH
T ss_pred CCCceeEEEEE----------eCCCCcHHHHHh-------------------------------CCCCHHHHHHHHHHHH
Confidence 799999 666677765432 2578899999999999
Q ss_pred HHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 617 ~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
.||.|||+.+|+||||||+|||++.+ .+||+|||+++..... ...+||+.|+|||++.+.. +.++||||
T Consensus 193 ~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~sDi~s 261 (681)
T 2pzi_A 193 PALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF-------GYLYGTPGFQAPEIVRTGP-TVATDIYT 261 (681)
T ss_dssp HHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC-------SCCCCCTTTSCTTHHHHCS-CHHHHHHH
T ss_pred HHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC-------CccCCCccccCHHHHcCCC-CCceehhh
Confidence 99999999999999999999999764 4899999999876532 3456899999999987654 89999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||++| .+||........ .........++++.++|.+||++||++|
T Consensus 262 lG~~l~~l~~g-~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~R 312 (681)
T 2pzi_A 262 VGRTLAALTLD-LPTRNGRYVDGL-----PEDDPVLKTYDSYGRLLRRAIDPDPRQR 312 (681)
T ss_dssp HHHHHHHHHSC-CCEETTEECSSC-----CTTCHHHHHCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHhC-CCCCcccccccc-----cccccccccCHHHHHHHhhhccCChhhC
Confidence 99999999998 666654311100 0001111235789999999999999998
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-33 Score=294.11 Aligned_cols=216 Identities=23% Similarity=0.348 Sum_probs=167.9
Q ss_pred ceEEEe-EEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC----CceEEEEE
Q 004442 473 KLVVFN-KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~-~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~LV~ 546 (753)
+.|.+. +.||+|+||.||++.. .+++.||||++... ....+|+..+.+..+||||+++++++.+ ....++||
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 94 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEE
Confidence 445555 8899999999999976 46899999999754 4566777766688899999999999876 77899999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++.... ...+++..++.++.|++.||+|||+.+
T Consensus 95 e----------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ 137 (299)
T 3m2w_A 95 E----------CLDGGELFSRIQDRG---------------------------DQAFTEREASEIMKSIGEAIQYLHSIN 137 (299)
T ss_dssp C----------CCCSCBHHHHHHHCT---------------------------TCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------ecCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 666778888775421 235788899999999999999999999
Q ss_pred ccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+||+++.++ +..+||+|||++.... +..++.++|||||||++|||+
T Consensus 138 i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------------~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------------GEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred cccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------------cccCCchhhHHHHHHHHHHHH
Confidence 99999999999997632 3469999999987542 234678999999999999999
Q ss_pred hCCCCCCCCChHHHHH-----HHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDAN-----IVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~-----~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||......... .+.......+ ..+++++.+||.+||+.||++|
T Consensus 193 tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 248 (299)
T 3m2w_A 193 CG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 248 (299)
T ss_dssp HS-SCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HC-CCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhC
Confidence 98 6677654322211 0011111112 4678999999999999999998
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=295.43 Aligned_cols=209 Identities=12% Similarity=0.069 Sum_probs=163.1
Q ss_pred eecceEEEeEEecccCceEEEEEEeeC-CcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
.+.++|.+.+.||+|+||.||++.... |+.||||++..... ..+.+|+. .++.++|+||+++++++.+++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL-RLSRIDKPGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHH-HHhcCCCCCcceeeEEEEECCcE
Confidence 456779999999999999999997754 89999999976432 23445554 67999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+++|+|.+++.. .....++.+|+.|++.||+||
T Consensus 107 ~lv~e----------~~~g~~L~~~l~~-------------------------------~~~~~~~~~i~~ql~~aL~~l 145 (286)
T 3uqc_A 107 LVVAE----------WIRGGSLQEVADT-------------------------------SPSPVGAIRAMQSLAAAADAA 145 (286)
T ss_dssp EEEEE----------CCCEEEHHHHHTT-------------------------------CCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ecCCCCHHHHHhc-------------------------------CCChHHHHHHHHHHHHHHHHH
Confidence 99999 6667777777632 123345688999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|++||+||||||+|||++.++. +||+++| |++ .++.++|||||||++|
T Consensus 146 H~~givH~Dikp~NIll~~~g~--~kl~~~~-----------------------~~~-------~~~~~~Di~slG~il~ 193 (286)
T 3uqc_A 146 HRAGVALSIDHPSRVRVSIDGD--VVLAYPA-----------------------TMP-------DANPQDDIRGIGASLY 193 (286)
T ss_dssp HHTTCCCCCCSGGGEEEETTSC--EEECSCC-----------------------CCT-------TCCHHHHHHHHHHHHH
T ss_pred HHCCCccCCCCcccEEEcCCCC--EEEEecc-----------------------ccC-------CCCchhHHHHHHHHHH
Confidence 9999999999999999988875 7887433 333 3789999999999999
Q ss_pred HHHhCCCCCCCCChHHH-H---HHHHccCc----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD-A---NIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~-~---~~i~~~~~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| ++||.+..... . ........ .....+++++.++|.+||++||++|
T Consensus 194 elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 251 (286)
T 3uqc_A 194 ALLVN-RWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR 251 (286)
T ss_dssp HHHHS-EECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC
T ss_pred HHHHC-CCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC
Confidence 99998 67876543211 0 00001111 1235678999999999999999998
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=310.97 Aligned_cols=237 Identities=16% Similarity=0.122 Sum_probs=166.5
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCC-Cceeeecc---------
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQH-PNIVRWYG--------- 534 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~H-pNIV~L~g--------- 534 (753)
..+.|...+.||+|+||+||+|.. .+|+.||||++..... ...++++..++..++| +|......
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345688899999999999999975 4699999999873221 2234444446677776 32221111
Q ss_pred ------------cccC-----CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhh
Q 004442 535 ------------VESD-----QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597 (753)
Q Consensus 535 ------------~~~~-----~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (753)
++.. ....+++|+++.++|.+++ .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll-----------~~l~~~~---------------------- 202 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG-----------EVLLSHS---------------------- 202 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHH-----------HHHHHHT----------------------
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHH-----------HHhhccc----------------------
Confidence 1111 1236778886665555444 2111000
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccc
Q 004442 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677 (753)
Q Consensus 598 ~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y 677 (753)
.....+++..++.|+.||++||+|||+.+|+||||||+|||++.++. +||+|||+++..... ....+| +.|
T Consensus 203 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG~a~~~~~~------~~~~~g-~~y 273 (413)
T 3dzo_A 203 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGAS------AVSPIG-RGF 273 (413)
T ss_dssp TTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTEE------ECCCCC-TTT
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEeccceeecCCc------cccCCC-Cce
Confidence 01223556778999999999999999999999999999999987765 999999999875432 234567 999
Q ss_pred cccccc----------cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccc
Q 004442 678 QAPEQL----------LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 678 ~APE~l----------~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~ 747 (753)
+|||++ ....++.++|||||||++|||+|| +.||......... .........+++++.+||.+||+
T Consensus 274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg-~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~ 349 (413)
T 3dzo_A 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA-DLPNTDDAALGGS---EWIFRSCKNIPQPVRALLEGFLR 349 (413)
T ss_dssp CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS-SCCCCTTGGGSCS---GGGGSSCCCCCHHHHHHHHHHTC
T ss_pred eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC-CCCCCCcchhhhH---HHHHhhcccCCHHHHHHHHHHcc
Confidence 999999 555688999999999999999998 6788665332110 01111224678999999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
.||++|
T Consensus 350 ~dP~~R 355 (413)
T 3dzo_A 350 YPKEDR 355 (413)
T ss_dssp SSGGGS
T ss_pred CChhhC
Confidence 999998
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.6e-34 Score=307.11 Aligned_cols=225 Identities=15% Similarity=0.132 Sum_probs=164.8
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCC---------CCcee--
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQ---------HPNIV-- 530 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~---------HpNIV-- 530 (753)
++|.+.+.||+|+||+||+|.. +|+.||||++..... +...+|+. +++.++ |+|||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII-ISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHH-HHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHH-HHHHHHHhhccccccCCchhhh
Confidence 4566778999999999999977 789999999975431 44556665 445554 55554
Q ss_pred ---------------eecccccC-------------CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhh
Q 004442 531 ---------------RWYGVESD-------------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582 (753)
Q Consensus 531 ---------------~L~g~~~~-------------~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~ 582 (753)
++++++.+ .+..||||||| .+|++.+.+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~----------~~g~ll~~~~------------- 154 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE----------FGGIDLEQMR------------- 154 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEE----------CCCEETGGGT-------------
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEec----------CCCccHHHHH-------------
Confidence 45555443 78899999954 4554433321
Q ss_pred hhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCcEEEecCC------------------
Q 004442 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK------------------ 643 (753)
Q Consensus 583 ~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH-~~~IiHrDLKp~NILL~~d~------------------ 643 (753)
...+++..+..|+.||+.||+||| +.+|+||||||+|||++.++
T Consensus 155 -----------------~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~ 217 (336)
T 2vuw_A 155 -----------------TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC 217 (336)
T ss_dssp -----------------TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECT
T ss_pred -----------------hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCC
Confidence 134688899999999999999999 89999999999999998875
Q ss_pred CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCh--HHHH
Q 004442 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI-LFFCITGGKHPYGESF--ERDA 720 (753)
Q Consensus 644 ~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv-L~EllTG~~~Pf~~~~--~~~~ 720 (753)
...+||+|||+|+..... ..+||+.|+|||++.+.. +.++|||||+++ .+++++| ..||.+.. ....
T Consensus 218 ~~~vkL~DFG~a~~~~~~--------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g-~~p~~~~~~~~~~~ 287 (336)
T 2vuw_A 218 GLQVSIIDYTLSRLERDG--------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGE-YHPYSNVLWLHYLT 287 (336)
T ss_dssp TEEEEECCCTTCBEEETT--------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTS-CCTHHHHHHHHHHH
T ss_pred CceEEEeeccccEecCCC--------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccc-cCCCcchhhhhHHH
Confidence 236999999999876532 236899999999998766 999999998777 6677777 67875421 1111
Q ss_pred HHHH-ccC------cccccCCCHHHHHHHHHccccC
Q 004442 721 NIVK-DRK------DLFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 721 ~~i~-~~~------~~~~~~~s~el~dLI~~cL~~D 749 (753)
..+. ... ...+..+++++.+||++||+.|
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 288 DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS
T ss_pred HhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC
Confidence 1221 111 1123356789999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=323.03 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=181.5
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC------Cce
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD------QDF 541 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------~~~ 541 (753)
++|.+.+.||+|+||.||++.. .+|+.||||++..... +.+.+|+. +++.++||||+++++++.+ .+.
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~-iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ-IMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHH-HHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHH-HHHhCCCCCCCceeeeecccccccCCCe
Confidence 5678889999999999999876 4589999999875432 23344554 7899999999999999765 677
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.+++..... ...+++..++.|+.+++.||+|
T Consensus 93 ~~LVmE----------y~~ggsL~~~L~~~~~--------------------------~~~lse~~i~~I~~QLl~aL~y 136 (676)
T 3qa8_A 93 PLLAME----------YCEGGDLRKYLNQFEN--------------------------CCGLKEGPIRTLLSDISSALRY 136 (676)
T ss_dssp CCCEEE----------CCSSCBHHHHHHSSSC--------------------------TTCCCSSHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------eCCCCCHHHHHHhccc--------------------------CCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 6777888888764321 2357778889999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCC-CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~-~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
||+.+|+||||||+||+++.++. ..+||+|||++....... ......||+.|+|||++.+..++.++|||||||+
T Consensus 137 LHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGvi 212 (676)
T 3qa8_A 137 LHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE----LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTL 212 (676)
T ss_dssp HHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC----CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHH
T ss_pred HHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc----ccccccCCcccCChHHhccCCCCchhHHHHHHHH
Confidence 99999999999999999987653 468999999998765432 2234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHH----------HH-H----HccC----------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERDA----------NI-V----KDRK----------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~~----------~~-i----~~~~----------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||++| ..||........ .. . .... ......+++++.+||.+||..||++|
T Consensus 213 LyeLltG-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kR 289 (676)
T 3qa8_A 213 AFECITG-FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQR 289 (676)
T ss_dssp HHHHHSS-CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC--
T ss_pred HHHHHHC-CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhC
Confidence 9999999 567754322111 00 0 0000 01122346789999999999999998
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-26 Score=269.70 Aligned_cols=180 Identities=15% Similarity=0.084 Sum_probs=119.4
Q ss_pred EEecccCceEEEEE-EeeCCcEEEEEEeecCC-------------chHHHHHHHHHHHhC-CCCceeeecccccCCceEE
Q 004442 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-------------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 479 ~~IG~G~fG~Vyka-~~~~g~~VAVK~l~~~~-------------~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~ 543 (753)
...+.|+.|.+..+ +..-|+.+|||.+.+.. .+++.+|+. +|+++ .|+||+++++++.+++..|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIK-FLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHH-HHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34677888877664 44569999999996532 122444554 67776 7999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++|... ..++. .+|+.||+.||+|||
T Consensus 319 LVME----------yv~G~~L~d~i~~~-----------------------------~~l~~---~~I~~QIl~AL~ylH 356 (569)
T 4azs_A 319 LVME----------KLPGRLLSDMLAAG-----------------------------EEIDR---EKILGSLLRSLAALE 356 (569)
T ss_dssp EEEE----------CCCSEEHHHHHHTT-----------------------------CCCCH---HHHHHHHHHHHHHHH
T ss_pred EEEe----------cCCCCcHHHHHHhC-----------------------------CCCCH---HHHHHHHHHHHHHHH
Confidence 9999 77788888887532 23333 358899999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
++|||||||||+||||+.++. +||+|||+|+...... ....+.+||++|||||++.+ .+..++|+||+|+++++
T Consensus 357 ~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~---~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 357 KQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDC---SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFN 430 (569)
T ss_dssp HTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC------CCSHHHHHHHHHHHHHHC------------------CC
T ss_pred HCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCC---ccccCceechhhccHHHhCC-CCCCcccccccccchhh
Confidence 999999999999999988765 9999999998775432 23345679999999999865 46778999999998877
Q ss_pred HHhC
Q 004442 704 CITG 707 (753)
Q Consensus 704 llTG 707 (753)
+.++
T Consensus 431 l~~~ 434 (569)
T 4azs_A 431 LPQP 434 (569)
T ss_dssp CCTT
T ss_pred hccc
Confidence 6554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-24 Score=246.84 Aligned_cols=182 Identities=18% Similarity=0.169 Sum_probs=136.5
Q ss_pred EeEEecccCceEEEEEEeeCCcEEEEEEeecCCc-----------hHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 477 i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
..+.||+|+||+||++ ...++.+|+|+...... +.+.+|+. +++.++||||+++..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD-SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREAR-YLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE-ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHH-HHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE-EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHH-HHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999998 55688999998743221 11344554 78899999999777777777788999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. +++++.|+++||+|||++
T Consensus 418 mE----------~~~ggsL~~~l~~-------------------------------------~~~i~~qi~~aL~~LH~~ 450 (540)
T 3en9_A 418 MS----------YINGKLAKDVIED-------------------------------------NLDIAYKIGEIVGKLHKN 450 (540)
T ss_dssp EE----------CCCSEEHHHHSTT-------------------------------------CTHHHHHHHHHHHHHHHT
T ss_pred EE----------CCCCCCHHHHHHH-------------------------------------HHHHHHHHHHHHHHHHHC
Confidence 99 6677888887643 268999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc----cCccCCCCccccccccccC--CCCCchhhHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT----QNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGC 699 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~----~~~~~~GT~~Y~APE~l~~--~~~t~ksDIwSfGv 699 (753)
+|+||||||+|||++. .+||+|||+++.......... .....+||+.|||||++.. ..|+..+|+|+..+
T Consensus 451 gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl 526 (540)
T 3en9_A 451 DVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIIL 526 (540)
T ss_dssp TEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHH
T ss_pred cCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHH
Confidence 9999999999999965 599999999998754211110 1134568999999999987 56788899999999
Q ss_pred HHHHHHhCCCCCC
Q 004442 700 ILFFCITGGKHPY 712 (753)
Q Consensus 700 vL~EllTG~~~Pf 712 (753)
-..+-+.+ +.+|
T Consensus 527 ~~l~~v~~-r~rY 538 (540)
T 3en9_A 527 ELMKDVER-RARY 538 (540)
T ss_dssp HHHHHHHT-CSCC
T ss_pred HHHHHHHh-cccc
Confidence 88888876 4455
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=4.1e-21 Score=203.49 Aligned_cols=142 Identities=18% Similarity=0.095 Sum_probs=108.2
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC---------------------chHHHHHHHHHHHhCCCCceee
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---------------------HDVALKEIQNLIASDQHPNIVR 531 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~---------------------~~~~~~Ei~~ll~~l~HpNIV~ 531 (753)
..|.+.+.||+|+||.||++...+|+.||||.++... ...+.+|+. +++.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~-~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHH-HHHhcc--C-CC
Confidence 4466779999999999999988779999999996422 112345555 677777 5 67
Q ss_pred ecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 532 L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
+.+++ +.+..++||| |+++|+|.+ +.. .....+
T Consensus 166 v~~~~-~~~~~~lvmE----------~~~g~~L~~-l~~-----------------------------------~~~~~i 198 (282)
T 1zar_A 166 VPKVY-AWEGNAVLME----------LIDAKELYR-VRV-----------------------------------ENPDEV 198 (282)
T ss_dssp SCCEE-EEETTEEEEE----------CCCCEEGGG-CCC-----------------------------------SCHHHH
T ss_pred cCeEE-eccceEEEEE----------ecCCCcHHH-cch-----------------------------------hhHHHH
Confidence 77754 3456799999 566666665 311 012579
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL 684 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 684 (753)
+.|++.||.|||+.+|+||||||+|||++ ++ .+||+|||+|+. +..++|||.+.
T Consensus 199 ~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~----------------~~~~~a~e~l~ 252 (282)
T 1zar_A 199 LDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE----------------VGEEGWREILE 252 (282)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE----------------TTSTTHHHHHH
T ss_pred HHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE----------------CCCCCHHHHHH
Confidence 99999999999999999999999999998 54 599999999974 34578999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2e-17 Score=172.53 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=96.7
Q ss_pred eEEEeEEecccCceEEEEEEe-eCCcE--EEEEEeecCCc---------------------------hHHHHHHHHHHHh
Q 004442 474 LVVFNKEIAKGSNGTVVLEGN-YEGRS--VAVKRLVKTHH---------------------------DVALKEIQNLIAS 523 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~-~~g~~--VAVK~l~~~~~---------------------------~~~~~Ei~~ll~~ 523 (753)
.|.+.+.||+|+||.||+|.. .+|+. ||||+++.... ....+|.. .+..
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~ 126 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR-NLER 126 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH-HHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH-HHHH
Confidence 467889999999999999987 68999 99998754310 12344544 6677
Q ss_pred CCCCce--eeecccccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcC
Q 004442 524 DQHPNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 601 (753)
Q Consensus 524 l~HpNI--V~L~g~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 601 (753)
++|+|| ...+++ +..+||||||+++- ....+|.++...
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g-----~~~~~L~~~~~~------------------------------- 166 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDE-----LPAPTLVELGRE------------------------------- 166 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETT-----EECCBHHHHGGG-------------------------------
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCC-----CccccHHHHhhc-------------------------------
Confidence 777654 233322 35689999653110 000144433211
Q ss_pred CCCHHHHHHHHHHHHHHHHHhh-hCCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 602 GHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 602 ~l~~~~~l~Ia~qIa~gL~yLH-~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
.++..+..++.|++.||.||| +.+|+||||||.|||++. .++|+|||+|...
T Consensus 167 -~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~----~~~liDFG~a~~~ 219 (258)
T 1zth_A 167 -LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID----KVYFIDMGQAVTL 219 (258)
T ss_dssp -GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS----SEEECCCTTCEET
T ss_pred -cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC----cEEEEECcccccC
Confidence 012234789999999999999 999999999999999965 4999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.7e-15 Score=166.57 Aligned_cols=140 Identities=13% Similarity=0.160 Sum_probs=96.4
Q ss_pred eEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC----------------chHHHHHHHHHHHhCCCCceeeeccccc
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNIVRWYGVES 537 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~----------------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~ 537 (753)
.|.+.+.||+|+||.||+|...+|+.||||+++... .......+..+.+...|+|+++++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 378899999999999999999999999999875321 0011111222333345666666654432
Q ss_pred CC------ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHH
Q 004442 538 DQ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (753)
Q Consensus 538 ~~------~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~I 611 (753)
.- ...+||||||+ ++.|.++.. .+....+
T Consensus 176 ~vp~p~~~~~~~LVME~i~----------G~~L~~l~~-----------------------------------~~~~~~l 210 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVD----------ALPMRQVSS-----------------------------------VPDPASL 210 (397)
T ss_dssp SCCCEEEEETTEEEEECCS----------CEEGGGCCC-----------------------------------CSCHHHH
T ss_pred CCCeeeeccCceEEEEecC----------CccHhhhcc-----------------------------------cHHHHHH
Confidence 21 22369999554 444432211 0122568
Q ss_pred HHHHHHHHHHhhhCCccccCCCCCcEEEecCCC--------CeEEEEeccCceec
Q 004442 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS--------FCAKLSDMGISKRL 658 (753)
Q Consensus 612 a~qIa~gL~yLH~~~IiHrDLKp~NILL~~d~~--------~~~KLsDFGla~~~ 658 (753)
+.|++.+|.|||+.|||||||||.|||++.++. ..+.|+||+.+...
T Consensus 211 ~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 211 YADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 899999999999999999999999999988763 24889999988764
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.39 E-value=2.4e-12 Score=139.25 Aligned_cols=174 Identities=21% Similarity=0.372 Sum_probs=125.9
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCC--CC-cccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTG--RP-IYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEE 124 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (753)
.|+.+|++.||+||.+|..+|+.+|+|.++ +| +..+..+.. .+..++..+...|++||.-+...| ..+.+.+++.
T Consensus 10 ~~~V~v~t~dG~l~Ald~~tG~~~W~~~~~~~~p~~~~~~~~~~-~~~~~~vv~p~~dG~l~a~~~~~G-~~~~~~~~~~ 87 (339)
T 2be1_A 10 SDILIAADVEGGLHAVDRRNGHIIWSIEPENFQPLIEIQEPSRL-ETYETLIIEPFGDGNIYYFNAHQG-LQKLPLSIRQ 87 (339)
T ss_dssp EEEEEEEETTSCEEEEETTTTEEEEEECGGGSCCSEECCCSCTT-TSSEEEEECCSTTTEEEEEETTTE-EEEEEEEHHH
T ss_pred CCEEEEEeCCCeEEEEECCCCcEEEEecCCccCCcEEecCCccc-cCCcEEEEEECCCCEEEEEECCCC-cEEeeecccc
Confidence 467899999999999999999999999997 44 444444333 233466677679999999998777 5668889999
Q ss_pred HHHhCcee-------------ecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhc
Q 004442 125 YIRRMPYI-------------SKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVE 191 (753)
Q Consensus 125 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (753)
++..+|+. +.||.|+.|++..+++++|++||+++..+.......++........++ ++
T Consensus 88 lv~~SP~~~~~~pvv~~~~~~~~~g~Vy~Gs~~g~l~ald~~tG~~~W~~~~~~~~~~~~~~~e~~~~~---------~d 158 (339)
T 2be1_A 88 LVSTSPLHLKTNIVVNDSGKIVEDEKVYTGSMRTIMYTINMLNGEIISAFGPGSKNGYFGSQSVDCSPE---------EK 158 (339)
T ss_dssp HHTTCSEEEECC----------CCEEEEECEEEEEEEEEETTTCCEEEEESTTCBCC-----------------------
T ss_pred ceeccccccCCCceeecccccccCCEEEEEecCCEEEEEECCCCcEEEEEecCCCcccccccccccccc---------cc
Confidence 99999998 389999999999999999999999999976543322211000000011 00
Q ss_pred cccccccccccceEEEEeeeeeeecCCCCceEEEEeeecccceeee
Q 004442 192 SGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAEFR 237 (753)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (753)
- +.+.....|.|-||+|.+-.++ ++|. .||+.++++.+...
T Consensus 159 ~---~~d~~~~~v~ig~~~y~v~~~~-~sG~-~W~~~~s~~~~~~~ 199 (339)
T 2be1_A 159 I---KLQECENMIVIGKTIFELGIHS-YDGA-SYNVTYSTWQQNVL 199 (339)
T ss_dssp ---------CCEEEEEEEEEECEECC-TTSC-CCCCEEEEEECCTT
T ss_pred c---ccccCCCeEEEecceEEEEEEC-CCCC-eEEEeccccccccc
Confidence 0 0112335799999999999999 5698 99999988866433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=3.3e-09 Score=109.54 Aligned_cols=75 Identities=11% Similarity=-0.028 Sum_probs=55.6
Q ss_pred EEEeEEecccCceEEEEEEeeCCcEEEEEEeec---CCchHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEcccc
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK---THHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~---~~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
|.+...++.|+.+.||+... .+..+++|+... .......+|.. ++..+ .|.++.++++++.+.+..|+|||+++
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~-~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 93 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKD-MMLWLEGKLPVPKVLHFERHDGWSNLLMSEAD 93 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHH-HHHHHTTTSCCCCEEEEEEETTEEEEEEECCS
T ss_pred ceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHH-HHHHHhcCCCCCeEEEEEecCCceEEEEEecC
Confidence 56677788899999998764 368999999864 22334555665 44544 46778889999888889999999555
Q ss_pred C
Q 004442 551 C 551 (753)
Q Consensus 551 ~ 551 (753)
+
T Consensus 94 G 94 (263)
T 3tm0_A 94 G 94 (263)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.85 E-value=2.5e-09 Score=109.41 Aligned_cols=69 Identities=12% Similarity=-0.032 Sum_probs=49.1
Q ss_pred cccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCc--eeeecccccCCceEEEEEccccC
Q 004442 482 AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN--IVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 482 G~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpN--IV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+.|..+.||+....+|..++||...........+|.. ++..+.+.+ +.++++++.+++..++|||++++
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~-~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAA-RLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHH-HHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcccchhhhHHHH-HHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 4666799999877778889999986543334445554 445554434 45688888877889999997766
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.68 E-value=7.2e-08 Score=105.22 Aligned_cols=152 Identities=24% Similarity=0.450 Sum_probs=96.9
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
..+...+++.||+|+++|..+|+.+|++.. .++.++ +...+..+ |+-+..|..||.-+...|+.. ++....++.
T Consensus 8 ~~~~v~~gs~dg~v~a~d~~tG~~~W~~~~-~~~~s~---p~~~~g~~-~v~~s~dg~l~a~d~~tG~~~w~~~~~~~~~ 82 (369)
T 2hz6_A 8 PETLLFVSTLDGSLHAVSKRTGSIKWTLKE-DPVLQV---PTHVEEPA-FLPDPNDGSLYTLGSKNNEGLTKLPFTIPEL 82 (369)
T ss_dssp CTTEEEEEETTSEEEEEETTTCCEEEEEEC-CCSCCC---C-----CC-EEECTTTCCEEEC-----CCSEECSCCHHHH
T ss_pred eCCEEEEEcCCCEEEEEECCCCCEEEEecC-CCceec---ceEcCCCE-EEEeCCCCEEEEEECCCCceeeeeeccCccc
Confidence 456778999999999999999999999998 454332 33233234 444568889999888888865 677778888
Q ss_pred HHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccccceE
Q 004442 126 IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVY 205 (753)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (753)
+..+|+++++|.|+.|+...+++++|++||+++..+........ .| ....|+
T Consensus 83 ~~~sp~~~~~~~v~~g~~dg~v~a~D~~tG~~~w~~~~~~~~~~---------------------~p-------~~~~v~ 134 (369)
T 2hz6_A 83 VQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQTLSSAFADSL---------------------SP-------STSLLY 134 (369)
T ss_dssp HTTCSCC-----CCCCEEEEEEEEECCC--------------------------------------------------EE
T ss_pred cccCceEecCCEEEEEeCCCEEEEEECCCCcEEEEecCCCcccc---------------------cc-------cCCEEE
Confidence 98999998889999999999999999999999987543221000 01 234678
Q ss_pred EEEeeeeeeecCCCCceEEEEeeecc
Q 004442 206 IMRTDYVLQSTSQDSGEVLWNVAYAD 231 (753)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (753)
+-.+|..+.-+.+++|+.+|+.....
T Consensus 135 ~~~~dg~v~a~d~~tG~~~W~~~~~~ 160 (369)
T 2hz6_A 135 LGRTEYTITMYDTKTRELRWNATYFD 160 (369)
T ss_dssp EEEEEEEEECCCSSSSSCCCEEEEEE
T ss_pred EEecCCEEEEEECCCCCEEEeEeccc
Confidence 88899999999999999999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.56 E-value=9.2e-08 Score=103.67 Aligned_cols=138 Identities=12% Similarity=0.185 Sum_probs=87.9
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEee--cCC----chHHHHHHHHHHHhCC--CCceeeecccccCC---ceEEEEE
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTH----HDVALKEIQNLIASDQ--HPNIVRWYGVESDQ---DFVYLSL 546 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~--~~~----~~~~~~Ei~~ll~~l~--HpNIV~L~g~~~~~---~~~~LV~ 546 (753)
.+.|+.|.++.||+.... +..+++|+.. ... .....+|.. +++.+. +..+.++++++.+. +..|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~-~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYR-VMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHH-HHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHH-HHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 466899999999987654 4688888876 321 123344544 555555 45578888888776 4589999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh--
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-- 624 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-- 624 (753)
|++++ ..+.+. ....++..+...++.++++.|+.||+
T Consensus 121 e~v~G----------~~l~~~-------------------------------~~~~l~~~~~~~~~~~l~~~La~LH~~~ 159 (359)
T 3dxp_A 121 EFVSG----------RVLWDQ-------------------------------SLPGMSPAERTAIYDEMNRVIAAMHTVD 159 (359)
T ss_dssp ECCCC----------BCCCCT-------------------------------TCTTCCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred EecCC----------eecCCC-------------------------------ccccCCHHHHHHHHHHHHHHHHHHhCCC
Confidence 96654 222110 00113334445555555555555554
Q ss_pred --------------------------------------------------------CCccccCCCCCcEEEecCCCCeEE
Q 004442 625 --------------------------------------------------------IGLIHRDLKPQNVLISKDKSFCAK 648 (753)
Q Consensus 625 --------------------------------------------------------~~IiHrDLKp~NILL~~d~~~~~K 648 (753)
..++|+|+++.||+++.++.-.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~ 239 (359)
T 3dxp_A 160 YQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLA 239 (359)
T ss_dssp TTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEE
T ss_pred chhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEE
Confidence 359999999999999876543468
Q ss_pred EEeccCceec
Q 004442 649 LSDMGISKRL 658 (753)
Q Consensus 649 LsDFGla~~~ 658 (753)
|.||+.+...
T Consensus 240 viDwe~a~~g 249 (359)
T 3dxp_A 240 VLDWELSTLG 249 (359)
T ss_dssp ECCCTTCEEE
T ss_pred EECccccccC
Confidence 9999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.34 E-value=1.3e-07 Score=100.16 Aligned_cols=84 Identities=19% Similarity=0.286 Sum_probs=48.9
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCcc--CCCCc-------cc--cc-cccccCCCCCchhh
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT--GYGSS-------GW--QA-PEQLLQGRQTRAID 693 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~--~~GT~-------~Y--~A-PE~l~~~~~t~ksD 693 (753)
.++|+|+++.||+++.+..-.+.|.||+.+.......+-...... ..+.. .| .. |+... ......+
T Consensus 192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~--r~~~~~~ 269 (304)
T 3sg8_A 192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLE--KYRMKEK 269 (304)
T ss_dssp EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHH--HHHHHHH
T ss_pred eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHH--HHHHHHH
Confidence 589999999999998752235789999998765432111000000 00000 01 11 22111 1123478
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q 004442 694 LFSLGCILFFCITGGKHPY 712 (753)
Q Consensus 694 IwSfGvvL~EllTG~~~Pf 712 (753)
.|+++.++|++.+| .++|
T Consensus 270 ~~~l~~~~~~~~~g-~~~~ 287 (304)
T 3sg8_A 270 YWSFEKIIYGKEYG-YMDW 287 (304)
T ss_dssp HHHHHHHHHHHHTT-CHHH
T ss_pred HHHHHHHHHHHHcC-CHHH
Confidence 99999999999998 4343
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.0002 Score=75.76 Aligned_cols=68 Identities=15% Similarity=0.138 Sum_probs=43.3
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCC---ceeeeccccc-CCceEEEEEccccC
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHP---NIVRWYGVES-DQDFVYLSLERCTC 551 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~Hp---NIV~L~g~~~-~~~~~~LV~E~c~~ 551 (753)
+.++.|....||+. |..++||+-..... ....+|.. ++..+.+. .+.+.+.++. ..+..++|||++++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~~~~~~~~~~E~~-~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKSQQGADELNKEIQ-LLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESSHHHHHHHHHHHH-HHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE----CCEEEEEecCCchHHHHHHHHHH-HHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 45788999999986 57788888533222 23334444 66665542 2456666653 45567899998876
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00029 Score=72.44 Aligned_cols=70 Identities=10% Similarity=-0.064 Sum_probs=45.2
Q ss_pred ecccCce-EEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEccccC
Q 004442 481 IAKGSNG-TVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 481 IG~G~fG-~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+..|..| .||+.... ++..++||+-.........+|.. .+..+ .+--+.+.++++.+.+..++|||++++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~-~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMV-RLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHH-HHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHH-HHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 4445444 68876544 46789999876543334444554 33433 233366788888888999999997776
|
| >3q7m_A Lipoprotein YFGL, BAMB; beta-propeller, BAM complex, outer membrane protein folding, negative, BAMA, protein binding; 1.65A {Escherichia coli} PDB: 3q7n_A 3q7o_A 3p1l_A 3prw_A 2yh3_A 3q54_A | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00094 Score=71.67 Aligned_cols=163 Identities=15% Similarity=0.173 Sum_probs=101.7
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
..+..++++.||.|+.+|..+|+.+|++..+.++.++-. -.+..+|.- ..+..||.-+...|++. +.....+.+
T Consensus 102 ~~~~v~v~~~~g~l~a~d~~tG~~~W~~~~~~~~~~~p~---~~~~~v~v~--~~~g~l~~~d~~tG~~~W~~~~~~~~~ 176 (376)
T 3q7m_A 102 SGGHVYIGSEKAQVYALNTSDGTVAWQTKVAGEALSRPV---VSDGLVLIH--TSNGQLQALNEADGAVKWTVNLDMPSL 176 (376)
T ss_dssp ETTEEEEEETTSEEEEEETTTCCEEEEEECSSCCCSCCE---EETTEEEEE--CTTSEEEEEETTTCCEEEEEECCC---
T ss_pred eCCEEEEEcCCCEEEEEECCCCCEEEEEeCCCceEcCCE---EECCEEEEE--cCCCeEEEEECCCCcEEEEEeCCCCce
Confidence 346788899999999999999999999998876643322 122223332 34567888888888876 444322211
Q ss_pred ---HHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhcccccccccccc
Q 004442 126 ---IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQ 202 (753)
Q Consensus 126 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (753)
...+|.+. +|.|.+|.....++.+|++||+++.....+... +..+...+..+... |.+. .-
T Consensus 177 ~~~~~~~~~~~-~~~v~~g~~~g~l~~~d~~tG~~~w~~~~~~~~-----~~~~~~~~~~~~~~-----p~~~-----~~ 240 (376)
T 3q7m_A 177 SLRGESAPTTA-FGAAVVGGDNGRVSAVLMEQGQMIWQQRISQAT-----GSTEIDRLSDVDTT-----PVVV-----NG 240 (376)
T ss_dssp --CCCCCCEEE-TTEEEECCTTTEEEEEETTTCCEEEEEECCC----------------CCCCC-----CEEE-----TT
T ss_pred eecCCCCcEEE-CCEEEEEcCCCEEEEEECCCCcEEEEEecccCC-----CCcccccccccCCC-----cEEE-----CC
Confidence 12567776 677999998889999999999999885443211 11111111111111 1111 23
Q ss_pred ceEEEEeeeeeeecCCCCceEEEEeeec
Q 004442 203 LVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (753)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (753)
.|++.-.+-.+-.+.+++|+.+|.....
T Consensus 241 ~v~~~~~~g~l~~~d~~tG~~~w~~~~~ 268 (376)
T 3q7m_A 241 VVFALAYNGNLTALDLRSGQIMWKRELG 268 (376)
T ss_dssp EEEEECTTSCEEEEETTTCCEEEEECCC
T ss_pred EEEEEecCcEEEEEECCCCcEEeeccCC
Confidence 4555545667778888999999987644
|
| >3q7m_A Lipoprotein YFGL, BAMB; beta-propeller, BAM complex, outer membrane protein folding, negative, BAMA, protein binding; 1.65A {Escherichia coli} PDB: 3q7n_A 3q7o_A 3p1l_A 3prw_A 2yh3_A 3q54_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00073 Score=72.51 Aligned_cols=155 Identities=14% Similarity=0.185 Sum_probs=99.1
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCC----------cccccccCCCCCCceeeeccCCCceeeeeccccCcee
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRP----------IYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK 116 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 116 (753)
..+...+++.||+|+.+|..+|+.+|++..+.. +.+. +.-.+..+|.- ..+..||.=+...|++.
T Consensus 52 ~~~~v~~~~~~g~v~a~d~~tG~~~W~~~~~~~~~~~~~~~~~~~~~---~~~~~~~v~v~--~~~g~l~a~d~~tG~~~ 126 (376)
T 3q7m_A 52 ADNVVYAADRAGLVKALNADDGKEIWSVSLAEKDGWFSKEPALLSGG---VTVSGGHVYIG--SEKAQVYALNTSDGTVA 126 (376)
T ss_dssp ETTEEEEECTTSEEEEEETTTCCEEEEEECCC---CCSCCCCCEEEE---EEEETTEEEEE--ETTSEEEEEETTTCCEE
T ss_pred ECCEEEEEcCCCeEEEEEccCCceeeeecCccccccccccCcccccC---ceEeCCEEEEE--cCCCEEEEEECCCCCEE
Confidence 457788889999999999999999999998543 2111 11112224332 34567888888888876
Q ss_pred -eeccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccc
Q 004442 117 -KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVG 195 (753)
Q Consensus 117 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (753)
+.... .-+...|.+. +|.|.+|+....++++|++||+++..+..+...... . . .. .|.+.
T Consensus 127 W~~~~~--~~~~~~p~~~-~~~v~v~~~~g~l~~~d~~tG~~~W~~~~~~~~~~~---~-~-------~~-----~~~~~ 187 (376)
T 3q7m_A 127 WQTKVA--GEALSRPVVS-DGLVLIHTSNGQLQALNEADGAVKWTVNLDMPSLSL---R-G-------ES-----APTTA 187 (376)
T ss_dssp EEEECS--SCCCSCCEEE-TTEEEEECTTSEEEEEETTTCCEEEEEECCC--------C-C-------CC-----CCEEE
T ss_pred EEEeCC--CceEcCCEEE-CCEEEEEcCCCeEEEEECCCCcEEEEEeCCCCceee---c-C-------CC-----CcEEE
Confidence 44322 2245567765 667999999999999999999999886553211000 0 0 00 01111
Q ss_pred cccccccceEEEEeeeeeeecCCCCceEEEEeeec
Q 004442 196 NLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (753)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (753)
.-.|++--.+-.+..+.+.+|+.+|.....
T Consensus 188 -----~~~v~~g~~~g~l~~~d~~tG~~~w~~~~~ 217 (376)
T 3q7m_A 188 -----FGAAVVGGDNGRVSAVLMEQGQMIWQQRIS 217 (376)
T ss_dssp -----TTEEEECCTTTEEEEEETTTCCEEEEEECC
T ss_pred -----CCEEEEEcCCCEEEEEECCCCcEEEEEecc
Confidence 123444333556778889999999998765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0021 Score=67.91 Aligned_cols=44 Identities=18% Similarity=0.167 Sum_probs=33.1
Q ss_pred HHHHHHHHHhhh-------------CCccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 613 RDIVSGLSHLHE-------------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 613 ~qIa~gL~yLH~-------------~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
..+..++.+|++ ..++|+|+++.||+++.++. +.|+||+.+...
T Consensus 197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~~g 253 (346)
T 2q83_A 197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQ--IWVIDLDTVSFD 253 (346)
T ss_dssp HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGC--EEECCCTTCEEC
T ss_pred HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCc--EEEEehhhcccC
Confidence 344556666652 47999999999999965544 889999987643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00026 Score=84.51 Aligned_cols=63 Identities=14% Similarity=-0.003 Sum_probs=39.3
Q ss_pred CCCcccccCCCCccccccccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCC
Q 004442 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQ 307 (753)
Q Consensus 245 ~~~~~~~~~~~l~~~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~ 307 (753)
+|+|.+.+..+-.-.....++.+.+.+|+|+|.|| .+.++ .|+.|||++|+|+|.||..+..+
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l 703 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCC
Confidence 55666654433211122344666777788888886 46666 67778888888888887666543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.001 Score=71.42 Aligned_cols=74 Identities=5% Similarity=0.029 Sum_probs=46.0
Q ss_pred EeEEe-cccCceEEEEEEee-------CCcEEEEEEeecCC------chHHHHHHHHHHHhCC-C--CceeeecccccCC
Q 004442 477 FNKEI-AKGSNGTVVLEGNY-------EGRSVAVKRLVKTH------HDVALKEIQNLIASDQ-H--PNIVRWYGVESDQ 539 (753)
Q Consensus 477 i~~~I-G~G~fG~Vyka~~~-------~g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~-H--pNIV~L~g~~~~~ 539 (753)
..+.| +.|....+|+.... ++..+++|+..... .....+|.. ++..+. + -.+.++++++.+.
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~-~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFE-VIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHH-HHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHH-HHHHHhhcCCCCCCcEEEEccCC
Confidence 44668 88999999986554 26788999865422 123444544 333332 2 2456677776654
Q ss_pred ---ceEEEEEccccC
Q 004442 540 ---DFVYLSLERCTC 551 (753)
Q Consensus 540 ---~~~~LV~E~c~~ 551 (753)
+..++|||++++
T Consensus 103 ~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 DVLGTPFFLMDYVEG 117 (357)
T ss_dssp TTTSSCEEEEECCCC
T ss_pred CccCCceEEEEecCC
Confidence 356899997765
|
| >1w6s_A Methanol dehydrogenase subunit 1; anisotropic, electron transfer, oxidoreductase, calcium- binding, methanol utilization, PQQ; HET: PQQ; 1.2A {Methylobacterium extorquens} SCOP: b.70.1.1 PDB: 1h4i_A* 1h4j_A* 2d0v_A* 1lrw_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0078 Score=69.79 Aligned_cols=110 Identities=13% Similarity=0.130 Sum_probs=73.9
Q ss_pred eEEEecCceEEEEeccCCeeeEEecCCCCc--ccccccCCCCCCceeeeccC-----CCceeeeeccccCcee-eeccCH
Q 004442 51 ALVAALDGTIHLVDTKLGKIRWSFGTGRPI--YSSYQASFNSNASEFYLDVD-----EDWELYFHSKRFGKMK-KLSSSA 122 (753)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~ 122 (753)
.+|++.||.|+.+|..+|+.+|++..+.+- |..+.+|.-.+-.+ |+-.. -+..||--+...|++. ++....
T Consensus 124 V~v~t~dg~l~AlDa~TG~~~W~~~~~~~~~~~~~~ssP~v~~g~V-~vg~~g~e~g~~g~v~A~D~~TG~~~W~~~~~~ 202 (599)
T 1w6s_A 124 ILKTQLDGNVAALNAETGETVWKVENSDIKVGSTLTIAPYVVKDKV-IIGSSGAELGVRGYLTAYDVKTGEQVWRAYATG 202 (599)
T ss_dssp EEEECTTSEEEEEETTTCCEEEEEECCCGGGTCBCCSCCEEETTEE-EECCBCGGGTCCCEEEEEETTTCCEEEEEESSS
T ss_pred EEEEcCCCEEEEEECCCCCEEEeecCCCCCccceeecCCEEECCEE-EEEecccccCCCCeEEEEECCCCcEEEEEcCCC
Confidence 788999999999999999999999877632 22222332222223 33332 3678888888899887 555443
Q ss_pred HHHHH------------------------------------hCcee-ecCCeeeeecee----------------eeEEE
Q 004442 123 EEYIR------------------------------------RMPYI-SKDGGVTLGAMK----------------TSVFL 149 (753)
Q Consensus 123 ~~~~~------------------------------------~~~~~-~~~~~~~~~~~~----------------~~~~~ 149 (753)
++.-. ..|.+ .++|.|++|.-. .++++
T Consensus 203 ~~~~~~~~p~~~~~~~~~g~~~~g~~tw~g~~~~~gg~~~W~~~a~d~~~g~vy~g~g~~~p~~~~~r~gd~~y~~sv~A 282 (599)
T 1w6s_A 203 PDKDLLLASDFNIKNPHYGQKGLGTGTWEGDAWKIGGGTNWGWYAYDPGTNLIYFGTGNPAPWNETMRPGDNKWTMTIFG 282 (599)
T ss_dssp CHHHHTBCTTTTTTCGGGCCTTHHHHTSSTTGGGGCCCCCCSCCEEETTTTEEEEECCCCSCSCGGGSCSCCTTSSEEEE
T ss_pred CccccccccccccccccccccccccccCCCcceecCCCccccceeEeCCCCEEEEeCCCCccccCcccCCCccccceEEE
Confidence 33110 01222 267889998764 48999
Q ss_pred EecccccEEecc
Q 004442 150 VDVKSGRVVDNY 161 (753)
Q Consensus 150 ~~~~~~~~~~~~ 161 (753)
+|++||+++-.+
T Consensus 283 ld~~TG~~~W~~ 294 (599)
T 1w6s_A 283 RDADTGEAKFGY 294 (599)
T ss_dssp EETTTCCEEEEE
T ss_pred EeCCCCceeeEe
Confidence 999999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0024 Score=69.69 Aligned_cols=71 Identities=20% Similarity=0.210 Sum_probs=42.1
Q ss_pred eEEecccCceEEEEEEee-CCcEEEEEEeecCC----------chHHHHHHHHHHHhCC-C-C-ceeeecccccCCceEE
Q 004442 478 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----------HDVALKEIQNLIASDQ-H-P-NIVRWYGVESDQDFVY 543 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----------~~~~~~Ei~~ll~~l~-H-p-NIV~L~g~~~~~~~~~ 543 (753)
.+.||.|..+.||++... +++.++||...... .+....|.. ++..+. + + .+.+++.+. .+..+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~-~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESS-ALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHH-HHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHH-HHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 467999999999998654 47899999764321 122344544 444332 1 3 334555443 34458
Q ss_pred EEEccccC
Q 004442 544 LSLERCTC 551 (753)
Q Consensus 544 LV~E~c~~ 551 (753)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99998875
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0012 Score=71.69 Aligned_cols=149 Identities=17% Similarity=0.116 Sum_probs=74.8
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCC-CCCceeeeccCCCceeeeeccccCcee-eeccCHHHHHH
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFN-SNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYIR 127 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 127 (753)
+.++++.||+|+++|..+|+.+|++....|- ..+.+|.- .+..+ | -+..|..+|.-+...|++. ++. ....++
T Consensus 51 ~~v~~s~dg~l~a~d~~tG~~~w~~~~~~~~-~~~~sp~~~~~~~v-~-~g~~dg~v~a~D~~tG~~~w~~~--~~~~~~ 125 (369)
T 2hz6_A 51 AFLPDPNDGSLYTLGSKNNEGLTKLPFTIPE-LVQASPCRSSDGIL-Y-MGKKQDIWYVIDLLTGEKQQTLS--SAFADS 125 (369)
T ss_dssp CEEECTTTCCEEEC-----CCSEECSCCHHH-HHTTCSCC-----C-C-CCEEEEEEEEECCC-----------------
T ss_pred EEEEeCCCCEEEEEECCCCceeeeeeccCcc-ccccCceEecCCEE-E-EEeCCCEEEEEECCCCcEEEEec--CCCccc
Confidence 3344479999999999999999987643221 00112221 22223 2 2456778888888888875 322 223345
Q ss_pred hCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccccceEEE
Q 004442 128 RMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIM 207 (753)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (753)
.+| +++.|++|+...+++++|++||+++-.......+++.-+++ ......|++.
T Consensus 126 ~~p---~~~~v~~~~~dg~v~a~d~~tG~~~W~~~~~~~~~~~~~~~-----------------------~~~~~~v~~~ 179 (369)
T 2hz6_A 126 LSP---STSLLYLGRTEYTITMYDTKTRELRWNATYFDYAASLPEDD-----------------------VDYKMSHFVS 179 (369)
T ss_dssp ----------EEEEEEEEEEECCCSSSSSCCCEEEEEEECCBCCCCC-----------------------TTCCCCEEEE
T ss_pred ccc---cCCEEEEEecCCEEEEEECCCCCEEEeEecccccCccccCC-----------------------ccccceEEEE
Confidence 566 78889999999999999999999887643321122211110 0011234444
Q ss_pred EeeeeeeecCCCCceEEEEeee
Q 004442 208 RTDYVLQSTSQDSGEVLWNVAY 229 (753)
Q Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~ 229 (753)
-.|=.+.-+.+++|+++|....
T Consensus 180 ~~dg~v~a~d~~tG~~~W~~~~ 201 (369)
T 2hz6_A 180 NGDGLVVTVDSESGDVLWIQNY 201 (369)
T ss_dssp ETSCEEEEECTTTCCEEEEEEC
T ss_pred CCCCEEEEEECCCCcEEEEecC
Confidence 4455677888889999998763
|
| >2ad6_A Methanol dehydrogenase subunit 1; PQQ configuration, native, oxidoredu; HET: PQQ; 1.50A {Methylophilus methylotrophus} SCOP: b.70.1.1 PDB: 2ad7_A* 2ad8_A* 4aah_A* 1g72_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0099 Score=68.48 Aligned_cols=114 Identities=16% Similarity=0.195 Sum_probs=75.4
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCc--ccccccCCCCCCceeeeccCC-----CceeeeeccccCcee-ee
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPI--YSSYQASFNSNASEFYLDVDE-----DWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~ 118 (753)
..+...|++.||+|+.+|..+|+.+|++..+.+- +....+|.-.+-.+ |+-+.. +..||.-+...|++. ++
T Consensus 114 ~~~~v~v~~~dg~l~alD~~tG~~~W~~~~~~~~~~~~~~~~P~v~~g~v-~vg~~~~~~~~~g~v~a~D~~tG~~~W~~ 192 (571)
T 2ad6_A 114 GAGQIVKKQANGHLLALDAKTGKINWEVEVCDPKVGSTLTQAPFVAKDTV-LMGCSGAELGVRGAVNAFDLKTGELKWRA 192 (571)
T ss_dssp ETTEEEEECTTSEEEEEETTTCCEEEEEECCCGGGTCBCCSCCEEETTEE-EEECBCGGGTCCCEEEEEETTTCCEEEEE
T ss_pred ECCEEEEEeCCCEEEEEECCCCCEEEEecCCCCCccceeccCCEEECCEE-EEEecCCccCCCCEEEEEECCCCcEEEEE
Confidence 3567788899999999999999999999887632 11222222222234 444332 788999999999987 55
Q ss_pred ccCHHHHHH-------------------------------------hCceee-cCCeeeeecee----------------
Q 004442 119 SSSAEEYIR-------------------------------------RMPYIS-KDGGVTLGAMK---------------- 144 (753)
Q Consensus 119 ~~~~~~~~~-------------------------------------~~~~~~-~~~~~~~~~~~---------------- 144 (753)
....+. .. ..+.+. ++|.|++|...
T Consensus 193 ~~~~~~-~~~~~~p~~~~~~~~~G~~~~g~~~w~~~~~~~gg~~~w~~~a~d~~~g~vy~~~g~~~~~~~~~~~gd~~y~ 271 (571)
T 2ad6_A 193 FATGSD-DSVRLAKDFNSANPHYGQFGLGTKTWEGDAWKIGGGTNWGWYAYDPKLNLFYYGSGNPAPWNETMRPGDNKWT 271 (571)
T ss_dssp ESSSCH-HHHTBCTTTTTTCGGGCCSSHHHHTSSTTGGGGCCCCCCSCCEEETTTTEEEEECCCCSCSCGGGSCSCCTTT
T ss_pred ccCCCc-cccccCcccccccccccccccccccCcccceecCCCCeeeeEEEcCCCCeEEEECCCCccccCCccCCCceeE
Confidence 533222 10 012222 35788888742
Q ss_pred eeEEEEecccccEEeccc
Q 004442 145 TSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~ 162 (753)
.+++++|++||+++-.+.
T Consensus 272 ~~v~Ald~~tG~~~W~~~ 289 (571)
T 2ad6_A 272 MTIWGRDLDTGMAKWGYQ 289 (571)
T ss_dssp TEEEEEETTTCCEEEEEE
T ss_pred EEEEEEecCCCcEEEEec
Confidence 379999999999998753
|
| >1kb0_A Quinohemoprotein alcohol dehydrogenase; beta-propeller fold, cytochrome C, oxidoreductase; HET: TRO HEC PQQ; 1.44A {Comamonas testosteroni} SCOP: a.3.1.6 b.70.1.1 | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0078 Score=70.81 Aligned_cols=116 Identities=16% Similarity=0.080 Sum_probs=74.7
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCC-CCc--ccccccCCCCCCceeeeccC----CCceeeeeccccCcee-ee
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTG-RPI--YSSYQASFNSNASEFYLDVD----EDWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~ 118 (753)
..+..+|++.||+|+.+|..+|+.+|+|..+ .+- +....+|.-.+..+|.-... .+..||.-+...|++. ++
T Consensus 127 ~~~~v~v~~~dg~l~alD~~tG~~~W~~~~~~~~~~~~~~~~~p~v~~~~v~v~~~~~~~~~~g~v~a~D~~tG~~~W~~ 206 (677)
T 1kb0_A 127 WKGKVYVGAWDGRLIALDAATGKEVWHQNTFEGQKGSLTITGAPRVFKGKVIIGNGGAEYGVRGYITAYDAETGERKWRW 206 (677)
T ss_dssp ETTEEEEECTTSEEEEEETTTCCEEEEEETTTTCCSSCBCCSCCEEETTEEEECCBCTTTCCBCEEEEEETTTCCEEEEE
T ss_pred ECCEEEEEcCCCEEEEEECCCCCEEeeecCCcCcCcCcccccCcEEECCEEEEEecccccCCCCEEEEEECCCCcEEEEe
Confidence 4577888899999999999999999999987 221 11122222222234332221 2677888888888876 44
Q ss_pred ccCH----------------------HHHHHh--------Cceee-cCCeeeeeceee-------------------eEE
Q 004442 119 SSSA----------------------EEYIRR--------MPYIS-KDGGVTLGAMKT-------------------SVF 148 (753)
Q Consensus 119 ~~~~----------------------~~~~~~--------~~~~~-~~~~~~~~~~~~-------------------~~~ 148 (753)
.... .+..+. .|.+. +.|.|++|.... +++
T Consensus 207 ~~~~~~~~~~~~~~~~~~g~~~w~~~g~~~~~~~g~~~w~~~~~d~~~~~vy~~~~~~~~w~~~~~~~~~gd~~~~~sv~ 286 (677)
T 1kb0_A 207 FSVPGDPSKPFEDESMKRAARTWDPSGKWWEAGGGGTMWDSMTFDAELNTMYVGTGNGSPWSHKVRSPKGGDNLYLASIV 286 (677)
T ss_dssp ESSCCCTTSCCSSHHHHHHHTTSCGGGCHHHHCEECCCCSCEEEETTTTEEEEECCCEESSCHHHHSTTCCCCTTTTEEE
T ss_pred ccCCCCccccccccccccccccccccCceeEeCCCcccccceeEcCCCCEEEEECCCCccccCCCCCccCCCCeeeEEEE
Confidence 3221 122221 23333 467888887653 699
Q ss_pred EEecccccEEeccc
Q 004442 149 LVDVKSGRVVDNYV 162 (753)
Q Consensus 149 ~~~~~~~~~~~~~~ 162 (753)
++|++||+++-.+.
T Consensus 287 AlD~~TG~~~W~~~ 300 (677)
T 1kb0_A 287 ALDPDTGKYKWHYQ 300 (677)
T ss_dssp EECTTTCCEEEEEE
T ss_pred EEECCCCCEEEEEe
Confidence 99999999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.004 Score=68.71 Aligned_cols=80 Identities=14% Similarity=0.034 Sum_probs=47.8
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC---CCCchhhHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGC 699 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~t~ksDIwSfGv 699 (753)
+...++|+|+++.||+++.++ ++|.||+.+.......+-...... -...|++|+..... ......++.....
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS---TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIE 304 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC---EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC---CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHH
Confidence 456799999999999997654 789999998765321110000000 02346666654311 1123455667777
Q ss_pred HHHHHHhC
Q 004442 700 ILFFCITG 707 (753)
Q Consensus 700 vL~EllTG 707 (753)
.+|+.+++
T Consensus 305 ~~~~~y~~ 312 (420)
T 2pyw_A 305 QTWNLFNK 312 (420)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 77776654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=96.52 E-value=0.018 Score=59.66 Aligned_cols=156 Identities=10% Similarity=0.154 Sum_probs=88.7
Q ss_pred CCCeeE-EEecCceEEEEeccCCeeeEEecCCCC--cccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCH
Q 004442 47 EPDVAL-VAALDGTIHLVDTKLGKIRWSFGTGRP--IYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSA 122 (753)
Q Consensus 47 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 122 (753)
.||-.| ++.-||+|+++|.++|+++|+|..+.+ .++.+..+ +.+ +++ . .+-.+|.-++ .|++. ++...
T Consensus 3 ~~~~~lv~~~~~~~v~~~d~~tG~~~w~~~~~~~~~~~~~~~~p-dG~--ilv-s--~~~~V~~~d~-~G~~~W~~~~~- 74 (276)
T 3no2_A 3 SPQHLLVGGSGWNKIAIINKDTKEIVWEYPLEKGWECNSVAATK-AGE--ILF-S--YSKGAKMITR-DGRELWNIAAP- 74 (276)
T ss_dssp CCCEEEEECTTCSEEEEEETTTTEEEEEEECCTTCCCCEEEECT-TSC--EEE-E--CBSEEEEECT-TSCEEEEEECC-
T ss_pred CCCcEEEeeCCCCEEEEEECCCCeEEEEeCCCccCCCcCeEECC-CCC--EEE-e--CCCCEEEECC-CCCEEEEEcCC-
Confidence 344344 445699999999999999999999762 34444433 322 333 2 2445666666 67665 44321
Q ss_pred HHHHHhCceeecCCeeeeece--eeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhcccccccccc
Q 004442 123 EEYIRRMPYISKDGGVTLGAM--KTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRI 200 (753)
Q Consensus 123 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (753)
...--...-+..||.+.++.. ...+++||+ +|+++.....+..... .......+...++-
T Consensus 75 ~~~~~~~~~~~~dG~~lv~~~~~~~~v~~vd~-~Gk~l~~~~~~~~~~~---~~~~~~~v~~~~~G-------------- 136 (276)
T 3no2_A 75 AGCEMQTARILPDGNALVAWCGHPSTILEVNM-KGEVLSKTEFETGIER---PHAQFRQINKNKKG-------------- 136 (276)
T ss_dssp TTCEEEEEEECTTSCEEEEEESTTEEEEEECT-TSCEEEEEEECCSCSS---GGGSCSCCEECTTS--------------
T ss_pred CCccccccEECCCCCEEEEecCCCCEEEEEeC-CCCEEEEEeccCCCCc---ccccccCceECCCC--------------
Confidence 000011234567887777643 578999997 8999988655321100 00000111111111
Q ss_pred ccceEEEEeeeeeeecCCCCceEEEEeeec
Q 004442 201 RQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (753)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (753)
..|.....+..++-+.++ |+.+|.....
T Consensus 137 -~~lv~~~~~~~v~~~d~~-G~~~w~~~~~ 164 (276)
T 3no2_A 137 -NYLVPLFATSEVREIAPN-GQLLNSVKLS 164 (276)
T ss_dssp -CEEEEETTTTEEEEECTT-SCEEEEEECS
T ss_pred -CEEEEecCCCEEEEECCC-CCEEEEEECC
Confidence 122222235668888898 9999998763
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0033 Score=75.82 Aligned_cols=55 Identities=7% Similarity=-0.252 Sum_probs=32.1
Q ss_pred ccccccccCCccccccccccCCCcccceeecCccccccCCCCCCCCCC--cCCCCCC
Q 004442 263 DVESHLPCHTQMTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSL--LGPVDRN 317 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l~L~~LnlsnN~fsG~IP~~l~s~n~l--~G~~~~~ 317 (753)
.|+.+.+.+|++++-.+..-...|+.|||++|+++|.+|..+.++..+ .||.+.+
T Consensus 505 ~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 505 ALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561 (844)
T ss_dssp SCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCC
T ss_pred hhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccc
Confidence 345666667777664432222357777777777777777666544332 2666553
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0024 Score=76.14 Aligned_cols=59 Identities=7% Similarity=-0.032 Sum_probs=47.0
Q ss_pred CCCcccccCCCCccccccccccccccCCccccccc-cccCC-CcccceeecCccccccCCC
Q 004442 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 303 (753)
Q Consensus 245 ~~~~~~~~~~~l~~~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~ 303 (753)
+++|.+.+..+-.-.....|+.+.+.+|+|+|.|| .+..+ .|+.|||++|+|+|.||..
T Consensus 663 Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~ 723 (768)
T 3rgz_A 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS
T ss_pred CcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc
Confidence 77787775554332233456889999999999998 57888 7999999999999999964
|
| >2ad6_A Methanol dehydrogenase subunit 1; PQQ configuration, native, oxidoredu; HET: PQQ; 1.50A {Methylophilus methylotrophus} SCOP: b.70.1.1 PDB: 2ad7_A* 2ad8_A* 4aah_A* 1g72_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.01 Score=68.30 Aligned_cols=60 Identities=17% Similarity=0.067 Sum_probs=44.8
Q ss_pred CceeeeeccccCcee-eeccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccC
Q 004442 102 DWELYFHSKRFGKMK-KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 102 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
+..||.=+...|++. ++.. +.-+.-.|++..+|.|.+|+....++++|++||+++..+..
T Consensus 443 ~g~l~a~D~~tG~~~W~~~~--~~~~~~~~~~t~gg~v~~g~~dg~l~a~D~~tG~~lw~~~~ 503 (571)
T 2ad6_A 443 MGQIRAFDLTTGKAKWTKWE--KFAAWGGTLYTKGGLVWYATLDGYLKALDNKDGKELWNFKM 503 (571)
T ss_dssp CEEEEEECTTTCCEEEEEEE--SSCCCSBCEEETTTEEEEECTTSEEEEEETTTCCEEEEEEC
T ss_pred CCeEEEEECCCCCEEEEecC--CCCccceeEEECCCEEEEEcCCCeEEEEECCCCCEEEEEeC
Confidence 456777777777765 3331 11233467888899999999999999999999999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.031 Score=57.98 Aligned_cols=74 Identities=15% Similarity=-0.041 Sum_probs=46.8
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHH-HHHHHHHHHhCC-CC--ceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVA-LKEIQNLIASDQ-HP--NIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~-~~Ei~~ll~~l~-Hp--NIV~L~g~~~~~~~~~LV~ 546 (753)
..+.-.+.+|.|..+.||+....+|+.|.||+-..... ... ..|.. .++.+. .. -+.+.+++. .-++||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~-~L~~L~~~~~vpvP~v~~~~----~~~lv~ 89 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEAL-GLDWLGRSFGSPVPQVAGWD----DRTLAM 89 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHH-HHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHH-HHHHHHhhCCCCcceEEecc----CceEEE
Confidence 34455678999999999999999999999998654321 223 34544 444332 21 233444442 237889
Q ss_pred ccccC
Q 004442 547 ERCTC 551 (753)
Q Consensus 547 E~c~~ 551 (753)
|++..
T Consensus 90 e~l~~ 94 (288)
T 3f7w_A 90 EWVDE 94 (288)
T ss_dssp ECCCC
T ss_pred Eeecc
Confidence 97664
|
| >1yiq_A Quinohemoprotein alcohol dehydrogenase; electron transfer, oxidoreductase; HET: PQQ HEM; 2.20A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.034 Score=65.46 Aligned_cols=115 Identities=18% Similarity=0.160 Sum_probs=73.3
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCC-CCc--ccccccCCCCCCceeeeccC-----CCceeeeeccccCcee-e
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTG-RPI--YSSYQASFNSNASEFYLDVD-----EDWELYFHSKRFGKMK-K 117 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~ 117 (753)
..+...|++.||+|+.+|..+|+.+|++..+ .+- +....+|.-.+-.+| +-.. .+..||.-+...|++. +
T Consensus 120 ~~g~v~v~~~dg~l~AlDa~TG~~~W~~~~~~~~~~~~~~~~sP~v~~g~v~-vg~~~~~~~~~g~v~a~D~~tG~~~W~ 198 (689)
T 1yiq_A 120 WKGKVYVGVLDGRLEAIDAKTGQRAWSVDTRADHKRSYTITGAPRVVNGKVV-IGNGGAEFGVRGYVTAYDAETGKEAWR 198 (689)
T ss_dssp ETTEEEEECTTSEEEEEETTTCCEEEEEECCSCTTSCCBCCSCCEEETTEEE-ECCBCTTTCCBCEEEEEETTTCCEEEE
T ss_pred ECCEEEEEccCCEEEEEECCCCCEeeeecCcCCCCCCccccCCcEEECCEEE-EEeCCCccCCCCEEEEEECCCCcEEEE
Confidence 3567788999999999999999999999986 322 111112211122233 3222 3677888888888876 4
Q ss_pred eccCH---------HHHHH--------------------hCceee-cCCeeeeeceee-------------------eEE
Q 004442 118 LSSSA---------EEYIR--------------------RMPYIS-KDGGVTLGAMKT-------------------SVF 148 (753)
Q Consensus 118 ~~~~~---------~~~~~--------------------~~~~~~-~~~~~~~~~~~~-------------------~~~ 148 (753)
+.... +.+.. ..+.++ +.|.|++|+..- +++
T Consensus 199 ~~~~~~~p~~~~~~~~~~~~~~~~~g~~w~~~~~g~~~w~~~~~d~~~~~vy~~~~~g~~w~~~~~~~~~gd~~y~~~v~ 278 (689)
T 1yiq_A 199 FYTVPGDPKLPPEGKGMEIAAKTWFGDAYVEQGGGGTAWDSFAYDPELNLLYIGVGNGSLWDPKWRSQAKGDNLFLSSIV 278 (689)
T ss_dssp EESSCCCTTSCCCSHHHHHHHTTCCSSTHHHHCEECCCCSCEEEETTTTEEEEECCCEESSCHHHHHTTCSCCTTTTEEE
T ss_pred ecccCCCcccccccccccccccccCCceeeecCCCCccccceeEcCCCCEEEEeCCCCCccccCCCCCCCCCceeeeeEE
Confidence 43111 11110 123333 468899998764 499
Q ss_pred EEecccccEEeccc
Q 004442 149 LVDVKSGRVVDNYV 162 (753)
Q Consensus 149 ~~~~~~~~~~~~~~ 162 (753)
++|++||+++-.+.
T Consensus 279 AlD~~TG~~~W~~~ 292 (689)
T 1yiq_A 279 AVNADTGEYVWHYQ 292 (689)
T ss_dssp EEETTTCCEEEEEE
T ss_pred EEEccCCceeEeee
Confidence 99999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0099 Score=63.20 Aligned_cols=72 Identities=21% Similarity=0.215 Sum_probs=51.0
Q ss_pred eEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhC---CCCceeeecccccCCceEEEEEccccC
Q 004442 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD---QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l---~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.+.|+.|....+|+... ++..++||+........+..|.. .++.+ ....+.+.++++...+..++|||++++
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~~~~~~~E~~-~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSYRSMFRAEAD-QLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGGGHHHHHHHHH-HHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcccHHHHHHHHH-HHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 46789999999998765 57788999876543333444444 33333 235677888888777889999998876
|
| >1kb0_A Quinohemoprotein alcohol dehydrogenase; beta-propeller fold, cytochrome C, oxidoreductase; HET: TRO HEC PQQ; 1.44A {Comamonas testosteroni} SCOP: a.3.1.6 b.70.1.1 | Back alignment and structure |
|---|
Probab=95.91 E-value=0.014 Score=68.57 Aligned_cols=113 Identities=16% Similarity=0.168 Sum_probs=78.5
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCccccc--------ccCCCCCCceeeeccCCCceeeeeccccCcee-e
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY--------QASFNSNASEFYLDVDEDWELYFHSKRFGKMK-K 117 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 117 (753)
.-++..|++.+|+||.+|..+|+.+|++..+.+..... ..++-.+..+|.- ..|..||.-+...|++. +
T Consensus 76 ~~g~vyv~~~~~~v~AlD~~tG~~~W~~~~~~~~~~~~~~~~~~~~~~~a~~~~~v~v~--~~dg~l~alD~~tG~~~W~ 153 (677)
T 1kb0_A 76 VDGIMYVSASWSVVHAIDTRTGNRIWTYDPQIDRSTGFKGCCDVVNRGVALWKGKVYVG--AWDGRLIALDAATGKEVWH 153 (677)
T ss_dssp ETTEEEEECGGGCEEEEETTTTEEEEEECCCCCGGGGGGSSSCSCCCCCEEETTEEEEE--CTTSEEEEEETTTCCEEEE
T ss_pred ECCEEEEECCCCeEEEEECCCCcEEEEEcCCCCccccccccccCCCCCceEECCEEEEE--cCCCEEEEEECCCCCEEee
Confidence 34667788999999999999999999999887652211 1111122234443 34678888888889887 4
Q ss_pred eccCHH----HHHHhCceeecCCeeeeece------eeeEEEEecccccEEeccc
Q 004442 118 LSSSAE----EYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 118 ~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 162 (753)
+..... ..+.-+|.+. +|.|++|+. ...++++|++||+++-...
T Consensus 154 ~~~~~~~~~~~~~~~~p~v~-~~~v~v~~~~~~~~~~g~v~a~D~~tG~~~W~~~ 207 (677)
T 1kb0_A 154 QNTFEGQKGSLTITGAPRVF-KGKVIIGNGGAEYGVRGYITAYDAETGERKWRWF 207 (677)
T ss_dssp EETTTTCCSSCBCCSCCEEE-TTEEEECCBCTTTCCBCEEEEEETTTCCEEEEEE
T ss_pred ecCCcCcCcCcccccCcEEE-CCEEEEEecccccCCCCEEEEEECCCCcEEEEec
Confidence 442201 1345577776 566999875 5789999999999997743
|
| >1flg_A Protein (quinoprotein ethanol dehydrogenase); superbarrel, oxidoreductase; HET: PQQ; 2.60A {Pseudomonas aeruginosa} SCOP: b.70.1.1 | Back alignment and structure |
|---|
Probab=95.80 E-value=0.031 Score=64.46 Aligned_cols=60 Identities=15% Similarity=-0.020 Sum_probs=42.2
Q ss_pred CceeeeeccccCcee-eeccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecccC
Q 004442 102 DWELYFHSKRFGKMK-KLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 102 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
+.+||-=+...|++. ++... .-+--.|++..+|.|.+|+..-.+.++|++||+++-.+..
T Consensus 465 ~G~l~A~D~~tG~~~W~~~~~--~~~~~g~~~tagglvf~g~~dg~l~A~D~~tG~~lW~~~~ 525 (582)
T 1flg_A 465 VGSLRAMDPVSGKVVWEHKEH--LPLWAGVLATAGNLVFTGTGDGYFKAFDAKSGKELWKFQT 525 (582)
T ss_dssp SEEEEEECTTTCCEEEEEEES--SCCCSCCEEETTTEEEEECTTSEEEEEETTTCCEEEEEEC
T ss_pred cceEEEEECCCCCEEEEecCC--CCCcccceEeCCCEEEEECCCCcEEEEECCCCCEEEEecC
Confidence 345555555666665 33211 1122357788899999999999999999999999998655
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=95.79 E-value=0.0064 Score=65.41 Aligned_cols=113 Identities=16% Similarity=0.097 Sum_probs=72.1
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcc--c-ccc-cCCCCC-----C-ceeeeccCCCceeeeeccccCcee
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIY--S-SYQ-ASFNSN-----A-SEFYLDVDEDWELYFHSKRFGKMK 116 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~-~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~~ 116 (753)
..++..+++.||++|.+|..+|+++|+|++|.|.- + ... .+...| . ..-|+. ..+..++++++ .|.+-
T Consensus 110 ~~g~Vy~Gs~~g~l~ald~~tG~~~W~~~~~~~~~~~~~~~e~~~~~~d~~~d~~~~~v~ig-~~~y~v~~~~~-sG~~W 187 (339)
T 2be1_A 110 EDEKVYTGSMRTIMYTINMLNGEIISAFGPGSKNGYFGSQSVDCSPEEKIKLQECENMIVIG-KTIFELGIHSY-DGASY 187 (339)
T ss_dssp CCEEEEECEEEEEEEEEETTTCCEEEEESTTCBCC--------------------CCEEEEE-EEEEECEECCT-TSCCC
T ss_pred cCCEEEEEecCCEEEEEECCCCcEEEEEecCCCcccccccccccccccccccccCCCeEEEe-cceEEEEEECC-CCCeE
Confidence 67888999999999999999999999999997741 1 111 122111 1 123332 45567788884 46421
Q ss_pred ee------ccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEe-cc
Q 004442 117 KL------SSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVD-NY 161 (753)
Q Consensus 117 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 161 (753)
.+ +..+..-+...+-.+.||.++.|+....++++|+++|+.+- ..
T Consensus 188 ~~~~s~~~~~~~~~~~~~~~~~s~Dg~~~~~~~dg~v~A~d~~~G~~~W~~~ 239 (339)
T 2be1_A 188 NVTYSTWQQNVLDVPLALQNTFSKDGMCIAPFRDKSLLASDLDFRIARWVSP 239 (339)
T ss_dssp CCEEEEEECCTTTHHHHTTCSSCSSSCCEEEETTTEEEEECSTTCCEEEECC
T ss_pred EEecccccccccccccccccccccCCcEEEECCCCEEEEEECCCCcEEEEee
Confidence 11 00111112223444667888999999999999999999987 54
|
| >1kv9_A Type II quinohemoprotein alcohol dehydrogenase; electron transfer, oxidoreductase; HET: PQQ HEM EPE; 1.90A {Pseudomonas putida} SCOP: a.3.1.6 b.70.1.1 | Back alignment and structure |
|---|
Probab=95.72 E-value=0.059 Score=63.17 Aligned_cols=115 Identities=20% Similarity=0.194 Sum_probs=73.1
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCc--ccccccCCCCCCceeeeccC-----CCceeeeeccccCcee-ee
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPI--YSSYQASFNSNASEFYLDVD-----EDWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~ 118 (753)
..+..+|++.||+|+.+|..+|+.+|++..+.+- +....+|.-.+-.+ |+-+. .+..||.-+...|++. ++
T Consensus 116 ~~~~v~v~~~dg~l~alD~~tG~~~W~~~~~~~~~~~~~~~~P~v~~~~v-~vg~~~~~~~~~g~v~a~D~~tG~~~W~~ 194 (668)
T 1kv9_A 116 WGDKVYVGTLDGRLIALDAKTGKAIWSQQTTDPAKPYSITGAPRVVKGKV-IIGNGGAEYGVRGFVSAYDADTGKLAWRF 194 (668)
T ss_dssp EBTEEEEECTTSEEEEEETTTCCEEEEEECSCTTSSCBCCSCCEEETTEE-EECCBCTTTCCBCEEEEEETTTCCEEEEE
T ss_pred ECCEEEEEcCCCEEEEEECCCCCEeeeeccCCCCCcceecCCCEEECCEE-EEeCCCCCcCCCCEEEEEECCCCcEEEEe
Confidence 3567788999999999999999999999986442 11111121112223 33322 2567888888888876 44
Q ss_pred ccC---------HHHHHHh--------------------Cceee-cCCeeeeeceee-------------------eEEE
Q 004442 119 SSS---------AEEYIRR--------------------MPYIS-KDGGVTLGAMKT-------------------SVFL 149 (753)
Q Consensus 119 ~~~---------~~~~~~~--------------------~~~~~-~~~~~~~~~~~~-------------------~~~~ 149 (753)
... .+.++.- .|.+. +.|.|++|+... ++++
T Consensus 195 ~~~~~~p~~~~~~~~~~~~~~~~~g~~~w~~~~gg~~w~~~a~d~~~~~vy~~~~~g~~w~~~~~~~~~gd~l~~~~v~A 274 (668)
T 1kv9_A 195 YTVPGDPALPYEHPELREAAKTWQGDQYWKLGGGGTVWDSMAYDPELDLLYVGTGNGSPWNREVRSPGGGDNLYLSSILA 274 (668)
T ss_dssp ESSCCCTTSCCSSHHHHHHHTTCCSSCHHHHCEECCCCSCEEEETTTTEEEEECCCEESSCHHHHSTTCCCCTTTTEEEE
T ss_pred cccCCCCCccccccccccccccCCccceeeeCCCCccccceEEcCCCCEEEEeCCCCCccccCCCCCCCCCceeeeeEEE
Confidence 321 1111111 13333 458899998654 5999
Q ss_pred EecccccEEeccc
Q 004442 150 VDVKSGRVVDNYV 162 (753)
Q Consensus 150 ~~~~~~~~~~~~~ 162 (753)
+|++||+++-.+.
T Consensus 275 lD~~tG~~~W~~~ 287 (668)
T 1kv9_A 275 IRPDTGKLAWHYQ 287 (668)
T ss_dssp ECTTTCCEEEEEE
T ss_pred EcCCCCceeeEee
Confidence 9999999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.70 E-value=0.029 Score=59.05 Aligned_cols=174 Identities=13% Similarity=0.130 Sum_probs=80.5
Q ss_pred EEecccCceEEEEEEeeCCcEEEEEEeecC-CchHHHHHHHHHHHhCCC--Cceeeeccc-----ccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQH--PNIVRWYGV-----ESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~-~~~~~~~Ei~~ll~~l~H--pNIV~L~g~-----~~~~~~~~LV~E~c~ 550 (753)
..++ |....||+....+|+.+++|..... .....+.++..++..+.. -.+.+.+.. ....+..+++||+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3466 7788999877667878999998643 222233323233333321 124444443 112456688999887
Q ss_pred CC-hh---hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhc-CCCCH---HHHHHHHHHHHHHHHHh
Q 004442 551 CS-LN---DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA-NGHPS---AQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 551 ~~-L~---~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~---~~~l~Ia~qIa~gL~yL 622 (753)
+. +. .-.+..-|..--.+|...................... ....+.. ..++. ......+..++..+.-+
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIE--PRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHH--HHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhh--HHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 62 21 0011122222223343221110000000000000000 0000111 11221 11223333333333322
Q ss_pred ----hhCCccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 623 ----HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 623 ----H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
+...++|+|+++.||+++ + .+.|.||+.+....
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~---~~~lIDfe~a~~g~ 225 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D---GPMFVDLDDARNGP 225 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S---SEEECCCTTCCEEC
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C---CCEEEECCCCCcCc
Confidence 234589999999999996 3 48899999876543
|
| >1yiq_A Quinohemoprotein alcohol dehydrogenase; electron transfer, oxidoreductase; HET: PQQ HEM; 2.20A {Pseudomonas putida} | Back alignment and structure |
|---|
Probab=95.63 E-value=0.018 Score=67.76 Aligned_cols=113 Identities=14% Similarity=0.164 Sum_probs=77.5
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccc--------cCCCCCCceeeeccCCCceeeeeccccCcee-e
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQ--------ASFNSNASEFYLDVDEDWELYFHSKRFGKMK-K 117 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 117 (753)
..++..|++.||+||.+|..+|+.+|++..+.+....+. +++-.+..+|.- ..|..||.-+...|++. +
T Consensus 69 ~~g~vyv~~~~~~v~AlD~~tG~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~g~v~v~--~~dg~l~AlDa~TG~~~W~ 146 (689)
T 1yiq_A 69 VDGVMYTTGPFSVVYALDARDGRLIWKYDPQSDRHRAGEACCDAVNRGVAVWKGKVYVG--VLDGRLEAIDAKTGQRAWS 146 (689)
T ss_dssp ETTEEEEECGGGCEEEEETTTCCEEEEECCCCCGGGGGGCTTCSCCCCCEEETTEEEEE--CTTSEEEEEETTTCCEEEE
T ss_pred ECCEEEEEcCCCeEEEEECCCCceeEEEcCCCCccccccccccCCCCccEEECCEEEEE--ccCCEEEEEECCCCCEeee
Confidence 467788899999999999999999999998776422111 111112224432 24677888888888887 4
Q ss_pred eccCHH----HHHHhCceeecCCeeeeece------eeeEEEEecccccEEeccc
Q 004442 118 LSSSAE----EYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 118 ~~~~~~----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 162 (753)
+..... ..+.-+|.+. +|.|++|.. .-.++++|++||+++-.+.
T Consensus 147 ~~~~~~~~~~~~~~~sP~v~-~g~v~vg~~~~~~~~~g~v~a~D~~tG~~~W~~~ 200 (689)
T 1yiq_A 147 VDTRADHKRSYTITGAPRVV-NGKVVIGNGGAEFGVRGYVTAYDAETGKEAWRFY 200 (689)
T ss_dssp EECCSCTTSCCBCCSCCEEE-TTEEEECCBCTTTCCBCEEEEEETTTCCEEEEEE
T ss_pred ecCcCCCCCCccccCCcEEE-CCEEEEEeCCCccCCCCEEEEEECCCCcEEEEec
Confidence 443201 1344578775 566999874 5789999999999997743
|
| >1kv9_A Type II quinohemoprotein alcohol dehydrogenase; electron transfer, oxidoreductase; HET: PQQ HEM EPE; 1.90A {Pseudomonas putida} SCOP: a.3.1.6 b.70.1.1 | Back alignment and structure |
|---|
Probab=95.46 E-value=0.024 Score=66.52 Aligned_cols=113 Identities=16% Similarity=0.146 Sum_probs=78.7
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCccccccc--------CCCCCCceeeeccCCCceeeeeccccCcee-e
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQA--------SFNSNASEFYLDVDEDWELYFHSKRFGKMK-K 117 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 117 (753)
..++..|++.+|+||.+|..+|+.+|++..+.+....... ++-.+..+|.- ..|..||.-+...|++. +
T Consensus 65 ~~g~vyv~~~~~~v~AlD~~tG~~~W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~v~--~~dg~l~alD~~tG~~~W~ 142 (668)
T 1kv9_A 65 HDGVIYTSMSWSRVIAVDAASGKELWRYDPEVAKVKARTSCCDAVNRGVALWGDKVYVG--TLDGRLIALDAKTGKAIWS 142 (668)
T ss_dssp ETTEEEEEEGGGEEEEEETTTCCEEEEECCCCCGGGGGGCTTCSCCCCCEEEBTEEEEE--CTTSEEEEEETTTCCEEEE
T ss_pred ECCEEEEECCCCeEEEEECCCChhceEECCCCCccccccccccCCccceEEECCEEEEE--cCCCEEEEEECCCCCEeee
Confidence 4577888999999999999999999999988775332211 01111224433 24678888888889887 4
Q ss_pred eccCHH---HHHHhCceeecCCeeeeece------eeeEEEEecccccEEeccc
Q 004442 118 LSSSAE---EYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 118 ~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 162 (753)
+...-. ..+.-+|.+. +|.|++|.. ...++++|++||+++-.+.
T Consensus 143 ~~~~~~~~~~~~~~~P~v~-~~~v~vg~~~~~~~~~g~v~a~D~~tG~~~W~~~ 195 (668)
T 1kv9_A 143 QQTTDPAKPYSITGAPRVV-KGKVIIGNGGAEYGVRGFVSAYDADTGKLAWRFY 195 (668)
T ss_dssp EECSCTTSSCBCCSCCEEE-TTEEEECCBCTTTCCBCEEEEEETTTCCEEEEEE
T ss_pred eccCCCCCcceecCCCEEE-CCEEEEeCCCCCcCCCCEEEEEECCCCcEEEEec
Confidence 443111 1244578775 566999875 4789999999999998753
|
| >1flg_A Protein (quinoprotein ethanol dehydrogenase); superbarrel, oxidoreductase; HET: PQQ; 2.60A {Pseudomonas aeruginosa} SCOP: b.70.1.1 | Back alignment and structure |
|---|
Probab=95.23 E-value=0.039 Score=63.65 Aligned_cols=112 Identities=21% Similarity=0.211 Sum_probs=77.4
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCccccc------ccCCCCCCceeeeccCCCceeeeeccccCcee-eecc
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY------QASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSS 120 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 120 (753)
.++..|++.++.||.+|..+|+.+|++..+.|..+.. ..++-.+..+|.-. .|..||.-+...|++. +...
T Consensus 68 ~g~vyv~~~~~~v~AlD~~tG~~~W~~~~~~~~~~~~~~~~~~~g~a~~~~~v~~~t--~dg~l~AlD~~TG~~~W~~~~ 145 (582)
T 1flg_A 68 DGVIYVTASYSRLFALDAKTGKRLWTYNHRLPDDIRPCCDVVNRGAAIYGDKVFFGT--LDASVVALNKNTGKVVWKKKF 145 (582)
T ss_dssp TTEEEEEETTTEEEEEESSSCCEEEEEECCCCTTCCCSSCSCCCCCEEETTEEEEEE--TTTEEEEEESSSCCEEEEEEC
T ss_pred CCEEEEEcCCCCEEEEECCCCcEEEEEcCCCCcccccccccCCCccEEECCEEEEEe--CCCEEEEEECCCCCEEeeecC
Confidence 4566777775669999999999999999987753220 01111122354432 4678888888899887 4443
Q ss_pred CHHH---HHHhCceeecC---C--eeeeece------eeeEEEEecccccEEecc
Q 004442 121 SAEE---YIRRMPYISKD---G--GVTLGAM------KTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 121 ~~~~---~~~~~~~~~~~---~--~~~~~~~------~~~~~~~~~~~~~~~~~~ 161 (753)
.-.+ .+..+|.+.++ | .|++|+. ...++++|++||+++-..
T Consensus 146 ~~~~~~~~~~~sP~v~~~~~~G~~~v~vg~~~~e~~~~g~v~alD~~tG~~~W~~ 200 (582)
T 1flg_A 146 ADHGAGYTMTGAPTIVKDGKTGKVLLIHGSSGDEFGVVGRLFARDPDTGEEIWMR 200 (582)
T ss_dssp SCGGGTCBCCSCCEEEECTTTCCEEEEECCBCGGGCCBCEEEEECTTTCCEEEEE
T ss_pred CCCCcCcccccCCEEeCCCcCCcEEEEEeccccccCCCCEEEEEECCCCCEEeec
Confidence 3211 24568998766 2 6889874 678999999999999874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.059 Score=56.20 Aligned_cols=31 Identities=19% Similarity=0.038 Sum_probs=24.9
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
.++|+|+.+.||+. .++. +.|+||..+....
T Consensus 174 ~l~HgDl~~~Nil~-~~~~--~~lID~e~a~~g~ 204 (301)
T 3dxq_A 174 AACHCDPLCENFLD-TGER--MWIVDWEYSGMND 204 (301)
T ss_dssp EEECSCCCGGGEEE-CSSC--EEECCCTTCEEEC
T ss_pred eeeccCCCcCCEEE-CCCC--EEEEecccccCCC
Confidence 58999999999994 4444 7899999887543
|
| >1w6s_A Methanol dehydrogenase subunit 1; anisotropic, electron transfer, oxidoreductase, calcium- binding, methanol utilization, PQQ; HET: PQQ; 1.2A {Methylobacterium extorquens} SCOP: b.70.1.1 PDB: 1h4i_A* 1h4j_A* 2d0v_A* 1lrw_A* | Back alignment and structure |
|---|
Probab=95.14 E-value=0.051 Score=62.91 Aligned_cols=113 Identities=14% Similarity=0.130 Sum_probs=77.4
Q ss_pred CCeeEEEec-CceEEEEec-cCCeeeEEecCCCCccccc--------ccCCC--CCCc----eeeeccCCCceeeeeccc
Q 004442 48 PDVALVAAL-DGTIHLVDT-KLGKIRWSFGTGRPIYSSY--------QASFN--SNAS----EFYLDVDEDWELYFHSKR 111 (753)
Q Consensus 48 ~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~----~~~~~~~~~~~~~~~~~~ 111 (753)
-++..|++. +|.||.+|. .+|+.+|++..+.+....- -.++- .+.. ||.- ..|..||-=+..
T Consensus 62 ~g~vyv~~~~~~~v~AlD~~~tG~~lW~~~~~~~~~~~~~~~~~~~~~g~av~p~~g~~~~rV~v~--t~dg~l~AlDa~ 139 (599)
T 1w6s_A 62 DGKMYIHTSFPNNTFALGLDDPGTILWQDKPKQNPAARAVACCDLVNRGLAYWPGDGKTPALILKT--QLDGNVAALNAE 139 (599)
T ss_dssp TTEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCSSCSCCCCCEEECCCSSSCCEEEEE--CTTSEEEEEETT
T ss_pred CCEEEEEeCCCCEEEEEeCCCCCcEEEEECCCCCccccccccccccccceEEEecCCcceeEEEEE--cCCCEEEEEECC
Confidence 456677788 899999999 9999999999887642210 00111 1222 5443 246788888888
Q ss_pred cCcee-eeccCH---HHHHHhCceeecCCeeeeece------eeeEEEEecccccEEecccC
Q 004442 112 FGKMK-KLSSSA---EEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 112 ~~~~~-~~~~~~---~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~ 163 (753)
.|++. +....- ...+.-+|.|. +|.|++|+. ...++++|++||+++-.++.
T Consensus 140 TG~~~W~~~~~~~~~~~~~~ssP~v~-~g~V~vg~~g~e~g~~g~v~A~D~~TG~~~W~~~~ 200 (599)
T 1w6s_A 140 TGETVWKVENSDIKVGSTLTIAPYVV-KDKVIIGSSGAELGVRGYLTAYDVKTGEQVWRAYA 200 (599)
T ss_dssp TCCEEEEEECCCGGGTCBCCSCCEEE-TTEEEECCBCGGGTCCCEEEEEETTTCCEEEEEES
T ss_pred CCCEEEeecCCCCCccceeecCCEEE-CCEEEEEecccccCCCCeEEEEECCCCcEEEEEcC
Confidence 89887 433221 11345678886 567999984 67899999999999977544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.088 Score=55.64 Aligned_cols=36 Identities=22% Similarity=0.257 Sum_probs=28.0
Q ss_pred CCccccCCCCCcEEEecCC--CCeEEEEeccCceeccC
Q 004442 625 IGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQG 660 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~~~ 660 (753)
..++|+|+.+.||+++.+. .-.+.|.||+.+.....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~ 220 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHR 220 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECT
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCC
Confidence 4799999999999997641 12478999999876543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.04 E-value=0.047 Score=60.47 Aligned_cols=69 Identities=14% Similarity=0.090 Sum_probs=43.5
Q ss_pred eEEecccCceEEEEEEeeC--------CcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCce-eeecccccCCceEEEEEc
Q 004442 478 NKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNI-VRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNI-V~L~g~~~~~~~~~LV~E 547 (753)
.+.|+.|-...||+....+ +..+++|+...... .....|.. ++..+...++ .++++.+.+ .+|+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~-~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESV-IFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHH-HHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHH-HHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 3568888889999986653 57899998854333 45556655 3343322233 466666543 28999
Q ss_pred cccC
Q 004442 548 RCTC 551 (753)
Q Consensus 548 ~c~~ 551 (753)
++++
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 8765
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=94.97 E-value=0.028 Score=54.65 Aligned_cols=48 Identities=8% Similarity=-0.018 Sum_probs=28.0
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCC
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 310 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l 310 (753)
.|+.+.+.+|++++..+. +.++ .|+.|+|++|+++|.+|..+..+..|
T Consensus 79 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 128 (192)
T 1w8a_A 79 HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128 (192)
T ss_dssp TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTC
T ss_pred cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCC
Confidence 345566666666665543 5555 56666666666666666555544443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.95 E-value=0.067 Score=56.05 Aligned_cols=31 Identities=32% Similarity=0.382 Sum_probs=25.1
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
+++|+|+.+.||+++.++ .+.|.||+.+...
T Consensus 188 ~liHgDl~~~Nil~~~~~--~~~lIDf~~a~~g 218 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDE--LSGLIDFYFACND 218 (322)
T ss_dssp EEECSCCCGGGEEEETTE--EEEECCCTTCEEE
T ss_pred ccCCCCCCccCEEEeCCc--eEEEecchhccCc
Confidence 699999999999997653 2479999987643
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=94.67 E-value=0.047 Score=56.44 Aligned_cols=110 Identities=11% Similarity=0.116 Sum_probs=69.6
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eecc-CHH
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSS-SAE 123 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~ 123 (753)
+.-++..+...||+|+.+|.. |+.+|+|..+.+.|++-. .++.+ + ++-+.++-.+|.-++..|++. ++.- .++
T Consensus 134 ~~G~~lv~~~~~~~v~~~d~~-G~~~w~~~~~~~~~~~~~-~~~g~--~-~v~~~~~~~v~~~d~~tG~~~w~~~~~~~~ 208 (276)
T 3no2_A 134 KKGNYLVPLFATSEVREIAPN-GQLLNSVKLSGTPFSSAF-LDNGD--C-LVACGDAHCFVQLNLESNRIVRRVNANDIE 208 (276)
T ss_dssp TTSCEEEEETTTTEEEEECTT-SCEEEEEECSSCCCEEEE-CTTSC--E-EEECBTTSEEEEECTTTCCEEEEEEGGGSB
T ss_pred CCCCEEEEecCCCEEEEECCC-CCEEEEEECCCCccceeE-cCCCC--E-EEEeCCCCeEEEEeCcCCcEEEEecCCCCC
Confidence 344555555679999999988 999999998755555432 22222 3 333444456888888878876 4431 111
Q ss_pred H--HHH-hCceeecCCeeeeece-----------eeeEEEEecccccEEecc
Q 004442 124 E--YIR-RMPYISKDGGVTLGAM-----------KTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 124 ~--~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 161 (753)
. +.. ....+..+|.+++++- .-.+|+||+ +|+++-.|
T Consensus 209 ~~~l~~~~~~~~~~~G~i~v~~~~g~~~~~~~~~~~~~~~~~~-~g~~~W~~ 259 (276)
T 3no2_A 209 GVQLFFVAQLFPLQNGGLYICNWQGHDREAGKGKHPQLVEIDS-EGKVVWQL 259 (276)
T ss_dssp SCCCSEEEEEEECTTSCEEEEEECTTCTTGGGSCCCSEEEECT-TSBEEEEE
T ss_pred CccccccccceEcCCCCEEEEeccCccccccccCCceEEEECC-CCCEEEEe
Confidence 1 100 1122347898999873 335999997 99999774
|
| >3hxj_A Pyrrolo-quinoline quinone; all beta protein. incomplete 8-blade beta-propeller., struct genomics, PSI-2, protein structure initiative; 2.00A {Methanococcus maripaludis} | Back alignment and structure |
|---|
Probab=94.63 E-value=0.059 Score=55.66 Aligned_cols=144 Identities=15% Similarity=0.257 Sum_probs=86.8
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcc-cccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIY-SSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEE 124 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 124 (753)
..+...+++.||.|+.+| .+|+.+|.+..+.++. +.+... + ...|+-..+ ||.-++ .|+.. .+ ..++
T Consensus 29 ~~g~l~v~t~~~~l~~~d-~~g~~~~~~~~~~~~~~~~~~~~---~-g~l~v~t~~---l~~~d~-~g~~~~~~--~~~~ 97 (330)
T 3hxj_A 29 KNGTIYLGSSNKNLYAIN-TDGSVKWFFKSGEIIECRPSIGK---D-GTIYFGSDK---VYAINP-DGTEKWRF--DTKK 97 (330)
T ss_dssp TTSCEECSSTTTTTEEEC-TTSCEEESSCGGGEEEECCEETT---T-TEECCSSCE---EEEECC-CGGGGGGS--CC--
T ss_pred cCCeEEEEcCCCEEEEEC-CCCcEEEEEecCCCcccceEEec---C-CcEEEecCc---EEEECC-CCcEEEEE--ECCC
Confidence 456777888899999999 9999999998765542 222211 1 122333222 666554 45443 22 2333
Q ss_pred HHHhCceeecCCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccccccccccce
Q 004442 125 YIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLV 204 (753)
Q Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (753)
-+...|.+. +|.|.+|+....++.+|++ |+.+..+..+... ...++ + ..+-.|
T Consensus 98 ~~~~~~~~~-~~~l~v~t~~~~l~~~d~~-g~~~~~~~~~~~~---------~~~~~--------~--------~~~g~l 150 (330)
T 3hxj_A 98 AIVSDFTIF-EDILYVTSMDGHLYAINTD-GTEKWRFKTKKAI---------YATPI--------V--------SEDGTI 150 (330)
T ss_dssp ---CCEEEE-TTEEEEECTTSEEEEECTT-SCEEEEEECSSCC---------CSCCE--------E--------CTTSCE
T ss_pred CcccCceEE-CCEEEEEecCCEEEEEcCC-CCEEEEEcCCCce---------eeeeE--------E--------cCCCEE
Confidence 445677776 8889999988899999999 9988775432110 00010 0 011234
Q ss_pred EEEEeeeeeeecCCCCceEEEEeee
Q 004442 205 YIMRTDYVLQSTSQDSGEVLWNVAY 229 (753)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (753)
.|--.+-.|..|.++ |..+|....
T Consensus 151 ~vgt~~~~l~~~d~~-g~~~~~~~~ 174 (330)
T 3hxj_A 151 YVGSNDNYLYAINPD-GTEKWRFKT 174 (330)
T ss_dssp EEECTTSEEEEECTT-SCEEEEEEC
T ss_pred EEEcCCCEEEEECCC-CCEeEEEec
Confidence 444334677888888 999998763
|
| >3hxj_A Pyrrolo-quinoline quinone; all beta protein. incomplete 8-blade beta-propeller., struct genomics, PSI-2, protein structure initiative; 2.00A {Methanococcus maripaludis} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.11 Score=53.51 Aligned_cols=104 Identities=25% Similarity=0.464 Sum_probs=71.6
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYI 126 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 126 (753)
.+...|++.+|.|+.+|.. |+.+|.+..+.++.++-.... +-.++. +..+..||.-++. |++. .+.. +.-.
T Consensus 107 ~~~l~v~t~~~~l~~~d~~-g~~~~~~~~~~~~~~~~~~~~--~g~l~v--gt~~~~l~~~d~~-g~~~~~~~~--~~~~ 178 (330)
T 3hxj_A 107 EDILYVTSMDGHLYAINTD-GTEKWRFKTKKAIYATPIVSE--DGTIYV--GSNDNYLYAINPD-GTEKWRFKT--NDAI 178 (330)
T ss_dssp TTEEEEECTTSEEEEECTT-SCEEEEEECSSCCCSCCEECT--TSCEEE--ECTTSEEEEECTT-SCEEEEEEC--SSCC
T ss_pred CCEEEEEecCCEEEEEcCC-CCEEEEEcCCCceeeeeEEcC--CCEEEE--EcCCCEEEEECCC-CCEeEEEec--CCCc
Confidence 4667888899999999998 999999998776533221111 112332 3345667776666 7664 3332 2224
Q ss_pred HhCceeecCCeeeeeceeeeEEEEecccccEEeccc
Q 004442 127 RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (753)
-.+|++..+|.|.+|. ..++.+| .+|+.+..+.
T Consensus 179 ~~~~~~d~~g~l~v~t--~~l~~~d-~~g~~~~~~~ 211 (330)
T 3hxj_A 179 TSAASIGKDGTIYFGS--DKVYAIN-PDGTEKWNFY 211 (330)
T ss_dssp CSCCEECTTCCEEEES--SSEEEEC-TTSCEEEEEC
T ss_pred eeeeEEcCCCEEEEEe--CEEEEEC-CCCcEEEEEc
Confidence 4578888899999999 8899999 8998887754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.26 E-value=0.35 Score=48.50 Aligned_cols=114 Identities=15% Similarity=0.073 Sum_probs=72.3
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHhhh-CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccc
Q 004442 599 KANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677 (753)
Q Consensus 599 ~~~~l~~~~~l~Ia~qIa~gL~yLH~-~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y 677 (753)
...++.+.++|-++.|.+.+|.-+-. ..-..+=+.|..|+|..||+ +...+ +.+. .....+
T Consensus 42 ~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~---------------~~~~~~ 103 (229)
T 2yle_A 42 YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD---------------AGEPPP 103 (229)
T ss_dssp HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C------------------------
T ss_pred cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc---------------ccccCC
Confidence 45789999999999999999877621 11123344568999999987 33332 1100 013346
Q ss_pred cccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHcccc
Q 004442 678 QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 748 (753)
Q Consensus 678 ~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~ 748 (753)
.|||... ...+.+.=|||||++||.-+--+ .| .......|+++.+||..|.+-
T Consensus 104 ~~pe~~~-~~~te~~~IysLG~tLY~ALDyg-L~----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 104 VAGKLGY-SQCMETEVIESLGIIIYKALDYG-LK----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---CCSS-SSSCHHHHHHHHHHHHHHHHTTT-CC----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred CChhhcc-ccchHHHHHHHHHHHHHHHhhcC-CC----------------cccchhhCHHHHHHHHHHHhc
Confidence 6888653 45678999999999999877642 22 223457788888888888654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.04 E-value=0.28 Score=52.29 Aligned_cols=32 Identities=25% Similarity=0.304 Sum_probs=26.8
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceecc
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~ 659 (753)
.++|+|+.+.||+++.++. +.|.||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEES--IYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGC--EEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCe--EEEEECCCCeeCC
Confidence 6999999999999976544 7899999887654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=93.60 E-value=0.036 Score=58.30 Aligned_cols=42 Identities=10% Similarity=0.037 Sum_probs=31.4
Q ss_pred cccccccccCCccccccc-cccCC-CcccceeecCccccccCCC
Q 004442 262 GDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 303 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~ 303 (753)
..|+.+.+.+|+++|.+| .+..+ .|+.||+++|+++|.||..
T Consensus 244 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred CCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 345777777888888886 46666 6888888888888888764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=93.56 E-value=0.1 Score=49.64 Aligned_cols=51 Identities=8% Similarity=-0.164 Sum_probs=33.4
Q ss_pred ccccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 261 IGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 261 ~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
...++.+.+.+|++++-.| .+.++ .|+.|+|++|++++..|..+..+..|.
T Consensus 29 ~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~ 81 (170)
T 3g39_A 29 PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLT 81 (170)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCC
Confidence 3456777777787777765 36666 677788888888766555554444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=93.52 E-value=0.1 Score=49.68 Aligned_cols=67 Identities=9% Similarity=-0.092 Sum_probs=43.5
Q ss_pred CCCcccccCCCCccccccccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 245 ~~~~~~~~~~~l~~~~~~~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
+++|.+.+..+-.-.....|+.+.+.+|++++-.+. +..+ .|+.|+|++|+|++..|..+..+..|.
T Consensus 37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 105 (170)
T 3g39_A 37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLT 105 (170)
T ss_dssp CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCC
Confidence 566666654331111223567888889999865553 5677 689999999999987666565554443
|
| >3vgz_A Uncharacterized protein YNCE; beta-propeller, protein binding; 1.70A {Escherichia coli} PDB: 3vh0_A* | Back alignment and structure |
|---|
Probab=93.31 E-value=0.8 Score=47.13 Aligned_cols=111 Identities=17% Similarity=0.139 Sum_probs=74.9
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCC--cccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRP--IYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAE 123 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 123 (753)
.-+.+.+++.||+|+++|..+++..|.+..+.. -+..+......|....|..+.++..+|+-+...|++. .+...
T Consensus 195 dg~~l~~~~~~~~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~s~dg~~l~~~~~~~~~v~~~d~~~~~~~~~~~~~-- 272 (353)
T 3vgz_A 195 EGKRLYTTNADGELITIDTADNKILSRKKLLDDGKEHFFINISLDTARQRAFITDSKAAEVLVVDTRNGNILAKVAAP-- 272 (353)
T ss_dssp TTTEEEEECTTSEEEEEETTTTEEEEEEECCCSSSCCCEEEEEEETTTTEEEEEESSSSEEEEEETTTCCEEEEEECS--
T ss_pred CCCEEEEEcCCCeEEEEECCCCeEEEEEEcCCCCCCcccceEEECCCCCEEEEEeCCCCEEEEEECCCCcEEEEEEcC--
Confidence 345678888999999999999999999887432 2111111122233334666677788888887777765 44422
Q ss_pred HHHHhCceeecCCe-eeeec-eeeeEEEEecccccEEecc
Q 004442 124 EYIRRMPYISKDGG-VTLGA-MKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 124 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 161 (753)
+ .....++.||. +++.. ...++..+|..+|+++...
T Consensus 273 ~--~~~~~~s~dg~~l~v~~~~~~~v~~~d~~~~~~~~~~ 310 (353)
T 3vgz_A 273 E--SLAVLFNPARNEAYVTHRQAGKVSVIDAKSYKVVKTF 310 (353)
T ss_dssp S--CCCEEEETTTTEEEEEETTTTEEEEEETTTTEEEEEE
T ss_pred C--CceEEECCCCCEEEEEECCCCeEEEEECCCCeEEEEE
Confidence 1 24566788886 55554 5678899999999998874
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=93.21 E-value=0.12 Score=49.43 Aligned_cols=49 Identities=12% Similarity=-0.044 Sum_probs=29.4
Q ss_pred cccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCC
Q 004442 262 GDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 310 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l 310 (753)
..++.+.+.+|+|++.+| .+.++ .|+.|+|++|+|++-.+..+..+.+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L 83 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL 83 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchh
Confidence 455666677777776665 35555 57777777777776444334433333
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=93.11 E-value=0.13 Score=49.13 Aligned_cols=67 Identities=9% Similarity=-0.061 Sum_probs=40.2
Q ss_pred CCCcccccCCCCccccccccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 245 ~~~~~~~~~~~l~~~~~~~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
+++|.+.+..+-.-.....|+.+.+.+|+|++-.+. +..+ .|+.|||++|++++..+..+..+.+|.
T Consensus 40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~ 108 (174)
T 2r9u_A 40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLT 108 (174)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCS
T ss_pred eCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCC
Confidence 566666544321111223457778888888874443 4566 688888888888875554455444433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=92.87 E-value=0.1 Score=50.69 Aligned_cols=49 Identities=6% Similarity=-0.050 Sum_probs=27.6
Q ss_pred ccccccccCCcccccccc--ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYR--LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~--l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.++.+.+.+|++++..+. +..+ .|+.|+|++|++++.+|..+..+..|.
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 81 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCC
Confidence 455566666666555542 4455 466666666666666665555444433
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=92.73 E-value=0.13 Score=54.43 Aligned_cols=49 Identities=10% Similarity=-0.078 Sum_probs=39.6
Q ss_pred ccccccccC-Cccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCH-TQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~n-N~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.|.+ |+|++-.+ .+.+| .|+.|+|++|+|+|.+|..+..+.+|.
T Consensus 32 ~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 83 (347)
T 2ifg_A 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (347)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCC
Confidence 468888886 99998775 58888 799999999999998887776666555
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.59 E-value=0.11 Score=51.67 Aligned_cols=49 Identities=10% Similarity=0.013 Sum_probs=29.5
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|++++..+. +.++ .|+.|++++|++++..|..+..+..|.
T Consensus 82 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 132 (220)
T 2v70_A 82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR 132 (220)
T ss_dssp TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence 345666666666665543 5555 566677777777766666555444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=92.52 E-value=0.059 Score=56.64 Aligned_cols=50 Identities=6% Similarity=-0.029 Sum_probs=41.0
Q ss_pred cccccccccCCccccccccccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 262 GDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
..++.+.+.+|+++|.+|.+..+ .|+.|++++|+++|.+|..+..+..|.
T Consensus 221 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 271 (313)
T 1ogq_A 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271 (313)
T ss_dssp SCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCC
T ss_pred CCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCC
Confidence 35677888899999999887777 799999999999999998776665554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=92.41 E-value=0.15 Score=55.51 Aligned_cols=33 Identities=21% Similarity=0.250 Sum_probs=26.2
Q ss_pred CccccCCCCCcEEEecCC--CCeEEEEeccCceec
Q 004442 626 GLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRL 658 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~--~~~~KLsDFGla~~~ 658 (753)
.++|+|+.+.||+++.+. .-.+.|+||..+...
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 599999999999998761 124789999988753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=92.24 E-value=0.087 Score=55.81 Aligned_cols=49 Identities=8% Similarity=-0.143 Sum_probs=28.8
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|++.|.+|. +..+ .|+.|++++|++.|.+|..+..+..|.
T Consensus 230 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~ 280 (328)
T 4fcg_A 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE 280 (328)
T ss_dssp TCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCC
T ss_pred CCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCC
Confidence 345555666666666653 4444 566666666666666666555544444
|
| >3dsm_A Uncharacterized protein bacuni_02894; seven_blated beta propeller, structural genomics, PSI-2, Pro structure initiative; 1.90A {Bacteroides uniformis} | Back alignment and structure |
|---|
Probab=92.13 E-value=1.3 Score=46.30 Aligned_cols=164 Identities=11% Similarity=0.065 Sum_probs=94.5
Q ss_pred CeeEEEe--cCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCC---------CceeeeeccccCcee-
Q 004442 49 DVALVAA--LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDE---------DWELYFHSKRFGKMK- 116 (753)
Q Consensus 49 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~- 116 (753)
+.+.|++ .+++|+.+|..+++..+.+..|.-...-... .|-.+|+.+..+ .-.||+=+...+++.
T Consensus 141 ~~lyv~~~~~~~~v~viD~~t~~~~~~i~~g~~p~~i~~~---~dG~l~v~~~~~~~~~~~~~~~~~v~~id~~t~~v~~ 217 (328)
T 3dsm_A 141 KYVYVNCWSYQNRILKIDTETDKVVDELTIGIQPTSLVMD---KYNKMWTITDGGYEGSPYGYEAPSLYRIDAETFTVEK 217 (328)
T ss_dssp TEEEEEECTTCCEEEEEETTTTEEEEEEECSSCBCCCEEC---TTSEEEEEBCCBCTTCSSCBCCCEEEEEETTTTEEEE
T ss_pred CEEEEEcCCCCCEEEEEECCCCeEEEEEEcCCCccceEEc---CCCCEEEEECCCccCCccccCCceEEEEECCCCeEEE
Confidence 4556666 5899999999999999999876532222221 123355555433 257888777777776
Q ss_pred eeccCHHHHHHhCceeec-CCeeeeeceeeeEEEEecccccEEecccCCCCCCCCCCCcccCcceeccCCcchhhccccc
Q 004442 117 KLSSSAEEYIRRMPYISK-DGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVG 195 (753)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (753)
.+...... --..-.++. ++.++.... +++.+|.+||+++....... +......|
T Consensus 218 ~~~~~~g~-~p~~la~~~d~~~lyv~~~--~v~~~d~~t~~~~~~~~~~~-------~~~~p~gi--------------- 272 (328)
T 3dsm_A 218 QFKFKLGD-WPSEVQLNGTRDTLYWINN--DIWRMPVEADRVPVRPFLEF-------RDTKYYGL--------------- 272 (328)
T ss_dssp EEECCTTC-CCEEEEECTTSCEEEEESS--SEEEEETTCSSCCSSCSBCC-------CSSCEEEE---------------
T ss_pred EEecCCCC-CceeEEEecCCCEEEEEcc--EEEEEECCCCceeeeeeecC-------CCCceEEE---------------
Confidence 44322111 011224664 445666554 78889999988753321110 00000111
Q ss_pred cccccccceEEEE-----eeeeeeecCCCCceEEEEeeeccc--ceeeeeccc
Q 004442 196 NLKRIRQLVYIMR-----TDYVLQSTSQDSGEVLWNVAYADF--KAEFRCQEV 241 (753)
Q Consensus 196 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 241 (753)
..+...-.|++.- .+-.+.-|.++ |+++|.+.+-.. .-.|-|||.
T Consensus 273 ~vdp~~g~lyva~~~~y~~~~~V~v~d~~-g~~~~~i~~G~~P~~~~~~~~~~ 324 (328)
T 3dsm_A 273 TVNPNNGEVYVADAIDYQQQGIVYRYSPQ-GKLIDEFYVGIIPGAFCWKLEHH 324 (328)
T ss_dssp EECTTTCCEEEEECTTSSSEEEEEEECTT-CCEEEEEEEEESEEEEEEECCCC
T ss_pred EEcCCCCeEEEEcccccccCCEEEEECCC-CCEEEEEEeccCcceEEEecccc
Confidence 1111233466662 34467788888 999999988764 345678876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=91.94 E-value=0.14 Score=54.08 Aligned_cols=43 Identities=2% Similarity=-0.089 Sum_probs=35.4
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCC
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGS 305 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~ 305 (753)
.|+.+.|.+|+|+|..| .+.++ .|+.|||++|+|++-.|..+.
T Consensus 57 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 101 (347)
T 2ifg_A 57 ELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQ 101 (347)
T ss_dssp CCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTC
T ss_pred CCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcc
Confidence 56888999999999887 56888 799999999999976554443
|
| >1jmx_B Amine dehydrogenase; oxidoreductase; HET: TRQ HEC; 1.90A {Pseudomonas putida} SCOP: b.69.2.2 PDB: 1jmz_B* | Back alignment and structure |
|---|
Probab=91.76 E-value=0.3 Score=50.31 Aligned_cols=110 Identities=15% Similarity=0.066 Sum_probs=68.8
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecCCC---CcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccC
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGR---PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSS 121 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 121 (753)
+...+.+.+..||+|+++|..+++..+.+..+. |. + .+ ...|....|+-...+..||+-+...|++. .+...
T Consensus 9 ~~~~~~v~~~~~~~v~~~d~~~~~~~~~~~~~~~~~~~-~--~~-~s~dg~~~~v~~~~~~~i~~~d~~t~~~~~~~~~~ 84 (349)
T 1jmx_B 9 AGHEYMIVTNYPNNLHVVDVASDTVYKSCVMPDKFGPG-T--AM-MAPDNRTAYVLNNHYGDIYGIDLDTCKNTFHANLS 84 (349)
T ss_dssp TTCEEEEEEETTTEEEEEETTTTEEEEEEECSSCCSSC-E--EE-ECTTSSEEEEEETTTTEEEEEETTTTEEEEEEESC
T ss_pred CCCEEEEEeCCCCeEEEEECCCCcEEEEEecCCCCCCc-e--eE-ECCCCCEEEEEeCCCCcEEEEeCCCCcEEEEEEcc
Confidence 344556677789999999999999999998665 33 1 11 11222334555566777887776666655 33321
Q ss_pred HH----HHHHhCceeecCC-eeeeecee------------eeEEEEecccccEEe
Q 004442 122 AE----EYIRRMPYISKDG-GVTLGAMK------------TSVFLVDVKSGRVVD 159 (753)
Q Consensus 122 ~~----~~~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~~~~~~~ 159 (753)
-. ...-....++.|| .+..+... .+++.+|..+|++..
T Consensus 85 ~~~~~~~~~~~~~~~spdg~~l~~~~~~~~~~~~~~~~~~~~i~~~d~~~~~~~~ 139 (349)
T 1jmx_B 85 SVPGEVGRSMYSFAISPDGKEVYATVNPTQRLNDHYVVKPPRLEVFSTADGLEAK 139 (349)
T ss_dssp CSTTEEEECSSCEEECTTSSEEEEEEEEEEECSSCEEECCCEEEEEEGGGGGGBC
T ss_pred cccccccccccceEECCCCCEEEEEcccccccccccccCCCeEEEEECCCccccc
Confidence 00 0001234678888 46667654 788899999876544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=91.40 E-value=0.12 Score=59.30 Aligned_cols=48 Identities=17% Similarity=0.088 Sum_probs=30.6
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCcccccc-CCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWI-SLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~I-P~~l~s~n~l~ 311 (753)
.|+.+.+.+|+|+| ||.+.++ .|+.|||++|+++|.+ |..+..+..|.
T Consensus 487 ~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~ 536 (567)
T 1dce_A 487 CLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536 (567)
T ss_dssp TCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred CCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence 34666666777776 6666666 5777777777777766 66665555444
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=91.37 E-value=0.19 Score=57.26 Aligned_cols=49 Identities=14% Similarity=-0.002 Sum_probs=33.8
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.++.+.+.+|++++.+| .+.++ .|+.|+|++|++++-.|..+....+|.
T Consensus 495 ~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~ 545 (635)
T 4g8a_A 495 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 545 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCC
T ss_pred ccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCC
Confidence 45667777788887776 46666 688888888888877776665544444
|
| >1pby_B Quinohemoprotein amine dehydrogenase 40 kDa subunit; oxidoreductase; HET: TRW HEM; 1.70A {Paracoccus denitrificans} SCOP: b.69.2.2 PDB: 1jju_B* | Back alignment and structure |
|---|
Probab=90.93 E-value=1.4 Score=44.69 Aligned_cols=109 Identities=17% Similarity=0.134 Sum_probs=72.7
Q ss_pred CeeEEEecCceEEEEeccCCeeeEEecCCC----CcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHH
Q 004442 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGR----PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAE 123 (753)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 123 (753)
++++++..||+|+++|..+++.++.+..+. |..-. ...|....|..+.++..|++-+...|++. .+.....
T Consensus 2 ~~~v~~~~~~~v~~~d~~~~~~~~~~~~~~~~~~~~~~~----~s~dg~~l~v~~~~~~~v~~~d~~~~~~~~~~~~~~~ 77 (337)
T 1pby_B 2 DYILAPARPDKLVVIDTEKMAVDKVITIADAGPTPMVPM----VAPGGRIAYATVNKSESLVKIDLVTGETLGRIDLSTP 77 (337)
T ss_dssp EEEEEEETTTEEEEEETTTTEEEEEEECTTCTTCCCCEE----ECTTSSEEEEEETTTTEEEEEETTTCCEEEEEECCBT
T ss_pred cEEEEcCCCCeEEEEECCCCcEEEEEEcCCCCCCccceE----EcCCCCEEEEEeCCCCeEEEEECCCCCeEeeEEcCCc
Confidence 456778899999999999999999997654 43211 22233334556667778888777777765 4443210
Q ss_pred H---HHHhCceeecCC-eeeeec------------eeeeEEEEecccccEEecc
Q 004442 124 E---YIRRMPYISKDG-GVTLGA------------MKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 124 ~---~~~~~~~~~~~~-~~~~~~------------~~~~~~~~~~~~~~~~~~~ 161 (753)
. ---....++.|| .+..+. ...++..+|.++|++++..
T Consensus 78 ~~~~~~~~~~~~s~dg~~l~~~~~~~~~~~~~~~~~~~~i~v~d~~~~~~~~~~ 131 (337)
T 1pby_B 78 EERVKSLFGAALSPDGKTLAIYESPVRLELTHFEVQPTRVALYDAETLSRRKAF 131 (337)
T ss_dssp TEEEECTTCEEECTTSSEEEEEEEEEEECSSCEEECCCEEEEEETTTTEEEEEE
T ss_pred ccccccccceEECCCCCEEEEEecccccccccccccCceEEEEECCCCcEEEEE
Confidence 0 001244678888 566765 3478899999999998774
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.91 E-value=0.36 Score=47.76 Aligned_cols=41 Identities=7% Similarity=-0.051 Sum_probs=19.4
Q ss_pred cccccccCCccccccc-cccCC-CcccceeecCccccccCCCC
Q 004442 264 VESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPG 304 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l 304 (753)
|+.+.+.+|++++-.+ .+.++ .|+.|+|++|++++..|..+
T Consensus 59 L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 101 (220)
T 2v70_A 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMF 101 (220)
T ss_dssp CCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGG
T ss_pred CCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHh
Confidence 3444445555554443 34444 35555555555555444333
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.77 E-value=0.35 Score=53.97 Aligned_cols=69 Identities=10% Similarity=-0.019 Sum_probs=40.3
Q ss_pred eEEecccCceEEEEEEeeC-CcEEEEEEeecCCch--HHHHHHHHHHHhCCCCce-eeecccccCCceEEEEEccccC
Q 004442 478 NKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNI-VRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNI-V~L~g~~~~~~~~~LV~E~c~~ 551 (753)
.+.|+.|-...+|+....+ +..+++|+....... ...+|.. ++..+...++ .++++++. . .+||||+++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~-vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKK-ISCILYNKNIAKKIYVFFT-N---GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHH-HHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHH-HHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence 3568888889999876654 478889887432211 1234554 4454443444 46777663 2 259998875
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=90.63 E-value=0.26 Score=48.81 Aligned_cols=49 Identities=14% Similarity=-0.004 Sum_probs=28.5
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|++++-.+. +.++ .|+.|+|++|++++..|..+..+..|.
T Consensus 81 ~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 131 (220)
T 2v9t_B 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131 (220)
T ss_dssp SCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCC
Confidence 346666667776632222 4455 577777777777776666555444443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.33 E-value=0.32 Score=47.21 Aligned_cols=48 Identities=6% Similarity=-0.039 Sum_probs=27.5
Q ss_pred cccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 264 VESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
|+.+.+.+|++++-.+ .+.++ .|+.|+|++|++++..|..+..+..|.
T Consensus 56 L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 105 (193)
T 2wfh_A 56 LTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLR 105 (193)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCC
T ss_pred CCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCC
Confidence 4555666666665443 35555 566666666666666655554444433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=90.14 E-value=0.38 Score=48.43 Aligned_cols=42 Identities=7% Similarity=-0.080 Sum_probs=19.4
Q ss_pred cccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCC
Q 004442 264 VESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGS 305 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~ 305 (753)
|+.+.+.+|++++-.+. +..+ .|+.|+|++|++++..|..+.
T Consensus 109 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 152 (251)
T 3m19_A 109 LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152 (251)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcC
Confidence 34444555555533322 3333 455555555555544443333
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=90.07 E-value=0.43 Score=45.10 Aligned_cols=41 Identities=7% Similarity=-0.130 Sum_probs=19.9
Q ss_pred cccccccCCcccccccc-ccCC-CcccceeecCccccccCCCC
Q 004442 264 VESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPG 304 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l 304 (753)
|+.+.+.+|++++-.+. +..+ .|+.|++++|++++..|..+
T Consensus 54 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 96 (177)
T 2o6r_A 54 LTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVF 96 (177)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred ccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHh
Confidence 34555555555543322 3444 45555555555555444333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=90.03 E-value=0.38 Score=47.92 Aligned_cols=48 Identities=13% Similarity=-0.011 Sum_probs=26.9
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|+|++-.+. +..+ .|+.|++++|+++ .||..+..+..|.
T Consensus 89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 138 (229)
T 3e6j_A 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT 138 (229)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCS
T ss_pred CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCC
Confidence 345566666666654432 3445 5666666666666 5665554444433
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.84 E-value=0.12 Score=36.97 Aligned_cols=29 Identities=17% Similarity=-0.144 Sum_probs=15.3
Q ss_pred ccccceehhhHHHHHHHHHHHHhhheeee
Q 004442 361 VEGFRSYIQSFIVLFIALCPIIGFLFYHS 389 (753)
Q Consensus 361 ~~~~~i~Iv~~~~~vlvll~~i~~~~~~~ 389 (753)
+.+.++.|++++++.+++++.+++++|||
T Consensus 9 s~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 9 TGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 44455555555555555555555555544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.62 E-value=0.44 Score=51.05 Aligned_cols=30 Identities=23% Similarity=0.275 Sum_probs=24.4
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
.++|+|+.+.||+++.++ +.|+||..+...
T Consensus 213 ~l~HgDl~~~Nil~~~~~---~~lID~e~a~~g 242 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC---LRLIDFEYSGFN 242 (369)
T ss_dssp EEECSCCCGGGEEECC-C---EEECCCTTCEEE
T ss_pred EEEeCCCCcccEEecCCc---EEEEEecCCCCC
Confidence 699999999999996443 789999887643
|
| >3dsm_A Uncharacterized protein bacuni_02894; seven_blated beta propeller, structural genomics, PSI-2, Pro structure initiative; 1.90A {Bacteroides uniformis} | Back alignment and structure |
|---|
Probab=89.59 E-value=0.61 Score=48.87 Aligned_cols=108 Identities=12% Similarity=0.018 Sum_probs=64.7
Q ss_pred CeeEEEe-cCceEEEEeccCCeeeEEecCCCCc----ccccccCCCCCCceeeeccC-CCceeeeeccccCcee-eeccC
Q 004442 49 DVALVAA-LDGTIHLVDTKLGKIRWSFGTGRPI----YSSYQASFNSNASEFYLDVD-EDWELYFHSKRFGKMK-KLSSS 121 (753)
Q Consensus 49 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~ 121 (753)
+.+.|++ .||+|+.+|..+++..|.+..|... .....+- .+..+ |..+. .+-.+++-+...+++. ++...
T Consensus 95 g~lyv~~~~~~~v~~iD~~t~~~~~~i~~g~~~~~~~~p~~i~~--~~~~l-yv~~~~~~~~v~viD~~t~~~~~~i~~g 171 (328)
T 3dsm_A 95 EKAYVTQIWDYRIFIINPKTYEITGYIECPDMDMESGSTEQMVQ--YGKYV-YVNCWSYQNRILKIDTETDKVVDELTIG 171 (328)
T ss_dssp TEEEEEEBSCSEEEEEETTTTEEEEEEECTTCCTTTCBCCCEEE--ETTEE-EEEECTTCCEEEEEETTTTEEEEEEECS
T ss_pred CeEEEEECCCCeEEEEECCCCeEEEEEEcCCccccCCCcceEEE--ECCEE-EEEcCCCCCEEEEEECCCCeEEEEEEcC
Confidence 3455665 6899999999999999998877611 0011111 11122 23222 2445555555555554 33211
Q ss_pred HHHHHHhCceeecCCeeeeecee-----------eeEEEEecccccEEeccc
Q 004442 122 AEEYIRRMPYISKDGGVTLGAMK-----------TSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 162 (753)
. --..=.++.||.+.++... .+++.+|++||+++....
T Consensus 172 --~-~p~~i~~~~dG~l~v~~~~~~~~~~~~~~~~~v~~id~~t~~v~~~~~ 220 (328)
T 3dsm_A 172 --I-QPTSLVMDKYNKMWTITDGGYEGSPYGYEAPSLYRIDAETFTVEKQFK 220 (328)
T ss_dssp --S-CBCCCEECTTSEEEEEBCCBCTTCSSCBCCCEEEEEETTTTEEEEEEE
T ss_pred --C-CccceEEcCCCCEEEEECCCccCCccccCCceEEEEECCCCeEEEEEe
Confidence 0 0012246778999988875 489999999999987743
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.14 E-value=0.18 Score=37.28 Aligned_cols=6 Identities=33% Similarity=0.334 Sum_probs=2.2
Q ss_pred hheeee
Q 004442 384 FLFYHS 389 (753)
Q Consensus 384 ~~~~~~ 389 (753)
++++|+
T Consensus 32 ~~~~RR 37 (44)
T 2ks1_B 32 GLFMRR 37 (44)
T ss_dssp HHHHHT
T ss_pred HHHhhh
Confidence 333333
|
| >3vgz_A Uncharacterized protein YNCE; beta-propeller, protein binding; 1.70A {Escherichia coli} PDB: 3vh0_A* | Back alignment and structure |
|---|
Probab=88.90 E-value=0.94 Score=46.60 Aligned_cols=108 Identities=6% Similarity=0.135 Sum_probs=67.7
Q ss_pred EEEecCceEEEEeccCCeeeEEecCCCCccccccc-------CCCCCCc-eeeeccCCCceeeeeccccCcee-eeccCH
Q 004442 52 LVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQA-------SFNSNAS-EFYLDVDEDWELYFHSKRFGKMK-KLSSSA 122 (753)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 122 (753)
.....||+|+++|..+|+..|.+..+......+.. ....|.. +|.-+..++..+|+-+...+++. .+...
T Consensus 105 v~~~~~~~v~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~dg~~l~~~~~~~~~~i~~~d~~~~~~~~~~~~~- 183 (353)
T 3vgz_A 105 FGNTVNSAVTAIDAKTGEVKGRLVLDDRKRTEEVRPLQPRELVADDATNTVYISGIGKESVIWVVDGGNIKLKTAIQNT- 183 (353)
T ss_dssp EEETTTTEEEEEETTTCCEEEEEESCCCCCCSSCCCCEEEEEEEETTTTEEEEEEESSSCEEEEEETTTTEEEEEECCC-
T ss_pred EEecCCCEEEEEeCCCCeeEEEEecCCCccccccCCCCCceEEECCCCCEEEEEecCCCceEEEEcCCCCceEEEecCC-
Confidence 33345799999999999999999876532111111 1111222 44333356777888777777665 33311
Q ss_pred HHHHHhCceeecCCe-eeeeceeeeEEEEecccccEEecc
Q 004442 123 EEYIRRMPYISKDGG-VTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 123 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
... -....++.||. ++++.....++.+|..+|+++...
T Consensus 184 ~~~-~~~~~~s~dg~~l~~~~~~~~i~~~d~~~~~~~~~~ 222 (353)
T 3vgz_A 184 GKM-STGLALDSEGKRLYTTNADGELITIDTADNKILSRK 222 (353)
T ss_dssp CTT-CCCCEEETTTTEEEEECTTSEEEEEETTTTEEEEEE
T ss_pred CCc-cceEEECCCCCEEEEEcCCCeEEEEECCCCeEEEEE
Confidence 111 12345777775 788888888999999999999874
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.67 E-value=0.14 Score=37.75 Aligned_cols=6 Identities=0% Similarity=0.218 Sum_probs=2.2
Q ss_pred hheeee
Q 004442 384 FLFYHS 389 (753)
Q Consensus 384 ~~~~~~ 389 (753)
++++|+
T Consensus 31 ~~~~RR 36 (44)
T 2l2t_A 31 AVYVRR 36 (44)
T ss_dssp HHHHHT
T ss_pred HHHhhh
Confidence 333333
|
| >4gqb_B Methylosome protein 50; TIM barrel, beta-propeller, methyltransferase, methylation, transferase-protein binding complex; HET: 0XU; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.66 E-value=0.57 Score=49.61 Aligned_cols=113 Identities=15% Similarity=0.065 Sum_probs=62.9
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecCCCC---cccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccC
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGRP---IYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSS 121 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 121 (753)
..+.+++.+..||+|.++|..+++..-.+....+ +.+..-.+.+.. +...+.+|..+++-+-+.|+.. .+.--
T Consensus 180 ~~~~~l~s~s~D~~v~iwd~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~l~sg~~dg~v~~wd~~~~~~~~~~~~h 256 (344)
T 4gqb_B 180 HKDSVFLSCSEDNRILLWDTRCPKPASQIGCSAPGYLPTSLAWHPQQSE---VFVFGDENGTVSLVDTKSTSCVLSSAVH 256 (344)
T ss_dssp SCTTEEEEEETTSCEEEEETTSSSCEEECC----CCCEEEEEECSSCTT---EEEEEETTSEEEEEESCC--CCEEEECC
T ss_pred CCCCceeeeccccccccccccccceeeeeecceeeccceeeeecCCCCc---ceEEeccCCcEEEEECCCCcEEEEEcCC
Confidence 4456777889999999999999888777643322 222221122222 2344556666655444444322 22100
Q ss_pred HHHHHHhCceeecCCe--eeeeceeeeEEEEecccccEEecccC
Q 004442 122 AEEYIRRMPYISKDGG--VTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 122 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
- .-| ..=.++.||. |..|+..-++..-|..+|++++...|
T Consensus 257 ~-~~v-~~v~fsp~g~~~lasgs~D~~i~vwd~~~~~~~~~~~H 298 (344)
T 4gqb_B 257 S-QCV-TGLVFSPHSVPFLASLSEDCSLAVLDSSLSELFRSQAH 298 (344)
T ss_dssp S-SCE-EEEEECSSSSCCEEEEETTSCEEEECTTCCEEEEECCC
T ss_pred C-CCE-EEEEEccCCCeEEEEEeCCCeEEEEECCCCcEEEEcCC
Confidence 0 000 0012455663 56788888888899999999877655
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=88.51 E-value=0.28 Score=54.99 Aligned_cols=28 Identities=7% Similarity=-0.191 Sum_probs=22.3
Q ss_pred HHHHHHHHHHHhCCCCceeeecccccCCc
Q 004442 512 VALKEIQNLIASDQHPNIVRWYGVESDQD 540 (753)
Q Consensus 512 ~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~ 540 (753)
++..|+ +++++++|+|||+++|||....
T Consensus 325 eF~~Ev-e~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 325 TERLEC-ERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp CHHHHH-HHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHH-HHHhcccccchhhHHHHhcChH
Confidence 444455 4889999999999999998754
|
| >3ow8_A WD repeat-containing protein 61; structural genomics consortium, SGC, transcriptio; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.97 E-value=2.3 Score=44.06 Aligned_cols=107 Identities=21% Similarity=0.243 Sum_probs=60.0
Q ss_pred CeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHHH
Q 004442 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYIR 127 (753)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 127 (753)
.+++.+..||+|.++|..+|+....+..+.--...-.-.++. -+.+.+..|..+++-+-..++.. .+. .-.+.+
T Consensus 93 ~~l~s~s~D~~i~lWd~~~~~~~~~~~~~~~~~~~~~~spdg---~~l~~g~~dg~v~i~~~~~~~~~~~~~-~~~~~v- 167 (321)
T 3ow8_A 93 PIAASSSLDAHIRLWDLENGKQIKSIDAGPVDAWTLAFSPDS---QYLATGTHVGKVNIFGVESGKKEYSLD-TRGKFI- 167 (321)
T ss_dssp SEEEEEETTSEEEEEETTTTEEEEEEECCTTCCCCEEECTTS---SEEEEECTTSEEEEEETTTCSEEEEEE-CSSSCE-
T ss_pred CEEEEEeCCCcEEEEECCCCCEEEEEeCCCccEEEEEECCCC---CEEEEEcCCCcEEEEEcCCCceeEEec-CCCceE-
Confidence 466778899999999999999999887654211111111111 12333444444444333333322 111 000000
Q ss_pred hCceeecCC-eeeeeceeeeEEEEecccccEEec
Q 004442 128 RMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 128 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 160 (753)
..-.++.|| .+..|+...++...|.++|+.++.
T Consensus 168 ~~~~~spdg~~lasg~~dg~i~iwd~~~~~~~~~ 201 (321)
T 3ow8_A 168 LSIAYSPDGKYLASGAIDGIINIFDIATGKLLHT 201 (321)
T ss_dssp EEEEECTTSSEEEEEETTSCEEEEETTTTEEEEE
T ss_pred EEEEECCCCCEEEEEcCCCeEEEEECCCCcEEEE
Confidence 011234455 366788888899999999999887
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.95 E-value=0.85 Score=44.14 Aligned_cols=54 Identities=19% Similarity=0.048 Sum_probs=42.4
Q ss_pred ccccccccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 257 GMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 257 ~~~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
+..+...++.+.+.+|+|+ .|| .+.++ .|+.|++++|++++..|..+..+..|.
T Consensus 26 p~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~ 81 (193)
T 2wfh_A 26 PKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLL 81 (193)
T ss_dssp CSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCC
Confidence 3334457888999999998 675 57777 799999999999998887777666655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=87.62 E-value=0.65 Score=43.85 Aligned_cols=52 Identities=4% Similarity=-0.110 Sum_probs=34.8
Q ss_pred cccccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 260 LIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 260 ~~~~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
....++.+.+.+|++++-.+. +..+ .|+.|++++|++++..+..+.....|.
T Consensus 26 ~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 79 (177)
T 2o6r_A 26 IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79 (177)
T ss_dssp CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccC
Confidence 334667778888888865543 4666 688888888888876665555444443
|
| >1l0q_A Surface layer protein; SLP, S-layer, 7-bladed beta-propeller superfamily, protein binding; HET: YCM; 2.40A {Methanosarcina mazei} SCOP: b.1.3.1 b.69.2.3 | Back alignment and structure |
|---|
Probab=87.01 E-value=2.9 Score=43.78 Aligned_cols=107 Identities=15% Similarity=0.184 Sum_probs=72.1
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHHHh
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYIRR 128 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 128 (753)
+++.+..||+|+++|..+++..+.+..+...++.- ...|....|+.+.+|..+|+-+...|++. .+.. ..-+ .
T Consensus 88 l~~~~~~~~~v~v~d~~~~~~~~~~~~~~~~~~~~---~s~dg~~l~~~~~~~~~v~~~d~~~~~~~~~~~~--~~~~-~ 161 (391)
T 1l0q_A 88 VYVTNMASSTLSVIDTTSNTVAGTVKTGKSPLGLA---LSPDGKKLYVTNNGDKTVSVINTVTKAVINTVSV--GRSP-K 161 (391)
T ss_dssp EEEEETTTTEEEEEETTTTEEEEEEECSSSEEEEE---ECTTSSEEEEEETTTTEEEEEETTTTEEEEEEEC--CSSE-E
T ss_pred EEEEECCCCEEEEEECCCCeEEEEEeCCCCcceEE---ECCCCCEEEEEeCCCCEEEEEECCCCcEEEEEec--CCCc-c
Confidence 33444467999999999999999998776553321 22333444567788888988887777765 2221 1111 3
Q ss_pred CceeecCCe-e-eeeceeeeEEEEecccccEEeccc
Q 004442 129 MPYISKDGG-V-TLGAMKTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 129 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 162 (753)
...++.||. + ..++...++...|.++|+.+....
T Consensus 162 ~~~~~~dg~~l~~~~~~~~~v~~~d~~~~~~~~~~~ 197 (391)
T 1l0q_A 162 GIAVTPDGTKVYVANFDSMSISVIDTVTNSVIDTVK 197 (391)
T ss_dssp EEEECTTSSEEEEEETTTTEEEEEETTTTEEEEEEE
T ss_pred eEEECCCCCEEEEEeCCCCEEEEEECCCCeEEEEEe
Confidence 445777884 4 456777789999999999887743
|
| >3gre_A Serine/threonine-protein kinase VPS15; seven-bladed propeller, WD repeat, scaffold protein, ATP- binding, endosome, golgi apparatus; 1.80A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=86.83 E-value=2.3 Score=45.50 Aligned_cols=115 Identities=11% Similarity=0.013 Sum_probs=73.0
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecC---CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccC
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGT---GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSS 121 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 121 (753)
+..+..++++.||+|.++|..+++..+.|.. ..++.+.--.+ + .-+.+.+..|..+++-+-+.++.. .+...
T Consensus 180 ~~~~~l~~~~~d~~i~iwd~~~~~~~~~~~~~~h~~~v~~~~~s~-~---~~~l~s~~~dg~i~iwd~~~~~~~~~~~~~ 255 (437)
T 3gre_A 180 EEKSLLVALTNLSRVIIFDIRTLERLQIIENSPRHGAVSSICIDE-E---CCVLILGTTRGIIDIWDIRFNVLIRSWSFG 255 (437)
T ss_dssp SSCEEEEEEETTSEEEEEETTTCCEEEEEECCGGGCCEEEEEECT-T---SCEEEEEETTSCEEEEETTTTEEEEEEBCT
T ss_pred CCCCEEEEEeCCCeEEEEeCCCCeeeEEEccCCCCCceEEEEECC-C---CCEEEEEcCCCeEEEEEcCCccEEEEEecC
Confidence 3466888999999999999999999999975 34553322211 1 123445556666655554444433 22110
Q ss_pred HH---HHHHhCceeecCC-eeeeeceeeeEEEEecccccEEec-ccCC
Q 004442 122 AE---EYIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDN-YVLD 164 (753)
Q Consensus 122 ~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 164 (753)
-. .-++..|.++.|| .+..|+...++...|.++|+.+.. ..++
T Consensus 256 ~~~~v~~~~~~~~~s~~~~~l~s~~~dg~i~iwd~~~~~~~~~~~~~~ 303 (437)
T 3gre_A 256 DHAPITHVEVCQFYGKNSVIVVGGSSKTFLTIWNFVKGHCQYAFINSD 303 (437)
T ss_dssp TCEEEEEEEECTTTCTTEEEEEEESTTEEEEEEETTTTEEEEEEESSS
T ss_pred CCCceEEEEeccccCCCccEEEEEcCCCcEEEEEcCCCcEEEEEEcCC
Confidence 00 0112345666777 677888888999999999999988 4443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=86.70 E-value=0.85 Score=45.01 Aligned_cols=53 Identities=8% Similarity=-0.088 Sum_probs=38.6
Q ss_pred ccccccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 259 DLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 259 ~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.+...++.+.+.+|++++-.+ .+..+ .|+.|+|++|++++..|..+..+.+|.
T Consensus 29 ~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~ 83 (220)
T 2v9t_B 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLN 83 (220)
T ss_dssp SCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCC
T ss_pred ccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCC
Confidence 344567778888888886554 56666 688888888888888787776665554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=86.48 E-value=0.93 Score=46.12 Aligned_cols=38 Identities=5% Similarity=-0.136 Sum_probs=16.5
Q ss_pred ccccccCCcccccccc-ccCC-CcccceeecCccccccCC
Q 004442 265 ESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISL 302 (753)
Q Consensus 265 ~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~ 302 (753)
+.+.+.+|++++..+. +..+ .|+.|++++|+++|..|.
T Consensus 160 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 199 (272)
T 3rfs_A 160 TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDG 199 (272)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHH
Confidence 4444444444433322 2333 344445555555444443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=86.48 E-value=0.24 Score=45.42 Aligned_cols=45 Identities=9% Similarity=0.023 Sum_probs=24.9
Q ss_pred cccccccCCccccccccc-cCC-CcccceeecCccccc-cCCCCCCCC
Q 004442 264 VESHLPCHTQMTASVYRL-RDN-SLPEFLSVIGKVAGW-ISLPGSSQN 308 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~l-~~l-~L~~LnlsnN~fsG~-IP~~l~s~n 308 (753)
++.+.+.+|++++.+|.. ..+ .|+.|++++|++++. .|..+..+.
T Consensus 66 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~ 113 (149)
T 2je0_A 66 LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLE 113 (149)
T ss_dssp CCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCT
T ss_pred CCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCC
Confidence 455666666666666543 224 566666666666662 334444333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=86.02 E-value=1.1 Score=43.51 Aligned_cols=38 Identities=5% Similarity=-0.047 Sum_probs=18.5
Q ss_pred cccccccCCcccccccc-ccCC-CcccceeecCccccccC
Q 004442 264 VESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 301 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP 301 (753)
|+.+.+.+|++++-.+. +..+ .|+.|++++|++++..+
T Consensus 102 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 141 (208)
T 2o6s_A 102 LKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD 141 (208)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence 34445555555543332 3444 45555555555554444
|
| >1l0q_A Surface layer protein; SLP, S-layer, 7-bladed beta-propeller superfamily, protein binding; HET: YCM; 2.40A {Methanosarcina mazei} SCOP: b.1.3.1 b.69.2.3 | Back alignment and structure |
|---|
Probab=85.64 E-value=1.5 Score=46.13 Aligned_cols=106 Identities=10% Similarity=0.104 Sum_probs=71.1
Q ss_pred EEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhCce
Q 004442 52 LVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPY 131 (753)
Q Consensus 52 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (753)
+.+..||+|+++|..+|+..+.+..+.++.+.-. ..|....|..+.+|..+++-+...|++...- ....- -....
T Consensus 48 ~~~~~d~~i~v~d~~~~~~~~~~~~~~~v~~~~~---spdg~~l~~~~~~~~~v~v~d~~~~~~~~~~-~~~~~-~~~~~ 122 (391)
T 1l0q_A 48 VANAHSNDVSIIDTATNNVIATVPAGSSPQGVAV---SPDGKQVYVTNMASSTLSVIDTTSNTVAGTV-KTGKS-PLGLA 122 (391)
T ss_dssp EEEGGGTEEEEEETTTTEEEEEEECSSSEEEEEE---CTTSSEEEEEETTTTEEEEEETTTTEEEEEE-ECSSS-EEEEE
T ss_pred EECCCCCeEEEEECCCCeEEEEEECCCCccceEE---CCCCCEEEEEECCCCEEEEEECCCCeEEEEE-eCCCC-cceEE
Confidence 4444899999999999999999988876633222 1222333455667778888777777665221 11111 13345
Q ss_pred eecCCe-e-eeeceeeeEEEEecccccEEeccc
Q 004442 132 ISKDGG-V-TLGAMKTSVFLVDVKSGRVVDNYV 162 (753)
Q Consensus 132 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~ 162 (753)
++.||. + ..|+...++...|.++|++++...
T Consensus 123 ~s~dg~~l~~~~~~~~~v~~~d~~~~~~~~~~~ 155 (391)
T 1l0q_A 123 LSPDGKKLYVTNNGDKTVSVINTVTKAVINTVS 155 (391)
T ss_dssp ECTTSSEEEEEETTTTEEEEEETTTTEEEEEEE
T ss_pred ECCCCCEEEEEeCCCCEEEEEECCCCcEEEEEe
Confidence 777875 4 567778899999999999998843
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=85.56 E-value=0.65 Score=52.13 Aligned_cols=35 Identities=11% Similarity=-0.014 Sum_probs=17.1
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccccC
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 301 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP 301 (753)
.++.+.+.+|+++|.+ ..+ .|+.|||++|+++ .||
T Consensus 432 ~L~~L~Ls~N~l~~~~---~~l~~L~~L~Ls~N~l~-~ip 467 (549)
T 2z81_A 432 TLEVLDVSNNNLDSFS---LFLPRLQELYISRNKLK-TLP 467 (549)
T ss_dssp TCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-SCC
T ss_pred CceEEECCCCChhhhc---ccCChhcEEECCCCccC-cCC
Confidence 4455555555555533 122 3555555555555 344
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=85.55 E-value=0.46 Score=50.14 Aligned_cols=49 Identities=10% Similarity=-0.117 Sum_probs=38.4
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|+++|-.+.+..+ .|+.|++++|++.|.+|..+..+..|.
T Consensus 207 ~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~ 256 (328)
T 4fcg_A 207 NLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLK 256 (328)
T ss_dssp TCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCC
T ss_pred CCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCC
Confidence 5677788889998755667777 688899999999999988877666555
|
| >1gxr_A ESG1, transducin-like enhancer protein 1; transcriptional CO-repressor, WD40, transcription repressor, WD repeat; 1.65A {Homo sapiens} SCOP: b.69.4.1 PDB: 2ce8_A 2ce9_A | Back alignment and structure |
|---|
Probab=85.46 E-value=1.6 Score=44.20 Aligned_cols=109 Identities=11% Similarity=-0.026 Sum_probs=64.1
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYI 126 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (753)
..+..++++.||+|+++|..+++....+....++.+--..+ +.+ +.+-+.+|..+++-+-..+++..+.-. +..+
T Consensus 194 ~~~~l~~~~~dg~i~~~d~~~~~~~~~~~~~~~v~~~~~s~-~~~---~l~~~~~~~~i~~~~~~~~~~~~~~~~-~~~v 268 (337)
T 1gxr_A 194 DGTKLWTGGLDNTVRSWDLREGRQLQQHDFTSQIFSLGYCP-TGE---WLAVGMESSNVEVLHVNKPDKYQLHLH-ESCV 268 (337)
T ss_dssp TSSEEEEEETTSEEEEEETTTTEEEEEEECSSCEEEEEECT-TSS---EEEEEETTSCEEEEETTSSCEEEECCC-SSCE
T ss_pred CCCEEEEEecCCcEEEEECCCCceEeeecCCCceEEEEECC-CCC---EEEEEcCCCcEEEEECCCCCeEEEcCC-ccce
Confidence 45677888999999999999999999998877774432211 111 233334444555444444433322100 0000
Q ss_pred HhCceeecCC-eeeeeceeeeEEEEecccccEEecc
Q 004442 127 RRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 127 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
..-.++.|| .+..|+...++...|..+|+.+...
T Consensus 269 -~~~~~~~~~~~l~~~~~dg~i~~~~~~~~~~~~~~ 303 (337)
T 1gxr_A 269 -LSLKFAYCGKWFVSTGKDNLLNAWRTPYGASIFQS 303 (337)
T ss_dssp -EEEEECTTSSEEEEEETTSEEEEEETTTCCEEEEE
T ss_pred -eEEEECCCCCEEEEecCCCcEEEEECCCCeEEEEe
Confidence 011233344 3667777778888888888887654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=85.45 E-value=0.53 Score=53.98 Aligned_cols=46 Identities=11% Similarity=0.016 Sum_probs=29.1
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|+|+ +|| .+..+ .|+.|||++|+++| || .+..+.+|.
T Consensus 464 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~ 511 (567)
T 1dce_A 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQ 511 (567)
T ss_dssp TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCC
T ss_pred cCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCc
Confidence 4566667777777 665 45555 57777777777777 66 454444433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=85.39 E-value=0.52 Score=52.30 Aligned_cols=33 Identities=15% Similarity=0.163 Sum_probs=20.7
Q ss_pred cccccccCCccccccccccCC-CcccceeecCcccc
Q 004442 264 VESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAG 298 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG 298 (753)
++.+.+.+|+|+| ++ +..+ .|+.||+++|+|+|
T Consensus 320 L~~L~L~~N~l~~-l~-l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 320 LVYLYLNNTELTE-LD-VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CCEEECTTCCCSC-CC-CTTCTTCSEEECCSSCCCB
T ss_pred CCEEECCCCcccc-cc-cccCCcCcEEECCCCCCCC
Confidence 4555566777776 33 5555 56667777777766
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=85.36 E-value=1.5 Score=43.35 Aligned_cols=53 Identities=11% Similarity=-0.058 Sum_probs=35.1
Q ss_pred ccccccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 259 DLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 259 ~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.+...++.+.+.+|++++..| .+..+ .|+.|+|++|++++..+..+..+..|.
T Consensus 37 ~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 91 (229)
T 3e6j_A 37 GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT 91 (229)
T ss_dssp CCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred CCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence 344567778888888888765 35666 688888888888654444444444443
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=85.15 E-value=1.3 Score=44.42 Aligned_cols=44 Identities=11% Similarity=-0.114 Sum_probs=21.6
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCC
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSS 306 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s 306 (753)
+++.+.+.+|++++..+ .+.++ .|+.|++++|++++..|..+..
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 81 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDD 81 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhcc
Confidence 44555555555555443 24444 4555555555555544444433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=85.10 E-value=0.34 Score=44.37 Aligned_cols=41 Identities=15% Similarity=0.116 Sum_probs=28.4
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccccCCCC
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPG 304 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~~l 304 (753)
.++.+.+.+|++++. +.+..+ .|+.|++++|++++.+|..+
T Consensus 43 ~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~ 84 (149)
T 2je0_A 43 ELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLA 84 (149)
T ss_dssp TCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHH
T ss_pred CCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHh
Confidence 456667777777765 556666 67778888888877766543
|
| >4gqb_B Methylosome protein 50; TIM barrel, beta-propeller, methyltransferase, methylation, transferase-protein binding complex; HET: 0XU; 2.06A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.00 E-value=1.3 Score=46.71 Aligned_cols=110 Identities=19% Similarity=0.201 Sum_probs=65.9
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
-..++.++.||+|.++|..+|+....|.. ..++++.-- +.+..-.++.+++|..+.+-+-+.++.. .+.......
T Consensus 139 g~~l~sgs~d~~i~iwd~~~~~~~~~~~~h~~~V~~~~~---~~~~~~~l~s~s~D~~v~iwd~~~~~~~~~~~~~~~~~ 215 (344)
T 4gqb_B 139 GTQAVSGSKDICIKVWDLAQQVVLSSYRAHAAQVTCVAA---SPHKDSVFLSCSEDNRILLWDTRCPKPASQIGCSAPGY 215 (344)
T ss_dssp SSEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEE---CSSCTTEEEEEETTSCEEEEETTSSSCEEECC----CC
T ss_pred CCEEEEEeCCCeEEEEECCCCcEEEEEcCcCCceEEEEe---cCCCCCceeeeccccccccccccccceeeeeecceeec
Confidence 35667788999999999999999888863 344433221 1121123567888888877766666543 332211111
Q ss_pred HHhCceee-cCCe-eeeeceeeeEEEEecccccEEec
Q 004442 126 IRRMPYIS-KDGG-VTLGAMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 126 ~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 160 (753)
.-..=.++ +++. +..|+...++...|.++|+.+++
T Consensus 216 ~~~~~~~~p~~~~~l~sg~~dg~v~~wd~~~~~~~~~ 252 (344)
T 4gqb_B 216 LPTSLAWHPQQSEVFVFGDENGTVSLVDTKSTSCVLS 252 (344)
T ss_dssp CEEEEEECSSCTTEEEEEETTSEEEEEESCC--CCEE
T ss_pred cceeeeecCCCCcceEEeccCCcEEEEECCCCcEEEE
Confidence 10111122 3443 56788888899999999999888
|
| >4g56_B MGC81050 protein; protein arginine methyltransferase, protein complexes, histo methylation, transferase; HET: SAH; 2.95A {Xenopus laevis} | Back alignment and structure |
|---|
Probab=84.88 E-value=1.5 Score=46.24 Aligned_cols=111 Identities=14% Similarity=0.139 Sum_probs=66.8
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCC-CCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTG-RPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
...++.++.||+|.++|..+++....|... .++.+--- ..+..-+++.+.+|..+++-+-+.++.. .+.....+-
T Consensus 151 g~~l~sgs~dg~v~iwd~~~~~~~~~~~~h~~~v~~v~~---s~~~~~~~~s~~~dg~v~~wd~~~~~~~~~~~~~~~~~ 227 (357)
T 4g56_B 151 GTQAVSGGKDFSVKVWDLSQKAVLKSYNAHSSEVNCVAA---CPGKDTIFLSCGEDGRILLWDTRKPKPATRIDFCASDT 227 (357)
T ss_dssp SSEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEE---CTTCSSCEEEEETTSCEEECCTTSSSCBCBCCCTTCCS
T ss_pred CCEEEEEeCCCeEEEEECCCCcEEEEEcCCCCCEEEEEE---ccCCCceeeeeccCCceEEEECCCCceeeeeeeccccc
Confidence 356677889999999999999999998753 33432211 1111223567777777776555555433 121111100
Q ss_pred HHhCceeecC-C-eeeeeceeeeEEEEecccccEEecc
Q 004442 126 IRRMPYISKD-G-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 126 ~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.-..=.++.+ + .+..|+...++...|.++|+.+++.
T Consensus 228 ~v~~v~~sp~~~~~la~g~~d~~i~~wd~~~~~~~~~~ 265 (357)
T 4g56_B 228 IPTSVTWHPEKDDTFACGDETGNVSLVNIKNPDSAQTS 265 (357)
T ss_dssp CEEEEEECTTSTTEEEEEESSSCEEEEESSCGGGCEEE
T ss_pred cccchhhhhcccceEEEeecccceeEEECCCCcEeEEE
Confidence 0001112333 3 3667888888999999999988874
|
| >1sq9_A Antiviral protein SKI8; WD repeat, beta-transducin repeat, WD40 repeat, beta propeller, recombination; 1.90A {Saccharomyces cerevisiae} SCOP: b.69.4.1 PDB: 1s4u_X | Back alignment and structure |
|---|
Probab=84.41 E-value=2.6 Score=44.14 Aligned_cols=107 Identities=12% Similarity=0.152 Sum_probs=68.9
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecC-------CCCcccccccCCCCCCceeeeccCCC---ceeeeeccccCcee-ee
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGT-------GRPIYSSYQASFNSNASEFYLDVDED---WELYFHSKRFGKMK-KL 118 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~ 118 (753)
..++++.||+|+++|..+++..+.|.. ..++.+.--.+. . -+.+.+.+| ..+++-+-+.++.. .+
T Consensus 199 ~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~h~~~~~~i~~i~~~~~-~---~~l~~~~~d~~~g~i~i~d~~~~~~~~~~ 274 (397)
T 1sq9_A 199 LIATGFNNGTVQISELSTLRPLYNFESQHSMINNSNSIRSVKFSPQ-G---SLLAIAHDSNSFGCITLYETEFGERIGSL 274 (397)
T ss_dssp EEEEECTTSEEEEEETTTTEEEEEEECCC---CCCCCEEEEEECSS-T---TEEEEEEEETTEEEEEEEETTTCCEEEEE
T ss_pred eEEEEeCCCcEEEEECCCCceeEEEeccccccccCCccceEEECCC-C---CEEEEEecCCCCceEEEEECCCCccccee
Confidence 778889999999999999999999987 777744333221 1 234555666 67776665555543 22
Q ss_pred ccC------------HHHHHHhCceeecCC-eeeeeceeeeEEEEecccccEEecc
Q 004442 119 SSS------------AEEYIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 119 ~~~------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.-. -...| ..-.++.|| .+..|+...++...|.++|+.+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~v-~~~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~ 329 (397)
T 1sq9_A 275 SVPTHSSQASLGEFAHSSWV-MSLSFNDSGETLCSAGWDGKLRFWDVKTKERITTL 329 (397)
T ss_dssp CBC--------CCBSBSSCE-EEEEECSSSSEEEEEETTSEEEEEETTTTEEEEEE
T ss_pred ccCcccccccccccccCCcE-EEEEECCCCCEEEEEeCCCeEEEEEcCCCceeEEE
Confidence 210 00000 011233344 5667888888999999999998884
|
| >4aow_A Guanine nucleotide-binding protein subunit beta-2; receptor, WD-repeat, beta-propeller; 2.45A {Homo sapiens} PDB: 2zkq_a | Back alignment and structure |
|---|
Probab=84.34 E-value=3.2 Score=42.08 Aligned_cols=105 Identities=18% Similarity=0.165 Sum_probs=63.1
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
.....+.++.||+|.++|..+++.+..+..+.++.+....+ +. +++.+..|..+++-+-+.+.+. .+.......
T Consensus 226 ~~~~l~s~s~Dg~i~iwd~~~~~~~~~~~~~~~v~~~~~~~-~~----~~~~~~~d~~i~iwd~~~~~~~~~~~~~~~~~ 300 (340)
T 4aow_A 226 DGSLCASGGKDGQAMLWDLNEGKHLYTLDGGDIINALCFSP-NR----YWLCAATGPSIKIWDLEGKIIVDELKQEVIST 300 (340)
T ss_dssp TSSEEEEEETTCEEEEEETTTTEEEEEEECSSCEEEEEECS-SS----SEEEEEETTEEEEEETTTTEEEEEECCC----
T ss_pred CCCEEEEEeCCCeEEEEEeccCceeeeecCCceEEeeecCC-CC----ceeeccCCCEEEEEECCCCeEEEeccccceee
Confidence 44577788999999999999999999999998885544433 22 3667777777777654444332 222111110
Q ss_pred H--HhCc-----eeecCCe-eeeeceeeeEEEEeccccc
Q 004442 126 I--RRMP-----YISKDGG-VTLGAMKTSVFLVDVKSGR 156 (753)
Q Consensus 126 ~--~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~~~ 156 (753)
. .... .++.||. +..|+..-++..-|.+||.
T Consensus 301 ~~~~h~~~v~~l~~s~dg~~l~sgs~Dg~v~iW~~~tGt 339 (340)
T 4aow_A 301 SSKAEPPQCTSLAWSADGQTLFAGYTDNLVRVWQVTIGT 339 (340)
T ss_dssp ---CCCCCEEEEEECTTSSEEEEEETTSCEEEEEEEC--
T ss_pred eccCCCCCEEEEEECCCCCEEEEEeCCCEEEEEeCCCcC
Confidence 0 0011 1344553 4556666677777777774
|
| >3sjl_D Methylamine dehydrogenase heavy chain; MAUG, C-heme, quinone cofactor, oxidoreductase-electron transport complex; HET: 0AF HEC MES; 1.63A {Paracoccus denitrificans} PDB: 2gc7_A* 2j55_H* 2j56_H* 2j57_G* 3l4m_D* 3l4o_D* 3orv_D* 3pxs_D* 3pxt_D* 3rlm_D* 2gc4_A* 3rn0_D* 3rn1_D* 3rmz_D* 3svw_D* 3sws_D* 3sxt_D* 3pxw_D* 3sle_D* 1mg2_A* ... | Back alignment and structure |
|---|
Probab=84.14 E-value=1.5 Score=47.68 Aligned_cols=113 Identities=11% Similarity=0.055 Sum_probs=66.7
Q ss_pred CCCCCeeEEEec-----CceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeecc---------CCCceeeeecc
Q 004442 45 PPEPDVALVAAL-----DGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDV---------DEDWELYFHSK 110 (753)
Q Consensus 45 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 110 (753)
||-...+.|++. +|+|+.+|..++++.+.+.+|.--+ -.. ..|...-|... +++-.+.+=+.
T Consensus 41 ~pd~~~vyV~~~~~~~~~~~V~ViD~~t~~v~~~I~vG~~P~-va~---spDG~~lyVan~~~~r~~~G~~~~~VsviD~ 116 (386)
T 3sjl_D 41 APDARRVYVNDPAHFAAVTQQFVIDGEAGRVIGMIDGGFLPN-PVV---ADDGSFIAHASTVFSRIARGERTDYVEVFDP 116 (386)
T ss_dssp CCCTTEEEEEECGGGCSSEEEEEEETTTTEEEEEEEECSSCE-EEE---CTTSSCEEEEEEEEEETTEEEEEEEEEEECT
T ss_pred CCCCCEEEEEcCcccCCCCEEEEEECCCCeEEEEEECCCCCc-EEE---CCCCCEEEEEcccccccccCCCCCEEEEEEC
Confidence 466777888887 7999999999999999999885432 111 11222222221 12223444444
Q ss_pred ccCcee-eeccCHHH--HHHhCc---eeecCCe-eeeece--eeeEEEEecccccEEecc
Q 004442 111 RFGKMK-KLSSSAEE--YIRRMP---YISKDGG-VTLGAM--KTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 111 ~~~~~~-~~~~~~~~--~~~~~~---~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~ 161 (753)
..+++. .+...... .+...| .++.||. +++... ..++-.||..|++++.+-
T Consensus 117 ~t~~v~~~I~v~~g~r~~~g~~P~~~a~spDGk~lyVan~~~~~~VsVID~~t~~vv~tI 176 (386)
T 3sjl_D 117 VTLLPTADIELPDAPRFLVGTYPWMTSLTPDGKTLLFYQFSPAPAVGVVDLEGKAFKRML 176 (386)
T ss_dssp TTCCEEEEEEETTCCCCCBSCCGGGEEECTTSSEEEEEECSSSCEEEEEETTTTEEEEEE
T ss_pred CCCeEEEEEECCCccccccCCCCceEEEcCCCCEEEEEEcCCCCeEEEEECCCCcEEEEE
Confidence 444443 33321100 000122 5677885 666653 568889999999999874
|
| >3ow8_A WD repeat-containing protein 61; structural genomics consortium, SGC, transcriptio; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.92 E-value=6.5 Score=40.57 Aligned_cols=109 Identities=18% Similarity=0.252 Sum_probs=62.6
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEE 124 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 124 (753)
.....++++.||+|.++|..+++....|.. ..|+.+---.| +. -+.+.+++|..+++-+-+.++.. .+.-- ..
T Consensus 175 dg~~lasg~~dg~i~iwd~~~~~~~~~~~~h~~~v~~l~~sp-d~---~~l~s~s~dg~i~iwd~~~~~~~~~~~~h-~~ 249 (321)
T 3ow8_A 175 DGKYLASGAIDGIINIFDIATGKLLHTLEGHAMPIRSLTFSP-DS---QLLVTASDDGYIKIYDVQHANLAGTLSGH-AS 249 (321)
T ss_dssp TSSEEEEEETTSCEEEEETTTTEEEEEECCCSSCCCEEEECT-TS---CEEEEECTTSCEEEEETTTCCEEEEECCC-SS
T ss_pred CCCEEEEEcCCCeEEEEECCCCcEEEEEcccCCceeEEEEcC-CC---CEEEEEcCCCeEEEEECCCcceeEEEcCC-CC
Confidence 345677889999999999999999888863 33553221111 11 13445555555555444333322 11100 00
Q ss_pred HHHhCceeecCC-eeeeeceeeeEEEEecccccEEecc
Q 004442 125 YIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 125 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.| ..-.++.|| .+..|+...++..-|.++|+.+++.
T Consensus 250 ~v-~~~~~sp~~~~l~s~s~D~~v~iwd~~~~~~~~~~ 286 (321)
T 3ow8_A 250 WV-LNVAFCPDDTHFVSSSSDKSVKVWDVGTRTCVHTF 286 (321)
T ss_dssp CE-EEEEECTTSSEEEEEETTSCEEEEETTTTEEEEEE
T ss_pred ce-EEEEECCCCCEEEEEeCCCcEEEEeCCCCEEEEEE
Confidence 00 011233344 4667887788888999999999883
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.91 E-value=1.2 Score=46.29 Aligned_cols=42 Identities=12% Similarity=0.003 Sum_probs=28.2
Q ss_pred ccccccccCCccccccc-cccCC----CcccceeecCccccccCCCCC
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN----SLPEFLSVIGKVAGWISLPGS 305 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l----~L~~LnlsnN~fsG~IP~~l~ 305 (753)
.|+.+.+.+|++++.+| .+..+ .|+.||+++|+++ .||..+.
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~ 271 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP 271 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc
Confidence 45677777888887764 33333 5777888888888 6666553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=83.77 E-value=0.78 Score=50.43 Aligned_cols=47 Identities=13% Similarity=-0.042 Sum_probs=25.9
Q ss_pred cccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCC
Q 004442 264 VESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 310 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l 310 (753)
|+.+.+.+|+|++..| .+.++ .|+.|++++|++++..|..+..+.+|
T Consensus 220 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 268 (452)
T 3zyi_A 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268 (452)
T ss_dssp CCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCC
Confidence 4555556666666554 34455 46666666666666555555444333
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=83.54 E-value=4.7 Score=43.31 Aligned_cols=27 Identities=15% Similarity=0.161 Sum_probs=15.2
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEe
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSF 74 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 74 (753)
.+..+.++.||+|.++|..+|+..+.+
T Consensus 129 g~~l~sg~~dg~i~vwd~~~~~~~~~~ 155 (445)
T 2ovr_B 129 GNRIVSGSDDNTLKVWSAVTGKCLRTL 155 (445)
T ss_dssp TTEEEEEETTSCEEEEETTTCCEEEEC
T ss_pred CCEEEEEECCCcEEEEECCCCcEEEEE
Confidence 455556666666666665555554444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=83.25 E-value=0.65 Score=53.78 Aligned_cols=9 Identities=22% Similarity=0.372 Sum_probs=4.5
Q ss_pred chhHHHhhh
Q 004442 29 NRYVSEIYN 37 (753)
Q Consensus 29 ~~~~~~~~~ 37 (753)
..|+.+||+
T Consensus 32 ~~aL~~~~~ 40 (636)
T 4eco_A 32 YLALKEIWD 40 (636)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 345555555
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=83.12 E-value=1.1 Score=46.20 Aligned_cols=42 Identities=10% Similarity=-0.074 Sum_probs=22.3
Q ss_pred cccccccCCccccccc-cccCC-CcccceeecCccccccCCCCC
Q 004442 264 VESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGS 305 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~ 305 (753)
|+.+.+.+|++++..| .+..+ .|+.|++++|++++..+..+.
T Consensus 177 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 220 (306)
T 2z66_A 177 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220 (306)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGT
T ss_pred CCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhcc
Confidence 4555555666665543 34444 466666666666655443433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=83.11 E-value=1.4 Score=42.66 Aligned_cols=48 Identities=8% Similarity=-0.071 Sum_probs=28.2
Q ss_pred ccccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCCCCCCC
Q 004442 263 DVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 310 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l 310 (753)
.|+.+.+.+|++++-.+. +..+ .|+.|++++|++++..+..+..+..|
T Consensus 77 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 126 (208)
T 2o6s_A 77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQL 126 (208)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcC
Confidence 446666667777754432 4555 57777777777776555444444333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.63 E-value=0.94 Score=49.56 Aligned_cols=40 Identities=10% Similarity=-0.126 Sum_probs=18.5
Q ss_pred ccccccCCccccccc-cccCC-CcccceeecCccccccCCCC
Q 004442 265 ESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPG 304 (753)
Q Consensus 265 ~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l 304 (753)
+.+.+.+|++++..+ .+.++ .|+.|||++|++++..+..+
T Consensus 234 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 275 (440)
T 3zyj_A 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF 275 (440)
T ss_dssp CEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred CEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHh
Confidence 444444555554433 23344 45555555555554444333
|
| >3u4y_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center for structural genomi CS, MCSG; 2.99A {Desulfotomaculum acetoxidans} | Back alignment and structure |
|---|
Probab=82.61 E-value=2.7 Score=42.85 Aligned_cols=109 Identities=12% Similarity=-0.018 Sum_probs=66.6
Q ss_pred eeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhC
Q 004442 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRM 129 (753)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (753)
+.+.+..||+|+++|..+|+....+..|..-. +.+ ...|....|..+..+..||+-+...|++....++...-....
T Consensus 12 ~~v~~~~~~~v~~~d~~~~~~~~~~~~~~~~~--~~~-~s~dg~~l~~~~~~~~~i~~~d~~~~~~~~~~~~~~~~~~~~ 88 (331)
T 3u4y_A 12 GIVVEQHLRRISFFSTDTLEILNQITLGYDFV--DTA-ITSDCSNVVVTSDFCQTLVQIETQLEPPKVVAIQEGQSSMAD 88 (331)
T ss_dssp EEEEEGGGTEEEEEETTTCCEEEEEECCCCEE--EEE-ECSSSCEEEEEESTTCEEEEEECSSSSCEEEEEEECSSCCCC
T ss_pred EEEEecCCCeEEEEeCcccceeeeEEccCCcc--eEE-EcCCCCEEEEEeCCCCeEEEEECCCCceeEEecccCCCCccc
Confidence 34555678999999999999988776542211 222 222333345555556688887777777521112222211112
Q ss_pred ceeecCCe-eeeeceee---eEEEEecccccEEecc
Q 004442 130 PYISKDGG-VTLGAMKT---SVFLVDVKSGRVVDNY 161 (753)
Q Consensus 130 ~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~ 161 (753)
..++.||. +..+.... ++..+|.++|++++..
T Consensus 89 ~~~s~dg~~l~~~~~~~~~~~i~v~d~~~~~~~~~~ 124 (331)
T 3u4y_A 89 VDITPDDQFAVTVTGLNHPFNMQSYSFLKNKFISTI 124 (331)
T ss_dssp EEECTTSSEEEECCCSSSSCEEEEEETTTTEEEEEE
T ss_pred eEECCCCCEEEEecCCCCcccEEEEECCCCCeEEEE
Confidence 56788887 44444432 8999999999998874
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=82.56 E-value=1.1 Score=51.37 Aligned_cols=36 Identities=8% Similarity=-0.100 Sum_probs=18.8
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccccCC
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISL 302 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~ 302 (753)
.|+.+.+.+|+|+| ||. .+ .|+.|++++|++++ ||.
T Consensus 121 ~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~l~~-lp~ 157 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE--LPALLEYINADNNQLTM-LPE 157 (571)
T ss_dssp TCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC
T ss_pred CCCEEECCCCcCCC-CCC--cCccccEEeCCCCccCc-CCC
Confidence 44555555555555 544 23 45555555555555 444
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=82.52 E-value=2.5 Score=42.86 Aligned_cols=41 Identities=5% Similarity=-0.109 Sum_probs=19.8
Q ss_pred cccccccCCcccccccc-ccCC-CcccceeecCccccccCCCC
Q 004442 264 VESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPG 304 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l 304 (753)
|+.+.+.+|++++..+. +..+ .|+.|++++|++++..|..+
T Consensus 111 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 153 (272)
T 3rfs_A 111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVF 153 (272)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHh
Confidence 34445555555544432 3444 45555555555554444333
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=82.13 E-value=0.59 Score=43.66 Aligned_cols=37 Identities=11% Similarity=0.044 Sum_probs=19.4
Q ss_pred cccccccCCccccccccccCC-CcccceeecCccccccC
Q 004442 264 VESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 301 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP 301 (753)
|+.+.+.+|++++. +.+..+ .|+.|++++|++++.+|
T Consensus 51 L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~ 88 (168)
T 2ell_A 51 LEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLD 88 (168)
T ss_dssp CCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCC
T ss_pred CCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHH
Confidence 34445555555544 444444 45555555555555544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=82.12 E-value=1.1 Score=52.74 Aligned_cols=11 Identities=27% Similarity=0.111 Sum_probs=4.6
Q ss_pred cccceeecCcc
Q 004442 286 LPEFLSVIGKV 296 (753)
Q Consensus 286 L~~LnlsnN~f 296 (753)
|+.|+|++|+|
T Consensus 295 L~~L~L~~N~l 305 (727)
T 4b8c_D 295 LKYFYFFDNMV 305 (727)
T ss_dssp CSEEECCSSCC
T ss_pred CCEEECCCCCC
Confidence 44444444444
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=81.93 E-value=5.6 Score=42.74 Aligned_cols=105 Identities=12% Similarity=0.121 Sum_probs=55.5
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCC-CCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTG-RPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
++..++++.||+|.++|..+++..+.+... .++.+.-. +. -+.+.+..|..+++-+-+.++.. .+.-.-...
T Consensus 209 ~~~l~s~s~dg~i~~wd~~~~~~~~~~~~~~~~v~~~~~---~~---~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~v 282 (445)
T 2ovr_B 209 EKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQY---DG---RRVVSGAYDFMVKVWDPETETCLHTLQGHTNRV 282 (445)
T ss_dssp TTEEEEEETTSEEEEEESSSCCEEEEEECCSSCEEEEEE---CS---SCEEEEETTSCEEEEEGGGTEEEEEECCCSSCE
T ss_pred CCEEEEEeCCCEEEEEECCCCcEEEEEcCCcccEEEEEE---CC---CEEEEEcCCCEEEEEECCCCcEeEEecCCCCce
Confidence 355677778888888888777777777532 22211110 11 12344455555555444433322 111000000
Q ss_pred HHhCceeecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 126 IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.... + +...+..|+...++...|..+|+.+.+.
T Consensus 283 ~~~~--~-~~~~l~~~~~d~~i~i~d~~~~~~~~~~ 315 (445)
T 2ovr_B 283 YSLQ--F-DGIHVVSGSLDTSIRVWDVETGNCIHTL 315 (445)
T ss_dssp EEEE--E-CSSEEEEEETTSCEEEEETTTCCEEEEE
T ss_pred EEEE--E-CCCEEEEEeCCCeEEEEECCCCCEEEEE
Confidence 0000 1 3445777777788888888888888773
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=81.87 E-value=1.5 Score=47.77 Aligned_cols=48 Identities=4% Similarity=-0.173 Sum_probs=26.4
Q ss_pred cccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 264 VESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
|+.+.+.+|++++..| .+..+ .|+.||+++|++++.+|..+..+..|.
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 374 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccccc
Confidence 4555555666655543 34444 566666666666666665555444433
|
| >3vl1_A 26S proteasome regulatory subunit RPN14; beta-propeller, chaperone, RPT6; 1.60A {Saccharomyces cerevisiae} PDB: 3acp_A | Back alignment and structure |
|---|
Probab=81.85 E-value=3.8 Score=43.24 Aligned_cols=100 Identities=13% Similarity=0.176 Sum_probs=63.6
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEe-cCCCCcccccccCCCCCCceeeeccCCCceeeeecccc-----------C
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSF-GTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRF-----------G 113 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~ 113 (753)
+..+..++++.||+|.++|..+++....+ ....++.+.--.+ +. -+.+.+..|..+++-+-.. +
T Consensus 107 ~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~h~~~v~~~~~~~-~~---~~l~s~s~d~~i~iwd~~~~~~~~~~~~h~~ 182 (420)
T 3vl1_A 107 LQMRRFILGTTEGDIKVLDSNFNLQREIDQAHVSEITKLKFFP-SG---EALISSSQDMQLKIWSVKDGSNPRTLIGHRA 182 (420)
T ss_dssp SSSCEEEEEETTSCEEEECTTSCEEEEETTSSSSCEEEEEECT-TS---SEEEEEETTSEEEEEETTTCCCCEEEECCSS
T ss_pred cCCCEEEEEECCCCEEEEeCCCcceeeecccccCccEEEEECC-CC---CEEEEEeCCCeEEEEeCCCCcCceEEcCCCC
Confidence 45567888899999999999999888876 3444553221111 11 1234455555555444333 3
Q ss_pred ceeeeccCHHHHHHhCceeecCC-eeeeeceeeeEEEEecccccEEecc
Q 004442 114 KMKKLSSSAEEYIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.|..+.| +.|| .+..|+...++...|.++|+.++..
T Consensus 183 ~v~~~~~------------~~~~~~l~s~~~d~~v~iwd~~~~~~~~~~ 219 (420)
T 3vl1_A 183 TVTDIAI------------IDRGRNVLSASLDGTIRLWECGTGTTIHTF 219 (420)
T ss_dssp CEEEEEE------------ETTTTEEEEEETTSCEEEEETTTTEEEEEE
T ss_pred cEEEEEE------------cCCCCEEEEEcCCCcEEEeECCCCceeEEe
Confidence 3333333 3354 4777888888999999999999884
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=81.77 E-value=1.2 Score=50.94 Aligned_cols=37 Identities=14% Similarity=-0.065 Sum_probs=24.6
Q ss_pred cccccccccCCccccccccccCC-CcccceeecCccccccCC
Q 004442 262 GDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISL 302 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~ 302 (753)
..|+.+.+.+|+|++ ||. .+ .|+.|+|++|++++ ||.
T Consensus 140 ~~L~~L~Ls~N~l~~-lp~--~l~~L~~L~Ls~N~L~~-lp~ 177 (571)
T 3cvr_A 140 ALLEYINADNNQLTM-LPE--LPTSLEVLSVRNNQLTF-LPE 177 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSC-CCC
T ss_pred ccccEEeCCCCccCc-CCC--cCCCcCEEECCCCCCCC-cch
Confidence 355666677777776 655 33 57777777777777 665
|
| >2pm9_A Protein WEB1, protein transport protein SEC31; beta propeller; 3.30A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=81.68 E-value=5.9 Score=41.53 Aligned_cols=101 Identities=12% Similarity=0.012 Sum_probs=62.3
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecC-------CCCcccccccCCCCCCceeeeccCCCc---eeeeeccc------
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGT-------GRPIYSSYQASFNSNASEFYLDVDEDW---ELYFHSKR------ 111 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~------ 111 (753)
..+.+.++.||+|.++|..+++....+.. +.++.+.-..+.+ .-+++.+.+|. .+++-+-+
T Consensus 178 ~~~l~~~~~dg~v~iwd~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~---~~~l~~~~~d~~~~~i~~~d~~~~~~~~ 254 (416)
T 2pm9_A 178 AHVFASAGSSNFASIWDLKAKKEVIHLSYTSPNSGIKQQLSVVEWHPKN---STRVATATGSDNDPSILIWDLRNANTPL 254 (416)
T ss_dssp TTEEEEESSSSCEEEEETTTTEEEEEECCCCCSSCCCCCEEEEEECSSC---TTEEEEEECCSSSCCCCEEETTSTTSCS
T ss_pred CcEEEEEcCCCCEEEEECCCCCcceEEeccccccccCCceEEEEECCCC---CCEEEEEECCCCCceEEEEeCCCCCCCc
Confidence 56778889999999999999999998886 4455332221111 11233333443 44433333
Q ss_pred -------cCceeeeccCHHHHHHhCceeecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 112 -------FGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 112 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
.+.|..+.|+. .+...+..|+...++...|.++|+.+...
T Consensus 255 ~~~~~~~~~~v~~~~~s~----------~~~~~l~s~~~dg~v~~wd~~~~~~~~~~ 301 (416)
T 2pm9_A 255 QTLNQGHQKGILSLDWCH----------QDEHLLLSSGRDNTVLLWNPESAEQLSQF 301 (416)
T ss_dssp BCCCSCCSSCEEEEEECS----------SCSSCEEEEESSSEEEEECSSSCCEEEEE
T ss_pred EEeecCccCceeEEEeCC----------CCCCeEEEEeCCCCEEEeeCCCCccceee
Confidence 33344444332 12334677888888999999999998873
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=81.65 E-value=6.2 Score=43.35 Aligned_cols=30 Identities=23% Similarity=0.328 Sum_probs=24.7
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceec
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~ 658 (753)
.++|+|+.+.||+ +.++. +.|+||..+...
T Consensus 263 ~~~H~D~~~~N~l-~~~~~--~~~IDwe~a~~~ 292 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNN--IRMIDYEYSAIN 292 (424)
T ss_dssp EEECSCCCGGGEE-ECSSC--EEECCCTTCEEE
T ss_pred eEECCCCCcccee-cCCCc--EEEEecccCCcC
Confidence 5999999999999 55544 889999988754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=81.62 E-value=1.2 Score=52.64 Aligned_cols=48 Identities=8% Similarity=-0.046 Sum_probs=40.3
Q ss_pred cccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 262 GDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
..|+.+.|.+|+|+ .|| .+.++ .|+.|||++|+|+ .||..+..+..|.
T Consensus 247 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 296 (727)
T 4b8c_D 247 DFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK 296 (727)
T ss_dssp CSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCS
T ss_pred CCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCC
Confidence 35688899999999 887 47777 7999999999999 8998887766655
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=81.54 E-value=0.86 Score=47.05 Aligned_cols=38 Identities=5% Similarity=0.025 Sum_probs=16.2
Q ss_pred cccccccCCcccc--ccccccCCCcccceeecCccccccC
Q 004442 264 VESHLPCHTQMTA--SVYRLRDNSLPEFLSVIGKVAGWIS 301 (753)
Q Consensus 264 ~~~~l~~nN~ftG--sIp~l~~l~L~~LnlsnN~fsG~IP 301 (753)
|+.+.|.+|+|++ ++..+..+.|+.|+|++|.+++.+|
T Consensus 198 L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 198 LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCEEECCCCccCCchhhhhcccCCcceEEccCCcCccccC
Confidence 3444444444444 2223333344444444444444433
|
| >1r5m_A SIR4-interacting protein SIF2; transcription corepressor, WD40 repeat, beta propeller; 1.55A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=81.41 E-value=4 Score=42.66 Aligned_cols=110 Identities=11% Similarity=0.105 Sum_probs=71.5
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEE 124 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 124 (753)
..+..++++.||+|+++| .+++..+.+.. ..++.+.--.+ +.+ +.+.+..|..+++-+-..++.. .+...-..
T Consensus 119 ~~~~l~~~~~dg~i~i~~-~~~~~~~~~~~~~~~v~~~~~~~-~~~---~l~~~~~d~~i~iwd~~~~~~~~~~~~~~~~ 193 (425)
T 1r5m_A 119 DGNSIVTGVENGELRLWN-KTGALLNVLNFHRAPIVSVKWNK-DGT---HIISMDVENVTILWNVISGTVMQHFELKETG 193 (425)
T ss_dssp TSSEEEEEETTSCEEEEE-TTSCEEEEECCCCSCEEEEEECT-TSS---EEEEEETTCCEEEEETTTTEEEEEECCC---
T ss_pred CCCEEEEEeCCCeEEEEe-CCCCeeeeccCCCccEEEEEECC-CCC---EEEEEecCCeEEEEECCCCcEEEEeeccccC
Confidence 456778899999999999 78888888874 34553333222 111 3456667777777666666554 33322111
Q ss_pred HH-------------HhCceeecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 125 YI-------------RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 125 ~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
-. -..-.++.++.+..|+...++...|.++|+.+...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~~d~~~~~~~~~~ 243 (425)
T 1r5m_A 194 GSSINAENHSGDGSLGVDVEWVDDDKFVIPGPKGAIFVYQITEKTPTGKL 243 (425)
T ss_dssp ------------CCCBSCCEEEETTEEEEECGGGCEEEEETTCSSCSEEE
T ss_pred ccceeeccccCCcceeeEEEEcCCCEEEEEcCCCeEEEEEcCCCceeeee
Confidence 00 23345567888999999999999999999877663
|
| >3odt_A Protein DOA1; ubiquitin, nuclear protein; HET: MSE MES; 1.35A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=81.39 E-value=1.7 Score=43.65 Aligned_cols=103 Identities=18% Similarity=0.224 Sum_probs=66.9
Q ss_pred eEEEecCceEEEEeccCCeeeEEec-CCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHHHHh
Q 004442 51 ALVAALDGTIHLVDTKLGKIRWSFG-TGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEYIRR 128 (753)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 128 (753)
.++++.||+|+++|..+++....+. ...++.+.--.+ +. +++.+..|..+++-+-..++.. .+... ..- -.
T Consensus 198 ~~~~~~dg~i~i~d~~~~~~~~~~~~~~~~i~~~~~~~-~~----~l~~~~~dg~v~iwd~~~~~~~~~~~~~-~~~-i~ 270 (313)
T 3odt_A 198 FISCSNDGLIKLVDMHTGDVLRTYEGHESFVYCIKLLP-NG----DIVSCGEDRTVRIWSKENGSLKQVITLP-AIS-IW 270 (313)
T ss_dssp EEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEECT-TS----CEEEEETTSEEEEECTTTCCEEEEEECS-SSC-EE
T ss_pred EEEccCCCeEEEEECCchhhhhhhhcCCceEEEEEEec-CC----CEEEEecCCEEEEEECCCCceeEEEecc-Cce-EE
Confidence 6788899999999999999988886 344553332222 11 2677788888888777766654 33211 100 11
Q ss_pred CceeecCCeeeeeceeeeEEEEecccccEEec
Q 004442 129 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (753)
.-.++.||.+..|+...++...|.++|+.+..
T Consensus 271 ~~~~~~~~~~~~~~~dg~i~iw~~~~~~~~~~ 302 (313)
T 3odt_A 271 SVDCMSNGDIIVGSSDNLVRIFSQEKSRWASE 302 (313)
T ss_dssp EEEECTTSCEEEEETTSCEEEEESCGGGCCC-
T ss_pred EEEEccCCCEEEEeCCCcEEEEeCCCCceeeh
Confidence 22356777777788888888888888877665
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=81.35 E-value=1.1 Score=48.93 Aligned_cols=36 Identities=8% Similarity=-0.130 Sum_probs=16.9
Q ss_pred ccccccCCccccccc-cccCC-CcccceeecCcccccc
Q 004442 265 ESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWI 300 (753)
Q Consensus 265 ~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~I 300 (753)
+.+.+.+|++++.+| .+.++ .|+.|++++|+++|.+
T Consensus 82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 119 (455)
T 3v47_A 82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAV 119 (455)
T ss_dssp CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHH
T ss_pred CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccc
Confidence 444444555544443 24444 4555555555555443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=80.99 E-value=0.71 Score=43.12 Aligned_cols=37 Identities=8% Similarity=0.010 Sum_probs=25.0
Q ss_pred ccccccccCCccccccccccC-C-CcccceeecCccccc
Q 004442 263 DVESHLPCHTQMTASVYRLRD-N-SLPEFLSVIGKVAGW 299 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~-l-~L~~LnlsnN~fsG~ 299 (753)
.++.+.+.+|++++.+|.+.. + .|+.|++++|++++.
T Consensus 72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 110 (168)
T 2ell_A 72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI 110 (168)
T ss_dssp SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSS
T ss_pred CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcc
Confidence 346667777777777664332 5 577778888877773
|
| >1jmx_B Amine dehydrogenase; oxidoreductase; HET: TRQ HEC; 1.90A {Pseudomonas putida} SCOP: b.69.2.2 PDB: 1jmz_B* | Back alignment and structure |
|---|
Probab=80.88 E-value=2.7 Score=42.91 Aligned_cols=108 Identities=22% Similarity=0.252 Sum_probs=57.8
Q ss_pred eeEEE-ecCceEEEEeccCCeeeEEecCCC-C---cccccccCCCCCCceeeeccCC-----------CceeeeeccccC
Q 004442 50 VALVA-ALDGTIHLVDTKLGKIRWSFGTGR-P---IYSSYQASFNSNASEFYLDVDE-----------DWELYFHSKRFG 113 (753)
Q Consensus 50 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ 113 (753)
.++++ ..+|+|+++|..+++..+.+..+. | -...+......|-...|....+ +-.+++-+-..|
T Consensus 56 ~~~v~~~~~~~i~~~d~~t~~~~~~~~~~~~~~~~~~~~~~~~~spdg~~l~~~~~~~~~~~~~~~~~~~~i~~~d~~~~ 135 (349)
T 1jmx_B 56 TAYVLNNHYGDIYGIDLDTCKNTFHANLSSVPGEVGRSMYSFAISPDGKEVYATVNPTQRLNDHYVVKPPRLEVFSTADG 135 (349)
T ss_dssp EEEEEETTTTEEEEEETTTTEEEEEEESCCSTTEEEECSSCEEECTTSSEEEEEEEEEEECSSCEEECCCEEEEEEGGGG
T ss_pred EEEEEeCCCCcEEEEeCCCCcEEEEEEcccccccccccccceEECCCCCEEEEEcccccccccccccCCCeEEEEECCCc
Confidence 34444 468999999999999998887543 1 0000111111222222222211 245555444443
Q ss_pred ceeeeccCHHHHHHhCce---eecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 114 KMKKLSSSAEEYIRRMPY---ISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
++.+.-.+.+ ....+. ++.||.+..++.. ++.+|.++|+++...
T Consensus 136 ~~~~~~~~~~--~~~~~~~~~~s~dg~l~~~~~~--i~~~d~~~~~~~~~~ 182 (349)
T 1jmx_B 136 LEAKPVRTFP--MPRQVYLMRAADDGSLYVAGPD--IYKMDVKTGKYTVAL 182 (349)
T ss_dssp GGBCCSEEEE--CCSSCCCEEECTTSCEEEESSS--EEEECTTTCCEEEEE
T ss_pred cccceeeecc--CCCcccceeECCCCcEEEccCc--EEEEeCCCCceeccc
Confidence 3221100000 011345 8899988887654 889999999998863
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=80.76 E-value=0.7 Score=43.70 Aligned_cols=36 Identities=6% Similarity=-0.047 Sum_probs=22.6
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccc
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGW 299 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~ 299 (753)
.++.+.+.+|++++- +.+..+ .|+.|++++|++++.
T Consensus 43 ~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~ 79 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRI 79 (176)
T ss_dssp CCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEE
T ss_pred CCCEEECCCCCCCcc-cccccCCCCCEEECCCCccccc
Confidence 456666666766653 555555 566677777777654
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=80.76 E-value=7.2 Score=41.82 Aligned_cols=27 Identities=7% Similarity=0.075 Sum_probs=21.4
Q ss_pred cCCeeeeeceeeeEEEEecccccEEec
Q 004442 134 KDGGVTLGAMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (753)
+...+..|+...++...|.++|+.++.
T Consensus 265 ~~~~l~s~~~dg~i~vwd~~~~~~~~~ 291 (435)
T 1p22_A 265 DDKYIVSASGDRTIKVWNTSTCEFVRT 291 (435)
T ss_dssp ETTEEEEEETTSEEEEEETTTCCEEEE
T ss_pred CCCEEEEEeCCCeEEEEECCcCcEEEE
Confidence 344577788888888889999988887
|
| >3c75_H MADH, methylamine dehydrogenase heavy chain; copper proteins, electron transfer complex, TTQ, electron transport, oxidoreductase, periplasm, transport, metal- binding; HET: TRQ; 2.50A {Paracoccus versutus} | Back alignment and structure |
|---|
Probab=80.61 E-value=2.3 Score=46.81 Aligned_cols=112 Identities=12% Similarity=0.055 Sum_probs=66.2
Q ss_pred CCCCeeEEEecC-----ceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeecc---------CCCceeeeeccc
Q 004442 46 PEPDVALVAALD-----GTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDV---------DEDWELYFHSKR 111 (753)
Q Consensus 46 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 111 (753)
+.++.+.|++.. |+|+++|..++++.+.+.+|.-- . .+- ..|...-|... +.+-.+.+=+..
T Consensus 82 ~~~~~vyV~n~~~~~~~~~VsVID~~t~~vv~~I~vG~~P-g--ia~-SpDgk~lyVan~~~~~~~~G~~~~~VsviD~~ 157 (426)
T 3c75_H 82 PDARRVYIQDPAHFAAITQQFVIDGSTGRILGMTDGGFLP-H--PVA-AEDGSFFAQASTVFERIARGKRTDYVEVFDPV 157 (426)
T ss_dssp CCTTEEEEEECTTTCSSEEEEEEETTTTEEEEEEEECSSC-E--EEE-CTTSSCEEEEEEEEEETTEEEEEEEEEEECTT
T ss_pred CCCCEEEEECCCcCCCCCeEEEEECCCCEEEEEEECCCCC-c--eEE-CCCCCEEEEEeccccccccCCCCCEEEEEECC
Confidence 556777777764 79999999999999999998622 1 111 11222222322 123344444555
Q ss_pred cCcee-eeccC-HHHH----HHhCceeecCC-eeeeece--eeeEEEEecccccEEecc
Q 004442 112 FGKMK-KLSSS-AEEY----IRRMPYISKDG-GVTLGAM--KTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 112 ~~~~~-~~~~~-~~~~----~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~~~~~ 161 (753)
.+++. ++.+. ...+ --..=.+|.|| .+++... ..++..||.+|++++...
T Consensus 158 t~~vv~~I~v~g~~r~~~g~~P~~~~~spDGk~lyV~n~~~~~~VsVID~~t~kvv~~I 216 (426)
T 3c75_H 158 TFLPIADIELPDAPRFLVGTYQWMNALTPDNKNLLFYQFSPAPAVGVVDLEGKTFDRML 216 (426)
T ss_dssp TCCEEEEEEETTCCCCCBSCCGGGSEECTTSSEEEEEECSSSCEEEEEETTTTEEEEEE
T ss_pred CCcEEEEEECCCccccccCCCcceEEEcCCCCEEEEEecCCCCeEEEEECCCCeEEEEE
Confidence 55554 33321 0000 00122577788 5777654 468899999999999874
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=80.39 E-value=2.4 Score=42.91 Aligned_cols=42 Identities=7% Similarity=-0.163 Sum_probs=19.7
Q ss_pred cccccccCCcccccccc-ccCC-CcccceeecCccccccCCCCC
Q 004442 264 VESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGS 305 (753)
Q Consensus 264 ~~~~l~~nN~ftGsIp~-l~~l-~L~~LnlsnN~fsG~IP~~l~ 305 (753)
|+.+.+.+|++++-.+. +..+ .|+.|++++|++++..|..+.
T Consensus 135 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 178 (270)
T 2o6q_A 135 LTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFD 178 (270)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred CCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhc
Confidence 34445555555543321 3444 455555555555554443333
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=80.19 E-value=1.4 Score=46.98 Aligned_cols=49 Identities=8% Similarity=-0.108 Sum_probs=29.6
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|+|++-.+ .+.++ .|+.|+|++|++++..|..+..+..|.
T Consensus 89 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 139 (361)
T 2xot_A 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ 139 (361)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCC
Confidence 34666666777665443 35555 577777777777766666555544443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=80.09 E-value=1.7 Score=44.28 Aligned_cols=49 Identities=14% Similarity=0.080 Sum_probs=33.1
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
.|+.+.+.+|++++-.+ .+..+ .|+.|++++|++++.+|..+.....|.
T Consensus 154 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 204 (285)
T 1ozn_A 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204 (285)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCccccc
Confidence 45666777777775444 36666 677788888888887777766555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 753 | ||||
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-37 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-36 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-35 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-35 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-35 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-34 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-34 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-33 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-33 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-25 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-17 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-09 |
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 34/291 (11%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQH 526
F K + G+ G V+ VAVK L + + E++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 527 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
NIV G + +YL E C L + + F E E L E + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L LL + G+ L +HRDL +NVL+
Sbjct: 161 LTF-----------------EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGK 201
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + D S W APE L +G T D++S G +L+
Sbjct: 202 VVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 706 TGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ G +PY ++++ + + E + + R
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 7e-39
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 31/289 (10%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHP 527
+ ++I +G+ G V VAVK L + + Q L+A +P
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 528 NIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NIV+ GV + + L E LN+ + + L+ +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR----------SMSPHTVCSLSHSDLSTR 126
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ + L A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 127 ARVSSPGPPPL------SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMV 178
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K++D G+S+ + + W PE + R T D+++ G +L+ +
Sbjct: 179 VKIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 707 GGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
G PY G + E V+D L E+ P E +L P R
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 8e-39
Identities = 62/292 (21%), Positives = 110/292 (37%), Gaps = 55/292 (18%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALK-----EIQNLIASD 524
L + +KE+ G+ GTV + ++VAVK L +D ALK E ++
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQL 65
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+P IVR G+ + + L +E LN +
Sbjct: 66 DNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-------------------------- 98
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 99 --------------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ- 143
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
AK+SD G+SK L+ D + G W APE + + + D++S G +++
Sbjct: 144 -HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 704 CITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ G+ PY G +++ + + P E DL + + R
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 7e-38
Identities = 57/290 (19%), Positives = 102/290 (35%), Gaps = 51/290 (17%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
L++ + E+ G+ G+V V + VA+K L + +E+ ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 527 PNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
P IVR GV + L +E L+ +
Sbjct: 69 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS------------------ 109
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ ++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------------NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--H 146
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
AK+SD G+SK L D S T + G W APE + + + D++S G ++ +
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206
Query: 706 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ G+ PY ++ K + P E L + + R
Sbjct: 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 2e-37
Identities = 63/280 (22%), Positives = 111/280 (39%), Gaps = 49/280 (17%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 536
+ I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV
Sbjct: 11 LLQTIGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 537 SDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
++ +Y+ E Y+ GS + L + + ++L
Sbjct: 70 VEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVLGG--------------- 102
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++
Sbjct: 103 ----------DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLT 150
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GE 714
K TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 151 KEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 715 SFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ V+ + + P ++ + +R
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (354), Expect = 4e-37
Identities = 55/285 (19%), Positives = 106/285 (37%), Gaps = 55/285 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
+E+ G+ G V G + A K ++ H + KEIQ + + +HP +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM-SVLRHPTLVNLHD 90
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D + + + E + L + + E
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------------------------- 124
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ ++ R + GL H+HE +H DLKP+N++ + +S KL D G
Sbjct: 125 -------------EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713
++ L S G++ + APE D++S+G + + ++ G P+G
Sbjct: 172 LTAHLDPKQSVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFG 226
Query: 714 ESFERD--ANIVKDRKDL--FLVEHI-PEAVDLFTRLLDPNPDLR 753
+ + N+ ++ I + D +LL +P+ R
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 271
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 47/281 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 534
+ + G G V + VAVK L + D L E L+ QH +VR Y
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYA 75
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + +Y+ E Y+ +GS + L
Sbjct: 76 VVTQEP-IYIITE----------YMENGSLVDFLKTP----------------------- 101
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+LL + I G++ + E IHRDL+ N+L+ + K++D G+
Sbjct: 102 ----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGL 155
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ ++ + + W APE + G T D++S G +L +T G+ PY G
Sbjct: 156 ARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ ++ + ++ P E L P+ R
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 9e-37
Identities = 61/293 (20%), Positives = 107/293 (36%), Gaps = 42/293 (14%)
Query: 476 VFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALK----EIQNLIAS 523
V K + +G+ G VVL + VAVK L + L E++ +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ G + +Y+ +E + +L + + +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL------------------------Q 111
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P +E + + S L+ + G+ +L IHRDL +NVL+++D
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + G W APE L T D++S G +L+
Sbjct: 172 --NVMKIADFGLARDIHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 703 FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
T G PY G E ++K+ + + E + P R
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 65/290 (22%), Positives = 110/290 (37%), Gaps = 37/290 (12%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQH 526
F K + G+ G VV + +VAVK L + H + + E++ L H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NIV G + + E Y G L +++DS + ++ ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITE----------YCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
E D+E LL + + G++ L IHRDL +N+L++
Sbjct: 136 EDDELALDLE----------DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RI 183
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+ D G+++ ++ D S W APE + T D++S G L+ +
Sbjct: 184 TKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 707 GGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
G PY ++K+ + EH P E D+ D +P R
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 63/283 (22%), Positives = 105/283 (37%), Gaps = 56/283 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVR 531
+ + KG G V L +A+K L K + +E++ + + +HPNI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILR 70
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YG D VYL LE F+EQ
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------------------------ 106
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ ++ + LS+ H +IHRD+KP+N+L+ + K++D
Sbjct: 107 ---------------RTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIAD 149
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G S T G+ + PE + +DL+SLG + + + GK P
Sbjct: 150 FGWSVHAPSSRRT-----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV-GKPP 203
Query: 712 YGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ + ++ R + + + A DL +RLL NP R
Sbjct: 204 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 246
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-36
Identities = 55/281 (19%), Positives = 98/281 (34%), Gaps = 47/281 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYG 534
F +EI G G V L VA+K + + ++E + ++ HP +V+ YG
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYG 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V +Q + L E D
Sbjct: 68 VCLEQAPICLVFEFMEHGCLS--------------------------------------D 89
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ + LL + D+ G+++L E +IHRDL +N L+ ++ K+SD G+
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGM 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ + D T + W +PE R + D++S G +++ + GK PY
Sbjct: 148 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
S + L+ + P+ R
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-36
Identities = 59/287 (20%), Positives = 99/287 (34%), Gaps = 50/287 (17%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
K I G G V + VA+K L + + + ++ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
I+R GV S + + E D
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALD--------------------------------- 97
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
K QL+ + R I +G+ +L + +HRDL +N+L+ + + K
Sbjct: 98 -----KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCK 150
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+SD G+S+ L+ D + G W APE + + T A D++S G +++ +T G
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 709 KHPYGESFERDA-NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+ PY E + + D L P A+ L + R
Sbjct: 211 ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-36
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 49/282 (17%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 534
F KE+ G G V VA+K + + D ++E + ++ + H +V+ YG
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQLYG 66
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + Q +++ E L + + + F+ Q
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-------------------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLL++ +D+ + +L +HRDL +N L+ + K+SD G
Sbjct: 101 -------------QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
+S+ + D T + W PE L+ + + D+++ G +++ + GK PY
Sbjct: 146 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+ A + L+ E V + D R
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 5e-36
Identities = 59/289 (20%), Positives = 101/289 (34%), Gaps = 60/289 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYG 534
E+ G+ G V + A K + + + EI L AS HPNIV+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL-ASCDHPNIVKLLD 76
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
++ +++ +E C +++ ++ L E
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------------------------- 110
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V + + L++LH+ +IHRDLK N+L + D KL+D G
Sbjct: 111 -------------QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFG 155
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGG 708
+S + + + G+ W APE ++ D++SLG L
Sbjct: 156 VSAKNTRTIQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-I 211
Query: 709 KHPYGESFERDA--NIVK-DRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ P+ E I K + L D + L+ N D R
Sbjct: 212 EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR 260
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 61/284 (21%), Positives = 110/284 (38%), Gaps = 57/284 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
++I +G++GTV G+ VA++++ ++ + EI ++ +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLD 84
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E SL D++
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT----------------------------------- 109
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 110 ------ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713
++ + S + T G+ W APE + + +D++SLG + I G+ PY
Sbjct: 162 FCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYL 217
Query: 714 ESFERDA---NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
A +L E + D R LD + + R
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (341), Expect = 6e-36
Identities = 55/288 (19%), Positives = 103/288 (35%), Gaps = 51/288 (17%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
+ I G G V VA+K L + + ++ + ++ HPN+
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ GV + V + E D
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLR------------------------------ 119
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+
Sbjct: 120 --------QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKV 169
Query: 650 SDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
SD G+S+ L+ D S T + W APE + + T A D++S G +++ ++
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 708 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
G+ PY + + N ++ L P A+ L + + R
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 1e-35
Identities = 57/283 (20%), Positives = 108/283 (38%), Gaps = 50/283 (17%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
+ + +G+ G V L +VAVK + + I+ + H N+V++YG
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + YL LE Y G +++
Sbjct: 71 HRREGNIQYLFLE----------YCSGGELFDRIEPD----------------------- 97
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
G P + +++G+ +LH IG+ HRD+KP+N+L+ + K+SD G+
Sbjct: 98 ------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGL 149
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYG 713
+ + + N G+ + APE L + +D++S G +L + G
Sbjct: 150 ATVFRYNNRERLLN-KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 714 ES--FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
S + ++ + + L + I + L ++L NP R
Sbjct: 209 PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-35
Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 38/286 (13%)
Query: 477 FNKEIAKGSNGTV---VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNI 529
F I +G+ G V ++ + A+KR+ K H E++ L HPNI
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ G + ++YL++E NLL+ +R +
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHG-----------------------NLLDFLRKSRVLET 110
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ +++ AK+
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKI 168
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G+S+ + G W A E L T D++S G +L+ ++ G
Sbjct: 169 ADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 710 HPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
PY G + + L + E DL + P R
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 8e-35
Identities = 61/289 (21%), Positives = 105/289 (36%), Gaps = 55/289 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
I GS G +G+ + K L + + E+ L+ +HPNIVR+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRY 68
Query: 533 YGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y D+ +Y+ +E Y G + ++ L+E
Sbjct: 69 YDRIIDRTNTTLYIVME----------YCEGGDLASVITKGTKERQYLDE---------- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQNVLISKDKSF 645
+L+V + L H ++HRDLKP NV + D
Sbjct: 109 ---------------EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQ 151
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
KL D G+++ L D S G+ + +PEQ+ + D++SLGC+L+
Sbjct: 152 NVKLGDFGLARILNHDTSFAK---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 706 TGGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
S + A +++ K + E ++ TR+L+ R
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 132 bits (333), Expect = 9e-35
Identities = 60/288 (20%), Positives = 103/288 (35%), Gaps = 63/288 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVR 531
+EI GS G V VA+K++ + +KE++ + +HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQ 79
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ G + +L +E C S +DL+ V +E
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------ 115
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 116 ---------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGD 158
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 708
G + + + G+ W APE +L +G+ +D++SLG
Sbjct: 159 FGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R 210
Query: 709 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
K P A +I ++ H + L P R
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 63/297 (21%), Positives = 108/297 (36%), Gaps = 67/297 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHHD-VALKEIQN---LIASDQHP 527
+ + I GS GTV Y+G+ VAVK L T L+ +N ++ +H
Sbjct: 10 ITVGQRIGSGSFGTV-----YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 528 NIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + G + + + C SL ++++ FE
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI------------------- 104
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+L+ + R G+ +LH +IHRDLK N+ + +D
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED--LT 142
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 703
K+ D G++ ++ S Q GS W APE + + + D+++ G +L+
Sbjct: 143 VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 704 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLR 753
+T G+ PY RD +V + + L L D R
Sbjct: 202 LMT-GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 51/288 (17%), Positives = 101/288 (35%), Gaps = 51/288 (17%)
Query: 477 FNKEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
FN+ I +G G V +L+ + + AVK L + + + ++ HPN+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 530 VRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ G+ + + L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLR--------------------------------- 117
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ + + L+ + G+ L +HRDL +N ++ D+ F K
Sbjct: 118 -----NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVK 170
Query: 649 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
++D G+++ + N TG W A E L + T D++S G +L+ +T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 708 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
G PY + D + + L E+ P+ + ++ + P ++R
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 3e-34
Identities = 59/298 (19%), Positives = 103/298 (34%), Gaps = 64/298 (21%)
Query: 472 GKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQ 525
G+ + F+ EI +GS TV VA L + +E + ++ Q
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQ 66
Query: 526 HPNIVRWYGV----ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNIVR+Y + + L E + SG+ + L
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYLK------------ 104
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 639
+ L R I+ GL LH +IHRDLK N+ I
Sbjct: 105 -----------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ + K+ D+G++ + + G+ + APE + + ++D+++ G
Sbjct: 148 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEM-YEEKYDESVDVYAFGM 200
Query: 700 ILFFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ T ++PY E + K + PE ++ + N D R
Sbjct: 201 CMLEMAT-SEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 56/281 (19%), Positives = 105/281 (37%), Gaps = 47/281 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYG 534
++ +G G V + VA+K L L+E Q ++ +H +V+ Y
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYA 79
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V S++ +Y+ E +
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFL------------------------------------ 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+
Sbjct: 103 -KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGL 159
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ ++ + Q W APE L GR T D++S G +L T G+ PY G
Sbjct: 160 ARLIEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 714 ESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
+ V+ + PE++ DL + P+ R
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (324), Expect = 9e-34
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 52/285 (18%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV 530
F K + +GS TVVL R A+K L K H + +++++ HP V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ Y D + +Y L Y +G + +
Sbjct: 72 KLYFTFQDDEKLYFGLS----------YAKNGELLKYI---------------------- 99
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
K T +IVS L +LH G+IHRDLKP+N+L+++D +++
Sbjct: 100 -------RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQIT 150
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G +K + S + + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 151 DFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLP 208
Query: 711 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
P+ E I+K D F + P+A DL +LL + R
Sbjct: 209 PFRAGNEYLIFQKIIKLEYD-FPEKFFPKARDLVEKLLVLDATKR 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (328), Expect = 9e-34
Identities = 59/285 (20%), Positives = 100/285 (35%), Gaps = 55/285 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
+E+ G+ G V GR K + + EI ++ HP ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHD 93
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D+ + L LE + L D I E
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------------------------- 126
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
A+++ R GL H+HE ++H D+KP+N++ K+ K+ D G
Sbjct: 127 ------------AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
++ +L D AT + APE + + D++++G + + ++ G P+
Sbjct: 175 LATKLNPDEIVKVTTATAE----FAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFA 229
Query: 713 GESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR 753
GE VK F + PEA D LL P R
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 274
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 59/285 (20%), Positives = 101/285 (35%), Gaps = 52/285 (18%)
Query: 479 KEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 530
K + G+ GTV EG VA+K L + A KEI + ++AS +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R G+ ++ L D +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVR-------------------------------- 102
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ S LL I G+++L + L+HRDL +NVL+ K++
Sbjct: 103 -------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKIT 153
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++K L + G W A E +L T D++S G ++ +T G
Sbjct: 154 DFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 711 PY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
PY G ++I++ + L + + + + D R
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 56/281 (19%), Positives = 100/281 (35%), Gaps = 53/281 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
E+ G+ G V G +A K + +I ++ P IV +YG
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + +E ++ GS ++ L
Sbjct: 72 AFYSDGEISICME----------HMDGGSLDQVL-------------------------- 95
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMG 653
KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D G
Sbjct: 96 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFG 150
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
+S +L M+ + G+ + +PE+L + D++S+G L G++P
Sbjct: 151 VSGQLIDSMAN-----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPIP 204
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ + + + E P L D R
Sbjct: 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-33
Identities = 46/284 (16%), Positives = 101/284 (35%), Gaps = 54/284 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGV 535
+++ +G G V ++ K + D L KEI L +H NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISIL-NIARHRNILHLHES 69
Query: 536 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + + E + + + I + E+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNER--------------------------- 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+++ + L LH + H D++P+N++ +S K+ + G
Sbjct: 103 ------------EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
+++ + + + + APE + A D++SLG +++ ++ G +P+
Sbjct: 151 ARQ----LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLA 205
Query: 714 ESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
E+ ++ + + + F E EA+D RLL R
Sbjct: 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-33
Identities = 57/288 (19%), Positives = 94/288 (32%), Gaps = 55/288 (19%)
Query: 479 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPN 528
+++ GS G V + + SVAVK L D ++E+ + S H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRN 72
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R YGV ++ SL D + G F
Sbjct: 73 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL---------------------- 110
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
L + + G+ +L IHRDL +N+L+ K
Sbjct: 111 -----------------GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVK 151
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+ D G+ + L + W APE L + A D + G L+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 709 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
+ P+ I K+ + L E P + ++ + P+ R
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 6e-33
Identities = 56/287 (19%), Positives = 102/287 (35%), Gaps = 54/287 (18%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
+ I +G G V +VA+K D ++ + HP+I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V+ GV ++ + V++ +E CT L + V S +
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL---------------------- 107
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
A L+ + + L++L +HRD+ +NVL+ + C K
Sbjct: 108 -----------------ASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVK 148
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L D G+S+ ++ G W APE + R T A D++ G ++ + G
Sbjct: 149 LGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 709 KHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
P+ G +++ + L + + P L T+ +P R
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 7e-33
Identities = 60/284 (21%), Positives = 102/284 (35%), Gaps = 47/284 (16%)
Query: 475 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ ++ G G V +VAVK L + +V LKE ++ +HPN+V+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQ 77
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
GV + + Y+ E T E
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------------------------- 112
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ LL + I S + +L + IHRDL +N L+ ++ K++D
Sbjct: 113 ------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVAD 158
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+S+ + GD A W APE L + + D+++ G +L+ T G P
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 712 Y-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
Y G + +++ + E P + +L NP R
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 8e-33
Identities = 56/290 (19%), Positives = 108/290 (37%), Gaps = 45/290 (15%)
Query: 476 VFNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
++E+ +GS G V + VA+K + + E N ++
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 527 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
++VR GV S + +E T L + L +
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL---------- 132
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++++++ +I G+++L+ +HRDL +N ++++D F
Sbjct: 133 --------------------SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--F 170
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + + + G W +PE L G T D++S G +L+
Sbjct: 171 TVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 706 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
T + PY G S E+ V + L ++ P +L NP +R
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 1e-32
Identities = 56/291 (19%), Positives = 101/291 (34%), Gaps = 40/291 (13%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH 526
K + +G+ G V+ + R+VAVK L + H + E++ LI H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 527 PNIVRWYGV-ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
N+V G + + +E C + NL +R +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFC-----------------------KFGNLSTYLRSKR 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--N 171
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + D + W APE + T D++S G +L+
Sbjct: 172 VVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 706 TGGKHPYGESFERD--ANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ G PY + +K+ + ++ PE P R
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-32
Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 53/286 (18%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPN 528
+ +K + KGS G V L E + A+K L K + + E + L + +HP
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ + ++ ++ +E L I Q + + R
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---------------QSCHKFDLSRAT--- 106
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+I+ GL LH G+++RDLK N+L+ KD
Sbjct: 107 ----------------------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHI 142
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K++D G+ K + T G+ + APE LL + ++D +S G +L+ + G
Sbjct: 143 KIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
Query: 708 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+G+ E + ++ + EA DL +L P+ R
Sbjct: 200 QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 63/298 (21%), Positives = 105/298 (35%), Gaps = 59/298 (19%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
I V ++ + G NG V+ A+K L A +E++ + Q P+I
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHI 67
Query: 530 VRWYGV----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
VR V + + + + +E L I +++ E
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTEREAS 114
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 643
++ + I + +LH I + HRD+KP+N+L SK
Sbjct: 115 -------------------------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
+ KL+D G +K S T T Y + APE L + ++ D++SLG I++
Sbjct: 150 NAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 704 CITGGKHPYGESFERDANIVKDR--------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ G Y + +K R + E E L LL P R
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 4e-31
Identities = 61/291 (20%), Positives = 104/291 (35%), Gaps = 59/291 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
+ + G V L R VAVK L + +E QN A+ HP IV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-AALNHPAIVA 71
Query: 532 WYGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
Y + Y+ +E I G +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-------------------- 111
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ ++V D L+ H+ G+IHRD+KP N++I +
Sbjct: 112 -------------------RAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAV 150
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D GI++ + + +TQ A G++ + +PEQ D++SLGC+L+ +T
Sbjct: 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT- 209
Query: 708 GKHPYGESFERDA--NIVKD--RKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
G+ P+ V++ E + + + + L NP+ R
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 121 bits (304), Expect = 6e-31
Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 55/282 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
+ + GS G V L + GR A+K L K + E +++ HP I+R
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVTHPFIIR 68
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+G D +++ ++ +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLL--------------------------------- 95
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K+ P+ ++ L +LH +I+RDLKP+N+L+ DK+ K++D
Sbjct: 96 ------RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +K + T G+ + APE + ++ID +S G +++ + G
Sbjct: 148 FGFAKYVPDVTY------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
Y + + + + + F + DL +RL+ + R
Sbjct: 202 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 243
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 120 bits (302), Expect = 8e-31
Identities = 45/300 (15%), Positives = 91/300 (30%), Gaps = 56/300 (18%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EIQNLIASDQHPN 528
+G + I +GS G + + VA+K + L+ E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
I Y + L ++ SL DL+ + F +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--------------------- 101
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---KSF 645
+ + +++ + +HE L++RD+KP N LI + +
Sbjct: 102 ------------------TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 646 CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+ D G+ K + ++ + G++ + + L Q+R DL +LG +
Sbjct: 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203
Query: 702 FFCITGGKHPYGESFERDANIVKDRKDLF-------LVEHIPEAV-DLFTRLLDPNPDLR 753
+ + G G + + + L PE + D
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 122 bits (306), Expect = 1e-30
Identities = 61/288 (21%), Positives = 102/288 (35%), Gaps = 59/288 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNI 529
+ I +G G V G+ A+K L K +AL E +L+++ P I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V D + L+ + G L+
Sbjct: 70 VCMSYAFHTPDKLSFILD----------LMNGGDLHYHLSQHGV---------------- 103
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
A + +I+ GL H+H +++RDLKP N+L+ D+ ++
Sbjct: 104 -------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRI 148
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 708
SD+G++ + G+ G+ APE L +G + D FSLGC+LF + G
Sbjct: 149 SDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
Query: 709 KHPYGESFERDANIVK--DRKDLFLVEHI-PEAVDLFTRLLDPNPDLR 753
+ I + + L + PE L LL + + R
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (300), Expect = 2e-30
Identities = 56/299 (18%), Positives = 95/299 (31%), Gaps = 54/299 (18%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 527
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
I ++ D+ + +E SL DL S F +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK-------------------- 103
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFC 646
+L + ++S + ++H IHRD+KP N L+ K
Sbjct: 104 -------------------TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144
Query: 647 AKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
+ D G++K+ + + +N G++ + + L Q+R DL SLG +L
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHI--------PEAVDLFTRLLDPNPDLR 753
+ G G + + + I E D +
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 118 bits (296), Expect = 4e-30
Identities = 58/299 (19%), Positives = 100/299 (33%), Gaps = 70/299 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------------ALKEIQNLIASDQ 525
+ + +G + V + AVK + T LKE+ L
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNI++ F +L + + G + L K L+E R
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFD----------LMKKGELFDYLTEKVT----LSEKETR- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
K+ R ++ + LH++ ++HRDLKP+N+L+ D +
Sbjct: 114 ------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDDMN- 148
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFSLGC 699
KL+D G S +L G+ + APE + + +D++S G
Sbjct: 149 -IKLTDFGFSCQLDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 700 ILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR 753
I++ + G P+ ++ F DL +R L P R
Sbjct: 204 IMYTLLA-GSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (297), Expect = 6e-30
Identities = 61/288 (21%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRW 532
F + G+ V+L E + VA+K + K + ++N ++ +HPNIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ +YL ++ + L D I
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIV--------------------------------- 99
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLS 650
+ + ++ ++ + +LH++G++HRDLKP+N+L S D+ +S
Sbjct: 100 -------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+SK + +T G+ G+ APE L Q ++A+D +S+G I + + G
Sbjct: 153 DFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC-GYP 207
Query: 711 PYGESFERD--ANIVKDRKDLF--LVEHIP-EAVDLFTRLLDPNPDLR 753
P+ + + I+K + + I A D L++ +P+ R
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 255
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 2e-29
Identities = 56/288 (19%), Positives = 94/288 (32%), Gaps = 64/288 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---------THHDVALKEIQNLIA-SDQHP 527
+ G G+V + VA+K + K + E+ L S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
++R D L LER + ++ + L E R
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-------------TERGALQEELAR--- 113
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
++ + H H G++HRD+K +N+LI ++
Sbjct: 114 ----------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GEL 150
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706
KL D G L+ + G+ + PE + R R+ ++SLG +L+ +
Sbjct: 151 KLIDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLR 753
G P FE D I+ R +F + + E L L P R
Sbjct: 206 -GDIP----FEHDEEII--RGQVFFRQRVSSECQHLIRWCLALRPSDR 246
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 59/282 (20%), Positives = 100/282 (35%), Gaps = 52/282 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
K + KG+ G V+L GR A+K L K + E + L + +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTA 69
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D + +E
Sbjct: 70 LKYAFQTHDRLCFVMEYANG---------------------------------------G 90
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L + + +IVS L +LH +++RD+K +N+++ DK K++D
Sbjct: 91 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITD 148
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+ K D + + G+ + APE L RA+D + LG +++ + G
Sbjct: 149 FGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
Y + ER ++ + F PEA L LL +P R
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 5e-29
Identities = 56/321 (17%), Positives = 102/321 (31%), Gaps = 77/321 (23%)
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNI 529
I + +V + I KG G V G + G VAVK +E + +H NI
Sbjct: 1 IARTIVLQESIGKGRFGEVWR-GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + ++ + + L + Y GS + LN
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRY------------------ 95
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI--------GLIHRDLKPQNVLISK 641
++K+ SGL+HLH + HRDLK +N+L+
Sbjct: 96 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 141
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLL------QGRQTRAIDL 694
K+ ++D+G++ R + G+ + APE L + D+
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 695 FSLGCILFFCITG---------GKHPYGESFERDANIVKDRK-------------DLFLV 732
+++G + + + PY + D ++ + RK
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 733 EHIPEAVDLFTRLLDPNPDLR 753
E + + N R
Sbjct: 262 EALRVMAKIMRECWYANGAAR 282
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 54/291 (18%), Positives = 100/291 (34%), Gaps = 60/291 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA---------LKEIQNLIASDQHPN 528
+E+ G V G A K + K + +E+ L QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL-KEIQHPN 74
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++ + V ++ V L LE +L + L E
Sbjct: 75 VITLHEVYENKTDVILILELVAG--------------GELFDFLAEKESLTEEEAT---- 116
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFC 646
+ + I++G+ +LH + + H DLKP+N+++
Sbjct: 117 ---------------------EFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+ D G++ ++ + +G+ + APE + D++S+G I + ++
Sbjct: 156 IKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLR 753
G G++ + V F E+ A D RLL +P R
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-27
Identities = 55/312 (17%), Positives = 110/312 (35%), Gaps = 76/312 (24%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
I +G+ G V N VA+K++ H + ++ +H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + +Y+++ +
Sbjct: 74 IIRAPTIEQM----------KDVYLVTH--------------------------LMGADL 97
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+L K + + I+ GL ++H ++HRDLKP N+L++ K+ D G+
Sbjct: 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGL 155
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY- 712
++ D + ++APE +L + T++ID++S+GCIL ++ + +
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFP 214
Query: 713 ---------------GESFERDANIVKDRKDLFLVEHIP----------------EAVDL 741
G + D N + + K + +P +A+DL
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
Query: 742 FTRLLDPNPDLR 753
++L NP R
Sbjct: 275 LDKMLTFNPHKR 286
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 2e-26
Identities = 63/312 (20%), Positives = 111/312 (35%), Gaps = 82/312 (26%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
++I +G+ G V G VA+K++ A++EI L+ HPNIV+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V ++ +YL E L +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFM----------------------------------- 91
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ G P + ++ GL+ H ++HRDLKPQN+LI+ + KL+D
Sbjct: 92 ---DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE--GAIKLADF 146
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
G+++ + T + ++APE LL + + A+D++SLGCI +T +
Sbjct: 147 GLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202
Query: 712 YGESFERD--ANIVKDRKDLFLVEHI----------------------------PEAVDL 741
+ E D I + V + L
Sbjct: 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 742 FTRLLDPNPDLR 753
+++L +P+ R
Sbjct: 263 LSQMLHYDPNKR 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-25
Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 58/291 (19%)
Query: 479 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHP 527
K + G+ G V L G+ G+ A+K L K + E Q L Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+V + + ++L L+
Sbjct: 90 FLVTLHYAFQTETKLHLILDYI-------------------------------------- 111
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L + ++ +IV L HLH++G+I+RD+K +N+L+ +
Sbjct: 112 -NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHV 168
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
L+D G+SK D + + G + +A+D +SLG +++ +T
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT- 227
Query: 708 GKHPYGESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLR 753
G P+ E+++ R+ L P A DL RLL +P R
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 65/315 (20%), Positives = 113/315 (35%), Gaps = 83/315 (26%)
Query: 479 KEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHD-----VALKEIQNL--IASDQHPNI 529
EI +G+ G V + GR VA+KR+ + ++E+ L + + +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 530 VRWYGVESDQDF---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
VR + V + L+L + Y
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY---------------------------- 104
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ G P+ + + ++ GL LH ++HRDLKPQN+L++
Sbjct: 105 --------LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI- 155
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
KL+D G+++ M+ + + ++APE LLQ +DL+S+GCI
Sbjct: 156 -KLADFGLARIYSFQMALTSV----VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210
Query: 707 GGKHPY--------------------------GESFERDANIVKDRKDL--FLVEHIPEA 738
K + + R A K + + F+ +
Sbjct: 211 -RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 739 VDLFTRLLDPNPDLR 753
DL + L NP R
Sbjct: 270 KDLLLKCLTFNPAKR 284
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 2e-25
Identities = 58/313 (18%), Positives = 100/313 (31%), Gaps = 83/313 (26%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNI 529
+ +G TV + VA+K++ H + AL+EI+ L+ HPNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNI 62
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + + L + L +I S
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS---------------------- 100
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ + GL +LH+ ++HRDLKP N+L+ ++ KL
Sbjct: 101 -----------------HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--GVLKL 141
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 708
+D G++K T + ++APE L R +D++++GCIL +
Sbjct: 142 ADFGLAKSFGSPNRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 709 KHPYGESFERDANIVKDRKDLFLVEHIP----------------------------EAVD 740
G+S + + E P + +D
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 741 LFTRLLDPNPDLR 753
L L NP R
Sbjct: 259 LIQGLFLFNPCAR 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-25
Identities = 59/325 (18%), Positives = 112/325 (34%), Gaps = 75/325 (23%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIA 522
+ K +I +G+ G V G+ VA+K+++ + AL+EI+ L
Sbjct: 7 DEVSKYEKL-AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-Q 64
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H N+V + + Y + + D
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-------------------------- 98
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ + +++ +V + +++GL ++H ++HRD+K NVLI++D
Sbjct: 99 -----CEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD 153
Query: 643 KSFCAKLSDMGISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI 700
KL+D G+++ S + + ++ PE LL R IDL+ GCI
Sbjct: 154 GV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 701 LFFCITGGKHPYGESFERDANIVKD--------------------------------RKD 728
+ T G + + ++ +
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 729 LFLVEHIPEAVDLFTRLLDPNPDLR 753
L P A+DL +LL +P R
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQR 296
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-24
Identities = 68/311 (21%), Positives = 113/311 (36%), Gaps = 78/311 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
K I GS G V + G VA+K++++ +E+Q ++ H NIVR
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ-IMRKLDHCNIVRLRYFFY 83
Query: 536 --ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+D VYL+L S +Q L + ++
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPVIYVK--------- 125
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ L+++H G+ HRD+KPQN+L+ D + KL D G
Sbjct: 126 ----------------LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFG 168
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 712
+K+L ++ + Y ++APE + T +ID++S GC+L + G+ +
Sbjct: 169 SAKQLVRGEPNVSYICSRY----YRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIF 223
Query: 713 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 742
D I+K +F PEA+ L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 743 TRLLDPNPDLR 753
+RLL+ P R
Sbjct: 284 SRLLEYTPTAR 294
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 101 bits (251), Expect = 3e-24
Identities = 59/311 (18%), Positives = 116/311 (37%), Gaps = 82/311 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
++I +G+ G V N G + A+K++ D ++EI ++ +H NIV+ Y
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLY 66
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + + L E L L+ V G E
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-------------------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+++G+++ H+ ++HRDLKPQN+LI+++ K++D G
Sbjct: 101 -------------TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPY 712
+++ + + + ++AP+ L+ + + ID++S+GCI + G +
Sbjct: 146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLF 201
Query: 713 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 742
E D I + + FL +DL
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 743 TRLLDPNPDLR 753
+++L +P+ R
Sbjct: 262 SKMLKLDPNQR 272
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (253), Expect = 5e-24
Identities = 56/282 (19%), Positives = 97/282 (34%), Gaps = 55/282 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
K + GS G V+L + G A+K L K + L E + ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVK 105
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D +Y+ +E
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG---------------------------------------G 126
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L + IV +LH + LI+RDLKP+N+LI + ++D
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ--VTD 184
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +KR++G T G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTW------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+ + + + K F + DL LL + R
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (248), Expect = 8e-24
Identities = 61/311 (19%), Positives = 98/311 (31%), Gaps = 80/311 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
++I +G+ GTV + VA+KR+ D AL+EI L +H NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL-KELKHKNIVRL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ V + L E C L +G + +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE------------------------- 101
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ ++ GL H ++HRDLKPQN+LI+++ KL++
Sbjct: 102 --------------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+++ + C + + +ID++S GCI G+ +
Sbjct: 146 GLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 713 ----------------GESFERDANIVKDRKDLFLVEHIP--------------EAVDLF 742
G E + D P DL
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 743 TRLLDPNPDLR 753
LL NP R
Sbjct: 264 QNLLKCNPVQR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.2 bits (241), Expect = 2e-22
Identities = 63/314 (20%), Positives = 121/314 (38%), Gaps = 84/314 (26%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ + G+ G V G VA+K+L + A +E++ L+ +H N++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 82
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + + + + L+ G+ +
Sbjct: 83 LDVFTPDETLDDFTDFY------LVMPFMGTDLGK------------------------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K ++ + ++ GL ++H G+IHRDLKP N+ +++D K+ D
Sbjct: 112 ----LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDF 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHP 711
G++++ +M+ + ++APE +L R T+ +D++S+GCI+ IT GK
Sbjct: 166 GLARQADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTL 218
Query: 712 YGESFERDA--NIVK----------------------------DRKDL--FLVEHIPEAV 739
+ S D I+K ++KD L P AV
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 740 DLFTRLLDPNPDLR 753
+L ++L + + R
Sbjct: 279 NLLEKMLVLDAEQR 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 96.1 bits (238), Expect = 3e-22
Identities = 54/314 (17%), Positives = 94/314 (29%), Gaps = 83/314 (26%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 537
+++ +G V V VK L +EI+ L PNI+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
D +L + D + L + IR
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT---------------LTDYDIR------------- 132
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+I+ L + H +G++HRD+KP NV+I + +L D G+++
Sbjct: 133 ------------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL-RLIDWGLAEF 179
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717
+ A+ Y + ++D++SLGC+L I + +
Sbjct: 180 YHPGQEYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 718 RD--ANIVKDRKDLFLVEHI------------------------------------PEAV 739
D I K L ++I PEA+
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 740 DLFTRLLDPNPDLR 753
D +LL + R
Sbjct: 297 DFLDKLLRYDHQSR 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 3e-20
Identities = 53/313 (16%), Positives = 105/313 (33%), Gaps = 82/313 (26%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V G VAVK+L + + +E++ L+ +H N++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 82
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + + + L+ +
Sbjct: 83 LDVFTPARSLE-----------------------------------EFNDVYLVTHLMGA 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ K + + I+ GL ++H +IHRDLKP N+ + ++ K+ D
Sbjct: 108 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDF 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
G+++ +M+ + ++APE +L + +D++S+GCI+ +TG
Sbjct: 166 GLARHTDDEMT------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 712 YGESFERDANIVKDRKDLFLVEHI-------------------------------PEAVD 740
G ++ E + P AVD
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 741 LFTRLLDPNPDLR 753
L ++L + D R
Sbjct: 280 LLEKMLVLDSDKR 292
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (203), Expect = 2e-17
Identities = 48/280 (17%), Positives = 99/280 (35%), Gaps = 51/280 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
K I G+ G V R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 81
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + Q + + + ++ + + +
Sbjct: 82 LNVFTPQKTLEEFQDVYLV-----MELMDANLCQVIQ----------------------- 113
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ + ++ G+ HLH G+IHRDLKP N+++ D + +
Sbjct: 114 --------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ M+ + ++APE +L +D++S+GCI+ + K +
Sbjct: 166 ARTAGTSFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILF 218
Query: 713 -GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
G + N V ++ E + + ++ P
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 81.6 bits (200), Expect = 3e-17
Identities = 43/238 (18%), Positives = 90/238 (37%), Gaps = 31/238 (13%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRL--VKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
+++ G TV L + VA+K + K + + A EI+ L+ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSM 77
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
++ L + N ++ V + + I
Sbjct: 78 GANHILKLLDHFN-----------------------HKGPNGVHVVMVFEVLGENLLALI 114
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ ++ G P + ++++ ++ GL ++H G+IH D+KP+NVL+ L + I
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKI 173
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + +++PE LL D++S C++F IT G +
Sbjct: 174 ADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT-GDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 54.8 bits (131), Expect = 3e-09
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 33/185 (17%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 538
K + +G V + + VK V+ D
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKV---------------GHTSFKKVKEKRDYGD 50
Query: 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598
F L++ L + + + + N + +ME EL+
Sbjct: 51 LHFSVLAIRSARNEFRALQKLQGLAVPKVY---AWEGNAV---------LMELIDAKELY 98
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658
+ ++L I+ ++ + G++H DL NVL+S+ + D S +
Sbjct: 99 RVRVENPDEVL---DMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVEV 152
Query: 659 QGDMS 663
+
Sbjct: 153 GEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 753 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.21 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.88 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 96.44 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.86 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 95.78 | |
| d1flga_ | 582 | Ethanol dehydrogenase {Pseudomonas aeruginosa [Tax | 95.46 | |
| d1kv9a2 | 560 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 95.13 | |
| d1kb0a2 | 573 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 94.92 | |
| d2ad6a1 | 571 | Methanol dehydrogenase, heavy chain {Methylophilus | 94.3 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 93.88 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.64 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 92.27 | |
| d2ovrb2 | 342 | F-box/WD repeat-containing protein 7, FBXW7 {Human | 91.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 91.31 | |
| d2ad6a1 | 571 | Methanol dehydrogenase, heavy chain {Methylophilus | 91.13 | |
| d1flga_ | 582 | Ethanol dehydrogenase {Pseudomonas aeruginosa [Tax | 90.74 | |
| d1w6sa_ | 596 | Methanol dehydrogenase, heavy chain {Methylobacter | 90.42 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 90.42 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 89.94 | |
| d1pbyb_ | 337 | Quinohemoprotein amine dehydrogenase B chain {Para | 89.86 | |
| d1nexb2 | 355 | Cdc4 propeller domain {Baker's yeast (Saccharomyce | 88.57 | |
| d1w6sa_ | 596 | Methanol dehydrogenase, heavy chain {Methylobacter | 87.9 | |
| d1gxra_ | 337 | Groucho/tle1, C-terminal domain {Human (Homo sapie | 87.04 | |
| d1hzua2 | 426 | C-terminal (heme d1) domain of cytochrome cd1-nitr | 86.48 | |
| d1tbga_ | 340 | beta1-subunit of the signal-transducing G protein | 86.34 | |
| d1kb0a2 | 573 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 85.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 84.55 | |
| d1nr0a1 | 311 | Actin interacting protein 1 {Nematode (Caenorhabdi | 82.32 | |
| d1kv9a2 | 560 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 81.88 | |
| d1gxra_ | 337 | Groucho/tle1, C-terminal domain {Human (Homo sapie | 81.76 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 81.44 | |
| d1vyhc1 | 317 | Platelet-activating factor acetylhydrolase IB subu | 81.13 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 80.3 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=391.02 Aligned_cols=233 Identities=27% Similarity=0.409 Sum_probs=198.7
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC-----C-chHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT-----H-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~-----~-~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|++.+.||+|+||+||+|... +|+.||||++.+. . .....+|+. +++.++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHH-HHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46889999999999999999775 5899999998632 2 223445554 88999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ...+++.++..++.||+.||+|||++
T Consensus 85 mE----------y~~~g~L~~~l~~-----------------------------~~~l~e~~~~~i~~qi~~al~~lH~~ 125 (263)
T d2j4za1 85 LE----------YAPLGTVYRELQK-----------------------------LSKFDEQRTATYITELANALSYCHSK 125 (263)
T ss_dssp EE----------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------ecCCCcHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 6677888887753 24588899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+|+..... .....+||+.|||||++.+..++.++|||||||++|||+
T Consensus 126 ~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 126 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CeeeeeeccccceecCCCC--EeecccceeeecCCC-----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence 9999999999999987765 999999999876543 223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| ++||.+. .......+......++..+++++++||.+||++||++|
T Consensus 199 ~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R 246 (263)
T d2j4za1 199 VG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQR 246 (263)
T ss_dssp HS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cC-CCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHC
Confidence 99 6677655 44555666777777888899999999999999999998
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=391.47 Aligned_cols=238 Identities=23% Similarity=0.362 Sum_probs=189.4
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
++|++.+.||+|+||+||+|...+++.||||++.... .+.+.+|+. +++.++|||||+++|+|.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~~~~~~lv~E--- 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYGVCLEQAPICLVFE--- 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEE---
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHH-HHHhcCCCCcccccceeccCCceEEEEE---
Confidence 4688999999999999999998889999999997543 234455555 7899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.+++... ...+++..+++|+.|||+||+|||+.+|+||
T Consensus 81 -------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr 125 (263)
T d1sm2a_ 81 -------FMEHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125 (263)
T ss_dssp -------CCTTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred -------ecCCCcHHHHhhcc----------------------------ccCCCHHHHHHHHHHHHHHHHhhhccceeec
Confidence 77889998887542 2457888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.+
T Consensus 126 DlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 126 DLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp TCSGGGEEECGGG--CEEECSCC--------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchhheeecCCC--CeEecccchheeccCCCc--eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCC
Confidence 9999999997665 599999999987754322 222334689999999999999999999999999999999998788
Q ss_pred CCCCChH-HHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~-~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||..... .....+.. .....+..+++++.+||.+||+.||++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~R 246 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDR 246 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHC
Confidence 8876543 33333433 3445667788999999999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=390.82 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=197.9
Q ss_pred ecceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
..++|++.+.||+|+||+||+|...+++.||||+++... .+.+.+|+. +++.++|||||+++|+|.+ +..++|||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~-~~~~iv~E- 87 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYAVVTQ-EPIYIITE- 87 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEE-
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHH-HHHhCCCCCEeEEEeeecc-CCeEEEEE-
Confidence 346789999999999999999998888999999997543 334555655 7899999999999999865 45789999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.++++... ...+++.++++|+.|||+||.|||+++|+
T Consensus 88 ---------y~~~g~L~~~~~~~~---------------------------~~~l~~~~~~~i~~qi~~gl~~lH~~~iv 131 (272)
T d1qpca_ 88 ---------YMENGSLVDFLKTPS---------------------------GIKLTINKLLDMAAQIAEGMAFIEERNYI 131 (272)
T ss_dssp ---------CCTTCBHHHHTTSHH---------------------------HHTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------eCCCCcHHHHHhhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 778899988775432 23588999999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||||+.++ .+||+|||+|+....... .......||+.|||||++.++.++.++|||||||++|||+||+
T Consensus 132 HrDiKp~NIll~~~~--~~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~ 207 (272)
T d1qpca_ 132 HRDLRAANILVSDTL--SCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG 207 (272)
T ss_dssp CSCCSGGGEEECTTS--CEEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTT
T ss_pred cCccchhheeeeccc--ceeeccccceEEccCCcc--ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCC
Confidence 999999999997664 599999999998764322 2233456899999999999999999999999999999999987
Q ss_pred CCCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+|+...... ....+.. .....+..+++++.+||.+||+.||++|
T Consensus 208 ~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~R 254 (272)
T d1qpca_ 208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDR 254 (272)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHC
Confidence 8888765433 3333433 3455677889999999999999999998
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=393.27 Aligned_cols=238 Identities=27% Similarity=0.410 Sum_probs=197.3
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-----Cc-hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-----~~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+. .. +...+|+. +++.++|||||++++++.+++..|+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHH-HHHHcCCCCeeEEEEEEEECCEEEE
Confidence 35799999999999999999976 46999999998642 22 23445555 7899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 86 vmE----------y~~gg~L~~~~~~-----------------------------~~~l~e~~~~~~~~qi~~al~ylH~ 126 (288)
T d1uu3a_ 86 GLS----------YAKNGELLKYIRK-----------------------------IGSFDETCTRFYTAEIVSALEYLHG 126 (288)
T ss_dssp EEC----------CCTTEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------ccCCCCHHHhhhc-----------------------------cCCCCHHHHHHHHHHHHHHHHhhcc
Confidence 999 6667888777643 2468889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++. +||+|||+|+.+..... .......+||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 ~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 127 KGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred ccEEcCcCCccccccCCCce--EEecccccceecccCCc-ccccccccCCccccCceeeccCCCCcccceehhhHHHHHH
Confidence 99999999999999977765 99999999998754321 2223456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|| .+||... .......+......++..+++++++||++||++||++|
T Consensus 204 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 204 VAG-LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKR 252 (288)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGS
T ss_pred hhC-CCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHC
Confidence 999 6777655 44445666677777888999999999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=388.60 Aligned_cols=238 Identities=25% Similarity=0.388 Sum_probs=191.5
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .+...+|+. +++.++|||||++++++.+++..||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-INKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHH-HHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 35789999999999999999976 469999999996543 223456665 889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.++|.. ...+++.++..++.||+.||+|||+++
T Consensus 83 E----------y~~gg~L~~~l~~-----------------------------~~~l~e~~~~~i~~qi~~al~ylH~~~ 123 (271)
T d1nvra_ 83 E----------YCSGGELFDRIEP-----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIG 123 (271)
T ss_dssp E----------CCTTEEGGGGSBT-----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------ccCCCcHHHHHhc-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 9 6667777776632 245788999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+|||++.++. +||+|||+|+....... .......+||+.|||||++.+..+ +.++|||||||++|||+
T Consensus 124 IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml 200 (271)
T d1nvra_ 124 ITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200 (271)
T ss_dssp EECSCCCGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHH
T ss_pred CccCcccHHHEEECCCCC--EEEccchhheeeccCCc-cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHH
Confidence 999999999999977765 99999999998754322 122345679999999999988876 68899999999999999
Q ss_pred hCCCCCCCCChHH--HHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER--DANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~--~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| ++||...... ......... .......++++.+||++||++||++|
T Consensus 201 ~G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (271)
T d1nvra_ 201 AG-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251 (271)
T ss_dssp HS-SCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred hC-CCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 98 6787654322 222222222 22335678999999999999999998
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.3e-46 Score=391.72 Aligned_cols=240 Identities=23% Similarity=0.320 Sum_probs=199.0
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.++|++.+.||+|+||+||+|... +|+.||||+++... .+.+.+|+. +++.++|||||+++|+|.+++..++|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~iv~E- 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE- 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEE-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHH-HHHhCCCCCEecCCccEeeCCeeEEEee-
Confidence 356888999999999999999765 58999999997543 344556665 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.++|.... ...+++..+++|+.|||+||+|||+++|+
T Consensus 94 ---------~~~~g~l~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~ii 137 (287)
T d1opja_ 94 ---------FMTYGNLLDYLRECN---------------------------RQEVSAVVLLYMATQISSAMEYLEKKNFI 137 (287)
T ss_dssp ---------CCTTCBHHHHHHHSC---------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ---------cccCcchHHHhhhcc---------------------------ccchHHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 777888888876432 24678889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+||||+.++ .+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 138 HrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~ 213 (287)
T d1opja_ 138 HRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 213 (287)
T ss_dssp CSCCSGGGEEECGGG--CEEECCCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTS
T ss_pred cCccccCeEEECCCC--cEEEccccceeecCCCCce--eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCC
Confidence 999999999997765 5999999999877543222 222334789999999999999999999999999999999987
Q ss_pred CCCCCCChHHH-HHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~~~-~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||....... ...+... ....+..+++++.+||.+||+.||++|
T Consensus 214 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 260 (287)
T d1opja_ 214 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260 (287)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHC
Confidence 77776654433 3344433 455677889999999999999999998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=390.92 Aligned_cols=234 Identities=25% Similarity=0.411 Sum_probs=193.3
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
++|++.+.||+|+||+||+|.. .+|+.||||++.... .+...+|+. +++.++|||||++++++.+++..|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmE- 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVME- 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEE-
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHH-HHHhCCCCCEeeEeEEEEECCEEEEEEE-
Confidence 4678889999999999999975 469999999986432 234556665 8899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++. ...+++.++..++.||+.||+|||++||+
T Consensus 98 ---------y~~gg~L~~~~~------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ii 138 (293)
T d1yhwa1 98 ---------YLAGGSLTDVVT------------------------------ETCMDEGQIAAVCRECLQALEFLHSNQVI 138 (293)
T ss_dssp ---------CCTTCBHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------ecCCCcHHHHhh------------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 666788877643 23578889999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~ 708 (753)
||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++.+..++.++|||||||++|||+||
T Consensus 139 HrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG- 212 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG- 212 (293)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS-
T ss_pred ccCCcHHHeEECCCCc--Eeeccchhheeecccc---ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhC-
Confidence 9999999999987765 9999999999875432 223455799999999999999999999999999999999998
Q ss_pred CCCCCCChH-HHHHH-HHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 709 KHPYGESFE-RDANI-VKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 709 ~~Pf~~~~~-~~~~~-i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.+... ..... ..... ...+..+++++++||.+||++||++|
T Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 261 (293)
T d1yhwa1 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR 261 (293)
T ss_dssp SCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHC
Confidence 678765533 33322 22222 33456789999999999999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=394.45 Aligned_cols=236 Identities=26% Similarity=0.344 Sum_probs=201.9
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|++.+.||+|+||+||++.. .+|+.||||++++. ..+...+|+. +++.++|||||++++++.+++.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHH-HHHhCCCCCEEEEEeeeccccccccc
Confidence 4689999999999999999976 56999999999643 2234556655 88999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.+++.. ...+++..+..++.||+.||+|||++
T Consensus 84 ~e----------y~~gg~L~~~~~~-----------------------------~~~~~e~~~~~~~~qil~al~ylH~~ 124 (337)
T d1o6la_ 84 ME----------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EE----------CCTTCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ee----------ccCCCchhhhhhc-----------------------------ccCCcHHHHHHHHHHHhhhhhhhhhc
Confidence 99 7778888887753 35678889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 125 ~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CccccccCHHHeEecCCCC--EEEeecccccccccCC---cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 9999999999999987765 9999999998764322 2334567999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+.++.+.........+......++..+++++++||++||++||++|
T Consensus 200 ~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 247 (337)
T d1o6la_ 200 CGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhh
Confidence 995444444555666777777888899999999999999999999998
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=387.46 Aligned_cols=239 Identities=23% Similarity=0.355 Sum_probs=184.8
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC--CceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~--~~~~~L 544 (753)
++|++.+.||+|+||+||+|.. .+|+.||||.+..... +.+.+|+. +++.++|||||++++++.+ ++.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHH-HTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHH-HHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 5689999999999999999976 4689999999965432 22344554 7899999999999999865 456899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++..... ....+++..+++++.||+.||.|||+
T Consensus 83 vmE----------y~~~g~L~~~i~~~~~-------------------------~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 83 VME----------YCEGGDLASVITKGTK-------------------------ERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EEE----------CCTTEEHHHHHHHHHH-------------------------HTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEe----------cCCCCcHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 7778888888764421 23568999999999999999999998
Q ss_pred CC-----ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 625 IG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 625 ~~-----IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
.+ |+||||||+||||+.++. +||+|||+|+...... ......+||+.|||||++.+..++.++|||||||
T Consensus 128 ~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 202 (269)
T d2java1 128 RSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDT---SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202 (269)
T ss_dssp HCC---------CCGGGEEECTTSC--EEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred hcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCC---CccccCCCCcccCCHHHHcCCCCChHHHHHhhCH
Confidence 76 999999999999977765 9999999999875432 2234567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|| .+||.+... .....+... ....+..+++++.+||++||+.||++|
T Consensus 203 ilyel~tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R 257 (269)
T d2java1 203 LLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHR 257 (269)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhhC-CCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHC
Confidence 99999999 667766543 334444443 345677899999999999999999998
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-45 Score=389.93 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=185.2
Q ss_pred ecceEEEeEEecccCceEEEEEEeeC-C---cEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNYE-G---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~~-g---~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
..+.|.+.+.||+|+||+||+|.... | ..||||++...... .+.+|+. +++.++|||||+++|+|.+++..
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSC
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHH-HHHhCCCCCCccEEEEEeeCCEE
Confidence 34678999999999999999997642 3 36999998654332 3455555 78999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|+|.+++... ...+++.++++|+.|||+||+||
T Consensus 103 ~iv~E----------y~~~g~L~~~~~~~----------------------------~~~l~~~~~~~i~~qia~gl~yL 144 (299)
T d1jpaa_ 103 MIITE----------FMENGSLDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYL 144 (299)
T ss_dssp EEEEE----------CCTTEEHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ecCCCcceeeeccc----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 77788888876532 24588999999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccc--cCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|+++|+||||||+||||+.++ .+||+|||+|+.......... ......||+.|||||.+.++.++.++|||||||+
T Consensus 145 H~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvv 222 (299)
T d1jpaa_ 145 ADMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIV 222 (299)
T ss_dssp HHTTCCCSCCCGGGEEECTTC--CEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred hhCCCccCccccceEEECCCC--cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHH
Confidence 999999999999999997665 599999999998764322211 1222457999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|++++||.+.. ......+... ..+.+..+++++.+||.+||+.||++|
T Consensus 223 l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 277 (299)
T d1jpaa_ 223 MWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277 (299)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHC
Confidence 9999995477886653 3344444443 455677889999999999999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-45 Score=387.31 Aligned_cols=236 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+.|++.+.||+|+||+||+|... +|+.||||++..... +.+.+|+. +++.++|||||++++++.+++..+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lvmE- 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIE- 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEE-
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCeEEEEEe-
Confidence 46889999999999999999764 689999999965432 34566665 7899999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|+++|+|.+++... ...+++.++..++.||+.||.|||+++|+
T Consensus 90 ---------y~~~g~L~~~~~~~----------------------------~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 90 ---------FCAGGAVDAVMLEL----------------------------ERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp ---------CCTTEEHHHHHHHH----------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ---------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 66778888776432 24588899999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccccccc-----CCCCCchhhHHHHHHHHHH
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDIwSfGvvL~E 703 (753)
||||||+|||++.++. +||+|||+|+..... .......+||+.|+|||++. +..|+.++|||||||++||
T Consensus 133 HrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 133 HRDLKAGNILFTLDGD--IKLADFGVSAKNTRT---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp CCCCSGGGEEECTTSC--EEECCCTTCEECHHH---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred EeecChhheeECCCCC--EEEEechhhhccCCC---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 9999999999987765 999999999865432 12234567999999999984 4568999999999999999
Q ss_pred HHhCCCCCCCCC-hHHHHHHHHccC---cccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGES-FERDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~-~~~~~~~i~~~~---~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| ++||.+. .......+.... ...+..+++++.+||++||++||++|
T Consensus 208 mltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 208 MAEI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp HHHS-SCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HhhC-CCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHC
Confidence 9999 6677654 333333333332 23456789999999999999999998
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=383.54 Aligned_cols=241 Identities=25% Similarity=0.342 Sum_probs=186.5
Q ss_pred cceEEEeEEecccCceEEEEEEeeCC-----cEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEG-----RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g-----~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
...|++.+.||+|+||.||+|..... ..||||++.....+ .+.+|+. +++.++|||||+++|+|.+.+..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-IMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHH-HHHhcCCCCEeeeeEEEecCCce
Confidence 34688889999999999999976542 47999999654322 3445554 88999999999999999999999
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+.+|++.+++... ...+++.++++++.|||.||+||
T Consensus 85 ~~v~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~gl~~l 126 (283)
T d1mqba_ 85 MIITE----------YMENGALDKFLREK----------------------------DGEFSVLQLVGMLRGIAAGMKYL 126 (283)
T ss_dssp EEEEE----------CCTTEEHHHHHHHT----------------------------TTCSCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ecccCcchhhhhcc----------------------------cccccHHHHHHHHHHHHHhhhhc
Confidence 99999 55667776655422 24588899999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+.+|+||||||+||||+.++ .+||+|||+++.+..............||+.|||||++.++.++.++|||||||++|
T Consensus 127 H~~~iiHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~ 204 (283)
T d1mqba_ 127 ANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 204 (283)
T ss_dssp HHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred cccccccCccccceEEECCCC--eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHH
Confidence 999999999999999997765 599999999998765433222333446899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+||+.+|+..... .....+..+ ..+.+..+++++.+||.+||+.||++|
T Consensus 205 el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 257 (283)
T d1mqba_ 205 EVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257 (283)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTS
T ss_pred HHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHC
Confidence 999987777766533 334444443 455677789999999999999999998
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=385.14 Aligned_cols=239 Identities=24% Similarity=0.331 Sum_probs=194.6
Q ss_pred ceEEEeEE-ecccCceEEEEEEee---CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKE-IAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~-IG~G~fG~Vyka~~~---~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
+++.+.+. ||+|+||+||+|... ++..||||+++.... +.+.+|+. +++.++|||||+++|+|.+ +..||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHH-HHHhCCCCCEeeEeeeecc-CeEEE
Confidence 45667774 999999999999543 356899999975432 23445554 7899999999999999865 46899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ...+++.++++|+.|||.||+|||+
T Consensus 86 vmE----------~~~~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 86 VME----------MAGGGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp EEE----------CCTTEEHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eCCCCcHHHHhhcc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 77788888876432 2457889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
++|+||||||+|||++.++ .+||+|||+|+.+..............||+.|+|||++.+..++.++|||||||++|||
T Consensus 128 ~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 128 KNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205 (285)
T ss_dssp TTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCeecCcCchhheeeccCC--ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHH
Confidence 9999999999999998775 59999999999887654444444556789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~-~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|.+.+||.+.. .+....+..+ ....+..+++++.+||.+||+.||++|
T Consensus 206 lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~R 256 (285)
T d1u59a_ 206 LSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDR 256 (285)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHC
Confidence 994478887653 3344444443 455678899999999999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=385.46 Aligned_cols=232 Identities=25% Similarity=0.343 Sum_probs=187.1
Q ss_pred EEecccCceEEEEEEeeC---CcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 479 KEIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~---g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
+.||+|+||+||+|...+ ++.||||+++.... +.+.+|+. +++.++|||||+++|+|.+ +..+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~g~~~~-~~~~lvmE--- 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVME--- 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHH-HHHTCCCTTBCCEEEEEES-SSEEEEEE---
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHH-HHHhCCCCCCceEEEEecc-CCEEEEEE---
Confidence 569999999999996543 57899999964321 23455554 7899999999999999865 45789999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++++. ...+++.++++|+.|||.||+|||+.+|+||
T Consensus 88 -------~~~~g~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 88 -------MAELGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp -------CCTTEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred -------cCCCCcHHHHHhh-----------------------------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence 7778888887753 2458889999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++ .+||+|||+++................||+.|||||++.+..++.++|||||||++|||+|.+++
T Consensus 132 DlKp~Nill~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 132 DLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp CCSGGGEEEEETT--EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcchhhcccccC--cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence 9999999998775 49999999999876554444444556799999999999999999999999999999999984478
Q ss_pred CCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||.+.... ....+.. .....+..+++++.+||.+||+.||++|
T Consensus 210 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~R 254 (277)
T d1xbba_ 210 PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENR 254 (277)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHC
Confidence 88765433 3344444 3455678889999999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=379.89 Aligned_cols=238 Identities=22% Similarity=0.349 Sum_probs=196.9
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC--chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~--~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c~ 550 (753)
++|++.+.||+|+||+||+|...+++.||||+++... .+.+.+|+. +++.++|||||+++|+|.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~-~~~~l~HpnIv~~~g~~~~~~~~~iv~E--- 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQLYGVCTKQRPIFIITE--- 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHH-HHHTCCCTTBCCEEEEECCSSSEEEEEE---
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHH-HHHhcCCCceeeEEEEEeeCCceEEEEE---
Confidence 3566778899999999999998888899999997643 344555554 8899999999999999999999999999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+.+|+|.+++... ...+++..+++++.|||+||+|||+.+|+||
T Consensus 80 -------y~~~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~ 124 (258)
T d1k2pa_ 80 -------YMANGCLLNYLREM----------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124 (258)
T ss_dssp -------CCTTEEHHHHHHSG----------------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCS
T ss_pred -------ccCCCcHHHhhhcc----------------------------ccCCcHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence 77778888776433 2457788899999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|+++.
T Consensus 125 dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 125 DLAARNCLVNDQG--VVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp CCSGGGEEECTTC--CEEECCCSSCCBCSSSSC--CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccceeEEEcCCC--cEEECcchhheeccCCCc--eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCC
Confidence 9999999997765 499999999987654322 222345689999999999999999999999999999999995588
Q ss_pred CCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+... ....+...++++.+||++||+.||++|
T Consensus 201 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 245 (258)
T d1k2pa_ 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADER 245 (258)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred CCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHC
Confidence 99876443 33444443 445667788999999999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=387.52 Aligned_cols=236 Identities=24% Similarity=0.376 Sum_probs=201.2
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|.+.+.||+|+||+||+|... +|+.||||++++. ..+..++|+..+...++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46889999999999999999765 5999999999642 2335667776566689999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.++++.. ..+++.++..++.||+.||+|||++
T Consensus 82 mE----------y~~~g~L~~~i~~~-----------------------------~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 82 ME----------YLNGGDLMYHIQSC-----------------------------HKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp EE----------CCTTCBHHHHHHHH-----------------------------SSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred Ee----------ecCCCcHHHHhhcc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 77788998887532 4578889999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 123 ~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml 197 (320)
T d1xjda_ 123 GIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197 (320)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CeeeccCcccceeecCCCc--eeccccchhhhccccc---ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHH
Confidence 9999999999999977765 9999999998765332 2234457999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| ++||.+. .......+......++..+++++.+||++||++||++|
T Consensus 198 tG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R 245 (320)
T d1xjda_ 198 IG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 245 (320)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hC-CCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCC
Confidence 98 6677654 44555666777778888899999999999999999998
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-45 Score=388.49 Aligned_cols=240 Identities=24% Similarity=0.398 Sum_probs=183.3
Q ss_pred ceecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
+.+.+.|++.+.||+|+||+||+|... +|+.||||++.+.. .....+|+. +++.++|||||++++++.+++..|
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA-VLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHH-HHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEE
Confidence 345677999999999999999999764 58999999996543 223345665 789999999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
|||| |+++|+|.++|.. ...+++.++..++.||+.||+|||
T Consensus 84 lvmE----------~~~gg~L~~~l~~-----------------------------~~~l~e~~~~~~~~qi~~al~ylH 124 (307)
T d1a06a_ 84 LIMQ----------LVSGGELFDRIVE-----------------------------KGFYTERDASRLIFQVLDAVKYLH 124 (307)
T ss_dssp EEEC----------CCCSCBHHHHHHT-----------------------------CSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEe----------ccCCCcHHHhhhc-----------------------------ccCCCHHHHHHHHHHHHHHHHhhh
Confidence 9999 6667888887742 246889999999999999999999
Q ss_pred hCCccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
+.+|+||||||+|||+.. +.+..+||+|||+|+..... ......+||+.|||||++.+..++.++|||||||++|
T Consensus 125 ~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvily 200 (307)
T d1a06a_ 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAY 200 (307)
T ss_dssp HTTCCCSCCCGGGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred hceeeeEEecccceeecccCCCceEEEeccceeEEccCC----CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHH
Confidence 999999999999999964 22345999999999876432 2234567999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESF-ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~-~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| .+||.+.. ......+...... .+..+++++.+||++||++||++|
T Consensus 201 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 255 (307)
T d1a06a_ 201 ILLCG-YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKR 255 (307)
T ss_dssp HHHHS-SCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHC
Confidence 99998 66776654 3344444444332 335788999999999999999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-44 Score=385.90 Aligned_cols=233 Identities=24% Similarity=0.372 Sum_probs=196.2
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC-----CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~-----~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|+||+||+|.. .+|+.||||++++. ...+.+.++..+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999976 46999999999642 22233334445889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+.+|+|..++.. ...+++..+..++.||+.||+|||+++
T Consensus 84 E----------~~~gg~l~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 124 (316)
T d1fota_ 84 D----------YIEGGELFSLLRK-----------------------------SQRFPNPVAKFYAAEVCLALEYLHSKD 124 (316)
T ss_dssp C----------CCCSCBHHHHHHH-----------------------------TSSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred e----------ecCCccccccccc-----------------------------cccccccHHHHHHHHHHHhhhhhccCc
Confidence 9 6666777766543 345677888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||||+.++. +||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||+|
T Consensus 125 iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemlt 196 (316)
T d1fota_ 125 IIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196 (316)
T ss_dssp EECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred EEccccCchheeEcCCCC--EEEecCccceEeccc------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHh
Confidence 999999999999977765 999999999987542 234679999999999999999999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.+. .......+......++..+++++.++|++||.+||++|
T Consensus 197 G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R 243 (316)
T d1fota_ 197 G-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQR 243 (316)
T ss_dssp S-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTC
T ss_pred C-CCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhc
Confidence 9 5677554 44555666677777888999999999999999999998
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=379.77 Aligned_cols=240 Identities=21% Similarity=0.320 Sum_probs=198.1
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC---------chHHHHHHHHHHHhCCCCceeeecccccC
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 538 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~ 538 (753)
..+.++|++.+.||+|+||+||+|.. .+|+.||||++.+.. .+.+.+|+. +++.++|||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEE
Confidence 34567899999999999999999976 469999999996432 123456665 7899999999999999999
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
++..||||| |+++|+|.+++.. ...+++..+..++.||+.|
T Consensus 85 ~~~~~iv~E----------~~~gg~L~~~i~~-----------------------------~~~l~~~~~~~~~~qi~~a 125 (293)
T d1jksa_ 85 KTDVILILE----------LVAGGELFDFLAE-----------------------------KESLTEEEATEFLKQILNG 125 (293)
T ss_dssp SSEEEEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEE----------cCCCccccchhcc-----------------------------ccccchhHHHHHHHHHHHH
Confidence 999999999 6677888887743 2458889999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCC--CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~--~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwS 696 (753)
|+|||+.+|+||||||+|||++.++. ..+||+|||+|+...... ......||+.|+|||++.+..++.++||||
T Consensus 126 l~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwS 201 (293)
T d1jksa_ 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201 (293)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred HHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc----cccccCCCCcccCHHHHcCCCCCCcccchh
Confidence 99999999999999999999987663 259999999998875432 234456899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh-HHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 697 LGCILFFCITGGKHPYGESF-ERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 697 fGvvL~EllTG~~~Pf~~~~-~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|||+|| ++||.+.. ......+...... .+...++++++||++||++||++|
T Consensus 202 lGvilyell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 262 (293)
T d1jksa_ 202 IGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 262 (293)
T ss_dssp HHHHHHHHHHS-SCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred hhHHHHHHHcC-CCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHC
Confidence 99999999999 66776543 3444444444333 335788999999999999999998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=381.75 Aligned_cols=239 Identities=25% Similarity=0.378 Sum_probs=192.3
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc--hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~c 549 (753)
.++|++.+.||+|+||+||+|...+++.||||+++.... +.+.+|+. +++.++|+|||+++|+|.+ +..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~-~l~~l~h~nIv~~~g~~~~-~~~~lv~E-- 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE-- 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEC--
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHH-HHHhcccCCEeEEEEEEec-CCeEEEEE--
Confidence 357899999999999999999988888999999975432 34555554 7899999999999999965 56789999
Q ss_pred cCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCccc
Q 004442 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (753)
Q Consensus 550 ~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiH 629 (753)
|+++|+|.++++... ...+++.++++|+.|||.||+|||+.+|+|
T Consensus 92 --------y~~~g~l~~~~~~~~---------------------------~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH 136 (285)
T d1fmka3 92 --------YMSKGSLLDFLKGET---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVH 136 (285)
T ss_dssp --------CCTTCBHHHHHSHHH---------------------------HTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --------ecCCCchhhhhhhcc---------------------------cccchHHHHHHHHHHHHHHHHHHhhhheec
Confidence 777888888876532 245899999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCC
Q 004442 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (753)
Q Consensus 630 rDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~ 709 (753)
|||||+||||+.++ .+||+|||+++....... .......||+.|+|||++..+.++.++|||||||++|||+||+.
T Consensus 137 ~DlKp~NIll~~~~--~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~ 212 (285)
T d1fmka3 137 RDLRAANILVGENL--VCKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212 (285)
T ss_dssp SCCSGGGEEECGGG--CEEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccceEEEECCCC--cEEEcccchhhhccCCCc--eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCC
Confidence 99999999997665 599999999987654322 22234568999999999999999999999999999999999878
Q ss_pred CCCCCChHH-HHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 710 HPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 710 ~Pf~~~~~~-~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+...... ....+.. ...+.+..+++++.+||.+||+.||++|
T Consensus 213 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 258 (285)
T d1fmka3 213 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 258 (285)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHC
Confidence 777765443 3343433 3456778889999999999999999998
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=381.54 Aligned_cols=236 Identities=23% Similarity=0.311 Sum_probs=181.0
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC----c-hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~----~-~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++|.+.+.||+|+||+||+|... ..||||+++... . +.+.+|+ .+++.++|||||+++|++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 355677889999999999998653 469999996432 1 2333454 48899999999999999865 4679999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.++|+.. ...+++.++++|+.|||+||+|||+++
T Consensus 83 E----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ 124 (276)
T d1uwha_ 83 Q----------WCEGSSLYHHLHII----------------------------ETKFEMIKLIDIARQTAQGMDYLHAKS 124 (276)
T ss_dssp E----------CCCEEEHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred e----------cCCCCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 9 77788888888542 235788999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL~E 703 (753)
|+||||||+||||+.++. +||+|||+|+....... ........||+.|||||++.+ ..++.++|||||||++||
T Consensus 125 ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~e 201 (276)
T d1uwha_ 125 IIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201 (276)
T ss_dssp CCCSCCCGGGEEEETTSS--EEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHH
T ss_pred EeccccCHHHEEEcCCCC--EEEccccceeeccccCC-cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHH
Confidence 999999999999977754 99999999987654321 123345579999999999864 358999999999999999
Q ss_pred HHhCCCCCCCCChH--HHHHHHHccC-c----ccccCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFE--RDANIVKDRK-D----LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~--~~~~~i~~~~-~----~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| +.||.+... .....+.... . ..+.++++++.+||.+||+.||++|
T Consensus 202 l~tg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~R 257 (276)
T d1uwha_ 202 LMTG-QLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257 (276)
T ss_dssp HHHS-SCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHC-CCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHC
Confidence 9998 678876432 2233333322 1 2345678999999999999999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-44 Score=384.15 Aligned_cols=232 Identities=24% Similarity=0.333 Sum_probs=186.3
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.+.|+..+.||+|+||+||+|.. .+|+.||||++..... +.+.+|+. +++.++|||||++++++.+++..||
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHH-HHHHCCCCCEeeEEEEEEECCEEEE
Confidence 35688999999999999999975 5689999999975431 23455665 7899999999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||||| .+|+|..++. ....+++.++..++.||+.||.|||+
T Consensus 93 v~E~~----------~~g~l~~~~~-----------------------------~~~~l~e~~~~~i~~qi~~aL~yLH~ 133 (309)
T d1u5ra_ 93 VMEYC----------LGSASDLLEV-----------------------------HKKPLQEVEIAAVTHGALQGLAYLHS 133 (309)
T ss_dssp EEECC----------SEEHHHHHHH-----------------------------HTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEec----------CCCchHHHHH-----------------------------hCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99955 4555544332 23468899999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC---CCCCchhhHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 701 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDIwSfGvvL 701 (753)
++|+||||||+||||+.++ .+||+|||+|+..... ...+||+.|||||++.+ +.|+.++|||||||++
T Consensus 134 ~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~~~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvil 204 (309)
T d1u5ra_ 134 HNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (309)
T ss_dssp TTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHH
T ss_pred CCEeccCCCcceEEECCCC--CEEEeecccccccCCC-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHH
Confidence 9999999999999998775 4999999999865432 34569999999999864 4589999999999999
Q ss_pred HHHHhCCCCCCCCC-hHHHHHHHHccC-cc-cccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGES-FERDANIVKDRK-DL-FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~-~~~~~~~i~~~~-~~-~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++| .+||.+. .......+.... +. ....+++++.+||.+||++||++|
T Consensus 205 yel~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 258 (309)
T d1u5ra_ 205 IELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258 (309)
T ss_dssp HHHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHC
Confidence 999999 5677554 333333333332 22 344679999999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-44 Score=389.79 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=197.7
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+-++|.+.+.||+|+||+||+|.. .+|+.||||++..... +...+|+. +++.++|||||++++++.+++..||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHH-HHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345799999999999999999976 4699999999976542 23345554 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ...+++..+..|+.||+.||+|||+++
T Consensus 103 E----------~~~gg~L~~~l~~~----------------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~ 144 (350)
T d1koaa2 103 E----------FMSGGELFEKVADE----------------------------HNKMSEDEAVEYMRQVCKGLCHMHENN 144 (350)
T ss_dssp C----------CCCSCBHHHHHTCT----------------------------TSCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------cCCCCCHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 9 77788888877432 245889999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+|||++.+++..+||+|||+|+.+.... ......||+.|||||++.+..++.++|||||||++|||+|
T Consensus 145 iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~ 220 (350)
T d1koaa2 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220 (350)
T ss_dssp EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH
T ss_pred CeeeeechhHeeeccCCCCeEEEeecchheeccccc----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh
Confidence 999999999999977655679999999999875432 2234568999999999999999999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES-FERDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~-~~~~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.+. .......+...... ....+++++++||++||++||++|
T Consensus 221 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 271 (350)
T d1koaa2 221 G-LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTR 271 (350)
T ss_dssp S-SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGS
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHC
Confidence 8 6677654 34444444443322 335688999999999999999998
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=373.90 Aligned_cols=232 Identities=26% Similarity=0.357 Sum_probs=185.4
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC----CceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~ 542 (753)
+.|++.+.||+|+||+||+|... +++.||||++..... +.+.+|+. +++.++|||||+++++|.+ +..+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 34578889999999999999765 588999999865421 22344554 8899999999999999754 4568
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
|+||| |+++|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 88 ~ivmE----------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~gl~yL 128 (270)
T d1t4ha_ 88 VLVTE----------LMTSGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKGLQFL 128 (270)
T ss_dssp EEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEe----------CCCCCcHHHHHhc-----------------------------cccccHHHHHHHHHHHHHHHHHH
Confidence 99999 7778888888753 24578889999999999999999
Q ss_pred hhCC--ccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 623 HEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 623 H~~~--IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
|+++ |+||||||+|||++. ++ .+||+|||+|+..... .....+||+.|||||++.+ .++.++|||||||
T Consensus 129 H~~~~~IiHrDiKp~NILl~~~~~--~~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGv 200 (270)
T d1t4ha_ 129 HTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGM 200 (270)
T ss_dssp HTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHH
T ss_pred HHCCCCEEeCCcChhhceeeCCCC--CEEEeecCcceeccCC-----ccCCcccCccccCHHHhCC-CCCCcCchhhHHH
Confidence 9998 999999999999964 44 5999999999865432 2235679999999999865 5999999999999
Q ss_pred HHHHHHhCCCCCCCCCh--HHHHHHHHccC--cccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESF--ERDANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~--~~~~~~i~~~~--~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|| ++||.+.. ......+.... ..++...++++.+||++||++||++|
T Consensus 201 ilyel~~g-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 257 (270)
T d1t4ha_ 201 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDER 257 (270)
T ss_dssp HHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHC-CCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHC
Confidence 99999999 67886532 23333443332 23456678999999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=389.91 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=186.7
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
.++|++.+.||+|+||+||+|... +|+.||||+++.... ....+|+. +++.++|||||+++++|.+++..|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGG-GGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 467999999999999999999764 689999999975422 23455655 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC-
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 625 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~- 625 (753)
| |+++|+|.+++.. ...+++..+.+++.|++.||.|||++
T Consensus 84 E----------y~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qil~aL~yLH~~~ 124 (322)
T d1s9ja_ 84 E----------HMDGGSLDQVLKK-----------------------------AGRIPEQILGKVSIAVIKGLTYLREKH 124 (322)
T ss_dssp E----------CCTTEEHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred E----------cCCCCcHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 9 7777888887753 24578889999999999999999975
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+|+||||||+||||+.++. +||+|||+|+.... ....+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 125 ~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 125 KIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred CEEccccCHHHeeECCCCC--EEEeeCCCccccCC-----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999977765 99999999987643 2234567999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHH-------------------------------------------HHccC-cccc-cCCCHHHHH
Q 004442 706 TGGKHPYGESFERDANI-------------------------------------------VKDRK-DLFL-VEHIPEAVD 740 (753)
Q Consensus 706 TG~~~Pf~~~~~~~~~~-------------------------------------------i~~~~-~~~~-~~~s~el~d 740 (753)
|| ++||.......... +.... +..+ ..+++++.+
T Consensus 198 ~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 198 VG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HS-SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HC-CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHH
Confidence 98 56764432111100 00000 1111 235789999
Q ss_pred HHHHccccCcCCC
Q 004442 741 LFTRLLDPNPDLR 753 (753)
Q Consensus 741 LI~~cL~~DP~~R 753 (753)
||++||..||++|
T Consensus 277 li~~~L~~dP~~R 289 (322)
T d1s9ja_ 277 FVNKCLIKNPAER 289 (322)
T ss_dssp HHHHHTCSSTTTS
T ss_pred HHHHHcCCChhHC
Confidence 9999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-44 Score=387.20 Aligned_cols=232 Identities=26% Similarity=0.347 Sum_probs=199.5
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecC------CchHHHHHHHHHHHhCCCCceeeecccccCCceEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~------~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
++|++.+.||+|+||.||+|.. .+|+.||||++.+. ..+...+|+. +++.++|||||++++++.+.+..++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHH-HHHHcCCCcEeecccccccccccccc
Confidence 5799999999999999999976 46999999998642 2234556665 78999999999999999999999999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+.+|+|.+++.. ...+++.++..++.||+.||.|||++
T Consensus 120 ~e----------~~~~g~l~~~l~~-----------------------------~~~l~e~~~~~i~~qi~~aL~yLH~~ 160 (350)
T d1rdqe_ 120 ME----------YVAGGEMFSHLRR-----------------------------IGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp EE----------CCTTCBHHHHHHH-----------------------------HCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cc----------cccccchhhhHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 7778888887743 24588899999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~Ell 705 (753)
+||||||||+||||+.++. +||+|||+|+..... ....+||+.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp TEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEecCcCCHHHcccCCCCC--EEeeeceeeeecccc------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 9999999999999977765 999999999987542 23456999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~-~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|| .+||.+. .......+.......+..+++++.+||++||++||++|
T Consensus 233 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR 280 (350)
T d1rdqe_ 233 AG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280 (350)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTC
T ss_pred hC-CCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhc
Confidence 99 5676554 44555666777778888999999999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=384.56 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=195.1
Q ss_pred cceEEEeEEecccCceEEEEEEeeC------CcEEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~------g~~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|++.+.||+|+||+||+|.... ...||||++.... ...+.+|+..+.+..+|||||+++|+|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678999999999999999997653 2379999985432 23456677644444599999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.+|||| |+++|+|.++|+.......... .................+++..++.|+.|||+||+|
T Consensus 116 ~~lv~E----------y~~~g~L~~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 179 (325)
T d1rjba_ 116 IYLIFE----------YCCYGDLLNYLRSKREKFSEDE------IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179 (325)
T ss_dssp CEEEEE----------CCTTCBHHHHHHTTTTCC---------------------------CCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------cCCCCcHHHHHHhccCCCcchh------hhhccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 7778899998876543211000 000000011111234568999999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+++|+||||||+|||++.++ .+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++
T Consensus 180 LH~~~IiHRDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil 256 (325)
T d1rjba_ 180 LEFKSCVHRDLAARNVLVTHGK--VVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256 (325)
T ss_dssp HHHTTEEETTCSGGGEEEETTT--EEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCeeeccCchhccccccCC--eEEEeeccccccccCCCce-eeeccccCCCccCChHHHcCCCCCcceeccchhHHH
Confidence 9999999999999999997775 5999999999876543221 222344579999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCh--HHHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~--~~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+|++.+||.+.. ......+... ....+..+++++.+||.+||+.||++|
T Consensus 257 ~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp HHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHC
Confidence 999984478887642 2233344433 345667889999999999999999998
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.6e-44 Score=387.16 Aligned_cols=239 Identities=22% Similarity=0.342 Sum_probs=196.9
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc---hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~---~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
+.+.|++.+.||+|+||+||+|.. .+|+.||||++..... ....+|+. +++.++|||||++++++.+++.+||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHH-HHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345699999999999999999976 4699999999976542 23345655 889999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
| |+++|+|.+++... ...+++.++..|+.||+.||+|||++|
T Consensus 106 E----------~~~gg~L~~~~~~~----------------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~ 147 (352)
T d1koba_ 106 E----------FLSGGELFDRIAAE----------------------------DYKMSEAEVINYMRQACEGLKHMHEHS 147 (352)
T ss_dssp E----------CCCCCBHHHHTTCT----------------------------TCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred E----------cCCCChHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 66678887765422 245889999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHh
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllT 706 (753)
|+||||||+||||+.++...+||+|||+|+.+.... ......||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 148 iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt 223 (352)
T d1koba_ 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223 (352)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred eeecccccccccccccCCCeEEEeecccceecCCCC----ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh
Confidence 999999999999975444569999999999876432 2234568999999999999999999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHHccCccc----ccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGES-FERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~-~~~~~~~i~~~~~~~----~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| .+||.+. .......+......+ +..+++++.+||++||++||++|
T Consensus 224 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 274 (352)
T d1koba_ 224 G-LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKR 274 (352)
T ss_dssp S-CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGS
T ss_pred C-CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHC
Confidence 9 6677665 334444444444333 34678999999999999999998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=373.62 Aligned_cols=234 Identities=27% Similarity=0.381 Sum_probs=187.5
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchH-HHHHHHHHHHhCCCCceeeecccccC-CceEEEEEcccc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLERCT 550 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~-~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~~LV~E~c~ 550 (753)
++|++.+.||+|+||.||+|.. .|+.||||++++....+ +.+|+ .+++.++|||||+++|+|.+ ++.+++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e--- 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTH-HHHTTCCCTTBCCEEEEECCC--CCEEEEC---
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHHHHHHHHHH-HHHHhCCCCCEeeEEEEEEecCCcEEEEEe---
Confidence 4678899999999999999876 58899999997765444 44555 58899999999999999865 466899999
Q ss_pred CChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcccc
Q 004442 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (753)
Q Consensus 551 ~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~IiHr 630 (753)
|+++|+|.++|+... ...+++..+++|+.|||.||.|||+.+|+||
T Consensus 82 -------y~~~g~L~~~l~~~~---------------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~ 127 (262)
T d1byga_ 82 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127 (262)
T ss_dssp -------CCTTEEHHHHHHHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -------ccCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence 888899999886532 1247888999999999999999999999999
Q ss_pred CCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 004442 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (753)
Q Consensus 631 DLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG~~~ 710 (753)
||||+|||++.++. +||+|||+++...... ....+|..|+|||++.+..++.++|||||||++|||+|++++
T Consensus 128 dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~~------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~ 199 (262)
T d1byga_ 128 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199 (262)
T ss_dssp CCSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchHhheecCCCC--EeecccccceecCCCC------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCC
Confidence 99999999977754 9999999998764321 234579999999999999999999999999999999996688
Q ss_pred CCCCChHH-HHHHHH-ccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 711 PYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 711 Pf~~~~~~-~~~~i~-~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||...... ....+. .....++..+++++.+||++||+.||++|
T Consensus 200 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 244 (262)
T d1byga_ 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMR 244 (262)
T ss_dssp SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHC
Confidence 88776443 333333 34566778889999999999999999998
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=374.32 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=189.7
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC-c
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-D 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~-~ 540 (753)
.++|++.+.||+|+||.||+|... +++.||||+++.... +.+.+|+..+.+..+|+|||++++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357899999999999999999754 357899999975432 24455666566667899999999997764 5
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++|+.......... ..........+++.++++++.|||+||+
T Consensus 92 ~~~iv~E----------~~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 148 (299)
T d1ywna1 92 PLMVIVE----------FCKFGNLSTYLRSKRNEFVPYK-------------VAPEDLYKDFLTLEHLICYSFQVAKGME 148 (299)
T ss_dssp CCEEEEE----------CCTTCBHHHHHHHTGGGBCC------------------------CBCHHHHHHHHHHHHHHHH
T ss_pred eEEEEEE----------ecCCCcHHHHHHhccccccccc-------------cchhhhhcccCCHHHHHHHHHHHHHHHH
Confidence 6899999 7778899998876543211100 0001122356899999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+++|+||||||+||||+.++ .+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||+
T Consensus 149 ylH~~~ivHrDlKp~NILl~~~~--~~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvi 225 (299)
T d1ywna1 149 FLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225 (299)
T ss_dssp HHHHTTCCCSCCCGGGEEECGGG--CEEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCCCcCCcCCccceeECCCC--cEEEccCcchhhcccccc-ccccCceeeCccccchhHhhcCCCCcccceeehHHH
Confidence 99999999999999999997665 599999999987654322 223345579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh--HHHHHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESF--ERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~--~~~~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+||+.+||.... +.....+.. .....+..+++++.+||.+||+.||++|
T Consensus 226 l~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1ywna1 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 281 (299)
T ss_dssp HHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHC
Confidence 9999998888887643 233333333 3455667789999999999999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-43 Score=377.23 Aligned_cols=263 Identities=22% Similarity=0.284 Sum_probs=198.4
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|++.+.||+|+||+||+|... +++.||||++...... .+.+|+. +++.++||||++++++|.+.+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHH-HHHhcCCCCcccceeeeccCCc
Confidence 456889999999999999999754 3578999999764422 3455554 7899999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.+++|| |+++|+|.++|+............. ...............+++.++++|+.|+|.||+|
T Consensus 91 ~~~v~e----------~~~~g~L~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~y 155 (301)
T d1lufa_ 91 MCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHS-----DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 155 (301)
T ss_dssp CEEEEE----------CCTTCBHHHHHHHTCC---------------------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred eEEEEE----------ecCCCcHHHHHHhcCcccccccccc-----ccchhhhccccCCCCCCHHHHHHHHHHHHHHhhh
Confidence 999999 7778888888875543221111000 0000111112234568999999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+.+|+||||||+|||++.+ ..+||+|||+|+...... .........||+.|+|||.+.+..++.++|||||||++
T Consensus 156 lH~~~ivHrDlKp~NILld~~--~~~Kl~DFGls~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl 232 (301)
T d1lufa_ 156 LSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSAD-YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232 (301)
T ss_dssp HHHTTCCCSCCSGGGEEECGG--GCEEECCCSCHHHHTGGG-CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cccCCeEeeEEcccceEECCC--CcEEEccchhheeccCCc-cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhH
Confidence 999999999999999999666 459999999998764432 12223345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||++|+.+||.+... +....+..+. ...+..+++++.+||.+||+.||++|
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~R 286 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHC
Confidence 9999997778876644 3344444444 34567889999999999999999998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=379.34 Aligned_cols=239 Identities=19% Similarity=0.281 Sum_probs=198.7
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCch--HHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~--~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
+.++|++.+.||+|+||+||+|... +|+.||||.++....+ ...+|+. +++.++|||||++++++.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHH-HHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4567999999999999999999765 5899999999765533 3345654 8899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
|+.+|+|.+++... ...+++.++..|+.||+.||+|||+.+|
T Consensus 82 ----------~~~gg~L~~~i~~~----------------------------~~~l~e~~~~~i~~qi~~al~yLH~~~i 123 (321)
T d1tkia_ 82 ----------FISGLDIFERINTS----------------------------AFELNEREIVSYVHQVCEALQFLHSHNI 123 (321)
T ss_dssp ----------CCCCCBHHHHHTSS----------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 66678888877432 2358899999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~EllTG 707 (753)
+||||||+|||++.++...+||+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 124 iHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CcccccccceeecCCCceEEEEcccchhhccccCC----cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhC
Confidence 99999999999987777789999999998875432 22344689999999999999999999999999999999998
Q ss_pred CCCCCCCCh-HHHHHHHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESF-ERDANIVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~-~~~~~~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||.... ......+......++ ..+++++++||++||.+||++|
T Consensus 200 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 249 (321)
T d1tkia_ 200 -INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249 (321)
T ss_dssp -SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGS
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHC
Confidence 67776654 444455555444333 3689999999999999999998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.3e-43 Score=369.59 Aligned_cols=242 Identities=25% Similarity=0.356 Sum_probs=185.8
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc------hHHHHHHHHHHHhCCCCceeeecccccCCc-
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQD- 540 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~------~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~- 540 (753)
..+.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ..+.+|+. +++.++|||||++++++.+.+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ-NAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEEECS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHH-HHHhcCCCCCCcccceeeeccC
Confidence 34567899999999999999999975 5699999999975421 12344554 789999999999999987543
Q ss_pred ---eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 541 ---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 541 ---~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
..||||| |+++|+|.+++.. ...+++.+++.|+.||+.
T Consensus 82 ~~~~~~lvmE----------~~~g~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~ 122 (277)
T d1o6ya_ 82 AGPLPYIVME----------YVDGVTLRDIVHT-----------------------------EGPMTPKRAIEVIADACQ 122 (277)
T ss_dssp SSEEEEEEEE----------CCCEEEHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHH
T ss_pred CCceEEEEEE----------CCCCCEehhhhcc-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 4899999 6667777776532 346888999999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+.+|+||||||+|||++.++. .+|+|||.++...............+||+.|+|||++.+..++.++|||||
T Consensus 123 al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl 200 (277)
T d1o6ya_ 123 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200 (277)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccc
Confidence 999999999999999999999988765 899999999877654444444556679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH-HHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 698 GCILFFCITGGKHPYGESFER-DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||++|||+|| .+||.+.... ........... ....+++++.+||.+||++||++|
T Consensus 201 GvilyelltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R 260 (277)
T d1o6ya_ 201 GCVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 260 (277)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHhC-CCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHC
Confidence 9999999999 6788765433 33333332222 235678999999999999999998
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-43 Score=384.33 Aligned_cols=234 Identities=25% Similarity=0.378 Sum_probs=190.1
Q ss_pred ceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC------chHHHHHH--HHHHHhCCCCceeeecccccCCceEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEI--QNLIASDQHPNIVRWYGVESDQDFVY 543 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~------~~~~~~Ei--~~ll~~l~HpNIV~L~g~~~~~~~~~ 543 (753)
++|.+.+.||+|+||+||+|... +|+.||||++.+.. .....+|. ..+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 46889999999999999999765 59999999986421 12233332 23566788999999999999999999
Q ss_pred EEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhh
Q 004442 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (753)
Q Consensus 544 LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH 623 (753)
+||| |+++|+|.++|... ..+++..+..++.||+.||+|||
T Consensus 84 ivmE----------~~~gg~L~~~l~~~-----------------------------~~~~e~~~~~~~~qi~~aL~ylH 124 (364)
T d1omwa3 84 FILD----------LMNGGDLHYHLSQH-----------------------------GVFSEADMRFYAAEIILGLEHMH 124 (364)
T ss_dssp EEEC----------CCCSCBHHHHHHHH-----------------------------CSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ecCCCcHHHHHHhc-----------------------------ccccHHHHHHHHHHHHHHHHHHH
Confidence 9999 77788888887532 45678889999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHH
Q 004442 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (753)
Q Consensus 624 ~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~ 702 (753)
+++|+||||||+||||+.++. +||+|||+|+..... .....+||+.|+|||++.. ..++.++|||||||++|
T Consensus 125 ~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 125 NRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp HTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred HCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC-----cccccccccccchhHHhhcCCCCCcccchhHHHHHHH
Confidence 999999999999999977765 999999999977543 2344579999999999975 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHH----HHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFERD----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~~----~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|| ++||....... ...........+..+++++++||.+||++||++|
T Consensus 198 emltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (364)
T d1omwa3 198 KLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 251 (364)
T ss_dssp HHHHS-SCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTS
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHh
Confidence 99998 67876543222 2222233445667899999999999999999998
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=368.70 Aligned_cols=239 Identities=22% Similarity=0.332 Sum_probs=182.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCCch---HHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~~~---~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.++|++.+.||+|+||.||+|.... +..||||.++..... ..+.++..+++.++|||||+++|+|.+ +..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence 4679999999999999999996542 457999998654322 223333448899999999999999864 67899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.+++... ...+++..++.++.||++||.|||+
T Consensus 85 v~E----------~~~~g~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 85 IME----------LCTLGELRSFLQVR----------------------------KYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp EEE----------CCTTEEHHHHHHHT----------------------------TTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eccCCcHHhhhhcc----------------------------CCCCCHHHHHHHHHHHHHHhhhhcc
Confidence 999 66778887766432 2457889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+||+++.++ .+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 ~~iiHrDlKp~NIll~~~~--~~Kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp TTCCCSCCSGGGEEEEETT--EEEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred cCeeccccchhheeecCCC--cEEEccchhheeccCCcc--eeccceecCcccchhhHhccCCCCCccccccchHHHHHH
Confidence 9999999999999998775 499999999987654322 222345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++.+||.+... .....+... ..+.+.++++++.+||.+||+.||++|
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~R 253 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 253 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHC
Confidence 9955888876543 334444443 456778899999999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-43 Score=374.17 Aligned_cols=237 Identities=24% Similarity=0.288 Sum_probs=186.4
Q ss_pred eEEEeEEecccCceEEEEEEee-CCc----EEEEEEeecCC----chHHHHHHHHHHHhCCCCceeeecccccCCceEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~----~VAVK~l~~~~----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~L 544 (753)
.|++.+.||+|+||+||+|... +|+ .||||+++... .+.+.+|+. +++.++|||||+++|+|.+++ .++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHH-HHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCC-eeE
Confidence 4889999999999999999654 343 68999886432 234455554 789999999999999998754 567
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
++| |+.+|+|.+++... ...+++..+++|+.|||.||+|||+
T Consensus 88 v~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~gl~yLH~ 129 (317)
T d1xkka_ 88 ITQ----------LMPFGCLLDYVREH----------------------------KDNIGSQYLLNWCVQIAKGMNYLED 129 (317)
T ss_dssp EEE----------CCTTCBHHHHHHHT----------------------------SSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------eccCCccccccccc----------------------------ccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 778 66677777766432 3467889999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
++|+||||||+|||++.++ .+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||
T Consensus 130 ~~iiHrDlKp~NIll~~~~--~~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 130 RRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp TTCCCSCCCGGGEEEEETT--EEEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cCcccCcchhhcceeCCCC--CeEeeccccceeccccccc-ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHH
Confidence 9999999999999997775 5999999999987543222 222334689999999999999999999999999999999
Q ss_pred HhCCCCCCCCChH-HHHHHHHccC-cccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFE-RDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~-~~~~~i~~~~-~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|++.+||++... .....+..+. .+.+..+++++.+||.+||+.||++|
T Consensus 207 ~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~R 257 (317)
T d1xkka_ 207 MTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257 (317)
T ss_dssp HTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhC
Confidence 9976889987643 3444444433 55677889999999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-42 Score=362.04 Aligned_cols=235 Identities=22% Similarity=0.337 Sum_probs=192.0
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc------------hHHHHHHHHHHHhCC-CCceeeeccccc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQ-HPNIVRWYGVES 537 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~------------~~~~~Ei~~ll~~l~-HpNIV~L~g~~~ 537 (753)
.++|++.+.||+|+||+||+|.. .+|+.||||++.+... +...+|+. +++.++ |||||++++++.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD-ILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHH-HHHHHTTCTTBCCEEEEEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHH-HHHHhcCCCCeEEEEeecc
Confidence 46789999999999999999976 4689999999965421 13455655 667765 999999999999
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
+++..||||| |+++|+|.++|.. ...+++.++.+++.||+.
T Consensus 81 ~~~~~~ivmE----------~~~~g~L~~~l~~-----------------------------~~~l~e~~~~~~~~qi~~ 121 (277)
T d1phka_ 81 TNTFFFLVFD----------LMKKGELFDYLTE-----------------------------KVTLSEKETRKIMRALLE 121 (277)
T ss_dssp CSSEEEEEEE----------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHH
T ss_pred cCcceEEEEE----------cCCCchHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999999999 7778888888753 246889999999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC------CCCCch
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRA 691 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~k 691 (753)
||+|||+++|+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||.+.+ ..++.+
T Consensus 122 al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~ 195 (277)
T d1phka_ 122 VICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKE 195 (277)
T ss_dssp HHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH
T ss_pred HHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCC----ceeeeeccCCCCCHHHhhccccccCCCCCch
Confidence 999999999999999999999977765 9999999999875432 2234579999999999853 346899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHccCcc----cccCCCHHHHHHHHHccccCcCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~~----~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||||+||++|||+|| ++||.+.... ....+...... ....+++++++||++||+.||++|
T Consensus 196 ~DiwslGvilyeml~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R 261 (277)
T d1phka_ 196 VDMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKR 261 (277)
T ss_dssp HHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGS
T ss_pred heEcccchhhhhhccC-CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHC
Confidence 9999999999999998 6777665443 33334433322 334789999999999999999998
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-43 Score=367.36 Aligned_cols=239 Identities=22% Similarity=0.271 Sum_probs=183.7
Q ss_pred ceEEEeEEecccCceEEEEEEeeC----CcEEEEEEeecCC------chHHHHHHHHHHHhCCCCceeeecccccCCceE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~----g~~VAVK~l~~~~------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~ 542 (753)
++|++.+.||+|+||.||+|.... ...||||++.+.. .+.+.+|+ .+++.++|||||+++|+|.++ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV-NAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHH-HHHHHCCCTTBCCEEEEECSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEeec-ch
Confidence 568999999999999999996542 2479999986432 12445565 488999999999999999764 67
Q ss_pred EEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHh
Q 004442 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (753)
Q Consensus 543 ~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yL 622 (753)
++||| |+++|++.+++... ...+++..+++++.|||.||.||
T Consensus 86 ~lv~e----------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 86 KMVTE----------LAPLGSLLDRLRKH----------------------------QGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp EEEEE----------CCTTCBHHHHHHHH----------------------------GGGSCHHHHHHHHHHHHHHHHHH
T ss_pred heeee----------eecCcchhhhhhcc----------------------------cCCCCHHHHHHHHHHHHHHHHHh
Confidence 89999 66678888776532 23578889999999999999999
Q ss_pred hhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHH
Q 004442 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (753)
Q Consensus 623 H~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~ 702 (753)
|+++|+||||||+|||++.++ .+||+|||+++................||..|+|||++.+..++.++|||||||++|
T Consensus 128 H~~~iiHrDikp~NIll~~~~--~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 128 ESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp HHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hhCCEeeeeecHHHhcccccc--ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 999999999999999998875 599999999998876554444455556889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHH-HHHHHHcc--CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 703 FCITGGKHPYGESFER-DANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 703 EllTG~~~Pf~~~~~~-~~~~i~~~--~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
||+|++++||.+.... ....+... ....+..+++++.+||++||++||++|
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 259 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 9999447888765433 33333332 234567789999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=371.87 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=195.7
Q ss_pred ceEEEeEEecccCceEEEEEEeeC-Cc--EEEEEEeecCC----chHHHHHHHHHHHhC-CCCceeeecccccCCceEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~-g~--~VAVK~l~~~~----~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~L 544 (753)
++|++.+.||+|+||+||+|...+ |. .||||+++... .+.+.+|+. +++.+ +|||||+++|+|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHH-HHHhccCCCCEeeEEEEEecCCeeEE
Confidence 467788999999999999997654 43 57888885432 234566765 66776 79999999999999999999
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++|+.......... ..........+++.++++++.|||+||.|||+
T Consensus 89 V~e----------y~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 89 AIE----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp EEC----------CCTTCBHHHHHHTTCHHHHCHH-------------HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------ecCCCcHHHHHhhccccccchh-------------hhccccccCCCCHHHHHHHHHHHHHHHHhhhc
Confidence 999 7778899988875432110000 00111335679999999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
.+|+||||||+|||++.++ .+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||
T Consensus 146 ~~iiHrDlkp~NIL~~~~~--~~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGENY--VAKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp TTEECSCCSGGGEEECGGG--CEEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCccccccccceEEEcCCC--ceEEccccccccccccc----cccceecCCcccchHHhccCCCCccceeehhHHHHHHH
Confidence 9999999999999996664 59999999998654321 22344589999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHH-HHHHHc-cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~~-~~~i~~-~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|+.+||.+..... ...+.. .....+..+++++.+||.+||+.||++|
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 270 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYER 270 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred HhcCCCCCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHC
Confidence 998788887664443 333333 3455667889999999999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=376.48 Aligned_cols=239 Identities=23% Similarity=0.317 Sum_probs=190.0
Q ss_pred ecceEEEe-EEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC----CceEEE
Q 004442 471 IGKLVVFN-KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYL 544 (753)
Q Consensus 471 i~~~~~i~-~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~----~~~~~L 544 (753)
+.++|.+. +.||+|+||+||+|.. .+|+.||||++++. ....+|+..+++..+|||||++++++.+ +..+||
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence 34567765 5699999999999976 56999999999754 5667788766677899999999998754 567899
Q ss_pred EEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh
Q 004442 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (753)
Q Consensus 545 V~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~ 624 (753)
||| |+++|+|.++|.... ...+++.++..|+.||+.||+|||+
T Consensus 87 vmE----------y~~gg~L~~~i~~~~---------------------------~~~l~e~~~~~i~~qi~~al~ylH~ 129 (335)
T d2ozaa1 87 VME----------CLDGGELFSRIQDRG---------------------------DQAFTEREASEIMKSIGEAIQYLHS 129 (335)
T ss_dssp EEE----------CCCSEEHHHHHHSCS---------------------------CCCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------CCCCCcHHHHHHhcC---------------------------CCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 999 667788888875321 2457888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCC-CCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHHHH
Q 004442 625 IGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (753)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~-~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~E 703 (753)
.+|+||||||+|||++.++ ...+||+|||+|+...... .....+||+.|||||++.+..|+.++|||||||++||
T Consensus 130 ~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ 205 (335)
T d2ozaa1 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205 (335)
T ss_dssp TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHH
T ss_pred cCCccccccccccccccccccccccccccceeeeccCCC----ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHH
Confidence 9999999999999997643 3469999999999875432 2345679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHH----HHHccCcccc----cCCCHHHHHHHHHccccCcCCC
Q 004442 704 CITGGKHPYGESFER-DAN----IVKDRKDLFL----VEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 704 llTG~~~Pf~~~~~~-~~~----~i~~~~~~~~----~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+|| ++||.+.... ... .+......++ ..+++++.+||++||++||++|
T Consensus 206 lltg-~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 263 (335)
T d2ozaa1 206 LLCG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQR 263 (335)
T ss_dssp HTTS-SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTS
T ss_pred HhhC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHC
Confidence 9998 6787554321 111 1111222222 3578999999999999999998
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-42 Score=366.23 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=195.1
Q ss_pred cceEEEeEEecccCceEEEEEEeeC--------CcEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccCC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~ 539 (753)
.++|.+.+.||+|+||.||+|.... +..||||++++... ....+|+..+.+..+|||||+++|+|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4578899999999999999986532 35799999976543 23445555454555899999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++||| |+.+|+|.++|........... ..........+++.++++++.|||.||
T Consensus 92 ~~~~~v~e----------~~~~g~l~~~i~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~al 148 (299)
T d1fgka_ 92 GPLYVIVE----------YASKGNLREYLQARRPPGLEYS-------------YNPSHNPEEQLSSKDLVSCAYQVARGM 148 (299)
T ss_dssp SSCEEEEC----------CCTTCBHHHHHHTTSCC-------------------------CCCCCHHHHHHHHHHHHHHH
T ss_pred CeEEEEEE----------ccCCCcHHHHHHhhcCCccccc-------------cccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999999 7778888888876542211000 001112345689999999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGv 699 (753)
+|||+.+|+||||||+|||++.++. +||+|||+++........ .......||+.|+|||.+.++.|+.++|||||||
T Consensus 149 ~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gv 225 (299)
T d1fgka_ 149 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225 (299)
T ss_dssp HHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHhhhCCEEeeeecccceeecCCCC--eEeccchhhccccccccc-cccccCCCChhhhhhhHhcCCCCCchhhhHHhHH
Confidence 9999999999999999999977764 999999999987654322 2334456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHH-HHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 700 ILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 700 vL~EllTG~~~Pf~~~~~~-~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
++|||+|++.+||.+.... ....+..+ ....+..+++++.+||.+||+.||++|
T Consensus 226 vl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1fgka_ 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281 (299)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHC
Confidence 9999999768888766443 33444443 445677889999999999999999998
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=366.48 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=200.4
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCce
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~ 541 (753)
.++|.+.+.||+|+||+||+|... ++..||||+++..... .+.+|+. +++.++|||||+++|+|..++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHH-HGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHH-HHHHcCCCCEeeeeeEEecCCc
Confidence 467889999999999999998653 3679999999754332 2345554 7899999999999999999999
Q ss_pred EEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHH
Q 004442 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (753)
Q Consensus 542 ~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~y 621 (753)
.++||| |+.+|+|.++++....... .......+++..+.+++.|+|+||.|
T Consensus 98 ~~lv~e----------~~~~g~l~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~ia~gl~~ 148 (308)
T d1p4oa_ 98 TLVIME----------LMTRGDLKSYLRSLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIADGMAY 148 (308)
T ss_dssp CEEEEE----------CCTTCBHHHHHHHHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred eeEEEe----------ecCCCCHHHHHHhcccccc-------------------cccccCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 7788999888875432111 00122357889999999999999999
Q ss_pred hhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHHH
Q 004442 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (753)
Q Consensus 622 LH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL 701 (753)
||+++|+||||||+|||++.+ ..+||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++
T Consensus 149 LH~~~ivHrDlk~~NiLld~~--~~~Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 149 LNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp HHHTTCBCSCCSGGGEEECTT--CCEEECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCCeeeceEcCCceeecCC--ceEEEeecccceeccCCcc-eeeccceecccccCCHHHHccCCCCcccccccHHHHH
Confidence 999999999999999999665 4599999999987754322 2223344689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChH-HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 702 FFCITGGKHPYGESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 702 ~EllTG~~~Pf~~~~~-~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|||+||+.+||.+... +....+... ....+..+++++.++|.+||+.||++|
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~R 279 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMR 279 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 9999998889977644 334444443 344567889999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=364.47 Aligned_cols=238 Identities=21% Similarity=0.325 Sum_probs=186.6
Q ss_pred EEEeEEecccCceEEEEEEeeCC----cEEEEEEeecCCc----hHHHHHHHHHHHhCCCCceeeecccccC-CceEEEE
Q 004442 475 VVFNKEIAKGSNGTVVLEGNYEG----RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLS 545 (753)
Q Consensus 475 ~~i~~~IG~G~fG~Vyka~~~~g----~~VAVK~l~~~~~----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-~~~~~LV 545 (753)
+.+.++||+|+||+||+|...++ ..||||+++.... +.+.+|+ .++++++|||||+++|+|.+ ++..++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHH-HHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34568899999999999976542 3699999975332 2344555 48899999999999999875 5689999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
|| |+++|+|.++++.. ...+++..+++++.|+|.||.|||+.
T Consensus 108 ~E----------~~~~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 108 LP----------YMKHGDLRNFIRNE----------------------------THNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp EE----------CCTTCBHHHHHHCT----------------------------TCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------EeecCchhhhhccc----------------------------cccchHHHHHHHHHHHHHhhhhhccc
Confidence 99 77788888887543 23466778899999999999999999
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcc-cccCccCCCCccccccccccCCCCCchhhHHHHHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvvL~El 704 (753)
+|+||||||+||||+++ ..+||+|||+++........ ........||+.|+|||.+....++.++||||||+++|||
T Consensus 150 ~iiHrDLK~~NILl~~~--~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El 227 (311)
T d1r0pa_ 150 KFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227 (311)
T ss_dssp TCCCSCCSGGGEEECTT--CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CcccCCccHHhEeECCC--CCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHH
Confidence 99999999999999665 45999999999987543222 1223345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHH-HHHHH-HccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 705 ITGGKHPYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 705 lTG~~~Pf~~~~~~-~~~~i-~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+||+.+|+...... ....+ .......+..+++++.+||.+||+.||++|
T Consensus 228 ~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~R 278 (311)
T d1r0pa_ 228 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278 (311)
T ss_dssp HTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHC
Confidence 99877666554322 22333 334455667788999999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-42 Score=362.00 Aligned_cols=231 Identities=20% Similarity=0.248 Sum_probs=187.7
Q ss_pred cceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCC---------chHHHHHHHHHHHhCC--CCceeeecccccCC
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---------HDVALKEIQNLIASDQ--HPNIVRWYGVESDQ 539 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~---------~~~~~~Ei~~ll~~l~--HpNIV~L~g~~~~~ 539 (753)
.++|++.+.||+|+||+||+|... +|+.||||++.+.. .....+|+. +++.++ |||||++++++.++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV-LLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHH-HHHHHCSSSCSBCCEEEEEECS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHH-HHHHhccCCCCccEEEEEEeeC
Confidence 467999999999999999999764 68999999986431 122456776 556655 99999999999999
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
+..++|||+|.+ ++++.+++. ....+++.++..++.||+.||
T Consensus 82 ~~~~lv~e~~~~---------~~~l~~~~~-----------------------------~~~~l~e~~~~~~~~qi~~al 123 (273)
T d1xwsa_ 82 DSFVLILERPEP---------VQDLFDFIT-----------------------------ERGALQEELARSFFWQVLEAV 123 (273)
T ss_dssp SEEEEEEECCSS---------EEEHHHHHH-----------------------------HHCSCCHHHHHHHHHHHHHHH
T ss_pred CeEEEEEEeccC---------cchHHHHHh-----------------------------ccCCCCHHHHHHHHHHHHHHH
Confidence 999999996643 234444432 234688899999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfG 698 (753)
+|||+++|+||||||+|||++.++ ..+||+|||+|+..... .....+||+.|+|||++.+..+ +.++||||||
T Consensus 124 ~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlG 197 (273)
T d1xwsa_ 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 197 (273)
T ss_dssp HHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH
T ss_pred HHHHHCCCccccCcccceEEecCC-CeEEECccccceecccc-----cccccccCCCcCCHHHHcCCCCCCcccccccce
Confidence 999999999999999999997654 35999999999876432 2235679999999999987775 6789999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|++|||+|| ++||.... .+......++..+++++++||++||++||++|
T Consensus 198 vilyell~g-~~Pf~~~~-----~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R 246 (273)
T d1xwsa_ 198 ILLYDMVCG-DIPFEHDE-----EIIRGQVFFRQRVSSECQHLIRWCLALRPSDR 246 (273)
T ss_dssp HHHHHHHHS-SCSCCSHH-----HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred eeehhHhhC-CCCCCCch-----HHhhcccCCCCCCCHHHHHHHHHHccCCHhHC
Confidence 999999998 77887642 23445566778899999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=362.89 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=197.5
Q ss_pred cceEEEeEEecccCceEEEEEEee------CCcEEEEEEeecCCch----HHHHHHHHHHHhC-CCCceeeecccccCCc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~------~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~ 540 (753)
.++|++.+.||+|+||.||+|... +++.||||+++..... .+.+|+. +++.+ +|||||+++|+|.+.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHH-HHHhccCCCCEEEEEEEEeeCC
Confidence 367889999999999999999652 4679999999764422 3445555 45555 7999999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..++||| |+++|+|.++|+.......... ............+++..+++++.|||+||+
T Consensus 101 ~~~lvmE----------~~~~g~l~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 101 PTLVITE----------YCCYGDLLNFLRRKRDSFICSK-----------TSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp SCEEEEE----------CCTTEEHHHHHHHTTTTC-------------------------CCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEE----------cCCCCCHHHHHHhccccccccc-----------cccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 7778888888876543211100 000111133457999999999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
|||+++|+||||||+||+++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||+
T Consensus 160 ~LH~~~ivHrDLKp~NIl~~~~~--~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHTTCCCSCCSGGGEEEETTT--EEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCCeeecccccccccccccC--cccccccchheeccCCCc-ceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 99999999999999999997765 599999999998754332 233344578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH--HHHHHHHcc-CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~--~~~~~i~~~-~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|++.+||..... .....+... ....+...++++.+||.+||+.||++|
T Consensus 237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 292 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHC
Confidence 99999976877765432 333444443 344556788999999999999999998
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=357.65 Aligned_cols=236 Identities=26% Similarity=0.387 Sum_probs=185.3
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|+||+||+|.. .+|+.||||+++... .+...+|+. +++.++|||||++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHH-HHHhCCCCcEEEeccccccccceeEEE
Confidence 4688999999999999999976 569999999995432 234556665 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|+|.+++.+++.. .....+++.++..++.||+.||+|||+++
T Consensus 81 e~~~~~~~~~~~~--------------------------------------~~~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 81 EFLHQDLKKFMDA--------------------------------------SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp ECCSEEHHHHHHH--------------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eecCCchhhhhhh--------------------------------------hcccCCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 9776554433311 12346899999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCC-CchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDIwSfGvvL~Ell 705 (753)
||||||||+|||++.++. +||+|||+|+...... .......||+.|+|||.+....+ +.++|||||||++|||+
T Consensus 123 IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp CCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EEccccCchheeecccCc--ceeccCCcceeccCCc---ccceeecccceeeehhhhccccCCCccccccccchhhhHHh
Confidence 999999999999977754 8999999998775432 23344569999999999877664 89999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHcc--C----------------c-----------ccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKDR--K----------------D-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~~--~----------------~-----------~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| ++||.+..... ...+... . . ......++++.+||++||..||++|
T Consensus 198 ~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (298)
T d1gz8a_ 198 TR-RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKR 274 (298)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTS
T ss_pred hC-CCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHC
Confidence 98 67886654322 2211100 0 0 0123557899999999999999998
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-41 Score=359.68 Aligned_cols=230 Identities=21% Similarity=0.271 Sum_probs=177.6
Q ss_pred eEEecccCceEEEEEEee-CCcEEEEEEeecCC--------chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEcc
Q 004442 478 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 478 ~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~--------~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
.+.||+|+||+||+|... +|+.||||+++... .....+|+. +++.++|||||++++++.+++..||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHH-HHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 478999999999999764 59999999986432 124556765 78999999999999999999999999996
Q ss_pred ccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCcc
Q 004442 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (753)
Q Consensus 549 c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~Ii 628 (753)
|.+ |++..+.. ....+++.++..++.||+.||+|||+++|+
T Consensus 82 ~~~----------~~~~~~~~-----------------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~ii 122 (299)
T d1ua2a_ 82 MET----------DLEVIIKD-----------------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122 (299)
T ss_dssp CSE----------EHHHHHTT-----------------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hcc----------hHHhhhhh-----------------------------cccCCCHHHHHHHHHHHHHHHHHhhcccee
Confidence 654 33332221 134577788899999999999999999999
Q ss_pred ccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHHHHHHHHHHhC
Q 004442 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (753)
Q Consensus 629 HrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSfGvvL~EllTG 707 (753)
||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++... .++.++|||||||++|||+||
T Consensus 123 HrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 197 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197 (299)
T ss_dssp CCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred cccCCcceEEecCCCc--cccccCccccccCCCc---ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC
Confidence 9999999999977765 9999999998765432 223345799999999998755 579999999999999999998
Q ss_pred CCCCCCCChH-HHHHHHHccC----------------------------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 708 GKHPYGESFE-RDANIVKDRK----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 708 ~~~Pf~~~~~-~~~~~i~~~~----------------------------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
.+||..... .....+.... .......++++.+||++||+.||++|
T Consensus 198 -~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 198 -VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp -SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred -cCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 677765433 3222222100 00123467899999999999999998
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-41 Score=360.30 Aligned_cols=238 Identities=22% Similarity=0.318 Sum_probs=180.2
Q ss_pred cceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHH-HHHhCCCCceeeecccccCCc----eEEEEE
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN-LIASDQHPNIVRWYGVESDQD----FVYLSL 546 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~-ll~~l~HpNIV~L~g~~~~~~----~~~LV~ 546 (753)
.+.|.+.+.||+|+||+||+|.. +|+.||||+++........+|.+. .+..++|||||+++|+|.+++ .+++||
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 46788999999999999999874 789999999977665555555432 235689999999999998643 689999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhh--
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-- 624 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~-- 624 (753)
| |+++|+|.++|+. ..++|.++++++.|+|.||+|||+
T Consensus 81 E----------y~~~g~L~~~l~~------------------------------~~l~~~~~~~~~~~ia~gl~~lH~~~ 120 (303)
T d1vjya_ 81 D----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp E----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred e----------cccCCCHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHhh
Confidence 9 8888999998853 246788889999999999999996
Q ss_pred ------CCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCccc-ccCccCCCCccccccccccCCC------CCch
Q 004442 625 ------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------QTRA 691 (753)
Q Consensus 625 ------~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~------~t~k 691 (753)
.+|+||||||+||||+.++ .+||+|||+++......... ......+||+.|+|||++.+.. ++.+
T Consensus 121 ~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k 198 (303)
T d1vjya_ 121 VGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp CSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred hhhccCCCeeccccCccceEEcCCC--CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcc
Confidence 5899999999999996664 59999999999876543222 2334567999999999987643 5779
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC----------------ChHHHHHHHHc-cC-cccccC-----CCHHHHHHHHHcccc
Q 004442 692 IDLFSLGCILFFCITGGKHPYGE----------------SFERDANIVKD-RK-DLFLVE-----HIPEAVDLFTRLLDP 748 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~----------------~~~~~~~~i~~-~~-~~~~~~-----~s~el~dLI~~cL~~ 748 (753)
+|||||||+||||+|| .+|+.. ........... .. +..+.. ...++.+||.+||+.
T Consensus 199 ~Di~S~Gvvl~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~ 277 (303)
T d1vjya_ 199 ADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHHHT-BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCS
T ss_pred hhhhhhHHHHHHHhhC-CCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHccc
Confidence 9999999999999998 444422 11122222221 11 122222 124588999999999
Q ss_pred CcCCC
Q 004442 749 NPDLR 753 (753)
Q Consensus 749 DP~~R 753 (753)
||++|
T Consensus 278 dp~~R 282 (303)
T d1vjya_ 278 NGAAR 282 (303)
T ss_dssp SGGGS
T ss_pred CHhHC
Confidence 99998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=352.05 Aligned_cols=237 Identities=26% Similarity=0.378 Sum_probs=182.5
Q ss_pred cceEEEeEEecccCceEEEEEEee-C-CcEEEEEEeecC-----CchHHHHHHHH--HHHhCCCCceeeeccccc-----
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGNY-E-GRSVAVKRLVKT-----HHDVALKEIQN--LIASDQHPNIVRWYGVES----- 537 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~~-~-g~~VAVK~l~~~-----~~~~~~~Ei~~--ll~~l~HpNIV~L~g~~~----- 537 (753)
.++|++.+.||+|+||+||+|... + ++.||||+++.. ......+|+.. .++..+||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 467999999999999999999763 3 678999998542 12345667653 345568999999999985
Q ss_pred CCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 538 ~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
.....+++||+|.+++..+ ... .....+++..+..++.|++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~----------~~~----------------------------~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTY----------LDK----------------------------VPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp SEEEEEEEEECCSCBHHHH----------HHH----------------------------SCTTCSCHHHHHHHHHHHHH
T ss_pred cCceEEEEEEeccCCchhh----------hhh----------------------------ccCCCCCHHHHHHHHHHHHH
Confidence 3457899999666543222 111 12356788899999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSf 697 (753)
||+|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..|+.++||||+
T Consensus 128 aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 128 GLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhccc----ccCCCcccChhhcCcchhcCCCCChhehhhch
Confidence 999999999999999999999977665 999999998865422 23355679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH-HHHHHHcc---------------------------CcccccCCCHHHHHHHHHccccC
Q 004442 698 GCILFFCITGGKHPYGESFER-DANIVKDR---------------------------KDLFLVEHIPEAVDLFTRLLDPN 749 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~-~~~~i~~~---------------------------~~~~~~~~s~el~dLI~~cL~~D 749 (753)
||++|||+|| ++||.+.... ....+... ...+....++++.+||++||++|
T Consensus 202 G~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 202 GCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC
Confidence 9999999998 6787665332 22222110 01123456889999999999999
Q ss_pred cCCC
Q 004442 750 PDLR 753 (753)
Q Consensus 750 P~~R 753 (753)
|++|
T Consensus 281 P~~R 284 (305)
T d1blxa_ 281 PAKR 284 (305)
T ss_dssp TTTS
T ss_pred hhHC
Confidence 9998
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-40 Score=351.14 Aligned_cols=235 Identities=24% Similarity=0.388 Sum_probs=183.7
Q ss_pred ceEEEeEEecccCceEEEEEEeeCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccCCceEEEEEc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~E 547 (753)
++|.+.+.||+|+||+||+|...+|+.||||++.... .+.+.+|+. +++.++|||||++++++.+++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHH-HHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 4688999999999999999998899999999996532 234556665 7899999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|.+++.+.+ . .....+++.++.+|+.||+.||+|||+.+|
T Consensus 81 ~~~~~~~~~~----------~-----------------------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~I 121 (286)
T d1ob3a_ 81 HLDQDLKKLL----------D-----------------------------VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (286)
T ss_dssp CCSEEHHHHH----------H-----------------------------TSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eehhhhHHHH----------H-----------------------------hhcCCcchhhhHHHHHHHHHHHHHhccCcE
Confidence 6655433222 2 123568899999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. +||+|||++....... .......|++.|+|||.+.+.. ++.++|||||||++|||++
T Consensus 122 vHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 122 LHRDLKPQNLLINREGE--LKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp CCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCceeeEcCCCC--EEecccccceecccCc---cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH
Confidence 99999999999977765 9999999998765432 1223446899999999997654 6999999999999999999
Q ss_pred CCCCCCCCChHHH-HHHHHc--c---------------------------CcccccCCCHHHHHHHHHccccCcCCC
Q 004442 707 GGKHPYGESFERD-ANIVKD--R---------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 707 G~~~Pf~~~~~~~-~~~i~~--~---------------------------~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
| ++||.+..+.. ...+.. . ........++++++||++||++||++|
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R 272 (286)
T d1ob3a_ 197 G-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272 (286)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred C-CCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHC
Confidence 8 67887654332 222110 0 011234567899999999999999998
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-40 Score=348.21 Aligned_cols=244 Identities=20% Similarity=0.251 Sum_probs=185.9
Q ss_pred ceecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-hHHHHHHHHHHHhCCCCceeee-cccccCCceEEEE
Q 004442 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRW-YGVESDQDFVYLS 545 (753)
Q Consensus 469 ~~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~HpNIV~L-~g~~~~~~~~~LV 545 (753)
.+++++|++.+.||+|+||.||+|.. .+|+.||||++..... ....+|+. +++.++|+|++.. .++..+.+..++|
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHH-HHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHH-HHHHccCCCcccEEEEEEecCCEEEEE
Confidence 35677899999999999999999975 4689999999875443 34555555 7788887775555 4555678889999
Q ss_pred EccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhC
Q 004442 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (753)
Q Consensus 546 ~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~ 625 (753)
||+|++++.+.+ . .....+++..++.++.|++.||+|||++
T Consensus 82 me~~~~~l~~~~-----------~----------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (299)
T d1ckia_ 82 MELLGPSLEDLF-----------N----------------------------FCSRKFSLKTVLLLADQMISRIEYIHSK 122 (299)
T ss_dssp EECCCCBHHHHH-----------H----------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEcCCchhhhh-----------h----------------------------hccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence 997765544332 1 1234688899999999999999999999
Q ss_pred CccccCCCCCcEEEec-CCCCeEEEEeccCceeccCCCcc----cccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 626 GLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~-d~~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
+|+||||||+|||++. +.+..+||+|||+|+........ ........||+.|||||++.+..++.++|||||||+
T Consensus 123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202 (299)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHH
Confidence 9999999999999854 23456999999999987643321 123345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-HH---HHHc-----cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESFERD-AN---IVKD-----RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~~~~-~~---~i~~-----~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| .+||....... .. .... ........+++++.++|++||+.||++|
T Consensus 203 l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~R 263 (299)
T d1ckia_ 203 LMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 263 (299)
T ss_dssp HHHHHHS-SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCC
T ss_pred HHHHHhC-CCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHC
Confidence 9999999 67876532211 11 1111 1112345788999999999999999998
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-39 Score=352.56 Aligned_cols=239 Identities=23% Similarity=0.357 Sum_probs=181.4
Q ss_pred eecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCch----HHHHHHHHHHHhCCCCceeeecccccCCc----
Q 004442 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (753)
Q Consensus 470 ~i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~----~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~---- 540 (753)
.++.+|.+.+.||+|+||+||+|.. .+|+.||||++.+.... ...+|+. +++.++||||+++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHH-HHHHcCCCCCCcEEEEEeecccccc
Confidence 3456799999999999999999965 57999999999754432 3455665 789999999999999986543
Q ss_pred -eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 541 -FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 541 -~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
..+++++. .+|+|.+++. .+++++..+..++.||+.||
T Consensus 84 ~~~~l~~~~-----------~~g~L~~~l~------------------------------~~~l~~~~i~~i~~qil~al 122 (345)
T d1pmea_ 84 KDVYLVTHL-----------MGADLYKLLK------------------------------TQHLSNDHICYFLYQILRGL 122 (345)
T ss_dssp CCEEEEEEC-----------CCEEHHHHHH------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_pred ceEEEEEee-----------cCCchhhhhh------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 35666553 3556666552 23578899999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfG 698 (753)
+|||+++||||||||+||||+.++. +||+|||+++...............+||+.|+|||++.. ..++.++||||+|
T Consensus 123 ~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 200 (345)
T d1pmea_ 123 KYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH
T ss_pred HHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccC
Confidence 9999999999999999999977764 999999999887654333334456679999999999854 4579999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHH-HHHHc------------------------cC-------cccccCCCHHHHHHHHHcc
Q 004442 699 CILFFCITGGKHPYGESFERDA-NIVKD------------------------RK-------DLFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~~~-~~i~~------------------------~~-------~~~~~~~s~el~dLI~~cL 746 (753)
|++|||++| ++||........ ..... .. .......++++.+||.+||
T Consensus 201 ~il~eml~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 279 (345)
T d1pmea_ 201 CILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279 (345)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHS
T ss_pred ceehHHhhC-CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHc
Confidence 999999999 678866533221 11100 00 0112356789999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
+.||++|
T Consensus 280 ~~dP~~R 286 (345)
T d1pmea_ 280 TFNPHKR 286 (345)
T ss_dssp CSSTTTS
T ss_pred cCChhHC
Confidence 9999998
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-39 Score=342.87 Aligned_cols=242 Identities=17% Similarity=0.220 Sum_probs=187.3
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-hHHHHHHHHHHHhCCC-CceeeecccccCCceEEEEEc
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-DVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLSLE 547 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l~H-pNIV~L~g~~~~~~~~~LV~E 547 (753)
++++|++.+.||+|+||+||+|... +|+.||||++..... ....+|+. .++.++| +||+.+++++.+....++|||
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~-~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYR-TYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHH-HHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHH-HHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 5678999999999999999999765 589999999865443 34445554 5566655 899999999999999999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
+|+++|. ++++.. ...+++.++.+++.|++.||+|||+.||
T Consensus 82 ~~~~~l~-----------~~~~~~----------------------------~~~~~~~~~~~i~~q~~~~l~~lH~~gi 122 (293)
T d1csna_ 82 LLGPSLE-----------DLLDLC----------------------------GRKFSVKTVAMAAKQMLARVQSIHEKSL 122 (293)
T ss_dssp CCCCBHH-----------HHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred ecCCCHH-----------HHHHhh----------------------------ccchhhHHHHHHHHHHHHHHHHHHHCCc
Confidence 6654444 433221 2357788889999999999999999999
Q ss_pred cccCCCCCcEEEecCC---CCeEEEEeccCceeccCCCcc----cccCccCCCCccccccccccCCCCCchhhHHHHHHH
Q 004442 628 IHRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (753)
Q Consensus 628 iHrDLKp~NILL~~d~---~~~~KLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfGvv 700 (753)
+||||||+|||++.+. ...+||+|||+|+........ .......+||+.|||||++.+..++.++|||||||+
T Consensus 123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (293)
T d1csna_ 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV 202 (293)
T ss_dssp ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHH
Confidence 9999999999996531 235999999999987543221 123345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCh----HHHHHHHHccC-----cccccCCCHHHHHHHHHccccCcCCC
Q 004442 701 LFFCITGGKHPYGESF----ERDANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 701 L~EllTG~~~Pf~~~~----~~~~~~i~~~~-----~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|||+|| ..||.... ......+...+ ......+++++.++|+.||..+|++|
T Consensus 203 l~elltg-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~r 263 (293)
T d1csna_ 203 FMYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263 (293)
T ss_dssp HHHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCC
T ss_pred HHHHHhC-CCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccC
Confidence 9999998 67886431 11122222211 12235678999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=351.41 Aligned_cols=236 Identities=26% Similarity=0.349 Sum_probs=181.0
Q ss_pred eEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCchHHHHHHHHHHHhCCCCceeeecccccC------CceEEEEE
Q 004442 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD------QDFVYLSL 546 (753)
Q Consensus 474 ~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------~~~~~LV~ 546 (753)
.|+..++||+|+||+||+|... +|+.||||++..... ...+|+. +++.++|+|||++++++.. ..+++|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~Ei~-il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-SCCHHHH-HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-HHHHHHH-HHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 5788899999999999999775 599999999976432 2335665 7799999999999999843 34579999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|||++++.+.+ .+.. .....+++.++..++.||+.||+|||++|
T Consensus 99 Ey~~~~~~~~l----------~~~~--------------------------~~~~~l~~~~~~~i~~qil~aL~yLH~~~ 142 (350)
T d1q5ka_ 99 DYVPETVYRVA----------RHYS--------------------------RAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142 (350)
T ss_dssp ECCSEEHHHHH----------HHHH--------------------------HTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred eccCCccHHHH----------Hhhh--------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 96665433222 1111 22456899999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccC-CCCCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+|||++.++ ..+||+|||+++...... .....+||..|+|||.+.+ ..++.++|||||||++|||+
T Consensus 143 IiHrDiKp~NILl~~~~-~~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 143 ICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp EECCCCCGGGEEECTTT-CCEEECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CcccCCCcceEEEecCC-CceeEecccchhhccCCc----ccccccccccccChHHhhcccCCCcceeecccceEEEehh
Confidence 99999999999997765 358999999998775432 2344578999999998875 46899999999999999999
Q ss_pred hCCCCCCCCChHH-HHHHHHc-------------------cC----------cccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFER-DANIVKD-------------------RK----------DLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~-~~~~i~~-------------------~~----------~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+| ++||...... ....+.. .. .......++++.+||++||..||++|
T Consensus 218 ~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R 294 (350)
T d1q5ka_ 218 LG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294 (350)
T ss_dssp HT-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence 98 6777654322 2221110 00 01123468899999999999999998
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=349.84 Aligned_cols=236 Identities=25% Similarity=0.378 Sum_probs=190.7
Q ss_pred ceEEEeEEecccCceEEEEEEee----CCcEEEEEEeecC-------CchHHHHHHHHHHHhCCC-CceeeecccccCCc
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKT-------HHDVALKEIQNLIASDQH-PNIVRWYGVESDQD 540 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~~----~g~~VAVK~l~~~-------~~~~~~~Ei~~ll~~l~H-pNIV~L~g~~~~~~ 540 (753)
++|++.+.||+|+||+||+|... +|+.||||.+++. ..+...+|+. ++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~-il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHH-HHHHHHTCTTBCCEEEEEEETT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHH-HHHhccCCCeEEEeeeeeccCC
Confidence 56999999999999999998642 4899999998532 1234456766 6677766 89999999999999
Q ss_pred eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHH
Q 004442 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (753)
Q Consensus 541 ~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~ 620 (753)
..+++|| |+.+|+|.+++... ..+++..+..++.||+.||+
T Consensus 103 ~~~~v~e----------~~~~~~L~~~i~~~-----------------------------~~~~e~~~~~~~~Qi~~al~ 143 (322)
T d1vzoa_ 103 KLHLILD----------YINGGELFTHLSQR-----------------------------ERFTEHEVQIYVGEIVLALE 143 (322)
T ss_dssp EEEEEEC----------CCCSCBHHHHHHHH-----------------------------SCCCHHHHHHHHHHHHHHHH
T ss_pred ceeeeee----------cccccHHHHHHHhc-----------------------------ccccHHHHHHHHHHHHHHHH
Confidence 9999999 77788888887543 35677788999999999999
Q ss_pred HhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC--CCchhhHHHHH
Q 004442 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLG 698 (753)
Q Consensus 621 yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~--~t~ksDIwSfG 698 (753)
|||+.+|+||||||+||||+.++. +||+|||+++.+..... .......|++.|+|||.+.+.. ++.++||||||
T Consensus 144 ~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 144 HLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219 (322)
T ss_dssp HHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred HhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhccccc--ccccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence 999999999999999999977764 99999999987754322 2234456899999999997654 68899999999
Q ss_pred HHHHHHHhCCCCCCCCCh-----HHHHHHHHccCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 699 CILFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~-----~~~~~~i~~~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
|+||||+|| .+||.... ..............+..+++++.+||++||++||++|
T Consensus 220 ~iLyelltG-~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R 278 (322)
T d1vzoa_ 220 VLMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278 (322)
T ss_dssp HHHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHc
Confidence 999999998 67775532 2223333445566778899999999999999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=350.64 Aligned_cols=232 Identities=25% Similarity=0.403 Sum_probs=177.5
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCc----
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~---- 540 (753)
+.++|++.+.||+|+||+||+|... +|+.||||+++.... +...+|+. +++.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHH-HHHhcCCCCeeEEEEEeccCccccc
Confidence 4678999999999999999999764 599999999975432 23456665 779999999999999987654
Q ss_pred --eEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 541 --~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
.+|+|||||+.+|..++ +...+++..+..++.||+.|
T Consensus 95 ~~~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~~~~qi~~a 133 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLM-----------------------------------------KHEKLGEDRIQFLVYQMLKG 133 (346)
T ss_dssp CCCCEEEEECCSEEHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_pred cceEEEEEecccccHHHHH-----------------------------------------HhccccHHHHHHHHHHHHHH
Confidence 57999998765443322 23468889999999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCC-CCCchhhHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 697 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIwSf 697 (753)
|+|||++||+||||||+|||++.++. +||+|||+|+..... .....||+.|+|||++.+. .++.++||||+
T Consensus 134 L~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 134 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHhCCCcccccCcchhhcccccc--cccccccceeccCCc------cccccccccccCHHHHcCCCCCCccchhhcc
Confidence 99999999999999999999977765 999999999876542 2345689999999998765 46999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHH-HHHHc------------------------c-------CcccccCCCHHHHHHHHHc
Q 004442 698 GCILFFCITGGKHPYGESFERDA-NIVKD------------------------R-------KDLFLVEHIPEAVDLFTRL 745 (753)
Q Consensus 698 GvvL~EllTG~~~Pf~~~~~~~~-~~i~~------------------------~-------~~~~~~~~s~el~dLI~~c 745 (753)
||++|||++| .+||.+...... ..... . ........++++.+||++|
T Consensus 206 Gvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 206 GCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred hHHHHHHHHC-cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHH
Confidence 9999999998 678766532221 11100 0 0112345688999999999
Q ss_pred cccCcCCC
Q 004442 746 LDPNPDLR 753 (753)
Q Consensus 746 L~~DP~~R 753 (753)
|..||++|
T Consensus 285 L~~dP~~R 292 (346)
T d1cm8a_ 285 LVLDAEQR 292 (346)
T ss_dssp SCSSTTTS
T ss_pred CcCChhHC
Confidence 99999998
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=343.18 Aligned_cols=239 Identities=24% Similarity=0.330 Sum_probs=179.0
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCC-----chHHHHHHHHHHHhCCCCceeeecccccC-------
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD------- 538 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~-----~~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------- 538 (753)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+|+. +++.++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHH-HHHHhcCCCccceEeeeecccccccc
Confidence 36789999999999999999976 469999999985432 235667776 7899999999999998754
Q ss_pred -CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHH
Q 004442 539 -QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (753)
Q Consensus 539 -~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~ 617 (753)
++..++|||+|..++... +. .....+++..+..++.|++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~----------~~-----------------------------~~~~~~~~~~~~~i~~qil~ 128 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGL----------LS-----------------------------NVLVKFTLSEIKRVMQMLLN 128 (318)
T ss_dssp ---CEEEEEECCCEEHHHH----------HT-----------------------------CTTCCCCHHHHHHHHHHHHH
T ss_pred cCceEEEEEeccCCCccch----------hh-----------------------------hcccccccHHHHHHHHHHHH
Confidence 346899999766543322 11 12345778888999999999
Q ss_pred HHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCc-ccccCccCCCCccccccccccCC-CCCchhhHH
Q 004442 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLF 695 (753)
Q Consensus 618 gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDIw 695 (753)
||.|||+.+|+||||||+|||++.++. +||+|||+++....... ........+||+.|+|||++.+. .++.++|||
T Consensus 129 ~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw 206 (318)
T d3blha1 129 GLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206 (318)
T ss_dssp HHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence 999999999999999999999977765 99999999987654321 22233445799999999998765 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHH-HHHHHHccCccc--------------------------------ccCCCHHHHHHH
Q 004442 696 SLGCILFFCITGGKHPYGESFER-DANIVKDRKDLF--------------------------------LVEHIPEAVDLF 742 (753)
Q Consensus 696 SfGvvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~~~--------------------------------~~~~s~el~dLI 742 (753)
||||++|||++| ++||.+.... ....+....... ....++++.+||
T Consensus 207 SlGvil~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl 285 (318)
T d3blha1 207 GAGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 285 (318)
T ss_dssp HHHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHH
T ss_pred cCCceeeeHhhC-CCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHH
Confidence 999999999998 6777654332 222221110000 011366889999
Q ss_pred HHccccCcCCC
Q 004442 743 TRLLDPNPDLR 753 (753)
Q Consensus 743 ~~cL~~DP~~R 753 (753)
++||+.||++|
T Consensus 286 ~~mL~~dP~~R 296 (318)
T d3blha1 286 DKLLVLDPAQR 296 (318)
T ss_dssp HHHSCSSTTTS
T ss_pred HHHCcCChhHC
Confidence 99999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-39 Score=336.47 Aligned_cols=236 Identities=24% Similarity=0.304 Sum_probs=185.2
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccCCceEEEEE
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~~~~~~LV~ 546 (753)
++|++.+.||+|+||+||+|.. .+|+.||||+++.... ....+|+. +++.++|+||++++++|.+.+..++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHH-HHHhcCcCCEEeeccccccccceeEEe
Confidence 4689999999999999999976 4689999999964331 23455665 789999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCC
Q 004442 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (753)
Q Consensus 547 E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~ 626 (753)
|+| .+++|..++.. ...+++..+..++.|++.||+|||+++
T Consensus 81 ~~~----------~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 81 EFC----------DQDLKKYFDSC-----------------------------NGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECC----------SEEHHHHHHHT-----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eec----------ccccccccccc-----------------------------ccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 954 44555444321 245678888999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHH
Q 004442 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 705 (753)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~Ell 705 (753)
|+||||||+|||++.++. +||+|||.++....... ......++..|+|||.+.... ++.++|||||||++|||+
T Consensus 122 IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred EeeecccCcccccccCCc--eeeeecchhhcccCCCc---cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHh
Confidence 999999999999977765 99999999998764322 223345788999999987765 699999999999999999
Q ss_pred hCCCCCCCCChHHH-HHHHHc-----------------------------cCcccccCCCHHHHHHHHHccccCcCCC
Q 004442 706 TGGKHPYGESFERD-ANIVKD-----------------------------RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (753)
Q Consensus 706 TG~~~Pf~~~~~~~-~~~i~~-----------------------------~~~~~~~~~s~el~dLI~~cL~~DP~~R 753 (753)
+|+.++|....... ...+.. .........++++.+||++||+.||++|
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (292)
T d1unla_ 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHC
Confidence 99777776554332 222111 0111234567899999999999999998
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.5e-38 Score=341.63 Aligned_cols=233 Identities=23% Similarity=0.316 Sum_probs=182.1
Q ss_pred cceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCchHHHHHHHHHHHhC-CCCceeeecccccC--CceEEEEEc
Q 004442 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASD-QHPNIVRWYGVESD--QDFVYLSLE 547 (753)
Q Consensus 472 ~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~--~~~~~LV~E 547 (753)
.++|++.+.||+|+||+||+|.. .+|+.||||+++....+...+|+. +++.+ .||||+++++++.. ....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~-il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIK-ILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHH-HHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHH-HHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 36799999999999999999976 469999999998877777778887 55665 59999999999864 467999999
Q ss_pred cccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q 004442 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (753)
Q Consensus 548 ~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL~yLH~~~I 627 (753)
| +.+|+|.++ .+.+++..+..++.||+.||+|||++||
T Consensus 113 ~----------~~~~~L~~~--------------------------------~~~l~e~~i~~i~~qil~aL~~LH~~gI 150 (328)
T d3bqca1 113 H----------VNNTDFKQL--------------------------------YQTLTDYDIRFYMYEILKALDYCHSMGI 150 (328)
T ss_dssp C----------CCSCBGGGT--------------------------------TTSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred e----------cCCCcHHHH--------------------------------hcCCCHHHHHHHHHHHHHHHHHHhhccc
Confidence 4 445555432 1357888899999999999999999999
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHHHHHHHHHh
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfGvvL~EllT 706 (753)
+||||||+|||++.++. .+||+|||+|+...... .....+||+.|+|||.+.+.. ++.++||||+||++|||++
T Consensus 151 vHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~ 225 (328)
T d3bqca1 151 MHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225 (328)
T ss_dssp ECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccceEEcCCCC-eeeecccccceeccCCC----cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc
Confidence 99999999999987653 58999999998775432 234456899999999987755 7999999999999999999
Q ss_pred CCCCCCCCC-hHHHH-HHHH-------------c------------------------cCcccccCCCHHHHHHHHHccc
Q 004442 707 GGKHPYGES-FERDA-NIVK-------------D------------------------RKDLFLVEHIPEAVDLFTRLLD 747 (753)
Q Consensus 707 G~~~Pf~~~-~~~~~-~~i~-------------~------------------------~~~~~~~~~s~el~dLI~~cL~ 747 (753)
| +.||... ..... ..+. . .........++++.|||++||.
T Consensus 226 g-~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~ 304 (328)
T d3bqca1 226 R-KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304 (328)
T ss_dssp T-CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSC
T ss_pred C-CCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHcc
Confidence 9 5566432 21111 1000 0 0001123467899999999999
Q ss_pred cCcCCC
Q 004442 748 PNPDLR 753 (753)
Q Consensus 748 ~DP~~R 753 (753)
+||++|
T Consensus 305 ~dP~~R 310 (328)
T d3bqca1 305 YDHQSR 310 (328)
T ss_dssp SSGGGS
T ss_pred CChhHC
Confidence 999998
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=337.79 Aligned_cols=195 Identities=26% Similarity=0.385 Sum_probs=150.5
Q ss_pred ecceEEEeEEecccCceEEEEEEee-CCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC------
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD------ 538 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~~-~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~------ 538 (753)
+.++|++.+.||+|+||+||+|... +|+.||||++..... ....+|+. +++.++|||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHH-HHHhcCCCCeeEEEEEEeccccccc
Confidence 4467999999999999999999765 599999999975431 12345555 7899999999999999853
Q ss_pred CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHH
Q 004442 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (753)
Q Consensus 539 ~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~g 618 (753)
....|+|||||.+++.+.+ ...+++..+..++.||+.|
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~------------------------------------------~~~~~~~~i~~~~~qil~g 131 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI------------------------------------------QMELDHERMSYLLYQMLCG 131 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH------------------------------------------TSCCCHHHHHHHHHHHHHH
T ss_pred CceeEEEEeccchHHHHhh------------------------------------------hcCCCHHHHHHHHHHHHHH
Confidence 4688999997665433222 1347788899999999999
Q ss_pred HHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCchhhHHHHH
Q 004442 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (753)
Q Consensus 619 L~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDIwSfG 698 (753)
|.|||+.||+||||||+|||++.++. +|++|||+++..... ......+||+.|+|||++.+..++.++||||+|
T Consensus 132 l~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG 205 (355)
T d2b1pa1 132 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred HHHhhhcccccccCCccccccccccc--eeeechhhhhccccc----cccccccccccccChhhhcCCCCCCCccccccc
Confidence 99999999999999999999987765 899999998876532 233445689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC
Q 004442 699 CILFFCITGGKHPYGES 715 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~ 715 (753)
|++|||++| ++||.+.
T Consensus 206 ~~l~ell~g-~~pF~~~ 221 (355)
T d2b1pa1 206 CIMGEMVRH-KILFPGR 221 (355)
T ss_dssp HHHHHHHHS-SCSSCCS
T ss_pred chHHHHhhC-CCCCCCC
Confidence 999999999 6787654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=335.89 Aligned_cols=233 Identities=21% Similarity=0.345 Sum_probs=175.6
Q ss_pred ecceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc-----hHHHHHHHHHHHhCCCCceeeecccccC-----C
Q 004442 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD-----Q 539 (753)
Q Consensus 471 i~~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~-----~~~~~Ei~~ll~~l~HpNIV~L~g~~~~-----~ 539 (753)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.+... +...+|+. +++.++|+|||++++++.. .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHH-HHHhcCCCCeeeEEEEEeecccccc
Confidence 456799999999999999999975 5699999999975432 23456665 7899999999999998753 2
Q ss_pred ceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHHHHH
Q 004442 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (753)
Q Consensus 540 ~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa~gL 619 (753)
...++++| |+.+|+|.++++ .+.+++.++..++.||+.||
T Consensus 95 ~~~~~i~~----------~~~gg~L~~~~~------------------------------~~~l~e~~~~~i~~qil~aL 134 (348)
T d2gfsa1 95 FNDVYLVT----------HLMGADLNNIVK------------------------------CQKLTDDHVQFLIYQILRGL 134 (348)
T ss_dssp CCCCEEEE----------ECCSEEHHHHHT------------------------------TCCCCHHHHHHHHHHHHHHH
T ss_pred CceEEEEE----------eecCCchhhhcc------------------------------cccccHHHHHHHHHHHHHHH
Confidence 33344555 344566666552 23578889999999999999
Q ss_pred HHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCC-CCchhhHHHHH
Q 004442 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLG 698 (753)
Q Consensus 620 ~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDIwSfG 698 (753)
+|||++||+||||||+|||++.++. +|++|||++..... ......||+.|+|||.+.+.. ++.++||||||
T Consensus 135 ~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlG 206 (348)
T d2gfsa1 135 KYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG 206 (348)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHH
T ss_pred HHHHhCCCcccccCCcccccccccc--ccccccchhcccCc------ccccccccccccCchhhcCCccCCcccchhhhh
Confidence 9999999999999999999977765 89999999976532 223456899999999877665 58999999999
Q ss_pred HHHHHHHhCCCCCCCCChHH-HHHHHHccCc-------------------------------ccccCCCHHHHHHHHHcc
Q 004442 699 CILFFCITGGKHPYGESFER-DANIVKDRKD-------------------------------LFLVEHIPEAVDLFTRLL 746 (753)
Q Consensus 699 vvL~EllTG~~~Pf~~~~~~-~~~~i~~~~~-------------------------------~~~~~~s~el~dLI~~cL 746 (753)
|++|||++| .+||.+.... ....+..... ......++++.+||++||
T Consensus 207 v~l~~ll~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 285 (348)
T d2gfsa1 207 CIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285 (348)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHC
Confidence 999999999 6777654322 2222111000 012356889999999999
Q ss_pred ccCcCCC
Q 004442 747 DPNPDLR 753 (753)
Q Consensus 747 ~~DP~~R 753 (753)
..||++|
T Consensus 286 ~~dP~~R 292 (348)
T d2gfsa1 286 VLDSDKR 292 (348)
T ss_dssp CSSGGGS
T ss_pred cCChhhC
Confidence 9999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-33 Score=304.12 Aligned_cols=198 Identities=21% Similarity=0.329 Sum_probs=150.9
Q ss_pred ceEEEeEEecccCceEEEEEEe-eCCcEEEEEEeecCCc--hHHHHHHHHHHHhC-----------CCCceeeecccccC
Q 004442 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-----------QHPNIVRWYGVESD 538 (753)
Q Consensus 473 ~~~~i~~~IG~G~fG~Vyka~~-~~g~~VAVK~l~~~~~--~~~~~Ei~~ll~~l-----------~HpNIV~L~g~~~~ 538 (753)
.+|++.+.||+|+||+||+|.. .+|+.||||++++... +...+|+. +++.+ .|+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~-~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHH-HHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHH-HHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3599999999999999999976 5699999999976532 33344544 44443 47899999998765
Q ss_pred --CceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHHHH
Q 004442 539 --QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616 (753)
Q Consensus 539 --~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~qIa 616 (753)
....+++++++.+.- +...... ......+++..+..++.||+
T Consensus 92 ~~~~~~~~~~~~~~~~~---------~~~~~~~---------------------------~~~~~~~~~~~i~~i~~qil 135 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGE---------NLLALIK---------------------------KYEHRGIPLIYVKQISKQLL 135 (362)
T ss_dssp EETTEEEEEEEECCCCE---------EHHHHHH---------------------------HTTTSCCCHHHHHHHHHHHH
T ss_pred ccccceeeeeeeccccc---------ccccccc---------------------------cccccCCcHHHHHHHHHHHH
Confidence 345666766443311 1111111 12345678889999999999
Q ss_pred HHHHHhhh-CCccccCCCCCcEEEecCCC----CeEEEEeccCceeccCCCcccccCccCCCCccccccccccCCCCCch
Q 004442 617 SGLSHLHE-IGLIHRDLKPQNVLISKDKS----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (753)
Q Consensus 617 ~gL~yLH~-~~IiHrDLKp~NILL~~d~~----~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~k 691 (753)
.||+|||+ .||+||||||+||||+.++. ..+|++|||.+...... ....+||+.|+|||++....++.+
T Consensus 136 ~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~ 209 (362)
T d1q8ya_ 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCG 209 (362)
T ss_dssp HHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred HHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc------cccccccccccChhhccccCCCcc
Confidence 99999997 89999999999999976654 25899999999865432 234569999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC
Q 004442 692 IDLFSLGCILFFCITGGKHPYGE 714 (753)
Q Consensus 692 sDIwSfGvvL~EllTG~~~Pf~~ 714 (753)
+||||+||+++||++| ++||..
T Consensus 210 ~DiwSlG~il~el~~g-~~pF~~ 231 (362)
T d1q8ya_ 210 ADIWSTACLIFELITG-DFLFEP 231 (362)
T ss_dssp HHHHHHHHHHHHHHHS-SCCC--
T ss_pred ccccchHHHHHHHHHC-CCCCCC
Confidence 9999999999999998 667753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.6e-21 Score=190.44 Aligned_cols=160 Identities=16% Similarity=0.079 Sum_probs=110.6
Q ss_pred EEeEEecccCceEEEEEEeeCCcEEEEEEeecCCc---------------------hHHHHHHHHHHHhCCCCceeeecc
Q 004442 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------DVALKEIQNLIASDQHPNIVRWYG 534 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~~---------------------~~~~~Ei~~ll~~l~HpNIV~L~g 534 (753)
.+.+.||+|+||+||+|...+|+.||||+++.... ....+|. ..+..+.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF-RALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH-HHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHH-HHHHHccCCCcceEEE
Confidence 46788999999999999988999999998753110 0112233 3567889999988876
Q ss_pred cccCCceEEEEEccccCChhhHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHHHHHHHHHH
Q 004442 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (753)
Q Consensus 535 ~~~~~~~~~LV~E~c~~~L~~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~Ia~q 614 (753)
+.. .+++||++++ +.+. .++.....+++.|
T Consensus 82 ~~~----~~lvme~~~~----------~~~~------------------------------------~l~~~~~~~i~~q 111 (191)
T d1zara2 82 WEG----NAVLMELIDA----------KELY------------------------------------RVRVENPDEVLDM 111 (191)
T ss_dssp EET----TEEEEECCCC----------EEGG------------------------------------GCCCSCHHHHHHH
T ss_pred ecC----CEEEEEeecc----------cccc------------------------------------chhhHHHHHHHHH
Confidence 532 3799996653 2111 1122234679999
Q ss_pred HHHHHHHhhhCCccccCCCCCcEEEecCCCCeEEEEeccCceeccCCCcccccCccCCCCcccccc--c---cccCCCCC
Q 004442 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP--E---QLLQGRQT 689 (753)
Q Consensus 615 Ia~gL~yLH~~~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP--E---~l~~~~~t 689 (753)
++++|+|||+.+|+||||||+|||+++++ ++|+|||+|+....... ..|... + ....+.|.
T Consensus 112 l~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~r~y~ 177 (191)
T d1zara2 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGW-----------REILERDVRNIITYFSRTYR 177 (191)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEETTSTTH-----------HHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCcccCCCCCc-----------HHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999997543 88999999987643211 111111 0 01235678
Q ss_pred chhhHHHHHHH
Q 004442 690 RAIDLFSLGCI 700 (753)
Q Consensus 690 ~ksDIwSfGvv 700 (753)
.++|+||..--
T Consensus 178 ~~~d~~s~~~~ 188 (191)
T d1zara2 178 TEKDINSAIDR 188 (191)
T ss_dssp CCCCHHHHHHH
T ss_pred CcccHHHHHHH
Confidence 88999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.21 E-value=0.00044 Score=68.17 Aligned_cols=75 Identities=11% Similarity=-0.051 Sum_probs=45.5
Q ss_pred EEeEEecccCceEEEEEEeeCCcEEEEEEeecCC---chHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEccccC
Q 004442 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 476 ~i~~~IG~G~fG~Vyka~~~~g~~VAVK~l~~~~---~~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
...+..+.++...||+.. .+++.++||+..... .....+|.. ++..+ .+--+.+++.++.+++..++||++.++
T Consensus 17 ~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~-~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G 94 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKD-MMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHH-HHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred EEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHH-HHHHHhccCCCCcEEEEEecCCceEEEEEeccc
Confidence 334444445557899764 456778889875432 223344544 33322 233356777777778889999998776
Q ss_pred C
Q 004442 552 S 552 (753)
Q Consensus 552 ~ 552 (753)
.
T Consensus 95 ~ 95 (263)
T d1j7la_ 95 V 95 (263)
T ss_dssp E
T ss_pred c
Confidence 3
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.88 E-value=0.00056 Score=67.08 Aligned_cols=70 Identities=11% Similarity=-0.028 Sum_probs=46.6
Q ss_pred ecccC-ceEEEEEEeeCCcEEEEEEeecCCchHHHHHHHHHHHhCC--CCceeeecccccCCceEEEEEccccC
Q 004442 481 IAKGS-NGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ--HPNIVRWYGVESDQDFVYLSLERCTC 551 (753)
Q Consensus 481 IG~G~-fG~Vyka~~~~g~~VAVK~l~~~~~~~~~~Ei~~ll~~l~--HpNIV~L~g~~~~~~~~~LV~E~c~~ 551 (753)
+..|. -+.||+.....+..++||.-..........|.. .+..+. .-.+.++++++.+.+..++|||++++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~-~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAA-RLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHH-HHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHhHHHHHHH-HHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 44444 367898887778889999876554444444444 333222 23356778888888889999998875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=96.44 E-value=0.00066 Score=68.94 Aligned_cols=41 Identities=10% Similarity=0.050 Sum_probs=35.9
Q ss_pred cccccccccCCccccccc-cccCC-CcccceeecCccccccCC
Q 004442 262 GDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL 302 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~ 302 (753)
..++.+.+.+|+|+|.|| .+.++ .|+.|||++|+|+|.||.
T Consensus 244 ~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 356778888999999998 58888 699999999999999995
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.86 E-value=0.0073 Score=61.74 Aligned_cols=166 Identities=15% Similarity=0.161 Sum_probs=78.0
Q ss_pred eEEEEEEeeCCcEEEEEEeecCC-chHHHHHHHHHHHhCCCCce-----eeecc--cccCCceEEEEEccccCCh----h
Q 004442 487 GTVVLEGNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNI-----VRWYG--VESDQDFVYLSLERCTCSL----N 554 (753)
Q Consensus 487 G~Vyka~~~~g~~VAVK~l~~~~-~~~~~~Ei~~ll~~l~HpNI-----V~L~g--~~~~~~~~~LV~E~c~~~L----~ 554 (753)
-.||+....+|..+++|..+... ....+.|+..++..+...+| +..-| .....+..+.+++++.+.. .
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 47999999999999999987653 23334333334443322221 12111 1223556788999887521 1
Q ss_pred hHHHHhcCChHHHhhhhhcccchhhhhhhhcccccccchhhhhhhcCCCCHH---HHHHHHHHHHHHHHHhh-h---CCc
Q 004442 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA---QLLKVTRDIVSGLSHLH-E---IGL 627 (753)
Q Consensus 555 ~liy~~~GsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~l~Ia~qIa~gL~yLH-~---~~I 627 (753)
.-.+..-|.+--.+|..................... ...........++.. .....+..+...+.-+- + .++
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLI-EPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTH-HHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhh-hhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 111223344444444332211100000000000000 000111111222222 22333333333333221 1 268
Q ss_pred cccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 628 iHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
||+|+.+.|||++. . ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~--~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRD--G--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESS--S--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeC--C--ceEEechhccc
Confidence 99999999999953 3 45899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=95.78 E-value=0.012 Score=61.73 Aligned_cols=71 Identities=20% Similarity=0.175 Sum_probs=42.0
Q ss_pred EEecccCceEEEEEEeeC-CcEEEEEEeec------C----CchHHHHHHHHH--HHhCCCCceeeecccccCCceEEEE
Q 004442 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVK------T----HHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLS 545 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~-g~~VAVK~l~~------~----~~~~~~~Ei~~l--l~~l~HpNIV~L~g~~~~~~~~~LV 545 (753)
+.||.|....||+....+ ++.|+||.-.. . ..++...|...+ +...-...+.++++++ ++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 568999999999987654 67899996432 1 112344454422 2222223455666554 4456789
Q ss_pred EccccC
Q 004442 546 LERCTC 551 (753)
Q Consensus 546 ~E~c~~ 551 (753)
||++.+
T Consensus 110 mE~L~~ 115 (392)
T d2pula1 110 MEDLSH 115 (392)
T ss_dssp ECCCTT
T ss_pred EeccCC
Confidence 998765
|
| >d1flga_ b.70.1.1 (A:) Ethanol dehydrogenase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Ethanol dehydrogenase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=95.46 E-value=0.047 Score=60.16 Aligned_cols=76 Identities=24% Similarity=0.290 Sum_probs=54.8
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIR 127 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 127 (753)
-++.-|++.+|+||.+|..+|+.+|+|....|.-.+-. .+ .+.
T Consensus 68 ~g~vy~~t~~~~v~AlDa~TG~~lW~~~~~~~~~~~~~--------------------------~~-----------~~~ 110 (582)
T d1flga_ 68 DGVIYVTASYSRLFALDAKTGKRLWTYNHRLPDDIRPC--------------------------CD-----------VVN 110 (582)
T ss_dssp TTEEEEEETTTEEEEEESSSCCEEEEEECCCCTTCCCS--------------------------SC-----------SCC
T ss_pred CCEEEEeCCCCeEEEEeCCCCCeEEEEcCCCCCccccc--------------------------cc-----------ccc
Confidence 46788999999999999999999999987665411100 00 011
Q ss_pred hCceeecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 128 RMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
|.|-+. ++.|.+|.....++++||+||+++-..
T Consensus 111 rg~a~~-~~~i~~~t~~~~l~alda~tG~~~W~~ 143 (582)
T d1flga_ 111 RGAAIY-GDKVFFGTLDASVVALNKNTGKVVWKK 143 (582)
T ss_dssp CCCEEE-TTEEEEEETTTEEEEEESSSCCEEEEE
T ss_pred CCceEe-CCceEEecCCCeEEEecccccceeeee
Confidence 223333 345889988889999999999998653
|
| >d1kv9a2 b.70.1.1 (A:1-560) Quinoprotein alcohol dehydrogenase, N-terminal domain {Pseudomonas putida, hk5 [TaxId: 303]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Pseudomonas putida, hk5 [TaxId: 303]
Probab=95.13 E-value=0.028 Score=61.78 Aligned_cols=78 Identities=15% Similarity=0.231 Sum_probs=53.0
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIR 127 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 127 (753)
-++..|++.+|+||.+|-.||+.+|+|..+.+....-...... +.
T Consensus 66 ~g~vyv~t~~~~v~AlDa~tG~~lW~~~~~~~~~~~~~~~~~~-----------------------------------~~ 110 (560)
T d1kv9a2 66 DGVIYTSMSWSRVIAVDAASGKELWRYDPEVAKVKARTSCCDA-----------------------------------VN 110 (560)
T ss_dssp TTEEEEEEGGGEEEEEETTTCCEEEEECCCCCGGGGGGCTTCS-----------------------------------CC
T ss_pred CCEEEEECCCCeEEEEeCCCCCEEEEECCCCCccccccccccc-----------------------------------cc
Confidence 4566789999999999999999999998665542111100000 01
Q ss_pred hCceeecCCeeeeeceeeeEEEEecccccEEecc
Q 004442 128 RMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
+.+.+ .++.|+.+.-.-.++++||+||+++-..
T Consensus 111 ~~~~~-~~~~v~~~~~~g~l~Alda~tG~~~w~~ 143 (560)
T d1kv9a2 111 RGVAL-WGDKVYVGTLDGRLIALDAKTGKAIWSQ 143 (560)
T ss_dssp CCCEE-EBTEEEEECTTSEEEEEETTTCCEEEEE
T ss_pred cCcce-eCCeEEEEeCCCEEEEEECCCCcEEecc
Confidence 11111 2345777777778999999999999873
|
| >d1kb0a2 b.70.1.1 (A:1-573) Quinoprotein alcohol dehydrogenase, N-terminal domain {Comamonas testosteroni [TaxId: 285]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Comamonas testosteroni [TaxId: 285]
Probab=94.92 E-value=0.032 Score=61.41 Aligned_cols=110 Identities=16% Similarity=0.196 Sum_probs=70.8
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCC--------ceeeeccCCCceeeeeccccCcee-ee
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNA--------SEFYLDVDEDWELYFHSKRFGKMK-KL 118 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~-~~ 118 (753)
-++.-|++.+|+||.+|-.+|+.+|+|....+..+.......... .+|+- ..|..||--+...|++. +.
T Consensus 77 ~g~vyv~t~~~~v~AlDa~TG~~~W~~~~~~~~~~~~~~~~~~~~~g~~~~~~~v~~~--t~~g~l~alda~tG~~~W~~ 154 (573)
T d1kb0a2 77 DGIMYVSASWSVVHAIDTRTGNRIWTYDPQIDRSTGFKGCCDVVNRGVALWKGKVYVG--AWDGRLIALDAATGKEVWHQ 154 (573)
T ss_dssp TTEEEEECGGGCEEEEETTTTEEEEEECCCCCGGGGGGSSSCSCCCCCEEETTEEEEE--CTTSEEEEEETTTCCEEEEE
T ss_pred CCEEEEECCCCeEEEEeCCCCCeEEEeCCCCCcccccccccccccccceEECCcEEEE--ecccceeeeccccccceecc
Confidence 467788899999999999999999999887776444332221111 13332 23556666666677765 22
Q ss_pred cc---CHHHH-HHhCceeecCCeeeeecee------eeEEEEecccccEEec
Q 004442 119 SS---SAEEY-IRRMPYISKDGGVTLGAMK------TSVFLVDVKSGRVVDN 160 (753)
Q Consensus 119 ~~---~~~~~-~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~ 160 (753)
.. ...++ +.-.|.+- +|.|++|... -.+++.|++||+++-.
T Consensus 155 ~~~~~~~~~~~~~~~p~v~-~~~vivg~~~~~~~~~G~v~a~D~~TG~~~W~ 205 (573)
T d1kb0a2 155 NTFEGQKGSLTITGAPRVF-KGKVIIGNGGAEYGVRGYITAYDAETGERKWR 205 (573)
T ss_dssp ETTTTCCSSCBCCSCCEEE-TTEEEECCBCTTTCCBCEEEEEETTTCCEEEE
T ss_pred cCccCCcceEEeecceEEE-eccEEEeeccccccccceEEEEecCCccceee
Confidence 21 11112 23345555 4558888653 3699999999999977
|
| >d2ad6a1 b.70.1.1 (A:1-571) Methanol dehydrogenase, heavy chain {Methylophilus methylotrophus, w3a1 [TaxId: 17]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylophilus methylotrophus, w3a1 [TaxId: 17]
Probab=94.30 E-value=0.059 Score=59.25 Aligned_cols=110 Identities=16% Similarity=0.255 Sum_probs=75.5
Q ss_pred CCeeEEEec-CceEEEEec-cCCeeeEEecCCCCcccccccC---CCCCC-----ceeeeccCCCceeeeeccccCcee-
Q 004442 48 PDVALVAAL-DGTIHLVDT-KLGKIRWSFGTGRPIYSSYQAS---FNSNA-----SEFYLDVDEDWELYFHSKRFGKMK- 116 (753)
Q Consensus 48 ~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~- 116 (753)
-++.-|++- +|+||.+|- .+|+.+|+|..+.+..++-... .+... .+|+-+ .|..||-=+...|++.
T Consensus 62 ~g~vyv~t~~~~~v~Alda~~tG~~~W~~~~~~~~~~~~~~~~~~~~rg~a~~~~~i~~~~--~~g~l~alda~tG~~~w 139 (571)
T d2ad6a1 62 GDMMYVHSAFPNNTYALNLNDPGKIVWQHKPKQDASTKAVMCCDVVDRGLAYGAGQIVKKQ--ANGHLLALDAKTGKINW 139 (571)
T ss_dssp TTEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCTTCSCCCCCEEETTEEEEEC--TTSEEEEEETTTCCEEE
T ss_pred CCEEEEecCCCCeEEEEeCCCCCceEEEecCCCCcccccccccCcCCCcceeeCCeEEEEe--CCCcEEeeehhhhhhhc
Confidence 355666675 799999996 5899999999888774432221 11111 244433 5678888888888875
Q ss_pred eecc---CHHHHHHhCceeecCCeeeeece------eeeEEEEecccccEEec
Q 004442 117 KLSS---SAEEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 117 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 160 (753)
+... ...-.+...|.|-++. |++|.. .-.+.++|++||+++-.
T Consensus 140 ~~~~~~~~~~~~~t~~p~v~~~~-vivg~~~~~~~~~G~v~a~D~~TG~~~W~ 191 (571)
T d2ad6a1 140 EVEVCDPKVGSTLTQAPFVAKDT-VLMGCSGAELGVRGAVNAFDLKTGELKWR 191 (571)
T ss_dssp EEECCCGGGTCBCCSCCEEETTE-EEEECBCGGGTCCCEEEEEETTTCCEEEE
T ss_pred cccccccccccceeecCeEeCCe-EEEeeccccccccCcEEEEECCCCcEEEE
Confidence 3321 2333456788888765 888875 45799999999999976
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=93.88 E-value=0.013 Score=58.94 Aligned_cols=50 Identities=6% Similarity=-0.029 Sum_probs=42.1
Q ss_pred cccccccccCCccccccccccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 262 GDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 262 ~~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
..+..+.+.+|+++|.+|.+..+ .|+.||+++|+|+|.||..+..+.+|.
T Consensus 221 ~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~ 271 (313)
T d1ogqa_ 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271 (313)
T ss_dssp SCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCC
T ss_pred ccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCC
Confidence 35577778899999999988777 799999999999999998887665554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.64 E-value=0.14 Score=50.93 Aligned_cols=30 Identities=33% Similarity=0.439 Sum_probs=25.2
Q ss_pred CccccCCCCCcEEEecCCCCeEEEEeccCcee
Q 004442 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (753)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~~KLsDFGla~~ 657 (753)
|+||+|+.+.||+++.++ ..-|.||+.+..
T Consensus 184 giIHgDl~~dNvl~~~~~--v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDE--LSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEEETTE--EEEECCCTTCEE
T ss_pred ccccCCcchhhhhccccc--ceeEeccccccc
Confidence 799999999999997664 357999998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=92.27 E-value=0.13 Score=53.36 Aligned_cols=68 Identities=15% Similarity=0.056 Sum_probs=39.6
Q ss_pred EEecccCceEEEEEEeeC--------CcEEEEEEeecCCc-hHHHHHHHHHHHhC-CCCceeeecccccCCceEEEEEcc
Q 004442 479 KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLER 548 (753)
Q Consensus 479 ~~IG~G~fG~Vyka~~~~--------g~~VAVK~l~~~~~-~~~~~Ei~~ll~~l-~HpNIV~L~g~~~~~~~~~LV~E~ 548 (753)
+.|+.|---.+|+....+ .+.|.+++.-.... ....+|.. +++.+ .|.=..++++++.+ .+|+|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~-i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESV-IFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHH-HHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHH-HHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 568888889999876654 34566666543222 23344544 33332 23223477777653 578997
Q ss_pred ccC
Q 004442 549 CTC 551 (753)
Q Consensus 549 c~~ 551 (753)
.++
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 765
|
| >d2ovrb2 b.69.4.1 (B:2365-2706) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD repeat-containing protein 7, FBXW7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.73 E-value=0.27 Score=47.05 Aligned_cols=109 Identities=16% Similarity=0.199 Sum_probs=68.6
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY 125 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 125 (753)
.+...+.++.||+|.++|..+++....+............ +.+ +.+.++.|..+++-+...++.. .+. ....-
T Consensus 186 ~~~~l~s~~~dg~i~~~d~~~~~~~~~~~~~~~~v~~~~~--~~~---~l~s~s~d~~i~iwd~~~~~~~~~~~-~~~~~ 259 (342)
T d2ovrb2 186 DGIHVVSGSLDTSIRVWDVETGNCIHTLTGHQSLTSGMEL--KDN---ILVSGNADSTVKIWDIKTGQCLQTLQ-GPNKH 259 (342)
T ss_dssp CSSEEEEEETTSCEEEEETTTCCEEEEECCCCSCEEEEEE--ETT---EEEEEETTSCEEEEETTTCCEEEEEC-STTSC
T ss_pred CCCEEEEEeCCCeEEEeecccceeeeEecccccceeEEec--CCC---EEEEEcCCCEEEEEeccccccccccc-cccee
Confidence 3456788899999999999999988888766554332221 122 4566777777777666555544 222 11111
Q ss_pred HHhCceeecC-CeeeeeceeeeEEEEecccccEEecc
Q 004442 126 IRRMPYISKD-GGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 126 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
....-+++.+ ..+..|+..-++..-|.+||+.++..
T Consensus 260 ~~~~~~~~~~~~~~~s~s~Dg~i~iwd~~tg~~i~~~ 296 (342)
T d2ovrb2 260 QSAVTCLQFNKNFVITSSDDGTVKLWDLKTGEFIRNL 296 (342)
T ss_dssp SSCEEEEEECSSEEEEEETTSEEEEEETTTCCEEEEE
T ss_pred eeceeecccCCCeeEEEcCCCEEEEEECCCCCEEEEE
Confidence 1111122222 34677888888999999999999883
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=91.31 E-value=0.091 Score=48.65 Aligned_cols=54 Identities=7% Similarity=-0.064 Sum_probs=40.6
Q ss_pred cccccccccccccCCccccccc--cccCC-CcccceeecCccccccCCCCCCCCCCc
Q 004442 258 MDLIGDVESHLPCHTQMTASVY--RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL 311 (753)
Q Consensus 258 ~~~~~~~~~~l~~nN~ftGsIp--~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~ 311 (753)
..+..++..+.+.+|++++.++ .+.++ .|+.|++++|++.+.++..+.....|.
T Consensus 25 ~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~ 81 (192)
T d1w8aa_ 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQ 81 (192)
T ss_dssp SCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCC
T ss_pred CCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccc
Confidence 3445677888899999988774 45666 789999999999988887776555544
|
| >d2ad6a1 b.70.1.1 (A:1-571) Methanol dehydrogenase, heavy chain {Methylophilus methylotrophus, w3a1 [TaxId: 17]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylophilus methylotrophus, w3a1 [TaxId: 17]
Probab=91.13 E-value=0.14 Score=56.19 Aligned_cols=66 Identities=20% Similarity=0.240 Sum_probs=54.2
Q ss_pred cCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhCceeecC
Q 004442 56 LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKD 135 (753)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (753)
..|+|..+|..+|++.|++..+.|..| .|+++.+
T Consensus 442 ~~G~l~AiD~~TG~~~W~~~~~~~~~~----------------------------------------------g~l~Tag 475 (571)
T d2ad6a1 442 EMGQIRAFDLTTGKAKWTKWEKFAAWG----------------------------------------------GTLYTKG 475 (571)
T ss_dssp CCEEEEEECTTTCCEEEEEEESSCCCS----------------------------------------------BCEEETT
T ss_pred CcccEEEeccCCCceeeEcCCCCCCCc----------------------------------------------ceeEecC
Confidence 348999999999999999887765421 2467788
Q ss_pred CeeeeeceeeeEEEEecccccEEecccCCCCC
Q 004442 136 GGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167 (753)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (753)
|.|..|+..-.++++|++||+++-.++.....
T Consensus 476 glVf~G~~dg~l~A~Da~tGe~lW~~~l~~~~ 507 (571)
T d2ad6a1 476 GLVWYATLDGYLKALDNKDGKELWNFKMPSGG 507 (571)
T ss_dssp TEEEEECTTSEEEEEETTTCCEEEEEECSSCC
T ss_pred CEEEEECCCCeEEEEECCCCcEEEEEECCCCc
Confidence 99999999999999999999999997765443
|
| >d1flga_ b.70.1.1 (A:) Ethanol dehydrogenase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Ethanol dehydrogenase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=90.74 E-value=0.16 Score=55.71 Aligned_cols=69 Identities=17% Similarity=0.226 Sum_probs=55.0
Q ss_pred ecCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhCceeec
Q 004442 55 ALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISK 134 (753)
Q Consensus 55 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (753)
...|+|+.+|..+|+++|++-.+.|..+ -|+.+.
T Consensus 463 ~~~G~l~AiD~~TG~i~W~~~~~~p~~~----------------------------------------------g~lsta 496 (582)
T d1flga_ 463 DHVGSLRAMDPVSGKVVWEHKEHLPLWA----------------------------------------------GVLATA 496 (582)
T ss_dssp SCSEEEEEECTTTCCEEEEEEESSCCCS----------------------------------------------CCEEET
T ss_pred CCCCeEEEEcCCCCcEEeecCCCCCCcc----------------------------------------------ceeEEc
Confidence 3469999999999999999987766421 135566
Q ss_pred CCeeeeeceeeeEEEEecccccEEecccCCCCCCC
Q 004442 135 DGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSAST 169 (753)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (753)
.|.|..|+..-.+.++|++||+++-.++...+..-
T Consensus 497 gglVF~Gt~dg~l~A~Da~TGe~LW~~~~~~~~~~ 531 (582)
T d1flga_ 497 GNLVFTGTGDGYFKAFDAKSGKELWKFQTGSGIVS 531 (582)
T ss_dssp TTEEEEECTTSEEEEEETTTCCEEEEEECSSCCCS
T ss_pred CCeEEEeCCCCeEEEEECCCCcEeEEEECCCCccc
Confidence 77788898888999999999999999887655444
|
| >d1w6sa_ b.70.1.1 (A:) Methanol dehydrogenase, heavy chain {Methylobacterium extorquens [TaxId: 408]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylobacterium extorquens [TaxId: 408]
Probab=90.42 E-value=0.38 Score=52.78 Aligned_cols=109 Identities=17% Similarity=0.171 Sum_probs=71.6
Q ss_pred CeeEEEec-CceEEEEec-cCCeeeEEecCCCCcccccccCC--------------CCCCceeeeccCCCceeeeecccc
Q 004442 49 DVALVAAL-DGTIHLVDT-KLGKIRWSFGTGRPIYSSYQASF--------------NSNASEFYLDVDEDWELYFHSKRF 112 (753)
Q Consensus 49 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~ 112 (753)
++.-|++. +|+||.+|- .+|+.+|+|....+.-....+.. ....-||+ ...|..||-=+...
T Consensus 63 g~ly~~t~~~~~v~a~d~~~tG~~~W~~~~~~~~~~~~~~~~~~~~RGv~~~~~~~~~~~~v~~--~t~dg~l~Alda~t 140 (596)
T d1w6sa_ 63 GKMYIHTSFPNNTFALGLDDPGTILWQDKPKQNPAARAVACCDLVNRGLAYWPGDGKTPALILK--TQLDGNVAALNAET 140 (596)
T ss_dssp TEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCSSCSCCCCCEEECCCSSSCCEEEE--ECTTSEEEEEETTT
T ss_pred CEEEEeeCCCCcEEEEeCCCCCCEEEEecCCCCcccccccccccccceeEEecCCCCCceEEEE--EeCCCCeEeecccc
Confidence 44445565 699999996 78999999987766533322211 11111333 23467777777777
Q ss_pred Ccee-eec---cCHHHHHHhCceeecCCeeeeece------eeeEEEEecccccEEec
Q 004442 113 GKMK-KLS---SSAEEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 113 ~~~~-~~~---~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 160 (753)
|++. ++. ......+-.+|.|-++- |++|.- +-.+.+.|++||+++=.
T Consensus 141 G~~~w~~~~~d~~~~~~~t~~P~v~~~~-vivg~~~~e~~~~G~v~A~Da~TG~~~W~ 197 (596)
T d1w6sa_ 141 GETVWKVENSDIKVGSTLTIAPYVVKDK-VIIGSSGAELGVRGYLTAYDVKTGEQVWR 197 (596)
T ss_dssp CCEEEEEECCCGGGTCBCCSCCEEETTE-EEECCBCGGGTCCCEEEEEETTTCCEEEE
T ss_pred CceeccccccccccccccccCCcEECCe-EEEeeccccccccCceEEEECCCCcEEEE
Confidence 8776 332 23334566788888776 999864 36799999999999965
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=90.42 E-value=0.16 Score=46.86 Aligned_cols=43 Identities=2% Similarity=-0.158 Sum_probs=20.2
Q ss_pred ccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCC
Q 004442 265 ESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQ 307 (753)
Q Consensus 265 ~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~ 307 (753)
+.+.+.+|++++-.+ .+.++ .|+.|+|++|++++-.|..|..+
T Consensus 81 ~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l 125 (192)
T d1w8aa_ 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125 (192)
T ss_dssp CEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTC
T ss_pred ceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCC
Confidence 444455555553332 24444 45555555555555444444333
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.94 E-value=0.18 Score=49.01 Aligned_cols=53 Identities=15% Similarity=-0.048 Sum_probs=40.3
Q ss_pred ccccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCCCc-----CCCCC
Q 004442 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSLL-----GPVDR 316 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~l~-----G~~~~ 316 (753)
.++.+.+.+|++++-.+ .+..+ .|+.|||++|+++ .||..+.+...|. ||.|.
T Consensus 149 ~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp TCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 45777888999998765 36777 7999999999999 8988776555544 66665
|
| >d1pbyb_ b.69.2.2 (B:) Quinohemoprotein amine dehydrogenase B chain {Paracoccus denitrificans [TaxId: 266]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: YVTN repeat-like/Quinoprotein amine dehydrogenase family: Quinohemoprotein amine dehydrogenase B chain domain: Quinohemoprotein amine dehydrogenase B chain species: Paracoccus denitrificans [TaxId: 266]
Probab=89.86 E-value=0.63 Score=44.50 Aligned_cols=110 Identities=18% Similarity=0.143 Sum_probs=69.5
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecC----CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGT----GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSA 122 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 122 (753)
+|.+++++.||+|+++|..+++..+++.. +.|. +.... .|-...|..+..+..|++-+-..|++. ++....
T Consensus 1 ~~~~vt~~~d~~v~v~D~~s~~~~~~i~~~~~~~~~~-~i~~s---pDg~~l~v~~~~~~~v~v~D~~t~~~~~~~~~~~ 76 (337)
T d1pbyb_ 1 RDYILAPARPDKLVVIDTEKMAVDKVITIADAGPTPM-VPMVA---PGGRIAYATVNKSESLVKIDLVTGETLGRIDLST 76 (337)
T ss_dssp CEEEEEEETTTEEEEEETTTTEEEEEEECTTCTTCCC-CEEEC---TTSSEEEEEETTTTEEEEEETTTCCEEEEEECCB
T ss_pred CeEEEEEcCCCEEEEEECCCCeEEEEEECCCCCCCcc-EEEEC---CCCCEEEEEECCCCeEEEEECCCCcEEEEEecCC
Confidence 46789999999999999999999999853 3344 32222 233334566666777777777777776 444332
Q ss_pred HHHHHhCc---eeecCCe-eeeece------------eeeEEEEecccccEEecc
Q 004442 123 EEYIRRMP---YISKDGG-VTLGAM------------KTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 123 ~~~~~~~~---~~~~~~~-~~~~~~------------~~~~~~~~~~~~~~~~~~ 161 (753)
++.....| .++.||. +..+.. ...+...|..+|++++..
T Consensus 77 ~~~~~~~~~~v~~s~dg~~l~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 131 (337)
T d1pbyb_ 77 PEERVKSLFGAALSPDGKTLAIYESPVRLELTHFEVQPTRVALYDAETLSRRKAF 131 (337)
T ss_dssp TTEEEECTTCEEECTTSSEEEEEEEEEEECSSCEEECCCEEEEEETTTTEEEEEE
T ss_pred CcccccceeeEEEcCCCcEEEEeecCCcceeeeccccccceeeccccCCeEEEec
Confidence 22111111 2455553 333332 346777899999998883
|
| >d1nexb2 b.69.4.1 (B:370-744) Cdc4 propeller domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Cdc4 propeller domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=88.57 E-value=0.73 Score=44.01 Aligned_cols=108 Identities=10% Similarity=0.059 Sum_probs=61.7
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYI 126 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (753)
.+..+.++.||+|.+||..+++.+..|.. ..|+.+---.+ ++ +.+.++.|..+++-....++............
T Consensus 23 ~~~l~tgs~Dg~i~vWd~~~~~~~~~l~~H~~~V~~l~~s~--~~---~l~s~s~D~~i~iw~~~~~~~~~~~~~~~~~~ 97 (355)
T d1nexb2 23 DNYVITGADDKMIRVYDSINKKFLLQLSGHDGGVWALKYAH--GG---ILVSGSTDRTVRVWDIKKGCCTHVFEGHNSTV 97 (355)
T ss_dssp TTEEEEEETTTEEEEEETTTTEEEEEEECCSSCEEEEEEET--TT---EEEEEETTCCEEEEETTTTEEEEEECCCSSCE
T ss_pred CCEEEEEeCCCeEEEEECCCCcEEEEEECCCCCEEEEEEcC--CC---EEEEEecccccccccccccccccccccccccc
Confidence 45678889999999999999999999974 45664433222 22 46677888888776666665543221111111
Q ss_pred -HhCceeecCC-eeeeeceeeeEEEEecccccEEec
Q 004442 127 -RRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 127 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 160 (753)
......+.++ .+..|+...++..-|..++..+..
T Consensus 98 ~~~~~~~~~~~~~~~~~~~d~~i~iw~~~~~~~~~~ 133 (355)
T d1nexb2 98 RCLDIVEYKNIKYIVTGSRDNTLHVWKLPKESSVPD 133 (355)
T ss_dssp EEEEEEEETTEEEEEEEETTSEEEEEECCC------
T ss_pred cccccccccccceeeeecCCCcEEEEEccCCceecc
Confidence 1111122333 345566666677777777766555
|
| >d1w6sa_ b.70.1.1 (A:) Methanol dehydrogenase, heavy chain {Methylobacterium extorquens [TaxId: 408]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylobacterium extorquens [TaxId: 408]
Probab=87.90 E-value=0.33 Score=53.29 Aligned_cols=63 Identities=13% Similarity=0.187 Sum_probs=52.1
Q ss_pred CceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhCceeecCC
Q 004442 57 DGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDG 136 (753)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (753)
-|+|..+|..+|++.|+...+.|.++ .|+++..|
T Consensus 452 ~G~l~A~D~~TG~~~W~~~~~~~~~g----------------------------------------------g~lsTagg 485 (596)
T d1w6sa_ 452 LGQIKAYNAITGDYKWEKMERFAVWG----------------------------------------------GTMATAGD 485 (596)
T ss_dssp CEEEEEECTTTCCEEEEEEESSCCCS----------------------------------------------BCEEETTT
T ss_pred cceEEEEeCCCCceecccCCCCCCcc----------------------------------------------ceeEecCC
Confidence 38999999999999999876665521 35677788
Q ss_pred eeeeeceeeeEEEEecccccEEecccCCC
Q 004442 137 GVTLGAMKTSVFLVDVKSGRVVDNYVLDF 165 (753)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (753)
.|..|+..-.+.++||+||+++-.++...
T Consensus 486 lVF~G~~Dg~l~A~Da~TGe~LW~~~~~~ 514 (596)
T d1w6sa_ 486 LVFYGTLDGYLKARDSDTGDLLWKFKIPS 514 (596)
T ss_dssp EEEEECTTSEEEEEETTTCCEEEEEECSS
T ss_pred EEEEECCCCeEEEEECCCCcEeeEEECCC
Confidence 88889999999999999999999976643
|
| >d1gxra_ b.69.4.1 (A:) Groucho/tle1, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Groucho/tle1, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.04 E-value=1.4 Score=43.00 Aligned_cols=105 Identities=13% Similarity=-0.008 Sum_probs=65.7
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecCCCCcccc-------cccCCCCCCceeeeccCCCceeeeeccccCceeee
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSS-------YQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKL 118 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (753)
+.....++++.||+|+++|..+++....+....++.+. +.+.+..|..++..|. +..+++..-.+.+.|..+
T Consensus 193 ~~~~~~~~~~~d~~v~i~d~~~~~~~~~~~~~~~i~~l~~~~~~~~l~~~~~d~~i~i~d~-~~~~~~~~~~~~~~i~~v 271 (337)
T d1gxra_ 193 NDGTKLWTGGLDNTVRSWDLREGRQLQQHDFTSQIFSLGYCPTGEWLAVGMESSNVEVLHV-NKPDKYQLHLHESCVLSL 271 (337)
T ss_dssp TTSSEEEEEETTSEEEEEETTTTEEEEEEECSSCEEEEEECTTSSEEEEEETTSCEEEEET-TSSCEEEECCCSSCEEEE
T ss_pred ccccccccccccccccccccccceeecccccccceEEEEEcccccccceeccccccccccc-cccccccccccccccceE
Confidence 34457788999999999999999999999888887543 2222222222222221 122233333444455555
Q ss_pred ccCHHHHHHhCceeecCC-eeeeeceeeeEEEEecccccEEecccC
Q 004442 119 SSSAEEYIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 119 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
.| +.|| .+..|+..-++..-|.++|+.+....+
T Consensus 272 ~~------------s~~g~~l~s~s~Dg~i~iwd~~~~~~~~~~~~ 305 (337)
T d1gxra_ 272 KF------------AYCGKWFVSTGKDNLLNAWRTPYGASIFQSKE 305 (337)
T ss_dssp EE------------CTTSSEEEEEETTSEEEEEETTTCCEEEEEEC
T ss_pred EE------------CCCCCEEEEEeCCCeEEEEECCCCCEEEEccC
Confidence 43 3455 355577767788889999999988654
|
| >d1hzua2 b.70.2.1 (A:118-543) C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase family: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase domain: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=86.48 E-value=0.76 Score=47.05 Aligned_cols=109 Identities=14% Similarity=0.102 Sum_probs=65.1
Q ss_pred CCeeEEEe-cCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceee---ecc-CH
Q 004442 48 PDVALVAA-LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKK---LSS-SA 122 (753)
Q Consensus 48 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~ 122 (753)
+++.+|+. .||+|.+||..+++.+..|..|.-.++ -.+..|-...|.- +.|..+.+=+-..++... +.. .-
T Consensus 31 ~~~~~V~~~~dg~v~vwD~~t~~~~~~l~~g~~~~~---vafSPDGk~l~~~-~~d~~v~vwd~~t~~~~~~~~i~~~~~ 106 (426)
T d1hzua2 31 PNLFSVTLRDAGQIALVDGDSKKIVKVIDTGYAVHI---SRMSASGRYLLVI-GRDARIDMIDLWAKEPTKVAEIKIGIE 106 (426)
T ss_dssp GGEEEEEETTTTEEEEEETTTCSEEEEEECCSSEEE---EEECTTSCEEEEE-ETTSEEEEEETTSSSCEEEEEEECCSE
T ss_pred CeEEEEEEcCCCEEEEEECCCCcEEEEEeCCCCeeE---EEECCCCCEEEEE-eCCCCEEEEEccCCceeEEEEEeCCCC
Confidence 55666655 579999999999999999998854332 2222233323332 334444443333333221 110 01
Q ss_pred HHHHHhCceeecCCe-eeee-ceeeeEEEEecccccEEec
Q 004442 123 EEYIRRMPYISKDGG-VTLG-AMKTSVFLVDVKSGRVVDN 160 (753)
Q Consensus 123 ~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 160 (753)
.+-+..+|..|.||. +..+ +...++-..|+.+|+++..
T Consensus 107 ~~~~~~s~~~spDG~~l~v~~~~~~~v~i~d~~~~~~~~~ 146 (426)
T d1hzua2 107 ARSVESSKFKGYEDRYTIAGAYWPPQFAIMDGETLEPKQI 146 (426)
T ss_dssp EEEEEECCSTTCTTTEEEEEEEESSEEEEEETTTCCEEEE
T ss_pred CcceEEeeeecCCCCEEEEeecCCCeEEEEcCCccceeEE
Confidence 122344778888995 3444 4566777889999999877
|
| >d1tbga_ b.69.4.1 (A:) beta1-subunit of the signal-transducing G protein heterotrimer {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: beta1-subunit of the signal-transducing G protein heterotrimer species: Cow (Bos taurus) [TaxId: 9913]
Probab=86.34 E-value=1.3 Score=42.14 Aligned_cols=114 Identities=17% Similarity=0.049 Sum_probs=65.8
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHH
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAE 123 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 123 (753)
+...+.+.+..||+|+++|..+++..++|.. ..++.+--.. ++.+ +.+.+..|..+++-+-+.++.. .+.....
T Consensus 194 ~~~~~~~~~~~d~~v~i~d~~~~~~~~~~~~h~~~i~~v~~~-p~~~---~l~s~s~d~~i~~~~~~~~~~~~~~~~~~~ 269 (340)
T d1tbga_ 194 PDTRLFVSGACDASAKLWDVREGMCRQTFTGHESDINAICFF-PNGN---AFATGSDDATCRLFDLRADQELMTYSHDNI 269 (340)
T ss_dssp TTSSEEEEEETTTEEEEEETTTTEEEEEECCCSSCEEEEEEC-TTSS---EEEEEETTSCEEEEETTTTEEEEEECCTTC
T ss_pred cccceeEEeecCceEEEEECCCCcEEEEEeCCCCCeEEEEEC-CCCC---EEEEEeCCCeEEEEeecccccccccccccc
Confidence 4567778899999999999999999999874 3444332111 1111 2344555555555444333322 2211100
Q ss_pred HHHHhCceeecCC-eeeeeceeeeEEEEecccccEEec-ccC
Q 004442 124 EYIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDN-YVL 163 (753)
Q Consensus 124 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 163 (753)
..--..=.++.|| .|..|+..-++...|..+|+.+.+ ..|
T Consensus 270 ~~~i~~~~~s~~~~~l~~g~~dg~i~iwd~~~~~~~~~~~~H 311 (340)
T d1tbga_ 270 ICGITSVSFSKSGRLLLAGYDDFNCNVWDALKADRAGVLAGH 311 (340)
T ss_dssp CSCEEEEEECSSSCEEEEEETTSCEEEEETTTCCEEEEECCC
T ss_pred cCceEEEEECCCCCEEEEEECCCEEEEEECCCCcEEEEEcCC
Confidence 0000001134455 466788888888899999999988 434
|
| >d1kb0a2 b.70.1.1 (A:1-573) Quinoprotein alcohol dehydrogenase, N-terminal domain {Comamonas testosteroni [TaxId: 285]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Comamonas testosteroni [TaxId: 285]
Probab=85.68 E-value=0.53 Score=51.17 Aligned_cols=66 Identities=14% Similarity=0.067 Sum_probs=53.3
Q ss_pred cCceEEEEeccCCeeeEEecCCCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHHHhCceeecC
Q 004442 56 LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKD 135 (753)
Q Consensus 56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (753)
.-|+|..+|..+|+++|++-.+.|..+ .++++..
T Consensus 455 ~~G~l~AiD~~tGk~~W~~~~~~p~~g----------------------------------------------g~lstag 488 (573)
T d1kb0a2 455 PFGRLLAWDPVAQKAAWSVEHVSPWNG----------------------------------------------GTLTTAG 488 (573)
T ss_dssp CEEEEEEEETTTTEEEEEEEESSSCCC----------------------------------------------CEEEETT
T ss_pred CcccEEEeCCCCCceEeeecCCCCCCC----------------------------------------------ceEEEcC
Confidence 348999999999999999987766421 2356677
Q ss_pred CeeeeeceeeeEEEEecccccEEecccCCCCC
Q 004442 136 GGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167 (753)
Q Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (753)
|.|..|...-.+.++||+||+++-.++...+.
T Consensus 489 glVF~G~~dg~l~A~Da~TGe~LW~~~~~~~~ 520 (573)
T d1kb0a2 489 NVVFQGTADGRLVAYHAATGEKLWEAPTGTGV 520 (573)
T ss_dssp TEEEEECTTSEEEEEETTTCCEEEEEECSSCC
T ss_pred CEEEEECCCCeEEEEECCCCcEeEEEECCCCc
Confidence 88888998889999999999999998775443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=84.55 E-value=0.31 Score=49.05 Aligned_cols=38 Identities=5% Similarity=0.088 Sum_probs=23.1
Q ss_pred ccccccccCCccccccccccCC-CcccceeecCccccccC
Q 004442 263 DVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 301 (753)
Q Consensus 263 ~~~~~l~~nN~ftGsIp~l~~l-~L~~LnlsnN~fsG~IP 301 (753)
.|+.+.+.+|++++ |+.+.++ .|+.|++++|++++-+|
T Consensus 330 ~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 330 KLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp TCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh
Confidence 34666666666664 5555555 46666666666666554
|
| >d1nr0a1 b.69.4.1 (A:2-312) Actin interacting protein 1 {Nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Actin interacting protein 1 species: Nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=82.32 E-value=2.7 Score=40.67 Aligned_cols=111 Identities=13% Similarity=0.134 Sum_probs=63.0
Q ss_pred CCCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCcee-eeccCHHH
Q 004442 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEE 124 (753)
Q Consensus 47 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 124 (753)
.+.+.+.+..||+|.++|-.+++....+.. ..|+.+-...| +.+ +.+.+..|..+++-+...++.. .+.-....
T Consensus 158 ~~~~l~sgs~d~~i~i~d~~~~~~~~~~~~~~~~i~~v~~~p-~~~---~l~~~~~d~~v~~~d~~~~~~~~~~~~~~~~ 233 (311)
T d1nr0a1 158 RPFRIISGSDDNTVAIFEGPPFKFKSTFGEHTKFVHSVRYNP-DGS---LFASTGGDGTIVLYNGVDGTKTGVFEDDSLK 233 (311)
T ss_dssp SSCEEEEEETTSCEEEEETTTBEEEEEECCCSSCEEEEEECT-TSS---EEEEEETTSCEEEEETTTCCEEEECBCTTSS
T ss_pred ceeeecccccccccccccccccccccccccccccccccccCc-ccc---ccccccccccccccccccccccccccccccc
Confidence 334455577999999999999999988876 45664433322 222 2445556666655444433322 22211000
Q ss_pred HHH-----hCceeecCC-eeeeeceeeeEEEEecccccEEecc
Q 004442 125 YIR-----RMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 125 ~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
... ..=.++.|| .+..|+..-++..-|..||+++++.
T Consensus 234 ~~~h~~~V~~~~~s~~~~~l~tgs~Dg~v~iwd~~t~~~~~~l 276 (311)
T d1nr0a1 234 NVAHSGSVFGLTWSPDGTKIASASADKTIKIWNVATLKVEKTI 276 (311)
T ss_dssp SCSSSSCEEEEEECTTSSEEEEEETTSEEEEEETTTTEEEEEE
T ss_pred cccccccccccccCCCCCEEEEEeCCCeEEEEECCCCcEEEEE
Confidence 000 000123333 3555777667888899999999874
|
| >d1kv9a2 b.70.1.1 (A:1-560) Quinoprotein alcohol dehydrogenase, N-terminal domain {Pseudomonas putida, hk5 [TaxId: 303]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Pseudomonas putida, hk5 [TaxId: 303]
Probab=81.88 E-value=0.45 Score=51.66 Aligned_cols=36 Identities=17% Similarity=0.382 Sum_probs=31.4
Q ss_pred CCCCeeEEEecCceEEEEeccCCeeeEEecCCCCcc
Q 004442 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIY 81 (753)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (753)
+..++..+++.||+++++|..||+.+|+|.++.++.
T Consensus 467 TagglVF~G~~dg~l~A~Da~tGe~LW~~~l~~~~~ 502 (560)
T d1kv9a2 467 TAGNLVFQGTAAGQMHAYSADKGEALWQFEAQSGIV 502 (560)
T ss_dssp ETTTEEEEECTTSEEEEEETTTCCEEEEEECSSCCC
T ss_pred ECCCEEEEECCCCcEEEEECCCCcEeEEEECCCCcc
Confidence 346777778999999999999999999999988773
|
| >d1gxra_ b.69.4.1 (A:) Groucho/tle1, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Groucho/tle1, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.76 E-value=1.4 Score=42.99 Aligned_cols=111 Identities=14% Similarity=0.148 Sum_probs=63.0
Q ss_pred CCeeEEEecCceEEEEecc--CCeeeEEecCCC-CcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHH
Q 004442 48 PDVALVAALDGTIHLVDTK--LGKIRWSFGTGR-PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEE 124 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (753)
.+..++++.||+|.++|.. +++....+.... ++..... +.| ..+.+.+.+|..+++.+-+.+++........+
T Consensus 109 g~~l~s~~~dg~i~iwd~~~~~~~~~~~~~~~~~~v~~~~~---~~~-~~~l~s~~~d~~i~~~~~~~~~~~~~~~~~~~ 184 (337)
T d1gxra_ 109 GCTLIVGGEASTLSIWDLAAPTPRIKAELTSSAPACYALAI---SPD-SKVCFSCCSDGNIAVWDLHNQTLVRQFQGHTD 184 (337)
T ss_dssp SSEEEEEESSSEEEEEECCCC--EEEEEEECSSSCEEEEEE---CTT-SSEEEEEETTSCEEEEETTTTEEEEEECCCSS
T ss_pred CCEEEEeeccccccccccccccccccccccccccccccccc---ccc-cccccccccccccccccccccccccccccccc
Confidence 4566778899999999964 455556654433 3322111 111 12334556666666666555555433221111
Q ss_pred HHHhCceeecCC-eeeeeceeeeEEEEecccccEEecccC
Q 004442 125 YIRRMPYISKDG-GVTLGAMKTSVFLVDVKSGRVVDNYVL 163 (753)
Q Consensus 125 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (753)
-+. .-.++.+| .+..|+...++...|.++|+.++..++
T Consensus 185 ~v~-~l~~s~~~~~~~~~~~d~~v~i~d~~~~~~~~~~~~ 223 (337)
T d1gxra_ 185 GAS-CIDISNDGTKLWTGGLDNTVRSWDLREGRQLQQHDF 223 (337)
T ss_dssp CEE-EEEECTTSSEEEEEETTSEEEEEETTTTEEEEEEEC
T ss_pred ccc-cccccccccccccccccccccccccccceeeccccc
Confidence 111 01233444 577788888899999999999988655
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.44 E-value=0.3 Score=47.64 Aligned_cols=45 Identities=13% Similarity=0.008 Sum_probs=20.9
Q ss_pred ccccccCCccccccc-cccCC-CcccceeecCccccccCCCCCCCCC
Q 004442 265 ESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNS 309 (753)
Q Consensus 265 ~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~IP~~l~s~n~ 309 (753)
+.+.+.+|+|++-.+ .+.++ .|+.|++++|++++.+|..+..+.+
T Consensus 156 ~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~ 202 (284)
T d1ozna_ 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (284)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred hhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhh
Confidence 344444555544332 23444 4555555555555555544444333
|
| >d1vyhc1 b.69.4.1 (C:92-408) Platelet-activating factor acetylhydrolase IB subunit alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Platelet-activating factor acetylhydrolase IB subunit alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=81.13 E-value=1.1 Score=41.86 Aligned_cols=109 Identities=11% Similarity=0.124 Sum_probs=53.3
Q ss_pred CCeeEEEecCceEEEEeccCCeeeEEecC-CCCcccccccCCCCCCceeeeccCCCceeeeeccccCceeeeccCHHHHH
Q 004442 48 PDVALVAALDGTIHLVDTKLGKIRWSFGT-GRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYI 126 (753)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 126 (753)
.+.++.|+.||+|.++|..+++....|.. ..++.+.-..+ +. .+...+..+..+++......+....-......+
T Consensus 29 ~~~l~s~s~Dg~i~iWd~~~~~~~~~~~~h~~~V~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 104 (317)
T d1vyhc1 29 FSVMVSASEDATIKVWDYETGDFERTLKGHTDSVQDISFDH---SG-KLLASCSADMTIKLWDFQGFECIRTMHGHDHNV 104 (317)
T ss_dssp SSEEEEEESSSCEEEEETTTCCCCEEECCCSSCEEEEEECT---TS-SEEEEEETTSCCCEEETTSSCEEECCCCCSSCE
T ss_pred CCEEEEEeCCCeEEEEECCCCCEEEEEeCCCCcEEEEeeec---cc-ccccccccccccccccccccccccccccccccc
Confidence 35677888999999999999988888863 23332211111 10 011112222222222222222221110101111
Q ss_pred HhCceeec-CCeeeeeceeeeEEEEecccccEEecc
Q 004442 127 RRMPYISK-DGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (753)
Q Consensus 127 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (753)
..-.++. +..+..++...++...|.++|+.++..
T Consensus 105 -~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 139 (317)
T d1vyhc1 105 -SSVSIMPNGDHIVSASRDKTIKMWEVQTGYCVKTF 139 (317)
T ss_dssp -EEEEECSSSSEEEEEETTSEEEEEETTTCCEEEEE
T ss_pred -eeeeccCCCceEEeeccCcceeEeecccceeeeEE
Confidence 1111222 333556666677778899999888773
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=80.30 E-value=0.32 Score=41.67 Aligned_cols=52 Identities=10% Similarity=-0.059 Sum_probs=35.6
Q ss_pred CCCcccccCCCCccccccccccccccCCccccccc-cccCC-CcccceeecCccccc
Q 004442 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGW 299 (753)
Q Consensus 245 ~~~~~~~~~~~l~~~~~~~~~~~l~~nN~ftGsIp-~l~~l-~L~~LnlsnN~fsG~ 299 (753)
+++|.+..-..++.. ..++.+.+.+|+++ +|| .+..+ .|+.|++++|++++.
T Consensus 5 Ls~n~l~~l~~l~~l--~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l 58 (124)
T d1dcea3 5 LAHKDLTVLCHLEQL--LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV 58 (124)
T ss_dssp CTTSCCSSCCCGGGG--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred cCCCCCCCCcccccC--CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc
Confidence 456666655545433 24577788888887 465 46667 688889999888863
|